PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bhan, U; Podsiad, AB; Kovach, MA; Ballinger, MN; Keshamouni, V; Standiford, TJ				Bhan, Urvashi; Podsiad, Amy B.; Kovach, Melissa A.; Ballinger, Megan N.; Keshamouni, Venkateshwar; Standiford, Theodore J.			Linezolid Has Unique Immunomodulatory Effects in Post-Influenza Community Acquired MRSA Pneumonia	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; TUMOR-NECROSIS-FACTOR; 2 DOUBLE-BLIND; BACTERIAL PNEUMONIA; CYTOKINE PRODUCTION; BINDING PROTEINS; EPITHELIAL-CELLS; VIRUS; INFECTION	Introduction Post influenza pneumonia is a leading cause of mortality and morbidity, with mortality rates approaching 60% when bacterial infections are secondary to multi-drug resistant (MDR) pathogens. Staphylococcus aureus, in particular community acquired MRSA (cMRSA), has emerged as a leading cause of post influenza pneumonia. Hypothesis Linezolid (LZD) prevents acute lung injury in murine model of post influenza bacterial pneumonia Methods Mice were infected with HINI strain of influenza and then challenged with cMRSA at day 7, treated with antibiotics (LZD or Vanco) or vehicle 6 hours post bacterial challenge and lungs and bronchoalveolar lavage fluid (BAL) harvested at 24 hours for bacterial clearance, inflammatory cell influx, cytokine/chemokine analysis and assessment of lung injury. Results Mice treated with LZD or Vanco had lower bacterial burden in the lung and no systemic dissemination, as compared to the control (no antibiotic) group at 24 hours post bacterial challenge. As compared to animals receiving Vanco, LZD group had significantly lower numbers of neutrophils in the BAL (9x10(3) vs. 2.3x10(4), p < 0.01), which was associated with reduced levels of chemotactic chemokines and inflammatory cytokines KC, MIP-2, IFN-gamma, TNF-alpha and IL-1 beta in the BAL. Interestingly, LZD treatment also protected mice from lung injury, as assessed by albumin concentration in the BAL post treatment with H1N1 and cMRSA when compared to vanco treatment. Moreover, treatment with LZD was associated with significantly lower levels of PVL toxin in lungs. Conclusion Linezolid has unique immunomodulatory effects on host inflammatory response and lung injury in a murine model of post-viral cMRSA pneumonia.	[Bhan, Urvashi; Podsiad, Amy B.; Kovach, Melissa A.; Keshamouni, Venkateshwar; Standiford, Theodore J.] Univ Michigan, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Ballinger, Megan N.] Ohio State Univ, Dept Med, Div Pulm & Crit Care Med, Columbus, OH 43210 USA	University of Michigan System; University of Michigan; University System of Ohio; Ohio State University	Bhan, U (corresponding author), Univ Michigan, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.	ubhan@umich.edu		Keshamouni, Venkateshwar/0000-0003-1947-791X; Ballinger, Megan/0000-0002-2202-3049	Pfizer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123515, R01HL097564, R01HL119682, K08HL121089] Funding Source: NIH RePORTER	Pfizer(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by a grant through Pfizer but this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; ABRAMSON JS, 1982, J CLIN INVEST, V69, P1393, DOI 10.1172/JCI110580; ABRAMSON JS, 1982, INFECT IMMUN, V36, P289, DOI 10.1128/IAI.36.1.289-296.1982; Araujo FG, 2002, ANTIMICROB AGENTS CH, V46, P3327, DOI 10.1128/AAC.46.10.3327-3330.2002; Bhan U, 2008, INFECT IMMUN, V76, P2895, DOI 10.1128/IAI.01489-07; Bhan U, 2007, J IMMUNOL, V179, P3937, DOI 10.4049/jimmunol.179.6.3937; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Breslow-Deckman JM, 2013, J IMMUNOL, V191, P1792, DOI 10.4049/jimmunol.1300180; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chavanet P, 2013, MED MALADIES INFECT, V43, P451, DOI 10.1016/j.medmal.2013.09.011; COLIN DA, 1994, INFECT IMMUN, V62, P3184, DOI 10.1128/IAI.62.8.3184-3188.1994; Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P1475, DOI 10.1128/AAC.46.5.1475-1480.2002; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; DAVISON VE, 1981, INFECT IMMUN, V32, P118, DOI 10.1128/IAI.32.1.118-126.1981; Dumitrescu O, 2007, ANTIMICROB AGENTS CH, V51, P1515, DOI 10.1128/AAC.01201-06; Estes KS, 2010, EUR J MED RES, V15, P533, DOI 10.1186/2047-783X-15-12-533; Finelli L, 2008, PEDIATRICS, V122, P805, DOI 10.1542/peds.2008-1336; Garcia-Roca P, 2006, ARCH MED RES, V37, P31, DOI 10.1016/j.arcmed.2005.05.022; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; HENSLER T, 1994, INFECT IMMUN, V62, P5281, DOI 10.1128/IAI.62.12.5281-5289.1994; HENSLER T, 1994, INFECT IMMUN, V62, P2529, DOI 10.1128/IAI.62.6.2529-2535.1994; Holzinger D, 2012, J LEUKOCYTE BIOL, V92, P1069, DOI 10.1189/jlb.0112014; Honeybourne D, 2003, J ANTIMICROB CHEMOTH, V51, P1431, DOI 10.1093/jac/dkg262; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Keel RA, 2012, ANTIMICROB AGENTS CH, V56, P3420, DOI 10.1128/AAC.06121-11; Khan AA, 1999, INT J ANTIMICROB AG, V11, P121, DOI 10.1016/S0924-8579(98)00091-0; KLEIN B, 1995, IMMUNOL TODAY, V16, P216, DOI 10.1016/0167-5699(95)80161-8; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kollef MH, 2004, INTENS CARE MED, V30, P388, DOI 10.1007/s00134-003-2088-1; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; Liu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057483; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Mandell LA, 2012, CLIN INFECT DIS, V54, P1134, DOI 10.1093/cid/cis045; Manzer R, 2008, AM J RESP CELL MOL, V38, P318, DOI 10.1165/rcmb.2007-0250OC; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; MARTIN CM, 1959, ARCH INTERN MED, V103, P532, DOI 10.1001/archinte.1959.00270040018002; MATTHAY MA, 1984, J CLIN IMMUNOL, V4, P479, DOI 10.1007/BF00916578; McNamee LA, 2006, INFECT IMMUN, V74, P6707, DOI 10.1128/IAI.00789-06; Melles DC, 2006, EMERG INFECT DIS, V12, P1174, DOI 10.3201/eid1207.050865; MEUNIER O, 1995, CYTOMETRY, V21, P241, DOI 10.1002/cyto.990210304; Morikawa K, 1996, ANTIMICROB AGENTS CH, V40, P1366, DOI 10.1128/AAC.40.6.1366; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Murray RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008705; NICKERSON CL, 1990, INFECT IMMUN, V58, P2809, DOI 10.1128/IAI.58.9.2809-2814.1990; Niemann S, 2012, J INFECT DIS, V206, P1138, DOI 10.1093/infdis/jis468; PARSONS PE, 1985, AM REV RESPIR DIS, V132, P490; Patel BV, 2013, J IMMUNOL, V190, P4274, DOI 10.4049/jimmunol.1202437; Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365; Rubinstein E, 2008, CLIN INFECT DIS, V46, pS378, DOI 10.1086/533594; SCHWARZMANN SW, 1971, ARCH INTERN MED, V127, P1037, DOI 10.1001/archinte.127.6.1037; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Sun K, 2014, J IMMUNOL, V192, P3301, DOI 10.4049/jimmunol.1303049; SUTER PM, 1992, AM REV RESPIR DIS, V145, P1016, DOI 10.1164/ajrccm/145.5.1016; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; TASHIRO M, 1987, J GEN VIROL, V68, P2039, DOI 10.1099/0022-1317-68-7-2039; TASHIRO M, 1987, NATURE, V325, P536, DOI 10.1038/325536a0; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; Wunderink RG, 2003, CHEST, V124, P1789, DOI 10.1378/chest.124.5.1789; Wunderink RG, 2013, INFECT DIS CLIN N AM, V27, P177, DOI 10.1016/j.idc.2012.11.006; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895; Yoshizawa S, 2012, ANTIMICROB AGENTS CH, V56, P1744, DOI 10.1128/AAC.05430-11	65	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0114574	10.1371/journal.pone.0114574	http://dx.doi.org/10.1371/journal.pone.0114574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635685	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700003
J	Oscherwitz, J; Cease, KB				Oscherwitz, Jon; Cease, Kemp B.			Identification and Validation of a Linear Protective Neutralizing Epitope in the beta-Pore Domain of Alpha Toxin	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SITE-DIRECTED MUTAGENESIS; HUMAN-ANTIBODY RESPONSE; T-CELL EPITOPES; MONOCLONAL-ANTIBODIES; IN-VIVO; PASSIVE-IMMUNIZATION; LETHAL TOXIN; HEMOLYSIN; VIRULENCE	The plethora of virulence factors associated with Staphylococcus aureus make this bacterium an attractive candidate for a molecularly-designed epitope-focused vaccine. This approach, which necessitates the identification of neutralizing epitopes for incorporation into a vaccine construct, is being evaluated for pathogens where conventional approaches have failed to elicit protective humoral responses, like HIV-1 and malaria, but may also hold promise for pathogens like S. aureus, where the elicitation of humoral immunity against multiple virulence factors may be required for development of an effective vaccine. Among the virulence factors employed by S. aureus, animal model and epidemiological data suggest that alpha toxin, a multimeric beta-pore forming toxin like protective antigen from Bacillus anthracis, is particularly critical, yet no candidate neutralizing epitopes have been delineated in alpha toxin to date. We have previously shown that a linear determinant in the 2 beta 2-2 beta 3 loop of the pore forming domain of B. anthracis protective antigen is a linear neutralizing epitope. Antibody against this site is highly potent for neutralizing anthrax lethal toxin in vitro and for protection of rabbits in vivo from virulent B. anthracis. We hypothesized that sequences in the beta-pore of S. aureus alpha toxin that share structural and functional homology to beta-pore sequences in protective antigen would contain a similarly critical neutralizing epitope. Using an in vivo mapping strategy employing peptide immunogens, an optimized in vitro toxin neutralization assay, and an in vivo dermonecrosis model, we have now confirmed the presence of this epitope in alpha toxin, termed the pore neutralizing determinant. Antibody specific for this determinant neutralizes alpha toxin in vitro, and is highly effective for mitigating dermonecrosis and bacterial growth in a mouse model of S. aureus USA300 skin infection. The delineation of this linear neutralizing determinant in alpha toxin could facilitate the development of an epitope-focused vaccine against S. aureus.	[Oscherwitz, Jon; Cease, Kemp B.] Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48105 USA; [Oscherwitz, Jon; Cease, Kemp B.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Oscherwitz, J (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48105 USA.	joscher@umich.edu			Department of Veterans Affairs Merit Award [I01BX000429]	Department of Veterans Affairs Merit Award(US Department of Veterans Affairs)	This work was supported by Department of Veterans Affairs Merit Award I01BX000429 (to KBC) and by resources and the use of facilities at the Veterans Administration Ann Arbor Healthcare System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Bartlett AH, 2008, J INFECT DIS, V198, P1529, DOI 10.1086/592758; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; BHAKDI S, 1984, INFECT IMMUN, V46, P318, DOI 10.1128/IAI.46.2.318-323.1984; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Brady RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063040; Brandt S, 2003, CLIN DIAGN LAB IMMUN, V10, P903, DOI 10.1128/CDLI.10.5.903-909.2003; Calvo-Calle JM, 2006, INFECT IMMUN, V74, P6929, DOI 10.1128/IAI.01151-06; CalvoCalle JM, 1997, J IMMUNOL, V159, P1362; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Correia BE, 2014, NATURE, DOI [10.1038/nature14135, DOI 10.1038/NATURE14135]; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2008, J EXP MED, V205, P271, DOI 10.1084/jem.20080167; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deresinski S, 2005, CLIN INFECT DIS, V40, P562, DOI 10.1086/427701; Dormitzer PR, 2012, NAT REV MICROBIOL, V10, P807, DOI 10.1038/nrmicro2893; Folettit D, 2013, J MOL BIOL, V425, P1641, DOI 10.1016/j.jmb.2013.02.008; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Hering D, 2004, BIOLOGICALS, V32, P17, DOI 10.1016/j.biologicals.2003.09.003; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; Karginov VA, 2007, BIOORGAN MED CHEM, V15, P5424, DOI 10.1016/j.bmc.2007.05.058; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lattar SM, 2014, INFECT IMMUN, V82, P83, DOI 10.1128/IAI.01050-13; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Little SF, 2004, VACCINE, V22, P422, DOI 10.1016/j.vaccine.2003.07.004; Malito E, 2013, P NATL ACAD SCI USA, V110, P3304, DOI 10.1073/pnas.1222845110; Menzies BE, 1996, INFECT IMMUN, V64, P1839, DOI 10.1128/IAI.64.5.1839-1841.1996; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Mocca CP, 2014, CLIN VACCINE IMMUNOL; Molne L, 2003, CLIN EXP IMMUNOL, V132, P209, DOI 10.1046/j.1365-2249.2003.02151.x; MORENO A, 1991, INT IMMUNOL, V3, P997, DOI 10.1093/intimm/3.10.997; Moyle PM, 2013, CHEMMEDCHEM, V8, P360, DOI 10.1002/cmdc.201200487; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Nygaard TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036532; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; OREILLY M, 1986, MICROB PATHOGENESIS, V1, P125, DOI 10.1016/0882-4010(86)90015-X; Oscherwitz J, 2014, MOL IMMUNOL, V60, P62, DOI 10.1016/j.molimm.2014.03.012; Oscherwitz J, 2013, CLIN VACCINE IMMUNOL, V20, P341, DOI 10.1128/CVI.00612-12; Oscherwitz J, 2010, J IMMUNOL, V185, P3661, DOI 10.4049/jimmunol.1001749; Oscherwitz J, 2009, INFECT IMMUN, V77, P5509, DOI 10.1128/IAI.00899-09; Oscherwitz J, 2009, INFECT IMMUN, V77, P3380, DOI 10.1128/IAI.00358-09; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Plaut RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059232; Plotkin SA, 2009, CLIN VACCINE IMMUNOL, V16, P1709, DOI 10.1128/CVI.00290-09; Powers ME, 2012, J INFECT DIS, V206, P352, DOI 10.1093/infdis/jis192; Prabhakara R, 2013, INFECT IMMUN, V81, P1306, DOI 10.1128/IAI.01304-12; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rauch S, 2012, INFECT IMMUN, V80, P3721, DOI 10.1128/IAI.00442-12; Reason D, 2009, INFECT IMMUN, V77, P2030, DOI 10.1128/IAI.01254-08; Reason DC, 2008, VACCINE, V26, P4041, DOI 10.1016/j.vaccine.2008.05.023; SCHMIDT MA, 1991, INFECT IMMUN, V59, P1402, DOI 10.1128/IAI.59.4.1402-1408.1991; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Spaulding A. R, 2014, J INFECT DIS; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Tkaczyk C, 2012, CLIN VACCINE IMMUNOL, V19, P377, DOI 10.1128/CVI.05589-11; Tkaczyk C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075103; Tominaga H, 1999, ANAL COMMUN, V36, P47, DOI 10.1039/a809656b; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Zuo QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081212	72	11	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116882	10.1371/journal.pone.0116882	http://dx.doi.org/10.1371/journal.pone.0116882			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635901	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700063
J	Sonego, M; Pellegrin, MC; Becker, G; Lazzerini, M				Sonego, Michela; Pellegrin, Maria Chiara; Becker, Genevieve; Lazzerini, Marzia			Risk Factors for Mortality from Acute Lower Respiratory Infections (ALRI) in Children under Five Years of Age in Low and Middle-Income Countries: A Systematic Review and Meta-Analysis of Observational Studies	PLOS ONE			English	Review							CHILDHOOD PNEUMONIA; AIR-POLLUTION; CARE-SEEKING; ILLNESS; MORBIDITY; ETIOLOGY; BURDEN; HEALTH	Objective To evaluate risk factors for death from acute lower respiratory infections (ALRI) in children in low- and middle-income countries. Design Systematic review and meta-analysis. Study selection Observational studies reporting on risk factors for death from ALRI in children below five years in low-and middle income countries. Data sources Medline, Embase, Global Health Library, Lilacs, and Web of Science to January 2014 Risk of bias assessment Quality In Prognosis Studies tool with minor adaptations to assess the risk of bias; funnel plots and Egger's test to evaluate publication bias. Results Out of 10655 papers retrieved, 77 studies from 39 countries (198359 children) met the inclusion criteria. Host and disease characteristics more strongly associated with ALRI mortality were: diagnosis of very severe pneumonia as per WHO definition (odds ratio 9.42, 95% confidence interval 6.37. 13.92); age below two months (5.22, 1.70-16.03); diagnosis of Pneumocystis Carinii (4.79, 2.67-8.61), chronic underlying diseases (4.76, 3.27-6.93); HIV/AIDS (4.68, 3.72-5.90); and severe malnutrition (OR 4.27, 3.47-5.25). Socio-economic and environmental factors significantly associated with increased odds of death from ALRI were: young maternal age (1.84, 1.03-3.31); low maternal education (1.43, 1.13-1.82); low socio-economic status (1.62, 1.32-2.00); second-hand smoke exposure (1.52, 1.20 to 1.93); indoor air pollution (3.02, 2.11-4.31). Immunisation (0.46, 0.36-0.58) and good antenatal practices (0.50, 0.31-0.81) were associated with decreased odds of death. Conclusions Host and disease characteristics as well as socio-economic and environmental determinants affect the risk of death from ALRI in children. Together with the prevention and treatment of chronic diseases, interventions to modify underlying risk factors such as poverty, lack of female education, and poor environmental conditions, should be considered among the strategies to reduce ALRI mortality in children in low-and middle-income countries.	[Sonego, Michela; Becker, Genevieve; Lazzerini, Marzia] WHO Collaborating Ctr Maternal & Child Hlth, Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Sonego, Michela; Pellegrin, Maria Chiara] Univ Trieste, I-34127 Trieste, Italy	IRCCS Burlo Garofolo; University of Trieste	Lazzerini, M (corresponding author), WHO Collaborating Ctr Maternal & Child Hlth, Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.	marzia.lazzerini@burlo.trieste.it	Becker, Genevieve Ellen/Z-1213-2019; Pellegrin, Maria Chiara/AAC-6557-2022	Becker, Genevieve Ellen/0000-0002-7200-3169; 				Alkema L, 2014, LANCET GLOB HEALTH, V2, pE521, DOI 10.1016/S2214-109X(14)70280-3; Ayieko P, 2007, PEDIATR INFECT DIS J, V26, P432, DOI 10.1097/01.inf.0000260107.79355.7d; Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203; Bruce NG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S8; Chinn S, 2002, THORAX, V57, P393, DOI 10.1136/thorax.57.5.393; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; CSDH, 2008, FINAL REPORT OF THE; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El Arifeen S, 2008, J HEALTH POPUL NUTR, V26, P22; Falagas ME, 2007, RESP MED, V101, P1845, DOI 10.1016/j.rmed.2007.04.011; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gwatkin D, 2007, SOCIO ECONOMIC DIFFE; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horta B, 2013, SHORT TERM EFFECTS O; Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110; Jones LL, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-5; Lamberti LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S18; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS140, DOI 10.1097/INF.0000000000000082; Lozano JM, 2001, INT J TUBERC LUNG D, V5, P496; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Najnin N, 2011, J HEALTH POPUL NUTR, V29, P523, DOI 10.3329/jhpn.v29i5.8907; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; STATA, 2014, STAT STAT SOFTW REL; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Szabo Shelagh M, 2013, Paediatr Respir Rev, V13 Suppl 2, pS1, DOI 10.1016/S1526-0542(12)00095-4; The World Bank, 2014, HISTORICAL CLASSIFIC; The World Bank, 2014, PREVALENCE OF HIV TO; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Willis JR, 2009, J HEALTH POPUL NUTR, V27, P62; Wonodi CB, 2012, CLIN INFECT DIS, V54, pS124, DOI 10.1093/cid/cir1067; World Health Organization, 2005, POCKET BOOK OF HOSPI; World Health Organization, 2009, WHO REPORT ON THE GL; World Health Organization, 2013, POCKET BOOK OF HOSPI; World Health Organization, 2013, ENDING PREVENTABLE C; World Health Organization, 1991, TECHNICAL BASES FOR; World Health Organization (WHO) and The United Nations Children's Fund (UNICEF), 2009, GLOBAL ACTION PLAN F	48	120	125	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116380	10.1371/journal.pone.0116380	http://dx.doi.org/10.1371/journal.pone.0116380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635911	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700033
J	Xue, F; Zhang, N; Feng, XW; Zheng, XG; Kan, JG				Xue, Fei; Zhang, Nong; Feng, Xiaowei; Zheng, Xigui; Kan, Jiaguang			Strengthening Borehole Configuration from the Retaining Roadway for Greenhouse Gas Reduction: A Case Study	PLOS ONE			English	Article							COALBED METHANE; EMISSIONS; OPTIMIZATION; STABILITY; WELL	A monitoring trial was carried out to investigate the effect of boreholes configuration on the stability and gas production rate. These boreholes were drilled from the retaining roadway at longwall mining panel 1111(1) of the Zhuji Coalmine, in China. A borehole camera exploration device and multiple gas parameter measuring device were adopted to monitor the stability and gas production rate. Research results show that boreholes 1 similar to 8 with low intensity and thin casing thickness were broken at the depth of 5 similar to 10m along the casing and with a distance of 2 similar to 14 m behind the coal face, while boreholes 9 similar to 11 with a special thick-walled high-strength oil casing did not fracture during the whole extraction period. The gas extraction volume is closely related to the boreholes stability. After the stability of boreholes 9 similar to 11 being improved, the average gas flow rate increased dramatically 16-fold from 0.13 to 2.21 m(3)/min, and the maximum gas flow rate reached 4.9 m(3)/min. Strengthening boreholes configuration is demonstrated to be a good option to improve gas extraction effect. These findings can make a significant contribution to the reduction of greenhouse gas emissions from the coal mining industry.	[Xue, Fei; Zhang, Nong; Feng, Xiaowei; Zheng, Xigui; Kan, Jiaguang] China Univ Min & Technol, Sch Mines, Key Lab Deep Coal Resource Min, Minist Educ China, Xuzhou 221116, Jiangsu, Peoples R China; [Zhang, Nong] Hunan Univ Sci & Technol, Hunan Key Lab Safe Min Tech Coal Mines, Xiangtan 411201, Peoples R China	China University of Mining & Technology; Ministry of Education, China; Hunan University of Science & Technology	Zhang, N (corresponding author), China Univ Min & Technol, Sch Mines, Key Lab Deep Coal Resource Min, Minist Educ China, Xuzhou 221116, Jiangsu, Peoples R China.	zhangnong@126.com	Feng, Xiaowei/P-8126-2019; 冯, 晓巍/E-7039-2015	冯, 晓巍/0000-0002-9348-9874; Zhang, Nong/0000-0001-6961-0729	Program for Changjiang Scholars and Innovative Research Team in University [IRT_14R55]; Fundamental Research Funds for the Central Universities [2014XT01]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was sponsored by Program for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT_14R55) and the Fundamental Research Funds for the Central Universities (Grant No. 2014XT01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibler CJ, 1998, INT J COAL GEOL, V35, P283, DOI 10.1016/S0166-5162(97)00038-4; Chen JH, 2012, INT J COAL GEOL, V90, P135, DOI 10.1016/j.coal.2011.11.007; Cheng Y., 2009, J MIN SAF ENG, V26, P127, DOI DOI 10.1016/J.TIV.2014.12.011; Feng QH, 2012, INT J COAL GEOL, V104, P34, DOI 10.1016/j.coal.2012.09.004; Flores RM, 1998, INT J COAL GEOL, V35, P3, DOI 10.1016/S0166-5162(97)00043-8; Gentzis T, 2009, INT J COAL GEOL, V78, P149, DOI 10.1016/j.coal.2008.11.001; Gentzis T, 2009, INT J COAL GEOL, V77, P328, DOI 10.1016/j.coal.2008.05.016; Huang H.Z, 2010, MIN SCI TECHNOL, V20, P230; Jellison MJ, 2000, SPE DRILL COMPLETION, V15, P241, DOI 10.2118/67608-PA; Karacan CO, 2007, INT J COAL GEOL, V72, P15, DOI 10.1016/j.coal.2006.12.007; Karacan CO, 2007, INT J COAL GEOL, V71, P225, DOI 10.1016/j.coal.2006.08.003; Karacan CO, 2011, INT J COAL GEOL, V86, P121, DOI 10.1016/j.coal.2011.02.009; Keim SA, 2011, INT J COAL GEOL, V86, P306, DOI 10.1016/j.coal.2011.03.004; Tan YL, 2012, INT J ROCK MECH MIN, V49, P113, DOI 10.1016/j.ijrmms.2011.11.015; Wang FT, 2012, INT J GREENH GAS CON, V11, P290, DOI 10.1016/j.ijggc.2012.09.006; Warmuzinski K, 2008, PROCESS SAF ENVIRON, V86, P315, DOI 10.1016/j.psep.2008.04.003; Whittles DN, 2007, INT J COAL GEOL, V71, P313, DOI 10.1016/j.coal.2006.11.004; Whittles DN, 2006, INT J ROCK MECH MIN, V43, P369, DOI 10.1016/j.ijrmms.2005.07.006; Yuan L, 2008, INT J COAL SCI TECHN, V31, P174, DOI [10.1016/j.envres.2014.08.017, DOI 10.1016/J.ENVRES.2014.08.017]; Yuan L, 2008, INT J COAL SCI TECHN, V33, P898, DOI [10.1097/BRS.0b013e31816b1f83, DOI 10.1097/BRS.0B013E31816B1F83]	20	6	6	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0115874	10.1371/journal.pone.0115874	http://dx.doi.org/10.1371/journal.pone.0115874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633368	gold, Green Published, Green Submitted			2022-12-27	WOS:000348609800004
J	Dutta-Roy, R; Rosenmund, C; Edelstein, SJ; Le Novere, N				Dutta-Roy, Ranjita; Rosenmund, Christian; Edelstein, Stuart J.; Le Novere, Nicolas			Ligand-Dependent Opening of the Multiple AMPA Receptor Conductance States: A Concerted Model	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR; ALLOSTERIC TRANSITIONS; QUANTAL TRANSMISSION; HIPPOCAMPAL-NEURONS; MARKUP LANGUAGE; PYRAMIDAL CELLS; CHANNELS; BINDING; ACTIVATION; ACETYLCHOLINE	Modulation of the properties of AMPA receptors at the post-synaptic membrane is one of the main suggested mechanisms underlying fast synaptic transmission in the central nervous system of vertebrates. Electrophysiological recordings of single channels stimulated with agonists showed that both recombinant and native AMPA receptors visit multiple conductance states in an agonist concentration dependent manner. We propose an allosteric model of the multiple conductance states based on concerted conformational transitions of the four subunits, as an iris diaphragm. Our model predicts that the thermodynamic behaviour of the conductance states upon full and partial agonist stimulations can be described with increased affinity of receptors as they progress to higher conductance states. The model also predicts the existence of AMPA receptors in non-liganded conductive substates. However, the probability of spontaneous openings decreases with increasing conductances. Finally, we predict that the large conductance states are stabilized within the rise phase of a whole-cell EPSC in glutamatergic hippocampal neurons. Our model provides a mechanistic link between ligand concentration and conductance states that can explain thermodynamic and kinetic features of AMPA receptor gating.	[Dutta-Roy, Ranjita] Karolinska Inst, Dept Med Solna, S-17176 Stockholm, Sweden; [Dutta-Roy, Ranjita; Rosenmund, Christian] Charite, NWFZ, D-10117 Berlin, Germany; [Dutta-Roy, Ranjita; Le Novere, Nicolas] EBI, EMBL, Hinxton CB10 1SD, Cambs, England; [Edelstein, Stuart J.; Le Novere, Nicolas] Babraham Inst, Babraham CB22 3AT, Cambs, England	Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Le Novere, N (corresponding author), EBI, EMBL, Wellcome Trust Genome Campus, Hinxton CB10 1SD, Cambs, England.	lenov@babraham.ac.uk	Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444	BBSRC [BBS/E/B/000C0419] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0419] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; Diamond JS, 1997, J NEUROSCI, V17, P4672; Edelstein SJ, 1997, BIOCHEMISTRY-US, V36, P13755, DOI 10.1021/bi9718301; Edelstein SJ, 1996, BIOL CYBERN, V75, P361, DOI 10.1007/s004220050302; Gebhardt C, 2006, J PHYSIOL-LONDON, V573, P371, DOI 10.1113/jphysiol.2005.102723; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; JACKSON MB, 1984, P NATL ACAD SCI-BIOL, V81, P3901, DOI 10.1073/pnas.81.12.3901; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Lu M, 2010, NEUROSCI RES, V66, P92, DOI 10.1016/j.neures.2009.09.1713; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Prince RJ, 1999, J BIOL CHEM, V274, P19623, DOI 10.1074/jbc.274.28.19623; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Ruiz M, 1999, J GEN PHYSIOL, V113, P873, DOI 10.1085/jgp.113.6.873; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Smith TC, 2000, J NEUROSCI, V20, P2073; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stern-Bach Y, 2004, NEURON, V41, P309, DOI 10.1016/S0896-6273(04)00040-6; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Tigerholm J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044388; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turecek R, 1997, EUR J NEUROSCI, V9, P1999, DOI 10.1111/j.1460-9568.1997.tb01368.x; Waltemath D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-198; Wang QJ, 1997, ENVIRON MODELL SOFTW, V12, P27, DOI 10.1016/S1364-8152(96)00030-8	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116616	10.1371/journal.pone.0116616	http://dx.doi.org/10.1371/journal.pone.0116616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629405	Green Submitted, Green Published, gold			2022-12-27	WOS:000348732100043
J	Nelson, N; Xiang, SY; Zhang, XH; Gilvary, D; Djeu, J; Husain, K; Malafa, M; Vohra, N; Pilon-Thomas, S; Ghansah, T				Nelson, Nadine; Xiang, Shengyan; Zhang, Xiaohong; Gilvary, Danielle; Djeu, Julie; Husain, Kazim; Malafa, Mokenge; Vohra, Nasreen; Pilon-Thomas, Shari; Ghansah, Tomar			Murine Pancreatic Adenocarcinoma Reduces Ikaros Expression and Disrupts T Cell Homeostasis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR IKAROS; IL2 GENE-EXPRESSION; HELIOS; DIFFERENTIATION; IMMUNOTHERAPY; LENALIDOMIDE; INDUCTION; ISOFORMS; CANCER	Background Maintenance of T cell immune homeostasis is critical for adequate anti-tumor immunity. The transcription factor Ikaros is essential for lymphocyte development including T cells. Alterations in Ikaros expression occur in blood malignancies in humans and mice. In this study, we investigated the role of Ikaros in regulating T cell immune balance in pancreatic cancer mouse models. Methodology and Principal Findings Using our Panc02 tumor-bearing (TB) mouse model, western blot analysis revealed a reduction in Ikaros proteins while qRT-PCR showed no differences in Ikaros mRNA levels in TB splenocytes compared to control. Treatment of naive splenocytes with the proteasomal inhibitor, MG132, stabilized Ikaros expression and prevented Ikaros downregulation by Panc02 cells, in vitro. Western blot analyses showed a reduction in protein phosphatase 1 (PP1) and protein kinase CK2 expression in TB splenocytes while CK2 activity was increased. Immunofluorescence microscopy revealed altered punctate staining of Ikaros in TB splenocytes. Flow cytometry revealed a significant decrease in effector CD4(+) and CD8(+) T cell percentages but increased CD4(+)CD25(+) regulatory T cells in TB splenocytes. Similar alterations in T cell percentages, as well as reduced Ikaros and CK2 but not PP1 expression, were observed in a transgenic, triple mutant (TrM) pancreatic cancer model. Ikaros expression was also reduced in enriched TB CD3(+)T cells. MG132 treatment of naive CD3(+)T cells stabilized Ikaros expression in the presence of Panc02 cells. Western blots showed reduced PP1 and CK2 expression in TB CD3(+)T cells. Conclusions/Significance The results of this study suggest that the pancreatic tumor microenvironment may cause proteasomal degradation of Ikaros, possibly via dysregulation of PP1 and CK2 expression and activity, respectively. This loss of Ikaros expression may contribute to an imbalance in T cell percentages. Ikaros may potentially be a therapeutic target to restore T cell homeostasis in pancreatic cancer hosts, which may be critical for effective anti-tumor immunity.	[Nelson, Nadine; Ghansah, Tomar] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA; [Xiang, Shengyan; Zhang, Xiaohong] Univ S Florida, Dept Pathol & Cell Biol, Morsani Coll Med, Tampa, FL USA; [Gilvary, Danielle; Djeu, Julie; Pilon-Thomas, Shari; Ghansah, Tomar] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Immunol, Tampa, FL 33682 USA; [Husain, Kazim; Malafa, Mokenge] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Gastrointestinal Oncol, Tampa, FL 33682 USA; [Vohra, Nasreen] E Carolina Univ, Dept Surg, Brody Sch Med, Greenville, NC USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of North Carolina; East Carolina University	Ghansah, T (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA.	Tghansah@health.usf.edu	Vohra, Nasreen/AAW-3454-2021; XIANG, SHENGYAN/C-3176-2013	Vohra, Nasreen/0000-0002-6411-3042; XIANG, SHENGYAN/0000-0002-6940-3559	American Cancer Society [93-032-13]; National Cancer Institute; Center to Reduce Cancer Health Disparities [1R21 CA179668-01A1, R01CA164147]; National Science Foundation Bridge to Doctorate Fellowship; Florida Education Fund McKnight Dissertation Completion Fellowship; NATIONAL CANCER INSTITUTE [R21CA179668, P30CA076292, R01CA164147, R25CA174664] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center to Reduce Cancer Health Disparities; National Science Foundation Bridge to Doctorate Fellowship(National Science Foundation (NSF)); Florida Education Fund McKnight Dissertation Completion Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by an Institutional Research Grant #93-032-13 from the American Cancer Society, National Cancer Institute, Center to Reduce Cancer Health Disparities, 1R21 CA179668-01A1 grants awarded to TG and R01CA164147 grant awarded to XZ. NN graduate training supported in part, by the National Science Foundation Bridge to Doctorate Fellowship and the Florida Education Fund McKnight Dissertation Completion Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Antica M, 2008, BLOOD, V111, P3296, DOI 10.1182/blood-2007-12-125682; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Baine I, 2013, J IMMUNOL, V190, P1008, DOI 10.4049/jimmunol.1200792; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Bazhin AV, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25736; Bazhin AV, 2014, CANCER IMMUNOL IMMUN, V63, P59, DOI 10.1007/s00262-013-1485-8; Cai Q, 2009, J IMMUNOL, V183, P2303, DOI 10.4049/jimmunol.0901407; CORBETT TH, 1984, CANCER RES, V44, P717; Dovat S, 2011, MOL CELL BIOCHEM, V356, P201, DOI 10.1007/s11010-011-0964-5; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Gerloni M, 2005, SPRINGER SEMIN IMMUN, V27, P37, DOI 10.1007/s00281-004-0193-z; Ghansah T, 2013, CANCER IMMUNOL IMMUN, V62, P1083, DOI 10.1007/s00262-013-1407-9; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Gurel Z, 2008, J BIOL CHEM, V283, P8291, DOI 10.1074/jbc.M707906200; Hadrup S, 2013, CANCER MICROENVIRON, V6, P123, DOI 10.1007/s12307-012-0127-6; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; He LC, 2011, BIOCHEM BIOPH RES CO, V406, P430, DOI 10.1016/j.bbrc.2011.02.062; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Husain K, 2013, CANCER PREV RES, V6, P1074, DOI 10.1158/1940-6207.CAPR-13-0157; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Kastner Philippe, 2011, World J Biol Chem, V2, P108, DOI 10.4331/wjbc.v2.i6.108; Kathrein KL, 2008, J BIOL CHEM, V283, P10476, DOI 10.1074/jbc.M709643200; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Payne Kimberly J., 2011, Critical Reviews in Oncogenesis, V16, P3; Payne KJ, 2003, J IMMUNOL, V170, P3091, DOI 10.4049/jimmunol.170.6.3091; Payne KJ, 2001, J IMMUNOL, V167, P1867, DOI 10.4049/jimmunol.167.4.1867; Pilon-Thomas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027729; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Sun L, 1999, CLIN CANCER RES, V5, P2112; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Sun L, 1999, J CLIN ONCOL, V17, P3753, DOI 10.1200/JCO.1999.17.12.3753; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Thomas RM, 2010, J BIOL CHEM, V285, P2545, DOI 10.1074/jbc.M109.038794; Tinsley KW, 2013, BLOOD, V122, P2358, DOI 10.1182/blood-2012-12-472076; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wei S, 2000, J IMMUNOL, V165, P3811, DOI 10.4049/jimmunol.165.7.3811; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yap WH, 2005, FEBS LETT, V579, P4470, DOI 10.1016/j.febslet.2005.07.018; Zhang L, 2011, CELL CYCLE, V10, P3515, DOI 10.4161/cc.10.20.17789	50	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115546	10.1371/journal.pone.0115546	http://dx.doi.org/10.1371/journal.pone.0115546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629611	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100022
J	Sanchez, S; Llorente, MT; Echeita, MA; Herrera-Leon, S				Sanchez, Sergio; Teresa Llorente, Maria; Aurora Echeita, Maria; Herrera-Leon, Silvia			Development of Three Multiplex PCR Assays Targeting the 21 Most Clinically Relevant Serogroups Associated with Shiga Toxin-Producing E-coli Infection in Humans	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ANTIGEN GENE-CLUSTER; O-ANTIGEN; IDENTIFICATION; PREVALENCE; SEROTYPES; OUTBREAK; SEQUENCE; DIARRHEA	Escherichia coli serogroups O5, O15, O26, O45, O55, O76, O91, O103, O104, O111, O113, O118, O121, O123, O128, O145, O146, O157, O165, O172, and O177 are the O-antigen forms of the most clinically relevant Shiga toxin-producing E. coli (STEC) serotypes. In this study, three multiplex PCR assays able to specifically detect these 21 serogroups were developed and validated. For this purpose, the O-antigen gene clusters of E. coli O5 and O76 were fully sequenced, their associated genes were identified on the basis of homology, and serogroup-specific primers were designed. After preliminary evaluation, these two primer pairs were proven to be highly specific and suitable for the development of PCR assays for O5 and O76 serogroup identification. Specific primers were also designed for serogroups O15, O45, O55, O91, O104, O113, O118, O123, O128, O146, O157, O165, O172, and O177 based on previously published sequences, and previously published specific primers for serogroups O26, O103, O111, O121, and O145 were also included. These 21 primer pairs were shown to be specific for their target serogroup when tested against E. coli type strains representing 169 known O-antigen forms of E. coli and Shigella and therefore suitable for being used in PCR assays for serogroup identification. In order to validate the three multiplex PCR assays, 22 E. coli strains belonging to the 21 covered serogroups and 18 E. coli strains belonging to other serogroups were screened in a double-blind test and their sensitivity was determined as 1 ng chromosomal DNA. The PCR assays developed in this study could be a faster, simpler, and less expensive strategy for serotyping of the most clinically relevant STEC strains in both clinical microbiology and public health laboratories, and so their development could benefit for clinical diagnosis, epidemiological investigations, surveillance, and control of STEC infections.	[Sanchez, Sergio; Teresa Llorente, Maria; Aurora Echeita, Maria; Herrera-Leon, Silvia] Inst Hlth Carlos III, Natl Ctr Microbiol, Serv Bacteriol, Lab Enterobacteriaceae, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Sanchez, S (corresponding author), Inst Hlth Carlos III, Natl Ctr Microbiol, Serv Bacteriol, Lab Enterobacteriaceae, Madrid, Spain.	sergio.sanchez@isciii.es	Sanchez, Sergio/N-2756-2015	Sanchez, Sergio/0000-0001-9903-6203	Madrid Regional Government [P2009/AGR-1489]	Madrid Regional Government	This study was supported by the Madrid Regional Government (P2009/AGR-1489). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelheim KA, 2007, CRIT REV MICROBIOL, V33, P67, DOI 10.1080/10408410601172172; Beutin L, 2005, J CLIN MICROBIOL, V43, P5143, DOI 10.1128/JCM.43.10.5143-5149.2005; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bugarel M, 2010, INT J FOOD MICROBIOL, V142, P318, DOI 10.1016/j.ijfoodmicro.2010.07.010; Diaz-Sanchez S, 2013, VET MICROBIOL, V163, P274, DOI 10.1016/j.vetmic.2012.12.026; Eklund M, 2001, J CLIN MICROBIOL, V39, P2829, DOI 10.1128/JCM.39.8.2829-2834.2001; Guinee P. A. M., 1981, Laboratory diagnosis in neonatal calf and pig diarrhoea, P126; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; LEVINE MM, 1987, J INFECT DIS, V155, P377, DOI 10.1093/infdis/155.3.377; Liu B, 2010, FEMS IMMUNOL MED MIC, V60, P199, DOI 10.1111/j.1574-695X.2010.00738.x; Liu YH, 2007, MOL CELL PROBE, V21, P295, DOI 10.1016/j.mcp.2007.03.002; Maidhof H, 2002, APPL ENVIRON MICROB, V68, P5834, DOI 10.1128/AEM.68.12.5834-5842.2002; McLean C, 2005, J MED MICROBIOL, V54, P605, DOI 10.1099/jmm.0.45938-0; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Monday SR, 2007, MOL CELL PROBE, V21, P308, DOI 10.1016/j.mcp.2007.02.002; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Rey J, 2006, INT J FOOD MICROBIOL, V107, P212, DOI 10.1016/j.ijfoodmicro.2005.08.025; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Sanchez S, 2014, EPIDEMIOL INFECT, V142, P1029, DOI 10.1017/S0950268813001842; Sanchez S, 2010, SMALL RUMINANT RES, V93, P144, DOI 10.1016/j.smallrumres.2010.05.014; Schimmer B, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-41; Stritt A, 2013, CLIN INFECT DIS, V56, P114, DOI 10.1093/cid/cis851; Tarr PI, 2000, J BACTERIOL, V182, P6183, DOI 10.1128/JB.182.21.6183-6191.2000; Wang L, 2001, GENE, V270, P231, DOI 10.1016/S0378-1119(01)00471-1; Wang L, 2000, J BACTERIOL, V182, P5256, DOI 10.1128/JB.182.18.5256-5261.2000; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Wang QA, 2010, MOL CELL PROBE, V24, P286, DOI 10.1016/j.mcp.2010.06.002; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x	30	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117660	10.1371/journal.pone.0117660	http://dx.doi.org/10.1371/journal.pone.0117660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629697	Green Published, gold			2022-12-27	WOS:000348732100094
J	Sadegh, MK; Ekman, M; Krawczyk, K; Svensson, D; Goransson, O; Dahan, D; Nilsson, BO; Albinsson, S; Uvelius, B; Sward, K				Sadegh, Mardjaneh Karbalaei; Ekman, Mari; Krawczyk, Katarzyna; Svensson, Daniel; Goransson, Olga; Dahan, Diana; Nilsson, Bengt-Olof; Albinsson, Sebastian; Uvelius, Bengt; Sward, Karl			Detrusor Induction of miR-132/212 following Bladder Outlet Obstruction: Association with MeCP2 Repression and Cell Viability	PLOS ONE			English	Article							INDUCED MICRORNA; CIRCADIAN-CLOCK; EXPRESSION; DIFFERENTIATION; HYPERTROPHY; HYPERPLASIA; PLASTICITY; COMPLEX; CREB; RAT	The microRNAs (miRNAs) miR-132 and miR-212 have been found to regulate synaptic plasticity and cholinergic signaling and recent work has demonstrated roles outside of the CNS, including in smooth muscle. Here, we examined if miR-132 and miR-212 are induced in the urinary bladder following outlet obstruction and whether this correlates with effects on gene expression and cell growth. Three to seven-fold induction of miR-132/212 was found at 10 days of obstruction and this was selective for the detrusor layer. We cross-referenced putative binding sites in the miR-132/212 promoter with transcription factors that were predicted to be active in the obstruction model. This suggested involvement of Creb and Ahr in miR-132/212 induction. Creb phosphorylation (S-133) was not increased, but the number of Ahr positive nuclei increased. Moreover, we found that serum stimulation and protein kinase C activation induced miR-132/212 in human detrusor cells. To identify miR-132/212 targets, we correlated the mRNA levels of validated targets with the miRNA levels. Significant correlations between miR-132/212 and MeCP2, Ep300, Pnkd and Jarid1a were observed, and the protein levels of MeCP2, Pnkd and Ache were reduced after obstruction. Reduction of Ache however closely matched a 90% reduction of synapse density arguing that its repression was unrelated to miR-132/212 induction. Importantly, transfection of antimirs and mimics in cultured detrusor cells increased and decreased, respectively, the number of cells and led to changes in MeCP2 expression. In all, these findings show that obstruction of the urethra increases miR-132 and miR-212 in the detrusor and suggests that this influences gene expression and limits cell growth.	[Sadegh, Mardjaneh Karbalaei; Ekman, Mari; Krawczyk, Katarzyna; Svensson, Daniel; Goransson, Olga; Dahan, Diana; Nilsson, Bengt-Olof; Albinsson, Sebastian; Sward, Karl] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Uvelius, Bengt] Lund Univ, Dept Clin Sci, Lund, Sweden; [Ekman, Mari] Lund Univ, Dept Biol, Lund, Sweden	Lund University; Lund University; Lund University	Sward, K (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	karl.sward@med.lu.se	Svensson, Daniel/D-4497-2015; Svensson, Daniel/C-6279-2014; Albinsson, Sebastian/B-4105-2010	Svensson, Daniel/0000-0001-6670-2142; Svensson, Daniel/0000-0001-6670-2142; Albinsson, Sebastian/0000-0001-6936-3967; Goransson, Olga/0000-0002-7209-8022; Uvelius, Bengt/0000-0003-0201-8928; Sward, Karl/0000-0002-7255-5510	Swedish Research Council; Greta and Johan Kock's Foundation; Crafoord Foundation; Medical Faculty at Lund University; Gosta Jonsson's foundation; Olle Engkvist Byggmastare's foundation; Swedish National Health Service (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Greta and Johan Kock's Foundation; Crafoord Foundation; Medical Faculty at Lund University; Gosta Jonsson's foundation; Olle Engkvist Byggmastare's foundation; Swedish National Health Service (ALF)	This study was financially supported by The Swedish Research Council, The Greta and Johan Kock's Foundation, The Crafoord Foundation, The Medical Faculty at Lund University, Gosta Jonsson's foundation, Olle Engkvist Byggmastare's foundation and a clinical grant from the Swedish National Health Service (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Alvarez-Saavedra M, 2011, HUM MOL GENET, V20, P731, DOI 10.1093/hmg/ddq519; Alvarez-Saavedra M, 2010, HUM MOL GENET, V19, P2177, DOI 10.1093/hmg/ddq096; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Cambronne XA, 2012, P NATL ACAD SCI USA, V109, P20473, DOI 10.1073/pnas.1218887109; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang AY, 2011, AM J PHYSIOL-RENAL, V301, pF813, DOI 10.1152/ajprenal.00586.2010; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng TL, 2014, DEV CELL, V28, P547, DOI 10.1016/j.devcel.2014.01.032; Choe N, 2013, ATHEROSCLEROSIS, V229, P348, DOI 10.1016/j.atherosclerosis.2013.05.009; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Ekman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082308; Eskildsen TV, 2013, INT J MOL SCI, V14, P11190, DOI 10.3390/ijms140611190; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; GABELLA G, 1990, CELL TISSUE RES, V262, P67, DOI 10.1007/BF00327747; Gheinani AH, 2014, 29 ANN EAU C STOCKH; Hu B, 2011, AM J PATHOL, V178, P1500, DOI 10.1016/j.ajpath.2011.01.002; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Jin W, 2012, J BIOL CHEM, V287, P15672, DOI 10.1074/jbc.M111.322669; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; LINDNER P, 1988, J UROLOGY, V140, P642, DOI 10.1016/S0022-5347(17)41746-0; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Nakahama T, 2013, P NATL ACAD SCI USA, V110, P11964, DOI 10.1073/pnas.1311087110; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Sadegh MK, 2011, BRIT J PHARMACOL, V162, P1156, DOI 10.1111/j.1476-5381.2010.01115.x; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Tognini P, 2011, NAT NEUROSCI, V14, P1237, DOI 10.1038/nn.2920; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151	34	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116784	10.1371/journal.pone.0116784	http://dx.doi.org/10.1371/journal.pone.0116784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617893	gold, Green Published, Green Submitted			2022-12-27	WOS:000350336000026
J	Asghar, MS; Pereira, MP; Werner, MU; Martensson, J; Larsson, HBW; Dahl, JB				Asghar, Mohammad Sohail; Pereira, Manuel Pedro; Werner, Mads Utke; Martensson, Johan; Larsson, Henrik B. W.; Dahl, Jorgen Berg			Secondary Hyperalgesia Phenotypes Exhibit Differences in Brain Activation during Noxious Stimulation	PLOS ONE			English	Article							CENTRAL SENSITIZATION; CAUDATE-NUCLEUS; HEAT INJURY; PAIN; MODEL; SEGMENTATION; MODULATION; DEPRESSION; PREDICTION; NETWORK	Noxious stimulation of the skin with either chemical, electrical or heat stimuli leads to the development of primary hyperalgesia at the site of injury, and to secondary hyperalgesia in normal skin surrounding the injury. Secondary hyperalgesia is inducible in most individuals and is attributed to central neuronal sensitization. Some individuals develop large areas of secondary hyperalgesia (high-sensitization responders), while others develop small areas (low-sensitization responders). The magnitude of each area is reproducible within individuals, and can be regarded as a phenotypic characteristic. To study differences in the propensity to develop central sensitization we examined differences in brain activity and anatomy according to individual phenotypical expression of secondary hyperalgesia by magnetic resonance imaging. Forty healthy volunteers received a first-degree burn-injury (47 degrees C, 7 min, 9 cm(2)) on the non-dominant lower-leg. Areas of secondary hyperalgesia were assessed 100 min after the injury. We measured neuronal activation by recording bloodoxygen- level-dependent-signals (BOLD-signals) during mechanical noxious stimulation before burn injury and in both primary and secondary hyperalgesia areas after burn-injury. In addition, T1-weighted images were used to measure differences in gray-matter density in cortical and subcortical regions of the brain. We found significant differences in neuronal activity between high-and low-sensitization responders at baseline (before application of the burn-injury) (p < 0.05). After the burn-injury, we found significant differences between responders during noxious stimulation of both primary (p < 0.01) and secondary hyperalgesia (p = 0.04) skin areas. A decreased volume of the right (p = 0.001) and left caudate nucleus (p = 0.01) was detected in high-sensitization responders in comparison to low-sensitization responders. These findings suggest that brain-structure and neuronal activation to noxious stimulation differs according to secondary hyperalgesia phenotype. This indicates differences in central sensitization according to phenotype, which may have predictive value on the susceptibility to development of high-intensity acute and persistent pain.	[Asghar, Mohammad Sohail; Pereira, Manuel Pedro; Dahl, Jorgen Berg] Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, Copenhagen, Denmark; [Werner, Mads Utke] Copenhagen Univ Hosp, Rigshosp, Ctr Neurosci, Ctr Multidisciplinary Pain, Copenhagen, Denmark; [Martensson, Johan] Max Planck Inst Human Dev, Berlin, Germany; [Martensson, Johan] Lund Univ, Dept Psychol, Lund, Sweden; [Larsson, Henrik B. W.] Copenhagen Univ Hosp, Glostrup Hosp, Funct Imaging Unit, Glostrup, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Max Planck Society; Lund University; University of Copenhagen	Asghar, MS (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, Copenhagen, Denmark.	sohail@dadlnet.dk	Pereira, Manuel Pedro/AAP-8484-2020	Werner, Mads/0000-0003-1540-8845	Danish Society for Anaesthesiology and Intensive Medicine (DASAIM); Sofus Johannesens Foundation; Torben and Alice Frimodts Foundation; Aase and Einar Danielsens Foundation	Danish Society for Anaesthesiology and Intensive Medicine (DASAIM); Sofus Johannesens Foundation; Torben and Alice Frimodts Foundation; Aase and Einar Danielsens Foundation	The study was supported by grants from Danish Society for Anaesthesiology and Intensive Medicine (DASAIM), The Sofus Johannesens Foundation, Torben and Alice Frimodts Foundation, and Aase and Einar Danielsens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the study data and had the final responsibility to submit for publication.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baum C, 2011, PERCEPT MOTOR SKILL, V112, P926, DOI 10.2466/02.09.22.PMS.112.3.926-946; Bromm B, 2001, NEWS PHYSIOL SCI, V16, P244; Brooks J, 2005, TCE-THE CHEM ENG, P19; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; DAHL JB, 1993, PAIN, V53, P43, DOI 10.1016/0304-3959(93)90054-S; de Lange FP, 2004, BRAIN, V127, P1948, DOI 10.1093/brain/awh225; Dirks J, 2002, ANESTHESIOLOGY, V97, P102, DOI 10.1097/00000542-200207000-00015; DIXON WJ, 1991, NEUROSCI BIOBEHAV R, V15, P47, DOI 10.1016/S0149-7634(05)80090-9; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Emerson NM, 2013, PAIN SENSITIVITY IS; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Iannetti GD, 2005, P NATL ACAD SCI USA, V102, P18195, DOI 10.1073/pnas.0506624102; Koppert W, 2001, ANESTHESIOLOGY, V95, P395, DOI 10.1097/00000542-200108000-00022; KRISHNAN KRR, 1992, ARCH GEN PSYCHIAT, V49, P553; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lautenbacher S, 2010, PAIN, V151, P722, DOI 10.1016/j.pain.2010.08.041; Martinez V, 2012, PAIN, V153, P1478, DOI 10.1016/j.pain.2012.04.004; MOINICHE S, 1993, BRIT J ANAESTH, V71, P201, DOI 10.1093/bja/71.2.201; MOUNTZ JM, 1995, ARTHRITIS RHEUM, V38, P926, DOI 10.1002/art.1780380708; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Oshiro Y, 2007, J NEUROSCI, V27, P3388, DOI 10.1523/JNEUROSCI.5128-06.2007; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Petersen KL, 1999, NEUROREPORT, V10, P1511, DOI 10.1097/00001756-199905140-00022; Petersen KL, 2001, ANESTHESIOLOGY, V94, P15, DOI 10.1097/00000542-200101000-00008; Peyron R, 2004, NEUROLOGY, V63, P1838, DOI 10.1212/01.WNL.0000144177.61125.85; Pleger B, 2004, EXP BRAIN RES, V155, P115, DOI 10.1007/s00221-003-1738-4; Ravn Pernille, 2012, J Pain Res, V5, P313, DOI 10.2147/JPR.S33925; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reyns N, 2013, CLIN NEUROPHYSIOL, V124, P761, DOI 10.1016/j.clinph.2012.10.011; Rijpkema M, 2012, HUM BRAIN MAPP, V33, P1246, DOI 10.1002/hbm.21283; ROBINSON D, 1995, ARCH GEN PSYCHIAT, V52, P393; Salengros JC, 2010, J CARDIOTHOR VASC AN, V24, P608, DOI 10.1053/j.jvca.2009.10.006; Salomons TV, 2014, PAIN, V155, P1446, DOI 10.1016/j.pain.2014.02.012; SKULLERUD K, 1985, ACTA NEUROL SCAND, V71, P5; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tang TY, 2013, NEUROSCI LETT, V556, P79, DOI 10.1016/j.neulet.2013.09.060; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Veldhuijzen DS, 2009, PAIN, V141, P104, DOI 10.1016/j.pain.2008.10.027; Werner MU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062733; Werner MU, 2004, ANESTHESIOLOGY, V100, P115, DOI 10.1097/00000542-200401000-00020; Wiech K, 2005, NEUROIMAGE, V27, P59, DOI 10.1016/j.neuroimage.2005.03.044; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wunderlich Arthur P, 2011, Open Neuroimag J, V5, P1, DOI 10.2174/1874440001105010001; Yan B, 2005, NEUROSCI LETT, V383, P236, DOI 10.1016/j.neulet.2005.04.021; Zambreanu L, 2005, PAIN, V114, P397, DOI 10.1016/j.pain.2005.01.005	56	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0114840	10.1371/journal.pone.0114840	http://dx.doi.org/10.1371/journal.pone.0114840			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615578	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100005
J	Kwon, JY; Park, BS; Kim, YH; Kim, YD; Kim, CH; Yoon, Y; Yoon, JU				Kwon, Jae-Young; Park, Bong-Soo; Kim, Yong-Ho; Kim, Yong-Deok; Kim, Cheul-Hong; Yoon, Young; Yoon, Ji-Uk			Remifentanil Protects Human Keratinocytes against Hypoxia-Reoxygenation Injury through Activation of Autophagy	PLOS ONE			English	Article							ATG16L1; MOUSE; CELLS	The proliferation, differentiation, and migration of keratinocytes are essential in the early stages of wound healing. Hypoxia-Reoxygenation (H/R) injury to keratinocytes can occur in various stressful environments such as surgery, trauma, and various forms of ulcers. The effects of remifentanil on human keratinocytes under hypoxia-reoxygenation have not been fully studied. Therefore, we investigated the effects of remifentanil on the proliferation, apoptosis, and autophagic activation of human keratinocytes during hypoxic-reoxygenation. Human keratinocytes were cultured under 1% oxygen tension for 24 h. The cells were then treated with various concentrations of remifentanil (0.01, 0.1, 0.5, and 1 ng/mL) for 2 h. Thereafter, the cells were reoxygenated for 12 h at 37 degrees C. We measured cell viability via MTT assay. Using quantitative real-time PCR and western blot analysis, we measured the expression levels of proteins associated with apoptosis and autophagy. Quantification of apoptotic cells was performed using flow cytometer analysis and autophagic vacuoles were observed under a fluorescence microscope. Remifentanil treatment brought about an increase in the proliferation of human keratinocytes damaged by hypoxia-reoxygenation and decreased the apoptotic cell death, enhancing autophagic activity. However, the autophagy pathway inhibitor 3-MA inhibited the protective effect of remifentanil in hypoxiareoxygenation injury. In conclusion, the current study demonstrated that remifentanil treatment stimulated autophagy and reduced apoptotic cell death in a hypoxiareoxygenation model of human keratinocytes. Our results provide additional insights into the relationship between apoptosis and autophagy.	[Kwon, Jae-Young; Yoon, Ji-Uk] Pusan Natl Univ, Sch Med, Dept Anesthesia & Pain Med, Yangsan, South Korea; [Park, Bong-Soo; Kim, Yong-Ho] Pusan Natl Univ, Sch Dent, Dept Oral Anat, Yangsan, South Korea; [Kim, Yong-Deok] Pusan Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Yangsan, South Korea; [Kim, Cheul-Hong; Yoon, Young] Pusan Natl Univ, Sch Dent, Dept Dent Anesthesia & Pain Med, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Yoon, JU (corresponding author), Pusan Natl Univ, Sch Med, Dept Anesthesia & Pain Med, Yangsan, South Korea.	jiuk@pusan.ac.kr		Kim, Cheul Hong/0000-0003-1536-9460	medical Research Institute Grant, Pusan National University Hospital, Korea [2009-18]	medical Research Institute Grant, Pusan National University Hospital, Korea	This study was supported by medical Research Institute Grant (2009-18), Pusan National University Hospital, Korea [www.pnuh.co.kr]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cepero E, 2005, ONCOGENE, V24, P6354, DOI 10.1038/sj.onc.1208793; Coulombe PA, 2003, J INVEST DERMATOL, V121, P219, DOI 10.1046/j.1523-1747.2003.12387.x; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lazarides M K, 2007, Int J Low Extrem Wounds, V6, P254, DOI 10.1177/1534734607306878; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Wong GTC, 2010, J CARDIOTHOR VASC AN, V24, P790, DOI 10.1053/j.jvca.2009.09.012; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu WL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-24; Zhang ZZ, 2010, MOL BIOL REP, V37, P2803, DOI 10.1007/s11033-009-9828-4	23	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116982	10.1371/journal.pone.0116982	http://dx.doi.org/10.1371/journal.pone.0116982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615605	Green Submitted, Green Published, gold			2022-12-27	WOS:000349122100051
J	Li, H; Han, D; Hou, Y; Chen, H; Chen, Z				Li, Huimin; Han, Dong; Hou, Yawen; Chen, Huilin; Chen, Zheng			Statistical Inference Methods for Two Crossing Survival Curves: A Comparison of Methods	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; TESTS; HAZARDS; DIAGNOSTICS; HOMOGENEITY; PREVENTION; MANAGEMENT	A common problem that is encountered in medical applications is the overall homogeneity of survival distributions when two survival curves cross each other. A survey demonstrated that under this condition, which was an obvious violation of the assumption of proportional hazard rates, the log-rank test was still used in 70% of studies. Several statistical methods have been proposed to solve this problem. However, in many applications, it is difficult to specify the types of survival differences and choose an appropriate method prior to analysis. Thus, we conducted an extensive series of Monte Carlo simulations to investigate the power and type I error rate of these procedures under various patterns of crossing survival curves with different censoring rates and distribution parameters. Our objective was to evaluate the strengths and weaknesses of tests in different situations and for various censoring rates and to recommend an appropriate test that will not fail for a wide range of applications. Simulation studies demonstrated that adaptive Neyman's smooth tests and the two-stage procedure offer higher power and greater stability than other methods when the survival distributions cross at early, middle or late times. Even for proportional hazards, both methods maintain acceptable power compared with the log-rank test. In terms of the type I error rate, Renyi and Cramer-von Mises tests are relatively conservative, whereas the statistics of the Lin-Xu test exhibit apparent inflation as the censoring rate increases. Other tests produce results close to the nominal 0.05 level. In conclusion, adaptive Neyman's smooth tests and the two-stage procedure are found to be the most stable and feasible approaches for a variety of situations and censoring rates. Therefore, they are applicable to a wider spectrum of alternatives compared with other tests.	[Li, Huimin; Han, Dong; Chen, Huilin; Chen, Zheng] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China; [Hou, Yawen] Jinan Univ, Dept Stat, Coll Econ, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Jinan University	Chen, Z (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China.	zheng-chen@hotmail.com			National Natural Science Foundation of China [81202288]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81202288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PK, 1993, STAT MODELS BASED CO, P393; Ballatori E, 2009, NEW ENGL J MED, V361, P2485, DOI 10.1056/NEJMc0909634; Bouliotis G, 2011, TRIALS S1, V12, pA137, DOI [DOI 10.1186/1745-6215-12-S1-A137, 10.1186/1745-6215-12-1, DOI 10.1186/1745-6215-12-1]; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Cheng MY, 2009, LIFETIME DATA ANAL, V15, P441, DOI 10.1007/s10985-009-9132-6; Chew DP, 2008, MED J AUSTRALIA, V188, P691, DOI 10.5694/j.1326-5377.2008.tb01847.x; Crowther MJ, 2013, STAT MED, V32, P4118, DOI 10.1002/sim.5823; Delarue R, 2013, LANCET ONCOL, V14, P525, DOI 10.1016/S1470-2045(13)70122-0; Fleming T, 2005, COUNTING PROCESSES S; FLEMING TR, 1980, BIOMETRICS, V36, P607, DOI 10.2307/2556114; Gahrton G, 2013, BLOOD, V121, P5055, DOI 10.1182/blood-2012-11-469452; GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.2307/2333825; Gill RD., 1980, CENSORING STOCHASTIC, P124; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gulizia M, 2008, AM HEART J, V155, P100, DOI 10.1016/j.ahj.2007.08.033; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Klein JP, 2007, STAT MED, V26, P4505, DOI 10.1002/sim.2864; KOZIOL J A, 1978, Biometrical Journal, V20, P603, DOI 10.1002/bimj.4710200608; Kraus D, 2009, J STAT PLAN INFER, V139, P3559, DOI 10.1016/j.jspi.2009.04.009; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; Kristiansen IS, 2012, VALUE HEALTH, V15, pA652, DOI 10.1016/j.jval.2012.08.290; Le CT, 2004, HANDB STAT, V23, P277; Lee SH, 2007, COMPUT STAT DATA AN, V51, P6557, DOI 10.1016/j.csda.2007.03.006; Lin X, 2004, BIOMETRICAL J, V46, P489, DOI 10.1002/bimj.200310053; Lin X, 2010, PHARM STAT, V9, P67, DOI 10.1002/pst.376; Liu KJ, 2007, STAT MED, V26, P375, DOI 10.1002/sim.2544; Logan BR, 2008, BIOMETRICS, V64, P733, DOI 10.1111/j.1541-0420.2007.00975.x; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Park KY, 2014, STAT MED, V33, P4532, DOI 10.1002/sim.6259; PEPE MS, 1989, BIOMETRICS, V45, P497, DOI 10.2307/2531492; Qiu PH, 2008, J R STAT SOC B, V70, P191; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; SCHUMACHER M, 1984, INT STAT REV, V52, P263, DOI 10.2307/1403046; Shen Y, 2001, BIOMETRICS, V57, P837, DOI 10.1111/j.0006-341X.2001.00837.x; Smith MJF, 2014, RADIOTHER ONCOL, V110, P165, DOI 10.1016/j.radonc.2013.10.041; STABLEIN DM, 1985, BIOMETRICS, V41, P643, DOI 10.2307/2531284; TARONE RE, 1977, BIOMETRIKA, V64, P156, DOI 10.1093/biomet/64.1.156; Tikidzhieva A, 2012, BRIT J CANCER, V106, P1239, DOI 10.1038/bjc.2012.53; TUBERTBITTER P, 1994, COMPUT STAT DATA AN, V18, P547, DOI 10.1016/0167-9473(94)90084-1; Weeda VB, 2013, EUR J CANCER, V49, P2698, DOI 10.1016/j.ejca.2013.04.012; Yang S, 2005, J STAT PLAN INFER, V133, P139, DOI 10.1016/j.jspi.2004.03.007	41	60	65	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116774	10.1371/journal.pone.0116774	http://dx.doi.org/10.1371/journal.pone.0116774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615624	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100042
J	Nie, ZY; Kang, GJ; Li, Y; Dai, LJ; Zeng, RZ				Nie Zhiyi; Kang Guijuan; Li Yu; Dai Longjun; Zeng Rizhong			Whole-Transcriptome Survey of the Putative ATP-Binding Cassette (ABC) Transporter Family Genes in the Latex-Producing Laticifers of Hevea brasiliensis	PLOS ONE			English	Article							FUNCTIONAL CLASSIFICATION; RUBBER BIOSYNTHESIS; ARABIDOPSIS; PROTEIN; ACID; RESISTANCE; TRAFFICKING; EXPRESSION; MEMBRANE; OVEREXPRESSION	The ATP-binding cassette (ABC) proteins or transporters constitute a large protein family in plants and are involved in many different cellular functions and processes, including solute transportation, channel regulation and molecular switches, etc. Through transcriptome sequencing, a transcriptome-wide survey and expression analysis of the ABC protein genes were carried out using the laticiferous latex from Hevea brasiliensis (rubber tree). A total of 46 putative ABC family proteins were identified in the H. brasiliensis latex. These consisted of 12 'full-size', 21 'half-size' and 13 other putative ABC proteins, and all of them showed strong conservation with their Arabidopsis thaliana counterparts. This study indicated that all eight plant ABC protein paralog subfamilies were identified in the H. brasiliensis latex, of which ABCB, ABCG and ABCI were the most abundant. Real-time quantitative reverse transcription-polymerase chain reaction assays demonstrated that gene expression of several latex ABC proteins was regulated by ethylene, jasmonic acid or bark tapping (a wound stress) stimulation, and that HbABCB15, HbABCB19, HbABCD1 and HbABCG21 responded most significantly of all to the abiotic stresses. The identification and expression analysis of the latex ABC family proteins could facilitate further investigation into their physiological involvement in latex metabolism and rubber biosynthesis by H. brasiliensis.	[Zeng Rizhong] Chinese Acad Trop Agr Sci, Key Lab Biol & Genet Resources Rubber Tree, Minist Agr, Danzhou 571737, Hainan, Peoples R China; Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou 571737, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences	Zeng, RZ (corresponding author), Chinese Acad Trop Agr Sci, Key Lab Biol & Genet Resources Rubber Tree, Minist Agr, Danzhou 571737, Hainan, Peoples R China.	hnzrz@aliyun.com			National Natural Science Foundation;  [31070607];  [31270713]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); ; 	This work was supported by the National Natural Science Foundation with the website of (http://www.nsfc.gov.cn). The grant numbers are 31070607 and 31270713, which were received by the authors of NZY and ZRZ, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMALOU Z, 1992, PLANT PHYSIOL, V98, P1270, DOI 10.1104/pp.98.4.1270; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Boursiac Y, 2013, TRENDS PLANT SCI, V18, P325, DOI 10.1016/j.tplants.2013.01.007; Burla B, 2013, PLANT PHYSIOL, V163, P1446, DOI 10.1104/pp.113.222547; Cakir B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078860; CARCIA O, 2004, J MOL BIOL, V343, P249, DOI DOI 10.1016/J.JMB.2004.07.093; CHAO CJ, 2012, MOL MED, V18, P149; Cho M, 2012, PLANT PHYSIOL, V159, P642, DOI 10.1104/pp.112.196139; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cornish K, 1999, PLANTA, V210, P85, DOI 10.1007/s004250050657; Cornish K, 2001, PHYTOCHEMISTRY, V57, P1123, DOI 10.1016/S0031-9422(01)00097-8; d'Auzac J, 1989, PHYSL RUBBER TREE LA, P89; Dai LJ, 2013, PLANT MOL BIOL, V82, P155, DOI 10.1007/s11103-013-0047-y; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; DAUZAC J, 1995, PLANT PHYSIOL BIOCH, V33, P765; De Faiy E., 1989, PHYSL RUBBER TREE LA, P15; de Fay E, 1989, PHYSL RUBBER TREE LA, P3, DOI DOI 10.1111/J.1432-2277.2005.00166.X.; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Duan C, 2010, TREE PHYSIOL, V30, P1349, DOI 10.1093/treephys/tpq066; Dusotoit-Coucaud A, 2009, ANN BOT-LONDON, V104, P635, DOI 10.1093/aob/mcp150; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichhorn H, 2006, J EXP BOT, V57, P2193, DOI 10.1093/jxb/erj179; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Francisco RM, 2013, PLANT CELL, V25, P1840, DOI 10.1105/tpc.112.102152; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grec S, 2003, PLANT J, V35, P237, DOI 10.1046/j.1365-313X.2003.01792.x; Green P, 1996, PHRAP DOCUMENTATION; Hao BZ, 2000, ANN BOT-LONDON, V85, P37, DOI 10.1006/anbo.1999.0995; HASMA H, 1986, Journal of Natural Rubber Research, V1, P30; Herman E, 2004, PLANT PHYSIOL, V136, P3440, DOI 10.1104/pp.104.051722; Hillebrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041874; Kaneda M, 2011, J EXP BOT, V62, P2063, DOI 10.1093/jxb/erq416; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; KEKWICK RGO, 1989, PHYSL RUBBER TREE LA, P146; Kim DY, 2010, PHYSIOL PLANTARUM, V139, P170, DOI 10.1111/j.1399-3054.2010.01353.x; Kim S, 2013, P NATL ACAD SCI USA, V110, P773, DOI 10.1073/pnas.1214159110; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Le Hir R, 2013, PLANT J, V76, P811, DOI 10.1111/tpj.12334; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Lee M, 2008, NAT CELL BIOL, V10, P1217, DOI 10.1038/ncb1782; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Mantello CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102665; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marin E, 2006, PLANT SCI, V171, P84, DOI 10.1016/j.plantsci.2006.02.014; Mendiondo GM, 2014, J EXP BOT, V65, P4833, DOI 10.1093/jxb/eru243; Mentewab A, 2005, NAT BIOTECHNOL, V23, P1177, DOI 10.1038/nbt1134; Pang KY, 2013, GENE, V526, P411, DOI 10.1016/j.gene.2013.05.051; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Rayapuram N, 2007, J BIOL CHEM, V282, P21015, DOI 10.1074/jbc.M704091200; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Schmitz G, 2000, CURR OPIN LIPIDOL, V11, P493, DOI 10.1097/00041433-200010000-00007; Shimoni-Shor E, 2010, PLANT CELL ENVIRON, V33, P1029, DOI 10.1111/j.1365-3040.2010.02124.x; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CR, 2010, PLANT CELL ENVIRON, V33, P1708, DOI 10.1111/j.1365-3040.2010.02175.x; Tang CK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060038, 10.1371/journal.pone.0075307, 10.1371/journal.pone.0061093]; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; Theodoulou FL, 2005, PLANT PHYSIOL, V137, P835, DOI 10.1104/pp.105.059352; Titapiwatanakun B, 2009, J EXP BOT, V60, P1093, DOI 10.1093/jxb/ern240; Tupy J., 1989, PHYSL RUBBER TREE LA, P179; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Xu XM, 2005, J BIOL CHEM, V280, P6648, DOI 10.1074/jbc.M413082200; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Xu YX, 2014, PLANT J, V79, P106, DOI 10.1111/tpj.12544; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Yazaki K, 2009, INT REV CEL MOL BIO, V276, P263, DOI 10.1016/S1937-6448(09)76006-X; Zeng RZ, 2009, PLANT SCI, V176, P602, DOI 10.1016/j.plantsci.2009.01.009; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	86	13	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116857	10.1371/journal.pone.0116857	http://dx.doi.org/10.1371/journal.pone.0116857			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615936	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100046
J	Funakoshi, S; Shimizu, T; Numata, O; Ato, M; Melchers, F; Ohnishi, K				Funakoshi, Shuichi; Shimizu, Takeyuki; Numata, Osamu; Ato, Manabu; Melchers, Fritz; Ohnishi, Kazuo			BILL-Cadherin/Cadherin-17 Contributes to the Survival of Memory B Cells	PLOS ONE			English	Article							LIVER-INTESTINE CADHERIN; BONE-MARROW; EPITHELIAL-CELLS; ADHESION; EXPRESSION; INTEGRIN; LOCALIZATION; HOMEOSTASIS; MARKER	Memory B cells (MBCs) and long-lived plasma cells (LLPCs) are responsible for immunological "memory", which can last for many years. The long-term survival niche for LLPCs in the bone marrow is well characterized; however, the corresponding niche for MBCs is unclear. BILL-cadherin/cadherin-17 (CDH17) is the only member of the cadherin superfamily that is expressed on mouse B lymphocytes in a spatiotemporally regulated manner. Here, we show that half of all MBCs regain expression of CDH17 during the later stage of development. The maintenance of high affinity antigen-specific serum antibodies was impaired in CDH17(-/-)mice and the number of antigen-specific MBCs was reduced as compared to wildtype mice (WT). Also, specific responses to secondary antigens were ablated in CDH17(-/-)mice, whereas primary antibody responses were the same as those in WT mice. Cell cycle analysis revealed a decline in the proliferation of CDH17-MBCs as compared to CDH17(+) MBCs. In addition, we identified a subpopulation of splenic stromal cells, MAdCAM-1(+) blood endothelial cells (BEC), which was CDH17(+). Taken together, these results suggest that CDH17 plays a role in the long-term survival of MBCs, presumably via an "MBC niche" comprising, at least in part, BEC in the spleen.	[Funakoshi, Shuichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan; [Shimizu, Takeyuki] Kochi Univ, Dept Immunol, Kochi Med Sch, Kochi 780, Japan; [Numata, Osamu] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan; [Melchers, Fritz] Max Planck Inst Infect Biol, Res Grp Lymphocyte Dev, Berlin, Germany; [Funakoshi, Shuichi; Ato, Manabu; Ohnishi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan	University of Tsukuba; Kochi University; University of Tsukuba; Max Planck Society; National Institute of Infectious Diseases (NIID)	Ohnishi, K (corresponding author), Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan.	ohnishik@nih.go.jp	Ato, Manabu/K-6452-2019	Ato, Manabu/0000-0002-3178-2645	Health Science Foundation in the Ministry of Health, Labor and Welfare, Japan [KHC1015, KHC1218, H26-Shinkoujitsuyouka-Ippan-017]	Health Science Foundation in the Ministry of Health, Labor and Welfare, Japan	This work was supported by grants from the Health Science Foundation in the Ministry of Health, Labor and Welfare, Japan (to K.O., KHC1015, KHC1218; to M.A., H26-Shinkoujitsuyouka-Ippan-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Angres B, 2001, DEV DYNAM, V221, P182, DOI 10.1002/dvdy.1146; Bartolome RA, 2014, ONCOGENE, V33, P1658, DOI 10.1038/onc.2013.117; Baumgartner W, 2008, J MOL BIOL, V378, P44, DOI 10.1016/j.jmb.2008.02.023; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; BRUGGEMANN M, 1986, EMBO J, V5, P1561, DOI 10.1002/j.1460-2075.1986.tb04397.x; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Jones D, 2000, BLOOD, V95, P627, DOI 10.1182/blood.V95.2.627; KARECLA PI, 1995, EUR J IMMUNOL, V25, P852, DOI 10.1002/eji.1830250333; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; KRAAL G, 1995, AM J PATHOL, V147, P763; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lee NP, 2010, BBA-REV CANCER, V1806, P138, DOI 10.1016/j.bbcan.2010.05.002; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Ohnishi K, 2000, J BIOL CHEM, V275, P31134, DOI 10.1074/jbc.M005901200; Ohnishi K, 2005, EUR J IMMUNOL, V35, P957, DOI 10.1002/eji.200425853; Qiu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056959; Su MC, 2008, MODERN PATHOL, V21, P1379, DOI 10.1038/modpathol.2008.107; Takamura M, 2004, CANCER LETT, V212, P253, DOI 10.1016/j.canlet.2004.03.016; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Wendeler MW, 2007, J MOL BIOL, V370, P220, DOI 10.1016/j.jmb.2007.04.062; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440	46	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117566	10.1371/journal.pone.0117566	http://dx.doi.org/10.1371/journal.pone.0117566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612318	Green Published, gold, Green Submitted			2022-12-27	WOS:000348562900036
J	Haegele, S; Offensperger, F; Pereyra, D; Lahner, E; Assinger, A; Fleischmann, E; Gruenberger, B; Gruenberger, T; Brostjan, C; Starlinger, P				Haegele, Stefanie; Offensperger, Florian; Pereyra, David; Lahner, Elisabeth; Assinger, Alice; Fleischmann, Edith; Gruenberger, Birgit; Gruenberger, Thomas; Brostjan, Christine; Starlinger, Patrick			Deficiency in Thrombopoietin Induction after Liver Surgery Is Associated with Postoperative Liver Dysfunction	PLOS ONE			English	Article							GROWTH-FACTOR; SERUM THROMBOPOIETIN; PARTIAL-HEPATECTOMY; CHRONIC HEPATITIS; CIRRHOSIS; THROMBOCYTOPENIA; REGENERATION; PLATELETS; RESECTION; THROMBOSPONDIN-1	Background and Aims Thrombopoietin (TPO) has been implicated in the process of liver regeneration and was found to correlate with hepatic function in patients with liver disease. With this investigation we aimed to determine if perioperative TPO levels were associated with postoperative outcome in patients undergoing liver resection. Methods Perioperative TPO was analyzed prior to liver resection as well as on the first and fifth postoperative day in 46 colorectal cancer patients with liver metastasis (mCRC) as well as 23 hepatocellular carcinoma patients (HCC). Serum markers of liver function within the first postoperative week were used to define liver dysfunction. Results While circulating TPO levels significantly increased one day after liver resection in patients without liver cirrhosis (mCRC) (P < 0.001), patients with underlying liver disease (HCC) failed to significantly induce TPO postoperatively. Accordingly, HCC patients had significantly lower TPO levels on POD1 and 5. Similarly, patients with major resections failed to increase circulating TPO levels. Perioperative dynamics of TPO were found to specifically predict liver dysfunction (AUC: 0.893, P < 0.001) after hepatectomy and remained an independent predictor upon multivariate analysis. Conclusions We here demonstrate that perioperative TPO dynamics are associated with postoperative LD. Postoperative TPO levels were found to be lowest in high-risk patients (HCC patients undergoing major resection) but showed an independent predictive value. Thus, a dampened TPO increase after liver resection reflects a poor capacity for hepatic recovery and may help to identify patients who require close monitoring or intervention for potential complications.	[Haegele, Stefanie; Offensperger, Florian; Pereyra, David; Lahner, Elisabeth; Gruenberger, Thomas; Brostjan, Christine; Starlinger, Patrick] Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria; [Assinger, Alice] Med Univ Vienna, Inst Physiol, Vienna, Austria; [Fleischmann, Edith] Med Univ Vienna, Gen Hosp, Dept Anesthesiol, Vienna, Austria; [Gruenberger, Birgit] Bros Char Hosp, Dept Internal Med, Vienna, Austria; [Gruenberger, Thomas] Rudolf Fdn Clin, Dept Surg 1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Brostjan, C (corresponding author), Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria.	christine.brostjan@meduniwien.ac.at; patrick.starlinger@meduniwien.ac.at	Gruenberger, Thomas/ABA-1661-2020	Gruenberger, Thomas/0000-0002-2671-0540; Starlinger, Patrick/0000-0002-4666-5337; Pereyra, David/0000-0001-6700-9163; Brostjan, Christine/0000-0003-1462-5397; Assinger, Alice/0000-0002-5670-5910	Austrian Society of Surgical Oncology (ACO-ASSO) with the "Georg-Stumpf Grant"; Association of Research on the Biology of Liver Tumors	Austrian Society of Surgical Oncology (ACO-ASSO) with the "Georg-Stumpf Grant"; Association of Research on the Biology of Liver Tumors	This work was supported by the Austrian Society of Surgical Oncology (ACO-ASSO) with the "Georg-Stumpf Grant 2012" and the Association of Research on the Biology of Liver Tumors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2006, ANN SURG ONCOL, V13, P1271, DOI 10.1245/s10434-006-9045-5; Afdhal NH, 2012, NEW ENGL J MED, V367, P716, DOI 10.1056/NEJMoa1110709; Akkerman JWN, 2006, SEMIN THROMB HEMOST, V32, P295, DOI 10.1055/s-2006-939442; Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; Cardier JE, 1998, BLOOD, V91, P923, DOI 10.1182/blood.V91.3.923.923_923_929; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Dello SAWG, 2011, HPB, V13, P324, DOI 10.1111/j.1477-2574.2010.00289.x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Eissa LA, 2008, ANN HEPATOL, V7, P235, DOI 10.1016/S1665-2681(19)31854-X; Freni MA, 2002, HEPATO-GASTROENTEROL, V49, P1382; Giannini E, 2003, AM J GASTROENTEROL, V98, P2516, DOI 10.1111/j.1572-0241.2003.08665.x; Goulis J, 1999, GUT, V44, P754, DOI 10.1136/gut.44.5.754; Hidaka H, 2002, HEPATOL RES, V23, P265, DOI 10.1016/S1386-6346(02)00002-5; Ichiba M, 2005, BIOCHEM BIOPH RES CO, V335, P723, DOI 10.1016/j.bbrc.2005.07.127; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; KAUSHANSKY K, 1995, P NATL ACAD SCI USA, V92, P3234, DOI 10.1073/pnas.92.8.3234; Kawasaki T, 1999, AM J GASTROENTEROL, V94, P1918; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Koruk M, 2002, HEPATO-GASTROENTEROL, V49, P1645; Krieger PM, 2011, ANN SURG ONCOL, V18, P1644, DOI 10.1245/s10434-010-1494-1; Kuter DJ, 2007, BLOOD, V109, P4607, DOI 10.1182/blood-2006-10-019315; Kuter DJ, 2013, INT J HEMATOL, V98, P10, DOI 10.1007/s12185-013-1382-0; Larsen SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085566; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; McHutchison JG, 2007, NEW ENGL J MED, V357, P2227, DOI 10.1056/NEJMoa073255; Mullen JT, 2007, J AM COLL SURGEONS, V204, P854, DOI 10.1016/j.jamcollsurg.2006.12.032; Murata S, 2008, ANN SURG, V248, P821, DOI 10.1097/SLA.0b013e31818584c7; Murata S, 2008, WORLD J SURG, V32, P1088, DOI 10.1007/s00268-008-9493-0; Murata S, 2007, WORLD J SURG, V31, P808, DOI 10.1007/s00268-006-0772-3; Okubo M, 2000, CLIN SCI, V99, P207, DOI 10.1042/CS20000023; Panasiuk A, 2004, HEPATO-GASTROENTEROL, V51, P1124; Peck-Radosavljevic M, 2000, Can J Gastroenterol, V14 Suppl D, p60D; PeckRadosavljevic M, 1997, J HEPATOL, V27, P127, DOI 10.1016/S0168-8278(97)80291-7; Qian SG, 1998, BLOOD, V92, P2189, DOI 10.1182/blood.V92.6.2189; Rios R, 2005, AM J GASTROENTEROL, V100, P1311, DOI 10.1111/j.1572-0241.2005.41543.x; Schiodt FV, 2003, HEPATOLOGY, V37, P558, DOI 10.1053/jhep.2003.50113; Schmelzer E, 2008, EUR J GASTROEN HEPAT, V20, P209, DOI 10.1097/MEG.0b013e3282f246e6; Shimabukuro R, 2009, SURG TODAY, V39, P1054, DOI 10.1007/s00595-008-4054-6; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; Starlinger P, 2010, J THROMB HAEMOST, V8, P1809, DOI 10.1111/j.1538-7836.2010.03908.x; Starlinger P, 2013, J HEPATOL, V58, P1053, DOI 10.1016/j.jhep.2012.11.037; Starlinger P, 2011, DIS MARKERS, V31, P55, DOI [10.1155/2011/535109, 10.3233/DMA-2011-0798]; Starlinger P, 2011, NEOPLASIA, V13, P419, DOI 10.1593/neo.101508; Strasberg SM, 2005, J HEPATO-BILIARY-PAN, V12, P351, DOI 10.1007/s00534-005-0999-7; Tamandl D, 2010, ANN SURG, V252, P124, DOI 10.1097/SLA.0b013e3181deb67f; Tomikawa M, 1996, J AM COLL SURGEONS, V182, P12; Van Cutsem E, 2006, EUR J CANCER, V42, P2212, DOI 10.1016/j.ejca.2006.04.012; van Os E, 2003, BRIT J HAEMATOL, V121, P482, DOI 10.1046/j.1365-2141.2003.04292.x; van Willigen G, 2000, THROMB HAEMOSTASIS, V83, P610; Wei AC, 2003, BRIT J SURG, V90, P33, DOI 10.1002/bjs.4018	50	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116985	10.1371/journal.pone.0116985	http://dx.doi.org/10.1371/journal.pone.0116985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611592	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900028
J	Bach, JN; Bramkamp, M				Bach, Juri Nino; Bramkamp, Marc			Dissecting the Molecular Properties of Prokaryotic Flotillins	PLOS ONE			English	Article							SPFH DOMAIN; MEMBRANE TOPOLOGY; IN-VITRO; PROTEINS; IDENTIFICATION; OLIGOMERIZATION; ASSOCIATION; REGGIE-1; REGGIE-1/FLOTILLIN-2; PALMITOYLATION	Flotillins are universally conserved proteins that are present in all kingdoms of life. Recently it was demonstrated that the B. subtilis flotillin YuaG (FloT) has a direct influence on membrane domain formation by orchestrating lipid domains. Thereby it allocates a proper environment for diverse cellular machineries. YuaG creates platforms for signal transduction, processes crucial for biofilm formation, sporulation, competence, secretion, and others. Even though, flotillins are an emerging topic of research in the field of microbiology little is known about the molecular architecture of prokaryotic flotillins. All flotillins share common structural elements and are tethered to the membrane N'-terminally, followed by a so called PHB domain and a flotillin domain. We show here that prokaryotic flotillins are, similarly to eukaryotic flotillins, tethered to the membrane via a hairpin loop. Further it is demonstrated by sedimentation assays that B. subtilis flotillins do not bind to the membrane via their PHB domain contrary to eukaryotic flotillins. Size exclusion chromatography experiments, blue native PAGE and cross linking experiments revealed that B. subtilis YuaG can oligomerize into large clusters via the PHB domain. This illustrates an important difference in the setup of prokaryotic flotillins compared to the organization of eukaryotic flotillins.	[Bach, Juri Nino; Bramkamp, Marc] Univ Munich, Dept Biol 1, Munich, Germany	University of Munich	Bramkamp, M (corresponding author), Univ Munich, Dept Biol 1, Munich, Germany.	marc.bramkamp@lmu.de		Bramkamp, Marc/0000-0002-7704-3266	Deutsche Forschungsgemeinschaft [DFG BR 2915/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge financial support from the Deutsche Forschungsgemeinschaft (DFG BR 2915/2-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Bach JN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00059; Bach JN, 2013, MOL MICROBIOL, V88, P1205, DOI 10.1111/mmi.12252; Banning A, 2011, CURR PROTEIN PEPT SC, V12, P725, DOI 10.2174/138920311798841708; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bramkamp M, 2012, BIOL CHEM, V393, P1203, DOI 10.1515/hsz-2012-0185; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Burmann F, 2011, MOL MICROBIOL, V79, P1294, DOI 10.1111/j.1365-2958.2011.07523.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Donovan C, 2009, MICROBIOL-SGM, V155, P1786, DOI 10.1099/mic.0.025312-0; Feng XX, 2014, CHEM BIOL, V21, P1557, DOI 10.1016/j.chembiol.2014.08.018; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hinderhofer M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-10; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kadurin I, 2009, BIOCHEM J, V418, P587, DOI 10.1042/BJ20081662; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kuwahara Y, 2009, BIOPHYS J, V97, P2034, DOI 10.1016/j.bpj.2009.07.034; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Monier S, 1996, FEBS LETT, V388, P143, DOI 10.1016/0014-5793(96)00519-4; Monne M, 1999, J MOL BIOL, V293, P807, DOI 10.1006/jmbi.1999.3183; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; PARTRIDGE SR, 1991, MOL MICROBIOL, V5, P757, DOI 10.1111/j.1365-2958.1991.tb00746.x; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; SALZER U, 1993, BIOCHIM BIOPHYS ACTA, V1151, P149, DOI 10.1016/0005-2736(93)90098-K; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schurek EM, 2014, J BIOL CHEM, V289, P11262, DOI 10.1074/jbc.M113.521773; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Snyers L, 1999, FEBS LETT, V449, P101, DOI 10.1016/S0014-5793(99)00417-2; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Stuermer CAO, 2011, BBA-MOL BASIS DIS, V1812, P415, DOI 10.1016/j.bbadis.2010.12.004; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Vitrac H, 2013, P NATL ACAD SCI USA, V110, P9338, DOI 10.1073/pnas.1304375110; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yepes A, 2012, MOL MICROBIOL, V86, P457, DOI 10.1111/j.1365-2958.2012.08205.x	53	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116750	10.1371/journal.pone.0116750	http://dx.doi.org/10.1371/journal.pone.0116750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635948	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700057
J	Hofmann, F; Blasche, R; Kasper, M; Barth, K				Hofmann, Falk; Blaesche, Robert; Kasper, Michael; Barth, Kathrin			A Co-Culture System with an Organotypic Lung Slice and an Immortal Alveolar Macrophage Cell Line to Quantify Silica-Induced Inflammation	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; EPITHELIAL-CELLS; IN-VITRO; IMMUNOHISTOCHEMICAL EVIDENCE; INTRATRACHEAL INSTILLATION; DECREASED EXPRESSION; CAVEOLIN-1 PROTECTS; CRITICAL REGULATOR; BLEOMYCIN; NANOPARTICLES	There is growing evidence that amorphous silica nanoparticles cause toxic effects on lung cells in vivo as well as in vitro and induce inflammatory processes. The phagocytosis of silica by alveolar macrophages potentiates these effects. To understand the underlying molecular mechanisms of silica toxicity, we applied a co-culture system including the immortal alveolar epithelial mouse cell line E10 and the macrophage cell line AMJ2-C11. In parallel we exposed precision-cut lung slices (lacking any blood cells as well as residual alveolar macrophages) of wild type and P2rx7(-/-) mice with or without AMJ2-C11 cells to silica nanoparticles. Exposure of E10 cells as well as slices of wild type mice resulted in an increase of typical alveolar epithelial type 1 cell proteins like T1 alpha, caveolin-1 and -2 and PKC-beta 1, whereas the co-culture with AMJ2-C11 showed mostly a slightly lesser increase of these proteins. In P2rx7(-/-) mice most of these proteins were slightly decreased. ELISA analysis of the supernatant of wild type and P2rx7(-/-) mice precision-cut lung slices showed decreased amounts of IL-6 and TNF-alpha when incubated with nano-silica. Our findings indicate that alveolar macrophages influence the early inflammation of the lung and also that cell damaging reagents e.g. silica have a smaller impact on P2rx7(-/-) mice than on wild type mice. The co-culture system with an organotypic lung slice is a useful tool to study the role of alveolar macrophages during lung injury at the organoid level.	[Hofmann, Falk; Blaesche, Robert; Kasper, Michael; Barth, Kathrin] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Anat, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Barth, K (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Anat, Dresden, Germany.	kathrin.barth@tu-dresden.de	Barth, Kathrin/AGX-6107-2022					Antonini JM, 2000, LUNG, V178, P341, DOI 10.1007/s004080000038; Barth K, 2008, INT J BIOCHEM CELL B, V40, P2230, DOI 10.1016/j.biocel.2008.03.001; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; Blasche R, 2012, INT J BIOCHEM CELL B, V44, P514, DOI 10.1016/j.biocel.2011.12.003; Chen M, 2005, EXP CELL RES, V305, P51, DOI 10.1016/j.yexcr.2004.12.021; DieckmannSchuppert A, 1997, CELL TISSUE RES, V288, P119, DOI 10.1007/s004410050799; Ebeling G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100282; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Eom HJ, 2009, TOXICOL IN VITRO, V23, P1326, DOI 10.1016/j.tiv.2009.07.010; Fujimura N, 2000, Curr Opin Pulm Med, V6, P140, DOI 10.1097/00063198-200003000-00010; Gabazza EC, 2004, PATHOL INT, V54, P774, DOI 10.1111/j.1440-1827.2004.01754.x; Gilberti RM, 2008, AM J RESP CELL MOL, V39, P619, DOI 10.1165/rcmb.2008-0046OC; Green FHY, 2007, TOXICOL PATHOL, V35, P136, DOI 10.1080/01926230601132055; Held HD, 1999, BRIT J PHARMACOL, V126, P1191, DOI 10.1038/sj.bjp.0702394; Herold S, 2013, AM J PHYSIOL-LUNG C, V305, pL665, DOI 10.1152/ajplung.00232.2013; Herzog CR, 1996, ONCOGENE, V13, P1885; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Jin Y, 2008, AM J RESP CELL MOL, V39, P171, DOI 10.1165/rcmb.2007-0323OC; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Jin Y, 2009, FASEB J, V23, P341, DOI 10.1096/fj.08-108423; Kasper M, 2000, INT J RADIAT BIOL, V76, P493; KASPER M, 1995, HISTOCHEM CELL BIOL, V104, P397, DOI 10.1007/BF01458134; Kasper M, 2004, HISTOCHEM CELL BIOL, V121, P131, DOI 10.1007/s00418-003-0612-6; Kasper M, 1998, HISTOCHEM CELL BIOL, V109, P41; Kasper M, 2009, CURR CANCER DRUG TAR, V9, P341, DOI 10.2174/156800909788166501; Kojima S, 2014, TOXICOLOGY, V321, P13, DOI 10.1016/j.tox.2014.03.008; Koslowski R, 1998, EUR RESPIR J, V12, P1397, DOI 10.1183/09031936.98.12061397; Li XY, 1999, INHAL TOXICOL, V11, P709; Lin WS, 2006, TOXICOL APPL PHARM, V217, P252, DOI 10.1016/j.taap.2006.10.004; Linge A, 2007, ANTICANCER RES, V27, P1343; McElroy MC, 2004, EUR RESPIR J, V24, P664, DOI 10.1183/09031936.04.00096003; Moncao-Ribeiro LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110185; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mungunsukh O, 2010, AM J PHYSIOL-LUNG C, V298, pL696, DOI 10.1152/ajplung.00322.2009; Nabeshi H, 2010, PHARMAZIE, V65, P199, DOI 10.1691/ph.2010.9268; Nemmar A, 2003, TOXICOL APPL PHARM, V186, P38, DOI 10.1016/S0041-008X(02)00024-8; Odajima N, 2007, J HISTOCHEM CYTOCHEM, V55, P899, DOI 10.1369/jhc.7A7203.2007; PALLERONI AV, 1991, INT J CANCER, V49, P296, DOI 10.1002/ijc.2910490226; Rao KMK, 2004, ENVIRON HEALTH PERSP, V112, P1679, DOI 10.1289/ehp.7295; Rastrick J, 2014, MINERVA MED, V105, P9; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; Shi YL, 2010, J TOXICOL ENV HEAL A, V73, P748, DOI 10.1080/15287391003614042; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; VANHEE D, 1995, EUR RESPIR J, V8, P834; Wallach-Dayan SB, 2006, AM J PHYSIOL-LUNG C, V290, pL790, DOI 10.1152/ajplung.00300.2004; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wiley JS, 2012, PURINERG SIGNAL, V8, P579, DOI 10.1007/s11302-012-9308-5; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wottrich R, 2004, INT J HYG ENVIR HEAL, V207, P353, DOI 10.1078/1438-4639-00300; Ye YY, 2010, TOXICOL IN VITRO, V24, P751, DOI 10.1016/j.tiv.2010.01.001; Ye YY, 2010, ENVIRON TOXICOL PHAR, V29, P131, DOI 10.1016/j.etap.2009.12.002; Yu KO, 2009, J NANOPART RES, V11, P15, DOI 10.1007/s11051-008-9417-9; Zhang M, 2009, AM J PHYSIOL-LUNG C, V297, pL945, DOI 10.1152/ajplung.00081.2009; Zhang QW, 2003, J OCCUP HEALTH, V45, P23, DOI 10.1539/joh.45.23	55	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117056	10.1371/journal.pone.0117056	http://dx.doi.org/10.1371/journal.pone.0117056			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635824	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700069
J	Zhong, YF; Wang, K; Zhang, XW; Cai, XF; Chen, YP; Deng, YY				Zhong, Yifei; Wang, Ke; Zhang, Xianwen; Cai, Xiaofan; Chen, Yiping; Deng, Yueyi			Nephrokeli, a Chinese Herbal Formula, May Improve IgA Nephropathy through Regulation of the Sphingosine-1-Phosphate Pathway	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; PROTEIN-COUPLED RECEPTORS; SPHINGOSINE 1-PHOSPHATE; CELL-PROLIFERATION; CANCER CELLS; KINASE; ACTIVATION; EXPRESSION; APIGENIN; FRUITS	Nephrokeli (NPKL) is a Chinese herbal formula that has been used to treat patients with IgA nephropathy (IgAN) for improvement of proteinuria and kidney injury. However, the mechanism remains unclear. Sphingosine-1-phosphate (S1P) and its receptors S1PR2 and S1PR3 are known to play an important role in kidney disease. Here, we tested whether NPKL is able to regulate the S1P pathway in the kidney of IgAN rats. Four groups of rats were included in the study: Control, IgAN, IgAN treated with losartan, and IgAN treated with NPKL. The IgAN model was generated by injection of bovine serum albumin and staphylococcus enterotoxin B. We found that IgAN rats had increased staining for proliferating cell nuclear antigen (PCNA) in the mesangial area and increased mRNA and protein levels of S1PR2 and S1PR3 in the kidney compared to control rats. Connective tissue growth factor (CTGF), a downstream growth factor in the S1P pathway, was also elevated in the kidney of IgAN rats. Treatment with either NPKL or losartan was able to reduce PCNA staining and the expression of both S1PR2 and S1PR3 in the kidney of IgAN rats. However, NPKL (but not losartan treatment) reduced the expression of CTGF in the kidney of IgAN rats. In addition, we treated rat mesangial cells with sera collected from either NPKL-treated rats or control rats and found that NPKL-serum was able to reduce S1P-induced mesangial cell proliferation and the expression of S1PR2/S1PR3 and CTGF. NPKL also attenuates expression of fibrosis, inflammation, and oxidative stress markers in the kidney of IgAN rats. Our studies provide the mechanism by which NPKL attenuates kidney injury in IgAN rats.	[Zhong, Yifei; Zhang, Xianwen; Cai, Xiaofan; Chen, Yiping; Deng, Yueyi] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Nephrol, Shanghai, Peoples R China; [Wang, Ke] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Surg Res Inst Tradit Chinese Med Combined Western, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Zhong, YF (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Nephrol, Shanghai, Peoples R China.	yifeilily@126.com; dengyueyi@medmail.com.cn	Chen, Yi/HIR-2608-2022; zhang, xian/GYA-0290-2022		National Natural Science Foundation of China [1999-30901944]; Shanghai Bureau of Science and Technology [2000-10QA1406500]; Shanghai Bureau of Health [2011-XYQ2011059]; Shanghai Pujiang Program [14PJ1408000]; Shanghai Three-Years Development Program for Traditional Chinese Medicine [ZYSNXD-CC-HPGC-JD-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Bureau of Science and Technology; Shanghai Bureau of Health; Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Three-Years Development Program for Traditional Chinese Medicine	The research conducted in this manuscript was supported by the grants to Dr. Yifei Zhong from the National Natural Science Foundation of China for Young Investigators (1999-30901944), the Shanghai Bureau of Science and Technology for Young Investigator (2000-10QA1406500), and the Shanghai Bureau of Health for Young Investigators (2011-XYQ2011059). Shanghai Pujiang Program (14PJ1408000), Shanghai Three-Years Development Program for Traditional Chinese Medicine (ZYSNXD-CC-HPGC-JD-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 1999, J BIOL CHEM, V274, P3994, DOI 10.1074/jbc.274.7.3994; Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Brizuela L, 2007, J LIPID RES, V48, P2264, DOI 10.1194/jlr.M700291-JLR200; Coppo R, 2010, J NEPHROL, V23, P626; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; EMANCIPATOR SN, 1987, LAB INVEST, V57, P269; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Geoffroy K, 2004, J BIOL CHEM, V279, P34343, DOI 10.1074/jbc.M403273200; Harrison ME, 2014, EXP MOL PATHOL, V97, P211, DOI 10.1016/j.yexmp.2014.07.006; He ZD, 2001, CHEM PHARM BULL, V49, P780, DOI 10.1248/cpb.49.780; Heringdorf DM, 1999, FEBS LETT, V461, P217, DOI 10.1016/S0014-5793(99)01463-5; Huwiler A, 2006, CURR PHARM DESIGN, V12, P4625, DOI 10.2174/138161206779010422; Jin D, 2015, CELL BIOCHEM BIOPHYS, V71, P1349, DOI 10.1007/s12013-014-0355-0; Katsuma S, 2005, FEBS LETT, V579, P2576, DOI 10.1016/j.febslet.2005.03.073; Katsuma S, 2002, GENES CELLS, V7, P1217, DOI 10.1046/j.1365-2443.2002.00594.x; Katsuma S., 2001, Pharmacogenomics Journal, V1, P211; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Li LS, 2004, KIDNEY INT, V66, P920, DOI 10.1111/j.1523-1755.2004.00837.x; Liu RJ, 2014, DIABETES, V63, P2440, DOI 10.2337/db13-1810; Liu Yi, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P1308; Liu ZH., 1989, CHINESE J NEPHROL, V5, P6; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Olivera A, 2001, PROSTAG OTH LIPID M, V64, P123, DOI 10.1016/S0090-6980(01)00108-3; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Rithidech KN, 2012, MUTAT RES-GEN TOX EN, V749, P29, DOI 10.1016/j.mrgentox.2012.08.001; Shi LF, 1998, BIOMED CHROMATOGR, V12, P27; Wahab NA, 2001, BIOCHEM J, V359, P77, DOI 10.1042/0264-6021:3590077; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; WIDSTAMATTORPS U, 1992, CLIN NEPHROL, V38, P245; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Xiao WQ, 2014, INT J MOL SCI, V15, P11957, DOI 10.3390/ijms150711957; XU B, 2011, CHINESE J INTEGRATED, V12, P333; Yamashita H, 2006, J SURG RES, V130, P80, DOI 10.1016/j.jss.2005.08.004; Zhang GF, 1999, GENE, V227, P89, DOI 10.1016/S0378-1119(98)00589-7; Zhang XX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0107072, 10.1371/journal.pone.0110243]; ZHANG Y, 2007, J GUANGZHOU U TRADIT, V24, P231; Zhong YF, 2013, KIDNEY INT, V84, P1108, DOI 10.1038/ki.2013.276; [周玲 ZHOU Ling], 2008, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V19, P259; Zhu WJ, 2012, LIFE SCI, V91, P369, DOI 10.1016/j.lfs.2012.08.013	42	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116873	10.1371/journal.pone.0116873	http://dx.doi.org/10.1371/journal.pone.0116873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633986	Green Published, Green Submitted, gold			2022-12-27	WOS:000348609800011
J	Yamada, H; Yamaguchi, M; Chikamatsu, K; Aono, A; Mitarai, S				Yamada, Hiroyuki; Yamaguchi, Masashi; Chikamatsu, Kinuyo; Aono, Akio; Mitarai, Satoshi			Structome Analysis of Virulent Mycobacterium tuberculosis, Which Survives with Only 700 Ribosomes per 0.1 fl of Cytoplasm	PLOS ONE			English	Article							FREEZE-SUBSTITUTION; ELECTRON-MICROSCOPY; EXOPHIALA-DERMATITIDIS; OUTER-MEMBRANE; YEAST-CELLS; GROWTH; SUSCEPTIBILITY; RESISTANCE; SEQUENCE; RNA	We previously reported the exquisite preservation of the ultrastructures of virulent Mycobacterium tuberculosis cells processed through cryofixation and rapid freeze substitution. Here, we report the "structome" analysis (i.e., the quantitative three-dimensional structural analysis of a whole cell at the electron microscopic level) of virulent M. tuberculosis using serial ultrathin sections prepared after cryofixation and rapid freeze substitution and analyzed by transmission electron microscopy. Five M. tuberculosis cells, which were contained in the serial ultrathin cross sections encompassing from one end to the other, were cut into 24, 36, 69, 55, and 63 serial ultrathin sections, respectively. On average, the cells were 2.71 +/- 1.05 mu m in length, and the average diameter of the cell was 0.345 +/- 0.029 mu m. The outer membrane and plasma membrane surface areas were 3.04 +/- 1.33 mu m(2) and 2.67 +/- 1.19 mu m(2), respectively. The cell, outer membrane, periplasm, plasma membrane, and cytoplasm volumes were 0.293 +/- 0.113 fl (= mu m(3)), 0.006 +/- 0.003 fl, 0.060 +/- 0.021 fl, 0.019 +/- 0.008 fl, and 0.210 +/- 0.091 fl, respectively. The average total ribosome number was 1,672 +/- 568, and the ribosome density was 716.5 +/- 171.4/0.1 fl. This is the first report of a structome analysis of M. tuberculosis cells prepared as serial ultrathin sections following cryofixation and rapid freeze substitution and examined by transmission electron microscopy. These data are based on the direct measurement and enumeration of exquisitely preserved single-cell structures in transmission electron microscopy images rather than calculations or assumptions from indirect biochemical or molecular biological data. In addition, these data may explain the slow growth of M. tuberculosis and enhance understanding of the structural properties related to the expression of antigenicity, acid-fastness, and the mechanism of drug resistance, particularly in regard to the ratio of target to drug concentrations.	[Yamada, Hiroyuki; Chikamatsu, Kinuyo; Aono, Akio; Mitarai, Satoshi] Japan Anti TB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, Kiyose, Tokyo, Japan; [Yamaguchi, Masashi] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan	Chiba University	Yamada, H (corresponding author), Japan Anti TB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, Kiyose, Tokyo, Japan.	hyamada@jata.or.jp		Yamada, Hiroyuki/0000-0002-2720-9125	Ministry of Health, Labour and Welfare of Japan [H24-SHINKO-IPPAN-011]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Health Science Research grant (H24-SHINKO-IPPAN-011) from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Ardito F, 2001, J CLIN MICROBIOL, V39, P4440, DOI 10.1128/JCM.39.12.4440-4444.2001; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Biswas SK, 2003, J ELECTRON MICROSC, V52, P133, DOI 10.1093/jmicro/52.2.133; Calder N, 1976, THE HUMAN CONSPIRACY, P75; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox RA, 2003, MICROBIOL-SGM, V149, P729, DOI 10.1099/mic.0.25645-0; Cox RA, 2003, MICROBIOLOGY, V150, P1413; Cox RA, 2007, MICROBIOL-SGM, V153, P3337, DOI 10.1099/mic.0.2007/005868-0; Cox RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059883; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jagielski T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100078; Ohta K, 2012, MICRON, V43, P612, DOI 10.1016/j.micron.2011.11.001; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Pelchovich G, 2013, INT J ANTIMICROB AG, V42, P129, DOI 10.1016/j.ijantimicag.2013.04.001; Santi I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3470; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Tekwu EM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-113; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Yamada H, 2014, J MICROBIOL METH, V96, P50, DOI 10.1016/j.mimet.2013.10.019; Yamada H, 2012, TUBERCULOSIS, V92, P351, DOI 10.1016/j.tube.2012.02.006; Yamada H, 2010, J MICROBIOL METH, V80, P14, DOI 10.1016/j.mimet.2009.09.022; Yamaguchi M, 2002, EXP CELL RES, V279, P71, DOI 10.1006/excr.2002.5578; Yamaguchi M., 2006, Current trends in microbiology, Volume 2, P1; Yamaguchi M, 2011, J ELECTRON MICROSC, V60, P321, DOI 10.1093/jmicro/dfr052; Yamaguchi M, 2009, J ELECTRON MICROSC, V58, P261, DOI 10.1093/jmicro/dfp013; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	28	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117109	10.1371/journal.pone.0117109	http://dx.doi.org/10.1371/journal.pone.0117109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629354	gold, Green Submitted, Green Published			2022-12-27	WOS:000348732100066
J	Mather, KA; Armstrong, NJ; Wen, W; Kwok, JB; Assareh, AA; Thalamuthu, A; Reppermund, S; Duesing, K; Wright, MJ; Ames, D; Trollor, JN; Brodaty, H; Schofield, PR; Sachdev, PS				Mather, Karen A.; Armstrong, Nicola J.; Wen, Wei; Kwok, John B.; Assareh, Amelia A.; Thalamuthu, Anbupalam; Reppermund, Simone; Duesing, Konsta; Wright, Margaret J.; Ames, David; Trollor, Julian N.; Brodaty, Henry; Schofield, Peter R.; Sachdev, Perminder S.			Investigating the Genetics of Hippocampal Volume in Older Adults without Dementia	PLOS ONE			English	Article							COMMON VARIANTS; ASSOCIATION; GENOTYPE; HERITABILITY; METAANALYSIS; PERSPECTIVE	Hippocampal atrophy is observed with ageing and age-related neurodegenerative disease. Identification of the genetic correlates of hippocampal volume (HV) and atrophy may assist in elucidating the mechanisms of ageing and age-related neurodegeneration. Using two community cohorts of older Caucasians we estimated the heritability of HV and examined associations of HV with previously identified single nucleotide polymorphisms (SNPs). In addition we undertook genome-association studies (GWAS) examining HV and HV atrophy. Participants were community-dwelling non-demented older adults from the longitudinal Sydney Memory and Ageing Study (Sydney MAS) (N = 498) and the Older Australian Twins Study (OATS) (N = 351) aged 65 and over. HV was measured using T1-weighted magnetic resonance images. Heritability of HV was estimated in OATS. Genome-wide genotyping was imputed using the 1K Genomes reference set. Associations with HV-candidate and Alzheimer's disease (AD)-related SNPs were investigated. A GWAS examining HV (in both cohorts) and an exploratory GWAS of HV atrophy over two years (in Sydney MAS only) were also undertaken. HV heritability was estimated at 62-65%. The previously identified GWAS HV SNP (rs6581612) and the candidate BDNF SNP (rs6265) were nominally significant (p = 0.047 and p = 0.041 respectively). No AD-related SNPs, including the APOE epsilon 4 polymorphism, were significant. No significant results were observed for either of the GWAS undertaken. Despite our estimate of a high heritability of HV, our results are consistent with a highly polygenic model suggesting that SNPs identified from prior studies, including GWAS meta-analyses, can be difficult to replicate in smaller samples of older adults.	[Mather, Karen A.; Armstrong, Nicola J.; Wen, Wei; Assareh, Amelia A.; Thalamuthu, Anbupalam; Reppermund, Simone; Trollor, Julian N.; Brodaty, Henry; Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Armstrong, Nicola J.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Armstrong, Nicola J.] UNSW, Sch Math & Stat, Sydney, NSW, Australia; [Kwok, John B.; Schofield, Peter R.] Neurosci Res Australia, Sydney, NSW, Australia; [Kwok, John B.; Schofield, Peter R.] UNSW, Sch Med Sci, Sydney, NSW, Australia; [Duesing, Konsta] CSIRO, Anim Food & Hlth Sci Div, Sydney, NSW, Australia; [Wright, Margaret J.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Ames, David] Royal Melbourne Hosp, Natl Ageing Res Inst, Melbourne, Vic, Australia; [Ames, David] Univ Melbourne, Acad Unit Psychiat Old Age, Melbourne, Vic, Australia; [Trollor, Julian N.] UNSW, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia; [Brodaty, Henry] UNSW, Primary Dementia Collaborat Res Ctr, Sydney, NSW, Australia; [Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); QIMR Berghofer Medical Research Institute; National Ageing Research Institute; Royal Melbourne Hospital; University of Melbourne; University of New South Wales Sydney; University of New South Wales Sydney	Mather, KA (corresponding author), Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia.	karen.mather@unsw.edu.au	Wright, Margaret Jane/A-4560-2016; Karen, Mather A/O-9795-2016; Duesing, Konsta/H-2802-2013; Armstrong, Nicola J./AAF-3045-2021; Thalamuthu, Anbupalam/Z-5545-2019; Sachdev, Perminder/ABC-1137-2020; Schofield, Peter/C-9669-2011	Wright, Margaret Jane/0000-0001-7133-4970; Karen, Mather A/0000-0003-4143-8941; Duesing, Konsta/0000-0003-3103-0600; Armstrong, Nicola J./0000-0002-4477-293X; Thalamuthu, Anbupalam/0000-0002-7114-1260; Sachdev, Perminder/0000-0002-9595-3220; Kwok, John/0000-0001-9574-6195; Wen, Wei/0000-0003-2753-3870; Trollor, Julian/0000-0002-7685-2977; Schofield, Peter/0000-0003-2967-9662	Australian National Health and Medical Research Council (NHMRC) [350833, 568969]; NHMRC/Australian Research Council Strategic Award [401162]; NHMRC Project Grant [1045325, 525453]; NHMRC Enabling Grant [310667]; Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund Grant; NHMRC Grant [401184]; Australian Government - Dementia Collaborative Research Centre (DCRC), UNSW; DCRC; Alzheimer's Australia Dementia Research Foundation Postdoctoral Fellowship; NHMRC Capacity Building Grant [568940]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020403] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC/Australian Research Council Strategic Award(Australian Research Council); NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Enabling Grant(National Health and Medical Research Council (NHMRC) of Australia); Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund Grant; NHMRC Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Government - Dementia Collaborative Research Centre (DCRC), UNSW(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); DCRC; Alzheimer's Australia Dementia Research Foundation Postdoctoral Fellowship; NHMRC Capacity Building Grant(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a number of sources. Sydney MAS was supported by the Australian National Health and Medical Research Council (NHMRC) Program Grants 350833 and 568969. OATS is supported by the NHMRC/Australian Research Council Strategic Award 401162 and NHMRC Project Grant 1045325. OATS was facilitated through access to the Australian Twin Registry, a national research resource supported by the NHMRC Enabling Grant 310667, administered by the University of Melbourne. OATS genotyping was partly funded by a Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund Grant. DNA was extracted by Genetic Repositories Australia, an Enabling Facility supported by the NHMRC Grant 401184. Henry Brodaty is supported by the Australian Government funded Dementia Collaborative Research Centre (DCRC), UNSW. Amelia Assareh was supported by a PhD scholarship from the DCRC. Nicola Armstrong is supported by the NHMRC Project Grant 525453 and Karen Mather is supported by an Alzheimer's Australia Dementia Research Foundation Postdoctoral Fellowship. Both Simone Reppermund and Karen Mather are supported by the NHMRC Capacity Building Grant 568940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Batouli SAH, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.10.079; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Blokland GAM, 2012, TWIN RES HUM GENET, V15, P351, DOI 10.1017/thg.2012.11; Boker S.M., 2012, OPENMX 1 3 USER GUID; den Braber A, 2013, NEUROIMAGE, V83, P98, DOI 10.1016/j.neuroimage.2013.06.027; Ferencz B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00198; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Jak AJ, 2007, DEMENT GERIATR COGN, V23, P382, DOI 10.1159/000101340; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang JY, 2014, NEUROIMAGE, V86, P203, DOI 10.1016/j.neuroimage.2013.08.022; Kim H, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.013; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Melville SA, 2012, ANN NEUROL, V72, P65, DOI 10.1002/ana.23644; Molendijk ML, 2012, AM J MED GENET B, V159B, P731, DOI 10.1002/ajmg.b.32078; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Mueller SG, 2009, HIPPOCAMPUS, V19, P558, DOI 10.1002/hipo.20614; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Sachdev PS, 2009, TWIN RES HUM GENET, V12, P573, DOI 10.1375/twin.12.6.573; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034078; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Sullivan EV, 2001, HIPPOCAMPUS, V11, P754, DOI 10.1002/hipo.1091; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	32	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116920	10.1371/journal.pone.0116920	http://dx.doi.org/10.1371/journal.pone.0116920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625606	Green Published, gold			2022-12-27	WOS:000348821400023
J	Wahabzada, M; Mahlein, AK; Bauckhage, C; Steiner, U; Oerke, EC; Kersting, K				Wahabzada, Mirwaes; Mahlein, Anne-Katrin; Bauckhage, Christian; Steiner, Ulrike; Oerke, Erich-Christian; Kersting, Kristian			Metro Maps of Plant Disease Dynamics-Automated Mining of Differences Using Hyperspectral Images	PLOS ONE			English	Article							BARLEY; REFLECTANCE; SYMPTOMS; CROPS; RUST	Understanding the response dynamics of plants to biotic stress is essential to improve management practices and breeding strategies of crops and thus to proceed towards a more sustainable agriculture in the coming decades. In this context, hyperspectral imaging offers a particularly promising approach since it provides non-destructive measurements of plants correlated with internal structure and biochemical compounds. In this paper, we present a cascade of data mining techniques for fast and reliable data-driven sketching of complex hyperspectral dynamics in plant science and plant phenotyping. To achieve this, we build on top of a recent linear time matrix factorization technique, called Simplex Volume Maximization, in order to automatically discover archetypal hyperspectral signatures that are characteristic for particular diseases. The methods were applied on a data set of barley leaves (Hordeum vulgare) diseased with foliar plant pathogens Pyrenophora teres, Puccinia hordei and Blumeria graminis hordei. Towards more intuitive visualizations of plant disease dynamics, we use the archetypal signatures to create structured summaries that are inspired by metro maps, i.e. schematic diagrams of public transport networks. Metro maps of plant disease dynamics produced on several real-world data sets conform to plant physiological knowledge and explicitly illustrate the interaction between diseases and plants. Most importantly, they provide an abstract and interpretable view on plant disease progression.	[Wahabzada, Mirwaes; Mahlein, Anne-Katrin; Steiner, Ulrike; Oerke, Erich-Christian] Univ Bonn, INRES Phytomed, Bonn, Germany; [Bauckhage, Christian; Kersting, Kristian] Fraunhofer IAIS, St Augustin, Germany; [Bauckhage, Christian] Univ Bonn, B IT, Bonn, Germany; [Kersting, Kristian] Tech Univ Dortmund, CS Dept, D-44221 Dortmund, Germany	University of Bonn; University of Bonn; Dortmund University of Technology	Mahlein, AK (corresponding author), Univ Bonn, INRES Phytomed, Bonn, Germany.	amahlein@uni-bonn.de	Bauckhage, Christian/M-7872-2014	Bauckhage, Christian/0000-0001-6615-2128; Mahlein, Anne-Katrin/0000-0003-1091-3690	German Federal Ministry of Education and Research (BMBF) within the scope of the competitive grants program "Networks of excellence in agricultural and nutrition research" [0315529]; Fraunhofer IAIS	German Federal Ministry of Education and Research (BMBF) within the scope of the competitive grants program "Networks of excellence in agricultural and nutrition research"(Federal Ministry of Education & Research (BMBF)); Fraunhofer IAIS	This work could be carried out due to the financial support of the German Federal Ministry of Education and Research (BMBF) within the scope of the competitive grants program "Networks of excellence in agricultural and nutrition research - http://www.cropsense.uni-bonn.de/(Funding code: 0315529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CB and KK are with the Fraunhofer IAIS, a non-for-profit research institute of the Fraunhofer- Society in Germany. Fraunhofer IAIS provided support in the form of salaries for both of them, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Asner GP, 1998, REMOTE SENS ENVIRON, V64, P234, DOI 10.1016/S0034-4257(98)00014-5; Berger B, 2010, J EXP BOT, V61, P3519, DOI 10.1093/jxb/erq201; BORG I, 1997, SPRINGER SERIES IN S; Boyd S., 2004, CONVEX OPTIMIZATION; Civril A, 2009, THEOR COMPUT SCI, V410, P4801, DOI 10.1016/j.tcs.2009.06.018; CUTLER A, 1994, TECHNOMETRICS, V36, P338, DOI 10.2307/1269949; DAVIS J, 2006, PROCEEDINGS OF THE T; FENG P, 2008, PROCEEDINGS OF THE 2; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Frieze A, 2004, J ACM, V51, P1025, DOI 10.1145/1039488.1039494; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Gitelson AA, 1996, J PLANT PHYSIOL, V148, P494, DOI 10.1016/S0176-1617(96)80284-7; Goreinov S., 2001, CONTEMP MATH-SINGAP, V280, P47, DOI DOI 10.1090/C0NM/280/4620.MR1850400; Goreinov SA, 1997, LINEAR ALGEBRA APPL, V261, P1, DOI 10.1016/S0024-3795(96)00301-1; Granier C, 2014, CURR OPIN PLANT BIOL, V18, P96, DOI 10.1016/j.pbi.2014.02.009; Hastie T., 2001, THE ELEMENTS OF STAT; Huckelhoven R, 2011, CURR OPIN PLANT BIOL, V14, P738, DOI 10.1016/j.pbi.2011.08.002; Hyvonen S., 2008, P 14 ACM SIGKDD C KN, P345; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KERSTING K, 2012, PROCEEDINGS OF THE 1; KERSTING K, 2012, PROCEEDINGS OF THE T; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Liu ZH, 2011, MOL PLANT PATHOL, V12, P1, DOI 10.1111/j.1364-3703.2010.00649.x; LORENZEN B, 1989, REMOTE SENS ENVIRON, V27, P201, DOI 10.1016/0034-4257(89)90018-7; Mahlein AK, 2012, EUR J PLANT PATHOL, V133, P197, DOI 10.1007/s10658-011-9878-z; Mahlein AK, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-3; Mahoney MW, 2009, P NATL ACAD SCI USA, V106, P697, DOI [10.1073/pnas.0803205106, 10.1073/pnas.0803205105]; Minka TP, 2000, ESTIMATING DIRICHLET; Nesbitt KV, 2004, IEEE INFOR VIS, P488, DOI 10.1109/IV.2004.1320189; Newton AC, 2004, ANN APPL BIOL, V145, P95, DOI 10.1111/j.1744-7348.2004.tb00364.x; NOCEDAL J, 1999, SPRINGER SERIES IN O; Nollenburg M, 2011, IEEE T VIS COMPUT GR, V17, P626, DOI 10.1109/TVCG.2010.81; Oerke EC, 2004, CROP PROT, V23, P275, DOI 10.1016/j.cropro.2003.10.001; Purves D, 2013, NATURE, V493, P295, DOI 10.1038/493295a; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Richards RA, 2010, FUNCT PLANT BIOL, V37, P85, DOI 10.1071/FP09219; Romer C, 2012, FUNCT PLANT BIOL, V39, P878, DOI 10.1071/FP12060; Sakurai Y., 2008, P SIAM INT C DAT MIN, P632, DOI DOI 10.1137/1.9781611972788.58; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHOLES JD, 1987, NEW PHYTOL, V107, P103, DOI 10.1111/j.1469-8137.1987.tb04885.x; Scholes JD, 1996, PLANTA, V199, P573, DOI 10.1007/BF00195189; SHAHAF D, 2012, PROCEEDINGS OF THE 1, P1122, DOI DOI 10.1145/2339530.2339706; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; SUN J, 2008, STAT ANAL DATA MIN, V1, P6, DOI DOI 10.1002/SAM.102; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Teng P. S., 1977, APPS Newsletter, V6, P7, DOI 10.1071/APP9770007; Thurau Christian, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P4040, DOI 10.1109/ICPR.2010.982; Thurau C, 2011, KNOWL INF SYST, V29, P457, DOI 10.1007/s10115-010-0352-6; Thurau C, 2012, DATA MIN KNOWL DISC, V24, P325, DOI 10.1007/s10618-011-0216-z; WAHABZADA M, 2012, PROCEEDINGS OF THE 2; Walters DR, 2012, EUR J PLANT PATHOL, V133, P33, DOI 10.1007/s10658-012-9948-x; WANG HY, 2007, PROCEEDINGS OF THE 2, DOI DOI 10.1145/1273496.1273617	54	73	75	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116902	10.1371/journal.pone.0116902	http://dx.doi.org/10.1371/journal.pone.0116902			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621489	Green Submitted, Green Published, gold			2022-12-27	WOS:000348470400010
J	Benazza, A; Selleslagh, J; Breton, E; Rabhi, K; Cornille, V; Bacha, M; Lecuyer, E; Amara, R				Benazza, Achwak; Selleslagh, Jonathan; Breton, Elsa; Rabhi, Khalef; Cornille, Vincent; Bacha, Mahmoud; Lecuyer, Eric; Amara, Rachid			Environmental Control on Fish and Macrocrustacean Spring Community-Structure, on an Intertidal Sandy Beach	PLOS ONE			English	Article							EASTERN ENGLISH-CHANNEL; PLAICE PLEURONECTES-PLATESSA; SHRIMP CRANGON-CRANGON; WESTERN WADDEN SEA; SURF ZONE; MACROFAUNA COMMUNITIES; POPULATION-DYNAMICS; SPECIES COMPOSITION; SEASONAL PATTERNS; COASTAL WATERS	The inter-annual variability of the fish and macrocrustacean spring community on an intertidal sandy beach near the Canche estuary (North of France) was studied from 2000 to 2013 based on weekly spring sampling over an 11-year period. Twenty-eight species representing 21 families were collected during the course of the study. The community was dominated by a few abundant species accounting for > 99% of the total species densities. Most individuals caught were young-of-the-year indicating the importance of this ecosystem for juvenile fishes and macrocrustaceans. Although standard qualitative community ecology metrics (species composition, richness, diversity, evenness and similarity) indicated notable stability over the study period, community structure showed a clear change since 2009. Densities of P. platessa, P. microps and A. tobianus decreased significantly since 2009, whereas over the period 2010-2013, the contribution of S. sprattus to total species density increased 4-fold. Co-inertia and generalised linear model analyses identified winter NAO index, water temperature, salinity and suspended particular matter as the major environmental factors explaining these changes. Although the recurrent and dense spring blooms of the Prymnesiophyte Phaeocystis globosa is one of the main potential threats in shallow waters of the eastern English Channel, no negative impact of its temporal change was detected on the fish and macrocrustacean spring community structure.	[Benazza, Achwak; Selleslagh, Jonathan; Breton, Elsa; Rabhi, Khalef; Cornille, Vincent; Bacha, Mahmoud; Amara, Rachid] Univ Littoral, UMR LOG 8187, F-62930 Wimereux, France; [Benazza, Achwak; Selleslagh, Jonathan; Breton, Elsa; Rabhi, Khalef; Cornille, Vincent; Bacha, Mahmoud; Lecuyer, Eric; Amara, Rachid] CNRS, UMR LOG 8187, F-62930 Wimereux, France; [Selleslagh, Jonathan] Univ Bordeaux, CNRS, UMR EPOC 5805, Stn Marine Arcachon, F-33120 Arcachon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite du Littoral-Cote-d'Opale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Amara, R (corresponding author), Univ Littoral, UMR LOG 8187, F-62930 Wimereux, France.	rachid.amara@univ-littoral.fr	RACHID, AMARA/E-2525-2012; elsa, Breton/J-4996-2013	AMARA, Rachid/0000-0002-7183-1333; Breton, Elsa/0000-0002-9569-5436	French Ministere des Affaires Etrangeres et Europeennes (MAEE)	French Ministere des Affaires Etrangeres et Europeennes (MAEE)	This research was funded by a doctoral grant to AB by the French Ministere des Affaires Etrangeres et Europeennes (MAEE) as part of the "programme de cooperation decentralisee des territoires Dunkerquois et Annabis". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara R, 2004, HYDROBIOLOGIA, V518, P23, DOI 10.1023/B:HYDR.0000025053.62966.cd; Amara R, 2013, AQUACULTURE, V414, P149, DOI 10.1016/j.aquaculture.2013.07.048; Amara R, 2003, ESTUAR COAST SHELF S, V56, P807, DOI 10.1016/S0272-7714(02)00315-3; Amara R, 2000, OCEANOL ACTA, V23, P469, DOI 10.1016/S0399-1784(00)00134-1; Attrill MJ, 2002, NATURE, V417, P275, DOI 10.1038/417275a; Banikas EM, 2012, ESTUAR COAST, V35, P1346, DOI 10.1007/s12237-012-9517-8; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; BEUKEMA JJ, 1992, NETH J SEA RES, V30, P73, DOI 10.1016/0077-7579(92)90047-I; Beyst B, 2001, ESTUAR COAST SHELF S, V53, P877, DOI 10.1006/ecss.2001.0808; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Breton E, 2006, LIMNOL OCEANOGR, V51, P1401, DOI 10.4319/lo.2006.51.3.1401; Brown A.C., 1990, ECOLOGY SANDY SHORES; Brylinski JM, 1991, OCEANOL ACTA, V11, P197; Campos J, 2010, MAR ECOL PROG SER, V405, P203, DOI 10.3354/meps08493; CHANG FH, 1984, NEW ZEAL J MAR FRESH, V18, P303, DOI 10.1080/00288330.1984.9516052; Clark BM, 1996, MAR ECOL PROG SER, V131, P35, DOI 10.3354/meps131035; Clarke K., 2001, PRIMER V5 USER MANUA; Cornelius C, 2001, CONSERV BIOL, V15, P1396, DOI 10.1046/j.1523-1739.2001.00163.x; Costa-Dias S, 2010, MAR POLLUT BULL, V61, P240, DOI 10.1016/j.marpolbul.2010.02.020; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Defeo O, 2013, GEOMORPHOLOGY, V199, P106, DOI 10.1016/j.geomorph.2013.04.013; Desroy N, 2004, MAR ECOL PROG SER, V270, P41, DOI 10.3354/meps270041; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; EDWARDS R, 1968, Journal of Experimental Marine Biology and Ecology, V2, P215, DOI 10.1016/0022-0981(68)90017-8; Faria C, 1999, MAR ECOL PROG SER, V184, P197, DOI 10.3354/meps184197; Gibson R.N., 1999, P264, DOI 10.1016/B978-012356040-7/50014-7; GIBSON RN, 1993, MAR ECOL PROG SER, V98, P89, DOI 10.3354/meps098089; Gibson RN, 1996, MAR ECOL PROG SER, V130, P1, DOI 10.3354/meps130001; Gibson RN, 2002, MAR ECOL PROG SER, V229, P233, DOI 10.3354/meps229233; Grioche A, 1997, ICES J MAR SCI, V54, P93, DOI 10.1006/jmsc.1996.0162; Hamed KH, 1998, J HYDROL, V204, P182, DOI 10.1016/S0022-1694(97)00125-X; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Henderson PA, 2011, J EXP MAR BIOL ECOL, V400, P78, DOI 10.1016/j.jembe.2011.02.028; Henderson PA, 2006, J MAR BIOL ASSOC UK, V86, P287, DOI 10.1017/S0025315406013142; Herborg LM, 2003, HYDROBIOLOGIA, V503, P21, DOI 10.1023/B:HYDR.0000008483.63314.3c; Jackson G, 1999, MAR ECOL PROG SER, V182, P253, DOI 10.3354/meps182253; KAISER MJ, 1994, MAR ECOL PROG SER, V106, P131, DOI 10.3354/meps106131; KENDALL MG, 1955, BIOMETRICS, V11, P43, DOI 10.2307/3001479; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kroncke I, 2013, ESTUAR COAST SHELF S, V119, P79, DOI 10.1016/j.ecss.2012.12.024; Lazzari MA, 1999, ESTUARIES, V22, P636, DOI 10.2307/1353051; McLachlan A, 1996, REV CHILENA HIST NAT, V69; Oh CW, 2001, MAR ECOL PROG SER, V214, P211, DOI 10.3354/meps214211; Philippart CJM, 1996, ICES J MAR SCI, V53, P1120, DOI 10.1006/jmsc.1996.0138; PIHL L, 1990, HYDROBIOLOGIA, V195, P79, DOI 10.1007/BF00026815; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; POXTON MG, 1992, P ROY SOC EDINB B, V100, P141, DOI 10.1017/S0269727000011118; Riley J.D., 1966, ANN REP MAR BIOL STN, V78, P51; ROSS ST, 1987, ESTUAR COAST SHELF S, V25, P391, DOI 10.1016/0272-7714(87)90033-3; SANTOS RS, 1995, ESTUAR COAST SHELF S, V41, P579, DOI 10.1016/0272-7714(95)90028-4; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Schuckel U, 2013, ESTUAR COAST SHELF S, V117, P210, DOI 10.1016/j.ecss.2012.11.008; Selleslagh J, 2009, ESTUAR COAST SHELF S, V81, P149, DOI 10.1016/j.ecss.2008.10.008; Selleslagh J, 2008, ESTUAR COAST SHELF S, V79, P507, DOI 10.1016/j.ecss.2008.05.006; Selleslagh J, 2008, ESTUAR COAST SHELF S, V77, P721, DOI 10.1016/j.ecss.2007.11.004; Short A.D, 1999, HDB BEACH SHOREFACE; Spilmont N, 2009, MAR POLLUT BULL, V58, P55, DOI 10.1016/j.marpolbul.2008.09.007; THIEL R, 1995, J FISH BIOL, V46, P47, DOI 10.1111/j.1095-8649.1995.tb05946.x; Tulp I, 2012, MAR ECOL PROG SER, V458, P141, DOI 10.3354/meps09743; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; VANDERVEER HW, 1993, MAR ECOL PROG SER, V101, P81, DOI 10.3354/meps101081; VANDERVEER HW, 1987, MAR ECOL PROG SER, V35, P203, DOI 10.3354/meps035203; VANDERVEER HW, 1991, MAR ECOL PROG SER, V73, P141, DOI 10.3354/meps073141	64	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117220	10.1371/journal.pone.0117220	http://dx.doi.org/10.1371/journal.pone.0117220			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617852	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000041
J	Matsushita, M; Ozaki, Y; Hasegawa, Y; Terada, F; Tabata, N; Shiheido, H; Yanagawa, H; Oikawa, T; Matsuo, K; Du, WL; Yamada, T; Hozumi, M; Ichikawa, D; Hattori, Y				Matsushita, Maiko; Ozaki, Yoshie; Hasegawa, Yuka; Terada, Fukiko; Tabata, Noriko; Shiheido, Hirokazu; Yanagawa, Hiroshi; Oikawa, Tsukasa; Matsuo, Koichi; Du, Wenlin; Yamada, Taketo; Hozumi, Masashi; Ichikawa, Daiju; Hattori, Yutaka			A Novel Phthalimide Derivative, TC11, Has Preclinical Effects on High-Risk Myeloma Cells and Osteoclasts	PLOS ONE			English	Article							REFRACTORY MULTIPLE-MYELOMA; 2013 UPDATE; NUCLEOPHOSMIN; TARGET; LENALIDOMIDE; POMALIDOMIDE; MANAGEMENT; LEUKEMIA; CANCER; STRATIFICATION	Despite the recent advances in the treatment of multiple myeloma (MM), MM patients with high-risk cytogenetic changes such as t(4;14) translocation or deletion of chromosome 17 still have extremely poor prognoses. With the goal of helping these high-risk MM patients, we previously developed a novel phthalimide derivative, TC11. Here we report the further characterization of TC11 including anti-myeloma effects in vitro and in vivo, a pharmacokinetic study in mice, and anti-osteoclastogenic activity. Intraperitoneal injections of TC11 significantly delayed the growth of subcutaneous tumors in human myeloma-bearing SCID mice. Immunohistochemical analyses showed that TC11 induced apoptosis of MM cells in vivo. In the pharmacokinetic analyses, the C-max was 2.1 mu M at 1 h after the injection of TC11, with 1.2 h as the half-life. TC11 significantly inhibited the differentiation and function of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated osteoclasts in mouse osteoclast cultures using M-CSF and RANKL. We also revealed that TC11 induced the apoptosis of myeloma cells accompanied by alpha-tubulin fragmentation. In addition, TC11 and lenalidomide, another phthalimide derivative, directly bound to nucleophosmin 1 (NPM1), whose role in MM is unknown. Thus, through multiple molecular interactions, TC11 is a potentially effective drug for high-risk MM patients with bone lesions. The present results suggest the possibility of the further development of novel thalidomide derivatives by drug designing.	[Matsushita, Maiko; Ozaki, Yoshie; Hasegawa, Yuka; Terada, Fukiko; Hozumi, Masashi; Ichikawa, Daiju; Hattori, Yutaka] Keio Univ, Fac Pharm, Tokyo, Japan; [Tabata, Noriko; Shiheido, Hirokazu; Yanagawa, Hiroshi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Oikawa, Tsukasa; Matsuo, Koichi] Keio Univ, Sch Med, Tokyo, Japan; [Du, Wenlin; Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan	Keio University; Keio University; Keio University; Keio University	Hattori, Y (corresponding author), Keio Univ, Fac Pharm, Tokyo, Japan.	hattori-yt@pha.keio.ac.jp	Matsuo, Koichi/K-5695-2012; Oikawa, Tsukasa/B-7718-2013	Matsuo, Koichi/0000-0002-1490-8955; Oikawa, Tsukasa/0000-0003-2694-2699; Hattori, Yutaka/0000-0003-1080-9738; Shiheido, Hirokazu/0000-0002-1415-2019	Private University Strategic Research Base Development Program of MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan; Keio Gijuku Academic development Funds; Japan Leukemia Research Fund	Private University Strategic Research Base Development Program of MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan; Keio Gijuku Academic development Funds; Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF))	This work was supported in part by a Grant-in-Aid for Scientific Research (Y. Hattori, MM) and a grant from the Private University Strategic Research Base Development Program (Y. Hattori) of MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan, Keio Gijuku Academic development Funds (Y. Hattori) and Japan Leukemia Research Fund (Y. Hattori, MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparartion of the manuscript.	Avet-Loiseau H, 2012, J CLIN ONCOL, V30, P1949, DOI 10.1200/JCO.2011.36.5726; Balusu R, 2011, BLOOD, V118, P3096, DOI 10.1182/blood-2010-09-309674; Bergsagel PL, 2013, BLOOD, V121, P884, DOI 10.1182/blood-2012-05-432203; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Chang H, 2010, LEUKEMIA LYMPHOMA, V51, P2084, DOI 10.3109/10428194.2010.524325; Chesi M, 2013, INT J HEMATOL, V97, P313, DOI 10.1007/s12185-013-1291-2; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Du WL, 2007, BLOOD, V109, P3042, DOI 10.1182/blood-2006-02-003103; Ebert BL, 2011, SEMIN ONCOL, V38, P621, DOI 10.1053/j.seminoncol.2011.04.010; Estey EH, 2013, AM J HEMATOL, V88, P317, DOI 10.1002/ajh.23404; Falini B, 2009, LEUKEMIA, V23, P1731, DOI 10.1038/leu.2009.124; Falini B, 2011, BLOOD REV, V25, P247, DOI 10.1016/j.blre.2011.06.001; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hattori Y, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.13; Ito T, 2011, CELL MOL LIFE SCI, V68, P1569, DOI 10.1007/s00018-010-0619-9; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Lacy MQ, 2011, CURR HEMATOL MALIG R, V6, P120, DOI 10.1007/s11899-011-0077-y; Lee HH, 2007, PROTEINS, V69, P672, DOI 10.1002/prot.21504; Li J, 2006, J BIOL CHEM, V281, P16536, DOI 10.1074/jbc.M601386200; Lindstrom MS, 2011, BIOCH RES INT, V2011, P195; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Mateos MV, 2011, BLOOD, V118, P4547, DOI 10.1182/blood-2011-04-345801; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; McCurdy AR, 2013, THER ADV HEMATOL, V4, P211, DOI 10.1177/2040620713480155; Modi ND, 2012, LEUKEMIA, V26, P589, DOI 10.1038/leu.2011.282; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Oikawa T, 2012, J CELL BIOL, V197, P553, DOI 10.1083/jcb.201111116; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Pan BQ, 2012, PHARMACOL THERAPEUT, V136, P56, DOI 10.1016/j.pharmthera.2012.07.004; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Qi W, 2008, ONCOGENE, V27, P4210, DOI 10.1038/onc.2008.54; Raje N, 2011, CLIN CANCER RES, V17, P1278, DOI 10.1158/1078-0432.CCR-10-1804; Rajkumar SV, 2013, AM J HEMATOL, V88, P225, DOI 10.1002/ajh.23390; Sawyer JR, 2011, CANCER GENET-NY, V204, P3, DOI 10.1016/j.cancergencyto.2010.11.002; Shiheido H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038878; Siegel DS, 2012, SEMIN HEMATOL, V49, pS3, DOI 10.1053/j.seminhematol.2012.05.005; Spagnuolo PA, 2010, BLOOD, V115, P4824, DOI 10.1182/blood-2009-09-243055; Terpos E, 2013, ONCOTARGETS THER, V6, P531, DOI 10.2147/OTT.S34498; Weinhold N, 2010, GENE CHROMOSOME CANC, V49, P333, DOI 10.1002/gcc.20745; Zangari M, 2012, CANCER TREAT REV, V38, P968, DOI 10.1016/j.ctrv.2011.12.007; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	41	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116135	10.1371/journal.pone.0116135	http://dx.doi.org/10.1371/journal.pone.0116135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617756	Green Published, gold, Green Submitted			2022-12-27	WOS:000350336000008
J	Musto, AE; Walker, CP; Petasis, NA; Bazan, NG				Musto, Alberto E.; Walker, Chelsey P.; Petasis, Nicos A.; Bazan, Nicolas G.			Hippocampal Neuro-Networks and Dendritic Spine Perturbations in Epileptogenesis Are Attenuated by Neuroprotectin D1	PLOS ONE			English	Article							EPILEPTIFORM ACTIVITY; PILOCARPINE MODEL; SPONTANEOUS SEIZURES; EPILEPSY; INHIBITION; SUSCEPTIBILITY; EXPRESSION; CELLS	Purpose Limbic epileptogenesis triggers molecular and cellular events that foster the establishment of aberrant neuronal networks that, in turn, contribute to temporal lobe epilepsy (TLE). Here we have examined hippocampal neuronal network activities in the pilocarpine post-status epilepticus model of limbic epileptogenesis and asked whether or not the docosahexaenoic acid (DHA)-derived lipid mediator, neuroprotectin D1 (NPD1), modulates epileptogenesis. Methods Status epilepticus (SE) was induced by intraperitoneal administration of pilocarpine in adult male C57BL/6 mice. To evaluate simultaneous hippocampal neuronal networks, local field potentials were recorded from multi-microelectrode arrays (silicon probe) chronically implanted in the dorsal hippocampus. NPD1 (570 mu g/kg) or vehicle was administered intraperitoneally daily for five consecutive days 24 hours after termination of SE. Seizures and epileptiform activity were analyzed in freely-moving control and treated mice during epileptogenesis and epileptic periods. Then hippocampal dendritic spines were evaluated using Golgi-staining. Results We found brief spontaneous microepileptiform activity with high amplitudes in the CA1 pyramidal and stratum radiatum in epileptogenesis. These aberrant activities were attenuated following systemic NPD1 administration, with concomitant hippocampal dendritic spine protection. Moreover, NPD1 treatment led to a reduction in spontaneous recurrent seizures. Conclusions Our results indicate that NPD1 displays neuroprotective bioactivity on the hippocampal neuronal network ensemble that mediates aberrant circuit activity during epileptogenesis. Insight into the molecular signaling mediated by neuroprotective bioactivity of NPD1 on neuronal network dysfunction may contribute to the development of anti-epileptogenic therapeutic strategies.	[Musto, Alberto E.; Walker, Chelsey P.; Bazan, Nicolas G.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Petasis, Nicos A.] Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Southern California	Musto, AE (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA.	amusto@lsuhsc.edu; nbazan@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020; Petasis, Nicos/B-3162-2009	Bazan, Nicolas/0000-0002-9243-5444; Petasis, Nicos/0000-0002-8864-4446	NIH/NIGMS [P30-GM103340]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funds from NIH/NIGMS Grant P30-GM103340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060.abs; Barros CS, 2009, P NATL ACAD SCI USA, V106, P4507, DOI 10.1073/pnas.0900355106; Bazan NG, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P610; Bazan NG, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P643; Bazan NG, 2011, MOL NEUROBIOL, V44, P216, DOI 10.1007/s12035-011-8200-6; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Bertram EH, 2013, EXP NEUROL, V244, P67, DOI 10.1016/j.expneurol.2012.01.028; Bialer M, 2013, EPILEPSY RES, V103, P2, DOI 10.1016/j.eplepsyres.2012.10.001; Bragin A, 2011, EPILEPSIA, V52, P45, DOI 10.1111/j.1528-1167.2010.02896.x; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; CHATT AB, 1982, BRAIN RES, V241, P382, DOI 10.1016/0006-8993(82)91084-8; Chen J, 2005, NEUROSCI LETT, V375, P192, DOI 10.1016/j.neulet.2004.11.008; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Danzer E, 2010, NEUROPEDIATRICS, V41, P140, DOI 10.1055/s-0030-1263164; Dichter MA, 2009, ARCH NEUROL-CHICAGO, V66, P443, DOI 10.1001/archneurol.2009.10; Dinocourt C, 2003, J COMP NEUROL, V459, P407, DOI 10.1002/cne.10622; Dudek FE, 2011, EPILEPSY RES, V97, P324, DOI 10.1016/j.eplepsyres.2011.10.017; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Galvez R, 2006, J NEUROSCI, V26, P6062, DOI 10.1523/JNEUROSCI.5582-05.2006; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Grabenstatter HL, 2014, NEUROBIOL DIS, V62, P73, DOI 10.1016/j.nbd.2013.09.003; Helgager J, 2013, J COMP NEUROL, V521, P499, DOI 10.1002/cne.23225; Jette N, 2013, CURR OPIN NEUROL, V26, P201, DOI 10.1097/WCO.0b013e32835ef345; Jiang JX, 2013, P NATL ACAD SCI USA, V110, P3591, DOI 10.1073/pnas.1218498110; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kohling R, 2011, EPILEPSY RES, V97, P318, DOI 10.1016/j.eplepsyres.2011.03.006; Kurz JE, 2008, EPILEPSIA, V49, P1696, DOI 10.1111/j.1528-1167.2008.01616.x; Mani R, 2011, NEUROSCI LETT, V497, P251, DOI 10.1016/j.neulet.2011.03.010; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Marx M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00167; Mattson MP, 1999, J NEUROSCI RES, V58, P152, DOI 10.1002/(SICI)1097-4547(19991001)58:1<152::AID-JNR15>3.0.CO;2-V; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; McAuliffe JJ, 2011, HIPPOCAMPUS, V21, P93, DOI 10.1002/hipo.20726; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13152, DOI 10.1073/pnas.0705949104; Muldoon SF, 2013, P NATL ACAD SCI USA, V110, P3567, DOI 10.1073/pnas.1216958110; Musto AE, 2011, EPILEPSIA, V52, P1601, DOI 10.1111/j.1528-1167.2011.03081.x; Musto AE, 2009, EPILEPSY RES, V85, P199, DOI 10.1016/j.eplepsyres.2009.02.020; Osawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060928; Pitkanen A, 2011, BIOMARK MED, V5, P629, DOI [10.2217/BMM.11.67, 10.2217/bmm.11.67]; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rusan ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101117; Schevon CA, 2008, J CLIN NEUROPHYSIOL, V25, P321, DOI 10.1097/WNP.0b013e31818e8010; Seo J, 2012, EXP NEUROL, VS0014-4886, P441; Sfondouris JL, 2012, COMPUT BIOL MED, V42, P129, DOI 10.1016/j.compbiomed.2011.10.017; Sheets KG, 2010, MOL VIS, V16, P320; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Sloviter RS, 2013, NEUROPHARMACOLOGY, V69, P3, DOI 10.1016/j.neuropharm.2012.01.022; Soussi R, 2015, BRAIN STRUCT FUNCT, V220, P2449, DOI 10.1007/s00429-014-0800-2; Stead M, 2010, BRAIN, V133, P2789, DOI 10.1093/brain/awq190; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Timofeev I, 2002, NEUROSCIENCE, V114, P1115, DOI 10.1016/S0306-4522(02)00300-7; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; Tu B, 2003, EXP NEUROL, V179, P167, DOI 10.1016/S0014-4886(02)00019-5; Vandecasteele M, 2012, JOVE-J VIS EXP, DOI 10.3791/3568; Young C, 2000, SYNAPSE, V37, P90, DOI 10.1002/1098-2396(200008)37:2&lt;90::AID-SYN2&gt;3.0.CO;2-Z; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	58	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116543	10.1371/journal.pone.0116543	http://dx.doi.org/10.1371/journal.pone.0116543			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617763	Green Submitted, Green Published, gold			2022-12-27	WOS:000350336000016
J	Lin, LL; Wang, D; Wang, W; Cheng, YQ; Su, DF; Liu, AJ				Lin, Li-Li; Wang, Dong; Wang, Wei; Cheng, Yan-Qiong; Su, Ding-Feng; Liu, Ai-Jun			Long-Term Treatment of Clonidine, Atenolol, Amlodipine and Dihydrochlorothiazide, but Not Enalapril, Impairs the Sexual Function in Male Spontaneously Hypertensive Rats	PLOS ONE			English	Article							BLOOD-PRESSURE VARIABILITY; ERECTILE DYSFUNCTION; ARTERIAL BAROREFLEX; ANTIHYPERTENSIVE DRUGS; CARDIOVASCULAR-DISEASE; COMBINATION THERAPY; ORGAN DAMAGE; STROKE-PRONE; RISK; MEN	This study was designed to investigate the impact of representative antihypertensive drugs of 5 classes on the sexual function in male spontaneously hypertensive rats (SHR) at doses that achieved similar blood pressure (BP) reduction. The experiment was performed in 6 groups of male SHR. The dose are 20 mu g/kg/day for clonidine, 3 mg/kg/day for enalapril, 20 mg/kg/day for atenolol, 2 mg/kg/day for amlodipine, and 10 mg/kg/day for dihydrochlorothiazide. SHR were treated for 3 months, and then the penile erection and sexual behavior were detected. After BP recording, SHR were killed to evaluate the organ-damage, weight of accessory sex organs and levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and testosterone in serum. Five drugs had the similar efficacy on BP reduction. All drugs except of enalapril, significantly prolonged the mount latency, and decreased the mount frequency (P<0.05). Clonidine also reduced the conception rate (45% vs. 80% in control group, P<0.05). Amlodipine and dihydrochlorothiazide significantly increased the testosterone level (0.79 +/- 0.30, 0.80 +/- 0.34 vs. 0.49 +/- 0.20 in control group, unit: ng/dl, P<0.05). Enalapril, atenolol and amlodipine also significantly decreased the BP variability (systolic, 8.2 +/- 2.5, 7.6 +/- 1.8, 8.9 +/- 2.0 vs. 12.2 +/- 3.8 in control group, unit: mm Hg). All these drugs significantly decreased the organ-damage (P<0.05). In conclusion, long-term treatment with 5 common antihypertensive drugs possessed obvious organ protection in SHR. Clonidine, atenolol, amlodipine and dihydrochlorothiazide, but not enalapril, impair sexual function.	[Lin, Li-Li] Wuxi Higher Hlth Vocat Technol Sch, Dept Pharmacol, Wuxi, Jiangsu, Peoples R China; [Lin, Li-Li; Wang, Dong; Wang, Wei; Cheng, Yan-Qiong; Su, Ding-Feng; Liu, Ai-Jun] Second Mil Med Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Wang, Dong] Chinese Peoples Liberat Army Gen Hosp, Dept Pharm Adm, Beijing 100853, Peoples R China; [Cheng, Yan-Qiong] Second Mil Med Univ, Changhai Hosp, Dept Urinary Surg, Shanghai, Peoples R China	Naval Medical University; Chinese People's Liberation Army General Hospital; Naval Medical University	Su, DF (corresponding author), Second Mil Med Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China.	dfsu@smmu.edu.cn; mrliuaijun@163.com	aijun, liu/X-6413-2019		National Natural Science Foundation of China [81273505, 81230083]; Science and Technology Support Project of Wuxi Science and Technology Bureau [CSE01N1236]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Project of Wuxi Science and Technology Bureau	This study was supported by the National Natural Science Foundation of China (81273505, 81230083) and Science and Technology Support Project of Wuxi Science and Technology Bureau (CSE01N1236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; Aversa A, 2010, INT J UROL, V17, P38, DOI 10.1111/j.1442-2042.2009.02426.x; Baumhakel M, 2011, INT J CLIN PRACT, V65, P289, DOI 10.1111/j.1742-1241.2010.02563.x; Bohm M, 2010, CIRCULATION, V121, P1439, DOI 10.1161/CIRCULATIONAHA.109.864199; Chauhan NS, 2011, NAT PROD RES, V25, P1423, DOI 10.1080/14786410802588493; Ciccone MM, 2013, MOLECULES, V18, P15314, DOI 10.3390/molecules181215314; Cordero A, 2010, POSTGRAD MED, V122, P51, DOI 10.3810/pgm.2010.11.2223; Dorrance AM, 2002, INT J IMPOT RES, V14, P494, DOI 10.1038/sj.ijir.3900915; Dusing R, 2005, DRUGS, V65, P773; ENGELMAN K, 1988, HYPERTENSION, V11, pS30; Erdmann Erland, 2010, Indian Heart J, V62, P132; Fogari R, 2001, AM J HYPERTENS, V14, P27, DOI 10.1016/S0895-7061(00)01214-0; Franzen D, 2001, INT J IMPOT RES, V13, P348, DOI 10.1038/sj.ijir.3900787; Glina S, 2013, J SEX MED, V10, P115, DOI 10.1111/j.1743-6109.2012.02816.x; Grimm RH, 1997, HYPERTENSION, V29, P8, DOI 10.1161/01.HYP.29.1.8; Gui H, 2013, CNS NEUROSCI THER, V19, P178, DOI 10.1111/cns.12057; Hale TM, 2001, J UROLOGY, V166, P739, DOI 10.1016/S0022-5347(05)66053-3; Jackson G, 2002, INT J CLIN PRACT, V56, P663; Ko DT, 2002, JAMA-J AM MED ASSOC, V288, P351, DOI 10.1001/jama.288.3.351; Kriston L, 2010, J SEX MED, V7, P2044, DOI 10.1111/j.1743-6109.2010.01761.x; Levine GN, 2012, CIRCULATION, V125, P1058, DOI 10.1161/CIR.0b013e3182447787; Liu AJ, 2013, J CEREBR BLOOD F MET, V33, P906, DOI 10.1038/jcbfm.2013.28; Liu AJ, 2012, CNS NEUROSCI THER, V18, P918, DOI 10.1111/cns.12011; Liu W, 2012, CNS NEUROSCI THER, V18, P873, DOI 10.1111/j.1755-5949.2012.00381.x; Llisterri JL, 2001, AM J MED SCI, V321, P336; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Ma RX, 2012, J HYPERTENS, V30, P210, DOI 10.1097/HJH.0b013e32834e1e2e; Manolis A, 2012, CURR HYPERTENS REP, V14, P285, DOI 10.1007/s11906-012-0276-5; Miao CY, 2006, J HYPERTENS, V24, P1125, DOI 10.1097/01.hjh.0000226203.57818.88; Nunes KP, 2012, CURR OPIN NEPHROL HY, V21, P163, DOI 10.1097/MNH.0b013e32835021bd; Sharma V, 2011, PHYTOMEDICINE, V18, P1161, DOI 10.1016/j.phymed.2011.06.001; Spatz ES, 2013, J HYPERTENS, V31, P1096, DOI 10.1097/HJH.0b013e32835fdefa; Thakur M, 2009, ARCH SEX BEHAV, V38, P1009, DOI 10.1007/s10508-008-9444-8; Wei D, 2012, CNS NEUROSCI THER, V18, P400, DOI 10.1111/j.1755-5949.2012.00304.x; Xie HH, 2007, J HYPERTENS, V25, P2334, DOI 10.1097/HJH.0b013e3282ef547f; Xie HH, 2006, EUR J PHARMACOL, V543, P77, DOI 10.1016/j.ejphar.2006.05.034; Ma XJ, 2007, ACTA PHARMACOL SIN, V28, P1550, DOI 10.1111/j.1745-7254.2007.00644.x; Zang P, 2013, CNS NEUROSCI THER, V19, P367, DOI 10.1111/cns.12097; Zhang TL, 2012, CNS NEUROSCI THER, V18, P981, DOI 10.1111/cns.12015	39	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116155	10.1371/journal.pone.0116155	http://dx.doi.org/10.1371/journal.pone.0116155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615941	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100023
J	Shivaprasad, PV; Hohn, T; Akbergenov, R				Shivaprasad, Padubidri V.; Hohn, Thomas; Akbergenov, Rashid			Biochemical Requirements for Two Dicer-Like Activities from Wheat Germ	PLOS ONE			English	Article							BINDING-PROTEIN HYL1; RNA-BINDING; FUNCTIONAL DIVERSIFICATION; SIRNA BIOGENESIS; MICRO-RNA; PRI-MIRNA; ARABIDOPSIS; DCL4; RIBONUCLEASE; INTERFERENCE	RNA silencing pathways were first discovered in plants. Through genetic analysis, it has been established that the key silencing components called Dicer-like (DCL) genes have been shown to cooperatively process RNA substrates of multiple origin into distinct 21, 22 and 24 nt small RNAs. However, only few detailed biochemical analysis of the corresponding complexes has been carried out in plants, mainly due to the large unstable complexes that are hard to obtain or reconstitute in heterologous systems. Reconstitution of activity needs thorough understanding of all protein partners in the complex, something that is still an ongoing process in plant systems. Here, we use biochemical analysis to uncover properties of two previously identified native dicer-like activities from wheat germ. We find that standard wheat germ extract contains Dicer-like enzymes that convert double-stranded RNA (dsRNA) into two classes of small interfering RNAs of 21 and 24 nt in size. The 21 nt dicing activity, likely an siRNA producing complex known as DCL4, is 950 kDa-1.2 mDa in size and is highly unstable during purification processes but has a rather vast range for activity. On the contrary, the 24 nt dicing complex, likely the DCL3 activity, is relatively stable and comparatively smaller in size, but has stricter conditions for effective processing of dsRNA substrates. While both activities could process completely complementary dsRNA albeit with varying abilities, we show that DCL3-like 24 nt producing activity is equally good in processing incompletely complementary RNAs.	[Shivaprasad, Padubidri V.] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Hohn, Thomas] Univ Basel, Inst Bot, Dept Plant Physiol, CH-4056 Basel, Switzerland; [Akbergenov, Rashid] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Basel; University of Zurich	Shivaprasad, PV (corresponding author), Natl Ctr Biol Sci, GKVK Campus, Bangalore, Karnataka, India.	shivaprasad@ncbs.res.in; rashidakber@yahoo.com		Shivaprasad, Padubidri/0000-0002-9296-4848	Marie Curie Actions	Marie Curie Actions(European Commission)	Support was provided by Marie Curie Actions (http://ec. europa. eu/research/mariecurieactions/) to RA; National Centre for Biological Sciences (http://www. ncbs. res. in/) to PVS; Ramanujan Fellowship, Department of Science and Technology, Government of India (http://www. snf. ch/en/Pages/default. aspx) to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; ANDERSON CW, 1983, METHOD ENZYMOL, V101, P635; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cho SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000314; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Du QS, 2007, J VIROL, V81, P9142, DOI 10.1128/JVI.02885-06; Dugas DV, 2004, CURR OPIN PLANT BIOL, V7, P512, DOI 10.1016/j.pbi.2004.07.011; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Eamens AL, 2012, PLANT SIGNAL BEHAV, V7, P1224, DOI 10.4161/psb.21518; Fu DQ, 2006, MOL CELLS, V21, P153; Fukudome A, 2011, RNA, V17, P750, DOI 10.1261/rna.2455411; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; Ho T, 2008, BIOCHEM BIOPH RES CO, V368, P433, DOI 10.1016/j.bbrc.2008.01.110; Hohjoh H, 1997, J MOL BIOL, V271, P7, DOI 10.1006/jmbi.1997.1159; Iwata Y, 2013, NUCLEIC ACIDS RES, V41, P9129, DOI 10.1093/nar/gkt667; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Kapoor M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-451; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Li HL, 1996, EMBO J, V15, P1421, DOI 10.1002/j.1460-2075.1996.tb00484.x; Liu B, 2007, PLANT CELL, V19, P2705, DOI 10.1105/tpc.107.052209; Liu QP, 2009, FUNCT INTEGR GENOMIC, V9, P277, DOI 10.1007/s10142-009-0111-5; LOBBES D, 2006, EMBO REP IN PRESS; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Manavella PA, 2012, CELL, V151, P859, DOI 10.1016/j.cell.2012.09.039; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Nagano H, 2014, NUCLEIC ACIDS RES, V42, P1845, DOI 10.1093/nar/gkt1077; Nakazawa Y, 2007, PLANT MOL BIOL, V63, P777, DOI 10.1007/s11103-006-9125-8; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Pouch-Pelissier MN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000096; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Ren GD, 2012, P NATL ACAD SCI USA, V109, P12817, DOI 10.1073/pnas.1204915109; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Sandoval PY, 2014, DEV CELL, V28, P174, DOI 10.1016/j.devcel.2013.12.010; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Song L, 2010, CURR BIOL, V20, P37, DOI 10.1016/j.cub.2009.10.076; SONG X, 2011, PLANT J IN PRINT; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Tang Guiliang, 2004, Methods Mol Biol, V257, P223, DOI 10.1385/1-59259-750-5:223; Ueki S, 2001, PLANT J, V28, P283, DOI 10.1046/j.1365-313X.2001.01145.x; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wei LY, 2014, P NATL ACAD SCI USA, V111, P3877, DOI 10.1073/pnas.1318131111; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; YANG L, 2006, PLANT J IN PRESS; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhong SH, 2013, P NATL ACAD SCI USA, V110, P9171, DOI 10.1073/pnas.1219655110; Zhu HL, 2013, NAT STRUCT MOL BIOL, V20, P1106, DOI 10.1038/nsmb.2646	69	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116736	10.1371/journal.pone.0116736	http://dx.doi.org/10.1371/journal.pone.0116736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615604	gold, Green Submitted, Green Published			2022-12-27	WOS:000349122100040
J	Jiang, XX; Hardy, LL; Baur, LA; Ding, D; Wang, L; Shi, HJ				Jiang, Xiaoxiao; Hardy, Louise L.; Baur, Louise A.; Ding, Ding; Wang, Ling; Shi, Huijing			Sleep Duration, Schedule and Quality among Urban Chinese Children and Adolescents: Associations with Routine After-School Activities	PLOS ONE			English	Article							AGED CHILDREN; PATTERNS; HABITS; HEALTH; IMPACT; TIME; DISORDERS; OBESITY; MEDIA	Background With rapid urbanization accompanied by lifestyle changes, children and adolescents living in metropolitan areas are faced with many time use choices that compete with sleep. This study reports on the sleep hygiene of urban Chinese school students, and investigates the relationship between habitual after-school activities and sleep duration, schedule and quality on a regular school day. Methods Cross-sectional, school-based survey of school children (Grades 4-8) living in Shanghai, China, conducted in 2011. Self-reported data were collected on students' sleep duration and timing, sleep quality, habitual after-school activities (i.e. homework, leisure-time physical activity, recreational screen time and school commuting time), and potential correlates. Results Mean sleep duration of this sample (mean age: 11.5-years; 48.6% girls) was 9 hours. Nearly 30% of students reported daytime tiredness. On school nights, girls slept less (p<0.001) and went to bed later (p<0.001), a sex difference that was more pronounced in older students. Age by sex interactions were observed for both sleep duration (p=0.005) and bedtime (p=0.002). Prolonged time spent on homework and mobile phone playing was related to shorter sleep duration and later bedtime. Adjusting for all other factors, with each additional hour of mobile phone playing, the odds of daytime tiredness and having difficulty maintaining sleep increased by 30% and 27% among secondary students, respectively. Conclusion There are sex differences in sleep duration, schedule and quality. Habitual activities had small but significant associations with sleep hygiene outcomes especially among secondary school students. Intervention strategies such as limiting children's use of electronic screen devices after school are implicated.	[Jiang, Xiaoxiao; Wang, Ling; Shi, Huijing] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Jiang, Xiaoxiao; Wang, Ling; Shi, Huijing] Fudan Univ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Jiang, Xiaoxiao; Hardy, Louise L.; Baur, Louise A.; Ding, Ding] Univ Sydney, Prevent Res Collaborat, Sch Publ Hlth, Sydney, NSW 2006, Australia	Fudan University; Fudan University; University of Sydney	Shi, HJ (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China.	hjshi@fudan.edu.cn	Ding, Ding/AAF-9985-2021; Hardy, Louise L./E-7043-2010; Baur, Louise/AAE-3413-2021; Shi, Huijing/GRR-8564-2022	Ding, Ding/0000-0001-9850-9224; Hardy, Louise L./0000-0001-8656-6758; Baur, Louise/0000-0002-4521-9482	Shanghai Municipal Committee of Education; Shanghai Municipal Health Bureau [12GWZX0301]; China Scholarship Council (CSC); University of Sydney	Shanghai Municipal Committee of Education; Shanghai Municipal Health Bureau; China Scholarship Council (CSC)(China Scholarship Council); University of Sydney(University of Sydney)	The study is mainly funded by the Shanghai Municipal Committee of Education and also sponsored by Shanghai Municipal Health Bureau (Award Number: 12GWZX0301). The authors also thank the China Scholarship Council (CSC) for funding Xiaoxiao Jiang's doctoral scholarship in joint-PhD program with University of Sydney and this analysis, which is part of the requirements for her PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Biggs SN, 2013, SLEEP MED, V14, P1304, DOI 10.1016/j.sleep.2013.06.014; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Chahal H, 2013, PEDIATR OBES, V8, P42, DOI 10.1111/j.2047-6310.2012.00085.x; Chen MY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-59; Chen Wen-juan, 2011, Zhonghua Er Ke Za Zhi, V49, P333; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; Chung KF, 2013, BIOL RHYTHM RES, V44, P169, DOI 10.1080/09291016.2012.656247; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cortese S, 2013, J AM ACAD CHILD PSY, V52, P784, DOI 10.1016/j.jaac.2013.06.001; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Dworak M, 2007, PEDIATRICS, V120, P978, DOI 10.1542/peds.2007-0476; Firouzi S, 2013, SLEEP BIOL RHYTHMS, V11, P185, DOI 10.1111/sbr.12020; Foti KE, 2011, AM J PREV MED, V41, P596, DOI 10.1016/j.amepre.2011.08.009; *GLOB MOB STAT, 2013, MOB SUBSCR HANDS MAR; Guo XF, 2011, CLIN CARDIOL, V34, P774, DOI 10.1002/clc.20976; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Lee YJ, 2012, SLEEP, V35, P455, DOI 10.5665/sleep.1722; Li SH, 2007, SLEEP, V30, P361, DOI 10.1093/sleep/30.3.361; Li SH, 2010, SLEEP MED, V11, P907, DOI 10.1016/j.sleep.2010.03.018; Liu XC, 2005, PEDIATRICS, V115, P241, DOI 10.1542/peds.2004-0815F; Loessl B, 2008, CHILD CARE HLTH DEV, V34, P549, DOI 10.1111/j.1365-2214.2008.00845.x; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; Matricciani LA, 2012, PEDIATRICS, V129, P548, DOI 10.1542/peds.2011-2039; McKnight-Eily LR, 2011, PREV MED, V53, P271, DOI 10.1016/j.ypmed.2011.06.020; Merrill RM, 2007, J NUTR HEALTH AGING, V11, P242; Nuutinen T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-684; Olds T, 2010, SLEEP MED REV, V14, P371, DOI 10.1016/j.smrv.2009.12.002; Ortega FB, 2010, EUR J APPL PHYSIOL, V110, P563, DOI 10.1007/s00421-010-1536-1; Owens JA, 2010, ARCH PEDIAT ADOL MED, V164, P608, DOI 10.1001/archpediatrics.2010.96; Paavonen EJ, 2002, EUR CHILD ADOLES PSY, V11, P10, DOI 10.1007/s007870200002; Passos GS, 2011, SLEEP MED, V12, P1018, DOI 10.1016/j.sleep.2011.02.007; Russo PM, 2007, J SLEEP RES, V16, P163, DOI 10.1111/j.1365-2869.2007.00584.x; Sadeh A, 2007, SLEEP MED CLIN, V2, P513, DOI 10.1016/j.jsmc.2007.05.012; Smaldone A, 2007, PEDIATRICS, V119, pS29, DOI 10.1542/peds.2006-2089F; Tagaya H, 2004, SLEEP BIOL RHYTHMS, V2, P57, DOI [10.1111/j.1479-8425.2003.00079.x, DOI 10.1111/J.1479-8425.2003.00079.X]; Tao F., 2008, CHIN J DIS CONTROL P, V12, P309, DOI [10.3969/j.issn.1674-3679.2008.04.003, DOI 10.3969/J.ISSN.1674-3679.2008.04.003]; Tie LJ, 2010, BIOL RHYTHM RES, V41, P183, DOI 10.1080/09291011003687957; Van den Bulck J, 2007, SLEEP, V30, P1220, DOI 10.1093/sleep/30.9.1220; Wang GH, 2013, SLEEP MED, V14, P45, DOI 10.1016/j.sleep.2012.09.022; Wolfson Amy R, 2007, Behav Sleep Med, V5, P194; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G; Yang QZ, 2009, J PAEDIATR CHILD H, V45, P414, DOI 10.1111/j.1440-1754.2009.01530.x; Yen CF, 2008, SLEEP, V31, P1515, DOI 10.1093/sleep/31.11.1515; Zhang Zhi-Qiang, 2011, Zootaxa, V3148, P1, DOI 10.11646/zootaxa.3703.1.1	47	46	49	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115326	10.1371/journal.pone.0115326	http://dx.doi.org/10.1371/journal.pone.0115326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UU	25611973	gold, Green Published, Green Submitted			2022-12-27	WOS:000348562900007
J	Mandler, M; Santic, R; Gruber, P; Cinar, Y; Pichler, D; Funke, SA; Willbold, D; Schneeberger, A; Schmidt, W; Mattner, F				Mandler, Markus; Santic, Radmila; Gruber, Petra; Cinar, Yeliz; Pichler, Dagmar; Funke, Susanne Aileen; Willbold, Dieter; Schneeberger, Achim; Schmidt, Walter; Mattner, Frank			Tailoring the Antibody Response to Aggregated A beta Using Novel Alzheimer-Vaccines	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; MOUSE MODEL; TRANSGENIC MICE; SECRETED FORM; DISEASE; APP; IMMUNOTHERAPY; PATHOLOGY; PEPTIDE; BRAIN	Recent evidence suggests Alzheimer-Disease (AD) to be driven by aggregated A beta. Capitalizing on the mechanism of molecular mimicry and applying several selection layers, we screened peptide libraries for moieties inducing antibodies selectively reacting with A beta-aggregates. The technology identified a pool of peptide candidates; two, AFFITOPES AD01 and AD02, were assessed as vaccination antigens and compared to A beta 1-6, the targeted epitope. When conjugated to Keyhole Limpet Hemocyanin (KLH) and adjuvanted with aluminum, all three peptides induced A beta-targeting antibodies (Abs). In contrast to A beta 1-6, AD01- or AD02-induced Abs were characterized by selectivity for aggregated forms of A beta and absence of reactivity with related molecules such as Amyloid Precursor Protein (APP)/secreted APP-alpha (sAPPa). Administration of AFFITOPE-vaccines to APP-transgenic mice was found to reduce their cerebral amyloid burden, the associated neuropathological alterations and to improve their cognitive functions. Thus, the AFFITOME-technology delivers vaccines capable of inducing a distinct Ab response. Their features may be beneficial to AD-patients, a hypothesis currently tested within a phase-II-study.	[Mandler, Markus; Santic, Radmila; Gruber, Petra; Pichler, Dagmar; Schneeberger, Achim; Schmidt, Walter; Mattner, Frank] AFFiRiS AG, A-1030 Vienna, Austria; [Cinar, Yeliz; Funke, Susanne Aileen; Willbold, Dieter] Forschungszentrum Julich, Inst Struct Biochem, Inst Complex Syst 6, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Mandler, M (corresponding author), AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria.	markus.mandler@affiris.com; achim.schneeberger@affiris.com	Willbold, Dieter/A-6280-2013	Willbold, Dieter/0000-0002-0065-7366	AFFiRiS AG, Vienna; Austrian Science promotion agency [807619, 809649, 811169]; FFG	AFFiRiS AG, Vienna; Austrian Science promotion agency; FFG	AFFiRiS AG (www.affiris.com), Vienna, and Austrian Science promotion agency (www.ffg.at; Grant numbers: 807619, 809649 and 811169) provided the study funding. FFG-Funding was provided for MM, RS and PG. AFFiRiS Funding was provided to employees (MM, RS, PG, AS, FM and WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Chen Y, 2009, CELL DEATH DIFFER, V16, P386, DOI 10.1038/cdd.2008.94; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Le Poole I. Caroline, 2008, V10, P227, DOI 10.1159/000131485; Lemere CA, 2003, NEUROBIOL DIS, V14, P10, DOI 10.1016/S0969-9961(03)00044-5; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Liu B, 2013, J NEUROSCI, V33, P7027, DOI 10.1523/JNEUROSCI.5924-12.2013; Lyketsos CG, 2006, AM J GERIAT PSYCHIAT, V14, P561, DOI 10.1097/01.JGP.0000221334.65330.55; Mandler M, 2014, ACTA NEUROPATHOL, V127, P861, DOI 10.1007/s00401-014-1256-4; Mandler M, 2012, J ALZHEIMERS DIS, V28, P783, DOI 10.3233/JAD-2011-111208; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Muhs A, 2007, P NATL ACAD SCI USA, V104, P9810, DOI 10.1073/pnas.0703137104; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Oyarbide-Valencia K, 2006, AUTOIMMUN REV, V5, P486, DOI 10.1016/j.autrev.2006.03.012; Pride M, 2008, NEURODEGENER DIS, V5, P194, DOI 10.1159/000113700; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Rogers DC, 1999, BEHAV BRAIN RES, V105, P207, DOI 10.1016/S0166-4328(99)00072-8; Rosenfeld MR, 2010, SEMIN NEUROL, V30, P320, DOI 10.1055/s-0030-1255223; Schneeberger A, 2010, HUM VACCINES, V6, P948, DOI 10.4161/hv.6.11.13217; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SMALL DH, 1994, J NEUROSCI, V14, P2117; Sotthibundhu A, 2009, NEUROBIOL AGING, V30, P1975, DOI 10.1016/j.neurobiolaging.2008.02.004; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Wang CY, 2007, VACCINE, V25, P3041, DOI 10.1016/j.vaccine.2007.01.031; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wiessner C, 2011, J NEUROSCI, V31, P9323, DOI 10.1523/JNEUROSCI.0293-11.2011; Wilcock DM, 2007, NEUROSCIENCE, V144, P950, DOI 10.1016/j.neuroscience.2006.10.020; Wilcock DM, 2009, J NEUROSCI, V29, P7957, DOI 10.1523/JNEUROSCI.1339-09.2009; Wilcock DM, 2009, CNS NEUROL DISORD-DR, V8, P50, DOI 10.2174/187152709787601858; Wimo A, 2010, WORLD ALZHEIMER REPO; YANKNER BA, 1990, P NATL ACAD SCI USA, V87, P9020, DOI 10.1073/pnas.87.22.9020	54	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115237	10.1371/journal.pone.0115237	http://dx.doi.org/10.1371/journal.pone.0115237			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611858	gold, Green Published			2022-12-27	WOS:000348562900006
J	Ren, ZP; Wang, DQ; Hwang, J; Bennett, A; Sturrock, HJW; Ma, AM; Huang, JX; Xia, ZG; Feng, XY; Wang, JF				Ren, Zhoupeng; Wang, Duoquan; Hwang, Jimee; Bennett, Adam; Sturrock, Hugh J. W.; Ma, Aimin; Huang, Jixia; Xia, Zhigui; Feng, Xinyu; Wang, Jinfeng			Spatial-Temporal Variation and Primary Ecological Drivers of Anopheles sinensis Human Biting Rates in Malaria Epidemic-Prone Regions of China	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; SUB-SAHARAN AFRICA; INFORMATION-SYSTEMS; MULTILEVEL ANALYSIS; TRANSMISSION; VECTORS; MANAGEMENT; GAMBIAE; MODEL; KENYA	Background Robust malaria vector surveillance is essential for optimally selecting and targeting vector control measures. Sixty-two vector surveillance sites were established between 2005 and 2008 by the national malaria surveillance program in China to measure Anopheles sinensis human biting rates. Using these data to determine the primary ecological drivers of malaria vector human biting rates in malaria epidemic-prone regions of China will allow better targeting of vector control resources in space and time as the country aims to eliminate malaria. Methods We analyzed data from 62 malaria surveillance sentinel sites from 2005 to 2008. Linear mixed effects models were used to identify the primary ecological drivers for Anopheles sinensis human biting rates as well as to explore the spatial-temporal variation of relevant factors at surveillance sites throughout China. Results Minimum semimonthly temperature (beta = 2.99; 95% confidence interval (CI) 2.07-3.92), enhanced vegetation index (beta = 1.07; 95% CI 0.11-2.03), and paddy index (the percentage of rice paddy field in the total cultivated land area of each site) (beta = 0.86; 95% CI 0.17-1.56) were associated with greater An. Sinensis human biting rates, while increasing distance to the nearest river was associated with lower An. Sinensis human biting rates (beta = -1.47; 95% CI -2.88, -0.06). The temporal variation (sigma(2)(t0) = 1: 35) in biting rates was much larger than the spatial variation (sigma(2)(s0) = 0: 83), with 19.3% of temporal variation attributable to differences in minimum temperature and enhanced vegetation index and 16.9% of spatial variance due to distance to the nearest river and the paddy index. Discussion Substantial spatial-temporal variation in An. Sinensis human biting rates exists in malaria epidemic-prone regions of China, with minimum temperature and enhanced vegetation index accounting for the greatest proportion of temporal variation and distance to nearest river and paddy index accounting for the greatest proportion of spatial variation amongst observed ecological drivers. Conclusions Targeted vector control measures based on these findings can support the ongoing malaria elimination efforts in China more effectively.	[Ren, Zhoupeng; Ma, Aimin; Huang, Jixia; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Ren, Zhoupeng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ren, Zhoupeng; Ma, Aimin; Huang, Jixia; Wang, Jinfeng] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Wang, Duoquan; Xia, Zhigui; Feng, Xinyu] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, WHO Collaborating Ctr Malaria Schistosomiasis & F, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai, Peoples R China; [Hwang, Jimee; Bennett, Adam; Sturrock, Hugh J. W.] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Hwang, Jimee] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA USA; [Ma, Aimin] China Univ Min & Technol, Coll Geosci & Surveying Engn, Beijing, Peoples R China; [Huang, Jixia] Beijing Forestry Univ, Ctr Technol & Mapping 3S, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; China University of Mining & Technology; Beijing Forestry University	Wang, JF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	duoquan2006@hotmail.com; wangjf@Lreis.ac.cn	Ren, Zhoupeng/AAV-2806-2020	Ren, Zhoupeng/0000-0003-1766-2820; FENG, XINYU/0000-0002-4120-7759; Wang, Jinfeng/0000-0002-6687-9420; Sturrock, Hugh/0000-0002-0029-3101	National S & T Major Program [2012ZX10004-220, 2012CB955503, 2012 ZX10004-201]	National S & T Major Program	This study was supported by the National S & T Major Program (Grant No. 2012ZX10004-220, 2012CB955503 and 2012 ZX10004-201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1 MARAARMA; Antonio-Nkondjio C, 2005, T ROY SOC TROP MED H, V99, P347, DOI 10.1016/j.trstmh.2004.07.003; Arifin SMN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-290; Baltagi B. H., 2005, ECONOMETRIC ANAL PAN; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Buckley YM, 2003, J APPL ECOL, V40, P481, DOI 10.1046/j.1365-2664.2003.00821.x; Chen HL, 2002, J PRACTICAL PARASITI, V10, P5; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; ESRI, 2013, ARCGIS DESKT REL 10; Gao HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043686; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Haque U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014341; Hay SI, 2000, ADV PARASIT, V47, P173, DOI 10.1016/S0065-308X(00)47009-0; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hsiao Cheng., 2003, ANAL PANEL DATA, VSecond; Imbahale SS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-81; Jacob BG, 2009, GEOSPATIAL HEALTH, V3, P157, DOI 10.4081/gh.2009.218; Kitron U, 1998, J MED ENTOMOL, V35, P435, DOI 10.1093/jmedent/35.4.435; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Liu MD, 2008, CHI J PUBLIC HLTH, V1; Liu XB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-58; Lourenco PM, 2011, J VECTOR ECOL, V36, P279, DOI 10.1111/j.1948-7134.2011.00168.x; Ma S.-f., 1981, Sinozoologia, V1, P59; Magesa SM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-34; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; *MIN HLTH, 2005, MAL SURV PROJ CHIN; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; Ministry of Health Disease Prevention and Control Bureau, 2007, HDB MAL CONTR PREV; Omumbo JA, 2005, TROP MED INT HEALTH, V10, P557, DOI 10.1111/j.1365-3156.2005.01424.x; Pan B, 2003, J TROPICAL MED, V1, P477; Pan JY, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-136; Ren ZP, 2013, STOCH ENV RES RISK A, V27, P1695, DOI 10.1007/s00477-013-0707-0; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rueda LM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-55; Sacker A, 2006, HEALTH PLACE, V12, P279, DOI 10.1016/j.healthplace.2004.08.011; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sleigh AC, 1998, B WORLD HEALTH ORGAN, V76, P265; StataCorp, 2011, STAT STAT SOFTW REL; Thomson MC, 2000, MED VET ENTOMOL, V14, P227, DOI 10.1046/j.1365-2915.2000.00250.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; Vythilingam Indra, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P83; Wang DQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068766; Wardlow BD, 2010, INT J REMOTE SENS, V31, P805, DOI 10.1080/01431160902897858; *WHO DIV MAL OTH P, 1975, MAN PRACT ENT MAL; Wong J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-143; World Health Organization, 2009, WORLD MALARIA REPORT; Xia Z, 2014, PARASITE VECTO UNPUB; XU J-J, 1975, Acta Entomologica Sinica, V18, P77; Yamana TK, 2013, ENVIRON HEALTH PERSP, V121, P1179, DOI 10.1289/ehp.1206174; Zhang, 2006, J PATHOG BIO, V1, P117; Zhang Y, 2010, ENVIRON INT, V36, P439, DOI 10.1016/j.envint.2010.03.005	57	18	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116932	10.1371/journal.pone.0116932	http://dx.doi.org/10.1371/journal.pone.0116932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611483	Green Submitted, gold, Green Published			2022-12-27	WOS:000348562900027
J	Xie, J; Tong, A; Kim, SC				Xie, Jing; Tong, Angela; Kim, Seoyoung C.			Patterns of Bisphosphonates Utilization in Patients under Age 45 in a Large Cohort of Commercial Insurance Beneficiaries in the United States	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED OSTEOPOROSIS; POSTMENOPAUSAL OSTEOPOROSIS; WOMEN; ALENDRONATE; FRACTURES; RISK; RISEDRONATE; PREVENTION; THERAPY; TRIAL	Background The effectiveness and safety of bisphosphonates treatment used in the young population have not been well studied. Despite insufficient data on effectiveness and safety of bisphosphonates in young patients, bisphosphonates are still considered in younger patients at high risk for osteoporosis or fracture. The objectives of this study were to identify bisphosphonate initiators aged 10-45 years and describe their clinical characteristics and to assess time trends of bisphosphonate use over the past decade in a large U.S. population-based cohort. Methods Using the medical and pharmacy claims data from a U.S. commercial insurance (20032012), patients aged 10-45 years without malignancy who initiated an oral or intravenous bisphosphonate after at least 1 year of insurance enrollment were selected. Baseline demographics, comorbidities, medications and health care utilization were assessed in the year prior to initiating a bisphosphonate. The trend of bisphosphonate use over time was examined. Results There were 9,082 bisphosphonate initiators (0.02% of the same age group in the population). The mean age was 38.1 years and 79.6% female. Osteoporosis was the most common diagnosis (41.2%). At baseline, 10.8% had a diagnosis of fracture and 29.0% had a bone mineral density measured. Of those who used glucocorticoids (39%) at baseline, the mean 1-year cumulative prednisone-equivalent dose was 2,669 milligrams. The use of bisphosphonates in the young population significantly decreased over the past decade (p < 0.001). Conclusions Among young patients aged 10-45, the use of bisphosphonates was uncommon and significantly decreased over the past decade in the U.S. While most patients initiating bisphosphonates had a diagnosis of osteoporosis and fracture in the preceding year, some had no recorded claims with a diagnosis of fracture, osteoporosis, or long-term glucocorticoids use at baseline. Future research is needed to examine the effectiveness and safety of bisphosphonates in young patients at risk for osteoporosis.	[Xie, Jing; Tong, Angela; Kim, Seoyoung C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kim, Seoyoung C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kim, SC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA.	skim62@partners.org	Kim, Seoyoung/L-6561-2019	Kim, Seoyoung/0000-0002-2517-3579	NIH [K23 AR059677]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR059677] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Kim is supported by the NIH grant K23 AR059677. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Boskey AL, 2009, OSTEOPOROSIS INT, V20, P793, DOI 10.1007/s00198-008-0725-9; Boyce AM, 2014, PM&R, V6, P427, DOI 10.1016/j.pmrj.2013.10.009; da Fonseca MA, 2011, PEDIATR DENT, V33, P241; Feldstein AC, 2005, OSTEOPOROSIS INT, V16, P2168, DOI 10.1007/s00198-005-2016-z; Grossman JM, 2010, ARTHRIT CARE RES, V62, P1515, DOI 10.1002/acr.20295; Hansen KE, 2011, J BONE MINER RES, V26, P1989, DOI 10.1002/jbmr.362; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Khan SA, 1997, J BONE MINER RES, V12, P1700, DOI 10.1359/jbmr.1997.12.10.1700; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Patlas N, 1999, TERATOLOGY, V60, P68, DOI 10.1002/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H; Pazianas M, 2012, OSTEOPOROSIS INT, V23, P2873, DOI 10.1007/s00198-012-1952-7; Ro C, 2013, CURR OSTEOPOROS REP, V11, P45, DOI 10.1007/s11914-012-0129-9; Suresh E, 2014, RHEUMATOLOGY, V53, P19, DOI 10.1093/rheumatology/ket236; Whyte MP, 2003, NEW ENGL J MED, V349, P457, DOI 10.1056/NEJMoa023110	15	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115091	10.1371/journal.pone.0115091	http://dx.doi.org/10.1371/journal.pone.0115091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611596	Green Published, gold, Green Submitted			2022-12-27	WOS:000348562900004
J	Fujita, T; Kitaura, F; Fujii, H				Fujita, Toshitsugu; Kitaura, Fusako; Fujii, Hodaka			A Critical Role of the Thy28-MYH9 Axis in B Cell-Specific Expression of the Pax5 Gene in Chicken B Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; BRUTONS TYROSINE KINASE; GENOMIC REGIONS; CHROMATIN IMMUNOPRECIPITATION; STIMULATED TRANSCRIPTION; NEUROENDOCRINE CELLS; EFFICIENT ISOLATION; MYOSIN-I; PROTEIN; DIFFERENTIATION	Accumulating evidence suggests that Pax5 plays essential roles in B cell lineage commitment. However, molecular mechanisms of B cell-specific expression of Pax5 are not fully understood. Here, we applied insertional chromatin immunoprecipitation iChIP) combined with stable isotope labeling using amino acids in cell culture (SILAC) (iChIP-SILAC) to direct identification of proteins interacting with the promoter region of the endogenous single-copy chicken Pax5 gene. By comparing B cells with macrophage-like cells trans-differentiated by ectopic expression of C/EBP beta, iChIP-SILAC detected B cell-specific interaction of a nuclear protein, Thy28/Thyn1, with the Pax5 1A promoter. Trans-differentiation of B cells into macrophage- like cells caused down-regulation of Thy28 expression. Loss-of-function of Thy28 induced decrease in Pax5 expression and recruitment of myosin-9 (MYH9), one of Thy28-interacting proteins, to the Pax5 1A promoter. Loss-of-function of MYH9 also induced decrease in Pax5 expression. Thus, our analysis revealed that Thy28 is functionally required for B cell-specific expression of Pax5 via recruitment of MYH9 to the Pax5 locus in chicken B cells.	[Fujita, Toshitsugu; Kitaura, Fusako; Fujii, Hodaka] Osaka Univ, Microbial Dis Res Inst, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, Suita, Osaka, Japan	Osaka University	Fujii, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, Suita, Osaka, Japan.	hodaka@biken.osaka-u.ac.jp	Fujii, Hodaka/A-2420-2008; FUJITA, Toshitsugu/ABH-5101-2020; Fujita, Toshitsugu/AAB-4964-2022; Fujii, Hodaka/N-9792-2019	Fujii, Hodaka/0000-0003-1296-4256; FUJITA, Toshitsugu/0000-0002-9536-9999; Fujii, Hodaka/0000-0003-1296-4256	Tokyo Biochemical Research Foundation; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Asahi Glass Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) by the Japan Science and Technology Agency (JST) [AS242Z00789Q]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23118516, 23114707, 25118512]; Program for Combined Research Fields from Immunology Frontier Research Center, Osaka University;  [22710185];  [25830131]	Tokyo Biochemical Research Foundation; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Asahi Glass Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kurata Memorial Hitachi Science and Technology Foundation; Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) by the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Combined Research Fields from Immunology Frontier Research Center, Osaka University; ; 	This work was supported by the Tokyo Biochemical Research Foundation, Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering (T.F.), the Asahi Glass Foundation, the Uehara Memorial Foundation (H.F.), Takeda Science Foundation, the Kurata Memorial Hitachi Science and Technology Foundation (T.F. and H.F.), Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) by the Japan Science and Technology Agency (JST) (#AS242Z00789Q) (T.F.), Grant-in-Aid for Young Scientists (B) (#22710185 and #25830131) (T.F.), Grant-in-Aid for Scientific Research on Innovative Areas "Cell Fate" (#23118516) (T.F.), "The Genofield" (#23114707), " Transcription Cycle" (#25118512) (H. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Program for Combined Research Fields from Immunology Frontier Research Center, Osaka University (H.F.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Balduini CL, 2011, BRIT J HAEMATOL, V154, P161, DOI 10.1111/j.1365-2141.2011.08716.x; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Chen CMA, 2000, MECH DEVELOP, V90, P293; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Compton MM, 2001, APOPTOSIS, V6, P299, DOI 10.1023/A:1011339626128; de Lanerolle P, 2011, NAT CELL BIOL, V13, P1282, DOI 10.1038/ncb2364; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; Fujita T, 2012, ADV BIOSCI BIOTECHNO, V3, P626, DOI [10.4236/abb.2012.35081., DOI 10.4236/ABB.2012.35081]; Fujita T, 2008, MOL CELL BIOL, V28, P1630, DOI 10.1128/MCB.01767-07; Fujita T, 2007, NUCLEIC ACIDS RES, V35, P1007, DOI 10.1093/nar/gkl1138; Fujita T, 2014, BMC MOL BIOL, V15, DOI 10.1186/s12867-014-0026-0; Fujita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103084; Fujita Toshitsugu, 2013, ISRN Biochem, V2013, P913273, DOI 10.1155/2013/913273; Fujita T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03171; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Fujita T, 2012, MOL BIOL REP, V39, P9613, DOI 10.1007/s11033-012-1825-3; Fujita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026109; Fujita T, 2011, GENE, V477, P24, DOI 10.1016/j.gene.2011.01.008; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Hirano M, 2004, INT IMMUNOL, V16, P747, DOI 10.1093/intimm/dxh076; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hofmann WA, 2006, J CELL BIOCHEM, V99, P1001, DOI 10.1002/jcb.21035; Hoshino A, 2009, J BIOSCI BIOENG, V108, P446, DOI 10.1016/j.jbiosc.2009.05.005; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Jiang XZ, 2003, APOPTOSIS, V8, P509, DOI 10.1023/A:1025594409056; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Miyaji H, 2002, GENE, V297, P189, DOI 10.1016/S0378-1119(02)00886-7; Munemasa Y, 2008, MOL CELL BIOL, V28, P1171, DOI 10.1128/MCB.01396-07; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Saint Fleur S, 2009, BLOOD, V114, P1355, DOI 10.1182/blood-2008-11-189118; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; Toyota H, 2012, CELL MOL BIOL LETT, V17, P36, DOI 10.2478/s11658-011-0034-8; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Vreugde S, 2006, MOL CELL, V23, P749, DOI 10.1016/j.molcel.2006.07.005; Webb CF, 2000, J IMMUNOL, V165, P6956, DOI 10.4049/jimmunol.165.12.6956; Woolner S, 2009, TRENDS CELL BIOL, V19, P245, DOI 10.1016/j.tcb.2009.03.003; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yang WC, 2000, INT IMMUNOL, V12, P1547, DOI 10.1093/intimm/12.11.1547; Yu F, 2009, ACTA CRYSTALLOGR D, V65, P212, DOI 10.1107/S0907444908041474	46	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116579	10.1371/journal.pone.0116579	http://dx.doi.org/10.1371/journal.pone.0116579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607658	Green Submitted, gold, Green Published			2022-12-27	WOS:000348205300029
J	Barrios, YV; Gelaye, B; Zhong, QY; Nicolaidis, C; Rondon, MB; Garcia, PJ; Sanchez, PAM; Sanchez, SE; Williams, MA				Barrios, Yasmin V.; Gelaye, Bizu; Zhong, Qiuyue; Nicolaidis, Christina; Rondon, Marta B.; Garcia, Pedro J.; Sanchez, Pedro A. Mascaro; Sanchez, Sixto E.; Williams, Michelle A.			Association of Childhood Physical and Sexual Abuse with Intimate Partner Violence, Poor General Health and Depressive Symptoms among Pregnant Women	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; DOMESTIC VIOLENCE; SUICIDE ATTEMPTS; HOUSEHOLD DYSFUNCTION; PERUVIAN WOMEN; RISK-FACTOR; PREVALENCE; IMPACT; MALTREATMENT	Objective We examined associations of childhood physical and sexual abuse with risk of intimate partner violence (IPV). We also evaluated the extent to which childhood abuse was associated with self-reported general health status and symptoms of antepartum depression in a cohort of pregnant Peruvian women. Methods In-person interviews were conducted to collect information regarding history of childhood abuse and IPV from 1,521 women during early pregnancy. Antepartum depressive symptomatology was evaluated using the Patient Health Questionnaire-9. Multivariable logistic regression procedures were used to estimate adjusted odds ratios (aOR) and 95%Confidence intervals (95%CI). Results Any childhood abuse was associated with 2.2-fold increased odds of lifetime IPV (95%CI: 1.72-2.83). Compared with women who reported no childhood abuse, those who reported both, childhood physical and sexual abuse had a 7.14-fold lifetime risk of physical and sexual IPV (95%CI: 4.15-12.26). The odds of experiencing physical and sexual abuse by an intimate partner in the past year was 3.33-fold higher among women with a history of childhood physical and sexual abuse as compared to women who were not abused as children (95%CI 1.60-6.89). Childhood abuse was associated with higher odds of self-reported poor health status during early pregnancy (aOR = 1.32, 95%CI: 1.04-1.68) and with symptoms of antepartum depression (aOR = 2.07, 95%CI: 1.58-2.71). Conclusion These data indicate that childhood sexual and physical abuse is associated with IPV, poor general health and depressive symptoms in early pregnancy. The high prevalence of childhood trauma and its enduring effects of on women's health warrant concerted global health efforts in preventing violence.	[Barrios, Yasmin V.; Gelaye, Bizu; Zhong, Qiuyue; Williams, Michelle A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Nicolaidis, Christina] Portland State Univ, Sch Social Work, Portland, OR 97207 USA; [Rondon, Marta B.] Cayetano Heredia Peruvian Univ, Sect Psychiat & Mental Hlth, Dept Med, Lima, Peru; [Garcia, Pedro J.; Sanchez, Pedro A. Mascaro] Inst Nacl Materno Perinatal, Lima, Peru; [Sanchez, Sixto E.] Univ Peruana Ciencias Aplicadas, Lima, Peru; [Sanchez, Sixto E.] Asociac Civil PROESA, Lima, Peru	Harvard University; Harvard T.H. Chan School of Public Health; Portland State University; Universidad Peruana Cayetano Heredia; Universidad Peruana de Ciencias Aplicadas (UPC)	Gelaye, B (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	bgelaye@hsph.harvard.edu	Nicolaidis, Christina/CAC-0028-2022; Nicolaidis, Christina/X-6468-2019	Nicolaidis, Christina/0000-0002-9394-5956; Nicolaidis, Christina/0000-0002-9394-5956; Mascaro Sanchez, Pedro Arnaldo/0000-0001-7868-771X; Gelaye, Bizu/0000-0001-7934-548X; Rondon, Marta/0000-0001-8459-6785; Sanchez, Sixto/0000-0003-0354-0523	National Institutes of Health (NIH), the Eunice Kennedy Shriver Institute of Child Health and Human Development [R01-HD-059835]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052468, R01HD059835] Funding Source: NIH RePORTER	National Institutes of Health (NIH), the Eunice Kennedy Shriver Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by an award from the National Institutes of Health (NIH), the Eunice Kennedy Shriver Institute of Child Health and Human Development (R01-HD-059835). The NIH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Aquino Nicole Moraes Rego de, 2009, Rev Saude Publica, V43, P954, DOI 10.1590/S0034-89102009005000068; Arata C M, 2000, Child Maltreat, V5, P28, DOI 10.1177/1077559500005001004; Banducci AN, 2014, CHILD ABUSE NEGLECT, V38, P928, DOI 10.1016/j.chiabu.2013.12.007; Barnes JE, 2009, CHILD ABUSE NEGLECT, V33, P412, DOI 10.1016/j.chiabu.2008.09.013; Barth J, 2013, INT J PUBLIC HEALTH, V58, P469, DOI 10.1007/s00038-012-0426-1; Benedict MI, 1999, CHILD ABUSE NEGLECT, V23, P659, DOI 10.1016/S0145-2134(99)00040-X; Bensley L, 2003, AM J PREV MED, V25, P38, DOI 10.1016/S0749-3797(03)00094-1; BERGMAN B, 1991, ACTA PSYCHIAT SCAND, V83, P380, DOI 10.1111/j.1600-0447.1991.tb05560.x; Bertone-Johnson ER, 2012, AM J PREV MED, V43, P611, DOI 10.1016/j.amepre.2012.08.014; Bonomi AE, 2008, CHILD ABUSE NEGLECT, V32, P693, DOI 10.1016/j.chiabu.2007.10.004; BRIERE J, 1990, CHILD ABUSE NEGLECT, V14, P357, DOI 10.1016/0145-2134(90)90007-G; Brodsky BS, 2008, J CLIN PSYCHIAT, V69, P584, DOI 10.4088/JCP.v69n0410; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Clark DB, 2003, DRUG ALCOHOL DEPEN, V69, P51, DOI 10.1016/S0376-8716(02)00254-5; Coid J, 2001, LANCET, V358, P450, DOI 10.1016/S0140-6736(01)05622-7; Coogan PF, 2013, J ALLERGY CLIN IMMUN, V131, P1058, DOI 10.1016/j.jaci.2012.10.023; Cripe SM, 2011, HEADACHE, V51, P208, DOI 10.1111/j.1526-4610.2010.01777.x; Cripe SM, 2010, J INTERPERS VIOLENCE, V25, P2054, DOI 10.1177/0886260509354517; Cyr K, 2014, J INTERPERS VIOLENCE, V29, P616, DOI 10.1177/0886260513505220; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; de Paz NC, 2011, J AFFECT DISORDERS, V130, P280, DOI 10.1016/j.jad.2010.07.024; DELLAFEMINA D, 1990, CHILD ABUSE NEGLECT, V14, P227; Devries KM, 2014, PEDIATRICS; DHS, 2005, DEMOGRAPHIC HEALTH S; Dinwiddie S, 2000, PSYCHOL MED, V30, P41, DOI 10.1017/S0033291799001373; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Dunkle KL, 2004, AM J EPIDEMIOL, V160, P230, DOI 10.1093/aje/kwh194; Easton SD, 2013, CHILD ABUSE NEGLECT, V37, P380, DOI 10.1016/j.chiabu.2012.11.007; Ellsberg MC, 2001, J EPIDEMIOL COMMUN H, V55, P547, DOI 10.1136/jech.55.8.547; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finkelhor D, 2013, JAMA PEDIATR, V167, P614, DOI 10.1001/jamapediatrics.2013.42; Frank JB, 1999, EMERG MED CLIN N AM, V17, P657, DOI 10.1016/S0733-8627(05)70089-4; Fraser JA, 2000, CHILD ABUSE NEGLECT, V24, P1399, DOI 10.1016/S0145-2134(00)00193-9; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gelaye B, 2010, J INTERPERS VIOLENCE, V25, P136, DOI 10.1177/0886260508329127; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Gomez-Beloz A, 2009, VIOLENCE VICTIMS, V24, P380, DOI 10.1891/0886-6708.24.3.380; Gonzalez A, 2012, J PSYCHIATR RES, V46, P1475, DOI 10.1016/j.jpsychires.2012.08.004; Harrison PA, 2008, J HEALTH CARE POOR U, V19, P258, DOI 10.1353/hpu.2008.0003; Hart C, 2012, SOC PSYCH PSYCH EPID, V47, P1581, DOI 10.1007/s00127-011-0464-7; Hedin LW, 1999, ACTA OBSTET GYN SCAN, V78, P310, DOI 10.1034/j.1600-0412.1999.780407.x; Heffernan K, 2000, J NERV MENT DIS, V188, P589, DOI 10.1097/00005053-200009000-00005; Hornor G, 2010, J PEDIATR HEALTH CAR, V24, P358, DOI 10.1016/j.pedhc.2009.07.003; Hotaling G. T., 1990, J FAM VIOLENCE, V5, P1, DOI DOI 10.1007/BF00979135; Irish L, 2010, J PEDIATR PSYCHOL, V35, P450, DOI 10.1093/jpepsy/jsp118; Miranda JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099662; KENDALLTACKETT KA, 1988, CHILD ABUSE NEGLECT, V12, P73, DOI 10.1016/0145-2134(88)90009-9; KENDALLTACKETT KA, 1993, PSYCHOL BULL, V113, P164, DOI 10.1037/0033-2909.113.1.164; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Kernic MA, 2000, AM J PUBLIC HEALTH, V90, P1416, DOI 10.2105/AJPH.90.9.1416; Kessler RC, 1997, AM J PSYCHIAT, V154, P1405; Knox M, 2013, J COMMUNITY PSYCHOL, V41, P395, DOI 10.1002/jcop.21543; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leeners B, 2014, J PERINAT MED, V42, P171, DOI 10.1515/jpm-2013-0003; Lindert J, 2014, INT J PUBLIC HEALTH, V59, P359, DOI 10.1007/s00038-013-0519-5; Molnar BE, 2001, PSYCHOL MED, V31, P965, DOI 10.1017/S0033291701004329; Nelson DB, 2010, J WOMENS HEALTH, V19, P1177, DOI 10.1089/jwh.2009.1539; Nicolaidis C, 2004, J GEN INTERN MED, V19, P819, DOI 10.1111/j.1525-1497.2004.30382.x; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Perales MT, 2009, VIOLENCE AGAINST WOM, V15, P224, DOI 10.1177/1077801208329387; Pereda N, 2009, CLIN PSYCHOL REV, V29, P328, DOI 10.1016/j.cpr.2009.02.007; Pico-Alfonso MA, 2006, J WOMENS HEALTH, V15, P599, DOI 10.1089/jwh.2006.15.599; Pineda-Lucatero AG, 2009, CHILD CARE HLTH DEV, V35, P184, DOI 10.1111/j.1365-2214.2008.00888.x; Roberts GL, 1997, GEN HOSP PSYCHIAT, V19, P5, DOI 10.1016/S0163-8343(96)00119-3; Runtz MG, 1997, CHILD ABUSE NEGLECT, V21, P211, DOI 10.1016/S0145-2134(96)00147-0; Russell D E, 1983, Child Abuse Negl, V7, P133, DOI 10.1016/0145-2134(83)90065-0; Sachs-Ericsson N, 2005, HEALTH PSYCHOL, V24, P32, DOI 10.1037/0278-6133.24.1.32; Sanders MR, 2000, J CHILD PSYCHOL PSYC, V41, P939, DOI 10.1111/1469-7610.00681; Sarkar NN, 2008, J OBSTET GYNAECOL, V28, P266, DOI 10.1080/01443610802042415; Schaaf KK, 1998, CHILD ABUSE NEGLECT, V22, P1119, DOI 10.1016/S0145-2134(98)00090-8; Seng JS, 2008, J MIDWIFERY WOM HEAL, V53, P511, DOI 10.1016/j.jmwh.2008.04.013; SIEGEL JM, 1987, AM J EPIDEMIOL, V126, P1141, DOI 10.1093/oxfordjournals.aje.a114752; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; STERN AE, 1995, J CHILD PSYCHOL PSYC, V36, P1077, DOI 10.1111/j.1469-7610.1995.tb01352.x; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; Teicher MH, 2006, AM J PSYCHIAT, V163, P993, DOI 10.1176/appi.ajp.163.6.993; Thompson Martie P, 2002, Violence Vict, V17, P283; Trickett PK, 2011, DEV PSYCHOPATHOL, V23, P453, DOI 10.1017/S0954579411000174; Watts-English T, 2006, J SOC ISSUES, V62, P717, DOI 10.1111/j.1540-4560.2006.00484.x; WILLIAMS LM, 1995, J TRAUMA STRESS, V8, P649, DOI 10.1007/BF02102893; Wise LA, 2009, AM J PUBLIC HEALTH, V99, pS460, DOI 10.2105/AJPH.2008.149005; Woods S J, 2000, Issues Ment Health Nurs, V21, P309, DOI 10.1080/016128400248112; World Health Organization (WHO), 2005, PROMOTING MENTAL HEA; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; Yampolsky L, 2010, J ADV NURS, V66, P2025, DOI 10.1111/j.1365-2648.2010.05387.x; Zhang TH, 2013, COMPR PSYCHIAT, V54, P856, DOI 10.1016/j.comppsych.2013.03.014; Zhong QY, 2014, J AFFECT DISORDERS, V162, P1, DOI 10.1016/j.jad.2014.03.028; Zhong QY, 2014, J AFFECT DISORDERS, V158, P148, DOI 10.1016/j.jad.2014.02.012	91	85	88	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116609	10.1371/journal.pone.0116609	http://dx.doi.org/10.1371/journal.pone.0116609			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HX	25635902	Green Published, gold			2022-12-27	WOS:000350680700047
J	Daivajna, S; Bajwa, A; Villar, R				Daivajna, Sachin; Bajwa, Ali; Villar, Richard			Outcome of Arthroscopy in Patients with Advanced Osteoarthritis of the Hip	PLOS ONE			English	Article							FEMOROACETABULAR IMPINGEMENT; FEMORAL OSTEOCHONDROPLASTY; LABRAL DEBRIDEMENT; PAIN; OSTEOPLASTY; ATHLETE	Hip arthroscopy has continued to expand its horizons in treating many conditions other than femoroacetabular impingement (FAI). However, the results of hip arthroscopy are known to be poor if the degree of articular cartilage damage is significant. We wanted to assess, whether the procedure might have a role in the management of young and active patients with advanced osteoarthritis (OA) and whether it should be offered as a treatment modality. 77 consecutive patients with Tonnis grade 2 and 3 osteoarthritis of the hip who had undergone hip arthroscopy were included in the study. Patients' medical notes, plain radiographs and outcome scores (modified Harris hip score (mHHS), non-arthritic hip score (NAHS)) preoperatively and postoperatively at six weeks, six months, one year and annually thereafter, were analysed. 77 patients consisted of 63 men and 14 women with mean follow-up of 2.8 years (2.2 to 4.2) and mean age at surgery of 43 years (19 to 64). The mean preoperative mHHS and NAHS scores were 58 (28 to 87) and 64 (27 to 93) respectively. The mean improvements in both the mHHS and NAHS scores were significant (p = 0.003 and p = 0.0001 for mHHS at one and two years, p = 0.002 and p = 0.0003 for NAHS at one and two years, respectively). There were 34 patients (44%) who required a total hip replacement at mean of 18 months (6 to 48) after hip arthroscopy. We conclude that hip arthroscopy improves outcome scores in 56% of patients with severe OA of the hip (Tonnis grade 2 and 3) for at least two years after surgery. We thus consider the procedure to be a reasonable option for patients with hip OA, although success of the procedure will be less than if undertaken for certain other conditions.	[Daivajna, Sachin; Bajwa, Ali; Villar, Richard] Spire Cambridge Lea Hosp, Cambridge CB24 9EL, England		Daivajna, S (corresponding author), Spire Cambridge Lea Hosp, Cambridge CB24 9EL, England.	sachin.daivajna@gmail.com						Bardakos NV, 2008, J BONE JOINT SURG BR, V90B, P1570, DOI 10.1302/0301-620X.90B12.21012; Bozic KJ, 2013, J ARTHROPLASTY, V28, P140, DOI 10.1016/j.arth.2013.02.039; Byrd JWT, 2009, ARTHROSCOPY, V25, P365, DOI 10.1016/j.arthro.2009.02.001; Byrd JWT, 2000, ARTHROSCOPY, V16, P578, DOI 10.1053/jars.2000.7683; Christensen CP, 2003, CLIN ORTHOP RELAT R, P75, DOI 10.1097/01.blo.0000043047.84315.4b; Dienst M, 1999, ORTHOPADE, V28, P812, DOI 10.1007/PL00003671; Gomberawalla MM, 2014, SPORTS HEALTH, V6, P70, DOI 10.1177/1941738113497678; Hassouna H, 2007, ACTA ORTHOP BELG, V73, P737; Haviv B, 2010, J BONE JOINT SURG BR, V92B, P629, DOI 10.1302/0301-620X.92B5.23667; Haviv B, 2010, BMC SPORTS SCI MED R, V2, DOI 10.1186/1758-2555-2-18; Helenius I, 2001, ANN CHIR GYNAECOL, V90, P28; Sanchez VMI, 2007, REUMATOL CLIN, V3, P50; Javed A, 2011, J BONE JOINT SURG BR, V93B, P326, DOI 10.1302/0301-620X.93B3.25262; Kim KC, 2007, CLIN ORTHOP RELAT R, P128, DOI 10.1097/01.blo.0000246542.49575.2c; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Krych AJ, 2013, SPORTS MED ARTHROSC, V21, P23, DOI 10.1097/JSA.0b013e318270d1bd; Larson CM, 2011, CLIN ORTHOP RELAT R, V469, P1667, DOI 10.1007/s11999-010-1741-6; Malviya A, 2012, J BONE JOINT SURG BR, V94B, P466, DOI 10.1302/0301-620X.94B4.28023; Margheritini F, 1999, Chir Organi Mov, V84, P257; McCarthy JC, 2011, CLIN ORTHOP RELAT R, V469, P362, DOI 10.1007/s11999-010-1559-2; Meftah M, 2011, ORTHOPEDICS, V34, pE588, DOI 10.3928/01477447-20110826-04; Philippon MJ, 2007, AM J SPORT MED, V35, P1571, DOI 10.1177/0363546507300258; Philippon MJ, 2012, ARTHROSCOPY, V28, P59, DOI 10.1016/j.arthro.2011.07.004; Simpson J, 2010, ORTHOP TRAUMATOL-SUR, V96, pS68, DOI 10.1016/j.otsr.2010.09.010; TONNIS D, 1979, Z ORTHOP GRENZGEB, V117, P808; Wilkin G, 2014, J BONE JOINT SURG AM, V96A, P113, DOI 10.2106/JBJS.L.01710	26	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0113970	10.1371/journal.pone.0113970	http://dx.doi.org/10.1371/journal.pone.0113970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635392	gold, Green Submitted, Green Published			2022-12-27	WOS:000350680700002
J	Hite, RK; Chiu, PL; Schuller, JM; Walz, T				Hite, Richard Kevin; Chiu, Po-Lin; Schuller, Jan Michael; Walz, Thomas			Effect of Lipid Head Groups on Double-Layered Two-Dimensional Crystals Formed by Aquaporin-0	PLOS ONE			English	Article							PROTEIN INTERACTIONS; PHOSPHATIDIC-ACID; 2D CRYSTALS; MICROSCOPY; MEMBRANES; IMAGES	Aquaporin-0 (AQP0) is a lens-specific water channel that also forms membrane junctions. Reconstitution of AQP0 with dimyristoyl phosphatidylcholine (DMPC) and E. coli polar lipids (EPL) yielded well-ordered, double-layered two-dimensional (2D) crystals that allowed electron crystallographic structure determination of the AQP0-mediated membrane junction. The interacting tetramers in the two crystalline layers are exactly in register, resulting in crystals with p422 symmetry. The high-resolution density maps also allowed modeling of the annular lipids surrounding the tetramers. Comparison of the DMPC and EPL bilayers suggested that the lipid head groups do not play an important role in the interaction of annular lipids with AQP0. We now reconstituted AQP0 with the anionic lipid dimyristoyl phosphatidylglycerol (DMPG), which yielded a mixture of 2D crystals with different symmetries. The different crystal symmetries result from shifts between the two crystalline layers, suggesting that the negatively charged PG head group destabilizes the interaction between the extracellular AQP0 surfaces. Reconstitution of AQP0 with dimyristoyl phosphatidylserine (DMPS), another anionic lipid, yielded crystals that had the usual p422 symmetry, but the crystals showed a pH-dependent tendency to stack through their cytoplasmic surfaces. Finally, AQP0 failed to reconstitute into membranes that were composed of more than 40% dimyristoyl phosphatidic acid (DMPA). Hence, although DMPG, DMPS, and DMPA are all negatively charged lipids, they have very different effects on AQP0 2D crystals, illustrating the importance of the specific lipid head group chemistry beyond its mere charge.	[Hite, Richard Kevin; Chiu, Po-Lin; Schuller, Jan Michael; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Walz, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	twalz@hms.harvard.edu	Chiu, Po-Lin/D-2762-2013; Chiu, Po-Lin/ABB-7848-2021; Chiu, Po-Lin/GWV-6758-2022	Chiu, Po-Lin/0000-0001-8608-7650; Chiu, Po-Lin/0000-0001-8608-7650; Walz, Thomas/0000-0003-2606-2835; Schuller, Jan Michael/0000-0002-9121-1764	National Institutes of Health [R01 EY015107, P01 GM62580]; NATIONAL EYE INSTITUTE [R01EY015107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 EY015107 (to TW). TW is an investigator with the Howard Hughes Medical Institute. The molecular electron microscopy facility at Harvard Medical School was established with a generous donation from the Giovanni Armenise Harvard Center for Structural Biology and is maintained with funds from NIH grant P01 GM62580 (to Stephen C. Harrison). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzhynskyy N, 2007, EMBO REP, V8, P51, DOI 10.1038/sj.embor.7400858; ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9; Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920; Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012; HARLOS K, 1984, CHEM PHYS LIPIDS, V34, P115, DOI 10.1016/0009-3084(84)90037-9; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Hite RK, 2010, METHOD ENZYMOL, V481, P251, DOI 10.1016/S0076-6879(10)81011-0; Hite RK, 2010, EMBO J, V29, P1652, DOI 10.1038/emboj.2010.68; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Marsh D., 1990, CRC HDB LIPID BILAYE; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Peterson E, 2011, BBA-BIOMEMBRANES, V1808, P516, DOI 10.1016/j.bbamem.2010.10.010; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Tani K, 2009, J MOL BIOL, V389, P694, DOI 10.1016/j.jmb.2009.04.049; VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Zampighi G, 1982, J CELL BIOL, V93, P172, DOI 1016/j.jmb.2009.04.049; ZELENKA PS, 1984, CURR EYE RES, V3, P1337, DOI 10.3109/02713688409007421	24	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117371	10.1371/journal.pone.0117371	http://dx.doi.org/10.1371/journal.pone.0117371			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635393	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700082
J	Meziane, HB; Moisello, C; Perfetti, B; Kvint, S; Isaias, IU; Quartarone, A; Di Rocco, A; Ghilardi, MF				Meziane, Hadj Boumediene; Moisello, Clara; Perfetti, Bernardo; Kvint, Svetlana; Isaias, Ioannis Ugo; Quartarone, Angelo; Di Rocco, Alessandro; Ghilardi, Maria Felice			Movement Preparation and Bilateral Modulation of Beta Activity in Aging and Parkinson's Disease	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; OSCILLATORY ACTIVITY; CORTICAL RHYTHMS; EEG DATA; L-DOPA; TIME; COHERENCE; BRADYKINESIA; ACTIVATION; PARADIGMS	In previous studies of young subjects performing a reaction-time reaching task, we found that faster reaction times are associated with increased suppression of beta power over primary sensorimotor areas just before target presentation. Here we ascertain whether such beta decrease similarly occurs in normally aging subjects and also in patients with Parkinson's disease (PD), where deficits in movement execution and abnormalities of beta power are usually present. We found that in both groups, beta power decreased during the motor task in the electrodes over the two primary sensorimotor areas. However, before target presentation, beta decreases in PD were significantly smaller over the right than over the left areas, while they were symmetrical in controls. In both groups, functional connectivity between the two regions, measured with imaginary coherence, increased before the target appearance; however, in PD, it decreased immediately after, while in controls, it remained elevated throughout motor planning. As in previous studies with young subjects, the degree of beta power before target appearance correlated with reaction time. The values of coherence during motor planning, instead, correlated with movement time, peak velocity and acceleration. We conclude that planning of prompt and fast movements partially depends on coordinated beta activity of both sensorimotor areas, already at the time of target presentation. The delayed onset of beta decreases over the right region observed in PD is possibly related to a decreased functional connectivity between the two areas, and this might account for deficits in force programming, movement duration and velocity modulation.	[Meziane, Hadj Boumediene; Moisello, Clara; Perfetti, Bernardo; Kvint, Svetlana; Ghilardi, Maria Felice] CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA; [Isaias, Ioannis Ugo] Univ Hosp Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; [Quartarone, Angelo] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol Sci, Messina, Italy; [Quartarone, Angelo; Di Rocco, Alessandro; Ghilardi, Maria Felice] NYU, Langone Sch Med, Movement Disorders Ctr, Dept Neurol, New York, NY USA	City University of New York (CUNY) System; University of Wurzburg; University of Messina; New York University; NYU Langone Medical Center	Ghilardi, MF (corresponding author), CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA.	lice.mg79@gmail.com	Isaias, Ioannis Ugo/F-4492-2014	Isaias, Ioannis Ugo/0000-0002-3552-5144; Meziane, Hadj Boumediene/0000-0001-9284-5016; Di Rocco (also publications under DiRocco), Alessandro/0000-0002-5508-5043	McDonnell Foundation; National Parkinson Foundation; National Institute of Health [NS-054864]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054864] Funding Source: NIH RePORTER	McDonnell Foundation; National Parkinson Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the McDonnell Foundation to MFG, the National Parkinson Foundation to MFG & ADR, and the National Institute of Health (NS-054864 to MFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2003, EXP BRAIN RES, V148, P17, DOI 10.1007/s00221-002-1255-x; Babiloni C, 2004, BEHAV BRAIN RES, V153, P261, DOI 10.1016/j.bbr.2003.12.012; Beaule V, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/627816; Brown P, 1999, MOVEMENT DISORD, V14, P423, DOI 10.1002/1531-8257(199905)14:3<423::AID-MDS1006>3.0.CO;2-V; Defebvre L, 1998, ELECTROMYOGR MOTOR C, V109, P161, DOI 10.1016/S0924-980X(97)00085-4; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DERAMBURE P, 1993, ELECTROEN CLIN NEURO, V89, P197, DOI 10.1016/0168-5597(93)90133-A; Doyle LMF, 2005, CLIN NEUROPHYSIOL, V116, P1879, DOI 10.1016/j.clinph.2005.03.017; Formaggio E, BRAIN TOPOGR; Freyer F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00144; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Ghilardi MF, 2003, NEUROLOGY, V60, P1313, DOI 10.1212/01.WNL.0000059545.69089.EE; Ghilardi MF, 2000, BRAIN RES, V876, P112, DOI 10.1016/S0006-8993(00)02635-4; Giannicola G, 2010, EXP NEUROL, V226, P120, DOI 10.1016/j.expneurol.2010.08.011; Gross J, 2005, NEUROIMAGE, V26, P91, DOI 10.1016/j.neuroimage.2005.01.025; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Heinrichs-Graham E, 2013, CEREB CORTEX; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; Koeda T, 1995, ELECTROEN CLIN NEURO, V95, P397, DOI 10.1016/0013-4694(95)00171-9; Kuhn AA, 2006, EUR J NEUROSCI, V23, P1956, DOI 10.1111/j.1460-9568.2006.04717.x; Kuhn AA, 2006, BRAIN, V129, P695, DOI 10.1093/brain/awh715; Kvint S, 2011, ARCH ITAL BIOL, V149, P303, DOI 10.4449/aib.v149i3.1244; Labyt E, 2005, J CLIN NEUROPHYSIOL, V22, P192; Leocani L, 2001, CLIN NEUROPHYSIOL, V112, P923, DOI 10.1016/S1388-2457(01)00530-2; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; Magnani G, 1998, MOVEMENT DISORD, V13, P653, DOI 10.1002/mds.870130408; Magnani G, 2002, NEUROL SCI, V23, P91, DOI 10.1007/s100720200033; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Manganotti P, 1998, ELECTROMYOGR MOTOR C, V109, P50, DOI 10.1016/S0924-980X(97)00074-X; Mani S, 2013, BRAIN, V136, P1288, DOI 10.1093/brain/aws283; Marinelli L, 2010, MOVEMENT DISORD, V25, P1498, DOI 10.1002/mds.23156; Mima T, 2000, NEUROSCI LETT, V287, P93, DOI 10.1016/S0304-3940(00)01165-4; MONTPLAISIR J, 1990, CLIN ELECTROENCEPHAL, V21, P42, DOI 10.1177/155005949002100114; Mutha PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058582; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez PL, 1999, CLIN NEUROPHYSIOL, V110, P469, DOI 10.1016/S1388-2457(98)00043-1; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onton J, 2006, PROG BRAIN RES, V159, P99, DOI 10.1016/S0079-6123(06)59007-7; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Priori A, 2004, EXP NEUROL, V189, P369, DOI 10.1016/j.expneurol.2004.06.001; Sailer A, 2000, NEUROLOGY, V55, P979, DOI 10.1212/WNL.55.7.979; Salmelin R, 1995, ELECTROEN CLIN NEURO, V95, P444, DOI 10.1016/0013-4694(95)00193-X; Schaefer SY, 2012, CEREB CORTEX, V22, P1407, DOI 10.1093/cercor/bhr237; Tan HL, 2013, EXP NEUROL, V240, P122, DOI 10.1016/j.expneurol.2012.11.011; Tombini M, 2009, NEUROIMAGE, V47, P1735, DOI 10.1016/j.neuroimage.2009.04.046; Vallesi A, 2010, BIOL PSYCHOL, V85, P213, DOI 10.1016/j.biopsycho.2010.07.003; Zaepffel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060060; Zhang Y, 2008, J COGNITIVE NEUROSCI, V20, P1915, DOI 10.1162/jocn.2008.20132	53	21	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0114817	10.1371/journal.pone.0114817	http://dx.doi.org/10.1371/journal.pone.0114817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635777	Green Published, gold			2022-12-27	WOS:000350680700004
J	Ohsumi, T; Takenaka, S; Wakamatsu, R; Sakaue, Y; Narisawa, N; Senpuku, H; Ohshima, H; Terao, Y; Okiji, T				Ohsumi, Tatsuya; Takenaka, Shoji; Wakamatsu, Rika; Sakaue, Yuuki; Narisawa, Naoki; Senpuku, Hidenobu; Ohshima, Hayato; Terao, Yutaka; Okiji, Takashi			Residual Structure of Streptococcus mutans Biofilm following Complete Disinfection Favors Secondary Bacterial Adhesion and Biofilm Re-Development	PLOS ONE			English	Article							SUBMINIMAL INHIBITORY CONCENTRATIONS; STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS; PORPHYROMONAS-GINGIVALIS; ANTIMICROBIAL AGENTS; SUPRAGINGIVAL PLAQUE; TEMPORAL PATTERNS; DENTAL BIOFILMS; ORAL BIOFILM; MODEL; ANTIBIOTICS	Chemical disinfection of oral biofilms often leaves biofilm structures intact. This study aimed to examine whether the residual structure promotes secondary bacterial adhesion. Streptococcus mutans biofilms generated on resin-composite disks in a rotating disc reactor were disinfected completely with 70% isopropyl alcohol, and were again cultured in the same reactor after resupplying with the same bacterial solution. Specimens were subjected to fluorescence confocal laser scanning microscopy, viable cell counts and PCR-Invader assay in order to observe and quantify secondarily adhered cells. Fluorescence microscopic analysis, particularly after longitudinal cryosectioning, demonstrated stratified patterns of viable cells on the disinfected biofilm structure. Viable cell counts of test specimens were significantly higher than those of controls, and increased according to the amount of residual structure and culture period. Linear regression analysis exhibited a high correlation between viable and total cell counts. It was concluded that disinfected biofilm structures favored secondary bacterial adhesion.	[Ohsumi, Tatsuya; Takenaka, Shoji; Wakamatsu, Rika; Sakaue, Yuuki; Okiji, Takashi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Div Cariol Operat Dent & Endodont, Niigata, Japan; [Narisawa, Naoki] Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan; [Senpuku, Hidenobu] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Ohshima, Hayato] Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Anat & Cell Biol Hard Tissue, Niigata, Japan; [Terao, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Div Microbiol & Infect Dis, Niigata, Japan	Niigata University; Nihon University; National Institute of Infectious Diseases (NIID); Niigata University; Niigata University	Takenaka, S (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Div Cariol Operat Dent & Endodont, Niigata, Japan.	takenaka@dent.niigata-u.ac.jp	Ohshima, Hayato/AAW-5545-2020; narisawa, naoki/GQZ-2781-2022; SENPUKU, HIDENOBU/ABC-6160-2021; Okiji, Takashi/W-3841-2019; Takenaka, Shoji/AAM-2347-2020	Ohshima, Hayato/0000-0001-8571-9900; Okiji, Takashi/0000-0002-9791-4508; Terao, Yutaka/0000-0002-4450-5583; Narisawa, Naoki/0000-0002-5932-497X	Japan Society for the Promotion of Science (JSPS) [23592795]; Grants-in-Aid for Scientific Research [26462876] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (no. 23592795) from the Japan Society for the Promotion of Science (JSPS); and the JSPS Institutional Program for Young Researcher Overseas Visits. ST received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaker RP, 2009, INT J ANTIMICROB AG, V33, P8, DOI 10.1016/j.ijantimicag.2008.07.014; Augustin P, 2013, INFECT IMMUN, V81, P1721, DOI 10.1128/IAI.00775-12; Baehni PC, 2003, ORAL DIS, V9, P23, DOI 10.1034/j.1601-0825.9.s1.5.x; Bales PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067950; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; Bonito AJ, 2005, J PERIODONTOL, V76, P1227, DOI 10.1902/jop.2005.76.8.1227; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Brading MG, 2003, INT DENT J, V53, P353, DOI 10.1111/j.1875-595X.2003.tb00910.x; Compagnoni MA, 2014, GERODONTOLOGY, V31, P220, DOI 10.1111/ger.12031; Corbin A, 2011, ANTIMICROB AGENTS CH, V55, P3338, DOI 10.1128/AAC.00206-11; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cotter JJ, 2010, J APPL MICROBIOL, V109, P2105, DOI 10.1111/j.1365-2672.2010.04842.x; Davison WM, 2010, ANTIMICROB AGENTS CH, V54, P2920, DOI 10.1128/AAC.01734-09; Dong LP, 2012, INT J ANTIMICROB AG, V39, P390, DOI 10.1016/j.ijantimicag.2012.01.009; Frank KL, 2007, ANTIMICROB AGENTS CH, V51, P888, DOI 10.1128/AAC.01052-06; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Guggenheim B, 2004, CARIES RES, V38, P212, DOI 10.1159/000077757; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Haddadin RNS, 2010, J APPL MICROBIOL, V108, P1281, DOI 10.1111/j.1365-2672.2009.04529.x; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Ishihara K, 1999, FEMS MICROBIOL LETT, V181, P199; Jepsen S, 2011, PERIODONTOL 2000, V55, P167, DOI 10.1111/j.1600-0757.2010.00382.x; Jin Y, 2002, CRIT REV ORAL BIOL M, V13, P426, DOI 10.1177/154411130201300506; Kaplan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00198-12; Kaplan JB, 2011, INT J ARTIF ORGANS, V34, P737, DOI 10.5301/ijao.5000027; Kaplan JB, 2011, RES MICROBIOL, V162, P535, DOI 10.1016/j.resmic.2011.03.008; KOGA T, 1990, INFECT IMMUN, V58, P289, DOI 10.1128/IAI.58.2.289-296.1990; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lyons SR, 2000, J CLIN MICROBIOL, V38, P2362; Marra J, 2012, J APPL ORAL SCI, V20, P643, DOI 10.1590/S1678-77572012000600009; Marsh PD, 2010, J DENT, V38, pS11, DOI 10.1016/S0300-5712(10)70005-1; Matesanz-Perez P, 2013, J CLIN PERIODONTOL, V40, P227, DOI 10.1111/jcpe.12026; O'Brien-Simpson NM, 2004, PERIODONTOL 2000, V35, P101, DOI 10.1111/j.0906-6713.2004.003559.x; Pratten J, 1999, ANTIMICROB AGENTS CH, V43, P1595, DOI 10.1128/AAC.43.7.1595; Quirynen M, 2002, PERIODONTOL 2000, V28, P72, DOI 10.1034/j.1600-0757.2002.280104.x; Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07; Samaranayake YH, 2009, ARCH ORAL BIOL, V54, P115, DOI 10.1016/j.archoralbio.2008.09.015; Sato Y, 1997, INFECT IMMUN, V65, P668, DOI 10.1128/IAI.65.2.668-675.1997; Sedlacek MJ, 2007, ORAL MICROBIOL IMMUN, V22, P333, DOI 10.1111/j.1399-302X.2007.00366.x; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Stoodley P, 2008, J AM DENT ASSOC, V139, P1182, DOI 10.14219/jada.archive.2008.0333; Strydonck DAC, 2012, J CLIN PERIODONTOL, V39, P1042, DOI 10.1111/j.1600-051X.2012.01883.x; Tada A, 2012, JPN J INFECT DIS, V65, P415, DOI 10.7883/yoken.65.415; Tadokoro K, 2010, MICROBIOL RES, V165, P43, DOI 10.1016/j.micres.2008.06.001; Takenaka S, 2008, APPL ENVIRON MICROB, V74, P1869, DOI 10.1128/AEM.02218-07; Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011; Terao Y, 2009, ORAL MICROBIOL IMMUN, V24, P211, DOI 10.1111/j.1399-302X.2008.00497.x; Thurnheer T, 2003, APPL ENVIRON MICROB, V69, P1702, DOI 10.1128/AEM.69.3.1702-1709.2003; von Ohle C, 2010, APPL ENVIRON MICROB, V76, P2326, DOI 10.1128/AEM.02090-09; Wakamatsu R, 2014, CLIN ORAL INVEST, V18, P625, DOI 10.1007/s00784-013-1002-7; Watson PS, 2005, J DENT RES, V84, P451, DOI 10.1177/154405910508400510; Wood TK, 2013, APPL ENVIRON MICROB, V79, P7116, DOI 10.1128/AEM.02636-13; Yamaguchi M, 2013, EUR J ORAL SCI, V121, P162, DOI 10.1111/eos.12050	57	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116647	10.1371/journal.pone.0116647	http://dx.doi.org/10.1371/journal.pone.0116647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635770	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700052
J	Aoyagi, Y; Kawakami, R; Osanai, H; Hibi, T; Nemoto, T				Aoyagi, Yuka; Kawakami, Ryosuke; Osanai, Hisayuki; Hibi, Terumasa; Nemoto, Tomomi			A Rapid Optical Clearing Protocol Using 2,2'-Thiodiethanol for Microscopic Observation of Fixed Mouse Brain	PLOS ONE			English	Article							MULTIPHOTON MICROSCOPY; TISSUE	Elucidation of neural circuit functions requires visualization of the fine structure of neurons in the inner regions of thick brain specimens. However, the tissue penetration depth of laser scanning microscopy is limited by light scattering and/or absorption by the tissue. Recently, several optical clearing reagents have been proposed for visualization in fixed specimens. However, they require complicated protocols or long treatment times. Here we report the effects of 2,2'-thiodiethanol (TDE) solutions as an optical clearing reagent for fixed mouse brains expressing a yellow fluorescent protein. Immersion of fixed brains in TDE solutions rapidly (within 30 min in the case of 400-mu m-thick fixed brain slices) increased their transparency and enhanced the penetration depth in both confocal and two-photon microscopy. In addition, we succeeded in visualizing dendritic spines along single dendrites at deep positions in fixed thick brain slices. These results suggest that our proposed protocol using TDE solution is a rapid and useful method for optical clearing of fixed specimens expressing fluorescent proteins.	[Aoyagi, Yuka; Kawakami, Ryosuke; Osanai, Hisayuki; Hibi, Terumasa; Nemoto, Tomomi] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Aoyagi, Yuka; Kawakami, Ryosuke; Osanai, Hisayuki; Hibi, Terumasa; Nemoto, Tomomi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan; [Kawakami, Ryosuke; Hibi, Terumasa; Nemoto, Tomomi] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama, Japan	Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Nemoto, T (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan.	tn@es.hokudai.ac.jp	Nemoto, Tomomi/B-4412-2012; Kawakami, Ryosuke/AAU-6087-2020; Hibi, Terumasa/I-3407-2013	Nemoto, Tomomi/0000-0001-6102-1495; Hibi, Terumasa/0000-0001-9373-9602; Osanai, Hisayuki/0000-0002-0920-8428	JSPS KAKENHI grants of the Ministry of Education, Culture, Sports, Science and Technology, Japan [26242082, 22113005]; Nano-Macro Materials, Devices and System Research Alliance; Network Joint Research Center for Materials and Devices;  [26-1533]; Grants-in-Aid for Scientific Research [14J01533] Funding Source: KAKEN	JSPS KAKENHI grants of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Nano-Macro Materials, Devices and System Research Alliance; Network Joint Research Center for Materials and Devices; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for JSPS Fellows (No. 26-1533 for YA) (http://www.jsps.go. jp/english/), by JSPS KAKENHI grants of the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 26242082 and 22113005 for TN) (MEXT;http://www.mext.go.jp/english/), by the Nano-Macro Materials, Devices and System Research Alliance (MEXT; http://www.mext.go.jp/english/) and by the Network Joint Research Center for Materials and Devices (MEXT; http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024695; Appleton PL, 2009, J MICROSC-OXFORD, V234, P196, DOI 10.1111/j.1365-2818.2009.03163.x; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/nphoton.2012.336, 10.1038/NPHOTON.2012.336]; Jung Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094054; Kawakami R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01014; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Parra SG, 2012, JOVE-J VIS EXP, DOI 10.3791/3848; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Reddy G, 2005, INT J TOXICOL, V24, P435, DOI 10.1080/10915810500368878; Sakhalkar HS, 2007, PHYS MED BIOL, V52, P2035, DOI 10.1088/0031-9155/52/8/001; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ward WW, 2006, METHOD BIOCHEM ANAL, V47, P39; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	27	94	101	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116280	10.1371/journal.pone.0116280	http://dx.doi.org/10.1371/journal.pone.0116280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633541	Green Published, Green Submitted, gold			2022-12-27	WOS:000348609800007
J	Raikwar, SP; Kim, EM; Sivitz, WI; Allamargot, C; Thedens, DR; Zavazava, N				Raikwar, Sudhanshu P.; Kim, Eun-Mi; Sivitz, William I.; Allamargot, Chantal; Thedens, Daniel R.; Zavazava, Nicholas			Human iPS Cell-Derived Insulin Producing Cells Form Vascularized Organoids under the Kidney Capsules of Diabetic Mice	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MOUSE; GENERATION; DIFFERENTIATION; TRANSPLANTATION; HYPERGLYCEMIA	Type 1 diabetes (T1D) is caused by autoimmune disease that leads to the destruction of pancreatic beta-cells. Transplantation of cadaveric pancreatic organs or pancreatic islets can restore normal physiology. However, there is a chronic shortage of cadaveric organs, limiting the treatment of the majority of patients on the pancreas transplantation waiting list. Here, we hypothesized that human iPS cells can be directly differentiated into insulin producing cells (IPCs) capable of secreting insulin. Using a series of pancreatic growth factors, we successfully generated iPS cells derived IPCs. Furthermore, to investigate the capability of these cells to secrete insulin in vivo, the differentiated cells were transplanted under the kidney capsules of diabetic immunodeficient mice. Serum glucose levels gradually declined to either normal or near normal levels over 150 days, suggesting that the IPCs were secreting insulin. In addition, using MRI, a 3D organoid appeared as a white patch on the transplanted kidneys but not on the control kidneys. These organoids showed neovascularization and stained positive for insulin and glucagon. All together, these data show that a pancreatic organ can be created in vivo providing evidence that iPS cells might be a novel option for the treatment of T1D.	[Raikwar, Sudhanshu P.; Kim, Eun-Mi; Zavazava, Nicholas] Univ Iowa, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA; [Sivitz, William I.] Univ Iowa, Div Endocrinol & Metab, Iowa City, IA 52242 USA; [Allamargot, Chantal] Univ Iowa, Cent Microscopy Res Facil, Iowa City, IA 52242 USA; [Thedens, Daniel R.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Raikwar, Sudhanshu P.; Kim, Eun-Mi; Zavazava, Nicholas] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Zavazava, N (corresponding author), Univ Iowa, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA.	nicholas-zavazava@uiowa.edu	Raikwar, Sudhanshu/AAT-5128-2021	Raikwar, Sudhanshu/0000-0001-8549-8570; Sivitz, William/0000-0002-7829-0189	Veterans Affairs [1I01BX001125-01A1]; NIH/NHLBI [R01 HLO73015]; NIH/NIDDK [P30 DK054759]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000285] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs (http://www.iowacity.va.gov/) Award #1I01BX001125-01A1 to NZ, NIH/NHLBI Award Number NIH/NHLBI #R01 HLO73015 (http://NIH.gov) to NZ, and NIH/NIDDK #P30 DK054759 to SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIHANNA D, 1988, TRANSPLANTATION, V45, P610, DOI 10.1097/00007890-198803000-00021; Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Ben Nasr M, 2014, THE RISE FALL AND RE; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Bonde S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003212; D'Addio F, 2014, DIABETES, V63, P3041, DOI 10.2337/db14-0295; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dao LT, 2014, TRANSPLANTATION OF I; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Guo TX, 2013, DIABETES, V62, P1581, DOI 10.2337/db12-0167; Hua XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102198; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kim EM, 2013, BLOOD, V121, P5167, DOI 10.1182/blood-2012-11-467753; Luo J, 2013, METABOLISM, V62, P90, DOI 10.1016/j.metabol.2012.07.010; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Raikwar SP, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-19; Raikwar SP, 2011, TRANSPLANTATION, V91, P11, DOI 10.1097/TP.0b013e3181fdd98b; Raikwar SP, 2009, METHODS MOL BIOL, V590, P317, DOI 10.1007/978-1-60327-378-7_21; Rezania A, 2014, NAT BIOTECHNOL; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04488	29	32	37	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116582	10.1371/journal.pone.0116582	http://dx.doi.org/10.1371/journal.pone.0116582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629318	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100042
J	Yost, EA; Hynes, TR; Hartle, CM; Ott, BJ; Berlot, CH				Yost, Evan A.; Hynes, Thomas R.; Hartle, Cassandra M.; Ott, Braden J.; Berlot, Catherine H.			Inhibition of G-Protein beta gamma Signaling Enhances T Cell Receptor-Stimulated Interleukin 2 Transcription in CD4(+) T Helper Cells	PLOS ONE			English	Article							SMALL-MOLECULE DISRUPTION; PHOSPHOLIPASE-C-BETA; IN-VIVO; RHEUMATOID-ARTHRITIS; GLUCOCORTICOID-RECEPTOR; DIFFERENTIAL REGULATION; SYNOVIAL FIBROBLASTS; NUCLEAR-LOCALIZATION; FLUORESCENT PROTEIN; CALCIUM-CHANNELS	G-protein-coupled receptor (GPCR) signaling modulates the expression of cytokines that are drug targets for immune disorders. However, although GPCRs are common targets for other diseases, there are few GPCR-based pharmaceuticals for inflammation. The purpose of this study was to determine whether targeting G-protein beta gamma (G beta gamma) complexes could provide a useful new approach for modulating interleukin 2 (IL-2) levels in CD4(+) T helper cells. Gallein, a small molecule inhibitor of G beta gamma, increased levels of T cell receptor (TCR)-stimulated IL-2 mRNA in primary human naive and memory CD4(+) T helper cells and in Jurkat human CD4(+) leukemia T cells. G beta(1) and G beta(2) mRNA accounted for > 99% of G beta mRNA, and small interfering RNA (siRNA)-mediated silencing of G beta(1) but not G beta(2) enhanced TCR-stimulated IL-2 mRNA increases. Blocking G beta gamma enhanced TCR-stimulated increases in IL-2 transcription without affecting IL-2 mRNA stability. Blocking G beta gamma also enhanced TCR-stimulated increases in nuclear localization of nuclear factor of activated T cells 1 (NFAT1), NFAT transcriptional activity, and levels of intracellular Ca2+. Potentiation of IL-2 transcription required continuous G beta gamma inhibition during at least two days of TCR stimulation, suggesting that induction or repression of additional signaling proteins during T cell activation and differentiation might be involved. The potentiation of TCR-stimulated IL-2 transcription that results from blocking G beta gamma in CD4(+) T helper cells could have applications for autoimmune diseases.	[Yost, Evan A.; Hynes, Thomas R.; Hartle, Cassandra M.; Ott, Braden J.; Berlot, Catherine H.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Berlot, CH (corresponding author), Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA.	chberlot@geisinger.edu			National Institutes of Health [GM050369]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050369, R29GM050369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health Grant GM050369 (to CHB) http://www.nigms.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bach TL, 2007, J IMMUNOL, V179, P2223, DOI 10.4049/jimmunol.179.4.2223; Badou A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00243; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Bhatnagar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052689; Bluestone JA, 2011, NEW ENGL J MED, V365, P2129, DOI 10.1056/NEJMe1110900; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Borner C, 2009, J BIOL CHEM, V284, P35450, DOI 10.1074/jbc.M109.006338; Borner C, 2009, J IMMUNOL, V183, P882, DOI 10.4049/jimmunol.0802763; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Boomer JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002436; Boularan C, 2014, CELL SIGNAL, V26, P1269, DOI 10.1016/j.cellsig.2014.02.010; Bunting K, 2006, VITAM HORM, V74, P105, DOI 10.1016/S0083-6729(06)74005-5; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Fan J, 1998, CLIN DIAGN LAB IMMUN, V5, P335, DOI 10.1128/CDLI.5.3.335-340.1998; Gavi S, 2006, TRENDS ENDOCRIN MET, V17, P46, DOI 10.1016/j.tem.2006.01.006; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; Harada K, 2011, CLIN EXP NEPHROL, V15, P966, DOI 10.1007/s10157-011-0518-x; Harris SJ, 2012, EUR J IMMUNOL, V42, P3394, DOI 10.1002/eji.201242463; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Jenabian MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003319; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Kawakami Toshiaki, 2013, Advances in Biological Regulation, V53, P249, DOI 10.1016/j.jbior.2013.08.001; Kerppola TK, 1998, STRUCT FOLD DES, V6, P549, DOI 10.1016/S0969-2126(98)00057-4; Kerr JS, 2013, CELL SIGNAL, V25, P729, DOI 10.1016/j.cellsig.2012.12.015; Kershaw MH, 2013, NAT REV CANCER, V13, P525, DOI 10.1038/nrc3565; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kino T, 2005, EUR J CLIN INVEST, V35, P508, DOI 10.1111/j.1365-2362.2005.01539.x; Kino T, 2005, J CELL BIOL, V169, P885, DOI 10.1083/jcb.200409150; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Ladygina N, 2013, EUR J IMMUNOL, V43, P3183, DOI 10.1002/eji.201343812; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; LOTZE MT, 1985, J IMMUNOL, V135, P2865; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; Medina R, 1996, J BIOL CHEM, V271, P24720, DOI 10.1074/jbc.271.40.24720; Molloy MJ, 2009, J IMMUNOL, V182, P4512, DOI 10.4049/jimmunol.0804175; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Norii M, 2006, ACTA MED OKAYAMA, V60, P149; Park JG, 1999, EMBO J, V18, P4004, DOI 10.1093/emboj/18.14.4004; Pease J, 2012, J MED CHEM, V55, P9363, DOI 10.1021/jm300682j; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; Riether C, 2011, BRAIN BEHAV IMMUN, V25, P59, DOI 10.1016/j.bbi.2010.07.248; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Robitaille M, 2010, CELL SIGNAL, V22, P1254, DOI 10.1016/j.cellsig.2010.04.005; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; SALMON M, 1994, EUR J IMMUNOL, V24, P892, DOI 10.1002/eji.1830240417; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Seneviratne AMPB, 2011, BBA-PROTEINS PROTEOM, V1814, P1210, DOI 10.1016/j.bbapap.2011.05.010; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHAW J, 1988, J IMMUNOL, V140, P2243; Simmons DL, 2006, DRUG DISCOV TODAY, V11, P210, DOI 10.1016/S1359-6446(05)03721-9; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Smrcka AV, 2008, COMB CHEM HIGH T SCR, V11, P382, DOI 10.2174/138620708784534761; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Spiegelberg BD, 2005, J BIOL CHEM, V280, P41769, DOI 10.1074/jbc.M504066200; Srinivasan M, 2007, J IMMUNOL, V179, P3734, DOI 10.4049/jimmunol.179.6.3734; Steinman L, 2012, J CELL BIOL, V199, P413, DOI 10.1083/jcb.201207175; Sun L, 2012, ACTA PHARMACOL SIN, V33, P342, DOI 10.1038/aps.2011.200; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Tsubaki T, 2005, CLIN EXP IMMUNOL, V141, P363, DOI 10.1111/j.1365-2249.2005.02850.x; Ueno A, 2005, RHEUMATOL INT, V25, P361, DOI 10.1007/s00296-004-0449-x; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Weiss N, 2010, J PHYSIOL-LONDON, V588, P2945, DOI 10.1113/jphysiol.2010.191593; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zheng YH, 2000, FASEB J, V14, P2387	88	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116575	10.1371/journal.pone.0116575	http://dx.doi.org/10.1371/journal.pone.0116575			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629163	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100041
J	Paiva, I; da Costa, RMG; Ribeiro, J; Sousa, H; Bastos, M; Rocha, AFC; Oliveira, PA; Medeiros, R				Paiva, Isabel; da Costa, Rui M. Gil; Ribeiro, Joana; Sousa, Hugo; Bastos, Margarida; Rocha, Ana Faustino Carlos; Oliveira, Paula A.; Medeiros, Rui			A Role for MicroRNA-155 Expression in Microenvironment Associated to HPV-Induced Carcinogenesis in K14-HPV16 Transgenic Mice	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; B-CELL; DOWN-REGULATION; CANCER; MIR-155; GENE; PROLIFERATION; HEAD	Human Papillomavirus cause a number of diseases most notably cervical cancer. K14-HPV16 transgenic mice expressing the HPV16 early genes in squamous epithelial cells provide a suitable experimental model for studying these diseases. MicroRNAs are small non-coding RNAs that play an important role in regulating gene expression and have been suggested to play an important role in cancer development. The role of miR-155 in cancer remains controversial and there is limited evidence linking this miRNA to HPV-associated diseases. We hypothesized that miR-155 expression modulates each tissue's susceptibility to develop HPV-associated carcinogenesis. In this study, we analyzed miR-155 expression in ear and chest skin samples from 22-26 weeks old, female K14-HPV16 transgenic (HPV16+/-) and wild-type (HPV-/-) mice. Among wild-type mice the expression of miR-155 was lower in ear skin compared with chest skin (p = 0.028). In transgenic animals, in situ carcinoma was present in all ear samples whereas chest tissues only showed epidermal hyperplasia. Furthermore, in hyperplastic chest skin samples, miR-155 expression was lower than in normal chest skin (p = 0,026). These results suggest that miR-155 expression may modulate the microenvironmental susceptibility to cancer development and that high miR155 levels may be protective against the carcinogenesis induced by HPV16.	[Paiva, Isabel; Ribeiro, Joana; Sousa, Hugo; Medeiros, Rui] CI IPOP, Portuguese Inst Oncol Porto, Mol Oncol & Viral Pathol Grp, P-4200072 Porto, Portugal; [Paiva, Isabel; Medeiros, Rui] Univ Porto, Abel Salazar Inst Biomed Sci, ICBAS, P-4050313 Porto, Portugal; [da Costa, Rui M. Gil; Bastos, Margarida] Univ Porto, Fac Engn, LEPABE, P-4200465 Porto, Portugal; [da Costa, Rui M. Gil; Rocha, Ana Faustino Carlos] CI IPOP, Portuguese Inst Oncol, Expt Pathol & Therapeut Grp, P-4200072 Porto, Portugal; [Ribeiro, Joana; Sousa, Hugo; Medeiros, Rui] Portuguese Inst Oncol Porto, Virol Serv, P-4200072 Porto, Portugal; [Oliveira, Paula A.] Univ Tras Os Montes & Alto Douro UTAD, Dept Vet Sci, P-5001801 Vila Real, Portugal; [Rocha, Ana Faustino Carlos; Oliveira, Paula A.] Univ Tras Os Montes & Alto Douro UTAD, Ctr Res & Technol Agro Environm & Biol Sci CITAB, P-5001911 Vila Real, Portugal; [Medeiros, Rui] Fernando Pessoa Univ, Fac Hlth Sci, CEBIMED, Porto, Portugal; [Medeiros, Rui] Portuguese League Againt Canc Liga Portuguesa Can, P-4200177 Porto, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra; University of Tras-os-Montes & Alto Douro; University of Tras-os-Montes & Alto Douro; Universidade Fernando Pessoa	Medeiros, R (corresponding author), CI IPOP, Portuguese Inst Oncol Porto, Mol Oncol & Viral Pathol Grp, Rua Dr Antonio Bernardino Almeida, P-4200072 Porto, Portugal.	ruimedei@ipoporto.min-saude.pt	Bastos, Margarida/O-4945-2018; Oliveira, Paula Alexandra/F-2510-2013; Sousa, Hugo/B-7714-2011; Paiva, Isabel/GNP-7941-2022; Medeiros, Rui/C-7938-2009; Gil da Costa, Rui/O-5029-2018	Bastos, Margarida/0000-0002-8605-0054; Oliveira, Paula Alexandra/0000-0001-9519-4044; Sousa, Hugo/0000-0001-5795-2131; Paiva, Isabel/0000-0001-7607-9390; Medeiros, Rui/0000-0003-3010-8373; Ribeiro, Joana/0000-0002-8431-9718; Gil da Costa, Rui/0000-0002-2151-2449	Liga Portuguesa Contra o Cancro; Portuguese Foundation for Science and Technology - Portuguese Government [SFRH/BPD/85462/2012]; Social European Fund	Liga Portuguesa Contra o Cancro; Portuguese Foundation for Science and Technology - Portuguese Government; Social European Fund(European Social Fund (ESF))	This study was supported by Liga Portuguesa Contra o Cancro. Rui M. Gil da Costa is supported by grant SFRH/BPD/85462/2012 from the Portuguese Foundation for Science and Technology, financed by the Portuguese Government and the Social European Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Bosch FX, 2007, DIS MARKERS, V23, P213, DOI 10.1155/2007/914823; Canadas MP, 2010, CLIN MICROBIOL INFEC, V16, P836, DOI 10.1111/j.1469-0691.2009.02964.x; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Cheung ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071336; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Coussens LM, 1996, AM J PATHOL, V149, P1899; Das LM, 2013, MUCOSAL IMMUNOL, V6, P167, DOI 10.1038/mi.2012.60; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fan XL, 2005, APOPTOSIS, V10, P63, DOI 10.1007/s10495-005-6062-y; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Huffaker TB, 2012, CELL REP, V2, P1697, DOI 10.1016/j.celrep.2012.10.025; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kjaer SK, 2001, CANCER EPIDEM BIOMAR, V10, P101; KONKEL DA, 1978, CELL, V15, P1125, DOI 10.1016/0092-8674(78)90040-5; Lei C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052310; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Major T, 2005, J CLIN PATHOL, V58, P51, DOI 10.1136/jcp.2004.016634; Masset A, 2011, INT J CANCER, V128, P283, DOI 10.1002/ijc.25326; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Paranjape T, 2009, GUT, V58, P1546, DOI 10.1136/gut.2009.179531; Ribeiro J, 2014, INT J GYNECOL OBSTET, V125, P107, DOI 10.1016/j.ijgo.2013.10.011; Stanczuk GA, 2001, INT J CANCER, V94, P792, DOI 10.1002/ijc.1543; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Street D, 1997, GYNECOL ONCOL, V65, P265, DOI 10.1006/gyno.1997.4667; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; Turner M, 2008, BIOCHEM SOC T, V36, P531, DOI 10.1042/BST0360531; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wald AI, 2011, HEAD NECK-J SCI SPEC, V33, P504, DOI 10.1002/hed.21475; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2841, DOI 10.1002/cncr.23758; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Willimott S, 2012, J BIOL CHEM, V287, P2608, DOI 10.1074/jbc.M111.285718; Wong TS, 2008, INT J CANCER, V123, P251, DOI 10.1002/ijc.23583; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Zonari E, 2013, BLOOD, V122, P243, DOI 10.1182/blood-2012-08-449306; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	43	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116868	10.1371/journal.pone.0116868	http://dx.doi.org/10.1371/journal.pone.0116868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625305	Green Published, gold			2022-12-27	WOS:000348821400020
J	Pascoe, SJS; Langhaug, LF; Mavhu, W; Hargreaves, J; Jaffar, S; Hayes, R; Cowan, FM				Pascoe, Sophie J. S.; Langhaug, Lisa F.; Mavhu, Webster; Hargreaves, James; Jaffar, Shabbar; Hayes, Richard; Cowan, Frances M.			Poverty, Food Insufficiency and HIV Infection and Sexual Behaviour among Young Rural Zimbabwean Women	PLOS ONE			English	Article							INTIMATE-PARTNER VIOLENCE; COMMON MENTAL-DISORDERS; DZIVE SHIRI PROJECT; RISK-FACTORS; PREVENTION INTERVENTION; EDUCATIONAL-ATTAINMENT; SOUTH-AFRICA; 4 CITIES; POPULATION; ASSOCIATION	Background Despite a recent decline, Zimbabwe still has the fifth highest adult HIV prevalence in the world at 14.7%; 56% of the population are currently living in extreme poverty. Design Cross-sectional population-based survey of 18-22 year olds, conducted in 30 communities in south-eastern Zimbabwe in 2007. Objective To examine whether the risk of HIV infection among young rural Zimbabwean women is associated with socio-economic position and whether different socio-economic domains, including food sufficiency, might be associated with HIV risk in different ways. Methods Eligible participants completed a structured questionnaire and provided a finger-prick blood sample tested for antibodies to HIV and HSV-2. The relationship between poverty and HIV was explored for three socio-economic domains: ability to afford essential items; asset wealth; food sufficiency. Analyses were performed to examine whether these domains were associated with HIV infection or risk factors for infection among young women, and to explore which factors might mediate the relationship between poverty and HIV. Results 2593 eligible females participated in the survey and were included in the analyses. Overall HIV prevalence among these young females was 7.7% (95% CI: 6.7-8.7); HSV-2 prevalence was 11.2% (95% CI: 9.9-12.4). Lower socio-economic position was associated with lower educational attainment, earlier marriage, increased risk of depression and anxiety disorders and increased reporting of higher risk sexual behaviours such as earlier sexual debut, more and older sexual partners and transactional sex. Young women reporting insufficient food were at increased risk of HIV infection and HSV-2. Conclusions This study provides evidence from Zimbabwe that among young poor women, economic need and food insufficiency are associated with the adoption of unsafe behaviours. Targeted structural interventions that aim to tackle social and economic constraints including insufficient food should be developed and evaluated alongside behaviour and biomedical interventions, as a component of HIV prevention programming and policy.	[Pascoe, Sophie J. S.; Hargreaves, James; Jaffar, Shabbar; Hayes, Richard] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Langhaug, Lisa F.; Cowan, Frances M.] Royal Free & Univ Coll, Sch Med, Ctr Sexual Hlth & HIV Res, London, England; [Mavhu, Webster; Cowan, Frances M.] Ctr Sexual Hlth & HIV AIDS Res CeSHHAR Zimbabw, Harare, Zimbabwe	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School	Cowan, FM (corresponding author), Royal Free & Univ Coll, Sch Med, Ctr Sexual Hlth & HIV Res, London, England.	f.cowan@ucl.ac.uk		Mavhu, Webster/0000-0003-1881-4398; Hargreaves, James/0000-0002-3509-3572; Jaffar, Shabbar/0000-0002-9615-1588; Cowan, Frances/0000-0003-3087-4422; Pascoe, Sophie/0000-0002-9199-8333; Langhaug, Lisa/0000-0002-9131-8158; Hayes, Richard/0000-0002-1729-9892	National Institute of Mental Health [RO1 MH66570]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066570] Funding Source: NIH RePORTER; Medical Research Council [MR/K012126/1] Funding Source: researchfish	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded through the National Institute of Mental Health (RO1 MH66570). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], REP GLOB AIDS EP 200; [Anonymous], AIDS EP UPD DEC 2007; Auerbach JD, 2006, WHO TECH REP SER, V938, P43; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Bachmann MO, 2006, AIDS, V20, P1861, DOI 10.1097/01.aids.0000244205.03382.84; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Barnett T, 2008, AIDS, V22, pS27, DOI 10.1097/01.aids.0000327434.28538.51; Booysen FL, 2002, J HEALTH POPUL NUTR, V20, P285; Brook DW, 2006, AIDS EDUC PREV, V18, P259, DOI 10.1521/aeap.2006.18.3.259; Bryceson D. F., 2006, AIDS, poverty, and hunger: challenges and responses. Highlights of the International Conference on HIV/AIDS and Food and Nutrition Security, Durban, South Africa, 14-16 April, 2005, P97; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Cohen-Or D, 1998, GRAPHICS INTERFACE '98 - PROCEEDINGS, P1; COWAN F, 2005, 16 INT SOC SEX TRANS, P42331; Cowan FM, 2008, TROP MED INT HEALTH, V13, P1235, DOI 10.1111/j.1365-3156.2008.02137.x; Cowan FM, 2010, AIDS, V24, P2533, DOI 10.1097/QAD.0b013e32833e77c9; de Walque D, 2005, TROP MED INT HEALTH, V10, P993, DOI 10.1111/j.1365-3156.2005.01475.x; Dinkelman T, 2007, AIDS, V21, pS49, DOI 10.1097/01.aids.0000300535.05226.a9; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Fenton L, 2004, LANCET, V364, P1186, DOI 10.1016/S0140-6736(04)17109-2; Freeman EE, 2004, AIDS, V18, P1715, DOI 10.1097/01.aids.0000139075.13906.2f; Gillespie S. R., 2006, AIDS POVERTY HUNGER; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Gillespie S, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000300530.67107.45; Glynn JR, 2004, TROP MED INT HEALTH, V9, P4, DOI 10.1046/j.1365-3156.2003.01168.x; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; Gregson S, 2009, SEX TRANSM INFECT, V85, pI1, DOI 10.1136/sti.2009.036053; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x; Hewett PC, 2004, SEX TRANSM INFECT, V80, P43, DOI 10.1136/sti.2004.013250; *INT DISPL MON CTR, 2008, MAN FAC DISPL IDPS Z, P42331; *IPPF, 2007, UN POP FUND YOUNG PO, P42331; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Johnson K, 2006, JAIDS-J ACQ IMM DEF, V42, P627, DOI 10.1097/01.qai.0000225870.87456.ae; Kaufman CE, 2004, STUD FAMILY PLANN, V35, P261, DOI 10.1111/j.0039-3665.2004.00030.x; Kim J, 2008, AIDS, V22, pS57, DOI 10.1097/01.aids.0000341777.78876.40; Kim JC, 2007, AM J PUBLIC HEALTH, V97, P1794, DOI 10.2105/AJPH.2006.095521; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; Lopman B, 2007, AIDS, V21, pS57, DOI 10.1097/01.aids.0000300536.82354.52; [Macro International Inc Central Statistical Office (CSO) [Zimbabwe]], 2007, ZIMB DEM HLTH SURV 2; Madise Nyovani, 2007, Afr J Reprod Health, V11, P83, DOI 10.2307/25549733; Mahomva A, 2006, SEX TRANSM INFECT, V82, pI42, DOI 10.1136/sti.2005.019174; MCCOY S, 2013, 7 IAS C HIV PATH TRE, P42331; Mensch BS, 2003, DEMOGRAPHY, V40, P247, DOI 10.1353/dem.2003.0017; Miller CL, 2011, AIDS BEHAV, V15, P1512, DOI 10.1007/s10461-010-9693-0; *MIN HLTH CHILD WE, 2004, ZIMB NAT FAM PLANN, P42331; MISHRA V, 2007, DHS WORKING PAPERS S, V31, P42331; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; Morrow RA, 2006, J CLIN VIROL, V36, P141, DOI 10.1016/j.jcv.2006.02.006; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; O'Farrell N, 2001, LANCET, V357, P636, DOI 10.1016/S0140-6736(05)71428-8; Pascoe SJS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074977; Patel V, 1997, ACTA PSYCHIAT SCAND, V95, P469, DOI 10.1111/j.1600-0447.1997.tb10134.x; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Pettifor AE, 2008, INT J EPIDEMIOL, V37, P1266, DOI 10.1093/ije/dyn131; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Pronyk PM, 2008, AIDS, V22, P1659, DOI 10.1097/QAD.0b013e328307a040; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Rollins N, 2007, PLOS MED, V4, P1576, DOI 10.1371/journal.pmed.0040301; Shelton JD, 2007, LANCET, V370, P1809, DOI 10.1016/S0140-6736(07)61755-3; Shelton JD, 2005, LANCET, V366, P1057, DOI 10.1016/S0140-6736(05)67401-6; The World Bank, 2007, HIV AIDS NUTR FOOD S; Todd J, 2004, SEX TRANSM INFECT, V80, P35, DOI 10.1136/sti.2003.005413; Tsai AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001557; Tsai AC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001203; *UN FAO WFP, 2009, FAO WFP CROP FOOD SE, P42331; *UNAIDS, 2008, HIV FOOD SEC NUTR PO, P42331; *UNAIDS, 2005, EV HIV DECL ZIMB COM; UNICEF, 2003, STAT WORLDS CHILDR 2; *UNICEF, 2005, GUIDE TO MONITORING, P42331; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; United nations Development Programme (UNDP), 2007, NAT HUM DEV REP RUSS; US Department of Health and Human Services, 2000, SER ASS HUM IMM VIR; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2; *ZIMSTAT, 2012, ZIMB POP CENS 2012 N, P42331	90	59	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115290	10.1371/journal.pone.0115290	http://dx.doi.org/10.1371/journal.pone.0115290			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QM	25625868	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000348821400007
J	Parhar, A; Gao, ZW; Heffernan, C; Ahmed, R; Egedahl, ML; Long, R				Parhar, Anu; Gao, Zhiwei; Heffernan, Courtney; Ahmed, Rabia; Egedahl, Mary Lou; Long, Richard			Is Early Tuberculosis Death Associated with Increased Tuberculosis Transmission?	PLOS ONE			English	Article							ACTIVE PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS; FOREIGN-BORN; MORTALITY; ADULTS; RECOMMENDATIONS; EPIDEMIOLOGY; POPULATIONS; INFECTION	Introduction Tuberculosis (TB) is now a relatively uncommon disease in high income countries. As such, its diagnosis may be missed or delayed resulting in death before or shortly after the introduction of treatment. Whether early TB death is associated with increased TB transmission is unknown. To determine the transmission risk attributable to early TB death we undertook a case-control study. Methods All adults who were: (1) diagnosed with culture-positive pulmonary TB in the Province of Alberta, Canada between 1996 and 2012, and (2) died a TB-related death before or within the first 60 days of treatment, were identified. For each of these "cases" two sets of "controls" were randomly selected from among culture-positive pulmonary TB cases that survived beyond 60 days of treatment. "Controls" were matched by age, sex, population group, +/- smear status. Secondary cases of "cases" and "controls" were identified using conventional and molecular epidemiologic tools and compared. In addition, new infections were identified and compared in contacts of "cases" that died before treatment and contacts of their smearmatched "controls". Conditional logistic regression was used to find associations in both univariate and multivariate analysis. Results "Cases" were as, but not more, likely than "controls" to transmit. This was so whether transmission was measured in terms of the number of "cases" and smear-unmatched or -matched "controls" that had a secondary case, the number of secondary cases that they had or the number of new infections found in contacts of "cases" that died before treatment and their smear-matched "controls". Conclusion In a low TB incidence/low HIV prevalence country, pulmonary TB patients that die a TB-related death before or in the initial phase of treatment and pulmonary TB patients that survive beyond the initial phase of treatment are equally likely to transmit.	[Parhar, Anu; Gao, Zhiwei; Heffernan, Courtney; Ahmed, Rabia; Egedahl, Mary Lou; Long, Richard] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Long, Richard] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Gao, Zhiwei] Mem Univ Canada, Dept Med, St John, NF, Canada	University of Alberta; University of Alberta; Memorial University Newfoundland	Long, R (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	richard.long@ualberta.ca	Heffernan, Courtney E/G-5296-2016					Bailey WC, 2002, JAMA-J AM MED ASSOC, V287, P996, DOI 10.1001/jama.287.8.996; Borgdorff MW, 2001, AM J EPIDEMIOL, V154, P934, DOI 10.1093/aje/154.10.934; *CAN LUNG ASS PUBL, 2007, CANADIAN TUBERCULOSI; CATANZARO A, 1982, AM REV RESPIR DIS, V125, P559, DOI 10.1164/arrd.1982.125.5.559; *CDC, 2013, REPORTED TUBERCULOSI; CULLINAN P, 1991, THORAX, V46, P347, DOI 10.1136/thx.46.5.347; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; DeRiemer K, 1999, INT J TUBERC LUNG D, V3, P488; Dewan PK, 2004, INT J TUBERC LUNG D, V8, P598; ENARSON DA, 1978, CAN MED ASSOC J, V118, P1520; Erbes R, 2006, EUR RESPIR J, V27, P1223, DOI 10.1183/09031936.06.00088105; Fielder JF, 2002, INT J TUBERC LUNG D, V6, P1114; *GOV CAN STAT CAN, POSTAL CODE; Jensen M, 2012, INT J TUBERC LUNG D, V16, P43, DOI 10.5588/ijtld.11.0374; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; KATZ I, 1985, CHEST, V87, P770, DOI 10.1378/chest.87.6.770; KHAN MA, 1977, AM J MED, V62, P31, DOI 10.1016/0002-9343(77)90346-1; Kourbatova EV, 2006, INT J TUBERC LUNG D, V10, P1224; Kunimoto D, 2004, INT J TUBERC LUNG D, V8, P1213; Long R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098993; Long R, 2013, CAN J PUBLIC HEALTH, V104, pE22, DOI 10.1007/BF03405649; Lubart E, 2007, ISR MED ASSOC J, V9, P870; Madhi F, 2002, PEDIATR PULM, V34, P159, DOI 10.1002/ppul.10153; Mathew TA, 2006, INT J TUBERC LUNG D, V10, P857; MILLER W T, 1978, AJR (American Journal of Roentgenology), V130, P867; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Murray J, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000299416.61808.24; NAALSUND A, 1994, J INTERN MED, V236, P137, DOI 10.1111/j.1365-2796.1994.tb01275.x; Oursler KK, 2002, CLIN INFECT DIS, V34, P752, DOI 10.1086/338784; Perez-Guzman Carlos, 1999, Chest, V116, P961, DOI 10.1378/chest.116.4.961; *PUBL HLTH AG CAN, 2013, TUBERCULOSIS IN CANA; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; Shen X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-95; STEAD WW, 1981, ANN INTERN MED, V94, P606, DOI 10.7326/0003-4819-94-5-606; STEAD WW, 1985, NEW ENGL J MED, V312, P1483, DOI 10.1056/NEJM198506063122304; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; XIE HJ, 1992, TUBERCLE LUNG DIS, V73, P77, DOI 10.1016/0962-8479(92)90059-S; Yen YF, 2013, INT J TUBERC LUNG D, V17, P1310, DOI [10.5588/ijtld.12.0888, 10.5588/ijtid.12.0888]; Zahar JR, 2001, INTENS CARE MED, V27, P513, DOI 10.1007/s001340000849	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117036	10.1371/journal.pone.0117036	http://dx.doi.org/10.1371/journal.pone.0117036			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622038	Green Published, Green Submitted, gold			2022-12-27	WOS:000348470400015
J	Hagman, A; Piskur, J				Hagman, Arne; Piskur, Jure			A Study on the Fundamental Mechanism and the Evolutionary Driving Forces behind Aerobic Fermentation in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GLUCOSE-TRANSPORT; RESPIRATORY CAPACITY; KLUYVEROMYCES-LACTIS; GROWTH; GENE; DUPLICATION; NETWORK; ABILITY; COMPLEX	Baker's yeast Saccharomyces cerevisiae rapidly converts sugars to ethanol and carbon dioxide at both anaerobic and aerobic conditions. The later phenomenon is called Crabtree effect and has been described in two forms, long-term and short-term effect. We have previously studied under fully controlled aerobic conditions forty yeast species for their central carbon metabolism and the presence of long-term Crabtree effect. We have also studied ten steady-state yeast cultures, pulsed them with glucose, and followed the central carbon metabolism and the appearance of ethanol at dynamic conditions. In this paper we analyzed those wet laboratory data to elucidate possible mechanisms that determine the fate of glucose in different yeast species that cover approximately 250 million years of evolutionary history. We determine overflow metabolism to be the fundamental mechanism behind both long-and short-term Crabtree effect, which originated approximately 125-150 million years ago in the Saccharomyces lineage. The "invention" of overflow metabolism was the first step in the evolution of aerobic fermentation in yeast. It provides a general strategy to increase energy production rates, which we show is positively correlated to growth. The "invention" of overflow has also simultaneously enabled rapid glucose consumption in yeast, which is a trait that could have been selected for, to "starve" competitors in nature. We also show that glucose repression of respiration is confined mainly among S. cerevisiae and closely related species that diverged after the whole genome duplication event, less than 100 million years ago. Thus, glucose repression of respiration was apparently "invented" as a second step to further increase overflow and ethanol production, to inhibit growth of other microbes. The driving force behind the initial evolutionary steps was most likely competition with other microbes to faster consume and convert sugar into biomass, in niches that were semi-anaerobic.	[Hagman, Arne; Piskur, Jure] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Hagman, A (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	arne.hagman@biol.lu.se			Swedish Research Council (VR); Crafoord Foundation; Fysiografen Foundation; Sorensen Foundation; Lindstrom Foundation	Swedish Research Council (VR)(Swedish Research Council); Crafoord Foundation; Fysiografen Foundation; Sorensen Foundation; Lindstrom Foundation	This work was supported by the Swedish Research Council (VR), Crafoord, Fysiografen, Sorensen, and Lindstrom Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MA, 1990, ENZYME MICROB TECH, V12, P2, DOI 10.1016/0141-0229(90)90173-N; BARFORD JP, 1981, BIOTECHNOL BIOENG, V23, P1735, DOI 10.1002/bit.260230806; Billard P, 1996, J BACTERIOL, V178, P5860, DOI 10.1128/jb.178.20.5860-5866.1996; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; CHEN XJ, 1992, MOL GEN GENET, V233, P97, DOI 10.1007/BF00587566; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; Hagman A, 2014, FEBS J, V281, P4805, DOI 10.1111/febs.13019; Hagman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068734; Huberts DHEW, 2012, FEMS YEAST RES, V12, P118, DOI 10.1111/j.1567-1364.2011.00767.x; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Kim JH, 2013, BBA-GEN SUBJECTS, V1830, P5204, DOI 10.1016/j.bbagen.2013.07.025; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Lin ZG, 2011, MOL BIOL EVOL, V28, P131, DOI 10.1093/molbev/msq184; Marcet-Houben M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-295; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Moller K, 2001, J BACTERIOL, V183, P2485, DOI 10.1128/JB.183.8.2485-2489.2001; PETRIK M, 1983, J GEN MICROBIOL, V129, P43; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; RIEGER M, 1983, J GEN MICROBIOL, V129, P653; SONNLEITNER B, 1986, BIOTECHNOL BIOENG, V28, P927, DOI 10.1002/bit.260280620; VANURK H, 1989, J GEN MICROBIOL, V135, P2399; VONMEYEN HK, 1969, ARCH MIKROBIOL, V66, P289; Westergaard SL, 2007, BIOTECHNOL BIOENG, V96, P134, DOI 10.1002/bit.21135; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	30	64	65	2	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116942	10.1371/journal.pone.0116942	http://dx.doi.org/10.1371/journal.pone.0116942			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617754	Green Submitted, Green Published, gold			2022-12-27	WOS:000350336000032
J	Yang, CC; Chen, PC; Hsu, CW; Chang, SL; Lee, CC				Yang, Ching-Chieh; Chen, Po-Chun; Hsu, Chia-Wen; Chang, Shih-Lun; Lee, Ching-Chih			Validity of the Age-Adjusted Charlson Comorbidity Index on Clinical Outcomes for Patients with Nasopharyngeal Cancer Post Radiation Treatment: A 5-Year Nationwide Cohort Study	PLOS ONE			English	Article							NECK-CANCER; ELDERLY-PATIENTS; CO-MORBIDITY; HEAD; CARCINOMA; IMPACT; VALIDATION; SURVIVAL; STAGE; SCORE	Purpose To characterize the impact of comorbidity on survival outcomes for patients with nasopharyngeal carcinoma (NPC) post radiotherapy (RT). Methods A total of 4095 patients with NPC treated by RT or RT plus chemotherapy (CT) in the period from 2007 to 2011 were included through Taiwan's National Health Insurance Research Database. Information on comorbidity present prior to the NPC diagnosis was obtained and adapted to the Charlson Comorbidity Index (CCI), Age-Adjusted Charlson Comorbidity Index (ACCI) and a revised head and neck comorbidity index (HN-CCI). The prevalence of comorbidity and the influence on survival were calculated and analyzed. Results Most of the patients (75%) were male (age 51 +/- 13 years) and 2470 of them (60%) had at least one comorbid condition. The most common comorbid condition was diabetes mellitus. According to these three different comorbidity index (CCI, ACCI and HN-CCI), higher scores were associated with worse overall survival (P < 0.001). The Receiver Operating Characteristic (ROC) curve was used to assess the discriminating ability of CCI, AACI and HN-CCI scores and it demonstrated the predictive ability for mortality with the ACCI (0.693, 95% CI 0.670-0.715) was superior to that of the CCI (0.619, 95% CI 0.593-0.644) and HN-CCI (0.545, 95% CI 0.519-0.570). Conclusion Comorbidities greatly influenced the clinical presentations, therapeutic interventions, and outcomes of patients with NPC post RT. Higher comorbidity index scores accurately was associated with worse survival. The ACCI seems to be a more appropriate prognostic indicator and should be considered in further clinical studies.	[Yang, Ching-Chieh] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Yang, Ching-Chieh] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Chen, Po-Chun] Pingtung Christian Hosp, Dept Radiat Oncol, Pingtung, Taiwan; [Hsu, Chia-Wen] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Med Res, Chiayi, Taiwan; [Chang, Shih-Lun] Chi Mei Med Ctr, Dept Otolaryngol, Tainan, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Ctr Canc, Chiayi, Taiwan; [Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Chi Mei Hospital; National Sun Yat Sen University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Chi Mei Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University	Lee, CC (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan.	hematcd2@hotamil.com		Chang, Shih-Lun/0000-0002-4031-7948				Boje CR, 2014, RADIOTHER ONCOL, V110, P91, DOI 10.1016/j.radonc.2013.11.009; Boje CR, 2013, ACTA ONCOL, V52, P285, DOI 10.3109/0284186X.2012.742964; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Charlson ME, 2008, J CLIN EPIDEMIOL, V61, P1234, DOI 10.1016/j.jclinepi.2008.01.006; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; DENG H, 1995, CHINESE MED J-PEKING, V108, P300; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Habbous S, 2014, HEAD NECK-J SCI SPEC, V36, P802, DOI 10.1002/hed.23360; HENDERSON BE, 1976, NEW ENGL J MED, V295, P1101, DOI 10.1056/NEJM197611112952003; Caballero PEJ, 2013, J STROKE CEREBROVASC, V22, pE214, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.014; Koppie TM, 2008, CANCER-AM CANCER SOC, V112, P2384, DOI 10.1002/cncr.23462; Lee CC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-92; LIN TM, 1973, J NATL CANCER I, V51, P1403, DOI 10.1093/jnci/51.5.1403; Lu JFR, 2011, HEALTH ECON POLICY L, V6, P85, DOI 10.1017/S1744133109990351; Mayr R, 2014, UROL INT, DOI [10.1159/000357626, DOI 10.1159/000357626]; NAM JM, 1992, J NATL CANCER I, V84, P619, DOI 10.1093/jnci/84.8.619; Paleri V, 2003, HEAD NECK-J SCI SPEC, V25, P1019, DOI 10.1002/hed.10333; Paleri V, 2010, ORAL ONCOL, V46, P712, DOI 10.1016/j.oraloncology.2010.07.008; Ramakrishnan Y, 2007, CLIN OTOLARYNGOL, V32, P484, DOI 10.1111/j.1749-4486.2007.01543.x; Read WL, 2004, J CLIN ONCOL, V22, P3099, DOI 10.1200/JCO.2004.08.040; Reid BC, 2001, CANCER, V92, P2109, DOI 10.1002/1097-0142(20011015)92:8<2109::AID-CNCR1552>3.0.CO;2-M; Robbins JR, 2013, GYNECOL ONCOL, V131, P593, DOI 10.1016/j.ygyno.2013.10.007; Sanabria A, 2008, ARCH OTOLARYNGOL, V134, P603, DOI 10.1001/archotol.134.6.603; Sanabria A, 2007, ANN SURG ONCOL, V14, P1449, DOI 10.1245/s10434-006-9296-1; Singh B, 1997, LARYNGOSCOPE, V107, P1469, DOI 10.1097/00005537-199711000-00009; Sze HCK, 2012, ORAL ONCOL, V48, P162, DOI 10.1016/j.oraloncology.2011.08.019; Tessier A, 2008, ARCH PHYS MED REHAB, V89, P1276, DOI 10.1016/j.apmr.2007.11.049	30	32	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117323	10.1371/journal.pone.0117323	http://dx.doi.org/10.1371/journal.pone.0117323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617629	Green Published, gold, Green Submitted			2022-12-27	WOS:000350336000043
J	Escobar, JV; Sornette, D				Escobar, Juan V.; Sornette, Didier			Dynamical Signatures of Collective Quality Grading in a Social Activity: Attendance to Motion Pictures	PLOS ONE			English	Article							EXOGENOUS SHOCKS; BOX-OFFICE; NETWORKS; MODEL; BOOK	We investigate the laws governing people's decisions and interactions by studying the collective dynamics of a well-documented social activity for which there exist ample records of the perceived quality: the attendance to movie theaters in the US. We picture the flows of attendance as impulses or "shocks" driven by external factors that in turn can create new cascades of attendances through direct recommendations whose effectiveness depends on the perceived quality of the movies. This corresponds to an epidemic branching model comprised of a decaying exponential function determining the time between cause and action, and a cascade of actions triggered by previous ones. We find that the vast majority of the similar to 3,500 movies studied fit our model remarkably well. From our results, we are able to translate a subjective concept such as movie quality into a probability of the deriving individual activity, and from it we build concrete quantitative predictions. Our analysis opens up the possibility of understanding other collective dynamics for which the perceived quality or appeal of an action is also known.	[Escobar, Juan V.] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City 04510, DF, Mexico; [Escobar, Juan V.] Univ Autonoma Metropolitana Iztapalapa, Dept Phys, Mexico City 09340, DF, Mexico; [Sornette, Didier] ETH, Dept Management Technol & Econ, Switzerland & Swiss Finance Inst, Zurich, Switzerland	Universidad Nacional Autonoma de Mexico; Universidad Autonoma Metropolitana - Mexico; Swiss Federal Institutes of Technology Domain; ETH Zurich	Escobar, JV (corresponding author), Univ Nacl Autonoma Mexico, Inst Fis, POB 20-364, Mexico City 04510, DF, Mexico.	escobarjuanvalentin@gmail.com	Escobar, Juan V/H-9617-2017	Escobar, Juan V/0000-0001-6048-2011	DGAPA's postdoctoral fellowship [CJIC/CTIC/2135/2009]; CONACYT's postdoctoral fellowship [177679, CVU 37905]	DGAPA's postdoctoral fellowship; CONACYT's postdoctoral fellowship	JVE acknowledges DGAPA's postdoctoral fellowship (CJIC/CTIC/2135/2009) and CONACYT's postdoctoral fellowship (project #177679, CVU 37905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, CO ARE MARKETING ONL; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Blumm N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128701; Borge-Holthoefer J, 2013, J STAT PHYS, V151, P383, DOI 10.1007/s10955-012-0595-6; Borge-Holthoefer J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066123; Borge-Holthoefer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023883; Borghesi C, 2007, QUAL QUANT, V41, P557, DOI 10.1007/s11135-007-9074-6; Cattuto C, 2007, P NATL ACAD SCI USA, V104, P1461, DOI 10.1073/pnas.0610487104; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; de Menezes MA, 2004, PHYS REV LETT, V93, P4; De Vany A, 2001, J ECON DYN CONTROL, V25, P593, DOI 10.1016/S0165-1889(00)00037-3; De Vany A., 2003, HOLLYWOOD EC EXTREME; Deschatres F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016112; Eliashberg J, 2007, MANAGE SCI, V53, P881, DOI 10.1287/mnsc.1060.0668; Filimonov V, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/46003; Gonzalez-Bailon S, 2013, AM BEHAV SCI, V57, P943, DOI 10.1177/0002764213479371; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; HAWKES AG, 1974, J APPL PROBAB, V11, P493, DOI 10.2307/3212693; Johansen A, 2000, PHYSICA A, V276, P338, DOI 10.1016/S0378-4371(99)00468-9; Lambiotte R, 2006, PHYSICA A, V362, P485, DOI 10.1016/j.physa.2005.08.047; Maillart T, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056101; McKenzie J, 2010, J CULT ECON, V34, P159, DOI 10.1007/s10824-010-9119-x; Moretti E, 2011, REV ECON STUD, V78, P356, DOI 10.1093/restud/rdq014; Moul CC, 2007, J ECON MANAGE STRAT, V16, P859, DOI 10.1111/j.1530-9134.2007.00160.x; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; Roehner BM, 2004, INT J MOD PHYS C, V15, P809, DOI 10.1142/S0129183104006236; Saichev A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016108; Saichev AI, 2010, EUR PHYS J B, V75, P343, DOI 10.1140/epjb/e2010-00121-7; Saiz A, 2007, PREDICTIONS PERCEPTI; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Sinha S, 2005, NEW ECON WINDOWS, P43, DOI 10.1007/88-470-0389-X_5; Sornette D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228701; Sornette D, 2003, PHYSICA A, V318, P577, DOI 10.1016/S0378-4371(02)01371-7; Sornette D, 2002, P NATL ACAD SCI USA, V99, P2522, DOI 10.1073/pnas.022581999; Sornette D, 2006, CRITICAL PHENOMENA N, P179; Sornette D, 2003, RISK MAG, V16, P67; Valverde S, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/20002	38	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116811	10.1371/journal.pone.0116811	http://dx.doi.org/10.1371/journal.pone.0116811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UU	25612292	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900022
J	Silvis, A; Ford, WM; Britzke, ER				Silvis, Alexander; Ford, W. Mark; Britzke, Eric R.			Effects of Hierarchical Roost Removal on Northern Long-Eared Bat (Myotis septentrionalis) Maternity Colonies	PLOS ONE			English	Article							BROWN BATS; NETWORK ANALYSIS; PRESCRIBED FIRE; SOCIAL NETWORKS; SOUTH-CAROLINA; INDIANA BATS; FOREST BATS; HABITAT USE; SELECTION; FEMALE	Forest roosting bats use a variety of ephemeral roosts such as snags and declining live trees. Although conservation of summer maternity habitat is considered critical for forest-roosting bats, bat response to roost loss still is poorly understood. To address this, we monitored 3 northern long-eared bat (Myotis septentrionalis) maternity colonies on Fort Knox Military Reservation, Kentucky, USA, before and after targeted roost removal during the dormant season when bats were hibernating in caves. We used 2 treatments: removal of a single highly used (primary) roost and removal of 24% of less used (secondary) roosts, and an un-manipulated control. Neither treatment altered the number of roosts used by individual bats, but secondary roost removal doubled the distances moved between sequentially used roosts. However, overall space use by and location of colonies was similar pre- and post-treatment. Patterns of roost use before and after removal treatments also were similar but bats maintained closer social connections after our treatments. Roost height, diameter at breast height, percent canopy openness, and roost species composition were similar pre- and post-treatment. We detected differences in the distribution of roosts among decay stages and crown classes pre- and post-roost removal, but this may have been a result of temperature differences between treatment years. Our results suggest that loss of a primary roost or <= 20% of secondary roosts in the dormant season may not cause northern long-eared bats to abandon roosting areas or substantially alter some roosting behaviors in the following active season when tree-roosts are used. Critically, tolerance limits to roost loss may be dependent upon local forest conditions, and continued research on this topic will be necessary for conservation of the northern long-eared bat across its range.	[Silvis, Alexander; Ford, W. Mark] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Ford, W. Mark] US Geol Survey, Virginia Cooperat Fish & Wildlife Res Unit, Blacksburg, VA USA; [Britzke, Eric R.] US Army, Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS USA	Virginia Polytechnic Institute & State University; United States Department of the Interior; United States Geological Survey; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Silvis, A (corresponding author), Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	silvis@vt.edu			United States Army	United States Army(United States Department of DefenseUnited States Army)	Funding for this research was provided through a United States Army 6.1 basic science grant. One of the authors in this manuscript works for the United States Army Corps of Engineers, but we have no conflicts of interest with the United States Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was conducted on an active military installation, and accordingly, our field sites were positioned within areas of the installation that were not used for active training. We, the authors, selected these sites from a list of several safe operation zones on the installation.	[Anonymous], 2002, OAK FOREST; [Anonymous], 2012, INT J FOREST RES, DOI DOI 10.1155/2012/148106; Arms ELP, 1979, SOIL SURVEY HARDIN L; Bagne KE, 2008, FOREST ECOL MANAG, V255, P99, DOI 10.1016/j.foreco.2007.08.024; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borgatti SP, 1997, SOC NETWORKS, V19, P243, DOI 10.1016/S0378-8733(96)00301-2; Borkin KM, 2011, BIODIVERS CONSERV, V20, P3537, DOI 10.1007/s10531-011-0144-7; Boyles JG, 2006, FOREST ECOL MANAG, V222, P108, DOI 10.1016/j.foreco.2005.09.024; Braun E.L, 1950, SOIL SCI, V71, P155, DOI [10.1097/00010694-195102000-00012, DOI 10.1097/00010694-195102000-00012]; BRIGHAM RM, 1986, CAN J ZOOL, V64, P1128, DOI 10.1139/z86-169; Broders HG, 2006, J WILDLIFE MANAGE, V70, P1174, DOI 10.2193/0022-541X(2006)70[1174:REASSF]2.0.CO;2; Brooks RT, 2005, NORTHEAST NAT, V12, P447, DOI 10.1656/1092-6194(2005)012[0447:BAIAFL]2.0.CO;2; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carter TC, 2005, FOREST ECOL MANAG, V219, P259, DOI 10.1016/j.foreco.2005.08.049; Chaverri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028821; CLINE SP, 1980, J WILDLIFE MANAGE, V44, P773, DOI 10.2307/3808305; Copenheaver CA, 2006, NORTHEAST NAT, V13, P477, DOI 10.1656/1092-6194(2006)13[477:FSDPIT]2.0.CO;2; CRANFILL R, 1991, Castanea, V56, P228; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davison AC, 1997, BOOTSTRAP METHODS TH; Dixon MD, 2013, J FISH WILDL MANAG, V4, P406, DOI 10.3996/122012-JFWM-106; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fenton MB, 1997, J MAMMAL, V78, P1, DOI 10.2307/1382633; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Ford WM, 2006, J WILDLIFE MANAGE, V70, P1200, DOI 10.2193/0022-541X(2006)70[1200:PAAOBA]2.0.CO;2; Ford WM, 2006, NORTHEAST NAT, V13, P15, DOI 10.1656/1092-6194(2006)13[15:RPBLAD]2.0.CO;2; Ford WM, 2005, BIOL CONSERV, V126, P528, DOI 10.1016/j.biocon.2005.07.003; Fortuna MA, 2009, ECOLOGY, V90, P934, DOI 10.1890/08-0174.1; Foster RW, 1999, J MAMMAL, V80, P659, DOI 10.2307/1383310; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Garroway CJ, 2008, ECOSCIENCE, V15, P89, DOI 10.2980/1195-6860(2008)15[89:DRCONL]2.0.CO;2; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Goodreau SM, 2009, DEMOGRAPHY, V46, P103, DOI 10.1353/dem.0.0045; GRINDAL SD, 1992, AM MIDL NAT, V128, P339, DOI 10.2307/2426468; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hutchinson TF, 2008, CAN J FOREST RES, V38, P1184, DOI 10.1139/X07-216; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Johnson JS, 2012, J MAMMAL, V93, P1545, DOI 10.1644/12-MAMM-A-097.1; Johnson JB, 2012, FOREST ECOL MANAG, V266, P223, DOI 10.1016/j.foreco.2011.11.032; Johnson JB, 2010, J FISH WILDL MANAG, V1, P111, DOI 10.3996/042010-JFWM-007; Johnson JB, 2009, FOREST ECOL MANAG, V258, P233, DOI 10.1016/j.foreco.2009.04.008; Jung TS, 1999, J WILDLIFE MANAGE, V63, P1306, DOI 10.2307/3802849; Kerth G, 2001, OECOLOGIA, V126, P1, DOI 10.1007/s004420000489; Kunz TH, 2003, BAT ECOLOGY, P3; Lacki MJ, 2009, J MAMMAL, V90, P1165, DOI 10.1644/08-MAMM-A-349.1; Lacki MJ, 2001, J WILDLIFE MANAGE, V65, P482, DOI 10.2307/3803101; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Loeb SC, 2006, J WILDLIFE MANAGE, V70, P1210, DOI 10.2193/0022-541X(2006)70[1210:HUBFBI]2.0.CO;2; Lorimer CG, 2003, FOREST ECOL MANAG, V185, P41, DOI 10.1016/S0378-1127(03)00245-7; Menzel MA, 2002, FOREST ECOL MANAG, V155, P107, DOI 10.1016/S0378-1127(01)00551-5; Menzel MA, 2002, FOREST ECOL MANAG, V162, P209, DOI 10.1016/S0378-1127(01)00516-3; Metheny JD, 2008, BEHAV ECOL SOCIOBIOL, V62, P1043, DOI 10.1007/s00265-007-0531-y; Moorman CE, 1999, FOREST ECOL MANAG, V118, P37, DOI 10.1016/S0378-1127(98)00482-4; Morris AD, 2010, J WILDLIFE MANAGE, V74, P26, DOI 10.2193/2008-471; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NEILSON AL, 1994, WILDLIFE SOC B, V22, P8; Nyland R., 2002, SILVICULTURE CONCEPT; Olson CR, 2013, CAN J ZOOL, V91, P149, DOI 10.1139/cjz-2012-0267; Opsahl T., 2009, STRUCTURE EVOLUTION; Owen SF, 2004, NORTH J APPL FOR, V21, P154, DOI 10.1093/njaf/21.3.154; Patriquin KJ, 2013, BEHAV ECOL, V24, P949, DOI 10.1093/beheco/art012; Patriquin KJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P899, DOI 10.1007/s00265-010-0905-4; Perry RW, 2007, FOREST ECOL MANAG, V247, P220, DOI 10.1016/j.foreco.2007.04.041; Perry RW, 2011, J FISH WILDL MANAG, V2, P112, DOI 10.3996/082010-JFWM-030; Popa-Lisseanu AG, 2008, ANIM BEHAV, V75, P471, DOI 10.1016/j.anbehav.2007.05.011; R Development Core Team, 2014, R LANG ENV STAT COMP; Rhodes M, 2006, CONSERV BIOL, V20, P861, DOI 10.1111/j.1523-1739.2006.00415.x; Signell SA, 2005, FOREST ECOL MANAG, V218, P146, DOI 10.1016/j.foreco.2005.07.006; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Silvis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096937; Silvis A, 2014, BEHAV PROCESS, V103, P283, DOI 10.1016/j.beproc.2014.01.016; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stone EL, 2013, CONSERV BIOL, V27, P1324, DOI 10.1111/cobi.12154; Timpone JC, 2010, AM MIDL NAT, V163, P115, DOI 10.1674/0003-0031-163.1.115; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weller Theodore J., 2009, Endangered Species Research, V8, P129, DOI 10.3354/esr00149; Willis CKR, 2005, CAN J ZOOL, V83, P871, DOI 10.1139/Z05-074; Wisdom MJ, 2008, FOREST ECOL MANAG, V255, P2085, DOI 10.1016/j.foreco.2007.12.027; Womack KM, 2013, J WILDLIFE MANAGE, V77, P707, DOI 10.1002/jwmg.498; Zahn A, 1999, J ZOOL, V247, P275, DOI 10.1111/j.1469-7998.1999.tb00991.x; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115	87	22	22	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116356	10.1371/journal.pone.0116356	http://dx.doi.org/10.1371/journal.pone.0116356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611060	gold, Green Submitted, Green Published			2022-12-27	WOS:000348562900013
J	Zariffard, MR; Anastos, K; French, AL; Munyazesa, E; Cohen, M; Landay, AL; Spear, GT				Zariffard, M. Reza; Anastos, Kathryn; French, Audrey L.; Munyazesa, Elisaphane; Cohen, Mardge; Landay, Alan L.; Spear, Gregory T.			Cleavage/Alteration of Interleukin-8 by Matrix Metalloproteinase-9 in the Female Lower Genital Tract	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; BACTERIAL VAGINOSIS; EPITHELIAL-CELLS; WOMEN; IL-8; HIV; METALLOPROTEINASES; IDENTIFICATION; GINGIPAINS; CHEMOKINES	Objective Interleukin-8 (IL-8, CXCL8) plays important roles in immune responses at mucosal sites including in the lower genital tract. Since several types of bacteria produce proteases that cleave IL-8 and many types of bacteria can be present in lower genital tract microbiota, we assessed genital fluids for IL-8 cleavage/alteration. Study Design Genital fluids collected by lavage from 200 women (23 HIV-seronegative and 177 HIV-seropositive) were tested for IL-8 cleavage/alteration by ELISA. Results IL-8 cleaving/altering activity was observed in fluids from both HIV-positive (28%) and HIV-negative women (35%). There was no clear relationship between the activity and the types of bacteria present in the lower genital tract as determined by high-throughput sequencing of the 16S rRNA gene. Protease inhibitors specific for matrix metalloproteinases (MMPs) reduced the activity and a multiplex assay that detects both inactive and active MMPs showed the presence of multiple MMPs, including MMP-1, -3, -7, -8, -9, -10 and -12 in genital secretions from many of the women. The IL-8-cleaving/altering activity significantly correlated with active MMP-9 as well as with cleavage of a substrate that is acted on by several active MMPs. Conclusions These studies show that multiple MMPs are present in the genital tract of women and strongly suggest that MMP-9 in genital secretions can cleave IL-8 at this mucosal site. These studies suggest that MMP-mediated cleavage of IL-8 can modulate inflammatory responses in the lower genital tract.	[Zariffard, M. Reza; Landay, Alan L.; Spear, Gregory T.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Anastos, Kathryn] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Anastos, Kathryn] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Anastos, Kathryn] Montefiore Med Ctr, Bronx, NY 10467 USA; [French, Audrey L.; Cohen, Mardge] John H Stroger Jr Hosp Cook Cty, Ruth M Rothstein CORE Ctr, Chicago, IL USA; [Munyazesa, Elisaphane] Rwanda Biomed Ctr, Natl Reference Lab Div, Lab Qual Assurance Direct, Kigali, Rwanda	Rush University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rwanda Biomedical Center	Spear, GT (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	gspear@rush.edu			National Institutes of Health [P01 AI08297, P30 AI082151]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034993, P30AI082151, U01AI035004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	GTS and AL received National Institutes of Health grant P01 AI08297. ALF received National Institutes of Health grant P30 AI082151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpagot T, 2006, J PERIODONTAL RES, V41, P491, DOI 10.1111/j.1600-0765.2006.00887.x; Basso Beatriz, 2005, Infect Dis Obstet Gynecol, V13, P207, DOI 10.1155/2005/358107; Cauci S, 2002, AM J REPROD IMMUNOL, V47, P257, DOI 10.1034/j.1600-0897.2002.01096.x; Cummins JE, 2006, AIDS RES HUM RETROV, V22, P788, DOI 10.1089/aid.2006.22.788; Dias IHK, 2008, INFECT IMMUN, V76, P317, DOI 10.1128/IAI.00618-07; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Heng YJJ, 2012, REPROD SCI, V19, P55, DOI 10.1177/1933719111413299; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Mikolajczyk-Pawlinska J, 1998, FEBS LETT, V440, P282, DOI 10.1016/S0014-5793(98)01461-6; Mitchell CM, 2008, AIDS RES HUM RETROV, V24, P667, DOI [10.1089/aid.2007.0268, 10.1089/aid.2008.0268]; Mukaida N, 1998, CYTOKINE GROWTH F R, V9, P9, DOI 10.1016/S1359-6101(97)00022-1; Nissinen L, 2014, BIOCH BIOPHYS ACTA; Pivarcsi A, 2005, MICROBES INFECT, V7, P1117, DOI 10.1016/j.micinf.2005.03.016; Roberts L, 2012, BEST PRACT RES CL OB, V26, P441, DOI 10.1016/j.bpobgyn.2012.02.002; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; ROTTINI G, 1990, INFECT IMMUN, V58, P3751, DOI 10.1128/IAI.58.11.3751-3758.1990; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; SHAIO MF, 1995, INFECT IMMUN, V63, P3864, DOI 10.1128/IAI.63.10.3864-3870.1995; Simhan HN, 2007, AM J OBSTET GYNECOL, V196, P59, DOI 10.1016/j.ajog.2006.08.035; Spear G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052992; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Spear GT, 2008, J REPROD IMMUNOL, V78, P76, DOI 10.1016/j.jri.2007.11.001; Spear GT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019560; Spear GT, 2012, AIDS RES HUM RETROVI; Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002; Turner CE, 2009, J INFECT DIS, V200, P555, DOI 10.1086/603541; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Yudin MH, 2003, OBSTET GYNECOL, V102, P527, DOI 10.1016/S0029-7844(03)00566-0	32	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116911	10.1371/journal.pone.0116911	http://dx.doi.org/10.1371/journal.pone.0116911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611319	gold, Green Submitted, Green Published			2022-12-27	WOS:000348562900026
J	Cerna, L; Munzbergova, Z				Cerna, Lucie; Muenzbergova, Zuzana			Conditions in Home and Transplant Soils Have Differential Effects on the Performance of Diploid and Allotetraploid Anthericum Species	PLOS ONE			English	Article							LOCAL ADAPTATION; NICHE DIFFERENTIATION; POPULATION BIOLOGY; GENETIC-VARIATION; PERENNIAL HERB; PLANT; PLASTICITY; POLYPLOIDY; COMPETITION; LEVEL	Due to increased levels of heterozygosity, polyploids are expected to have a greater ability to adapt to different environments than their diploid ancestors. While this theoretical pattern has been suggested repeatedly, studies comparing adaptability to changing conditions in diploids and polyploids are rare. The aim of the study was to determine the importance of environmental conditions of origin as well as target conditions on performance of two Anthericum species, allotetraploid A. liliago and diploid A. ramosum and to explore whether the two species differ in the ability to adapt to these environmental conditions. Specifically, we performed a common garden experiment using soil from 6 localities within the species' natural range, and we simulated the forest and open environments in which they might occur. We compared the performance of diploid A. ramosum and allotetraploid A. liliago originating from different locations in the different soils. The performance of the two species was not affected by simulated shading but differed strongly between the different target soils. Growth of the tetraploids was not affected by the origin of the plants. In contrast, diploids from the most nutrient poor soil performed best in the richest soil, indicating that diploids from deprived environments have an increased ability to acquire nutrients when available. They are thus able to profit from transfer to novel nutrient rich environments. Therefore, the results of the study did not support the general expectation that the polyploids should have a greater ability than the diploids to adapt to a wide range of conditions. In contrast, the results are in line with the observation that diploids occupy a wider range of environments than the allotetraploids in our system.	[Cerna, Lucie; Muenzbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Muenzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Munzbergova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	zuzmun@natur.cuni.cz	Münzbergová, Zuzana/F-6321-2013; Černá, Lucie/GSJ-0030-2022	Münzbergová, Zuzana/0000-0002-4026-6220; 	Grant agency of the Czech Republic (GACR) [13-2048S]; Developmental project of the Academy of Sciences [RVO 67985939]; Ministry of education (MSMT)	Grant agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); Developmental project of the Academy of Sciences; Ministry of education (MSMT)	The study was supported by a project of the Grant agency of the Czech Republic (GACR 13-2048S) and also in part by the Developmental project of the Academy of Sciences (RVO 67985939) and an institutional research project provided by the Ministry of education (MSMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela-Hofbauerova I, 2011, FLORA, V206, P1012, DOI 10.1016/j.flora.2011.07.007; Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Baack EJ, 2005, EVOLUTION, V59, P1936; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; Bischoff A, 2013, AM J BOT, V100, P1162, DOI 10.3732/ajb.1200500; BRETAGNOLLE F, 1995, EUPHYTICA, V84, P197, DOI 10.1007/BF01681812; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Bucharova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045855; Bucharova A, 2010, AM J BOT, V97, P1260, DOI 10.3732/ajb.0900351; Buggs RJA, 2007, EVOLUTION, V61, P125, DOI 10.1111/j.1558-5646.2007.00010.x; Burkle LA, 2010, J ECOL, V98, P705, DOI 10.1111/j.1365-2745.2010.01648.x; Castro S, 2011, EVOL ECOL, V25, P795, DOI 10.1007/s10682-010-9439-5; Cerna L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075563; Chun YJ, 2011, MOL ECOL, V20, P1378, DOI 10.1111/j.1365-294X.2011.05013.x; D'Hertefeldt T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085407; Dostalek T, 2013, FOLIA GEOBOT, V48, P75, DOI 10.1007/s12224-012-9132-2; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ehrenberger F., 1973, METHODEN ORG ELEMENT; Eliasova A, 2014, ANN BOT-LONDON, V113, P159, DOI 10.1093/aob/mct252; Ellenberg H., 1988, VEGETATION ECOLOGY C; FelberGirard M, 1996, NEW PHYTOL, V133, P531, DOI 10.1111/j.1469-8137.1996.tb01921.x; Flegrova M, 1999, FOLIA GEOBOT, V34, P19, DOI 10.1007/BF02803074; Francis B., 1993, STAT SYSTEM GEN LINE; Freville H, 2004, ECOLOGY, V85, P694, DOI 10.1890/03-0119; Galloway LF, 2000, EVOLUTION, V54, P1173, DOI 10.1111/j.0014-3820.2000.tb00552.x; Godsoe W, 2013, AM J BOT, V100, P496, DOI 10.3732/ajb.1200275; GRANT V, 1994, P NATL ACAD SCI USA, V91, P3, DOI 10.1073/pnas.91.1.3; Hahn MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050284; Heinken-Smidova A, 2012, FOLIA GEOBOT, V47, P193, DOI 10.1007/s12224-011-9116-7; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hulber K, 2011, ALPINE BOT, V121, P123, DOI 10.1007/s00035-011-0091-7; Husband BC, 2000, P ROY SOC B-BIOL SCI, V267, P217, DOI 10.1098/rspb.2000.0990; JAIN SK, 1966, HEREDITY, V21, P407, DOI 10.1038/hdy.1966.42; Jersakova J, 2010, EVOL ECOL, V24, P1199, DOI 10.1007/s10682-010-9356-7; Jolivet C, 2007, ANN BOT-LONDON, V100, P119, DOI 10.1093/aob/mcm088; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Laine AL, 2007, J EVOLUTION BIOL, V20, P1665, DOI 10.1111/j.1420-9101.2007.01359.x; Lankau RA, 2013, ECOLOGY, V94, P32, DOI 10.1890/12-0675.1; Latzel V, 2010, OIKOS, V119, P1700, DOI 10.1111/j.1600-0706.2010.18737.x; Latzel V, 2009, OIKOS, V118, P1669, DOI 10.1111/j.1600-0706.2009.17767.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lembicz M, 2011, FLORA, V206, P158, DOI 10.1016/j.flora.2010.09.006; Lenssen JPM, 2004, J ECOL, V92, P696, DOI 10.1111/j.0022-0477.2004.00895.x; Levin D. A, 2002, OX ECOL EV; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; LEWIS HARLAN, 1967, TAXON, V16, P267, DOI 10.2307/1216373; Munzbergova Z, 2007, ANN BOT-LONDON, V100, P1259, DOI 10.1093/aob/mcm204; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; Manzaneda AJ, 2012, NEW PHYTOL, V193, P797, DOI 10.1111/j.1469-8137.2011.03988.x; Marques I, 2007, AM J BOT, V94, P1352, DOI 10.3732/ajb.94.8.1352; Martin SL, 2013, EVOLUTION, V67, P1780, DOI 10.1111/evo.12065; Martina JP, 2013, PLANT ECOL, V214, P1443, DOI 10.1007/s11258-013-0265-z; MCNEILLY T, 1968, EVOLUTION, V22, P108, DOI [10.1111/j.1558-5646.1968.tb03454.x, 10.2307/2406655]; Meeus S, 2012, AM J BOT, V99, P1809, DOI 10.3732/ajb.1200223; Muenzbergova Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Munzbergova Z, 2007, BIOL J LINN SOC, V92, P211, DOI 10.1111/j.1095-8312.2007.00820.x; Munzbergova Z, 2005, AM J BOT, V92, P1987, DOI 10.3732/ajb.92.12.1987; Munzbergova Z, 2005, FLORA, V200, P275, DOI 10.1016/j.flora.2004.08.002; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Munzbergova Z, 2010, FLORA, V205, P552, DOI 10.1016/j.flora.2010.04.001; Nuismer SL, 2005, EVOLUTION, V59, P1928; Oberprieler C, 2012, FLORA, V207, P862, DOI 10.1016/j.flora.2012.09.012; Oleksyn J, 2003, OECOLOGIA, V136, P220, DOI 10.1007/s00442-003-1265-9; Olsen R., 1954, US DEP AGR CIRCULAR, V939, P1; Pankova H, 2008, OECOLOGIA, V157, P211, DOI 10.1007/s00442-008-1064-4; Pankova H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093967; Pankova H, 2011, AM J BOT, V98, P850, DOI 10.3732/ajb.0900350; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Petit C, 1997, HEREDITY, V79, P31, DOI 10.1038/hdy.1997.120; Raabova J, 2008, OECOLOGIA, V158, P463, DOI 10.1007/s00442-008-1156-1; Raabova J, 2007, BIOL CONSERV, V139, P348, DOI 10.1016/j.biocon.2007.07.007; Raabova J, 2011, BASIC APPL ECOL, V12, P152, DOI 10.1016/j.baae.2011.01.001; Reckinger C, 2010, RESTOR ECOL, V18, P904, DOI 10.1111/j.1526-100X.2009.00522.x; Rosquist G, 2002, PLANT SYST EVOL, V236, P55, DOI 10.1007/s00606-002-0238-5; Schlaepfer DR, 2010, OECOLOGIA, V163, P661, DOI 10.1007/s00442-010-1595-3; Skalicky V, 1959, ACTA U CAROLINAE BIO, V2, P117; Skalova H, 2005, FOLIA GEOBOT, V40, P77, DOI 10.1007/BF02803046; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smidova A, 2011, FLORA, V206, P151, DOI 10.1016/j.flora.2010.03.003; Soltis DE, 2010, TAXON, V59, P1387, DOI 10.1002/tax.595006; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Sterck FJ, 2013, J ECOL, V101, P971, DOI 10.1111/1365-2745.12076; SYMEONIDIS L, 1985, NEW PHYTOL, V101, P317, DOI 10.1111/j.1469-8137.1985.tb02838.x; Tajek P, 2011, ACTA OECOL, V37, P495, DOI 10.1016/j.actao.2011.06.009; van Kleunen M, 2007, J EVOLUTION BIOL, V20, P2126, DOI 10.1111/j.1420-9101.2007.01431.x; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Weisshuhn K, 2012, BASIC APPL ECOL, V13, P551, DOI 10.1016/j.baae.2012.07.004; Wright JW, 2006, EVOL ECOL RES, V8, P1; Xu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035873; Zhang ST, 2011, ANN BOT-LONDON, V107, P437, DOI 10.1093/aob/mcq259	90	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116992	10.1371/journal.pone.0116992	http://dx.doi.org/10.1371/journal.pone.0116992			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607545	Green Submitted, Green Published, gold			2022-12-27	WOS:000348205300046
J	Nathalang, O; Intharanut, K; Siriphanthong, K; Nathalang, S; Leetrakool, N				Nathalang, Oytip; Intharanut, Kamphon; Siriphanthong, Kanokpol; Nathalang, Siriporn; Leetrakool, Nipapan			Risk Estimation of HNA-3 Incompatibility and Alloimmunization in Thai Populations	PLOS ONE			English	Article							HUMAN NEUTROPHIL ALLOANTIGENS; BLOOD-DONORS; GENOTYPE FREQUENCIES; TRALI; GENE; 5B	Severe transfusion-related acute lung injury (TRALI) is often due to antibodies in blood components directed against human neutrophil antigen (HNA)-3a. This study aimed to report the genotype frequencies of the HNA-3 system and to estimate the potential risk of HNA-3 incompatibility and alloimmunization in two Thai populations. Eight hundred DNA samples obtained from 500 unrelated healthy blood donors at the National Blood Centre, Thai Red Cross Society, Bangkok and 300 samples from the Blood Bank, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand were included. HNA-3 genotyping was performed using an in-house polymerase chain reaction with sequence-specific primer (PCR-SSP) technique. The observed frequencies of the HNA-3a/3a, HNA-3a/3b, and HNA3b/3b genotypes were 0.528, 0.380, and 0.092 in central Thais and 0.600, 0.350, and 0.050 in northern Thais, respectively. The frequencies were used to estimate HNA-3 incompatibility and risk of HNA-3a alloimmunization. The HNA-3 incompatibility in central Thais (33.28%) was higher than northern Thais (28.75%), corresponding to a significantly higher probability of HNA-3a alloimmunization (P<0.05) similar to Japanese and Chinese populations. This study showed the high risk of HNA-3 incompatibility and alloimmunization, especially in central Thai blood donors. A molecular-based identification of the HNA-3 genotype of female donors is suggested to reduce the risk of TRALI following plasma and whole blood allogeneic transfusion.	[Nathalang, Oytip; Intharanut, Kamphon; Siriphanthong, Kanokpol] Thammasat Univ, Fac Allied Hlth Sci, Grad Program Biomed Sci, Pathum Thani, Thailand; [Nathalang, Siriporn] Red Cross Soc, Natl Blood Ctr, Bangkok, Thailand; [Leetrakool, Nipapan] Chiang Mai Univ, Fac Med, Blood Bank Sect, Chiang Mai 50000, Thailand	Thammasat University; Thai Red Cross Society; Chiang Mai University	Nathalang, O (corresponding author), Thammasat Univ, Fac Allied Hlth Sci, Grad Program Biomed Sci, Pathum Thani, Thailand.	oytipntl@hotmail.com		Intharanut, Kamphon/0000-0002-2978-1432	Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission	Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission	This work was supported by grants of the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bux J, 2008, VOX SANG, V94, P277, DOI 10.1111/j.1423-0410.2007.01031.x; Cardoso SP, 2013, VOX SANG, V105, P65, DOI 10.1111/vox.12016; Changsri K, 2014, BLOOD TRANSFUS-ITALY, V12, pS286, DOI 10.2450/2013.0161-12; Chapman CE, 2008, TRANSFUS MED HEMOTH, V35, P93, DOI 10.1159/000119116; Curtis BR, 2010, BLOOD, V115, P2073, DOI 10.1182/blood-2009-11-248336; Davoren A, 2003, TRANSFUSION, V43, P641, DOI 10.1046/j.1537-2995.2003.00374.x; Flesch BK, 2011, TRANSFUSION, V51, P2391, DOI 10.1111/j.1537-2995.2011.03155.x; Greinacher A, 2010, NAT MED, V16, P45, DOI 10.1038/nm.2070; Hauck B, 2011, TISSUE ANTIGENS, V78, P416, DOI 10.1111/j.1399-0039.2011.01779.x; He JJ, 2014, BLOOD TRANSFUS-ITALY, V12, pS292, DOI 10.2450/2013.0308-12; Huvard MJ, 2012, TRANSFUSION, V52, P1106, DOI 10.1111/j.1537-2995.2011.03396.x; Lopes LB, 2014, TRANSFUSION, V54, P1619, DOI 10.1111/trf.12493; Matsuhashi M, 2012, TISSUE ANTIGENS, V80, P336, DOI 10.1111/j.1399-0039.2012.01930.x; Miller AS, 1988, NUCLEIC ACIDS RES, V16, P1215; Nielsen KR, 2012, TISSUE ANTIGENS, V80, P249, DOI 10.1111/j.1399-0039.2012.01912.x; Reil A, 2011, TRANSFUSION, V51, P18, DOI 10.1111/j.1537-2995.2010.02751.x; Xia WJ, 2011, TRANSFUSION, V51, P1271, DOI 10.1111/j.1537-2995.2010.02979.x	17	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116905	10.1371/journal.pone.0116905	http://dx.doi.org/10.1371/journal.pone.0116905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608003	Green Published, gold, Green Submitted			2022-12-27	WOS:000348205300042
J	Ioannidou, E; Rosania, A				Ioannidou, Effie; Rosania, Amy			Under-Representation of Women on Dental Journal Editorial Boards	PLOS ONE			English	Article							ACADEMIC MEDICINE; LEADERSHIP; AUTHORSHIP	Introduction Each journal's editorial and advisory board plays a critical role in resolving gender bias in the peer-review and publication process. Thus, this study aimed to quantify women's participation in editorial and advisory boards of major dental journals. Gender data on editorial and advisory boards were extracted from major dental journals, which were then categorized by journal specialty focus. The gender of the editor-in-chief and associate editor-in-chief was noted to assess the effect of journal leadership on women's participation in journal boards. For comparison purposes, data were also obtained regarding the percentage of women faculty for each dental specialty. Results Overall, in the major 69 dental journals, 14.8% of editorial board members were women. An one-way ANOVA analysis revealed statistically significant gender differences between journal specialty categories (p = 0.003) with some dental specialties' journals demonstrating a relatively high participation of women as editorial board members. There was a significant positive correlation for various dental specialties between women's representation in editorial and advisory boards and women in similar dental academic specialties (p = 0.02, r(2) = 0.55). Furthermore, there was a positive correlation between the presence of women in journal editorial leadership and the percentage of women serving as advisory board members (p = 0.03). Our results confirmed that the under-representation of women on dental journal editorial boards was significantly different between dental science specialties. When there were more women in journal editorial leadership positions, there was a higher participation of women as editorial and advisory board members. Journals should increase the numbers of women on editorial boards in order to secure diversity, improve publication quality and recognize women's contribution to dental science.	[Ioannidou, Effie] Univ Connecticut, Ctr Hlth, Div Periodontol, Dent Clin Res Ctr, Farmington, CT 06030 USA; [Rosania, Amy] Univ Connecticut, Ctr Hlth, Div Periodontol, Adv Educ Program Periodontol, Farmington, CT USA	University of Connecticut; University of Connecticut	Ioannidou, E (corresponding author), Univ Connecticut, Ctr Hlth, Div Periodontol, Dent Clin Res Ctr, Farmington, CT 06030 USA.	ioannidou@uchc.edu	Ioannidou, Effie/P-4068-2014	Ioannidou, Effie/0000-0003-1954-5900	National Institute of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR) [K23 DE018689]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K23DE018689] Funding Source: NIH RePORTER	National Institute of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the National Institute of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR) K23 DE018689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA, 2010, PRACT WORKF SURV DIS; Amrein K, 2011, GENDER MED, V8, P378, DOI 10.1016/j.genm.2011.10.007; Association ADE, 2011, DENT SCH FAC SAL EX; Buckley LM, 2000, ARCH INTERN MED, V160, P2625, DOI 10.1001/archinte.160.17.2625; Carnes M, 2008, J WOMENS HEALTH, V17, P1453, DOI 10.1089/jwh.2007.0688; Dragstrem Kristina G, 2012, Orthodontics (Chic.), V13, P176; Handelsman J, 2005, SCIENCE, V309, P1190, DOI 10.1126/science.1113252; Ioannidou E, 2014, J DENT RES, V93, P5, DOI 10.1177/0022034513510178; Jagsi R, 2008, ARCH INTERN MED, V168, P544, DOI 10.1001/archinte.168.5.544; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; Kennedy BL, 2001, ACAD MED, V76, P849, DOI 10.1097/00001888-200108000-00021; Kongkiatkamon S, 2010, J PROSTHODONT, V19, P565, DOI 10.1111/j.1532-849X.2010.00620.x; Ledford H, 2013, NATURE, V495, P28, DOI 10.1038/495028a; Marchant A, 2007, J WOMENS HEALTH, V16, P998, DOI 10.1089/jwh.2007.0348; McCook A, 2013, NATURE, V495, P25, DOI 10.1038/495025a; Miro O, 2010, EUR J EMERG MED, V17, P84, DOI 10.1097/MEJ.0b013e32832e98f7; Morton MJ, 2007, J NATL MED ASSOC, V99, P764; National Research Council, 2007, BEYOND BIAS AND BARR; Nesbitt Paula E, 2003, J Dent Educ, V67, P916; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; Reed MJ, 2012, J DENT EDUC, V76, P1427; Robinson S, 2010, EUR J EMERG MED, V17, P61, DOI 10.1097/MEJ.0b013e32833096cb; Thompson Reuters Web of Knowledge, 2012, J CITATION REPORTS; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Yuan JCC, 2010, J DENT EDUC, V74, P372	25	43	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116630	10.1371/journal.pone.0116630	http://dx.doi.org/10.1371/journal.pone.0116630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635691	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700051
J	Lindholm, B; Hagell, P; Hansson, O; Nilsson, MH				Lindholm, Beata; Hagell, Peter; Hansson, Oskar; Nilsson, Maria H.			Prediction of Falls and/or Near Falls in People with Mild Parkinson's Disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTURAL INSTABILITY; GAIT QUESTIONNAIRE; SYDNEY MULTICENTER; MEASURING FATIGUE; FEAR; SCALE; RISK; PROGRESSION; MORTALITY	Objective To determine factors associated with future falls and/or near falls in people with mild PD. Methods The study included 141 participants with PD. Mean (SD) age and PD-duration were 68 (9.7) and 4 years (3.9), respectively. Their median (q1-q3) UPDRS III score was 13 (8-18). Those >80 years of age, requiring support in standing or unable to understand instructions were excluded. Self-administered questionnaires targeted freezing of gait, turning hesitations, walking difficulties in daily life, fatigue, fear of falling, independence in activities of daily living, dyskinesia, demographics, falls/near falls history, balance problems while dual tasking and pain. Clinical assessments addressed functional balance performance, retropulsion, comfortable gait speed, motor symptoms and cognition. All falls and near falls were subsequently registered in a diary during a six-month period. Risk factors for prospective falls and/or near falls were determined using logistic regression. Results Sixty-three participants (45%) experienced >= 1 fall and/or near fall. Three factors were independent predictors of falls and/or near falls: fear of falling (OR = 1.032, p<0.001) history of near falls (OR = 3.475, p = 0.009) and retropulsion (OR = 2.813, p = 0.035). The strongest contributing factor was fear of falling, followed by a history of near falls and retropulsion. Conclusions Fear of falling seems to be an important issue to address already in mild PD as well as asking about prior near falls.	[Lindholm, Beata] Skane Univ Hosp, Dept Neurol, Malmo, Sweden; [Hagell, Peter] Kristianstad Univ, PRO CARE Grp, Sch Hlth & Soc, Kristianstad, Sweden; [Lindholm, Beata; Hansson, Oskar] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Hansson, Oskar] Skane Univ Hosp, Memory Clin, Malmo, Sweden; [Nilsson, Maria H.] Lund Univ, Dept Hlth Sci, Lund, Sweden	Lund University; Skane University Hospital; Kristianstad University; Lund University; Lund University; Skane University Hospital; Lund University	Lindholm, B (corresponding author), Skane Univ Hosp, Dept Neurol, Malmo, Sweden.	Beata.Lindholm@med.lu.se	Nilsson, Maria H/AAQ-6987-2020; Hansson, Oskar/A-7134-2013; Lindholm, Bengt/P-1334-2017	Nilsson, Maria H/0000-0002-6580-6721; Hansson, Oskar/0000-0001-8467-7286; Lindholm, Bengt/0000-0003-4269-4293	Swedish Parkinson Academy; Stoltz fund (Department of Neurology, Malmo, Skane University Hospital, Sweden); Academy of Caring Sciences (Skane University Hospital, Sweden); Skane county council's research and development foundation; strategic research area for neuroscience at Lund University (MultiPark), Sweden; Swedish Council for Working Life, Public Health and Welfare (Forte)	Swedish Parkinson Academy; Stoltz fund (Department of Neurology, Malmo, Skane University Hospital, Sweden); Academy of Caring Sciences (Skane University Hospital, Sweden); Skane county council's research and development foundation; strategic research area for neuroscience at Lund University (MultiPark), Sweden; Swedish Council for Working Life, Public Health and Welfare (Forte)	This work was supported by grants from the Swedish Parkinson Academy, the Stoltz fund (Department of Neurology, Malmo, Skane University Hospital, Sweden), the Academy of Caring Sciences (Skane University Hospital, Sweden), Skane county council's research and development foundation, and the strategic research area for neuroscience at Lund University (MultiPark), Sweden. None of the funders had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was accomplished within BAGADILICO (the Basal Ganglia Disorders Linnaeus Consortium) research consortium at Lund University, Sweden, and within the context of the Centre for Ageing and Supportive Environments (CASE) at Lund University, financed by the Swedish Council for Working Life, Public Health and Welfare (Forte).	Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; Allcock LM, 2009, PARKINSONISM RELAT D, V15, P110, DOI 10.1016/j.parkreldis.2008.03.010; Allen NE, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/906274; Ashburn A, 2001, GERONTOLOGY, V47, P277, DOI 10.1159/000052812; Ashburn A, 2001, AGE AGEING, V30, P47, DOI 10.1093/ageing/30.1.47; Ashburn A, 2007, J NEUROL NEUROSUR PS, V78, P678, DOI 10.1136/jnnp.2006.099333; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bladh S, 2012, J NEUROL, V259, P729, DOI 10.1007/s00415-011-6254-z; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Brozova H, 2009, NEUROENDOCRINOL LETT, V30, P453; Carpenter MG, 2004, J NEUROL NEUROSUR PS, V75, P1245, DOI 10.1136/jnnp.2003.021147; Cole MH, 2010, MOVEMENT DISORD, V25, P2369, DOI 10.1002/mds.23292; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Ellis T, 2013, PHYS THER, V93, P628, DOI 10.2522/ptj.20120279; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Giladi N, 2009, MOVEMENT DISORD, V24, P655, DOI 10.1002/mds.21745; Gray P, 2000, J Neurosci Nurs, V32, P222; Grimbergen YAM, 2013, J PARKINSON DIS, V3, P409, DOI 10.3233/JPD-120113; Hagell P, 2009, PARKINSONISM RELAT D, V15, pS62, DOI 10.1016/S1353-8020(09)70253-6; Hagell P, 2006, J PAIN SYMPTOM MANAG, V32, P420, DOI 10.1016/j.jpainsymman.2006.05.021; Hariz GM, 2011, ACTA NEUROL SCAND, V123, P20, DOI 10.1111/j.1600-0404.2010.01344.x; HELY MA, 1989, J NEUROL NEUROSUR PS, V52, P324, DOI 10.1136/jnnp.52.3.324; Hely MA, 1999, J NEUROL NEUROSUR PS, V67, P300, DOI 10.1136/jnnp.67.3.300; Hobson JP, 2001, CLIN REHABIL, V15, P241, DOI 10.1191/026921501666767060; Hoehn MM, 2001, NEUROLOGY, V57, pS11; Horak FB, 2005, EXP NEUROL, V193, P504, DOI 10.1016/j.expneurol.2004.12.008; Jonasson SB, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-66; Kelly VE, 2012, PARKINSONS DIS-US, V2012, DOI [10.1155/2012/918719, 10.1073/pnas.1207553109]; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Latt MD, 2009, MOVEMENT DISORD, V24, P1280, DOI 10.1002/mds.22561; Lessig S, 2012, MOVEMENT DISORD, V27, P1125, DOI 10.1002/mds.25070; Lindholm B, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-19; Nieuwboer A, 1998, DISABIL REHABIL, V20, P142, DOI 10.3109/09638289809166074; Nilsson MH, 2011, ACTA NEUROL SCAND, V123, P424, DOI 10.1111/j.1600-0404.2010.01418.x; Nilsson MH, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/713236; Nilsson MH, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-78; Nilsson MH, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-85; Nutt J, 1992, DIAGNOSIS IS IT PARK, P3, DOI DOI 10.1111/JVH.12392; Sipp AR, 2008, IEEE ENG MED BIO, P1262, DOI 10.1109/IEMBS.2008.4649393; Stack E, 1999, Physiother Res Int, V4, P190, DOI 10.1002/pri.165; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; TENO J, 1990, J AM GERIATR SOC, V38, P1321, DOI 10.1111/j.1532-5415.1990.tb03455.x; Thordardottir B, 2014, DISABIL REHABIL; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Visser M, 2003, ARCH PHYS MED REHAB, V84, P1669, DOI 10.1053/S0003-9993(03)00348-4; Wood BH, 2002, J NEUROL NEUROSUR PS, V72, P721, DOI 10.1136/jnnp.72.6.721; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6	51	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117018	10.1371/journal.pone.0117018	http://dx.doi.org/10.1371/journal.pone.0117018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HX	25635687	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700067
J	McEwan, P; Ward, T; Bennett, H; Kalsekar, A; Webster, S; Brenner, M; Yuan, Y				McEwan, Phil; Ward, Thomas; Bennett, Hayley; Kalsekar, Anupama; Webster, Samantha; Brenner, Michael; Yuan, Yong			Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C	PLOS ONE			English	Article							COST-EFFECTIVENESS; GENOTYPE 1; PEGYLATED INTERFERON; PEGINTERFERON ALPHA-2A; VIRUS-INFECTION; PLUS RIBAVIRIN; THERAPY; CIRRHOSIS; RISK; COMBINATION	Introduction Hepatitis C virus (HCV) infection is one of the principle causes of chronic liver disease. Successful treatment significantly decreases the risk of hepatic morbidity and mortality. Current standard of care achieves sustained virologic response (SVR) rates of 40-80%; however, the HCV therapy landscape is rapidly evolving. The objective of this study was to quantify the clinical and economic benefit associated with increasing levels of SVR. Methods A published Markov model (MONARCH) that simulates the natural history of hepatitis C over a lifetime horizon was used. Discounted and non-discounted life-years (LYs), quality-adjusted life-years (QALYs) and cost of complication management were estimated for various plausible SVR rates. To demonstrate the robustness of projections obtained, the model was validated to ten UK-specific HCV studies. Results QALY estimates ranged from 18.0 years for those treated successfully in fibrosis stage F0 to 7.5 years (discounted) for patients in fibrosis stage F4 who remain untreated. Predicted QALY gains per 10% improvement in SVR ranged from 0.23 (F0) to 0.64 (F4) and 0.58 (F0) to 1.35 (F4) in 40 year old patients (discounted and non-discounted results respectively). In those aged 40, projected discounted HCV-related costs are minimised with successful treatment in F0/F1 (at approximately 300) pound, increasing to 49,300 pound in F4 patients who remain untreated. Validation of the model to published UK cost-effectiveness studies produce R2 goodness of fit statistics of 0.988, 0.978 and of 0.973 for total costs, QALYs and incremental cost effectiveness ratios, respectively. Conclusion Projecting the long-term clinical and economic consequences associated with chronic hepatitis C is a necessary requirement for the evaluation of new treatments. The principle analysis demonstrates the significant impact on expected costs, LYs and QALYs associated with increasing SVR. A validation analysis demonstrated the robustness of the results reported.	[McEwan, Phil; Ward, Thomas; Bennett, Hayley; Webster, Samantha] HEOR Ltd, Monmouth, Wales; [McEwan, Phil; Ward, Thomas] Swansea Univ, Sch Human & Hlth Sci, Swansea Ctr Hlth Econ, Swansea, W Glam, Wales; [Kalsekar, Anupama; Yuan, Yong] Bristol Myers Squibb Co, Global Hlth Econ & Outcomes Res, Princeton, NJ USA; [Brenner, Michael] Bristol Myers Squibb Co, Uxbridge, Middx, England	Swansea University; Bristol-Myers Squibb; Bristol-Myers Squibb	McEwan, P (corresponding author), HEOR Ltd, Singleton Court Business Pk, Monmouth, Wales.	phil.mcewan@heor.co.uk			BMS Pharmaceuticals Ltd.	BMS Pharmaceuticals Ltd.	PM, TW, SW and HB are employed by HEOR Ltd., which received funding support in the form of a grant from BMS Pharmaceuticals Ltd. The funding agreement ensured PM, TW, SW and HB's independence in designing the study, interpreting the data, writing, and publishing the report. Authors YY, AK and MB are employed by BMS Pharmaceuticals Ltd. and critically reviewed the manuscript for intellectual content and appropriate interpretation of findings. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Coon JT, 2008, BRIT J CANCER, V98, P1166, DOI 10.1038/sj.bjc.6604301; Cooper C, 2013, QJM-INT J MED, V106, P153, DOI 10.1093/qjmed/hcs214; Cooper CL, 2012, THER CLIN RISK MANAG, V8, P105, DOI 10.2147/TCRM.S29830; Dore GJ, 2012, MED J AUSTRALIA, V196, P629, DOI 10.5694/mja11.11531; Druyts E, 2012, CLIN EXP GASTROENTER, V5, P11, DOI 10.2147/CEG.S28253; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Grieve R, 2002, ACTA GASTRO-ENT BELG, V65, P104; Grishchenko M, 2009, INT J TECHNOL ASSESS, V25, P171, DOI 10.1017/S0266462309090229; Harris HE, 2006, EPIDEMIOL INFECT, V134, P472, DOI 10.1017/S0950268805005340; Harris HE, 2002, BMJ-BRIT MED J, V324, P450, DOI 10.1136/bmj.324.7335.450; Huang YW, 2014, HEPATOLOGY, V60, P807, DOI 10.1002/hep.27212; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Law AM., 1991, SIMULATION MODELING, V2nd; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; McCombs J, 2014, JAMA INTERN MED, V174, P204, DOI 10.1001/jamainternmed.2013.12505; McEwan P, 2013, VALUE HLTH REGIONAL, V3, P5; McEwan P, 2013, HEPATOLOGY, V58, P54, DOI 10.1002/hep.26304; McEwan P, 2013, APPL HEALTH ECON HEA, V11, P53, DOI 10.1007/s40258-012-0002-0; Miller MH, 2014, ALIMENT PHARM THER, V39, P1363, DOI 10.1111/apt.12764; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence, 2012, JANSS SUBM TEL TREAT; National Institute for Health and Care Excellence, 2012, TECHN APPR TA253 BOC; National Institute for Health and Care Excellence, 2010, TECHN ASS TA200 HEP; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Public Health England, 2014, COMM TEMPL EST HCV P; Public Health England, 2014, HEP C UK 2014 REP; Saab S, 2010, LIVER TRANSPLANT, V16, P748, DOI 10.1002/lt.22072; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Shepherd J, 2004, HEALTH TECHNOL ASSES, V8, P1; Shepherd J, 2000, Health Technol Assess, V4, P1; Stein K, 2002, GUT, V50, P253, DOI 10.1136/gut.50.2.253; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Swain MG, 2010, GASTROENTEROLOGY, V139, P1593, DOI 10.1053/j.gastro.2010.07.009; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Townsend R, 2011, VALUE HEALTH, V14, P1068, DOI 10.1016/j.jval.2011.06.006	44	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117334	10.1371/journal.pone.0117334	http://dx.doi.org/10.1371/journal.pone.0117334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635922	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700081
J	Wanzirah, H; Tusting, LS; Arinaitwe, E; Katureebe, A; Maxwell, K; Rek, J; Bottomley, C; Staedke, SG; Kamya, M; Dorsey, G; Lindsay, SW				Wanzirah, Humphrey; Tusting, Lucy S.; Arinaitwe, Emmanuel; Katureebe, Agaba; Maxwell, Kilama; Rek, John; Bottomley, Christian; Staedke, Sarah G.; Kamya, Moses; Dorsey, Grant; Lindsay, Steve W.			Mind the Gap: House Structure and the Risk of Malaria in Uganda	PLOS ONE			English	Article							TRANSMISSION; CHILDREN; ENTRY; VECTORS; DISEASE; AREA	Background Good house construction may reduce the risk of malaria by limiting the entry of mosquito vectors. We assessed how house design may affect mosquito house entry and malaria risk in Uganda. Methods 100 households were enrolled in each of three sub-counties: Walukuba, Jinja district; Kihihi, Kanungu district; and Nagongera, Tororo district. CDC light trap collections of mosquitoes were done monthly in all homes. All children aged six months to ten years (n = 878) were followed prospectively for a total of 24 months to measure parasite prevalence every three months and malaria incidence. Homes were classified as modern (cement, wood or metal walls; and tiled or metal roof; and closed eaves) or traditional (all other homes). Results A total of 113,618 female Anopheles were collected over 6,765 nights. 6,816 routine blood smears were taken of which 1,061 (15.6%) were malaria parasite positive. 2,582 episodes of uncomplicated malaria were diagnosed after 1,569 person years of follow-up, giving an overall incidence of 1.6 episodes per person year at risk. The human biting rate was lower in modern homes than in traditional homes (adjusted incidence rate ratio (IRR) 0.48, 95% confidence interval (CI) 0.37-0.64, p < 0.001). The odds of malaria infection were lower in modern homes across all the sub-counties (adjusted odds ratio 0.44, 95%CI 0.30-0.65, p < 0.001), while malaria incidence was lower in modern homes in Kihihi (adjusted IRR 0.61, 95%CI 0.40-0.91, p = 0.02) but not in Walukuba or Nagongera. Conclusions House design is likely to explain some of the heterogeneity of malaria transmission in and represents a promising target for future interventions, even in highly endemic areas.	[Wanzirah, Humphrey; Arinaitwe, Emmanuel; Katureebe, Agaba; Maxwell, Kilama; Rek, John] Infect Dis Res Collaborat, Kampala, Uganda; [Tusting, Lucy S.; Lindsay, Steve W.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Bottomley, Christian] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Staedke, Sarah G.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Kamya, Moses] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Makerere University; University of California System; University of California San Francisco; Durham University	Tusting, LS (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	lucy.tusting@lshtm.ac.uk	Wanzira, Humphrey/AAF-1373-2020	Wanzira, Humphrey/0000-0003-1074-5340; Bottomley, Christian/0000-0002-5241-8412; Tusting, Lucy/0000-0002-6897-8625; Lindsay, Steve/0000-0002-3461-9050	National Institutes of Health, International Centers of Excellence in Malaria Research (ICMER) program [U19AI089674]; Global Health Trials (MRC-DfID-Wellcome Trust) [MR/M007383/1]; Leverhulme Centre for Integrative Research in Agriculture and Health; Medical Research Council [MR/K012126/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER	National Institutes of Health, International Centers of Excellence in Malaria Research (ICMER) program; Global Health Trials (MRC-DfID-Wellcome Trust); Leverhulme Centre for Integrative Research in Agriculture and Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National Institutes of Health as part of the International Centers of Excellence in Malaria Research (ICMER) program (U19AI089674). SWL received support from the Global Health Trials (MRC-DfID-Wellcome Trust; MR/M007383/1). LST was supported by the Leverhulme Centre for Integrative Research in Agriculture and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIAMAH JH, 1993, ANN TROP MED PARASIT, V87, P491, DOI 10.1080/00034983.1993.11812801; Al-Taiar A, 2008, TROP MED INT HEALTH, V13, P762, DOI 10.1111/j.1365-3156.2008.02066.x; Anderson L, 2014, DURABLE HOUSING IMPR, DOI [10.1016/j.aca.2014.12.042, DOI 10.1016/J.ACA.2014.12.042]; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Barat LM, 2004, AM J TROP MED HYG, V71, P174, DOI 10.4269/ajtmh.2004.71.174; Bruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Habitat UN, 2010, STAT AFR CIT 2010 GO, DOI [10.2174/157340310793566145, DOI 10.2174/157340310793566145]; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Huho B, 2013, INT J EPIDEMIOL, V42, P235, DOI 10.1093/ije/dys214; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; LINDSAY SW, 1988, T ROY SOC TROP MED H, V82, P645, DOI 10.1016/0035-9203(88)90546-9; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087358; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Mmbando BP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-145; Njie M, 2009, J MED ENTOMOL, V46, P977; Ogoma SB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000773; RBM/UNDP, 2013, MULT ACT FRAM MAL, DOI [10.1007/s13224-012-0272-3, DOI 10.1007/S13224-012-0272-3]; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Somi MF, 2007, AM J TROP MED HYG, V77, P1020, DOI 10.4269/ajtmh.2007.77.1020; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	29	71	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117396	10.1371/journal.pone.0117396	http://dx.doi.org/10.1371/journal.pone.0117396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635688	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700083
J	Awad, AI; Alsaleh, FM				Awad, Abdelmoneim Ismail; Alsaleh, Fatemah Mohammad			10-Year Risk Estimation for Type 2 Diabetes Mellitus and Coronary Heart Disease in Kuwait: A Cross-Sectional Population-Based Study	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; LIFE-STYLE INTERVENTION; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; IDENTIFY INDIVIDUALS; INSULIN-RESISTANCE; NATIONAL-HEALTH; PRIMARY-CARE; PREVALENCE	Background Type 2 diabetes mellitus (T2DM), coronary heart disease (CHD) and metabolic syndrome (MetS) are major healthcare problems in Kuwait. The present study was designed to determine the prevalence of MetS, and to estimate the 10-year risk for developing T2DM and CHD among the general population in Kuwait. Methods A descriptive, cross-sectional survey was undertaken in 1800 individuals without diabetes or a history of cardiovascular disease (CVD). They were selected from six governorates using two stage convenience sampling. The questionnaire was developed using the Finnish Diabetes Risk Score (FINDRISK), Framingham Risk Score [FRS] and the 2009 Joint Statement criteria for diagnosis of MetS as a framework. Descriptive and multivariate logistic regression analyses were used. Results The response rate was 89.4%. More than half (60.8%; 95% CI: 58.4-63.2) of responders were either overweight or obese. One hundred and ninety seven (12.2%) subjects had blood pressure (BP) >= 140/90 mm Hg. Almost three-in-ten (28.3%: 26.2-30.6) subjects had fasting plasma glucose (FPG) levels >= 5.6 mmol/l, of whom 86.0% and 14.0% had impaired fasting glucose (IFG) and screen detected T2DM, respectively. MetS was present in 512 (31.8%; 29.5-34.2) respondents. Just under one third (n = 481; 29.9%; 27.7-32.2) of participants were at moderate, high, or very high risk of developing T2DM, while 283 (17.6%: 15.8-19.6) were at moderate/high 10-year risk of developing CHD. Approximately one-in-ten (8.5%; 7.2-9.9) subjects were at moderate/high/very high 10-year risk of developing both T2DM/CHD. T2DM risk was higher for females compared to males (p < 0.001); however, the pattern was reversed in terms of the risk of developing CHD or T2DM/CHD. The risk of developing T2DM, CHD, or T2DM/CHD was greater among those aged >= 45 years, and those having MetS (p<0.001). Conclusions The current findings highlight the need for multifaceted interventions for prevention.	[Awad, Abdelmoneim Ismail; Alsaleh, Fatemah Mohammad] Kuwait Univ, Fac Pharm, Dept Pharm Practice, Kuwait, Kuwait	Kuwait University	Awad, AI (corresponding author), Kuwait Univ, Fac Pharm, Dept Pharm Practice, Kuwait, Kuwait.	amoneim@hsc.edu.kw	Awad, Abdelmoneim Ismail/AAU-1963-2020	Awad, Abdelmoneim Ismail/0000-0002-2266-3687				Abduelkarem A. R., 2009, Practical Diabetes International, V26, P148, DOI 10.1002/pdi.1359; Ahmed F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-103; Ajani UA, 2006, J AM COLL CARDIOL, V48, P1177, DOI 10.1016/j.jacc.2006.05.055; Al Khalaf M. M., 2010, Eastern Mediterranean Health Journal, V16, P725; Al Rashdan I, 2010, ANGIOLOGY, V61, P42, DOI 10.1177/0003319709333226; Al Zenki S, 2012, INT J ENV RES PUB HE, V9, P1984, DOI 10.3390/ijerph9051984; Al-Dahi S, 2013, MIL MED, V178, P299, DOI 10.7205/MILMED-D-12-00079; Al-Shaibani H, 2004, FAM MED, V36, P540; Al-Taweel DM, 2013, INT J CLIN PHARM-NET, V35, P244, DOI 10.1007/s11096-012-9738-8; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alzohairy MA, 2011, GLOB J HEAL SCI, V3, P123; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Blenkinsopp A, 2003, J PUBLIC HEALTH MED, V25, P144, DOI 10.1093/pubmed/fdg030; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Dupront WD, 2011, POWER SAMPLE SIZE CA; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Garca-Alcala H, 2012, DIABET METAB SYND OB, V5, P403, DOI 10.2147/DMSO.S35545; George J, 2011, AUSTRALAS MED J, V4, P266, DOI 10.4066/AMJ.2011.698; Golagiuri S, 2002, DIABETES CARE, V25, P1410; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Hjellset VT, 2011, J IMMIGR MINOR HEALT, V13, P101, DOI 10.1007/s10903-009-9290-3; Hu G, 2007, EUR HEART J, V28, P492, DOI 10.1093/eurheartj/ehl475; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Ismail M N, 2002, Obes Rev, V3, P203, DOI 10.1046/j.1467-789X.2002.00074.x; Jaber LA, 2004, DIABETES CARE, V27, P234, DOI 10.2337/diacare.27.1.234; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kuwait Central Statistical Bureau, 2011, GEN POP CENS; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Memon A, 2000, B WORLD HEALTH ORGAN, V78, P1306; Menon VU, 2006, DIABETES RES CLIN PR, V74, P289, DOI 10.1016/j.diabres.2006.03.025; Musaiger AO, 2002, MED PRIN PRACT, V11, P9, DOI 10.1159/000066415; Dominguez AAN, 2013, MEDICC REV, V15, P16, DOI 10.37757/MR2013V15.N2.4; Nestle M, 2005, AM J PUBLIC HEALTH, V95, P1497, DOI 10.2105/AJPH.2005.069120; Olusi SO, 2003, ANN SAUDI MED, V23, P162, DOI 10.5144/0256-4947.2003.162; Organization WH, 2009, GLOB HLTH RISKS MORT; Rajala U, 1998, DIABETES CARE, V21, P1664, DOI 10.2337/diacare.21.10.1664; Rice Virginia Hill, 2013, Cochrane Database Syst Rev, pCD001188, DOI 10.1002/14651858.CD001188.pub4; Rodondi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034287; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Schwarz PEH, 2009, J CLIN ENDOCR METAB, V94, P920, DOI 10.1210/jc.2007-2427; Sorkhou EI, 2004, MED PRIN PRACT, V13, P39, DOI 10.1159/000074050; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Vermunt PWA, 2010, FAM PRACT, V27, P312, DOI 10.1093/fampra/cmp100; WHO, 2014, GLOB DAT BOD MASS IN; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Winkler G, 2013, MED SCI MONITOR, V19, P67, DOI 10.12659/MSM.883747; World Health Organization, 2013, WORLD HLTH STAT KUW; World Health Organization, 2004, WHO TECHN REP SER, V894; World Health Organization, 2017, CARD DIS CVDS; Xie J, 2010, J EPIDEMIOL COMMUN H, V64, P236, DOI 10.1136/jech.2009.087544; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zubaid M, 2004, CAN J CARDIOL, V20, P783	60	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116742	10.1371/journal.pone.0116742	http://dx.doi.org/10.1371/journal.pone.0116742			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629920	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100047
J	Dallmeier, D; Pencina, MJ; Rajman, I; Koenig, W; Rothenbacher, D; Brenner, H				Dallmeier, Dhayana; Pencina, Michael J.; Rajman, Iris; Koenig, Wolfgang; Rothenbacher, Dietrich; Brenner, Hermann			Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR EVENTS; PROGNOSTIC VALUE; FOLLOW-UP; PREDICTION; RISK; MORTALITY; BIOMARKERS; FAILURE; ISCHEMIA	Objective To assess the prognostic value of 12-months N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) levels on adverse cardiovascular events in patients with stable coronary heart disease. Methods NT-proBNP concentrations were measured at baseline and at 12-months follow-up in participants of cardiac rehabilitation (median follow-up 8.96 years). Cox-proportional hazards models evaluated the prognostic value of log-transformed NT-proBNP levels, and of 12-months NT-proBNP relative changes on adverse cardiovascular events adjusting for established risk factors measured at baseline. Results Among 798 participants (84.7% men, mean age 59 years) there were 114 adverse cardiovascular events. 12-months NT-proBNP levels were higher than baseline levels in 60 patients (7.5%) and numerically more strongly associated with the outcome in multivariable analysis (HR 1.65 [95% CI 1.33-2.05] vs. HR 1.41 [95% CI 1.12-1.78], with a net reclassification improvement (NRI) of 0.098 [95% CI 0.002-0.194] compared to NRI of 0.047 [95% CI -0.0004-0.133] for baseline NT-proBNP levels. A 12-month 10% increment of NTproBNP was associated with a HR of 1.35 [95% CI 1.12-1.63] for the onset of an adverse cardiovascular event. Subjects with a 12-month increment of NT-proBNP had a HR of 2.56 [95% CI 1.10-5.95] compared to those with the highest 12-months reduction. Conclusions Twelve-months NT-proBNP levels after an acute cardiovascular event are strongly associated with a subsequent event and may provide numerically better reclassification of patients at risk for an adverse cardiovascular event compared to NT-proBNP baseline levels after adjustment for established risk factors.	[Dallmeier, Dhayana; Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Dallmeier, Dhayana] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Dallmeier, Dhayana; Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Pencina, Michael J.] Duke Univ, Duke Clin Res Inst, Dept Biostat & Bioinformat, Durham, NC USA; [Rajman, Iris] Novartis Inst Biomed Res, Basel, Switzerland; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany	Ulm University; Boston University; Ulm University; Duke University; Novartis; Helmholtz Association; German Cancer Research Center (DKFZ)	Koenig, W (corresponding author), Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany.	wolfgang.koenig@uniklinik-ulm.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017; Dallmeier, Dhayana/A-1169-2015	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Dallmeier, Dhayana/0000-0003-3665-7023; Koenig, Wolfgang/0000-0002-2064-9603; Rothenbacher, Dietrich/0000-0002-3563-2791	German Federal Ministry of Education and Research [01GD9820/0]; Pitzer Foundation (Bad Nauheim, Germany); Novartis Institute of Biomedical Research (NIBR) (Basel, Switzerland) [PRSUPPC 1050213]; University of Ulm	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Pitzer Foundation (Bad Nauheim, Germany); Novartis Institute of Biomedical Research (NIBR) (Basel, Switzerland); University of Ulm	This work was supported in part by the German Federal Ministry of Education and Research [#01GD9820/0] and the Pitzer Foundation (Bad Nauheim, Germany). Part of this work was financed by Novartis Institute of Biomedical Research (NIBR) (Basel, Switzerland) [by an unrestricted grant, PRSUPPC 1050213], and by additional funds from the University of Ulm. Dr. Rajman is a full-time employee of Novartis at their Institute of Biomedical Research. Novartis, as one of the funders of this work, provided support in the form of salary for Dr. Rajman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bibbins-Domingo K, 2003, CIRCULATION, V108, P2987, DOI 10.1161/01.CIR.0000103681.04726.9C; Bibbins-Domingo K, 2007, JAMA-J AM MED ASSOC, V297, P169, DOI 10.1001/jama.297.2.169; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; deFilippi CR, 2010, J AM COLL CARDIOL, V55, P441, DOI 10.1016/j.jacc.2009.07.069; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Franke J, 2011, CLIN RES CARDIOL, V100, P1059, DOI 10.1007/s00392-011-0340-1; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Linssen GCM, 2010, EUR HEART J, V31, P120, DOI 10.1093/eurheartj/ehp420; Masson S, 2008, J AM COLL CARDIOL, V52, P997, DOI 10.1016/j.jacc.2008.04.069; Morrow DA, 2005, JAMA-J AM MED ASSOC, V294, P2866, DOI 10.1001/jama.294.22.2866; Noveanu M, 2011, CRIT CARE, V15, DOI 10.1186/cc9398; O'Donoghue ML, 2011, AM HEART J, V162, P613, DOI 10.1016/j.ahj.2011.07.018; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Omland T, 2008, AM J CARDIOL, V101, p61A, DOI 10.1016/j.amjcard.2007.11.025; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Richards M, 2006, J AM COLL CARDIOL, V47, P52, DOI 10.1016/j.jacc.2005.06.085; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rothenbacher D, 2006, ARCH INTERN MED, V166, P2455, DOI 10.1001/archinte.166.22.2455; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Singh HS, 2009, CLIN CARDIOL, V32, P447, DOI 10.1002/clc.20569; Steyerberg EW, 2014, BIOMETRICAL J; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Thygesen K, 2012, EUR HEART J, V33, P2001, DOI 10.1093/eurheartj/ehq509; Toggweiler S, 2011, CLIN CARDIOL, V34, P183, DOI 10.1002/clc.20894; Wannamethee SG, 2011, J AM COLL CARDIOL, V58, P56, DOI 10.1016/j.jacc.2011.02.041; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Health Organization, 2011, CARDIOVASCULAR DISEA; Wu AHB, 2006, AM HEART J, V152, P828, DOI 10.1016/j.ahj.2006.08.021	31	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117143	10.1371/journal.pone.0117143	http://dx.doi.org/10.1371/journal.pone.0117143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629613	gold, Green Submitted, Green Published			2022-12-27	WOS:000348732100069
J	Rao, MY; Li, JB; Qin, J; Zhang, JH; Gao, XB; Yu, SY; Yu, J; Chen, GZ; Xu, BD; Li, HJ; Rao, RS; Huang, L; Jin, J				Rao, Mingyue; Li, Jiabei; Qin, Jun; Zhang, Jihang; Gao, Xubin; Yu, Shiyong; Yu, Jie; Chen, Guozhu; Xu, Baida; Li, Huijie; Rao, Rongsheng; Huang, Lan; Jin, Jun			Left Ventricular Function during Acute High-Altitude Exposure in a Large Group of Healthy Young Chinese Men	PLOS ONE			English	Article							MYOCARDIAL PERFORMANCE INDEX; ACUTE MOUNTAIN-SICKNESS; OPERATION EVEREST-II; CARDIAC-FUNCTION; PULMONARY-EDEMA; DIASTOLIC FUNCTION; ACUTE-HYPOXIA; DOPPLER; EXERCISE; ECHOCARDIOGRAPHY	Objective The purpose of this study was to observe left ventricular function during acute high-altitude exposure in a large group of healthy young males. Methods A prospective trial was conducted in Szechwan and Tibet from June to August, 2012. By Doppler echocardiography, left ventricular function was examined in 139 healthy young Chinese men at sea level; within 24 hours after arrival in Lhasa, Tibet, at 3700 m; and on day 7 following an ascent to Yangbajing at 4400 m after 7 days of acclimatization at 3700 m. The resting oxygen saturation (SaO2), heart rate (HR) and blood pressure (BP) were also measured at the above mentioned three time points. Results Within 24 hours of arrival at 3700 m, the HR, ejection fraction (EF), fractional shortening (FS), stroke volume (SV), cardiac output (CO), and left ventricular (LV) Tei index were significantly increased, but the LV end-systolic dimension (ESD), end-systolic volume (ESV), SaO2, E/A ratio, and ejection time (ET) were significantly decreased compared to the baseline levels in all subjects. On day 7 at 4400 m, the SV and CO were significantly decreased; the EF and FS Tei were not decreased compared with the values at 3700 m; the HR was further elevated; and the SaO2, ESV, ESD, and ET were further reduced. Additionally, the E/A ratio was significantly increased on day 7 but was still lower than it was at low altitude. Conclusion Upon acute high-altitude exposure, left ventricular systolic function was elevated with increased stroke volume, but diastolic function was decreased in healthy young males. With higher altitude exposure and prolonged acclimatization, the left ventricular systolic function was preserved with reduced stroke volume and improved diastolic function.	[Rao, Mingyue; Li, Jiabei; Qin, Jun; Zhang, Jihang; Gao, Xubin; Yu, Shiyong; Yu, Jie; Chen, Guozhu; Xu, Baida; Huang, Lan; Jin, Jun] Third Mil Med Univ, Inst Cardiovasc Dis PLA, Chongqing 400037, Peoples R China; [Rao, Mingyue; Li, Jiabei; Qin, Jun; Yu, Shiyong; Chen, Guozhu; Xu, Baida; Li, Huijie; Huang, Lan; Jin, Jun] Third Mil Med Univ, Xinqiao Hosp, Dept Cardiol, Chongqing 400037, Peoples R China; [Rao, Rongsheng] Third Mil Med Univ, Xinqiao Hosp, Dept Med Ultrason, Chongqing 400037, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Huang, L (corresponding author), Third Mil Med Univ, Inst Cardiovasc Dis PLA, Chongqing 400037, Peoples R China.	huanglan260@126.com; jjxqyy@163.com			Special Health Research Project, Ministry of Health of PR China [201002012]	Special Health Research Project, Ministry of Health of PR China	This work was supported by grants from the Special Health Research Project, Ministry of Health of PR China (no. 201002012) and was conducted by Professor Huang Lan and team members, whose work on the Tibet trek allowed the authors' research to be conducted. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemann Y, 2004, AM J PHYSIOL-HEART C, V286, pH856, DOI 10.1152/ajpheart.00518.2003; Allemann Y, 2012, AM J PHYSIOL-HEART C, V302, pH2646, DOI 10.1152/ajpheart.00053.2012; Asmussen E, 1941, AM J PHYSIOL, V132, P0555, DOI 10.1152/ajplegacy.1941.132.2.555; BALASUBRAMANIAN V, 1978, BRIT HEART J, V40, P276; Boos CJ, 2014, CLIN RES CARDIOL, V103, P291, DOI 10.1007/s00392-013-0654-2; Boussuges A, 2000, AM J RESP CRIT CARE, V161, P264, DOI 10.1164/ajrccm.161.1.9902096; Bouzat P, 2013, RESP PHYSIOL NEUROBI, V186, P16, DOI 10.1016/j.resp.2012.12.009; Cheung MMH, 2004, EUR HEART J, V25, P2238, DOI 10.1016/j.ehj.2004.07.034; Duplain H, 1999, CIRCULATION, V99, P1713, DOI 10.1161/01.CIR.99.13.1713; FOWLES RE, 1983, AM J CARDIOL, V52, P862, DOI 10.1016/0002-9149(83)90429-0; GOMEZ A, 1992, AM REV RESPIR DIS, V146, P313, DOI 10.1164/ajrccm/146.2.313; Grollman A, 1930, AM J PHYSIOL, V93, P19, DOI 10.1152/ajplegacy.1930.93.1.19; Grunig E, 2000, J AM COLL CARDIOL, V35, P980, DOI 10.1016/S0735-1097(99)00633-6; Hanaoka M, 2011, INTERNAL MED, V50, P2967, DOI 10.2169/internalmedicine.50.5942; Holloway C, 2011, FASEB J, V25, P3130, DOI 10.1096/fj.11-183426; Holloway CJ, 2011, FASEB J, V25, P792, DOI 10.1096/fj.10-172999; Huez S, 2005, AM J PHYSIOL-HEART C, V289, pH1391, DOI 10.1152/ajpheart.00332.2005; Huez S, 2009, AM J CARDIOL, V103, P1605, DOI 10.1016/j.amjcard.2009.02.006; JUNG RC, 1971, J APPL PHYSIOL, V31, P593, DOI 10.1152/jappl.1971.31.4.593; Kjaergaard J, 2006, EUR J APPL PHYSIOL, V98, P411, DOI 10.1007/s00421-006-0299-1; Misumi Ikuo, 2002, J Cardiol, V39, P85; OLIVER RM, 1991, INT J CARDIOL, V31, P235, DOI 10.1016/0167-5273(91)90221-A; OLSEN N, 1992, J APPL PHYSIOL, V73, P2036, DOI 10.1152/jappl.1992.73.5.2036; Poulsen SH, 2000, J AM SOC ECHOCARDIOG, V13, P379, DOI 10.1016/S0894-7317(00)70007-1; REEVES JT, 1987, J APPL PHYSIOL, V63, P531, DOI 10.1152/jappl.1987.63.2.531; Riepl RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044445; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Sawka MN, 1996, J APPL PHYSIOL, V81, P636, DOI 10.1152/jappl.1996.81.2.636; Shave RE, 2004, BRIT J SPORT MED, V38, P86, DOI 10.1136/bjsm.2002.002832; Strobel G, 1996, EUR J APPL PHYSIOL, V73, P82, DOI 10.1007/BF00262813; SUAREZ J, 1987, AM J CARDIOL, V60, P137, DOI 10.1016/0002-9149(87)91000-9; SURKS MI, 1966, J APPL PHYSIOL, V21, P1741, DOI 10.1152/jappl.1966.21.6.1741; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Tei C, 1995, J Cardiol, V26, P135; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tian R, 1997, CIRCULATION, V96, P1313, DOI 10.1161/01.CIR.96.4.1313; Vallecilla C, 2014, J BIOMECH, DOI [10.1016/j.jbiomech.2014.12.037, DOI 10.1016/J.JBIOMECH.2014.12.037]; Westerterp KR, 1996, J APPL PHYSIOL, V80, P1968, DOI 10.1152/jappl.1996.80.6.1968; Wu TY, 2012, THORAX, V67, P914, DOI 10.1136/thoraxjnl-2011-200623; Yakabe K, 2008, CLIN NEPHROL, V70, P41; Zhou QQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031097	41	24	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116936	10.1371/journal.pone.0116936	http://dx.doi.org/10.1371/journal.pone.0116936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629435	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100051
J	Relevy, NZ; Bechor, S; Harari, A; Ben-Amotz, A; Kamari, Y; Harats, D; Shaish, A				Relevy, Noa Zolberg; Bechor, Sapir; Harari, Ayelet; Ben-Amotz, Ami; Kamari, Yehuda; Harats, Dror; Shaish, Aviv			The Inhibition of Macrophage Foam Cell Formation by 9-Cis beta-Carotene Is Driven by BCMO1 Activity	PLOS ONE			English	Article							ALGA DUNALIELLA-BARDAWIL; CARDIOVASCULAR-DISEASE; RETINOIC ACID; 9-CIS-RETINOIC ACID; GENE-EXPRESSION; VITAMIN-A; ATHEROSCLEROSIS; MICE; ALPHA; RISK	Atherosclerosis is a major cause of morbidity and mortality in developed societies, and begins when activated endothelial cells recruit monocytes and T-cells from the bloodstream into the arterial wall. Macrophages that accumulate cholesterol and other fatty materials are transformed into foam cells. Several epidemiological studies have demonstrated that a diet rich in carotenoids is associated with a reduced risk of heart disease; while previous work in our laboratory has shown that the 9-cis beta-carotene rich alga Dunaliella inhibits atherogenesis in mice. The effect of 9-cis beta-carotene on macrophage foam cell formation has not yet been investigated. In the present work, we sought to study whether the 9-cis eta-carotene isomer, isolated from the alga Dunaliella, can inhibit macrophage foam cell formation upon its conversion to retinoids. The 9-cis beta-carotene and Dunaliella lipid extract inhibited foam cell formation in the RAW264.7 cell line, similar to 9-cis retinoic acid. Furthermore, dietary enrichment with the algal powder in mice resulted in carotenoid accumulation in the peritoneal macrophages and in the inhibition of foam cell formation ex-vivo and in-vivo. We also found that the beta-carotene cleavage enzyme beta-carotene 15,15'-monooxygenase (BCMO1) is expressed and active in macrophages. Finally, 9-cis beta-carotene, as well as the Dunaliella extract, activated the nuclear receptor RXR in hepa1-6 cells. These results indicate that dietary carotenoids, such as 9-cis beta-carotene, accumulate in macrophages and can be locally cleaved by endogenous BCMO1 to form 9-cis retinoic acid and other retinoids. Subsequently, these retinoids activate the nuclear receptor RXR that, along with additional nuclear receptors, can affect various metabolic pathways, including those involved in foam cell formation and atherosclerosis.	[Relevy, Noa Zolberg; Bechor, Sapir; Harari, Ayelet; Kamari, Yehuda; Harats, Dror; Shaish, Aviv] Sheba Med Ctr, Bert W Strassburger Lipid Ctr, IL-5265601 Ramat Gan, Israel; [Relevy, Noa Zolberg; Bechor, Sapir; Kamari, Yehuda; Harats, Dror] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ben-Amotz, Ami] NBT, Elat, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Shaish, A (corresponding author), Sheba Med Ctr, Bert W Strassburger Lipid Ctr, IL-5265601 Ramat Gan, Israel.	Aviv.Shaish@sheba.health.gov.il			Nikken Sohonsha Corporation, Japan	Nikken Sohonsha Corporation, Japan	This work was supported by Nikken Sohonsha Corporation, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. N.B.T. Israel provided support in the form of a salary for author ABA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions' section.	BENAMOTZ A, 1988, PLANT PHYSIOL, V86, P1286, DOI 10.1104/pp.86.4.1286; BENAMOTZ A, 1983, PLANT PHYSIOL, V72, P593, DOI 10.1104/pp.72.3.593; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Chichili GR, 2005, INVEST OPHTH VIS SCI, V46, P3562, DOI 10.1167/iovs.05-0089; Cui YX, 2009, J BIOL CHEM, V284, P24925, DOI 10.1074/jbc.M109.026609; D'Odorico A, 2000, ATHEROSCLEROSIS, V153, P231, DOI 10.1016/S0021-9150(00)00403-2; Dushkin MI, 2007, B EXP BIOL MED+, V144, P713, DOI 10.1007/s10517-007-0413-3; Erdman JW, 1998, J NUTR, V128, P2009, DOI 10.1093/jn/128.11.2009; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Glise D, 1998, IN VIVO, V12, P447; Harari A, 2008, J NUTR, V138, P1923, DOI 10.1093/jn/138.10.1923; Harari A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/169517; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HEBUTERNE X, 1995, J LIPID RES, V36, P1264; Helmersson J, 2009, BRIT J NUTR, V101, P1775, DOI 10.1017/S0007114508147377; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENRIKSEN T, 1983, ARTERIOSCLEROSIS, V3, P149, DOI 10.1161/01.ATV.3.2.149; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Iizuka M, 2012, J NUTR SCI VITAMINOL, V58, P96, DOI 10.3177/jnsv.58.96; Iyama T, 1996, INT J VITAM NUTR RES, V66, P301; Jung WJ, 2004, BIOFACTORS, V21, P113, DOI 10.1002/biof.552210122; Karppi J, 2012, NUTR METAB CARDIOVAS, V22, P921, DOI 10.1016/j.numecd.2012.01.008; Karppi J, 2013, INT J CARDIOL, V168, P1841, DOI 10.1016/j.ijcard.2012.12.072; Karppi J, 2013, ATHEROSCLEROSIS, V226, P172, DOI 10.1016/j.atherosclerosis.2012.10.077; Katsuura S, 2009, MOL NUTR FOOD RES, V53, P1396, DOI 10.1002/mnfr.200800566; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; KRAEMER FB, 1985, J CLIN ENDOCR METAB, V61, P335, DOI 10.1210/jcem-61-2-335; Langmann T, 2005, BBA-MOL BASIS DIS, V1740, P155, DOI 10.1016/j.bbadis.2004.11.016; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Lo HM, 2014, FOOD FUNCT, V5, P140, DOI 10.1039/c3fo60309a; Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACCREHAN WA, 1987, J CHROMATOGR-BIOMED, V417, P65, DOI 10.1016/0378-4347(87)80092-0; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Napolitano M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1820, DOI 10.1152/ajpendo.00315.2007; Palozza P, 2011, J NUTR BIOCHEM, V22, P971, DOI 10.1016/j.jnutbio.2010.08.010; Park CS, 2008, BIOTECHNOL LETT, V30, P735, DOI 10.1007/s10529-007-9598-9; Rhee EJ, 2012, BBA-MOL CELL BIOL L, V1821, P230, DOI 10.1016/j.bbalip.2011.07.001; Scott J, 2004, CURR OPIN GENET DEV, V14, P271, DOI 10.1016/j.gde.2004.04.012; Shaish A, 2006, ATHEROSCLEROSIS, V189, P215, DOI 10.1016/j.atherosclerosis.2005.12.004; Takeda N, 2006, ARTERIOSCL THROM VAS, V26, P1177, DOI 10.1161/01.ATV.0000214296.94849.1c; WANG XD, 1994, ARCH BIOCHEM BIOPHYS, V313, P150, DOI 10.1006/abbi.1994.1371; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Yan WM, 2001, GENOMICS, V72, P193, DOI 10.1006/geno.2000.6476; Yeum KJ, 1996, AM J CLIN NUTR, V64, P594, DOI 10.1093/ajcn/64.4.594	48	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115272	10.1371/journal.pone.0115272	http://dx.doi.org/10.1371/journal.pone.0115272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629601	Green Submitted, Green Published, gold			2022-12-27	WOS:000348732100014
J	Ye, X; Zhang, L; Wang, H; Chen, Y; Zhang, WW; Zhu, RR; Fang, CP; Deng, AM; Qian, BH				Ye, Xin; Zhang, Lei; Wang, Hui; Chen, Yan; Zhang, Weiwei; Zhu, Rongrong; Fang, Chaoping; Deng, Anmei; Qian, Baohua			The Role of IL-23/Th17 Pathway in Patients with Primary Immune Thrombocytopenia	PLOS ONE			English	Article							HIGH-DOSE DEXAMETHASONE; T-CELLS; THERAPEUTIC TARGET; AUTOIMMUNE; CYTOKINE; TH17; PATHOGENESIS; EXPRESSION; DIFFERENTIATION; INTERLEUKIN-17	Background Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with an unclear etiology. This study aims to investigate the role of IL-23/Th17 pathway in patients with ITP. Method The gene expressions of IL-17, IL-23 and their receptors in ITP patients and healthy controls were analyzed by quantitative real-time PCR. ELISA was used to test the IL-17 and IL-23 levels in plasma. Flow cytometry was used to detect the frequency of Th17 cells. The correlation between plasma IL-23 and IL-17 levels, Th17 cells, platelets were analyzed. The level of Th17-related cytokines was measured by ELISA following stimulation with IL-23. Subsequently, the IL-23 and IL-17 levels were measured in patients post-treatment. Results The PBMCs of ITP patients showed increased mRNA expression levels in each of the following: IL-23p19, IL-12p40, IL-23R, IL-12R beta 1, IL-17A, IL-17F, and RORC. In addition, elevated Th17 cells and plasma IL-17, IL-23 levels were also observed in these ITP patients. Furthermore, it was found that IL-23 levels in plasma are positively correlated with IL-17 levels and Th17 cells, yet negatively correlated with platelet count. Following IL-23 stimulation in vitro, IL-17 levels showed significant elevation. Furthermore, both IL-23 and IL-17 levels decreased after effective treatment. Conclusion The IL-23/Th17 pathway may be involved in the pathogenesis of ITP through enhancement of the Th17 response. Moreover, our results suggest that the IL-23/Th17 pathway is a potential therapeutic target in future attempts of ITP treatment.	[Ye, Xin; Qian, Baohua] Second Mil Med Univ, Changhai Hosp, Dept Transfus Med, Shanghai 200433, Peoples R China; [Zhang, Lei; Wang, Hui; Chen, Yan; Zhang, Weiwei; Zhu, Rongrong; Fang, Chaoping; Deng, Anmei] Second Mil Med Univ, Changhai Hosp, Dept Lab Diag, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	Deng, AM (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Lab Diag, 168 Changhai Rd, Shanghai 200433, Peoples R China.	amdeng70@163.com; qianbh1963@163.com	Ye, Xin/ABC-6619-2020; Zhang, Lei/ABD-4003-2020	Zhang, Lei/0000-0003-3189-4118	973 Foundation [2013CB531606]; National Science Foundation of China [81273282, 81202353, 81371786, 81302579]; Shanghai Municipal Commission for Science and Technology [11JC1410902]; Changhai Hospital [CH125530300]; Grant of Nanjing District [12MA056]; Educational reform fund of SMMU; The master's fund of SMMU graduate school	973 Foundation(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Changhai Hospital; Grant of Nanjing District; Educational reform fund of SMMU; The master's fund of SMMU graduate school	This research was supported by grants from 973 Foundation (2013CB531606), National Science Foundation of China (81273282, 81202353, 81371786, 81302579), Shanghai Municipal Commission for Science and Technology (11JC1410902), Changhai Hospital (CH125530300), Grant of Nanjing District (12MA056), The Educational reform fund of SMMU, The master's fund of SMMU graduate school. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantine LE, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-4; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brentano F, 2009, ANN RHEUM DIS, V68, P143, DOI 10.1136/ard.2007.082081; Rocha AMC, 2011, HAEMATOL-HEMATOL J, V96, P1560, DOI 10.3324/haematol.2011.046417; Christensen JR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-215; Coopamah MD, 2003, TRANSFUS MED REV, V17, P69, DOI 10.1053/tmrv.2003.50004; Cooper N, 2006, BRIT J HAEMATOL, V133, P364, DOI 10.1111/j.1365-2141.2006.06024.x; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Fahey AJ, 2006, J LEUKOCYTE BIOL, V80, P133, DOI 10.1189/jlb.0605296; Fransen K, 2014, INFLAMM BOWEL DIS, V20, P777, DOI 10.1097/MIB.0000000000000013; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Gomez-Almaguer D, 2013, EUR J HAEMATOL, V90, P494, DOI 10.1111/ejh.12102; Guo CS, 2007, J CLIN IMMUNOL, V27, P557, DOI 10.1007/s10875-007-9111-1; Hu Y, 2012, HUM IMMUNOL, V73, P629, DOI 10.1016/j.humimm.2012.04.015; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Ji LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050909; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Kuhne T, 2013, PEDIATR BLOOD CANCER, V60, pS15, DOI 10.1002/pbc.24342; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li JQ, 2013, IMMUNOL LETT, V154, P42, DOI 10.1016/j.imlet.2013.08.006; Liu HY, 2013, THROMB RES, V132, P196, DOI 10.1016/j.thromres.2013.04.025; Liu XG, 2011, BLOOD, V117, P2061, DOI 10.1182/blood-2010-07-295477; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McKenzie CGJ, 2013, BRIT J HAEMATOL, V163, P10, DOI 10.1111/bjh.12480; Mottaghi A, 2014, SCAND J IMMUNOL, DOI [10.1111/sji.12260, DOI 10.1111/SJI.12260]; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Paradowska-Gorycka A, 2010, SCAND J IMMUNOL, V71, P134, DOI 10.1111/j.1365-3083.2009.02361.x; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Qian C, 2013, CYTOKINE, V64, P172, DOI 10.1016/j.cyto.2013.07.005; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Roeleveld DM, 2013, BIODRUGS, V27, P439, DOI 10.1007/s40259-013-0035-4; Romagnani S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2392; Semple JW, 2012, CURR OPIN HEMATOL, V19, P357, DOI 10.1097/MOH.0b013e3283567541; Semple JW, 2010, CURR OPIN HEMATOL, V17, P590, DOI 10.1097/MOH.0b013e32833eaef3; Toussirot Eric, 2012, Inflammation & Allergy Drug Targets, V11, P159; Wang JD, 2011, PEDIATR BLOOD CANCER, V57, P636, DOI 10.1002/pbc.22984; Wang X, 2014, SCAND J IMMUNOL, DOI [10.1111/sji.12260, DOI 10.1111/SJI.12260]; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhan YX, 2014, IMMUNOL LETT, V160, P33, DOI 10.1016/j.imlet.2014.03.002; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu XJ, 2010, J CLIN IMMUNOL, V30, P253, DOI 10.1007/s10875-009-9353-1	46	22	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117704	10.1371/journal.pone.0117704	http://dx.doi.org/10.1371/journal.pone.0117704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621490	gold, Green Published, Green Submitted			2022-12-27	WOS:000348470400026
J	Chang, KV; Hung, CY; Li, CM; Lin, YH; Wang, TG; Tsai, KS; Han, DS				Chang, Ke-Vin; Hung, Chen-Yu; Li, Chia-Ming; Lin, Yu-Hung; Wang, Tyng-Guey; Tsai, Keh-Sung; Han, Der-Sheng			Reduced Flexibility Associated with Metabolic Syndrome in Community-Dwelling Elders	PLOS ONE			English	Article							MUSCLE STRENGTH; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; AEROBIC FITNESS; OLDER-ADULTS; RISK; INFLAMMATION; WOMEN; MASS; MEN	Background The ageing process may lead to reductions in physical fitness, a known risk factor in the development of metabolic syndrome. The purpose of the current study was to evaluate cross-sectional and combined associations of metabolic syndrome with body composition and physical fitness in a community based geriatric population. Methods A total of 628 community-dwelling elders attending a geriatric health examination were enrolled in the study. The diagnosis of metabolic syndrome was based on the modified National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criterion with Asian cutoff of waist girth was adopted in this study. Body composition was obtained using bioimpedance analysis, and physical fitness was evaluated through the measurement of muscle strength (handgrip force), lower extremity muscle endurance (sit-to-stand test), flexibility (sit-and-reach test), and cardiorespiratory endurance (2-minute step test). Multivariable logistic regression and correlation analysis were performed to determine the association of metabolic syndrome with body composition and functionality variables. Results Metabolic syndrome was associated with increased skeletal muscle index (SMI) (odds ratio (OR), 1.61, 95% confidence interval (CI), 1.25-2.07) and decreased flexibility (OR, 0.97, 95% CI, 0.95-0.99) compared with those without metabolic syndrome. When body mass index was accounted for in the analysis, the association of SMI with metabolic syndrome was reduced. Waist circumference was positively correlated with SMI but negatively correlated with flexibility, whereas high density lipoprotein was positively correlated with flexibility but negatively correlated with SMI. Conclusion Reduced flexibility was positively associated with metabolic syndrome independent of age, gender, body composition, and functionality measurements in a community based geriatric population. Significant associations between metabolic syndrome with muscle strength and cardiorespiratory fitness in the elderly were not observed. Furthermore, flexibility should be included in the complete evaluation for metabolic syndrome.	[Chang, Ke-Vin; Han, Der-Sheng] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Bei Hu Branch, Taipei, Taiwan; [Chang, Ke-Vin; Li, Chia-Ming; Wang, Tyng-Guey; Tsai, Keh-Sung; Han, Der-Sheng] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hung, Chen-Yu] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Chu Tung Branch, Hsinchu, Taiwan; [Li, Chia-Ming] Natl Taiwan Univ Hosp, Dept Family Med, Bei Hu Branch, Taipei, Taiwan; [Lin, Yu-Hung] Natl Taiwan Univ Hosp, Dept Social Work, Bei Hu Branch, Taipei, Taiwan; [Wang, Tyng-Guey] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Tsai, Keh-Sung] Natl Taiwan Univ Hosp, Dept Internal Med, Bei Hu Branch, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Han, DS (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Bei Hu Branch, Taipei, Taiwan.	dshan1121@yahoo.com.tw	LI, CHIAMING/AAC-4034-2020	HAN, DER-SHENG/0000-0001-7642-8060; WANG, TYNG-GUEY/0000-0003-3298-4916; TSAI, KEH-SUNG/0000-0001-8528-1566	Ministry of Science and Technology [MOST103-2314-B-002-010]; National Taiwan University Hospital [101-S1919]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University Hospital(National Taiwan University)	This research was supported by grants from the Ministry of Science and Technology (MOST103-2314-B-002-010) and National Taiwan University Hospital (101-S1919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio VA, 2013, EUR J CARDIOVASC NUR; Barzilay JI, 2009, DIABETES CARE, V32, P736, DOI 10.2337/dc08-1781; Brinkley TE, 2009, J GERONTOL A-BIOL, V64, P455, DOI 10.1093/gerona/gln038; Chang CL, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-60; Chang KV, 2014, ULTRASOUND MED BIOL, V40, P313, DOI 10.1016/j.ultrasmedbio.2013.10.002; Choi M, 2013, NURS HEALTH SCI, V15, P379, DOI 10.1111/nhs.12045; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DESROSIERS J, 1995, AM J OCCUP THER, V49, P637, DOI 10.5014/ajot.49.7.637; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Farias DL, 2013, EINSTEIN-SAO PAULO, V11, P174, DOI 10.1590/S1679-45082013000200007; Gottlieb MG, 2014, METAB SYNDR RELAT DI; Hageman PA, 2012, J OBES, V2012, DOI 10.1155/2012/618728; Han DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108230; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Kao Feng-Chun, 2014, Biomed J, V37, P78, DOI 10.4103/2319-4170.113182; Kim M, 2013, EUR J CLIN NUTR, V67, P395, DOI 10.1038/ejcn.2013.9; Laursen AH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001711; Lee SC., 2008, J SPORT RECREATION M, V5, P35, DOI [10.6214/JSRM.200806_5(1).0003, DOI 10.6214/JSRM.200806_5(1).0003]; Lee W. L., 2007, J HUMANITIES SOCIAL, V3, P27, DOI [10.7118/JHSS.200712.0027, DOI 10.7118/JHSS.200712.0027]; Vieira DCL, 2013, CLIN INTERV AGING, V8, P1377, DOI 10.2147/CIA.S50333; Miyatake N, 2004, DIABETES RES CLIN PR, V64, P173, DOI 10.1016/j.diabres.2003.11.004; Morrell JS, 2013, METAB SYNDR RELAT D, V11, P370, DOI 10.1089/met.2013.0011; Park BS, 2013, DIABETES METAB J, V37, P458, DOI 10.4093/dmj.2013.37.6.458; Pedrosa R, 2009, BRAZ J PHYS THER, V13, P252, DOI 10.1590/S1413-35552009005000030; Rikli RE, 2001, HUMAN KINETICS; Ruggero CR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-182; Shin JA, 2013, J DIABETES INVEST, V4, P334, DOI 10.1111/jdi.12075; Silva G, 2013, INT J SPORTS MED, V34, P912, DOI 10.1055/s-0033-1334967; Wang CY, 2002, ARCH PHYS MED REHAB, V83, P811, DOI 10.1053/apmr.2002.32743; Wijndaele K, 2007, MED SCI SPORT EXER, V39, P233, DOI 10.1249/01.mss.0000247003.32589.a6; Yang JZ, 2014, PROG MOL BIOL TRANSL, V121, P133, DOI 10.1016/B978-0-12-800101-1.00005-3; Zhang P, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/729194	33	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117167	10.1371/journal.pone.0117167	http://dx.doi.org/10.1371/journal.pone.0117167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25614984	gold, Green Published, Green Submitted			2022-12-27	WOS:000349122100058
J	Olsen, RR; Mary-Sinclair, MN; Yin, ZR; Freeman, KW				Olsen, Rachelle R.; Mary-Sinclair, Michelle N.; Yin, Zhirong; Freeman, Kevin W.			Antagonizing Bcl-2 Family Members Sensitizes Neuroblastoma and Ewing's Sarcoma to an Inhibitor of Glutamine Metabolism	PLOS ONE			English	Article							CANCER; BIOLOGY; GLYCOLYSIS	Neuroblastomas (NBL) and Ewing's sarcomas (EWS) together cause 18% of all pediatric cancer deaths. Though there is growing interest in targeting the dysregulated metabolism of cancer as a therapeutic strategy, this approach has not been fully examined in NBL and EWS. In this study, we first tested a panel of metabolic inhibitors and identified the glutamine antagonist 6-diazo-5-oxo-L-norleucine (DON) as the most potent chemotherapeutic across all NBL and EWS cell lines tested. Myc, a master regulator of metabolism, is commonly overexpressed in both of these pediatric malignancies and recent studies have established that Myc causes cancer cells to become "addicted" to glutamine. We found DON strongly inhibited tumor growth of multiple tumor lines in mouse xenograft models. In vitro, inhibition of caspases partially reversed the effects of DON in high Myc expressing cell lines, but not in low Myc expressing lines. We further showed that induction of apoptosis by DON in Myc-overexpressing cancers is via the pro-apoptotic factor Bax. To relieve inhibition of Bax, we tested DON in combination with the Bcl-2 family antagonist navitoclax (ABT-263). In vitro, this combination caused an increase in DON activity across the entire panel of cell lines tested, with synergistic effects in two of the N-Myc amplified neuroblastoma cell lines. Our study supports targeting glutamine metabolism to treat Myc overexpressing cancers, such as NBL and EWS, particularly in combination with Bcl-2 family antagonists.	[Olsen, Rachelle R.; Mary-Sinclair, Michelle N.; Yin, Zhirong; Freeman, Kevin W.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Freeman, KW (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	kevin.freeman@stjude.org			American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding by American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Biswas S, 2012, CANCER METAST REV, V31, P689, DOI 10.1007/s10555-012-9384-6; Bodur C, 2012, CURR MED CHEM, V19, P1804, DOI 10.2174/092986712800099839; Chin YR, 2014, CANC DISCOV; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DUNN T, 1994, CANCER GENET CYTOGEN, V76, P19, DOI 10.1016/0165-4608(94)90063-9; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Howlader N, 2011, SEER CANC STAT REV 1; KISNER DL, 1980, RECENT RES CANCER, V74, P258; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Novick SJ, 2013, STAT MED, V32, P5145, DOI 10.1002/sim.5905; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Saqcena M, 2014, ONCOGENE; SULLIVAN MP, 1988, CANCER CHEMOTH PHARM, V21, P78, DOI 10.1007/BF00262746; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003	31	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116998	10.1371/journal.pone.0116998	http://dx.doi.org/10.1371/journal.pone.0116998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615615	gold, Green Submitted, Green Published			2022-12-27	WOS:000349122100052
J	Shiau, CE; Kaufman, Z; Meireles, AM; Talbot, WS				Shiau, Celia E.; Kaufman, Zoe; Meireles, Ana M.; Talbot, William S.			Differential Requirement for irf8 in Formation of Embryonic and Adult Macrophages in Zebrafish	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; IN-VIVO; B-CELL; MICROGLIA; ICSBP; INFLAMMATION; EXPRESSION; RESPONSES; MUTATION; RECEPTOR	Interferon regulatory factor 8 (Irf8) is critical for mammalian macrophage development and innate immunity, but its role in teleost myelopoiesis remains incompletely understood. In particular, genetic tools to analyze the role of Irf8 in zebrafish macrophage development at larval and adult stages are lacking. We generated irf8 null mutants in zebrafish using TALEN-mediated targeting. Our analysis defines different requirements for irf8 at different stages. irf8 is required for formation of all macrophages during primitive and transient definitive hematopoiesis, but not during adult-phase definitive hematopoiesis starting at 5-6 days postfertilization. At early stages, irf8 mutants have excess neutrophils and excess cell death in pu.1-expressing myeloid cells. Macrophage fates were recovered in irf8 mutants after wildtype irf8 expression in neutrophil and macrophage lineages, suggesting that irf8 regulates macrophage specification and survival. In juvenile irf8 mutant fish, mature macrophages are present, but at numbers significantly reduced compared to wildtype, indicating an ongoing requirement for irf8 after embryogenesis. As development progresses, tissue macrophages become apparent in zebrafish irf8 mutants, with the possible exception of microglia. Our study defines distinct requirement for irf8 in myelopoiesis before and after transition to the adult hematopoietic system.	[Shiau, Celia E.; Kaufman, Zoe; Meireles, Ana M.; Talbot, William S.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University	Shiau, CE (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	shiauc@ornl.gov; wtalbot@stanford.edu	Shiau, Celia/C-7679-2015	, William/0000-0002-2048-7472; Kaufman, Zoe/0000-0001-7745-1000; Shiau, Celia/0000-0002-9347-9158	NIH NRSA fellowship [5F32NS067754]; ORNL Liane Russell Fellowship; Stanford Undergraduate VPUE funds; EMBO fellowship [ALTF 1125-2011]; NIH [R01 NS065787, R56 HL125040]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL125040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065787, F32NS067754] Funding Source: NIH RePORTER	NIH NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ORNL Liane Russell Fellowship; Stanford Undergraduate VPUE funds; EMBO fellowship(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	C.E.S. was supported by NIH NRSA fellowship 5F32NS067754 and ORNL Liane Russell Fellowship, Z.K. was supported by Stanford Undergraduate VPUE funds, and A.M.M. was supported by EMBO fellowship ALTF 1125-2011. This work was supported by NIH grants R01 NS065787 and R56 HL125040 to W.S.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; Ellett Felix, 2011, Blood, V117, pe49, DOI 10.1182/blood-2010-10-314120; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Marquis JF, 2009, J IMMUNOL, V182, P3008, DOI 10.4049/jimmunol.0800680; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Pogosova-Agadjanyan EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070812; Qi CF, 2009, IMMUNOL RES, V45, P62, DOI 10.1007/s12026-008-8032-2; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Richards DM, 2013, CANCER MICROENVIRON, V6, P179, DOI 10.1007/s12307-012-0123-x; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Shiau CE, 2013, CELL REP, V5, P1342, DOI 10.1016/j.celrep.2013.11.004; Stachura DL, 2011, METHOD CELL BIOL, V101, P75, DOI 10.1016/B978-0-12-387036-0.00004-9; Svahn AJ, 2013, DEV NEUROBIOL, V73, P60, DOI 10.1002/dneu.22039; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; TERRY RL, 2014, CELL IMMUNOL, DOI DOI 10.1016/J.CELLIMM.2014.12.004; Tsujimura H, 2002, J IMMUNOL, V169, P1261, DOI 10.4049/jimmunol.169.3.1261; Turcotte K, 2007, J IMMUNOL, V179, P2467, DOI 10.4049/jimmunol.179.4.2467; WANG H, 2014, J IMMUNOL; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Yoshida Y, 2014, IMMUNITY, V40, P187, DOI 10.1016/j.immuni.2013.11.022	43	79	81	10	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117513	10.1371/journal.pone.0117513	http://dx.doi.org/10.1371/journal.pone.0117513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615614	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100063
J	Sagova-Mareckova, M; Daniel, O; Omelka, M; Kristufek, V; Divis, J; Kopecky, J				Sagova-Mareckova, Marketa; Daniel, Ondrej; Omelka, Marek; Kristufek, Vaclav; Divis, Jiri; Kopecky, Jan			Determination of Factors Associated with Natural Soil Suppressivity to Potato Common Scab	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; STREPTOMYCES; DISEASES; POPULATIONS; MANAGEMENT; CULTIVARS; ELEMENTS; TUBERS; GROWTH; PH	Common scab of potatoes is a disease, which is difficult to manage due to complex interactions of the pathogenic bacteria (Streptomyces spp.) with soil, microbial community and potato plants. In Bohemian-Moravian Highlands in the Czech Republic two sites (Vyklantice and Zdirec) were selected for a study of common scab disease suppressivity. At both sites, a field with low disease severity occurs next to one with high severity and the situation was regularly observed over four decades although all four fields undergo a crop rotation. In the four fields, quantities of bacteria, actinobacteria and the gene txtB from the biosynthetic gene cluster of thaxtomin, the main pathogenicity factor of common scab, were analyzed by real-time PCR. Microbial community structure was compared by terminal fragment length polymorphism analysis. Soil and potato periderm were characterized by contents of carbon, nitrogen, phosporus, sulphur, calcium, magnesium, and iron. Quality of organic matter was assessed by high performance liquid chromatography of soil extracts. The study demonstrated that the suppressive character of the fields is locally specific. At Zdirec, the suppressivity was associated with low txtB gene copies in bulk soil, while at Vyklantice site it was associated with low txtB gene copies in the tuberosphere. The differences were discussed with respect to the effect of abiotic conditions at Zdirec and interaction between potato plant and soil microbial community at Vyklantice. Soil pH, Ca soil content or cation concentrations, although different were not in the range to predict the disease severity. Low severity of common scab was associated with low content of soil C, N, C/N, Ca and Fe suggesting that oligotrophic conditions may be favorable to common scab suppression.	[Sagova-Mareckova, Marketa; Daniel, Ondrej; Kopecky, Jan] Crop Res Inst, Dept Epidemiol & Ecol Microorganisms, Prague, Czech Republic; [Omelka, Marek] Charles Univ Prague, Dept Probabil & Math Stat, Fac Math & Phys, Prague, Czech Republic; [Kristufek, Vaclav] Acad Sci Czech Republ, Inst Soil Biol, Ctr Biol, Vvi, CR-37005 Ceske Budejovice, Czech Republic; [Divis, Jiri] Univ South Bohemia, Dept Plant Prod, Fac Agr, Ceske Budejovice, Czech Republic	Czech Crop Research Institute (CRI); Charles University Prague; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Sagova-Mareckova, M (corresponding author), Crop Res Inst, Dept Epidemiol & Ecol Microorganisms, Prague, Czech Republic.	sagova@vurv.cz	Omelka, Marek/I-2447-2014; Mareckova, Marketa/AAD-7361-2021; Krištůfek, Václav/G-3846-2014; Mareckova, Marketa/D-9898-2017; Omelka, Marek/AAG-9535-2019; Kopecky, Jan/C-7400-2013	Omelka, Marek/0000-0002-0396-9373; Mareckova, Marketa/0000-0002-0331-8570; Mareckova, Marketa/0000-0002-0331-8570; Kopecky, Jan/0000-0002-3437-257X	Ministry of Agriculture of the Czech Republic [QJ1210359, MZe RO0414]; Czech Science Foundation [P201/11/P290]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	The study was supported by the Ministry of Agriculture of the Czech Republic, grant No. QJ1210359 and project MZe RO0414 (http://www.mze.cz), and Czech Science Foundation, grant No. P201/11/P290 (http://www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almario J, 2013, PLANT SOIL, V371, P397, DOI 10.1007/s11104-013-1677-1; [Anonymous], 2014, R LANG ENV STAT COMP; ARCHULETA JG, 1981, AM POTATO J, V58, P385, DOI 10.1007/BF02852950; Bailey KL, 2003, SOIL TILL RES, V72, P169, DOI 10.1016/S0167-1987(03)00086-2; BAKER KF, 1974, BIOL CONTROL PLANT P, P34217, DOI DOI 10.2307/3758248; Bonanomi G, 2007, J PLANT PATHOL, V89, P311; Cermak L, 2008, APPL SOIL ECOL, V40, P348, DOI 10.1016/j.apsoil.2008.06.001; DAVIS JR, 1976, PHYTOPATHOLOGY, V66, P1236, DOI 10.1094/Phyto-66-1236; DAVIS JR, 1976, PHYTOPATHOLOGY, V66, P1404, DOI DOI 10.1094/PHYTO-66-1236; Dees MW, 2012, POTATO RES, V55, P249, DOI 10.1007/s11540-012-9206-9; Errakhi R, 2008, J EXP BOT, V59, P4259, DOI 10.1093/jxb/ern267; Gijbels I, 2013, BIOMETRICS, V69, P137, DOI 10.1111/j.1541-0420.2012.01797.x; Hiltunen LH, 2006, J AGR FOOD CHEM, V54, P3372, DOI 10.1021/jf060270m; Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x; Kinkel LL, 2011, ANNU REV PHYTOPATHOL, V49, P47, DOI 10.1146/annurev-phyto-072910-095232; KOPACEK J, 1995, COMMUN SOIL SCI PLAN, V26, P1935, DOI 10.1080/00103629509369419; Kristufek V, 2000, POTATO RES, V43, P107, DOI 10.1007/BF02357951; KYSELKOVA M, 2012, SUSTAINABLE AGR REV, V9, P93, DOI DOI 10.1007/978-94-007-4113-3_5; Kyselkova M, 2008, ANTON LEEUW INT J G, V94, P439, DOI 10.1007/s10482-008-9261-z; Kyselkova M, 2014, ENV MICROBIOL REP, V6, P346, DOI 10.1111/1758-2229.12131; Lacey MJ, 2001, J PHYTOPATHOL, V149, P679, DOI 10.1046/j.1439-0434.2001.00693.x; Lambert DH, 2005, AM J POTATO RES, V82, P309, DOI 10.1007/BF02871961; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lazarovits G, 2007, PHYTOPATHOLOGY, V97, P1071, DOI 10.1094/PHYTO-97-9-1071; Lorang JM, 1989, AM POTATO J, V66, P531; Mazzola M, 2002, ANTON LEEUW INT J G, V81, P557, DOI 10.1023/A:1020557523557; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MEERA MS, 1995, EUR J PLANT PATHOL, V101, P421, DOI 10.1007/BF01874856; Meng QX, 2012, PLANT DIS, V96, P712, DOI 10.1094/PDIS-05-11-0441; Merchant SS, 2010, PLANT PHYSIOL, V154, P512, DOI 10.1104/pp.110.161810; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Noble R, 2005, BIOCONTROL SCI TECHN, V15, P3, DOI 10.1080/09583150400015904; Omelka M, 2012, J STAT PLAN INFER, V142, P1396, DOI 10.1016/j.jspi.2011.12.018; Qu XS, 2008, PHYTOPATHOLOGY, V98, P405, DOI 10.1094/PHYTO-98-4-0405; Rosenzweig N, 2012, PLANT DIS, V96, P718, DOI 10.1094/PDIS-07-11-0571; Sagova-Mareckova M, 2008, APPL ENVIRON MICROB, V74, P2902, DOI 10.1128/AEM.02161-07; Schlatter DC, 2013, MICROB ECOL, V66, P961, DOI 10.1007/s00248-013-0280-6; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Tokala RK, 2002, APPL ENVIRON MICROB, V68, P2161, DOI 10.1128/AEM.68.5.2161-2171.2002; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Weinert N, 2010, FEMS MICROBIOL ECOL, V74, P114, DOI 10.1111/j.1574-6941.2010.00936.x; Wenzl H., 1967, PFLANZENARZT, V20, P77; Yergeau E, 2010, ENVIRON MICROBIOL, V12, P2096, DOI 10.1111/j.1462-2920.2009.02053.x	43	29	29	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116291	10.1371/journal.pone.0116291	http://dx.doi.org/10.1371/journal.pone.0116291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612311	Green Submitted, Green Published, gold			2022-12-27	WOS:000348562900011
J	Gutpell, KM; Hrinivich, WT; Hoffman, LM				Gutpell, Kelly M.; Hrinivich, William T.; Hoffman, Lisa M.			Skeletal Muscle Fibrosis in the mdx/utrn plus /- Mouse Validates Its Suitability as a Murine Model of Duchenne Muscular Dystrophy	PLOS ONE			English	Article							DEFICIENT MICE; STEM-CELLS; MDX MOUSE; UTROPHIN; EXPRESSION; MYOFIBERS; TRANSPLANTATION; INJECTIONS; PATIENT	Various therapeutic approaches have been studied for the treatment of Duchenne muscular dystrophy (DMD), but none of these approaches have led to significant long-term effects in patients. One reason for this observed inefficacy may be the use of inappropriate animal models for the testing of therapeutic agents. The mdx mouse is the most widely used murine model of DMD, yet it does not model the fibrotic progression observed in patients. Other murine models of DMD are available that lack one or both alleles of utrophin, a functional analog of dystrophin. The aim of this study was to compare fibrosis and myofiber damage in the mdx, mdx/utrn+/- and double knockout (dko) mouse models. We used Masson's trichrome stain and percentage of centrally-nucleated myofibers as indicators of fibrosis and myofiber regeneration, respectively, to assess disease progression in diaphragm and gastrocnemius muscles harvested from young and aged wild-type, mdx, mdx/utrn+/- and dko mice. Our results indicated that eight week-old gastrocnemius muscles of both mdx/utrn+/- and dko hind limb developed fibrosis whereas age-matched mdx gastrocnemius muscle did not (p = 0.002). The amount of collagen found in the mdx/utrn+/- diaphragm was significantly higher than that found in the corresponding diaphragm muscles of wild-type animals, but not of mdx animals (p = 0.0003). Aged mdx/utrn+/- mice developed fibrosis in both diaphragm and gastrocnemius muscles compared to wild-type controls (p = 0.003). Mdx diaphragm was fibrotic in aged mice as well (p = 0.0235), whereas the gastrocnemius muscle in these animals was not fibrotic. We did not measure a significant difference in collagen staining between wild-type and mdx gastrocnemius muscles. The results of this study support previous reports that the moderately-affected mdx/utrn+/- mouse is a better model of DMD, and we show here that this difference is apparent by 2 months of age.	[Gutpell, Kelly M.] Univ Western Ontario, Dept Anat & Cell Biol, Lawson Hlth Res Inst, Imaging Program, London, ON, Canada; [Hrinivich, William T.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Hoffman, Lisa M.] Univ Western Ontario, Dept Anat & Cell Biol, Dept Med Biophys, Imaging Program,Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Gutpell, KM (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, Lawson Hlth Res Inst, Imaging Program, London, ON, Canada.	kgutpell@uwo.ca	Hoffman, Lisa/B-5324-2015	Hrinivich, William/0000-0002-0048-9411	Natural Sciences and Engineering Research Council of Canada [RGPIN/401944-2011]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by Natural Sciences and Engineering Research Council of Canada (RGPIN/401944-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1987, ANAT REC, V219, P243, DOI 10.1002/ar.1092190305; Beckman SA, 2013, ARTERIOSCL THROM VAS, V33, P2004, DOI 10.1161/ATVBAHA.112.301166; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Church JE, 2014, EXP PHYSIOL, V99, P675, DOI 10.1113/expphysiol.2013.077255; Cirak S, 2012, MOL THER, V20, P462, DOI 10.1038/mt.2011.248; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883; Desguerre I, 2012, MUSCLE NERVE, V45, P803, DOI 10.1002/mus.23341; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Fletcher S, 2006, J GENE MED, V8, P207, DOI 10.1002/jgm.838; GILGOFF I, 1989, CHEST, V95, P519, DOI 10.1378/chest.95.3.519; Goyenvalle A, 2012, HUM MOL GENET, V21, P2559, DOI 10.1093/hmg/dds082; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Hindi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072121; Hogrel JY, 2013, NEUROMUSCULAR DISORD, V23, P575, DOI 10.1016/j.nmd.2013.04.007; Huang P, 2011, MUSCLE NERVE, V43, P263, DOI 10.1002/mus.21848; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; Narita S, 1999, NEUROREPORT, V10, P3233, DOI 10.1097/00001756-199910190-00020; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Passerini L, 2002, NEUROMUSCULAR DISORD, V12, P828, DOI 10.1016/S0960-8966(02)00071-8; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Rodino-Klapac LR, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0332-1; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Seto Jane T, 2014, Curr Pediatr Rep, V2, P102; Skuk D, 2004, MOL THER, V9, P475, DOI 10.1016/j.ymthe.2003.11.023; Skuk D, 2007, NEUROMUSCULAR DISORD, V17, P38, DOI 10.1016/j.nmd.2006.10.003; Skuk D, 2006, J NEUROPATH EXP NEUR, V65, P371, DOI 10.1097/01.jnen.0000218443.45782.81; van Putten M, 2012, NEUROMUSCULAR DISORD, V22, P406, DOI 10.1016/j.nmd.2011.10.011; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	35	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0117306	10.1371/journal.pone.0117306	http://dx.doi.org/10.1371/journal.pone.0117306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607927	Green Submitted, gold, Green Published			2022-12-27	WOS:000348205300049
J	Iglesias-Bexiga, M; Castillo, F; Cobos, ES; Oka, T; Sudol, M; Luque, I				Iglesias-Bexiga, Manuel; Castillo, Francisco; Cobos, Eva S.; Oka, Tsutomu; Sudol, Marius; Luque, Irene			WWDomains of the Yes-Kinase-AssociatedProtein (YAP) Transcriptional Regulator Behave as Independent Units with Different Binding Preferences for PPxY MotifContaining Ligands	PLOS ONE			English	Article							WW DOMAIN; STRUCTURAL-CHARACTERIZATION; TUMOR-SUPPRESSOR; HEAT-CAPACITY; SH3 DOMAINS; ORGAN SIZE; PROLINE; SPECIFICITY; PATHWAY; RECOGNITION	YAP is a WW domain-containing effector of the Hippo tumor suppressor pathway, and the object of heightened interest as a potent oncogene and stemness factor. YAP has two major isoforms that differ in the number ofWWdomains they harbor. Elucidating the degree of co-operation between these WW domains is important for a full understanding of the molecular function of YAP. We present here a detailed biophysical study of the structural stability and binding properties of the two YAP WW domains aimed at investigating the relationship between both domains in terms of structural stability and partner recognition. We have carried out a calorimetric study of the structural stability of the two YAP WW domains, both isolated and in a tandem configuration, and their interaction with a set of functionally relevant ligands derived from PTCH1 and LATS kinases. We find that the two YAP WW domains behave as independent units with different binding preferences, suggesting that the presence of the second WW domain might contribute to modulate target recognition between the two YAP isoforms. Analysis of structural models and phage-display studies indicate that electrostatic interactions play a critical role in binding specificity. Together, these results are relevant to understand of YAP function and open the door to the design of highly specific ligands of interest to delineate the functional role of each WW domain in YAP signaling.	[Iglesias-Bexiga, Manuel; Castillo, Francisco; Cobos, Eva S.; Luque, Irene] Univ Granada, Fac Sci, Dept Phys Chem, E-18071 Granada, Spain; [Iglesias-Bexiga, Manuel; Castillo, Francisco; Cobos, Eva S.; Luque, Irene] Univ Granada, Fac Sci, Inst Biotechnol, E-18071 Granada, Spain; [Oka, Tsutomu; Sudol, Marius] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA	University of Granada; University of Granada	Luque, I (corresponding author), Univ Granada, Fac Sci, Dept Phys Chem, E-18071 Granada, Spain.	iluque@ugr.es	S. Cobos, Eva/H-7703-2015; Luque, Irene/K-4758-2012	S. Cobos, Eva/0000-0002-4622-8698; Luque, Irene/0000-0003-2757-4779; Iglesias Bexiga, Manuel/0000-0001-5737-1601; Castillo Correa, Francisco Jose/0000-0001-5587-9612	Spanish Ministry of Education and Science [BIO2009-13261-CO2]; Spanish Ministry of Economy and Competitivity including FEDER [BIO2012-39922-CO2]; Governement of Andalusia [CVI-5915]; PA Breast Cancer Coalition plus the Geisinger Clinic [60707, 920093]	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Economy and Competitivity including FEDER; Governement of Andalusia; PA Breast Cancer Coalition plus the Geisinger Clinic	This work was supported by the Spanish Ministry of Education and Science [grant BIO2009-13261-CO2], the Spanish Ministry of Economy and Competitivity [grant BIO2012-39922-CO2] including FEDER (European Funds for Regional Development) funds and the Governement of Andalusia [grant CVI-5915]. Marius Sudol was supported by PA Breast Cancer Coalition Grants (# 60707 and # 920093) plus the Geisinger Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon E, 2012, STRUCTURE, V20, P1726, DOI 10.1016/j.str.2012.07.014; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen HJ, 2011, DEV BIOL, V357, P370, DOI 10.1016/j.ydbio.2011.07.003; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Cobos ES, 2009, BIOCHEMISTRY-US, V48, P8712, DOI 10.1021/bi9007758; Cordier F, 2000, J MOL BIOL, V304, P497, DOI 10.1006/jmbi.2000.4274; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Ferreon JC, 2004, BIOCHEMISTRY-US, V43, P7787, DOI 10.1021/bi049752m; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Freire E, 2009, CHEM BIOL DRUG DES, V74, P468, DOI 10.1111/j.1747-0285.2009.00880.x; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Klett J, 2012, J CHEM THEORY COMPUT, V8, P3395, DOI 10.1021/ct300497z; Klippel S, 2011, J BIOL CHEM, V286, P38478, DOI 10.1074/jbc.M111.265710; Koepf EK, 1999, PROTEIN SCI, V8, P841, DOI 10.1110/ps.8.4.841; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lin YT, 2012, EXP CELL RES, V318, P1877, DOI 10.1016/j.yexcr.2012.05.005; Linn H, 1997, BIOL CHEM, V378, P531, DOI 10.1515/bchm.1997.378.6.531; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Martin-Garcia JM, 2012, BIOCHEM J, V442, P443, DOI 10.1042/BJ20111089; McDonald CB, 2012, J MOL BIOL, V422, P58, DOI 10.1016/j.jmb.2012.05.015; Morales B, 2007, STRUCTURE, V15, P473, DOI 10.1016/j.str.2007.03.005; Ng CA, 2008, BBA-PROTEINS PROTEOM, V1784, P1208, DOI 10.1016/j.bbapap.2008.04.026; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Palencia A, 2004, J MOL BIOL, V336, P527, DOI 10.1016/j.jmb.2003.12.030; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piana S, 2011, J MOL BIOL, V405, P43, DOI 10.1016/j.jmb.2010.10.023; Pires JR, 2001, J MOL BIOL, V314, P1147, DOI 10.1006/jmbi.2000.5199; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; Ramirez-Espain X, 2007, J MOL BIOL, V373, P1255, DOI 10.1016/j.jmb.2007.08.052; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schleinkofer K, 2004, J MOL BIOL, V344, P865, DOI 10.1016/j.jmb.2004.09.063; Schlundt A, 2009, MOL CELL PROTEOMICS, V8, P2474, DOI 10.1074/mcp.M800337-MCP200; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sudol M, 2005, IUBMB LIFE, V57, P773, DOI 10.1080/15216540500389039; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2013, HIPPO SIGNALING PATH, P53; SUDOL M, 2004, MODULAR PROTEIN DOMA, P59; Sudol M, 2012, STRUCTURE, V20, P1619, DOI 10.1016/j.str.2012.09.007; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Varelas X, 2013, HIPPO SIGNALING PATH, P327; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P2142, DOI 10.1021/bi00174a022; Wang CY, 2001, J MOL BIOL, V313, P873, DOI 10.1006/jmbi.2001.5083; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Yu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001761; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015	66	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0113828	10.1371/journal.pone.0113828	http://dx.doi.org/10.1371/journal.pone.0113828			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607641	Green Published, gold, Green Submitted			2022-12-27	WOS:000348205300002
J	Klumpers, UMH; Veltman, DJ; van Tol, MJ; Kloet, RW; Boellaard, R; Lammertsma, AA; Hoogendijk, WJG				Klumpers, Ursula M. H.; Veltman, Dick J.; van Tol, Marie-Jose; Kloet, Reina W.; Boellaard, Ronald; Lammertsma, Adriaan A.; Hoogendijk, Witte J. G.			Neurophysiological Effects of Sleep Deprivation in Healthy Adults, a Pilot Study	PLOS ONE			English	Article							UNDER-THE-CURVE; GO/NO-GO TASK; DOPAMINE-D-2 RECEPTOR; NEGATIVE AFFECT; NEURAL BASIS; PET; PERFORMANCE; BINDING; IMAGES; ACTIVATION	Total sleep deprivation (TSD) may induce fatigue, neurocognitive slowing and mood changes, which are partly compensated by stress regulating brain systems, resulting in altered dopamine and cortisol levels in order to stay awake if needed. These systems, however, have never been studied in concert. At baseline, after a regular night of sleep, and the next morning after TSD, 12 healthy subjects performed a semantic affective classification functional magnetic resonance imaging (fMRI) task, followed by a [C-11]raclopride positron emission tomography (PET) scan. Saliva cortisol levels were acquired at 7 time points during both days. Affective symptoms were measured using Beck Depression Inventory (BDI), Spielberger State Trait Anxiety Index (STAI) and visual analogue scales. After TSD, perceived energy levels, concentration, and speed of thought decreased significantly, whereas mood did not. During fMRI, response speed decreased for neutral words and positive targets, and accuracy decreased trendwise for neutral words and for positive targets with a negative distracter. Following TSD, processing of positive words was associated with increased left dorsolateral prefrontal activation. Processing of emotional words in general was associated with increased insular activity, whereas contrasting positive vs. negative words showed subthreshold increased activation in the (para) hippocampal area. Cortisol secretion was significantly lower after TSD. Decreased voxel-by-voxel [C-11]raclopride binding potential (BPND) was observed in left caudate. TSD induces widespread cognitive, neurophysiologic and endocrine changes in healthy adults, characterized by reduced cognitive functioning, despite increased regional brain activity. The blunted HPA-axis response together with altered [C-11]raclopride binding in the basal ganglia indicate that sustained wakefulness requires involvement of additional adaptive biological systems.	[Klumpers, Ursula M. H.; Veltman, Dick J.; Hoogendijk, Witte J. G.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Kloet, Reina W.; Boellaard, Ronald; Lammertsma, Adriaan A.] Vrije Univ Amsterdam Med Ctr, Dept Nucl Med, Amsterdam, Netherlands; [Kloet, Reina W.; Boellaard, Ronald; Lammertsma, Adriaan A.] Vrije Univ Amsterdam Med Ctr, PET Res, Amsterdam, Netherlands; [Klumpers, Ursula M. H.; Veltman, Dick J.; Kloet, Reina W.; Boellaard, Ronald; Lammertsma, Adriaan A.; Hoogendijk, Witte J. G.] Vrije Univ Amsterdam Med Ctr, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [van Tol, Marie-Jose] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen	Klumpers, UMH (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands.	u.klumpers@vumc.nl		Boellaard, Ronald/0000-0002-0313-5686; Lammertsma, Adriaan/0000-0003-1237-2891	ZONMW (Dutch Organization for Health Research and Development), The Netherlands [016.066.309]	ZONMW (Dutch Organization for Health Research and Development), The Netherlands	This study was supported in part by ZONMW (Dutch Organization for Health Research and Development), The Netherlands, grant no. 016.066.309, to Dr. Ronald Boellaard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2010, J COGNITIVE NEUROSCI, V22, P2369, DOI 10.1162/jocn.2009.21352; Balbo M, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/759234; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boellaard R, 2006, NEUROIMAGE, V31, pT62, DOI 10.1016/j.neuroimage.2006.04.053; Born J, 1999, NATURE, V397, P29, DOI 10.1038/16166; BOROWSKY B, 1992, NEUROPHARMACOLOGY, V31, P671, DOI 10.1016/0028-3908(92)90145-F; Brody AL, 2010, PSYCHIAT RES-NEUROIM, V183, P218, DOI 10.1016/j.pscychresns.2009.06.004; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Chee MWL, 2006, NEUROIMAGE, V31, P419, DOI 10.1016/j.neuroimage.2005.12.001; Chee MWL, 2010, NEUROIMAGE, V51, P835, DOI 10.1016/j.neuroimage.2010.02.031; Cizek J, 2004, NEUROIMAGE, V22, P434, DOI 10.1016/j.neuroimage.2004.01.016; Colombo C, 1999, PSYCHIAT RES, V86, P267, DOI 10.1016/S0165-1781(99)00036-0; Cook NR, 2004, STAT MED, V23, P3421, DOI 10.1002/sim.1921; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Defrise M, 1997, IEEE T MED IMAGING, V16, P145, DOI 10.1109/42.563660; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Egerton A, 2009, NEUROSCI BIOBEHAV R, V33, P1109, DOI 10.1016/j.neubiorev.2009.05.005; Elliott R, 2004, BIOL PSYCHIAT, V55, P1163, DOI 10.1016/j.biopsych.2004.03.007; Elliott R, 2002, ARCH GEN PSYCHIAT, V59, P597, DOI 10.1001/archpsyc.59.7.597; Elliott R, 2000, NEUROREPORT, V11, P1739, DOI 10.1097/00001756-200006050-00028; Elmenhorst D, 2012, J NUCL MED, V53, P1723, DOI 10.2967/jnumed.112.105114; FADDA P, 1992, NEUROCHEM INT, V20, pS153; Garcao P, 2013, BRIT J PHARMACOL, V169, P1600, DOI 10.1111/bph.12234; Giedke H, 2002, SLEEP MED REV, V6, P361, DOI 10.1053/smrv.2002.0235; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Huettel SA, 2009, FUNCTIONAL MAGNETIC; Huettel SA, 2012, NEUROIMAGE, V62, P1152, DOI 10.1016/j.neuroimage.2011.08.113; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Isaac SO, 2003, J PHARMACOL EXP THER, V307, P386, DOI 10.1124/jpet.103.053918; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Laruelle M, 1997, NEUROPSYCHOPHARMACOL, V17, P162, DOI 10.1016/S0893-133X(97)00043-2; Levens SM, 2010, J COGNITIVE NEUROSCI, V22, P2790, DOI 10.1162/jocn.2010.21428; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McNair D.M., 1971, MANUAL PROFILES MOOD; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Narendran R, 2006, SYNAPSE, V60, P485, DOI 10.1002/syn.20325; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; SIBLEY DR, 1982, J BIOL CHEM, V257, P6351; Spielberger C.D., 1970, STAI MANUAL; Stalder T, 2010, PSYCHONEUROENDOCRINO, V35, P209, DOI 10.1016/j.psyneuen.2009.06.006; Svarer C, 2005, NEUROIMAGE, V24, P969, DOI 10.1016/j.neuroimage.2004.10.017; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tops M, 2003, PSYCHOPHYSIOLOGY, V40, P167, DOI 10.1111/1469-8986.00018; van Aken MO, 2003, CLIN CHEM, V49, P1408, DOI 10.1373/49.8.1408; van Vliet I M, 2007, Tijdschr Psychiatr, V49, P393; Vgontzas AN, 1999, CLIN ENDOCRINOL, V51, P205, DOI 10.1046/j.1365-2265.1999.00763.x; Volkow ND, 2008, J NEUROSCI, V28, P8454, DOI 10.1523/JNEUROSCI.1443-08.2008; Volkow ND, 2012, J NEUROSCI, V32, P6711, DOI 10.1523/JNEUROSCI.0045-12.2012; Vreeburg SA, 2009, PSYCHONEUROENDOCRINO, V34, P1109, DOI 10.1016/j.psyneuen.2009.04.024; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wilhelm I, 2007, PSYCHONEUROENDOCRINO, V32, P358, DOI 10.1016/j.psyneuen.2007.01.008; WU JC, 1991, SLEEP, V14, P155; Wust Stefan, 2000, Noise Health, V2, P79	60	32	33	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116906	10.1371/journal.pone.0116906	http://dx.doi.org/10.1371/journal.pone.0116906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608023	Green Published, Green Submitted, gold			2022-12-27	WOS:000348205300043
J	Bhakta, MS; Jones, VA; Vallejos, CE				Bhakta, Mehul S.; Jones, Valerie A.; Vallejos, C. Eduardo			Punctuated Distribution of Recombination Hotspots and Demarcation of Pericentromeric Regions in Phaseolus vulgaris L.	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; LINKAGE MAP; DNA; GENOME; CROSSOVERS; DISCOVERY; SEQUENCE; MARKERS; GENERATION; CONVERSION	High density genetic maps are a reliable tool for genetic dissection of complex plant traits. Mapping resolution is often hampered by the variable crossover and non-crossover events occurring across the genome, with pericentromeric regions (pCENR) showing highly suppressed recombination rates. The efficiency of linkage mapping can further be improved by characterizing and understanding the distribution of recombinational activity along individual chromosomes. In order to evaluate the genome wide recombination rate in common beans (Phaseolus vulgaris L.) we developed a SNP-based linkage map using the genotype-by-sequencing approach with a 188 recombinant inbred line family generated from an inter gene pool cross (Andean x Mesoamerican). We identified 1,112 SNPs that were subsequently used to construct a robust linkage map with 11 groups, comprising 513 recombinationally unique marker loci spanning 943 cM (LOD 3.0). Comparative analysis showed that the linkage map spanned >95% of the physical map, indicating that the map is almost saturated. Evaluation of genome-wide recombination rate indicated that at least 45% of the genome is highly recombinationally suppressed, and allowed us to estimate locations of pCENRs. We observed an average recombination rate of 0.25 cM/Mb in pCENRs as compared to the rest of genome that showed 3.72 cM/Mb. However, several hot spots of recombination were also detected with recombination rates reaching as high as 34 cM/Mb. Hotspots were mostly found towards the end of chromosomes, which also happened to be gene-rich regions. Analyzing relationships between linkage and physical map indicated a punctuated distribution of recombinational hot spots across the genome.	[Bhakta, Mehul S.; Jones, Valerie A.; Vallejos, C. Eduardo] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Vallejos, C. Eduardo] Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Vallejos, CE (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.	vallejos@ufl.edu		Vallejos, Carlos/0000-0001-8936-7885	National Science Foundation [DBI/PGRP-0923975]; University of Florida Agricultural Experiment Station	National Science Foundation(National Science Foundation (NSF)); University of Florida Agricultural Experiment Station	This work was funded in part by a grant from the National Science Foundation (DBI/PGRP-0923975), and by the University of Florida Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Basten C. J., 2003, QTL CARTOGRAPHER VER; Basu-Roy S, 2013, GENETICS, V195, P769, DOI 10.1534/genetics.113.155549; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Blair MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049488; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; CHASE CD, 1991, THEOR APPL GENET, V81, P806, DOI 10.1007/BF00224994; Choi K, 2013, NAT GENET, V45, P1; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cole F, 2012, ANN NY ACAD SCI, V1267, P95, DOI 10.1111/j.1749-6632.2012.06595.x; Da Ines O, 2013, PLANT J, V74, P959, DOI 10.1111/tpj.12182; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DOBRITSA AP, 1980, GENE, V10, P105, DOI 10.1016/0378-1119(80)90128-6; Drouaud J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003922; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Freyre R, 1998, THEOR APPL GENET, V97, P847, DOI 10.1007/s001220050964; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; GRUENBAUM Y, 1981, NUCLEIC ACIDS RES, V9, P2509, DOI 10.1093/nar/9.11.2509; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Harushima Y, 1998, GENETICS, V148, P479; Hellsten U, 2013, P NATL ACAD SCI USA, V110, P19478, DOI 10.1073/pnas.1319032110; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Huang BE, 2014, GENETICS, V197, P401, DOI 10.1534/genetics.113.158014; Jung G, 1997, J AM SOC HORTIC SCI, V122, P329, DOI 10.21273/JASHS.122.3.329; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kozik A, 2006, P PLANT AN GEN 14 C; LAMPRECHT HERBERT, 1936, HEREDITAS, V21, P129; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lhuissier FGP, 2007, PLANT CELL, V19, P862, DOI 10.1105/tpc.106.049106; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin JY, 2005, GENETICS, V170, P1221, DOI 10.1534/genetics.105.041616; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Ma JX, 2007, TRENDS GENET, V23, P134, DOI 10.1016/j.tig.2007.01.004; Mamidi S, 2013, HEREDITY, V110, P267, DOI 10.1038/hdy.2012.82; Matos J, 2014, DNA REPAIR, V19, P176, DOI 10.1016/j.dnarep.2014.03.013; Matsubara K, 2011, MOL GENET GENOMICS, V286, P307, DOI 10.1007/s00438-011-0648-6; Murray J, 2002, GENOME, V45, P1013, DOI 10.1139/G02-069; NELSON M, 1984, NUCLEIC ACIDS RES, V12, P5165, DOI 10.1093/nar/12.13.5165; NELSON PS, 1993, NUCLEIC ACIDS RES, V21, P681, DOI 10.1093/nar/21.3.681; Palhares AC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-51; Pedrosa A, 2003, THEOR APPL GENET, V106, P205, DOI 10.1007/s00122-002-1138-3; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Pradillo M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00023; Prakken R, 1974, MEDEDLANDBOUWHOGESCH, V24, P1; Repinski SL, 2012, THEOR APPL GENET, V124, P1539, DOI 10.1007/s00122-012-1808-8; Sagawa H, 1995, NUCLEIC ACIDS RES, V23, P2; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Stange M, 2013, THEOR APPL GENET, V126, P2563, DOI 10.1007/s00122-013-2155-0; Topp CN, 2006, CURR OPIN PLANT BIOL, V9, P647, DOI 10.1016/j.pbi.2006.09.008; Vallejos C, 2001, DNA BASED MARKERS PL; Vallejos C Eduardo, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4765; VALLEJOS CE, 1992, GENETICS, V131, P733; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; Yuste-Lisbona FJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-136	63	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116822	10.1371/journal.pone.0116822	http://dx.doi.org/10.1371/journal.pone.0116822			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629314	gold, Green Submitted, Green Published			2022-12-27	WOS:000348732100050
J	Vaidya, S; Vundinti, BR; Shanmukhaiah, C; Chakrabarti, P; Ghosh, K				Vaidya, Shantashri; Vundinti, Babu Rao; Shanmukhaiah, Chandrakala; Chakrabarti, Prantar; Ghosh, Kanjaksha			Evolution of BCR/ABL Gene Mutation in CML Is Time Dependent and Dependent on the Pressure Exerted by Tyrosine Kinase Inhibitor	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; IMATINIB MESYLATE; DOMAIN MUTATIONS; RESISTANCE; DISCONTINUATION	Background Mutations in the ABL kinase domain and SH3-SH2 domain of the BCR/ABL gene and amplification of the Philadelphia chromosome are the two important BCR/ABL dependent mechanisms of imatinib resistance. Here, we intended to study the role played by TKI, imatinib, in selection of gene mutations and development of chromosomal abnormalities in Indian CML patients. Methods Direct sequencing methodology was employed to detect mutations and conventional cytogenetics was done to identify Philadelphia duplication. Results Among the different mechanisms of imatinib resistance, kinase domain mutations (39%) of the BCR/ABL gene were seen to be more prevalent, followed by mutations in the SH3-SH2 domain (4%) and then BCR/ABL amplification with the least frequency (1%). The median duration of occurrence of mutation was significantly shorter for patients with front line imatinib than those pre-treated with hydroxyurea. Patients with high Sokal score (p = 0.003) showed significantly higher incidence of mutations, as compared to patients with low/intermediate score. Impact of mutations on the clinical outcome in AP and BC was observed to be insignificant. Of the 94 imatinib resistant patients, only 1 patient exhibited duplication of Philadelphia chromosome, suggesting a less frequent occurrence of this abnormality in Indian CML patients. Conclusion C lose monitoring at regular intervals and proper analysis of the disease resistance would facilitate early detection of resistance and thus aid in the selection of the most appropriate therapy.	[Vaidya, Shantashri; Vundinti, Babu Rao; Ghosh, Kanjaksha] Natl Inst Immunohaematol, Dept Cytogenet, Bombay 400012, Maharashtra, India; [Shanmukhaiah, Chandrakala] King Edward Mem Hosp, Dept Haematol, Bombay 400012, Maharashtra, India; [Chakrabarti, Prantar] Inst Haematol & Transfus Med, Kolkata 700073, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	Ghosh, K (corresponding author), Natl Inst Immunohaematol, Dept Cytogenet, 13th Floor,New Multistoried Bldg,KEM Hosp Campus, Bombay 400012, Maharashtra, India.	kanjakshaghosh@hotmail.com	Ghosh, Kanjaksha/D-7621-2015; Chakrabarti, Prantar/G-3440-2010	Ghosh, Kanjaksha/0000-0002-0645-6565; Chakrabarti, Prantar/0000-0003-1026-5427	Indian Council of Medical Research [53/8/2006-BMS]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by Indian Council of Medical Research, Grant no. 53/8/2006-BMS (KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1996, J BIOL CHEM, V271, P19585, DOI 10.1074/jbc.271.32.19585; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; CAIRNS J, 1981, NATURE, V289, P353, DOI 10.1038/289353a0; Ghanima W, 2004, EUR J HAEMATOL, V72, P441, DOI 10.1111/j.1600-0609.2004.00257.x; Jabbour E, 2008, BLOOD, V112, P53, DOI 10.1182/blood-2007-11-123950; Kim SH, 2009, HEMATOL ONCOL, V27, P190, DOI 10.1002/hon.894; LOEB LA, 1991, CANCER RES, V51, P3075; Merante S, 2005, HAEMATOLOGICA, V90, P979; Qin YZ, 2011, ANN HEMATOL, V90, P47, DOI 10.1007/s00277-010-1039-5; Quintas-Cardama A, 2009, CANCER-AM CANCER SOC, V115, P5382, DOI 10.1002/cncr.24601; Razga F, 2012, MOL DIAGN THER, V16, P251, DOI 10.2165/11635340-000000000-00000; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Shaffer LG, 2009, ISCN INT SYSTEM HUMA; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sherbenou DW, 2008, LEUKEMIA, V22, P1184, DOI 10.1038/leu.2008.65; Sherbenou DW, 2010, BLOOD, V116, P3278, DOI 10.1182/blood-2008-10-183665; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; Vaidya S, 2012, LEUKEMIA RES, V36, pE110, DOI 10.1016/j.leukres.2012.02.005; Wang LH, 2006, HAEMATOL-HEMATOL J, V91, P235	22	17	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0114828	10.1371/journal.pone.0114828	http://dx.doi.org/10.1371/journal.pone.0114828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629972	gold, Green Published, Green Submitted			2022-12-27	WOS:000348732100009
J	van der Post, DJ; Verbrugge, R; Hemelrijk, CK				van der Post, Daniel J.; Verbrugge, Rineke; Hemelrijk, Charlotte K.			The Evolution of Different Forms of Sociality: Behavioral Mechanisms and Eco-Evolutionary Feedback	PLOS ONE			English	Article							GROUP-SIZE; VIGILANCE; EMERGENCE; DIET; INDIVIDUALS; PRIMATE; BRAIN; MODEL	Different forms of sociality have evolved via unique evolutionary trajectories. However, it remains unknown to what extent trajectories of social evolution depend on the specific characteristics of different species. Our approach to studying such trajectories is to use evolutionary case-studies, so that we can investigate how grouping co-evolves with a multitude of individual characteristics. Here we focus on anti-predator vigilance and foraging. We use an individual-based model, where behavioral mechanisms are specified, and costs and benefits are not predefined. We show that evolutionary changes in grouping alter selection pressures on vigilance, and vice versa. This eco-evolutionary feedback generates an evolutionary progression from "leader-follower" societies to "fission-fusion" societies, where cooperative vigilance in groups is maintained via a balance between within-and between-group selection. Group-level selection is generated from an assortment that arises spontaneously when vigilant and non-vigilant foragers have different grouping tendencies. The evolutionary maintenance of small groups, and cooperative vigilance in those groups, is therefore achieved simultaneously. The evolutionary phases, and the transitions between them, depend strongly on behavioral mechanisms. Thus, integrating behavioral mechanisms and eco-evolutionary feedback is critical for understanding what kinds of intermediate stages are involved during the evolution of particular forms of sociality.	[van der Post, Daniel J.; Verbrugge, Rineke] Univ Groningen, Inst Artificial Intelligence, Groningen, Netherlands; [van der Post, Daniel J.; Hemelrijk, Charlotte K.] Univ Groningen, Groningen, Netherlands; [van der Post, Daniel J.] Univ St Andrews, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland	University of Groningen; University of Groningen; University of St Andrews	van der Post, DJ (corresponding author), Univ Groningen, Inst Artificial Intelligence, Groningen, Netherlands.	d.j.vanderpost@gmail.com	Verbrugge, Rineke/D-3781-2012; Hemelrijk, Charlotte/E-4828-2013	Verbrugge, Rineke/0000-0003-3829-0106; Hemelrijk, Charlotte/0000-0001-6160-077X	Netherlands Organization for Scientific Research [NWO-277-80-001]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was funded by the Netherlands Organization for Scientific Research (http://www.nwo.nl/en): Vici grant NWO-277-80-001 awarded to Rineke Verbrugge (in the project Cognitive systems in interaction: Logical and computational models of higher-order social cognition). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Aviles L, 2002, P NATL ACAD SCI USA, V99, P14268, DOI 10.1073/pnas.212408299; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Beauchamp G, 2003, AM NAT, V161, P672, DOI 10.1086/368225; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Brashares JS, 2000, BEHAV ECOL, V11, P452, DOI 10.1093/beheco/11.4.452; Byrne RW, 2010, NEURON, V65, P815, DOI 10.1016/j.neuron.2010.03.010; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; Fawcett TW, 2013, BEHAV ECOL, V24, P2, DOI 10.1093/beheco/ars085; GIRALDEAU LA, 1993, EVOL ECOL, V7, P429, DOI 10.1007/BF01237874; Grafen A., 1984, BEHAV ECOLOGY EVOLUT, V2, P62; Hamilton IM, 2000, AM NAT, V155, P684, DOI 10.1086/303349; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hemelrijk CK, 2008, ETHOLOGY, V114, P245, DOI 10.1111/j.1439-0310.2007.01459.x; Hemelrijk CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037271; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; HIGASHI M, 1993, AM NAT, V142, P553, DOI 10.1086/285555; HOGEWEG P, 1989, BIOSYSTEMS, V23, P231, DOI 10.1016/0303-2647(89)90029-4; HOGEWEG P, 1983, BEHAV ECOL SOCIOBIOL, V12, P271, DOI 10.1007/BF00302895; HOGEWEG P, 1985, J THEOR BIOL, V113, P311, DOI 10.1016/S0022-5193(85)80230-7; Hogeweg Paulien, 2005, P166; Hogeweg P, 2012, ADV EXP MED BIOL, V751, P195, DOI 10.1007/978-1-4614-3567-9_10; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Laland KN, 2011, SCIENCE, V334, P1512, DOI 10.1126/science.1210879; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; MCNAMARA JM, 1992, ANIM BEHAV, V43, P641, DOI 10.1016/0003-3472(92)90086-O; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; Powers ST, 2011, EVOLUTION, V65, P1527, DOI 10.1111/j.1558-5646.2011.01250.x; Puga-Gonzalez I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000630; PULLIAM HR, 1982, J THEOR BIOL, V95, P89, DOI 10.1016/0022-5193(82)90289-2; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Reed Kaye E., 1999, P116, DOI 10.1017/CBO9780511542381.008; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Sanchez A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001547; Shultz S, 2007, P ROY SOC B-BIOL SCI, V274, P2429, DOI 10.1098/rspb.2007.0693; SIBLY RM, 1983, ANIM BEHAV, V31, P947, DOI 10.1016/S0003-3472(83)80250-4; Sirot Etienne, 2012, Proceedings of the Royal Society Biological Sciences Series B, V279, P2862; Smith J. M., 1997, MAJOR TRANSITIONS EV; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; Van der Post DJ, 2008, ANIM BEHAV, V75, P133, DOI 10.1016/j.anbehav.2007.04.021; van der Post DJ, 2013, AM NAT, V182, P682, DOI 10.1086/673298; van der Post DJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-335; van der Post DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002186; van der Post DJ, 2009, ANIM BEHAV, V78, P155, DOI 10.1016/j.anbehav.2009.04.009; van Schaik CP, 2012, TRENDS COGN SCI, V16, P277, DOI 10.1016/j.tics.2012.04.004; VANDERLAAN JD, 1995, P ROY SOC B-BIOL SCI, V259, P35, DOI 10.1098/rspb.1995.0006; Wood AJ, 2007, P R SOC B, V274, P1637, DOI 10.1098/rspb.2007.0306; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447	54	12	12	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117027	10.1371/journal.pone.0117027	http://dx.doi.org/10.1371/journal.pone.0117027			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629313	Green Submitted, Green Published, gold			2022-12-27	WOS:000348732100058
J	Li, SJ; Sun, QZ; Wei, XY; Klena, JD; Wang, JP; Liu, Y; Tian, KC; Luo, X; Ye, CY; Xu, JG; Wang, DM; Tang, GP				Li, Shijun; Sun, Qiangzheng; Wei, Xiaoyu; Klena, John D.; Wang, Jianping; Liu, Ying; Tian, Kecheng; Luo, Xia; Ye, Changyun; Xu, Jianguo; Wang, Dingming; Tang, Guangpeng			Genetic Characterization of Shigella flexneri Isolates in Guizhou Province, China	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; ASIAN COUNTRIES; DISEASE BURDEN; SALMONELLA; PULSENET; SONNEI	Shigella flexneri is one of the major etiologic causes of shigellosis in Guizhou Province, China. However, the genetic characteristics of circulating isolates are unknown. Phenotypic and molecular profiles of 60 S. flexneri isolates recovered in Guizhou between 1972 to 1982 and 2008 to 2010 were determined. Nine serotypes (1a, 2a, 3a, 1b, 2b, X, Y, 4av and Yv) were identified. Multi-locus sequence typing differentiated the isolates into 20 sequence types (STs); 18 were novel. Four STs, ST 129, ST 100, ST 126 and ST 18, were most abundant, accounting for 65% of the isolates. Thirty-nine NotI-pulsed field gel electrophoresis patterns (pulsotypes, PTs) were observed; eight PTs were represented by more than one isolate with six isolates sharing the PT 13 profile. Multi-locus variable-nucleotide tandem-repeat analysis recognized 44 different types (MTs); seven MTs were represented by more than one isolate and MT 1 was most commonly encountered. Correlation between genetic relationships and serotypes was observed among the isolates studied; the majority of isolates belonging to the same serotype from different years clustered together based on the molecular data. These clustered isolates were also from similar geographical origins. These results enhance our understanding of genetic relationships between S. flexneri in Guizhou Province and can be used to help understand the changing etiology of shigellosis in China.	[Li, Shijun; Wei, Xiaoyu; Liu, Ying; Tian, Kecheng; Wang, Dingming; Tang, Guangpeng] Guizhou Prov Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, Guiyang 550004, Guizhou, Peoples R China; [Sun, Qiangzheng; Wang, Jianping; Luo, Xia; Ye, Changyun; Xu, Jianguo] China CDC, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Klena, John D.] US Ctr Dis Control & Prevent, Int Emerging Infect Program, Beijing, Peoples R China; [Klena, John D.] Ctr Dis Control & Prevent, Global Dis Detect Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Centers for Disease Control & Prevention - USA	Li, SJ (corresponding author), Guizhou Prov Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, 101 Bageyan Rd, Guiyang 550004, Guizhou, Peoples R China.	zjumedjun@163.com			grant of national science and technology major project of China [2009ZX10602-12]; Talent Base Funds for Infectious Disease Control and Prevention in Guizhou Provincial Government [Qian Ren Ling Fa [2013]15]; National Natural Science Foundation of China [81271788, 81290345]; National Basic Research Priorities Program [2011CB504901]; National Key Program for Infectious Diseases of China [2013ZX10004221, 013ZX10004216-001-002, 2ZX10004215]	grant of national science and technology major project of China; Talent Base Funds for Infectious Disease Control and Prevention in Guizhou Provincial Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Priorities Program(National Basic Research Program of China); National Key Program for Infectious Diseases of China	This work was supported by the grant of national science and technology major project of China (No. 2009ZX10602-12), Talent Base Funds for Infectious Disease Control and Prevention in Guizhou Provincial Government (No. Qian Ren Ling Fa [2013]15), National Natural Science Foundation of China (No. 81271788 and 81290345), National Basic Research Priorities Program (No. 2011CB504901) and National Key Program for Infectious Diseases of China (No. 2013ZX10004221, 013ZX10004216-001-002 and 2ZX10004215. We acknowledge the use of the EcMLST database which is operated by the Microbial Evolution Laboratory at Michigan State University. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2014, INT J FOOD MICROBIOL, V168, P57, DOI 10.1016/j.ijfoodmicro.2013.10.014; [Anonymous], J MODERN LAB MED, V24, P3; Cao Y, 2012, INT J MOL EPIDEMIOL, V3, P321; Chen WWJ, 2006, MODERN PREVENTIVE ME, V33, P2; Chiou CS, 2009, J CLIN MICROBIOL, V47, P1149, DOI 10.1128/JCM.01607-08; Choi SY, 2007, J MED MICROBIOL, V56, P1460, DOI 10.1099/jmm.0.47322-0; Gorge O, 2008, J CLIN MICROBIOL, V46, P1026, DOI 10.1128/JCM.02027-07; Hyytia-Trees E, 2006, FOODBORNE PATHOG DIS, V3, P118, DOI 10.1089/fpd.2006.3.118; Islam MA, 2013, J MED MICROBIOL, V62, P62, DOI 10.1099/jmm.0.048066-0; Izumiya H, 2009, J MED MICROBIOL, V58, P1486, DOI 10.1099/jmm.0.011809-0; Knirel YA, 2013, GLYCOBIOLOGY, V23, P475, DOI 10.1093/glycob/cws222; Liu J MY, 2011, OCCUPATION HLTH, V27, P3; Niyogi SK, 2005, J MICROBIOL, V43, P133; Qiu SF, 2013, EMERG INFECT DIS, V19, P1147, DOI 10.3201/eid1907.111221; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Ru WHL, 2011, CHINESE J PRACTICAL, V38, P4; Sun QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070238; Sun QZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046095; Sun QZ, 2011, J CLIN MICROBIOL, V49, P3766, DOI 10.1128/JCM.01259-11; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; Wang YW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-278; Wei XY., 2012, PRACT PREV MED, V19, P1185; Xia SL, 2011, J CLIN MICROBIOL, V49, P232, DOI 10.1128/JCM.01508-10; Xu Y, 2009, ANAL COMMUNITY ACQUI; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09; Zhu Li TQ, 2013, J PREVENTIVE MED, V24, P3	27	3	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116708	10.1371/journal.pone.0116708	http://dx.doi.org/10.1371/journal.pone.0116708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617838	Green Published, gold			2022-12-27	WOS:000350336000021
J	Fumis, RRL; Ranzani, OT; Martins, PS; Schettino, G				Lins Fumis, Renata Rego; Ranzani, Otavio T.; Martins, Paulo Sergio; Schettino, Guilherme			Emotional Disorders in Pairs of Patients and Their Family Members during and after ICU Stay	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; POSTTRAUMATIC STRESS SYMPTOMS; ILL CANCER-PATIENTS; DEPRESSION SYMPTOMS; CRITICAL ILLNESS; VISITING POLICY; ANXIETY; SPIRITUALITY; RELATIVES; COMMUNICATION	Introduction Patients and family members undergo different experiences of suffering from emotional disorders during ICU stay and after ICU discharge. The purpose of this study was to compare the incidence of anxiety, depression and post-traumatic stress disorder (PTSD) symptoms in pairs (patient and respective family member), during stay at an open visit ICU and at 30 and 90-days post-ICU discharge. We hypothesized that there was a positive correlation with the severity of symptoms among pairs and different patterns of suffering over time. Methods A prospective study was conducted in a 22-bed adult general ICU including patients with >48 hours stay. The Hospital Anxiety and Depression Scale (HADS) was completed by the pairs (patients/respective family member). Interviews were made by phone at 30 and 90-days post-ICU discharge using the Impact of Event Scale (IES) and the HADS. Multivariate models were constructed to predict IES score at 30 days for patients and family members. Results Four hundred and seventy one family members and 289 patients were interviewed in the ICU forming 184 pairs for analysis. Regarding HADS score, patients presented less symptoms than family members of patients who survived and who deceased at 30 and 90-days (p<0.001). However, family members of patients who deceased scored higher anxiety and depression symptoms (p = 0.048) at 90-days when compared with family members of patients who survived. Patients and family members at 30-days had a similar IES score, but it was higher in family members at 90-days (p = 0.019). For both family members and patients, age and symptoms of anxiety and depression during ICU were the major determinants for PTSD at 30-days. Conclusions Anxiety, depression and PTSD symptoms were higher in family members than in the patients. Furthermore, these symptoms in family members persisted at 3 months, while they decreased in patients.	[Lins Fumis, Renata Rego; Martins, Paulo Sergio; Schettino, Guilherme] Hosp Sirio Libanes, Intens Care Unit, BR-01308050 Sao Paulo, Brazil; [Ranzani, Otavio T.] Univ Sao Paulo, Hosp Clin, Inst Heart, Resp Intens Care Unit,Pulm Div, BR-05403900 Sao Paulo, Brazil	Universidade de Sao Paulo	Fumis, RRL (corresponding author), Hosp Sirio Libanes, Intens Care Unit, Rua Dona Adma Jafet 91, BR-01308050 Sao Paulo, Brazil.	regolins@uol.com.br	Ranzani, Otavio T./K-1196-2012; Fumis, R R/J-6993-2015	Ranzani, Otavio T./0000-0002-4677-6862; Fumis, Renata/0000-0003-4780-704X	'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' - FAPESP [11/05672-1]	'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study is supported by 'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' - FAPESP - Process no 11/05672-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay Elie, 2003, Curr Opin Crit Care, V9, P545; Berwick DM, 2004, JAMA-J AM MED ASSOC, V292, P736, DOI 10.1001/jama.292.6.736; Boscaglia N, 2005, INT J GYNECOL CANCER, V15, P755, DOI 10.1111/j.1525-1438.2005.00248.x; Botega NJ, 1995, REV SAUDE PUBL, V29, P355, DOI 10.1590/S0034-89101995000500004; Curtis JR, 2002, J CRIT CARE, V17, P147, DOI 10.1053/jcrc.2002.35929; da Silva Ramos Fernando Jose, 2013, Ann Intensive Care, V3, P34, DOI 10.1186/2110-5820-3-34; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; de Miranda S, 2011, CRIT CARE MED, V39, P112, DOI 10.1097/CCM.0b013e3181feb824; Fumagalli S, 2006, CIRCULATION, V113, P946, DOI 10.1161/CIRCULATIONAHA.105.572537; Fumis RR, 2013, INTENS CARE MED, V39, P324; Fumis RRL, 2006, INTENS CARE MED, V32, P124, DOI 10.1007/s00134-005-2857-0; Garrouste-Orgeas M, 2008, CRIT CARE MED, V36, P30, DOI 10.1097/01.CCM.0000295310.29099.F8; Jackson JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5707; Janiszewska J, 2013, INT UROL NEPHROL, V45, P1379, DOI 10.1007/s11255-012-0326-6; Jones C, 2007, INTENS CARE MED, V33, P978, DOI 10.1007/s00134-007-0600-8; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lee MD, 2007, CRIT CARE MED, V35, P497, DOI 10.1097/01.CCM.0000254338.87182.AC; Fumis RRL, 2009, INTENS CARE MED, V35, P899, DOI 10.1007/s00134-009-1406-7; McCoubrie R, 2006, SUPPORT CARE CANCER, V14, P379, DOI 10.1007/s00520-005-0892-6; McKercher C, 2013, NEPHROLOGY, V18, P585, DOI 10.1111/nep.12138; Myhren H, 2010, CRIT CARE, V14, DOI 10.1186/cc8870; Paparrigopoulos T, 2014, INT J PSYCHIAT CLIN, V18, P25, DOI 10.3109/13651501.2013.855793; Peris A, 2011, CRIT CARE, V15, DOI 10.1186/cc10003; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Pochard F, 2001, CRIT CARE MED, V29, P1893, DOI 10.1097/00003246-200110000-00007; Rosendahl J, 2013, CRIT CARE MED, V41, P69, DOI 10.1097/CCM.0b013e31826766b0; Schleder LP, 2013, ACTA PAUL ENFERM, V26, P71, DOI 10.1590/S0103-21002013000100012; Silva Adriana Cardoso de Oliveira e, 2010, Rev. psiquiatr. Rio Gd. Sul, V32, P86, DOI 10.1590/S0101-81082010000300005; Steyerberg E., 2009, CLIN PREDICTION MODE; Sukantarat K, 2007, BRIT J HEALTH PSYCH, V12, P65, DOI 10.1348/135910706X94096; Tramm R, 2014, AUST CRIT CARE; Vandijck DM, 2010, HEART LUNG, V39, P137, DOI 10.1016/j.hrtlng.2009.06.001; Wall RJ, 2007, CHEST, V132, P1425, DOI 10.1378/chest.07-0419; Young E, 2005, INTENS CARE MED, V31, P86, DOI 10.1007/s00134-004-2495-y	35	61	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115332	10.1371/journal.pone.0115332	http://dx.doi.org/10.1371/journal.pone.0115332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25616059	gold, Green Published, Green Submitted			2022-12-27	WOS:000349122100011
J	Ambrosio-Gallardo, F; Cruz-Fuentes, C; Heinze-Martin, G; Caraveo-Anduaga, J; Cortes-Sotres, J				Ambrosio-Gallardo, Felix; Cruz-Fuentes, Carlos; Heinze-Martin, Gerhard; Caraveo-Anduaga, Jorge; Cortes-Sotres, Jose			Study of Minor Physical Anomalies in Complete Nuclear Mexican Families. Evidence of Neurodevelopmental Problems in Schizophrenia	PLOS ONE			English	Article							FEATURES; VALIDATION; INTERVIEW; ORIGIN; SCALE	Introduction Minor physical anomalies (MPA) are dysmorphic features that reflect deviations in early development, are morphological variants that appear during the first trimester of pregnancy and could be used as a marker of disease risk in susceptible people. The literature agrees that the number of MPA is higher in patients with schizophrenia compared with their relatives and healthy subjects. The purpose of this study is to compare the MPA, assessed using the Gourion Scale, in complete nuclear families (families with a member with schizophrenia and control families) by determining the MPA mean, concordance and heritability for the total score on the MPA Gourion Scale for each anomaly. Method The sample consisted of 60 families with at least one schizophrenic patient (284 members) and 61 control families (249 members). Results: The mean total score for the scale was 5.72 +/- 2.3 MPA in the case of families with at least one schizophrenic patient and 1.8 +/- 4.46 MPA for control families. The average for families of patients without considering the patient in the analysis was 5.59 +/- 2.3 MPA; for patients, the mean was 6.14 +/- 2.4 MPA. In the analysis by anomaly differences were found only in eleven anomalies found no evidence of heritability or concordance. Conclusions MPA occur more frequently in patients, but a pattern of low consistency between them persists. It is concluded that MPA could be a marker of neurodevelopmental problems, but it is not suitable to consider them a Gourion scale as endophenotype.	[Ambrosio-Gallardo, Felix] Hosp Psiquiatr Fray Bernardino Alvarez, Mexico City, DF, Mexico; [Cruz-Fuentes, Carlos] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Dept Genet, Mexico City, Mexico; [Heinze-Martin, Gerhard] Univ Autonoma Mexico, Fac Med, Dept Psiquiatria & Salud Mental, Mexico City, DF, Mexico; [Caraveo-Anduaga, Jorge] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Mexico City, DF, Mexico; [Cortes-Sotres, Jose] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Dept Apoyo Acad, Mexico City, DF, Mexico	Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz	Ambrosio-Gallardo, F (corresponding author), Hosp Psiquiatr Fray Bernardino Alvarez, Mexico City, DF, Mexico.	fambrosiog@hotmail.com						Akabaliev Valentin H, 2011, Folia Med (Plovdiv), V53, P45; Aksoy-Poyraz C, 2011, PSYCHIAT RES, V190, P85, DOI 10.1016/j.psychres.2011.04.023; Gallardo FA, 2013, SCHIZOPHR RES, V147, P406, DOI 10.1016/j.schres.2013.03.029; BLOOM FE, 1993, ARCH GEN PSYCHIAT, V50, P224; Elizarraras-Rivas J, 2003, SCHIZOPHR RES, V62, P285, DOI 10.1016/S0920-9964(02)00345-6; Falconer D. S., 1996, INTRO QUANTITATIVE G; Franco JG, 2010, ACTAS ESP PSIQUIATRI, V38, P365; Gassab L, 2013, COMPR PSYCHIAT, V54, P575, DOI 10.1016/j.comppsych.2012.11.007; GOLDFARB W, 1956, PHYS STIGMATA UNPUB; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gourion D, 2001, ENCEPHALE, V27, P143; GREEN MF, 1994, SCHIZOPHRENIA BULL, V20, P433, DOI 10.1093/schbul/20.3.433; Griffiths TD, 1998, J NEUROL NEUROSUR PS, V64, P56, DOI 10.1136/jnnp.64.1.56; GUY JD, 1983, SCHIZOPHRENIA BULL, V9, P571, DOI 10.1093/schbul/9.4.571; HEINZE G, 2000, MINIINTERNATIONAL NE; Ismail B, 1998, AM J PSYCHIAT, V155, P1695, DOI 10.1176/ajp.155.12.1695; Koen L, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-47; Lane A, 1997, PSYCHOL MED, V27, P1155, DOI 10.1017/S0033291797005503; Lieberman JA, 1999, BIOL PSYCHIAT, V46, P729, DOI 10.1016/S0006-3223(99)00147-X; Lin Y, 2012, PSYCHIAT RES, V200, P223, DOI 10.1016/j.psychres.2012.07.022; McClure RK, 2003, CURR OPIN PSYCHIATR, V16, pS15, DOI 10.1097/00001504-200304002-00004; McGrath JJ, 1995, SCHIZOPHR RES, V18, P9, DOI 10.1016/0920-9964(95)00016-X; Nizamie S H, 1989, Indian J Psychiatry, V31, P230; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Nyhan W, 1990, CLIN SCI, V41, P11; OCALLAGHAN E, 1991, AM J PSYCHIAT, V148, P479; Schiffman J, 2002, AM J PSYCHIAT, V159, P238, DOI 10.1176/appi.ajp.159.2.238; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sivkov ST, 2003, PSYCHIATRY, V66, P222, DOI 10.1521/psyc.66.3.222.25163; Tarrant CJ, 1999, CAN J PSYCHIAT, V44, P335, DOI 10.1177/070674379904400403; Tenyi Tamas, 2011, Neuropsychopharmacol Hung, V13, P229; TORREY EF, 1994, SCHIZOPHRENIA BULL, V20, P423, DOI 10.1093/schbul/20.3.423; Waldman ID, 2005, BIOL PSYCHIAT, V57, P1347, DOI 10.1016/j.biopsych.2005.03.002; WALDROP MF, 1968, CHILD DEV, V39, P391, DOI 10.1111/j.1467-8624.1968.tb04433.x; Weinberg SM, 2007, SCHIZOPHR RES, V89, P72, DOI 10.1016/j.schres.2006.09.002; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weinberger DR, 1996, NEUROPSYCHOPHARMACOL, V14, pS1, DOI 10.1016/0893-133X(95)00199-N; Xu T., 2011, PLOS ONE, V6; Yoshitsugu K, 2006, PSYCHIAT RES, V145, P249, DOI 10.1016/j.psychres.2005.10.013	39	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117080	10.1371/journal.pone.0117080	http://dx.doi.org/10.1371/journal.pone.0117080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612094	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900032
J	Ghose, S; Min, YF; Lin, PC				Ghose, Sampa; Min, Yongfen; Lin, P. Charles			delta-Catenin Activates Rho GTPase, Promotes Lymphangiogenesis and Growth of Tumor Metastases	PLOS ONE			English	Article								delta-catenin, an adherens junctions protein, is not only involved in early development, cell-cell adhesion and cell motility in neuronal cells, but it also plays an important role in vascular endothelial cell motility and pathological angiogenesis. In this study, we report a new function of delta-catenin in lymphangiogenesis. Consistent with expression of delta-catenin in vascular endothelial cells, we detected expression of the gene in lymphatic endothelial cells (LECs). Ectopic expression of delta-catenin in LECs increased cell motility and lymphatic vascular network formation in vitro and lymphangiogenesis in vivo in a Matrigel plug assay. Conversely, knockdown of delta-catenin in LECs impaired lymphangiogenesis in vitro and in vivo. Biochemical analysis shows that delta-catenin regulates activation of Rho family small GTPases, key mediators in cell motility. delta-catenin activates Rac1 and Cdc42 but inhibits RhoA in LECs. Notably, blocking of Rac1 activation impaired delta-catenin mediated lymphangiogenesis in a Matrigel assay. Consistently, loss of delta-catenin in mice inhibited the growth of tumor metastases. Taken together, these findings identify a new function of delta-catenin in lymphangiogenesis and tumor growth/metastasis, likely through modulation of small Rho GTPase activation. Targeting delta-catenin may offer a new way to control tumor metastasis.	[Ghose, Sampa] Jawaharlal Nehru Univ, Ctr Mol Med, New Delhi 110067, India; [Min, Yongfen; Lin, P. Charles] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA	Jawaharlal Nehru University, New Delhi; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lin, PC (corresponding author), NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA.	p.lin@NIH.gov			Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH); NIH [CA108856, NS45888, AR053718]; NATIONAL CANCER INSTITUTE [R01CA108856, ZIABC011390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045888] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH) and by the grants from NIH (CA108856, NS45888 and AR053718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; DeBusk LM, 2010, J EXP MED, V207, P77, DOI 10.1084/jem.20091097; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jones CA, 2007, CURR OPIN GENET DEV, V17, P332, DOI 10.1016/j.gde.2007.07.004; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019	12	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116338	10.1371/journal.pone.0116338	http://dx.doi.org/10.1371/journal.pone.0116338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635825	gold, Green Submitted, Green Published			2022-12-27	WOS:000350680700029
J	Grigson, ER; Ozerova, M; Pisklakova, A; Liu, H; Sullivan, DM; Nefedova, Y				Grigson, Eileen R.; Ozerova, Maria; Pisklakova, Alexandra; Liu, Hao; Sullivan, Daniel M.; Nefedova, Yulia			Canonical Wnt Pathway Inhibitor ICG-001 Induces Cytotoxicity of Multiple Myeloma Cells in Wnt-Independent Manner	PLOS ONE			English	Article							NOVO DRUG-RESISTANCE; APOPTOSIS; PROLIFERATION	Canonical Wnt signaling has been implicated in the regulation of multiple myeloma ( MM) growth. Here, we investigated whether the targeting of this pathway with a novel pharmacological inhibitor ICG-001 would result in an anti-tumor effect and improvement of chemosensitivity in MM. As expected, ICG-001 specifically down-regulated beta-catenin/TCF-mediated transcription in MM cells. Treatment with ICG-001 resulted in growth arrest and apoptosis in MM cell lines and primary MM cells. Moreover, ICG-001 enhanced the cytotoxic effects of doxorubicin and melphalan and abrogated chemoresistance of MM cells to these chemotherapeutics induced by bone marrow stroma. The cytotoxic effect of ICG-001 was caspase-dependent and mediated through transcriptional up-regulation of BH3-only proapoptotic members of the Bcl-2 family Noxa and Puma but not through inhibition of canonical Wnt signaling. ICG-001 selectively induced apoptosis in primary MM cells but did not affect non-MM cells of the bone marrow microenvironment. Experiments using a xenograft model of MM showed substantial anti-tumor effects of this compound in vivo. Thus, our study demonstrated that the small molecule inhibitor ICG-001 has strong anti-MM effects and could be developed further for therapeutic intervention in this disease.	[Grigson, Eileen R.; Pisklakova, Alexandra; Liu, Hao; Sullivan, Daniel M.; Nefedova, Yulia] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Grigson, Eileen R.; Ozerova, Maria; Nefedova, Yulia] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; The Wistar Institute	Nefedova, Y (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	ynefedova@wistar.org		Nefedova, Yulia/0000-0002-5121-9294	Multiple Myeloma Research Foundation Senior Award; National Cancer Institute of the National Institutes of Health [R01CA130923]; Cancer Center Support Grant (CCSG) [P30-CA76292, CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815, R25CA174664, R01CA130923, P30CA076292] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation Senior Award; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the Multiple Myeloma Research Foundation (http://www.themmrf.org) Senior Award (to YN) and by the National Cancer Institute of the National Institutes of Health under award number R01CA130923 (to YN). Support for Shared Resources utilized in the study was provided by Cancer Center Support Grant (CCSG) P30-CA76292 to the Moffitt Cancer Center and Research Institute and CA010815 to The Wistar Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Ashihara E, 2009, CLIN CANCER RES, V15, P2731, DOI 10.1158/1078-0432.CCR-08-1350; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Colla S, 2007, BLOOD, V109, P4470, DOI 10.1182/blood-2006-11-056747; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Gang E.J., 2013, ONCOGENE; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Huang ML, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-221; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Khin ZP, 2014, CANCER RES, V74, P56, DOI 10.1158/0008-5472.CAN-13-2397; Lento W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008011; Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/sj.onc.1208568; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Qiang YW, 2008, BLOOD, V112, P374, DOI 10.1182/blood-2007-10-120253; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Qiang YW, 2003, ONCOGENE, V22, P1536, DOI 10.1038/sj.onc.1206239; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Shibue T, 2006, INT J CANC; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Sun P, 2006, MOL PHARMACOL, V69, P520, DOI 10.1124/mol.105.019620; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Veeramachaneni NK, 2004, J THORAC CARDIOV SUR, V127, P92, DOI 10.1016/j.jtcvs.2003.06.008; Wend P, 2013, EMBO J, V32, P1977, DOI 10.1038/emboj.2013.127; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	31	36	36	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117693	10.1371/journal.pone.0117693	http://dx.doi.org/10.1371/journal.pone.0117693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635944	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700097
J	Lanza, D; Perna, AF; Oliva, A; Vanholder, R; Pletinck, A; Guastafierro, S; Di Nunzio, A; Vigorito, C; Capasso, G; Jankowski, V; Jankowski, J; Ingrosso, D				Lanza, Diana; Perna, Alessandra F.; Oliva, Adriana; Vanholder, Raymond; Pletinck, Anneleen; Guastafierro, Salvatore; Di Nunzio, Annarita; Vigorito, Carmela; Capasso, Giovambattista; Jankowski, Vera; Jankowski, Joachim; Ingrosso, Diego			Impact of the Uremic Milieu on the Osteogenic Potential of Mesenchymal Stem Cells	PLOS ONE			English	Article							ALIZARIN RED-S; HYDROGEN-SULFIDE; MINERAL METABOLISM; SECONDARY HYPERPARATHYROIDISM; HEMODIALYSIS-PATIENTS; BONE; MARKERS; CALCIFICATION; EXPRESSION; CINACALCET	Human mesenchymal stem cells (hMSCs), the precursors of osteoblasts during osteogenesis, play a role in the balance of bone formation and resorption, but their functioning in uremia has not been well defined. To study the effects of the uremic milieu on osteogenic properties, we applied an in vitro assay culturing hMSCs in osteogenic medium supplemented with serum from healthy donors and from uremic patients on hemodialysis. Compared to control, serum from uremic patients induces, in hMSC cultures, a modification of several key regulators of bone remodeling, in particular a reduction of the ratio Receptor Activator of Nuclear factor Kappa B Receptor (RANKL) over osteoprotegerin, indicating an adaptive response of the system to favor osteogenesis over osteoclastosis. However, the levels of osteopontin, osteocalcin, and collagen type I, are increased in cell medium, while BMP-2, and alizarin red staining were decreased, pointing to a reduction of bone formation favoring resorption. Selected uremic toxins, such as p-cresylsulfate, p-cresylglucuronide, parathyroid hormone, indoxyl sulfate, asymmetric dimethylarginine, homocysteine, were able to mimic some of the effects of whole serum from uremic patients. Serum from cinacalcet-treated patients antagonizes these effects. Hydrogen sulfide (H2S) donors as well as hemodialysis treatment are able to induce beneficial effects. In conclusion, bone modifications in uremia are influenced by the capability of the uremic milieu to alter hMSC osteogenic differentiation. Cinacalcet, H2S donors and a hemodialysis session can ameliorate the hampered calcium deposition.	[Lanza, Diana; Perna, Alessandra F.; Di Nunzio, Annarita; Capasso, Giovambattista] Univ Naples 2, Sch Med, Dept Cardiothorac & Resp Sci, Div Nephrol 1, Naples, Italy; [Oliva, Adriana; Vigorito, Carmela; Ingrosso, Diego] Univ Naples 2, Sch Med, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Vanholder, Raymond; Pletinck, Anneleen] Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium; [Guastafierro, Salvatore] Univ Naples 2, Sch Med, Dept Clin & Expt Med, Div Hematol & Med Oncol, Naples, Italy; [Jankowski, Vera; Jankowski, Joachim] Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res IMCAR, Aachen, Germany	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Ghent University; Ghent University Hospital; Universita della Campania Vanvitelli; RWTH Aachen University	Perna, AF (corresponding author), Univ Naples 2, Sch Med, Dept Cardiothorac & Resp Sci, Div Nephrol 1, Naples, Italy.	alessandra.perna@unina2.it	Ingrosso, Diego/AHE-4980-2022; Perna, Alessandra F/AAC-3952-2022	Capasso, Giovambattista/0000-0003-3469-8614; PERNA, Alessandra/0000-0003-4048-9392	Italian Society of Nephrology (SIN), GRANT "Ricercando"	Italian Society of Nephrology (SIN), GRANT "Ricercando"	This work was supported by the Italian Society of Nephrology (SIN), http://www.sin-italy.org, GRANT "Ricercando 2011" to AFP. Project name: "Exploring the osteogenic properties of mesenchymal stem cells for bone structural -functional repair in hemodialysis patients: role of uremic toxins." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeras C, 2009, SEMIN DIALYSIS, V22, P329, DOI 10.1111/j.1525-139X.2009.00575.x; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Boncler M, 2014, J PHARMACOL TOX MET, V69, P9, DOI 10.1016/j.vascn.2013.09.003; Bordia A, 1998, PROSTAG LEUKOTR ESS, V58, P257, DOI 10.1016/S0952-3278(98)90034-5; Borriello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028555; Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210/er.17.4.333; Chen NX, 2006, KIDNEY INT, V70, P1046, DOI 10.1038/sj.ki.5001663; Cook DA, 2014, STEM CELL RES, V12, P415, DOI 10.1016/j.scr.2013.10.002; Costa E, 2012, RENAL FAILURE, V34, P1355, DOI 10.3109/0886022X.2012.725289; Cunningham J, 2011, CLIN J AM SOC NEPHRO, V6, P913, DOI 10.2215/CJN.06040710; Dalfino G, 2010, ATHEROSCLEROSIS, V211, P418, DOI 10.1016/j.atherosclerosis.2010.04.023; DAWSONSAUNDERS B, 1990, BASIC CLIN BIOSTATIS; Doumouchtsis KK, 2007, J ENDOCRINOL INVEST, V30, P762, DOI 10.1007/BF03350814; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; Feigenbaum J, 1941, J AM CHEM SOC, V63, P3529, DOI 10.1021/ja01857a508; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Graneli C, 2014, STEM CELL RES, V12, P153, DOI 10.1016/j.scr.2013.09.009; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Guida L, 2010, CLIN ORAL IMPLAN RES, V21, P1234, DOI 10.1111/j.1600-0501.2010.01929.x; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Huang YT, 2013, J APPL PHYSIOL, V114, P402, DOI 10.1152/japplphysiol.00672.2012; Iwasaki Y, 2006, J BONE MINER METAB, V24, P172, DOI 10.1007/s00774-005-0667-7; Jankowski J, 2003, J CLIN INVEST, V112, P256, DOI 10.1172/JCI200315524; Kawata T, 2008, KIDNEY INT, V74, P1270, DOI 10.1038/ki.2008.407; Kazama JJ, 2004, CURR OPIN NEPHROL HY, V13, P411, DOI 10.1097/01.mnh.0000133982.40182.8a; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kolluru GK, 2013, NITRIC OXIDE-BIOL CH, V35, P5, DOI 10.1016/j.niox.2013.07.002; Kramann R, 2011, ARTERIOSCL THROM VAS, V31, pE45, DOI 10.1161/ATVBAHA.111.228601; Lall Namrita, 2013, Int J Microbiol, V2013, P420601, DOI 10.1155/2013/420601; Lesaffer G, 2000, NEPHROL DIAL TRANSPL, V15, P50, DOI 10.1093/ndt/15.1.50; Li D, 2013, ENDOCRINE, V43, P68, DOI 10.1007/s12020-012-9711-2; Liabeuf S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067168; Liao CS, 2013, ARCH ORAL BIOL, V58, P1784, DOI 10.1016/j.archoralbio.2013.08.004; LIEVREMONT M, 1982, ACTA ANAT, V114, P268; Liu Y, 2014, CELL STEM CELL, V15, P66, DOI 10.1016/j.stem.2014.03.005; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Meert N, 2012, NEPHROL DIAL TRANSPL, V27, P2388, DOI 10.1093/ndt/gfr672; Nemcsik Janos, 2012, World J Nephrol, V1, P25, DOI 10.5527/wjn.v1.i1.25; Nii-Kono T, 2007, KIDNEY INT, V71, P738, DOI 10.1038/sj.ki.5002097; Nitta K, 2001, NEPHRON, V89, P455, DOI 10.1159/000046119; Oliva A, 2005, Int J Immunopathol Pharmacol, V18, P47; Perna AF, 2004, J AM SOC NEPHROL, V15, P2747, DOI 10.1097/01.ASN.0000141041.71717.11; Perna AF, 2013, J CELL BIOCHEM, V114, P1536, DOI 10.1002/jcb.24495; Perna AF, 2009, NEPHROL DIAL TRANSPL, V24, P3756, DOI 10.1093/ndt/gfp378; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Takano M, 2011, CLIN INVEST MED, V34, pE267; Tanaka H, 2011, BIOCHEM BIOPH RES CO, V411, P690, DOI 10.1016/j.bbrc.2011.07.001; Tanaka H, 2013, BONE, V56, P347, DOI 10.1016/j.bone.2013.07.002; Urena P, 1996, J AM SOC NEPHROL, V7, P506; Urena P, 2009, NEPHROL DIAL TRANSPL, V24, P2852, DOI 10.1093/ndt/gfp144; Van der Eycken E, 2000, PLANT CELL REP, V19, P966, DOI 10.1007/s002990000219; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Xiao ZS, 2001, KIDNEY INT, V60, P1699, DOI 10.1046/j.1523-1755.2001.00011.x; Xu ZS, 2011, FREE RADICAL BIO MED, V50, P1314, DOI 10.1016/j.freeradbiomed.2011.02.016; Yang J, 2012, BONE, V51, P376, DOI 10.1016/j.bone.2012.05.024	61	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116468	10.1371/journal.pone.0116468	http://dx.doi.org/10.1371/journal.pone.0116468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635832	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700038
J	Granito, C; Scorolli, C; Borghi, AM				Granito, Carmen; Scorolli, Claudia; Borghi, Anna Maria			Naming a Lego World. The Role of Language in the Acquisition of Abstract Concepts	PLOS ONE			English	Article							CONCRETE; WORDS; MODE	While embodied approaches of cognition have proved to be successful in explaining concrete concepts and words, they have more difficulties in accounting for abstract concepts and words, and several proposals have been put forward. This work aims to test the Words As Tools proposal, according to which both abstract and concrete concepts are grounded in perception, action and emotional systems, but linguistic information is more important for abstract than for concrete concept representation, due to the different ways they are acquired: while for the acquisition of the latter linguistic information might play a role, for the acquisition of the former it is instead crucial. We investigated the acquisition of concrete and abstract concepts and words, and verified its impact on conceptual representation. In Experiment 1, participants explored and categorized novel concrete and abstract entities, and were taught a novel label for each category. Later they performed a categorical recognition task and an image-word matching task to verify a) whether and how the introduction of language changed the previously formed categories, b) whether language had a major weight for abstract than for concrete words representation, and c) whether this difference had consequences on bodily responses. The results confirm that, even though both concrete and abstract concepts are grounded, language facilitates the acquisition of the latter and plays a major role in their representation, resulting in faster responses with the mouth, typically associated with language production. Experiment 2 was a rating test aiming to verify whether the findings of Experiment 1 were simply due to heterogeneity, i.e. to the fact that the members of abstract categories were more heterogeneous than those of concrete categories. The results confirmed the effectiveness of our operationalization, showing that abstract concepts are more associated with the mouth and concrete ones with the hand, independently from heterogeneity.	[Granito, Carmen; Scorolli, Claudia; Borghi, Anna Maria] Univ Bologna, Dept Psychol, Bologna, Italy; [Borghi, Anna Maria] CNR, Inst Cognit Sci & Technol, Rome, Italy	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Granito, C (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	carmen.granito@gmail.com; annamaria.borghi@unibo.it	Scorolli, Claudia/AAX-6608-2021	Scorolli, Claudia/0000-0003-1375-1500; Borghi, Anna M./0000-0001-9455-8408	AMB's funds [216125]	AMB's funds	This work was supported by AMB's funds within the European Community project ROSSI: Emergence of communication in RObots through Sensorimotor and Social Interaction (Grant agreement n. 216125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barca L., 2011, LEXICAL SUBLEXICAL V; Barsalou L., 2008, SYMBOLS EMBODIMENT D, P245, DOI [DOI 10.1093/ACPROF:OSO/9780199217274.003.0013, 10.1093/acprof:oso/9780199217274.003.0013, DOI 10.1093/ACPROF:OSO/9780199217274.003]; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2003, PHILOS T R SOC B, V358, P1177, DOI 10.1098/rstb.2003.1319; Borghi A.M., 2009, P ANN C COGENTIVE SC, P2304; Borghi AM, 2014, SPRINGERBR PSYCHOL, P1, DOI 10.1007/978-1-4614-9539-0; Borghi AM, 2013, MOUTON GRUYTER, DOI [10.1016/j.brainres.2012.10.004, DOI 10.1016/J.BRAINRES.2012.10.004]; Borghi AM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00811; Borghi AM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00187; Borghi AM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00015; D'Ausilio A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0418; Della Rosa PA, 2010, BEHAV RES METHODS, V42, P1042, DOI 10.3758/BRM.42.4.1042; Dove G, 2013, TOP COGN SC IN PRESS; Dove G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00242; Gentner D., 2001, LANG ACQUIS, P215, DOI [10.1017/CBO9780511620669.010, DOI 10.1017/CBO9780511620669.010]; Ghio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067090; Gillette J, 1999, COGNITION, V73, P135, DOI 10.1016/S0010-0277(99)00036-0; Gleitman LR, 2005, LANG LEARN DEV, V1, P23, DOI 10.1207/s15473341lld0101_4; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Pecher D, 2011, PSYCHOL LEARN MOTIV, V54, P217, DOI 10.1016/B978-0-12-385527-5.00007-3; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; Sakreida K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00125; Scorolli C, 2007, BRAIN RES, V1130, P119, DOI 10.1016/j.brainres.2006.10.033; Scorolli C, 2012, BRAIN RES, V1488, P60, DOI 10.1016/j.brainres.2012.10.004; Scorolli C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00227; Tomasino B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00498; Wauters LN, 2003, APPL PSYCHOLINGUIST, V24, P385, DOI 10.1017/S0142716403000201; Weizman ZO, 2001, DEV PSYCHOL, V37, P265, DOI 10.1037//0012-1649.37.2.265; Wiemer-Hastings K, 2001, P 23 ANN M COGN SCI, V23, P1106; Yu C, 2012, COGNITION, V125, P244, DOI 10.1016/j.cognition.2012.06.016	31	35	35	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0114615	10.1371/journal.pone.0114615	http://dx.doi.org/10.1371/journal.pone.0114615			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629816	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100008
J	Liu, TY; Chen, YS; Hsieh, JC; Chen, LF				Liu, Tai-Ying; Chen, Yong-Sheng; Hsieh, Jen-Chuen; Chen, Li-Fen			Asymmetric Engagement of Amygdala and Its Gamma Connectivity in Early Emotional Face Processing	PLOS ONE			English	Article							GRANGER CAUSALITY ANALYSIS; FACIAL EXPRESSIONS; BIPOLAR DISORDER; PERCEPTION; SYNCHRONIZATION; RESPONSES; NEUROBIOLOGY; METAANALYSIS; ACTIVATION; DYNAMICS	The amygdala has been regarded as a key substrate for emotion processing. However, the engagement of the left and right amygdala during the early perceptual processing of different emotional faces remains unclear. We investigated the temporal profiles of oscillatory gamma activity in the amygdala and effective connectivity of the amygdala with the thalamus and cortical areas during implicit emotion-perceptual tasks using event-related magnetoencephalography (MEG). We found that within 100 ms after stimulus onset the right amygdala habituated to emotional faces rapidly (with duration around 20-30 ms), whereas activity in the left amygdala (with duration around 50-60 ms) sustained longer than that in the right. Our data suggest that the right amygdala could be linked to autonomic arousal generated by facial emotions and the left amygdala might be involved in decoding or evaluating expressive faces in the early perceptual emotion processing. The results of effective connectivity provide evidence that only negative emotional processing engages both cortical and subcortical pathways connected to the right amygdala, representing its evolutional significance (survival). These findings demonstrate the asymmetric engagement of bilateral amygdala in emotional face processing as well as the capability of MEG for assessing tha-lamo-cortico-limbic circuitry.	[Liu, Tai-Ying; Hsieh, Jen-Chuen; Chen, Li-Fen] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Liu, Tai-Ying; Hsieh, Jen-Chuen; Chen, Li-Fen] Taipei Vet Gen Hosp, Dept Med Res, Integrated Brain Res Unit, Taipei, Taiwan; [Liu, Tai-Ying; Chen, Li-Fen] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Yong-Sheng] Natl Chiao Tung Univ, Dept Comp Sci, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, LF (corresponding author), Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan.	lfchen@ym.edu.tw	Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019		National Science Council [NSC100-2628-E-010-001, NSC 97-2752-B-010-003-PAE]; Taipei Veterans General Hospital [V97ER1-001]; Brain Research Center, National Yang-Ming University	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Brain Research Center, National Yang-Ming University	This study was supported in part by National Science Council (NSC100-2628-E-010-001, NSC 97-2752-B-010-003-PAE) and Taipei Veterans General Hospital (V97ER1-001) and Brain Research Center, National Yang-Ming University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P396, DOI 10.1037//0894-4105.15.3.396; Adolphs R, 1997, BILATERAL DAMAGE TO, P1582; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amaral DG, 1992, ANATOMICAL ORGANIZAT; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Braeutigam S, 2001, NEUROREPORT, V12, P1531, DOI 10.1097/00001756-200105250-00046; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; Chen YS, 2006, IEEE T BIO-MED ENG, V53, P1765, DOI 10.1109/TBME.2006.878115; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; Csibra G, 2000, SCIENCE, V290, P1582, DOI 10.1126/science.290.5496.1582; Davidson RJ, 1995, BRAIN ASYMMETRY; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Freese JL, 2005, J COMP NEUROL, V486, P295, DOI 10.1002/cne.20520; Fusar-Poli P, 2009, NEUROSCI LETT, V452, P262, DOI 10.1016/j.neulet.2009.01.065; Garrido MI, 2012, CURR BIOL, V22, P129, DOI 10.1016/j.cub.2011.11.056; Glascher J, 2003, J NEUROSCI, V23, P10274; Gow DW, 2008, NEUROIMAGE, V43, P614, DOI 10.1016/j.neuroimage.2008.07.027; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grossman ED, 2005, VISION RES, V45, P2847, DOI 10.1016/j.visres.2005.05.027; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Ide JS, 2011, NEUROIMAGE, V54, P455, DOI 10.1016/j.neuroimage.2010.07.042; Im CH, 2010, OPT EXPRESS, V18, P5730, DOI 10.1364/OE.18.005730; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kujala J, 2012, CEREB CORTEX, V22, P2305, DOI 10.1093/cercor/bhr307; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; LeDoux J. E., 1996, EMOTIONAL BRAIN; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Liu JX, 2010, ANN BIOMED ENG, V38, P138, DOI 10.1007/s10439-009-9840-9; Liu LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009790; Liu TY, 2012, NEUROPSYCHOLOGIA, V50, P1514, DOI 10.1016/j.neuropsychologia.2012.03.004; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; Luo Q, 2009, CEREB CORTEX, V19, P1896, DOI 10.1093/cercor/bhn216; Maior RS, 2010, BEHAV BRAIN RES, V215, P129, DOI 10.1016/j.bbr.2010.07.009; Maldonado PE, 2000, CEREB CORTEX, V10, P1117, DOI 10.1093/cercor/10.11.1117; Markowitsch HJ, 1998, BEHAV NEUROL, V11, P233; Martin A, 2003, COGN NEUROPSYCHOL, V20, P575, DOI 10.1080/02643290342000005; Morel S, 2012, NEUROIMAGE, V61, P1461, DOI 10.1016/j.neuroimage.2012.04.016; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Santos A, 2011, NEUROIMAGE, V54, P3111, DOI 10.1016/j.neuroimage.2010.11.024; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Stangor C, 2010, INTRODUCTION TO PSYC; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Williams LM, 2001, NEUROIMAGE, V14, P1070, DOI 10.1006/nimg.2001.0904; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	65	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115677	10.1371/journal.pone.0115677	http://dx.doi.org/10.1371/journal.pone.0115677			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629899	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100024
J	Harms, RZ; Lorenzo, KM; Corley, KP; Cabrera, MS; Sarvetnick, NE				Harms, Robert Z.; Lorenzo, Kristina M.; Corley, Kevin P.; Cabrera, Monina S.; Sarvetnick, Nora E.			Altered CD161(bright) CD8(+) Mucosal Associated Invariant T (MAIT)-Like Cell Dynamics and Increased Differentiation States among Juvenile Type 1 Diabetics	PLOS ONE			English	Article							INCREASED INTESTINAL PERMEABILITY; GENOME-WIDE ASSOCIATION; GUT MICROBIOTA; HEALTHY-CHILDREN; MAIT CELLS; RISK; INSULIN; AUTOIMMUNITY; ACTIVATION; POPULATION	Type 1A diabetes (T1D) is believed to be caused by immune-mediated destruction of beta-cells, but the immunological basis for T1D remains controversial. Microbial diversity promotes the maturation and activation of certain immune subsets, including CD161(bright) CD8(+) mucosal associated invariant T (MAIT) cells, and alterations in gut mucosal responses have been reported in type 1 diabetics (T1Ds). We analyzed T cell populations in peripheral blood leukocytes from juvenile T1Ds and healthy controls. We found that proportion and absolute number of MAIT cells were similar between T1Ds and controls. Furthermore, while MAIT cell proportions increased with age among healthy controls, this trend was not observed among long-standing T1Ds. Additionally, the CD27-MAIT cell subset is significantly increased in T1Ds and positively correlated with HbA1c levels. However, after T1Ds are stratified by age, the younger group has significantly increased proportions of CD27-MAIT cells compared to age-matched controls, and this proportional increase appears to be independent of HbA1c levels. Finally, we analyzed function of the CD27-MAIT cells and observed that IL-17A production is increased in CD27-compared to CD27(+) MAIT cells. Overall, our data reveal disparate MAIT cell dynamics between T1Ds and controls, as well as signs of increased MAIT cell activation in T1Ds. These changes may be linked to hyperglycemia and increased mucosal challenge among T1Ds.	[Harms, Robert Z.; Lorenzo, Kristina M.; Sarvetnick, Nora E.] Univ Nebraska Med Ctr, Dept Surg Transplant, Omaha, NE 68198 USA; [Corley, Kevin P.; Cabrera, Monina S.] Childrens Hosp & Med Ctr, Omaha, NE USA; [Sarvetnick, Nora E.] Univ Nebraska Med Ctr, Nebraska Regenerat Med Program, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Harms, RZ (corresponding author), Univ Nebraska Med Ctr, Dept Surg Transplant, Omaha, NE 68198 USA.	rharms@unmc.edu			National Institute of Diabetes and Digestive and Kidney Diseases [5 U01 AI102012-02]; J.W. Kieckhefer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI102012] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); J.W. Kieckhefer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding to NES from the National Institute of Diabetes and Digestive and Kidney Diseases (5 U01 AI102012-02) and the J.W. Kieckhefer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNER T, 1987, DIABETES CARE, V10, P164, DOI 10.2337/diacare.10.2.164; Altinova AE, 2008, CYTOKINE, V42, P217, DOI 10.1016/j.cyto.2008.02.006; Altobelli E, 2005, CLIN EXP MED, V5, P72, DOI 10.1007/s10238-005-0069-0; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Borchers AT, 2010, AUTOIMMUN REV, V9, pA355, DOI 10.1016/j.autrev.2009.12.003; Bosi E, 2006, DIABETOLOGIA, V49, P2824, DOI 10.1007/s00125-006-0465-3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Campbell-Thompson M, 2012, JAMA-J AM MED ASSOC, V308, P2337, DOI 10.1001/jama.2012.15008; Canivell S, 2014, AUTOIMMUN REV, V13, P403, DOI 10.1016/j.autrev.2014.01.020; Cengiz E, 2014, PEDIATR DIABETES, V15, P287, DOI 10.1111/pedi.12068; Charlton M, 2000, GASTROENTEROLOGY, V118, P299, DOI 10.1016/S0016-5085(00)70212-5; Chillaron JJ, 2014, METABOLISM, V63, P181, DOI 10.1016/j.metabol.2013.10.002; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Costa VS, 2010, DIABETES RES CLIN PR, V88, P222, DOI 10.1016/j.diabres.2010.03.014; Damci T, 2003, EUR J CLIN INVEST, V33, P397, DOI 10.1046/j.1365-2362.2003.01161.x; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Donath MY, 2014, DIABETOLOGIA, V57, P653, DOI 10.1007/s00125-013-3153-0; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Endesfelder D, 2014, DIABETES, V63, P2006, DOI 10.2337/db13-1676; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Mejia-Leon ME, 2014, SCI REP-UK, V4, DOI 10.1038/srep03814; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Goto Y, 2013, IMMUNOL CELL BIOL, V91, P204, DOI 10.1038/icb.2012.80; Heptulla RA, 2008, PEDIATR DIABETES, V9, P561, DOI 10.1111/j.1399-5448.2008.00430.x; Huber S, 2012, EUR J IMMUNOL, V42, P2238, DOI 10.1002/eji.201242619; Ilonen J, 2002, AM J MED GENET, V115, P30, DOI 10.1002/ajmg.10341; Katakami N, 2007, DIABETES CARE, V30, P159, DOI 10.2337/dc06-1768; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Korsgren S, 2012, AM J PATHOL, V181, P1735, DOI 10.1016/j.ajpath.2012.07.022; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lee OJ, 2014, EXP GERONTOL, V49, P47, DOI 10.1016/j.exger.2013.11.003; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; McCarthy NE, 2013, J IMMUNOL, V191, P2752, DOI 10.4049/jimmunol.1202959; Mortensen HB, 2010, PEDIATR DIABETES, V11, P218, DOI 10.1111/j.1399-5448.2009.00566.x; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Reutens AT, 2013, MED CLIN N AM, V97, P1, DOI 10.1016/j.mcna.2012.10.001; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Sapone A, 2006, DIABETES, V55, P1443, DOI 10.2337/db05-1593; Savilahti E, 1999, CLIN EXP IMMUNOL, V116, P70; Secondulfo M, 2004, DIGEST LIVER DIS, V36, P35, DOI 10.1016/j.dld.2003.09.016; Skog O, 2013, CURR OPIN ENDOCRINOL, V20, P118, DOI 10.1097/MED.0b013e32835edb89; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x; Sorini C, 2013, AM J CLIN EXP IMMUNO, V2, P156; Soyucen E, 2014, PEDIATR INT, V56, P336, DOI 10.1111/ped.12243; Thaiss CA, 2014, CURR OPIN IMMUNOL, V26, P41, DOI 10.1016/j.coi.2013.10.016; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Westerholm-Ormio M, 2003, DIABETES, V52, P2287, DOI 10.2337/diabetes.52.9.2287	58	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117335	10.1371/journal.pone.0117335	http://dx.doi.org/10.1371/journal.pone.0117335			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625430	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821400031
J	Langaee, T; Hamadeh, I; Chapman, AB; Gums, JG; Johnson, JA				Langaee, Taimour; Hamadeh, Issam; Chapman, Arlene B.; Gums, John G.; Johnson, Julie A.			A Novel Simple Method for Determining CYP2D6 Gene Copy Number and Identifying Allele(s) with Duplication/Multiplication	PLOS ONE			English	Article							DELETION; STRATEGY; LOCUS	Background Cytochrome P450 2D6 (CYP2D6) gene duplication and multiplication can result in ultrarapid drug metabolism and therapeutic failure or excessive response in patients. Long range polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP) and sequencing are usually used for genotyping CYP2D6 duplication/multiplications and identification, but are labor intensive, time consuming, and costly. Methods We developed a simple allele quantification-based Pyrosequencing genotyping method that facilitates CYP2D6 copy number variation (CNV) genotyping while also identifying allele-specific CYP2D6 CNV in heterozygous samples. Most routine assays do not identify the allele containing a CNV. A total of 237 clinical and Coriell DNA samples with different known CYP2D6 gene copy numbers were genotyped for CYP2D6 *2, *3, *4, *6, *10, *17, *41 polymorphisms and CNV determination. Results The CYP2D6 gene allele quantification/identification were determined simultaneously with CYP2D6*2, *3, *4, *6, *10, *17, *41 genotyping. We determined the exact CYP2D6 gene copy number, identified which allele had the duplication or multiplication, and assigned the correct phenotype and activity score for all samples. Conclusions Our method can efficiently identify the duplicated CYP2D6 allele in heterozygous samples, determine its copy number in a fraction of time compared to conventional methods and prevent incorrect ultrarapid phenotype calls. It also greatly reduces the cost, effort and time associated with CYP2D6 CNV genotyping.	[Langaee, Taimour; Hamadeh, Issam; Gums, John G.; Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA; [Langaee, Taimour; Hamadeh, Issam; Gums, John G.; Johnson, Julie A.] Univ Florida, Coll Pharm, Ctr Pharmacogen, Gainesville, FL USA; [Chapman, Arlene B.] Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Emory University	Johnson, JA (corresponding author), Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA.	Johnson@cop.ufl.edu			National Institute of General Medical Sciences (NIGMS) [U01 GM074492]; National Institutes of Health; National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trial Implementation Cooperative Agreement [U01, U01 HG007269]; NIH [UL1 TR000064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trial Implementation Cooperative Agreement; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of General Medical Sciences (NIGMS) U01 GM074492, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trial Implementation (U01) Cooperative Agreement, U01 HG007269 and the UL1 administratively linked to another project or projects to support clinical and translational research, NIH award UL1 TR000064.	Crews KR, 2012, CLIN PHARMACOL THER, V91, P321, DOI 10.1038/clpt.2011.287; Dorado P, 2005, BIOTECHNIQUES, V39, P571, DOI 10.2144/000112044; Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724; Gaedigk A, 2008, CLIN PHARMACOL THER, V83, P234, DOI 10.1038/sj.clpt.6100406; Gaedigk A, 2007, CLIN PHARMACOL THER, V81, P242, DOI 10.1038/sj.clpt.6100033; GAEDIGK A, 1991, AM J HUM GENET, V48, P943; Gaedigk A, 2012, PHARMACOGENOMICS, V13, P91, DOI [10.2217/PGS.11.135, 10.2217/pgs.11.135]; GONZALEZ F J, 1988, Genomics, V2, P174, DOI 10.1016/0888-7543(88)90100-0; HAMADEH IS, 2014, CLIN PHARM THER, P42331; Hosono N, 2009, CLIN CHEM, V55, P1546, DOI 10.1373/clinchem.2009.123620; KIMURA S, 1989, AM J HUM GENET, V45, P889; Kramer WE, 2009, PHARMACOGENET GENOM, V19, P813, DOI 10.1097/FPC.0b013e3283317b95; Langaee T, 2005, MUTAT RES-FUND MOL M, V573, P96, DOI 10.1016/j.mrfmmm.2004.07.023; Leandro-Garcia LJ, 2009, ANAL BIOCHEM, V389, P74, DOI 10.1016/j.ab.2009.03.021; Meijerman I, 2007, DRUG METAB REV, V39, P45, DOI 10.1080/03602530600952206; Pratt VM, 2010, J MOL DIAGN, V12, P835, DOI 10.2353/jmoldx.2010.100090; Ramamoorthy A, 2010, PHARMACOGENET GENOM, V20, P451, DOI 10.1097/FPC.0b013e32833a1083; Schaeffeler E, 2003, HUM MUTAT, V22, P476, DOI 10.1002/humu.10280; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soderback E, 2005, CLIN CHEM, V51, P522, DOI 10.1373/clinchem.2004.043182	20	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0113808	10.1371/journal.pone.0113808	http://dx.doi.org/10.1371/journal.pone.0113808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625348	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821400002
J	Huffaker, R; Bittelli, M				Huffaker, Ray; Bittelli, Marco			A Nonlinear Dynamics Approach for Incorporating Wind-Speed Patterns into Wind-Power Project Evaluation	PLOS ONE			English	Article							TIME-SERIES	Wind-energy production may be expanded beyond regions with high-average wind speeds (such as the Midwest U.S.A.) to sites with lower-average speeds (such as the Southeast U.S.A.) by locating favorable regional matches between natural wind-speed and energy-demand patterns. A critical component of wind-power evaluation is to incorporate wind-speed dynamics reflecting documented diurnal and seasonal behavioral patterns. Conventional probabilistic approaches remove patterns from wind-speed data. These patterns must be restored synthetically before they can be matched with energy-demand patterns. How to accurately restore wind-speed patterns is a vexing problem spurring an expanding line of papers. We propose a paradigm shift in wind power evaluation that employs signal-detection and nonlinear-dynamics techniques to empirically diagnose whether synthetic pattern restoration can be avoided altogether. If the complex behavior of observed wind-speed records is due to nonlinear, low-dimensional, and deterministic system dynamics, then nonlinear dynamics techniques can reconstruct wind-speed dynamics from observed wind-speed data without recourse to conventional probabilistic approaches. In the first study of its kind, we test a nonlinear dynamics approach in an application to Sugarland Wind-the first utility-scale wind project proposed in Florida, USA. We find empirical evidence of a low-dimensional and nonlinear wind-speed attractor characterized by strong temporal patterns that match up well with regular daily and seasonal electricity demand patterns.	[Huffaker, Ray] Univ Florida, Agr & Biol Engn Dept, Gainesville, FL 32611 USA; [Bittelli, Marco] Univ Bologna, Dept Agr Sci, Bologna, Italy	State University System of Florida; University of Florida; University of Bologna	Huffaker, R (corresponding author), Univ Florida, Agr & Biol Engn Dept, Gainesville, FL 32611 USA.	rhuffaker@ufl.edu		BITTELLI, MARCO/0000-0001-9638-6005				[Anonymous], 6 100 WIND TURB; [Anonymous], CHAMB SUPP SUG WIND; Blake D, 2008, PHYS PRINCIPLES METE, DOI 10.14219/jada.archive.2008.0268; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; BROWN BG, 1984, J CLIM APPL METEOROL, V23, P1184, DOI 10.1175/1520-0450(1984)023<1184:TSMTSA>2.0.CO;2; Durak M, 2002, RENEW ENERG, V25, P463, DOI 10.1016/S0960-1481(01)00003-9; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Gokcek M, 2007, RENEW ENERG, V32, P1739, DOI 10.1016/j.renene.2006.11.017; Golyandida N., 2001, ANAL TIME SERIES STR, DOI [DOI 10.1201/9780367801687, 10.1201/9780367801687]; Greco G, 2011, SCI REPORTS NATURE S; Hassani H, 2007, THE J, V5, P239, DOI [10.6339/JDS.2007.05(2).396, DOI 10.6339/JDS.2007.05(2).396]; Kantz H., 1997, NONLINEAR TIME SERIE; KAPLAN D, 1995, UNDERSTANDING NONLIN; Karamanis D, 2011, RENEW ENERG, V36, P815, DOI 10.1016/j.renene.2010.08.007; Lima LD, 2010, RENEW ENERG, V35, P2705, DOI 10.1016/j.renene.2010.04.019; Lu L, 2002, RENEW ENERG, V27, P1, DOI 10.1016/S0960-1481(01)00164-1; Morris L, 2012, BRINGING WIND SE; Oke T. R., 1978, Boundary layer climates.; Palm-Beach-County, 2012, APPL ZV CA 2011 0094, DOI [10.1111/cob.12003, DOI 10.1111/COB.12003]; Salisbury S, 2012, PALM BEACH POST 0102; Schreiber T, 1999, PHYS REP, V308, P2, DOI 10.1016/S0370-1573(98)00035-0; Small M, 2002, PHYSICA D, V164, P187, DOI 10.1016/S0167-2789(02)00382-2; Small M, 2003, IEEE T CIRCUITS-I, V50, P663, DOI 10.1109/TCSI.2003.811020; Sprott JC, 2003, CHAOS TIME SERIES AN; Sreelekshmi RC, 2012, ANN GEOPHYS-GERMANY, V30, P1503, DOI 10.5194/angeo-30-1503-2012; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Suomalainen K, 2012, J RENEW SUSTAIN ENER, V4, DOI 10.1063/1.3692220; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Trabish H, 2011, WIND CAPITAL GROUP G; Vautard R., 1999, ANAL CLIMATE VARIABI; Vincent C, 2010, J APPL METEOROL CLIM, V49, P253, DOI 10.1175/2009JAMC2058.1; Weisser D, 2003, RENEW ENERG, V28, P1803, DOI 10.1016/S0960-1481(03)00016-8; Williams GP, 1997, CHAOS THEORY TAMED; Winsberg M, ANAL BEGINNING END L; Zhou W, 2006, RENEW ENERG, V31, P739, DOI 10.1016/j.renene.2005.05.006	35	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0115123	10.1371/journal.pone.0115123	http://dx.doi.org/10.1371/journal.pone.0115123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617767	gold, Green Published, Green Submitted			2022-12-27	WOS:000350336000004
J	Lehri-Boufala, S; Ouidja, MO; Barbier-Chassefiere, V; Henault, E; Raisman-Vozari, R; Garrigue-Antar, L; Papy-Garcia, D; Morin, C				Lehri-Boufala, Sonia; Ouidja, Mohand-Ouidir; Barbier-ChassefiSre, Veronique; Henault, Emilie; Raisman-Vozari, Rita; Garrigue-Antar, Laure; Papy-Garcia, Dulce; Morin, Christophe			New Roles of Glycosaminoglycans in alpha-Synuclein Aggregation in a Cellular Model of Parkinson Disease	PLOS ONE			English	Article							OXIDATIVE STRESS; CATHEPSIN-D; DEGRADATION; PROTEOGLYCANS; EXPRESSION; APOPTOSIS; AUTOPHAGY; SULFATION; MICE	The causes of Parkinson disease (PD) remain mysterious, although some evidence supports mitochondrial dysfunctions and alpha-synuclein accumulation in Lewy bodies as major events. The abnormal accumulation of alpha-synuclein has been associated with a deficiency in the ubiquitin-proteasome system and the autophagy-lysosomal pathway. Cathepsin D ( cathD), the major lysosomal protease responsible of a-synuclein degradation was described to be up-regulated in PD model. As glycosaminoglycans ( GAGs) regulate cathD activity, and have been recently suggested to participate in PD physiopathology, we investigated their role in a-synuclein accumulation by their intracellular regulation of cathD activity. In a classical neuroblastoma cell model of PD induced by MPP+, the genetic expression of GAGs-biosynthetic enzymes was modified, leading to an increase of GAGs amounts whereas intracellular level of a-synuclein increased. The absence of sulfated GAGs increased intracellular cathD activity and limited alpha-synuclein accumulation. GAGs effects on cathD further suggested that specific sequences or sulfation patterns could be responsible for this regulation. The present study identifies, for the first time, GAGs as new regulators of the lysosome degradation pathway, regulating cathD activity and affecting two main biological processes, alpha-synuclein aggregation and apoptosis. Finally, this opens new insights into intracellular GAGs functions and new fields of investigation for glycobiological approaches in PD and neurobiology.	[Lehri-Boufala, Sonia; Ouidja, Mohand-Ouidir; Barbier-ChassefiSre, Veronique; Henault, Emilie; Garrigue-Antar, Laure; Papy-Garcia, Dulce; Morin, Christophe] Univ Paris Est Creteil, Lab CRRET EAC CNRS 7149, F-94010 Creteil, France; [Raisman-Vozari, Rita] Univ Paris 06, CNRS UMR 7225, ICM,Ctr Rech,Inst Cerveau & Moelle Epiniere, Hop Salpetriere Batiment,CRICM, F-75651 Paris, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Morin, C (corresponding author), Univ Paris Est Creteil, Lab CRRET EAC CNRS 7149, 61 Ave Gen Gaulle, F-94010 Creteil, France.	ch.morin@u-pec.fr	Morin, christophe/V-6238-2017; Morin, christophe/O-8796-2019	Morin, christophe/0000-0002-2490-7585; Morin, christophe/0000-0002-2490-7585; Garrigue-Antar, Laure/0000-0001-6331-8882				AVILA JL, 1976, BIOCHEM J, V160, P129, DOI 10.1042/bj1600129; AVILA JL, 1975, BIOCHEM J, V152, P57, DOI 10.1042/bj1520057; Bandopadhyay R, 2010, TRENDS MOL MED, V16, P27, DOI 10.1016/j.molmed.2009.11.004; Barbosa I, 2005, J CELL SCI, V118, P253, DOI 10.1242/jcs.01607; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Barret A, 2005, J BIOL CHEM, V280, P10516, DOI 10.1074/jbc.M412635200; BATES TE, 1994, J NEUROCHEM, V63, P640; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Engelender S, 2008, AUTOPHAGY, V4, P372, DOI 10.4161/auto.5604; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Kalivendi SV, 2004, J BIOL CHEM, V279, P15240, DOI 10.1074/jbc.M312497200; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Huynh MB, 2012, J BIOL CHEM, V287, P11363, DOI 10.1074/jbc.M111.335901; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Nakayama F, 2008, CELL MOL BIOL LETT, V13, P475, DOI 10.2478/s11658-008-0016-7; Nara A, 2012, BRAIN RES, V1466, P1, DOI 10.1016/j.brainres.2012.05.017; Narkiewicz J, 2014, PRION, V8, P19, DOI 10.4161/pri.28125; Okuda T, 2003, J BIOCHEM, V134, P111, DOI 10.1093/jb/mvg118; Papy-Garcia D, 2011, CURR PROTEIN PEPT SC, V12, P258, DOI 10.2174/138920311795860188; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Rott R, 2013, CNS NEUROL DISORD-DR; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Winder-Rhodes SE, 2012, MOVEMENT DISORD, V27, P312, DOI 10.1002/mds.24029; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Yelamanchili SV, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-52; Yue XL, 2009, CELL DEATH DIFFER, V16, P770, DOI 10.1038/cdd.2009.9; Zhang GL, 2013, J NEUROSCI RES, V91, P273, DOI 10.1002/jnr.23146	44	32	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116641	10.1371/journal.pone.0116641	http://dx.doi.org/10.1371/journal.pone.0116641			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617759	gold, Green Published, Green Submitted			2022-12-27	WOS:000350336000020
J	van Maanen, MA; Papke, RL; Koopman, FA; Koepke, J; Bevaart, L; Clark, R; Lamppu, D; Elbaum, D; LaRosa, GJ; Tak, PP; Vervoordeldonk, MJ				van Maanen, Marjolein A.; Papke, Roger L.; Koopman, Frieda A.; Koepke, Jessica; Bevaart, Lisette; Clark, Roger; Lamppu, Diana; Elbaum, Daniel; LaRosa, Gregory J.; Tak, Paul P.; Vervoordeldonk, Margriet J.			Two Novel alpha 7 Nicotinic Acetylcholine Receptor Ligands: In Vitro Properties and Their Efficacy in Collagen-Induced Arthritis in Mice	PLOS ONE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; POSITIVE ALLOSTERIC MODULATION; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; VAGUS NERVE; XENOPUS OOCYTES; ACTIVATION; STIMULATION; INFLAMMATION; EXPRESSION	Introduction The cholinergic anti-inflammatory pathway can downregulate inflammation via the release of acetylcholine (ACh) by the vagus nerve. This neurotransmitter binds to the alpha 7 subunit of nicotinic acetylcholine receptors (alpha 7nAChR), expressed on macrophages and other immune cells. We tested the pharmacological and functional profile of two novel compounds, PMP-311 and PMP-072 and investigated their role in modulating collagen-induced arthritis (CIA) in mice. Methods Both compounds were characterized with binding, electrophysiological, and pharmacokinetic studies. For in vivo efficacy studies in the CIA model the compounds were administered daily by oral gavage from day 20 till sacrifice at day 34. Disease progression was monitored by visual clinical scoring and measurement of paw swelling. Inflammation and joint destruction were examined by histology and radiology. Results Treatment with PMP-311 was effective in preventing disease onset, reducing clinical signs of arthritis, and reducing synovial inflammation and bone destruction. PMP-072 also showed a trend in arthritis reduction at all concentrations tested. The data showed that while both compounds bind to a7nAChR with high affinity, PMP-311 acts like a classical agonist of ion channel activity, and PMP-072 can actually act as an ion channel antagonist. Moreover, PMP-072 was clearly distinct from typical competitive antagonists, since it was able to act as a silent agonist. It synergizes with the allosteric modulator PNU-120596, and subsequently activates desensitized alpha 7nAChR. However, PMP-072 was less efficacious than PMP-311 at both channel activation and desensitization, suggesting that both conducting and non-conducting states maybe of importance in driving an anti-inflammatory response. Finally, we found that the anti-arthritic effect can be observed despite limited penetration of the central nervous system. Conclusions These data provide direct evidence that the alpha 7nAChR in immune cells does not require typical ion channel activation to exert its antiinflammatory effects.	[van Maanen, Marjolein A.; Koopman, Frieda A.; Koepke, Jessica; Bevaart, Lisette; Tak, Paul P.; Vervoordeldonk, Margriet J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Papke, Roger L.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Koepke, Jessica; Bevaart, Lisette; Vervoordeldonk, Margriet J.] Arthrogen BV, Amsterdam, Netherlands; [Clark, Roger; Lamppu, Diana; LaRosa, Gregory J.] Cornerstone Therapeut Inc, Cary, NC USA; [Elbaum, Daniel] DEC Associates LLC, Newton, MA USA	University of Amsterdam; Academic Medical Center Amsterdam; State University System of Florida; University of Florida	Vervoordeldonk, MJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.j.vervoordeldonk@amc.uva.nl			Dutch Arthritis Association [NR 05-1-102)]; NIH [GM57481]; Cornerstone Therapeutics Inc.; SetPoint Medical and Critical Therapeutics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057481] Funding Source: NIH RePORTER	Dutch Arthritis Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornerstone Therapeutics Inc.; SetPoint Medical and Critical Therapeutics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Dutch Arthritis Association (NR 05-1-102), a NIH grant GM57481 and a research award from Cornerstone Therapeutics Inc. PPT received research support from SetPoint Medical and Critical Therapeutics. The funders SetPoint Medical and Critical Therapeutics had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Roger Clark, Diana Lamppu and Gregory J. LaRosa were employed by Cornerstone Therapeutics, Inc. during the course of the study. Co-authors Jessica Koepke, Lisette Bevaart and Margriet J. Vervoordeldonk are employed by Arthrogen BV. Co-author Daniel Elbaum is employed by DEC Associates, LLC. Cornerstone Therapeutics Inc., Arthrogen BV. and DEC Associates, LLC provided support in the form of salaries for authors RC, DL, GJLR, JK, LB, MJV and DE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; Arredondo J, 2007, LIFE SCI, V80, P2191, DOI 10.1016/j.lfs.2007.01.013; Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2; Briggs CA, 2009, BRIT J PHARMACOL, V158, P1486, DOI 10.1111/j.1476-5381.2009.00426.x; Chojnacka K, 2013, BIOORG MED CHEM LETT, V23, P4145, DOI 10.1016/j.bmcl.2013.05.039; Clark R, 2007, NOVEL PIPERAZINES PH; Cloez-Tayarani I, 2007, J LEUKOCYTE BIOL, V81, P599, DOI 10.1189/jlb.0906544; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Feldmann M, 2008, IMMUNOL REV, V223, P7, DOI 10.1111/j.1600-065X.2008.00626.x; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Giebelen IAJ, 2007, SHOCK, V28, P700, DOI 10.1097/shk.0b013e318054dd89; Giebelen IAJ, 2007, SHOCK, V27, P443, DOI 10.1097/01.shk.0000245016.78493.bb; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Horenstein NA, 2008, MOL PHARMACOL, V74, P1496, DOI 10.1124/mol.108.048892; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jull BA, 2001, J CANCER RES CLIN, V127, P707; Kageyama-Yahara N, 2008, BIOCHEM BIOPH RES CO, V377, P321, DOI 10.1016/j.bbrc.2008.10.004; Kop EN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2049; Lopez-Hernandez GY, 2009, MOL PHARMACOL, V76, P652, DOI 10.1124/mol.109.056176; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Papke RL, 1998, NEUROSCI LETT, V256, P163, DOI 10.1016/S0304-3940(98)00786-1; Papke RL, 2004, BIOORG MED CHEM LETT, V14, P1849, DOI 10.1016/j.bmcl.2003.09.104; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Papke RL, 2014, J PHARM EXP THER; Papke RL, 2009, J PHARMACOL EXP THER, V329, P791, DOI 10.1124/jpet.108.150151; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Peng C, 2013, MOL PHARMACOL, V84, P459, DOI 10.1124/mol.113.086462; Shimohama S, 2009, BIOL PHARM BULL, V32, P332, DOI 10.1248/bpb.32.332; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Thomsen MS, 2012, J NEUROIMMUNOL, V251, P65, DOI 10.1016/j.jneuroim.2012.07.006; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; VAN HJ, 2004, ARTHRITIS RES THER, V6, pR239, DOI DOI 10.1186/AR1165; van Holten J, 2004, ARTHRITIS RES THER, V6, pR239, DOI 10.1186/ar1165; van Maanen MA, 2010, ANN RHEUM DIS, V69, P1717, DOI 10.1136/ard.2009.118554; van Maanen MA, 2009, NAT REV RHEUMATOL, V5, P229, DOI 10.1038/nrrheum.2009.31; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P1272, DOI 10.1002/art.24470; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P114, DOI 10.1002/art.24177; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7; Waldburger JM, 2008, ARTHRITIS RHEUM, V58, P3439, DOI 10.1002/art.23987; Williams DK, 2012, MOL PHARMACOL, V82, P746, DOI 10.1124/mol.112.080317; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Xiao YX, 2006, MOL PHARMACOL, V70, P1454, DOI 10.1124/mol.106.027318; Yoshida S, 2005, J MED CHEM, V48, P7075, DOI 10.1021/jm050209t	52	29	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116227	10.1371/journal.pone.0116227	http://dx.doi.org/10.1371/journal.pone.0116227			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617631	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000011
J	Rivera-Hoyos, CM; Morales-Alvarez, ED; Poveda-Cuevas, SA; Reyes-Guzman, EA; Poutou-Pinales, RA; Reyes-Montano, EA; Pedroza-Rodriguez, AM; Rodriguez-Vazquez, R; Cardozo-Bernal, AM				Rivera-Hoyos, Claudia M.; Morales-Alvarez, Edwin David; Poveda-Cuevas, Sergio Alejandro; Reyes-Guzman, Edwin Alfredo; Poutou-Pinales, Raul A.; Reyes-Montano, Edgar Antonio; Pedroza-Rodriguez, Aura Marina; Rodriguez-Vazquez, Refugio; Cardozo-Bernal, Angela M.			Computational Analysis and Low-Scale Constitutive Expression of Laccases Synthetic Genes GlLCC1 from Ganoderma lucidum and POXA 1B from Pleurotus ostreatus in Pichia pastoris	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; TRAMETES-VERSICOLOR; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; SCORING FUNCTION; MODEL QUALITY; OPTIMIZATION; DEGRADATION; SUBSTRATE	Lacasses are multicopper oxidases that can catalyze aromatic and non-aromatic compounds concomitantly with reduction of molecular oxygen to water. Fungal laccases have generated a growing interest due to their biotechnological potential applications, such as lignocellulosic material delignification, biopulping and biobleaching, wastewater treatment, and transformation of toxic organic pollutants. In this work we selected fungal genes encoding for laccase enzymes GlLCC1 in Ganoderma lucidum and POXA 1B in Pleurotus ostreatus. These genes were optimized for codon use, GC content, and regions generating secondary structures. Laccase proposed computational models, and their interaction with ABTS [2, 2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)] substrate was evaluated by molecular docking. Synthetic genes were cloned under the control of Pichia pastoris glyceraldehyde-3-phosphate dehydrogenase (GAP) constitutive promoter. P. pastoris X-33 was transformed with pGAPZ alpha A-LaccGluc-Stop and pGAPZ alpha A-LaccPost-Stop constructs. Optimization reduced GC content by 47 and 49% for LaccGluc-Stop and LaccPost-Stop genes, respectively. A codon adaptation index of 0.84 was obtained for both genes. 3D structure analysis using SuperPose revealed LaccGluc-Stop is similar to the laccase crystallographic structure 1GYC of Trametes versicolor. Interaction analysis of the 3D models validated through ABTS, demonstrated higher substrate affinity for LaccPost-Stop, in agreement with our experimental results with enzymatic activities of 451.08 +/- 6.46 UL-1 compared to activities of 0.13 +/- 0.028 UL-1 for LaccGluc-Stop. This study demonstrated that G. lucidum GlLCC1 and P. ostreatus POXA 1B gene optimization resulted in constitutive gene expression under GAP promoter and alpha-factor leader in P. pastoris. These are important findings in light of recombinant enzyme expression system utility for environmentally friendly designed expression systems, because of the wide range of substrates that laccases can transform. This contributes to a great gamut of products in diverse settings: industry, clinical and chemical use, and environmental applications.	[Rivera-Hoyos, Claudia M.; Poutou-Pinales, Raul A.; Cardozo-Bernal, Angela M.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Biotecnol Mol,GBAI, Bogota, DC, Colombia; [Morales-Alvarez, Edwin David; Pedroza-Rodriguez, Aura Marina] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Microbiol Ambiental & Suelos,GBAI, Bogota, DC, Colombia; [Morales-Alvarez, Edwin David] Univ Caldas, Fac Ciencias Exactas & Nat, Grupo Invest Genet Biodiversidad & Manejo Ecosist, Dept Quim, Manizales Caldas, Colombia; [Poveda-Cuevas, Sergio Alejandro] UPTC, Fac Ciencias Basicas, Escuela Ciencias Biol, Tunja Boyaca, Colombia; [Reyes-Guzman, Edwin Alfredo; Pedroza-Rodriguez, Aura Marina] Univ Nacl Colombia UNAL, Fac Ciencias, Dept Quim, Bogota, DC, Colombia; [Rodriguez-Vazquez, Refugio] IPN, Ctr Invest & Estudios Avanzados, Dept Biotecnol & Bioingn, Mexico City, DF, Mexico	Pontificia Universidad Javeriana; Pontificia Universidad Javeriana; Universidad de Caldas; Universidad Pedagogica y Tecnologica de Colombia (UPTC); Universidad Nacional de Colombia; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Poutou-Pinales, RA (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Biotecnol Mol,GBAI, Bogota, DC, Colombia.	rpoutou@javeriana.edu.co; eareyesm@unal.edu.co; apedroza@javeriana.edu.co	Poutou-Piñales, Raúl A./AAF-2962-2019; Marina, Aura/AAF-7657-2019; Poveda Cuevas, Sergio Alejandro Alejandro Poveda/AAX-1132-2021; Rivera-Hoyos, Claudia M./AAF-2954-2019	Poutou-Piñales, Raúl A./0000-0001-8841-2357; Poveda Cuevas, Sergio Alejandro Alejandro Poveda/0000-0002-3087-6674; Morales-Alvarez, Edwin David/0000-0003-2622-2130; Rivera-Hoyos, Claudia Marcela/0000-0003-0915-8229; Reyes Montano, Edgar Antonio/0000-0003-0921-2125	Pontificia Universidad Javeriana, Bogota, D.C. Colombia [00004334, 00004335]; Universidad Nacional de Colombia, Bogota, D.C. Colombia [DIB 12929]	Pontificia Universidad Javeriana, Bogota, D.C. Colombia; Universidad Nacional de Colombia, Bogota, D.C. Colombia	This work was supported by Pontificia Universidad Javeriana, Bogota, D.C. Colombia (Grants 00004334 and 00004335) and by Universidad Nacional de Colombia, Bogota, D.C. Colombia (grant DIB 12929). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Barragan CE, 2005, NOVA, V3, P80; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Bertrand T, 2002, BIOCHEMISTRY-US, V41, P7325, DOI 10.1021/bi0201318; Bleve G, 2008, APPL MICROBIOL BIOT, V79, P731, DOI 10.1007/s00253-008-1479-1; Bulter T, 2003, APPL ENVIRON MICROB, V69, P987, DOI 10.1128/AEM.69.2.987-995.2003; Cambria MT, 2010, J BIOMOL STRUCT DYN, V27, P501, DOI 10.1080/07391102.2010.10507334; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cordoba-Ruiz HA, 2009, AFR J BIOTECHNOL, V8, P1786; Doran PM, 1998, PRINCIPIOS INGENIERI; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Enguita FJ, 2004, J BIOL CHEM, V279, P23472, DOI 10.1074/jbc.M314000200; Fernández Jorge Andrés, 2009, Rev. colomb. biotecnol, V11, P59; Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guo M, 2006, APPL MICROBIOL BIOT, V71, P848, DOI 10.1007/s00253-005-0210-8; Helles G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-338; Henao-Jaramillo LM, 2011, INT BIOTECHNOL COLOR, V1, P9; Huang H, 2008, APPL MICROBIOL BIOT, V78, P95, DOI 10.1007/s00253-007-1290-4; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Joo SS, 2008, MOL CELLS, V25, P112; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Ko EM, 2001, APPL MICROBIOL BIOT, V57, P98, DOI 10.1007/s002530100727; Landazuri P, 2009, AFR J BIOTECHNOL, V8, P2871; Loera Corral O., 2006, Advances in agricultural and food biotechnology, P323; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Callaghan J, 2002, J IND MICROBIOL BIOT, V29, P55, DOI 10.1038/sj.jim.7000268; Palmieri G, 1997, J BIOL CHEM, V272, P31301, DOI 10.1074/jbc.272.50.31301; Pedroza AM, 2007, CHEMOSPHERE, V67, P793, DOI 10.1016/j.chemosphere.2006.10.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Piscitelli A, 2005, APPL MICROBIOL BIOT, V69, P428, DOI 10.1007/s00253-005-0004-z; Piscitelli Alessandra, 2010, Bioeng Bugs, V1, P252, DOI 10.4161/bbug.1.4.11438; Plummer DT, 1981, INTRO BIOQUIMICA PRA; Poutou-Pinales RA, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue3-fulltext-8; Poutou-Pinales RA, 2010, AFR J BIOTECHNOL, V9, P2173; Prasad NK, 2011, J MOL MODEL, P1; Rivera-Hoyos CM, 2013, FUNGAL BIOL REV, V27, P67, DOI 10.1016/j.fbr.2013.07.001; Robert V, 2011, CURR GENOMICS, V12, P123, DOI 10.2174/138920211795564340; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Sambrook J., 2001, MOL CLONING LAB MANU; Santo M, 2013, INT BIODETER BIODEGR, V84, P204, DOI 10.1016/j.ibiod.2012.03.001; Sun J, 2012, MOL BIOL REP, V39, P3807, DOI 10.1007/s11033-011-1158-7; Suresh PS, 2008, J MOL GRAPH MODEL, V26, P845, DOI 10.1016/j.jmgm.2007.05.005; Theerachat M, 2012, BIORESOURCE TECHNOL, V125, P267, DOI 10.1016/j.biortech.2012.07.117; Tinoco R, 2001, LETT APPL MICROBIOL, V32, P331, DOI 10.1046/j.1472-765X.2001.00913.x; Velu C, 2011, J BIOPROCESSING BIOT, V1; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Xie HF, 2013, J MICROBIOL BIOTECHN, V23, P864, DOI 10.4014/jmb.1212.12057; Yu GC, 2006, PROCESS BIOCHEM, V41, P1987, DOI 10.1016/j.procbio.2006.04.008	62	28	30	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116524	10.1371/journal.pone.0116524	http://dx.doi.org/10.1371/journal.pone.0116524			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611746	gold, Green Published, Green Submitted			2022-12-27	WOS:000348562900017
J	Johnson, ME; Mahoney, JM; Taroni, J; Sargent, JL; Marmarelis, E; Wu, MR; Varga, J; Hinchcliff, ME; Whitfield, ML				Johnson, Michael E.; Mahoney, J. Matthew; Taroni, Jaclyn; Sargent, Jennifer L.; Marmarelis, Eleni; Wu, Ming-Ru; Varga, John; Hinchcliff, Monique E.; Whitfield, Michael L.			Experimentally-Derived Fibroblast Gene Signatures Identify Molecular Pathways Associated with Distinct Subsets of Systemic Sclerosis Patients in Three Independent Cohorts	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; ELEVATED SERUM-LEVELS; GROWTH-FACTOR; EXPRESSION PATTERNS; PULMONARY-FIBROSIS; INTERFERON-ALPHA; SCLERODERMA SKIN; TGF-BETA; DISEASE; PATHOGENESIS	Genome-wide expression profiling in systemic sclerosis (SSc) has identified four 'intrinsic' subsets of disease (fibroproliferative, inflammatory, limited, and normal-like), each of which shows deregulation of distinct signaling pathways; however, the full set of pathways contributing to this differential gene expression has not been fully elucidated. Here we examine experimentally derived gene expression signatures in dermal fibroblasts for thirteen different signaling pathways implicated in SSc pathogenesis. These data show distinct and overlapping sets of genes induced by each pathway, allowing for a better understanding of the molecular relationship between profibrotic and immune signaling networks. Pathway-specific gene signatures were analyzed across a compendium of microarray datasets consisting of skin biopsies from three independent cohorts representing 80 SSc patients, 4 morphea, and 26 controls. IFN alpha signaling showed a strong association with early disease, while TGF beta signaling spanned the fibroproliferative and inflammatory subsets, was associated with worse MRSS, and was higher in lesional than non-lesional skin. The fibroproliferative subset was most strongly associated with PDGF signaling, while the inflammatory subset demonstrated strong activation of innate immune pathways including TLR signaling upstream of NF-kappa B. The limited and normal-like subsets did not show associations with fibrotic and inflammatory mediators such as TGF beta and TNF alpha. The normal-like subset showed high expression of genes associated with lipid signaling, which was absent in the inflammatory and limited subsets. Together, these data suggest a model by which IFN alpha is involved in early disease pathology, and disease severity is associated with active TGF beta signaling.	[Johnson, Michael E.; Mahoney, J. Matthew; Taroni, Jaclyn; Sargent, Jennifer L.; Marmarelis, Eleni; Wu, Ming-Ru; Whitfield, Michael L.] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH 03755 USA; [Varga, John; Hinchcliff, Monique E.] Northwestern Univ, Feinberg Sch Med, Dept Internal Med, Div Rheumatol, Chicago, IL USA	Dartmouth College; Northwestern University; Feinberg School of Medicine	Whitfield, ML (corresponding author), Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH 03755 USA.	Michael.L.Whitfield@Dartmouth.edu	Whitfield, Michael/AAC-5010-2020; Varga, John/AAK-6472-2021	Hinchcliff, Monique/0000-0002-8652-9890; Taroni, Jaclyn/0000-0003-4734-4508	Scleroderma Research Foundation (SRF) [P50AR060780, P30AR061271, U01AR055063]; National Cancer Institute (NCI) [R25 CA134286-01]; National Institute of General Medical Sciences (NIGMS) [T32GM008704]; SYNERGY Grant from the Geisel School of Medicine at Dartmouth; NATIONAL CANCER INSTITUTE [R25CA134286, P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061271, U01AR055063, P50AR060780, K23AR059763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704] Funding Source: NIH RePORTER	Scleroderma Research Foundation (SRF); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); SYNERGY Grant from the Geisel School of Medicine at Dartmouth; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Scleroderma Research Foundation (SRF) (MLW, MH), P50AR060780 (MLW), P30AR061271 (MLW) and U01AR055063 (MLW and R. Lafyatis). JMM was supported by Award Number R25 CA134286-01 from the National Cancer Institute (NCI). JT was supported by Award Number T32GM008704 from the National Institute of General Medical Sciences (NIGMS). MEJ was also supported by a SYNERGY Grant from the Geisel School of Medicine at Dartmouth (to MLW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS, NIAMS, NCI or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assassi S, 2010, ARTHRITIS RHEUM-US, V62, P589, DOI 10.1002/art.27224; Atamas SP, 2003, CYTOKINE GROWTH F R, V14, P537, DOI 10.1016/S1359-6101(03)00060-1; Axtell RC, 2012, IMMUNOL REV, V248, P23, DOI 10.1111/j.1600-065X.2012.01131.x; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Black CM, 1999, ARTHRITIS RHEUM, V42, P299, DOI 10.1002/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R; Bode C, 2012, ARCH IMMUNOL THER EX, V60, P3, DOI 10.1007/s00005-011-0159-5; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Bolster MB, 1997, ARTHRITIS RHEUM-US, V40, P743, DOI 10.1002/art.1780400422; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brown XQ, 2010, J CELL PHYSIOL, V225, P115, DOI 10.1002/jcp.22202; Bu SZ, 2010, ARTHRITIS RHEUM-US, V62, P2117, DOI 10.1002/art.27463; Camporeale A, 2012, FRONT BIOSCI-LANDMRK, V17, P2306, DOI 10.2741/4054; Choubey D, 2011, J INTERF CYTOK RES, V31, P857, DOI 10.1089/jir.2011.0101; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; Chung L, 2009, ARTHRITIS RHEUM-US, V60, P584, DOI 10.1002/art.24221; Deleuran B, 2007, NAT CLIN PRACT RHEUM, V3, P682, DOI 10.1038/ncprheum0618; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Donati C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020389; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FALANGA V, 1992, Journal of Dermatological Science, V3, P131, DOI 10.1016/0923-1811(92)90026-8; Farina GA, 2010, J INVEST DERMATOL, V130, P2583, DOI 10.1038/jid.2010.200; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; GAY S, 1989, J INVEST DERMATOL, V92, P301, DOI 10.1111/1523-1747.ep12276895; Gerber EE, 2013, NATURE, V503, P126, DOI 10.1038/nature12614; Ghosh AK, 2009, FASEB J, V23, P2968, DOI 10.1096/fj.08-128736; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Greenblatt MB, 2012, AM J PATHOL, V180, P1080, DOI 10.1016/j.ajpath.2011.11.024; Hamidi A, 2012, J BIOL CHEM, V287, P123, DOI 10.1074/jbc.M111.285122; Hasegawa M, 1997, J RHEUMATOL, V24, P328; Higashi-Kuwata N, 2009, EXP DERMATOL, V18, P727, DOI 10.1111/j.1600-0625.2008.00828.x; Hinchcliff M, 2013, J INVEST DERMATOL; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Homer RJ, 2010, CURR OPIN RHEUMATOL, V22, P683, DOI 10.1097/BOR.0b013e32833ddcc9; Huang LS, 2013, FASEB J, V27, P1749, DOI 10.1096/fj.12-219634; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kimura A, 2011, INT IMMUNOPHARMACOL, V11, P319, DOI 10.1016/j.intimp.2010.10.004; LEROY EC, 1988, J RHEUMATOL, V15, P202; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDWICKA A, 1995, J RHEUMATOL, V22, P1876; MALLAT A, 1995, HEPATOLOGY, V21, P1003, DOI 10.1016/0270-9139(95)90247-3; Mathai SK, 2010, LAB INVEST, V90, P812, DOI 10.1038/labinvest.2010.73; Mathian A, 2012, ANN RHEUM DIS, V71, P1227, DOI 10.1136/annrheumdis-2011-200709; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Murata M, 2008, J DERMATOL SCI, V50, P240, DOI 10.1016/j.jdermsci.2008.01.001; Nakayama W, 2012, RHEUMATOL INT, V32, P403, DOI 10.1007/s00296-010-1691-z; O'Reilly S, 2014, CLIN SCI, V126, P329, DOI 10.1042/CS20130367; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; PANDOLFI A, 1989, P SOC EXP BIOL MED, V191, P1; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Pendergrass SA, 2012, J INVEST DERMATOL, V132, P1363, DOI 10.1038/jid.2011.472; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005903; Rodriguez-Reyna TS, 2012, RHEUMATOL INT, V32, P2653, DOI 10.1007/s00296-011-2056-y; Rubins KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015615; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sargent JL, 2010, J INVEST DERMATOL, V130, P694, DOI 10.1038/jid.2009.318; SFIKAKIS PP, 1993, CLIN IMMUNOL IMMUNOP, V69, P199, DOI 10.1006/clin.1993.1170; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Tokumura A, 2009, INT J MED SCI, V6, P168; Tompkins WA, 1999, J INTERF CYTOK RES, V19, P817, DOI 10.1089/107999099313325; Trojanowska M, 2008, RHEUMATOLOGY, V47, pV2, DOI 10.1093/rheumatology/ken265; Truchetet ME, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3486; Wei J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013778; Wei J, 2010, CURR OPIN RHEUMATOL, V22, P671, DOI 10.1097/BOR.0b013e32833de1a7; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Wu M, 2013, FRONT IMMUNOL, V4	68	62	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0114017	10.1371/journal.pone.0114017	http://dx.doi.org/10.1371/journal.pone.0114017			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607805	Green Published, Green Submitted, gold			2022-12-27	WOS:000348205300003
J	Newman, SJ; Easteal, S				Newman, Saul J.; Easteal, Simon			A New Metric of Inclusive Fitness Predicts the Human Mortality Profile	PLOS ONE			English	Article							POSTREPRODUCTIVE LIFE-SPAN; CHILDREN; GROWTH; RATES	Biological species have evolved characteristic patterns of age-specific mortality across their life spans. If these mortality profiles are shaped by natural selection they should reflect underlying variation in the fitness effect of mortality with age. Direct fitness models, however, do not accurately predict the mortality profiles of many species. For several species, including humans, mortality rates vary considerably before and after reproductive ages, during life-stages when no variation in direct fitness is possible. Variation in mortality rates at these ages may reflect indirect effects of natural selection acting through kin. To test this possibility we developed a new two-variable measure of inclusive fitness, which we term the extended genomic output or EGO. Using EGO, we estimate the inclusive fitness effect of mortality at different ages in a small hunter-gatherer population with a typical human mortality profile. EGO in this population predicts 90% of the variation in age-specific mortality. This result represents the first empirical measurement of inclusive fitness of a trait in any species. It shows that the pattern of human survival can largely be explained by variation in the inclusive fitness cost of mortality at different ages. More generally, our approach can be used to estimate the inclusive fitness of any trait or genotype from population data on birth dates and relatedness.	[Newman, Saul J.; Easteal, Simon] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Newman, SJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	saul.newman@anu.edu.au		Newman, Saul/0000-0001-9841-1518; Easteal, Simon/0000-0002-0462-502X				CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540; Caswell, 2000, MATRIX POPULATION MO; CHARLESWORTH B, 1993, GENETICA, V91, P11, DOI 10.1007/BF01435984; COALE AJ, 1957, POP STUD-J DEMOG, V11, P92, DOI 10.2307/2172513; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; EULER L, 1760, GEN RES MORTALITY MU, P1; Fisher RA, 1930, GENETICAL THEORY NAT; Haldane J.B.S., 1941, NEW PATHS GENETICS; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HEADLAND J, 2011, AGTA DEMOGRAPHIC DAT, P89023; Jones JH, 2009, EVOL HUM BEHAV, V30, P305, DOI 10.1016/j.evolhumbehav.2009.01.005; Jones OR, 2014, NATURE, V505, P169, DOI 10.1038/nature12789; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Lotka AJ, 1907, SCIENCE, V26, P21, DOI 10.1126/science.26.653.21-a; Lotka AJ, 1907, AM J SCI, V24, P199; MEDAWAR PB, 1957, UNIQUENESS INDIVIDUA, V36, P89023; RIFFE T, 2013, LOTKA, P89023; Roff DA, 2008, J GENET, V87, P339, DOI 10.1007/s12041-008-0056-9; Rose MR, 2008, J GENET, V87, P363, DOI 10.1007/s12041-008-0059-6; Sear R, 2000, P ROY SOC B-BIOL SCI, V267, P1641, DOI 10.1098/rspb.2000.1190; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; United Nations, 2011, WORLD POP PROSP 2010; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Yang QH, 1997, GENET EPIDEMIOL, V14, P493, DOI 10.1002/(SICI)1098-2272(1997)14:5<493::AID-GEPI4>3.0.CO;2-2	28	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0117019	10.1371/journal.pone.0117019	http://dx.doi.org/10.1371/journal.pone.0117019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607654	Green Submitted, Green Published, gold			2022-12-27	WOS:000348205300047
J	Zhang, LY; Chen, SY; Deng, AW; Liu, XY; Liang, Y; Shao, XF; Sun, MX; Zou, HQ				Zhang, Liying; Chen, Shanying; Deng, Aiwen; Liu, Xinyu; Liang, Yan; Shao, Xiaofei; Sun, Mingxia; Zou, Hequn			Association between Lipid Ratios and Insulin Resistance in a Chinese Population	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; METABOLIC SYNDROME; RISK; TRIGLYCERIDE; DISEASE; INDIVIDUALS; SENSITIVITY; KIDNEY; OBESE; INDEX	Aim To explore the association of lipid ratios and triglyceride (TG) with insulin resistance (IR) in a Chinese population. We also provide the clinical utility of lipid ratios to identify men and women with IR. Methods This cross-sectional study included 614 men and 1055 women without diabetes. Insulin resistance was defined by homeostatic model assessment of IR > 2.69. Lipid ratios included the TG/high density lipoprotein cholesterol (HDL-C), the total cholesterol (TC)/HDL-C and the low density lipoprotein cholesterol (LDL-C)/HDL-C. Logistic regression models and accurate estimates of the area under the receiver operating characteristic (AUROC) curves were obtained. Results In normal-weight men, none of lipid ratios nor TG was associated with IR. In overweight/obese men, normal-weight women and overweight/obese women, the TG/HDL-C, the TC/HDL-C and TG were significantly associated with IR, and the associations were independent of waist circumference. All of the AUROCs for the TG/HDL-C and TG were > 0.7. The AUROCs for TC/HDL-C ratio were 0.69-0.77. The optimal cut-offs for TG/HDL-C were 1.51 in men and 0.84 in women. The optimal cut-offs for TG were 1.78 mmol/L in men and 1.49 mmol/L in women, respectively. In men, the optimal cut-off for LDL-C/HDL-C is 3.80. In women, the optimal cut-off for LDL-C/HDL-C is 3.82. Conclusion The TG/HDL-C, the TC/HDL-C and TG are associated with IR in overweight/obese men, normal-weight and overweight/obese women. The LDL-C/HDL-C is only associated with IR in normal-weight women. The TG/HDL-C and TG might be used as surrogate markers for assessing IR.	[Zhang, Liying; Chen, Shanying; Liu, Xinyu; Liang, Yan; Shao, Xiaofei; Sun, Mingxia; Zou, Hequn] Southern Med Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Zhang, Liying] Inner Mongolia Med Univ, Affiliated Hosp 1, Dept Nephrol, Hohhot, Peoples R China; [Chen, Shanying] Fujian Med Univ, Zhangzhou Affiliated Hosp, Dept Nephrol, Zhangzhou, Fujian, Peoples R China; [Deng, Aiwen] Southern Med Univ, Affiliated Hosp 3, Dept Rehabil, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Inner Mongolia Medical University; Fujian Medical University; Southern Medical University - China	Zou, HQ (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	hequnzou@hotmail.com	Zou, He/GXH-0280-2022		EU FP7 Program, UroSense; ISN Research Committee grant; Guangdong Provincial Science and Technique Program [2011B031800386]	EU FP7 Program, UroSense; ISN Research Committee grant; Guangdong Provincial Science and Technique Program	This study was supported by the following Science Foundations: 1. EU FP7 Program, UroSense, 2011; 2. ISN Research Committee grant, 2007; 3. ISN Research Committee grant, 2004; 4. Guangdong Provincial Science and Technique Program (No. 2011B031800386), 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault BJ, 2011, NAT REV CARDIOL, V8, P197, DOI 10.1038/nrcardio.2010.223; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Chen SY, 2014, ENDOCRINE, V46, P496, DOI 10.1007/s12020-013-0079-8; Chen SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074058; Chiang JK, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-93; Elahl D, 1996, DIABETES CARE, V19, P278, DOI 10.2337/diacare.19.3.278; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gasevic D, 2012, METABOLISM, V61, P583, DOI 10.1016/j.metabol.2011.09.009; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hanley AJG, 2003, DIABETES, V52, P463, DOI 10.2337/diabetes.52.2.463; He JY, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/105168; HOSMER DW, 2000, WILEY PS TX, P1; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kawamoto R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-138; Kim-Dorner SJ, 2010, METABOLISM, V59, P299, DOI 10.1016/j.metabol.2009.07.027; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Li CY, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-4; Li GW, 1996, CHINESE J CARDIOLOGY, V24, P57; McLaughlin T, 2005, AM J CARDIOL, V96, P399, DOI 10.1016/j.amjcard.2005.03.085; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Molarius A, 1999, INT J OBESITY, V23, P116, DOI 10.1038/sj.ijo.0800772; Mostafa SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050931; Ray Sayantan, 2012, Indian J Endocrinol Metab, V16, pS460, DOI 10.4103/2230-8210.104132; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; Xiang SK, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/173281; [邢小燕 Xing Xiaoyan], 2004, [中华糖尿病杂志, Chinese Journal of Diabetes], V12, P182; Zhang LY, 2014, INT J ENV RES PUB HE, V11, P7622, DOI 10.3390/ijerph110807622	33	21	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116110	10.1371/journal.pone.0116110	http://dx.doi.org/10.1371/journal.pone.0116110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635876	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700024
J	Zhang, ZK; Lei, ZR				Zhang, Zhi-Ke; Lei, Zhong-Ren			Identification, Expression Profiling and Fluorescence-Based Binding Assays of a Chemosensory Protein Gene from the Western Flower Thrips, Frankliniella occidentalis	PLOS ONE			English	Article							LOCUSTA-MIGRATORIA ORTHOPTERA; ODORANT-BINDING; MOLECULAR-CLONING; SOLUBLE-PROTEINS; REGENERATING LEGS; MOTH; PURIFICATION; PATTERN; GENOME; FAMILY	Using RT-PCR and RACE-PCR strategies, we cloned and identified a new chemosensory protein (FoccCSP) from the Western flower thrips, Frankliniella occidentalis, a species for which no chemosensory protein (CSP) has yet been identified. The FoccCSP gene contains a 387 bp open-reading frame encoding a putative protein of 128 amino acids with a molecular weight of 14.51 kDa and an isoelectric point of 5.41. The deduced amino acid sequence contains a putative signal peptide of 19 amino acid residues at the N-terminus, as well as the typical four-cysteine signature found in other insect CSPs. As FoccCSP is from a different order of insect than other known CSPs, the GenBank FoccCSP homolog showed only 31-50% sequence identity with them. A neighbor-joining tree was constructed and revealed that FoccCSP is in a group with CSPs from Homopteran insects (e.g., AgosCSP4, AgosCSP10, ApisCSP, and NlugCSP9), suggesting that these genes likely developed from a common ancestral gene. The FoccCSP gene expression profile of different tissues and development stages was measured by quantitative real-time PCR. The results of this analysis revealed this gene is predominantly expressed in the antennae and also highly expressed in the first instar nymph, suggesting a function for FoccCSP in olfactory reception and in particular life activities during the first instar nymph stage. We expressed recombinant FoccCSP protein in a prokaryotic expression system and purified FoccCSP protein by affinity chromatography using a Ni-NTA-Sepharose column. Using N-phenyl-1-naphthylamine (1-NPN) as a fluorescent probe in fluorescence-based competitive binding assay, we determined the binding affinities of 19 volatile substances for FoccCSP protein. This analysis revealed that anisic aldehyde, geraniol and methyl salicylate have high binding affinities for FoccCSP, with KD values of 10.50, 15.35 and 35.24 mu M, respectively. Thus, our study indicates that FoccCSP may play an important role in regulating the development of the first instar nymph and mediate F. occidentalis host recognition.	[Zhang, Zhi-Ke; Lei, Zhong-Ren] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Zhang, Zhi-Ke] Ningxia Acad Agr & Forestry Sci, Inst Plant Protect, Yinchuan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhang, ZK (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	zhangzhike98@163.com; zrlei@ippcaas.cn			China Agriculture Research System [CARS-25-B-07]; National Modern Agricultural Science and Technology City Industry of Beijing [Z121100001212006]	China Agriculture Research System; National Modern Agricultural Science and Technology City Industry of Beijing	This research is partially funded by the China Agriculture Research System (CARS-25-B-07) and the National Modern Agricultural Science and Technology City Industry of Beijing (Z121100001212006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Benton R, 2008, CURR OPIN NEUROBIOL, V18, P357, DOI 10.1016/j.conb.2008.08.012; Bohbot J, 1998, BIOCHEM BIOPH RES CO, V253, P489, DOI 10.1006/bbrc.1998.9806; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; Calvello M, 2005, INSECT BIOCHEM MOLEC, V35, P297, DOI 10.1016/j.ibmb.2005.01.002; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Deng YP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-264; Du Yu-zhou, 2005, Scientia Agricultura Sinica, V38, P2360; DYANOV HM, 1995, BIOTECHNIQUES, V18, P822; FELLAND CM, 1995, J ECON ENTOMOL, V88, P1004, DOI 10.1093/jee/88.4.1004; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gu SH, 2012, PLOS ONE, V7, P1; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Hagen-Larsen H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-171; Ishida Y, 2002, NATURWISSENSCHAFTEN, V89, P505, DOI 10.1007/s00114-002-0368-1; Jacobs SP, 2005, INSECT MOL BIOL, V14, P423, DOI 10.1111/j.1365-2583.2005.00573.x; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jin X, 2005, CELL MOL LIFE SCI, V62, P1156, DOI 10.1007/s00018-005-5014-6; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Kirk WDJ, 2003, AGR FOREST ENTOMOL, V5, P301, DOI 10.1046/j.1461-9563.2003.00192.x; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Li XR, 2011, INT J BIOL SCI, V7, P848, DOI 10.7150/ijbs.7.848; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Liu XL, 2010, J BIOCHEM, V148, P189, DOI 10.1093/jb/mvq050; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DG, 2007, J CHEM ECOL, V33, P1359, DOI 10.1007/s10886-007-9310-5; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mameli M, 1996, INSECT BIOCHEM MOLEC, V26, P875, DOI 10.1016/S0965-1748(96)00055-0; Marchese S, 2000, INSECT BIOCHEM MOLEC, V30, P1091, DOI 10.1016/S0965-1748(00)00084-9; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Oduol F, 2000, P NATL ACAD SCI USA, V97, P11397, DOI 10.1073/pnas.180060997; Ozaki K, 2008, INSECT BIOCHEM MOLEC, V38, P969, DOI 10.1016/j.ibmb.2008.07.010; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Picimbon JF, 2000, ARCH INSECT BIOCHEM, V44, P120, DOI 10.1002/1520-6327(200007)44:3&lt;120::AID-ARCH3&gt;3.0.CO;2-H; Picimbon JF, 1999, INSECT BIOCHEM MOLEC, V29, P973, DOI 10.1016/S0965-1748(99)00073-9; Picimbon JF, 2000, INSECT BIOCHEM MOLEC, V30, P233, DOI 10.1016/S0965-1748(99)00121-6; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Ronderos DS, 2009, FLY, V3, P290, DOI 10.4161/fly.9801; Sabatier L, 2003, EUR J BIOCHEM, V270, P3398, DOI 10.1046/j.1432-1033.2003.03725.x; SCHNEIDER D, 1969, SCIENCE, V163, P1031, DOI 10.1126/science.163.3871.1031; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Steinbrecht RA, 1996, ENTOMOL EXP APPL, V80, P15, DOI 10.1007/BF00194714; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang JL, 2012, THESIS SHAANXI NORMA, P22; Wanner KW, 2005, INSECT MOL BIOL, V14, P289, DOI 10.1111/j.1365-2583.2005.00559.x; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Yoshizawa Y, 2011, INSECT BIOCHEM MOLEC, V41, P545, DOI 10.1016/j.ibmb.2011.03.006; Zhang GF, 2012, J APPL ENTOMOL, V136, P410, DOI 10.1111/j.1439-0418.2011.01661.x; Zhang SA, 2011, J CHEM ECOL, V37, P189, DOI 10.1007/s10886-010-9902-3; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x	63	10	16	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117726	10.1371/journal.pone.0117726	http://dx.doi.org/10.1371/journal.pone.0117726			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635391	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700098
J	Zhu, Y; Lei, Y; Du, BC; Zheng, YB; Lu, XF; Tan, T; Kang, JT; Sun, L; Liang, QJ				Zhu, Yan; Lei, Yan; Du, Baochen; Zheng, Yanbo; Lu, Xiangfeng; Tan, Tan; Kang, Jingting; Sun, Le; Liang, Qianjin			INMAP Overexpression Inhibits Cell Proliferation, Induces Genomic Instability and Functions through p53/p21 Pathways	PLOS ONE			English	Article							P53 TRANSCRIPTIONAL ACTIVITY; STRAND BREAK REPAIR; COLORECTAL-CANCER; POOR-PROGNOSIS; TUMOR ANGIOGENESIS; GASTRIC-CANCER; STROMAL CELLS; TARGET GENES; LUNG-CANCER; HYPOXIA	INMAP is a spindle protein that plays essential role for mitosis, by ensuring spindle and centromere integrality. The aim of this study was to investigate the relevant functions of INMAP for genomic stability and its functional pathway. We overexpressed INMAP in HeLa cells, resulting in growth inhibition in monolayer cell cultures, anchorage-independent growth in soft agar and xenograft growth in nude mice. In this system caused micronuclei (MNi) formation, chromosome distortion and gamma H2AX expression upregulation, suggesting DNA damage induction and genomic stability impairment. As a tumour biochemical marker, lactate dehydrogenase (LDH) isoenzymes were detected to evaluate cell metabolic activity, the results confirming that total activity of LDH, as well as that of its LDH5 isoform, is significantly decreased in INMAP-overexpressing HeLa cells. The levels of p53 and p21 were upregulated, and however, that of PCNA and Bcl-2, downregulated. Indirect immunofluorescence (IIF) and coimmunoprecipitation (CoIP) analyses revealed the interaction between INMAP and p21. These results suggest that INMAP might function through p53/p21 pathways.	[Zhu, Yan; Du, Baochen; Tan, Tan; Liang, Qianjin] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Zhu, Yan; Lei, Yan; Kang, Jingting; Liang, Qianjin] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Zheng, Yanbo] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Lu, Xiangfeng] Beijing Univ Chinese Tradit Med, Dongzhimen Hosp, Beijing 100700, Peoples R China; [Sun, Le] AbMax Biotechnol Co, Beijing 100085, Peoples R China	Beijing Normal University; Beijing Normal University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Beijing University of Chinese Medicine	Liang, QJ (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China.	lqj@bnu.edu.cn			Beijing Natural Science Foundation [5122017]; National Natural Science Foundation of China [30971470]; open fund of Beijing Key Laboratory of Gene Resource and Molecular Development [201204]; Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education of China [201307]; Fund for the Doctoral Innovative Research of Science & Technology Review [kjdb2012003]; AbMax Biotechnology Co	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); open fund of Beijing Key Laboratory of Gene Resource and Molecular Development; Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education of China(Ministry of Education, China); Fund for the Doctoral Innovative Research of Science & Technology Review; AbMax Biotechnology Co	This study was supported by the Beijing Natural Science Foundation (no. 5122017 to QL), the National Natural Science Foundation of China (no. 30971470 to QL), the open fund of Beijing Key Laboratory of Gene Resource and Molecular Development (no. 201204 to YZ), the Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education of China (no. 201307 to YZ), and the Fund for the Doctoral Innovative Research of Science & Technology Review (no. kjdb2012003 to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AbMax Biotechnology Co provided support in the form of a salary for LS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors are articulated in the 'author contributions' section.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Giatromanolaki A, 2012, CLIN EXP METASTAS, V29, P11, DOI 10.1007/s10585-011-9424-6; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Grimm M, 2013, CLIN EXP METASTAS, V30, P529, DOI 10.1007/s10585-012-9557-2; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hill R, 2008, CELL CYCLE, V7, P2535; Kennedy BWC, 2012, J AM CHEM SOC, V134, P4969, DOI 10.1021/ja300222e; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Koukourakis MI, 2003, TUMOR BIOL, V24, P199, DOI 10.1159/000074430; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2006, J CLIN ONCOL, V24, P4301, DOI 10.1200/JCO.2006.05.9501; Koukourakis MI, 2011, CLIN CANCER RES, V17, P4892, DOI 10.1158/1078-0432.CCR-10-2918; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu WL, 2011, HEPATOLOGY, V53, P843, DOI 10.1002/hep.24124; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Mauro M, 2012, NUCLEIC ACIDS RES, V40, P8348, DOI 10.1093/nar/gks612; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Neal JL, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-128; Ohata H, 2013, MOL CELL BIOL, V33, P2447, DOI 10.1128/MCB.01221-12; Rao XT, 2008, MUTAT RES-FUND MOL M, V646, P41, DOI 10.1016/j.mrfmmm.2008.09.004; Salnikow K, 2000, CANCER RES, V60, P5630; Shao SJ, 2010, J CLIN INVEST, V120, P498, DOI 10.1172/JCI39447; Shen EZ, 2009, EXP CELL RES, V315, P1100, DOI 10.1016/j.yexcr.2009.01.022; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Tan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091937; Trempus CS, 2011, MOL CARCINOGEN, V50, P981, DOI 10.1002/mc.20768; Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Xu RH, 2005, CANCER RES, V65, P613; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zhou YL, 2013, MOL CELL BIOCHEM, V374, P81, DOI 10.1007/s11010-012-1507-4	46	0	0	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115704	10.1371/journal.pone.0115704	http://dx.doi.org/10.1371/journal.pone.0115704			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635878	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700017
J	Guo, AL; Daniels, NA; Thuma, J; McCall, KD; Malgor, R; Schwartz, FL				Guo, Aili; Daniels, Nigel A.; Thuma, Jean; McCall, Kelly D.; Malgor, Ramiro; Schwartz, Frank L.			Diet Is Critical for Prolonged Glycemic Control after Short-Term Insulin Treatment in High-Fat Diet-Induced Type 2 Diabetic Male Mice	PLOS ONE			English	Article							BETA-CELL FUNCTION; HOMEOSTASIS MODEL ASSESSMENT; LONG-TERM; MOUSE MODEL; THERAPY; RESISTANCE; REMISSION; INFUSION; MELLITUS; GLUCOSE	Background Clinical studies suggest that short-term insulin treatment in new-onset type 2 diabetes (T2DM) can promote prolonged glycemic control. The purpose of this study was to establish an animal model to examine such a "legacy" effect of early insulin therapy (EIT) in long-term glycemic control in new-onset T2DM. The objective of the study was to investigate the role of diet following onset of diabetes in the favorable outcomes of EIT. Methodology As such, C57BL6/J male mice were fed a high-fat diet (HFD) for 21 weeks to induce diabetes and then received 4 weeks of daily insulin glargine or sham subcutaneous injections. Subsequently, mice were either kept on the HFD or switched to a low-fat diet (LFD) for 4 additional weeks. Principal Findings Mice fed a HFD gained significant fat mass and displayed increased leptin levels, increasing insulin resistance (poor HOMA-IR) and worse glucose tolerance test (GTT) performance in comparison to mice fed a LFD, as expected. Insulin-treated diabetic mice but maintained on the HFD demonstrated even greater weight gain and insulin resistance compared to shamtreated mice. However, insulin-treated mice switched to the LFD exhibited a better HOMA-IR compared to those mice left on a HFD. Further, between the insulin-treated and sham control mice, in spite of similar HOMA-IR values, the insulin-treated mice switched to a LFD following insulin therapy did demonstrate significantly better HOMA-B% values than sham control and insulin-treated HFD mice. Conclusion/Interpretation Early insulin treatment in HFD-induced T2DM in C57BL6/J mice was only beneficial in animals that were switched to a LFD after insulin treatment which may explain why a similar legacy effect in humans is achieved clinically in only a portion of cases studied, emphasizing a vital role for diet adherence in diabetes control.	[Guo, Aili; Daniels, Nigel A.; Thuma, Jean; McCall, Kelly D.; Malgor, Ramiro; Schwartz, Frank L.] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Guo, Aili; Daniels, Nigel A.; Thuma, Jean; McCall, Kelly D.; Malgor, Ramiro; Schwartz, Frank L.] Ohio Univ, Inst Diabet, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Guo, AL (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA.	guoa@ohio.edu	McCall, Kelly D/T-3251-2018; Daniels, Nigel/HIA-0660-2022		Ohio University Heritage College of Osteopathic Medicine	Ohio University Heritage College of Osteopathic Medicine	This work was supported by start-up funding for Aili Guo from the Ohio University Heritage College of Osteopathic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren J, 2010, ISLETS, V2, P353, DOI 10.4161.islets.2.6.13619; Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen AL, 2012, DIABETES CARE, V35, P474, DOI 10.2337/dc11-1638; Chen HB, 2007, DIABETES RES CLIN PR, V75, P327, DOI 10.1016/j.diabres.2006.07.001; Chen HS, 2008, DIABETES CARE, V31, P1927, DOI 10.2337/dc08-0075; Dandona P, 2005, J CLIN INVEST, V115, P2069, DOI 10.1172/JCI26045; Dandona P, 2007, CURR OPIN CLIN NUTR, V10, P511, DOI 10.1097/MCO.0b013e3281e38774; Dandona P, 2007, AM J CARDIOL, V99, p15B, DOI 10.1016/j.amjcard.2006.11.003; DEFRONZO RA, 1981, DIABETOLOGIA, V21, P165, DOI 10.1007/BF00252649; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Ghanim H, 2010, DIABETES CARE, V33, P1103, DOI 10.2337/dc09-2193; Hu Y, 2011, DIABETES CARE, V34, P1848, DOI 10.2337/dc10-2105; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Klaus S, 2005, PHYSIOL GENOMICS, V21, P193, DOI 10.1152/physiolgenomics.00299.2004; Kramer CK, 2013, LANCET DIABETES ENDO, V1, P28, DOI 10.1016/S2213-8587(13)70006-8; Leahy JL, 2010, J CLIN ENDOCR METAB, V95, P4206, DOI 10.1210/jc.2010-0668; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Li HQ, 2011, METABOLISM, V60, P1566, DOI 10.1016/j.metabol.2011.01.018; Li YB, 2004, DIABETES CARE, V27, P2597, DOI 10.2337/diacare.27.11.2597; Liu LH, 2012, DIABETES TECHNOL THE, V14, P756, DOI 10.1089/dia.2012.0055; Makimattila S, 1999, DIABETOLOGIA, V42, P406, DOI 10.1007/s001250051172; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meneghini LF, 2009, DIABETES CARE, V32, pS266, DOI 10.2337/dc09-S320; Nagel Jutta M., 2010, Hormones & Cancer, V1, P320, DOI 10.1007/s12672-010-0020-z; Omar BA, 2013, DIABETOLOGIA, V56, P1752, DOI 10.1007/s00125-013-2927-8; Son JW, 2013, ENDOCR RES, V38, P160, DOI 10.3109/07435800.2012.745870; Suzuki Jun, 2004, Nihon Yakurigaku Zasshi, V123, P281; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Viberti G, 2002, DIABETES CARE, V25, P1737, DOI 10.2337/diacare.25.10.1737; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Zhao Qing-bin, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1878	37	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0117556	10.1371/journal.pone.0117556	http://dx.doi.org/10.1371/journal.pone.0117556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633992	gold, Green Published, Green Submitted			2022-12-27	WOS:000348609800012
J	Cruz, ICS; Loiola, M; Albuquerque, T; Reis, R; Nunes, JDCC; Reimer, JD; Mizuyama, M; Kikuchi, RKP; Creed, JC				Cruz, Igor C. S.; Loiola, Miguel; Albuquerque, Tiago; Reis, Rodrigo; Nunes, Jose de Anchieta C. C.; Reimer, James D.; Mizuyama, Masaru; Kikuchi, Ruy K. P.; Creed, Joel C.			Effect of Phase Shift from Corals to Zoantharia on Reef Fish Assemblages	PLOS ONE			English	Article							HABITAT COMPLEXITY; COMMUNITY STRUCTURE; DIVERSITY; COMPETITION; CNIDARIA; PATTERNS; MACROALGAE; FISHERIES; ABUNDANCE; ANTHOZOA	Consequences of reef phase shifts on fish communities remain poorly understood. Studies on the causes, effects and consequences of phase shifts on reef fish communities have only been considered for coral-to-macroalgae shifts. Therefore, there is a large information gap regarding the consequences of novel phase shifts and how these kinds of phase shifts impact on fish assemblages. This study aimed to compare the fish assemblages on reefs under normal conditions (relatively high cover of corals) to those which have shifted to a dominance of the zoantharian Palythoa cf. variabilis on coral reefs in Todos os Santos Bay (TSB), Brazilian eastern coast. We examined eight reefs, where we estimated cover of corals and P. cf. variabilis and coral reef fish richness, abundance and body size. Fish richness differed significantly between normal reefs (48 species) and phase-shift reefs (38 species), a 20% reduction in species. However there was no difference in fish abundance between normal and phase shift reefs. One fish species, Chaetodon striatus, was significantly less abundant on normal reefs. The differences in fish assemblages between different reef phases was due to differences in trophic groups of fish; on normal reefs carnivorous fishes were more abundant, while on phase shift reefs mobile invertivores dominated.	[Cruz, Igor C. S.] Univ Estado Rio de Janeiro, Programa Pos Grad Ecol, BR-20550011 Rio De Janeiro, RJ, Brazil; [Cruz, Igor C. S.; Loiola, Miguel; Albuquerque, Tiago; Reis, Rodrigo; Kikuchi, Ruy K. P.] Univ Fed Bahia, Inst Geociencias, Lab Recifes Corais & Mudancas Globais, Salvador, BA, Brazil; [Loiola, Miguel; Reis, Rodrigo; Nunes, Jose de Anchieta C. C.] Univ Fed Bahia, Programa Pos Grad Ecol & Biomonitoramento, Salvador, BA, Brazil; [Nunes, Jose de Anchieta C. C.] Univ Fed Bahia, Inst Biol, Lab Ecol Benton, Salvador, BA, Brazil; [Reimer, James D.; Mizuyama, Masaru] Univ Ryukyus, Grad Sch Engn & Sci, Mol Invertebrate Systemat & Ecol Lab, Nishihara, Okinawa 90301, Japan; [Cruz, Igor C. S.; Creed, Joel C.] Univ Estado Rio de Janeiro UERJ, Dept Ecol, Inst Biol Roberto Alcantara Gomes, Lab Ecol Marinha Bent, BR-20550011 Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; University of the Ryukyus; Universidade do Estado do Rio de Janeiro	Cruz, ICS (corresponding author), Univ Estado Rio de Janeiro, Programa Pos Grad Ecol, BR-20550011 Rio De Janeiro, RJ, Brazil.	igorcruz@gmail.com	Reimer, James Davis/AAP-1331-2020; Cruz, Igor Cristino Silva/O-9525-2014; Creed, Joel Christopher/C-4764-2013; Cruz, Igor Cristino Silva/H-3292-2019; Mizuyama, Masaru/AAP-9920-2020; Kikuchi, Ruy K P/I-4884-2013	Cruz, Igor Cristino Silva/0000-0002-7475-533X; Creed, Joel Christopher/0000-0002-1722-0806; Cruz, Igor Cristino Silva/0000-0002-7475-533X; Mizuyama, Masaru/0000-0002-1671-4046; Kikuchi, Ruy K P/0000-0002-6271-7491; C. C. Nunes, Jose de Anchieta/0000-0002-2743-797X	Conselho Nacional de Pesquisa [556755/2010-3, PQ 1D]; Fundacao de Amparo a Pesquisa do Estado da Bahia [6935/2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Programa de Incentivo a Producao Cientifica, Tecnica e Artistica; UERJ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico from the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-25/170669/2004]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [1137/2010]; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus	Conselho Nacional de Pesquisa; Fundacao de Amparo a Pesquisa do Estado da Bahia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Incentivo a Producao Cientifica, Tecnica e Artistica; UERJ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico from the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus	I. C. S. C. is supported by PhD scholarships of Conselho Nacional de Pesquisa (No 556755/2010-3). M. L. by PhD scholarships OF Fundacao de Amparo a Pesquisa do Estado da Bahia (No 6935/2014). J.A.C.C.N. by PhD scholarships of Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. R. K. P. K. by Grant of Conselho Nacional de Pesquisa (PQ 1D). J.C.C. by Financial support of the Programa de Incentivo a Producao Cientifica, Tecnica e Artistica, UERJ and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grants from the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (No. E-25/170669/2004) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Ciencias do Mar 1137/2010). J.D.R.and M. M. were funded in part by the International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta C, 2014, MAR ECOL; Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bo M, 2012, PAC SCI, V66, P63, DOI 10.2984/66.1.4; Bonaldo R. M., 2005, Braz. J. Biol., V65, P211, DOI 10.1590/S1519-69842005000200004; Bonaldo RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085786; Caley MJ, 1996, J ANIM ECOL, V65, P414, DOI 10.2307/5777; CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070; Carpenter K.E., 1982, Proceedings of the International Coral Reef Symposium, P497; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Chaves LDT, 2010, BRAZ J OCEANOGR, V58, P33, DOI 10.1590/S1679-87592010000800006; Cirano M., 2007, REVIS BRASILEIRA GEO, V25, P363, DOI DOI 10.1590/S0102-261X2007000400002; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; COX EF, 1994, B MAR SCI, V54, P535; Cruz ICS, 2014, MAR ECOL; Cruz ICS, 2009, GEST COSTEIRA INTEG, V9, P3, DOI DOI 10.5894/RGCI150; Cruz ICS, 2008, BRAZ J OCEANOGR, V56, P271, DOI 10.1590/S1679-87592008000400002; den Hartog J.C., 1991, Zoologische Mededelingen (Leiden), V65, P209; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Done TJ, 1999, AM ZOOL, V39, P66; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; Dustan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057386; Dutra LXC, 2008, J SUSTAIN DEV, V1, P13, DOI DOI 10.5539/JSD.V1N1P13; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Ferreira CEL, 2006, J FISH BIOL, V69, P1533, DOI 10.1111/j.1095-8649.2006.01220.x; Ferreira CEL, 2004, J BIOGEOGR, V31, P1093, DOI 10.1111/j.1365-2699.2004.01044.x; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; FOWLER AJ, 1990, MAR ECOL PROG SER, V64, P39, DOI 10.3354/meps064039; GLADFELTER WB, 1978, REV BIOL TROP, V26, P65; Gotelli NJ, 2013, ECOSIMR 1 00; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2014, CURR BIOL, V24, pR359, DOI 10.1016/j.cub.2014.03.069; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Grutter AS, 2003, CURR BIOL, V13, P64, DOI 10.1016/S0960-9822(02)01393-3; Harborne AR, 2011, ENV BIOL FISHES; Hoegh-Guldberg O, 2006, SCIENCE, V311, P42, DOI 10.1126/science.1122951; Holt BG, 2013, METHODS ECOL EVOL, V4, P383, DOI 10.1111/2041-210X.12031; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; JONES GP, 1988, J EXP MAR BIOL ECOL, V123, P115, DOI 10.1016/0022-0981(88)90164-5; Khalaf MA, 2002, MAR ECOL PROG SER, V239, P287, DOI 10.3354/meps239287; Knowlton N, 2001, MARINE COMMUNITY ECOLOGY, P395; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Krajewski JP, 2011, ENV BIOL FISHES; Laborel J. L., 1970, MADREPORAIRES HYDROC; LADD HS, 1961, SCIENCE, V134, P703, DOI 10.1126/science.134.3481.703; Lang JC, 2010, AGRRA PROTOCOLS VERS, P1; Leao Z.M.A.N., 2010, Pan-American Journal of Aquatic Sciences, V5, P224; Leao ZMAN, 2003, LATIN AMERICAN CORAL REEFS, P9, DOI 10.1016/B978-044451388-5/50003-5; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Medeiros PR, 2010, ENVIRON BIOL FISH, V87, P237, DOI 10.1007/s10641-010-9593-1; Medeiros Paulo R., 2007, Pan-American Journal of Aquatic Sciences, V2, P288; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Niendonca-Neto JP, 2008, AN ACAD BRAS CIENC, V80, P495, DOI 10.1590/S0001-37652008000300010; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Page C, 2001, SURVERYS BENTHIC REE; Pereira PHC, 2013, J FISH BIOL, V82, P1226, DOI 10.1111/jfb.12054; Perez CD, 2005, HYDROBIOLOGIA, V548, P207, DOI 10.1007/s10750-005-5441-2; Reimer JD, 2007, CORAL REEFS, V26, P399, DOI 10.1007/s00338-007-0210-5; Reimer J. D., 2012, J MAR BIOL, DOI 10.1155/2012/856079; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; Rocha LA, 2008, MOL PHYLOGENET EVOL, V48, P918, DOI 10.1016/j.ympev.2008.05.024; Rogers A, 2014, CURR BIOL, V24, P1000, DOI 10.1016/j.cub.2014.03.026; Sampaio CLS, 2008, GUIA IDENTIFICACAO P, P205, DOI [10.1039/b815601h, DOI 10.1039/B815601H]; Sazima I, 2000, ENV BIOL FISHES; Silva M, 2005, CONSERV BIOL, V19, P608, DOI 10.1111/j.1523-1739.2005.00707.x; Sinniger F, 2005, MAR BIOL, V147, P1121, DOI 10.1007/s00227-005-0016-3; Sinniger F, 2008, ZOOL SCI, V25, P1253, DOI 10.2108/zsj.25.1253; Smith JE, 2010, OECOLOGIA, V163, P497, DOI 10.1007/s00442-009-1546-z; Sorokin Y., 1993, CORAL REEF ECOLOGY; Swain TD, 2010, MOL ECOL, V19, P2587, DOI 10.1111/j.1365-294X.2010.04672.x; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Taylor MS, 2002, COPEIA, P1134, DOI 10.1643/0045-8511(2002)002[1134:OOMUBT]2.0.CO;2; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Verges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017115; Vermeij MJA, 2010, MAR ECOL-EVOL PERSP, V31, P291, DOI 10.1111/j.1439-0485.2009.00343.x; Vila-Nova DA, 2014, OCEAN COAST MANAGE, V102, P88, DOI 10.1016/j.ocecoaman.2014.09.005; WELLINGTON GM, 1985, OECOLOGIA, V68, P15, DOI 10.1007/BF00379466; Wilkinson C, 2008, STATUS CORAL REEFS W; Willis SC, 2005, OECOLOGIA, V142, P284, DOI 10.1007/s00442-004-1723-z; Work TM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002989; Yang SY, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-39; Zar JH., 2010, BIOSTAT ANAL, V5th	94	34	36	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116944	10.1371/journal.pone.0116944	http://dx.doi.org/10.1371/journal.pone.0116944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629532	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100052
J	Han, XB; Patters, AB; Ito, T; Azuma, J; Schaffer, SW; Chesney, RW				Han, Xiaobin; Patters, Andrea B.; Ito, Takashi; Azuma, Junichi; Schaffer, Stephen W.; Chesney, Russell W.			Knockout of the TauT Gene Predisposes C57BL/6 Mice to Streptozotocin-Induced Diabetic Nephropathy	PLOS ONE			English	Article							TAURINE-TRANSPORTER GENE; DOWN-REGULATION; KIDNEY INJURY; CELLS; COMPLICATIONS; NEUROPATHY; EXCRETION; MELLITUS; GLUCOSE; OBESITY	Diabetic nephropathy is the leading cause of end stage renal disease in the world. Although tremendous efforts have been made, scientists have yet to identify an ideal animal model that can reproduce the characteristics of human diabetic nephropathy. In this study, we hypothesize that taurine insufficiency is a critical risk factor for development of diabetic nephropathy associated with diabetes mellitus. This hypothesis was tested in vivo in TauT heterozygous (TauT(+/-)) and homozygous (TauT(-/-)) knockout in C57BL/6 background mice. We have shown that alteration of the TauT gene (also known as SLC6A6) has a substantial effect on the susceptibility to development of extensive diabetic kidney disease in both TauT(+/-) and TauT(-/-)mouse models of diabetes. These animals developed histological changes characteristic of human diabetic nephropathy that included glomerulosclerosis, nodular lesions, arteriosclerosis, arteriolar dilation, and tubulointerstitial fibrosis. Immunohistochemical staining of molecular markers of smooth muscle actin, CD34, Ki67 and collagen IV further confirmed these observations. Our results demonstrated that both homozygous and heterozygous TauT gene deletion predispose C57BL/6 mice to develop end-stage diabetic kidney disease, which closely replicates the pathological features of diabetic nephropathy in human diabetic patients.	[Han, Xiaobin; Patters, Andrea B.; Chesney, Russell W.] Univ Tennessee, Dept Pediat, Hlth Sci Ctr, Memphis, TN 38163 USA; [Han, Xiaobin; Patters, Andrea B.; Chesney, Russell W.] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Ito, Takashi; Azuma, Junichi] Univ Hyogo, Coll Pharm, Dept Pharm, Kobe, Hyogo 6500044, Japan; [Schaffer, Stephen W.] Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Hyogo; University of South Alabama	Han, XB (corresponding author), Univ Tennessee, Dept Pediat, Hlth Sci Ctr, Memphis, TN 38163 USA.	xhan@uthsc.edu						Askwith T, 2009, AM J PHYSIOL-ENDOC M, V297, pE620, DOI 10.1152/ajpendo.00287.2009; Astorri E, 1997, CARDIOLOGY, V88, P152, DOI 10.1159/000177322; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Cefalu WT, 2014, DIABETES CARE, V37, P5, DOI 10.2337/dc13-2369; Chertow GM, 2006, J AM SOC NEPHROL, V17, P1501, DOI 10.1681/ASN.2006040327; Emanuela F, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/476380; Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363; Fiorina P, 2014, J AM SOC NEPHROL, V25, P1415, DOI 10.1681/ASN.2013050518; Folli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009923; FRANCONI F, 1995, AM J CLIN NUTR, V61, P1115, DOI 10.1093/ajcn/61.5.1115; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Han X, 2000, AMINO ACIDS, V19, P499, DOI 10.1007/s007260070002; Han XB, 2002, J BIOL CHEM, V277, P39266, DOI 10.1074/jbc.M205939200; Han XB, 2009, J AM SOC NEPHROL, V20, P1323, DOI 10.1681/ASN.2008050465; Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Huang DY, 2006, PFLUG ARCH EUR J PHY, V451, P668, DOI 10.1007/s00424-005-1499-y; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001; Ito T, 2012, AMINO ACIDS, V42, P1529, DOI 10.1007/s00726-011-0883-5; Kakoki M, 2010, P NATL ACAD SCI USA, V107, P10190, DOI 10.1073/pnas.1005144107; Merheb M, 2007, DIABETES CARE, V30, P2652, DOI 10.2337/dc07-0872; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Renier G, 2007, CURR DIABETES REV, V3, P103, DOI 10.2174/157339907780598225; Schlondorff D, 2010, KIDNEY INT, V77, P749, DOI 10.1038/ki.2009.545; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stevens MJ, 1999, AM J PHYSIOL-ENDOC M, V277, pE760, DOI 10.1152/ajpendo.1999.277.4.E760; Wang LJ, 2008, EUR J PHARMACOL, V597, P75, DOI 10.1016/j.ejphar.2008.08.031	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117718	10.1371/journal.pone.0117718	http://dx.doi.org/10.1371/journal.pone.0117718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629817	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100095
J	Waqas, A; Raza, N; Lodhi, HW; Muhammad, Z; Jamal, M; Rehman, A				Waqas, Ahmed; Raza, Nahal; Lodhi, Haneen Wajid; Muhammad, Zerwah; Jamal, Mehak; Rehman, Abdul			Psychosocial Factors of Antenatal Anxiety and Depression in Pakistan: Is Social Support a Mediator?	PLOS ONE			English	Article							PREGNANT-WOMEN; PERINATAL DEPRESSION; GENDER PREFERENCES; PRENATAL ANXIETY; RISK-FACTORS; STRESS; SYMPTOMS; PREVALENCE; PREDICTORS; ASSOCIATION	Introduction Pregnancy is generally viewed as a time of fulfillment and joy; however, for many women it can be a stressful event. In South Asia it is associated with cultural stigmas revolving around gender discrimination, abnormal births and genetic abnormalities. Methodology This cross-sectional study was done at four teaching hospitals in Lahore from February, 2014 to June, 2014. A total of 500 pregnant women seen at hospital obstetrics and gynecology departments were interviewed with a questionnaire consisting of three sections: demographics, the Hospital Anxiety and Depression Scale (HADS) and the Social Provisions Scale (SPS). Pearson's chi-squared test, bivariate correlations and multiple linear regression were used to analyze associations between the independent variables and scores on the HADS and SPS. Results Mean age among the 500 respondents was 27.41 years (5.65). Anxiety levels in participants were categorized as normal (145 women, 29%), borderline (110, 22%) or anxious (245, 49%). Depression levels were categorized as normal (218 women, 43.6%), borderline (123, 24.6%) or depressed (159, 31.8%). Inferential analysis revealed that higher HADS scores were significantly associated with lower scores on the SPS, rural background, history of harassment, abortion, cesarean delivery and unplanned pregnancies (P < .05). Social support (SPS score) mediated the relationship between the total number of children, gender of previous children and HADS score. Women with more daughters were significantly more likely to score higher on the HADS and lower on the SPS, whereas higher numbers of sons were associated with the opposite trends in the scores (P < .05). Conclusion Because of the predominantly patriarchal sociocultural context in Pakistan, the predictors of antenatal anxiety and depression may differ from those in developed countries. We therefore suggest that interventions designed and implemented to reduce antenatal anxiety and depression should take into account these unique factors.	[Waqas, Ahmed; Raza, Nahal; Lodhi, Haneen Wajid; Muhammad, Zerwah; Jamal, Mehak] CMH Lahore Med Coll & Inst Dent, Lahore Cantt, Pakistan; [Rehman, Abdul] Allama Iqbal Med Coll, Lahore, Pakistan		Waqas, A (corresponding author), CMH Lahore Med Coll & Inst Dent, Shami Rd, Lahore Cantt, Pakistan.	ahmedwaqas1990@hotmail.com	Waqas, Ahmed/V-6682-2019	Waqas, Ahmed/0000-0002-3772-194X				Abrejo FG, 2009, EUR J CONTRACEP REPR, V14, P10, DOI 10.1080/13625180802518231; Ahmer S, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-59; Ali NS, 2012, SCIENTIFICWORLDJOURN, V2012; Anwar Alam, 2011, Sarhad Journal of Agriculture, V27, P329; Atta-ur-Rahman, 2011, Sarhad Journal of Agriculture, V27, P477; Beijers R, 2010, PEDIATRICS, V126, pE401, DOI 10.1542/peds.2009-3226; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; Bhutta Shereen, 2003, J PAKISTAN MED ASS, V53, P286; Blackmore ER, 2011, BRIT J PSYCHIAT, V198, P373, DOI 10.1192/bjp.bp.110.083105; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Casterline J, 2004, UNWANTED PREGNANCY A; Chan CY, 2013, OJPSYCH, V2013, P301; Cougle JR, 2005, J ANXIETY DISORD, V19, P137, DOI 10.1016/j.janxdis.2003.12.003; Dayan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012942; Faisal-Cury A, 2007, ARCH WOMEN MENT HLTH, V10, P25, DOI 10.1007/s00737-006-0164-6; Fall A, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-201; Fergusson DM, 2006, J CHILD PSYCHOL PSYC, V47, P16, DOI 10.1111/j.1469-7610.2005.01538.x; Fuse K, 2010, DEMOGR RES, V23, P1031, DOI 10.4054/DemRes.2010.23.36; Gaynes B N, 2005, Evid Rep Technol Assess (Summ), P1; Grav S, 2012, J CLIN NURS, V21, P111, DOI 10.1111/j.1365-2702.2011.03868.x; Gurung RAR, 2005, J SOC CLIN PSYCHOL, V24, P497, DOI 10.1521/jscp.2005.24.4.497; Hamirani MM, 2006, J LIAQUAT UNIV MED H, V5, P106; Hashemieh C, 2013, IRAN RED CRESCENT ME, V15, DOI 10.5812/ircmj.14465; Humayun A, 2013, E MEDITERR HEALTH J, V19, P327, DOI 10.26719/2013.19.4.327; Husain N, 2000, PSYCHOL MED, V30, P395, DOI 10.1017/S0033291700001707; Husain N, 2011, ARCH WOMEN MENT HLTH, V14, P395, DOI 10.1007/s00737-011-0233-3; Ilyas Muhammad, 2009, Hum Reprod Genet Ethics, V15, P55; Karmaliani R, 2009, INT J SOC PSYCHIATR, V55, P414, DOI 10.1177/0020764008094645; Kazi A, 2006, SOC SCI MED, V63, P1466, DOI 10.1016/j.socscimed.2006.05.019; Kinsella MT, 2009, CLIN OBSTET GYNECOL, V52, P425, DOI 10.1097/GRF.0b013e3181b52df1; Koleva H, 2011, ARCH WOMEN MENT HLTH, V14, P99, DOI 10.1007/s00737-010-0184-0; Kuo SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086653; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Melchior M, 2007, PSYCHOL MED, V37, P1119, DOI 10.1017/S0033291707000414; Mezey G, 2005, BJOG-INT J OBSTET GY, V112, P197, DOI 10.1111/j.1471-0528.2004.00307.x; MUMFORD DB, 1991, ACTA PSYCHIAT SCAND, V83, P81, DOI 10.1111/j.1600-0447.1991.tb07370.x; Nasreen HE, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-22; Nisar N, 2009, J LIAQUAT UNIV MED H, V8, P228; O'Connor TG, 2005, BIOL PSYCHIAT, V58, P211, DOI 10.1016/j.biopsych.2005.03.032; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Qadir F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-745; Rahman A, 2007, ARCH WOMEN MENT HLTH, V10, P211, DOI 10.1007/s00737-007-0193-9; Rahman A, 2007, ACTA PSYCHIAT SCAND, V115, P481, DOI 10.1111/j.1600-0447.2006.00950.x; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Rizwan M., 2010, INT J ED PSYCHOL ASS, V4, P33; Rodriguez MA, 2008, ANN FAM MED, V6, P44, DOI 10.1370/afm.743; Saleem S, 2001, J Pak Med Assoc, V51, P275; Sanchez SE, 2013, J REPROD MED, V58, P25; Schetter CD, 2012, CURR OPIN PSYCHIATR, V25, P141, DOI 10.1097/YCO.0b013e3283503680; Shah SMA, 2011, J PAK MED ASSOC, V61, P242; Soomro RH, 2012, IJCRB, V3, P354; Stewart RC, 2014, ARCH WOMEN MENT HLTH, V17, P145, DOI 10.1007/s00737-013-0387-2; Tohid O, 2004, PAKISTANS NOVEL ATTA; Westdahl C, 2007, OBSTET GYNECOL, V110, P134, DOI 10.1097/01.AOG.0000265352.61822.1b; Witt WP, 2010, ARCH WOMEN MENT HLTH, V13, P425, DOI 10.1007/s00737-010-0176-0; Zahidie A, 2011, J PAK MED ASSOC, V61, P1183; Zubair F, 2007, HUM REPROD, V22, P605, DOI 10.1093/humrep/del409	58	74	74	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116510	10.1371/journal.pone.0116510	http://dx.doi.org/10.1371/journal.pone.0116510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629925	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100039
J	Liu, ZS; Yan, CW; Kang, C; Zhang, B; Li, Y				Liu, Zhongshuang; Yan, Chengwei; Kang, Chen; Zhang, Bin; Li, Ying			Distributional Variations in Trabecular Architecture of the Mandibular Bone: An In Vivo Micro-CT Analysis in Rats	PLOS ONE			English	Article							MINERAL DENSITY; MORPHOMETRIC-ANALYSIS; POSTMENOPAUSAL WOMEN; OVARIECTOMIZED RATS; SKELETAL BONE; ALVEOLAR BONE; OSTEOPOROSIS; MICROSTRUCTURE; OSTEOPENIA; ESTROGEN	Purpose To evaluate the effect of trabecular thickness and trabecular separation on modulating the trabecular architecture of the mandibular bone in ovariectomized rats. Materials and Methods Fourteen 12-week-old adult female Wistar rats were divided into an ovariectomy group (OVX) and a sham-ovariectomy group (sham). Five months after the surgery, the mandibles from 14 rats (seven OVX and seven sham) were analyzed by micro-CT. Images of inter-radicular alveolar bone of the mandibular first molars underwent three-dimensional reconstruction and were analyzed. Results Compared to the sham group, trabecular thickness in OVX alveolar bone decreased by 27% (P = 0.012), but trabecular separation in OVX alveolar bone increased by 59% (P = 0.005). A thickness and separation map showed that trabeculae of less than 100 mu m increased by 46%, whereas trabeculae of more than 200 mu m decreased by more than 40% in the OVX group compared to those in the sham group. Furthermore, the OVX separation of those trabecular of more than 200 mu m was 65% higher compared to the sham group. Bone mineral density (P = 0.028) and bone volume fraction (p = 0.001) were also significantly decreased in the OVX group compared to the sham group. Conclusions Ovariectomy-induced bone loss in mandibular bone may be related to the distributional variations in trabecular thickness and separation which profoundly impact the modulation of the trabecular architecture.	[Liu, Zhongshuang; Kang, Chen; Zhang, Bin; Li, Ying] Harbin Med Univ, Affiliated Hosp 2, Sino Russian Inst Hard Tissue Dev & Regenerat, Harbin 150001, Heilongjiang, Peoples R China; [Yan, Chengwei] Harbin Med Univ, Affiliated Hosp 1, Dept Pediat Dent, Harbin 150001, Heilongjiang, Peoples R China; [Zhang, Bin] Heilongjiang Acad Med Sci, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Zhang, B (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Sino Russian Inst Hard Tissue Dev & Regenerat, Harbin 150001, Heilongjiang, Peoples R China.	zhangbhyd@126.com; bonnieli1122@gmail.com	liu, shuang/O-5181-2015	liu, zhongshuang/0000-0002-8137-7349	Heilongjiang postgraduate innovation science foundation [YJSCX2012-240HLJ]; Natural Science Foundation of China [81170960]; National Key Science Instrument and Equipment Development Project [2011YQ04008708]; Specialized Research Fund for the Doctoral Program of Higher Education [20102307110006]	Heilongjiang postgraduate innovation science foundation; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Science Instrument and Equipment Development Project; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the Heilongjiang postgraduate innovation science foundation (Grant No. YJSCX2012-240HLJ) and Natural Science Foundation of China (Grant No. 81170960), the National Key Science Instrument and Equipment Development Project (Grant No. 2011YQ04008708), and Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20102307110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brouwers JEM, 2008, CALCIFIED TISSUE INT, V82, P202, DOI 10.1007/s00223-007-9084-3; Cardoso L, 2013, J BIOMECH, V46, P253, DOI 10.1016/j.jbiomech.2012.10.025; Cui GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082815; Dai QG, 2013, ORAL DIS; Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6; Ejiri S, 2008, J BONE MINER METAB, V26, P409, DOI 10.1007/s00774-008-0870-4; ELOVIC RP, 1995, CALCIFIED TISSUE INT, V56, P305, DOI 10.1007/BF00318051; Frost HM, 1999, J BONE MINER RES, V14, P1473, DOI 10.1359/jbmr.1999.14.9.1473; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Genant HK, 2008, RHEUMATOLOGY, V47, P9, DOI 10.1093/rheumatology/ken180; Genant HK, 1999, OSTEOPOROSIS INT, V10, P259, DOI 10.1007/s001980050224; Gonzalez-Garcia R, 2013, CLIN ORAL IMPLAN RES, V24, P730, DOI 10.1111/j.1600-0501.2012.02478.x; Hanson NA, 2004, BONE, V35, P326, DOI 10.1016/j.bone.2004.02.019; Heshmati HM, 2002, J BONE MINER RES, V17, P172, DOI 10.1359/jbmr.2002.17.1.172; Hildebolt CF, 1997, DENTOMAXILLOFAC RAD, V26, P3, DOI 10.1038/sj.dmfr.4600226; Jeffcoat M K, 1998, Ann Periodontol, V3, P312, DOI 10.1902/annals.1998.3.1.312; Jeffcoat MK, 2000, PERIODONTOL 2000, V23, P94, DOI 10.1034/j.1600-0757.2000.2230109.x; Jiang GZ, 2008, J BONE MINER METAB, V26, P130, DOI 10.1007/s00774-007-0811-7; Jiang Guizhen, 2004, J Oral Sci, V46, P75, DOI 10.2334/josnusd.46.75; Jiang GZ, 2003, J BONE MINER METAB, V21, P388, DOI 10.1007/s00774-003-0433-7; Jiang YB, 2005, J BONE MINER METAB, V23, P122, DOI 10.1007/BF03026336; Jonasson G, 2001, ORAL SURG ORAL MED O, V92, P346, DOI 10.1067/moe.2001.116494; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; KRIBBS PJ, 1989, J PROSTHET DENT, V62, P703, DOI 10.1016/0022-3913(89)90596-9; Kuroda S, 2003, ORAL DIS, V9, P24, DOI 10.1034/j.1601-0825.2003.01810.x; Laib A, 2001, OSTEOPOROSIS INT, V12, P936, DOI 10.1007/s001980170022; Legrand E, 2000, J BONE MINER RES, V15, P13, DOI 10.1359/jbmr.2000.15.1.13; Leppanen OV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002540; Lerouxel E, 2004, OSTEOPOROSIS INT, V15, P814, DOI 10.1007/s00198-004-1611-8; Litzlbauer HD, 2006, AM J PHYSIOL-LUNG C, V291, pL535, DOI 10.1152/ajplung.00088.2005; MAJESKA RJ, 1994, J BONE JOINT SURG AM, V76A, P713, DOI 10.2106/00004623-199405000-00013; Moon HS, 2004, SURG RADIOL ANAT, V26, P466, DOI 10.1007/s00276-004-0247-x; Moriya Y, 1998, J Oral Sci, V40, P171; Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4; OMI N, 1995, BONE, V17, pS163, DOI 10.1016/8756-3282(95)00329-C; Orrico SRP, 2007, J PERIODONTOL, V78, P164, DOI 10.1902/jop.2007.060136; Rawlinson SCF, 2009, J DENT RES, V88, P615, DOI 10.1177/0022034509340132; RIGGS BL, 1991, WESTERN J MED, V154, P63; Shimizu Y, 2013, ARCH ORAL BIOL, V58, P907, DOI 10.1016/j.archoralbio.2013.02.003; Sornay-Rendu E, 2007, J BONE MINER RES, V22, P425, DOI 10.1359/JBMR.061206; Tanaka M, 2003, ORAL SURG ORAL MED O, V95, P495, DOI 10.1067/moe.2003.135; WactawskiWende J, 1996, J PERIODONTOL, V67, P1076, DOI 10.1902/jop.1996.67.10s.1076; WRONSKI TJ, 1987, CALCIFIED TISSUE INT, V40, P155, DOI 10.1007/BF02555700	44	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116194	10.1371/journal.pone.0116194	http://dx.doi.org/10.1371/journal.pone.0116194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625431	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821400012
J	Suzuki, R; Okamoto, T; Arita, T				Suzuki, Reiji; Okamoto, Tomoko; Arita, Takaya			Emergent Dynamics of Fairness in the Spatial Coevolution of Proposer and Responder Species in the Ultimatum Game	PLOS ONE			English	Article							OBLIGATE POLLINATION MUTUALISM; EVOLUTION	While spatially local interactions are ubiquitous between coevolving species sharing recourses (e.g., plant-insect interactions), their effects on such coevolution processes of strategies involving the share of a resource are still not clearly understood. We construct a two-dimensional spatial model of the coevolution of the proposer and responder species in the ultimatum game (UG), in which a pair of proposer and responder individuals at each site plays the UG. We investigate the effects of the locality of interactions and the intensity of selection on the emergence of fairness between these species. We show that the lower intensity of selection favors fair strategies in general, and there are no significant differences in the evolution of fairness between the cases with local and global interactions when the intensity of selection is low. However, as the intensity of selection becomes higher, the spatially local interactions contribute to the evolution of fairer strategies more than the global interactions, even though fair strategies become more difficult to evolve. This positive effect of spatial interactions is expected to be due to the mutual benefit of fairness for both proposer and responder species in future generations, which brings about a dynamic evolution process of fairness.	[Suzuki, Reiji; Arita, Takaya] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Okamoto, Tomoko] Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 305, Japan	Nagoya University; Forestry & Forest Products Research Institute - Japan	Suzuki, R (corresponding author), Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan.	reiji@nagoya-u.jp	Suzuki, Reiji/M-5038-2014; Arita, Takaya/GLU-7953-2022; Okamoto, Tomoko/L-8550-2013	Suzuki, Reiji/0000-0002-1953-2926; Okamoto, Tomoko/0000-0001-8135-481X	JSPS KAKENHI [23500176, 24500168]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 23500176 (TA), 24500168 (RS) (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciampaglia GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099039; Gao J, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/48003; Goto R, 2010, ECOL LETT, V13, P321, DOI 10.1111/j.1461-0248.2009.01425.x; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Henrich J, 2000, AM ECON REV, V90, P973, DOI 10.1257/aer.90.4.973; Ichinose G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05104; Iranzo J, 2011, J THEOR BIOL, V278, P1, DOI 10.1016/j.jtbi.2011.02.020; Kato M, 2003, P NATL ACAD SCI USA, V100, P5264, DOI 10.1073/pnas.0837153100; Kawakita A, 2004, AM J BOT, V91, P410, DOI 10.3732/ajb.91.3.410; Okamoto T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2280; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; Szolnoki A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078701; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104	14	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116901	10.1371/journal.pone.0116901	http://dx.doi.org/10.1371/journal.pone.0116901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625524	Green Submitted, gold, Green Published			2022-12-27	WOS:000348821400022
J	Liou, JW; Hung, YJ; Yang, CH; Chen, YC				Liou, Je-Wen; Hung, Yu-Jiun; Yang, Chin-Hao; Chen, Yi-Cheng			The Antimicrobial Activity of Gramicidin A Is Associated with Hydroxyl Radical Formation	PLOS ONE			English	Article							PHOSPHOLIPID-MEMBRANES; STAPHYLOCOCCUS-AUREUS; STRUCTURAL FEATURES; CELL-MEMBRANE; BUFORIN II; PEPTIDES; ANTIBIOTICS; MECHANISM; CHANNELS; CONFORMATION	Gramicidin A is an antimicrobial peptide that destroys gram-positive bacteria. The bactericidal mechanism of antimicrobial peptides has been linked to membrane permeation and metabolism disruption as well as interruption of DNA and protein functions. However, the exact bacterial killing mechanism of gramicidin A is not clearly understood. In the present study, we examined the antimicrobial activity of gramicidin A on Staphylococcus aureus using biochemical and biophysical methods, including hydroxyl radical and NAD(+)/NADH cycling assays, atomic force microscopy, and Fourier transform infrared spectroscopy. Gramicidin A induced membrane permeabilization and changed the composition of the membrane. The morphology of Staphylococcus aureus during gramicidin A destruction was divided into four stages: pore formation, water permeability, bacterial flattening, and lysis. Changes in membrane composition included the destruction of membrane lipids, proteins, and carbohydrates. Most interestingly, we demonstrated that gramicidin A not only caused membrane permeabilization but also induced the formation of hydroxyl radicals, which are a possible end product of the transient depletion of NADH from the tricarboxylic acid cycle. The latter may be the main cause of complete Staphylococcus aureus killing. This new finding may provide insight into the underlying bactericidal mechanism of gA.	[Liou, Je-Wen; Hung, Yu-Jiun] Tzu Chi Univ, Inst Biochem, Hualien 970, Taiwan; [Yang, Chin-Hao] Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan; [Chen, Yi-Cheng] MacKay Med Coll, Dept Med, New Taipei City 252, Taiwan	Tzu Chi University; Tzu Chi University; Mackay Medical College	Chen, YC (corresponding author), MacKay Med Coll, Dept Med, New Taipei City 252, Taiwan.	chen15@mmc.edu.tw	Liou, Je-Wen/ABB-2157-2020	Liou, Je-Wen/0000-0002-6181-7263	Tzu Chi University [TCIRP96004-01]; National Science Council of Taiwan [NSC101-2627-M-715-001, NSC102-2627-M-715-002]	Tzu Chi University; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Tzu Chi University (TCIRP96004-01 to JWL) and the National Science Council of Taiwan (NSC101-2627-M-715-001 and NSC102-2627-M-715-002 to YCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN OS, 1984, ANNU REV PHYSIOL, V46, P531; Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9; BIERBAUM G, 1987, J BACTERIOL, V169, P5452, DOI 10.1128/jb.169.12.5452-5458.1987; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Cheng FC, 2002, J CHROMATOGR B, V781, P481, DOI 10.1016/S1570-0232(02)00620-7; Choi H, 2012, BBA-GEN SUBJECTS, V1820, P1831, DOI 10.1016/j.bbagen.2012.08.012; DECALEYA RF, 1972, APPL MICROBIOL, V23, P998, DOI 10.1128/AEM.23.5.998-1000.1972; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; Gue M, 2001, BIOCHEMISTRY-US, V40, P11938; HENDERSO.PJ, 1969, BIOCHEM J, V111, P521, DOI 10.1042/bj1110521; HLADKY SB, 1972, BIOCHIM BIOPHYS ACTA, V274, P294, DOI 10.1016/0005-2736(72)90178-2; Hotchkiss RD, 1940, J BIOL CHEM, V132, P791; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kacurakova M, 1996, CARBOHYD RES, V284, P145, DOI 10.1016/0008-6215(95)00412-2; KILLIAN JA, 1992, BIOCHIM BIOPHYS ACTA, V1113, P391; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; MILLER RJ, 1970, PLANT PHYSIOL, V46, P471, DOI 10.1104/pp.46.3.471; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; Sampson TR, 2012, ANTIMICROB AGENTS CH, V56, P5642, DOI 10.1128/AAC.00756-12; SARGES R, 1965, J AM CHEM SOC, V87, P2011, DOI 10.1021/ja01087a027; SHAI Y, 1995, TRENDS BIOCHEM SCI, V20, P460, DOI 10.1016/S0968-0004(00)89101-X; Shea KM, 2003, PEDIATRICS, V112, P253; STADTMAN ER, 1991, J BIOL CHEM, V266, P17201; Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011; Tossi A, 2000, BIOPOLYMERS, V55, P4; Vizioli J, 2002, TRENDS PHARMACOL SCI, V23, P494, DOI 10.1016/S0165-6147(02)02105-3; Wallace BA, 2000, BIOESSAYS, V22, P227, DOI 10.1002/(SICI)1521-1878(200003)22:3<227::AID-BIES4>3.0.CO;2-6; Wallace BA, 1998, J STRUCT BIOL, V121, P123, DOI 10.1006/jsbi.1997.3948; WEINSTEIN S, 1980, J MOL BIOL, V143, P1, DOI 10.1016/0022-2836(80)90121-7; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P3114, DOI 10.1128/AAC.49.8.3114-3121.2005; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zoumpopoulou G, 2010, INT J FOOD MICROBIOL, V144, P202, DOI 10.1016/j.ijfoodmicro.2010.09.023	41	45	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117065	10.1371/journal.pone.0117065	http://dx.doi.org/10.1371/journal.pone.0117065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622083	Green Submitted, Green Published, gold			2022-12-27	WOS:000348470400017
J	Burigo, M; Knoeferle, P				Burigo, Michele; Knoeferle, Pia			Visual Attention during Spatial Language Comprehension	PLOS ONE			English	Article							SPOKEN-WORD RECOGNITION; EYE-MOVEMENTS; TIME-COURSE; MEMORY; INFORMATION; PERCEPTION; APPREHENSION; INTEGRATION; FIXATION; TRACKING	Spatial terms such as "above", "in front of", and "on the left of" are all essential for describing the location of one object relative to another object in everyday communication. Apprehending such spatial relations involves relating linguistic to object representations by means of attention. This requires at least one attentional shift, and models such as the Attentional Vector Sum (AVS) predict the direction of that attention shift, from the sausage to the box for spatial utterances such as "The box is above the sausage". To the extent that this prediction generalizes to overt gaze shifts, a listener's visual attention should shift from the sausage to the box. However, listeners tend to rapidly look at referents in their order of mention and even anticipate them based on linguistic cues, a behavior that predicts a converse attentional shift from the box to the sausage. Four eye-tracking experiments assessed the role of overt attention in spatial language comprehension by examining to which extent visual attention is guided by words in the utterance and to which extent it also shifts "against the grain" of the unfolding sentence. The outcome suggests that comprehenders' visual attention is predominantly guided by their interpretation of the spatial description. Visual shifts against the grain occurred only when comprehenders had some extra time, and their absence did not affect comprehension accuracy. However, the timing of this reverse gaze shift on a trial correlated with that trial's verification time. Thus, while the timing of these gaze shifts is subtly related to the verification time, their presence is not necessary for successful verification of spatial relations.	[Burigo, Michele] Univ Bielefeld, Dept Linguist, D-33615 Bielefeld, Germany; Univ Bielefeld, Cognit Interact Technol Ctr Excellence CITEC, Language & Cognit Res Grp, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Burigo, M (corresponding author), Univ Bielefeld, Dept Linguist, D-33615 Bielefeld, Germany.	mburigo@cit-ec.uni-bielefeld.de		Burigo, Michele/0000-0003-2068-9936	German Research Foundation "Cognitive Interaction Technology" (CITEC) [DFG EXC 277]; Deutsche Forschungsgemeinschaft; Open Access Publication Funds of Bielefeld University Library	German Research Foundation "Cognitive Interaction Technology" (CITEC); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University Library	This research was supported by German Research Foundation Grant DFG EXC 277 "Cognitive Interaction Technology" (CITEC). The authors also acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Altmann GTM, 2004, COGNITION, V93, pB79, DOI 10.1016/j.cognition.2004.02.005; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Andersson R, 2011, ACTA PSYCHOL, V137, P208, DOI 10.1016/j.actpsy.2011.01.007; Arai M, 2007, COGNITIVE PSYCHOL, V54, P218, DOI 10.1016/j.cogpsych.2006.07.001; Baayen R. H., 2008, ANAL LINGUISTIC DATA; BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Bates D. M., 2007, LME4 LINEAR MIXED EF; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Carlson LA, 2002, J EXP PSYCHOL HUMAN, V28, P1391, DOI 10.1037//0096-1523.28.6.1391; Carlson LA, 2006, SPAT COGN COMPUT, V6, P295, DOI DOI 10.1207/S15427633SCC0604_1; Carlson Laura A., 2005, P330, DOI 10.1016/B978-012375731-9/50058-6; Carlson-Radvansky LA, 1999, PERCEPT PSYCHOPHYS, V61, P919, DOI 10.3758/BF03206906; Carminati MN, 2008, J EXP PSYCHOL LEARN, V34, P1098, DOI 10.1037/a0012795; Chambers CG, 2002, J MEM LANG, V47, P30, DOI 10.1006/jmla.2001.2832; CLARK HH, 1972, COGNITIVE PSYCHOL, V3, P472, DOI 10.1016/0010-0285(72)90019-9; COOPER RM, 1974, COGNITIVE PSYCHOL, V6, P84, DOI 10.1016/0010-0285(74)90005-X; Coventry KR, 2010, BRAIN LANG, V112, P202, DOI 10.1016/j.bandl.2009.06.001; Coventry KR, 2004, ESSAYS COGN PSYCHOL, P1; Coventry KR, 2001, J MEM LANG, V44, P376, DOI 10.1006/jmla.2000.2742; Dahan D, 2001, COGNITIVE PSYCHOL, V42, P317, DOI 10.1006/cogp.2001.0750; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Droll JA, 2007, J EXP PSYCHOL HUMAN, V33, P1352, DOI 10.1037/0096-1523.33.6.1352; EBERHARD KM, 1995, J PSYCHOLINGUIST RES, V24, P409, DOI 10.1007/BF02143160; FISCHER B, 1987, NEUROPSYCHOLOGIA, V25, P73, DOI 10.1016/0028-3932(87)90044-3; Franconeri SL, 2012, COGNITION, V122, P210, DOI 10.1016/j.cognition.2011.11.002; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gersch TM, 2008, J VISION, V8, DOI 10.1167/8.16.15; Gersch TM, 2009, VISION RES, V49, P1256, DOI 10.1016/j.visres.2007.10.030; GOUGH PB, 1965, J VERB LEARN VERB BE, V4, P107, DOI 10.1016/S0022-5371(65)80093-7; Holcombe AO, 2011, CURR BIOL, V21, P1135, DOI 10.1016/j.cub.2011.05.031; Huettig F, 2011, ACTA PSYCHOL, V137, P138, DOI 10.1016/j.actpsy.2010.07.013; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; JAEGER TF, 2011, LING R LANG L MAILIN; Knoeferle P, 2007, J MEM LANG, V57, P519, DOI 10.1016/j.jml.2007.01.003; Knoeferle P, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00538; Knoeferle P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00376; Knoeferle P, 2011, PSYCHOPHYSIOLOGY, V48, P495, DOI 10.1111/j.1469-8986.2010.01080.x; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; Kraemer HC, 2004, INT J METH PSYCH RES, V13, P141, DOI 10.1002/mpr.170; Logan G.D., 1996, LANGUAGE SPACE, P493; LOGAN GD, 1994, J EXP PSYCHOL HUMAN, V20, P1015, DOI 10.1037/0096-1523.20.5.1015; LOGAN GD, 1995, COGNITIVE PSYCHOL, V28, P103, DOI 10.1006/cogp.1995.1004; Logan GD, 1996, J EXP PSYCHOL HUMAN, V22, P159, DOI 10.1037/0096-1523.22.1.159; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; Miller GA., 1976, LANGUAGE PERCEPTION; Peterson MS, 2004, PERCEPT PSYCHOPHYS, V66, P398, DOI 10.3758/BF03194888; R Development Core Team, 2007, R LANG ENV STAT COMP; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Regier T, 2001, J EXP PSYCHOL GEN, V130, P273, DOI 10.1037//0096-3445.130.2.273; Rosielle LJ, 2002, PSYCHON B REV, V9, P319, DOI 10.3758/BF03196288; Salverda AP, 2011, ACTA PSYCHOL, V137, P172, DOI 10.1016/j.actpsy.2010.09.010; SEYMOUR PHK, 1969, BRIT J PSYCHOL, V60, P31, DOI 10.1111/j.2044-8295.1969.tb01173.x; Singer M, 2006, J MEM LANG, V54, P574, DOI 10.1016/j.jml.2005.11.003; Talmy L., 1983, SPATIAL ORIENTATION, V225, P282, DOI [DOI 10.1007/978-1-4615-9325-6_11, 10.1007/978-1-4615-9325-6_11]; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Wilder JD, 2009, VISION RES, V49, P1017, DOI 10.1016/j.visres.2008.04.032; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; Woodman GF, 2003, J EXP PSYCHOL HUMAN, V29, P121, DOI 10.1037/0096-1523.29.1.121; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	62	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115758	10.1371/journal.pone.0115758	http://dx.doi.org/10.1371/journal.pone.0115758			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4PR	25607540	Green Published, Green Submitted, gold			2022-12-27	WOS:000348205300019
J	Gengler, S; Laudisoit, A; Batoko, H; Wattiau, P				Gengler, Samuel; Laudisoit, Anne; Batoko, Henri; Wattiau, Pierre			Long-Term Persistence of Yersinia pseudotuberculosis in Entomopathogenic Nematodes	PLOS ONE			English	Article							MUSCA-DOMESTICA DIPTERA; GRAM-NEGATIVE BACTERIA; TOXIN COMPLEX PROTEINS; PHOTORHABDUS-LUMINESCENS; CAENORHABDITIS-ELEGANS; SUICIDE VECTOR; VI SECRETION; XENORHABDUS; PESTIS; ENTEROCOLITICA	Entomopathogenic nematodes (EPNs) are small worms whose ecological behaviour consists to invade, kill insects and feed on their cadavers thanks to a species-specific symbiotic bacterium belonging to any of the genera Xenorhabdus or Photorhabdus hosted in the gastro-intestinal tract of EPNs. The symbiont provides a number of biological functions that are essential for its EPN host including the production of entomotoxins, of enzymes able to degrade the insect constitutive macromolecules and of antimicrobial compounds able to prevent the growth of competitors in the insect cadaver. The question addressed in this study was to investigate whether a mammalian pathogen taxonomically related to Xenorhabdus was able to substitute for or "hijack" the symbiotic relationship associating Xenorhabdus and Steinernema EPNs. To deal with this question, a laboratory experimental model was developed consisting in Galleria mellonella insect larvae, Steinernema EPNs with or without their natural Xenorhabdus symbiont and Yersinia pseudotuberculosis brought artificially either in the gut of EPNs or in the haemocoel of the insect larva prior to infection. The developed model demonstrated the capacity of EPNs to act as an efficient reservoir ensuring exponential multiplication, maintenance and dissemination of Y. pseudotuberculosis.	[Gengler, Samuel; Wattiau, Pierre] Vet & Agrochem Res Ctr VAR, Brussels, Belgium; [Gengler, Samuel; Batoko, Henri] Catholic Univ Louvain, Inst Life Sci, Louvain, Belgium; [Laudisoit, Anne] Univ Antwerp, Evolutionary Biol, B-2020 Antwerp, Belgium; [Laudisoit, Anne] Univ Liverpool, Sch Biol Sci, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	Universite Catholique Louvain; University of Antwerp; University of Liverpool	Wattiau, P (corresponding author), Vet & Agrochem Res Ctr VAR, Brussels, Belgium.	Pierre.Wattiau@coda-cerva.be	Batoko, Henri/Y-4238-2019; LAUDISOIT, Anne/O-5773-2019	Batoko, Henri/0000-0002-8256-519X; LAUDISOIT, Anne/0000-0001-7626-9426	Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture	Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS)	This study was funded by the "Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture"; http://www.fnrs.be/. SG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; AKHURST RJ, 1980, J GEN MICROBIOL, V121, P303; Ayyadurai S, 2008, MICROBIOL-SGM, V154, P2865, DOI 10.1099/mic.0.2007/016154-0; Babic I, 2000, MICROBIOL-UK, V146, P709, DOI 10.1099/00221287-146-3-709; Bari ML, 2011, J PATHOG, V2011, DOI 10.4061/2011/420732; Bertherat E, 2007, EMERG INFECT DIS, V13, P1459, DOI 10.3201/eid1310.070284; Brusselman E, 2006, Commun Agric Appl Biol Sci, V71, P701; Buzoleva LS, 2003, B EXP BIOL MED+, V135, P456, DOI 10.1023/A:1024915409187; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Collyn F, 2002, INFECT IMMUN, V70, P6196, DOI 10.1128/IAI.70.11.6196-6205.2002; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Derbise A, 2013, J INFECT DIS, V207, P1535, DOI 10.1093/infdis/jit057; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; Emelianoff V, 2008, EVOLUTION, V62, P932, DOI 10.1111/j.1558-5646.2008.00319.x; FARMER JJ, 1989, J CLIN MICROBIOL, V27, P1594, DOI 10.1128/JCM.27.7.1594-1600.1989; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Hatab Moeen Abu, 1998, Journal of Parasitology, V84, P215, DOI 10.2307/3284473; Heermann R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-40; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; Jalava K, 2006, J INFECT DIS, V194, P1209, DOI 10.1086/508191; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Lambrecht E, 2013, APPL ENVIRON MICROB, V79, P6407, DOI 10.1128/AEM.01915-13; Lancaster Jeremiah D, 2012, BMC Res Notes, V5, P688, DOI 10.1186/1756-0500-5-688; Li JX, 1997, CAN J MICROBIOL, V43, P770, DOI 10.1139/m97-110; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; MCFARLANE GJB, 1987, J MICROBIOL METH, V6, P301, DOI 10.1016/0167-7012(87)90067-4; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Mwaitulo S., 2011, International Journal of Tropical Insect Science, V31, P154, DOI 10.1017/S1742758411000294; NIKULSHIN SV, 1992, ZH MIKROB EPID IMMUN, P2; Pinheiro VB, 2007, CELL MICROBIOL, V9, P2372, DOI 10.1111/j.1462-5822.2007.00966.x; POINER GO, 1966, PARASITOLOGY, V56, P385, DOI 10.1017/S0031182000070980; Rahuma N, 2005, ANN TROP MED PARASIT, V99, P795, DOI 10.1179/136485905X65134; Reznikoff WS, 2008, ANNU REV GENET, V42, P269, DOI 10.1146/annurev.genet.42.110807.091656; Schmiel DH, 1998, INFECT IMMUN, V66, P3941, DOI 10.1128/IAI.66.8.3941-3951.1998; Schubert S, 2004, INT J MED MICROBIOL, V294, P83, DOI 10.1016/j.ijmm.2004.06.026; Sheets JJ, 2011, J BIOL CHEM, V286, P22742, DOI 10.1074/jbc.M111.227009; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Tan L, 2004, J BACTERIOL, V186, P5087, DOI 10.1128/jb.186.15.5087-5092.2004; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Wilkinson P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-302; Wilson M, 2004, BIOTECHNOL LETT, V26, P1167, DOI 10.1023/B:BILE.0000035492.25214.3b; WOUTS WM, 1981, J NEMATOL, V13, P467; Zhang CX, 2009, INT J SYST EVOL MICR, V59, P1603, DOI 10.1099/ijs.0.65718-0; Zhang CX, 2008, J INVERTEBR PATHOL, V98, P153, DOI 10.1016/j.jip.2008.02.011; Zurek L, 2000, J MED ENTOMOL, V37, P924, DOI 10.1603/0022-2585-37.6.924; Zurek L, 2001, J MED ENTOMOL, V38, P333, DOI 10.1603/0022-2585-38.2.333	54	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116818	10.1371/journal.pone.0116818	http://dx.doi.org/10.1371/journal.pone.0116818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635766	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700060
J	Jennings, WB; Berry, KH				Jennings, W. Bryan; Berry, Kristin H.			Desert Tortoises (Gopherus agassizii) Are Selective Herbivores that Track the Flowering Phenology of Their Preferred Food Plants	PLOS ONE			English	Article							FREE-RANGING DESERT; MOJAVE-DESERT; NUTRITIONAL QUALITY; GEOCHELONE-PARDALIS; XEROBATES-AGASSIZII; SOUTHERN NEVADA; FEEDING ECOLOGY; GIANT TORTOISES; NATURAL FOODS; DIET	Previous studies of desert tortoise foraging ecology in the western Mojave Desert suggest that these animals are selective herbivores, which alter their diet according to the temporal availability of preferred food plants. These studies, however, did not estimate availability of potential food plants by taking into account the spatial and temporal variability in ephemeral plant abundance that occurs within the spring season. In this study, we observed 18 free-ranging adult tortoises take 35,388 bites during the spring foraging season. We also estimated the relative abundance of potential food plants by stratifying our sampling across different phenological periods of the 3-month long spring season and by different habitats and microhabitats. This methodology allowed us to conduct statistical tests comparing tortoise diet against plant abundance. Our results show that tortoises choose food plants non-randomly throughout the foraging season, a finding that corroborates the hypothesis that desert tortoises rely on key plants during different phenological periods of spring. Moreover, tortoises only consumed plants in a succulent state until the last few weeks of spring, at which time most annuals and herbaceous perennials had dried and most tortoises had ceased foraging. Many species of food plants-including several frequently eaten species-were not detected in our plant surveys, yet tortoises located these rare plants in their home ranges. Over 50% of bites consumed were in the group of undetected species. Interestingly, tortoises focused heavily on several leguminous species, which could be nutritious foods owing to their presumably high nitrogen contents. We suggest that herbaceous perennials, which were rare on our study area but represented similar to 30% of tortoise diet, may be important in sustaining tortoise populations during droughts when native annuals are absent. These findings highlight the vulnerability of desert tortoises to climate change if such changes alter the availability of their preferred food plants.	[Jennings, W. Bryan] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, BR-20940040 Rio De Janeiro, RJ, Brazil; [Berry, Kristin H.] US Geol Survey, Western Ecol Res Ctr, Riverside, CA 92518 USA	Universidade Federal do Rio de Janeiro; United States Department of the Interior; United States Geological Survey	Jennings, WB (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, BR-20940040 Rio De Janeiro, RJ, Brazil.	wbjenn@gmail.com	Jennings, Bryan/ABE-9193-2020	Jennings, Bryan/0000-0001-7700-8981	U.S. Bureau of Land Management [B950-C2-0014]	U.S. Bureau of Land Management	This study was funded by the U.S. Bureau of Land Management (Contract No. B950-C2-0014 awarded to WBJ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; BEATLEY JC, 1974, ECOLOGY, V55, P856, DOI 10.2307/1934421; BEATLEY JC, 1976, OECOLOGIA, V24, P21, DOI 10.1007/BF00545485; Bedford DR, 2009, MOJAVE DESERT, P252; Berry K.H., 1978, Transactions of the North American Wildlife and Natural Resources Conference, P505; Bolling JD, 2002, WEST N AM NATURALIST, V62, P88; Bourn D, 1999, P ROY SOC B-BIOL SCI, V266, P1091, DOI 10.1098/rspb.1999.0748; Brooks ML, 2006, J ARID ENVIRON, V67, P148, DOI 10.1016/j.jaridenv.2006.09.027; Brooks ML, 2006, J ARID ENVIRON, V67, P100, DOI 10.1016/j.jaridenv.2006.09.021; Brooks ML, 2006, J ARID ENVIRON, V67, P125, DOI 10.1016/j.jaridenv.2006.09.022; Brooks Matthew L., 2002, Chelonian Conservation and Biology, V4, P330; Brooks ML, 2009, MOJAVE DESERT, P168; Brooks ML, 2009, MOJAVE DESERT, P101; Brooks Matthew L., 1999, Madrono, V46, P13; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; BROOKS ML, 1995, ENVIRON MANAGE, V19, P65, DOI 10.1007/BF02472004; Brooks ML, 2000, AM MIDL NAT, V144, P92, DOI 10.1674/0003-0031(2000)144[0092:CBAAGA]2.0.CO;2; Brossard CC, 2000, INVASIVE PLANTS CALI; Burge BL, 1978, DES TORT COUNC S P, P80; Christopher MM, 1999, J WILDLIFE DIS, V35, P212, DOI 10.7589/0090-3558-35.2.212; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Del Vecchio S, 2011, HERPETOLOGICA, V67, P236, DOI 10.1655/HERPETOLOGICA-D-10-00064.1; El Mouden EH, 2006, J ARID ENVIRON, V64, P422, DOI 10.1016/j.jaridenv.2005.06.010; Fish and Wildlife Service, 1990, FED REG, V55, P12178; GIBSON CWD, 1983, OECOLOGIA, V56, P84, DOI 10.1007/BF00378221; GRUBB P, 1971, PHILOS T ROY SOC B, V260, P327, DOI 10.1098/rstb.1971.0018; Hailey A, 1998, FUNCT ECOL, V12, P373, DOI 10.1046/j.1365-2435.1998.00203.x; Hazard LC, 2010, J HERPETOL, V44, P135, DOI 10.1670/08-134.1; Hazard LC, 2009, J HERPETOL, V43, P38, DOI 10.1670/07-160R1.1; Henen BT, 1998, OECOLOGIA, V117, P365, DOI 10.1007/s004420050669; HNATIUK R J, 1976, Biological Conservation, V9, P305, DOI 10.1016/0006-3207(76)90052-5; JACOBSON ER, 1991, J WILDLIFE DIS, V27, P296, DOI 10.7589/0090-3558-27.2.296; Jennings W. Bryan, 2001, Madrono, V48, P162; Jennings W. Bryan, 2002, Chelonian Conservation and Biology, V4, P353; Jennings WB, 1993, P DES TORT COUNC 199, P69; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Joshua QI, 2010, J HERPETOL, V44, P124, DOI 10.1670/08-306R1.1; Kabigumila J, 2001, AFR J ECOL, V39, P276, DOI 10.1046/j.1365-2028.2001.00316.x; Krebs C. J, 1989, ECOLOGICAL METHODOLO; Lagarde FR, 2003, ECOGRAPHY, V26, P236, DOI 10.1034/j.1600-0587.2003.03365.x; MACDONALD LA, 1988, HERPETOLOGICA, V44, P345; Mason Mervyn C., 1999, Chelonian Conservation and Biology, V3, P435; MEIENBERGER C, 1993, PHYSIOL ZOOL, V66, P847, DOI 10.1086/physzool.66.5.30163827; MERTON L F H, 1976, Biological Conservation, V9, P293, DOI 10.1016/0006-3207(76)90051-3; MINNICH JE, 1972, COMP BIOCHEM PHYSIOL, V41, P535, DOI 10.1016/0300-9629(72)90011-4; Minnich JE, 1977, P DESERT TORTOISE CO, V1977, P102; MOSKOVITS DK, 1990, HERPETOLOGICA, V46, P207; Mushinsky HR, 2003, HERPETOLOGICA, V59, P475, DOI 10.1655/02-50; NAGY KA, 1986, HERPETOLOGICA, V42, P73; Oftedal Olav T., 2002, Chelonian Conservation and Biology, V4, P341; Oftedal Olav T., 2002, P194; OWENSMITH N, 1982, AM NAT, V119, P151, DOI 10.1086/283902; Peterson CC, 1996, PHYSIOL ZOOL, V69, P1324, DOI 10.1086/physzool.69.6.30164263; Peterson CC, 1996, ECOLOGY, V77, P1831, DOI 10.2307/2265787; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RALL M, 1993, S AFR J WILDL RES, V23, P63; Raven PH., 1992, BIOL PLANTS, V5th, P791; ROWLANDS P. G., 1978, THESIS U CALIFORNIA; Rowlands PG, 1986, P DES TORT COUNC 199, P41; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Sokol R.R., 1981, BIOMETRY, P859; U. S. Fish and Wildlife Service, 1994, DES TORT MOJ POP REC, P73; US Fish and Wildlife Service, 2010, MOJ POP DES TORT GOP; US Fish and Wildlife Service, 1994, FED REG, V59, P5820; WEBB RH, 1979, ENVIRON MANAGE, V3, P517, DOI 10.1007/BF01866321; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921	66	24	25	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116716	10.1371/journal.pone.0116716	http://dx.doi.org/10.1371/journal.pone.0116716			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635840	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700054
J	Nelson, LE; Wilton, L; Agyarko-Poku, T; Zhang, NH; Zou, YS; Aluoch, M; Apea, V; Hanson, SO; Adu-Sarkodie, Y				Nelson, LaRon E.; Wilton, Leo; Agyarko-Poku, Thomas; Zhang, Nanhua; Zou, Yuanshu; Aluoch, Marilyn; Apea, Vanessa; Hanson, Samuel Owiredu; Adu-Sarkodie, Yaw			Predictors of Condom Use among Peer Social Networks of Men Who Have Sex with Men in Ghana, West Africa	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; HIV-RELATED STIGMA; DETERMINATION THEORY PERSPECTIVE; BLACK-MEN; PREVENTION INTERVENTIONS; STRUCTURAL INTERVENTION; PSYCHOMETRIC EVALUATION; MEDICATION ADHERENCE; GENDER NONCONFORMITY; NEED SATISFACTION	Ghanaian men who have sex with men (MSM) have high rates of HIV infection. A first step in designing culturally relevant prevention interventions for MSM in Ghana is to understand the influence that peer social networks have on their attitudes and behaviors. We aimed to examine whether, in a sample of Ghanaian MSM, mean scores on psychosocial variables theorized to influence HIV/STI risk differed between peer social networks and to examine whether these variables were associated with condom use. We conducted a formative, cross-sectional survey with 22 peer social networks of MSM (n = 137) in Ghana. We assessed basic psychological- needs satisfaction, HIV/STI knowledge, sense of community, HIV and gender non-conformity stigmas, gender equitable norms, sexual behavior and condom use. Data were analyzed using analysis of variance, generalized estimating equations, and Wilcoxon two sample tests. All models were adjusted for age and income, ethnicity, education, housing and community of residence. Mean scores for all psychosocial variables differed significantly by social network. Men who reported experiencing more autonomy support by their healthcare providers had higher odds of condom use for anal (AOR = 3.29, p < 0.01), oral (AOR = 5.06, p < 0.01) and vaginal (AOR = 1.8, p < 0.05) sex. Those with a stronger sense of community also had higher odds of condom use for anal sex (AOR = 1.26, p < 0.001). Compared to networks with low prevalence of consistent condom users, networks with higher prevalence of consistent condom users had higher STD and HIV knowledge, had norms that were more supportive of gender equity, and experienced more autonomy support in their healthcare encounters. Healthcare providers and peer social networks can have an important influence on safer-sex behaviors in Ghanaian MSM. More research with Ghanaian MSM is needed that considers knowledge, attitudes, and norms of their social networks in the development and implementation of culturally relevant HIV/STI prevention intervention strategies.	[Nelson, LaRon E.] Univ Rochester, Sch Nursing, Rochester, NY 14627 USA; [Nelson, LaRon E.] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Wilton, Leo] SUNY Binghamton, Coll Community & Publ Affairs, Dept Human Dev, Binghamton, NY USA; [Wilton, Leo] Univ Johannesburg, Fac Humanities, Johannesburg, South Africa; [Agyarko-Poku, Thomas] Ashanti Reg Hlth Directorate, Ghana Hlth Serv, Kumasi, Ghana; [Zhang, Nanhua; Zou, Yuanshu] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Aluoch, Marilyn] Univ S Florida, Coll Nursing, Tampa, FL USA; [Apea, Vanessa] Barts & Royal London Hosp, Dept Genitourinary Med, London, England; [Hanson, Samuel Owiredu] Ctr Popular Educ & Human Rights Ghana, Accra, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana	University of Rochester; University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Johannesburg; Ghana Health Service; Cincinnati Children's Hospital Medical Center; State University System of Florida; University of South Florida; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; Kwame Nkrumah University Science & Technology	Nelson, LE (corresponding author), Univ Rochester, Sch Nursing, Rochester, NY 14627 USA.	laron_nelson@urmc.rochester.edu	AGYARKO-POKU, THOMAS/AAM-2462-2021; Zhang, Nanhua/L-7606-2015	Nelson, LaRon/0000-0002-2630-602X; Zhang, Nanhua/0000-0001-5796-3404	Grand Challenges Canada [CRS0024-0101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER	Grand Challenges Canada(CGIAR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by Grand Challenges Canada CRS0024-0101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Airhihenbuwa CO, 2012, J HEALTH COMMUN, V17, P629, DOI 10.1080/10810730.2012.703913; Alvergne A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022515; Auerbach J, 2009, HEALTH AFFAIR, V28, P1655, DOI 10.1377/hlthaff.28.6.1655; Baral S, 2012, AIDS BEHAV; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Berg R, 2009, EURO SURVEILL, V14; Bosu WK., 2009, MODES HIV TRANSMISSI; Boulay M, 2008, AJAR-AFR J AIDS RES, V7, P133, DOI 10.2989/AJAR.2008.7.1.13.441; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Carey M.P., 1997, AIDS BEHAV, V1, P61, DOI [DOI 10.1023/A:1026218005943, 10.1023/A:1026218005943]; Carey MP, 2010, AIDS BEHAV, V14, P504, DOI 10.1007/s10461-009-9587-1; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Chirkov V, 2003, J PERS SOC PSYCHOL, V84, P97, DOI 10.1037/0022-3514.84.1.97; Chirkov VI, 2005, J CROSS CULT PSYCHOL, V36, P423, DOI 10.1177/0022022105275960; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Clark AE, 2007, J HEALTH ECON, V26, P763, DOI 10.1016/j.jhealeco.2006.11.005; Commission GA, 2012, RESULTS FROM A NATIO; Deci EL, 2001, PERS SOC PSYCHOL B, V27, P930, DOI 10.1177/0146167201278002; Diaz Rafael M, 2004, Cultur Divers Ethnic Minor Psychol, V10, P255, DOI 10.1037/1099-9809.10.3.255; Drame F. M., 2012, CULT HEALTH SEX; El-Sayed AM, 2013, AM J EPIDEMIOL, V178, P287, DOI 10.1093/aje/kws455; FESTINGER L, 1959, J ABNORM SOC PSYCH, V58, P203, DOI 10.1037/h0041593; Fowler JH, 2008, J HEALTH ECON, V27, P1400, DOI 10.1016/j.jhealeco.2008.07.001; Geibel S, 2012, SEX TRANSM INFECT, V88, P357, DOI 10.1136/sextrans-2011-050224; Gillet N, 2013, J ADV NURS, V69, P2560, DOI 10.1111/jan.12144; Gordon Allegra R, 2007, J LGBT Health Res, V3, P55; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Gurnani V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-755; Harawa N, 2014, AIDS BEHAV; Hatzenbuehler ML, 2014, SOC SCI MED, V103, P33, DOI 10.1016/j.socscimed.2013.06.005; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Hatzenbuehler ML, 2009, PSYCHOL BULL, V135, P707, DOI 10.1037/a0016441; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Huang GC, 2013, J ADOLESC HLTH; Hurt CB, 2012, JAIDS-J ACQ IMM DEF, V61, P515, DOI 10.1097/QAI.0b013e31827076a4; Irvin R, 2014, AIDS BEHAV IN PRESS; Jaworski BC, 2007, AIDS BEHAV, V11, P557, DOI 10.1007/s10461-006-9168-5; Jeffries WL, 2013, AIDS BEHAV, V17, P1442, DOI 10.1007/s10461-012-0189-y; Johnson BT, 2010, AIDS BEHAV, V14, pS204, DOI 10.1007/s10461-010-9803-z; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Jones KT, 2008, AM J PUBLIC HEALTH, V98, P1043, DOI 10.2105/AJPH.2007.120337; Kang DM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-717; Kelly JA, 2013, AIDS EDUC PREV, V25, P49, DOI 10.1521/aeap.2013.25.1.49; Kennedy S, 2004, COGNITIVE THER RES, V28, P611, DOI 10.1023/B:COTR.0000045568.95219.e2; Kidder DP, 2007, AIDS BEHAV, V11, pS149, DOI 10.1007/s10461-007-9249-0; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; La Guardia JG, 2000, J PERS SOC PSYCHOL, V79, P367, DOI 10.1037//0022-3514.79.3.367; Latkin Carl, 2011, Am J Public Health, V101, pe18, DOI 10.2105/AJPH.2011.300281; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Levy ME, 2014, AIDS BEHAV; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; Logie CH, 2012, SOC SCI MED, V74, P1261, DOI 10.1016/j.socscimed.2012.01.008; Logie CH, 2011, EXPLORING EXPERIENCE; Lorimer K, 2013, AIDS CARE, V25, P133, DOI 10.1080/09540121.2012.699672; Lorway R, 2010, SEX TRANSM INFECT, V86, P70, DOI 10.1136/sti.2010.044909; Lynch MF, 2009, J POSIT PSYCHOL, V4, P290, DOI 10.1080/17439760902933765; Malebranche DJ, 2012, GAY LESBIAN MED ASS; Marks G, 2009, AIDS BEHAV, V13, P682, DOI 10.1007/s10461-008-9380-6; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Merrigan M, 2011, SEX TRANSM INFECT, V87, P65, DOI 10.1136/sti.2008.034991; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Millett GA, 2012, LANCET, V380, P411, DOI 10.1016/S0140-6736(12)60722-3; Mimiaga MJ, 2009, J URBAN HEALTH, V86, P602, DOI 10.1007/s11524-009-9363-6; Minkler M, 2008, COMMUNITY BASED PART; Moller AC, 2006, J PUBLIC POLICY MARK, V25, P104, DOI 10.1509/jppm.25.1.104; Mwinituo PP, 2006, WESTERN J NURS RES, V28, P369, DOI 10.1177/0193945906286602; Neilands TB, 2008, ARCH SEX BEHAV, V37, P838, DOI 10.1007/s10508-007-9305-x; Nelson LE, 2014, NURSING INQUIRY; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Ory MG, 2010, AM J HEALTH BEHAV, V34, P647, DOI 10.5993/AJHB.34.6.2; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Pachankis JE, 2014, SOC SCI MED, V103, P67, DOI 10.1016/j.socscimed.2013.10.005; Peterson JL, 2009, HEALTH EDUC RES, V24, P119, DOI 10.1093/her/cyn003; Peterson JL, 1996, AM J COMMUN PSYCHOL, V24, P461, DOI 10.1007/BF02506793; Peterson NA, 2008, J COMMUNITY PSYCHOL, V36, P61, DOI 10.1002/jcop.20217; Petty RD, 1992, IMPACT ADVERTISING L; Phelan JC, 2014, SOC SCI MED, V103, P15, DOI 10.1016/j.socscimed.2013.10.004; Poku Kwabena A, 2005, SAHARA J, V2, P344; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; Reeve J, 2002, MOTIV EMOTION, V26, P183, DOI 10.1023/A:1021711629417; Reid AE, 2014, SOC SCI MED, V103, P118, DOI 10.1016/j.socscimed.2013.06.028; Risher K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18715; Ryan R.M., 2005, HDB COMPETENCE MOTIV, P354; Ryan R. M., 2008, EUROPEAN HLTH PSYCHO, V10, P2, DOI DOI 10.1080/17509840701827437; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sabin L., 2013, EXPLORING BELIEFS AT; Sandfort TGM, 2007, J SEX RES, V44, P181, DOI 10.1080/00224490701263819; Sayegh M Aaron, 2005, J Adolesc Health, V37, P163, DOI 10.1016/j.jadohealth.2004.08.018; Schimmack U, 2005, PERS SOC PSYCHOL REV, V9, P17, DOI 10.1207/s15327957pspr0901_2; Schneider J, 2012, JAIDS-J ACQ IMM DEF, V61, P627, DOI 10.1097/QAI.0b013e318270d3cb; Schneider J, 2012, AIDS PATIENT CARE ST, V26, P631, DOI 10.1089/apc.2012.0188; Schneider John A, 2013, Am J Public Health, V103, pe28, DOI 10.2105/AJPH.2012.301003; Sheldon KM, 2012, WORLD PSYCHIATRY, V11, P101, DOI 10.1016/j.wpsyc.2012.05.017; Sheldon KM, 2009, INT J BEHAV DEV, V33, P451, DOI 10.1177/0165025409340095; Smit PJ, 2012, AIDS CARE, V24, P405, DOI 10.1080/09540121.2011.613910; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Stephenson R, 2009, AIDS CARE, V21, P403, DOI 10.1080/09540120802290365; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Stuber J, 2008, SOC SCI MED, V67, P351, DOI 10.1016/j.socscimed.2008.03.023; Ulasi CI, 2009, HEALTH PLACE, V15, P255, DOI 10.1016/j.healthplace.2008.05.006; Williams GC, 2000, J APPL SOC PSYCHOL, V30, P1756, DOI 10.1111/j.1559-1816.2000.tb02466.x; Williams GC, 1998, HEALTH PSYCHOL, V17, P269, DOI 10.1037/0278-6133.17.3.269; Williams GC, 1999, ARCH PEDIAT ADOL MED, V153, P959, DOI 10.1001/archpedi.153.9.959; Williams GC, 2006, J GEN INTERN MED, V21, P1288, DOI 10.1111/j.1525-1497.2006.00621.x; Williams GC, 2009, ANN BEHAV MED, V37, P315, DOI 10.1007/s12160-009-9090-y; Williams GC, 2009, DIABETES EDUCATOR, V35, P484, DOI 10.1177/0145721709333856; Williams JK, 2013, AM J PUBLIC HEALTH, V103, P1476, DOI 10.2105/AJPH.2012.301121; Williams M, 2001, SEX TRANSM INFECT, V77, P433, DOI 10.1136/sti.77.6.433; Wilton L, 2009, AIDS BEHAV, V13, P532, DOI 10.1007/s10461-009-9529-y	114	27	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115504	10.1371/journal.pone.0115504	http://dx.doi.org/10.1371/journal.pone.0115504			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HX	25635774	Green Submitted, gold, Green Published			2022-12-27	WOS:000350680700012
J	Welleweerd, JC; Nelissen, BGL; Koole, D; de Vries, JPPM; Moll, FL; Pasterkamp, G; Vink, A; de Borst, GJ				Welleweerd, Janna C.; Nelissen, Bastiaan G. L.; Koole, Dave; de Vries, Jean-Paul P. M.; Moll, Frans L.; Pasterkamp, Gerard; Vink, Aryan; de Borst, Gert Jan			Histological Analysis of Extracranial Carotid Artery Aneurysms	PLOS ONE			English	Article								Introduction Extracranial carotid artery aneurysms (ECAA) are rare but may be accompanied with significant morbidity. Previous studies mostly focused on diagnostic imaging and treatment. In contrast, the pathophysiological mechanisms and natural course of ECAA are largely unknown. Understanding the pathophysiological background may add to prediction of risk for adverse outcome and need for surgical exclusion. The aim of this study was to investigate the histopathological characteristics of ECAA in patients who underwent complete surgical ECAA resection. Material and Methods From March 2004 till June 2013, 13 patients were treated with open ECAA repair. During surgery the aneurysm sac was resected and processed for standardized histological analysis. Sections were stained with routine hematoxylin and eosin and special stains to detect elastin, collagen, different types of inflammatory cells, vascular smooth muscle cells and endothelial cells. Results Histopathological characterization revealed two distinct categories: dissection (abrupt interruption of the media; n = 3) and degeneration (general loss of elastin fibers in the media; n = 10). In the degenerative samples the elastin fibers in the media were fragmented and were partly absent. Inflammatory cells were observed in the vessel wall of the aneurysms. Conclusion Histological analysis in this small sample size revealed dissection and degeneration as the two distinct underlying mechanisms in ECAA formation.	[Welleweerd, Janna C.; Nelissen, Bastiaan G. L.; Koole, Dave; Moll, Frans L.; de Borst, Gert Jan] Univ Med Ctr Utrecht, Vasc Surg, NL-3584 CX Utrecht, Netherlands; [Nelissen, Bastiaan G. L.; Koole, Dave; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Expt Cardiol Lab, NL-3584 CX Utrecht, Netherlands; [de Vries, Jean-Paul P. M.] St Antonius Hosp, Vasc Surg, NL-3435 CM Nieuwegein, Netherlands; [Vink, Aryan] Univ Med Ctr Utrecht, Pathol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center	de Borst, GJ (corresponding author), Univ Med Ctr Utrecht, Vasc Surg, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	G.J.deBorst-2@umcutrecht.nl						Burdorf A, 2011, HUMAN TISSUE MED RES; Chedgy ECP, 2010, ANN VASC SURG, V24, DOI 10.1016/j.avsg.2010.02.040; Dawson I, 1997, BRIT J SURG, V84, P293; de Jong K P, 1989, Eur J Vasc Surg, V3, P557, DOI 10.1016/S0950-821X(89)80132-X; Dobrin PB, 2000, MED INTELL UNIT, V17, P42; Donas KP, 2009, J VASC SURG, V49, P93, DOI 10.1016/j.jvs.2008.08.006; El-Sabrout R, 2000, J VASC SURG, V31, P702, DOI 10.1067/mva.2000.104101; Guillon B, 1999, NEUROLOGY, V53, P117, DOI 10.1212/WNL.53.1.117; Hanabusa K, 2010, NEUROL MED-CHIR, V50, P917, DOI 10.2176/nmc.50.917; James AL, 1999, J LARYNGOL OTOL, V113, P373, DOI 10.1017/S0022215100144020; Longo G Matthew, 2005, Semin Vasc Surg, V18, P178, DOI 10.1053/j.semvascsurg.2005.09.002; MCCOLLUM CH, 1979, AM J SURG, V137, P196, DOI 10.1016/0002-9610(79)90144-2; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Radak D, 2007, ANN VASC SURG, V21, P23, DOI 10.1016/j.avsg.2006.10.004; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; SAKALIHASAN N, 1993, EUR J VASCULAR SURG, V7, P633, DOI 10.1016/S0950-821X(05)80708-X; Troisi N, 2010, J VASC SURG, V51, P225, DOI 10.1016/j.jvs.2009.08.057; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Welleweerd JC, 2012, EXPERT REV CARDIOVAS, V10, P925, DOI [10.1586/ERC.12.61, 10.1586/erc.12.61]; Welleweerd JC, 2014, TREATMENT EXTR UNPUB; ZWOLAK RM, 1984, J VASC SURG, V1, P415, DOI 10.1067/mva.1984.avs0010415	21	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117915	10.1371/journal.pone.0117915	http://dx.doi.org/10.1371/journal.pone.0117915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635813	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700109
J	Bone, JE; Wallace, B; Bshary, R; Raihani, NJ				Bone, Jonathan E.; Wallace, Brian; Bshary, Redouan; Raihani, Nichola J.			The Effect of Power Asymmetries on Cooperation and Punishment in a Prisoner's Dilemma Game	PLOS ONE			English	Article							PUBLIC GOOD GAMES; ALTRUISTIC PUNISHMENT; EVOLUTION; ENFORCEMENT; SANCTIONS; GOODS; RETALIATION; RECIPROCITY; PROVISION; COERCION	Recent work has suggested that punishment is detrimental because punishment provokes retaliation, not cooperation, resulting in lower overall payoffs. These findings may stem from the unrealistic assumption that all players are equal: in reality individuals are expected to vary in the power with which they can punish defectors. Here, we allowed strong players to interact with weak players in an iterated prisoner's dilemma game with punishment. Defecting players were most likely to switch to cooperation if the partner cooperated: adding punishment yielded no additional benefit and, under some circumstances, increased the chance that the partner would both defect and retaliate against the punisher. Our findings show that, in a two-player game, cooperation begets cooperation and that punishment does not seem to yield any additional benefits. Further work should explore whether strong punishers might prevail in multi-player games.	[Bone, Jonathan E.] UCL, CoMPLEX, London, England; [Wallace, Brian] UCL, Dept Econ, London, England; [Bshary, Redouan] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [Raihani, Nichola J.] UCL, Dept Genet Evolut & Environm, London, England	University of London; University College London; University of London; University College London; University of Neuchatel; University of London; University College London	Raihani, NJ (corresponding author), UCL, Dept Genet Evolut & Environm, London, England.	nicholaraihani@gmail.com	Raihani, Nichola J/C-2083-2015	Raihani, Nichola J/0000-0003-2339-9889; Bshary, Redouan/0000-0001-7198-8472	Royal Society University Research Fellowship	Royal Society University Research Fellowship(Royal Society of London)	This study was funded by a Royal Society University Research Fellowship to N.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Balafoutas L, 2014, P NATL ACAD SCI USA, V111, P15924, DOI 10.1073/pnas.1413170111; Baldassarri D, 2011, P NATL ACAD SCI USA, V108, P11023, DOI 10.1073/pnas.1105456108; Barton K, 2013, MULTIMODEL INFERENCE; Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Bshary R, 2008, NATURE, V455, P964, DOI 10.1038/nature07184; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Denant-Boemont L, 2007, ECON THEOR, V33, P145, DOI 10.1007/s00199-007-0212-0; dos Santos M, 2013, EVOLUTION, V67, P2446, DOI 10.1111/evo.12108; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Engelmann D, 2012, WORK PAP, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Fehl K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045093; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hauert Christoph, 2008, Biology Theory, V3, P114, DOI 10.1162/biot.2008.3.2.114; Houser D, 2008, GAME ECON BEHAV, V62, P509, DOI 10.1016/j.geb.2007.05.001; Hurvich CM., 1993, J TIME SER ANAL, V14, P271, DOI 10.1111/j.1467-9892.1993.tb00144.x; Janssen MA, 2008, J THEOR BIOL, V254, P541, DOI 10.1016/j.jtbi.2008.06.017; Janssen MA, 2011, EXP ECON, V14, P547, DOI 10.1007/s10683-011-9281-9; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Killingback T, 2002, AM NAT, V160, P421, DOI 10.1086/342070; Killingback T, 1999, P ROY SOC B-BIOL SCI, V266, P1723, DOI 10.1098/rspb.1999.0838; Luce R. D., 1989, GAMES DECISIONS INTR; Nikiforakis N, 2008, EXP ECON, V11, P358, DOI 10.1007/s10683-007-9171-3; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Nikiforakis N, 2014, J ECON BEHAV ORGAN, V97, P155, DOI 10.1016/j.jebo.2013.06.008; Nikiforakis N, 2012, J PUBLIC ECON, V96, P797, DOI 10.1016/j.jpubeco.2012.05.014; Nikiforakis N, 2010, SOUTH ECON J, V76, P638, DOI 10.4284/sej.2010.76.3.638; Noussair CN, 2011, J PUBLIC ECON THEORY, V13, P661, DOI 10.1111/j.1467-9779.2011.01516.x; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Page T, 2005, ECON J, V115, P1032, DOI 10.1111/j.1468-0297.2005.01031.x; Przepiorka W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0247; R Core Team, 2016, R FDN STAT COMP; Raihani NJ, 2012, TRENDS ECOL EVOL, V27, P288, DOI 10.1016/j.tree.2011.12.004; Raihani NJ, 2010, SCIENCE, V327, P171, DOI 10.1126/science.1183068; Raihani NJ, 2012, P BIOL SCI; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; RAPOPORT A, 1966, J CONFLICT RESOLUT, V10, P363, DOI 10.1177/002200276601000308; Reuben E, 2013, GAME ECON BEHAV, V77, P122, DOI 10.1016/j.geb.2012.10.001; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sefton M, 2007, ECON INQ, V45, P671, DOI 10.1111/j.1465-7295.2007.00051.x; Sherratt TN, 1998, J THEOR BIOL, V193, P167, DOI 10.1006/jtbi.1998.0703; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Tan FF, 2008, ECONOMIST-NETHERLAND, V156, P269, DOI 10.1007/s10645-008-9094-1; Vukov J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002868; Wahl LM, 1999, J THEOR BIOL, V200, P307, DOI 10.1006/jtbi.1999.0996; Wang RW, 2010, SCI CHINA LIFE SCI, V53, P1041, DOI 10.1007/s11427-010-4016-2; Xiao ET, 2013, GAME ECON BEHAV, V77, P321, DOI 10.1016/j.geb.2012.10.010; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	61	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117183	10.1371/journal.pone.0117183	http://dx.doi.org/10.1371/journal.pone.0117183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629971	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100072
J	Choi, SC; Lee, H; Choi, JH; Kim, JH; Park, CY; Joo, HJ; Park, JH; Hong, SJ; Yu, CW; Lim, DS				Choi, Seung-Cheol; Lee, Hyunjoo; Choi, Ji-Hyun; Kim, Jong-Ho; Park, Chi-Yeon; Joo, Hyung-Joon; Park, Jae-Hyoung; Hong, Soon-Jun; Yu, Cheol-Woong; Lim, Do-Sun			Cyclosporin A Induces Cardiac Differentiation but Inhibits Hemato-Endothelial Differentiation of P19 Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CARDIOMYOCYTE DIFFERENTIATION; PROGENITOR SPECIFICATION; SIGNALING PATHWAY; MOUSE; PROLIFERATION; NFAT; EXPRESSION; MESODERM; NANOG	Little is known about the mechanisms underlying the effects of Cyclosporin A (CsA) on the fate of stem cells, including cardiomyogenic differentiation. Therefore, we investigated the effects and the molecular mechanisms behind the actions of CsA on cell lineage determination of P19 cells. CsA induced cardiomyocyte-specific differentiation of P19 cells, with the highest efficiency at a concentration of 0.32 mu M during embryoid body (EB) formation via activation of the Wnt signaling pathway molecules, Wnt3a, Wnt5a, and Wnt8a, and the cardiac mesoderm markers, Mixl1, Mesp1, and Mesp2. Interestingly, cotreatment of P19 cells with CsA plus dimethyl sulfoxide (DMSO) during EB formation significantly increases cardiac differentiation. In contrast, mRNA expression levels of hematopoietic and endothelial lineage markers, including Flk1 and Er71, were severely reduced in CsA-treated P19 cells. Furthermore, expression of Flk1 protein and the percentage of Flk1+ cells were severely reduced in 0.32 mu M CsA-treated P19 cells compared to control cells. CsA significantly modulated mRNA expression levels of the cell cycle molecules, p53 and Cyclins D1, D2, and E2 in P19 cells during EB formation. Moreover, CsA significantly increased cell death and reduced cell number in P19 cells during EB formation. These results demonstrate that CsA induces cardiac differentiation but inhibits hemato-endothelial differentiation via activation of the Wnt signaling pathway, followed by modulation of cell lineage-determining genes in P19 cells during EB formation.	[Choi, Seung-Cheol; Lee, Hyunjoo; Choi, Ji-Hyun; Kim, Jong-Ho; Park, Chi-Yeon; Joo, Hyung-Joon; Park, Jae-Hyoung; Hong, Soon-Jun; Yu, Cheol-Woong; Lim, Do-Sun] Korea Univ, Anam Hosp, Ctr Cardiovasc, Dept Cardiol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Lim, DS (corresponding author), Korea Univ, Anam Hosp, Ctr Cardiovasc, Dept Cardiol, Seoul, South Korea.	dslmd@kumc.or.kr	Park, Chi-Yeon/ABH-9980-2020; Joo, Hyung Joon/Q-4875-2016	Joo, Hyung Joon/0000-0003-1846-8464; Kim, Jong-Ho/0000-0002-1309-0821; Park, Chi-Yeon/0000-0002-9400-9078	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2012R1A1A2004485]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2012R1A1A2004485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Beyer TA, 2013, BBA-GEN SUBJECTS, V1830, P2268, DOI 10.1016/j.bbagen.2012.08.025; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Bryja V, 2008, CELL PROLIFERAT, V41, P875, DOI 10.1111/j.1365-2184.2008.00556.x; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Chen TL, 2008, SCAND J CLIN LAB INV, V68, P585, DOI 10.1080/00365510801918761; Choi SC, 2004, EXP MOL MED, V36, P515, DOI 10.1038/emm.2004.66; Choi SC, 2012, J CELL PHYSIOL, V227, P3678, DOI 10.1002/jcp.24076; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Faast R, 2004, ONCOGENE, V23, P491, DOI 10.1038/sj.onc.1207133; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Fric J, 2012, BLOOD, V120, P1380, DOI 10.1182/blood-2012-02-404475; Fujiwara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016734; Gertow K, 2013, STEM CELL REP, V1, P53, DOI 10.1016/j.stemcr.2013.04.002; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Guo JS, 2007, NEUROREPORT, V18, P863, DOI 10.1097/WNR.0b013e32811d6d36; Hadjal Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.246; Hart AH, 2002, DEVELOPMENT, V129, P3597; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Huang T, 2011, J BIOL CHEM, V286, P37399, DOI 10.1074/jbc.M111.251165; Hunt J, 2010, J NEUROSCI, V30, P2888, DOI 10.1523/JNEUROSCI.5991-09.2010; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Liu F, 2012, BLOOD, V119, P3295, DOI 10.1182/blood-2012-01-403766; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Pal R, 2006, STEM CELLS DEV, V15, P29, DOI 10.1089/scd.2006.15.29; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Paslaru L, 2007, J CELL MOL MED, V11, P369, DOI 10.1111/j.1582-4934.2007.00029.x; Pereira LA, 2012, DEV BIOL, V367, P163, DOI 10.1016/j.ydbio.2012.04.033; Preclikova H, 2002, CELL GROWTH DIFFER, V13, P421; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Sachinidis A, 2006, CELL PHYSIOL BIOCHEM, V18, P303, DOI 10.1159/000097608; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Solozobova Valeriya, 2011, World J Biol Chem, V2, P202, DOI 10.4331/wjbc.v2.i9.202; Song LH, 2006, TOXICOL IN VITRO, V20, P915, DOI 10.1016/j.tiv.2006.01.016; van der Heyden MAG, 2003, CARDIOVASC RES, V58, P292, DOI 10.1016/S0008-6363(02)00771-X; Verma MK, 2010, J CELL MOL MED, V14, P2094, DOI 10.1111/j.1582-4934.2009.00774.x; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje; Yan P, 2009, BIOCHEM BIOPH RES CO, V379, P115, DOI 10.1016/j.bbrc.2008.12.019; Yang L, 2008, INTERNAL MED, V47, P1457, DOI 10.2169/internalmedicine.47.1042; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009; Zhu DY, 2005, EUR J PHARMACOL, V514, P99, DOI 10.1016/j.ejphar.2005.03.031	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117410	10.1371/journal.pone.0117410	http://dx.doi.org/10.1371/journal.pone.0117410			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629977	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100080
J	Kuo, CF; Tsao, N; Cheng, MH; Yang, HC; Wang, YC; Chen, YP; Lin, KJ				Kuo, Chih-Feng; Tsao, Nina; Cheng, Miao-Hui; Yang, Hsiu-Chen; Wang, Yu-Chieh; Chen, Ying-Pin; Lin, Kai-Jen			Application of the C3-Binding Motif of Streptococcal Pyrogenic Exotoxin B to Protect Mice from Invasive Group A Streptococcal Infection	PLOS ONE			English	Article							EXTRACELLULAR CYSTEINE PROTEASE; STAPHYLOCOCCUS-AUREUS; POSTSTREPTOCOCCAL GLOMERULONEPHRITIS; ENDOTHELIAL-CELLS; BINDING PROTEIN; INNATE IMMUNITY; MOUSE MODEL; COMPLEMENT; PYOGENES; SPEB	Group A streptococcus (GAS) is an important human pathogen that produces several extracellular exotoxins to facilitate invasion and infection. Streptococcal pyrogenic exotoxin B (SPE B) has been demonstrated to be an important virulence factor of GAS. Our previous studies indicate that SPE B cleaves complement 3 (C3) and inhibits the activation of complement pathways. In this study, we constructed and expressed recombinant fragments of SPE B to examine the C3-binding site of SPE B. Using enzyme-linked immunosorbent assays and pull-down assays, we found that the C-terminal domain, containing amino-acid residues 345-398, of SPE B was the major binding site of human serum C3. We further identified a major, Ala(376)-Pro(398), and a minor C3-binding motif, Gly(346)-Gly(360), that both mediated the binding of C3 complement. Immunization with the C3-binding motifs protected mice against challenge with a lethal dose of non-invasive M49 strain GAS but not invasive M1 strains. To achieve higher efficiency against invasive M1 GAS infection, a combination of synthetic peptides derived from C-terminal epitope of streptolysin S (SLSpp) and from the major C3-binding motif of SPE B (PP6, Ala(376)-Pro(398)) was used to elicit specific immune response to those two important streptococcal exotoxins. Death rates and the severity of skin lesions decreased significantly in PP6/SLSpp-immunized mice that were infected with invasive M1 strains of GAS. These results indicate a combination of the C3-binding motif of SPE B and the protective epitope of SLS could be used as a subunit vaccine against invasive M1 strains group A streptococcal infection.	[Kuo, Chih-Feng] I Shou Univ, Dept Nursing, Kaohsiung, Taiwan; [Tsao, Nina; Cheng, Miao-Hui; Yang, Hsiu-Chen; Wang, Yu-Chieh; Chen, Ying-Pin] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan; [Lin, Kai-Jen] E DA Hosp, Dept Pathol, Kaohsiung, Taiwan	I Shou University; I Shou University; E-Da Hospital	Kuo, CF (corresponding author), I Shou Univ, Dept Nursing, Kaohsiung, Taiwan.	kuo@isu.edu.tw			Ministry of Science and Technology [MOST97-2320-B214-001-MY3, MOST100-2320-B214-007, MOST 103-2320-B-214-006]; I-Shou University, Taiwan [ISU102-07-07]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); I-Shou University, Taiwan	This work was supported by grants MOST97-2320-B214-001-MY3, MOST100-2320-B214-007, and MOST 103-2320-B-214-006 from the Ministry of Science and Technology, and ISU102-07-07 from I-Shou University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batsford SR, 2005, KIDNEY INT, V68, P1120, DOI 10.1111/j.1523-1755.2005.00504.x; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Burns EH, 1996, INFECT IMMUN, V64, P4744, DOI 10.1128/IAI.64.11.4744-4750.1996; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Cu GA, 1998, KIDNEY INT, V54, P819, DOI 10.1046/j.1523-1755.1998.00052.x; Dale JB, 2002, INFECT IMMUN, V70, P2166, DOI 10.1128/IAI.70.4.2166-2170.2002; Ender M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081298; Eriksson A, 2003, INFECT IMMUN, V71, P211, DOI 10.1128/IAI.71.1.211-217.2003; Ermert D, 2013, J BIOL CHEM, V288, P32172, DOI 10.1074/jbc.M113.502955; Fernie-King BA, 2001, IMMUNOLOGY, V103, P390, DOI 10.1046/j.1365-2567.2001.01249.x; Gonzalez-Paez GE, 2012, J BIOL CHEM, V287, P24412, DOI 10.1074/jbc.M112.361576; Haapasalo K, 2012, J IMMUNOL, V188, P426, DOI 10.4049/jimmunol.1102545; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Henningham A, 2012, DISCOV MED, V13, P329; Honda-Ogawa M, 2013, J BIOL CHEM, V288, P15854, DOI 10.1074/jbc.M113.469106; Hung CH, 2012, MED MICROBIOL IMMUN, V201, P357, DOI 10.1007/s00430-012-0241-6; Jackson SJ, 2011, TROP MED INT HEALTH, V16, P2, DOI 10.1111/j.1365-3156.2010.02670.x; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Kagawa TF, 2000, P NATL ACAD SCI USA, V97, P2235, DOI 10.1073/pnas.040549997; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Kuo CF, 2004, MICROB PATHOGENESIS, V36, P273, DOI 10.1016/j.micpath.2004.01.003; Kuo CF, 2008, INFECT IMMUN, V76, P1163, DOI 10.1128/IAI.01116-07; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Luo YH, 2007, KIDNEY INT, V72, P716, DOI 10.1038/sj.ki.5002407; Luo YH, 2010, LAB INVEST, V90, P1492, DOI 10.1038/labinvest.2010.93; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Olsen JG, 2009, J MOL BIOL, V393, P693, DOI 10.1016/j.jmb.2009.08.046; Parra G, 1998, KIDNEY INT, V54, P509, DOI 10.1046/j.1523-1755.1998.00012.x; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Steer AC, 2012, DRUGS, V72, P1213, DOI 10.2165/11634180-000000000-00000; Steer AC, 2009, CURR OPIN INFECT DIS, V22, P544, DOI 10.1097/QCO.0b013e328332bbfe; Sumitomo T, 2013, J BIOL CHEM, V288, P13317, DOI 10.1074/jbc.M113.459875; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Tsao N, 2006, BIOCHEM BIOPH RES CO, V339, P779, DOI 10.1016/j.bbrc.2005.11.078; Tsao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055028; Upadhyay A, 2008, J BIOL CHEM, V283, P22113, DOI 10.1074/jbc.M802636200	42	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117268	10.1371/journal.pone.0117268	http://dx.doi.org/10.1371/journal.pone.0117268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629609	gold, Green Submitted, Green Published			2022-12-27	WOS:000348732100077
J	Long, Y; Wang, YY; Wu, SS; Wang, J; Tian, XJ; Pei, XW				Long, Yan; Wang, Yanyan; Wu, Shanshan; Wang, Jiao; Tian, Xinjie; Pei, Xinwu			De Novo Assembly of Transcriptome Sequencing in Caragana korshinskii Kom. and Characterization of EST-SSR Markers	PLOS ONE			English	Article							MICROSATELLITE MARKERS; GENETIC DIVERSITY; ANNOTATION; TOLERANCE; DISCOVERY; REPEATS; BARLEY; RICE; TOOL; MAP	Caragana korshinskii Kom. is widely distributed in various habitats, including gravel desert, clay desert, fixed and semi-fixed sand, and saline land in the Asian and African deserts. To date, no previous genomic information or EST-SSR marker has been reported in Caragana Fabr. genus. In this study, more than two billion bases of high-quality sequence of C. korshinskii were generated by using illumina sequencing technology and demonstrated the de novo assembly and annotation of genes without prior genome information. These reads were assembled into 86,265 unigenes (mean length = 709 bp). The similarity search indicated that 33,955 and 21,978 unigenes showed significant similarities to known proteins from NCBI non-redundant and Swissprot protein databases, respectively. Among these annotated unigenes, 26,232 a unigenes were separately assigned to Gene Ontology (GO) database. When 22,756 unigenes searched against the Kyoto Encyclopedia of Genes and Genomes Pathway (KEGG) database, 5,598 unigenes were assigned to 5 main categories including 32 KEGG pathways. Among the main KEGG categories, metabolism was the biggest category (2,862, 43.7%), suggesting the active metabolic processes in the desert tree. In addition, a total of 19,150 EST-SSRs were identified from 15,484 unigenes, and the characterizations of EST-SSRs were further compared with other four species in Fabraceae. 126 potential marker sites were randomly selected to validate the assembly quality and develop EST-SSR markers. Among the 9 germplasms in Caranaga Fabr. genus, PCR success rate were 93.7% and the phylogenic tree was constructed based on the genotypic data. This research generated a substantial fraction of transcriptome sequences, which were very useful resources for gene annotation and discovery, molecular markers development, genome assembly and annotation. The EST-SSR markers identified and developed in this study will facilitate marker-assisted selection breeding.	[Long, Yan; Wang, Jiao; Tian, Xinjie; Pei, Xinwu] Chinese Acad Agr Sci, Inst Biotechnol, Beijing 100081, Peoples R China; [Wang, Yanyan; Wu, Shanshan] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China	Chinese Academy of Agricultural Sciences; Huazhong Agricultural University	Pei, XW (corresponding author), Chinese Acad Agr Sci, Inst Biotechnol, Beijing 100081, Peoples R China.	peixinwu@caas.cn	pei, xinwu/O-7083-2019; Wang, Yanbo/HFZ-8018-2022; Pei, Xinwu/AAI-1736-2019; wang, yan/GSE-6489-2022	Pei, Xinwu/0000-0001-7828-3037; 	National Special Program for Transgenic Research [2014ZX08011-001]	National Special Program for Transgenic Research	This work is financially supported by the National Special Program for Transgenic Research (Nos. 2014ZX08011-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2014, MOL BIOL REP, V41, P6755, DOI 10.1007/s11033-014-3561-3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuadrado A, 2008, CYTOGENET GENOME RES, V120, P210, DOI 10.1159/000121069; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; Durand J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-570; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo Qiang, 2008, Acta Agrestia Sinica, V16, P227; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Hyun TK, 2012, PLANT MOL BIOL, V79, P413, DOI 10.1007/s11103-012-9919-9; Jung Sook, 2005, Functional & Integrative Genomics, V5, P136, DOI 10.1007/s10142-005-0139-0; [康红梅 KANG Hongmei], 2011, [西南农业学报, Southwest China Journal of Agricultural Sciences], V24, P1099; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; [李彦瑾 LI Yanjin], 2008, [西北林学院学报, Journal of Northwest Forestry College], V23, P1; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Ma CC, 2003, ACTA BOT SIN, V45, P1218; Miah G, 2013, INT J MOL SCI, V14, P22499, DOI 10.3390/ijms141122499; Mogea JP, 1999, MEM NEW YORK BOTAN G, V83, P169; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naegele R, 2014, PHYTOPATHOLOGY; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Nunome T, 2009, THEOR APPL GENET, V119, P1143, DOI 10.1007/s00122-009-1116-0; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Talukder ZI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098628; Ting NC, 2010, J GENET, V89, P135, DOI 10.1007/s12041-010-0053-7; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang BH, 2014, GENET MOL RES, V13, P3732, DOI 10.4238/2014.May.13.1; Wang CB, 2006, CHINESE SCI BULL, V51, P557, DOI 10.1007/s11434-006-0557-y; Wang XM, 2011, MOL BIOL REP, V38, P2801, DOI 10.1007/s11033-010-0425-3; Wang Z, 2007, CROP SCI, V47, P1737, DOI 10.2135/cropsci2006.09.0562; [王赞 WANG Zan], 2008, [植物遗传资源学报, Journal of Plant Genetic Resources], V9, P397; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Xu P, 2013, GENE, V525, P26, DOI 10.1016/j.gene.2013.04.066; Yan DW, 2014, PLANT CELL PHYSIOL, V55, P1521, DOI 10.1093/pcp/pcu089; Yang DH, 2012, BIOCHEM BIOPH RES CO, V417, P732, DOI 10.1016/j.bbrc.2011.12.023; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zhang HY, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-591, DOI 10.1186/1471-2164-13-591]; Zhang ML, 2009, MOL PHYLOGENET EVOL, V50, P547, DOI 10.1016/j.ympev.2008.12.001; Zhou A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00413	48	14	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115805	10.1371/journal.pone.0115805	http://dx.doi.org/10.1371/journal.pone.0115805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629164	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100025
J	Mantani, PT; Duner, P; Bengtsson, E; Alm, R; Ljungcrantz, I; Soderberg, I; Sundius, L; To, F; Nilsson, J; Bjorkbacka, H; Fredrikson, GN				Mantani, Polyxeni T.; Duner, Pontus; Bengtsson, Eva; Alm, Ragnar; Ljungcrantz, Irena; Soderberg, Ingrid; Sundius, Lena; To, Fong; Nilsson, Jan; Bjorkbacka, Harry; Fredrikson, Gunilla Nordin			IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; INNATE LYMPHOID-CELLS; TYPE-2 IMMUNITY; REDUCES ATHEROSCLEROSIS; OXIDIZED LDL; NATURAL IGM; IMMUNIZATION; EXPRESSION; ANTIBODIES; CYTOKINES	Objective IL-25 has been implicated in the initiation of type 2 immunity and in the protection against autoimmune inflammatory diseases. Recent studies have identified the novel innate lymphoid type 2 cells (ILC2s) as an IL-25 target cell population. The purpose of this study was to evaluate if IL-25 has any influence on atherosclerosis development in mice. Methods and Results Administration of 1 mu g IL-25 per day for one week to atherosclerosis-prone apolipoprotein (apo) E deficient mice, had limited effect on the frequency of T cell populations, but resulted in a large expansion of ILC2s in the spleen. The expansion was accompanied by increased levels of anti-phosphorylcholine (PC) natural IgM antibodies in plasma and elevated levels of IL-5 in plasma and spleen. Transfer of ILC2s to apoE deficient mice elevated the natural antibody-producing B1a cell population in the spleen. Treatment of apoE/Rag-1 deficient mice with IL-25 was also associated with extensive expansion of splenic ILC2s and increased plasma IL-5, suggesting ILC2s to be the source of IL-5. Administration of IL-25 in IL-5 deficient mice resulted in an expanded ILC2 population, but did not stimulate generation of anti-PC IgM, indicating that IL-5 is not required for ILC2 expansion but for the downstream production of natural antibodies. Additionally, administration of 1 mu g IL-25 per day for 4 weeks in apoE deficient mice reduced atherosclerosis in the aorta both during initiation and progression of the disease. Conclusions The present findings demonstrate that IL-25 has a protective role in atherosclerosis mediated by innate responses, including ILC2 expansion, increased IL-5 secretion, B1a expansion and natural anti-PC IgM generation, rather than adaptive Th2 responses.	[Mantani, Polyxeni T.; Duner, Pontus; Bengtsson, Eva; Alm, Ragnar; Ljungcrantz, Irena; Soderberg, Ingrid; Sundius, Lena; To, Fong; Nilsson, Jan; Bjorkbacka, Harry; Fredrikson, Gunilla Nordin] Lund Univ, Skane Univ Hosp Malmo, Dept Clin Sci, Malmo, Sweden; [Fredrikson, Gunilla Nordin] Malmo Univ, Fac Hlth & Soc, Malmo, Sweden	Lund University; Skane University Hospital; Malmo University	Fredrikson, GN (corresponding author), Lund Univ, Skane Univ Hosp Malmo, Dept Clin Sci, Malmo, Sweden.	gunilla.nordin_fredrikson@med.lu.se	Bengtsson, Eva/AAA-1968-2019; Björkbacka, Harry/I-7157-2019; Bengtsson, Eva/AGH-2754-2022	Björkbacka, Harry/0000-0003-3918-0857; Bengtsson, Eva/0000-0001-7075-1772; Duner, Pontus/0000-0003-4171-5646				Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ameli S, 1996, ARTERIOSCL THROM VAS, V16, P1074, DOI 10.1161/01.ATV.16.8.1074; Barlow JL, 2011, J LEUKOCYTE BIOL, V90, P867, DOI 10.1189/jlb.0311160; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Buono C, 2003, ARTERIOSCL THROM VAS, V23, P454, DOI 10.1161/01.ATV.0000059419.11002.6E; Caligiuri G, 2007, J AM COLL CARDIOL, V50, P540, DOI 10.1016/j.jacc.2006.11.054; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Foks AC, 2013, J IMMUNOL, V191, P4573, DOI 10.4049/jimmunol.1200708; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gronlund H, 2009, EUR J CARDIOV PREV R, V16, P382, DOI 10.1097/HJR.0b013e32832a05df; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kyaw T, 2012, TRENDS CARDIOVAS MED, V22, P48, DOI 10.1016/j.tcm.2012.06.011; Kyaw T, 2011, CIRC RES, V109, P830, DOI 10.1161/CIRCRESAHA.111.248542; Lajoie-Kadoch S, 2006, AM J PHYSIOL-LUNG C, V290, pL1238, DOI 10.1152/ajplung.00301.2005; Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108; Mallat Z, 2007, TRENDS CARDIOVAS MED, V17, P113, DOI 10.1016/j.tcm.2007.03.001; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monteleone G, 2010, CYTOKINE GROWTH F R, V21, P471, DOI 10.1016/j.cytogfr.2010.05.001; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Perry HM, 2013, ARTERIOSCL THROM VAS, V33, P2771, DOI 10.1161/ATVBAHA.113.302571; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Sampi M, 2008, J AM COLL CARDIOL, V52, P1370, DOI 10.1016/j.jacc.2008.06.047; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349	35	39	41	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117255	10.1371/journal.pone.0117255	http://dx.doi.org/10.1371/journal.pone.0117255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629516	gold, Green Published, Green Submitted			2022-12-27	WOS:000348732100076
J	Mista, D; Kroliczewska, B; Marounek, M; Pecka, E; Zawadzki, W; Nicpon, J				Mista, Dorota; Kroliczewska, Bozena; Marounek, Milan; Pecka, Ewa; Zawadzki, Wojciech; Nicpon, Jzef			In Vitro Study and Comparison of Caecal Methanogenesis and Fermentation Pattern in the Brown Hare (Lepus europaeus) and Domestic Rabbit (Oryctolagus cuniculus)	PLOS ONE			English	Article							METHANE PRODUCTION; FATTY-ACIDS; DIET; AGE; IDENTIFICATION; DIGESTIBILITY; COMPETITION; COPROPHAGY; BACTERIA; HYDROGEN	The brown hare and the domestic rabbit are mid-sized herbivorous mammals and hindgut fermenters, though their digestive physiologies differ in some traits. The objective of this study was to estimate and compare the caecal microbial activity in hares and rabbits via an analysis of the following end-products of in vitro caecal fermentation: methane, total gas production, short chain fatty acids and ammonia concentration. Hare caecal methanogenesis occurred at a much lower level (0.25 mmol/kg for samples incubated without substrate and 0.22 mmol/kg for samples incubated with substrate) than that of the rabbit (15.49 and 11.73 mmol/kg, respectively) (P<0.001). The impact of the substrate's presence on caecal methanogenesis was not significant, though its presence increased the total gas production during fermentation (P<0.001). Hare caecal microflora produced a lower short chain fatty acids concentration than did rabbit microorganisms (P<0.05). In unincubated hare samples, the short chain fatty acids concentration was 28.4 mmol/kg, whereas in unincubated rabbit samples, the short chain fatty acids concentration was 51.8 mmol/kg. The caecal fermentation pattern of the hare was characterised by higher propionate and isobutyrate molar proportions compared with those observed in rabbit caecum (P<0.01). No significant changes in the ammonia concentration in either rabbit or hare caecum were found. The results obtained indicate some differences in the activity of the microbial populations colonising the hare and rabbit caecum, particularly in regards to methanogenic Archaea.	[Mista, Dorota; Kroliczewska, Bozena; Pecka, Ewa; Zawadzki, Wojciech] Wroclaw Univ Environm & Life Sci, Dept Biostruct & Anim Physiol, Wroclaw, Poland; [Marounek, Milan] Inst Anim Sci, Prague, Czech Republic; [Nicpon, Jzef] Wroclaw Univ Environm & Life Sci, Dept Internal Med & Clin Dis Horses, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Czech Research Institute of Animal Science; Wroclaw University of Environmental & Life Sciences	Mista, D (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Biostruct & Anim Physiol, Wroclaw, Poland.	dorota.mista@up.wroc.pl	Króliczewska, Bożena/AAO-5730-2021; Kroliczewska, Bozena/A-8324-2017; Miśta, Dorota/AAD-5644-2020	Króliczewska, Bożena/0000-0002-0291-3562; Kroliczewska, Bozena/0000-0002-0291-3562; Miśta, Dorota/0000-0002-0147-3681	Ministry of Science and Higher Education of the Republic of Poland [R1207003]; Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center)	Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland); Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center)	This research was supported by the Ministry of Science and Higher Education of the Republic of Poland http://www.nauka.gov.pl/en/grant number R1207003, author who received the funding: JN. The publication fee was paid by the Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center) 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADJIRI D, 1992, REPROD NUTR DEV, V32, P351, DOI 10.1051/rnd:19920405; AOAC Association of Official Analytical Chemists, 2005, AOAC OFF METH AN; Belenguer A, 2011, WORLD RABBIT SCI, V19, P75, DOI 10.4995/wrs.2011.826; BELLIER R, 1995, J ANIM SCI, V73, P128; Bennegadi Nadia, 2003, Microbial Ecology in Health and Disease, V15, P23, DOI 10.1080/08910600310015574; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bernalier A, 1993, P NUTR SOC, V52, p118A; Carabano R., 1998, P1; CARABANO R, 1988, J ANIM SCI, V66, P901; Chapuis JL, 1990, MAMM BIOL, V55, P176; Cheeke PR., 1987, RABBIT FEEDING NUTR; De Blas C., 1998, NUTR RABBIT, P3441; DEGRAEVE KG, 1994, J APPL BACTERIOL, V76, P55; Drake H.L., 1994, ACETOGENESIS, P3; Falcao-e-Cunha L, 2004, ANIM FEED SCI TECH, V117, P131, DOI 10.1016/j.anifeedsci.2004.07.014; Fortun-Lamothe L, 2007, LIVEST SCI, V107, P1, DOI 10.1016/j.livsci.2006.09.005; Fraga M. J., 1998, P39; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P177, DOI 10.1016/j.cbpa.2010.10.019; Garcia J, 2002, ANIM RES, V51, P165, DOI 10.1051/animres:2002011; Garcia J, 2000, J ANIM SCI, V78, P638; GIBSON GR, 1990, GUT, V31, P679, DOI 10.1136/gut.31.6.679; Hacklander K, 2002, PHYSIOL BIOCHEM ZOOL, V75, P19, DOI 10.1086/324770; Hackstein JHP, 1996, EVOLUTION, V50, P559, DOI [10.2307/2410831, 10.1111/j.1558-5646.1996.tb03868.x]; HIRAKAWA H, 1994, J ZOOL, V232, P447, DOI 10.1111/j.1469-7998.1994.tb01585.x; Hirakawa H, 2001, MAMMAL REV, V31, P61, DOI 10.1046/j.1365-2907.2001.00079.x; Hirakawa Hirofumi, 1995, Journal of the Mammalogical Society of Japan, V20, P89; HOMOLKA M, 1987, FOLIA ZOOL, V36, P103; JARRELL KF, 1981, CAN J MICROBIOL, V27, P720, DOI 10.1139/m81-110; Kuijper DPJ, 2004, J ZOOL, V264, P171, DOI 10.1017/S0952836904005722; Kusar D, 2010, FEMS MICROBIOL ECOL, V74, P623, DOI 10.1111/j.1574-6941.2010.00980.x; Levitt MD, 2006, CLIN GASTROENTEROL H, V4, P123, DOI 10.1016/j.cgh.2005.11.006; Macfarlane G. T., 1995, P87; Marounek M, 1998, PHYSIOL RES, V47, P259; Marounek M, 1999, ARCH ANIM NUTR, V52, P195, DOI 10.1080/17450399909386162; Marounek M, 2000, ARCH ANIM NUTR, V53, P241, DOI 10.1080/17450390009381950; Marounek M, 2005, ACTA VET BRNO, V74, P3, DOI 10.2754/avb200574010003; Marounek M, 2013, ANIMAL BIOL, V15, P94; MILLER TL, 1982, ARCH MICROBIOL, V131, P14, DOI 10.1007/BF00451492; Mista D, 2011, POL J VET SCI, V14, P557, DOI 10.2478/v10181-011-0083-y; Morvan B, 1996, CURR MICROBIOL, V32, P129, DOI 10.1007/s002849900023; Piattoni F, 1996, REPROD NUTR DEV, V36, P253, DOI 10.1051/rnd:19960303; Remesy C., 1995, P171; Saemann MD, 2002, WIEN KLIN WOCHENSCHR, V114, P289; Smith RK, 2005, ACTA THERIOL, V50, P391, DOI 10.1007/BF03192634; Stott P, 2008, MAMM BIOL, V73, P276, DOI 10.1016/j.mambio.2007.07.002; STROCCHI A, 1991, GUT, V32, P1498, DOI 10.1136/gut.32.12.1498; VanNevel CJ, 1996, ENVIRON MONIT ASSESS, V42, P73, DOI 10.1007/BF00394043; Wolski K., 2009, Alternative functions of grassland. Proceedings of the 15th European Grassland Federation Symposium, Brno, Czech Republic, 7-9 September 2009, P277; WOLSTRUP J, 1979, ANN RECH VET, V10, P283; Yang HJ, 2010, ANIM FEED SCI TECH, V162, P149, DOI 10.1016/j.anifeedsci.2010.09.008	50	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117117	10.1371/journal.pone.0117117	http://dx.doi.org/10.1371/journal.pone.0117117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629411	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100067
J	Barker, B; Xu, L; Gu, ZL				Barker, Brandon; Xu, Lin; Gu, Zhenglong			Dynamic Epistasis under Varying Environmental Perturbations	PLOS ONE			English	Article							CONSTRAINT-BASED MODELS; FLUX BALANCE MODELS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; QUANTITATIVE PREDICTION; SPONTANEOUS MUTATIONS; CELLULAR-METABOLISM; FITNESS; LOAD; BIOLOGY	Epistasis describes the phenomenon that mutations at different loci do not have independent effects with regard to certain phenotypes. Understanding the global epistatic landscape is vital for many genetic and evolutionary theories. Current knowledge for epistatic dynamics under multiple conditions is limited by the technological difficulties in experimentally screening epistatic relations among genes. We explored this issue by applying flux balance analysis to simulate epistatic landscapes under various environmental perturbations. Specifically, we looked at gene-gene epistatic interactions, where the mutations were assumed to occur in different genes. We predicted that epistasis tends to become more positive from glucose-abundant to nutrient-limiting conditions, indicating that selection might be less effective in removing deleterious mutations in the latter. We also observed a stable core of epistatic interactions in all tested conditions, as well as many epistatic interactions unique to each condition. Interestingly, genes in the stable epistatic interaction network are directly linked to most other genes whereas genes with condition-specific epistasis form a scale-free network. Furthermore, genes with stable epistasis tend to have similar evolutionary rates, whereas this co-evolving relationship does not hold for genes with condition-specific epistasis. Our findings provide a novel genome-wide picture about epistatic dynamics under environmental perturbations.	[Barker, Brandon] Cornell Univ, Ctr Adv Comp, Ithaca, NY 14853 USA; [Xu, Lin] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Hematol Oncol, Dallas, TX 75390 USA; [Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Gu, Zhenglong] Tri Inst Training Program Computat Biol & Med, New York, NY USA	Cornell University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University	Gu, ZL (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	zg27@cornell.edu	xu, lin/H-8560-2016	Barker, Brandon/0000-0001-5732-9550	NSF [DEB-0949556]; NIH [1R01AI085286]; Direct For Biological Sciences [1243588] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083937] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF DEB-0949556 and NIH 1R01AI085286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2010, TRENDS ECOL EVOL, V25, P450, DOI 10.1016/j.tree.2010.05.003; Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Baer CF, 2006, GENETICS, V174, P1387, DOI 10.1534/genetics.106.061200; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Brochado AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002758; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cooper TF, 2005, P ROY SOC B-BIOL SCI, V272, P311, DOI 10.1098/rspb.2004.2975; CORNELIUS SP, 2011, CONTROLLING COMPLEX; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Fry JD, 2002, GENETICS, V161, P1155; Hansen TF, 2001, GENETICS, V158, P477; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Jakubowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033132; Jasnos L, 2008, GENETICS, V178, P2105, DOI 10.1534/genetics.107.084533; Kishony Roy, 2003, J Biol, V2, P14, DOI 10.1186/1475-4924-2-14; KONDRASHOV AS, 1982, GENET RES, V40, P325, DOI 10.1017/S0016672300019194; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Korona R, 1999, EVOLUTION, V53, P1966, DOI 10.1111/j.1558-5646.1999.tb04577.x; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Measday V, 2005, P NATL ACAD SCI USA, V102, P13956, DOI 10.1073/pnas.0503504102; Measday V, 2002, METHOD ENZYMOL, V350, P316, DOI 10.1016/S0076-6879(02)50971-X; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Otto SP, 2007, GENET RES, V89, P447, DOI 10.1017/S001667230800966X; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Perez-Figueroa A, 2009, GENETICS, V183, P299, DOI 10.1534/genetics.109.104893; Presgraves DC, 2007, CURR BIOL, V17, pR125, DOI 10.1016/j.cub.2006.12.030; Remold SK, 2001, P NATL ACAD SCI USA, V98, P11388, DOI 10.1073/pnas.201140198; Sanjuan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002663; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Smallbone K, 2009, J THEOR BIOL, V258, P311, DOI 10.1016/j.jtbi.2009.01.027; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Szafraniec K, 2001, P NATL ACAD SCI USA, V98, P1107, DOI 10.1073/pnas.021390798; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang AD, 2009, AM NAT, V174, P863, DOI 10.1086/645088; Xu L, 2012, P NATL ACAD SCI USA, V109, P10420, DOI 10.1073/pnas.1121507109; Xu L, 2011, GENOME BIOL EVOL, V3, P909, DOI 10.1093/gbe/evr065; Yang HP, 2001, GENETICS, V157, P1257; Young JA, 2009, J EVOLUTION BIOL, V22, P2125, DOI 10.1111/j.1420-9101.2009.01830.x	58	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0114911	10.1371/journal.pone.0114911	http://dx.doi.org/10.1371/journal.pone.0114911			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625594	gold, Green Submitted, Green Published			2022-12-27	WOS:000348821400004
J	Kakehi, JI; Kawano, E; Yoshimoto, K; Cai, QQ; Imai, A; Takahashi, T				Kakehi, Jun-Ichi; Kawano, Eri; Yoshimoto, Kaori; Cai, Qingqing; Imai, Akihiro; Takahashi, Taku			Mutations in Ribosomal Proteins, RPL4 and RACK1, Suppress the Phenotype of a Thermospermine-Deficient Mutant of Arabidopsis thaliana	PLOS ONE			English	Article							MESSENGER-RNA DECAY; OPEN READING FRAME; TRANSCRIPTION FACTOR; SCAFFOLD PROTEIN; STEM ELONGATION; DWARF PHENOTYPE; ACL5 MUTANT; TRANSLATION; AUXIN; POLYAMINE	Thermospermine acts in negative regulation of xylem differentiation and its deficient mutant of Arabidopsis thaliana, acaulis5 (acl5), shows excessive xylem formation and severe dwarfism. Studies of two dominant suppressors of acl5, sac51-d and sac52-d, have revealed that SAC51 and SAC52 encode a transcription factor and a ribosomal protein L10 (RPL10), respectively, and these mutations enhance translation of the SAC51 mRNA, which contains conserved upstream open reading frames in the 5' leader. Here we report identification of SAC53 and SAC56 responsible for additional suppressors of acl5. sac53-d is a semi-dominant allele of the gene encoding a receptor for activated C kinase 1 (RACK1) homolog, a component of the 40S ribosomal subunit. sac56-d represents a semi-dominant allele of the gene for RPL4. We show that the GUS reporter activity driven by the CaMV 35S promoter plus the SAC51 5' leader is reduced in acl5 and restored by sac52-d, sac53-d, and sac56-d as well as thermospermine. Furthermore, the SAC51 mRNA, which may be a target of nonsense-mediated mRNA decay, was found to be stabilized in these ribosomal mutants and by thermospermine. These ribosomal proteins are suggested to act in the control of uORF-mediated translation repression of SAC51, which is derepressed by thermospermine.	[Kakehi, Jun-Ichi; Kawano, Eri; Yoshimoto, Kaori; Cai, Qingqing; Imai, Akihiro; Takahashi, Taku] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan	Okayama University	Takahashi, T (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan.	perfect@cc.okayama-u.ac.jp	TAKAHASHI, Taku/B-1462-2011	TAKAHASHI, Taku/0000-0002-8879-0718	Japan Society for the Promotion of Science (JSPS) [22370021, 26113516]; Ryobi-Teien Memorial Foundation; JSPS research fellowship; Grants-in-Aid for Scientific Research [26113516] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ryobi-Teien Memorial Foundation; JSPS research fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research No. 22370021 and No. 26113516 from the Japan Society for the Promotion of Science (JSPS) and a grant from the Ryobi-Teien Memorial Foundation to TT. JIK was a recipient of a JSPS research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Atkinson GC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-290; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Baima S, 2014, MOL PLANT, V7, P1006, DOI 10.1093/mp/ssu051; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Clay NK, 2005, PLANT PHYSIOL, V138, P767, DOI 10.1104/pp.104.055756; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Dick FA, 1998, NUCLEIC ACIDS RES, V26, P2442, DOI 10.1093/nar/26.10.2442; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Ferreyra MLF, 2013, PLANT PHYSIOL, V163, P378, DOI 10.1104/pp.113.223222; Ferreyra MLF, 2010, PLANT PHYSIOL, V153, P1878, DOI 10.1104/pp.110.157057; Guo JJ, 2011, PLANT PHYSIOL, V155, P370, DOI 10.1104/pp.110.160663; Guo JJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-108; Hanfrey C, 2005, J BIOL CHEM, V280, P39229, DOI 10.1074/jbc.M509340200; Hanzawa Y, 2000, EMBO J, V19, P4248, DOI 10.1093/emboj/19.16.4248; Hanzawa Y, 1997, PLANT J, V12, P863, DOI 10.1046/j.1365-313X.1997.12040863.x; Hayden CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-32; Hori K, 2005, PLANT J, V43, P530, DOI 10.1111/j.1365-313X.2005.02473.x; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Imai A, 2004, FEBS LETT, V556, P148, DOI 10.1016/S0014-5793(03)01395-4; Imai A, 2008, PLANT J, V56, P881, DOI 10.1111/j.1365-313X.2008.03647.x; Imai A, 2006, DEVELOPMENT, V133, P3575, DOI 10.1242/dev.02535; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jorgensen RA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00191; Kakehi JI, 2008, PLANT CELL PHYSIOL, V49, P1342, DOI 10.1093/pcp/pcn109; Kim BH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r60; Knott JM, 2007, FEBS LETT, V581, P3081, DOI 10.1016/j.febslet.2007.05.074; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Law GL, 2001, J BIOL CHEM, V276, P38036; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Milhinhos A, 2013, PLANT J, V75, P685, DOI 10.1111/tpj.12231; Muniz L, 2008, DEVELOPMENT, V135, P2573, DOI 10.1242/dev.019349; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Naka Y, 2010, PLANT PHYSIOL BIOCH, V48, P527, DOI 10.1016/j.plaphy.2010.01.013; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Nyiko T, 2009, PLANT MOL BIOL, V71, P367, DOI 10.1007/s11103-009-9528-4; OSHIMA T, 1979, J BIOL CHEM, V254, P8720; Pachler K, 2004, FEMS YEAST RES, V5, P271, DOI 10.1016/j.femsyr.2004.07.009; Rahmani F, 2009, PLANT PHYSIOL, V150, P1356, DOI 10.1104/pp.109.136036; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; Rosado A, 2012, P NATL ACAD SCI USA, V109, P19537, DOI 10.1073/pnas.1214774109; Rosado A, 2010, PLANT CELL, V22, P143, DOI 10.1105/tpc.109.068320; Saul H, 2009, PLANT J, V60, P1031, DOI 10.1111/j.1365-313X.2009.04021.x; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Takano A, 2012, PLANT CELL PHYSIOL, V53, P606, DOI 10.1093/pcp/pcs019; Tiruneh BS, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-123; Tong WRN, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00094; von Arnim AG, 2014, PLANT SCI, V214, P1, DOI 10.1016/j.plantsci.2013.09.006; Wu C, 2012, J MOL BIOL, V416, P518, DOI 10.1016/j.jmb.2011.12.064; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Yoine M, 2006, PLANT J, V47, P49, DOI 10.1111/j.1365-313X.2006.02771.x; Yoshimoto K, 2012, PLANT CELL PHYSIOL, V53, P635, DOI 10.1093/pcp/pcs017; ZHOU F, 2010, BMC PLANT BIOL, V10, P178, DOI DOI 10.1186/1471-2229-10-178	64	27	28	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117309	10.1371/journal.pone.0117309	http://dx.doi.org/10.1371/journal.pone.0117309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625317	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821400030
J	Mani, A; Ravindran, R; Mannepalli, S; Vang, D; Luciw, PA; Hogarth, M; Khan, IH; Krishnan, VV				Mani, Akshay; Ravindran, Resmi; Mannepalli, Soujanya; Vang, Daniel; Luciw, Paul A.; Hogarth, Michael; Khan, Imran H.; Krishnan, Viswanathan V.			Data Mining Strategies to Improve Multiplex Microbead Immunoassay Tolerance in a Mouse Model of Infectious Diseases	PLOS ONE			English	Article							SIMULTANEOUS SERODETECTION; MICE; VIRUS; PARVOVIRUS; CYTOKINES	Multiplex methodologies, especially those with high-throughput capabilities generate large volumes of data. Accumulation of such data (e.g., genomics, proteomics, metabolomics etc.) is fast becoming more common and thus requires the development and implementation of effective data mining strategies designed for biological and clinical applications. Multiplex microbead immunoassay (MMIA), on xMAP or MagPix platform (Luminex), which is amenable to automation, offers a major advantage over conventional methods such as Western blot or ELISA, for increasing the efficiencies in serodiagnosis of infectious diseases. MMIA allows detection of antibodies and/or antigens efficiently for a wide range of infectious agents simultaneously in host blood samples, in one reaction vessel. In the process, MMIA generates large volumes of data. In this report we demonstrate the application of data mining tools on how the inherent large volume data can improve the assay tolerance (measured in terms of sensitivity and specificity) by analysis of experimental data accumulated over a span of two years. The combination of prior knowledge with machine learning tools provides an efficient approach to improve the diagnostic power of the assay in a continuous basis. Furthermore, this study provides an in-depth knowledge base to study pathological trends of infectious agents in mouse colonies on a multivariate scale. Data mining techniques using serodetection of infections in mice, developed in this study, can be used as a general model for more complex applications in epidemiology and clinical translational research.	[Mani, Akshay; Ravindran, Resmi; Vang, Daniel; Luciw, Paul A.; Khan, Imran H.; Krishnan, Viswanathan V.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Mannepalli, Soujanya; Krishnan, Viswanathan V.] Calif State Univ Fresno, Dept Chem, Fresno, CA 93740 USA; [Luciw, Paul A.; Hogarth, Michael; Khan, Imran H.; Krishnan, Viswanathan V.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Davis, CA 95616 USA	University of California System; University of California Davis; California State University System; California State University Fresno; University of California System; University of California Davis	Khan, IH (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	Ihkhan@ucdavis.edu; vvkrishnan@ucdavis.edu	Khan, Imran Ali/GVT-0232-2022; Khan, imran/GQQ-2176-2022	Khan, Imran Ali/0000-0002-8774-2896; 	Department of Pathology and Laboratory Medicine's proteomics and informatics initiative at UC Davis Medical Center; NIH [P20 MD 002732, P20 CA 138025]; NATIONAL CANCER INSTITUTE [P20CA138025] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD002732] Funding Source: NIH RePORTER	Department of Pathology and Laboratory Medicine's proteomics and informatics initiative at UC Davis Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Partial funding from Department of Pathology and Laboratory Medicine's proteomics and informatics initiative at UC Davis Medical Center is acknowledged. VVK and SM were supported in part by NIH grants P20 MD 002732 and P20 CA 138025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Amancio DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094137; ANDERSON CA, 1986, J CLIN MICROBIOL, V23, P1152, DOI 10.1128/JCM.23.6.1152-1154.1986; Bishop C.M., 2006, PATTERN RECOGN, V4; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; Carugo O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-380; Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244; Compton SR, 2004, COMPARATIVE MED, V54, P382; Couzin-Frankel J, 2014, SCIENCE, V346, P28, DOI 10.1126/science.346.6205.28; Couzin-Frankel J, 2014, SCIENCE, V344, P24, DOI [10.1126/science.344.6179.24, 10.1126/science.346.6205.24]; Davies MN, 2007, BIOINFORMATICS, V23, P3113, DOI 10.1093/bioinformatics/btm506; DUCATELLE F, 2006, SOFTWARE DATA MINING; DUDA RO, 2001, PATTERN CLASSIFICATI; Fayyad U, 1996, COMMUN ACM, V39, P27, DOI 10.1145/240455.240464; FOSTER HL, 1981, MOUSE BIOMEDICAL RES; FOX RR, 1997, HDB GENETICALLY STAN; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Gunnarsson RK, 2002, STAT MED, V21, P1773, DOI 10.1002/sim.1119; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hu J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-297; IWARSSON K, 1990, ACTA PHYSIOL SCAND, V140, P139; Jacoby RO, 1997, FASEB J, V11, P609, DOI 10.1096/fasebj.11.8.9240962; JEROLMACK C, 2005, QUALITATIVE SOCIOLOG, V3; Khan IH, 2005, CLIN DIAGN LAB IMMUN, V12, P513, DOI 10.1128/CDLI.12.4.513-519.2005; Khan IH, 2009, CYTOM PART B-CLIN CY, V76B, P159, DOI 10.1002/cyto.b.20452; Krishhan VV, 2009, CRIT REV BIOTECHNOL, V29, P29, DOI 10.1080/07388550802688847; KRISHNAN VV, 2014, CYTOMETRY B; Kumar P, 2012, PATTERN DISCOVERY USING SEQUENCE DATA MINING: APPLICATIONS AND STUDIES, P1, DOI 10.4018/978-1-61350-056-9; Liu LY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-236; Livingston RS, 2002, CLIN DIAGN LAB IMMUN, V9, P1025, DOI 10.1128/CDLI.9.5.1025-1031.2002; LUSSIER G, 1986, LAB ANIM SCI, V36, P145; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; POROPUDAS J, 2007, ANAL AIR COMBAT SIMU; Pullium JK, 2004, CONTEMP TOP LAB ANIM, V43, P8; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; R Core Team, 2021, R LANGUAGE ENV STAT; Ravindran R, 2010, J IMMUNOL METHODS, V363, P51, DOI 10.1016/j.jim.2010.10.003; Selvaraj S, 2011, BIOINFORMATION, V6, P95, DOI 10.6026/97320630006095; SUZUKI E, 1982, JPN J MED SCI BIOL, V35, P249, DOI 10.7883/yoken1952.35.249; *US DEP AGR AAPHIS, 2011, ANN REP AN US FISC Y; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Witten I.H., 2000, DATA MINING PRACTICA; Witten IH, 2011, MOR KAUF D, pXXI; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Wolpert DH, 2005, IEEE T EVOLUT COMPUT, V9, P721, DOI 10.1109/TEVC.2005.856205; Wolpert DH, 1996, PHYS REV E, V54, P6973, DOI 10.1103/PhysRevE.54.6973.2; Wu X, 2009, CH CRC DATA MIN KNOW, P1, DOI 10.1201/9781420089653; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2	53	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116262	10.1371/journal.pone.0116262	http://dx.doi.org/10.1371/journal.pone.0116262			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25614982	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100025
J	Vijay, V; Han, T; Moland, CL; Kwekel, JC; Fuscoe, JC; Desai, VG				Vijay, Vikrant; Han, Tao; Moland, Carrie L.; Kwekel, Joshua C.; Fuscoe, James C.; Desai, Varsha G.			Sexual Dimorphism in the Expression of Mitochondria-Related Genes in Rat Heart at Different Ages	PLOS ONE			English	Article							GENDER-RELATED DIFFERENCES; MOUSE MODEL; CARDIOMYOPATHY; DYSFUNCTION; APOPTOSIS; DEHYDROGENASE; INJURY; LIVER; HYPERTROPHY; DEFICIENCY	Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Moreover, sex and age are considered major risk factors in the development of CVDs. Mitochondria are vital for normal cardiac function, and regulation of mitochondrial structure and function may impact susceptibility to CVD. To identify potential role of mitochondria in sex-related differences in susceptibility to CVD, we analyzed the basal expression levels of mitochondria-related genes in the hearts of male and female rats. Whole genome expression profiling was performed in the hearts of young (8-week), adult (21-week), and old (78-week) male and female Fischer 344 rats and the expression of 670 unique genes related to various mitochondrial functions was analyzed. A significant (p<0.05) sexual dimorphism in expression levels of 46, 114, and 41 genes was observed in young, adult and old rats, respectively. Gene Ontology analysis revealed the influence of sex on various biological pathways related to cardiac energy metabolism at different ages. The expression of genes involved in fatty acid metabolism was significantly different between the sexes in young and adult rat hearts. Adult male rats also showed higher expression of genes associated with the pyruvate dehydrogenase complex compared to females. In young and adult hearts, sexual dimorphism was not noted in genes encoding oxidative phosphorylation. In old rats, however, a majority of genes involved in oxidative phosphorylation had higher expression in females compared to males. Such basal differences between the sexes in cardiac expression of genes associated with energy metabolism may indicate a likely involvement of mitochondria in susceptibility to CVDs. In addition, female rats showed lower expression levels of apoptotic genes in hearts compared to males at all ages, which may have implications for better preservation of cardiac mass in females than in males.	[Vijay, Vikrant; Han, Tao; Moland, Carrie L.; Kwekel, Joshua C.; Fuscoe, James C.; Desai, Varsha G.] US FDA, Personalized Med Branch, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	US Food & Drug Administration (FDA)	Desai, VG (corresponding author), US FDA, Personalized Med Branch, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	varsha.desai@fda.hhs.gov	Vijay, Vikrant/E-7651-2010	Vijay, Vikrant/0000-0001-8425-1285; Desai, Varsha/0000-0002-5285-3801	FDA Office of Women's Health; U.S. Department of Energy; U.S. Food and Drug Administration	FDA Office of Women's Health; U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Food and Drug Administration	We thank the FDA Office of Women's Health for support of this project. This research was supported in part by an appointment to the Research Participation Program at the National Center for Toxicological Research administered by the Oak Ridge Institute for Science and Education through an inter-agency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MT, 2004, BIOCHEM SOC T, V32, P1021, DOI 10.1042/BST0321021; Arieli Y, 2004, J MOL CELL CARDIOL, V37, P507, DOI 10.1016/j.yjmcc.2004.04.023; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; BUCHWALD A, 1990, EUR HEART J, V11, P509, DOI 10.1093/oxfordjournals.eurheartj.a059743; Colom B, 2007, CARDIOVASC RES, V74, P456, DOI 10.1016/j.cardiores.2007.02.001; Conner P, 2007, ANN MED, V39, P28, DOI 10.1080/07853890601039842; Czubryt MP, 2006, CAN J PHYSIOL PHARM, V84, P93, DOI 10.1139/Y05-151; Delongchamp R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S11; Desai VG, 2009, MITOCHONDRION, V9, P9, DOI 10.1016/j.mito.2008.09.002; Du XJ, 2004, CARDIOVASC RES, V63, P510, DOI 10.1016/j.cardiores.2004.03.027; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Forman DE, 1997, J AM COLL CARDIOL, V30, P1872, DOI 10.1016/S0735-1097(97)00411-7; Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010; GERTZ EW, 1988, J CLIN INVEST, V82, P2017, DOI 10.1172/JCI113822; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Griffin M, 2000, MOL CELL BIOCHEM, V215, P21, DOI 10.1023/A:1026585420021; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Ibdah JA, 2001, J CLIN INVEST, V107, P1403, DOI 10.1172/JCI12590; Jian BX, 2011, MOL MED, V17, P542, DOI 10.2119/molmed.2010.00195; Joseph A, 2009, MITOCHONDRION, V9, P149, DOI 10.1016/j.mito.2009.02.002; KAJSTURA J, 1995, EXP CELL RES, V219, P110, DOI 10.1006/excr.1995.1211; Kashimshetty R, 2009, TOXICOL APPL PHARM, V238, P150, DOI 10.1016/j.taap.2009.05.007; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; Kodde IF, 2007, COMP BIOCHEM PHYS A, V146, P26, DOI 10.1016/j.cbpa.2006.09.014; KUKA S, 2013, GEN PHYSL BIOPHYS; Kurdi Mazen, 2011, Congest Heart Fail, V17, P255, DOI 10.1111/j.1751-7133.2011.00269.x; Kwekel JC, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-14; Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lee TW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S20; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luczak ED, 2009, ANNU REV PHYSIOL, V71, P1, DOI 10.1146/annurev.physiol.010908.163156; Mahmoodzadeh S, 2012, Handb Exp Pharmacol, P23, DOI 10.1007/978-3-642-30726-3_2; MarinGarcia J, 1997, BIOCHEM CELL BIOL, V75, P137, DOI 10.1139/bcb-75-2-137; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Merz CNB, 1996, AM HEART J, V131, P704; Mihl C, 2008, NETH HEART J, V16, P129, DOI 10.1007/BF03086131; Miller VM, 2010, WOMENS HEALTH, V6, P737, DOI [10.2217/whe.10.53, 10.2217/WHE.10.53]; Miller Virginia M, 2011, Sex Reprod Menopause, V9, P21; Mosca L, 1997, CIRCULATION, V96, P2468; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Organization WH, 2011, GLOB STAT REP NONC D; Ostadal B, 2007, RESP PHYSIOL NEUROBI, V158, P224, DOI 10.1016/j.resp.2007.03.005; Ostadal B, 2009, EXP BIOL MED, V234, P1011, DOI 10.3181/0812-MR-362; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Regitz-Zagrosek V, 2010, CIRC J, V74, P1265, DOI 10.1253/circj.CJ-10-0196; ROCCHICCIOLI F, 1990, PEDIATR RES, V28, P657, DOI 10.1203/00006450-199012000-00023; Rosenberg P, 2004, MITOCHONDRION, V4, P621, DOI 10.1016/j.mito.2004.07.016; RUSTIN P, 1994, J PEDIATR-US, V124, P224, DOI 10.1016/S0022-3476(94)70308-6; Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003; SASS B, 1975, J NATL CANCER I, V54, P1449, DOI 10.1093/jnci/54.6.1449; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Speijer D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0446; Stanley William C, 2002, Heart Fail Rev, V7, P115, DOI 10.1023/A:1015320423577; Tein I, 1999, SEMIN PERINATOL, V23, P125, DOI 10.1016/S0146-0005(99)80046-9; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Vassalle C, 2012, GYNECOL ENDOCRINOL, V28, P746, DOI 10.3109/09513590.2011.652720; Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yan L, 2004, J MOL CELL CARDIOL, V37, P921, DOI 10.1016/j.yjmcc.2004.06.012; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230	67	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117047	10.1371/journal.pone.0117047	http://dx.doi.org/10.1371/journal.pone.0117047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615628	Green Submitted, Green Published, gold			2022-12-27	WOS:000349122100053
J	Yasumoto, Y; Nakao, R; Oishi, K				Yasumoto, Yuki; Nakao, Reiko; Oishi, Katsutaka			Free Access to a Running-Wheel Advances the Phase of Behavioral and Physiological Circadian Rhythms and Peripheral Molecular Clocks in Mice	PLOS ONE			English	Article							GENE-EXPRESSION; VOLUNTARY EXERCISE; SLEEP-WAKE; LIGHT; TIME; SYSTEM; PGC-1-ALPHA; PROTEIN; ALTERS; ALPHA	Behavioral and physiological circadian rhythms are controlled by endogenous oscillators in animals. Voluntary wheel-running in rodents is thought to be an appropriate model of aerobic exercise in humans. We evaluated the effects of chronic voluntary exercise on the circadian system by analyzing temporal profiles of feeding, core body temperature, plasma hormone concentrations and peripheral expression of clock and clock-controlled genes in mice housed under sedentary (SED) conditions or given free access to a running-wheel (RW) for four weeks. Voluntary wheel-running activity advanced the circadian phases of increases in body temperature, food intake and corticosterone secretion in the mice. The circadian expression of clock and clock-controlled genes was tissue-and gene-specifically affected in the RW mice. The temporal expression of E-box-dependent circadian clock genes such as Per1, Per2, Nr1d1 and Dbp were slightly, but significantly phase-advanced in the liver and white adipose tissue, but not in brown adipose tissue and skeletal muscle. Peak levels of Per1, Per2 and Nr1d1 expression were significantly increased in the skeletal muscle of RW mice. The circadian phase and levels of hepatic mRNA expression of the clock-controlled genes that are involved in cholesterol and fatty acid metabolism significantly differed between SED and RW mice. These findings indicated that endogenous clock-governed voluntary wheel-running activity provides feedback to the central circadian clock that systemically governs behavioral and physiological rhythms.	[Yasumoto, Yuki; Nakao, Reiko; Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Biol Clock Res Grp, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Yasumoto, Yuki; Oishi, Katsutaka] Tokyo Univ Sci, Grad Sch Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Oishi, Katsutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Science; University of Tokyo	Oishi, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Biol Clock Res Grp, Biomed Res Inst, Tsukuba, Ibaraki, Japan.	k-ooishi@aist.go.jp	Oishi, Katsutaka/L-6906-2018	Oishi, Katsutaka/0000-0002-4870-0837	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25350179, 24620015]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by Grants-in-Aid for Scientific Research (C) KAKENHI to K. Oishi (25350179) and R. Nakao (24620015) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamah-Biassi EB, 2013, BEHAV BRAIN RES, V243, P306, DOI 10.1016/j.bbr.2013.01.003; Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chikahisa S, 2008, ENDOCRINOLOGY, V149, P5262, DOI 10.1210/en.2008-0285; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; EDGAR DM, 1991, PHYSIOL BEHAV, V50, P373, DOI 10.1016/0031-9384(91)90080-8; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Husse J, 2014, FASEB J, V28, P4950, DOI 10.1096/fj.14-256594; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kuroda H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00711; Lakka TA, 2005, HANDB EXP PHARM, V170, P137; Leise TL, 2013, AGE, V35, P2137, DOI 10.1007/s11357-012-9502-y; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva Biliana, 2013, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-25950-0_6; Mendoza J, 2008, J PHYSIOL-LONDON, V586, P5901, DOI 10.1113/jphysiol.2008.159566; Mistlberger RE, 2000, AM J PHYSIOL-REG I, V279, pR813, DOI 10.1152/ajpregu.2000.279.3.R813; Novak CM, 2012, NEUROSCI BIOBEHAV R, V36, P1001, DOI 10.1016/j.neubiorev.2011.12.012; Ohkura N, 2007, CHRONOBIOL INT, V24, P651, DOI 10.1080/07420520701534673; Oike Hideaki, 2014, Curr Nutr Rep, V3, P204; Oishi K, 2013, FEBS OPEN BIO, V3, P192, DOI 10.1016/j.fob.2013.03.005; Oishi K, 2011, BIOCHEM BIOPH RES CO, V412, P396, DOI 10.1016/j.bbrc.2011.07.125; Oishi K, 2009, ARTERIOSCL THROM VAS, V29, P1571, DOI 10.1161/ATVBAHA.109.190140; Pendergast JS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00177; Robinson I, 2014, FEBS LETT, V588, P2477, DOI 10.1016/j.febslet.2014.06.005; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sakurai T, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/801743; Schroeder AM, 2012, J PHYSIOL-LONDON, V590, P6213, DOI 10.1113/jphysiol.2012.233676; Shibata S, 2010, ADV DRUG DELIVER REV, V62, P918, DOI 10.1016/j.addr.2010.06.003; Shirai H, 2007, BIOCHEM BIOPH RES CO, V357, P679, DOI 10.1016/j.bbrc.2007.04.002; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wolff G, 2012, MED SCI SPORT EXER, V44, P1663, DOI 10.1249/MSS.0b013e318255cf4c; Yamanaka Y, 2014, AM J PHYSIOL-REG I, V307, pR546, DOI 10.1152/ajpregu.00087.2014; Yamanaka Y, 2013, AM J PHYSIOL-REG I, V305, pR1367, DOI 10.1152/ajpregu.00389.2013; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	44	40	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116476	10.1371/journal.pone.0116476	http://dx.doi.org/10.1371/journal.pone.0116476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615603	gold, Green Submitted, Green Published			2022-12-27	WOS:000349122100029
J	Zhao, RQ; Xu, ZG; Zhao, MH				Zhao, Renqing; Xu, Zhengang; Zhao, Meihua			Antiresorptive Agents Increase the Effects of Exercise on Preventing Postmenopausal Bone Loss in Women: A Meta-Analysis	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; MINERAL DENSITY; COMBINED INTERVENTION; IMMUNE REGULATION; JAPANESE WOMEN; FAT MASS; BODY-FAT; ESTROGEN; IMPACT; ISOFLAVONE	Background and Objectives It remains unknown whether the combination of antiresorptive agents and exercise would generate additive effects on bone mineral density (BMD) in postmenopausal women, though their separate roles in preventing bone loss have been well established. This meta-analysis aimed to evaluate the combined impact of antiresorptive treatment and exercise on the lumbar spine and femoral neck BMD in postmenopausal women compared with an exercise-only intervention. Methods A systematic literature search of PubMed, EMBASE, SportDiscus and ProQuest up to Jun 2014 was conducted to identify the influence of antiresorptive agents and exercise on BMD in postmenopausal women. The study quality of the included trials was evaluated. The effect sizes were estimated by calculating the standardized mean difference (SMD). Subgroup analyses were conducted by pharmacological regimens and exercise categories. Results Nine studies with a total of 1,248 postmenopausal women met the inclusion criteria. The heterogeneity between the studies was evident at the spine (I-2 = 78.7%) and hip (I-2 = 41.7%) measurements; random-effects models were used in the data analysis. The pooled effect sizes associated with the combined interventions of antiresorptive agents and exercise were significant at the lumbar spine BMD (SMD = 0.511, 95% CI = 0.118-0.904, p = 0.011). Combining hormone replacement therapy (HRT) and exercise training generated greater beneficial effects on lumbar spine (SMD = 0.729, 95% CI = 0.186-1.273, p = 0.009) and femoral neck BMD (SMD = 0.220, 95% CI = 0.0110-429, p = 0.039) than the exercise-only intervention. Impact exercise was sensitive to antiresorptive agents in preventing postmenopausal bone loss both at the spine (SMD = 1.252, 95% CI = 0.465-2.039, p = 0.002) and hips (SMD = 0.414, 95% CI = 0.106-0.723, p = 0.008). Conclusions Our findings indicate that antiresorptive agents significantly increase the impact of exercise on the prevention of bone loss in postmenopausal women, which implies that the combination of antiresorptive agents and exercise may generate additive effects.	[Zhao, Renqing; Xu, Zhengang; Zhao, Meihua] Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, Jinhua, Zhejiang, Peoples R China	Zhejiang Normal University	Zhao, RQ (corresponding author), Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, Jinhua, Zhejiang, Peoples R China.	renzhao@zjnu.cn			Zhejiang Provincial Natural Science Foundation of China [LY14H070001]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This material was based upon work funded by Zhejiang Provincial Natural Science Foundation of China under Grant No. LY14H070001 (http://www.zjnsf.gov.cn/index.aspx). RZ received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4; Ankrom MA, 1998, BIOCHEM J, V333, P787, DOI 10.1042/bj3330787; Babatunde OO, 2012, OSTEOPOROSIS INT, V23, P109, DOI 10.1007/s00198-011-1801-0; Bassey EJ, 1998, J BONE MINER RES, V13, P1805, DOI 10.1359/jbmr.1998.13.12.1805; Borer KT, 2005, SPORTS MED, V35, P779, DOI 10.2165/00007256-200535090-00004; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; Cheng S, 2002, BONE, V31, P126, DOI 10.1016/S8756-3282(02)00794-9; Chilibeck PD, 2002, CAN J PHYSIOL PHARM, V80, P941, DOI 10.1139/y02-126; Chilibeck PD, 2013, J BONE MINER RES, V28, P780, DOI 10.1002/jbmr.1815; Chuin A, 2009, OSTEOPOROSIS INT, V20, P1253, DOI 10.1007/s00198-008-0798-5; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Damien E, 1998, J BONE MINER RES, V13, P1275, DOI 10.1359/jbmr.1998.13.8.1275; Going S, 2003, OSTEOPOROSIS INT, V14, P637, DOI 10.1007/s00198-003-1436-x; Gurney EP, 2014, J STEROID BIOCHEM, V142, P4, DOI 10.1016/j.jsbmb.2013.10.009; Hahn S, 2000, STAT MED, V19, P3325, DOI 10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D; HIGGINS J, 2008, COCHRANE REVIEWERS H, P6472; Howe TE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000333, 10.1002/14651858.CD000333.pub2]; Ishimi Y, 2000, BIOCHEM BIOPH RES CO, V274, P697, DOI 10.1006/bbrc.2000.3175; Ishimi Y, 2002, BONE, V31, P180, DOI 10.1016/S8756-3282(02)00780-9; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kelley GA, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-177; KOHRT WM, 1995, J BONE MINER RES, V10, P1303, DOI 10.1002/jbmr.5650100906; Kohrt WM, 1998, J APPL PHYSIOL, V84, P1506, DOI 10.1152/jappl.1998.84.5.1506; Lagari VS, 2014, J STEROID BIOCHEM, V139, P294, DOI 10.1016/j.jsbmb.2012.12.002; Lorrain J, 2003, MENOPAUSE, V10, P228, DOI 10.1097/00042192-200310030-00010; Maddalozzo GF, 2007, BONE, V40, P1244, DOI 10.1016/j.bone.2006.12.059; Martyn-St James M, 2006, OSTEOPOROSIS INT, V17, P1225, DOI 10.1007/s00198-006-0083-4; Martyn-St James M, 2008, BONE, V43, P521, DOI 10.1016/j.bone.2008.05.012; Milliken LA, 2003, CALCIFIED TISSUE INT, V72, P478, DOI 10.1007/s00223-001-1128-5; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sugiyama T, 2002, J BONE MINER METAB, V20, P196, DOI 10.1007/s007740200028; Tobias JH, 2003, TRENDS ENDOCRIN MET, V14, P441, DOI 10.1016/j.tem.2003.09.010; Torgerson DJ, 2001, JAMA-J AM MED ASSOC, V285, P2891, DOI 10.1001/jama.285.22.2891; Umland EM, 2000, PHARMACOTHERAPY, V20, P981, DOI 10.1592/phco.20.11.981.35259; Uusi-Rasi K, 2003, BONE, V33, P132, DOI 10.1016/S8756-3282(03)00082-6; Wang QJ, 2004, J CLIN ENDOCR METAB, V89, P1698, DOI 10.1210/jc.2003-031113; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Wu J, 2006, J BONE MINER RES, V21, P780, DOI 10.1359/JBMR.060208; Wu J, 2006, METABOLISM, V55, P423, DOI 10.1016/j.metabol.2005.10.002; Wu J, 2004, METABOLISM, V53, P942, DOI 10.1016/j.metabol.2004.01.019; Wu J, 2003, J APPL PHYSIOL, V94, P335, DOI 10.1152/japplphysiol.00498.2002; Zhang J, 2014, OSTEOPOROSIS INT, V25, P1585, DOI 10.1007/s00198-014-2644-2; ZHAO R, 2014, EFFICIENCY JUMPING E, P6472; Zhao RQ, 2014, SPORTS MED, V44, P1393, DOI 10.1007/s40279-014-0220-8; Zhao RQ, 2013, EUR J CLIN INVEST, V43, P1195, DOI 10.1111/eci.12158; Zhao RQ, 2012, INT J MED SCI, V9, P825, DOI 10.7150/ijms.5180	49	10	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116729	10.1371/journal.pone.0116729	http://dx.doi.org/10.1371/journal.pone.0116729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615597	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100039
J	Assarag, B; Dujardin, B; Delamou, A; Meski, FZ; De Brouwere, V				Assarag, Bouchra; Dujardin, Bruno; Delamou, Alexandre; Meski, Fatima-Zahra; De Brouwere, Vincent			Determinants of Maternal Near-Miss in Morocco: Too Late, Too Far, Too Sloppy?	PLOS ONE			English	Article							ANTENATAL CARE; MORTALITY; MORBIDITY; INFORMATION; DEATHS; HEALTH	Background In Morocco, there is little information on the circumstances surrounding maternal near misses. This study aimed to determine the incidence, characteristics, and determinants of maternal near misses in Morocco. Method A prospective case-control study was conducted at 3 referral maternity hospitals in the Marrakech region of Morocco between February and July 2012. Near-miss cases included severe hemorrhage, hypertensive disorders, and prolonged obstructed labor. Three unmatched controls were selected for each near-miss case. Three categories of risk factors (sociodemographics, reproductive history, and delays), as well as perinatal outcomes, were assessed, and bivariate and multivariate analyses of the determinants were performed. A sample of 30 near misses and 30 non-near misses was interviewed. Results The incidence of near misses was 12% of births. Hypertensive disorders during pregnancy (45%) and severe hemorrhage (39%) were the most frequent direct causes of near miss. The main risk factors were illiteracy [OR = 2.35; 95% CI: (1.07-5.15)], lack of antenatal care [OR = 3.97; 95% CI: (1.42-11.09)], complications during pregnancy [OR = 2.81; 95% CI: (1.26-6.29)], and having experienced a first phase delay [OR = 8.71; 95% CI: (3.97-19.12)] and a first phase of third delay [OR = 4.03; 95% CI: (1.75-9.25)]. The main reasons for the first delay were lack of a family authority figure who could make a decision, lack of sufficient financial resources, lack of a vehicle, and fear of health facilities. The majority of near misses demonstrated a third delay with many referrals. The women's perceptions of the quality of their care highlighted the importance of information, good communication, and attitude. Conclusion Women and newborns with serious obstetric complications have a greater chance of successful outcomes if they are immediately directed to a functioning referral hospital and if the providers are responsive.	[Assarag, Bouchra; Meski, Fatima-Zahra] Natl Sch Publ Hlth, Rabat, Morocco; [Assarag, Bouchra; Delamou, Alexandre; De Brouwere, Vincent] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Assarag, Bouchra; Dujardin, Bruno; Delamou, Alexandre] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Delamou, Alexandre] Natl Ctr Res & Training Rural Hlth, Maferinyah, Guinea	Institute of Tropical Medicine (ITM); Universite Libre de Bruxelles	Assarag, B (corresponding author), Natl Sch Publ Hlth, Rabat, Morocco.	bassarag@gmail.com			United Nations Population Fund (UNFPA) [MOR7R21A]; Ministry of Health of Morocco; European Union: Project FP7-PEOPLE-2013-IRSES [PIRSES-GA-2013-612216]	United Nations Population Fund (UNFPA); Ministry of Health of Morocco; European Union: Project FP7-PEOPLE-2013-IRSES	Support was provided by United Nations Population Fund (UNFPA):Project MOR7R21A with Ministry of Health of Morocco [http://www.moroccounfpa.org/]; European Union: Project FP7-PEOPLE-2013-IRSES, Grant Agreement Number: PIRSES-GA-2013-612216, MNSIRSES [http://ec.europa.eu/research/mariecurieactions/funded-projects/how-tomanage/irses/index_en.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeoye IA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-93; Adisasmita Asri, 2008, BMC Pregnancy Childbirth, V8, P10, DOI 10.1186/1471-2393-8-10; Agan TU, 2010, INT J WOMENS HEALTH, V2, P249; Ayers S, 2007, BIRTH-ISS PERINAT C, V34, P253, DOI 10.1111/j.1523-536X.2007.00178.x; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22; Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9; Cham Mamady, 2009, Reprod Health, V6, P5, DOI 10.1186/1742-4755-6-5; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; Direction des Hopitaux et des Soins Ambulatoires (DHSA), 2010, RAPP NAT ENQ CONF DE; Dujardin A, 1993, THESIS I MED TROPICA, P198; Evjen-Olsen B, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-52; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; Filippi V, 2004, HEALTH POLICY PLANN, V19, P57, DOI 10.1093/heapol/czh007; Filippi V, 2009, BEST PRACT RES CL OB, V23, P389, DOI 10.1016/j.bpobgyn.2008.12.006; Fillippi V., 2004, NUMBERS REV MATERNAL, P103; Geller SE, 2004, AM J OBSTET GYNECOL, V191, P939, DOI 10.1016/j.ajog.2004.05.099; Gonzalez-Block MA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-164; Graner S, 2010, PAEDIATR PERINAT EP, V24, P535, DOI 10.1111/j.1365-3016.2010.01135.x; Haut-Commissariat au Plan, 2007, IND PROV PAUVR VULN; Jacques Saizonou, 2006, Afr J Reprod Health, V10, P28; Jafarey SN, 2009, J HEALTH POPUL NUTR, V27, P170; Jeffery P, 2010, SOC SCI MED, V71, P1711, DOI 10.1016/j.socscimed.2010.05.002; Jithesh V, 2012, SOCIAL DETERMINANTS, DOI 10.1016/j.jfma.2012.09.018; Khanal V, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-4; Murphy DJ, 2002, EUR J OBSTET GYN R B, V102, P173, DOI 10.1016/S0301-2115(01)00320-7; Nelissen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061248; Nelissen EJT, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-141; Roost M, 2010, ACTA OBSTET GYN SCAN, V89, P335, DOI 10.3109/00016340903511050; Sahel A, 2011, SANTE, V11, P229, DOI [10.1016/j.jinf.2014.12.008PMID: 25546345, DOI 10.1016/J.JINF.2014.12.008]; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Say L, 2010, INDIAN J MED RES, V132, P123; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Seely EW, 2007, CIRCULATION, V115, pE188, DOI 10.1161/CIRCULATIONAHA.106.636472; Souza J P, 2007, BMC Pregnancy Childbirth, V7, P20, DOI 10.1186/1471-2393-7-20; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tuncalp O, 2012, SEVERE MATERNAL COMP; Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x; Tuncalp O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044536; van Roosmalen J, 2009, BEST PRACT RES CL OB, V23, P297, DOI 10.1016/j.bpobgyn.2009.01.004; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1084; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	42	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116675	10.1371/journal.pone.0116675	http://dx.doi.org/10.1371/journal.pone.0116675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612095	Green Published, gold			2022-12-27	WOS:000348562900020
J	Perrier, J; Clochon, P; Bertran, F; Couque, C; Bulla, J; Denise, P; Bocca, ML				Perrier, Joy; Clochon, Patrice; Bertran, Francoise; Couque, Colette; Bulla, Jan; Denise, Pierre; Bocca, Marie-Laure			Specific EEG Sleep Pattern in the Prefrontal Cortex in Primary Insomnia	PLOS ONE			English	Article							PSYCHOPHYSIOLOGICAL INSOMNIA; INDIRECT COSTS; NREM SLEEP; REM-SLEEP; NIGHT; CLASSIFICATION; EPIDEMIOLOGY; PERFORMANCE; SPINDLES; SPECTRA	Objective To assess the specific prefrontal activity in comparison to those in the other main cortical areas in primary insomnia patients and in good sleepers. Methods Fourteen primary insomnia patients and 11 good sleepers were included in the analysis. Participants completed one night of polysomnography in the sleep lab. Power spectra were calculated during the NREM (Non-rapid eyes movements) and the REM (Rapid eyes movements) sleep periods at prefrontal, occipital, temporal and central electrode positions. Results During the NREM sleep, the power spectra did not differ between groups in the prefrontal cortex; while primary insomnia patients exhibited a higher beta power spectrum and a lower delta power spectrum compared to good sleepers in other areas. During the REM sleep, the beta1 power spectrum was lower in the prefrontal cortex in primary insomnia patients compared to good sleepers; while no significant difference between groups was obtained for the other areas. Conclusions The present study shows a specific prefrontal sleep pattern during the whole sleep period. In addition, we suggest that primary insomnia patients displayed a dysfunction in the reactivation of the limbic system during the REM sleep and we give additional arguments in favor of a sleep-protection mechanism displayed by primary insomnia patients.	[Perrier, Joy; Denise, Pierre; Bocca, Marie-Laure] Normandie Univ, F-14032 Caen, France; [Perrier, Joy; Denise, Pierre; Bocca, Marie-Laure] UNICAEN, COMETE, F-14032 Caen, France; [Perrier, Joy; Denise, Pierre; Bocca, Marie-Laure] INSERM, COMETE, U 1075, F-14032 Caen, France; [Bertran, Francoise; Couque, Colette; Denise, Pierre] CHU Caen, Dept Clin Physiol, F-14033 Caen, France; [Clochon, Patrice; Bertran, Francoise] INSERM, U1077, F-14074 Caen, France; [Clochon, Patrice; Bertran, Francoise] UNICAEN, UMR S1077, F-14074 Caen, France; [Clochon, Patrice; Bertran, Francoise] Ecole Prat Hautes Etud, UMR S1077, F-14074 Caen, France; [Bulla, Jan] Univ Bergen, Dept Math, N-5020 Bergen, Norway	Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; University of Bergen	Perrier, J (corresponding author), Normandie Univ, F-14032 Caen, France.	perrier-j@phycog.org	Bocca, Marie-Laure/O-1541-2015; Denise, Pierre/E-2174-2011; Clochon, Patrice/M-1281-2015	Denise, Pierre/0000-0002-9049-7692; Perrier, Joy/0000-0002-8639-9985	European Union [TREN-05-FP6TR-S07.61320-518404-DRUID]	European Union(European Commission)	This work was conducted as part of the Driving under the influence of drugs, alcohol, and medicines (DRUID) research consortium funded by European Union grant TREN-05-FP6TR-S07.61320-518404-DRUID. This report reflects only the authors' view. The European Community is not liable for any use of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altena E, 2008, SLEEP, V31, P1271; Altena E, 2010, BIOL PSYCHIAT, V67, P182, DOI 10.1016/j.biopsych.2009.08.003; [Anonymous], 2014, R LANG ENV STAT COMP; Baglioni C, 2014, SLEEP MED REV, V18, P195, DOI 10.1016/j.smrv.2013.04.001; Bastien CH, 2009, J PSYCHOSOM RES, V66, P59, DOI 10.1016/j.jpsychores.2008.05.013; Besset A, 1998, ELECTROEN CLIN NEURO, V107, P122, DOI 10.1016/S0013-4694(98)00048-0; Bonnet MH, 2010, SLEEP MED REV, V14, P9, DOI 10.1016/j.smrv.2009.05.002; BORBELY AA, 1985, HUM NEUROBIOL, V4, P189; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Braver TS, 2001, NEUROIMAGE, V14, P48, DOI 10.1006/nimg.2001.0791; BRUNNER DP, 1991, PSYCHOPHARMACOLOGY, V104, P1, DOI 10.1007/BF02244546; Buysse DJ, 2008, SLEEP, V31, P1673, DOI 10.1093/sleep/31.12.1673; Chan-Chee C, 2011, REV EPIDEMIOL SANTE, V59, P409, DOI 10.1016/j.respe.2011.05.005; Daley M, 2009, SLEEP, V32, P55; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; Dang-Vu TT, 2005, NEUROIMAGE, V28, P14, DOI 10.1016/j.neuroimage.2005.05.028; Feige B, 2013, INT J PSYCHOPHYSIOL; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Iber C., 2007, AASM MANUAL SCORING; Joo EY, 2013, SLEEP, V36, P999, DOI 10.5665/sleep.2796; Krystal AD, 2002, SLEEP, V25, P630; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Le Bon O, 2003, REV NEUROL-FRANCE, V159, pS42; Maquet P, 1996, NATURE, V383, P163, DOI 10.1038/383163a0; Merica H, 1998, EUR J NEUROSCI, V10, P1826, DOI 10.1046/j.1460-9568.1998.00189.x; Muzur A, 2002, TRENDS COGN SCI, V6, P475, DOI 10.1016/S1364-6613(02)01992-7; Newell J, 2012, PSYCHIAT RES, V200, P795, DOI 10.1016/j.psychres.2012.07.045; Nofzinger EA, 1997, BRAIN RES, V770, P192, DOI 10.1016/S0006-8993(97)00807-X; Nofzinger EA, 2004, AM J PSYCHIAT, V161, P2126, DOI 10.1176/appi.ajp.161.11.2126; Ohayon MM, 2012, SLEEP MED, V13, P52, DOI 10.1016/j.sleep.2011.06.010; Ohayon MM, 2009, SLEEP MED, V10, P952, DOI 10.1016/j.sleep.2009.07.008; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ozminkowski RJ, 2007, SLEEP, V30, P263, DOI 10.1093/sleep/30.3.263; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; Perlis ML, 1997, J SLEEP RES, V6, P179, DOI 10.1046/j.1365-2869.1997.00045.x; Perlis ML, 2001, J SLEEP RES, V10, P93, DOI 10.1046/j.1365-2869.2001.00247.x; Perlis ML, 2001, SLEEP MED REV, V5, P365, DOI 10.1053/smrv.2001.0151; Perrier J, 2014, SLEEP, V37, P1565, DOI 10.5665/sleep.4012; Riedel BW, 2001, SLEEP MED, V2, P125, DOI 10.1016/S1389-9457(00)00054-X; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Spiegelhalder K, 2012, BIOL PSYCHOL, V91, P329, DOI 10.1016/j.biopsycho.2012.08.009; Unterrainer JM, 2004, CEREB CORTEX, V14, P1390, DOI 10.1093/cercor/bhh100; Wilckens KA, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/624795	43	20	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116864	10.1371/journal.pone.0116864	http://dx.doi.org/10.1371/journal.pone.0116864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611059	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900025
J	Tanno, J; Nakano, S; Kasai, T; Ako, J; Nakamura, S; Senbonmatsu, T; Nishimura, S				Tanno, Jun; Nakano, Shintaro; Kasai, Takatoshi; Ako, Junya; Nakamura, Sunao; Senbonmatsu, Takaaki; Nishimura, Shigeyuki			Increase in Ultrasonic Intensity of Blood Speckle across Moderate Coronary Artery Stenosis Is an Independent Predictor of Functional Coronary Artery Stenosis Measured by Fractional Flow Reserve: Pilot Study	PLOS ONE			English	Article							EXPERT CONSENSUS DOCUMENT; ASSOCIATION TASK-FORCE; INTRAVASCULAR ULTRASOUND; MYOCARDIAL PERFUSION; PRACTICE GUIDELINES; EUROPEAN-SOCIETY; ANGIOGRAPHY; ACQUISITION; STANDARDS; SEVERITY	Background and Aims The degree of coronary artery stenosis should be assessed both anatomically and functionally. We observed that the intensity of blood speckle (IBS) on intravascular ultrasound (IVUS) is low proximal to a coronary artery stenosis, and high distal to the stenosis. We defined step-up IBS as the distal minus the proximal IBS, and speculated that this new parameter could be used for the functional evaluation of stenosis on IVUS. The aims of this study were to assess the relationships between step-up IBS and factors that affect coronary blood flow, and between step-up IBS and fractional flow reserve (FFR). Methods and Results This study enrolled 36 consecutive patients with angina who had a single moderate stenosis in the left anterior descending artery. All patients were evaluated by integrated backscatter IVUS and intracoronary pressure measurements. FFR was calculated from measurements using a coronary pressure wire during hyperemia. Conventional gray-scale IVUS images were recorded, and integrated backscatter was measured in three cross-sectional slices proximal and distal to the stenosis. Step-up IBS was calculated as (mean distal integrated backscatter value) - (mean proximal integrated backscatter value). Stepwise multiple linear regression analysis showed that the heart rate (r = 0.45, P = 0.005), ejection fraction (r = -0.39, P = 0.01), and hemoglobin level (r = -0.32, P = 0.04) were independently correlated with step-up IBS, whereas proximal and distal IBS were not associated with these factors. There was a strong inverse correlation between step-up IBS and FFR (r = -0.84, P < 0.001), which remained significant on stepwise multiple linear regression analysis. Conclusions The newly defined parameter of step-up IBS is potentially useful for the functional assessment of coronary artery stenosis.	[Tanno, Jun; Nakano, Shintaro; Senbonmatsu, Takaaki; Nishimura, Shigeyuki] Saitama Med Univ, Int Med Ctr, Dept Cardiol, Saitama, Japan; [Nakamura, Sunao] New Tokyo Hosp, Chiba, Japan; [Kasai, Takatoshi] Juntendo Univ, Sch Med, Dept Cardiol, Tokyo 113, Japan; [Ako, Junya] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Kanagawa, Japan	Saitama Medical University; Juntendo University; Kitasato University	Tanno, J (corresponding author), Saitama Med Univ, Int Med Ctr, Dept Cardiol, Saitama, Japan.	j_tanno@saitama-med.ac.jp						BACHE RJ, 1977, CIRC RES, V41, P648, DOI 10.1161/01.RES.41.5.648; BRAUNWALD E, 1971, AM J CARDIOL, V27, P416, DOI 10.1016/0002-9149(71)90439-5; Cho I, 2012, CIRCULATION, V126, P304, DOI 10.1161/CIRCULATIONAHA.111.081380; Crossman DC, 2004, HEART, V90, P576, DOI 10.1136/hrt.2003.029017; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; ELLIS AK, 1980, CIRC RES, V46, P68, DOI 10.1161/01.RES.46.1.68; Ercan M, 2003, ANESTH ANALG, V96, P307, DOI 10.1097/00000539-200301000-00073; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Govindaraju K, 2012, PHYS MED; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Jeremias A, 2000, CIRCULATION, V101, P318, DOI 10.1161/01.CIR.101.3.318; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Matsuo H, 2002, CIRCULATION, V105, P1060, DOI 10.1161/hc0902.104719; Mintz GS, 2011, EUROINTERVENTION, V6, P1123, DOI 10.4244/EIJV6I9A195; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Pakkal M, 2011, Br J Radiol, V84 Spec No 3, pS280, DOI 10.1259/bjr/50903757; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Pijls NHJ, 2012, J AM COLL CARDIOL, V59, P1045, DOI 10.1016/j.jacc.2011.09.077; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tobis J, 2007, J AM COLL CARDIOL, V49, P839, DOI 10.1016/j.jacc.2006.10.055; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; VANDERHEIDEN MS, 1995, ULTRASOUND MED BIOL, V21, P817, DOI 10.1016/0301-5629(95)00012-G	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116727	10.1371/journal.pone.0116727	http://dx.doi.org/10.1371/journal.pone.0116727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607986	gold, Green Published, Green Submitted			2022-12-27	WOS:000348205300033
J	Zhang, CX; Guo, ZX; Liu, HY; Shi, YL; Ge, SL				Zhang, Chengxin; Guo, Zhixiang; Liu, Haiyuan; Shi, Yinglu; Ge, Shenglin			Influence of Levosimendan Postconditioning on Apoptosis of Rat Lung Cells in a Model of Ischemia-Reperfusion Injury	PLOS ONE			English	Article							CONTROLLED OXYGEN REPERFUSION; CARDIOPULMONARY BYPASS; HEART-FAILURE; SURGERY; CHANNELS	Objective To ascertain if levosimendan postconditioning can alleviate lung ischemia-reperfusion injury (LIRI) in rats. Method One hundred rats were divided into five groups: Sham (sham), ischemia-reperfusion group (I/R group), ischemic postconditioning (IPO group), levosimendan postconditioning (Levo group) and combination postconditioning group of levosimendan and 5-Hydroxydecanoic acid (Levo+5-HD group). The apoptotic index (AI) of lung tissue cells was determined using the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Expression of active cysteine aspartate specific protease-3 (active caspase-3), Bcl-2 and Bax in lung tissue was determined by immunohistochemical staining. The morphopathology of lung tissue was observed using light and electron microscopy. Results AI values and expression of active caspase-3, Bcl-2 and Bax of lung tissue in I/R and Levo+5-HD groups were significantly higher than those in the sham group (P<0.05). AI values and expression of active caspase-3 and Bax were significantly lower, whereas that of Bcl-2 was higher significantly in the Levo group, compared with I/R and Levo+5-HD groups (P<0.05). Significant differences were not observed in comparisons between I/R and Levo+5-HD groups as well as IPO and Levo groups. Conclusion LIRI can be alleviated by levosimendan, which simulates an IPO protective function. A postulated lung-protective mechanism of action could involve opening of mitochondrial adenosine triphosphate-sensitive potassium channels, relieving Ca2+ overload, upregulation of expression of Bcl-2, and downregulation of expression of active caspase-3 and Bax.	[Zhang, Chengxin; Guo, Zhixiang; Ge, Shenglin] Anhui Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Hefei, Anhui, Peoples R China; [Liu, Haiyuan] An Hui Med Univ, He Fei Hosp Affiliated, Dept Oncol, Hefei, Anhui, Peoples R China; [Shi, Yinglu] Chest Hosp Anhui Prov, Dept Cerebral Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Ge, SL (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Hefei, Anhui, Peoples R China.	aydgsl@sina.com			Anhui Provincial Natural Science Research Projects in Colleges and Universities in China [KJ2013Z108]	Anhui Provincial Natural Science Research Projects in Colleges and Universities in China	This study was funded by grant number KJ2013Z108 from Anhui Provincial Natural Science Research Projects in Colleges and Universities in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis EE, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-1; Canbaz S, 2003, THORAC CARDIOV SURG, V51, P57, DOI 10.1055/s-2003-38983; Dezfulian C, 2013, TRANSL STROKE RES, V4, P19, DOI 10.1007/s12975-012-0224-3; Ersoy O, 2013, CARDIOVASC J AFR, V24, P260, DOI 10.5830/CVJA-2013-047; Hsiao ST, 2014, PHARMACOL THERAPEUT, V142, P141, DOI 10.1016/j.pharmthera.2013.12.002; Jin CH, 2012, J PHYSIOL SCI, V62, P325, DOI 10.1007/s12576-012-0206-y; Kagawa H, 2010, J THORAC CARDIOV SUR, V139, P174, DOI 10.1016/j.jtcvs.2009.08.036; Kim JC, 2012, CHEST, V142, P467, DOI 10.1378/chest.11-2246; Lin YM, 2008, J CELL SCI, V121, P2382, DOI 10.1242/jcs.021394; Maytin M, 2005, AM J CARDIOL, V96, p26G, DOI 10.1016/j.amjcard.2005.07.018; Mockford KA, 2009, EUR J VASC ENDOVASC, V37, P437, DOI 10.1016/j.ejvs.2008.12.017; Moghtadaei M, 2012, MOL BIOL REP, V39, P11093, DOI 10.1007/s11033-012-2015-z; Mykytenko J, 2008, BASIC RES CARDIOL, V103, P472, DOI 10.1007/s00395-008-0731-2; Ng SC, 2005, EUR RESPIR J, V25, P356, DOI 10.1183/09031936.05.00030304; Oikawa M, 2008, CIRC J, V72, P2081, DOI 10.1253/circj.CJ-08-0098; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Rong J, 2013, ASAIO J, V59, P302, DOI 10.1097/MAT.0b013e318290504e; Rong J, 2012, EXP LUNG RES, V38, P183, DOI 10.3109/01902148.2012.662667; Soeding PF, 2011, EUR J PHARMACOL, V655, P59, DOI 10.1016/j.ejphar.2010.12.035; Tasal A, 2014, J CARDIOL, V63, P418, DOI 10.1016/j.jjcc.2013.10.009; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wu Q, 2011, J SURG RES, V169, pE155, DOI 10.1016/j.jss.2010.04.009; Xanthos T, 2009, AM J EMERG MED, V27, P651, DOI 10.1016/j.ajem.2008.05.004; Yapic D, 2008, EUR J ANAESTH, V25, P8, DOI 10.1017/S0265021507002736	24	26	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0114963	10.1371/journal.pone.0114963	http://dx.doi.org/10.1371/journal.pone.0114963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608001	gold, Green Submitted, Green Published			2022-12-27	WOS:000348205300006
J	Liu, LM; Wang, SH; Fu, CS; Han, XZ; Wei, BF				Liu, Lan-Mei; Wang, Shuai-Hua; Fu, Chuan-Sheng; Han, Xiang-Zhen; Wei, Bao-Fu			Serum Levels of 25-Hydroxyvitamin D and Functional Outcome among Postmenopausal Women with Hip Fracture	PLOS ONE			English	Article							VITAMIN-D STATUS; BONE TURNOVER; D DEFICIENCY; OLDER WOMEN; OSTEOPOROSIS; ASSOCIATION; PREVALENCE; RECOVERY; MARKERS; RISK	Objective The main objective of the current study was to assess the distribution and its prognostic value of serum 25-hydroxyvitamin D (25[OH] D) levels assessed at admission in Chinese postmenopausal women with hip fracture. Methods From January 1, 2012 to December 31, 2013, all postmenopausal women with first-ever hip fracture were recruited to participate in the study. Serum 25[OH] D levels were measured at admission. The functional evaluation at the time of discharge was performed by the Barthel Index (BI). The prognostic value of 25[OH] D to predict the functional outcome within discharge was analyzed by logistic regression analysis, after adjusting for the possible confounders. Results In our study, 261 patients were included and assessed. In the 76 patients with an unfavorable functional outcome, serum 25(OH) D levels were lower compared with those in patients with a favorable outcome [11.8(IQR, 9.9-16.1) ng/ml; 16.8(IQR, 13.6-21.4) ng/ml, respectively; P<0.0001]. In multivariate analysis, there was an increased risk of unfavorable outcome associated with serum 25(OH) D levels <= 20ng/ml (OR 5.24, 95% CI: 3.11-8.15; P<0.0001) after adjusting for possible confounders. Conclusions Our data support an association between serum 25[OH] D levels and prognosis in Chinese postmenopausal women with hip fracture.	[Liu, Lan-Mei; Wang, Shuai-Hua; Fu, Chuan-Sheng; Han, Xiang-Zhen] Linyi Peoples Hosp, Dept Orthoped, Linyi, Shandong, Peoples R China; [Wei, Bao-Fu] Shandong Prov Hosp, Hand & Foot Surg Dept, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences	Wei, BF (corresponding author), Shandong Prov Hosp, Hand & Foot Surg Dept, Jinan, Shandong, Peoples R China.	bluesky861@126.com						Bakhtiyarova S, 2006, OSTEOPOROSIS INT, V17, P441, DOI 10.1007/s00198-005-0006-9; Barr R, 2010, OSTEOPOROSIS INT, V21, P457, DOI 10.1007/s00198-009-1019-6; Bikle DD, 2012, CURR OSTEOPOROS REP, V10, P151, DOI 10.1007/s11914-012-0098-z; Dhanwal DK, 2013, OSTEOPOROSIS INT, V24, P553, DOI 10.1007/s00198-012-1993-y; Di Monaco M, 2005, ARCH PHYS MED REHAB, V86, P64, DOI 10.1016/j.apmr.2004.02.013; Di Monaco M, 2014, EUR GERIATR MED, V5, P14, DOI 10.1016/j.eurger.2013.10.003; Di Monaco M, 2011, ARCH PHYS MED REHAB, V92, P271, DOI 10.1016/j.apmr.2010.09.028; Di Monaco M, 2011, MATURITAS, V68, P79, DOI 10.1016/j.maturitas.2010.09.001; Di Monaco M, 2011, ARCH GERONTOL GERIAT, V52, P71, DOI 10.1016/j.archger.2010.02.002; FOLMAN Y, 1994, ARCH PHYS MED REHAB, V75, P454, DOI 10.1016/0003-9993(94)90171-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Isaia G, 2003, OSTEOPOROSIS INT, V14, P577, DOI 10.1007/s00198-003-1390-7; Jesudason D, 2002, BONE, V31, P626, DOI 10.1016/S8756-3282(02)00866-9; Jurutka PW, 2007, J BONE MINER RES, V22, pV2, DOI 10.1359/JBMR.07S216; LeBoff MS, 1999, JAMA-J AM MED ASSOC, V281, P1505, DOI 10.1001/jama.281.16.1505; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; MAHONEY F I, 1965, Md State Med J, V14, P61; Mata-Granados JM, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0124-5; Nuti R, 2004, CLIN ORTHOP RELAT R, P208, DOI 10.1097/01.blo.0000129163.97988.06; Ohta H, 2014, CLIN THER, V36, P225, DOI 10.1016/j.clinthera.2013.12.007; Oyen J, 2011, BONE, V48, P1140, DOI 10.1016/j.bone.2011.01.021; Pfeifer M, 2002, OSTEOPOROSIS INT, V13, P187, DOI 10.1007/s001980200012; Stel VS, 2004, J CLIN EPIDEMIOL, V57, P252, DOI 10.1016/j.jclinepi.2003.07.008; TODD CJ, 1995, BRIT MED J, V310, P904, DOI 10.1136/bmj.310.6984.904; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Tu WJ, 2014, CLIN SCI, V126, P339, DOI 10.1042/CS20130284; Zhao J, 2011, MENOPAUSE, V18, P1237, DOI 10.1097/gme.0b013e31821d7ff7	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116375	10.1371/journal.pone.0116375	http://dx.doi.org/10.1371/journal.pone.0116375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635882	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700032
J	Seipke, RF				Seipke, Ryan F.			Strain-Level Diversity of Secondary Metabolism in Streptomyces albus	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; HETEROLOGOUS EXPRESSION; HOMOLOGOUS RECOMBINATION; MARINE ACTINOMYCETE; DIRECT CLONING; OPEN SOFTWARE; SIGMA-FACTOR; SEQUENCE; PRODUCT; IDENTIFICATION	Streptomyces spp. are robust producers of medicinally-, industrially- and agriculturally-important small molecules. Increased resistance to antibacterial agents and the lack of new antibiotics in the pipeline have led to a renaissance in natural product discovery. This endeavor has benefited from inexpensive high quality DNA sequencing technology, which has generated more than 140 genome sequences for taxonomic type strains and environmental Streptomyces spp. isolates. Many of the sequenced streptomycetes belong to the same species. For instance, Streptomyces albus has been isolated from diverse environmental niches and seven strains have been sequenced, consequently this species has been sequenced more than any other streptomycete, allowing valuable analyses of strain-level diversity in secondary metabolism. Bioinformatics analyses identified a total of 48 unique biosynthetic gene clusters harboured by Streptomyces albus strains. Eighteen of these gene clusters specify the core secondary metabolome of the species. Fourteen of the gene clusters are contained by one or more strain and are considered auxiliary, while 16 of the gene clusters encode the production of putative strain-specific secondary metabolites. Analysis of Streptomyces albus strains suggests that each strain of a Streptomyces species likely harbours at least one strain-specific biosynthetic gene cluster. Importantly, this implies that deep sequencing of a species will not exhaust gene cluster diversity and will continue to yield novelty.	Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Seipke, RF (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	r.seipke@leeds.ac.uk		Seipke, Ryan/0000-0002-6156-8498	University of Leeds	University of Leeds	The New Lecturer Startup Fund provided by the University of Leeds financially supported this work. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Brana AF, 2014, ARCH MICROBIOL, V196, P345, DOI 10.1007/s00203-014-0977-z; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; CHATER KF, 1976, J BACTERIOL, V128, P644, DOI 10.1128/JB.128.2.644-650.1976; Craney A, 2013, J ANTIBIOT, V66, P387, DOI 10.1038/ja.2013.25; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/NCHEMBIO.1659, 10.1038/nchembio.1659]; Doroghazi JR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-611; Doroghazi JR, 2010, ISME J, V4, P1136, DOI 10.1038/ismej.2010.45; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fan LJ, 2011, J BACTERIOL, V193, P3691, DOI 10.1128/JB.05097-11; Feng ZY, 2009, BIOORGAN MED CHEM, V17, P2147, DOI 10.1016/j.bmc.2008.10.074; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; GERBER NN, 1965, APPL MICROBIOL, V13, P935, DOI 10.1128/AEM.13.6.935-938.1965; Gullon S, 2006, APPL ENVIRON MICROB, V72, P4172, DOI 10.1128/AEM.00734-06; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; GURTLER H, 1994, J ANTIBIOT, V47, P434; Hanshew AS, 2015, MICROB ECOL, V69, P192, DOI 10.1007/s00248-014-0469-3; Ian E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096719; IMBERT M, 1995, CURR MICROBIOL, V31, P129, DOI 10.1007/BF00294289; Izumikawa M, 2003, J IND MICROBIOL BIOT, V30, P510, DOI 10.1007/s10295-003-0075-8; Kaltenpoth M, 2012, APPL ENVIRON MICROB, V78, P822, DOI 10.1128/AEM.06809-11; Kim SY, 2009, CHEM BIOL, V16, P736, DOI 10.1016/j.chembiol.2009.06.007; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Labeda DP, 2012, ANTON LEEUW INT J G, V101, P73, DOI 10.1007/s10482-011-9656-0; Lombo F, 2006, CHEMBIOCHEM, V7, P366, DOI 10.1002/cbic.200500325; Makitrynskyy R, 2010, J IND MICROBIOL BIOT, V37, P559, DOI 10.1007/s10295-010-0701-1; Malin G, 1996, J BACTERIOL, V178, P385, DOI 10.1128/jb.178.2.385-395.1996; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; Medema MH, 2011, NAT REV MICROBIOL, V9, P131, DOI 10.1038/nrmicro2478; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Olano C, 2014, MICROB BIOTECHNOL, V7, P242, DOI 10.1111/1751-7915.12116; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schoenian I, 2011, P NATL ACAD SCI USA, V108, P1955, DOI 10.1073/pnas.1008441108; Seipke RF, 2014, PEERJ, V2, DOI 10.7717/peerj.253; Seipke RF, 2013, BEILSTEIN J ORG CHEM, V9, P2556, DOI 10.3762/bjoc.9.290; Seipke RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022028; Seipke RF, 2009, J BACTERIOL, V191, P5216, DOI 10.1128/JB.00390-09; Shao ZY, 2011, MOL BIOSYST, V7, P1056, DOI 10.1039/c0mb00338g; SHIGEMORI H, 1992, J ORG CHEM, V57, P4317, DOI 10.1021/jo00041a053; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Takano H, 2005, J BACTERIOL, V187, P1825, DOI 10.1128/JB.187.5.1825-1832.2005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Viegelmann C, 2014, MAR DRUGS, V12, P3323, DOI 10.3390/md12063323; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u; Winter JM, 2007, J BIOL CHEM, V282, P16362, DOI 10.1074/jbc.M611046200; Yamanaka K, 2014, P NATL ACAD SCI USA, V111, P1957, DOI 10.1073/pnas.1319584111; Zaburannyi N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-97; Ziemert N, 2014, P NATL ACAD SCI USA, V111, pE1130, DOI 10.1073/pnas.1324161111; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	58	65	65	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116457	10.1371/journal.pone.0116457	http://dx.doi.org/10.1371/journal.pone.0116457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635820	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700037
J	Starzyk, EJ; Kelley, MA; Caskey, RN; Schwartz, A; Kennelly, JF; Bailey, RC				Starzyk, Erin J.; Kelley, Michele A.; Caskey, Rachel N.; Schwartz, Alan; Kennelly, Joan F.; Bailey, Robert C.			Infant Male Circumcision: Healthcare Provider Knowledge and Associated Factors	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; URINARY-TRACT-INFECTIONS; NEWBORN CIRCUMCISION; YOUNG MEN; HIV PREVENTION; UNITED-STATES; ORANGE FARM; RATES; RISK; PHYSICIANS	Background and Objectives The emerging science demonstrates various health benefits associated with infant male circumcision and adult male circumcision; yet rates are declining in the United States. The American Academy of Pediatrics and the Centers for Disease Control and Prevention recommend that healthcare providers present evidence-based risk and benefit information for infant male circumcision to parent(s) and guardian(s). The purpose of this study was to assess providers' level of infant male circumcision knowledge and to identify the associated characteristics. Methods An online survey was administered to healthcare providers in the family medicine, obstetrics, and pediatrics medical specialties at an urban academic health center. To assess infant male circumcision knowledge, a 17 point summary score was constructed to identify level of provider knowledge within the survey. Results Ninety-two providers completed the survey. Providers scored high for the following knowledge items: adverse event rates, protects against phimosis and urinary tract infections, and does not prevent hypospadias. Providers scored lower for items related to more recent research: protection against cervical cancer, genital ulcer disease, bacterial vaginosis, and reduction in HIV acquisition. Two models were constructed looking at (1) overall knowledge about male circumcision, and (2) knowledge about male circumcision reduction in HIV acquisition. Pediatricians demonstrated greater overall infant male circumcision knowledge, while obstetricians exhibited significantly greater knowledge for the HIV acquisition item. Conclusion Providers' knowledge levels regarding the risks and benefits of infant male circumcision are highly variable, indicating the need for system-based educational interventions.	[Starzyk, Erin J.; Kelley, Michele A.; Kennelly, Joan F.] Univ Illinois, Sch Publ Hlth, Div Community Hlth Sci, Chicago, IL 60607 USA; [Caskey, Rachel N.] Univ Illinois, Coll Med, Dept Internal Med & Pediat, Chicago, IL USA; [Schwartz, Alan] Univ Illinois, Coll Med, Dept Med Educ, Chicago, IL USA; [Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Starzyk, EJ (corresponding author), Univ Illinois, Sch Publ Hlth, Div Community Hlth Sci, Chicago, IL 60607 USA.	ecloherty@gmail.com		Schwartz, Alan/0000-0003-3809-6637	CDC-funded Illinois Public Health Research Fellowship [5T01CD000189-05]; Health Professions Student/Fellow Grant Awards [HRSA U76HP20207]; OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION [T01CD000189] Funding Source: NIH RePORTER	CDC-funded Illinois Public Health Research Fellowship; Health Professions Student/Fellow Grant Awards; OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was supported by funding from the CDC-funded Illinois Public Health Research Fellowship (5T01CD000189-05) and Health Professions Student/Fellow Grant Awards 2011 (HRSA U76HP20207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.2.e20; American Academy of Pediatrics, 2005, PEDIATRICS, V116, P796; American College of Obstetricians, 2012, NEW EVIDENCE POINTS; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey R C, 2001, Lancet Infect Dis, V1, P223, DOI 10.1016/S1473-3099(01)00117-7; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bauchner H, 2001, ARCH DIS CHILD, V84, P459, DOI 10.1136/adc.84.6.459; Bisono GM, 2012, CLIN PEDIATR, V51, P956, DOI 10.1177/0009922812441662; Blank S, 2012, PEDIATRICS, V130, P585, DOI 10.1542/peds.2012-1989; Carbery B, 2012, AIDS EDUC PREV, V24, P377, DOI 10.1521/aeap.2012.24.4.377; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Castro JG, 2010, INT J STD AIDS, V21, P591, DOI 10.1258/ijsa.2010.010201; Cherpes TL, 2003, SEX TRANSM DIS, V30, P405, DOI 10.1097/00007435-200305000-00006; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Diekema DS, 2010, ATTITUDES AND EXPERI; Donaldson GW, 1999, EVAL HEALTH PROF, V22, P427, DOI 10.1177/01632789922034392; El Bcheraoui C, 2010, 8TH INTERNATIONAL AI; Elashoff J.D., 2007, NQUERY ADVISOR VERSI; Field TS, 2002, MED CARE, V40, P596, DOI 10.1097/00005650-200207000-00006; Gore-Felton C, 2002, EVAL HEALTH PROF, V25, P152, DOI 10.1177/01678702025002002; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kahn JA, 2007, AMBUL PEDIATR, V7, P367, DOI 10.1016/j.ambp.2007.05.010; Kasprzyk D, 2001, EVAL HEALTH PROF, V24, P3, DOI 10.1177/01632780122034740; Lannon CM, 1999, PEDIATRICS, V103, P686; Larke NL, 2011, CANCER CAUSE CONTROL, V22, P1097, DOI 10.1007/s10552-011-9785-9; Leung GM, 2002, J CLIN EPIDEMIOL, V55, P801, DOI 10.1016/S0895-4356(02)00442-0; Mavis BE, 1998, EVAL HEALTH PROF, V21, P395, DOI 10.1177/016327879802100306; Mor Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000861; Morris BJ, 2014, MAYO CLIN PROC, V89, P677, DOI 10.1016/j.mayocp.2014.01.001; Nelson CP, 2005, J UROLOGY, V173, P978, DOI 10.1097/01.ju.0000145758.80937.7d; Nielson CM, 2009, J INFECT DIS, V199, P7, DOI 10.1086/595567; RIMM EB, 1990, AM J EPIDEMIOL, V131, P1068, DOI 10.1093/oxfordjournals.aje.a115598; Schleyer TKL, 2000, J AM MED INFORM ASSN, V7, P416, DOI 10.1136/jamia.2000.0070416; Schoen EJ, 2006, PEDIATRICS, V118, P385, DOI 10.1542/peds.2005-2881; Schoen EJ, 2000, PEDIATRICS, V105, P789, DOI 10.1542/peds.105.4.789; Schoen EJ, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e36; Smith DK, 2010, PUBLIC HEALTH REP, V125, P72, DOI 10.1177/00333549101250S110; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Straus SE, 2011, J CLIN EPIDEMIOL, V64, P6, DOI 10.1016/j.jclinepi.2009.08.016; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; WISWELL TE, 1987, PEDIATRICS, V79, P338; Wright JL, 2012, CANCER-AM CANCER SOC, V118, P4437, DOI 10.1002/cncr.26653	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115891	10.1371/journal.pone.0115891	http://dx.doi.org/10.1371/journal.pone.0115891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HX	25635664	Green Published, gold			2022-12-27	WOS:000350680700019
J	McClelland, KS; Wainwright, EN; Bowles, J; Koopman, P				McClelland, Kathryn S.; Wainwright, Elanor N.; Bowles, Josephine; Koopman, Peter			Rapid Screening of Gene Function by Systemic Delivery of Morpholino Oligonucleotides to Live Mouse Embryos	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; BRANCHING-MORPHOGENESIS; TESTIS DEVELOPMENT; KIDNEY DEVELOPMENT; SEX DETERMINATION; VIVO-MORPHOLINOS; CELL FATE; IN-VIVO; SOX9; EXPRESSION	Traditional gene targeting methods in mice are complex and time consuming, especially when conditional deletion methods are required. Here, we describe a novel technique for assessing gene function by injection of modified antisense morpholino oligonucleotides (MOs) into the heart of mid-gestation mouse embryos. After allowing MOs to circulate through the embryonic vasculature, target tissues were explanted, cultured and analysed for expression of key markers. We established proof-of-principle by partially phenocopying known gene knockout phenotypes in the fetal gonads (Stra8, Sox9) and pancreas (Sox9). We also generated a novel double knockdown of Gli1 and Gli2, revealing defects in Leydig cell differentiation in the fetal testis. Finally, we gained insight into the roles of Adamts19 and Ctrb1, genes of unknown function in sex determination and gonadal development. These studies reveal the utility of this method as a means of first-pass analysis of gene function during organogenesis before committing to detailed genetic analysis.	[McClelland, Kathryn S.; Wainwright, Elanor N.; Bowles, Josephine; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Bowles, J (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	j.bowles@imb.uq.edu.au	Koopman, Peter A/C-9416-2009; Bowles, Josephine/B-6583-2013; Bowles, Josephine/AAG-4903-2020	Koopman, Peter A/0000-0001-6939-0914; Bowles, Josephine/0000-0003-2867-7438; Bowles, Josephine/0000-0003-2867-7438; Wainwright, Elanor/0000-0001-6409-3881; McClelland, Kathryn S/0000-0003-2845-5448	Australian Research Council; National Health and Medical Research Council (NHMRC) of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council and the National Health and Medical Research Council (NHMRC) of Australia. P. K. is a Senior Principal Research Fellow of the NHMRC.	Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Barsoum I, 2011, BIOL REPROD, V84, P894, DOI 10.1095/biolreprod.110.088997; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Combes AN, 2009, DEV DYNAM, V238, P1033, DOI 10.1002/dvdy.21925; Cool J, 2011, P NATL ACAD SCI USA, V108, P167, DOI 10.1073/pnas.1010299108; Coveney D, 2008, GENE EXPR PATTERNS, V8, P529, DOI 10.1016/j.gep.2008.05.006; Dean CH, 2005, DEV BIOL, V286, P270, DOI 10.1016/j.ydbio.2005.07.034; Dubois CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023131; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Feng CW, 2014, MOL CELL ENDOCRINOL, V382, P488, DOI 10.1016/j.mce.2013.09.026; Gao LY, 2011, BIOL REPROD, V84, P422, DOI 10.1095/biolreprod.110.084590; Gross I, 2003, J BIOL CHEM, V278, P41420, DOI 10.1074/jbc.M306425200; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Knauff EAH, 2009, HUM REPROD, V24, P2372, DOI 10.1093/humrep/dep197; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Menke Douglas B., 2002, Gene Expression Patterns, V2, P359, DOI 10.1016/S1567-133X(02)00022-4; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Moulton JD, 2009, MOLECULES, V14, P1304, DOI 10.3390/molecules14031304; Nagy Andras, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5371; Nakamura Y, 2002, REPROD FERT DEVELOP, V14, P259, DOI 10.1071/RD01130; Pyun JA, 2013, HUM REPROD, V28, P3146, DOI 10.1093/humrep/det365; Quaggin SE, 1998, MECH DEVELOP, V71, P37, DOI 10.1016/S0925-4773(97)00201-3; Ryan J, 2011, SEX DEV, V5, P7, DOI 10.1159/000322162; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Schulte-Merker S, 2014, DEVELOPMENT, V141, P3103, DOI 10.1242/dev.112003; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Svingen T, 2009, DEV DYNAM, V238, P956, DOI 10.1002/dvdy.21919; Wainwright EN, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110155; Wainwright EN, 2010, CURR TOP DEV BIOL, V90, P231, DOI 10.1016/S0070-2153(10)90006-9; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wu B, 2009, MOL THER, V17, P864, DOI 10.1038/mt.2009.38; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Yates LL, 2010, HUM MOL GENET, V19, P2251, DOI 10.1093/hmg/ddq104; Zhao L, 2008, BLOOD CELL MOL DIS, V41, P188, DOI 10.1016/j.bcmd.2008.03.006	44	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0114932	10.1371/journal.pone.0114932	http://dx.doi.org/10.1371/journal.pone.0114932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629157	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100010
J	Schmeisser, F; Vasudevan, A; Verma, S; Wang, W; Alvarado, E; Weiss, C; Atukorale, V; Meseda, C; Weir, JP				Schmeisser, Falko; Vasudevan, Anupama; Verma, Swati; Wang, Wei; Alvarado, Esmeralda; Weiss, Carol; Atukorale, Vajini; Meseda, Clement; Weir, Jerry P.			Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge	PLOS ONE			English	Article							A VIRUS; CANDIDATE	Identifying major antigenic and protective epitopes of the H7 hemagglutinin (HA) will be important for understanding the antibody response to vaccines developed against the novel influenza H7N9 viruses that emerged in China in 2013. To facilitate antigenic characterization of the H7N9 HA and to develop reagents for evaluation of H7N9 candidate vaccines, we generated a panel of murine monoclonal antibodies (mAbs) to the HA of A/Shanghai/2/2013 using mammalian cell-derived virus-like particles (VLP) containing the H7 HA. Neutralizing antibodies identified an HA epitope corresponding to antigenic site A on the structurally similar influenza H3 hemagglutinin. Importantly, the neutralizing antibodies protect against A/Shanghai/2/2013 challenge. This antigenic site is conserved among many H7 viruses, including strains of both Eurasian and North American lineage, and the isolated neutralizing antibodies are cross-reactive with older H7 vaccine strains. The results indicate that the identified antigenic site is a potentially important protective epitope and suggest the potential benefit of cross-reactive antibody responses to vaccination with H7 candidate vaccines.	[Schmeisser, Falko; Vasudevan, Anupama; Verma, Swati; Wang, Wei; Alvarado, Esmeralda; Weiss, Carol; Atukorale, Vajini; Meseda, Clement; Weir, Jerry P.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Weir, JP (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	jerry.weir@fda.hhs.gov	Weiss, Carol D./F-6438-2011; Meseda, Clement/I-6336-2019	Weiss, Carol D./0000-0002-9965-1289; 	U.S. Food and Drug Administration; Biomedical Advanced Research and Development Authority, Department of Health and Human Services	U.S. Food and Drug Administration; Biomedical Advanced Research and Development Authority, Department of Health and Human Services	This work was supported by the U.S. Food and Drug Administration and by the Biomedical Advanced Research and Development Authority, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008761; Belser JA, 2013, J VIROL, V87, P5746, DOI 10.1128/JVI.00154-13; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Goff PH, 2013, J VIROL, V87, P8235, DOI 10.1128/JVI.01085-13; Guo L, 2014, EMERG INFECT DIS, V20, P192, DOI 10.3201/eid2002.131094; Jadhao SJ, 2008, VACCINE, V26, P1742, DOI 10.1016/j.vaccine.2008.01.036; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Palmer DF, 1975, ADV LAB TECHNINQUES; Pappas C, 2007, CLIN VACCINE IMMUNOL, V14, P1425, DOI 10.1128/CVI.00174-07; Schmeisser F, 2013, INFLUENZA OTHER RESP, V7, P480, DOI 10.1111/irv.12029; Schmeisser F, 2012, VACCINE, V30, P3413, DOI 10.1016/j.vaccine.2012.03.033; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Wang W, 2010, J VIROL METHODS, V165, P305, DOI 10.1016/j.jviromet.2010.02.009; Whiteley A, 2007, INFLUENZA OTHER RESP, V1, P157, DOI 10.1111/j.1750-2659.2007.00022.x; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0	25	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117108	10.1371/journal.pone.0117108	http://dx.doi.org/10.1371/journal.pone.0117108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629172	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100065
J	Adams, MP; Mallet, DG; Pettet, GJ				Adams, Matthew P.; Mallet, Daniel G.; Pettet, Graeme J.			Towards a Quantitative Theory of Epidermal Calcium Profile Formation in Unwounded Skin	PLOS ONE			English	Article							TRANSEPIDERMAL WATER-LOSS; KERATINOCYTE STEM-CELLS; STRATUM-CORNEUM; PERMEABILITY BARRIER; TIGHT JUNCTIONS; ULTRASTRUCTURAL-LOCALIZATION; ELECTRON-MICROPROBE; MURINE EPIDERMIS; PROGENITOR CELLS; TUMOR DYNAMICS	We propose and mathematically examine a theory of calcium profile formation in unwounded mammalian epidermis based on: changes in keratinocyte proliferation, fluid and calcium exchange with the extracellular fluid during these cells' passage through the epidermal sublayers, and the barrier functions of both the stratum corneum and tight junctions localised in the stratum granulosum. Using this theory, we develop a mathematical model that predicts epidermal sublayer transit times, partitioning of the epidermal calcium gradient between intracellular and extracellular domains, and the permeability of the tight junction barrier to calcium ions. Comparison of our model's predictions of epidermal transit times with experimental data indicates that keratinocytes lose at least 87% of their volume during their disintegration to become corneocytes. Intracellular calcium is suggested as the main contributor to the epidermal calcium gradient, with its distribution actively regulated by a phenotypic switch in calcium exchange between keratinocytes and extracellular fluid present at the boundary between the stratum spinosum and the stratum granulosum. Formation of the extracellular calcium distribution, which rises in concentration through the stratum granulosum towards the skin surface, is attributed to a tight junction barrier in this sublayer possessing permeability to calcium ions that is less than 15 nm s(-1) in human epidermis and less than 37 nm s(-1) in murine epidermis. Future experimental work may refine the presented theory and reduce the mathematical uncertainty present in the model predictions.	[Adams, Matthew P.] Univ Queensland, Sch Math Sci, Brisbane, Qld, Australia; [Adams, Matthew P.] Univ Queensland, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Adams, Matthew P.] Univ Queensland, Sch Chem Engn, Brisbane, Qld, Australia; [Mallet, Daniel G.; Pettet, Graeme J.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Mallet, Daniel G.; Pettet, Graeme J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	University of Queensland; University of Queensland; University of Queensland; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Adams, MP (corresponding author), Univ Queensland, Sch Math Sci, Brisbane, Qld, Australia.	mp.adams@qut.edu.au	Pettet, Graeme/ABC-5209-2020; Adams, Matthew/C-5589-2018; Adams, Matthew Philip P/C-8870-2018	Adams, Matthew/0000-0003-4875-0225; Adams, Matthew Philip P/0000-0003-4875-0225; Mallet, Dann/0000-0003-4125-9900	Mathematical Sciences School, Queensland University of Technology	Mathematical Sciences School, Queensland University of Technology	Matthew P. Adams received a scholarship from the Mathematical Sciences School, Queensland University of Technology, to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MP, 2011, ANZIAM J, V53, pC90; Adams MP, 2012, J THEOR BIOL, V301, P112, DOI 10.1016/j.jtbi.2012.02.017; ADAMS MP, 2012, P 4 INT C COMP METH, P42331; Agren J, 2003, PEDIATR RES, V53, P558, DOI 10.1203/01.PDR.0000055777.25933.98; Ahn SK, 1999, J INVEST DERMATOL, V113, P189, DOI 10.1046/j.1523-1747.1999.00650.x; ALLEN TD, 1976, J CELL SCI, V21, P341; Baek JH, 2013, YONSEI MED J, V54, P523, DOI 10.3349/ymj.2013.54.2.523; BAKER H, 1967, ARCH DERMATOL, V95, P408, DOI 10.1001/archderm.95.4.408; Bashir SJ, 2001, SKIN RES TECHNOL, V7, P40, DOI 10.1034/j.1600-0846.2001.007001040.x; Behne MJ, 2011, ARCH DERMATOL RES, V303, P103, DOI 10.1007/s00403-010-1113-9; Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; BERGSTRESSER PR, 1978, J INVEST DERMATOL, V70, P280, DOI 10.1111/1523-1747.ep12541516; BERNSTAM LI, 1986, IN VITRO CELL DEV B, V22, P695; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BLANK IH, 1984, J INVEST DERMATOL, V82, P188, DOI 10.1111/1523-1747.ep12259835; Bleich M, 2012, ANN NY ACAD SCI, V1258, P93, DOI 10.1111/j.1749-6632.2012.06539.x; Bloksgaard M, 2013, EUR J PHARM SCI, V50, P586, DOI 10.1016/j.ejps.2013.04.010; BORGERS M, 1981, ACTA HISTOCHEMICA S, V24, pS327; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Castelijns FACM, 1998, HISTOCHEM J, V30, P869, DOI 10.1023/A:1003457709690; Celli A, 2010, BIOPHYS J, V98, P911, DOI 10.1016/j.bpj.2009.10.055; CELLI A, 2012, EXPT DERMATOLOGY, V21, P783; Cho JK, 1997, J CELL PHYSIOL, V172, P146, DOI 10.1002/(SICI)1097-4652(199708)172:2<146::AID-JCP2>3.0.CO;2-O; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; CORCUFF P, 1993, ARCH DERMATOL RES, V285, P475, DOI 10.1007/BF00376820; Cornelissen LH, 2007, SKIN RES TECHNOL, V13, P369, DOI 10.1111/j.1600-0846.2007.00239.x; Denda M, 2000, BIOCHEM BIOPH RES CO, V272, P134, DOI 10.1006/bbrc.2000.2739; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; DOWNES AM, 1967, J INVEST DERMATOL, V49, P400, DOI 10.1038/jid.1967.156; ELIAS P, 1979, CLIN RES, V27, pA525; Elias PM, 1998, J INVEST DERMATOL, V110, P399, DOI 10.1046/j.1523-1747.1998.00151.x; Elias PM, 2002, J INVEST DERMATOL, V119, P1269, DOI 10.1046/j.1523-1747.2002.19622.x; EPSTEIN WL, 1965, ARCH DERMATOL, V92, P462, DOI 10.1001/archderm.92.4.462; Feingold K. R., 2006, SKIN BARRIER; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; FORSLIND B, 1984, SCAN ELECTRON MICROS, P755; FORSLIND B, 2004, SKIN HAIR NAILS STRU, P42331; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gandolfi A, 2011, J MATH BIOL, V62, P111, DOI 10.1007/s00285-010-0330-3; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; Grabe N, 2005, BIOINFORMATICS, V21, P3541, DOI 10.1093/bioinformatics/bti585; Gunzel D, 2010, CURR TOP MEMBR, V65, P39, DOI 10.1016/S1063-5823(10)65003-X; Haftek M, 2011, EXP DERMATOL, V20, P617, DOI 10.1111/j.1600-0625.2011.01315.x; HALPRIN KM, 1967, J INVEST DERMATOL, V49, P561, DOI 10.1038/jid.1967.181; HALPRIN KM, 1972, BRIT J DERMATOL, V86, P14, DOI 10.1111/j.1365-2133.1972.tb01886.x; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Houben E, 2007, SKIN PHARMACOL PHYS, V20, P122, DOI 10.1159/000098163; Iizuka Hajime, 1994, Journal of Dermatological Science, V8, P215; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Kalia YN, 2000, PHARMACEUT RES, V17, P1148, DOI 10.1023/A:1026474200575; KAMPMEYER PM, 1952, J APPL PHYS, V23, P99, DOI 10.1063/1.1701986; Kirschner N, 2013, J INVEST DERMATOL, V133, P1161, DOI 10.1038/jid.2012.507; Kirschner N, 2010, EUR J CELL BIOL, V89, P839, DOI 10.1016/j.ejcb.2010.07.010; Kitson N, 2000, ACTA DERM-VENEREOL, P12; KU HH, 1966, J RES NBS C ENG INST, VC 70, P263, DOI 10.6028/jres.070C.025; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kurasawa M, 2011, BIOCHEM BIOPH RES CO, V406, P506, DOI 10.1016/j.bbrc.2011.02.057; Landman KA, 2001, IMA J MATH APPL MED, V18, P131; Lemon G, 2007, MATH MED BIOL, V24, P57, DOI 10.1093/imammb/dql020; Lemon G, 2006, J MATH BIOL, V52, P571, DOI 10.1007/s00285-005-0363-1; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; MALMQVIST KG, 1984, NUCL INSTRUM METH B, V3, P611, DOI 10.1016/0168-583X(84)90447-6; Mandel J., 1964, STAT ANAL EXPT DATA; MARKOVA NG, 1993, MOL CELL BIOL, V13, P613, DOI 10.1128/MCB.13.1.613; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Mauro T, 1998, J INVEST DERMATOL, V111, P1198, DOI 10.1046/j.1523-1747.1998.00421.x; MAURO TM, 2013, COMMUNICATION, P42331; Meldolesi J, 2001, CELL CALCIUM, V30, P1, DOI 10.1054/ceca.2001.0216; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; MENON GK, 1994, BRIT J DERMATOL, V130, P139, DOI 10.1111/j.1365-2133.1994.tb02892.x; MENON GK, 1992, CELL TISSUE RES, V270, P503, DOI 10.1007/BF00645052; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Norlen L, 2004, J INVEST DERMATOL, V123, P715, DOI 10.1111/j.0022-202X.2004.23213.x; Pallon J, 1996, CELL MOL BIOL, V42, P111; Petrova A, 2014, STEM CELL REP, V2, P675, DOI 10.1016/j.stemcr.2014.03.009; PETTET GJ, 2014, COMMUNICATION, P42331; Pierard GE, 2000, INT J MOL MED, V6, P217; Please CP, 1998, APPL MATH LETT, V11, P89, DOI 10.1016/S0893-9659(98)00038-X; Please CP, 1999, MATH MOD METH APPL S, V9, P569, DOI 10.1142/S0218202599000294; POTTEN CS, 1987, CELL TISSUE KINET, V20, P461, DOI 10.1111/j.1365-2184.1987.tb01355.x; Potten CS, 2002, J INVEST DERMATOL, V119, P888, DOI 10.1046/j.1523-1747.2002.00020.x; POTTEN CS, 1975, BRIT J DERMATOL, V93, P649, DOI 10.1111/j.1365-2133.1975.tb05115.x; POTTEN CS, 1975, J INVEST DERMATOL, V65, P488, DOI 10.1111/1523-1747.ep12610194; POTTS RO, 1992, PHARMACEUT RES, V9, P663, DOI 10.1023/A:1015810312465; REEMPTS JV, 1982, HISTOCHEM J, V14, P517, DOI DOI 10.1007/BF01011861; Rodrigues LHT, 2002, J COSMET SCI, V53, P269; ROTHBERG S, 1961, J INVEST DERMATOL, V37, P497, DOI 10.1038/jid.1961.150; ROWDEN G, 1975, J INVEST DERMATOL, V64, P1, DOI 10.1111/1523-1747.ep12540840; Schluter H, 2004, EUR J CELL BIOL, V83, P655, DOI 10.1078/0171-9335-00434; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Sougrat R, 2002, J INVEST DERMATOL, V118, P678, DOI 10.1046/j.1523-1747.2002.01710.x; Sun R, 2015, TISSUE ENG PART C-ME, V21, P15, DOI [10.1089/ten.tec.2014.0065, 10.1089/ten.TEC.2014.0065]; Sun T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008515; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Vicanova J, 1998, J INVEST DERMATOL, V111, P97, DOI 10.1046/j.1523-1747.1998.00251.x; Watt FM, 2001, CURR OPIN GENET DEV, V11, P410, DOI 10.1016/S0959-437X(00)00211-2; Williams EM, 2008, PHYSIOL MEAS, V29, P341, DOI 10.1088/0967-3334/29/3/005; Yow HN, 2009, EUR J PHARM BIOPHARM, V72, P62, DOI 10.1016/j.ejpb.2008.11.004	104	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116751	10.1371/journal.pone.0116751	http://dx.doi.org/10.1371/journal.pone.0116751			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625723	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821400015
J	Palomares-Rius, JE; Castillo, P; Montes-Borrego, M; Navas-Cortes, JA; Landa, BB				Palomares-Rius, Juan E.; Castillo, Pablo; Montes-Borrego, Miguel; Navas-Cortes, Juan A.; Landa, Blanca B.			Soil Properties and Olive Cultivar Determine the Structure and Diversity of Plant-Parasitic Nematode Communities Infesting Olive Orchards Soils in Southern Spain	PLOS ONE			English	Article							ROOT-KNOT NEMATODES; HETERODERA-MEDITERRANEA; MATURITY INDEX; MANAGEMENT; TREES; AGROECOSYSTEMS; RHIZOSPHERE; INDICATORS; TILLAGE; ECOLOGY	This work has studied for the first time the structure and diversity of plant-parasitic nematodes (PPNs) infesting olive orchard soils in a wide-region in Spain that included 92 locations. It aims at determining which agronomical or environmental factors associated to the olive orchards are the main drivers of the PPNs community structure and diversity. Classical morphological and morphometric identification methods were used to determine the frequency and densities of PPNs. Thirteen families, 34 genera and 77 species of PPNs were identified. The highest diversity was found in Helicotylenchus genus, with six species previously reported in Spain and with H. oleae being a first report. Neodolichorhynchus microphasmis and Diptenchus sp., Diphtherophora sp., and Discotylenchus sp., usually considered fungal feeders, were also reported for the first time associated to olive rhizosphere. PPNs abundance ranged from 66 to 16,288 individuals/500-cm(3) of soil with Helicotylenchus digonicus being the most prevalent species, followed by Filenchus sp., Merlinius brevidens and Xiphinema pachtaicum. Nematode abundance and diversity indexes were influenced by olive cultivar, and orchard and soil management practices; while olive variety and soil texture were the main factors driving PPN community composition. Soil physicochemical properties and climatic characteristics most strongly associated to the PPN community composition included pH, sand content and exchangeable K, and maximum and minimum average temperature of the sampled locations. Our data suggests that there is a high diversity of PPNs associated to olive in Southern Spain that can exert different damage to olive roots depending on the olive variety and their abundance. Further analysis to determine the resistance levels of most common olive varieties to the prevalent PPNs in Spain will help to choose the most appropriate ones for the establishment of new plantations. This choice will take into consideration the specific soils and environments where those olive varieties will be established.	[Palomares-Rius, Juan E.; Castillo, Pablo; Montes-Borrego, Miguel; Navas-Cortes, Juan A.; Landa, Blanca B.] CSIC, Inst Agr Sostenible, Cordoba 14080, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Landa, BB (corresponding author), CSIC, Inst Agr Sostenible, Apartado 4084, Cordoba 14080, Spain.	blanca.landa@csic.es	Navas-Cortes, Juan A./M-2060-2019; Navas-Cortes, Juan A/H-3381-2014; Palomares-Rius, Juan/K-8004-2015; Castillo, Pablo/A-1445-2011; Castillo, Pablo/L-3397-2019; Landa, Blanca B/K-9629-2014	Navas-Cortes, Juan A/0000-0001-6480-1104; Palomares-Rius, Juan/0000-0003-1776-8131; Castillo, Pablo/0000-0003-0256-876X; Castillo, Pablo/0000-0001-6657-6385; Landa, Blanca B/0000-0002-9511-3731	Ministerio de Ciencia e Innovacion [AGL2008-00344/AGR]; 'Ministerio de Economia y Competitividad' of Spain [AGL-2012-37521]; 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia [P10-AGR-5908, P12-AGR-1486]; European Union; ArimNET ERANET FP7 from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [219262]; 'Internacional del Aceite de Oliva Espanol-Citoliva'	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); 'Ministerio de Economia y Competitividad' of Spain(Spanish Government); 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia; European Union(European Commission); ArimNET ERANET FP7 from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); 'Internacional del Aceite de Oliva Espanol-Citoliva'	Financial support was received by Projects AGL2008-00344/AGR from 'Ministerio de Ciencia e Innovacion', Project AGL-2012-37521 from 'Ministerio de Economia y Competitividad' of Spain and Projects P10-AGR-5908 and P12-AGR-1486 from 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia, and FEDER financial support from the European Union is gratefully acknowledged. The grant 219262 ArimNET ERANET FP7 2012-2015 Project PESTOLIVE 'Contribution of olive history for the management of soilborne parasites in the Mediterranean basin' from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA), and the 'Internacional del Aceite de Oliva Espanol-Citoliva' also provided partial financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar FJ, 2014, HELMINTHOLOGIA, V51, P46, DOI 10.2478/s11687-014-0207-x; Ali N, 2014, CR BIOL, V337, P423, DOI 10.1016/j.crvi.2014.05.006; [Anonymous], EST AGR; Bongers T, 1997, APPL SOIL ECOL, V6, P195, DOI 10.1016/S0929-1393(96)00136-9; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Briar SS, 2007, APPL SOIL ECOL, V37, P256, DOI 10.1016/j.apsoil.2007.08.004; Brown D.J.F., 1994, Nematologia Mediterranea, V22, P253; CAP-JA, 2014, EST AGR; Castillo P, 2006, PLANT PATHOL, V55, P705, DOI 10.1111/j.1365-3059.2006.01400.x; Castillo P, 2002, J NEMATOL, V34, P146; Castillo P, 1999, PLANT DIS, V83, P710, DOI 10.1094/PDIS.1999.83.8.710; Castillo P, 2010, PLANT DIS, V94, P148, DOI 10.1094/PDIS-94-2-0148; Chen SY, 2012, J NEMATOL, V44, P361; Coll P, 2012, NEMATOLOGY, V14, P665, DOI 10.1163/156854112X624195; Cooler W.A., 1979, P317; Davis E. E., 2004, MINIRISK ASSESSMENT; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; DIAB K. A., 1968, PLANT DIS REPORT, V52, P150; DuPont ST, 2009, APPL SOIL ECOL, V41, P157, DOI 10.1016/j.apsoil.2008.10.004; Elliott AC, 2011, COMPUT METH PROG BIO, V102, P75, DOI 10.1016/j.cmpb.2010.11.002; Ferris JM, 1998, AGRONOMY, P21; FRECKMAN DW, 1993, AGR ECOSYST ENVIRON, V45, P239, DOI 10.1016/0167-8809(93)90074-Y; Garcia-Ruiz R, 2009, APPL SOIL ECOL, V41, P305, DOI 10.1016/j.apsoil.2008.12.004; Gardner CMK, 1999, SOIL PHYS CONSTRAINT, P51; Gomez JA, 2008, J ENVIRON MANAGE, V89, P99, DOI 10.1016/j.jenvman.2007.04.025; HASHIM Z, 1982, Revue de Nematologie, V5, P169; INSERRA RN, 1979, J NEMATOL, V11, P56; International Olive Council (IOC), 2014, WORLD EUR UN OL OIL; Khodakaramian N, 2012, INT C EC BIOL SCI ID, P51; Koenning SR, 1999, J NEMATOL, V31, P587; Kruger DHM, 2013, S AFR J ENOL VITIC, V34, P287; Lamberti F., 2001, Nematologia Mediterranea, V29, P3; LAMBERTI F, 1969, Plant Disease Reporter, V53, P557; Lamberti F., 1993, EPPO B, V23, P481, DOI DOI 10.1111/J.1365-2338.1993.TB01356.X; Landa BB, 2014, ENV MICROBIOL REP, V6, P196, DOI 10.1111/1758-2229.12148; Lodolini E. M., 2013, African Journal of Agricultural Research, V8, P6426; Maechler M, 2014, CLUSTER CLUSTER ANAL; McKenry MV, 1994, U CALIFORNIA PUBL, V3353, P97; Milgroom J, 2007, RENEW AGR FOOD SYST, V22, P1, DOI 10.1017/S1742170507001500; Montes-Borrego M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096397; Montes-Borrego M, 2013, AGR ECOSYST ENVIRON, V181, P169, DOI 10.1016/j.agee.2013.09.021; Mulder C, 2003, FUNCT ECOL, V17, P516, DOI 10.1046/j.1365-2435.2003.00755.x; NAVAS A, 1988, NEMATOLOGICA, V34, P314, DOI 10.1163/002825988X00170; Neher DA, 1999, J NEMATOL, V31, P142; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; Nico AI, 2003, J NEMATOL, V35, P29; Nico AI, 2002, PLANT DIS, V86, P1075, DOI 10.1094/PDIS.2002.86.10.1075; Nielsen UN, 2014, GLOBAL ECOL BIOGEOGR, V23, P968, DOI 10.1111/geb.12177; NORTON DC, 1989, J NEMATOL, V21, P299; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Palomares-Rius JE, 2014, EUR J PLANT PATHOL, V140, P53, DOI 10.1007/s10658-014-0443-4; Palomares-Rius JE, 2012, SOIL BIOL BIOCHEM, V45, P168, DOI 10.1016/j.soilbio.2011.11.009; PARMELEE RW, 1986, J NEMATOL, V18, P403; Pena-Santiago R, 2004, TYLENCHID SPECIES NE; Perez B. A., 2001, Phytopathology, V91, pS71; Sasanelli Nicola, 2009, V4, P275, DOI 10.1007/978-1-4020-9858-1_12; SEINHORST J. W., 1962, NEMATOLOGICA, V8, P29; Siddiqui I. A., 2003, Nematologia Mediterranea, V31, P111; Soriano MA, 2014, RENEW AGR FOOD SYST, V29, P83, DOI 10.1017/S1742170512000361; Stirling G. R., 2010, Proceedings of the 2010 Conference of the Australian Society of Sugar Cane Technologists held at Bundaberg, Queensland, Australia, 11-14 May 2010, P152; Todd TC, 1999, APPL SOIL ECOL, V13, P45, DOI 10.1016/S0929-1393(99)00022-0; Ugarte CM, 2013, SOIL BIOL BIOCHEM, V64, P103, DOI 10.1016/j.soilbio.2013.03.035; van Bruggen AHC, 2000, APPL SOIL ECOL, V15, P13, DOI 10.1016/S0929-1393(00)00068-8; van Diepeningen AD, 2006, APPL SOIL ECOL, V31, P120, DOI 10.1016/j.apsoil.2005.03.003; VOVLAS N, 1983, J NEMATOL, V15, P571; WALLACE MK, 1993, J NEMATOL, V25, P642; Wang KH, 2004, NEMATROPICA, V34, P83; Wardle D.A., 1995, Advances in Ecological Research, V26, P105, DOI 10.1016/S0065-2504(08)60065-3; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1997, J APPL ECOL, V34, P453, DOI 10.2307/2404890; Zhang XK, 2012, ECOL INDIC, V13, P75, DOI 10.1016/j.ecolind.2011.05.009	72	33	33	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116890	10.1371/journal.pone.0116890	http://dx.doi.org/10.1371/journal.pone.0116890			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625375	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821400021
J	Peng, C; Yu, JY; Zhao, ZJ; Dai, J; Fu, JY; Zhao, ML; Wang, W				Peng, Chao; Yu, Jianying; Zhao, Zhijie; Dai, Jing; Fu, Jingyi; Zhao, Meiling; Wang, Wei			Synthesis and Properties of a Clean and Sustainable Deicing Additive for Asphalt Mixture	PLOS ONE			English	Article							LAYERED DOUBLE HYDROXIDES; CATALYTIC-PROPERTIES; MIXED OXIDES; ICE CONTROL; INTERCALATION; ACCUMULATION; DEICERS; SURFACE; SOILS; WATER	A clean and sustainable deicing additive was prepared via the adsorption of acetate anions (Ac-) by magnesium (Mg) and aluminum (Al) calcined layered double hydroxide (Mg/Al-CLDH). Fourier transform infrared spectroscopy spectrums proved that Ac- had intercalated into LDH structure. X-ray diffraction patterns, scanning electron microscopy and transmission electron microscopy images showed that the intercalation spacing and platelet thickness of Mg and Al layered double hydroxide containing Ac- anions (Mg/Al-Ac- LDH) had been enlarged due to substitution of divalent CO32- anions by a larger quantity of monovalent Ac- anions. Differential scanning calorimetry tests testified that the insoluble Mg2/Al-Ac- LDH evidently decreased the freeze point (FP) of water to -10.68 degrees C. X-ray photoelectron spectroscopy analyses confirmed that the Ac- were strongly confined by the metal layers of LDHs. FP test of asphalt mixtures confirmed that Mg/Al-Ac- LDHs reduced FP to -5.5 degrees C. Immersion test results indicated that Mg/Al-Ac- LDH had a good deicing durability and Ac- did not released from asphalt mixture. Snow melting observation was conducted further testified that Mg/Al-Ac- LDH melted snow or ice sustainably.	[Peng, Chao; Yu, Jianying; Zhao, Zhijie; Fu, Jingyi; Zhao, Meiling; Wang, Wei] Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan 430070, Peoples R China; [Zhao, Zhijie; Zhao, Meiling] Minist Transport, Res Inst Highway, Beijing 100088, Peoples R China; [Dai, Jing] Minist Educ, Key Lab Adv Technol Special Funct Mat, Wuhan 430070, Peoples R China	Wuhan University of Technology; Ministry of Transport of the People's Republic of China	Yu, JY (corresponding author), Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan 430070, Peoples R China.	jyyu@whut.edu.cn	Fu, JY/GRR-6179-2022		Ministry of Transport of the People's Republic of China [2013 318 800 020]; Independent Innovation Foundation of Wuhan University of Technology [145201016]	Ministry of Transport of the People's Republic of China; Independent Innovation Foundation of Wuhan University of Technology	This work is financially supported by the Ministry of Transport of the People's Republic of China (grant No. 2013 318 800 020, URL: http://www.moc.gov.cn/ and the Independent Innovation Foundation of Wuhan University of Technology (grant No: 145201016, URL: http://cxjj.whut.edu.cn/).	Bang SS, 1998, ARCH ENVIRON CON TOX, V35, P580, DOI 10.1007/s002449900419; Bryson GM, 2002, COMMUN SOIL SCI PLAN, V33, P67, DOI 10.1081/CSS-120002378; Cairon O, 2007, J PHYS CHEM C, V111, P8015, DOI 10.1021/jp0673011; Cavani F, 1991, CATAL TODAY, V11, P173, DOI 10.1016/0920-5861(91)80068-K; Chuang YH, 2010, COLLOID SURFACE A, V366, P170, DOI 10.1016/j.colsurfa.2010.06.009; Cunningham Mary Ann, 2008, Urban Ecosystems, V11, P17, DOI 10.1007/s11252-007-0031-x; Di Cosimo JI, 1998, J CATAL, V178, P499, DOI 10.1006/jcat.1998.2161; Dong LJ, 2014, SOLID STATE SCI, V31, P8, DOI 10.1016/j.solidstatesciences.2014.02.006; Dussault L, 2005, THERMOCHIM ACTA, V434, P93, DOI 10.1016/j.tca.2005.01.012; Fay L, 2012, WATER AIR SOIL POLL, V223, P2751, DOI 10.1007/s11270-011-1064-6; Feng DC, 2010, COLD REG SCI TECHNOL, V62, P34, DOI 10.1016/j.coldregions.2010.02.002; Galuszka A, 2011, ENVIRON MONIT ASSESS, V176, P451, DOI 10.1007/s10661-010-1596-z; Gao XR, 2013, J SOLID STATE CHEM, V203, P174, DOI 10.1016/j.jssc.2013.04.028; Giuliani F, 2012, CONSTR BUILD MATER, V30, P174, DOI 10.1016/j.conbuildmat.2011.12.036; Hellsten PP, 2005, ENVIRON SCI TECHNOL, V39, P5095, DOI 10.1021/es0482738; Huang ZJ, 2012, APPL CLAY SCI, V65-66, P87, DOI 10.1016/j.clay.2012.05.007; Iyi N, 2004, CHEM MATER, V16, P2926, DOI 10.1021/cm049579g; JONES PH, 1981, ENVIRON CONSERV, V8, P33, DOI 10.1017/S0376892900026655; Liu ZZ, 2014, CONSTR BUILD MATER, V51, P133, DOI 10.1016/j.conbuildmat.2013.09.057; LOCKE CE, 1987, TRANSPORT RES REC, V1113, P30; Mameri N, 1998, WATER RES, V32, P1604, DOI 10.1016/S0043-1354(97)00357-6; MANNING DG, 1989, TRANSPORT RES REC, V1246, P18; MIYATA S, 1983, CLAY CLAY MINER, V31, P305, DOI 10.1346/CCMN.1983.0310409; Ninomiya H, 1993, TRANSPORT RES REC, V1387, P151; PALMER DA, 1987, TRANSPORT RES REC, V1127, P34; Shi XM, 2009, CORROS REV, V27, P23, DOI 10.1515/CORRREV.2009.27.1-2.23; Starck P, 2007, J MATER SCI, V42, P676, DOI 10.1007/s10853-006-0316-0; SZATKOWSKI WS, 1986, RES REP TRANSPORT RO, V84, P1; [谭忆秋 Tan Yiqiu], 2013, [中国公路学报, China Journal of Highway and Transport], V26, P23; WANG ZJ, 2013, INT J PAVEMENT RES T, V6, P372; Wong F, 2004, PROG ORG COAT, V51, P91, DOI 10.1016/j.porgcoat.2004.07.001; Yong Z, 2002, ENERG CONVERS MANAGE, V43, P1865, DOI 10.1016/S0196-8904(01)00125-X; Zhou JB, 2011, J MATER CHEM, V21, P19353, DOI 10.1039/c1jm13645c; Zhou JB, 2011, J HAZARD MATER, V192, P1114, DOI 10.1016/j.jhazmat.2011.06.013	34	7	8	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115721	10.1371/journal.pone.0115721	http://dx.doi.org/10.1371/journal.pone.0115721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625279	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821400009
J	Tidd, AN; Vermard, Y; Marchal, P; Pinnegar, J; Blanchard, JL; Milner-Gulland, EJ				Tidd, Alex N.; Vermard, Youen; Marchal, Paul; Pinnegar, John; Blanchard, Julia L.; Milner-Gulland, E. J.			Fishing for Space: Fine-Scale Multi-Sector Maritime Activities Influence Fisher Location Choice	PLOS ONE			English	Article							MODEL; DYNAMICS; BEHAVIOR; EXAMPLE; BAY	The European Union and other states are moving towards Ecosystem Based Fisheries Management to balance food production and security with wider ecosystem concerns. Fishing is only one of several sectors operating within the ocean environment, competing for renewable and non-renewable resources that overlap in a limited space. Other sectors include marine mining, energy generation, recreation, transport and conservation. Trade-offs of these competing sectors are already part of the process but attempts to detail how the seas are being utilised have been primarily based on compilations of data on human activity at large spatial scales. Advances including satellite and shipping automatic tracking enable investigation of factors influencing fishers' choice of fishing grounds at spatial scales relevant to decision-making, including the presence or avoidance of activities by other sectors. We analyse the determinants of English and Welsh scallop-dredging fleet behaviour, including competing sectors, operating in the eastern English Channel. Results indicate aggregate mining activity, maritime traffic, increased fishing costs, and the English inshore 6 and French 12 nautical mile limits negatively impact fishers' likelihood of fishing in otherwise suitable areas. Past success, net-benefits and fishing within the 12 NM predispose fishers to use areas. Systematic conservation planning has yet to be widely applied in marine systems, and the dynamics of spatial overlap of fishing with other activities have not been studied at scales relevant to fisher decision-making. This study demonstrates fisher decision-making is indeed affected by the real-time presence of other sectors in an area, and therefore trade-offs which need to be accounted for in marine planning. As marine resource extraction demands intensify, governments will need to take a more proactive approach to resolving these trade-offs, and studies such as this will be required as the evidential foundation for future seascape planning.	[Tidd, Alex N.] SPC, Noumea 98848, New Caledonia; [Tidd, Alex N.; Pinnegar, John] Cefas, Lowestoft NR33 0HT, Suffolk, England; [Vermard, Youen; Marchal, Paul] IFREMER, Dept Ressources Biol & Environm Responsable, Unite Halieut Manche Mer Nord, U150, Boulogne, France; [Blanchard, Julia L.] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Milner-Gulland, E. J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England	Centre for Environment Fisheries & Aquaculture Science; Ifremer; University of Sheffield; Imperial College London	Tidd, AN (corresponding author), SPC, BP D5, Noumea 98848, New Caledonia.	alext@spc.int	Blanchard, Julia L/E-4919-2010	Blanchard, Julia L/0000-0003-0532-4824; Vermard, Youen/0000-0003-2828-2815; Marchal, Paul/0000-0003-2047-4599; Pinnegar, John/0000-0001-5061-9520	European Union's Seventh Framework Programme for research, technological development and demonstration (FP7) within the Ocean of Tomorrow [266445]; Cefas United Kingdom (Project Cefas Seedcorn)	European Union's Seventh Framework Programme for research, technological development and demonstration (FP7) within the Ocean of Tomorrow; Cefas United Kingdom (Project Cefas Seedcorn)	The research leading to these results has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration (FP7/2007-2013) within the Ocean of Tomorrow call under Grant Agreement No. 266445 for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors "(VECTORS)" and Cefas United Kingdom (Project Cefas Seedcorn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KE, 2010, ICES J MAR SCI, V67, P1076, DOI 10.1093/icesjms/fsp289; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Andersen BS, 2010, FISH RES, V102, P26, DOI 10.1016/j.fishres.2009.10.004; Bastardie F, 2010, FISH RES, V101, P188, DOI 10.1016/j.fishres.2009.10.009; Berman M, 2006, MAR RESOUR ECON, V21, P121; Coglan L, 2004, P 12 INT C INT I FIS; Cooper KM, 2005, SCI SERIES TECHNICAL, V126; Defra, 2011, CONS NEW EV BAS PROP; Degnbol D, 2008, MAR POLICY, V32, P189, DOI 10.1016/j.marpol.2007.09.006; Desprez M., 2012, SUIVI IMPACTS EXTRAC; Dobby H, 2012, SCOTTISH SCALLOP STO; Domenech T, 1975, URBAN TRAVEL DEMAND; DUGAN JE, 1993, CAN J FISH AQUAT SCI, V50, P2029, DOI 10.1139/f93-227; EC, 2009, OFFICIAL J EUROPEA L, V343; EC, 2007, COM2007575 EC; EC, 2008, COM2008791 EC; EC, 1992, OFFICIAL J L, V206; European Commission, 2008, OFFICIAL J EUROPEAN, VL164, P19, DOI DOI 10.1016/J.MARENVRES.2012.03.003; European Union, 2003, OFFICIAL J EUROPEA L, V71, P17; FAO, 2003, FAO TECHNICAL GUI S2, V4; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; GILLIS DM, 1993, CAN J FISH AQUAT SCI, V50, P323, DOI 10.1139/f93-038; Hensher DA, 2003, TRANSPORTATION, V30, P133, DOI 10.1023/A:1022558715350; Hintzen NT, 2012, FISH RES, V115, P31, DOI 10.1016/j.fishres.2011.11.007; Holland DS, 1999, CAN J FISH AQUAT SCI, V56, P253, DOI 10.1139/cjfas-56-2-253; Howell TRW, 2006, 0806 FISH RES SERV; Kraus G, 2009, ICES J MAR SCI, V66, P109, DOI 10.1093/icesjms/fsn166; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Maddala G.S., 1983, LTD DEPENDENT QUALIT, V3; Mangi SC, 2011, AMBIO, V40, P457, DOI 10.1007/s13280-011-0154-4; Marchal P, 2007, FISH RES, V83, P33, DOI 10.1016/j.fishres.2006.08.025; Marchal P, 2014, ESTUAR COAST SHELF S, V149, P168, DOI 10.1016/j.ecss.2014.08.005; Marine Management Organisation, 2012, UK SEA FISH STAT 201; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; McFadden D, 1981, STRUCTURAL ANAL DISC; McFadden D.L., 1979, BEHAV TRAVEL MODELLI, P279; Mills CM, 2007, ICES J MAR SCI, V64, P248, DOI 10.1093/icesjms/fsl026; NSRAC, 2005, FISH SECR 05 13 2005; Pawson M.G., 1995, FISHERIES RES TECHNI, V99, P72; Pet-Soede C, 2001, FISHERIES MANAG ECOL, V8, P15, DOI 10.1046/j.1365-2400.2001.00215.x; Peterman RM, 2004, ICES J MAR SCI, V61, P1331, DOI 10.1016/j.icesjms.2004.08.017; Radford L, 2013, UK SEA FISH STAT 201, P182; Ran T., 2011, Journal of Agricultural and Applied Economics, V43, P29; Robinson C, 1997, 110 CEMARE U PORTSM; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; SAS Institute Inc, 1999, SAS STAT US GUID; SINNOTT RW, 1984, SKY TELESCOPE, V68, P159; SMITH C L, 1986, North American Journal of Fisheries Management, V6, P88, DOI 10.1577/1548-8659(1986)6<88:SAG>2.0.CO;2; Smith MD, 2002, LAND ECON, V78, P522, DOI 10.2307/3146851; Tidd AN, 2012, FISH RES, V125, P243, DOI 10.1016/j.fishres.2012.03.004; Train K. E., 2003, DISCRETE CHOICE METH; Train KE, 1998, LAND ECON, V74, P230, DOI 10.2307/3147053; Vanstaen K, 2007, SCALE IMPACT FISHING; Vermard Y, 2008, CAN J FISH AQUAT SCI, V65, P2444, DOI 10.1139/F08-147	54	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116335	10.1371/journal.pone.0116335	http://dx.doi.org/10.1371/journal.pone.0116335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625555	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000348821400013
J	Nowak, JK; Grulkowski, I; Karnowski, K; Wojtkowski, M; Walkowiak, J				Nowak, Jan K.; Grulkowski, Ireneusz; Karnowski, Karol; Wojtkowski, Maciej; Walkowiak, Jaroslaw			Optical Coherence Tomography Identifies Lower Labial Salivary Gland Surface Density in Cystic Fibrosis	PLOS ONE			English	Article							3-DIMENSIONAL ENDOMICROSCOPY; TRANSPORT	The labial minor salivary glands (LSGs) are easily accessible mucus-secreting structures of the alimentary tract that may provide new information on the basis of gastrointestinal complications of cystic fibrosis (CF). It was shown that they are destructed in the course of cystic fibrosis. We employed wide-field, micrometer resolution in vivo optical coherence tomography to assess the surface density of LSGs in 18 patients with CF and 18 healthy subjects. The median LSGs' surface densities in CF patients, and in the control group were 4.32 glands/cm(2) and 6.58 glands/cm(2), respectively (p = 0.006; Mann-Whitney U test). A lower LSG surface density is a previously unrecognized CF-related pathology of the alimentary tract.	[Nowak, Jan K.; Walkowiak, Jaroslaw] Poznan Univ Med Sci, Dept Pediat Gastroenterol & Metab Dis, PL-60572 Poznan, Poland; [Grulkowski, Ireneusz; Karnowski, Karol; Wojtkowski, Maciej] Nicholas Copernicus Univ, Inst Phys, Fac Phys Astron & Informat, PL-87100 Torun, Poland	Poznan University of Medical Sciences; Nicolaus Copernicus University	Nowak, JK (corresponding author), Poznan Univ Med Sci, Dept Pediat Gastroenterol & Metab Dis, Ul Szpitalna 27-33, PL-60572 Poznan, Poland.	jarwalk@ump.edu.pl	Nowak, Jan Krzysztof/J-7775-2019; Karnowski, Karol/D-6222-2014; Wojtkowski, Maciej/D-6822-2014; Grulkowski, Ireneusz/N-9655-2013	Nowak, Jan Krzysztof/0000-0003-0953-2188; Karnowski, Karol/0000-0002-5426-5878; Grulkowski, Ireneusz/0000-0001-7688-1826; Wojtkowski, Maciej/0000-0003-0599-0878; Walkowiak, Jaroslaw/0000-0001-5813-5707	Polish National Science Centre grants [2013/09/N/NZ5/02820, 2011/02/A/ST2/00302]; Polish Ministry of Science and Higher Education	Polish National Science Centre grants; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Supported by the Polish National Science Centre grants (JKN-no. 2013/09/N/NZ5/02820; MW-no.2011/02/A/ST2/00302)-http://ncn.gov.pl/, and the scholarship of the Polish Ministry of Science and Higher Education for 2013-2016 (IG)-http://mnisw.gov.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DC, 2007, NAT PHOTONICS, V1, P709, DOI 10.1038/nphoton.2007.228; Adler DC, 2009, OPT EXPRESS, V17, P784, DOI 10.1364/OE.17.000784; [Anonymous], 2007, Z13612007 ANSI; Aps JKM, 2002, CLIN CHEM LAB MED, V40, P345, DOI 10.1515/CCLM.2002.055; AUBERT B, 1990, BIOCHEM BIOPH RES CO, V170, P1144, DOI 10.1016/0006-291X(90)90512-L; Birket SE, 2014, AM J RESP CRIT CARE, V190, P421, DOI 10.1164/rccm.201404-0670OC; Bouma BE, 2000, GASTROINTEST ENDOSC, V51, P467, DOI 10.1016/S0016-5107(00)70449-4; Bradley PJ, 2011, SALIVARY GLAND DISOR; Eliasson L, 2010, EUR J ORAL SCI, V118, P435, DOI 10.1111/j.1600-0722.2010.00766.x; Familiari L, 2006, AM J GASTROENTEROL, V101, P2833, DOI 10.1111/j.1572-0241.2006.00826.x; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Gelfond D, 2013, CLIN GASTROENTEROL H, V11, P333, DOI 10.1016/j.cgh.2012.11.006; Grulkowski I, 2014, BIOMED OPT EXPRESS, V5, P259, DOI 10.1364/BOE.5.000259; Hand AR, 1999, ARCH ORAL BIOL, V44, pS3, DOI 10.1016/S0003-9969(99)00042-4; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Liu LB, 2014, AM J RESP CELL MOL, V51, P485, DOI 10.1165/rcmb.2013-0499MA; MESKIN LH, 1964, JAMA-J AM MED ASSOC, V188, P82; Nowak JK, 2014, ZENODO, DOI [10.5281/zenodo.13257, DOI 10.5281/ZENODO.13257]; Park S, 2013, GASTROENTEROLOGY, V145, P232, DOI 10.1053/j.gastro.2013.03.047; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Walkowiak J, 2004, J PEDIATR-US, V145, P285, DOI 10.1016/j.jpeds.2004.06.033; Walkowiak J, 2004, ACTA PAEDIATR, V93, P1042, DOI 10.1111/j.1651-2227.2004.tb02715.x; WARWICK WJ, 1964, PEDIATRICS, V34, P621; WIESMANN UN, 1972, LANCET, V2, P510; Wojtkowski M, 2010, APPL OPTICS, V49, pD30, DOI 10.1364/AO.49.000D30; Zhou C, 2012, GASTROINTEST ENDOSC, V76, P32, DOI 10.1016/j.gie.2012.02.003; [No title captured]	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117517	10.1371/journal.pone.0117517	http://dx.doi.org/10.1371/journal.pone.0117517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622042	Green Published, Green Submitted, gold			2022-12-27	WOS:000348470400024
J	Tan, XQ; Goh, WP; Venkatachalam, I; Goh, D; Sridhar, R; Chan, HC; Archuleta, S				Tan, Xin Quan; Goh, Wei-Ping; Venkatachalam, Indumathi; Goh, Diana; Sridhar, Revathi; Chan, Hwang Ching; Archuleta, Sophia			Evaluation of a HIV Voluntary Opt-Out Screening Program in a Singapore Hospital	PLOS ONE			English	Article							DETERMINANTS; TRANSMISSION; INFECTION; SURVIVAL; BARRIERS; VIRUS	Background Early diagnosis of human immunodeficiency virus (HIV) allows for appropriately timed interventions with improved outcomes, but HIV screening among asymptomatic persons and the general population in Singapore remains low. In 2008, Singapore's Ministry of Health implemented HIV voluntary opt-out screening (VOS) for hospitalised adults. We evaluated the outcome of VOS and surveyed reasons for its low uptake in our institution. Methods We assessed the outcomes of the VOS programme from January 2010 to December 2013 at National University Hospital, a 1081-bed tertiary hospital in Singapore. We also examined reasons for opting-in and opting-out using an interviewer-administered structured questionnaire in a representative sample in January 2013. Results 107,523 patients fulfilled VOS criteria and were offered HIV screening, of which 5215 (4.9%) agreed to testing. 4850 (93.1%) of those who opted-in had an HIV test done. Three (0.06%) tested positive for HIV. 238 patients (14.2%) were surveyed regarding reasons for opting-in or out of VOS. 21 (8.8%) had opted-in. Patients who opted-in were likely to be younger, more educated and reported having more regular sexual partners. Type of housing, number of casual sexual partners, sexual orientation, intravenous drug use, condom use and previous sexually transmitted infection were not associated with deciding to opt-in/out. Patients' most common reasons for opting-out were: belief that they were at low risk (50.2%), belief that they were too old (26.8%), cost (6.9%) and aversion to venepuncture (6.5%). The most common reason for opting-in was desire to know their HIV status (47.6%). Conclusion The success of an HIV-VOS program is largely determined by test uptake. Our study showed that the majority of eligible VOS patients opted-out of HIV screening. Given the considerable cost and low yield of this programme, more needs to be done to better equip patients in self-risk assessment and opting in to testing.	[Tan, Xin Quan; Venkatachalam, Indumathi; Archuleta, Sophia] Natl Univ Singapore Hosp, Univ Med Cluster, Div Infect Dis, Singapore 117548, Singapore; [Goh, Wei-Ping] Natl Univ Singapore Hosp, Div Gen Med & Therapeut, Dept Med, Singapore 117548, Singapore; [Venkatachalam, Indumathi; Goh, Diana; Sridhar, Revathi; Chan, Hwang Ching] Natl Univ Singapore Hosp, Div Infect Dis, Dept Med, Epidemiol Unit, Singapore 117548, Singapore; [Archuleta, Sophia] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Tan, XQ (corresponding author), Natl Univ Singapore Hosp, Univ Med Cluster, Div Infect Dis, Singapore 117548, Singapore.	xin_quan_tan@nuhs.edu.sg		Archuleta, Sophia/0000-0002-8414-6327				Abdullah ASM, 2004, INT J STD AIDS, V15, P608, DOI 10.1258/0956462041724307; [Anonymous], 2000, JAMA, V284, P171; [Anonymous], 2013, UPD HIV AIDS SIT SIN, DOI [10.1016/j.amsu.2013.12.001, DOI 10.1016/J.AMSU.2013.12.001]; [Anonymous], 2012, AN TEST SIT STAT 201; [Anonymous], 2007, UPDATE HIV AIDS SITU; [Anonymous], 2010, AN TEST SIT STAT 201; [Anonymous], COMM DIS SURV SING 2; [Anonymous], 2011, AN TEST SIT STAT 201; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Chou R, 2005, ANN INTERN MED, V143, P55, DOI 10.7326/0003-4819-143-1-200507050-00010; Chua AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034663; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; de Wit JBF, 2008, HIV MED, V9, P20, DOI 10.1111/j.1468-1293.2008.00586.x; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dowson L, 2012, AIDS CARE, V24, P204, DOI 10.1080/09540121.2011.597711; Johnson A. Satcher, 2010, Morbidity and Mortality Weekly Report, V59, P1550; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Merchant RC, 2008, PUBLIC HEALTH REP, V123, P27, DOI 10.1177/00333549081230S305; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Tan XQ, 2013, EVALUATING HIV VOLUN; Tey JSH, 2012, ANN ACAD MED SINGAP, V41, P194; Verrall A, 2012, ANN ACAD MED SINGAP, V41, P617; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; Ziraba AK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-663	30	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116987	10.1371/journal.pone.0116987	http://dx.doi.org/10.1371/journal.pone.0116987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611741	Green Published, gold, Green Submitted			2022-12-27	WOS:000348562900029
J	Acevedo, R; Orench-Rivera, N; Quarles, KA; Showalter, SA				Acevedo, Roderico; Orench-Rivera, Nichole; Quarles, Kaycee A.; Showalter, Scott A.			Helical Defects in MicroRNA Influence Protein Binding by TAR RNA Binding Protein	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MICROPROCESSOR COMPLEX; KINASE PKR; HUMAN TRBP; CANCER; REGION; DGCR8; MOTIF; INTERFERENCE; RECOGNITION	Background MicroRNAs (miRNAs) are critical post-transcriptional regulators of gene expression. Their precursors have a globally A-form helical geometry, which prevents most proteins from identifying their nucleotide sequence. This suggests the hypothesis that local structural features (e. g., bulges, internal loops) play a central role in specific double-stranded RNA (dsRNA) selection from cellular RNA pools by dsRNA binding domain (dsRBD) containing proteins. Furthermore, the processing enzymes in the miRNA maturation pathway require tandem-dsRBD cofactor proteins for optimal function, suggesting that dsRBDs play a key role in the molecular mechanism for precise positioning of the RNA within these multi-protein complexes. Here, we focus on the tandem-dsRBDs of TRBP, which have been shown to bind dsRNA tightly. Methodology/Principal Findings We present a combination of dsRNA binding assays demonstrating that TRBP binds dsRNA in an RNA-length dependent manner. Moreover, circular dichroism data shows that the number of dsRBD moieties bound to RNA at saturation is different for a tandem-dsRBD construct than for constructs with only one dsRBD per polypeptide, revealing another reason for the selective pressure to maintain multiple domains within a polypeptide chain. Finally, we show that helical defects in precursor miRNA alter the apparent dsRNA size, demonstrating that imperfections in RNA structure influence the strength of TRBP binding. Conclusion/Significance We conclude that TRBP is responsible for recognizing structural imperfections in miRNA precursors, in the sense that TRBP is unable to bind imperfections efficiently and thus is positioned around them. We propose that once positioned around structural defects, TRBP assists Dicer and the rest of the RNA-induced silencing complex (RISC) in providing efficient and homogenous conversion of substrate precursor miRNA into mature miRNA downstream.	[Acevedo, Roderico; Orench-Rivera, Nichole; Quarles, Kaycee A.; Showalter, Scott A.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Acevedo, Roderico; Orench-Rivera, Nichole; Quarles, Kaycee A.; Showalter, Scott A.] Penn State Univ, Ctr RNA Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Showalter, SA (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sas76@psu.edu	Showalter, Scott A/A-1655-2012	Showalter, Scott A/0000-0001-5179-032X	National Institutes of Health (NIH) [R01GM098451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098451] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health (NIH) Grant R01GM098451 to SAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benoit MPMH, 2013, BIOMOL NMR ASSIGN, V7, P229, DOI 10.1007/s12104-012-9416-8; Benoit MPMH, 2013, NUCLEIC ACIDS RES, V41, P4241, DOI 10.1093/nar/gkt086; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Clemens MJ, 1997, INT J BIOCHEM CELL B, V29, P945, DOI 10.1016/S1357-2725(96)00169-0; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; Daviet L, 2000, EUR J BIOCHEM, V267, P2419, DOI 10.1046/j.1432-1327.2000.01256.x; Dong JT, 2001, PROSTATE, V49, P166, DOI 10.1002/pros.1131; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; Gredell JA, 2010, BIOCHEMISTRY-US, V49, P3148, DOI 10.1021/bi902189s; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kini HK, 2009, FEBS J, V276, P6576, DOI 10.1111/j.1742-4658.2009.07364.x; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Laraki G, 2008, RNA BIOL, V5, P92, DOI 10.4161/rna.5.2.6069; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Nicholson AW, 2014, WIRES RNA, V5, P31, DOI 10.1002/wrna.1195; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Perron Marjorie P., 2009, V487, P369, DOI 10.1007/978-1-60327-547-7_18; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Quarles KA, 2013, BIOCHEMISTRY-US, V52, P795, DOI 10.1021/bi301452a; Roth BM, 2013, J BIOL CHEM, V288, P26785, DOI 10.1074/jbc.M112.446880; Sanghvi VR, 2011, J VIROL, V85, P12614, DOI 10.1128/JVI.05240-11; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Ucci JW, 2007, BIOCHEMISTRY-US, V46, P55, DOI 10.1021/bi061531o; Warf MB, 2011, RNA, V17, P563, DOI 10.1261/rna.2432311; Wostenberg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051829; Wostenberg C, 2010, BIOCHEMISTRY-US, V49, P10728, DOI 10.1021/bi1015716; Wostenberg C, 2010, BIOPHYS J, V99, P248, DOI 10.1016/j.bpj.2010.04.010; Yamashita S, 2011, PROTEIN SCI, V20, P118, DOI 10.1002/pro.543; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	41	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116749	10.1371/journal.pone.0116749	http://dx.doi.org/10.1371/journal.pone.0116749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608000	Green Published, gold			2022-12-27	WOS:000348205300034
J	Beaz-Hidalgo, R; Hossain, MJ; Liles, MR; Figueras, MJ				Beaz-Hidalgo, Roxana; Hossain, Mohammad J.; Liles, Mark R.; Figueras, Maria-Jose			Strategies to Avoid Wrongly Labelled Genomes Using as Example the Detected Wrong Taxonomic Affiliation for Aeromonas Genomes in the GenBank Database	PLOS ONE			English	Article							SPECIES DEFINITION; VIRULENCE FACTORS; SP NOV.; STRAINS	Around 27,000 prokaryote genomes are presently deposited in the Genome database of GenBank at the National Center for Biotechnology Information (NCBI) and this number is exponentially growing. However, it is not known how many of these genomes correspond correctly to their designated taxon. The taxonomic affiliation of 44 Aeromonas genomes (only five of these are type strains) deposited at the NCBI was determined by a multilocus phylogenetic analysis (MLPA) and by pairwise average nucleotide identity (ANI). Discordant results in relation to taxa assignation were found for 14 (35.9%) of the 39 non-type strain genomes on the basis of both the MLPA and ANI results. Data presented in this study also demonstrated that if the genome of the type strain is not available, a genome of the same species correctly identified can be used as a reference for ANI calculations. Of the three ANI calculating tools compared (ANI calculator, EzGenome and JSpecies), EzGenome and JSpecies provided very similar results. However, the ANI calculator provided higher intra- and inter-species values than the other two tools (differences within the ranges 0.06-0.82% and 0.92-3.38%, respectively). Nevertheless each of these tools produced the same species classification for the studied Aeromonas genomes. To avoid possible misinterpretations with the ANI calculator, particularly when values are at the borderline of the 95% cutoff, one of the other calculation tools (EzGenome or JSpecies) should be used in combination. It is recommended that once a genome sequence is obtained the correct taxonomic affiliation is verified using ANI or a MLPA before it is submitted to the NCBI and that researchers should amend the existing taxonomic errors present in databases.	[Beaz-Hidalgo, Roxana; Figueras, Maria-Jose] Univ Rovira & Virgili, Fac Med & Ciencies Salut, IISPV, Dept Ciences Med Basiques,Unitat Microbiol, E-43201 Reus, Spain; [Hossain, Mohammad J.; Liles, Mark R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Auburn University System; Auburn University	Figueras, MJ (corresponding author), Univ Rovira & Virgili, Fac Med & Ciencies Salut, IISPV, Dept Ciences Med Basiques,Unitat Microbiol, C St Llorenc 21, E-43201 Reus, Spain.	mariajose.figueras@urv.cat	Hossain, Mohammad J/I-1542-2014	Hossain, Mohammad J/0000-0003-3848-9035; Figueras, Maria J./0000-0002-2268-8980	"Ministerio de Ciencia e Innovacion" (Spain) [AGL2011-30461-C02-02]; European Union [311846]	"Ministerio de Ciencia e Innovacion" (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission)	This work was supported in part by the project with reference AGL2011-30461-C02-02 by the "Ministerio de Ciencia e Innovacion" (Spain) and by funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 311846. The authors are solely responsible for the content of this publication. It does not represent the opinion of the European Commission. The European Commission is not responsible for any use that might be made of data appearing therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena-Roman M, 2013, INT J SYST EVOL MICR, V63, P2270, DOI 10.1099/ijs.0.040162-0; Beaz-Hidalgo R, 2013, J FISH DIS, V36, P371, DOI 10.1111/jfd.12025; Beaz-Hidalgo R, 2013, SYST APPL MICROBIOL, V36, P171, DOI 10.1016/j.syapm.2012.12.007; Chen PL, 2014, CLIN MICROBIOL INFEC, V20, pO428, DOI 10.1111/1469-0691.12456; Chun J, 2014, INT J SYST EVOL MICR, V64, P316, DOI 10.1099/ijs.0.054171-0; Colston SM, 2014, MBIO, V5, DOI 10.1128/mBio.02136-14; Figueras M.J., 2011, B BISMIS 1, V2, P1; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grim CJ, 2014, APPL ENVIRON MICROB, V80, P4162, DOI 10.1128/AEM.00486-14; Hossain MJ, 2014, MBIO, V5, DOI 10.1128/mBio.00848-14; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jimenez G, 2013, SYST APPL MICROBIOL, V36, P383, DOI 10.1016/j.syapm.2013.04.008; Figueras MJ, 2015, AEROMONAS, P65; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Konstantinidis KT, 2006, APPL ENVIRON MICROB, V72, P7286, DOI 10.1128/AEM.01398-06; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Konstantinidis KT, 2014, MICROBE, V9, P111, DOI [10.1128/microbe.9.111.1, DOI 10.1128/MICROBE.9.111.1]; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; Martinez-Murcia A, 2013, CURR MICROBIOL, V66, P197, DOI 10.1007/s00284-012-0253-x; Martinez-Murcia AJ, 2011, SYST APPL MICROBIOL, V34, P189, DOI 10.1016/j.syapm.2010.11.014; Pascual J, 2010, INT J SYST EVOL MICR, V60, P154, DOI 10.1099/ijs.0.010702-0; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Serrano W, 2010, SYST APPL MICROBIOL, V33, P116, DOI 10.1016/j.syapm.2009.12.003; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Wu CJ, 2013, INT J ANTIMICROB AG, V42, P456, DOI 10.1016/j.ijantimicag.2013.08.002	28	55	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115813	10.1371/journal.pone.0115813	http://dx.doi.org/10.1371/journal.pone.0115813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607802	gold, Green Published, Green Submitted			2022-12-27	WOS:000348205300021
J	Cornelius, RJ; Wen, DH; Li, HQ; Yuan, Y; Wang-France, J; Warner, PC; Sansom, SC				Cornelius, Ryan J.; Wen, Donghai; Li, Huaqing; Yuan, Yang; Wang-France, Jun; Warner, Paige C.; Sansom, Steven C.			Low Na, High K Diet and the Role of Aldosterone in BK-Mediated K Excretion	PLOS ONE			English	Article							POTASSIUM SECRETION; DISTAL NEPHRON; DIFFERENTIAL REGULATION; DEPENDENT REGULATION; BETA-1 SUBUNIT; ION-TRANSPORT; CHANNEL; SODIUM; BICARBONATE; EXPRESSION	A low Na, high K diet (LNaHK) is associated with a low rate of cardiovascular (CV) disease in many societies. Part of the benefit of LNaHK relies on its diuretic effects; however, the role of aldosterone (aldo) in the diuresis is not understood. LNaHK mice exhibit an increase in renal K secretion that is dependent on the large, Ca-activated K channel, (BK-alpha with accessory BK-beta 4; BK-alpha/beta 4). We hypothesized that aldo causes an osmotic diuresis by increasing BK-alpha/beta-mediated K secretion in LNaHK mice. We found that the plasma aldo concentration (P[aldo]) was elevated by 10-fold in LNaHK mice compared with control diet (Con) mice. We subjected LNaHK mice to either sham surgery (sham), adrenalectomy (ADX) with low aldo replacement (ADX-LA), or ADX with high aldo replacement (ADX-HA). Compared to sham, the urinary flow, K excretion rate, transtubular K gradient (TTKG), and BK-alpha and BK-beta 4 expressions, were decreased in ADX-LA, but not different in ADX-HA. BK-beta 4 knockout (beta 4KO) and WT mice exhibited similar K clearance and TTKG in the ADX-LA groups; however, in sham and ADX-HA, the K clearance and TTKG of beta 4KO were less than WT. In response to amiloride treatment, the osmolar clearance was increased in WT Con, decreased in WT LNaHK, and unchanged in beta 4KO LNaHK. These data show that the high P[aldo] of LNaHK mice is necessary to generate a high rate of BK-alpha/beta 4-mediated K secretion, which creates an osmotic diuresis that may contribute to a reduction in CV disease.	[Cornelius, Ryan J.; Wen, Donghai; Li, Huaqing; Yuan, Yang; Wang-France, Jun; Warner, Paige C.; Sansom, Steven C.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Sansom, SC (corresponding author), Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA.	ssansom@unmc.edu			National Institute of Diabetes and Digestive and Kidney Diseases [RO1 DK071014, RO1 DK73070]; American Heart Association MWA Affiliate [11PRE7530018]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092474, R01DK071014, R01DK073070] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association MWA Affiliate(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by National Institute of Diabetes and Digestive and Kidney Diseases Grants RO1 DK071014 and RO1 DK73070 (SCS), and a fellowship (#11PRE7530018) from the American Heart Association MWA Affiliate (RJC).	Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Bailey MA, 2006, KIDNEY INT, V70, P51, DOI 10.1038/sj.ki.5000388; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Cornelius RJ, 2012, AM J PHYSIOL-RENAL, V303, pF1563, DOI 10.1152/ajprenal.00490.2012; Dijkink L, 1999, PFLUG ARCH EUR J PHY, V438, P354, DOI 10.1007/s004240050920; Dooley R, 2012, MOL CELL ENDOCRINOL, V350, P223, DOI 10.1016/j.mce.2011.07.019; Dunn SR, 2004, KIDNEY INT, V65, P1959, DOI 10.1111/j.1523-1755.2004.00600.x; EATON SB, 1985, NEW ENGL J MED, V312, P283, DOI 10.1056/NEJM198501313120505; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; FIELD MJ, 1984, J CLIN INVEST, V74, P1792, DOI 10.1172/JCI111598; Frassetto L, 2001, EUR J NUTR, V40, P200, DOI 10.1007/s394-001-8347-4; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF389, DOI 10.1152/ajprenal.90528.2008; Gamliel-Lazarovich A, 2013, EUR J GASTROEN HEPAT, V25, P1086, DOI 10.1097/MEG.0b013e328360554a; GARG LC, 1981, AM J PHYSIOL, V240, pF536, DOI 10.1152/ajprenal.1981.240.6.F536; GARG LC, 1987, PFLUG ARCH EUR J PHY, V409, P126, DOI 10.1007/BF00584759; Gertner RA, 2004, J AM SOC NEPHROL, V15, P558, DOI 10.1097/01.ASN.0000113244.37857.AC; GORDON RD, 1994, CLIN EXP PHARMACOL P, V21, P315, DOI 10.1111/j.1440-1681.1994.tb02519.x; GREEN HH, 1970, J CLIN INVEST, V49, P1724, DOI 10.1172/JCI106390; Grimm PR, 2010, KIDNEY INT, V78, P956, DOI 10.1038/ki.2010.272; Grimm PR, 2009, P NATL ACAD SCI USA, V106, P11800, DOI 10.1073/pnas.0904635106; Grimm PR, 2009, AM J PHYSIOL-RENAL, V297, pF420, DOI 10.1152/ajprenal.00191.2009; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; Holtzclaw JD, 2011, AM J PHYSIOL-RENAL, V300, pF1319, DOI 10.1152/ajprenal.00112.2011; Holtzclaw JD, 2010, J AM SOC NEPHROL, V21, P634, DOI 10.1681/ASN.2009080817; Huang DY, 2004, J AM SOC NEPHROL, V15, P885, DOI 10.1097/01.ASN.0000120368.59693.A8; Keith NM, 1935, J AMER MED ASSOC, V105, P1584; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Kobayashi M, 2011, CLIN EXP NEPHROL, V15, P355, DOI 10.1007/s10157-011-0414-4; Mancilha-Carvalho Jairo de Jesus, 2003, Arq. Bras. Cardiol., V80, P295, DOI 10.1590/S0066-782X2003000300005; Manolopoulou J, 2008, J ENDOCRINOL, V196, P215, DOI 10.1677/JOE-07-0134; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Nesterov V, 2012, AM J PHYSIOL-RENAL, V303, pF1289, DOI 10.1152/ajprenal.00247.2012; NICKERSON PA, 1969, AM J PATHOL, V57, P335; OLIVER WJ, 1975, CIRCULATION, V52, P146, DOI 10.1161/01.CIR.52.1.146; Onogawa Toshiyuki, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS67, DOI 10.1007/s10557-011-6350-4; Arroyo JP, 2011, PHYSIOLOGY, V26, P115, DOI 10.1152/physiol.00049.2010; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Rengarajan S, 2014, AM J PHYSIOL-RENAL, V306, pF1059, DOI 10.1152/ajprenal.00015.2014; Sansom SC, 2007, KIDNEY INT, V72, P529, DOI 10.1038/sj.ki.5002438; SANSOM SC, 1985, AM J PHYSIOL, V248, pF858, DOI 10.1152/ajprenal.1985.248.6.F858; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; STOKES JB, 1982, J CLIN INVEST, V70, P219, DOI 10.1172/JCI110609; TODKAR A, 2014, J AM SOC NEPHROL; TREASURE J, 1983, HYPERTENSION, V5, P864, DOI 10.1161/01.HYP.5.6.864; Tsuchiya K, 1996, AM J PHYSIOL-RENAL, V271, pF7, DOI 10.1152/ajprenal.1996.271.1.F7; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; Velazquez H, 1996, AM J PHYSIOL-RENAL, V270, pF211, DOI 10.1152/ajprenal.1996.270.1.F211; Wade JB, 2011, AM J PHYSIOL-RENAL, V300, pF1385, DOI 10.1152/ajprenal.00592.2010; Wang XF, 2003, NAT CELL BIOL, V5, P902, DOI 10.1038/ncb1047; Welling PA, 2013, SEMIN NEPHROL, V33, P215, DOI 10.1016/j.semnephrol.2013.04.002; Wen DH, 2014, KIDNEY INT, V86, P139, DOI 10.1038/ki.2014.14; Wen DH, 2014, CURR OPIN PHARMACOL, V15, P28, DOI 10.1016/j.coph.2013.11.001; Wen DH, 2013, AM J PHYSIOL-RENAL, V305, pF463, DOI 10.1152/ajprenal.00171.2013; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200	55	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115515	10.1371/journal.pone.0115515	http://dx.doi.org/10.1371/journal.pone.0115515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607984	gold, Green Submitted, Green Published			2022-12-27	WOS:000348205300015
J	Xu, XF; Zhang, XW				Xu, Xiaofei; Zhang, Xuewu			Lentinula edodes-Derived Polysaccharide Alters the Spatial Structure of Gut Microbiota in Mice	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; DIETARY RESISTANT; WEANED PIGLETS; OAT CULTIVARS; INFLAMMATION; EXPRESSION; INTESTINE; RESPONSES; HEALTH; BARLEY	Lentinula edodes-derived polysaccharides possess many therapeutic characteristics, including anti-tumor and immuno-modulation. The gut microbes play a critical role inmodulation of immune function. However, the impact of Lentinula edodes-derived polysaccharides on the gut microbes have not yet been explored. In this study, high-throughput pyrosequencing technique was employed to investigate the effects of a new heteropolysaccharide L2 from Lentinula edodes on microbiota diversity and composition of small intestine, cecum, colon and distal end of colon (feces) in mice. The results demonstrated that along mouse intestine the microbiota exhibit distinctly different space distribution. L2 treatment reduced the diversity and evenness of gut microbiota along the intestine, especially in the cecum and colon. In the fecal microbial communities, the decrease of Bacteroidetes by significantly increasing Proteobacteria were observed, which were characterized by the increased Helicobacteraceae and reduced S24-7 at family level. Some OTUs, corresponding to Bacteroides acidifaciens, Alistipes and Helicobacter suncus, were found to be significantly increased in L2 treatedmice. In particular, 4 phyla Chloroflexi, Gemmatimonadetes, Nitrospirae and Planctomycetes are exclusively present in L2-treated mice. This is helpful for further demonstrating healthy action mechanism of Lentinula edodes-derived polysaccharide L2.	[Xu, Xiaofei; Zhang, Xuewu] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Zhang, XW (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China.	snow_dance@sina.com						Abell GCJ, 2011, BRIT J NUTR, V105, P1480, DOI 10.1017/S0007114510005349; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Aida FMNA, 2009, TRENDS FOOD SCI TECH, V20, P567, DOI 10.1016/j.tifs.2009.07.007; Bisen PS, 2010, CURR MED CHEM, V17, P2419, DOI 10.2174/092986710791698495; Bolam DN, 2011, GUT MICROBES, V2, P86, DOI 10.4161/gmic.2.2.15232; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Chou WT, 2013, J FOOD SCI, V78, pM1041, DOI 10.1111/1750-3841.12160; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Finimundy T. C., 2014, Food and Nutrition Sciences, V5, P1095; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jeffery IB, 2013, NUTRIENTS, V5, P234, DOI 10.3390/nu5010234; Jha R, 2010, ANIMAL, V4, P724, DOI 10.1017/S1751731109991510; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Lavelle A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078835; Li F, 2009, J NUTR, V139, P1685, DOI 10.3945/jn.109.108191; Low D, 2013, DRUG DES DEV THER, V7, P1341, DOI 10.2147/DDDT.S40107; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Mirpuri J, 2014, GUT MICROBES, V5, P28, DOI 10.4161/gmic.26489; Mizoguchi A, 2010, CURR OPIN PHARMACOL, V10, P578, DOI 10.1016/j.coph.2010.05.007; Mizuno M, 2009, BIOSCI BIOTECH BIOCH, V73, P2324, DOI 10.1271/bbb.90326; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Nishitani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062441; Pieper R, 2008, FEMS MICROBIOL ECOL, V66, P556, DOI 10.1111/j.1574-6941.2008.00605.x; Pieper R, 2009, APPL ENVIRON MICROB, V75, P7006, DOI 10.1128/AEM.01343-09; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramakers JD, 2007, MOL NUTR FOOD RES, V51, P211, DOI 10.1002/mnfr.200600149; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Tachon S, 2013, FEMS MICROBIOL ECOL, V83, P299, DOI 10.1111/j.1574-6941.2012.01475.x; Volman JJ, 2010, MOL NUTR FOOD RES, V54, P268, DOI 10.1002/mnfr.200900009; Wang CL, 2014, INFLAMMATION, V37, P83, DOI 10.1007/s10753-013-9714-z; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu WZ, 2013, APPL MICROBIOL BIOT, V97, P2725, DOI 10.1007/s00253-012-4110-4; Xu XF, 2014, CRIT REV FOOD SCI, V54, P474, DOI 10.1080/10408398.2011.587616; Xu XF, 2013, BIOTECHNOL ADV, V31, P318, DOI 10.1016/j.biotechadv.2012.12.009; Xu XF, 2012, J AGR FOOD CHEM, V60, P11560, DOI 10.1021/jf304364c; Yanagibashi T, 2013, IMMUNOBIOLOGY, V218, P645, DOI 10.1016/j.imbio.2012.07.033	49	55	57	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115037	10.1371/journal.pone.0115037	http://dx.doi.org/10.1371/journal.pone.0115037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608087	Green Published, Green Submitted, gold			2022-12-27	WOS:000348205300008
J	Psifidi, A; Dovas, CI; Bramis, G; Lazou, T; Russel, CL; Arsenos, G; Banos, G				Psifidi, Androniki; Dovas, Chrysostomos I.; Bramis, Georgios; Lazou, Thomai; Russel, Claire L.; Arsenos, Georgios; Banos, Georgios			Comparison of Eleven Methods for Genomic DNA Extraction Suitable for Large-Scale Whole-Genome Genotyping and Long-Term DNA Banking Using Blood Samples	PLOS ONE			English	Article							REAL-TIME PCR; MICROARRAY ANALYSIS; SEQUENCING TECHNOLOGIES; BACTERIAL; AMPLIFICATION; QUANTITY; RECOVERY; DISEASE; BIOLOGY; TISSUE	Over the recent years, next generation sequencing and microarray technologies have revolutionized scientific research with their applications to high-throughput analysis of biological systems. Isolation of high quantities of pure, intact, double stranded, highly concentrated, not contaminated genomic DNA is prerequisite for successful and reliable large scale genotyping analysis. High quantities of pure DNA are also required for the creation of DNA-banks. In the present study, eleven different DNA extraction procedures, including phenol-chloroform, silica and magnetic beads based extractions, were examined to ascertain their relative effectiveness for extracting DNA from ovine blood samples. The quality and quantity of the differentially extracted DNA was subsequently assessed by spectrophotometric measurements, Qubit measurements, real-time PCR amplifications and gel electrophoresis. Processing time, intensity of labor and cost for each method were also evaluated. Results revealed significant differences among the eleven procedures and only four of the methods yielded satisfactory outputs. These four methods, comprising three modified silica based commercial kits ( Modified Blood, Modified Tissue, Modified Dx kits) and an in-house developed magnetic beads based protocol, were most appropriate for extracting high quality and quantity DNA suitable for large-scale microarray genotyping and also for long-term DNA storage as demonstrated by their successful application to 600 individuals.	[Psifidi, Androniki; Bramis, Georgios; Arsenos, Georgios; Banos, Georgios] Aristotle Univ Thessaloniki, Sch Vet Med, Anim Prod Lab, GR-54006 Thessaloniki, Greece; [Psifidi, Androniki; Banos, Georgios] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Psifidi, Androniki; Banos, Georgios] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Dovas, Chrysostomos I.] Aristotle Univ Thessaloniki, Sch Vet Med, Microbiol & Infect Dis Lab, GR-54006 Thessaloniki, Greece; [Lazou, Thomai] Aristotle Univ Thessaloniki, Sch Vet Med, Food Safety Lab, GR-54006 Thessaloniki, Greece; [Russel, Claire L.] Univ Bristol, Dept Vet Clin Sci, Bristol, Avon, England; [Banos, Georgios] Scotlands Rural Coll, Edinburgh, Midlothian, Scotland	Aristotle University of Thessaloniki; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; University of Bristol; Scotland's Rural College	Psifidi, A (corresponding author), Aristotle Univ Thessaloniki, Sch Vet Med, Anim Prod Lab, GR-54006 Thessaloniki, Greece.	androniki.psifidi@roslin.ed.ac.uk	Lazou, Thomai/ABK-4345-2022; Lazou, Thomai/AAW-5849-2020; Dovas, Chrysostomos/AAF-9663-2019; Arsenos, Georgios/AAO-7147-2021; Arsenos, Georgios I/M-7822-2017	Dovas, Chrysostomos/0000-0003-2947-1765; Arsenos, Georgios/0000-0003-3224-5128; Arsenos, Georgios I/0000-0003-3224-5128; Lazou, Thomai/0000-0001-6223-5655; Banos, Georgios/0000-0002-7674-858X	Seven Framework Program of the European Commission, project 3SR (Sustainable Solutions for Small ruminants) [FP7-KBBE-2009-3-245140]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [MR/K001744/1, G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010003] Funding Source: researchfish; BBSRC [BBS/E/D/20310000] Funding Source: UKRI; MRC [MR/K001744/1, G0900740] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI	Seven Framework Program of the European Commission, project 3SR (Sustainable Solutions for Small ruminants); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the Seven Framework Program of the European Commission, project 3SR (Sustainable Solutions for Small ruminants). 3SR Grant agreement no.: FP7-KBBE-2009-3-245140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amandeep Singh NK, 2013, INTERNATIONAL JOURNA, V5; Arif IA, 2010, INT J MOL SCI, V11, P3149, DOI 10.3390/ijms11093149; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Black JA, 2007, J MICROBIOL METH, V70, P75, DOI 10.1016/j.mimet.2007.03.017; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clarke A. G., 2009, International Zoo Yearbook, V43, P222, DOI 10.1111/j.1748-1090.2008.00074.x; Clausen FB, 2007, PRENATAL DIAG, V27, P6, DOI 10.1002/pd.1605; Clements DN, 2008, RES VET SCI, V85, P74, DOI 10.1016/j.rvsc.2007.09.009; Cler L, 2006, MOL CELL PROBE, V20, P191, DOI 10.1016/j.mcp.2005.12.003; Corthals A, 2005, SYST BIOL, V54, P819, DOI 10.1080/10635150590950353; Dauphin LA, 2011, DIAGN MICR INFEC DIS, V70, P299, DOI 10.1016/j.diagmicrobio.2011.02.010; Fahle GA, 2000, J CLIN MICROBIOL, V38, P3860, DOI 10.1128/JCM.38.10.3860-3863.2000; Gilmour A.R., 2012, ASREML USER GUIDE RE; Griffiths LJ, 2006, J MED MICROBIOL, V55, P1187, DOI 10.1099/jmm.0.46510-0; Hardin J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-38; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Jaluria P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-4; Keegan H, 2005, CYTOPATHOLOGY, V16, P82, DOI 10.1111/j.1365-2303.2005.00239.x; Kong WJ, 2006, CHINESE MED J-PEKING, V119, P986, DOI 10.1097/00029330-200606020-00004; Kumar RM, 2009, AM J INFECT DIS, V5, P207, DOI 10.3844/ajidsp.2009.207.218; Leblanc-Maridor M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-113; Lemarchand K, 2005, J MICROBIOL METH, V63, P115, DOI 10.1016/j.mimet.2005.02.021; Li GX, 2012, BIOINFORMATICS, V28, P358, DOI 10.1093/bioinformatics/btr673; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Ning J, 2009, APPL MICROBIOL BIOT, V82, P983, DOI 10.1007/s00253-009-1912-0; O'Neill M, 2011, J PHYS CONF SER, V307, DOI 10.1088/1742-6596/307/1/012047; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Page Grier P., 2007, V404, P409, DOI 10.1007/978-1-59745-530-5_20; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Psifidi A, 2010, MOL CELL PROBE, V24, P93, DOI 10.1016/j.mcp.2009.11.001; Riemann K, 2007, J CLIN LAB ANAL, V21, P244, DOI 10.1002/jcla.20174; Rupp R, 2013, P 64 EAAP M NANT FRA; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sechi SC, 2013, EAAP M NANT FRANC AU; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Smith K, 2003, J CLIN MICROBIOL, V41, P2440, DOI 10.1128/JCM.41.6.2440-2443.2003; Sobek J, 2006, COMB CHEM HIGH T SCR, V9, P365, DOI 10.2174/138620706777452429; Stoughton RB, 2005, ANNU REV BIOCHEM, V74, P53, DOI 10.1146/annurev.biochem.74.082803.133212; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Xie H, 2004, CLIN CHEM, V50, P1231, DOI 10.1373/clinchem.2004.031559; Zhang LX, 2005, BIOTECHNIQUES, V39, P640, DOI 10.2144/000112038	48	85	91	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115960	10.1371/journal.pone.0115960	http://dx.doi.org/10.1371/journal.pone.0115960			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635817	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000350680700021
J	Andersen, JP; Bogsted, M; Dybkaer, K; Mellqvist, UH; Morgan, GJ; Goldschmidt, H; Dimopoulos, MA; Einsele, H; San Miguel, J; Palumbo, A; Sonneveld, P; Johnsen, HE				Andersen, Jens Peter; Bogsted, Martin; Dybkaer, Karen; Mellqvist, Ulf-Henrik; Morgan, Gareth J.; Goldschmidt, Hartmut; Dimopoulos, Meletios A.; Einsele, Hermann; San Miguel, Jesus; Palumbo, Antonio; Sonneveld, Pieter; Johnsen, Hans Erik			Global Myeloma Research Clusters, Output, and Citations: A Bibliometric Mapping and Clustering Analysis	PLOS ONE			English	Article							MULTIPARAMETRIC FLOW-CYTOMETRY; MULTIPLE-MYELOMA; NAME DISAMBIGUATION; CONSENSUS STATEMENT; EUROPEAN EXPERTS; NETWORK; THERAPY	Background International collaborative research is a mechanism for improving the development of disease-specific therapies and for improving health at the population level. However, limited data are available to assess the trends in research output related to orphan diseases. Methods and Findings We used bibliometric mapping and clustering methods to illustrate the level of fragmentation in myeloma research and the development of collaborative efforts. Publication data from Thomson Reuters Web of Science were retrieved for 2005-2009 and followed until 2013. We created a database of multiple myeloma publications, and we analysed impact and co-authorship density to identify scientific collaborations, developments, and international key players over time. The global annual publication volume for studies on multiple myeloma increased from 1,144 in 2005 to 1,628 in 2009, which represents a 43% increase. This increase is high compared to the 24% and 14% increases observed for lymphoma and leukaemia. The major proportion (> 90% of publications) was from the US and EU over the study period. The output and impact in terms of citations, identified several successful groups with a large number of intra-cluster collaborations in the US and EU. The US-based myeloma clusters clearly stand out as the most productive and highly cited, and the European Myeloma Network members exhibited a doubling of collaborative publications from 2005 to 2009, still increasing up to 2013. Conclusion and Perspective Multiple myeloma research output has increased substantially in the past decade. The fragmented European myeloma research activities based on national or regional groups are progressing, but they require a broad range of targeted research investments to improve multiple myeloma health care.	[Andersen, Jens Peter] Aalborg Univ Hosp, Med Lib, Aalborg, Denmark; [Bogsted, Martin; Dybkaer, Karen; Johnsen, Hans Erik] Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark; [Mellqvist, Ulf-Henrik] Sahlgrenska Hosp, Dept Hematol, Gothenburg, Sweden; [Morgan, Gareth J.] Inst Canc Res Haematol & Oncol, London, England; [Goldschmidt, Hartmut] Natl Ctr Tumorerkrankungen, Heidelberg, Germany; [Dimopoulos, Meletios A.] Univ Athens, Alexandra Gen Hosp, Dept Clin Therapeut, Athens, Greece; [Einsele, Hermann] Univ Wurzburg, Dept Internal Med 2, D-97070 Wurzburg, Germany; [San Miguel, Jesus] Univ Navarra, E-31080 Pamplona, Spain; [Palumbo, Antonio] Univ Turin, Dept Hematol, Turin, Italy; [Sonneveld, Pieter] Erasmus Univ Hosp, Dept Hematol, Rotterdam, Netherlands; [Mellqvist, Ulf-Henrik; Morgan, Gareth J.; Goldschmidt, Hartmut; Dimopoulos, Meletios A.; Einsele, Hermann; San Miguel, Jesus; Palumbo, Antonio; Sonneveld, Pieter; Johnsen, Hans Erik] European Myeloma Network Board, Aalborg, Denmark; [Bogsted, Martin; Dybkaer, Karen; Johnsen, Hans Erik] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark; [Bogsted, Martin; Dybkaer, Karen; Johnsen, Hans Erik] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Sahlgrenska University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Alexandra Hospital; National & Kapodistrian University of Athens; University of Wurzburg; University of Navarra; University of Turin; Erasmus University Rotterdam; Erasmus MC; Aalborg University; Aalborg University Hospital; Aalborg University	Johnsen, HE (corresponding author), Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark.	haej@rn.dk	Andersen, Jens Peter/H-4247-2019; Dimopoulos, Meletios Athanasios/AAD-4130-2019; San-Miguel, Jesús F./V-8977-2018; Goldschmidt, Hartmut/AAL-8069-2021	Andersen, Jens Peter/0000-0003-2444-6210; San-Miguel, Jesús F./0000-0002-9183-4857; Dybkaer, Karen/0000-0003-2488-435X; Dimopoulos, Meletios/0000-0001-8990-3254; Bogsted, Martin/0000-0001-9192-1814; Johnsen, Hans Erik/0000-0001-8253-2913; morgan, gareth/0000-0002-4271-6360	EU 6th FP [LSHC-CT-2006-037602]; Danish Cancer Society; Danish Research Agency [2101-07-0007]; KE Jensen Foundation; Obelske Family Foundation	EU 6th FP(European Commission); Danish Cancer Society(Danish Cancer Society); Danish Research Agency; KE Jensen Foundation; Obelske Family Foundation	This study was supported by research funds from the EU 6th FP to MSCNET (LSHC-CT-2006-037602, coordinator HEJ) (http://ec.europa.eu/research/fp6/index_en.cfm); from the Danish Cancer Society (http://www.cancer.dk/research/research+center+danish+cancer+society/); from the Danish Research Agency to CHEPRE (#2101-07-0007) (http://ufm.dk/en); from the KE Jensen Foundation 2006-2013) to HEJ and KD (http://www.kejfond.dk/); and from the Obelske Family Foundation to HEJ and MB (2006-2013) (http://www.obel.com/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DW, 2012, J INFORMETR, V6, P36, DOI 10.1016/j.joi.2011.08.002; Batagelj V, 2011, PAJEK PROGRAM ANAL V; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Dana Farber Cancer Institute Mayo Clinic, 2011, MULT MYEL SPORE GRAN; Dimopoulos MA, 2011, LEUKEMIA, V25, P749, DOI 10.1038/leu.2011.3; Engelhardt M, 2010, LEUKEMIA LYMPHOMA, V51, P2006, DOI 10.3109/10428194.2010.516378; Engelhardt M, 2010, LEUKEMIA LYMPHOMA, V51, P1424, DOI 10.3109/10428194.2010.487959; Fayers PM, 2011, BLOOD, V118, P1239, DOI 10.1182/blood-2011-03-341669; GARFIELD E, 1979, SCIENTOMETRICS, V1, P359, DOI 10.1007/BF02019306; Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257; Han H, 2005, ACM-IEEE J CONF DIG, P334, DOI 10.1145/1065385.1065462; Han H, 2004, ACM-IEEE J CONF DIG, P296, DOI 10.1145/996350.996419; Johnsen HE, 2010, CYTOM PART B-CLIN CY, V78B, P338, DOI 10.1002/cyto.b.20523; Leydesdorff L, 2010, J INFORMETR, V4, P644, DOI 10.1016/j.joi.2010.05.003; Liu WL, 2014, J ASSOC INF SCI TECH, V65, P765, DOI 10.1002/asi.23063; Morgan G, 2012, MYELOMA GENETICS INT; Morris A, 2008, ANNU REV INFORM SCI, V42, P213, DOI [10.1002/aris.2008.1440420113, DOI 10.1002/ARIS.2008.1440420113]; Otte E, 2002, J INF SCI, V28, P441, DOI 10.1177/016555150202800601; Palumbo A, 2011, BLOOD, V118, P4519, DOI 10.1182/blood-2011-06-358812; PETERS HPF, 1991, SCIENTOMETRICS, V20, P235, DOI 10.1007/BF02018157; Rawstron AC, 2008, HAEMATOLOGICA, V93, P431, DOI 10.3324/haematol.11080; Ross FM, 2012, HAEMATOL-HEMATOL J, V97, P1272, DOI 10.3324/haematol.2011.056176; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Sonneveld P, 2005, ACTA HAEMATOL-BASEL, V114, P14, DOI 10.1159/000087039; Sonneveld P, 2009, LEUKEMIA LYMPHOMA, V50, P1581, DOI [10.3109/10428190903191874, 10.1080/10428190903191874]; Terpos E, 2009, ANN ONCOL, V20, P1303, DOI 10.1093/annonc/mdn796; The U.S. National Cancer Institute, 2011, MYEL RES GRANT; Waltman L, 2013, J AM SOC INF SCI TEC, V64, P372, DOI 10.1002/asi.22775; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P2419, DOI 10.1002/asi.22708; Waltman L, 2011, J INFORMETR, V5, P37, DOI 10.1016/j.joi.2010.08.001	30	5	5	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116966	10.1371/journal.pone.0116966	http://dx.doi.org/10.1371/journal.pone.0116966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629620	Green Published, gold			2022-12-27	WOS:000348732100053
J	Chaudhry, V; Bhatia, A; Bharti, SK; Mishra, SK; Chauhan, PS; Mishra, A; Sidhu, OP; Nautiyal, CS				Chaudhry, Vasvi; Bhatia, Anil; Bharti, Santosh Kumar; Mishra, Shashank Kumar; Chauhan, Puneet Singh; Mishra, Aradhana; Sidhu, Om Prakash; Nautiyal, Chandra Shekhar			Metabolite Profiling Reveals Abiotic Stress Tolerance in Tn5 Mutant of Pseudomonas putida	PLOS ONE			English	Article							CYTOCHROME MUTANTS; GLYCINE-BETAINE; PLANT-GROWTH; PHOSPHATIDYLCHOLINE; EXPRESSION; ACID; TEMPERATURE; POLYAMINES; GENES; NMR	Pseudomonas is an efficient plant growth-promoting rhizobacteria (PGPR); however, intolerance to drought and high temperature limit its application in agriculture as a bioinoculant. Transposon 5 (Tn5) mutagenesis was used to generate a stress tolerant mutant from a PGPR Pseudomonas putida NBRI1108 isolated from chickpea rhizosphere. A mutant NBRI1108T, selected after screening of nearly 10,000 transconjugants, exhibited significant tolerance towards high temperature and drought. Southern hybridization analysis of EcoRI and XhoI restricted genomic DNA of NBRI1108T confirmed that it had a single Tn5 insertion. The metabolic changes in the polar and non-polar extracts of NBRI1108 and NBRI1108T were examined using H-1, P-31 nuclear magnetic resonance (NMR) spectroscopy and gas chromatography-mass spectrometry (GC-MS). Thirty six chemically diverse metabolites consisting of amino acids, fatty acids and phospholipids were identified and quantified. Insertion of Tn5 influenced amino acid and phospholipid metabolism and resulted in significantly higher concentration of aspartic acid, glutamic acid, glycinebetaine, glycerophosphatidylcholine (GPC) and putrescine in NBRI1108T as compared to that in NBRI1108. The concentration of glutamic acid, glycinebetaine and GPC increased by 34%, 95% and 100%, respectively in the NBRI1108T as compared to that in NBRI1108. High concentration of glycerophosphatidylethanolamine (GPE) and undetected GPC in NBRI1108 indicates that biosynthesis of GPE may have taken place via the methylation pathway of phospholipid biosynthesis. However, high GPC and low GPE concentration in NBRI1108T suggest that methylation pathway and phosphatidylcholine synthase (PCS) pathway of phospholipid biosynthesis are being followed in the NBRI1108T. Application of multivariate principal component analysis (PCA) on the quantified metabolites revealed clear variations in NBRI1108 and NBRI1108T in polar and non-polar metabolites. Identification of abiotic stress tolerant metabolites from the NBRI1108T suggest that Tn5 mutagenesis enhanced tolerance towards high temperature and drought. Tolerance to drought was further confirmed in greenhouse experiments with maize as host plant, where NBRI1108T showed relatively high biomass under drought conditions.	[Chaudhry, Vasvi; Bhatia, Anil; Bharti, Santosh Kumar; Mishra, Shashank Kumar; Chauhan, Puneet Singh; Mishra, Aradhana; Sidhu, Om Prakash; Nautiyal, Chandra Shekhar] Natl Bot Res Inst, CSIR, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Nautiyal, CS (corresponding author), Natl Bot Res Inst, CSIR, Rana Pratap Marg, Lucknow 226001, Uttar Pradesh, India.	nautiyalnbri@lycos.com	Chaudhry, Vasvi/AAH-9871-2020; Chauhan, Puneet Singh/AAB-7606-2019; Chaudhry, Vasvi/AAB-9095-2020; Bhatia, Anil/G-4566-2015	Chaudhry, Vasvi/0000-0001-9078-9292; Chauhan, Puneet Singh/0000-0001-5955-8656; Bhatia, Anil/0000-0001-8286-5574; Nautiyal, Chandra/0000-0003-3899-5034	New Initiative (as a Cross Flow Technology project) "Root Biology and its Correlation to Sustainable Plant Development and Soil Fertility" from Council of Scientific and Industrial Research (CSIR), New Delhi, India	New Initiative (as a Cross Flow Technology project) "Root Biology and its Correlation to Sustainable Plant Development and Soil Fertility" from Council of Scientific and Industrial Research (CSIR), New Delhi, India	The study was supported by New Initiative (as a Cross Flow Technology project) "Root Biology and its Correlation to Sustainable Plant Development and Soil Fertility" from Council of Scientific and Industrial Research (CSIR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELSALAM MS, 1987, MOL GEN GENET, V210, P165, DOI 10.1007/BF00337774; Bhatia A, 2013, PHYTOCHEMISTRY, V93, P105, DOI 10.1016/j.phytochem.2013.03.013; Boeris PS, 2012, MICROBIOL-SGM, V158, P1249, DOI 10.1099/mic.0.054072-0; BOTSFORD JL, 1990, APPL ENVIRON MICROB, V56, P488, DOI 10.1128/AEM.56.2.488-494.1990; Canamas TP, 2007, LETT APPL MICROBIOL, V45, P6, DOI 10.1111/j.1472-765X.2007.02156.x; Canovas D, 2000, MICROBIOL-SGM, V146, P455, DOI 10.1099/00221287-146-2-455; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Chaudhry V, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00560-13; Chauhan PS, 2010, LETT APPL MICROBIOL, V50, P205, DOI 10.1111/j.1472-765X.2009.02779.x; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukumori F, 1998, EXTREMOPHILES, V2, P395, DOI 10.1007/s007920050084; Kiewietdejonge A, 2006, FEMS YEAST RES, V6, P205, DOI 10.1111/j.1567-1364.2006.00030.x; KLOEPPER JW, 1980, NATURE, V286, P885, DOI 10.1038/286885a0; KRIAT M, 1993, J LIPID RES, V34, P1009; Kruger NJ, 2008, NAT PROTOC, V3, P1001, DOI 10.1038/nprot.2008.64; Markley JL, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P157; Martinez-Morales F, 2003, MICROBIOL-SGM, V149, P3461, DOI 10.1099/mic.0.26522-0; Medeot DB, 2007, CURR MICROBIOL, V54, P31, DOI 10.1007/s00284-006-0233-0; MENESES P, 1988, J LIPID RES, V29, P679; Mishra S, 2012, J APPL MICROBIOL, V112, P793, DOI 10.1111/j.1365-2672.2012.05256.x; Nakada Y, 2003, MICROBIOL-SGM, V149, P707, DOI 10.1099/mic.0.26009-0; NAUTIYAL CS, 1989, PLANT PHYSIOL, V90, P553, DOI 10.1104/pp.90.2.553; OBRIAN MR, 1987, J BACTERIOL, V169, P1089, DOI 10.1128/jb.169.3.1089-1094.1987; Oshima T, 2007, AMINO ACIDS, V33, P367, DOI 10.1007/s00726-007-0526-z; Page AF, 2012, AMINO ACIDS, V42, P295, DOI 10.1007/s00726-010-0807-9; Pinkart HC, 1997, J BACTERIOL, V179, P4219, DOI 10.1128/jb.179.13.4219-4226.1997; Rehman A, 2002, CURR MICROBIOL, V45, P368, DOI 10.1007/s00284-002-3770-1; Shen B, 1999, PLANT PHYSIOL, V121, P45, DOI 10.1104/pp.121.1.45; Srivastava S, 2008, CURR MICROBIOL, V56, P453, DOI 10.1007/s00284-008-9105-0; Srivastava S, 2012, PLANT SIGNAL BEHAV, V7, P235, DOI 10.4161/psb.18957; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; TALIBART R, 1994, J BACTERIOL, V176, P5210, DOI 10.1128/JB.176.17.5210-5217.1994; Viant MR, 2008, MOL BIOSYST, V4, P980, DOI 10.1039/b805354e; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; Wright LC, 1997, EUR J BIOCHEM, V243, P328, DOI 10.1111/j.1432-1033.1997.0328a.x; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	39	11	12	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0113487	10.1371/journal.pone.0113487	http://dx.doi.org/10.1371/journal.pone.0113487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629312	Green Submitted, Green Published, gold			2022-12-27	WOS:000348732100003
J	Tai, MLS; Norhatta, N; Goh, KJ; Moy, FM; Sujarita, R; Asraff, AA; Lee, QZ; Ng, JH; Tan, ECL; Mahadeva, S				Tai, Mei-Ling Sharon; Norhatta, Norbelinda; Goh, Khean Jin; Moy, Foong Ming; Sujarita, Ramanujam; Asraff, Azman Ahmad; Lee, Qin Zhi; Ng, Jiun Hoong; Tan, Eugene Choon Li; Mahadeva, Sanjiv			The Impact of Dyspepsia on Symptom Severity and Quality of Life in Adults with Headache	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; FUNCTIONAL GASTROINTESTINAL DISORDERS; NONULCER DYSPEPSIA; DEPRESSION SCALE; LEEDS DYSPEPSIA; ANXIETY; QUESTIONNAIRE; COMORBIDITY; PREVALENCE; VALIDATION	Background Dyspepsia and headache frequently co-exist, but the clinical implication of this association is uncertain. We planned to examine the prevalence and impact of dyspepsia in adults with headache. Methods A cross-sectional study was conducted in a secondary care setting. Clinical, psychological and health-related quality of life (HRQOL) data were compared between subjects with headache and controls (non-headache subjects). The impact of dyspepsia was analysed further in subjects with headache alone. Results 280 subjects (93 cases with headache and 187 matched controls) were recruited. The following baseline characteristics of subjects were as follows: mean age 45.0 +/- 17.3 years, 57.0% females and ethnic distribution-Malaysian = 45 (48.4%), Chinese n = 24 (25.8%) and Indians n = 24 (25.8%). Headache sub-types among cases with headache were as follows: tension-type headache (TTH) n = 53 (57.0%) and migraine n = 40 (43.0%). Dyspepsia was more prevalent in cases with headache compared to controls (25.8% vs 12.8%, p = 0.011), and headache was independently associated with dyspepsia (OR 2.75, 95% CI 1.39-5.43). Among cases with headache, there was a trend towards a higher prevalence of dyspepsia in those with migraine (27.5%) compared to TTH (24.5%). Subjects with headache and dyspepsia, compared to those with headache alone, had a greater severity of headache symptoms (63.67 +/- 22.85 mm vs 51.20 +/- 24.0 mm VAS, p = 0.029). Overall HRQOL scores were lower in headache subjects with dyspepsia (EQ-5D summary score 0.82 +/- 0.18 vs 0.90 +/- 0.16, p = 0.037 and EQ-5D VAS 62.08 +/- 17.50 mmvs 72.62 +/- 18.85mm, p = 0.018), compared to those without dyspepsia. Conclusion Dyspepsia is associated with more severe headache symptoms and results in a lower HRQOL in patients with headache.	[Tai, Mei-Ling Sharon; Norhatta, Norbelinda; Goh, Khean Jin; Asraff, Azman Ahmad; Lee, Qin Zhi; Ng, Jiun Hoong; Tan, Eugene Choon Li] Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur, Malaysia; [Moy, Foong Ming] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Sujarita, Ramanujam] Univ Malaya, Fac Med, Dept Primary Care, Kuala Lumpur, Malaysia; [Mahadeva, Sanjiv] Univ Malaya, Fac Med, Dept Med, Div Gastroenterol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Tai, MLS (corresponding author), Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur, Malaysia.	sharont1990@gmail.com	Moy, Foong Ming/B-7899-2010; Sharon, Tai Mei Ling/C-4458-2011; Goh, Khean Jin/D-1990-2010; Mahadeva, Sanjiv/E-1711-2011	Moy, Foong Ming/0000-0002-0306-4419; Sharon, Tai Mei Ling/0000-0001-9900-0446; Goh, Khean Jin/0000-0001-5416-9627; Mahadeva, Sanjiv/0000-0001-5824-0590	High Impact Research, University of Malaya [UM.C/625/1/HIR/MED/08 H-50001-00-E000035]	High Impact Research, University of Malaya	This work was supported by a grant from High Impact Research, University of Malaya UM.C/625/1/HIR/MED/08 H-50001-00-E000035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt AH, 2008, CEPHALALGIA, V28, P144, DOI 10.1111/j.1468-2982.2007.01486.x; Arakawa Tetsuo, 1997, Journal of Smooth Muscle Research, V33, P81; BECH P, 1981, ACTA PSYCHIAT SCAND, V63, P290, DOI 10.1111/j.1600-0447.1981.tb00676.x; Beghi E, 2007, NEUROL SCI, V28, pS217, DOI 10.1007/s10072-007-0780-6; Beghi E, 2010, J HEADACHE PAIN, V11, P141, DOI 10.1007/s10194-010-0187-2; Brooks R, 2005, QUAL LIFE RES, V14, P571; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Edvinsson L, 2001, CNS DRUGS, V15, P745, DOI 10.2165/00023210-200115100-00001; Fatt QK, 2007, INT J IMPOT RES, V19, P321, DOI 10.1038/sj.ijir.3901528; Guitera V, 2002, NEUROLOGY, V58, P1062, DOI 10.1212/WNL.58.7.1062; Hartono JL, 2012, J DIGEST DIS, V13, P252, DOI 10.1111/j.1751-2980.2012.00581.x; Herdman M, 2003, MEASUREMENT VALUATIO; Holtmann G, 1996, AM J GASTROENTEROL, V91, P485; KANEKO H, 1993, AM J GASTROENTEROL, V88, P898; Kurth T, 2006, CEPHALALGIA, V26, P506, DOI 10.1111/j.1468-2982.2005.01076.x; Lebedeva ER, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-101; Lucas C, 2012, HEADACHE, V52, P1005, DOI 10.1111/j.1526-4610.2012.02157.x; Mahadeva S, 2010, ALIMENT PHARM THER, V31, P1141, DOI 10.1111/j.1365-2036.2010.04270.x; Mahadeva S, 2006, WORLD J GASTROENTERO, V12, P2661, DOI 10.3748/wjg.v12.i17.2661; Mahadeva S, 2011, J GASTROEN HEPATOL, V26, P1669, DOI 10.1111/j.1440-1746.2011.06806.x; Mahadeva S, 2011, J GASTROEN HEPATOL, V26, P49, DOI 10.1111/j.1440-1746.2011.06656.x; Mahadeva S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-20; Manabe N, 2010, SCAND J GASTROENTERO, V45, P567, DOI 10.3109/00365521003592663; Meucci G, 2005, ENDOSCOPY, V37, P622, DOI 10.1055/s-2005-870251; Moayyedi P, 1998, ALIMENT PHARM THER, V12, P1257; Plourde V, 1997, AM J PHYSIOL-GASTR L, V273, pG191, DOI 10.1152/ajpgi.1997.273.1.G191; SICUTERI F, 1991, CLIN J PAIN, V7, pS38; Tai MLS, 2012, J HEADACHE PAIN, V13, P291, DOI 10.1007/s10194-012-0434-9; Tajti J, 2001, CEPHALALGIA, V21, P96, DOI 10.1046/j.1468-2982.2001.00140.x; TALLEY NJ, 1991, ALIMENT PHARM THERAP, V5, P145; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; van Kerkhoven LAS, 2009, J CLIN GASTROENTEROL, V43, P118, DOI 10.1097/MCG.0b013e31815591f7; Yu SY, 2011, J HEADACHE PAIN, V12, P141, DOI 10.1007/s10194-011-0336-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115838	10.1371/journal.pone.0115838	http://dx.doi.org/10.1371/journal.pone.0115838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629323	Green Submitted, Green Published, gold			2022-12-27	WOS:000348732100026
J	Herrera, VL; Pasion, KA; Moran, AM; Zaninello, R; Ortu, MF; Fresu, G; Piras, DA; Argiolas, G; Troffa, C; Glorioso, V; Masala, W; Glorioso, N; Ruiz-Opazo, N				Herrera, Victoria L.; Pasion, Khristine A.; Moran, Ann Marie; Zaninello, Roberta; Ortu, Maria Francesca; Fresu, Giovanni; Piras, Daniela Antonella; Argiolas, Giuseppe; Troffa, Chiara; Glorioso, Valeria; Masala, Wanda; Glorioso, Nicola; Ruiz-Opazo, Nelson			A Functional 12T-Insertion Polymorphism in the ATP1A1 Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population	PLOS ONE			English	Article							INSERTION-DELETION POLYMORPHISM; NA,K-ATPASE GENE; NFKB1 GENE; SALT; ASSOCIATION; SODIUM; RISK; TRANSPORT; ATTG; NA+,K+-ATPASE	Identification of susceptibility genes for essential hypertension in humans has been a challenge due to its multifactorial pathogenesis complicated by gene-gene and gene-environment interactions, developmental programing and sex specific differences. These concurrent features make identification of causal hypertension susceptibility genes with a single approach difficult, thus requiring multiple lines of evidence involving genetic, biochemical and biological experimentation to establish causal functional mutations. Here we report experimental evidence encompassing genetic, biochemical and in vivo modeling that altogether support ATP1A1 as a hypertension susceptibility gene in males in Sardinia, Italy. ATP1A1 encodes the alpha 1Na, K-ATPase isoform, the sole sodium pump in vascular endothelial and renal tubular epithelial cells. DNA-sequencing detected a 12-nucleotide long thymidine (12T) insertion(ins)/deletion(del) polymorphism within a poly-T sequence (38T vs 26T) in the ATP1A1 5'-regulatory region associated with hypertension in a male Sardinian population. The 12T-insertion allele confers decreased susceptibility to hypertension (P = 0.035; OR = 0.50 [0.28-0.93]) accounting for 12.1 mmHg decrease in systolic BP (P = 0.02) and 6.6 mmHg in diastolic BP (P = 0.046). The ATP1A1 promoter containing the 12T-insertion exhibited decreased transcriptional activity in in vitro reporter-assay systems, indicating decreased a1Na, K-ATPase expression with the 12T-insertion, compared with the 12T-deletion ATP1A1 promoter. To test the effects of decreased a1Na, K-ATPase expression on blood pressure, we measured blood pressure by radiotelemetry in three month-old, highly inbred heterozygous knockout ATP1A1+/- male mice with resultant 58% reduction in ATP1A1 protein levels. Male ATP1A1+/- mice showed significantly lower blood pressure (P < 0.03) than age-matched male wild-type littermate controls. Concordantly, lower ATP1A1 expression is expected to lower Na-reabsorption in the kidney thereby decreasing sodium-associated risk for hypertension and sodium-induced endothelial stiffness and dysfunction. Altogether, data support ATP1A1 as a hypertension susceptibility gene in a male Sardinian population, and mandate further investigation of its involvement in hypertension in the general population.	[Zaninello, Roberta; Ortu, Maria Francesca; Fresu, Giovanni; Piras, Daniela Antonella; Argiolas, Giuseppe; Troffa, Chiara; Glorioso, Valeria; Masala, Wanda; Glorioso, Nicola] Univ Sassari, AOU, Hypertens & Related Dis Ctr, I-07100 Sassari, Sardinia, Italy; [Herrera, Victoria L.; Pasion, Khristine A.; Moran, Ann Marie; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	University of Sassari; Boston University	Ruiz-Opazo, N (corresponding author), Boston Univ, Sch Med, Dept Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA.	nruizo@bu.edu			National Institutes of Health [HL098939]; "Associazione per la ricerca sull'ipertensione arteriosa e le malattie cardiovascolari" ONLUS, Sassari, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Associazione per la ricerca sull'ipertensione arteriosa e le malattie cardiovascolari" ONLUS, Sassari, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by National Institutes of Health grant HL098939 to NR-O. Partial financial support for this project was provided by the "Associazione per la ricerca sull'ipertensione arteriosa e le malattie cardiovascolari" ONLUS, Sassari, Italy to NG, RZ, MFR, GF, DAP, GA, CT, WM, and VG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussemaker E, 2010, AM J KIDNEY DIS, V55, P1111, DOI 10.1053/j.ajkd.2009.12.022; Cai HZ, 2013, UROL INT, V91, P206, DOI 10.1159/000345630; CANESSA M, 1993, J MEMBRANE BIOL, V134, P107; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Chen ZQ, 2014, GENET TEST MOL BIOMA, V18, P112, DOI 10.1089/gtmb.2013.0375; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fukue Y, 2004, NUCLEIC ACIDS RES, V32, P5834, DOI 10.1093/nar/gkh905; Glorioso N, 2001, HYPERTENSION, V38, P204, DOI 10.1161/01.HYP.38.2.204; Glorioso N, 2007, CIRC RES, V100, P1522, DOI 10.1161/01.RES.0000267716.96196.60; Glorioso N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077562; Glorioso N, 2011, PHYSIOL GENOMICS, V43, P1219, DOI 10.1152/physiolgenomics.00012.2011; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; HERRERA VLM, 1994, J HYPERTENS, V12, P847; Herrera VLM, 2005, PHYSIOL GENOMICS, V23, P257, DOI 10.1152/physiolgenomics.00144.2005; Herrera VLM, 1998, J CLIN INVEST, V102, P1102, DOI 10.1172/JCI3868; HERRERA VLM, 1990, SCIENCE, V249, P1023, DOI 10.1126/science.1975705; Hoefgen B, 2005, BIOL PSYCHIAT, V57, P247, DOI 10.1016/j.biopsych.2004.11.027; Jaitovich A, 2010, LIFE SCI, V86, P73, DOI 10.1016/j.lfs.2009.10.019; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Kaneko Y, 2005, J HYPERTENS, V23, P745, DOI 10.1097/01.hjh.0000163142.89835.c7; Kava L, 2012, AM J HYPERTENS, V25, P487, DOI 10.1038/ajh.2011.247; Krenek P, 2006, J VASC RES, V43, P502, DOI 10.1159/000095963; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Li PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071604; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Oberleithner H, 2014, NEPHROL DIAL TRANSPL, V29, P240, DOI 10.1093/ndt/gft461; Oberleithner H, 2011, PFLUG ARCH EUR J PHY, V462, P519, DOI 10.1007/s00424-011-0999-1; Oberleithner H, 2011, BLOOD PURIFICAT, V31, P82, DOI 10.1159/000321842; PIAZZA A, 1993, SCIENCE, V260, P1767, DOI 10.1126/science.8511584; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; RUIZOPAZO N, 1994, HYPERTENSION, V24, P260, DOI 10.1161/01.HYP.24.3.260; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Suzairi MSM, 2013, CANCER EPIDEMIOL, V37, P634, DOI 10.1016/j.canep.2013.05.007; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; Wang XY, 2009, CURR OPIN NEPHROL HY, V18, P412, DOI 10.1097/MNH.0b013e32832f5775; Wang YB, 2014, J AM SOC NEPHROL, V25, P250, DOI 10.1681/ASN.2013040429	40	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116724	10.1371/journal.pone.0116724	http://dx.doi.org/10.1371/journal.pone.0116724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615575	gold, Green Submitted, Green Published			2022-12-27	WOS:000349122100038
J	Pavan, A; Greenlee, MW				Pavan, Andrea; Greenlee, Mark W.			Effects of Crowding and Attention on High-Levels of Motion Processing and Motion Adaptation	PLOS ONE			English	Article							CLASSICAL RECEPTIVE-FIELD; OPTIC FLOW STIMULI; CORTICAL AREAS MT; COMPLEX MOTION; VISUAL-MOTION; MST NEURONS; RESPONSE SELECTIVITY; SPATIAL ATTENTION; SPIRAL MOTION; PERCEPTION	The motion after-effect (MAE) persists in crowding conditions, i.e., when the adaptation direction cannot be reliably perceived. The MAE originating from complex moving patterns spreads into non-adapted sectors of a multi-sector adapting display (i.e., phantom MAE). In the present study we used global rotating patterns to measure the strength of the conventional and phantom MAEs in crowded and non-crowded conditions, and when attention was directed to the adapting stimulus and when it was diverted away from the adapting stimulus. The results show that: (i) the phantom MAE is weaker than the conventional MAE, for both non-crowded and crowded conditions, and when attention was focused on the adapting stimulus and when it was diverted from it, (ii) conventional and phantom MAEs in the crowded condition are weaker than in the non-crowded condition. Analysis conducted to assess the effect of crowding on high-level of motion adaptation suggests that crowding is likely to affect the awareness of the adapting stimulus rather than degrading its sensory representation, (iii) for high-level of motion processing the attentional manipulation does not affect the strength of either conventional or phantom MAEs, neither in the non-crowded nor in the crowded conditions. These results suggest that high-level MAEs do not depend on attention and that at high-level of motion adaptation the effects of crowding are not modulated by attention.	[Pavan, Andrea; Greenlee, Mark W.] Univ Regensburg, Inst Psychol, Expt & Clin Neurosci Study Programme, D-93053 Regensburg, Germany; [Pavan, Andrea] Lincoln Univ, Sch Psychol, Brayford Pool LN6 7TS, Lincoln, England	University of Regensburg; University of Lincoln	Pavan, A (corresponding author), Univ Regensburg, Inst Psychol, Expt & Clin Neurosci Study Programme, Univ Str 31, D-93053 Regensburg, Germany.	andrea.pavan@psychologie.uni-regensburg.de	Greenlee, Mark/M-6414-2018	Greenlee, Mark/0000-0003-2305-9286; Pavan, Andrea/0000-0002-7697-6320	Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft (DFG) [GR988/20-2]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by grants from the Alexander von Humboldt Foundation (author AP) and the Deutsche Forschungsgemeinschaft (DFG) (author MWG, GR988/20-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdaee SM, 2005, PERCEPTION, V34, P155, DOI 10.1068/p5298; Aghdaee SM, 2005, VISION RES, V45, P1099, DOI 10.1016/j.visres.2004.11.012; Alais D, 1999, NAT NEUROSCI, V2, P1015, DOI 10.1038/14814; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Anderson EJ, 2012, CURR BIOL, V22, P1199, DOI 10.1016/j.cub.2012.04.063; Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Bahrami B, 2008, J VISION, V8, DOI 10.1167/8.3.12; BERKSON J, 1953, J AM STAT ASSOC, V48, P565; Bi TY, 2009, J VISION, V9, DOI 10.1167/9.11.13; Bondarenko V M, 2012, Fiziol Cheloveka, V38, P33; BONNET C, 1972, PERCEPT PSYCHOPHYS, V12, P193, DOI 10.3758/BF03212869; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp JW, 2010, J COGNITIVE NEUROSCI, V22, P2326, DOI 10.1162/jocn.2009.21397; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Burr DC, 1998, VISION RES, V38, P1731, DOI 10.1016/S0042-6989(97)00346-5; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; CHAUDHURI A, 1990, NATURE, V344, P60, DOI 10.1038/344060a0; Chen J, 2014, J NEUROSCI, V34, P10465, DOI 10.1523/JNEUROSCI.1140-14.2014; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Cohen MA, 2012, TRENDS COGN SCI, V16, P411, DOI 10.1016/j.tics.2012.06.013; Culham JC, 2000, NEURON, V28, P607, DOI 10.1016/S0896-6273(00)00137-9; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.2.13; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Ezzati A, 2008, J VISION, V8, DOI 10.1167/8.14.23; Faivre N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00129; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Fang F, 2008, J VISION, V8, DOI 10.1167/8.9.6; Freeman J, 2011, J VISION, V11, DOI 10.1167/11.4.15; Geesaman BJ, 1998, VISION RES, V38, P1223, DOI 10.1016/S0042-6989(97)00279-4; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Greenlee M W, 2000, Int Rev Neurobiol, V44, P269; Greenwood JA, 2010, CURR BIOL, V20, P496, DOI 10.1016/j.cub.2010.01.023; Harp TD, 2007, J VISION, V7, DOI 10.1167/7.2.15; Haug BA, 1998, NEUROREPORT, V9, P611, DOI 10.1097/00001756-199803090-00009; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Ho C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028814; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Ikeda H, 2013, J VISION, V13, DOI 10.1167/13.4.20; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Kaunitz L, 2011, J VISION, V11, DOI 10.1167/11.13.10; Knapen T, 2009, J VISION, V9, DOI [10.1167/9.13.16, 10.1167/9.5.16]; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; LANKHEET MJM, 1995, VISION RES, V35, P1401, DOI 10.1016/0042-6989(95)98720-T; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Malania M, 2007, J VISION, V7, DOI 10.1167/7.2.1; Manassi M, 2012, J VISION, V12, DOI 10.1167/12.10.13; Mareschal I, 2010, VISION RES, V50, P805, DOI 10.1016/j.visres.2010.01.022; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; Maruya K, 2008, J VISION, V8, DOI 10.1167/8.11.7; Mather G, 2008, TRENDS COGN SCI, V12, P481, DOI 10.1016/j.tics.2008.09.002; Millin R, 2014, CEREB CORTEX, V24, P3107, DOI 10.1093/cercor/bht159; Mineault PJ, 2012, P NATL ACAD SCI USA, V109, pE972, DOI 10.1073/pnas.1115685109; Montaser-Kouhsari L, 2005, VISION RES, V45, P839, DOI 10.1016/j.visres.2004.10.020; Morgan M, 2013, J VISION, V13, DOI 10.1167/13.8.26; Morgan M, 2012, ATTEN PERCEPT PSYCHO, V74, P185, DOI 10.3758/s13414-011-0222-7; Morgan MJ, 2012, VISION RES, V55, P47, DOI 10.1016/j.visres.2011.12.009; Morgan MJ, 2011, VISION RES, V51, P2169, DOI 10.1016/j.visres.2011.07.018; MORGAN MJ, 1980, Q J EXP PSYCHOL, V32, P387, DOI 10.1080/14640748008401833; MORRONE MC, 1995, NATURE, V376, P507, DOI 10.1038/376507a0; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; MURAKAMI I, 1995, VISION RES, V35, P1835, DOI 10.1016/0042-6989(94)00269-R; Nandy AS, 2007, J VISION, V7, DOI 10.1167/7.2.5; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pavan A, 2013, J VISION, V13, DOI 10.1167/13.6.16; Pelli DG, 2008, CURR OPIN NEUROBIOL, V18, P445, DOI 10.1016/j.conb.2008.09.008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Petrov Y, 2011, VISION RES, V51, P1117, DOI 10.1016/j.visres.2011.03.001; Petrov Y, 2011, J VISION, V11, DOI 10.1167/11.4.1; Popple AV, 2005, VISION RES, V45, P1085, DOI 10.1016/j.visres.2004.11.008; Price NSC, 2004, VISION RES, V44, P1971, DOI 10.1016/j.visres.2004.04.001; Rajimehr R, 2004, VISION RES, V44, P925, DOI 10.1016/j.visres.2003.11.020; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; REGAN D, 1985, J OPT SOC AM A, V2, P280, DOI 10.1364/JOSAA.2.000280; Rutschmann RM, 2000, EXP BRAIN RES, V134, P533, DOI 10.1007/s002210000502; SAKATA H, 1985, VISION RES, V25, P453, DOI 10.1016/0042-6989(85)90070-7; SAKATA H, 1986, EXP BRAIN RES, V61, P658; Scase MO, 1996, VISION RES, V36, P2579, DOI 10.1016/0042-6989(95)00325-8; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Snowden RJ, 1996, J COGNITIVE NEUROSCI, V8, P435, DOI 10.1162/jocn.1996.8.5.435; Snowden RJ, 1997, CURR BIOL, V7, P717, DOI 10.1016/S0960-9822(06)00329-0; Solomon JA, 2010, J VISION, V10, DOI 10.1167/10.14.19; Spivey MJ, 2000, PERCEPT PSYCHOPHYS, V62, P1525, DOI 10.3758/BF03212153; Strasburger H, 2005, J VISION, V5, P1024, DOI 10.1167/5.11.8; Strasburger H, 2013, J VISION, V13, DOI 10.1167/13.1.24; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TOET A, 1992, VISION RES, V32, P1349, DOI 10.1016/0042-6989(92)90227-A; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Verstraten FAJ, 2005, VISION RES, V45, P1313, DOI 10.1016/j.visres.2004.11.007; Wade NJ, 1996, VISION RES, V36, P2167, DOI 10.1016/0042-6989(95)00266-9; Wall MB, 2008, EUR J NEUROSCI, V27, P2747, DOI 10.1111/j.1460-9568.2008.06249.x; Wallis TSA, 2011, CURR BIOL, V21, P254, DOI 10.1016/j.cub.2011.01.011; WEISSTEIN N, 1977, SCIENCE, V198, P955, DOI 10.1126/science.929181; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; Wohlgemuth A., 1911, AFTER EFFECT SEEN MO, V1; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008; Yeshurun Y, 2010, J VISION, V10, DOI 10.1167/10.10.16	114	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117233	10.1371/journal.pone.0117233	http://dx.doi.org/10.1371/journal.pone.0117233			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25615577	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100060
J	De Belder, M; Abrahamse, E; Kerckhof, E; Fias, W; van Dijck, JP				De Belder, Maya; Abrahamse, Elger; Kerckhof, Emma; Fias, Wim; van Dijck, Jean-Philippe			Serial Position Markers in Space: Visuospatial Priming of Serial Order Working Memory Retrieval	PLOS ONE			English	Article							SHORT-TERM; MENTAL REPRESENTATION; SPATIAL ATTENTION; INFORMATION; MODEL; TIME; INTERFERENCE; PERFORMANCE; LOCATIONS; SIMON	Most general theories on serial order working memory (WM) assume the existence of position markers that are bound to the to-be-remembered items to keep track of the serial order. So far, the exact cognitive/neural characteristics of these markers have remained largely underspecified, while direct empirical evidence for their existence is mostly lacking. In the current study we demonstrate that retrieval from verbal serial order WM can be facilitated or hindered by spatial cuing: begin elements of a verbal WM sequence are retrieved faster after cuing the left side of space, while end elements are retrieved faster after cuing the right side of space. In direct complement to our previous work-where we showed the reversed impact of WM retrieval on spatial processing-we argue that the current findings provide us with a crucial piece of evidence suggesting a direct and functional involvement of space in verbal serial order WM. We outline the idea that serial order in verbal WM is coded within a spatial coordinate system with spatial attention being involved when searching through WM, and we discuss how this account can explain several hallmark observations related to serial order WM.	[De Belder, Maya; Abrahamse, Elger; Kerckhof, Emma; Fias, Wim; van Dijck, Jean-Philippe] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Ghent University	De Belder, M (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	maya.debelder@ugent.be	Fias, Wim/D-6861-2010	Fias, Wim/0000-0002-5788-7306; Abrahamse, Elger/0000-0002-9361-2916; van Dijck, Jean-Philippe/0000-0003-0378-3891	Research Foundation Flanders (FWO) [FWOOPR2013013401]; FWO [12C4715N]; Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioural control"; Interuniversity Attraction Poles Program of the Belgian Federal Government [P7/11]	Research Foundation Flanders (FWO)(FWO); FWO(FWO); Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioural control"; Interuniversity Attraction Poles Program of the Belgian Federal Government(Belgian Federal Science Policy Office)	The project was funded by Research Foundation Flanders (FWO), grant number FWOOPR2013013401. Elger Abrahamse was supported by FWO under contract number 12C4715N. This work was further supported by the Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioural control," and by the Interuniversity Attraction Poles Program of the Belgian Federal Government (Grant number P7/11). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrahamse E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00932; Attout L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092049; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Bahcall DO, 1999, VISION RES, V39, P71, DOI 10.1016/S0042-6989(98)00090-X; Barrouillet P, 2013, ACTA PSYCHOL, V142, P155, DOI 10.1016/j.actpsy.2012.12.003; Bonato M, 2012, NEUROSCI BIOBEHAV R, V36, P2257, DOI 10.1016/j.neubiorev.2012.08.007; Botvinick M, 2007, J NEUROSCI, V27, P8636, DOI 10.1523/JNEUROSCI.2110-07.2007; BOWER GH, 1970, AM SCI, V58, P496; Brown GDA, 2000, PSYCHOL REV, V107, P127, DOI 10.1037/0033-295X.107.1.127; Cave KR, 1997, PSYCHOL SCI, V8, P399, DOI 10.1111/j.1467-9280.1997.tb00433.x; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Della Sala S, 2010, Q J EXP PSYCHOL, V63, P848, DOI 10.1080/17470211003690672; FIAS W, 2011, SPACE TIME NUMBER BR, V24, P34217; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; FISCHERBAUM S, 2014, PSYCHON B REV, P1; Ginsburg V, 2014, J EXP PSYCHOL LEARN, V40, P976, DOI 10.1037/a0036378; Henson RNA, 1998, COGNITIVE PSYCHOL, V36, P73, DOI 10.1006/cogp.1998.0685; Hurlstone MJ, 2014, PSYCHOL BULL, V140, P339, DOI 10.1037/a0034221; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Kalm K, 2014, J NEUROSCI, V34, P6879, DOI 10.1523/JNEUROSCI.4104-13.2014; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; Maass A, 2003, PSYCHOL SCI, V14, P296, DOI 10.1111/1467-9280.14421; Majerus S, 2010, J COGNITIVE NEUROSCI, V22, P2570, DOI 10.1162/jocn.2009.21378; Marshuetz C, 2000, J COGNITIVE NEUROSCI, V12, P130, DOI 10.1162/08989290051137459; Marshuetz C, 2005, PSYCHOL BULL, V131, P323, DOI 10.1037/0033-2909.131.3.323; Nobre AC, 2004, J COGNITIVE NEUROSCI, V16, P363, DOI 10.1162/089892904322926700; Oberauer K, 2009, PSYCHOL LEARN MOTIV, V51, P45, DOI 10.1016/S0079-7421(09)51002-X; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Pratt J, 1999, J EXP PSYCHOL HUMAN, V25, P730, DOI 10.1037/0096-1523.25.3.730; Spalek TM, 2005, PSYCHOL SCI, V16, P15, DOI 10.1111/j.0956-7976.2005.00774.x; STERNBERG S, 1967, PERCEPT PSYCHOPHYS, V2, P45, DOI 10.3758/BF03212460; Stoianov I, 2008, COGNITION, V106, P770, DOI 10.1016/j.cognition.2007.04.013; van Dijck JP, 2013, PSYCHOL SCI, V24, P1854, DOI 10.1177/0956797613479610; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013; VANDIJCK JP, 2014, Q J EXP PSYCHOL, P1; Volkmann Ludwig, 1929, JAHBURCH KUNSTHISTOR, V3, P111; ZORZI M, 1995, PSYCHOL RES-PSYCH FO, V58, P193, DOI 10.1007/BF00419634	38	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116469	10.1371/journal.pone.0116469	http://dx.doi.org/10.1371/journal.pone.0116469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611595	Green Published, gold			2022-12-27	WOS:000348562900016
J	Fan, HF; Liu, ZN; Chow, SY; Lu, YH; Li, H				Fan, Hsiu-Fang; Liu, Zi-Ning; Chow, Sih-Yao; Lu, Yi-Han; Li, Hsin			Histone Chaperone-Mediated Nucleosome Assembly Process	PLOS ONE			English	Article							TETHERED PARTICLE MOTION; SINGLE CHROMATIN FIBERS; PHYSIOLOGICAL IONIC-STRENGTH; CORE PARTICLE; MAGNETIC TWEEZERS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; H3.H4 TETRAMER; DNA MOLECULE; IN-VITRO	A huge amount of information is stored in genomic DNA and this stored information resides inside the nucleus with the aid of chromosomal condensation factors. It has been reported that the repeat nucleosome core particle (NCP) consists of 147-bp of DNA and two copies of H2A, H2B, H3 and H4. Regulation of chromosomal structure is important to many processes inside the cell. In vivo, a group of histone chaperones facilitate and regulate nucleosome assembly. How NCPs are constructed with the aid of histone chaperones remains unclear. In this study, the histone chaperone-mediated nucleosome assembly process was investigated using single-molecule tethered particle motion (TPM) experiments. It was found that Asf1 is able to exert more influence than Nap1 and poly glutamate acid (PGA) on the nucleosome formation process, which highlights Asf1's specific role in tetrasome formation. Thermodynamic parameters supported a model whereby energetically favored nucleosomal complexes compete with non-nucleosomal complexes. In addition, our kinetic findings propose the model that histone chaperones mediate nucleosome assembly along a path that leads to enthalpy-favored products with free histones as reaction substrates.	[Fan, Hsiu-Fang; Chow, Sih-Yao; Lu, Yi-Han] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Fan, Hsiu-Fang; Chow, Sih-Yao; Lu, Yi-Han] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Fan, Hsiu-Fang] Natl Yang Ming Univ, Biophoton Interdisciplinary Res Ctr, Taipei 112, Taiwan; [Liu, Zi-Ning; Li, Hsin] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Fan, HF (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	hffan2@ym.edu.tw	Chow, Sih-Yao/AAD-4236-2022	Chow, Sih-Yao/0000-0001-9994-691X	Ministry of Science and Technology of Taiwan; Yang Ming University	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Yang Ming University	This work is supported by the Ministry of Science and Technology of Taiwan and by Yang Ming University, with support to HFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bennink ML, 2001, NAT STRUCT BIOL, V8, P606, DOI 10.1038/89646; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; BONNER WM, 1975, J CELL BIOL, V64, P421, DOI 10.1083/jcb.64.2.421; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; D'Arcy S, 2013, MOL CELL, V51, P662, DOI 10.1016/j.molcel.2013.07.015; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dinant C, 2013, MOL CELL, V51, P469, DOI 10.1016/j.molcel.2013.08.007; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Donham DC, 2011, NUCLEIC ACIDS RES, V39, P5449, DOI 10.1093/nar/gkr097; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Elsasser SJ, 2012, BBA-GENE REGUL MECH, V1819, P211, DOI 10.1016/j.bbagrm.2011.07.007; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Fan HF, 2013, NUCLEIC ACIDS RES, V41, P7031, DOI 10.1093/nar/gkt424; Fan HF, 2012, NUCLEIC ACIDS RES, V40, P6208, DOI 10.1093/nar/gks274; Fan HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021359; Fan HF, 2009, BIOPHYS J, V96, P1875, DOI [10.1016/j.bpj.2008.11.048, 10.1016/j.bpj.2()08.11.048]; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Gupta P, 2009, BIOPHYS J, V97, P3150, DOI 10.1016/j.bpj.2009.09.032; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Ito T, 1996, MOL CELL BIOL, V16, P3112; JACKSON V, 1988, BIOCHEMISTRY-US, V27, P2109, DOI 10.1021/bi00406a044; JORCANO JL, 1979, BIOCHEMISTRY-US, V18, P768, DOI 10.1021/bi00572a005; Kadyrova LY, 2013, CELL CYCLE, V12, P3286, DOI 10.4161/cc.26310; KLEINSCHMIDT JA, 1990, EMBO J, V9, P1309, DOI 10.1002/j.1460-2075.1990.tb08240.x; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Ladoux B, 2000, P NATL ACAD SCI USA, V97, P14251, DOI 10.1073/pnas.250471597; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Leuba SH, 2003, P NATL ACAD SCI USA, V100, P495, DOI 10.1073/pnas.0136890100; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lu YW, 2013, BIOCHEMISTRY-US, V52, P7714, DOI 10.1021/bi4010478; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ma CH, 2013, J MOL BIOL; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Moshkin YM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003719; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Pascoalino B, 2014, NUCLEIC ACIDS RES, V42, P2906, DOI 10.1093/nar/gkt1267; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Platonova O, 2011, BIOCHEMISTRY-US, V50, P8078, DOI 10.1021/bi2006652; Pope LH, 2005, BIOPHYS J, V88, P3572, DOI 10.1529/biophysj.104.053074; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; RUIZCARRILLO A, 1979, BIOCHEMISTRY-US, V18, P760, DOI 10.1021/bi00572a004; RUIZCARRILLO A, 1979, P NATL ACAD SCI USA, V76, P3284, DOI 10.1073/pnas.76.7.3284; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; STEIN A, 1979, P NATL ACAD SCI USA, V76, P5000, DOI 10.1073/pnas.76.10.5000; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tanaka H, 2002, NATURE, V415, P192, DOI 10.1038/415192a; Tomschik M, 2005, P NATL ACAD SCI USA, V102, P3278, DOI 10.1073/pnas.0500189102; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Vlijm R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046306; Wagner G, 2005, BIOPHYS J, V89, P3647, DOI 10.1529/biophysj.105.062786; WILHELM FX, 1978, NUCLEIC ACIDS RES, V5, P505, DOI 10.1093/nar/5.2.505; Winkler DD, 2012, NUCLEIC ACIDS RES, V40, P10139, DOI 10.1093/nar/gks812; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Zhao H, 2012, CELL PHYSIOL BIOCHEM, V30, P1383, DOI 10.1159/000343327; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465; Zhou Z, 2011, NATURE, V472, P234, DOI 10.1038/nature09854; Zlatanova J, 2007, FASEB J, V21, P1294, DOI 10.1096/fj.06-7199rev	74	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115007	10.1371/journal.pone.0115007	http://dx.doi.org/10.1371/journal.pone.0115007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611318	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900002
J	Zhang, WC; Jia, CX; Zhang, JY; Wang, LL; Liu, XC				Zhang, Wen-Chao; Jia, Cun-Xian; Zhang, Ji-Yu; Wang, Lin-Lin; Liu, Xian-Chen			Negative Life Events and Attempted Suicide in Rural China	PLOS ONE			English	Article							RISK-FACTORS; MENTAL-HEALTH; IDEATION; BEHAVIOR; PREVALENCE; PREVENTION; DISORDERS; ILLNESS; ADULTS	Objective This study aimed to examine the association between negative life events (NLEs) and attempted suicide in rural China. Methods Six rural counties were selected from disease surveillance points in Shandong province, China. A total of 409 suicide attempters in rural areas between October 1, 2009, and March 31, 2011, and an equal number of matched controls were interviewed. We compared negative life events experienced within 1 month, 1-3 months, 3-6 months, and 6-2 months prior to attempted suicide for cases and prior to interview for controls. We used multivariate logistic regression to examine the association between NLEs and attempted suicide. Results Suicide attempters experienced more NLEs within the last year prior to suicide attempt than controls prior to interview (83.1% vs. 33.5%). There was a significant dose-response relationship between NLEs experienced within the last year and increased risk of attempted suicide. Timing of NLEs analysis showed that NLEs experienced in the last month and 6-12 months prior to suicide attempt were significantly associated with elevated risk of attempted suicide, even after adjusting for mental disorders and demographic factors. Of NLEs, quarrelling with spouse, quarrelling with other family members, conflicting with friends or neighbors, family financial difficulty, and serious illness were independently related to attempted suicide. Conclusion NLEs are significantly associated with increased risk for attempted suicide in rural China. Stress management and intervention may be important to prevent suicidal behavior in rural China.	[Zhang, Wen-Chao; Jia, Cun-Xian; Liu, Xian-Chen] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China; [Jia, Cun-Xian] Shandong Univ, Ctr Suicide Prevent Res, Jinan 250100, Peoples R China; [Zhang, Ji-Yu] Shandong Ctr Dis Prevent & Control, Jinan, Peoples R China; [Wang, Lin-Lin] Jinan Shizhongqu Ctr Dis Prevent & Control, Jinan, Peoples R China; [Liu, Xian-Chen] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA	Shandong University; Shandong University; University of Tennessee System; University of Tennessee Health Science Center	Jia, CX (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China.	jiacunxian@sdu.edu.cn	zhang, jiyu/W-9297-2018	zhang, jiyu/0000-0001-6236-8781	National Natural Science Foundation of China (NSFC) [30972527]; Distinguished Youth Cultivation Project of Shandong University School of Public Health; Fundamental Research Funds of Shandong University [2014JC043]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Distinguished Youth Cultivation Project of Shandong University School of Public Health; Fundamental Research Funds of Shandong University	This work was supported by the funds from National Natural Science Foundation of China (NSFC) [No: 30972527], the Distinguished Youth Cultivation Project of Shandong University School of Public Health, and the Fundamental Research Funds of Shandong University [No: 2014JC043]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagge CL, 2013, J ABNORM PSYCHOL, V122, P359, DOI 10.1037/a0030371; Beautrais AL, 2000, AUST NZ J PSYCHIAT, V34, P420, DOI 10.1080/j.1440-1614.2000.00691.x; Blasco-Fontecilla H, 2012, ARCH SUICIDE RES, V16, P13, DOI 10.1080/13811118.2012.640616; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Braunschweiger P, 2007, ACAD MED, V82, P861, DOI 10.1097/ACM.0b013e31812f7770; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; *CIOMS, 2002, INTERNATIONAL ETHICA; Conner Kenneth R, 2012, Drug Alcohol Depend, V120, P155, DOI 10.1016/j.drugalcdep.2011.07.013; Cooper J, 2002, SOC PSYCH PSYCH EPID, V37, P271, DOI 10.1007/s001270200019; DeLeo D., 2002, WORLD REPORT VIOLENC, P183; DOHRENWEND BS, 1978, J HEALTH SOC BEHAV, V19, P205, DOI 10.2307/2136536; Duberstein PR, 2004, PSYCHOL MED, V34, P137, DOI 10.1017/S0033291703008584; First M.B., 2016, STRUCTURED CLIN INTE; Foster T, 2011, ARCH SUICIDE RES, V15, P1, DOI 10.1080/13811118.2011.540213; Goodwin RD, 2011, CRISIS, V32, P346, DOI 10.1027/0227-5910/a000104; Greenland S, 2000, AM J EPIDEMIOL, V151, P531; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Horesh N, 2011, J AFFECT DISORDERS, V134, P434, DOI 10.1016/j.jad.2011.05.034; Horesh N, 2009, COMPR PSYCHIAT, V50, P496, DOI 10.1016/j.comppsych.2009.01.006; Hsiao FH, 2006, J CLIN NURS, V15, P998, DOI 10.1111/j.1365-2702.2006.01331.x; Jang JM, 2014, PSYCHIAT RES, V216, P74, DOI 10.1016/j.psychres.2013.12.054; Klonsky ED, 2012, SUICIDE LIFE-THREAT, V42, P1, DOI 10.1111/j.1943-278X.2011.00066.x; Kolves K, 2006, SOC SCI MED, V62, P2887, DOI 10.1016/j.socscimed.2005.11.048; [李献云 LI Xianyun], 2008, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V34, P156; Li Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-524; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Liu RT, 2014, CLIN PSYCHOL REV, V34, P181, DOI 10.1016/j.cpr.2014.01.006; Liu XC, 2005, J AFFECT DISORDERS, V86, P195, DOI 10.1016/j.jad.2005.01.016; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; *MIN HLTH CHIN, 2007, MEAS ETH REV BIOM RE; *NAT BUR STAT CHIN, 2009, CHIN STAT YB 2009; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Park SY, 2008, ARCH PSYCHIAT NURS, V22, P12, DOI 10.1016/j.apnu.2007.06.011; PAYKEL ES, 1971, ARCH GEN PSYCHIAT, V25, P340, DOI 10.1001/archpsyc.1971.01750160052010; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Pompili M, 2011, PSYCHIAT RES, V186, P300, DOI 10.1016/j.psychres.2010.09.003; Rubenowitz E, 2001, PSYCHOL MED, V31, P1193, DOI 10.1017/S0033291701004457; Stein DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010574; Sunnqvist C, 2008, EUR ARCH PSY CLIN N, V258, P456, DOI 10.1007/s00406-008-0819-6; Uwakwe R, 2012, ACTA PSYCHIAT SCAND, V126, P458, DOI 10.1111/j.1600-0447.2012.01852.x; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang YQ, 2012, PSYCHIAT ANN, V42, P101, DOI 10.3928/00485713-20120217-07; Webb RT, 2012, ARCH GEN PSYCHIAT, V69, P256, DOI 10.1001/archgenpsychiatry.2011.1561; Weyrauch KF, 2001, SUICIDE LIFE-THREAT, V31, P311, DOI 10.1521/suli.31.3.311.24240; Zhang J, 2012, J AFFECT DISORDERS, V140, P161, DOI 10.1016/j.jad.2012.01.010; Zhang J, 2012, REV RELIG RES, V54, P93, DOI 10.1007/s13644-011-0027-0; Zhang J, 2011, J AFFECT DISORDERS, V129, P244, DOI 10.1016/j.jad.2010.09.008; [周莉 Zhou Li], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P19	50	149	153	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116634	10.1371/journal.pone.0116634	http://dx.doi.org/10.1371/journal.pone.0116634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UU	25611854	Green Submitted, gold, Green Published			2022-12-27	WOS:000348562900018
J	Nieto, PS; Revelli, JA; Garbarino-Pico, E; Condat, CA; Guido, ME; Tamarit, FA				Nieto, Paula S.; Revelli, Jorge A.; Garbarino-Pico, Eduardo; Condat, Carlos A.; Guido, Mario E.; Tamarit, Francisco A.			Effects of Different PER Translational Kinetics on the Dynamics of a Core Circadian Clock Model	PLOS ONE			English	Article							MESSENGER-RNA; HNRNP Q; RHYTHMS; PROTEIN; PERIOD; EXPRESSION; MECHANISMS	Living beings display self-sustained daily rhythms in multiple biological processes, which persist in the absence of external cues since they are generated by endogenous circadian clocks. The period (per) gene is a central player within the core molecular mechanism for keeping circadian time in most animals. Recently, the modulation PER translation has been reported, both in mammals and flies, suggesting that translational regulation of clock components is important for the proper clock gene expression and molecular clock performance. Because translational regulation ultimately implies changes in the kinetics of translation and, therefore, in the circadian clock dynamics, we sought to study how and to what extent the molecular clock dynamics is affected by the kinetics of PER translation. With this objective, we used a minimal mathematical model of the molecular circadian clock to qualitatively characterize the dynamical changes derived from kinetically different PER translational mechanisms. We found that the emergence of self-sustained oscillations with characteristic period, amplitude, and phase lag (time delays) between per mRNA and protein expression depends on the kinetic parameters related to PER translation. Interestingly, under certain conditions, a PER translation mechanism with saturable kinetics introduces longer time delays than a mechanism ruled by a first-order kinetics. In addition, the kinetic laws of PER translation significantly changed the sensitivity of our model to parameters related to the synthesis and degradation of per mRNA and PER degradation. Lastly, we found a set of parameters, with realistic values, for which our model reproduces some experimental results reported recently for Drosophila melanogaster and we present some predictions derived from our analysis.	[Nieto, Paula S.; Revelli, Jorge A.; Condat, Carlos A.; Tamarit, Francisco A.] UNC, IFEG, CONICET, Cordoba, Argentina; [Nieto, Paula S.; Revelli, Jorge A.; Condat, Carlos A.; Tamarit, Francisco A.] UNC, FaMAF, Cordoba, Argentina; [Garbarino-Pico, Eduardo; Guido, Mario E.] UNC, Fac Ciencias Quim, CIQUIBIC, CONICET, Cordoba, Argentina; [Garbarino-Pico, Eduardo; Guido, Mario E.] UNC, Fac Ciencias Quim, Dept Quim Biol, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Nieto, PS (corresponding author), UNC, IFEG, CONICET, Ciudad Univ,CP X5000HUA, Cordoba, Argentina.	pnieto1@famaf.unc.edu.ar			CONICET (Argentina)	CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The authors thank CONICET (Argentina) for support.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Axmann IM, 2007, GENOME INFORM SER, V18, P54; Beersma DGM, 2005, J BIOL RHYTHM, V20, P304, DOI 10.1177/0748730405277388; Bordyugov G, 2013, Handb Exp Pharmacol, P335, DOI 10.1007/978-3-642-25950-0_14; Bradley S, 2012, GENETICS, V192, P943, DOI 10.1534/genetics.112.143248; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; DIBNER C, 2008, THE EMBO JOURNAL, V28, P123, DOI DOI 10.1038/EMBOJ.2008.262; Dunlap JC, 2006, SCIENCE, V311, P184, DOI 10.1126/science.1122839; Dunlap JC., 2004, CHRONOBIOLOGY BIOLOG; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Garbarino-Pico E, 2007, COLD SPRING HARB SYM, V72, P145, DOI 10.1101/sqb.2007.72.022; Garbarino-Pico E., 2011, CIRCADIAN RHYTHMS BI, P247; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gebauer F, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012245; Gerard C, 2009, PHILOS T R SOC A, V367, P4665, DOI 10.1098/rsta.2009.0133; GOLDBETER A, 1995, P ROY SOC B-BIOL SCI, V261, P319, DOI 10.1098/rspb.1995.0153; Goldbeter A, 2013, FEBS LETT, V587, P2778, DOI 10.1016/j.febslet.2013.07.031; Gonze D, 2006, CHAOS, V16, DOI 10.1063/1.2211767; Gonze D, 2000, CR ACAD SCI III-VIE, V323, P57, DOI 10.1016/S0764-4469(00)00111-6; Gonze D, 2002, J BIOL PHYS, V28, P637, DOI 10.1023/A:1021286607354; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Hafner M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002419; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Keene JD, 2007, COLD SPRING HARB SYM, V72, P157, DOI 10.1101/sqb.2007.72.013; Kim DY, 2010, NUCLEIC ACIDS RES, V38, P7068, DOI 10.1093/nar/gkq569; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; Kojima S, 2012, GENE DEV, V26, P2724, DOI 10.1101/gad.208306.112; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Korencic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046835; Kurosawa G, 2002, J BIOL RHYTHM, V17, P568, DOI 10.1177/0748730402238239; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; Lee KH, 2012, MOL CELL BIOL, V32, P717, DOI 10.1128/MCB.06177-11; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; Lema MA, 2000, J THEOR BIOL, V204, P565, DOI 10.1006/jtbi.2000.2038; Lim C, 2013, SCIENCE, V340, P875, DOI 10.1126/science.1234785; Lim C, 2011, NATURE, V470, P399, DOI 10.1038/nature09728; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Nandi A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-45; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Risau-Gusman S, 2012, J THEOR BIOL, V307, P53, DOI 10.1016/j.jtbi.2012.05.003; Roenneberg T, 2008, CURR BIOL, V18, pR826, DOI 10.1016/j.cub.2008.07.017; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stanewsky R, 2002, J BIOL RHYTHM, V17, P293, DOI 10.1177/074873002129002609; Thompson SR, 2012, WIRES RNA, V3, P697, DOI 10.1002/wrna.1129; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Zhang Y, 2013, SCIENCE, V340, P879, DOI 10.1126/science.1234746	55	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115067	10.1371/journal.pone.0115067	http://dx.doi.org/10.1371/journal.pone.0115067			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607544	Green Published, Green Submitted, gold			2022-12-27	WOS:000348205300010
J	Permuth-Wey, J; Chen, YA; Fisher, K; McCarthy, S; Qu, XT; Lloyd, MC; Kasprzak, A; Fournier, M; Williams, VL; Ghia, KM; Yoder, SJ; Hall, L; Georgeades, C; Olaoye, F; Husain, K; Springett, GM; Chen, DT; Yeatman, T; Centeno, A; Klapman, J; Coppola, D; Malafa, M				Permuth-Wey, Jennifer; Chen, Y. Ann; Fisher, Kate; McCarthy, Susan; Qu, Xiaotao; Lloyd, Mark C.; Kasprzak, Agnieszka; Fournier, Michelle; Williams, Vonetta L.; Ghia, Kavita M.; Yoder, Sean J.; Hall, Laura; Georgeades, Christina; Olaoye, Funmilayo; Husain, Kazim; Springett, Gregory M.; Chen, Dung-Tsa; Yeatman, Timothy; Centeno, Ann; Klapman, Jason; Coppola, Domenico; Malafa, Mokenge			A Genome-Wide Investigation of MicroRNA Expression Identifies Biologically-Meaningful MicroRNAs That Distinguish between High-Risk and Low-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas	PLOS ONE			English	Article							EARLY EVENT; CANCER; MIRNA; PRECURSORS; MANAGEMENT; MARKERS; MIR-155; CYSTS	Background Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic ductal adenocarcinoma (PDAC) precursors. Differentiating between high-risk IPMNs that warrant surgical resection and low-risk IPMNs that can be monitored is a significant clinical problem, and we sought to discover a panel of mi(cro) RNAs that accurately classify IPMN risk status. Methodology/Principal Findings In a discovery phase, genome-wide miRNA expression profiling was performed on 28 surgically-resected, pathologically-confirmed IPMNs (19 high-risk, 9 low-risk) using Taqman MicroRNA Arrays. A validation phase was performed in 21 independent IPMNs (13 high-risk, 8 low-risk). We also explored associations between miRNA expression level and various clinical and pathological factors and examined genes and pathways regulated by the identified miRNAs by integrating data from bioinformatic analyses and microarray analysis of miRNA gene targets. Six miRNAs (miR-100, miR-99b, miR-99a, miR-342-3p, miR-126, miR-130a) were down-regulated in high-risk versus low-risk IPMNs and distinguished between groups (P<10(-3), area underneath the curve (AUC) = 87%). The same trend was observed in the validation phase (AUC = 74%). Low miR-99b expression was associated with main pancreatic duct involvement (P = 0.021), and serum albumin levels were positively correlated with miR-99a (r = 0.52, P = 0.004) and miR-100 expression (r = 0.49, P = 0.008). Literature, validated miRNA: target gene interactions, and pathway enrichment analysis supported the candidate miRNAs as tumor suppressors and regulators of PDAC development. Microarray analysis revealed that oncogenic targets of miR-130a (ATG2B, MEOX2), miR-342-3p (DNMT1), and miR-126 (IRS-1) were up-regulated in high-versus low-risk IPMNs (P<0.10). Conclusions This pilot study highlights miRNAs that may aid in preoperative risk stratification of IPMNs and provides novel insights into miRNA-mediated progression to pancreatic malignancy. The miRNAs identified here and in other recent investigations warrant evaluation in biofluids in a well-powered prospective cohort of individuals newly-diagnosed with IPMNs and other pancreatic cysts and those at increased genetic risk for these lesions.	[Permuth-Wey, Jennifer; Georgeades, Christina; Olaoye, Funmilayo] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Tampa, FL 33682 USA; [Chen, Y. Ann; Fisher, Kate; Qu, Xiaotao; Chen, Dung-Tsa] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Biostat & Bioinformat, Tampa, FL 33682 USA; [McCarthy, Susan] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Clin Testing Dev, Tampa, FL 33682 USA; [Lloyd, Mark C.; Kasprzak, Agnieszka] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Analyt Microscopy, Tampa, FL 33682 USA; [Fournier, Michelle] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Tissue Core Adm, Tampa, FL 33682 USA; [Williams, Vonetta L.; Ghia, Kavita M.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Informat Shared Serv, Tampa, FL 33682 USA; [Yoder, Sean J.; Hall, Laura] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Mol Genom, Tampa, FL 33682 USA; [Husain, Kazim; Springett, Gregory M.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Gastrointestinal Oncol, Tampa, FL 33682 USA; [Centeno, Ann; Coppola, Domenico] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Anat Pathol, Tampa, FL 33682 USA; [Klapman, Jason] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Gastroenterol, Tampa, FL 33682 USA; [Malafa, Mokenge] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Gastrointestinal Surg Oncol, Tampa, FL 33682 USA; [Yeatman, Timothy] Gibbs Canc Ctr & Res Inst, Dept Surg, Spartanburg, SC USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Permuth-Wey, J (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Tampa, FL 33682 USA.			Georgeades, Christina/0000-0002-5415-1651; Chen, yian/0000-0003-1468-3490	American Cancer Society [93-032-16]; Programmatic Funds from Moffitt's Gastrointestinal Program; Total Cancer Care Protocol; Information Shared Services, Tissue, Molecular Genomics, Biostatistics, and Cancer Informatics Core Facilities at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center [P30-CA076292]; NATIONAL CANCER INSTITUTE [P30CA076292, R25CA174664] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Programmatic Funds from Moffitt's Gastrointestinal Program; Total Cancer Care Protocol(Total SA); Information Shared Services, Tissue, Molecular Genomics, Biostatistics, and Cancer Informatics Core Facilities at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by Institutional Research Grant number 93-032-16 from the American Cancer Society (PI: J. Permuth-Wey) and Programmatic Funds from Moffitt's Gastrointestinal Program. This work was also supported in part by the Total Cancer Care Protocol and by the Information Shared Services, Tissue, Molecular Genomics, Biostatistics, and Cancer Informatics Core Facilities at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center (P30-CA076292). The content is solely the responsibility of the authors and does not necessarily represent the official views of the American Cancer Society or the H. Lee Moffitt Cancer Center & Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay NV, 2010, WHO CLASSIFICATION T, P304; Allen PJ, 2010, SURG ONCOL CLIN N AM, V19, P297, DOI 10.1016/j.soc.2009.11.002; American Cancer Society, 2014, CANC FACTS FIG 2014; Bergmann U, 1996, BIOCHEM BIOPH RES CO, V220, P886, DOI 10.1006/bbrc.1996.0500; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Canto MI, 2006, CLIN GASTROENTEROL H, V4, P766, DOI 10.1016/j.cgh.2006.02.005; Caponi S, 2013, ANN ONCOL, V24, P734, DOI 10.1093/annonc/mds513; Correa-Gallego C, 2010, PANCREATOLOGY, V10, P144, DOI 10.1159/000243733; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Dweep H, 2014, METHODS MOL BIOL, V1182, P289, DOI 10.1007/978-1-4939-1062-5_25; Fenstermacher DA, 2011, CANCER J, V17, P528, DOI 10.1097/PPO.0b013e318238216e; Frampton AE, 2012, EXPERT REV ANTICANC, V12, P881, DOI [10.1586/ERA.12.67, 10.1586/era.12.67]; Goggins M, 2007, SEMIN ONCOL, V34, P303, DOI 10.1053/j.seminoncol.2007.05.003; Goswami RS, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-47; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Henry JC, 2013, ANN SURG ONCOL; Hines OJ, 2008, CURR OPIN GASTROEN, V24, P603, DOI 10.1097/MOG.0b013e32830b112e; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Jiao LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032068; Lee LS, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.18; Li A, 2013, CLIN CANC RES; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Liu J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-519; Lubezky N, 2013, SURGERY, V153, P663, DOI 10.1016/j.surg.2012.11.016; Maker AV, 2008, ANN SURG ONCOL, V15, P3187, DOI 10.1245/s10434-008-0110-0; Matthaei H, 2012, CLIN CANCER RES, V18, P4713, DOI 10.1158/1078-0432.CCR-12-0035; Matthaei H, 2011, NAT REV GASTRO HEPAT, V8, P141, DOI 10.1038/nrgastro.2011.2; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nissim S, 2012, PANCREAS, V41, P1195, DOI 10.1097/MPA.0b013e3182580fb4; Park Yun Gyoung, 2011, Korean J Gastroenterol, V58, P190; Pelaez-Luna M, 2007, AM J GASTROENTEROL, V102, P1759, DOI 10.1111/j.1572-0241.2007.01224.x; Ryu JK, 2010, PANCREATOLOGY, V10, P66, DOI 10.1159/000231984; Sachs T, 2009, J GASTROINTEST SURG, V13, P405, DOI 10.1007/s11605-008-0788-0; Sahani DV, 2009, CLIN GASTROENTEROL H, V7, P259, DOI 10.1016/j.cgh.2008.11.008; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song B, 2013, MOL CANCER THER, V12, P58, DOI 10.1158/1535-7163.MCT-12-0632; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Weichert W, 2005, PANCREATOLOGY, V5, P259, DOI 10.1159/000085280; Wong J, 2012, J GASTROINTEST SURG; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang DX, 2012, EXP THER MED, V3, P423, DOI 10.3892/etm.2011.412; Zhang JJ, 2012, CLIN TRANSL ONCOL, V14, P116, DOI 10.1007/s12094-012-0770-x	55	32	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116869	10.1371/journal.pone.0116869	http://dx.doi.org/10.1371/journal.pone.0116869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607660	Green Submitted, gold, Green Published			2022-12-27	WOS:000348205300038
J	Ma, XY; Zheng, CT; Hu, YJ; Wang, L; Yang, XF; Jiang, ZY				Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong			Dietary L-Arginine Supplementation Affects the Skeletal Longissimus Muscle Proteome in Finishing Pigs	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; MEAT QUALITY TRAITS; MYOSIN HEAVY-CHAIN; PORCINE ADIPOSE-TISSUE; SERUM RESPONSE FACTOR; TROPONIN-I GENE; INTRAMUSCULAR FAT; EXTRACELLULAR-MATRIX; PORK QUALITY; NITRIC-OXIDE	Forty-eight Duroc x Landrace x Large White gilts were used to determine the relationship between proteome changes of longissimus muscle and intramuscular fat (IMF) content in arginine-supplemented pigs. Beginning at 60 kg BW, pigs were fed a corn- and soybean meal-based diet supplemented or not with 1% L-arginine until they reached a BW of 100 kg. Supplementation with 1% L-arginine did not affect the growth performance or carcass traits, while it increased IMF content by 32% (P < 0.01), it also decreased the drip loss at 48 h post-mortem and the b* meat color value at 24 h post-mortem; supplementation with 1% dietary L-arginine did not change the proportion of SFA and MUFA in muscle lipids. The proteome changes in longissimus muscle between the control and supplemented pigs showed that L-arginine significantly influenced the abundance of proteins related to energy metabolism, fiber type and structure. The increase in IMF content was positively correlated with the increased abundance of slow twitch troponin I (TNNI1) protein and negatively correlated with myosin heavy chain IIb (MyHC IIb) protein content. It is suggested that the proteome changes in longissimus muscle contributed to the greater IMF content in L-arginine supplemented pigs.	[Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China; [Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong] State Key Lab Livestock & Poultry Breeding, Guangzhou, Guangdong, Peoples R China; [Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong] Minist Agr, Key Lab Anim Nutr & Feed Sci South China, Guangzhou, Guangdong, Peoples R China; [Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong] Guangdong Publ Lab Anim Breeding & Nutr, Guangzhou, Guangdong, Peoples R China; [Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong] Guangdong Key Lab Anim Breeding & Nutr, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Jiang, ZY (corresponding author), Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China.	jiangz28@qq.com	Yang, Xuefen/GQB-3094-2022	Zheng, Chuntian/0000-0002-1967-9477	Guangdong Natural Science foundation [10151064001000031]; earmarked fund for Modern Agro-industry Technology Research System [CARS-36]; National 973' Project of China [2012CB124706-4, 2012CB124706-5]; national 948 plan [2013-S24]	Guangdong Natural Science foundation(National Natural Science Foundation of Guangdong Province); earmarked fund for Modern Agro-industry Technology Research System; National 973' Project of China(National Basic Research Program of China); national 948 plan	This work was supported by grants from Guangdong Natural Science foundation (10151064001000031) (http://gdsf.gdstc.gov.cn/User/User.aspx), the earmarked fund for Modern Agro-industry Technology Research System (CARS-36) (http://119.253.58.231), the National 973' Project of China (2012CB124706-4 and 2012CB124706-5) (http://www.973.gov.cn/AreaMana.aspx) and the national 948 plan (2013-S24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1995, 99136 AOAC; AZAIN MJ, 1993, J ANIM SCI, V71, P3011, DOI 10.2527/1993.71113011x; BANKS RD, 1979, NATURE, V279, P773, DOI 10.1038/279773a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broos S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049281; Cameron ND, 2000, MEAT SCI, V55, P187, DOI 10.1016/S0309-1740(99)00142-4; Chang KC, 2003, MEAT SCI, V64, P93, DOI 10.1016/S0309-1740(02)00208-5; Choi SH, 2014, AMINO ACIDS, V46, P353, DOI 10.1007/s00726-013-1622-x; Choi YM, 2007, MEAT SCI, V76, P281, DOI 10.1016/j.meatsci.2006.11.009; CORIN SJ, 1994, J BIOL CHEM, V269, P10651; Dai ZL, 2013, BIOFACTORS, V39, P383, DOI 10.1002/biof.1099; ESSENGUSTAVSSON B, 1994, MEAT SCI, V38, P269, DOI 10.1016/0309-1740(94)90116-3; FERNANDEZ JLR, 1989, DIFFERENTIATION, V42, P65, DOI 10.1111/j.1432-0436.1989.tb00608.x; Fernandez X, 1999, MEAT SCI, V53, P59, DOI 10.1016/S0309-1740(99)00037-6; Fu WJJ, 2005, J NUTR, V135, P714, DOI 10.1093/jn/135.4.714; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Go G, 2012, AMINO ACIDS, V43, P1713, DOI 10.1007/s00726-012-1255-5; Grider A, 2007, J NUTR BIOCHEM, V18, P753, DOI 10.1016/j.jnutbio.2006.11.013; Guo W, 2008, ASIAN AUSTRAL J ANIM, V21, P11, DOI 10.5713/ajas.2008.60256; Han ZD, 2012, MED ONCOL, V29, P2877, DOI 10.1007/s12032-011-0149-9; He QH, 2009, AMINO ACIDS, V37, P199, DOI 10.1007/s00726-008-0192-9; Hwang IH, 2005, MEAT SCI, V69, P79, DOI 10.1016/j.meatsci.2004.06.019; Jobgen WJ, 2009, J NUTR, V139, P230, DOI 10.3945/jn.108.096362; Jobgen W, 2009, AMINO ACIDS, V37, P187, DOI 10.1007/s00726-009-0246-7; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Keady SM, 2013, J ANIM SCI, V91, P654, DOI 10.2527/jas.2012-5850; Kharbanda KK, 2009, BIOCHEM BIOPH RES CO, V381, P523, DOI 10.1016/j.bbrc.2009.02.082; Kim NK, 2009, BMB REP, V42, P433, DOI 10.5483/BMBRep.2009.42.7.433; Kim SW, 2004, J NUTR, V134, P625, DOI 10.1093/jn/134.3.625; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; Lametsch R, 2006, J ANIM SCI, V84, P918, DOI 10.2527/2006.844918x; Lawrie RA, 1985, MEAT SCI, DOI [10.1016/0309-1740(85)90052-X, DOI 10.1016/0309-1740(85)90052-X]; Li AN, 2013, MAMM GENOME, V24, P72, DOI 10.1007/s00335-012-9440-0; Lonergan SM, 2007, J ANIM SCI, V85, P1074, DOI 10.2527/jas.2006-413; Ma XY, 2010, AMINO ACIDS, V38, P95, DOI 10.1007/s00726-008-0213-8; Mason LM, 2005, MEAT SCI, V70, P307, DOI 10.1016/j.meatsci.2005.01.017; McKnight JR, 2010, AMINO ACIDS, V39, P349, DOI 10.1007/s00726-010-0598-z; Mullen AJ, 2000, GENE, V242, P313, DOI 10.1016/S0378-1119(99)00519-3; Muroya S, 2010, MEAT SCI, V86, P764, DOI 10.1016/j.meatsci.2010.06.019; Nall JL, 2009, J NUTR, V139, P1279, DOI 10.3945/jn.108.102301; Nirmalan NJ, 2009, J PATHOL, V217, P497, DOI 10.1002/path.2504; NPPC, 1991, 3 NAT PORK PROD COUN; Obel Linea F, 2012, Front Neuroenergetics, V4, P3, DOI 10.3389/fnene.2012.00003; Pas MFWT, 2009, MEAT SCI, V83, P744, DOI 10.1016/j.meatsci.2009.08.030; Pierzchala M, 2014, J ANIM BREED GENET, DOI [10.1111/jbg.12122, DOI 10.1111/JBG.12122]; Polly P, 2003, J BIOL CHEM, V278, P36603, DOI 10.1074/jbc.M212814200; Pomies P, 2007, MOL BIOL CELL, V18, P1723, DOI 10.1091/mbc.E06-09-0815; Raj S, 2010, MEAT SCI, V86, P324, DOI 10.1016/j.meatsci.2010.04.037; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Science and Technology Ministry of China, 2006, 398 SCI TECHN MIN CH; Sherwood RI, 2006, TRENDS MOL MED, V12, P189, DOI 10.1016/j.molmed.2006.03.002; Singh J, 2007, MOL CELL BIOCHEM, V294, P163, DOI 10.1007/s11010-006-9256-x; Tan BE, 2012, FRONT BIOSCI-LANDMRK, V17, P2237, DOI 10.2741/4047; Tan B, 2011, J NUTR BIOCHEM, V22, P441, DOI 10.1016/j.jnutbio.2010.03.012; Tan B, 2009, AMINO ACIDS, V37, P169, DOI 10.1007/s00726-008-0148-0; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; van de Wiel DFM, 2007, MEAT SCI, V77, P46, DOI 10.1016/j.meatsci.2007.04.017; Vincent B, 2007, PHYSIOL GENOMICS, V32, P58, DOI 10.1152/physiolgenomics.00173.2007; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wang JJ, 2006, J NUTR, V136, P1759, DOI 10.1093/jn/136.7.1759; Wimmers K, 2008, J ANIM SCI, V86, P795, DOI 10.2527/jas.2006-521; Wu GY, 2014, ANNU REV ANIM BIOSCI, V2, P387, DOI 10.1146/annurev-animal-022513-114113; Wu ZL, 2012, CURR OPIN CLIN NUTR, V15, P529, DOI 10.1097/MCO.0b013e3283595cff; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Xu YJ, 2008, BRIT J NUTR, V99, P455, DOI 10.1017/S0007114507812074; Xu YJ, 2012, J PROTEOMICS, V75, P2093, DOI 10.1016/j.jprot.2012.01.013; YAMASHITA K, 1991, J MUSCLE RES CELL M, V12, P37, DOI 10.1007/BF01781172; Yang H, 2010, J APPL GENET, V51, P51, DOI 10.1007/BF03195710; Yu KF, 2013, INT J BIOL SCI, V9, P108, DOI 10.7150/ijbs.5306	70	205	210	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117294	10.1371/journal.pone.0117294	http://dx.doi.org/10.1371/journal.pone.0117294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635834	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700078
J	Worku, AG; Tessema, GA; Zeleke, AA				Worku, Abebaw Gebeyehu; Tessema, Gizachew Assefa; Zeleke, Atinkut Alamirrew			Trends of Modern Contraceptive Use among Young Married Women Based on the 2000, 2005, and 2011 Ethiopian Demographic and Health Surveys: A Multivariate Decomposition Analysis	PLOS ONE			English	Article								Introduction Accessing family planning can reduce a significant proportion of maternal, infant, and childhood deaths. In Ethiopia, use of modern contraceptive methods is low but it is increasing. This study aimed to analyze the trends and determinants of changes in modern contraceptive use over time among young married women in Ethiopia. Methods T he study used data from the three Demographic Health Surveys conducted in Ethiopia, in 2000, 2005, and 2011. Young married women age 15-24 years with sample sizes of 2,157 in 2000, 1,904 in 2005, and 2,146 in 2011 were included. Logit-based decomposition analysis technique was used for analysis of factors contributing to the recent changes. STATA 12 was employed for data management and analyses. All calculations presented in this paper were weighted for the sampling probabilities and non-response. Complex sampling procedures were also considered during testing of statistical significance. Results Among young married women, modern contraceptive prevalence increased from 6% in 2000 to 16% in 2005 and to 36% in 2011. The decomposition analysis indicated that 34% of the overall change in modern contraceptive use was due to difference in women's characteristics. Changes in the composition of young women's characteristics according to age, educational status, religion, couple concordance on family size, and fertility preference were the major sources of this increase. Two-thirds of the increase in modern contraceptive use was due to difference in coefficients. Most importantly, the increase was due to change in contraceptive use behavior among the rural population (33%) and among Orthodox Christians (16%) and Protestants (4%). Conclusions Modern contraceptive use among young married women has showed a remarkable increase over the last decade in Ethiopia. Programmatic interventions targeting poor, younger (adolescent), illiterate, and Muslim women would help to maintain the increasing trend in modern contraceptive use.	[Worku, Abebaw Gebeyehu; Tessema, Gizachew Assefa] Univ Gondar, Inst Publ Hlth, Dept Reprod Hlth, Gondar, Ethiopia; [Zeleke, Atinkut Alamirrew] Univ Gondar, Inst Publ Hlth, Dept Hlth Informat, Gondar, Ethiopia	University of Gondar; University of Gondar	Worku, AG (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Reprod Hlth, Gondar, Ethiopia.	abebawgebeyehu@yahoo.com	Zeleke, Atinkut Alamirrew/I-4137-2019; Tessema, Gizachew A/J-9235-2018	Zeleke, Atinkut Alamirrew/0000-0001-7838-9050; Tessema, Gizachew A/0000-0002-4784-8151; Worku, Abebaw Gebeyehu/0000-0002-1146-3399	DHS fellowship program	DHS fellowship program	This study was supported by the 2014 DHS fellowship program. The program covered costs for preparation of the working paper. However, there is no funding support for publication in a journal. The funders had no role in study design, data collection (data extraction in our case) and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Cleland J, 2012, LANCET, V0140-6736, P60609; Cleland J, 2006, REPROD HEALTH MATTER, V14, P17, DOI 10.1016/S0968-8080(06)28250-8; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; CSA Ethiopia and DHS Macro, 2001, ETH DEM HLTH SURV RE; CSA [Ethiopia] and ICF International, 2012, ETH DEM HLTH SURV RE; CSA Ethiopia and ORC Macro, 2005, ETH DEM HLTH SURV PR; FMOH Ethiopia, 2011, NAT GUID FAM PLANN S; FMOH Ethiopia, 2007, HLTH EXT PROGR ETH; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Lakew Y, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-52; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Mekonnen W, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-37; Mohammed A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-13; Muhoza DN, 2013, MEASURING SUCCESS FA; Pillai VK, 2011, OPEN ACCESS J CONTRA, V2011; Population Action International, 2013, FAM PLANN SMART INV; RamaRao S, 2003, INT FAM PLAN PERSPEC, V29, P76, DOI 10.2307/3181061; Singh S, 2012, ADD IT COSTS BENEFIT; Transitional Government of Ethiopia, 1993, POP POL TRANS GOV ET; UNEPA, 2012, DEC CHANG CONTR US E; USAID/Africa Bureau, 2011, 3 SUCC SUBS AFR FAM; World Bank, 2007, WORLD DEV REP 2007 D; World Bank, 2010, WORLD DEV IND	24	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116525	10.1371/journal.pone.0116525	http://dx.doi.org/10.1371/journal.pone.0116525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635389	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700042
J	Yin, Q; Fan, Q; Zhao, Y; Cheng, MY; Liu, H; Li, J; Lu, FF; Jia, JT; Cheng, W; Yan, CD				Yin, Qin; Fan, Qin; Zhao, Yu; Cheng, Ming-Yue; Liu, He; Li, Jing; Lu, Fei-Fei; Jia, Jin-Tai; Cheng, Wei; Yan, Chang-Dong			Spinal NF-kappa B and Chemokine Ligand 5 Expression during Spinal Glial Cell Activation in a Neuropathic Pain Model	PLOS ONE			English	Article							NERVE-INJURY; MECHANICAL ALLODYNIA; INTRATHECAL INFUSION; UP-REGULATION; RAT MODEL; MINOCYCLINE; RECEPTORS; INVOLVEMENT; LIGATION; RANTES	Background The NF-kappa B pathway and chemokine (C-C motif) ligand 5 (CCL5) are involved in pain modulation; however, the precise mechanisms of their interactions in chronic neuropathic pain have yet to be established. Methods The present study examined the roles of spinal NF-kappa B and CCL5 in a neuropathic pain model after chronic constriction injury (CCI) surgery. CCI-induced pain facilitation was evaluated using the Plantar and von Frey tests. The changes in NF-kappa B and CCL5 expression were analyzed by immunohistochemistry and Western blot analyses. Results Spinal NF-kappa B and CCL5 expression increased after CCI surgery. Repeated intrathecal infusions of pyrrolidine dithiocarbamate (PDTC, a NF-kappa B inhibitor) decreased CCL5 expression, inhibited the activation of microglia and astrocytes, and attenuated CCI-induced allodynia and hyperalgesia. Intrathecal injection of a CCL5-neutralizing antibody attenuated CCI-induced pain facilitation and also suppressed spinal glial cell activation after CCI surgery. However, the CCL5-neutralizing antibody did not affect NF-kappa B expression. Furthermore, selective glial inhibitors, minocycline and fluorocitrate, attenuated the hyperalgesia induced by intrathecal CCL5. Conclusions The inhibition of spinal CCL5 expression may provide a new method to prevent and treat nerve injury-induced neuropathic pain.	[Yin, Qin; Zhao, Yu; Cheng, Ming-Yue; Liu, He; Li, Jing; Lu, Fei-Fei; Cheng, Wei; Yan, Chang-Dong] Xuzhou Med Coll, Xuzhou, Peoples R China; [Yin, Qin; Fan, Qin; Zhao, Yu; Cheng, Ming-Yue; Liu, He; Li, Jing; Lu, Fei-Fei; Cheng, Wei; Yan, Chang-Dong] Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Peoples R China; [Yin, Qin; Fan, Qin; Zhao, Yu; Cheng, Ming-Yue; Liu, He; Li, Jing; Lu, Fei-Fei; Cheng, Wei; Yan, Chang-Dong] Ctr Pain Res & Treatment, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Peoples R China; [Yin, Qin; Fan, Qin; Zhao, Yu; Cheng, Ming-Yue; Liu, He; Cheng, Wei] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Peoples R China; [Fan, Qin; Jia, Jin-Tai] Changzhi Med Coll, Affiliated Heping Hosp, Changzhi, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Changzhi Medical College	Jia, JT (corresponding author), Changzhi Med Coll, Affiliated Heping Hosp, Changzhi, Peoples R China.	1538753325@qq.com; cheng.wei.1@hotmail.com; yancd55@163.com	Liu, He/C-9799-2012	Liu, He/0000-0002-4103-312X	National Natural Science Foundation of China [31100801, 81200858, 81300957]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (31100801, 81200858, and 81300957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DK, 2005, BRAIN RES BULL, V66, P50, DOI 10.1016/j.brainresbull.2005.03.015; Bacon KB, 2000, J NEUROIMMUNOL, V104, P92, DOI 10.1016/S0165-5728(99)00266-0; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Bajetto A, 2001, FRONT NEUROENDOCRIN, V22, P147, DOI 10.1006/frne.2001.0214; Benamar K, 2008, EUR J PHARMACOL, V592, P93, DOI 10.1016/j.ejphar.2008.07.009; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Gosselin RD, 2008, CURR MED CHEM, V15, P2866, DOI 10.2174/092986708786242822; Guasti L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-35; Hang LH, 2013, BASIC CLIN PHARMACOL, V113, P325, DOI 10.1111/bcpt.12099; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hui J, 2013, J PAIN, V14, P747, DOI 10.1016/j.jpain.2013.02.003; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Keswani SC, 2003, ANN NEUROL, V54, P287, DOI 10.1002/ana.10645; Kiguchi N, 2010, NEUROSCI LETT, V484, P17, DOI 10.1016/j.neulet.2010.07.085; Knerlich-Lukoschus F, 2011, J NEUROSURG-SPINE, V14, P583, DOI 10.3171/2010.12.SPINE10480; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Laughlin TM, 2000, PAIN, V84, P159, DOI 10.1016/S0304-3959(99)00195-5; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Ledeboer A, 2005, EUR J NEUROSCI, V22, P1977, DOI 10.1111/j.1460-9568.2005.04379.x; Lin CS, 2007, REGION ANESTH PAIN M, V32, P209, DOI 10.1016/j.rapm.2007.01.005; Liou Jiin-Tarng, 2013, Acta Anaesthesiol Taiwan, V51, P127, DOI 10.1016/j.aat.2013.08.006; Liou JT, 2013, J PAIN, V14, P24, DOI 10.1016/j.jpain.2012.09.015; Liou JT, 2012, PAIN, V153, P1283, DOI 10.1016/j.pain.2012.03.008; Lunzer MM, 2007, P NATL ACAD SCI USA, V104, P6061, DOI 10.1073/pnas.0700295104; Mei XP, 2013, NEUROSIGNALS, V21, P184, DOI 10.1159/000338049; Mei XP, 2011, NEUROSCI RES, V70, P305, DOI 10.1016/j.neures.2011.03.012; Milligan ED, 1999, J NEUROSCI METH, V90, P81, DOI 10.1016/S0165-0270(99)00075-8; O'Rielly DD, 2008, NEUROSCIENCE, V155, P902, DOI 10.1016/j.neuroscience.2008.04.077; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Pan YD, 2010, REGION ANESTH PAIN M, V35, P231, DOI 10.1097/AAP.0b013e3181df245b; Pevida M, 2014, NEUROSCIENCE, V259, P113, DOI 10.1016/j.neuroscience.2013.11.055; Pu SF, 2013, J PHYSIOL BIOCHEM, V69, P349, DOI 10.1007/s13105-012-0217-4; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Sommer C, 2003, CURR OPIN NEUROL, V16, P623, DOI 10.1097/00019052-200310000-00009; Sun T, 2006, BRIT J ANAESTH, V97, P553, DOI 10.1093/bja/ael209; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Tokami H, 2013, BRAIN RES, V1517, P122, DOI 10.1016/j.brainres.2013.04.022; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002; Wei XH, 2007, EXP NEUROL, V205, P471, DOI 10.1016/j.expneurol.2007.03.012; White FA, 2008, CURR OPIN ANESTHESIO, V21, P580, DOI 10.1097/ACO.0b013e32830eb69d; Wieseler-Frank J, 2004, NEUROCHEM INT, V45, P389, DOI 10.1016/j.neuint.2003.09.009; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wu LC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-4; Zhang X, 2012, J NEURAL TRANSM, V119, P329, DOI 10.1007/s00702-011-0713-7; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	48	39	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115120	10.1371/journal.pone.0115120	http://dx.doi.org/10.1371/journal.pone.0115120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635831	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700006
J	Chen, WC; Bei, YJ; Li, HH				Chen, Weicai; Bei, Yongjian; Li, Hanhua			Genetic Variation of the Major Histocompatibility Complex (MHC Class II B Gene) in the Threatened Hume's Pheasant, Syrmaticus humiae	PLOS ONE			English	Article							DIVERSITY; POLYMORPHISM; POPULATION; SEQUENCE; LOCI; EVOLUTION; NUMBERS; QUAIL; BIRD	Major histocompatibility complex (MHC) genes are the most polymorphic genes in vertebrates and encode molecules that play a crucial role in pathogen resistance. As a result of their diversity, they have received much attention in the fields of evolutionary and conservation biology. Here, we described the genetic variation of MHC class II B (MHCIIB) exon 2 in a wild population of Hume's pheasant (Syrmaticus humiae), which has suffered a dramatic decline in population over the last three decades across its ranges in the face of heavy exploitation and habitat loss. Twenty-four distinct alleles were found in 73 S. humiae specimens. We found seven shared alleles among four geographical groups as well as six rare MHCIIB alleles. Most individuals displayed between one to five alleles, suggesting that there are at least three MHCIIB loci of the Hume's pheasant. The d(N)/d(S) ratio at putative antigen-binding sites (ABS) was significantly greater than one, indicating balancing selection is acting on MHCIIB exon 2. Additionally, recombination and gene conversion contributed to generating MHCIIB diversity in the Hume's pheasant. One to three recombination events and seventy-five significant gene conversion events were observed within the Hume's pheasant MHCIIB loci. The phylogenetic tree and network analysis revealed that the Hume's pheasant alleles do not cluster together, but are scattered through the tree or network indicating a trans-species evolutionary mode. These findings revealed the evolution of the Hume's pheasant MHC after suffering extreme habitat fragmentation.	[Chen, Weicai] Nat Hist Museum Guangxi, Nanning 530012, Peoples R China; [Bei, Yongjian] Yulin Normal Univ, Coll Life Sci & Technol, Yulin 537000, Peoples R China; [Li, Hanhua] Guangxi Normal Univ, Coll Life Sci, Guangxi Key Lab Rare & Endangered Anim Ecol, Guilin 541004, Peoples R China	Yulin Normal University; Guangxi Normal University	Bei, YJ (corresponding author), Yulin Normal Univ, Coll Life Sci & Technol, Yulin 537000, Peoples R China.	beiyongjian@163.com		Chen, Weicai/0000-0002-2398-4079	National Natural Science Foundation of China [31260150]; Natural Science Foundation of Guangxi Province, China [2012GXNSFAA053057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi Province, China(National Natural Science Foundation of Guangxi Province)	This study was supported by National Natural Science Foundation of China (Grant No. 31260150), Natural Science Foundation of Guangxi Province, China (Grant No. 2012GXNSFAA053057).	Alcaide M, 2007, J MOL EVOL, V65, P541, DOI 10.1007/s00239-007-9033-9; Alcaide M, 2014, ECOL EVOL, V4, P688, DOI 10.1002/ece3.974; Bei YJ, 2005, THESIS; Bei YJ, 2014, BIOCHEM SYST ECOL, V57, P69, DOI 10.1016/j.bse.2014.07.006; Boyce WM, 1997, GENETICS, V145, P421; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Canales-Delgadillo JC, 2012, J AVIAN BIOL, V43, P168, DOI 10.1111/j.1600-048X.2011.05372.x; Cheng K-m, 1998, CHINA RED DATA BOOK; Choudhury A, 2002, REPORT; Choudhury Anwaruddin, 2009, Tigerpaper (Bangkok), V36, P4; Collar NJ, 2001, THREATENED BIRDS OF; Doherty P C, 1975, Nature, V256, P50; Eimes JA, 2011, J EVOLUTION BIOL, V24, P1847, DOI 10.1111/j.1420-9101.2011.02311.x; Eimes JA, 2010, GENETICA, V138, P265, DOI 10.1007/s10709-009-9417-4; Garrigan D, 2003, EVOLUTION, V57, P1707; Hale ML, 2009, J EVOLUTION BIOL, V22, P1284, DOI 10.1111/j.1420-9101.2009.01746.x; Hedrick PW, 2001, MOL ECOL, V10, P1399, DOI 10.1046/j.1365-294X.2001.01289.x; Hosomichi K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-322; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Kennedy LJ, 2002, IMMUNOGENETICS, V54, P348, DOI 10.1007/s00251-002-0465-5; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; Klein J, 1998, SCAND J IMMUNOL, V47, P199; Klein J, 1986, NATURAL HISTORY OF T; Langefors AH, 2005, ENVIRON BIOL FISH, V74, P297, DOI 10.1007/s10641-005-0501-z; Li HH, 1998, J GUANGXI NORM U NAT, V16, P76; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ohta T, 1998, J MOL EVOL, V46, P633, DOI 10.1007/PL00006343; OHTA T, 1995, J MOL EVOL, V41, P115, DOI 10.1007/BF00170662; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Promerova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069135; Reed KM, 2011, IMMUNOGENETICS, V63, P753, DOI 10.1007/s00251-011-0549-1; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Sawyer S, 1999, GENECONV A COMPUTER; Shafer ABA, 2012, J HERED, V103, P371, DOI 10.1093/jhered/esr138; Shiina T, 2006, ANIM SCI J, V77, P151, DOI 10.1111/j.1740-0929.2006.00333.x; Shiina T, 2004, J IMMUNOL, V172, P6751, DOI 10.4049/jimmunol.172.11.6751; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Strand T, 2007, IMMUNOGENETICS, V59, P725, DOI 10.1007/s00251-007-0234-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wittzell H, 1999, MOL BIOL EVOL, V16, P479, DOI 10.1093/oxfordjournals.molbev.a026130; Worley K, 2008, IMMUNOGENETICS, V60, P233, DOI 10.1007/s00251-008-0288-0; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu Tailin, 2012, Jiyinzuxue Yu Yingyong Shengwuxue, V31, P369; Zhou TF, 2005, COASTAL ENTERPRISES, V68, P49, DOI [10.1016/j.chemosphere.2011.08.010, DOI 10.1016/J.CHEMOSPHERE.2011.08.010]; [No title captured]	50	3	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116499	10.1371/journal.pone.0116499	http://dx.doi.org/10.1371/journal.pone.0116499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629763	gold, Green Submitted, Green Published			2022-12-27	WOS:000348732100038
J	Hu, J; Lin, T; Gao, YH; Xu, JY; Jiang, C; Wang, GH; Bu, GJ; Xu, HX; Chen, HF; Zhang, YW				Hu, Jin; Lin, Ting; Gao, Yuehong; Xu, Junyue; Jiang, Chao; Wang, Guanghui; Bu, Guojun; Xu, Huaxi; Chen, Haifeng; Zhang, Yun-wu			The Resveratrol Trimer Miyabenol C Inhibits beta-Secretase Activity and beta-Amyloid Generation	PLOS ONE			English	Article							PROTEIN-CLEAVING ENZYME; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; OLIGOMERIC STILBENES; CARAGANA-SINICA; GAMMA-SECRETASE; CELL-LINES; IN-VIVO; BACE1; CLEAVAGE	Accumulation and deposition of amyloid-beta peptide (A beta) in the brain is a primary cause of the pathogenesis of Alzheimer's disease (AD). Aa is generated from amyloid-beta precursor protein (APP) through sequential cleavages first by beta-secretase and then by.-secretase. Inhibiting a-secretase activity is believed to be one of the most promising strategies for AD treatment. In the present study, we found that a resveratrol trimer, miyabenol C, isolated from stems and leaves of the small-leaf grape (Vitisthunbergii var. taiwaniana), can markedly reduce Aa and sAPP beta levels in both cell cultures and the brain of AD model mice. Mechanistic studies revealed that miyabenol C affects neither protein levels of APP, the two major alpha-secretases ADAM10 and TACE, and the gamma-secretase component Presenilin 1, nor gamma-secretase-mediated Notch processing and TACE activity. In contrast, although miyabenol C has no effect on altering protein levels of the beta-secretase BACE1, it can inhibit both in vitro and in vivo beta-secretase activity. Together, our results indicate that miyabenol C is a prominent beta-secretase inhibitor and lead compound for AD drug development.	[Hu, Jin; Lin, Ting; Xu, Junyue; Jiang, Chao; Wang, Guanghui; Xu, Huaxi; Chen, Haifeng] Xiamen Univ, Sch Pharmaceut Sci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361102, Peoples R China; [Hu, Jin; Gao, Yuehong; Bu, Guojun; Xu, Huaxi; Zhang, Yun-wu] Xiamen Univ, Coll Med, Inst Neurosci, Xiamen 361102, Peoples R China	Xiamen University; Xiamen University	Chen, HF (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361102, Peoples R China.	haifeng@xmu.edu.cn; yunzhang@xmu.edu.cn	Xu, Huaxi/AAV-7177-2021	Zhang, Yun-wu/0000-0002-7152-7630	National Natural Science Foundation of China [81202419, 81225008, 81161120496, 91332112, 91332114]; Xiamen Science and Technology Key program grant [3502Z20100006]; Fundamental Research Funds for the Central Universities of China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xiamen Science and Technology Key program grant; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Natural Science Foundation of China (Nos. 81202419, 81225008, 81161120496, 91332112, and 91332114), Xiamen Science and Technology Key program grant (No. 3502Z20100006), and Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barjot C, 2007, LIFE SCI, V81, P1565, DOI 10.1016/j.lfs.2007.08.047; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; BIEDLER JL, 1978, CANCER RES, V38, P3751; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Chaher N, 2014, J SCI FOOD AGR, V94, P951, DOI 10.1002/jsfa.6341; Chen G, 2001, PLANTA MED, V67, P665, DOI 10.1055/s-2001-17367; Das P, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-39; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Ebrahimi A, 2012, AGEING RES REV, V11, P329, DOI 10.1016/j.arr.2012.01.006; Gonzalez-Sarrias A, 2011, J AGR FOOD CHEM, V59, P8632, DOI 10.1021/jf201561e; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jin Q, 2012, BIOORG MED CHEM LETT, V22, P973, DOI 10.1016/j.bmcl.2011.12.012; Johnston JA, 2005, BIOCHEM SOC T, V33, P1096, DOI 10.1042/BST0331096; Kim DH, 2010, BIOL PHARM BULL, V33, P2024, DOI 10.1248/bpb.33.2024; KULANTHAIVEL P, 1995, PLANTA MED, V61, P41, DOI 10.1055/s-2006-957996; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lambert C, 2013, J AGR FOOD CHEM, V61, P11392, DOI 10.1021/jf403716y; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li XX, 2013, NEUROSCI LETT, V548, P90, DOI 10.1016/j.neulet.2013.05.018; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Meng YH, 2001, PHYTOCHEMISTRY, V57, P393, DOI 10.1016/S0031-9422(01)00061-9; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; ONO M, 1995, CHEM PHARM BULL, V43, P868; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sorensen EB, 2010, TRAFFIC, V11, P1234, DOI 10.1111/j.1600-0854.2010.01090.x; Tanaka T, 2000, PHYTOCHEMISTRY, V53, P1009, DOI 10.1016/S0031-9422(00)00016-9; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tian CY, 2003, ACTA BIOCH BIOPH SIN, V35, P77; Tian CY, 2002, ACTA PHARMACOL SIN, V23, P572; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Wang CK, 2010, J MED FOOD, V13, P170, DOI 10.1089/jmf.2009.1162; Wang KT, 2011, J AGR FOOD CHEM, V59, P3649, DOI 10.1021/jf104718g; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xu G., 1994, Yaoxue Xuebao, V29, P818; Yang JB, 2014, J ASIAN NAT PROD RES, V16, P275, DOI 10.1080/10286020.2013.877451; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhang YW, 2009, NEURON, V64, P328, DOI 10.1016/j.neuron.2009.08.036; Zhao YH, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-30; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	53	19	19	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115973	10.1371/journal.pone.0115973	http://dx.doi.org/10.1371/journal.pone.0115973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629409	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100027
J	Mohamad, S; Lsa, NM; Muhammad, R; Emran, NA; Kitan, NM; Kang, P; Kang, IN; Taid, NAM; Teo, SH; Akmal, SN				Mohamad, Suriati; lsa, Nurismah Md; Muhammad, Rohaizak; Emran, Nor Aina; Kitan, Nor Mayah; Kang, Peter; Kang, In Nee; Taid, Nur Aishah Mohd; Teo, Soo Hwang; Akmal, Sharifah Noor			Low Prevalence of CHEK2 Gene Mutations in Multiethnic Cohorts of Breast Cancer Patients in Malaysia	PLOS ONE			English	Article							HEREDITARY BREAST; 1100DELC MUTATION; DNA-DAMAGE; HIGH-RISK; SUSCEPTIBILITY; BRCA1; WOMEN; VARIANTS; FAMILIES; POPULATION	CHEK2 is a protein kinase that is involved in cell-cycle checkpoint control after DNA damage. Germline mutations in CHEK2 gene have been associated with increase in breast cancer risk. The aim of this study is to identify the CHEK2 gene germline mutations among high-risk breast cancer patients and its contribution to the multiethnic population in Malaysia. We screened the entire coding region of CHEK2 gene on 59 high-risk breast cancer patients who tested negative for BRCA1/2 germline mutations from UKM Medical Centre (UKMMC), Hospital Kuala Lumpur (HKL) and Hospital Putrajaya (HPJ). Sequence variants identified were screened further in case-control cohorts consisting of 878 unselected invasive breast cancer patients (180 Malays, 526 Chinese and 172 Indian) and 270 healthy individuals (90 Malays, 90 Chinese and 90 Indian). By screening the entire coding region of the CHEK2 gene, two missense mutations, c.480A>G (p.I160M) and c.538C>T (p.R180C) were identified in two unrelated patients (3.4%). Further screening of these missense mutations on the case-control cohorts unveiled the variant p.I160M in 2/172 (1.1%) Indian cases and 1/90 (1.1%) Indian control, variant p. R180C in 2/526 (0.38%) Chinese cases and 0/90 Chinese control, and in 2/180 (1.1%) of Malay cases and 1/90 (1.1%) of Malay control. The results of this study suggest that CHEK2 mutations are rare among high-risk breast cancer patients and may play a minor contributing role in breast carcinogenesis among Malaysian population.	[Mohamad, Suriati; lsa, Nurismah Md; Akmal, Sharifah Noor] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Muhammad, Rohaizak] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Emran, Nor Aina] Hosp Kuala Lumpur, Dept Gen Surg, Kuala Lumpur, Malaysia; [Kang, Peter; Kang, In Nee; Teo, Soo Hwang] Hosp Putrajaya, Dept Endocrine Surg, Putrajaya, Malaysia; [Kang, Peter; Kang, In Nee] Canc Res Initiat Fdn CARIF, Subang Jaya, Selangor, Malaysia; [Taid, Nur Aishah Mohd; Teo, Soo Hwang] Univ Malaya, Fac Med, Univ Malaya Canc Res Inst, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Malaya	Akmal, SN (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia.	sharifah@ppukm.ukm.edu.my	Kang, In Nee/AAK-7206-2020; Taib, Nur Aishah Mohd/B-2370-2010; Teo, Soo-hwang/H-2353-2014; Muhammad, Rohaizak/F-6199-2015	Taib, Nur Aishah Mohd/0000-0001-8419-0478; 	Research University Fund (UKM) [UKM-GUP-TKP-08-18-065]	Research University Fund (UKM)	This study was supported by The Research University Fund (UKM): UKM-GUP-TKP-08-18-065. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DW, 2007, INT J CANCER, V121, P2661, DOI 10.1002/ijc.23026; Bogdanova N, 2005, INT J CANCER, V116, P263, DOI 10.1002/ijc.21022; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Choi DH, 2008, BREAST CANCER RES TR, V112, P569, DOI 10.1007/s10549-007-9878-z; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Cybulski C, 2007, BREAST CANCER RES TR, V102, P119, DOI 10.1007/s10549-006-9320-y; Desrichard A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3062; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Dufault MR, 2004, INT J CANCER, V110, P320, DOI 10.1002/ijc.20073; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Friedrichsen DM, 2004, BREAST CANCER RES, V6, pR629, DOI 10.1186/bcr933; Gonzalez-Hormazabal P, 2008, BREAST CANCER RES TR, V110, P543, DOI 10.1007/s10549-007-9743-0; Kang PCE, 2014, BREAST CANCER RES TR, V144, P635, DOI 10.1007/s10549-014-2894-x; Kilpivaara O, 2004, INT J CANCER, V111, P543, DOI 10.1002/ijc.20299; Kleibl Z, 2005, BREAST CANCER RES TR, V90, P165, DOI 10.1007/s10549-004-4023-8; Kuusisto KM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2832; Laitman Y, 2007, ISRAEL MED ASSOC J, V9, P791; Le Calvez-Kelm F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2810; LEE ASG, 2008, J CLIN ONCOL, V26, P2419, DOI DOI 10.1200/JC0.2008.16.4335; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Liu Y, 2011, HUM MUTAT, V32, P1000, DOI 10.1002/humu.21538; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Nevanlinna H, 2006, ONCOGENE, V25, P5912, DOI 10.1038/sj.onc.1209877; Novak DJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-239; Osorio A, 2004, INT J CANCER, V108, P54, DOI 10.1002/ijc.11414; Rajkumar Thangarajan, 2003, Asian Pac J Cancer Prev, V4, P203; Rashid MU, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-312; Roeb W, 2012, HUMAN MOL GENETICS; Schutte M, 2003, AM J HUM GENET, V72, P1023, DOI 10.1086/373965; Shaag A, 2005, HUM MOL GENET, V14, P555, DOI 10.1093/hmg/ddi052; Sodha N, 2002, HUM MUTAT, V19, P173, DOI 10.1002/humu.10031; Sodha N, 2002, BRIT J CANCER, V87, P1445, DOI 10.1038/sj.bjc.6600637; Sodha N, 2006, CANCER RES, V66, P8966, DOI 10.1158/0008-5472.CAN-06-1990; Song Chuan-gui, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P443; Thirthagiri E, 2009, FAM CANC; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Wang C, 2008, ADV THER, V25, P496, DOI 10.1007/s12325-008-0057-3; Zhang SY, 2008, CANCER RES, V68, P2154, DOI 10.1158/0008-5472.CAN-07-5187	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117104	10.1371/journal.pone.0117104	http://dx.doi.org/10.1371/journal.pone.0117104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629968	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100064
J	Schweinhuber, SK; Messerschmidt, T; Hansch, R; Korte, M; Rothkegel, M				Schweinhuber, Stefanie K.; Messerschmidt, Tania; Haensch, Robert; Korte, Martin; Rothkegel, Martin			Profilin Isoforms Modulate Astrocytic Morphology and the Motility of Astrocytic Processes	PLOS ONE			English	Article							PROTEIN-KINASE-C; IN-VIVO; LENTIVIRAL VECTOR; ACTIN-BINDING; GENE DELIVERY; CELLS; CAMP; PHOSPHORYLATION; STELLATION; EXOCYTOSIS	The morphology of astrocytic processes determines their close structural association with synapses referred to as the 'tripartite synapse'. Concerted morphological plasticity processes at tripartite synapses are supposed to shape neuronal communication. Morphological changes in astrocytes as well as the motility of astrocytic processes require remodeling of the actin cytoskeleton. Among the regulators of fast timescale actin-based motility, the actin binding protein profilin 1 has recently been shown to control the activity-dependent outgrowth of astrocytic processes. Here, we demonstrate that cultured murine astrocytes in addition to the ubiquitous profilin 1 also express the neuronal isoform profilin 2a. To analyze the cellular function of both profilins in astrocytes, we took advantage of a shRNA mediated isoform-specific downregulation. Interestingly, consistent with earlier results in neurons, we found redundant as well as isoform-specific functions of both profilins in modulating cellular physiology. The knockdown of either profilin 1 or profilin 2a led to a significant decrease in cell spreading of astrocytes. In contrast, solely the knockdown of profilin 2a resulted in a significantly reduced morphological complexity of astrocytes in both dissociated and slice culture astrocytes. Moreover, both isoforms proved to be crucial for forskolin-induced astrocytic stellation. Furthermore, forskolin treatment resulted in isoform-specific changes in the phosphorylation level of profilin 1 and profilin 2a, leading to a PKA-dependent phosphorylation of profilin 2a. In addition, transwell assays revealed an involvement of both isoforms in the motility of astrocytic processes, while FRAP analysis displayed an isoform-specific role of profilin 1 in the regulation of actin dynamics in peripheral astrocytic processes. Taken together, we suggest profilin isoforms to be important modulators of astrocytic morphology and motility with overlapping as well as isoform-specific functions.	[Schweinhuber, Stefanie K.; Messerschmidt, Tania; Korte, Martin; Rothkegel, Martin] TU Braunschweig, Inst Zool, Braunschweig, Germany; [Haensch, Robert] TU Braunschweig, Inst Plant Biol, D-38106 Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology	Rothkegel, M (corresponding author), TU Braunschweig, Inst Zool, Braunschweig, Germany.	m.rothkegel@tu-bs.de		Hansch, Robert/0000-0003-1310-8419; , Martin/0000-0001-5041-4429				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; BAORTO DM, 1992, J CELL BIOL, V117, P357, DOI 10.1083/jcb.117.2.357; Bernardinelli Y, 2014, CURR BIOL, V24, P1679, DOI 10.1016/j.cub.2014.06.025; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Di Nardo A, 2000, J CELL SCI, V113, P3795; Ding ZH, 2012, ACTA APPL MATH, V118, P1, DOI 10.1007/s10440-012-9692-4; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Fang KM, 2012, J CELL BIOCHEM, V113, P3019, DOI 10.1002/jcb.24180; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Gorlich A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030068; GOLDMAN JE, 1990, BRAIN RES, V528, P189, DOI 10.1016/0006-8993(90)91657-3; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; Grantham J, 2012, PROTOPLASMA, V249, P1001, DOI 10.1007/s00709-012-0403-9; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hu ED, 2001, EXP NEPHROL, V9, P265; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kullmann JA, 2012, NEUROSCIENCE, V223, P355, DOI 10.1016/j.neuroscience.2012.07.055; Kullmann JA, 2012, EMBO REP, V13, P75, DOI 10.1038/embor.2011.211; Lambrechts A, 2000, MOL CELL BIOL, V20, P8209, DOI 10.1128/MCB.20.21.8209-8219.2000; Lorente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085817; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Mayboroda O, 1997, CELL MOTIL CYTOSKEL, V37, P166, DOI 10.1002/(SICI)1097-0169(1997)37:2<166::AID-CM9>3.0.CO;2-6; Michaelsen K, 2010, P NATL ACAD SCI USA, V107, P15780, DOI 10.1073/pnas.1004406107; Miki T, 2009, J BIOL CHEM, V284, P5753, DOI 10.1074/jbc.M806191200; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Molotkov D, 2013, CELL CALCIUM, V53, P338, DOI 10.1016/j.ceca.2013.03.001; Murk K, 2013, J CELL SCI, V126, P3873, DOI 10.1242/jcs.125146; Murk K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034167; Murk K, 2009, J CELL SCI, V122, P957, DOI 10.1242/jcs.041715; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neuhoff H, 2005, EUR J NEUROSCI, V21, P15, DOI 10.1111/j.1460-9568.2004.03814.x; Nolle A, 2011, HUM MOL GENET, V20, P4865, DOI 10.1093/hmg/ddr425; Obermann H, 2005, MOL HUM REPROD, V11, P53, DOI 10.1093/molehr/gah132; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perez V, 2005, EUR J NEUROSCI, V21, P26, DOI 10.1111/j.1460-9568.2004.03845.x; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Polet D, 2007, FEBS LETT, V581, P211, DOI 10.1016/j.febslet.2006.12.013; Racchetti G, 2012, GLIA, V60, P465, DOI 10.1002/glia.22280; Ramakers GJA, 1998, EXP CELL RES, V245, P252, DOI 10.1006/excr.1998.4224; Rawe VY, 2006, HUM REPROD, V21, P1143, DOI 10.1093/humrep/dei480; Reichenbach A, 2010, BRAIN RES REV, V63, P11, DOI 10.1016/j.brainresrev.2010.02.003; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Thomsen R, 2011, GLIA, V59, P1782, DOI 10.1002/glia.21223; Treisman R, 2013, TRENDS BIOCHEM SCI, V38, P376, DOI 10.1016/j.tibs.2013.06.004; Vemuri B, 2001, CELL SIGNAL, V13, P433, DOI 10.1016/S0898-6568(01)00164-4; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Won CK, 2000, BRAIN RES, V887, P250, DOI 10.1016/S0006-8993(00)02922-X; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	69	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117244	10.1371/journal.pone.0117244	http://dx.doi.org/10.1371/journal.pone.0117244			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629407	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100075
J	Wifling, D; Bernhardt, G; Dove, S; Buschauer, A				Wifling, David; Bernhardt, Guenther; Dove, Stefan; Buschauer, Armin			The Extracellular Loop 2 (ECL2) of the Human Histamine H-4 Receptor Substantially Contributes to Ligand Binding and Constitutive Activity	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HIGH-AFFINITY STATE; DISULFIDE BOND; DRY MOTIF; 2ND; ACTIVATION; AGONIST; POTENT; SITE; H-4-RECEPTOR	In contrast to the corresponding mouse and rat orthologs, the human histamine H-4 receptor (hH(4)R) shows extraordinarily high constitutive activity. In the extracellular loop (ECL), replacement of F169 by V as in the mouse H4R significantly reduced constitutive activity. Stabilization of the inactive state was even more pronounced for a double mutant, in which, in addition to F169V, S179 in the ligand binding site was replaced by M. To study the role of the FF motif in ECL2, we generated the hH(4)R-F168A mutant. The receptor was coexpressed in Sf9 insect cells with the G-protein subunits G alpha(12) and G beta(1)gamma(2), and the membranes were studied in [H-3] histamine binding and functional [S-35] GTP gamma S assays. The potency of various ligands at the hH(4)R-F168A mutant decreased compared to the wild-type hH(4)R, for example by 30-and more than 100-fold in case of the H4R agonist UR-PI376 and histamine, respectively. The high constitutive activity of the hH(4)R was completely lost in the hH(4)R-F168A mutant, as reflected by neutral antagonism of thioperamide, a full inverse agonist at the wild-type hH(4)R. By analogy, JNJ7777120 was a partial inverse agonist at the hH(4)R, but a partial agonist at the hH(4)R-F168A mutant, again demonstrating the decrease in constitutive activity due to F168A mutation. Thus, F168 was proven to play a key role not only in ligand binding and potency, but also in the high constitutive activity of the hH(4)R.	[Wifling, David; Bernhardt, Guenther; Dove, Stefan; Buschauer, Armin] Univ Regensburg, Inst Pharm, D-93053 Regensburg, Germany	University of Regensburg	Buschauer, A (corresponding author), Univ Regensburg, Inst Pharm, D-93053 Regensburg, Germany.	armin.buschauer@chemie.uni-regensburg.de	Wifling, David/AAB-8213-2020	Wifling, David/0000-0002-1370-2138	Deutsche Forschungsgemeinschaft (DFG) within the Graduate Training Programs [GRK760, GRK1910]; DFG	Deutsche Forschungsgemeinschaft (DFG) within the Graduate Training Programs(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) within the Graduate Training Programs GRK760, "Medicinal Chemistry: Molecular Recognition - Ligand-Receptor Interactions" and GRK1910, "Medicinal Chemistry of Selective GPCR Ligands", and within the DFG funding program Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewijnse AE, 2000, MOL PHARMACOL, V57, P890; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Brunskole I, 2011, N-S ARCH PHARMACOL, V384, P301, DOI 10.1007/s00210-011-0673-3; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cook JVF, 1997, ENDOCRINOLOGY, V138, P2800, DOI 10.1210/en.138.7.2800; DAVIDSON FF, 1994, P NATL ACAD SCI USA, V91, P4029, DOI 10.1073/pnas.91.9.4029; GETHER U, 1995, J BIOL CHEM, V270, P28268; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Igel P, 2009, J MED CHEM, V52, P6297, DOI 10.1021/jm900526h; Igel P, 2009, J MED CHEM, V52, P2623, DOI 10.1021/jm9000693; Jablonowski JA, 2003, J MED CHEM, V46, P3957, DOI 10.1021/jm0341047; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kooistra AJ, 2013, BRIT J PHARMACOL, V170, P101, DOI 10.1111/bph.12248; LANGE JHM, 1995, TETRAHEDRON, V51, P13447, DOI 10.1016/0040-4020(95)00881-8; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Lim HD, 2008, J PHARMACOL EXP THER, V327, P88, DOI 10.1124/jpet.108.140343; Lim HD, 2006, J MED CHEM, V49, P6650, DOI 10.1021/jm060880d; Lim HD, 2010, MOL PHARMACOL, V77, P734, DOI 10.1124/mol.109.063040; Massotte D, 2005, NAT STRUCT MOL BIOL, V12, P287, DOI 10.1038/nsmb0405-287; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Nanevicz T, 1996, J BIOL CHEM, V271, P702, DOI 10.1074/jbc.271.2.702; NODA K, 1994, J BIOL CHEM, V269, P6743; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; SCHMUTZ J, 1967, HELV CHIM ACTA, V50, P245, DOI 10.1002/hlca.19670500131; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Schneider EH, 2009, BIOCHEMISTRY-US, V48, P1424, DOI 10.1021/bi802050d; Schnell D, 2011, N-S ARCH PHARMACOL, V383, P457, DOI 10.1007/s00210-011-0612-3; Schultes S, 2013, MEDCHEMCOMM, V4, P193, DOI 10.1039/c2md20212c; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; Seifert R, 2013, TRENDS PHARMACOL SCI, V34, P33, DOI 10.1016/j.tips.2012.11.001; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Smits RA, 2006, J MED CHEM, V49, P4512, DOI 10.1021/jm051008s; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wifling D, 2015, BRIT J PHARMACOL, V172, P785, DOI 10.1111/bph.12801; Wittmann Hans-Joachim, 2014, In Silico Pharmacology, V2, P1, DOI 10.1186/s40203-014-0001-y	41	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117185	10.1371/journal.pone.0117185	http://dx.doi.org/10.1371/journal.pone.0117185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629160	gold, Green Published, Green Submitted			2022-12-27	WOS:000348732100073
J	Xiao, QY; Ma, ZW; Li, SS; Liu, Y				Xiao, Qingyang; Ma, Zongwei; Li, Shenshen; Liu, Yang			The Impact of Winter Heating on Air Pollution in China	PLOS ONE			English	Article							SOURCE APPORTIONMENT; LIFE EXPECTANCY; PM2.5; AEROSOL	Fossil-fuel combustion related winter heating has become a major air quality and public health concern in northern China recently. We analyzed the impact of winter heating on aerosol loadings over China using the MODIS-Aqua Collection 6 aerosol product from 2004-2012. Absolute humidity (AH) and planetary boundary layer height (PBL)-adjusted aerosol optical depth (AOD*) was constructed to reflect ground-level PM2.5 concentrations. GIS analysis, standard statistical tests, and statistical modeling indicate that winter heating is an important factor causing increased PM2.5 levels in more than three-quarters of central and eastern China. The heating season AOD* was more than five times higher as the nonheating season AOD*, and the increase in AOD* in the heating areas was greater than in the non-heating areas. Finally, central heating tend to contribute less to air pollution relative to other means of household heating.	[Xiao, Qingyang; Ma, Zongwei; Li, Shenshen; Liu, Yang] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Ma, Zongwei] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China; [Li, Shenshen] Chinese Acad Sci, Jointly Sponsored Inst Remote Sensing Applicat, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Li, Shenshen] Beijing Normal Univ, Beijing 100875, Peoples R China	Emory University; Rollins School Public Health; Nanjing University; Chinese Academy of Sciences; Beijing Normal University	Liu, Y (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	yang.liu@emory.edu	Ma, Zongwei/ABG-4851-2020; Liu, Yang/AAA-7224-2019; Xiao, Qingyang/AAE-4883-2022	Ma, Zongwei/0000-0003-0257-5695; Liu, Yang/0000-0001-5477-2186; 	USEPA [R834799]; Rollins Earn and Learn program; NASA Applied Sciences Program [NNX11AI53G]	USEPA(United States Environmental Protection Agency); Rollins Earn and Learn program; NASA Applied Sciences Program(National Aeronautics & Space Administration (NASA))	This publication was made possible by USEPA grant R834799 (http://www.epa.gov/ord/airscience/air-cleanairresearchcenters.htm). Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the USEPA. Further, USEPA does not endorse the purchase of any commercial products or services mentioned in the publication. The work of Q. Xiao was partly supported by the Rollins Earn and Learn program (http://sph.emory.edu/current_students/REAL/index.html). Additional funding was received from the NASA Applied Sciences Program (grant no. NNX11AI53G, PI: Yang Liu, http://www.nasa.gov/applied-sciences/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CHINA ELECT POWER YB, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; [Anonymous], 2005, CHINA STAT YB 2005; [Anonymous], 2013, CHINA STAT YB 2013, DOI [10.1016/j.amsu.2013.12.001, DOI 10.1016/J.AMSU.2013.12.001]; Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110; Donald MW, 1970, GEN INVERSES, P591; Hoff RM, 2009, J AIR WASTE MANAGE, V59, P645, DOI 10.3155/1047-3289.59.6.645; Koelemeijer RBA, 2006, ATMOS ENVIRON, V40, P5304, DOI 10.1016/j.atmosenv.2006.04.044; Lee YC, 2003, ATMOS ENVIRON, V37, P2927, DOI 10.1016/S1352-2310(03)00296-6; Levy RC, 2013, ATMOSPHERIC MEASUREM, P159; Liu Y, 2005, ENVIRON SCI TECHNOL, V39, P3269, DOI 10.1021/es049352m; Ma Z, 2014, ENV SCI TECHNOL; Molod A., 2012, NASA TECHNICAL REPOR; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2013, P NATL ACAD SCI USA, V110, P12861, DOI 10.1073/pnas.1310925110; Remer LA, 2008, J GEOPHYS RES ATMOSP; Song Y, 2006, ATMOS ENVIRON, V40, P1526, DOI 10.1016/j.atmosenv.2005.10.039; Song Y, 2006, SCI TOTAL ENVIRON, V372, P278, DOI 10.1016/j.scitotenv.2006.08.041; Tsai TC, 2011, ATMOS ENVIRON, V45, P4777, DOI 10.1016/j.atmosenv.2009.10.006; Wang XM, 2004, J ARID ENVIRON, V58, P559, DOI 10.1016/j.jaridenv.2003.11.009; Wang ZX, 2013, ENVIRON INT, V51, P150, DOI 10.1016/j.envint.2012.10.011; You CF, 2010, ENERGY, V35, P4467, DOI 10.1016/j.energy.2009.04.019; Yu Y, 2011, J ENVIRON MONITOR, V13, P334, DOI 10.1039/c0em00467g; Zhang L, 2010, ENERGIES, P26; Zhang L, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012299; Zhang R, 2013, ATMOS CHEM PHYS, V13, P7053, DOI 10.5194/acp-13-7053-2013; Zhang WJ, 2006, BIOMED ENVIRON SCI, V19, P461; Zhao PS, 2013, ATMOS CHEM PHYS, V13, P4631, DOI 10.5194/acp-13-4631-2013; Zhao Y, 2008, ATMOS ENVIRON, V42, P8442, DOI 10.1016/j.atmosenv.2008.08.021	28	90	91	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117311	10.1371/journal.pone.0117311	http://dx.doi.org/10.1371/journal.pone.0117311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629878	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100079
J	Silfver, T; Paaso, U; Rasehorn, M; Rousi, M; Mikola, J				Silfver, Tarja; Paaso, Ulla; Rasehorn, Mira; Rousi, Matti; Mikola, Juha			Genotype x Herbivore Effect on Leaf Litter Decomposition in Betula Pendula Saplings: Ecological and Evolutionary Consequences and the Role of Secondary Metabolites	PLOS ONE			English	Article							SILVER BIRCH; COMMUNITY GENETICS; ECOSYSTEM GENETICS; PHENOLIC-COMPOUNDS; NITROGEN DYNAMICS; INSECT HERBIVORY; PLANT DEFENSE; GROWTH; PUBESCENS; RESISTANCE	Plant genetic variation and herbivores can both influence ecosystem functioning by affecting the quantity and quality of leaf litter. Few studies have, however, investigated the effects of herbivore load on litter decomposition at plant genotype level. We reduced insect herbivory using an insecticide on one half of field-grown Betula Pendula saplings of 17 genotypes, representing random intrapopulation genetic variation, and allowed insects to naturally colonize the other half. We hypothesized that due to induced herbivore defence, saplings under natural herbivory produce litter of higher concentrations of secondary metabolites (terpenes and soluble phenolics) and have slower litter decomposition rate than saplings under reduced herbivory. We found that leaf damage was 89 and 53% lower in the insecticide treated saplings in the summer and autumn surveys, respectively, which led to 73% higher litter production. Litter decomposition rate was also affected by herbivore load, but the effect varied from positive to negative among genotypes and added up to an insignificant net effect at the population level. In contrast to our hypothesis, concentrations of terpenes and soluble phenolics were higher under reduced than natural herbivory. Those genotypes, whose leaves were most injured by herbivores, produced litter of lowest mass loss, but unlike we expected, the concentrations of terpenes and soluble phenolics were not linked to either leaf damage or litter decomposition. Our results show that (1) the genetic and herbivore effects on B. pendula litter decomposition are not mediated through variation in terpene or soluble phenolic concentrations and suggest that (2) the presumably higher insect herbivore pressure in the future warmer climate will not, at the ecological time scale, affect the mean decomposition rate in genetically diverse B. pendula populations. However, (3) due to the significant genetic variation in the response of decomposition to herbivory, evolutionary changes in mean decomposition rate are possible.	[Silfver, Tarja; Paaso, Ulla; Rasehorn, Mira; Mikola, Juha] Univ Helsinki, Dept Environm Sci, FI-15140 Lahti, Finland; [Rousi, Matti] Finnish Forest Res Inst, Vantaa Res Unit, FI-01301 Vantaa, Finland	University of Helsinki; Natural Resources Institute Finland (Luke)	Silfver, T (corresponding author), Univ Helsinki, Dept Environm Sci, Niemenkatu 73, FI-15140 Lahti, Finland.	tarja.h.silfver@gmail.com	Mikola, Juha/A-1630-2015	Mikola, Juha/0000-0002-4336-2648; Silfver, Tarja/0000-0003-0619-5008	Academy of Finland [1122444]	Academy of Finland(Academy of Finland)	The study was funded by the Academy of Finland (decision #1122444). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila U, 2010, OECOLOGIA, V164, P163, DOI 10.1007/s00442-010-1658-5; ATKINSON MD, 1992, J ECOL, V80, P837, DOI 10.2307/2260870; ATTIWILL PM, 1993, NEW PHYTOL, V124, P561, DOI 10.1111/j.1469-8137.1993.tb03847.x; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Berenbaum MR, 2008, PLANT PHYSIOL, V146, P804, DOI 10.1104/pp.107.113472; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Chapman SK, 2006, OIKOS, V114, P566, DOI 10.1111/j.2006.0030-1299.14676.x; Chapman SK, 2003, ECOLOGY, V84, P2867, DOI 10.1890/02-0046; Cornelissen JHC, 1999, NEW PHYTOL, V143, P191, DOI 10.1046/j.1469-8137.1999.00430.x; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; CRAWLEY MJ, 1983, HERBIVORY THE DYNAMI; CYR H, 1993, NATURE, V361, P148, DOI 10.1038/361148a0; Fierer N, 2001, SOIL BIOL BIOCHEM, V33, P1827, DOI 10.1016/S0038-0717(01)00111-0; Findlay S, 1996, ECOL APPL, V6, P269, DOI 10.2307/2269570; Fischer A, 2002, FOLIA GEOBOT, V37, P17, DOI 10.1007/BF02803188; Fritz RS, 1998, OIKOS, V83, P117, DOI 10.2307/3546552; Grime JP, 1996, OIKOS, V77, P489, DOI 10.2307/3545938; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Haukioja E, 2003, OECOLOGIA, V136, P161, DOI 10.1007/s00442-003-1238-z; Hersch-Green EI, 2011, PHILOS T R SOC B, V366, P1453, DOI 10.1098/rstb.2010.0331; Hunter MD, 2001, AGR FOREST ENTOMOL, V3, P153, DOI 10.1046/j.1461-9555.2001.00108.x; Hynynen J, 2010, FORESTRY, V83, P103, DOI 10.1093/forestry/cpp035; KARBAN R, 1997, INDUCED RESPONSES TO; Keinanen M, 1999, ECOLOGY, V80, P1970, DOI 10.1890/0012-9658(1999)080[1970:TOIPMO]2.0.CO;2; Keski-Saari S, 2005, GLOBAL CHANGE BIOL, V11, P1180, DOI 10.1111/j.1365-2486.2005.00964.x; Laitinen ML, 2000, J CHEM ECOL, V26, P1609, DOI 10.1023/A:1005582611863; Leroy CJ, 2012, FRESHW SCI, V31, P1244, DOI 10.1899/12-029.1; Madritch M, 2006, ECOSYSTEMS, V9, P528, DOI 10.1007/s10021-006-0008-2; Martemyanov VV, 2012, ARTHROPOD-PLANT INTE, V6, P507, DOI 10.1007/s11829-012-9202-7; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; Mikola J, 2014, EVOL ECOL, V28, P811, DOI 10.1007/s10682-014-9708-9; Nykanen H, 2004, OIKOS, V104, P247, DOI 10.1111/j.0030-1299.2004.12768.x; Orians CM, 2010, ANNU REV ENTOMOL, V55, P439, DOI 10.1146/annurev-ento-112408-085333; PASTOR J, 1993, ECOLOGY, V74, P467, DOI 10.2307/1939308; Prittinen K, 2003, OECOLOGIA, V137, P572, DOI 10.1007/s00442-003-1384-3; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; ROSENTHAL G, 1992, HERBIVORES THEIR INT, V2; Saikkonen K, 2003, FOREST PATHOL, V33, P215, DOI 10.1046/j.1439-0329.2003.00325.x; Schweitzer JA, 2005, OIKOS, V110, P133, DOI 10.1111/j.0030-1299.2005.13650.x; Silfver T, 2007, OECOLOGIA, V152, P707, DOI 10.1007/s00442-007-0695-1; Silfver Tarja, 2014, F1000Res, V3, P34, DOI 10.12688/f1000research.3-34.v1; Silfver T, 2013, ANN BOT FENN, V50, P337, DOI 10.5735/086.050.0508; Silfver T, 2009, FOREST ECOL MANAG, V257, P2145, DOI 10.1016/j.foreco.2009.02.020; Stark S, 2007, OECOLOGIA, V151, P486, DOI 10.1007/s00442-006-0593-y; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tegelberg R, 2001, GLOBAL CHANGE BIOL, V7, P839, DOI 10.1046/j.1354-1013.2001.00453.x; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877	58	18	18	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116806	10.1371/journal.pone.0116806	http://dx.doi.org/10.1371/journal.pone.0116806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622034	Green Published, gold, Green Submitted			2022-12-27	WOS:000348470400007
J	Bagchi, D; Andrade, J; Shupnik, MA				Bagchi, Debalina; Andrade, Josefa; Shupnik, Margaret A.			A New Role for Wilms Tumor Protein 1: Differential Activities of plus KTS and -KTS Variants to Regulate LH beta Transcription	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; GROWTH-RESPONSE PROTEIN-1; STEROIDOGENIC FACTOR-I; LUTEINIZING-HORMONE; GENE-EXPRESSION; FRASIER-SYNDROME; SUPPRESSOR GENE; TRANSGENIC MICE; SUBUNIT GENES; BINDING-SITES	Luteinizing hormone (LH) is synthesized and secreted throughout the reproductive cycle from gonadotrope cells in the anterior pituitary, and is required for steroidogenesis and ovulation. LH contains an a-subunit common with FSH, and a unique LH beta subunit that defines biological activity. Basal LH beta transcription is low and stimulated by hypothalamic GnRH, which induces synthesis of early growth response protein-1 (Egr1), and stimulates binding of transcription factors Egr1 and steroidogenic factor-1 (SF1) on the promoter. WT1 (Wilms tumor protein1) is a zinc finger transcription factor with an essential role in urogenital system development, and which regulates several reproductive genes via interactions with SF1 or binding to GC-rich elements such as Egr1 binding sites. We investigated a potential role for WT1 in LH beta transcription in clonal mouse gonadotrope L beta T2 cells. WT1 was present in L beta T2 and mouse pituitary cells, and protein bound to the endogenous LH beta promoter. Interestingly, mRNAs for WT1(+KTS), which contains a three amino-acid insertion between the 3rd and 4th zinc fingers, and the WT1 (-KTS) variant were both expressed at significant levels. WT1 mRNAs and protein were decreased approximately 50% by GnRH treatment, under conditions where Egr1 mRNA and protein, and LH beta transcription, were stimulated. Decreasing expression of mRNA for WT1 (-KTS) decreased stimulation of LH beta and Egr1 by GnRH, whereas decreasing both WT1 (-KTS) and (+KTS) increased endogenous LH beta transcription, and prevented LH beta but not Egr1 stimulation by GnRH, suggesting differing biological activities for the WT1 isoforms. Overexpression of WT1 showed that WT1(-KTS) enhanced LH beta promoter GnRH stimulation 2-to-3-fold and required the 3' Egr1 site, but WT1(+KTS) repressed both basal and GnRH-stimulated LH beta promoter activity by approximately 70%. Our data suggest that WT1 can modulate LH beta transcription, with differential roles for the two WT1 variants; WT1 (-KTS) enhances and WT1 (+KTS) suppresses transcription.	[Bagchi, Debalina] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Andrade, Josefa; Shupnik, Margaret A.] Univ Virginia, Sch Med, Dept Med, Div Endocrinol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Shupnik, MA (corresponding author), Univ Virginia, Sch Med, Dept Med, Div Endocrinol, Charlottesville, VA 22908 USA.	mas3x@virginia.edu			National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction Research through both an individual research project [U54 HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER	National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction Research through both an individual research project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health through cooperative agreement (U54 HD28934) as part of the Specialized Cooperative Centers Program in Reproduction Research through both an individual research project (to MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 2013, MOL ENDOCRINOL, V27, P828, DOI 10.1210/me.2012-1323; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Benz K, 2006, NEPHROL DIAL TRANSPL, V21, P1716, DOI 10.1093/ndt/gfl023; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; Call GB, 2002, MOL CELL ENDOCRINOL, V189, P85, DOI 10.1016/S0303-7207(01)00744-4; Chu ZG, 2009, J NEUROSCI, V29, P5616, DOI 10.1523/JNEUROSCI.0352-09.2009; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; Curtin D, 2004, MOL ENDOCRINOL, V18, P1263, DOI 10.1210/me.2003-0221; Dame C, 2006, BLOOD, V107, P4282, DOI 10.1182/blood-2005-07-2889; Dammer EB, 2007, MOL ENDOCRINOL, V21, P415, DOI 10.1210/me.2006-0361; Dorn C, 1999, J BIOL CHEM, V274, P13870, DOI 10.1074/jbc.274.20.13870; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; FALLEST PC, 1995, BIOL REPROD, V53, P103, DOI 10.1095/biolreprod53.1.103; Ferris HA, 2007, BIOL REPROD, V77, P1073, DOI 10.1095/biolreprod.107.064139; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Gannon AM, 2009, J MOL BIOL, V394, P29, DOI 10.1016/j.jmb.2009.09.007; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Halvorson LM, 1999, MOL ENDOCRINOL, V13, P106, DOI 10.1210/me.13.1.106; HAMILTON TB, 1995, NUCLEIC ACIDS RES, V23, P277, DOI 10.1093/nar/23.2.277; HEWITT SM, 1995, CANCER RES, V55, P5386; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Ji SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053140; Kaiser UB, 2000, MOL ENDOCRINOL, V14, P1235, DOI 10.1210/me.14.8.1235; Kim J, 1999, MOL CELL BIOL, V19, P2289; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Melo KFS, 2002, J CLIN ENDOCR METAB, V87, P2500, DOI 10.1210/jc.87.6.2500; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Oh S, 1999, J BIOL CHEM, V274, P37473, DOI 10.1074/jbc.274.52.37473; Ritchie MF, 2010, J BIOL CHEM, V285, P10591, DOI 10.1074/jbc.M109.083493; SAKAMOTO KM, 1991, ONCOGENE, V6, P867; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Walsh HE, 2009, MOL ENDOCRINOL, V23, P237, DOI 10.1210/me.2008-0098; Webster NJG, 1997, BIOCHEM MOL MED, V62, P139, DOI 10.1006/bmme.1997.2648; Weck J, 2000, MOL ENDOCRINOL, V14, P472, DOI 10.1210/me.14.4.472; Wells J, 2010, MOL CANCER RES, V8, P975, DOI 10.1158/1541-7786.MCR-10-0033; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Zhao LP, 2001, DEVELOPMENT, V128, P147	45	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116825	10.1371/journal.pone.0116825	http://dx.doi.org/10.1371/journal.pone.0116825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617744	gold, Green Published, Green Submitted			2022-12-27	WOS:000350336000028
J	Choi, DH; Kim, JH; Lee, KH; Kim, HY; Kim, YS; Choi, WS; Lee, J				Choi, Dong-Hee; Kim, Ji-Hye; Lee, Kyoung-Hee; Kim, Hahn-Young; Kim, Yoon-Seong; Choi, Wahn Soo; Lee, Jongmin			Role of Neuronal NADPH Oxidase 1 in the Peri-Infarct Regions after Stroke	PLOS ONE			English	Article							TABLE STAIR RECOMMENDATIONS; OXIDATIVE STRESS; ISCHEMIC-STROKE; MIGRATION; ADULT; BRAIN; RAT; NEUROPROTECTION; ACTIVATION; THERAPY	The molecular mechanism underlying the selective vulnerability of neurons to oxidative damage caused by ischemia-reperfusion (I/R) injury remains unknown. We sought to determine the role of NADPH oxidase 1 (Nox1) in cerebral I/R-induced brain injury and survival of newborn cells in the ischemic injured region. Male Wistar rats were subjected to 90 min middle cerebral artery occlusion (MCAO) followed by reperfusion. After reperfusion, infarction size, level of superoxide and 8-hydroxy-20-deoxyguanosine (8-oxo-2dG), and Nox1 immunoreactivity were determined. RNAi-mediated knockdown of Nox1 was used to investigate the role of Nox1 in I/R-induced oxidative damage, neuronal death, motor function recovery, and ischemic neurogenesis. After I/R, Nox1 expression and 8-oxo-2dG immunoreactivity was increased in cortical neurons of the peri-infarct regions. Both infarction size and neuronal death in I/R injury were significantly reduced by adeno-associated virus (AAV)-mediated transduction of Nox1 short hairpin RNA (shRNA). AAV-mediated Nox1 knockdown enhanced functional recovery after MCAO. The level of survival and differentiation of newborn cells in the peri-infarct regions were increased by Nox1 inhibition. Our data suggest that Nox-1 may be responsible for oxidative damage to DNA, subsequent cortical neuronal degeneration, functional recovery, and regulation of ischemic neurogenesis in the peri-infarct regions after stroke.	[Choi, Dong-Hee] Konkuk Univ, Sch Med, Dept Med Sci, Seoul, South Korea; [Lee, Jongmin] Konkuk Univ, Sch Med, Dept Rehabil Med, Seoul, South Korea; [Choi, Dong-Hee; Kim, Ji-Hye; Lee, Kyoung-Hee; Kim, Hahn-Young; Lee, Jongmin] Konkuk Univ, Inst Biomed Sci & Technol, Ctr Neurosci Res, Seoul, South Korea; [Kim, Yoon-Seong] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Choi, Wahn Soo] Konkuk Univ, Coll Med, Funct Genom Inst, Dept Immunol & Physiol, Chungju, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; State University System of Florida; University of Central Florida; Konkuk University; Konkuk University Medical Center	Lee, J (corresponding author), Konkuk Univ, Sch Med, Dept Rehabil Med, Seoul, South Korea.	leej@kuh.ac.kr	Lee, Jongmin/Q-4909-2019	Lee, Jongmin/0000-0001-8718-0099	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0025382, 2012R1A1A4A01013749]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A090123]; National Research Foundation of Korea (NRF) grant - Korean government (MEST) [2011-0017016]; US National Institutes of Health [RO1 NS062827]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) grant - Korean government (MEST); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0025382 grant to D-HC and 2012R1A1A4A01013749 grant to JL), the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (Grant to DHC, A090123), the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0017016), and the US National Institutes of Health (RO1 NS062827 to Y-SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2005, STROKE, V36, P1040, DOI 10.1161/01.STR.0000163111.05825.0b; Albers GW, 2011, STROKE, V42, P2645, DOI 10.1161/STROKEAHA.111.618850; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Amantea D, 2008, NEUROSCIENCE, V152, P8, DOI 10.1016/j.neuroscience.2007.12.030; Arab L, 2010, ARCH BIOCHEM BIOPHYS, V501, P31, DOI 10.1016/j.abb.2010.03.015; Bein B, 2011, EUR J ANAESTH, V28, P620, DOI 10.1097/EJA.0b013e328349d5f3; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Brennan-Minnella AM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.111; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Choi DH, 2012, ANTIOXID REDOX SIGN, V16, P1033, DOI 10.1089/ars.2011.3960; Cook DJ, 2012, NEUROTHERAPEUTICS, V9, P371, DOI 10.1007/s13311-012-0115-z; Cristovao AC, 2009, ANTIOXID REDOX SIGN, V11, P2105, DOI [10.1089/ars.2009.2459, 10.1089/ARS.2009.2459]; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; Ding YC, 2002, BEHAV BRAIN RES, V132, P29, DOI 10.1016/S0166-4328(01)00405-3; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Hossmann KA, 2009, FOLIA NEUROPATHOL, V47, P213; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Jackman KA, 2009, BRAIN RES, V1286, P215, DOI 10.1016/j.brainres.2009.06.056; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kahles T, 2010, NEUROBIOL DIS, V40, P185, DOI 10.1016/j.nbd.2010.05.023; Katsuyama M, 2005, BIOCHEM J, V386, P255, DOI 10.1042/BJ20041180; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000565, DOI 10.1371/JOURNAL.PBIO.1000565]; Koizumi J Y Y, 1986, JPN J STROKE, V8; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lee JH, 2013, CARDIOVASC RES, V99, P483, DOI 10.1093/cvr/cvt107; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Liu Shimin, 2009, J Exp Stroke Transl Med, V2, P2; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; O'Collins VE, 2011, J CEREBR BLOOD F MET, V31, P962, DOI 10.1038/jcbfm.2010.184; Radermacher KA, 2013, ANTIOXID REDOX SIGN, V18, P1418, DOI 10.1089/ars.2012.4797; Reyes RC, 2012, J NEUROSCI, V32, P12973, DOI 10.1523/JNEUROSCI.1597-12.2012; Saver JL, 2009, STROKE, V40, P2594, DOI 10.1161/STROKEAHA.109.552554; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; VanGilder RL, 2012, BRAIN RES BULL, V88, P313, DOI 10.1016/j.brainresbull.2012.02.002; Wali B, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/460909; Wang YM, 2013, STROKE, V44, P3529, DOI 10.1161/STROKEAHA.113.003350; Wey HY, 2012, TRANSL STROKE RES, V3, P84, DOI 10.1007/s12975-012-0145-1; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865	45	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116814	10.1371/journal.pone.0116814	http://dx.doi.org/10.1371/journal.pone.0116814			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617620	gold, Green Published, Green Submitted			2022-12-27	WOS:000350336000027
J	Krejcova, T; Smelcova, M; Petr, J; Bodart, JF; Sedmikova, M; Nevoral, J; Dvorakova, M; Vyskocilova, A; Weingartova, I; Kucerova-Chrpova, V; Chmelikova, E; Tumova, L; Jilek, F				Krejcova, Tereza; Smelcova, Miroslava; Petr, Jaroslav; Bodart, Jean-Francois; Sedmikova, Marketa; Nevoral, Jan; Dvorakova, Marketa; Vyskocilova, Alena; Weingartova, Ivona; Kucerova-Chrpova, Veronika; Chmelikova, Eva; Tumova, Lenka; Jilek, Frantisek			Hydrogen Sulfide Donor Protects Porcine Oocytes against Aging and Improves the Developmental Potential of Aged Porcine Oocytes	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; TERMINAL KINASE JNK; INDUCED APOPTOSIS; PIG OOCYTES; INHIBITION; ACTIVATION; CALCIUM; H2S; CARDIOPROTECTION; SULFHYDRATION	Porcine oocytes that have matured in in vitro conditions undergo the process of aging during prolonged cultivation, which is manifested by spontaneous parthenogenetic activation, lysis or fragmentation of aged oocytes. This study focused on the role of hydrogen sulfide (H2S) in the process of porcine oocyte aging. H2S is a gaseous signaling molecule and is produced endogenously by the enzymes cystathionine-beta-synthase (CBS), cystathionine-gamma-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (MPST). We demonstrated that H2S-producing enzymes are active in porcine oocytes and that a statistically significant decline in endogenous H2S production occurs during the first day of aging. Inhibition of these enzymes accelerates signs of aging in oocytes and significantly increases the ratio of fragmented oocytes. The presence of exogenous H2S from a donor (Na2S.9H(2)O) significantly suppressed the manifestations of aging, reversed the effects of inhibitors and resulted in the complete suppression of oocyte fragmentation. Cultivation of aging oocytes in the presence of H2S donor positively affected their subsequent embryonic development following parthenogenetic activation. Although no unambiguous effects of exogenous H2S on MPF and MAPK activities were detected and the intracellular mechanism underlying H2S activity remains unclear, our study clearly demonstrates the role of H2S in the regulation of porcine oocyte aging.	[Krejcova, Tereza; Smelcova, Miroslava; Sedmikova, Marketa; Nevoral, Jan; Dvorakova, Marketa; Vyskocilova, Alena; Weingartova, Ivona; Kucerova-Chrpova, Veronika; Chmelikova, Eva; Tumova, Lenka; Jilek, Frantisek] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic; [Petr, Jaroslav] Inst Anim Sci, Prague, Czech Republic; [Bodart, Jean-Francois] Univ Lille 1, Lab Regulat Signaux Div EA 4479, F-59655 Villeneuve Dascq, France	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Universite de Lille - ISITE; Universite de Lille	Sedmikova, M (corresponding author), Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic.	sedmikova@af.czu.cz	Chmelíková, Eva/W-8338-2018; Krejcova, Tereza/AAX-1542-2021; Bodart, Jean-François Laurent/AAZ-2075-2021; Sedmíková, Markéta/B-5768-2018	Chmelíková, Eva/0000-0001-8022-2794; Bodart, Jean-François Laurent/0000-0002-6113-7700; Sedmíková, Markéta/0000-0003-0947-4256; Krejcova, Tereza/0000-0001-5840-9499	Ministry of Agriculture of the Czech Republic (NAZV-Project) [QI101A166, MZeRO 0714]; Internal Grant Agency of the Czech University of Life Sciences Prague (CIGA) [CZU20142049]	Ministry of Agriculture of the Czech Republic (NAZV-Project); Internal Grant Agency of the Czech University of Life Sciences Prague (CIGA)	This work was supported by the Ministry of Agriculture of the Czech Republic (NAZV-Project No. QI101A166, MZeRO 0714) and by the Internal Grant Agency of the Czech University of Life Sciences Prague (CIGA) (Project No. CZU20142049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Carson RJ, 2010, EXPERT REV OBSTET GY, V5, P203, DOI [DOI 10.1586/E0G.10.5, 10.1586/eog.10.5]; Du Pasquier D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023672; Elsey DJ, 2010, CELL BIOCHEM FUNCT, V28, P95, DOI 10.1002/cbf.1618; Fang LP, 2009, J HYPERTENS, V27, P2174, DOI 10.1097/HJH.0b013e328330a900; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Guzman MA, 2006, HUM MOL GENET, V15, P3168, DOI 10.1093/hmg/ddl393; Jeseta M, 2008, ZYGOTE, V16, P145, DOI 10.1017/S0967199408004668; Jeseta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041509; Jiang GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028996; Jilek F, 2001, REPROD DOMEST ANIM, V36, P139, DOI 10.1046/j.1439-0531.2001.d01-27.x; Kikuchi K, 2000, BIOL REPROD, V63, P715, DOI 10.1095/biolreprod63.3.715; Kikuchi Kazuhiro, 2002, Cloning and Stem Cells, V4, P211, DOI 10.1089/15362300260339494; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Li CS, 2014, MOL MED REP, V9, P2467, DOI 10.3892/mmr.2014.2111; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Liang R, 2007, REPROD TOXICOL, V24, P89, DOI 10.1016/j.reprotox.2007.04.002; Liang R, 2006, CHINESE MED J-PEKING, V119, P1877, DOI 10.1097/00029330-200611020-00006; Liang XW, 2012, SCI CHINA LIFE SCI, V55, P670, DOI 10.1007/s11427-012-4354-3; Lowicka E, 2007, PHARMACOL REP, V59, P4; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Nevoral J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099613; Pan TT, 2006, J MOL CELL CARDIOL, V40, P119, DOI 10.1016/j.yjmcc.2005.10.003; Patel P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-10; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Petrova I, 2004, CZECH J ANIM SCI, V49, P93, DOI 10.17221/4285-CJAS; Petrova I, 2009, J REPROD DEVELOP, V55, P75, DOI 10.1262/jrd.20061; PETTERS RM, 1993, J REPROD FERTIL, P61; Rinaldi L, 2006, LAB INVEST, V86, P391, DOI 10.1038/labinvest.3700391; Sadler KC, 2004, MOL REPROD DEV, V67, P366, DOI 10.1002/mrd.20023; Sedmikova M, 2013, CZECH J ANIM SCI, V58, P535, DOI 10.17221/7088-CJAS; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Smelcova M., 2011, Scientia Agriculturae Bohemica, V42, P188; Srilatha B, 2009, J SEX MED, V6, P1875, DOI 10.1111/j.1743-6109.2009.01291.x; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Tang GH, 2010, CLIN EXP PHARMACOL P, V37, P753, DOI 10.1111/j.1440-1681.2010.05351.x; VITULLO AD, 1992, DEV BIOL, V151, P128, DOI 10.1016/0012-1606(92)90220-B; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Whitaker M, 1996, Rev Reprod, V1, P127, DOI 10.1530/ror.0.0010127; Wilcox AJ, 1998, HUM REPROD, V13, P394, DOI 10.1093/humrep/13.2.394; XU Z, 1994, DEVELOPMENT, V120, P1851; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang Guang-Dong, 2007, Shengli Xuebao, V59, P133; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhang JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064304; Zhao KX, 2014, EMBO REP, V15, P792, DOI 10.1002/embr.201338213; Zhao Y, 2013, ACS CHEM BIOL, V8, P1283, DOI 10.1021/cb400090d	50	9	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116964	10.1371/journal.pone.0116964	http://dx.doi.org/10.1371/journal.pone.0116964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615598	gold, Green Published, Green Submitted			2022-12-27	WOS:000349122100050
J	Chen, SC; Teng, CJ; Hu, YW; Yeh, CM; Hung, MH; Hu, LY; Ku, FC; Tzeng, CH; Chiou, TJ; Chen, TJ; Liu, CJ				Chen, San-Chi; Teng, Chung-Jen; Hu, Yu-Wen; Yeh, Chiu-Mei; Hung, Man-Hsin; Hu, Li-Yu; Ku, Fan-Chen; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Chen, Tzeng-Ji; Liu, Chia-Jen			Secondary Primary Malignancy Risk among Patients with Esophageal Cancer in Taiwan: A Nationwide Population-Based Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; 2ND PRIMARY-CANCER; POOLED ANALYSIS; INTERNATIONAL HEAD; BARRETTS-ESOPHAGUS; CIGARETTE-SMOKING; NECK-CANCER; EPIDEMIOLOGY; ADENOCARCINOMA; TOBACCO	Background To evaluate the risk and sites of metachronous secondary primary malignancies (SPMs) among patients with esophageal cancer. Methods Newly diagnosed esophageal cancer patients between 1997 and 2011 were recruited. To avoid surveillance bias, SPMs that developed within one year were excluded. Standardized incidence ratios (SIRs) of metachronous SPMs in these patients were calculated by comparing to the cancer incidence in the general population. Risk factors for SPM development, included age, sex, comorbidities and cancer-related treatments, were estimated by Cox proportional hazards models. Results During the 15-year study period, 870 SPMs developed among 18,026 esophageal cancer patients, with a follow-up of 27,056 person-years. The SIR for all cancers was 3.53. The SIR of follow-up period >= 10 years was 3.56; 5-10 years, 3.14; and 1-5 years, 3.06. The cancer SIRs of head and neck (15.83), stomach (3.30), lung and mediastinum (2.10), kidney (2.24) and leukemia (2.72), were significantly increased. Multivariate analysis showed that age >= 60 years (hazard ratio [HR] 0.74), being male (HR 1.46) and liver cirrhosis (HR 1.46) were independent factors. According to the treatments, major surgery (HR 1.24) increased the risk, but chemotherapy was nearly significant. Conclusions Patients with esophageal cancer were at increased risk of developing metachronous SPMs. The SIR remained high in follow-up > 10 years, so that close monitoring may be needed for early detection of SPM among these esophageal cancer patients.	[Chen, San-Chi; Hung, Man-Hsin; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Teng, Chung-Jen] Far Eastern Mem Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Teng, Chung-Jen; Hu, Yu-Wen; Hung, Man-Hsin; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Chen, Tzeng-Ji; Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Hu, Li-Yu] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Ku, Fan-Chen] Changhua Show Chwan Mem Hosp, Div Hematol & Oncol, Dept Med, Changhua, Taiwan; [Chiou, Tzeon-Jye] Taipei Vet Gen Hosp, Div Transfus Med, Dept Med, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Taipei Veterans General Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Kaohsiung Veterans General Hospital; Show Chwan Memorial Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Teng, CJ (corresponding author), Far Eastern Mem Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan.	dodol73@gmail.com; chiajenliu@gmail.com	Chen, TJ/AAH-8430-2021	Hu, Yu-Wen/0000-0002-7983-415X; Chen, San-Chi/0000-0002-9436-5400	Taipei Veterans General Hospital [V103B-022, V103E10-001]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study is supported by a grant from Taipei Veterans General Hospital (V103B-022 and V103E10-001) and is based in part on data from the National Health Insurance Research Database, provided by the Bureau of National Health Insurance, Department of Health, and managed by National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the Bureau of National Health Insurance, Department of Health or National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2007, WORLD J GASTROENTERO, V13, P1585, DOI 10.3748/wjg.v13.i10.1585; Chen S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062291, 10.1371/journal.pone.0082812]; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chuang SC, 2008, CANCER EPIDEM BIOMAR, V17, P1543, DOI 10.1158/1055-9965.EPI-07-2876; FOGEL TD, 1985, CANCER, V55, P1882, DOI 10.1002/1097-0142(19850501)55:9<1882::AID-CNCR2820550907>3.0.CO;2-I; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Hunt JD, 2005, INT J CANCER, V114, P101, DOI 10.1002/ijc.20618; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalaitzakis E, 2011, CLIN GASTROENTEROL H, V9, P168, DOI 10.1016/j.cgh.2010.10.014; Kleinberg L, 2003, INT J RADIAT ONCOL, V56, P328, DOI 10.1016/S0360-3016(02)04598-4; Kubo A, 2004, AM J GASTROENTEROL, V99, P582, DOI 10.1111/j.1572-0241.2004.04131.x; Lee CH, 2005, INT J CANCER, V113, P475, DOI 10.1002/ijc.20619; Lo SF, 2013, INT J CANCER, V132, P182, DOI 10.1002/ijc.27597; Lu CL, 2010, CANCER CAUSE CONTROL, V21, P269, DOI 10.1007/s10552-009-9458-0; Matsubara T, 2003, J CLIN ONCOL, V21, P4336, DOI 10.1200/JCO.2003.12.074; Motoyama S, 2003, J AM COLL SURGEONS, V197, P914, DOI 10.1016/j.jamcollsurg.2003.07.014; Natsugoe S, 2005, WORLD J SURG, V29, P46, DOI 10.1007/s00268-004-7525-y; Poon RTP, 1998, ANN THORAC SURG, V65, P1529, DOI 10.1016/S0003-4975(98)00177-5; SHIBUYA H, 1995, CANCER, V76, P101, DOI 10.1002/1097-0142(19950701)76:1<101::AID-CNCR2820760115>3.0.CO;2-D; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; Sugiura T, 2002, J AM COLL SURGEONS, V194, P578, DOI 10.1016/S1072-7515(02)01135-3; Vizcaino AP, 2002, INT J CANCER, V99, P860, DOI 10.1002/ijc.10427; Wong A, 2005, CLIN GASTROENTEROL H, V3, P1, DOI 10.1016/S1542-3565(04)00602-0; Wyss A, 2013, AM J EPIDEMIOL, V178, P679, DOI 10.1093/aje/kwt029; Zhu G, 2012, DIS ESOPHAGUS, V25, P505, DOI 10.1111/j.1442-2050.2011.01273.x	27	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116384	10.1371/journal.pone.0116384	http://dx.doi.org/10.1371/journal.pone.0116384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635388	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700034
J	Lee, HK; Tang, JWT; Loh, TP; Hurt, AC; Oon, LLE; Koay, ESC				Lee, Hong Kai; Tang, Julian Wei-Tze; Loh, Tze Ping; Hurt, Aeron C.; Oon, Lynette Lin-Ean; Koay, Evelyn Siew-Chuan			Molecular Surveillance of Antiviral Drug Resistance of Influenza A/H3N2 Virus in Singapore, 2009-2013	PLOS ONE			English	Article							NEURAMINIDASE INHIBITOR RESISTANCE; UNITED-STATES; B VIRUSES; A(H3N2) VIRUSES; GENETIC-CHARACTERISTICS; OSELTAMIVIR RESISTANCE; VACCINE EPIDEMIOLOGY; A VIRUSES; SUSCEPTIBILITY; WORLDWIDE	Adamantanes and neuraminidase inhibitors (NAIs) are two classes of antiviral drugs available for the chemoprophylaxis and treatment of influenza infections. To determine the frequency of drug resistance in influenza A/H3N2 viruses in Singapore, large-scale sequencing of neuraminidase (NA) and matrix protein (MP) genes was performed directly without initial culture amplification. 241 laboratory-confirmed influenza A/H3N2 clinical samples, collected between May 2009 and November 2013 were included. In total, 229 NA (95%) and 241 MP (100%) complete sequences were obtained. Drug resistance mutations in the NA and MP genes were interpreted according to published studies. For the NAIs, a visual inspection of the aligned NA sequences revealed no known drug resistant genotypes (DRGs). For the adamantanes, the well-recognised S31N DRG was identified in all 241 MP genes. In addition, there was an increasing number of viruses carrying the combination of D93G+Y155F+D251V (since May 2013) or D93G (since March 2011) mutations in the NA gene. However, in-vitro NAI testing indicated that neither D93G+Y155F+D251V nor D93G alone conferred any changes in NAI susceptibility. Lastly, an I222T mutation in the NA gene that has previously been reported to cause oseltamivir-resistance in influenza A/H1N1/2009, B, and A/H5N1, was detected from a treatment-naive patient. Further in-vitro NAI testing is required to confirm the effect of this mutation in A/H3N2 virus.	[Lee, Hong Kai; Koay, Evelyn Siew-Chuan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore; [Lee, Hong Kai; Loh, Tze Ping; Koay, Evelyn Siew-Chuan] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Lab Med, Singapore, Singapore; [Tang, Julian Wei-Tze] Leicester Royal Infirm, Clin Microbiol, Leicester, Leics, England; [Hurt, Aeron C.] WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia; [Hurt, Aeron C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia; [Oon, Lynette Lin-Ean] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore	National University of Singapore; National University of Singapore; University of Leicester; World Health Organization; University of Melbourne; Singapore General Hospital	Tang, JWT (corresponding author), Leicester Royal Infirm, Clin Microbiol, Leicester, Leics, England.	julian.tang@uhl-tr.nhs.uk; evelyn_koay@nuhs.edu.sg		Hurt, Aeron/0000-0003-1826-4314; Loh, Tze Ping/0000-0002-4272-0001; Tang, Julian/0000-0002-4963-1028	Singapore National Medical Research Council [NMRC/1247/2010]; Australian Government Department of Health	Singapore National Medical Research Council(National Medical Research Council, Singapore); Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This study was supported by a grant from Singapore National Medical Research Council, (http://www.nmrc.gov.sg) (ref: NMRC/1247/2010 to JWT and ESK). The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, Wkly Epidemiol Rec, V88, P477; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P101; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P369; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P83; Barr IG, 2014, VACCINE, V32, P4713, DOI 10.1016/j.vaccine.2014.02.014; Blanton Lenee, 2011, Morbidity and Mortality Weekly Report, V60, P1239; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Burnham AJ, 2014, ANTIMICROB AGENTS CH, V58, P2718, DOI 10.1128/AAC.02628-13; Dapat C, 2013, ANTIVIR RES, V99, P261, DOI 10.1016/j.antiviral.2013.06.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Epperson Scott, 2012, Morbidity and Mortality Weekly Report, V61, P785; Govorkova EA, 2013, ANTIVIR RES, V98, P297, DOI 10.1016/j.antiviral.2013.02.013; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Huang L, 2014, ANTIMICROB AGENTS CH, V58, P1639, DOI 10.1128/AAC.01848-13; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Hurt Aeron C, 2012, Methods Mol Biol, V865, P115, DOI 10.1007/978-1-61779-621-0_7; Jhung M., 2010, Morbidity and Mortality Weekly Report, V59, P1270; KLIMOV AI, 1995, J INFECT DIS, V172, P1352, DOI 10.1093/infdis/172.5.1352; Klimov AI, 2012, VACCINE, V30, P6461, DOI 10.1016/j.vaccine.2012.07.089; Leang SK, 2014, INFLUENZA OTHER RESP, V8, P135, DOI 10.1111/irv.12187; Lee HK, 2014, J CLIN MICROBIOL, V52, P1749, DOI 10.1128/JCM.00538-14; Lee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079252; Lee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064785; Lee HK, 2012, J MED VIROL, V84, P1646, DOI 10.1002/jmv.23375; Lee HK, 2010, J MOL DIAGN, V12, P636, DOI 10.2353/jmoldx.2010.100010; McKimm-Breschkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066105; Mishin VP, 2014, ANTIVIR RES, V101, P93, DOI 10.1016/j.antiviral.2013.11.001; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Nguyen HT, 2012, ANTIVIR THER, V17, P159, DOI 10.3851/IMP2067; Okomo-Adhiambo M, 2013, INFLUENZA OTHER RESP, V7, P44, DOI [10.1111/irv.12113, 10.1111/irv.12051]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pizzorno A, 2014, ANTIMICROB AGENTS CH, V58, P6398, DOI 10.1128/AAC.02956-14; Prudhomme IT, 1997, CLIN DIAGN VIROL, V8, P41, DOI 10.1016/S0928-0197(97)00011-1; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; Tang JW, 2008, J MED VIROL, V80, P895, DOI 10.1002/jmv.21155; Tang JW, 2012, EXPERT REV ANTI-INFE, V10, P751, DOI [10.1586/ERI.12.63, 10.1586/eri.12.63]; Wang DY, 2013, ANTIVIR RES, V97, P240, DOI 10.1016/j.antiviral.2012.12.013; Whitley RJ, 2013, CLIN INFECT DIS, V56, P1197, DOI 10.1093/cid/cis1220	40	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117822	10.1371/journal.pone.0117822	http://dx.doi.org/10.1371/journal.pone.0117822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635767	Green Published, gold			2022-12-27	WOS:000350680700100
J	Olofsson, JK; Pereira, V; Borsting, C; Morling, N				Olofsson, Jill Katharina; Pereira, Vania; Borsting, Claus; Morling, Niels			Peopling of the North Circumpolar Region - Insights from Y Chromosome STR and SNP Typing of Greenlanders	PLOS ONE			English	Article							NATIVE-AMERICANS; MICROSATELLITE HAPLOTYPES; POPULATION-STRUCTURE; MIGRATION HISTORY; MITOCHONDRIAL-DNA; GENETIC DIVERSITY; EAST-ASIA; RESOLUTION; EVOLUTIONARY; HIMALAYAS	The human population in Greenland is characterized by migration events of Paleo-and Neo-Eskimos, as well as admixture with Europeans. In this study, the Y-chromosomal variation in male Greenlanders was investigated in detail by typing 73 Y-chromosomal single nucleotide polymorphisms (Y-SNPs) and 17 Y-chromosomal short tandem repeats (Y-STRs). Approximately 40% of the analyzed Greenlandic Y chromosomes were of European origin (I-M170, R1a-M513 and R1b-M343). Y chromosomes of European origin were mainly found in individuals from the west and south coasts of Greenland, which is in agreement with the historic records of the geographic placements of European settlements in Greenland. Two Inuit Y-chromosomal lineages, Q-M3 (xM19, M194, L663, SA01 and L766) and Q-NWT01 (xM265) were found in 23% and 31% of the male Greenlanders, respectively. The time to the most recent common ancestor (TMRCA) of the Q-M3 lineage of the Greenlanders was estimated to be between 4,400 and 10,900 years ago (y. a.) using two different methods. This is in agreement with the theory that the North Circumpolar Region was populated via a second expansion of humans in the North American continent. The TMRCA of the Q-NWT01 (xM265) lineage in Greenland was estimated to be between 7,000 and 14,300 y. a. using two different methods, which is older than the previously reported TMRCA of this lineage in other Inuit populations. Our results indicate that Inuit individuals carrying the Q-NWT01 (xM265) lineage may have their origin in the northeastern parts of North America and could be descendants of the Dorset culture. This in turn points to the possibility that the current Inuit population in Greenland is comprised of individuals of both Thule and Dorset descent.	[Olofsson, Jill Katharina; Pereira, Vania; Borsting, Claus; Morling, Niels] Univ Copenhagen, Dept Forens Med, Fac Hlth & Med Sci, Sect Forens Genet, Copenhagen, Denmark	University of Copenhagen	Olofsson, JK (corresponding author), Univ Copenhagen, Dept Forens Med, Fac Hlth & Med Sci, Sect Forens Genet, Copenhagen, Denmark.	jill.olofsson@sund.ku.dk	Olofsson, Jill/ABE-9797-2020; Pereira, Vania/T-7709-2019; Pereira, Vania/S-8082-2018	Pereira, Vania/0000-0002-8789-5286; Pereira, Vania/0000-0002-8789-5286; Olofsson, Jill/0000-0002-9527-6573; Morling, Niels/0000-0002-9463-5087; Borsting, Claus/0000-0003-0421-7429				Andersen MM, 2014, FORENSIC SCI INT-GEN, V11, P182, DOI 10.1016/j.fsigen.2014.03.016; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Battaglia V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071390; Bisso-Machado R, 2011, AM J HUM BIOL, V23, P563, DOI 10.1002/ajhb.21173; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Bosch E, 2003, HUM GENET, V112, P353, DOI 10.1007/s00439-003-0913-9; Dulik Matthew C, 2012, Proc Natl Acad Sci U S A, V109, P8471, DOI 10.1073/pnas.1118760109; Dupuy BM, 2006, FORENSIC SCI INT, V164, P10, DOI 10.1016/j.forsciint.2005.11.009; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gad F., 1984, HDB N AM INDIANS, P556; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Gjertson DW, 2007, FORENSIC SCI INT-GEN, V1, P223, DOI 10.1016/j.fsigen.2007.06.006; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; Jensen J., 2006, MEDDELELSER GRONLAND, V32, P1; Johansen P, 2013, FORENSIC SCI INT-GEN, V7, P482, DOI 10.1016/j.fsigen.2013.04.009; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karlsson AO, 2006, EUR J HUM GENET, V14, P963, DOI 10.1038/sj.ejhg.5201651; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Kleivan Inge, 1984, HDB N AM INDIANS, V5, P549; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; McGhee R, 2000, IDENTITIES CULTURAL, P181; Mulligan CJ, 2004, ANNU REV GENOM HUM G, V5, P295, DOI 10.1146/annurev.genom.5.061903.175920; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Olofsson JK, 2013, FORENS SCI INT-GEN S, V4, pE220, DOI 10.1016/j.fsigss.2013.10.113; Oppenheimer S, 2012, PHILOS T R SOC B, V367, P770, DOI 10.1098/rstb.2011.0306; Park Robert, 2000, IDENTITIES CULTURE C, P192; Purps J, 2014, FORENSIC SCI INT-GEN, V12, P12, DOI 10.1016/j.fsigen.2014.04.008; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Regueiro M, 2013, AM J PHYS ANTHROPOL, V150, P333, DOI 10.1002/ajpa.22207; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Roewer L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003460; Sanchez JJ, 2004, INT CONGR SER, V1261, P347, DOI 10.1016/S0531-5131(03)01635-2; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; Schurr TG, 2012, AM J PHYS ANTHROPOL, V148, P422, DOI 10.1002/ajpa.22068; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Sutherland P.D., 2000, IDENTITIES CULTURAL, P159; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	46	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116573	10.1371/journal.pone.0116573	http://dx.doi.org/10.1371/journal.pone.0116573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635810	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700045
J	Li, W; Garringer, HJ; Goodwin, CB; Richine, B; Acton, A; VanDuyn, N; Muhoberac, BB; Irimia-Dominguez, J; Chan, RJ; Peacock, M; Nass, R; Ghetti, B; Vidal, R				Li, Wei; Garringer, Holly J.; Goodwin, Charles B.; Richine, Briana; Acton, Anthony; VanDuyn, Natalia; Muhoberac, Barry B.; Irimia-Dominguez, Jose; Chan, Rebecca J.; Peacock, Munro; Nass, Richard; Ghetti, Bernardino; Vidal, Ruben			Systemic and Cerebral Iron Homeostasis in Ferritin Knock-Out Mice	PLOS ONE			English	Article							LIGHT-CHAIN; H-FERRITIN; MUTANT FORM; NEURODEGENERATION; GENE; HYPERFERRITINEMIA; POLYPEPTIDE; HEREDITARY; DEFICIENCY; METABOLISM	Ferritin, a 24-mer heteropolymer of heavy (H) and light (L) subunits, is the main cellular iron storage protein and plays a pivotal role in iron homeostasis by modulating free iron levels thus reducing radical-mediated damage. The H subunit has ferroxidase activity (converting Fe(II) to Fe(III)), while the L subunit promotes iron nucleation and increases ferritin stability. Previous studies on the H gene (Fth) in mice have shown that complete inactivation of Fth is lethal during embryonic development, without ability to compensate by the L subunit. In humans, homozygous loss of the L gene (FTL) is associated with generalized seizure and atypical restless leg syndrome, while mutations in FTL cause a form of neurodegeneration with brain iron accumulation. Here we generated mice with genetic ablation of the Fth and Ftl genes. As previously reported, homozygous loss of the Fth allele on a wild-type Ftl background was embryonic lethal, whereas knock-out of the Ftl allele (Ftl(-/-)) led to a significant decrease in the percentage of Ftl(-/-)newborn mice. Analysis of Ftl(-/-)mice revealed systemic and brain iron dyshomeostasis, without any noticeable signs of neurodegeneration. Our findings indicate that expression of the H subunit can rescue the loss of the L subunit and that H ferritin homopolymers have the capacity to sequester iron in vivo. We also observed that a single allele expressing the H subunit is not sufficient for survival when both alleles encoding the L subunit are absent, suggesting the need of some degree of complementation between the subunits as well as a dosage effect.	[Li, Wei; Garringer, Holly J.; Irimia-Dominguez, Jose; Ghetti, Bernardino; Vidal, Ruben] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Goodwin, Charles B.; Richine, Briana; Chan, Rebecca J.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Acton, Anthony; Peacock, Munro] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [VanDuyn, Natalia; Nass, Richard] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Muhoberac, Barry B.] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Vidal, R (corresponding author), Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	rvidal@iupui.edu		Ryan, Natalia/0000-0003-1889-2169	National Institute on Neurological Disorders and Stroke [NS050227, NS063056]; NATIONAL CANCER INSTITUTE [R01CA134777] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063056, R01NS050227] Funding Source: NIH RePORTER	National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the National Institute on Neurological Disorders and Stroke NS050227 and NS063056 (RV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraibar MA, 2008, J BIOL CHEM, V283, P31679, DOI 10.1074/jbc.M805532200; Baraibar MA, 2012, FREE RADICAL BIO MED, V52, P1692, DOI 10.1016/j.freeradbiomed.2012.02.015; Baraibar MA, 2010, J BIOL CHEM, V285, P1950, DOI 10.1074/jbc.M109.042986; Barbeito AG, 2009, J NEUROCHEM, V109, P1067, DOI 10.1111/j.1471-4159.2009.06028.x; Bennett TM, 2013, MOL VIS, V19, P835; Berg Daniela, 2006, Top Magn Reson Imaging, V17, P5, DOI 10.1097/01.rmr.0000245461.90406.ad; Bowes O, 2014, LANCET, V383, P1520, DOI 10.1016/S0140-6736(14)60484-0; Cozzi A, 2013, J EXP MED, V210, P1779, DOI 10.1084/jem.20130315; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Ferreira C, 2001, BLOOD, V98, P525, DOI 10.1182/blood.V98.3.525; FINCH CA, 1986, WESTERN J MED, V145, P657; Gkouvatsos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085530; Kato J, 2001, AM J HUM GENET, V69, P191, DOI 10.1086/321261; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Muhoberac BB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00032; Patel BN, 2002, J NEUROSCI, V22, P6578; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Spijker S, 2011, NEUROMETHODS, V57, P13, DOI 10.1007/978-1-61779-111-6_2; Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463; VanDuyn N, 2013, J NEUROCHEM, V124, P147, DOI 10.1111/jnc.12072; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P787, DOI 10.1093/jnen/63.8.787; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008	22	42	43	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117435	10.1371/journal.pone.0117435	http://dx.doi.org/10.1371/journal.pone.0117435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629408	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100083
J	Moffitt, SE; Moffitt, RA; Sauthoff, W; Davis, CV; Hewett, K; Hill, TM				Moffitt, Sarah E.; Moffitt, Russell A.; Sauthoff, Wilson; Davis, Catherine V.; Hewett, Kathryn; Hill, Tessa M.			Paleoceanographic Insights on Recent Oxygen Minimum Zone Expansion: Lessons for Modern Oceanography	PLOS ONE			English	Article							SANTA-BARBARA BASIN; GLACIAL-INTERGLACIAL VARIABILITY; PACIFIC INTERMEDIATE WATER; CALIFORNIA CURRENT SYSTEM; TROPICAL NORTH PACIFIC; SUB-ARCTIC PACIFIC; ARABIAN SEA; BENTHIC FORAMINIFERA; LAST DEGLACIATION; LATE PLEISTOCENE	Climate-driven Oxygen Minimum Zone (OMZ) expansions in the geologic record provide an opportunity to characterize the spatial and temporal scales ofOMZ change. Here we investigate OMZ expansion through the global- scale warming event of the most recent deglaciation (18- 11 ka), an event with clear relevance to understanding modern anthropogenic climate change. Deglacial marine sediment records were compiled to quantify the vertical extent, intensity, surface area and volume impingements of hypoxic waters upon continental margins. By integrating sediment records (183-2,309 meters below sea level; mbsl) containing one or more geochemical, sedimentary or microfossil oxygenation proxies integrated with analyses of eustatic sea level rise, we reconstruct the timing, depth and intensity of seafloor hypoxia. The maximum vertical OMZ extent during the deglaciation was variable by region: Subarctic Pacific (similar to 600-2,900 mbsl), California Current (similar to 330-1,500 mbsl), Mexico Margin (similar to 330-830 mbsl), and the Humboldt Current and Equatorial Pacific (similar to 110-3,100 mbsl). The timing ofOMZ expansion is regionally coherent but not globally synchronous. Subarctic Pacific and California Current continental margins exhibit tight correlation to the oscillations of Northern Hemisphere deglacial events (Termination IA, Bolling-Allerod, Younger Dryas and Termination IB). Southern regions (Mexico Margin and the Equatorial Pacific and Humboldt Current) exhibit hypoxia expansion prior to Termination IA (similar to 14.7 ka), and no regional oxygenation oscillations. Our analyses provide new evidence for the geographically and vertically extensive expansion of OMZs, and the extreme compression of upper-ocean oxygenated ecosystems during the geologically recent deglaciation.	[Moffitt, Sarah E.; Davis, Catherine V.; Hill, Tessa M.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Moffitt, Sarah E.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Moffitt, Russell A.] Marine Conservat Inst, Glen Ellen, CA USA; [Sauthoff, Wilson; Davis, Catherine V.; Hill, Tessa M.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Hewett, Kathryn] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Moffitt, SE (corresponding author), Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA.	semoffitt@ucdavis.edu	Hill, Tessa Michelle/P-3401-2019; Sauthoff, Wilson/AAP-4898-2020	Hill, Tessa Michelle/0000-0003-4159-9104; Sauthoff, Wilson/0000-0001-9683-1578; Davis, Catherine/0000-0003-4279-5369	National Science Foundation (OCE) [0825322, 1255194]; University of California Multicampus Research Programs and Initiatives; University of California Davis REACH IGERT; Mia Tegner Historical Ecology; EPA STAR Fellowship; Switzer Environmental Fellowship; Division Of Ocean Sciences [1255194] Funding Source: National Science Foundation	National Science Foundation (OCE)(National Science Foundation (NSF)); University of California Multicampus Research Programs and Initiatives; University of California Davis REACH IGERT; Mia Tegner Historical Ecology; EPA STAR Fellowship(United States Environmental Protection Agency); Switzer Environmental Fellowship; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support was provided by the National Science Foundation (OCE 0825322 and OCE 1255194 to TMH), the University of California Multicampus Research Programs and Initiatives (to TMH), University of California Davis REACH IGERT (to SEM), Mia Tegner Historical Ecology Grant (to SEM), the EPA STAR Fellowship (to SEM) and Switzer Environmental Fellowship (to SEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes F, 2000, EARTH PLANET SC LETT, V176, P7, DOI 10.1016/S0012-821X(99)00312-X; Addison JA, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002161; Agnihotri R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025864; Agnihotri R, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001744; Alley RB, 1999, ANNU REV EARTH PL SC, V27, P149, DOI 10.1146/annurev.earth.27.1.149; Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; Altabet M.A., 1996, CARBON CYCLING GLACI, P281; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; ANDERSON RY, 1987, QUATERNARY RES, V28, P307, DOI 10.1016/0033-5894(87)90069-X; ANDREWS W R H, 1980, Progress in Oceanography, V9, P1, DOI 10.1016/0079-6611(80)90015-4; BAILEY GW, 1991, GEOL SOC SPEC PUBL, P171, DOI 10.1144/GSL.SP.1991.058.01.12; Banse K., 1984, MARINE GEOLOGY OCEAN, P271; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; Barron JA, 2007, PALAEOGEOGR PALAEOCL, V248, P313, DOI 10.1016/j.palaeo.2006.12.009; Barron JA, 2009, MAR MICROPALEONTOL, V72, P176, DOI 10.1016/j.marmicro.2009.04.006; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Behl R. J., 1995, P OCEAN DRILL PROGRA, V146, P295; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Benway HM, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001208; BERNHARD JM, 1991, BIOGEOCHEMISTRY, V15, P127; BERNHARD JM, 1986, J FORAMIN RES, V16, P207, DOI 10.2113/gsjfr.16.3.207; BERNHARD JM, 1992, DEEP-SEA RES, V39, P585, DOI 10.1016/0198-0149(92)90090-G; Bernhard JM, 2000, NATURE, V403, P77, DOI 10.1038/47476; Bindoff NL, 2000, J PHYS OCEANOGR, V30, P1207, DOI 10.1175/1520-0485(2000)030<1207:DCAAIO>2.0.CO;2; Blanchet CL, 2007, QUATERNARY SCI REV, V26, P3118, DOI 10.1016/j.quascirev.2007.07.008; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Bostock HC, 2010, DEEP-SEA RES PT I, V57, P847, DOI 10.1016/j.dsr.2010.04.005; Bradtmiller LI, 2010, EARTH PLANET SC LETT, V299, P417, DOI 10.1016/j.epsl.2010.09.022; Brandes JA, 2007, CHEM REV, V107, P577, DOI 10.1021/cr050377t; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; Bryan SP, 2010, EARTH PLANET SC LETT, V298, P244, DOI 10.1016/j.epsl.2010.08.025; Bull D, 2000, GEOLOGY, V28, P1007; CALVERT SE, 1970, NATURE, V227, P593, DOI 10.1038/227593a0; Cannariato KG, 1999, GEOLOGY, V27, P63, DOI 10.1130/0091-7613(1999)027<0063:BRTLQR>2.3.CO;2; Cannariato KG, 1999, GEOLOGY, V27, P975, DOI 10.1130/0091-7613(1999)027<0975:CRMSFI>2.3.CO;2; Cartapanis O, 2012, QUATERNARY SCI REV, V53, P24, DOI 10.1016/j.quascirev.2012.08.009; Cartapanis O, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002126; Chelton D.B., 1982, CAL COOP OCEAN FISH, V23, P130; Cheshire H, 2005, J QUATERNARY SCI, V20, P457, DOI 10.1002/jqs.944; CORLISS B, 1993, GEOLOGY, V21, P991, DOI 10.1130/0091-7613(1993)021<0991:RGODSB>2.3.CO;2; CORLISS BH, 1991, MAR MICROPALEONTOL, V17, P195, DOI 10.1016/0377-8398(91)90014-W; Cowie G, 2005, PROG OCEANOGR, V65, P260, DOI 10.1016/j.pocean.2005.03.003; Crusius J, 2004, GEOLOGY, V32, P633, DOI 10.1130/G20508.1; Crusius J, 1996, EARTH PLANET SC LETT, V145, P65, DOI 10.1016/S0012-821X(96)00204-X; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; Curry WB, 1987, PALEOCEANOGRAPHY, V2, P489, DOI 10.1029/PA002i005p00489; Daneri G, 2000, MAR ECOL PROG SER, V197, P41, DOI 10.3354/meps197041; Davies MH, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002051; De Pol-Holz R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024477; De Pol-Holz R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001308; de Vernal A, 1997, PALEOCEANOGRAPHY, V12, P821, DOI 10.1029/97PA02167; Dean WE, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001239; Dean WE, 2007, QUATERNARY SCI REV, V26, P98, DOI 10.1016/j.quascirev.2006.08.006; DEAN WE, 1994, PALEOCEANOGRAPHY, V9, P47, DOI 10.1029/93PA02829; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Deutsch C, 2014, SCIENCE, V345, P665, DOI 10.1126/science.1252332; DEVRIES TJ, 1981, MAR MICROPALEONTOL, V6, P157, DOI 10.1016/0377-8398(81)90003-7; DIESTERHAASS L, 1986, MAR GEOL, V73, P1, DOI 10.1016/0025-3227(86)90108-8; Dubois N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048325; Dubois N, 2011, QUATERNARY SCI REV, V30, P210, DOI 10.1016/j.quascirev.2010.10.012; Dugdale RC, 2002, DEEP-SEA RES PT II, V49, P2513, DOI 10.1016/S0967-0645(02)00046-2; DUPLESSY JC, 1989, RADIOCARBON, V31, P493; Emerson S, 2001, GLOBAL BIOGEOCHEM CY, V15, P535, DOI 10.1029/2000GB001320; EMERY KO, 1961, DEEP-SEA RES, V8, P165, DOI 10.1016/0146-6313(61)90019-3; Emmer E, 2000, PALEOCEANOGRAPHY, V15, P377, DOI 10.1029/1999PA000417; ESRI, 2009, ARCMAP 9 2 REDL; Farias L, 2007, DEEP-SEA RES PT I, V54, P164, DOI 10.1016/j.dsr.2006.11.003; Fiedler PC, 2006, PROG OCEANOGR, V69, P143, DOI 10.1016/j.pocean.2006.03.008; Fine RA, 2001, J GEOPHYS RES-OCEANS, V106, P22159, DOI 10.1029/1999JC000184; Fleming K, 1998, EARTH PLANET SC LETT, V163, P327, DOI 10.1016/S0012-821X(98)00198-8; Fontanier C, 2005, DEEP-SEA RES PT I, V52, P1189, DOI 10.1016/j.dsr.2005.01.006; Fontanier C, 2002, DEEP-SEA RES PT I, V49, P751, DOI 10.1016/S0967-0637(01)00078-4; FRANCOIS R, 1988, MAR GEOL, V83, P285, DOI 10.1016/0025-3227(88)90063-1; Frieder CA, 2012, BIOGEOSCIENCES, V9, P3917, DOI 10.5194/bg-9-3917-2012; Fuenzalida R, 2009, DEEP-SEA RES PT II, V56, P1027, DOI 10.1016/j.dsr2.2008.11.001; Gage JD, 2000, DEEP-SEA RES PT II, V47, P1; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Galbraith ED, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001518; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Ganeshram RS, 1998, PALEOCEANOGRAPHY, V13, P634, DOI 10.1029/98PA02508; Ganeshram RS, 1999, GEOCHIM COSMOCHIM AC, V63, P1723, DOI 10.1016/S0016-7037(99)00073-3; Ganeshram RS, 2002, NATURE, V415, P156, DOI 10.1038/415156a; Garcia HE, 2010, WORLD OCEAN ATLAS 20, P344; Gardner J.V., 1995, PROC OCEAN DRILL SCI, V146, P103; Gardner JV, 1997, PALEOCEANOGRAPHY, V12, P207, DOI 10.1029/96PA03567; GARDNER JV, 1986, GEOLOGY, V14, P691, DOI 10.1130/0091-7613(1986)14<691:EFASOZ>2.0.CO;2; Gardner JV, 1992, PALEOCEANOGRAPHY CAL; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Hanawa K., 2001, OCEAN CIRCULATION CL, P373, DOI DOI 10.1016/S0074-6142(01)80129-7; Hendy IL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025975; Hendy IL, 2000, PALEOCEANOGRAPHY, V15, P30, DOI 10.1029/1999PA000413; Hendy IL, 2003, QUATERNARY SCI REV, V22, P673, DOI 10.1016/S0277-3791(02)00186-5; Hendy IL, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001123; Hendy IL, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000965; Hendy IL, 1999, GEOLOGY, V27, P291, DOI 10.1130/0091-7613(1999)027<0291:LQNPSW>2.3.CO;2; Hendy IL, 2002, QUATERNARY SCI REV, V21, P1167, DOI 10.1016/S0277-3791(01)00138-X; Hermelin J.O.R., 1992, Geological Society Special Publication, P151; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; Hickey B.M., 1998, SEA, V11, P345; Higginson MJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020511; Hill TM, 2006, QUATERNARY SCI REV, V25, P2835, DOI 10.1016/j.quascirev.2006.03.012; Hill T. M., 2013, PALEOCEANOGRAPHY, V29, P1; Hofmann AF, 2011, DEEP-SEA RES PT I, V58, P1212, DOI 10.1016/j.dsr.2011.09.004; HOOD RR, 1990, J GEOPHYS RES-OCEANS, V95, P18081, DOI 10.1029/JC095iC10p18081; HOPKINS DM, 1959, SCIENCE, V129, P1519, DOI 10.1126/science.129.3362.1519; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Ivanochko TS, 2004, QUATERNARY SCI REV, V23, P467, DOI 10.1016/j.quascirev.2003.06.006; Jaccard SL, 2013, GEOPHYS RES LETT, V40, P199, DOI 10.1029/2012GL054118; Jaccard SL, 2009, EARTH PLANET SC LETT, V277, P156, DOI 10.1016/j.epsl.2008.10.017; Jaccard SL, 2012, NAT GEOSCI, V5, P151, DOI [10.1038/ngeo1352, 10.1038/NGEO1352]; Jorissen FJ, 2007, DEV MARINE GEOL, V1, P263, DOI 10.1016/S1572-5480(07)01012-3; Kaufman DS, 2004, DEV QUA SCI, V2, P9; Keeling RF, 2009, GEOCHIM COSMOCHIM AC, V73, pA632; Keigwin LD, 1990, PALEOCEANOGRAPHY, V5, P1009, DOI 10.1029/PA005i006p01009; Keigwin LD, 2002, J OCEANOGR, V58, P421, DOI 10.1023/A:1015830313175; KEIGWIN LD, 1992, EARTH PLANET SC LETT, V111, P425, DOI 10.1016/0012-821X(92)90194-Z; Keigwin LD, 1998, PALEOCEANOGRAPHY, V13, P323, DOI 10.1029/98PA00874; Kennett J.P., 1995, SCI RESULTS, V146, P3; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; KENNETT JP, 2000, P OC DRILL PROGR SCI, V0167; Kienast SS, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001357; Kienast SS, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000650; Kienast SS, 2001, GEOPHYS RES LETT, V28, P1563, DOI 10.1029/2000GL012543; KLINKHAMMER GP, 1991, GEOCHIM COSMOCHIM AC, V55, P1799, DOI 10.1016/0016-7037(91)90024-Y; Koutavas A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000894; Kusch S, 2010, EARTH PLANET SC LETT, V290, P340, DOI 10.1016/j.epsl.2009.12.030; Lambeck K, 1998, GEOPHYS J INT, V134, P102, DOI 10.1046/j.1365-246x.1998.00541.x; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; LEVIN LA, 1991, J MAR RES, V49, P763, DOI 10.1357/002224091784995756; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; Levin LA, 2009, TRENDS ECOL EVOL, V24, P606, DOI 10.1016/j.tree.2009.04.012; LEVINTON JS, 1970, LETHAIA, V3, P69, DOI 10.1111/j.1502-3931.1970.tb01264.x; Loubere P, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000986; LYNN RJ, 1987, J GEOPHYS RES-OCEANS, V92, P12947, DOI 10.1029/JC092iC12p12947; Mackas D. L, 2006, SEA, P21; Martin PA, 2002, EARTH PLANET SC LETT, V198, P193, DOI 10.1016/S0012-821X(02)00472-7; Martinez P, 2010, BIOGEOSCIENCES, V7, P1, DOI 10.5194/bg-7-1-2010; Martinez P, 1999, MAR GEOL, V158, P57, DOI 10.1016/S0025-3227(98)00161-3; Matear RJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001997; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; McDonald D, 1999, DEEP-SEA RES PT II, V46, P2993, DOI 10.1016/S0967-0645(99)00091-0; McGann M, 2011, QUATERN INT, V235, P26, DOI 10.1016/j.quaint.2010.09.005; McKay JL, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2003PA000979; Milne GA, 2005, QUATERNARY SCI REV, V24, P1183, DOI 10.1016/j.quascirev.2004.10.005; Mix AC, 1999, GEOPH MONOG SERIES, V112, P127; Moffitt SE, 2014, PALEOCEANOGRAPHY, V29, P44, DOI 10.1002/2013PA002483; Mohtadi M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001003; Molina V, 2005, MAR ECOL PROG SER, V288, P35, DOI 10.3354/meps288035; Mollenhauer G, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001488; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Montgomery RB, 1962, J HOPKINS OCEANOGRAP, V1, P68; Murray JW, 2001, MAR MICROPALEONTOL, V41, P1, DOI 10.1016/S0377-8398(00)00057-8; Naidu PD, 1995, MAR MICROPALEONTOL, V26, P49, DOI 10.1016/0377-8398(95)00014-3; Nam S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049549; Nameroff TJ, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000912; Nameroff TJ, 2002, GEOCHIM COSMOCHIM AC, V66, P1139, DOI 10.1016/S0016-7037(01)00843-2; O'Connor BM, 2002, DEEP-SEA RES PT I, V49, P1571, DOI 10.1016/S0967-0637(02)00087-0; Ono T, 2001, GEOPHYS RES LETT, V28, P3285, DOI 10.1029/2001GL012948; Ortiz JD, 2004, GEOLOGY, V32, P521, DOI 10.1130/G20234.1; Oschlies A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003147; Overpeck J, 1996, CLIM DYNAM, V12, P213, DOI 10.1007/BF00211619; PARULEKAR AH, 1982, DEEP-SEA RES, V29, P1531, DOI 10.1016/0198-0149(82)90041-3; PAULMIER A, 2009, PROG OCEANOGR, V80, P113, DOI DOI 10.1016/J.POCEAN.2008.08.001; Pedersen TF, 1988, PALEOCEANOGRAPHY, V3, P157, DOI 10.1029/PA003i002p00157; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Petit JR, 2001, IGBP PAGES WORLD CTR, V76; Pichevin L, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002852; Pichevin LE, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001754; Pride C, 1999, PALEOCEANOGRAPHY, V14, P397, DOI 10.1029/1999PA900004; Rea D.K., 1995, P ODP SCI RESULTS, V145, P577, DOI [10.2973/odp.proc.ir.145.1993, DOI 10.2973/ODP.PROC.IR.145.1993, 10.2973/odp.proc.sr.145.146.1995, DOI 10.2973/ODP.PROC.SR.145.146.1995]; Reichart GJ, 1997, PALAEOGEOGR PALAEOCL, V134, P149, DOI 10.1016/S0031-0182(97)00071-0; Reichart GJ, 1998, PALEOCEANOGRAPHY, V13, P607, DOI 10.1029/98PA02203; Reichart GJ, 2002, MAR GEOL, V185, P403, DOI 10.1016/S0025-3227(02)00184-6; Reid J. L., 1965, INTERMEDIATE WATERS; REID JL, 1962, J GEOPHYS RES, V67, P2491, DOI 10.1029/JZ067i006p02491; Reid JL, 1997, PROG OCEANOGR, V39, P263, DOI 10.1016/S0079-6611(97)00012-8; REIMERS CE, 1983, MAR CHEM, V13, P141, DOI 10.1016/0304-4203(83)90022-1; Robinson RS, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001702; Robinson RS, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002321; ROSENTHAL Y, 1995, EARTH PLANET SC LETT, V132, P99, DOI 10.1016/0012-821X(95)00056-I; SARKAR A, 1990, NATURE, V343, P549, DOI 10.1038/343549a0; SARKAR A, 1993, GEOCHIM COSMOCHIM AC, V57, P1009, DOI 10.1016/0016-7037(93)90036-V; Schmiedl G, 2003, PALAEOGEOGR PALAEOCL, V190, P139, DOI 10.1016/S0031-0182(02)00603-X; Schneider W, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017086; Schulte S, 1999, EARTH PLANET SC LETT, V173, P205, DOI 10.1016/S0012-821X(99)00232-0; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Sellanes J, 2010, MAR ECOL-EVOL PERSP, V31, P111, DOI 10.1111/j.1439-0485.2009.00332.x; Send U, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007517; SenGupta BK, 1996, GEOLOGY, V24, P227, DOI 10.1130/0091-7613(1996)024<0227:SODICS>2.3.CO;2; SHACKLETON NJ, 1983, EARTH PLANET SC LETT, V65, P233, DOI 10.1016/0012-821X(83)90162-0; Shaffer G, 2009, NAT GEOSCI, V2, P105, DOI 10.1038/NGEO420; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; SILVA N, 1979, DEEP-SEA RES, V26, P1387; Silva N, 2009, DEEP-SEA RES PT II, V56, P992, DOI 10.1016/j.dsr2.2008.12.013; Skinner LC, 2005, QUATERNARY SCI REV, V24, P571, DOI 10.1016/j.quascirev.2004.11.008; Somes CJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003767; SOUTAR A, 1977, GEOL SOC AM BULL, V88, P1161, DOI 10.1130/0016-7606(1977)88<1161:SACPIT>2.0.CO;2; Spero HJ, 2002, SCIENCE, V296, P522, DOI 10.1126/science.1069401; Stabeno PJ, 2004, CONT SHELF RES, V24, P859, DOI 10.1016/j.csr.2004.02.007; Stein R, 1995, P ODP SCI RES 2, P125; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; TALLEY LD, 1993, J PHYS OCEANOGR, V23, P517, DOI 10.1175/1520-0485(1993)023<0517:DAFONP>2.0.CO;2; TAPPAN H, 1986, J PALEONTOL, V60, P545, DOI 10.1017/S0022336000022113; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; Toggweiler JR, 1995, DAHL WS ENV, V18, P337; Tribovillard N, 2006, CHEM GEOL, V232, P12, DOI 10.1016/j.chemgeo.2006.02.012; TSUCHIYA M, 1981, J PHYS OCEANOGR, V11, P794, DOI 10.1175/1520-0485(1981)011<0794:TOOTPE>2.0.CO;2; van Geen A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000911; van Geen A, 2001, BAJA CALIFORNIA CORI; vanGeen A, 1996, PALEOCEANOGRAPHY, V11, P519, DOI 10.1029/96PA01860; VANGEEN A, 1995, PALEOCEANOGRAPHY, V10, P159, DOI 10.1029/94PA03352; VONRAD U, 1995, MAR GEOL, V125, P7, DOI 10.1016/0025-3227(95)00051-Y; Wang CZ, 2001, GEOPHYS RES LETT, V28, P1635, DOI 10.1029/2000GL011763; Watson EB, 2011, RESTOR ECOL, V19, P765, DOI 10.1111/j.1526-100X.2010.00722.x; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; Wijffels SE, 1996, DEEP-SEA RES PT I, V43, P501, DOI 10.1016/0967-0637(96)00006-4; Willard DA, 2007, FRONT ECOL ENVIRON, V5, P491, DOI 10.1890/070015; Wyllie JG, 1966, CALCOFI ATLAS 14, V14; WYRTKI K, 1962, DEEP-SEA RES, V9, P11, DOI 10.1016/0011-7471(62)90243-7; Wyrtki K., 1966, OCEANOGRAPHY MARINE, V4, P33; YANG YL, 1995, GEOLOGY, V23, P1115, DOI 10.1130/0091-7613(1995)023<1115:GROTPB>2.3.CO;2; Yu EF, 1999, TERR ATMOS OCEAN SCI, V10, P201, DOI 10.3319/TAO.1999.10.1.201(IMAGES); Zahn R, 1991, PALEOCEANOGRAPHY, V6, P543, DOI 10.1029/91PA01327; Zettler ML, 2009, MAR BIOL, V9, P1946; Zhang J, 2010, BIOGEOSCIENCES, V7, P1443, DOI 10.5194/bg-7-1443-2010; Zheng Y, 2000, GEOCHIM COSMOCHIM AC, V64, P4165, DOI 10.1016/S0016-7037(00)00495-6; Zheng Y, 2000, PALEOCEANOGRAPHY, V15, P528, DOI 10.1029/1999PA000473	235	64	65	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115246	10.1371/journal.pone.0115246	http://dx.doi.org/10.1371/journal.pone.0115246			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629508	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100013
J	Madhukar, NS; Warmoes, MO; Locasale, JW				Madhukar, Neel S.; Warmoes, Marc O.; Locasale, Jason W.			Organization of Enzyme Concentration across the Metabolic Network in Cancer Cells	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PROTEIN; GLYCOLYSIS; GLYCINE; IDENTIFICATION; PROLIFERATION; VISUALIZATION; PROTEOMICS; TARGET; SERINE	Rapid advances in mass spectrometry have allowed for estimates of absolute concentrations across entire proteomes, permitting the interrogation of many important biological questions. Here, we focus on a quantitative aspect of human cancer cell metabolism that has been limited by a paucity of available data on the abundance of metabolic enzymes. We integrate data from recent measurements of absolute protein concentration to analyze the statistics of protein abundance across the human metabolic network. At a global level, we find that the enzymes in glycolysis comprise approximately half of the total amount of metabolic proteins and can constitute up to 10% of the entire proteome. We then use this analysis to investigate several outstanding problems in cancer metabolism, including the diversion of glycolytic flux for biosynthesis, the relative contribution of nitrogen assimilating pathways, and the origin of cellular redox potential. We find many consistencies with current models, identify several inconsistencies, and find generalities that extend beyond current understanding. Together our results demonstrate that a relatively simple analysis of the abundance of metabolic enzymes was able to reveal many insights into the organization of the human cancer cell metabolic network.	[Madhukar, Neel S.; Locasale, Jason W.] Cornell Univ, Triinst Program Computat Biol & Med, Ithaca, NY 14850 USA; [Madhukar, Neel S.; Locasale, Jason W.] Weill Cornell Med Coll, New York, NY USA; [Madhukar, Neel S.; Locasale, Jason W.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Madhukar, Neel S.; Warmoes, Marc O.; Locasale, Jason W.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Locasale, JW (corresponding author), Cornell Univ, Triinst Program Computat Biol & Med, Ithaca, NY 14850 USA.	Locasale@cornell.edu	Locasale, Jason W/ABE-6505-2020	Locasale, Jason W/0000-0002-7766-3502; Warmoes, Marc/0000-0002-6632-3764	National Institutes of Health [CA168997, AI110613]; International Life Sciences Institute; Tri-Institutional Training Program in Computational Biology and Medicine [1T32GM083937]; NATIONAL CANCER INSTITUTE [R00CA168997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Life Sciences Institute; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JWL acknowledges support from National Institutes of Health (http://www.nih.gov/) awards CA168997 and AI110613 and the International Life Sciences Institute. NSM was supported by the Tri-Institutional Training Program in Computational Biology and Medicine (http://www.triiprograms.org/cbm/), Program number: 1T32GM083937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; ARGILES JM, 1990, MED HYPOTHESES, V32, P151, DOI 10.1016/0306-9877(90)90039-H; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Breker M, 2014, NAT REV MOL CELL BIO, V15, P453, DOI 10.1038/nrm3821; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dang CV, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-3; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Henry CS, 2006, BIOPHYS J, V90, P1453, DOI 10.1529/biophysj.105.071720; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lee K, 2013, ANGEW CHEM INT EDIT, V52, P10286, DOI 10.1002/anie.201304987; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Noor E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003483; Northrop DB, 1998, ARCH BIOCHEM BIOPHYS, V352, P288, DOI 10.1006/abbi.1997.0589; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Vazquez A, 2013, CANCER RES, V73, P478, DOI 10.1158/0008-5472.CAN-12-3709; Warmoes M, 2013, MOL CELL PROTEOMICS, V12, P1319, DOI 10.1074/mcp.M112.024182; WARMOES MO, 2014, HETEROGENEITY OF GLY; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934	41	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117131	10.1371/journal.pone.0117131	http://dx.doi.org/10.1371/journal.pone.0117131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621879	Green Published, Green Submitted, gold			2022-12-27	WOS:000348470400020
J	Nasi, M; De Biasi, S; Bianchini, E; Gibellini, L; Pinti, M; Scacchetti, T; Trenti, T; Borghi, V; Mussini, C; Cossarizza, A				Nasi, Milena; De Biasi, Sara; Bianchini, Elena; Gibellini, Lara; Pinti, Marcello; Scacchetti, Tiziana; Trenti, Tommaso; Borghi, Vanni; Mussini, Cristina; Cossarizza, Andrea			Reliable and Accurate CD4+T Cell Count and Percent by the Portable Flow Cytometer CyFlow MiniPOC and "CD4 Easy Count Kit-Dry", as Revealed by the Comparison with the Gold Standard Dual Platform Technology	PLOS ONE			English	Article							HIV-INFECTION; TREATMENT INTERRUPTION; THERAPY; APOPTOSIS; SETTINGS; EPIDEMIC	Background An accurate and affordable CD4+ T cells count is an essential tool in the fight against HIV/AIDS. Flow cytometry (FCM) is the "gold standard" for counting such cells, but this technique is expensive and requires sophisticated equipment, temperature-sensitive monoclonal antibodies (mAbs) and trained personnel. The lack of access to technical support and quality assurance programs thus limits the use of FCM in resource-constrained countries. We have tested the accuracy, the precision and the carry-over contamination of Partec CyFlow MiniPOC, a portable and economically affordable flow cytometer designed for CD4+ count and percentage, used along with the " CD4% Count Kit-Dry". Materials and Methods Venous blood from 59 adult HIV+ patients (age: 25-58 years; 43 males and 16 females) was collected and stained with the "MiniPOC CD4% Count Kit-Dry". CD4+ count and percentage were then determined in triplicate by the CyFlow MiniPOC. In parallel, CD4 count was performed using mAbs and a CyFlow Counter, or by a dual platform system (from Beckman Coulter) based upon Cytomic FC500 ("Cytostat tetrachrome kit" for mAbs) and Coulter HmX Hematology Analyzer (for absolute cell count). Results The accuracy of CyFlow MiniPOC against Cytomic FC500 showed a correlation coefficient (CC) of 0.98 and 0.97 for CD4+ count and percentage, respectively. The accuracy of CyFlow MiniPOC against CyFlow Counter showed a CC of 0.99 and 0.99 for CD4 T cell count and percentage, respectively. CyFlow MiniPOC showed an excellent repeatability: CD4+ cell count and percentage were analyzed on two instruments, with an intra-assay precision below +/- 5% deviation. Finally, there was no carry-over contamination for samples at all CD4 values, regardless of their position in the sequence of analysis. Conclusion The cost-effective CyFlow MiniPOC produces rapid, reliable and accurate results that are fully comparable with those from highly expensive dual platform systems.	[Nasi, Milena; De Biasi, Sara; Bianchini, Elena; Gibellini, Lara; Pinti, Marcello; Mussini, Cristina; Cossarizza, Andrea] Univ Modena & Reggio Emilia, Sch Med, Dept Surg Med Dent & Morphol Sci, I-41125 Modena, Italy; [Scacchetti, Tiziana; Trenti, Tommaso] Nuovo Osped Civile St Agostino Estense NOCSAE, BLU Lab, Dept Clin Pathol, Modena, Italy; [Borghi, Vanni; Mussini, Cristina] Azienda Osped Univ Policlin, Infect Dis Clin, I-41124 Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital	Cossarizza, A (corresponding author), Univ Modena & Reggio Emilia, Sch Med, Dept Surg Med Dent & Morphol Sci, Via Campi 287, I-41125 Modena, Italy.	andrea.cossarizza@unimore.it	De Biasi, Sara/AAB-7520-2019; Nasi, Milena/J-4425-2016; Mussini, Cristina/K-8672-2016; Pinti, Marcello/C-9351-2015; Trenti, Tommaso/K-8457-2016	De Biasi, Sara/0000-0002-3217-9821; Nasi, Milena/0000-0003-3079-8001; Mussini, Cristina/0000-0002-6615-4198; Pinti, Marcello/0000-0001-9118-1262; Cossarizza, Andrea/0000-0002-5381-1558; Trenti, Tommaso/0000-0001-8093-4011				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boyle DS, 2012, TRENDS BIOTECHNOL, V30, P45, DOI 10.1016/j.tibtech.2011.06.015; Cossarizza A, 2008, CURR PHARM DESIGN, V14, P237, DOI 10.2174/138161208783413293; Cossarizza A, 2013, CYTOM PART A, V83A, P680, DOI 10.1002/cyto.a.22318; Cossarizza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050728; Cossarizza A, 2012, EUR J IMMUNOL, V42, P3106, DOI 10.1002/eji.201270100; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; De Maria A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-93; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Doherty M, 2013, CURR OPIN HIV AIDS, V8, P528, DOI 10.1097/COH.0000000000000008; Franco RA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-147; Glynn MT, 2013, LAB CHIP, V13, P2731, DOI 10.1039/c3lc50213a; Guaraldi G, 2014, JAIDS-J ACQ IMM DEF, V65, P175, DOI 10.1097/QAI.0000000000000018; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Mussini C, 2002, AIDS, V16, P1609, DOI 10.1097/00002030-200208160-00006; Mussini C, 2011, AIDS, V25, P1041, DOI 10.1097/QAD.0b013e3283463ec5; Nasi M, 2014, IMMUNOL LETT, V161, P184, DOI 10.1016/j.imlet.2014.01.008; Nemes E, 2006, AIDS, V20, P2021, DOI 10.1097/01.aids.0000247575.41622.b1; Nemes E, 2011, AIDS, V25, P1443, DOI 10.1097/QAD.0b013e328347b5e2; Nemes E, 2010, AIDS, V24, P947, DOI 10.1097/QAD.0b013e328337b144; Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26; UNAIDS, 2013, UNAIDS REPORT ON THE; Wade D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075484; World Health Organization, 2010, ANTIRETROVIRAL THERA	24	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116848	10.1371/journal.pone.0116848	http://dx.doi.org/10.1371/journal.pone.0116848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622041	gold, Green Published, Green Submitted			2022-12-27	WOS:000348470400009
J	Zheng, HF; Rong, JJ; Liu, M; Han, F; Zhang, XW; Richards, JB; Wang, L				Zheng, Hou-Feng; Rong, Jing-Jing; Liu, Ming; Han, Fang; Zhang, Xing-Wei; Richards, J. Brent; Wang, Li			Performance of Genotype Imputation for Low Frequency and Rare Variants from the 1000 Genomes	PLOS ONE			English	Article							ASSOCIATION; OSTEOPOROSIS; HAPLOTYPES; STRATEGIES; INFERENCE; ACCURACY; SNPS	Genotype imputation is now routinely applied in genome-wide association studies (GWAS) and meta-analyses. However, most of the imputations have been run using HapMap samples as reference, imputation of low frequency and rare variants (minor allele frequency (MAF) < 5%) are not systemically assessed. With the emergence of next-generation sequencing, large reference panels (such as the 1000 Genomes panel) are available to facilitate imputation of these variants. Therefore, in order to estimate the performance of low frequency and rare variants imputation, we imputed 153 individuals, each of whom had 3 different genotype array data including 317k, 610k and 1 million SNPs, to three different reference panels: the 1000 Genomes pilot March 2010 release (1KGpilot), the 1000 Genomes interim August 2010 release (1KGinterim), and the 1000 Genomes phase1 November 2010 and May 2011 release (1KGphase1) by using IMPUTE version 2. The differences between these three releases of the 1000 Genomes data are the sample size, ancestry diversity, number of variants and their frequency spectrum. We found that both reference panel and GWAS chip density affect the imputation of low frequency and rare variants. 1KGphase1 outperformed the other 2 panels, at higher concordance rate, higher proportion of wellimputed variants (info>0.4) and higher mean info score in each MAF bin. Similarly, 1M chip array outperformed 610K and 317K. However for very rare variants (MAF <= 0.3%), only 0-1% of the variants were well imputed. We conclude that the imputation of low frequency and rare variants improves with larger reference panels and higher density of genome-wide genotyping arrays. Yet, despite a large reference panel size and dense genotyping density, very rare variants remain difficult to impute.	[Zheng, Hou-Feng; Rong, Jing-Jing; Liu, Ming; Zhang, Xing-Wei; Wang, Li] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China; [Zheng, Hou-Feng; Rong, Jing-Jing; Liu, Ming; Zhang, Xing-Wei; Wang, Li] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Zheng, Hou-Feng; Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Med Human Genet Epidemiol & Biostat, Montreal, PQ H3T 1E2, Canada; [Han, Fang] Peking Univ, Peoples Hosp, Dept Pulm, Beijing 100871, Peoples R China; [Richards, J. Brent] Kings Coll London, London WC2R 2LS, England	Hangzhou Normal University; Hangzhou Normal University; Lady Davis Institute; McGill University; Peking University; University of London; King's College London	Zheng, HF (corresponding author), Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China.	h-zheng@live.com	Zheng, Houfeng/K-4424-2012; Richards, J Brent/AAF-4225-2019	Zheng, Houfeng/0000-0001-5681-8598; Richards, J Brent/0000-0002-3746-9086	Canadian Institute of Health Research; State Key Development Program for Basic Research of China, 973 Program [2014CB541701]; Natural Science Foundation of China [81101560, 81472659]; Zhejiang Provincial Natural Science Foundation of China [LZ13H02001]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); State Key Development Program for Basic Research of China, 973 Program(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	HFZ and JBR are supported by Canadian Institute of Health Research. This study is supported by State Key Development Program for Basic Research of China, 973 Program (No. 2014CB541701), Natural Science Foundation of China (No. 81101560, No. 81472659), and Zhejiang Provincial Natural Science Foundation of China Grant (No. LZ13H02001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Jostins L, 2011, EUR J HUM GENET, V19, P662, DOI 10.1038/ejhg.2011.10; Ladouceur M, 2013, EUR J HUM GENET, V21, P1027, DOI 10.1038/ejhg.2012.284; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024945; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; MARCHINI J, 2013, AMERICAN SOCIETY OF; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Shea J, 2011, NAT GENET, V43, P801, DOI 10.1038/ng.871; Sung YJ, 2012, HUM HERED, V73, P18, DOI 10.1159/000334084; Zhang P, 2013, GENETICS, V195, P319, DOI 10.1534/genetics.113.154591	26	39	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116487	10.1371/journal.pone.0116487	http://dx.doi.org/10.1371/journal.pone.0116487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621886	Green Published, Green Submitted, gold			2022-12-27	WOS:000348470400004
J	Vidal, B; Cascao, R; Vale, AC; Cavaleiro, I; Vaz, MF; Brito, JAA; Canhao, H; Fonseca, JE				Vidal, Bruno; Cascao, Rita; Vale, Ana Catarina; Cavaleiro, Ines; Vaz, Maria Fatima; Almeida Brito, Jose Americo; Canhao, Helena; Fonseca, Joao Eurico			Arthritis Induces Early Bone High Turnover, Structural Degradation and Mechanical Weakness	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; BIOMECHANICAL PROPERTIES; RATS; HISTOMORPHOMETRY; DISTURBANCES; ACTIVATION; EXPRESSION; NETWORK; CALCIUM	Background We have previously found in the chronic SKG mouse model of arthritis that long standing (5 and 8 months) inflammation directly leads to high collagen bone turnover, disorganization of the collagen network, disturbed bone microstructure and degradation of bone biomechanical properties. The main goal of the present work was to study the effects of the first days of the inflammatory process on the microarchitecture and mechanical properties of bone. Methods Twenty eight Wistar adjuvant-induced arthritis (AIA) rats were monitored during 22 days after disease induction for the inflammatory score, ankle perimeter and body weight. Healthy non-arthritic rats were used as controls for compar-ison. After 22 days of disease progression rats were sacrificed and bone samples were collected for histomorphometrical, energy dispersive X-ray spectroscopical analysis and 3-point bending. Blood samples were also collected for bone turnover markers. Results AIA rats had an increased bone turnover (as inferred from increased P1NP and CTX1, p = 0.0010 and p = 0.0002, respectively) and this was paralleled by a decreased mineral content (calcium p = 0.0046 and phos-phorus p = 0.0046). Histomorphometry showed a lower trabecular thickness (p = 0.0002) and bone volume (p = 0.0003) and higher trabecular sepa-ration (p = 0.0009) in the arthritic group as compared with controls. In addition, bone mechanical tests showed evidence of fragility as depicted by diminished values of yield stress and ultimate fracture point (p = 0.0061 and p = 0.0279, re-spectively) in the arthritic group. Conclusions We have shown in an AIA rat model that arthritis induc-es early bone high turnover, structural degradation, mineral loss and mechanical weak-ness.	[Vidal, Bruno; Cascao, Rita; Canhao, Helena; Fonseca, Joao Eurico] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Vale, Ana Catarina; Vaz, Maria Fatima] Univ Lisbon, Inst Super Tecn, Inst Ciencia & Engn Mat & Superficies, P-1699 Lisbon, Portugal; [Cavaleiro, Ines; Almeida Brito, Jose Americo] Inst Super Ciencias Saude Egas Moniz, Quinta Da Granja, Caparica, Portugal; [Vaz, Maria Fatima] UL, Inst Super Tecn, Dept Engn Mecan, Lisbon, Portugal; [Canhao, Helena; Fonseca, Joao Eurico] Lisbon Acad Med Ctr, Dept Rheumatol, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa	Vidal, B (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	vidal.bmc@gmail.com	Vale, Ana Catarina/B-3771-2016; Canhao, Helena/C-9611-2018; Brito, José/AAM-5150-2020; Vale, Ana/GYQ-5168-2022; Vaz, Fatima/B-8840-2011	Vale, Ana Catarina/0000-0002-1590-6636; Canhao, Helena/0000-0003-1894-4870; Brito, José/0000-0002-8558-6754; Vaz, Fatima/0000-0003-1629-523X	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/81527/2011]; ECTS/Amgen Bone Biology Fellowship from European Calcified Tissue Society	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); ECTS/Amgen Bone Biology Fellowship from European Calcified Tissue Society	This work was supported by a grant SFRH/BD/81527/2011 from Fundacao para a Ciencia e a Tecnologia (FCT) and grant ECTS/Amgen Bone Biology Fellowship 2014 from European Calcified Tissue Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; Allen MR, 2008, CALCIFIED TISSUE INT, V82, P354, DOI 10.1007/s00223-008-9131-8; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P377; Bonjour JP, 2011, J AM COLL NUTR, V30, p438S, DOI 10.1080/07315724.2011.10719988; Caetano-Lopes J, 2009, CLIN EXP RHEUMATOL, V27, P475; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; Caetano-Lopes J, 2014, CLIN REV ALLERG IMMU, V47, P38, DOI 10.1007/s12016-013-8366-y; Caetano-Lopes J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2908; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Cortet B, 1998, J RHEUMATOL, V25, P2339; DaSilva JAP, 1996, CLIN EXP RHEUMATOL, V14, P43; Eric-Jan JA, 2000, CLINICAL AND EXPERIM; Fonseca JE, 2005, CLIN EXP RHEUMATOL, V23, P185; Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84; Haugeberg G, 2002, ARTHRITIS RHEUM-US, V46, P1720, DOI 10.1002/art.10408; Jiang YB, 1997, J BONE MINER RES, V12, P820, DOI 10.1359/jbmr.1997.12.5.820; Lin YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062926; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Moura RA, 2011, RHEUMATOLOGY, V50, P278, DOI 10.1093/rheumatology/keq338; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PEARSON CM, 1956, P SOC EXP BIOL MED, V91, P95, DOI 10.3181/00379727-91-22179; Schopf KAaBDJ Lisa R., 2006, RAT MODELS OF ARTHRI; Siebuhr AS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-195; van Schaardenburg D, 2011, ANN RHEUM DIS, V70, P1173, DOI 10.1136/ard.2010.135723; Vidal B, 2012, ACTA REUMATOL PORT, V37, P294; Wislowska M, 2009, RHEUMATOL INT, V29, P1403, DOI 10.1007/s00296-009-0867-x; YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117100	10.1371/journal.pone.0117100	http://dx.doi.org/10.1371/journal.pone.0117100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617902	Green Submitted, Green Published, gold			2022-12-27	WOS:000350336000038
J	Jewell, BL; Cremin, I; Pickles, M; Celum, C; Baeten, JM; Delany-Moretlwe, S; Hallett, TB				Jewell, Britta L.; Cremin, Ide; Pickles, Michael; Celum, Connie; Baeten, Jared M.; Delany-Moretlwe, Sinead; Hallett, Timothy B.			Estimating the Cost-Effectiveness of Pre-Exposure Prophylaxis to Reduce HIV-1 and HSV-2 Incidence in HIV-Serodiscordant Couples in South Africa	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; ANTIRETROVIRAL THERAPY; GENITAL HERPES; DISCORDANT COUPLES; MALE CIRCUMCISION; TRANSMISSION; INFECTION; PREVENTION; ACQUISITION; TENOFOVIR	Objective To estimate the cost-effectiveness of daily oral tenofovir-based PrEP, with a protective effect against HSV-2 as well as HIV-1, among HIV-1 serodiscordant couples in South Africa. Methods We incorporated HSV-2 acquisition, transmission, and interaction with HIV-1 into a microsimulation model of heterosexual HIV-1 serodiscordant couples in South Africa, with use of PrEP for the HIV-1 uninfected partner prior to ART initiation for the HIV-1 1infected partner, and for one year thereafter. Results We estimate the cost per disability-adjusted life-year (DALY) averted for two scenarios, one in which PrEP has no effect on reducing HSV-2 acquisition, and one in which there is a 33% reduction. After a twenty-year intervention, the cost per DALY averted is estimated to be $10,383 and $9,757, respectively - a 6% reduction, given the additional benefit of reduced HSV-2 acquisition. If all couples are discordant for both HIV-1 and HSV-2, the cost per DALY averted falls to $ 1,445, which shows that the impact is limited by HSV-2 concordance in couples. Conclusion After a 20-year PrEP intervention, the cost per DALY averted with a reduction in HSV-2 is estimated to be modestly lower than without any effect, providing an increase of health benefits in addition to HIV-1 prevention at no extra cost. The small degree of the effect is in part due to a high prevalence of HSV-2 infection in HIV-1 serodiscordant couples in South Africa.	[Jewell, Britta L.; Cremin, Ide; Pickles, Michael; Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Delany-Moretlwe, Sinead] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa	Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Witwatersrand	Jewell, BL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	b.jewell@imperial.ac.uk		Pickles, Michael/0000-0002-6754-3945; Cremin, Ide/0000-0003-2560-6247; Hallett, Timothy/0000-0002-9681-0424	Bill & Melinda Gates Foundation via from Georgetown University; National Institute of Mental Health of the US National Institutes of Health [R01MH095507]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095507] Funding Source: NIH RePORTER; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Bill & Melinda Gates Foundation via from Georgetown University; National Institute of Mental Health of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	B.L.J., I.C., and T.B.H. would like to thank the Bill & Melinda Gates Foundation for funding this research via a sub-contract from Georgetown University. This analysis was also supported by the National Institute of Mental Health of the US National Institutes of Health (R01MH095507) to J.M.B. The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; AUGENBRAUN M, 1995, ANN INTERN MED, V123, P845, DOI 10.7326/0003-4819-123-11-199512010-00006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Benedetti JK, 1999, ANN INTERN MED, V131, P14, DOI 10.7326/0003-4819-131-1-199907060-00004; BROWN ZA, 1991, NEW ENGL J MED, V324, P1247, DOI 10.1056/NEJM199105023241804; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; CELUM C, 2013, DAILY ORAL TENOFOVIR, DOI DOI 10.1002/JMRI.24478; Celum C, 2014, ANN INTERN MED, V161, P11, DOI 10.7326/M13-2471; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; Donnell D, 2014, J ACQUIR IMMUNE DEFI; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Haberer JE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001511; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; HOLMBERG SD, 1988, JAMA-J AM MED ASSOC, V259, P1048, DOI 10.1001/jama.259.7.1048; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Kamali A, 1999, SEX TRANSM INFECT, V75, P98, DOI 10.1136/sti.75.2.98; KARIM QA, 2014, SEX TRANSM INFECT, V2; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; KARIM SS, 2010, 18 INT AIDS C VIENN; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Mahy M, 2010, SEX TRANSM INFECT, V86, pI28, DOI 10.1136/sti.2010.044255; Menzies NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048726; Muiru AN, 2013, J INFECT DIS, V208, P1093, DOI 10.1093/infdis/jit303; Mujugira A, 2013, J INFECT DIS, V208, P1366, DOI 10.1093/infdis/jit333; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9; Ouedraogo A, 2006, AIDS, V20, P2305, DOI 10.1097/QAD.0b013e328010238d; Phipps W, 2011, J INFECT DIS, V203, P180, DOI 10.1093/infdis/jiq035; Schiffer Joshua T, 2009, Curr Infect Dis Rep, V11, P457, DOI 10.1007/s11908-009-0066-7; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Terris-Prestholt F, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-14; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; *WHO, 2011, GLOB HIV AIDS RESP E, DOI DOI 10.1080/17437199.2011.587961; World Health Organization, CHOOS INT AR COST EF; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	54	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115511	10.1371/journal.pone.0115511	http://dx.doi.org/10.1371/journal.pone.0115511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25616135	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100013
J	Lopez, S; Aguilar, L; Mercado, L; Bravo, M; Quiroz, W				Lopez, Silvana; Aguilar, Luis; Mercado, Luis; Bravo, Manuel; Quiroz, Waldo			Sb(V) Reactivity with Human Blood Components: Redox Effects	PLOS ONE			English	Article							PENTAVALENT ANTIMONY; SPECIATION ANALYSIS; PARTICULATE MATTER; TRACE-ELEMENTS; GLUTATHIONE; REDUCTION; SB(III); TRYPANOTHIONE; ENVIRONMENT; STABILITY	We assessed the reactivity of Sb(V) in human blood. Sb(V) reactivity was determined using an HPLC-HG-AFS hyphenated system. Sb(V) was partially reduced to Sb(III) in blood incubation experiments; however, Sb(III) was a highly unstable species. The addition of 0.1 mol L-1 EDTA prevented Sb(III) oxidation, thus enabling the detection of the reduction of Sb(V) to Sb (III). The transformation of Sb(V) to Sb(III) in human whole blood was assessed because the reduction of Sb(V) in human blood may likely generate redox side effects. Our results indicate that glutathione was the reducing agent in this reaction and that Sb(V) significantly decreased the GSH/GSSG ratio from 0.32 +/- 0.09 to 0.07 +/- 0.03. Moreover, the presence of 200 ng mL(-1) of Sb(V) increased the activity of superoxide dismutase from 4.4 +/- 0.1 to 7.0 +/- 0.4 U mL(-1) and decreased the activity of glutathione peroxidase from 62 +/- 1 to 34 +/- 2 nmol min(-1) mL(-1).	[Lopez, Silvana; Aguilar, Luis; Bravo, Manuel; Quiroz, Waldo] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Mercado, Luis] Pontificia Univ Catolica Valparaiso, Inst Biol, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso	Quiroz, W (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	waldo.quiroz@ucv.cl		Bravo, Manuel/0000-0002-4548-6265; Mercado, Luis/0000-0003-3883-5188; Aguilar, Luis/0000-0002-6038-3475	FONDECYT [1120203]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	WQ and LA gratefully acknowledge financial support FONDECYT 1120203 (www.fondecyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariza JLG, 2000, TRAC-TREND ANAL CHEM, V19, P200; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Bisacchi D, 2006, ACTA CRYSTALLOGR F, V62, P976, DOI 10.1107/S1744309106033537; De Gregori I, 2005, J CHROMATOGR A, V1091, P94, DOI 10.1016/j.chroma.2005.07.060; De Gregori I, 2007, TALANTA, V73, P458, DOI 10.1016/j.talanta.2007.04.015; Denton H, 2004, BIOCHEM J, V381, P405, DOI 10.1042/BJ20040283; Filella M, 2002, EARTH-SCI REV, V59, P265, DOI 10.1016/S0012-8252(02)00089-2; Frezard F, 2001, ANTIMICROB AGENTS CH, V45, P913, DOI 10.1128/AAC.45.3.913-916.2001; Frezard F, 2009, MOLECULES, V14, P2317, DOI 10.3390/molecules14072317; Furuta N, 2005, J ENVIRON MONITOR, V7, P1155, DOI 10.1039/b513988k; Gao Y, 2002, ATMOS ENVIRON, V36, P1077, DOI 10.1016/S1352-2310(01)00381-8; Ge RG, 2007, ACCOUNTS CHEM RES, V40, P267, DOI 10.1021/ar600001b; Hansen C, 2011, BIOL TRACE ELEM RES, V144, P234, DOI 10.1007/s12011-011-9079-9; Jang H, 2000, WEAR, V239, P229, DOI 10.1016/S0043-1648(00)00314-8; McCallum RI, 2005, J ENVIRON MONITOR, V7, P1245, DOI 10.1039/b509118g; Mukhopadhyay R, 2009, J MOL BIOL, V386, P1229, DOI 10.1016/j.jmb.2008.07.056; Organization W. H, 1990, CONTR LEISHM; Perrin D.D., 1979, CHEM DAT SER, V22, P770; Potin-Gautier M, 2005, ANAL CHIM ACTA, V553, P214, DOI 10.1016/j.aca.2005.07.055; Quiroz W, 2013, MICROCHEM J, V110, P266, DOI 10.1016/j.microc.2013.04.006; Quiroz W, 2013, TALANTA, V115, P902, DOI 10.1016/j.talanta.2013.06.052; Quiroz W, 2011, MICROCHEM J, V97, P78, DOI 10.1016/j.microc.2010.06.015; Quiroz W, 2009, J ENVIRON MONITOR, V11, P1051, DOI 10.1039/b815838j; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shaked-Mishan P, 2001, J BIOL CHEM, V276, P3971, DOI 10.1074/jbc.M005423200; Sun HZ, 2000, EUR J BIOCHEM, V267, P5450, DOI 10.1046/j.1432-1327.2000.01605.x; Thompson M, 2002, PURE APPL CHEM, V74, P835, DOI 10.1351/pac200274050835; Ulrich N, 2003, CHEM ENG NEWS, V81, P126; von Uexkull O, 2005, J CLEAN PROD, V13, P19, DOI 10.1016/j.jclepro.2003.10.008; Yan SC, 2003, CHEM COMMUN, P266, DOI 10.1039/b210240d; Yan SC, 2003, J BIOL INORG CHEM, V8, P689, DOI 10.1007/s00775-003-0468-1; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200	32	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0114796	10.1371/journal.pone.0114796	http://dx.doi.org/10.1371/journal.pone.0114796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615452	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100004
J	Vincent, G; Ferguson, SA; Tran, J; Larsen, B; Wolkow, A; Aisbett, B				Vincent, Grace; Ferguson, Sally A.; Jacqueline Tran; Larsen, Brianna; Wolkow, Alexander; Aisbett, Brad			Sleep Restriction during Simulated Wildfire Suppression: Effect on Physical Task Performance	PLOS ONE			English	Article							DEPRIVATION; WORK; MODELS; TEMPERATURE; FATIGUE; CAPACITY; DURATION; VALIDITY	Objectives To examine the effects of sleep restriction on firefighters' physical task performance during simulated wildfire suppression. Methods Thirty-five firefighters were matched and randomly allocated to either a control condition (8-hour sleep opportunity, n = 18) or a sleep restricted condition (4-hour sleep opportunity, n = 17). Performance on physical work tasks was evaluated across three days. In addition, heart rate, core temperature, and worker activity were measured continuously. Rate of perceived and exertion and effort sensation were evaluated during the physical work periods. Results There were no differences between the sleep-restricted and control groups in firefighters' task performance, heart rate, core temperature, or perceptual responses during self-paced simulated firefighting work tasks. However, the sleep-restricted group were less active during periods of non-physical work compared to the control group. Conclusions Under self-paced work conditions, 4 h of sleep restriction did not adversely affect firefighters' performance on physical work tasks. However, the sleep-restricted group were less physically active throughout the simulation. This may indicate that sleep-restricted participants adapted their behaviour to conserve effort during rest periods, to subsequently ensure they were able to maintain performance during the firefighter work tasks. This work contributes new knowledge to inform fire agencies of firefighters' operational capabilities when their sleep is restricted during multi-day wildfire events. The work also highlights the need for further research to explore how sleep restriction affects physical performance during tasks of varying duration, intensity, and complexity.	[Vincent, Grace; Larsen, Brianna; Wolkow, Alexander; Aisbett, Brad] Deakin Univ, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia; [Vincent, Grace; Ferguson, Sally A.; Larsen, Brianna; Wolkow, Alexander; Aisbett, Brad] Bushfire Cooperat Res Ctr, East Melbourne, Vic 3002, Australia; [Ferguson, Sally A.] Cent Queensland Univ, Appleton Inst, Wayville, SA 5034, Australia; [Jacqueline Tran] Deakin Univ, Ctr Exercise & Sport Sci, Burwood, Vic 3125, Australia	Deakin University; Central Queensland University; Deakin University	Vincent, G (corresponding author), Deakin Univ, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia.	gvincent@deakin.edu.au	; Aisbett, Brad/E-5178-2011	Tran, Jacqueline/0000-0002-5588-542X; Wolkow, Alexander/0000-0001-7845-3104; Ferguson, Sally/0000-0002-9682-7971; Larsen, Brianna/0000-0003-0885-795X; Vincent, Grace/0000-0002-7036-7823; Aisbett, Brad/0000-0001-8077-0272	Bushfire Co-operative Research Centre	Bushfire Co-operative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This project was funded by the Bushfire Co-operative Research Centre, http://www.bushfirecrc.com/. The funders had no role in the design of the study, data collection, analysis or preparation of the manuscript. Funders have approved the manuscript to be published and provided assistance in participant recruitment.	Abbiss CR, 2011, J APPL PHYSIOL, V110, P1248, DOI 10.1152/japplphysiol.01247.2010; ACSM, 2010, ACSMS GUID EX TEST P; Aisbett B, 2012, APPL ERGON, V43, P916, DOI 10.1016/j.apergo.2011.12.013; Akerstedt T, 2000, J SLEEP RES, V9, P395; American Academy of Sleep Medicine, 2007, AASM MANUAL SCORING; Araujo D, 2007, ECOL PSYCHOL, V19, P69, DOI 10.1080/10407410709336951; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Budd GM, 1997, INT J WILDLAND FIRE, V7, P105, DOI 10.1071/WF9970105; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Byrne C, 2007, BRIT J SPORT MED, V41, P126, DOI 10.1136/bjsm.2006.026344; Cajochen C, 2001, NEUROREPORT, V12, P2277, DOI 10.1097/00001756-200107200-00046; Caldwell JA, 1998, BEHAV RES METH INS C, V30, P651, DOI 10.3758/BF03209483; Carskadon M.A., 2011, PRINC PRACT SLEEP ME, V4, P16, DOI [10.1016/b978-1-4160-6645-3.00002-5, DOI 10.1016/B978-1-4160-6645-3.00002-5]; Cater H, 2007, AUSTR FIR AUTH COUNC; Cuddy JS, 2007, MED SCI SPORT EXER, V39, P1004, DOI 10.1249/mss.0b013e318040b2fb; Darwent D, 2008, APPL ERGON, V39, P614, DOI 10.1016/j.apergo.2008.02.012; Dettoni JL, 2012, J APPL PHYSIOL, V113, P232, DOI 10.1152/japplphysiol.01604.2011; Dinges DF, 2004, AVIAT SPACE ENVIR MD, V75, pA181; Edkins GD, 1997, ACCIDENT ANAL PREV, V29, P533, DOI 10.1016/S0001-4575(97)00033-X; Ferguson S, 2011, DESIGN VALID SIMULAT; Folkard S, 2003, OCCUP MED-OXFORD, V53, P95, DOI 10.1093/occmed/kqg047; Gaskill SE., 2004, HOURS REPORTED SLEEP; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; Gibson ASC, 2006, SPORTS MED, V36, P705; Gillberg M, 1998, PHYSIOL BEHAV, V64, P599, DOI 10.1016/S0031-9384(98)00063-8; Havenith G, 2004, APPL ERGON, V35, P3, DOI 10.1016/j.apergo.2003.11.001; Hopkins W., 2006, SPORTSCIENCE, V10, P63; Ingre M, 2004, CHRONOBIOL INT, V21, P973, DOI 10.1081/CBI-200036895; Kachman S, 2000, INTRO GENERALIZED LI, P59; LEGG SJ, 1987, EUR J APPL PHYSIOL O, V56, P64, DOI 10.1007/BF00696378; Lorenzo I, 1995, SLEEP J SLEEP RES SL; MARTIN BJ, 1981, EUR J APPL PHYSIOL O, V47, P345, DOI 10.1007/BF02332962; Mauger AR, 2009, MED SCI SPORT EXER, V41, P451, DOI 10.1249/MSS.0b013e3181854957; Meney I, 1998, CHRONOBIOL INT, V15, P349, DOI 10.3109/07420529808998695; Molenberghs G, 2001, STAT MODEL, V1, P235, DOI 10.1177/1471082X0100100402; Murphy MM, 1984, RELATIONSHIP ANAEROB; MYLES WS, 1985, MED SCI SPORT EXER, V17, P580; MYLES WS, 1987, ERGONOMICS, V30, P1175, DOI 10.1080/00140138708966006; PATTON JF, 1989, WORK STRESS, V3, P69, DOI 10.1080/02678378908256881; Phillips M., 2007, AUSTR FIR AUTH BUSHF; Phillips M, 2011, BUSHF CRC AFAC C SYD; Phillips M, 2012, APPL ERGON, V43, P435, DOI 10.1016/j.apergo.2011.06.018; PLYLEY MJ, 1987, EUR J APPL PHYSIOL O, V56, P338, DOI 10.1007/BF00690902; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Rama AN, 2006, SLEEP: A COMPREHENSIVE HANDBOOK, P3; RODGERS CD, 1995, SLEEP, V18, P30, DOI 10.1093/sleep/18.1.30; Rodriguez Janeth, 2011, International Journal of Tropical Insect Science, V31, P34, DOI 10.1017/S1742758411000014; RYMAN DH, 1989, WORK STRESS, V3, P57, DOI 10.1080/02678378908256880; SAWKA MN, 1992, MED SCI SPORT EXER, V24, P657; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; SYMONS JD, 1988, MED SCI SPORT EXER, V20, P374, DOI 10.1249/00005768-198808000-00008; Vaara J, 2009, EUR J APPL PHYSIOL, V105, P439, DOI 10.1007/s00421-008-0921-5; Van Dongen HP, 2004, ESSENTIAL NUMERICAL, P225; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2004, SLEEP, V27, P423	57	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115329	10.1371/journal.pone.0115329	http://dx.doi.org/10.1371/journal.pone.0115329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615988	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000349122100010
J	Kalamida, D; Karagounis, IV; Mitrakas, A; Kalamida, S; Giatromanolaki, A; Koukourakis, MI				Kalamida, Dimitra; Karagounis, Ilias V.; Mitrakas, Achilleas; Kalamida, Sofia; Giatromanolaki, Alexandra; Koukourakis, Michael I.			Fever-Range Hyperthermia vs. Hypothermia Effect on Cancer Cell Viability, Proliferation and HSP90 Expression	PLOS ONE			English	Article							MILD HYPERTHERMIA; CISPLATIN; CYTOTOXICITY; THERAPY; OXYGEN; TUMORS; ASSAY	Purpose The current study examines the effect of fever-range hyperthermia and mild hypothermia on human cancer cells focusing on cell viability, proliferation and HSP90 expression. Materials and Methods A549 and H1299 lung carcinoma, MCF7 breast adenocarcinoma, U87MG and T98G glioblastoma, DU145 and PC3 prostate carcinoma and MRC5 normal fetal lung fibroblasts cell lines were studied. After 3-day exposure to 34 degrees C, 37 degrees C and 40 degrees C, cell viability was determined. Cell proliferation (ki67 index), apoptosis (Caspase 9) and HSP90 expression was studied by confocal microscopy. Results Viability/proliferation experiments demonstrated that MRC5 fibroblasts were extremely sensitive to hyperthermia, while they were the most resistant to hypothermia. T98G and A549 were thermo-tolerant, the remaining being thermo-sensitive to a varying degree. Nonetheless, as a universal effect, hypothermia reduced viability/proliferation in all cell lines. Hyperthermia sharply induced Caspase 9 in the U87MG most thermo-sensitive cell line. In T98G and A549 thermo-tolerant cell lines, the levels of Caspase 9 declined. Moreover, hyperthermia strongly induced the HSP90 levels in T98G, whilst a sharp decrease was recorded in the thermo-sensitive PC3 and U87MG cell lines. Hyperthermia sensitized thermo-sensitive cancer cell lines to cisplatin and temozolomide, whilst its sensitizing effect was diminished in thermo-tolerant cell lines. Conclusions The existence of thermo-tolerant and thermo-sensitive cancer cell lines was confirmed, which further encourages research to classify human tumor thermic predilection for patient stratification in clinical trials. Of interest, mild hypothermia had a universal suppressing effect on cancer cell proliferation, further supporting the radio-sensitization hypothesis through reduction of oxygen and metabolic demands.	[Kalamida, Dimitra; Karagounis, Ilias V.; Mitrakas, Achilleas; Kalamida, Sofia; Koukourakis, Michael I.] Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis 68100, Greece; [Giatromanolaki, Alexandra] Democritus Univ Thrace, Dept Pathol, Alexandroupolis 68100, Greece	Democritus University of Thrace; Democritus University of Thrace	Koukourakis, MI (corresponding author), Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis 68100, Greece.	targ@her.forthnet.gr	Mitrakas, Achilleas/GPC-8600-2022; Karagounis, Ilias V/A-6497-2013	Karagounis, Ilias V/0000-0003-1642-1996; Mitrakas, Achilleas/0000-0002-9980-7773	TRAINING AND LIFELONG LEARNING - ARISTEIA project, ESPA, GGET [12605/26.09.2012, 520]	TRAINING AND LIFELONG LEARNING - ARISTEIA project, ESPA, GGET	The study has been funded by the TRAINING AND LIFELONG LEARNING - ARISTEIA project, code no 520, ESPA 2007-2013, GGET decision number 12605/26.09.2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICHETTI M, 1993, INT J RADIAT ONCOL, V26, P801, DOI 10.1016/0360-3016(93)90495-H; ARMOUR EP, 1993, CANCER RES, V53, P2740; Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Bull JMC, 2008, INT J HYPERTHER, V24, P649, DOI 10.1080/02656730802104740; Fiorentini Giammaria, 2006, J Cancer Res Ther, V2, P41; Issels RD, 2010, LANCET ONCOL, V11, P561, DOI 10.1016/S1470-2045(10)70071-1; Iwata K, 1996, BRIT J CANCER, V74, pS217; Krawczyk PM, 2011, P NATL ACAD SCI USA, V108, P9851, DOI 10.1073/pnas.1101053108; LEPOCK JR, 1993, J CELL BIOL, V122, P1267, DOI 10.1083/jcb.122.6.1267; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Matijasevic Z, 2002, ANTICANCER RES, V22, P3267; Mauz-Korholz C, 2003, ANTICANCER RES, V23, P2643; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morrissey JJ, 2009, J DRUG TARGET, V17, P719, DOI 10.3109/10611860903074968; NIAS AHW, 1988, J ROY SOC MED, V81, P633, DOI 10.1177/014107688808101106; PAGE B, 1993, INT J ONCOL, V3, P473; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Repasky EA, 2013, CANCER IMMUNOL RES, V1, P210, DOI 10.1158/2326-6066.CIR-13-0118; Rowe RW, 2010, INT J HYPERTHER, V26, P565, DOI 10.3109/02656736.2010.483635; SEALY R, 1986, BRIT J RADIOL, V59, P1093, DOI 10.1259/0007-1285-59-707-1093; Skitzki JJ, 2009, CURR OPIN INVEST DR, V10, P550; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Twiddy Davina, 2007, Biochem J, V405, pe1; VIDAIR CA, 1988, RADIAT RES, V116, P157, DOI 10.2307/3577486; Zachari MA, 2014, DOSE-RESPONSE, V12, P246, DOI 10.2203/dose-response.13-024.Koukourakis; Zhang XM, 2012, BIOSCI TRENDS, V6, P313, DOI 10.5582/bst.2012.v6.6.313	27	34	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116021	10.1371/journal.pone.0116021	http://dx.doi.org/10.1371/journal.pone.0116021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635828	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700022
J	Koprivnikar, J; Penalva, L				Koprivnikar, Janet; Penalva, Laura			Lesser of Two Evils? Foraging Choices in Response to Threats of Predation and Parasitism	PLOS ONE			English	Article							ANTIPARASITE BEHAVIOR; AMPHIBIAN METAMORPHOSIS; PREY INTERACTIONS; LIMB DEVELOPMENT; LARVAL ANURANS; LIFE-HISTORY; RISK; INFECTION; TADPOLES; AVOIDANCE	Predators have documented post-encounter (density-mediated) effects on prey but their pre-encounter impacts, including behavioural alterations, can be substantial as well. While it is increasingly evident that this "ecology of fear" is important to understand for natural enemy-victim relationships, fear responses of hosts to the threat of infection by a parasite are relatively unknown. We examined larval amphibian (Lithobates pipiens) foraging choices by experimentally manipulating the presence of cues relating to predator (larval odonate) or parasite (the trematode Ribeiroia ondatrae) threats. Tadpoles avoided foraging where predator or parasite cues were present; however, they did not treat these as equal hazards. When both threats were simultaneously present, tadpoles strongly preferred to forage under the threat of parasitism compared to predation, likely driven by their relative lethality in our study. Our results indicate that altered spatial use is an important anti-parasite behaviour, and demonstrate that parasite avoidance can affect foraging in a manner similar to predators, warranting greater study of the pre-encounter effects of this enemy type.	[Koprivnikar, Janet] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Penalva, Laura] Brandon Univ, Dept Biol, Brandon, MB R7A 6A9, Canada	Toronto Metropolitan University; Brandon University	Koprivnikar, J (corresponding author), Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada.	jkoprivn@ryerson.ca			Natural Sciences and Engineering Research Council of Canada [386691-2010]; Canada-Brazil Ciencia Sem Fronteiras Scholarship Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada-Brazil Ciencia Sem Fronteiras Scholarship Program	This study was supported by a Discovery Grant (386691-2010) to JK from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), and the Canada-Brazil Ciencia Sem Fronteiras Scholarship Program to LP (http://www.cbie.ca/what-we-do/student-portal/brazil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2010, ISR J ECOL EVOL, V56, P313, DOI 10.1560/IJEE.56.3-4.313; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Baker RL, 1997, OECOLOGIA, V109, P622, DOI 10.1007/s004420050125; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; BROWN JS, 1988, OECOLOGIA, V76, P408, DOI 10.1007/BF00377036; Bustnes JO, 2004, CAN J ZOOL, V82, P1566, DOI 10.1139/Z04-139; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; Daly EW, 2011, OECOLOGIA, V165, P1043, DOI 10.1007/s00442-010-1778-y; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; DOBSON AP, 1986, TRENDS ECOL EVOL, V1, P11, DOI 10.1016/0169-5347(86)90060-1; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Ferrari MCO, 2009, ANIM BEHAV, V78, P11, DOI 10.1016/j.anbehav.2009.03.016; Fritzsche A, 2012, ECOHEALTH, V9, P70, DOI 10.1007/s10393-012-0744-z; Garnick SW, 2010, BEHAV ECOL, V21, P129, DOI 10.1093/beheco/arp162; Goodman BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020193; Gosner K. L., 1960, Herpetologica, V16, P183; Hammond JI, 2007, ECOLOGY, V88, P1525, DOI 10.1890/06-1236; HART BL, 1994, PARASITOLOGY, V109, pS139, DOI 10.1017/S0031182000085140; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Hossie TJ, 2011, ETHOLOGY, V117, P777, DOI 10.1111/j.1439-0310.2011.01927.x; James CT, 2008, J FISH BIOL, V73, P2238, DOI 10.1111/j.1095-8649.2008.02052.x; Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104; Johnson Pieter T. J., 2009, P249, DOI 10.1007/978-0-387-09577-6_11; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Johnson PTJ, 2004, ADV PARASIT, V57, P191, DOI 10.1016/S0065-308X(04)57003-3; Kiesecker JM, 2000, ECOLOGY, V81, P2939, DOI 10.1890/0012-9658(2000)081[2939:COOSBG]2.0.CO;2; Kiesecker JM, 1999, P NATL ACAD SCI USA, V96, P9165, DOI 10.1073/pnas.96.16.9165; Koprivnikar J, 2006, CAN J ZOOL, V84, P1623, DOI 10.1139/Z06-158; Koprivnikar J, 2014, OECOLOGIA, V174, P1179, DOI 10.1007/s00442-013-2857-7; Koprivnikar J, 2012, ECOHEALTH, V9, P342, DOI 10.1007/s10393-012-0785-3; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Low PA, 2014, ANIM BEHAV, V90, P337, DOI 10.1016/j.anbehav.2014.02.020; LOZANO GA, 1991, OIKOS, V60, P391, DOI 10.2307/3545084; McCarthy TM, 2000, FRESHWATER BIOL, V44, P387, DOI 10.1046/j.1365-2427.2000.00576.x; MICHALAKIS Y, 1994, PARASITE, V1, P291, DOI 10.1051/parasite/1994014291; Moore J., 2002, PARASITES BEHAV ANIM; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Petranka J, 1998, BEHAV ECOL SOCIOBIOL, V42, P263, DOI 10.1007/s002650050438; Poulin R, 1999, INT J PARASITOL, V29, P903, DOI 10.1016/S0020-7519(99)00045-4; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Poulin R, 2011, BIOL LETTERS, V7, P241, DOI 10.1098/rsbl.2010.0640; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Preston DL, 2014, FUNCT ECOL, V28, P1472, DOI 10.1111/1365-2435.12293; Raffel TR, 2008, TRENDS ECOL EVOL, V23, P610, DOI 10.1016/j.tree.2008.06.015; Raveh A, 2011, ECOL LETT, V14, P47, DOI 10.1111/j.1461-0248.2010.01549.x; Relyea RA, 2003, ECOLOGY, V84, P1840, DOI 10.1890/0012-9658(2003)084[1840:PCAPGT]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P541, DOI 10.1890/0012-9658(2001)082[0541:TRBPRA]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Rohr JR, 2009, OECOLOGIA, V159, P447, DOI 10.1007/s00442-008-1208-6; Schotthoefer AM, 2003, CAN J ZOOL, V81, P1144, DOI [10.1139/z03-099, 10.1139/Z03-099]; Szuroczki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049592; Tan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075841; Taylor CN, 2004, CAN J ZOOL, V82, P701, DOI [10.1139/z04-037, 10.1139/Z04-037]; Thiemann GW, 2000, BIOL J LINN SOC, V71, P513, DOI [10.1111/j.1095-8312.2000.tb01272.x, 10.1006/bijl.2000.0459]; Tompkins DM, 1999, PARASITOL TODAY, V15, P311, DOI 10.1016/S0169-4758(99)01484-2; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; Yi M, 2011, EVOLUTION, V65, P1482, DOI [10.1111/j.1558-5646.2011.01240.x, DOI 10.1111/J.1558-5646.2011.01240.X]	60	28	28	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116569	10.1371/journal.pone.0116569	http://dx.doi.org/10.1371/journal.pone.0116569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635765	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700044
J	Weiss, R; Nassar, H; Sinnreich, R; Kark, JD				Weiss, Ram; Nassar, Hisham; Sinnreich, Ronit; Kark, Jeremy D.			Differences in the Triglyceride to HDL-Cholesterol Ratio between Palestinian and Israeli Adults	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; RISK-FACTORS; METABOLIC SYNDROME; ARABS; JEWS; PATHOPHYSIOLOGY; JERUSALEM; MORTALITY; OBESITY	Aims To evaluate differences in the triglyceride to HDL-cholesterol ratio (TG/HDL), thought to be a proxy measure of insulin resistance, between Palestinian and Israeli adults in view of the greater incidence of coronary heart disease and high prevalence of diabetes in Palestinian Arabs. Research Methods A population-based observational prevalence study of cardiovascular and diabetes risk factors in Jerusalem. Participants (968 Palestinians, 707 Israelis, sampled at ages 25-74 years) underwent fasting and 2h post-75g oral challenge plasma glucose determinations. Metabolic risk was assessed using the surrogate index TG/HDL. Sex-specific comparisons were stratified by categories of body mass index and sex-specific waist circumference quartiles, adjusted by regression for age, glucose tolerance status and use of statins. Results Prevalence of overweight and obesity was substantially larger in Palestinians (p = 0.005). Prevalence of diabetes was 2.4 and 4 fold higher among Palestinian men and women, respectively (p< 0.001). Adjusted TG/HDL was higher in Palestinians than Israelis across BMI and waist circumference categories (p< 0.001 for both). Higher TG/HDL in Palestinians persisted in analyses restricted to participants with normal glucose tolerance and off statins. Notably, higher TG/HDL among Palestinians prevailed at a young age (25-44 years) and in normal weight individuals of both sexes. Conclusions Palestinians have a higher TG/HDL ratio than Israelis. Notably, this is evident also in young, healthy and normal weight participants. These findings indicate the need to study the determinants of this biomarker and other measures of insulin resistance in urban Arab	[Weiss, Ram; Sinnreich, Ronit; Kark, Jeremy D.] Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth & Community Med, Jerusalem, Israel; [Nassar, Hisham] St Joseph Hosp, East Jerusalem, Israel; [Nassar, Hisham] Hadassah Univ, Med Ctr, Dept Cardiol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Weiss, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth & Community Med, Jerusalem, Israel.	ram.weiss@ekmd.huji.ac.il	Weiss, Ram/AAC-3964-2020		US-AID program for Middle East Regional Cooperation (MERC) [TA-MOU-01-M21-002]	US-AID program for Middle East Regional Cooperation (MERC)(United States Agency for International Development (USAID))	The study was funded by a research grant from the US-AID program for Middle East Regional Cooperation (MERC no.TA-MOU-01-M21-002) to JDK; http://www.usaid.gov/where-we-work/middle-east/merc-funding-process.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2005, ISR MED ASSOC J, V7, P143; Epel OB, 2010, ISR MED ASSOC J, V12, P732; FUJIMOTO WY, 1995, OBES RES, V3, pS179, DOI 10.1002/j.1550-8528.1995.tb00461.x; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Jaddoe VWV, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g14; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; Kalter-Leibovici O, 2012, DIABETIC MED, V29, P748, DOI 10.1111/j.1464-5491.2011.03516.x; Kalter-Leibovici O, 2007, ISR MED ASSOC J, V9, P525; Kark JD, 2000, LANCET, V356, P1410, DOI 10.1016/S0140-6736(00)02849-X; Kark JD, 2006, INT J EPIDEMIOL, V35, P448, DOI 10.1093/ije/dyl012; Koton S, 2001, STROKE, V32, P1984, DOI 10.1161/hs0901.095407; Liska D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000569; Merom D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-90; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Na'amnih W, 2010, INT J EPIDEMIOL, V39, P1324, DOI 10.1093/ije/dyq073; Ng SW, 2011, OBES REV, V12, P1, DOI 10.1111/j.1467-789X.2010.00750.x; Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003; Palaniappan LP, 2002, DIABETES CARE, V25, P1351, DOI 10.2337/diacare.25.8.1351; Reaven G, 2012, ARTERIOSCL THROM VAS, V32, P1754, DOI 10.1161/ATVBAHA.111.241885; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Ryder JR, 2013, NEW ENGL J MED, V369, P287, DOI 10.1056/NEJMc1306652; Salazar MR, 2012, AM J CARDIOL, V109, P1749, DOI 10.1016/j.amjcard.2012.02.016; St-Pierre AC, 2004, METAB SYNDR RELAT D, V2, P57, DOI 10.1089/met.2004.2.57; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Watt G, 2014, LANCET, V383, pE6, DOI 10.1016/S0140-6736(13)62234-5; Weiss R, 2011, J PEDIATR-US, V158, P135, DOI 10.1016/j.jpeds.2010.07.002; Weiss Ram, 2007, Eur J Endocrinol, V157 Suppl 1, pS39, DOI 10.1530/EJE-07-0125	30	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116617	10.1371/journal.pone.0116617	http://dx.doi.org/10.1371/journal.pone.0116617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635396	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700050
J	Afonso, AS; Hazin, FHV				Afonso, Andre S.; Hazin, Fabio H. V.			Vertical Movement Patterns and Ontogenetic Niche Expansion in the Tiger Shark, Galeocerdo cuvier	PLOS ONE			English	Article							FRENCH FRIGATE SHOALS; HABITAT USE; SEXUAL SEGREGATION; DIVING BEHAVIOR; LONGLINE CATCH; PELAGIC SHARKS; ABUNDANCE; BIOLOGY; RATES; CONSERVATION	Sharks are top predators in many marine ecosystems and can impact community dynamics, yet many shark populations are undergoing severe declines primarily due to overfishing. Obtaining species-specific knowledge on shark spatial ecology is important to implement adequate management strategies for the effective conservation of these taxa. This is particularly relevant concerning highly-mobile species that use wide home ranges comprising coastal and oceanic habitats, such as tiger sharks, Galeocerdo cuvier. We deployed satellite tags in 20 juvenile tiger sharks off northeastern Brazil to assess the effect of intrinsic and extrinsic factors on depth and temperature usage. Sharks were tracked for a total of 1184 d and used waters up to 1112 m in depth. The minimum temperature recorded equaled 4 degrees C. All sharks had a clear preference for surface (< 5 m) waters but variability in depth usage was observed as some sharks used mostly shallow (< 60 m) waters whereas others made frequent incursions into greater depths. A diel behavioral shift was detected, with sharks spending considerably more time in surface (< 10 m) waters during the night. Moreover, a clear ontogenetic expansion in the vertical range of tiger shark habitat was observed, with generalized linear models estimating a similar to 4-fold increase in maximum diving depth from 150- to 300-cm size-classes. The time spent in the upper 5 m of the water column did not vary ontogenetically but shark size was the most important factor explaining the utilization of deeper water layers. Young-of-the-year tiger sharks seem to associate with shallow, neritic habitats but they progressively move into deeper oceanic habitats as they grow larger. Such an early plasticity in habitat use could endow tiger sharks with access to previously unavailable prey, thus contributing to a wider ecological niche.	[Afonso, Andre S.; Hazin, Fabio H. V.] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil; [Afonso, Andre S.] Univ Algarve, Fac Ciencias & Tecnol, Faro, Portugal	Universidade Federal Rural de Pernambuco (UFRPE); Universidade do Algarve	Afonso, AS (corresponding author), Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil.	afonso.andre@gmail.com		Hazin, Fabio/0000-0003-3755-5379; Afonso, Andre/0000-0001-9129-278X	State Government of Pernambuco; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BJT/A049/2013]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/37065/2007]	State Government of Pernambuco; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This study received financial support from the State Government of Pernambuco (www.pe.gov.br). Research grants provided to the first author by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br; contract no. BJT/A049/2013) and by the Fundacao para a Ciencia e Tecnologia, Portugal (www.fct.pt; contract no. SFRH/BD/37065/2007) are deeply acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2011, MAR BIOL, V158, P1175, DOI 10.1007/s00227-011-1639-1; Afonso AS, 2012, J FISH BIOL, V81, P2080, DOI 10.1111/j.1095-8649.2012.03455.x; Afonso A.S., 2013, BIOECOLOGY MOVEMENT; Afonso AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102369; Afonso AS, 2014, J EXP MAR BIOL ECOL, V454, P55, DOI 10.1016/j.jembe.2014.02.008; Afonso AS, 2011, FISH RES, V108, P336, DOI 10.1016/j.fishres.2011.01.007; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Baum JK, 2010, FISH RES, V102, P229, DOI 10.1016/j.fishres.2009.11.006; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; BRANSTETTER S, 1987, FISH B-NOAA, V85, P269; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Campana SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016854; Campbell RA, 2004, FISH RES, V70, P209, DOI 10.1016/j.fishres.2004.08.026; Carlson JK, 2012, J FISH BIOL, V80, P1749, DOI 10.1111/j.1095-8649.2011.03193.x; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Compagno L.J.V., 1984, FAO Fisheries Synopsis, P251; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Driggers WB, 2008, AQUAT BIOL, V2, P161, DOI 10.3354/ab00045; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FAINSTEIN R, 1979, AAPG BULL, V63, P218; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Gallagher AJ, 2012, J FISH BIOL, V80, P1727, DOI 10.1111/j.1095-8649.2012.03235.x; Garcia VB, 2008, P ROY SOC B-BIOL SCI, V275, P83, DOI 10.1098/rspb.2007.1295; Grubbs RD, 2010, CRC MAR BIOL SER, P319; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hazin FHV, 2014, ANIM CONSERV, V17, P287, DOI 10.1111/acv.12096; Hazin FHV, 2008, B MAR SCI, V82, P199; Hazin FHV, 2013, AN ACAD BRAS CIENC, V85, P1053, DOI 10.1590/S0001-37652013005000055; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2013, MAR ECOL PROG SER, V481, P225, DOI 10.3354/meps10235; Heithaus MR, 2002, MAR BIOL, V140, P237, DOI 10.1007/s00227-001-0711-7; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Holmes BJ, 2014, MAR BIOL, V161, P2645, DOI 10.1007/s00227-014-2536-1; Jennings DE, 2008, ENVIRON BIOL FISH, V83, P369, DOI 10.1007/s10641-008-9357-3; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; Lowe Christopher G., 2006, Atoll Research Bulletin, P281; Lowry M, 2007, FISH RES, V88, P15, DOI 10.1016/j.fishres.2007.07.011; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; Polacheck T, 2006, MAR POLICY, V30, P470, DOI 10.1016/j.marpol.2005.06.016; Polovina JJ, 1993, MAR FISH REV, V55, P1; RANDALL JE, 1992, AUST J MAR FRESH RES, V43, P21; Rezende EL, 2009, ECOL LETT, V12, P779, DOI 10.1111/j.1461-0248.2009.01327.x; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Saunders RA, 2011, ICES J MAR SCI, V68, P166, DOI 10.1093/icesjms/fsq145; Seitz JC, 2006, MAR POLLUT BULL, V52, P1533, DOI 10.1016/j.marpolbul.2006.07.016; Sepulveda CA, 2004, MAR BIOL, V145, P191, DOI 10.1007/s00227-004-1356-0; Shepherd TD, 2005, ECOL LETT, V8, P1095, DOI 10.1111/j.1461-0248.2005.00807.x; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; Sims DW, 2010, CRC MAR BIOL SER, P351; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; TRICAS TC, 1981, COPEIA, P904, DOI 10.2307/1444199; Vaudo JJ, 2014, ECOL EVOL, V4, P1768, DOI 10.1002/ece3.1053; Walters C, 2003, CAN J FISH AQUAT SCI, V60, P1433, DOI 10.1139/F03-152; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; Whitney NM, 2007, MAR BIOL, V151, P63, DOI 10.1007/s00227-006-0476-0; Wirsing AJ, 2006, MAR BIOL, V149, P961, DOI 10.1007/s00227-006-0278-4; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	75	39	39	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116720	10.1371/journal.pone.0116720	http://dx.doi.org/10.1371/journal.pone.0116720			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629732	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100046
J	Mattoni, CI; Garcia-Hernandez, S; Botero-Trujillo, R; Ochoa, JA; Ojanguren-Affilastro, AA; Pinto-Da-Rocha, R; Prendini, L				Mattoni, Camilo I.; Garcia-Hernandez, Solimary; Botero-Trujillo, Ricardo; Ochoa, Jose A.; Ojanguren-Affilastro, Andres A.; Pinto-da-Rocha, Ricardo; Prendini, Lorenzo			Scorpion Sheds 'Tail' to Escape: Consequences and Implications of Autotomy in Scorpions (Buthidae: Ananteris)	PLOS ONE			English	Article							LIGHT; MICROANANTERIS; LOURENCO; URODACUS; THORELL; BRAZIL	Autotomy, the voluntary shedding or detachment of a body part at a determined cleavage plane, is a common anti-predation defense mechanism in several animal taxa, including arthropods. Among arachnids, autotomy has been observed in harvestmen, mites, and spiders, always involving the loss of legs. Autotomy of the opisthosoma (abdomen) was recently reported in a single species of the Neotropical buthid scorpion genus Ananteris Thorell, 1891, but few details were revealed. Based on observations in the field and laboratory, examination of material in museum collections, and scanning electron microscopy, we document autotomy of the metasoma (the hind part of the opisthosoma, or 'tail') in fourteen species of Ananteris. Autotomy is more common in males than females, and has not been observed in juveniles. When the scorpion is held by the metasoma, it is voluntarily severed at the joints between metasomal segments I and II, II and III, or III and IV, allowing the scorpion to escape. After detachment, the severed metasoma moves (twitches) automatically, much like the severed tail of a lizard or the severed leg of a spider, and reacts to contact, even attempting to sting. The severed surface heals rapidly, scar tissue forming in five days. The lost metasomal segments and telson cannot be regenerated. Autotomy of the metasoma and telson results in permanent loss of the posterior part of the scorpion's digestive system (the anus is situated posteriorly on metasomal segment V) and the ability to inject venom by stinging. After autotomy, scorpions do not defecate and can only capture small prey items. However, males can survive and mate successfully for up to eight months in the laboratory. In spite of diminished predation ability after autotomy, survival allows males to reproduce. Autotomy in Ananteris therefore appears to be an effective, adaptive, anti-predation escape mechanism.	[Mattoni, Camilo I.] Univ Nacl Cordoba, RA-5000 Cordoba, Argentina; [Garcia-Hernandez, Solimary] Univ Ind Santander, Bucaramanga, Colombia; [Botero-Trujillo, Ricardo; Ojanguren-Affilastro, Andres A.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina; [Ojanguren-Affilastro, Andres A.] Frankfurt Zool Soc, Cuzco, Peru; [Botero-Trujillo, Ricardo] Pontificia Univ Javeriana, Bogota, Colombia; [Ochoa, Jose A.; Pinto-da-Rocha, Ricardo] Univ Sao Paulo, Sao Paulo, Brazil; [Prendini, Lorenzo] Amer Museum Nat Hist, New York, NY USA	National University of Cordoba; Universidad Industrial de Santander; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Pontificia Universidad Javeriana; Universidade de Sao Paulo; American Museum of Natural History (AMNH)	Mattoni, CI (corresponding author), Univ Nacl Cordoba, RA-5000 Cordoba, Argentina.	cmattoni@efn.uncor.edu	GARCIA-HERNANDEZ, SOLIMARY/ABA-5826-2020; Pinto-da-Rocha, Ricardo/J-6774-2012; Prendini, Lorenzo/AAY-6611-2021	GARCIA-HERNANDEZ, SOLIMARY/0000-0002-4458-8948; Pinto-da-Rocha, Ricardo/0000-0002-3959-2205; Prendini, Lorenzo/0000-0001-8727-7106; Mattoni, Camilo/0000-0001-8570-8814; Jose Antonio, Ochoa/0000-0001-6580-7268	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/06604-7, 2012/02969-6]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-1764, PICT 2006-750, 2010-0906]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	Financial support was provided by: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, http://www.fapesp.br), grant numbers 2008/06604-7 and 2012/02969-6 to RPR; and Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar), grant numbers PICT 2010-1764 to AAOA, PICT 2006-750 and 2010-0906 to CIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; ARNOLD EN, 1984, J NAT HIST, V18, P127, DOI 10.1080/00222938400770131; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; Blass GRC, 2008, ANIM BEHAV, V76, P365, DOI 10.1016/j.anbehav.2007.12.022; Botero-Trujillo R, 2011, ZOOTAXA, P1; Botero-Trujillo R, 2011, ZOOTAXA, P37; Bradstock C. A., 1950, Zoology Publications from Victoria University College, V7, P1; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Chen XL, 2013, MAR FRESHW BEHAV PHY, V46, P321, DOI 10.1080/10236244.2013.833365; Fleming PA, 2007, BIOL REV, V82, P481, DOI 10.1111/j.1469-185X.2007.00020.x; Fredericq L, 1883, ARCH ZOOL EXP GEN 2, V1, P413; Garcia Hernandez S, 2011, 3 C LAT AR MEM RES, P135; Gnaspini Pedro, 2007, P374; Hadley N.F., 1990, P321; Higham TE, 2010, BIOL LETTERS, V6, P70, DOI 10.1098/rsbl.2009.0577; Hjelle J.T., 1990, P9; LAWRENCE JM, 1986, J EXP MAR BIOL ECOL, V102, P47, DOI 10.1016/0022-0981(86)90125-5; Lewis J. G. E., 1981, BIOL CENTIPEDES; Lira AFA, 2014, J INSECT BEHAV, V27, P279, DOI 10.1007/s10905-013-9431-3; Lourenco W. R., 2012, Entomologische Mitteilungen aus dem Zoologischen Museum Hamburg, V16, P41; Lourenco WR, 2013, AN ACAD BRAS CIENC, V85, P709, DOI 10.1590/S0001-37652013000200016; Lourenco Wilson R., 2012, Boletin de la SEA, V50, P73; Lourenco WR, 2012, CR BIOL, V335, P555, DOI 10.1016/j.crvi.2012.06.005; Lourenco Wilson R., 2011, Boletin de la SEA, V48, P105; Mattoni CI, 2001, 3 C LAT AR MEM RES, P83; Nelson Ximena J., 2011, P99; Ojanguren-Affilastro A.A., 2001, PHYSIS C, V58, P15; Polis G.A., 1990, P161; Polis GA, 1990, BIOL SCORPIONS; RAO G, 1973, J EXP BIOL, V58, P189; STAHNKE HL, 1972, BIOSCIENCE, V22, P604, DOI 10.2307/1296207; Weygoldt P., 2000, WHIP SPIDERS CHELICE; Wilkie IC, 2001, MICROSC RES TECHNIQ, V55, P369, DOI 10.1002/jemt.1185; Wood FD, 1926, J MORPHOL PHYSIOL, V42, P143, DOI 10.1002/jmor.1050420106; ZWICKY KT, 1968, LIFE SCI PT 1 PHYSI, V7, P257, DOI 10.1016/0024-3205(68)90020-9; ZWICKY KT, 1970, EXPERIENTIA, V26, P317, DOI 10.1007/BF01900120	36	17	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116639	10.1371/journal.pone.0116639	http://dx.doi.org/10.1371/journal.pone.0116639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629529	Green Submitted, Green Published, gold			2022-12-27	WOS:000348732100044
J	Fujita, T; Yamashita, D; Uehara, N; Inokuchi, G; Hasegawa, S; Otsuki, N; Nibu, K				Fujita, Takeshi; Yamashita, Daisuke; Uehara, Natsumi; Inokuchi, Go; Hasegawa, Shingo; Otsuki, Naoki; Nibu, Ken-ichi			A High-Fat Diet Delays Age-Related Hearing Loss Progression in C57BL/6J Mice	PLOS ONE			English	Article							INNER-EAR; OBESITY; PREVENTION; DAMAGE; ANTIOXIDANTS; RESTRICTION; CADHERIN-23; STRAINS; DISEASE; FORMS	Objective Age-related hearing loss (AHL), or presbycusis, is the most common sensory disorder among the elderly. We used C57BL/6J mice as an AHL model to determine a possible association between AHL and a high-fat diet (HFD). Methods Forty C57BL/6J mice were randomly assigned to a control or HFD group. Each group was divided into the following subgroups: 1-, 3-, 5- and 12-month groups (HFD, n = 5/subgroup; control, n = 5/subgroup). Nine CBA/N-slc mice were also used as a 12-month control (n = 5) or 12-month HFD (n = 4) group. The mice were fed a HFD or normal (control) diet throughout this study. Hearing function was evaluated at 1, 3, 5 and 12 months using auditory evoked brainstem responses (ABRs). Spiral ganglion cells (SGCs) were also counted. Results The elevation of ABR thresholds (at 4 and 32 kHz) at 3 and 5 months was significantly suppressed in the HFD group compared with the control groups for C57BL/6Jmice. After 12 months, the elevation of ABR thresholds was significantly suppressed in the HFD group at all frequencies for C57BL/6J mice. In contrast, CBA/N-slc mice displayed opposite outcomes, as ABR thresholds at all frequencies at 12 months were significantly elevated in the HFD group compared with the control group. For the C57BL/6J mice at 12 months, SGC numbers significantly decreased in all parts of the cochleae in the control group compared with the HFD groups. In contrast, for the CBA/N-slc mice, SGC numbers significantly decreased, particularly in the upper parts of the cochleae in the HFD group compared with the control groups. Conclusions The elevation in ABR thresholds and SGC loss associated with aging in the HFD-fed C57BL/6J mice were significantly suppressed compared with those in the normal diet-fed mice. These results suggest that HFD delays AHL progression in the C57B/6J mice.	[Fujita, Takeshi; Yamashita, Daisuke; Uehara, Natsumi; Inokuchi, Go; Hasegawa, Shingo; Otsuki, Naoki; Nibu, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo 657, Japan	Kobe University	Yamashita, D (corresponding author), Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo 657, Japan.	daiy1013@aol.com	Otsuki, Naoki/AAH-2468-2020; Fujita, Takeshi/ABD-6485-2021	Otsuki, Naoki/0000-0002-9682-2548	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported by a Grant-in-Aid for Young Scientists (B) (to T.F) and a Grant-in-Aid for Scientific Research (C) (to D.Y) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Brownlow BS, 1996, PHYSIOL BEHAV, V60, P37, DOI 10.1016/0031-9384(95)02210-4; Di Palma F, 2001, GENE, V281, P31, DOI 10.1016/S0378-1119(01)00761-2; Du ZD, 2012, HEARING RES, V287, P15, DOI 10.1016/j.heares.2012.04.012; Evans MB, 2006, OTOL NEUROTOL, V27, P609, DOI 10.1097/01.mao.0000226286.19295.34; Frisina RD, 2011, NEUROBIOL AGING, V32, P1716, DOI 10.1016/j.neurobiolaging.2009.09.009; Fujita T, 2012, DIABETES, V61, P2980, DOI 10.2337/db11-1845; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Gopinath B, 2011, J NUTR, V141, P1355, DOI 10.3945/jn.111.138610; Guilford B., 2011, EXP DIABETES RES, V2011, P1; Guimaraes P, 2004, HEARING RES, V192, P83, DOI 10.1016/j.heares.2004.01.013; Heman-Ackah SE, 2010, OTOLARYNG HEAD NECK, V143, P429, DOI 10.1016/j.otohns.2010.04.266; Hwang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060730; Jiang Q, 2014, FREE RADICAL BIO MED, V72, P76, DOI 10.1016/j.freeradbiomed.2014.03.035; Jones NS, 1999, CLIN OTOLARYNGOL, V24, P531, DOI 10.1046/j.1365-2273.1999.00310.x; Kashio A, 2009, BIOCHEM BIOPH RES CO, V390, P394, DOI 10.1016/j.bbrc.2009.09.003; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; Le Prell CG, 2011, TRANSL RES, V158, P38, DOI 10.1016/j.trsl.2011.02.006; Le T, 2007, HEARING RES, V226, P194, DOI 10.1016/j.heares.2006.04.003; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Seidman MD, 2000, LARYNGOSCOPE, V110, P727, DOI 10.1097/00005537-200005000-00003; Seidman MD, 2002, OTOLARYNG HEAD NECK, V127, P138, DOI 10.1067/mhn.2002.127627; Sha SH, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.023; Someya S, 2007, NEUROBIOL AGING, V28, P1613, DOI 10.1016/j.neurobiolaging.2006.06.024; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Suzuki K, 2000, LARYNGOSCOPE, V110, P1736, DOI 10.1097/00005537-200010000-00033; Vasilyeva ON, 2009, HEARING RES, V249, P44, DOI 10.1016/j.heares.2009.01.007; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	34	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117547	10.1371/journal.pone.0117547	http://dx.doi.org/10.1371/journal.pone.0117547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625852	gold, Green Submitted, Green Published			2022-12-27	WOS:000348821400035
J	Rand, DG; Kraft-Todd, G; Gruber, J				Rand, David G.; Kraft-Todd, Gordon; Gruber, June			The Collective Benefits of Feeling Good and Letting Go: Positive Emotion and (dis)Inhibition Interact to Predict Cooperative Behavior	PLOS ONE			English	Article							SOCIAL NETWORKS; GRATITUDE; WORDS; PERSPECTIVE; REFLECTION; COMPASSION; PUNISHMENT; HAPPINESS; EMPATHY; CHOICE	Cooperation is central to human existence, forming the bedrock of everyday social relationships and larger societal structures. Thus, understanding the psychological underpinnings of cooperation is of both scientific and practical importance. Recent work using a dual-process framework suggests that intuitive processing can promote cooperation while deliberative processing can undermine it. Here we add to this line of research by more specifically identifying deliberative and intuitive processes that affect cooperation. To do so, we applied automated text analysis using the Linguistic Inquiry and Word Count (LIWC) software to investigate the association between behavior in one-shot anonymous economic cooperation games and the presence inhibition (a deliberative process) and positive emotion (an intuitive process) in free-response narratives written after (Study 1, N = 4,218) or during (Study 2, N = 236) the decision-making process. Consistent with previous results, across both studies inhibition predicted reduced cooperation while positive emotion predicted increased cooperation (even when controlling for negative emotion). Importantly, there was a significant interaction between positive emotion and inhibition, such that the most cooperative individuals had high positive emotion and low inhibition. This suggests that inhibition (i.e., reflective or deliberative processing) may undermine cooperative behavior by suppressing the prosocial effects of positive emotion.	[Rand, David G.; Kraft-Todd, Gordon] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Rand, David G.] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Rand, David G.] Yale Univ, Sch Management, New Haven, CT USA; [Gruber, June] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	Yale University; Yale University; Yale University; University of Colorado System; University of Colorado Boulder	Rand, DG (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	david.rand@yale.edu	Kraft-Todd, Gordon/O-5520-2016	Kraft-Todd, Gordon/0000-0003-1220-9269; Rand, David/0000-0001-8975-2783	John Templeton Foundation	John Templeton Foundation	DR received funding from the John Templeton Foundation (http://www.templeton.org/) thru the New Paths to Purpose initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algoe SB, 2010, PERS RELATIONSHIP, V17, P217, DOI 10.1111/j.1475-6811.2010.01273.x; Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Balliet D, 2013, PERSPECT PSYCHOL SCI, V8, P363, DOI 10.1177/1745691613488533; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; BATSON CD, 1981, J PERS SOC PSYCHOL, V40, P290, DOI 10.1037/0022-3514.40.2.290; Berry DS, 1996, J PERS SOC PSYCHOL, V71, P796, DOI 10.1037/0022-3514.71.4.796; Bowles S, 2003, DAHL WS ENV, P429; Bowles S, 2002, EC EVOLVING COMPLEX, V3, P339; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Capraro V, 2014, SCI REP-UK, V4, DOI 10.1038/srep06790; Capraro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072427; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; CONE J, PLOS ONE IN PRESS; Cornelissen G, 2011, PERS SOC PSYCHOL B, V37, P1080, DOI 10.1177/0146167211405996; CROCKETT MJ, 2014, P NATL ACAD SCI; Crockett MJ, 2013, TRENDS COGN SCI, V17, P363, DOI 10.1016/j.tics.2013.06.005; CUSHMAN F, 2009, COEVOLUTION PUNISHME; de Hooge IE, 2007, COGNITION EMOTION, V21, P1025, DOI 10.1080/02699930600980874; DeSteno D, 2010, EMOTION, V10, P289, DOI 10.1037/a0017883; DeSteno D, 2009, CURR DIR PSYCHOL SCI, V18, P280, DOI 10.1111/j.1467-8721.2009.01652.x; Dreber A., 2014, ALTRUISM SELF CONTRO; Dreber A, 2013, EXP ECON, V16, P349, DOI 10.1007/s10683-012-9341-9; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Engel C, 2014, ECON LETT, V122, P386, DOI 10.1016/j.econlet.2013.12.020; Evans AM, 2014, REACTION TIMES REFLE; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Fredrickson BL, 1998, REV GEN PSYCHOL, V2, P300, DOI DOI 10.1037/1089-2680.2.3.300; Galinsky AD, 2008, PSYCHOL SCI, V19, P378, DOI 10.1111/j.1467-9280.2008.02096.x; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; Gonzaga GC, 2001, J PERS SOC PSYCHOL, V81, P247, DOI 10.1037//0022-3514.81.2.247; GRAY K, 2014, PSYCHOL SCI; GRUBER J, 2007, EMOTION PSYCHOPATHOL; Gruber J, 2011, PERSPECT PSYCHOL SCI, V6, P222, DOI 10.1177/1745691611406927; Haidt J., 2000, POSITIVE EMOTION ELE; HAUGE KE, 2014, U GOTHENBURG WORKING; Hauser OP, 2014, NATURE, V511, P220, DOI 10.1038/nature13530; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; ISEN AM, 1976, J PERS SOC PSYCHOL, V34, P385, DOI 10.1037/0022-3514.34.3.385; JORDAN JJ, MORAL BRAIN IN PRESS; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST SLOW; Kinnunen SP, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00193; Kovarik J, 2009, ECON LETT, V102, P152, DOI 10.1016/j.econlet.2008.12.005; Lotz S., 2014, SPONTANEOUS GIVING S; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Marsh AA, 2007, EMOTION, V7, P239, DOI 10.1037/1528-3542.7.2.239; Mehl MR, 2003, J PERS SOC PSYCHOL, V84, P857, DOI 10.1037/0022-3514.84.4.857; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; PAGE BI, 1979, AM POLIT SCI REV, V73, P1071, DOI 10.2307/1953990; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pennebaker J. W., 2001, LINGUISTIC INQUIRY W, P71; PENNEBAKER JW, 1993, BEHAV RES THER, V31, P539, DOI 10.1016/0005-7967(93)90105-4; Pennebaker JW, 1997, PSYCHOL SCI, V8, P162, DOI 10.1111/j.1467-9280.1997.tb00403.x; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; PENNEBAKER JW, 1988, J CONSULT CLIN PSYCH, V56, P239, DOI 10.1037/0022-006X.56.2.239; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; PEYSAKHOVICH A, 2014, HABITS VIRTUE CREATI; Peysakhovich A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5939; Pfeiffer T, 2012, J R SOC INTERFACE, V9, P2791, DOI 10.1098/rsif.2012.0332; Rand D. G., 2014, P NATL ACAD SCI; Rand D.G., 2014, POL INS BEH BRAIN SC, V1, P263, DOI [10.1177/2372732214548426, DOI 10.1177/2372732214548426]; Rand DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109687; Rand DG, 2015, J BEHAV DECIS MAKING, V28, P159, DOI 10.1002/bdm.1837; Rand DG, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00300; Rand DG, 2014, RELIG BRAIN BEHAV, V4, P31, DOI 10.1080/2153599X.2013.775664; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; RIGHETTI F, 2013, PSYCHOL SCI; ROBERTS ME, AM J POLITI IN PRESS; Roch SG, 2000, ORGAN BEHAV HUM DEC, V83, P185, DOI 10.1006/obhd.2000.2915; Ruff CC, 2013, SCIENCE, V342, P482, DOI 10.1126/science.1241399; SCHNALL S, 2010, PSYCHOL SCI; Schulz JF, 2014, J ECON PSYCHOL, V41, P77, DOI 10.1016/j.joep.2012.08.007; Seligman Martin EP, 2000, POSITIVE PSYCHOL INT, V55; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Shiota MN, 2004, REGULATION OF EMOTION, P127; Sigmund K., 2010, CALCULUS SELFISHNESS; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Small DA, 2007, ORGAN BEHAV HUM DEC, V102, P143, DOI 10.1016/j.obhdp.2006.01.005; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; STRAYER J, 1980, CHILD DEV; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Tinghog G, 2013, NATURE, V498, pE1, DOI 10.1038/nature12194; van den Bos K, 2011, J PERS SOC PSYCHOL, V101, P791, DOI 10.1037/a0023556; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Verkoeijen PPJL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096654; Yoeli E, 2013, P NATL ACAD SCI USA, V110, P10424, DOI 10.1073/pnas.1301210110; Zaki J, 2008, PSYCHOL SCI, V19, P399, DOI 10.1111/j.1467-9280.2008.02099.x; Zaki J, 2013, CURR DIR PSYCHOL SCI, V22, P466, DOI 10.1177/0963721413492764	98	36	38	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117426	10.1371/journal.pone.0117426	http://dx.doi.org/10.1371/journal.pone.0117426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QM	25625722	gold, Green Published			2022-12-27	WOS:000348821400034
J	Yates, SC; Zafar, A; Rabai, EM; Foxall, JB; Nagy, S; Morrison, KE; Clarke, C; Esiri, MM; Christie, S; Smith, AD; Nagy, Z				Yates, Sharon C.; Zafar, Amen; Rabai, Erzsebet M.; Foxall, James B.; Nagy, Sheila; Morrison, Karen E.; Clarke, Carl; Esiri, Margaret M.; Christie, Sharon; Smith, A. David; Nagy, Zsuzsanna			The Effects of Two Polymorphisms on p21(cip1) Function and Their Association with Alzheimer's Disease in a Population of European Descent	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; KINASE INHIBITOR GENE; CELL-CYCLE; IDENTIFIES VARIANTS; VASCULAR DEMENTIA; COMMON VARIANTS; HUMAN CANCER; EXPRESSION; ONSET	With the exception of ApoE4, genome-wide association studies have failed to identify strong genetic risk factors for late-onset Alzheimer's disease, despite strong evidence of heritability, suggesting that many low penetrance genes may be involved. Additionally, the nature of the identified genetic risk factors and their relation to disease pathology is also largely obscure. Previous studies have found that a cancer-associated variant of the cell cycle inhibitor gene p21(cip1) is associated with increased risk of Alzheimer's disease. The aim of this study was to confirm this association and to elucidate the effects of the variant on protein function and Alzheimer-type pathology. We examined the association of the p21(cip1) variant with Alzheimer's disease and Parkinson's disease with dementia. The genotyping studies were performed on 719 participants of the Oxford Project to Investigate Memory and Ageing, 225 participants of a Parkinson's disease DNA bank, and 477 participants of the Human Random Control collection available from the European Collection of Cell Cultures. The post mortem studies were carried out on 190 participants. In the in-vitro study, human embryonic kidney cells were transfected with either the common or rare p21(cip1) variant; and cytometry was used to assess cell cycle kinetics, p21(cip1) protein expression and sub-cellular localisation. The variant was associated with an increased risk of Alzheimer's disease, and Parkinson's disease with dementia, relative to age matched controls. Furthermore, the variant was associated with an earlier age of onset of Alzheimer's disease, and a more severe phenotype, with a primary influence on the accumulation of tangle pathology. In the in-vitro study, we found that the SNPs reduced the cell cycle inhibitory and anti-apoptotic activity of p21(cip1). The results suggest that the cancer-associated variant of p21(cip1) may contribute to the loss of cell cycle control in neurons that may lead to Alzheimer-type neurodegeneration.	[Yates, Sharon C.; Zafar, Amen; Rabai, Erzsebet M.; Foxall, James B.; Nagy, Sheila; Morrison, Karen E.; Clarke, Carl; Nagy, Zsuzsanna] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Esiri, Margaret M.] Univ Oxford, John Radcliffe Hosp, Dept Neuropathol, Oxford OX3 9DU, England; [Christie, Sharon] Univ Oxford, John Radcliffe Hosp, OPTIMA, Oxford OX3 9DU, England; [Smith, A. David] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Birmingham; University of Oxford; University of Oxford; University of Oxford	Nagy, Z (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England.	z.nagy@bham.ac.uk	Smith, Anthony D./A-4233-2010; Nagy, Zsuzsanna/L-8446-2013	Smith, Anthony D./0000-0002-1095-6722; Nagy, Zsuzsanna/0000-0002-6700-4829; Morrison, Karen Elaine/0000-0003-0216-5717; Clarke, Carl/0000-0003-2478-3436; Yates, Sharon Christine/0000-0002-3001-8725	Sir Jules Thorn Charitable Trust; CytOx Ltd; University of Birmingham; Medical Research Council UK; Midlands Neuroscience Teaching and Research Fund; Movement Disorders Research Charity; National Institute for Health Research via Oxford Biomedical Research Centre; MRC [MR/L022656/1] Funding Source: UKRI; Medical Research Council [MR/L022656/1] Funding Source: researchfish	Sir Jules Thorn Charitable Trust; CytOx Ltd; University of Birmingham; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Midlands Neuroscience Teaching and Research Fund; Movement Disorders Research Charity; National Institute for Health Research via Oxford Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by grants from The Sir Jules Thorn Charitable Trust (http://www.julesthorntrust.org.uk/) (ZN), CytOx Ltd (http://www.cytoxgroup.com/) (ZN), and the University of Birmingham (ZN). Funding for the PDGEN DNA bank was from the Medical Research Council UK (http://www.mrc.ac.uk/) (KEM and CC), Midlands Neuroscience Teaching and Research Fund (https://sites.google.com/site/mntrfund/projects) (KEM and CC), and Movement Disorders Research Charity (KEM and CC). The completion of the project was enabled by the generous support of a private donor. Margaret M Esiri was in receipt of financial support from The National Institute for Health Research via the Oxford Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Arendt T, 1996, NEUROREPORT, V7, P3047; Arendt T, 1998, J NEURAL TRANSM, V105, P949, DOI 10.1007/s007020050104; Arendt T, 2003, PROG NEUROBIOL, V71, P83, DOI 10.1016/j.pneurobio.2003.09.007; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Bahl R, 2000, ONCOGENE, V19, P323, DOI 10.1038/sj.onc.1203325; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bates S, 1998, ONCOGENE, V17, P1691, DOI 10.1038/sj.onc.1202104; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bialopiotrowicz E, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.017; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; CHEDID M, 1994, ONCOGENE, V9, P3021; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chen WC, 2002, UROL ONCOL, V7, P63, DOI 10.1016/S1078-1439(01)00152-1; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Clare R, 2010, J NEUROSCI RES, V88, P2083, DOI 10.1002/jnr.22392; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Crean S, 2011, DEMENT GERIATR COGN, V31, P20, DOI 10.1159/000321984; Currais A, 2009, AGING-US, V1, P363, DOI 10.18632/aging.100045; Darzynkierricz Z, 2001, CYTOMETRY METHODS CE; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Devlin AM, 2003, AM J PHYSIOL-RENAL, V284, pF753, DOI 10.1152/ajprenal.00252.2002; Elias-Sonnenschein LS, 2012, BIOMARK MED, V6, P477, DOI [10.2217/BMM.12.56, 10.2217/bmm.12.56]; Engidawork E, 2001, NEUROSCI LETT, V303, P79, DOI 10.1016/S0304-3940(01)01618-4; Esiri MM, 1997, J NEUROL NEUROSUR PS, V63, P749, DOI 10.1136/jnnp.63.6.749; Esiri MM, 2000, ANN NY ACAD SCI, V903, P239, DOI 10.1111/j.1749-6632.2000.tb06373.x; Esteras N, 2013, NEUROBIOL AGING, V34, P1090, DOI 10.1016/j.neurobiolaging.2012.10.014; Evdokiou A, 2000, J MOL ENDOCRINOL, V25, P195, DOI 10.1677/jme.0.0250195; Evdokiou A, 1999, MOL ENDOCRINOL, V13, P1738, DOI 10.1210/me.13.10.1738; Facher EA, 1997, CANCER, V79, P2424, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2424::AID-CNCR19>3.0.CO;2-T; Fiorelli T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057979; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Gravina S, 2009, AGING-US, V1, P470, DOI 10.18632/aging.100041; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hiltunen M, 2001, NEUROLOGY, V57, P1663, DOI 10.1212/WNL.57.9.1663; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holmans P, 2005, AM J MED GENET B, V135B, P24, DOI 10.1002/ajmg.b.30114; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; HUPPERT FA, 1995, BRIT J CLIN PSYCHOL, V34, P529, DOI 10.1111/j.2044-8260.1995.tb01487.x; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jaluria P, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-71; Jellinger KA, 2008, ACTA NEUROPATHOL, V115, P427, DOI 10.1007/s00401-008-0347-5; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Katsel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068361; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee JH, 2006, ARCH NEUROL-CHICAGO, V63, P1591, DOI 10.1001/archneur.63.11.1591; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Liu F, 2011, MUTAGENESIS, V26, P513, DOI 10.1093/mutage/ger010; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mirra S., 1991, NEUROLOGY, V4, P479; MOUSSES S, 1995, HUM MOL GENET, V4, P1089, DOI 10.1093/hmg/4.6.1089; Nagy Z, 1997, J NEUROPATH EXP NEUR, V56, P165, DOI 10.1097/00005072-199702000-00007; Nagy Z, 2005, J CELL MOL MED, V9, P531, DOI 10.1111/j.1582-4934.2005.tb00485.x; NAGY Z, 1995, NEUROSCIENCE, V69, P757, DOI 10.1016/0306-4522(95)00331-C; Nagy Z, 2007, BBA-MOL BASIS DIS, V1772, P402, DOI 10.1016/j.bbadis.2006.11.001; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Oh H, 2002, P NATL ACAD SCI USA, V99, P5430, DOI 10.1073/pnas.082123999; Ormerod MG, 2000, FLOW CYTOMETRY PRACT, P83; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Ressiniotis Thomas, 2005, BMC Ophthalmol, V5, P5, DOI 10.1186/1471-2415-5-5; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; Sjalander A, 1996, HUM HERED, V46, P221, DOI 10.1159/000154357; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Vechterova L, 2003, NEUROREPORT, V14, P87, DOI 10.1097/00001756-200301200-00017; Wider C, 2012, J NEUROL NEUROSUR PS, V83, P424, DOI 10.1136/jnnp-2011-301413; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Yoon MK, 2009, PROTEIN SCI, V18, P337, DOI 10.1002/pro.34	77	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0114050	10.1371/journal.pone.0114050	http://dx.doi.org/10.1371/journal.pone.0114050			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625488	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000348821400003
J	Li, ZW; Du, LT; Dong, ZG; Yang, YM; Zhang, X; Wang, LL; Li, J; Zheng, GX; Qu, AL; Wang, CX				Li, Zewu; Du, Lutao; Dong, Zhaogang; Yang, Yongmei; Zhang, Xin; Wang, Lili; Li, Juan; Zheng, Guixi; Qu, Ailin; Wang, Chuanxin			MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity	PLOS ONE			English	Article							COPY NUMBER; CHROMOSOMAL REGION; BARRETTS-ESOPHAGUS; MICRORNAS; BREAST; IDENTIFICATION; RECOGNITION; TARGET; GENES; HYBRIDIZATION	Zinc finger protein 217 (ZNF217) is essential for cell proliferation and has been implicated in tumorigenesis. However, its expression and exact roles in colorectal cancer (CRC) remain unclear. In this study, we demonstrated that ZNF217 expression was aberrantly upregulated in CRC tissues and associated with poor overall survival of CRC patients. In addition, we found that ZNF217 was a putative target of microRNA (miR)-203 using bioinformatics analysis and confirmed that using luciferase reporter assay. Moreover, in vitro knockdown of ZNF217 or enforced expression of miR-203 attenuated CRC cell proliferation, invasion and migration. Furthermore, combined treatment of ZNF217 siRNA and miR-203 exhibited synergistic inhibitory effects. Taken together, our results provide new evidences that ZNF217 has an oncogenic role in CRC and is regulated by miR-203, and open up the possibility of ZNF217- and miR-203-targeted therapy for CRC.	[Li, Zewu; Du, Lutao; Dong, Zhaogang; Yang, Yongmei; Zhang, Xin; Wang, Lili; Li, Juan; Zheng, Guixi; Qu, Ailin; Wang, Chuanxin] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China	Shandong University	Wang, CX (corresponding author), Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China.	cxwang@sdu.edu.cn	wang, lili/HDL-7210-2022	ZHENG, GUIXI/0000-0003-2856-9592	China National Natural Science Foundation [81072406, 81271916, 31270971, 81301506]; Research Fund for the Doctoral Program of Higher Education of China [20120131110055]; Shandong Province Natural Science Foundation [ZR2010HZ004]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province)	The project was supported by the China National Natural Science Foundation Projects (Grant No. 81072406, 81271916, 31270971 and 81301506), Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20120131110055), and the Shandong Province Natural Science Foundation (Grant No. ZR2010HZ004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht B, 2004, J PATHOL, V203, P780, DOI 10.1002/path.1576; Bar-Shira A, 2002, CANCER RES, V62, P6803; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bian K, 2012, FEBS LETT, V586, P804, DOI 10.1016/j.febslet.2012.01.050; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Brankley SM, 2012, HUM PATHOL, V43, P172, DOI 10.1016/j.humpath.2011.04.018; Buffart TE, 2009, VIRCHOWS ARCH, V455, P213, DOI 10.1007/s00428-009-0814-y; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dong Y, 2011, BRIT J CANCER, V104, P893, DOI 10.1038/bjc.2011.57; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Hidaka S, 2000, CLIN CANCER RES, V6, P2712; Huang HN, 2014, MODERN PATHOL, V27, P983, DOI 10.1038/modpathol.2013.216; Ikenaga N, 2010, ANN SURG ONCOL, V17, P3120, DOI 10.1245/s10434-010-1188-8; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Li PX, 2007, INT J CANCER, V120, P1863, DOI 10.1002/ijc.22300; Littlepage LE, 2012, CANCER DISCOV, V2, P638, DOI 10.1158/2159-8290.CD-12-0093; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Prestat E, 2013, COMPUT BIOL MED, V43, P334, DOI 10.1016/j.compbiomed.2012.12.002; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Rooney PH, 2004, J PATHOL, V204, P282, DOI 10.1002/path.1632; Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Smith CM, 2010, WORLD J GASTROENTERO, V16, P531, DOI 10.3748/wjg.v16.i5.531; Sun G, 2008, INT J ONCOL, V32, P1065; Szczyrba J, 2013, INT J CANCER, V132, P775, DOI 10.1002/ijc.27731; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Thillainadesan G, 2008, MOL CELL BIOL, V28, P6066, DOI 10.1128/MCB.00246-08; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang SH, 2005, CLIN CANCER RES, V11, P612	39	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116170	10.1371/journal.pone.0116170	http://dx.doi.org/10.1371/journal.pone.0116170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621839	Green Published, gold, Green Submitted			2022-12-27	WOS:000348470400003
J	Patra, M; Mukhopadhyay, C; Chakrabarti, A				Patra, Malay; Mukhopadhyay, Chaitali; Chakrabarti, Abhijit			Probing Conformational Stability and Dynamics of Erythroid and Nonerythroid Spectrin: Effects of Urea and Guanidine Hydrochloride	PLOS ONE			English	Article							ALPHA-SPECTRIN; BRAIN SPECTRIN; MULTIDOMAIN PROTEINS; TETRAMERIZATION SITE; CRYSTAL-STRUCTURE; WATER-STRUCTURE; TANDEM REPEATS; IN-VITRO; FLUORESCENCE; DENATURATION	We have studied the conformational stability of the two homologous membrane skeletal proteins, the erythroid and non-erythroid spectrins, in their dimeric and tetrameric forms respectively during unfolding in the presence of urea and guanidine hydrochloride (GuHCl). Fluorescence and circular dichroism (CD) spectroscopy have been used to study the changes of intrinsic tryptophan fluorescence, anisotropy, far UV-CD and extrinsic fluorescence of bound 1-anilinonapthalene-8-sulfonic acid (ANS). Chemical unfolding of both proteins were reversible and could be described as a two state transition. The folded erythroid spectrin and non-erythroid spectrin were directly converted to unfolded monomer without formation of any intermediate. Fluorescence quenching, anisotropy, ANS binding and dynamic light scattering data suggest that in presence of low concentrations of the denaturants (upto 1M) hydrogen bonding network and van der Waals interaction play a role inducing changes in quaternary as well as tertiary structures without complete dissociation of the subunits. This is the first report of two large worm like, multi-domain proteins obeying twofold rule which is commonly found in small globular proteins. The free energy of stabilization (Delta G(u)(2)(H)(0)) for the dimeric spectrin has been 20 kcal/mol lesser than the tetrameric from.	[Patra, Malay; Mukhopadhyay, Chaitali] Univ Calcutta, Dept Chem, Kolkata, W Bengal, India; [Chakrabarti, Abhijit] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India	University of Calcutta; Saha Institute of Nuclear Physics	Chakrabarti, A (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India.	abhijit.chakrabarti@saha.ac.in			MSACR project	MSACR project	Funding was obtained from the MSACR project to SINP from Department of Atomic Energy, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel A, 2008, MAT SCI ENG C-BIO S, V28, P594, DOI 10.1016/j.msec.2007.10.004; Akhtar MS, 2002, BIOCHEMISTRY-US, V41, P3819, DOI 10.1021/bi0116700; An XL, 2006, BIOCHEMISTRY-US, V45, P13670, DOI 10.1021/bi061368x; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; Batey S, 2006, BIOPHYS J, V90, P2120, DOI 10.1529/biophysj.105.072710; Batey S, 2005, J MOL BIOL, V349, P1045, DOI 10.1016/j.jmb.2005.04.028; Batey S, 2006, P NATL ACAD SCI USA, V103, P18113, DOI 10.1073/pnas.0604580103; Begg GE, 1997, BIOCHEMISTRY-US, V36, P6977, DOI 10.1021/bi970186n; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; Bhattacharyya M, 2004, J BIOL CHEM, V279, P55080, DOI 10.1074/jbc.M406418200; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; Bradford MM, 1976, ANAL BIOCHEM, V72, P9781; BRESLOW R, 1990, P NATL ACAD SCI USA, V87, P167, DOI 10.1073/pnas.87.1.167; BUDZYNSKI DM, 1992, BIOCHEMISTRY-US, V31, P3653, DOI 10.1021/bi00129a014; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; CALVERT R, 1980, EUR J BIOCHEM, V107, P363; Chattopadhyay A, 2003, PROTEIN SCI, V12, P2389, DOI 10.1110/ps.03302003; DAVIS J, 1983, J BIOL CHEM, V258, P7757; Del Vecchio P, 2002, BIOCHEM J, V367, P857, DOI 10.1042/BJ20020695; DeSilva TM, 1997, BIOCHEMISTRY-US, V36, P3991, DOI 10.1021/bi962412j; Diakowski W, 2002, BIOCHIM BIOPHYS ACTA, V1564, P13252; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; DUBIN SB, 1973, BIOCHEMISTRY-US, V12, P714, DOI 10.1021/bi00728a022; Dunbar J, 1997, PROTEIN SCI, V6, P1727, DOI 10.1002/pro.5560060813; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Fink AL, 1998, FOLD DES, V3, P19, DOI 10.1016/S1359-0278(98)00005-4; Franco G, 2008, BIOCHEMISTRY-US, V47, P7954, DOI 10.1021/bi8002555; GALLAGHER PG, 1993, BLOOD, V82, P2210; GLENNEY JR, 1982, J BIOL CHEM, V257, P9781; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Guidry JJ, 2000, PROTEIN SCI, V9, P2109, DOI 10.1110/ps.9.11.2109; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Haque ME, 1999, EUR J BIOCHEM, V259, P269, DOI 10.1046/j.1432-1327.1999.00062.x; Harper SL, 2013, BLOOD, V122, P3045, DOI 10.1182/blood-2013-02-487702; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jaenicke R, 2000, ADV PROTEIN CHEM, V53, P329; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Kloss E, 2008, J MOL BIOL, V383, P1195, DOI 10.1016/j.jmb.2008.08.069; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Lakowicz J.R, 2006, PRINCIPLES FLUORESCE; Lee CT, 2005, BIOCHEMISTRY-US, V44, P524, DOI 10.1021/bi048556c; Lehrer S S, 1978, Methods Enzymol, V49, P222; Li QF, 2009, BIOCHEMISTRY-US, V48, P206, DOI 10.1021/bi8013032; LIU SC, 1984, CELL, V37, P587, DOI 10.1016/0092-8674(84)90389-1; Long F, 2007, PROTEIN SCI, V16, P2519, DOI 10.1110/ps.073115307; MACDONALD RI, 1994, P NATL ACAD SCI USA, V91, P1299, DOI 10.1073/pnas.91.4.1299; MacDonald RI, 2004, P NATL ACAD SCI USA, V101, P1502, DOI 10.1073/pnas.0308059100; MacDonald RI, 2001, BIOCHEMISTRY-US, V40, P3974, DOI 10.1021/bi0025159; Mateu MG, 2002, J MOL BIOL, V318, P519, DOI 10.1016/S0022-2836(02)00091-8; MAYO SL, 1993, SCIENCE, V262, P873, DOI 10.1126/science.8235609; Mehboob S, 2003, BIOCHEMISTRY-US, V42, P14702, DOI 10.1021/bi0353833; Mehboob S, 2010, J BIOL CHEM, V285, P14572, DOI 10.1074/jbc.M109.080028; Menhart N, 1996, J BIOL CHEM, V271, P30410, DOI 10.1074/jbc.271.48.30410; MIKKELSEN A, 1984, BIOCHIM BIOPHYS ACTA, V786, P95, DOI 10.1016/0167-4838(84)90158-4; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; MOON RT, 1990, J BIOL CHEM, V265, P4427; MORROW JS, 1981, J CELL BIOL, V88, P463, DOI 10.1083/jcb.88.2.463; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Noppert A, 1996, FEBS LETT, V380, P179, DOI 10.1016/0014-5793(96)00048-8; O'Brien EP, 2007, J AM CHEM SOC, V129, P7346, DOI 10.1021/ja069232+; Pace C N, 1986, Methods Enzymol, V131, P266; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Pace CN, 2000, NAT STRUCT BIOL, V7, P345, DOI 10.1038/75100; Pantazatos DP, 1997, J BIOL CHEM, V272, P21052, DOI 10.1074/jbc.272.34.21052; PARKER W, 1992, BIOPHYS J, V61, P1435, DOI 10.1016/S0006-3495(92)81949-5; Pascual J, 1996, FEBS LETT, V383, P201, DOI 10.1016/0014-5793(96)00251-7; Patra M, 2014, J BIOMOL STRUCT DYN, V32, P852, DOI 10.1080/07391102.2013.793212; PIKE ACW, 1994, PROTEIN SCI, V3, P706; Povarova OI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015035; Prajapati S, 1998, EUR J BIOCHEM, V255, P178, DOI 10.1046/j.1432-1327.1998.2550178.x; Privalov PL, 1996, J MOL BIOL, V258, P707, DOI 10.1006/jmbi.1996.0280; RALSTON GB, 1976, BIOCHIM BIOPHYS ACTA, V455, P163, DOI 10.1016/0005-2736(76)90161-9; Ray S, 2005, J FLUORESC, V15, P61, DOI 10.1007/s10895-005-0214-x; Ray S, 2004, MOL MEMBR BIOL, V21, P93, DOI 10.1080/09687680310001625800; Ray S, 2003, CELL MOTIL CYTOSKEL, V54, P16, DOI 10.1002/cm.10082; Reddy GB, 1999, BIOCHEMISTRY-US, V38, P4462; SAHR KE, 1990, J BIOL CHEM, V265, P4434; Schellman JA, 2002, BIOPHYS CHEM, V96, P91, DOI 10.1016/S0301-4622(02)00009-1; Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260; SOSNICK TR, 1992, BIOCHEMISTRY-US, V31, P8329, DOI 10.1021/bi00150a029; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; Sriswasdi S, 2014, P NATL ACAD SCI USA, V111, P1801, DOI 10.1073/pnas.1317620111; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Street TO, 2008, METHOD CELL BIOL, V84, P295, DOI 10.1016/S0091-679X(07)84011-8; SUBBARAO NK, 1994, CELL MOTIL CYTOSKEL, V29, P72, DOI 10.1002/cm.970290107; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; TSE WT, 1990, J CLIN INVEST, V86, P909, DOI 10.1172/JCI114792; Vanzi F, 1998, J AM CHEM SOC, V120, P10748, DOI 10.1021/ja981529n; WILLIAMSON P, 1982, CELL, V30, P725, DOI 10.1016/0092-8674(82)90277-X; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; YOSHINO H, 1985, BIOCHIM BIOPHYS ACTA, V812, P786, DOI 10.1016/0005-2736(85)90273-1; YOSHINO H, 1984, J BIOL CHEM, V259, P4496; Zhou Z, 2005, BIOCHEMISTRY-US, V44, P12107, DOI 10.1021/bi050785r	100	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116991	10.1371/journal.pone.0116991	http://dx.doi.org/10.1371/journal.pone.0116991			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617632	Green Submitted, gold, Green Published			2022-12-27	WOS:000350336000035
J	Sun, X; Zhang, R; Jiang, F; Tang, SS; Chen, M; Peng, DF; Yan, J; Wang, T; Wang, SY; Bao, YQ; Hu, C; Jia, WP				Sun, Xue; Zhang, Rong; Jiang, Feng; Tang, Shanshan; Chen, Miao; Peng, Danfeng; Yan, Jing; Wang, Tao; Wang, Shiyun; Bao, Yuqian; Hu, Cheng; Jia, Weiping			Common Variants Related to Serum Uric Acid Concentrations Are Associated with Glucose Metabolism and Insulin Secretion in a Chinese Population	PLOS ONE			English	Article							TYPE-2 DIABETES RISK; BETA-CELL FUNCTION; OXIDATIVE STRESS; FASTING GLUCOSE; GOUT; IMPACT; LOCI; GENE; HOMEOSTASIS; RESISTANCE	Background Elevated serum uric acid concentration is an independent risk factor and predictor of type 2 diabetes (T2D). Whether the uric acid-associated genes have an impact on T2D remains unclear. We aimed to investigate the effects of the uric acid-associated genes on the risk of T2D as well as glucose metabolism and insulin secretion. Method We recruited 2,199 normal glucose tolerance subjects from the Shanghai Diabetes Study I and II and 2,999 T2D patients from the inpatient database of Shanghai Diabetes Institute. Fifteen single nucleotide polymorphisms (SNPs) mapped in or near 11 loci (PDZK1, GCKR, LRP2, SLC2A9, ABCG2, LRRC16A, SLC17A1, SLC17A3, SLC22A11, SLC22A12 and SF1) were genotyped and serum biochemical parameters related to uric acid and T2D were determined. Results SF1 rs606458 showed strong association to T2D in both males and females (p = 0.034 and 0.0008). In the males, LRRC16A was associated with 2-h insulin and insulin secretion (p = 0.009 and 0.009). SLC22A11 was correlated with HOMA-B and insulin secretion (p = 0.048 and 0.029). SLC2A9 rs3775948 was associated with 2-h glucose (p = 0.043). In the females, LRP2 rs2544390 and rs1333049 showed correlations with fasting insulin, HOMA-IR and insulin secretion (p = 0.028, 0.033 and 0.052 and p = 0.034, 0.047 and 0.038, respectively). SLC2A9 rs11722228 was correlated with 2-h glucose, 2-h insulin and insulin secretion (p = 0.024, 0.049 and 0.049, respectively). Conclusions Our results indicated that the uric acid-associated genes have an impact on the risk of T2D, glucose metabolism and insulin secretion in a Chinese population.	[Sun, Xue; Zhang, Rong; Jiang, Feng; Tang, Shanshan; Chen, Miao; Peng, Danfeng; Yan, Jing; Wang, Tao; Wang, Shiyun; Bao, Yuqian; Hu, Cheng; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet,Shanghai Key Lab Diabet, Shanghai Diabet Inst,Shanghai Key Clin Ctr Metab, Shanghai 200233, Peoples R China; [Hu, Cheng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 201400, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hu, C (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet,Shanghai Key Lab Diabet, Shanghai Diabet Inst,Shanghai Key Clin Ctr Metab, Shanghai 200233, Peoples R China.	alfredhc@sjtu.edu.cn; wpjia@sjtu.edu.cn	Hu, Cheng/C-3346-2008; Jia, Weiping/B-7483-2012	Hu, Cheng/0000-0003-4314-2386; 	NSFC [81322010]; Excellent Young Medical Expert of Shanghai [XYQ2011041]; Shanghai Rising Star Program [12QH1401700]; Shanghai Talent Development Grant [2012041]; National Program for Support of Top-notch Young Professionals	NSFC(National Natural Science Foundation of China (NSFC)); Excellent Young Medical Expert of Shanghai; Shanghai Rising Star Program; Shanghai Talent Development Grant; National Program for Support of Top-notch Young Professionals	The authors acknowledge grants from NSFC (81322010), Excellent Young Medical Expert of Shanghai (XYQ2011041), Shanghai Rising Star Program (12QH1401700), Shanghai Talent Development Grant (2012041) and National Program for Support of Top-notch Young Professionals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ekaratanawong S, 2004, J PHARMACOL SCI, V94, P297, DOI 10.1254/jphs.94.297; Evans SA, 2009, ENDOCRINOLOGY, V150, P5302, DOI 10.1210/en.2009-0747; Fan HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067759; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Heni M, 2010, J CLIN ENDOCR METAB, V95, pE479, DOI 10.1210/jc.2010-0860; Heni M, 2010, DIABETES, V59, P3247, DOI 10.2337/db10-0674; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011761; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Jia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078284; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Jia ZT, 2013, DIABETES RES CLIN PR, V101, P88, DOI 10.1016/j.diabres.2013.03.026; Keembiyehetty C, 2006, MOL ENDOCRINOL, V20, P686, DOI 10.1210/me.2005-0010; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Liu WC, 2011, EXP DIABETES RES, DOI 10.1155/2011/527520; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MODAN M, 1987, DIABETOLOGIA, V30, P713, DOI 10.1007/BF00296994; Nakayama A, 2014, RHEUMATOL INT, V34, P473, DOI 10.1007/s00296-013-2924-8; Nath SD, 2007, J AM SOC NEPHROL, V18, P3156, DOI 10.1681/ASN.2007040426; Orlando RA, 1998, J AM SOC NEPHROL, V9, P1759; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roncal CA, 2009, AM J NEPHROL, V30, P399, DOI 10.1159/000235731; Roy D, 1998, AM J PHYSIOL-ENDOC M, V274, pE692, DOI 10.1152/ajpendo.1998.274.4.E692; Sakiyama M, 2014, DRUG METAB PHARMACOK, V29, P208, DOI 10.2133/dmpk.DMPK-13-NT-070; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Simental-Mendia LE, 2009, DIABETES-METAB RES, V25, P535, DOI 10.1002/dmrr.988; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Stumvoll M, 2001, DIABETES CARE, V24, P796, DOI 10.2337/diacare.24.4.796; Sun X, 2014, ACTA PHARMACOL SIN, V35, P1421, DOI 10.1038/aps.2014.87; Tang W, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/709691; Tin A, 2011, HUM MOL GENET, V20, P4056, DOI 10.1093/hmg/ddr307; van der Harst P, 2010, HUM MOL GENET, V19, P387, DOI 10.1093/hmg/ddp489; Wang BB, 2011, RHEUMATOLOGY, V50, P1559, DOI 10.1093/rheumatology/ker135; Zhang YN, 2013, MOL CELL ENDOCRINOL, V375, P89, DOI 10.1016/j.mce.2013.04.027	39	12	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116714	10.1371/journal.pone.0116714	http://dx.doi.org/10.1371/journal.pone.0116714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617895	gold, Green Published, Green Submitted			2022-12-27	WOS:000350336000022
J	Kobler, C; Poulsen, SS; Saber, AT; Jacobsen, NR; Wallin, H; Yauk, CL; Halappanavar, S; Vogel, U; Qvortrup, K; Molhave, K				Kobler, Carsten; Poulsen, Sarah S.; Saber, Anne T.; Jacobsen, Nicklas R.; Wallin, Hakan; Yauk, Carole L.; Halappanavar, Sabina; Vogel, Ulla; Qvortrup, Klaus; Molhave, Kristian			Time-Dependent Subcellular Distribution and Effects of Carbon Nanotubes in Lungs of Mice	PLOS ONE			English	Article							MOUSE LUNG; INHALATION TOXICITY; AIRWAY INFLAMMATION; PULMONARY TOXICITY; RESPONSES; ACCUMULATION; EOSINOPHILS; MECHANISMS; SURFACTANT; PNEUMONIA	Background and Methods Pulmonary deposited carbon nanotubes (CNTs) are cleared very slowly from the lung, but there is limited information on how CNTs interact with the lung tissue over time. To address this, three different multiwalled CNTs were intratracheally instilled into female C57BL/6 mice: one short (850 nm) and tangled, and two longer (4 mu m and 5.7 mu m) and thicker. We assessed the cellular interaction with these CNTs using transmission electron microscopy (TEM) 1, 3 and 28 days after instillation. Results TEM analysis revealed that the three CNTs followed the same overall progression pattern over time. Initially, CNTs were taken up either by a diffusion mechanism or via endocytosis. Then CNTs were agglomerated in vesicles in macrophages. Lastly, at 28 days post-exposure, evidence suggesting CNT escape from vesicle enclosures were found. The longer and thicker CNTs more often perturbed and escaped vesicular enclosures in macrophages compared to the smaller CNTs. Bronchoalveolar lavage (BAL) showed that the CNT exposure induced both an eosinophil influx and also eosinophilic crystalline pneumonia. Conclusion Two very different types of multiwalled CNTs had very similar pattern of cellular interactions in lung tissue, with the longer and thicker CNTs resulting inmore severe effects in terms of eosinophil influx and incidence of eosinophilic crystalline pneumonia (ECP).	[Kobler, Carsten; Vogel, Ulla; Molhave, Kristian] Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark; [Kobler, Carsten] Tech Univ Denmark, DTU CEN, DK-2800 Lyngby, Denmark; [Poulsen, Sarah S.; Saber, Anne T.; Jacobsen, Nicklas R.; Wallin, Hakan; Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Poulsen, Sarah S.] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Wallin, Hakan] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Yauk, Carole L.; Halappanavar, Sabina] Hlth Canada, Environm & Radiat Hlth Sci Directorate, Ottawa, ON, Canada; [Qvortrup, Klaus] Univ Copenhagen, CFIM, Dept Biomed Sci, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; National Research Centre for the Working Environment; Roskilde University; University of Copenhagen; Health Canada; University of Copenhagen	Molhave, K (corresponding author), Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark.	kristian.molhave@nanotech.dtu.dk	Vogel, Ulla B/I-5048-2012; Mølhave, Kristian/AAP-5837-2020; Wallin, Håkan/I-6459-2012; Vogel, Ulla/ABC-2212-2020; Molhave, Kristian/B-9209-2008	Vogel, Ulla B/0000-0001-6807-1524; Mølhave, Kristian/0000-0002-6493-2750; Wallin, Håkan/0000-0001-7716-0166; Vogel, Ulla/0000-0001-6807-1524; Molhave, Kristian/0000-0002-6493-2750; Jacobsen, Nicklas Raun/0000-0002-2504-2229; Yauk, Carole/0000-0002-6725-3454; Yauk, Carole/0000-0003-4919-876X; Qvortrup, Klaus/0000-0001-8811-0260	Danish Centre for Nanosafety from the Danish Working Environment Research Foundation [20110092173/3]; European Community's Seventh Framework Programme (FP7) [247989]; Chemicals Management Plan of Health Canada	Danish Centre for Nanosafety from the Danish Working Environment Research Foundation; European Community's Seventh Framework Programme (FP7); Chemicals Management Plan of Health Canada	Work was supported by the Danish Centre for Nanosafety (20110092173/3) from the Danish Working Environment Research Foundation, and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 247989 (Nanosustain) and Chemicals Management Plan of Health Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jamal KT, 2011, NANOSCALE, V3, P2627, DOI 10.1039/c1nr10080g; ALI-BOUCETTA H., 2013, ANGEW CHEM, V125, P2330, DOI DOI 10.1002/ANGE.201207664; Andon FT, 2013, SMALL, V9, P2721, DOI 10.1002/smll.201202508; Aschberger K, 2010, CRIT REV TOXICOL, V40, P759, DOI 10.3109/10408444.2010.506638; Beamer CA, 2013, NANOTOXICOLOGY, V7, P1070, DOI 10.3109/17435390.2012.702230; Ben-Yehuda C, 2008, EXP LUNG RES, V34, P467, DOI 10.1080/01902140802220625; Bhattacharya K, 2013, ADV DRUG DELIVER REV, V65, P2087, DOI 10.1016/j.addr.2013.05.012; Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5; Canton I, 2012, CHEM SOC REV, V41, P2718, DOI 10.1039/c2cs15309b; Donaldson K, 2013, ADV DRUG DELIVER REV, V65, P2078, DOI 10.1016/j.addr.2013.07.014; Elmore SA, 2013, TOXICOL PATHOL, V41, P151, DOI 10.1177/0192623312467102; Erdely A, 2011, J OCCUP ENVIRON MED, V53, pS80, DOI 10.1097/JOM.0b013e31821ad724; Feldmesser M, 2001, INFECT IMMUN, V69, P2723, DOI 10.1128/IAI.69.4.2723-2727.2001; Girtsman TA, 2014, NANOTOXICOLOGY, V8, P17, DOI 10.3109/17435390.2012.744110; Guo L, 2000, J BIOL CHEM, V275, P8032, DOI 10.1074/jbc.275.11.8032; Guo RF, 2001, J IMMUNOL, V166, P5208, DOI 10.4049/jimmunol.166.8.5208; Hamilton RF, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-57; Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145; Hoenerhoff MJ, 2006, VET PATHOL, V43, P682, DOI 10.1354/vp.43-5-682; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Inoue K, 2009, TOXICOL APPL PHARM, V237, P306, DOI 10.1016/j.taap.2009.04.003; Kapralov AA, 2012, ACS NANO, V6, P4147, DOI 10.1021/nn300626q; Kobayashi N, 2010, TOXICOLOGY, V276, P143, DOI 10.1016/j.tox.2010.07.021; KOBLER C, 2014, ANAL BIOANALYTICAL C; Lacerda L, 2012, BIOMATERIALS, V33, P3334, DOI 10.1016/j.biomaterials.2012.01.024; Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146; Marangon I, 2012, NANO LETT, V12, P4830, DOI 10.1021/nl302273p; Monthioux M, 2006, CARBON, V44, P1621, DOI 10.1016/j.carbon.2006.03.019; Mu QX, 2009, NANO LETT, V9, P4370, DOI 10.1021/nl902647x; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Muller J, 2008, CHEM RES TOXICOL, V21, P1698, DOI 10.1021/tx800101p; MURRAY AB, 1990, VET PATHOL, V27, P274, DOI 10.1177/030098589002700409; Nagai H, 2011, P NATL ACAD SCI USA, V108, pE1330, DOI 10.1073/pnas.1110013108; *NAN, 2013, METH DET POT GEN NAN; NIO J, 2004, HISTOCHEMISTRY CELL, V121; Nygaard UC, 2009, TOXICOL SCI, V109, P113, DOI 10.1093/toxsci/kfp057; Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437; Pauluhn J, 2010, TOXICOL SCI, V113, P226, DOI 10.1093/toxsci/kfp247; Persson H, 2013, SMALL, V9, P4006, DOI 10.1002/smll.201300644; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Porter DW, 2013, NANOTOXICOLOGY, V7, P1179, DOI 10.3109/17435390.2012.719649; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Poulsen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080452; Ronzani C, 2012, ARCH TOXICOL, V86, P137, DOI 10.1007/s00204-011-0741-y; Ross MH., 2011, HISTOLOGY TEXT ATLAS, V6th ed; Ryman-Rasmussen JP, 2009, NAT NANOTECHNOL, V4, P747, DOI [10.1038/nnano.2009.305, 10.1038/NNANO.2009.305]; Saber AT, 2012, NANOTOXICOLOGY, V6, P453, DOI 10.3109/17435390.2011.587900; Saber AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069020; Saber AT, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-4; Sager TM, 2014, NANOTOXICOLOGY, V8, P317, DOI 10.3109/17435390.2013.779757; Teeguarden JG, 2011, TOXICOL SCI, V120, P123, DOI 10.1093/toxsci/kfq363; Treumann S, 2013, TOXICOL SCI, V134, P103, DOI 10.1093/toxsci/kft089; VANZWEITEN M, 1981, IMMUNOLOGICAL TECHNI; Waern I, 2010, MOL IMMUNOL, V47, P1467, DOI 10.1016/j.molimm.2010.02.004; Wang X, 2010, J NANOSCI NANOTECHNO, V10, P8516, DOI 10.1166/jnn.2010.2688; Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055; Wierzbicki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053307	57	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116481	10.1371/journal.pone.0116481	http://dx.doi.org/10.1371/journal.pone.0116481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615613	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100030
J	Qu, WN; Ge, Y; Xiong, YX; Carciofo, R; Zhao, WG; Zhang, K				Qu, Weina; Ge, Yan; Xiong, Yuexin; Carciofo, Richard; Zhao, Wenguo; Zhang, Kan			Dangerous Driving in a Chinese Sample: Associations with Morningness-Eveningness Preference and Personality	PLOS ONE			English	Article							CIRCADIAN TYPOLOGY; INDIVIDUAL-DIFFERENCES; CHRONOTYPE; TIME; QUESTIONNAIRE; RELIABILITY; SLEEPINESS; VALIDITY; VERSION; RHYTHM	Individual differences in morningness-eveningness preference may influence susceptibility and response to sleepiness. These differences could influence driving performance, but the influence of morningness-eveningness preference on driving behavior and accident risk has not been comprehensively studied. As morningness-eveningness preference is associated with personality characteristics, we also investigated how the interaction between morningness-eveningness preference and personality may be related to dangerous driving behaviors. Two hundred and ninety five drivers completed the reduced Morningness-Eveningness Questionnaire, the Dula Dangerous Driving Index, and personality scales for agreeableness, conscientiousness and neuroticism, and reported demographic information (gender, age, level of education, driving years and annual average driving mileage) and self-reported traffic violations (accidents, penalty points and fines). The results showed that more Risky Driving, Aggressive Driving, Negative Cognitive/Emotional Driving and Drunk Driving, as measured by the Dula Dangerous Driving Index, were all significantly correlated with more eveningness, corresponding to lower scores on the reduced Morningness-Eveningness Questionnaire. Moreover, eveningness was correlated with self-reported traffic accidents, penalty points and fines. Furthermore, a moderation effect was found: eveningness was more strongly associated with risky driving and negative emotional driving in those who scored high for trait agreeableness.	[Qu, Weina; Ge, Yan; Xiong, Yuexin; Carciofo, Richard; Zhao, Wenguo; Zhang, Kan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Ge, Y (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	gey@psych.ac.cn			National Natural Science Foundation of China [31100750, 31400886, 91124003]; Basic Project of National Science and Technology of China [2009FY110100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Project of National Science and Technology of China	This study was supported by grants from the National Natural Science Foundation of China (Grants No. 31100750, 31400886 and 91124003), the Basic Project of National Science and Technology of China (No. 2009FY110100). YG received NSFC 31100750, Q received NSFC 31400886, KZ received NSFC 91124003 and 2009FY110100. The URLs of the National Natural Science Foundation of China is http://www.nsfc.gov.cn/. The URLs of the Basic Project of National Science and Technology of China is http://www.most.gov.cn/kjjh/gjkjjh/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN A, 1991, PERS INDIV DIFFER, V12, P241, DOI 10.1016/0191-8869(91)90110-W; Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; Adan A, 2010, CHRONOBIOL INT, V27, P606, DOI 10.3109/07420521003663827; Aiken L. S., 1991, MULTIPLE REGRESSION; Arthur W, 2001, J PREVENTION INTERVE, V22, P35, DOI [10.1080/ 10852350109511209, DOI 10.1080/10852350109511209, 10.1300/J005v22n01_04]; Benfield JA, 2007, PERS INDIV DIFFER, V42, P247, DOI 10.1016/j.paid.2006.06.016; Bergomi M, 2010, Ann Ig, V22, P387; Bone S.A., 2006, J CONSUM BEHAV, V5, P454, DOI DOI 10.1002/(ISSN)1479-1838; Caci H, 2004, EUR PSYCHIAT, V19, P79, DOI 10.1016/j.eurpsy.2003.09.007; Carciofo R, 2012, SLEEP BIOL RHYTHMS, V10, P310, DOI 10.1111/j.1479-8425.2012.00577.x; Cavallera GM, 2008, PERS INDIV DIFFER, V44, P3, DOI 10.1016/j.paid.2007.07.009; Chipman M, 2009, SAFETY SCI, V47, P1364, DOI 10.1016/j.ssci.2009.03.005; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dahlen ER, 2006, PERS INDIV DIFFER, V41, P903, DOI 10.1016/j.paid.2006.03.016; Del Rio-Bermudez C, 2014, CHRONOBIOL INT, V31, P532, DOI 10.3109/07420528.2013.876427; DeYoung CG, 2007, PERS INDIV DIFFER, V43, P267, DOI 10.1016/j.paid.2006.11.030; Di Milia L, 2008, CHRONOBIOL INT, V25, P776, DOI 10.1080/07420520802391098; Di Milia L, 2011, ACCIDENT ANAL PREV, V43, P516, DOI 10.1016/j.aap.2009.12.018; Diaz-Morales JF, 2007, CHRONOBIOL INT, V24, P435, DOI 10.1080/07420520701420659; Dula CS, 2003, J APPL SOC PSYCHOL, V33, P263, DOI 10.1111/j.1559-1816.2003.tb01896.x; Fahrenberg J, 1999, PERS INDIV DIFFER, V26, P641, DOI 10.1016/S0191-8869(98)00160-3; Garbarino S, 2001, SLEEP, V24, P203; Gau SSF, 2007, J BIOL RHYTHM, V22, P268, DOI 10.1177/0748730406298447; Goldstein D, 2007, PERS INDIV DIFFER, V42, P431, DOI 10.1016/j.paid.2006.07.008; HARRIS W, 1977, FATIGUE CIRCADIAN RH, P133; Hirata FC, 2007, CHRONOBIOL INT, V24, P939, DOI 10.1080/07420520701657730; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; John O.P., 1999, HDB PERSONALITY THEO, V1999, P102, DOI DOI 10.1037/A0019265; KERKHOF GA, 1985, BIOL PSYCHOL, V20, P83, DOI 10.1016/0301-0511(85)90019-5; KIRKCALDY B, 2000, STUDIA PSYCHOL; Lajunen T, 2001, PERS INDIV DIFFER, V31, P1365, DOI 10.1016/S0191-8869(00)00230-0; Lenne MG, 1997, ACCIDENT ANAL PREV, V29, P431, DOI 10.1016/S0001-4575(97)00022-5; Li SX, 2011, SLEEP BIOL RHYTHMS, V9, P19, DOI 10.1111/j.1479-8425.2010.00480.x; MATTHEWS G, 1991, PERS INDIV DIFFER, V12, P535, DOI 10.1016/0191-8869(91)90248-A; MECACCI L, 1986, PERS INDIV DIFFER, V7, P911, DOI 10.1016/0191-8869(86)90094-2; Mecacci L, 1998, PERS INDIV DIFFER, V25, P537, DOI 10.1016/S0191-8869(98)00087-7; Natale V, 2002, PERS INDIV DIFFER, V32, P809, DOI 10.1016/S0191-8869(01)00085-X; NEUBAUER AC, 1992, PERS INDIV DIFFER, V13, P125, DOI 10.1016/0191-8869(92)90035-N; Oginska H, 2010, CHRONOBIOL INT, V27, P959, DOI 10.3109/07420528.2010.489412; Paine SJ, 2006, J BIOL RHYTHM, V21, P68, DOI 10.1177/0748730405283154; Qu WN, 2014, ACCIDENT ANAL PREV, V64, P62, DOI 10.1016/j.aap.2013.11.004; Randler C, 2008, SOC INDIC RES, V86, P297, DOI 10.1007/s11205-007-9139-x; Rosekind M.R., 1994, CREW FACTORS FLIGHT; Steele MT, 1999, ACAD EMERG MED, V6, P1050, DOI 10.1111/j.1553-2712.1999.tb01191.x; Stolarski M, 2013, BIOL RHYTHM RES, V44, P181, DOI 10.1080/09291016.2012.656248; Taillard J, 2004, J BIOL RHYTHM, V19, P76, DOI 10.1177/0748730403259849; TANKOVA I, 1994, PERS INDIV DIFFER, V16, P671, DOI 10.1016/0191-8869(94)90209-7; Tonetti L, 2010, EUR PSYCHIAT, V25, P111, DOI 10.1016/j.eurpsy.2009.09.007; Tonetti L, 2009, CHRONOBIOL INT, V26, P337, DOI 10.1080/07420520902750995; TORSVALL L, 1987, ELECTROEN CLIN NEURO, V66, P502, DOI 10.1016/0013-4694(87)90096-4; Wang LL, 2014, J APPL MATH, DOI 10.1155/2014/247836	51	13	13	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116717	10.1371/journal.pone.0116717	http://dx.doi.org/10.1371/journal.pone.0116717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25615447	gold, Green Published			2022-12-27	WOS:000349122100037
J	Redmond, SM; Alexander-Kisslig, K; Woodhall, SC; van den Broek, IVF; van Bergen, J; Ward, H; Uuskula, A; Herrmann, B; Andersen, B; Gotz, HM; Sfetcu, O; Low, N				Redmond, Shelagh M.; Alexander-Kisslig, Karin; Woodhall, Sarah C.; van den Broek, Ingrid V. F.; van Bergen, Jan; Ward, Helen; Uuskula, Anneli; Herrmann, Bjorn; Andersen, Berit; Gotz, Hannelore M.; Sfetcu, Otilia; Low, Nicola			Genital Chlamydia Prevalence in Europe and Non-European High Income Countries: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; POPULATION-BASED SURVEY; TRACHOMATIS INFECTION; GENERAL-POPULATION; YOUNG MEN; GONOCOCCAL INFECTIONS; UNITED-KINGDOM; WOMEN; BEHAVIOR; CARE	Background Accurate information about the prevalence of Chlamydia trachomatis is needed to assess national prevention and control measures. Methods We systematically reviewed population-based cross-sectional studies that estimated chlamydia prevalence in European Union/European Economic Area (EU/EEA) Member States and non-European high income countries from January 1990 to August 2012. We examined results in forest plots, explored heterogeneity using the I-2 statistic, and conducted random effects meta-analysis if appropriate. Meta-regression was used to examine the relationship between study characteristics and chlamydia prevalence estimates. Results We included 25 population-based studies from 11 EU/EEA countries and 14 studies from five other high income countries. Four EU/ EEAMember States reported on nationally representative surveys of sexually experienced adults aged 18-26 years (response rates 52-71%). In women, chlamydia point prevalence estimates ranged from 3.0-5.3%; the pooled average of these estimates was 3.6%(95% CI 2.4, 4.8, I-2 0%). In men, estimates ranged from 2.4-7.3% (pooled average 3.5%; 95% CI 1.9, 5.2, I-2 27%). Estimates in EU/EEA Member States were statistically consistent with those in other high income countries (I-2 0% for women, 6% for men). There was statistical evidence of an association between survey response rate and estimated chlamydia prevalence; estimates were higher in surveys with lower response rates, (p = 0.003 in women, 0.018 in men). Conclusions Population-based surveys that estimate chlamydia prevalence are at risk of participation bias owing to low response rates. Estimates obtained in nationally representative samples of the general population of EU/EEA Member States are similar to estimates from other high income countries.	[Redmond, Shelagh M.; Alexander-Kisslig, Karin; Low, Nicola] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Woodhall, Sarah C.] Publ Hlth England, Natl Ctr Infect Dis Surveillance & Control, HIV & STI Dept, London NW9 5EQ, England; [van den Broek, Ingrid V. F.] RIVM Ctr Infect Dis Control Netherlands, Unit Epidemiol & Surveillance, NL-3720 BA Bilthoven, Netherlands; [van Bergen, Jan] Univ Amsterdam, NL-1012 WX Amsterdam, Netherlands; [van Bergen, Jan] STI AIDS Netherlands, NL-1016 GB Amsterdam, Netherlands; [Ward, Helen] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London W2 1PG, England; [Uuskula, Anneli] Univ Tartu, Dept Publ Hlth, EE-50411 Tartu, Estonia; [Herrmann, Bjorn] Dept Clin Microbiol, S-75185 Uppsala, Sweden; [Andersen, Berit] Randers Cent Hosp, Dept Publ Hlth Intervent, DK-8900 Skovlyvej, Randers, Denmark; [Gotz, Hannelore M.] Municipal Publ Hlth Serv Rotterdam Rijnmond, Dept Infect Dis Control, NL-3000 LP Rotterdam, Netherlands; [Sfetcu, Otilia] European Ctr Dis Prevent & Control ECDC, S-17183 Stockholm, Sweden	University of Bern; Public Health England; University of Amsterdam; Imperial College London; University of Tartu; Aarhus University; European Centre for Disease Prevention & Control	Low, N (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	low@ispm.unibe.ch	Andersen, Berit/J-3402-2017; Uusküla, Anneli/H-3303-2015; Low, Nicola/H-4718-2019; Ward, Helen/A-1836-2009	Andersen, Berit/0000-0003-4074-6504; Uusküla, Anneli/0000-0002-4036-3856; Low, Nicola/0000-0003-4817-8986; Ward, Helen/0000-0001-8238-5036; Gotz, Hannelore Martha/0000-0002-1236-6224	European Centre for Disease Prevention and Control (ECDC) [ECDC/2011/031]; MRC [G0601699, G0902120] Funding Source: UKRI; Medical Research Council [G0601699, G0902120] Funding Source: researchfish	European Centre for Disease Prevention and Control (ECDC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded as part of European Centre for Disease Prevention and Control (ECDC) Framework Contract ECDC/2011/031, coordinated by Marita van de Laar and Otilia Sfetcu. Otilia Sfetcu is employed by ECDC and contributed to data interpretation and preparation of the manuscript.	Adams EJ, 2004, SEX TRANSM INFECT, V80, P354, DOI 10.1136/sti.2003.005454; Andersen B, 2002, J INFECT DIS, V185, P252, DOI 10.1086/338268; Baud D, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-45; Bennedsen M, 2001, Ugeskr Laeger, V163, P4583; Boyle MH, 1998, EVID-BASED MENT HEAL, V1, P37; Bozicevic I, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-230; Bracebridge S, 2012, SEX TRANSM INFECT, V88, P375, DOI 10.1136/sextrans-2011-050267; BRANNSTROM M, 1992, SCAND J INFECT DIS, V24, P41, DOI 10.3109/00365549209048399; Centers for Disease Control and Prevention, 2011, SEX TRANSM DIS SURV; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Copas AJ, 1997, AIDS, V11, P783, DOI 10.1097/00002030-199706000-00011; Corwin Paul, 2002, N Z Med J, V115, pU107; *COUNC AM SURV RES, 1982, DEF RESP RAT; Datta SD, 2012, SEX TRANSM DIS, V39, P92, DOI 10.1097/OLQ.0b013e31823e2ff7; Domeika M, 2007, J EUR ACAD DERMATOL, V21, P789, DOI 10.1111/j.1468-3083.2006.02088.x; Eggleston E, 2011, SEX TRANSM DIS, V38, P743, DOI 10.1097/OLQ.0b013e318214c149; ERENS B, 2001, NATL SURVEY SEXUAL A, P1; *EUR CTR DIS PREV, 2014, CHLAM CONTR EUR; European Centre for Disease Prevention and Control, 2013, SEX TRANSM INF EUR 2; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Franceschi S, 2007, SEX TRANSM DIS, V34, P563, DOI 10.1097/01.olq.0000258417.66619.0e; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; HAAR K, 2012, PRAVALENZ UROGENITAL; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hocking J, 2006, VICTORIA SEX HLTH, V3, P235, DOI DOI 10.1071/SH06033; Hodgins S, 2002, SEX TRANSM INFECT, V78, pI64, DOI 10.1136/sti.78.suppl_1.i64; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; Huang RL, 2008, MED J AUSTRALIA, V189, P442, DOI 10.5694/j.1326-5377.2008.tb02117.x; JONSSON M, 1995, GENITOURIN MED, V71, P158; Klausner JD, 2001, J INFECT DIS, V183, P1087, DOI 10.1086/319276; Klavs I, 2004, SEX TRANSM INFECT, V80, P121, DOI 10.1136/sti.2003.005900; Klovstad H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-150; Ku L, 2002, AM J PUBLIC HEALTH, V92, P1140, DOI 10.2105/AJPH.92.7.1140; LATIF AS, 2004, NT DIS CONTROL B, V11, P18; Low N, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11080; Low N, 2012, EUR J PUBLIC HEALTH, V22, P556, DOI 10.1093/eurpub/ckr046; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F; Meyers DS, 2007, ANN INTERN MED, V147, P135, DOI 10.7326/0003-4819-147-2-200707170-00173; Miller GC, 2003, SEX TRANSM INFECT, V79, P332, DOI 10.1136/sti.79.4.332; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Munk C, 1999, SEX TRANSM DIS, V26, P325, DOI 10.1097/00007435-199907000-00003; *NAT CHLAM SCREEN, 2012, NAT CHLAM SCREEN PRO; Novak D P, 2003, Euro Surveill, V8, P171; Novak DP, 2004, SCAND J PUBLIC HEALT, V32, P324, DOI 10.1080/14034940410026282; Op de Coul ELM, 2012, SEX TRANSM DIS, V39, P97, DOI 10.1097/OLQ.0b013e3182383097; *ORG EC COOP DEV, 2011, COUNT CLASS 2011; Ostergaard L, 1998, BRIT MED J, V317, P26, DOI 10.1136/bmj.317.7150.26; Pierpoint T, 2000, SEX TRANSM INFECT, V76, P273, DOI 10.1136/sti.76.4.273; Rours GIJG, 2011, EUR J EPIDEMIOL, V26, P493, DOI 10.1007/s10654-011-9586-1; *ROYAL COLL OBST G, 2007, GREEN TOP GUID 45 BI, P1; Singleton J. A., 2010, Morbidity and Mortality Weekly Report, V59, P44; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Steen Tore W, 2005, Tidsskr Nor Laegeforen, V125, P1637; Steenbeek A, 2009, SEX TRANSM DIS, V36, P79, DOI 10.1097/OLQ.0b013e3181898e4d; Stephenson J, 2000, SEX TRANSM INFECT, V76, P25, DOI 10.1136/sti.76.1.25; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; Uuskula A, 2008, INT J STD AIDS, V19, P455, DOI 10.1258/ijsa.2008.007325; van Bergen J, 2005, SEX TRANSM INFECT, V81, P17, DOI 10.1136/sti.2004.010173; van Bergen JEAM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-293; van Valkengoed IGM, 2000, SEX TRANSM INFECT, V76, P375, DOI 10.1136/sti.76.5.375; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; WARD H, 2009, ECDC GUIDANCE; Wilson JS, 2002, HUM REPROD UPDATE, V8, P385, DOI 10.1093/humupd/8.4.385; 2008, DICT EPIDEMIOLOGY	65	46	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115753	10.1371/journal.pone.0115753	http://dx.doi.org/10.1371/journal.pone.0115753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615574	gold, Green Submitted, Green Published			2022-12-27	WOS:000349122100016
J	Yoshida, K; Nishizawa, D; Ichinomiya, T; Ichinohe, T; Hayashida, M; Fukuda, K; Ikeda, K				Yoshida, Kaori; Nishizawa, Daisuke; Ichinomiya, Takashi; Ichinohe, Tatsuya; Hayashida, Masakazu; Fukuda, Ken-ichi; Ikeda, Kazutaka			Prediction Formulas for Individual Opioid Analgesic Requirements Based on Genetic Polymorphism Analyses	PLOS ONE			English	Article							MAJOR ABDOMINAL-SURGERY; GENOME-WIDE ASSOCIATION; PAIN; SENSITIVITY; MORPHINE; PHARMACOGENETICS; EQUIVALENT; GENOTYPE; DRUGS; TRIAL	Background The analgesic efficacy of opioids is well known to vary widely among individuals, and various factors related to individual differences in opioid sensitivity have been identified. However, a prediction model to calculate appropriate opioid analgesic requirements has not yet been established. The present study sought to construct prediction formulas for individual opioid analgesic requirements based on genetic polymorphisms and clinical data from patients who underwent cosmetic orthognathic surgery and validate the utility of the prediction formulas in patients who underwent major open abdominal surgery. Methods To construct the prediction formulas, we performed multiple linear regression analyses using data from subjects who underwent cosmetic orthognathic surgery. The dependent variable was 24-h postoperative or perioperative fentanyl use, and the independent variables were age, gender, height, weight, pain perception latencies (PPL), and genotype data of five single-nucleotide polymorphisms (SNPs). To examine the utility of the prediction formulas, we performed simple linear regression analyses using subjects who underwent major open abdominal surgery. Actual 24-h postoperative or perioperative analgesic use and the predicted values that were calculated using the multiple regression equations were incorporated as dependent and independent variables, respectively. Results Multiple linear regression analyses showed that the four SNPs, PPL, and weight were retained as independent predictors of 24-h postoperative fentanyl use (R-2 = 0.145, P = 5.66 x 10(-10)) and the two SNPs and weight were retained as independent predictors of perioperative fentanyl use (R-2 = 0.185, P = 1.99 x 10(-15)). Simple linear regression analyses showed that the predicted values were retained as an independent predictor of actual 24-h postoperative analgesic use (R-2 = 0.033, P = 0.030) and perioperative analgesic use (R-2 = 0.100, P = 1.09 x 10(-4)), respectively. Conclusions We constructed prediction formulas, and the possible utility of these prediction formulas was found in another type of surgery.	[Yoshida, Kaori; Nishizawa, Daisuke; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Substance Project, Tokyo 113, Japan; [Yoshida, Kaori; Fukuda, Ken-ichi] Tokyo Dent Coll, Dept Dent Anesthesiol, Tokyo, Japan; [Ichinomiya, Takashi] Gifu Univ, Grad Sch Med, Dept Biomed Informat, Gifu, Japan; [Hayashida, Masakazu] Juntendo Univ, Sch Med, Dept Anesthesiol & Pain Med, Tokyo 113, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Dental College; Gifu University; Juntendo University	Ikeda, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Addict Substance Project, Tokyo 113, Japan.	ikeda-kz@igakuken.or.jp	Ichinomiya, Takashi/W-2784-2018	Ichinomiya, Takashi/0000-0002-9173-4514; Ichinohe, Tatsuya/0000-0001-5793-3379	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Tokyo, Japan) [22790518, 23390377, 24659549, 24790544, 25116532, 26293347, 26860360]; Ministry of Health, Labour and Welfare (MHLW) of Japan (Tokyo, Japan) [H21-3jigan-ippan-011, H22-Iyaku-015, H25-Iyaku-020, H26-Kakushintekigan-ippan-060, 14524680]; Smoking Research Foundation (Tokyo, Japan); Astellas Foundation for Research on Metabolic Disorders (Tokyo, Japan); Grants-in-Aid for Scientific Research [25116532] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare (MHLW) of Japan (Tokyo, Japan)(Ministry of Health, Labour and Welfare, Japan); Smoking Research Foundation (Tokyo, Japan); Astellas Foundation for Research on Metabolic Disorders (Tokyo, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Tokyo, Japan; no. 22790518, 23390377, 24659549, 24790544, 25116532, 26293347, and 26860360), Ministry of Health, Labour and Welfare (MHLW) of Japan (Tokyo, Japan; no. H21-3jigan-ippan-011, H22-Iyaku-015, H25-Iyaku-020, H26-Kakushintekigan-ippan-060, and 14524680), Smoking Research Foundation (Tokyo, Japan), and Astellas Foundation for Research on Metabolic Disorders (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Aoki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098548; BAHAR M, 1985, ANAESTHESIA, V40, P529; Basar H, 2003, J ENDOUROL, V17, P3, DOI 10.1089/089277903321196706; Bisgaard T, 2001, PAIN, V90, P261, DOI 10.1016/S0304-3959(00)00406-1; BUCHANAN WW, 1986, AM J MED, V80, P145, DOI 10.1016/0002-9343(86)90134-8; Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389; Coulbault L, 2006, CLIN PHARMACOL THER, V79, P316, DOI 10.1016/j.clpt.2006.01.007; Fukuda K, 2009, PAIN, V147, P194, DOI 10.1016/j.pain.2009.09.004; Goldstein Frederick J., 2002, Journal of the American Osteopathic Association, V102, pS15; GUINARD JP, 1995, ANESTHESIOLOGY, V82, P377, DOI 10.1097/00000542-199502000-00008; Hayashida M, 2008, PHARMACOGENOMICS, V9, P1605, DOI 10.2217/14622416.9.11.1605; HOSKIN PJ, 1991, DRUGS, V41, P326, DOI 10.2165/00003495-199141030-00002; Ide S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070694; Ikeda K, 2005, TRENDS PHARMACOL SCI, V26, P311, DOI 10.1016/j.tips.2005.04.001; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Kasai S, 2008, N-S ARCH PHARMACOL, V377, P269, DOI 10.1007/s00210-007-0205-3; Klepstad P, 2004, ACTA ANAESTH SCAND, V48, P1232, DOI 10.1111/j.1399-6576.2004.00517.x; KLINCK JR, 1982, ANAESTHESIA, V37, P907, DOI 10.1111/j.1365-2044.1982.tb01852.x; Kobayashi D, 2009, PAIN ORIG DIAGN TREA, P101; LOPER KA, 1990, ANESTH ANALG, V70, P72; Maliepaard M, 2013, NAT REV DRUG DISCOV, V12, P103, DOI 10.1038/nrd3931; Martikainen IK, 2004, NEUROSCI LETT, V361, P140, DOI 10.1016/j.neulet.2003.12.060; Nielsen CS, 2008, PAIN, V136, P21, DOI 10.1016/j.pain.2007.06.008; Nishizawa D, 2014, MOL PSYCHIATR, V19, P55, DOI 10.1038/mp.2012.164; Nishizawa D, 2010, METHODS MOL BIOL, V617, P395, DOI 10.1007/978-1-60327-323-7_29; Nishizawa D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007060; Ozcan S, 2002, SCAND J UROL NEPHROL, V36, P281, DOI 10.1080/003655902320248254; PATHAK KS, 1983, ANESTH ANALG, V62, P841; Rogers JF, 2002, AM J MED, V113, P746, DOI 10.1016/S0002-9343(02)01363-3; SUNSHINE S, 1994, TXB PAIN, P923; Zineh I, 2011, PHARMACOTHERAPY, V31, P729, DOI 10.1592/phco.31.8.729	32	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116885	10.1371/journal.pone.0116885	http://dx.doi.org/10.1371/journal.pone.0116885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615449	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100048
J	Chand, S; Chue, CD; Edwards, NC; Hodson, J; Simmonds, MJ; Hamilton, A; Gough, SCL; Harper, L; Steeds, RP; Townend, JN; Ferro, CJ; Borrows, R				Chand, Sourabh; Chue, Colin D.; Edwards, Nicola C.; Hodson, James; Simmonds, Matthew J.; Hamilton, Alexander; Gough, Stephen C. L.; Harper, Lorraine; Steeds, Rick P.; Townend, Jonathan N.; Ferro, Charles J.; Borrows, Richard			Endothelial Nitric Oxide Synthase Single Nucleotide Polymorphism and Left Ventricular Function in Early Chronic Kidney Disease	PLOS ONE			English	Article							DIASTOLIC FUNCTION; AMERICAN-SOCIETY; HEART-FAILURE; GENE; ASSOCIATION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; OVEREXPRESSION; POPULATION; GUIDELINES	Background Chronic kidney disease (CKD) is associated with accelerated cardiovascular disease and heart failure. Endothelial nitric oxide synthase (eNOS) Glu298Asp single nucleotide polymorphism (SNP) genotype has been associated with a worse phenotype amongst patients with established heart failure and in patients with progression of their renal disease. The association of a cardiac functional difference in non-dialysis CKD patients with no known previous heart failure, and eNOS gene variant is investigated. Methods 140 non-dialysis CKD patients, who had cardiac magnetic resonance (CMR) imaging and tissue doppler echocardiography as part of two clinical trials, were genotyped for eNOS Glu298Asp SNP retrospectively. Results The median estimated glomerular filtration rate (eGFR) was 50mls/min and left ventricular ejection fraction (LVEF) was 74% with no overt diastolic dysfunction in this cohort. There were significant differences in LVEF across eNOS genotypes with GG genotype being associated with a worse LVEF compared to other genotypes (LVEF: GG 71%, TG 76%, TT 73%, p = 0.006). After multivariate analysis, (adjusting for age, eGFR, baseline mean arterial pressure, contemporary CMR heart rate, total cholesterol, high sensitive C-reactive protein, body mass index and gender) GG genotype was associated with a worse LVEF, and increased LV end-diastolic and systolic index (p = 0.004, 0.049 and 0.009 respectively). Conclusions eNOS Glu298Asp rs1799983 polymorphism in CKD patients is associated with relevant sub-clinical cardiac remodelling as detected by CMR. This gene variant may therefore represent an important genetic biomarker, and possibly highlight pathways for intervention, in these patients who are at particular risk of worsening cardiac disease as their renal dysfunction progresses.	[Chand, Sourabh; Harper, Lorraine; Ferro, Charles J.; Borrows, Richard] Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2WB, W Midlands, England; [Chand, Sourabh; Harper, Lorraine; Borrows, Richard] Univ Birmingham, Ctr Translat Inflammat Res, Birmingham B15 2WB, W Midlands, England; [Chue, Colin D.; Edwards, Nicola C.; Steeds, Rick P.; Townend, Jonathan N.] Queen Elizabeth Hosp, Dept Cardiol, Birmingham B15 2WB, W Midlands, England; [Hodson, James] Old Queen Elizabeth Hosp, Wolfson Lab, Dept Stat, Birmingham B15 2TH, W Midlands, England; [Simmonds, Matthew J.; Hamilton, Alexander; Gough, Stephen C. L.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Gough, Stephen C. L.] Churchill Hosp, Oxford Natl Inst Hlth Res Biomed Res Ctr, Oxford OX3 7LG, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Oxford; University of Oxford	Chand, S (corresponding author), Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2WB, W Midlands, England.	sourabh.chand@nhs.net	Ferro, Charles J./O-8912-2016; ferro, charles/L-7250-2019	Ferro, Charles J./0000-0003-0577-7081; ferro, charles/0000-0003-0577-7081; Townend, Jonathan/0000-0002-5881-5806; Steeds, Richard/0000-0001-5687-2535; Chand, Sourabh/0000-0002-6126-3678; Simmonds, Matt/0000-0003-3154-3510; harper, lorraine/0000-0003-1343-9234; Hodson, James/0000-0003-3487-0090	Queen Elizabeth Hospital Charity Funding [12-30-46]; Diabetes, Research and Wellness Foundation (DRWF); National Institute for Health Research [PDF-2012-05-205] Funding Source: researchfish	Queen Elizabeth Hospital Charity Funding; Diabetes, Research and Wellness Foundation (DRWF); National Institute for Health Research(National Institute for Health Research (NIHR))	SC is in receipt of Queen Elizabeth Hospital Charity Funding 12-30-46: http://www.qehb.org. MJS is in receipt of a Diabetes, Research and Wellness Foundation (DRWF) Non-Clinical Fellowship: https://drwf.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Tardin OMA, 2013, ARQ BRAS CARDIOL, V101, P352, DOI 10.5935/abc.20130167; Brunner F, 2001, CIRCULATION, V104, P3097, DOI 10.1161/hc5001.101966; Chapman CB, 2013, ECHOCARDIOGR-J CARD, V30, P1022, DOI 10.1111/echo.12185; Chue CD, 2013, J AM SOC NEPHROL, V24, P842, DOI 10.1681/ASN.2012070719; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Edwards NC, 2010, AM J CARDIOL, V106, P1505, DOI 10.1016/j.amjcard.2010.07.018; Ferguson JF, 2013, J AM COLL CARDIOL, V62, P789, DOI 10.1016/j.jacc.2013.01.103; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Massion PB, 2004, CIRCULATION, V110, P2666, DOI 10.1161/01.CIR.0000145608.80855.BC; Massy ZA, 2009, SEMIN DIALYSIS, V22, P405, DOI 10.1111/j.1525-139X.2009.00590.x; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McNamara DM, 2003, CIRCULATION, V107, P1598, DOI 10.1161/01.CIR.0000060540.93836.AA; Velloso MWM, 2010, NITRIC OXIDE-BIOL CH, V22, P220, DOI 10.1016/j.niox.2009.12.007; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Page A, 2005, J AM SOC NEPHROL, V16, P3053, DOI 10.1681/ASN.2004110905; Philip I, 1999, CIRCULATION, V99, P3096, DOI 10.1161/01.CIR.99.24.3096; Stringer S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-95; Tang LF, 2014, PHARMACOL THERAPEUT, V142, P306, DOI 10.1016/j.pharmthera.2013.12.013; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Testa A, 2012, AM J HYPERTENS, V25, P103, DOI 10.1038/ajh.2011.178; Wilkinson IB, 1998, J HYPERTENS, V16, P2079, DOI 10.1097/00004872-199816121-00033; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034217, 10.1371/journal.pone.0036563]	25	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116160	10.1371/journal.pone.0116160	http://dx.doi.org/10.1371/journal.pone.0116160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612295	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000348562900010
J	Oellrich, A; Collier, N; Smedley, D; Groza, T				Oellrich, Anika; Collier, Nigel; Smedley, Damian; Groza, Tudor			Generation of Silver Standard Concept Annotations from Biomedical Texts with Special Relevance to Phenotypes	PLOS ONE			English	Article							ONTOLOGY; SERVICES	Electronic health records and scientific articles possess differing linguistic characteristics that may impact the performance of natural language processing tools developed for one or the other. In this paper, we investigate the performance of four extant concept recognition tools: the clinical Text Analysis and Knowledge Extraction System (cTAKES), the National Center for Biomedical Ontology (NCBO) Annotator, the Biomedical Concept Annotation System (BeCAS) and MetaMap. Each of the four concept recognition systems is applied to four different corpora: the i2b2 corpus of clinical documents, a PubMed corpus of Medline abstracts, a clinical trails corpus and the ShARe/CLEF corpus. In addition, we assess the individual system performances with respect to one gold standard annotation set, available for the ShARe/CLEF corpus. Furthermore, we built a silver standard annotation set from the individual systems' output and assess the quality as well as the contribution of individual systems to the quality of the silver standard. Our results demonstrate that mainly the NCBO annotator and cTAKES contribute to the silver standard corpora (F1-measures in the range of 21% to 74%) and their quality (best F1-measure of 33%), independent from the type of text investigated. While BeCAS and MetaMap can contribute to the precision of silver standard annotations (precision of up to 42%), the F1-measure drops when combined with NCBO Annotator and cTAKES due to a low recall. In conclusion, the performances of individual systems need to be improved independently from the text types, and the leveraging strategies to best take advantage of individual systems' annotations need to be revised. The textual content of the PubMed corpus, accession numbers for the clinical trials corpus, and assigned annotations of the four concept recognition systems as well as the generated silver standard annotation sets are available from http://purl.org/phenotype/resources. The textual content of the ShARe/CLEF (https://sites.google.com/site/shareclefehealth/data) and i2b2 (https://i2b2.org/NLP/DataSets/) corpora needs to be requested with the individual corpus providers.	[Oellrich, Anika; Smedley, Damian] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Collier, Nigel] EMBL European Bioinformat Inst, Hinxton CB10 1SA, England; [Collier, Nigel] Natl Inst Informat, Tokyo 1018430, Japan; [Groza, Tudor] Univ Queensland, Sch ITEE, St Lucia, Qld 4072, Australia; [Groza, Tudor] Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; University of Queensland; Garvan Institute of Medical Research	Groza, T (corresponding author), Univ Queensland, Sch ITEE, St Lucia, Qld 4072, Australia.	t.groza@garvan.org.au	Smedley, Damian/AAL-8172-2021	Groza, Tudor/0000-0003-2267-8333; Collier, Nigel/0000-0002-7230-4164	European Commission through the Marie Curie International Incoming Fellowship (IIF) programme (Project: Phenominer) [301806]; Wellcome Trust [098051]; National Institutes of Health [1 U54 HG006370-01]; Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA) [DE120100508]; Western Australian Government Department of Health, IRDiRC; RD-Connect-European Union [305444]; Australian National Health; Medical Research Council under the NHMRC-European Union Collaborative Research Grants scheme [APP1055319]; Education Investment Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006370] Funding Source: NIH RePORTER	European Commission through the Marie Curie International Incoming Fellowship (IIF) programme (Project: Phenominer); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA)(Australian Research Council); Western Australian Government Department of Health, IRDiRC; RD-Connect-European Union; Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council under the NHMRC-European Union Collaborative Research Grants scheme; Education Investment Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Nigel Collier's research is supported by the European Commission through the Marie Curie International Incoming Fellowship (IIF) programme (Project: Phenominer, Ref: 301806). Anika Oellrich and Damian Smedley's work is funded by the Wellcome Trust grant 098051 and National Institutes of Health grant 1 U54 HG006370-01. Tudor Groza's research is funded by the Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA) -DE120100508. Tudor Groza acknowledges his involvement in the International Rare Disease Research Consortium (IRDiRC) and the support from The Western Australian Government Department of Health as part of its commitment to the goals of the IRDiRC. Furthermore, Tudor Groza gratefully acknowledges the combined financial support-in-part from the RD-Connect-European Union Seventh Framework Programme (HEALTH. 2012.2. 1. 1-1-C) under grant agreement number 305444: RD Connect: An integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research; and from the Australian National Health and Medical Research Council APP1055319 under the NHMRC-European Union Collaborative Research Grants scheme. The authors acknowledge use of computing resources from the NeCTAR research cloud (http://www.nectar.org.au). NeCTAR is an Australian Government project conducted as part of the Super Science initiative and financed by the Education Investment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Bada M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-161; Baumgartner WA, 2007, BIOINFORMATICS, V23, pI41, DOI 10.1093/bioinformatics/btm229; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Browne AC, 2000, NATL LIB MED TECHNIC, P18; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; *CLEM JONQ NHSMAM, 2009, SUMMIT ON TRANSLATIO, V56; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Fluck J, 2014, DRUG DISCOV TODAY, V19, P140, DOI 10.1016/j.drudis.2013.09.012; Funk C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-59; Groza Tudor, 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P481, DOI 10.1109/BIBM.2013.6732541; Hettne KM, 2009, BIOINFORMATICS, V25, P2983, DOI 10.1093/bioinformatics/btp535; Jimeno A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S3; KIM JD, 2003, BIOINFORMATICS S1, V19, P180, DOI DOI 10.1093/BIOINFORMATICS/BTG1023; Li C, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat030; Liu S., 2005, IT Professional, V7, P17, DOI 10.1109/MITP.2005.122; MCCRAY AT, 1993, B MED LIBR ASSOC, V81, P184; McDonald CJ, 2003, CLIN CHEM, V49, P624, DOI 10.1373/49.4.624; Nunes T, 2013, BIOINFORMATICS, V29, P1915, DOI 10.1093/bioinformatics/btt317; Rebholz-Schuhmann D, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-28; Rebholz-Schuhmann Dietrich, 2011, J Biomed Semantics, V2 Suppl 5, pS11, DOI 10.1186/2041-1480-2-S5-S11; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; SAGAE K, 2007, EMNLP CONLL; Sasaki Y, 2008, P 3 INT S SEM MIN BI, V3, P109; Schofield PN, 2012, HUM MUTAT, V33, P826, DOI 10.1002/humu.22077; Shah NH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S14; Stearns MQ, 2001, J AM MED INFORM ASSN, P662; Warren S T, 1993, Curr Opin Neurobiol, V3, P752, DOI 10.1016/0959-4388(93)90149-S; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469	30	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116040	10.1371/journal.pone.0116040	http://dx.doi.org/10.1371/journal.pone.0116040			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607983	Green Submitted, gold, Green Published			2022-12-27	WOS:000348205300023
J	Wu, JR; Hu, CT; You, RI; Ma, PL; Pan, SM; Lee, MC; Wu, WS				Wu, Jia-Ru; Hu, Chi-Tan; You, Ren-In; Ma, Pei-Ling; Pan, Siou-Mei; Lee, Ming-Che; Wu, Wen-Sheng			Preclinical Trials for Prevention of Tumor Progression of Hepatocellular Carcinoma by LZ-8 Targeting c-Met Dependent and Independent Pathways	PLOS ONE			English	Article							FUNGAL IMMUNOMODULATORY PROTEIN; HEPATOCYTE GROWTH-FACTOR; LUNG-CANCER CELLS; GANODERMA-TSUGAE; EXPRESSION; MIGRATION; MANAGEMENT; SORAFENIB; HGF; METASTASIS	Hepatocellular carcinoma (HCC) is among the most lethal cancers. Mounting studies highlighted the essential role of the HGF/c-MET axis in driving HCC tumor progression. Therefore, c-Met is a potential therapeutic target for HCC. However, several concerns remain unresolved in c-Met targeting. First, the status of active c-Met in HCC must be screened to determine patients suitable for therapy. Second, resistance and side effects have been observed frequently when using conventional c-Met inhibitors. Thus, a preclinical system for screening the status of c-Met signaling and identifying efficient and safe anti-HCC agents is urgently required. In this study, immunohistochemical staining of phosphorylated c-Met (Tyr1234) on tissue sections indicated that HCCs with positive c-Met signaling accounted for approximately 46% in 26 cases. Second, many patient-derived HCC cell lines were established and characterized according tomotility and c-Met signaling status. Moreover, LZ8, a medicinal peptide purified from the herb Lingzhi, featuring immunomodulatory and anticancer properties, was capable of suppressing cell migration and slightly reducing the survival rate of both c-Met positive and negative HCCs, HCC372, and HCC329, respectively. LZ8 also suppressed the intrahepatic metastasis of HCC329 in SCID mice. On the molecular level, LZ8 suppressed the expression of c-Met and phosphorylation of c-Met, ERK and AKT in HCC372, and suppressed the phosphorylation of JNK, ERK, and AKT in HCC329. According to receptor array screening, themajor receptor tyrosine kinase activated in HCC329 was found to be the epidermal growth factor receptor (EGFR). Moreover, tyrosine-phosphorylated EGFR (the active EGFR) was greatly suppressed in HCC329 by LZ8 treatment. In addition, LZ8 blocked HGF-induced cellmigration and c-Met-dependent signaling in HepG2. In summary, we designed a preclinical trial using LZ8 to prevent the tumor progression of patient-derived HCCs with c-Met-positive or -negative signaling.	[Wu, Jia-Ru; Wu, Wen-Sheng] Tzu Chi Univ, Inst Med Sci, Hualein, Taiwan; [You, Ren-In; Ma, Pei-Ling; Wu, Wen-Sheng] Tzu Chi Univ, Coll Med, Dept Lab Med & Biotechnol, Hualein, Taiwan; [Hu, Chi-Tan; Pan, Siou-Mei] Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Res Ctr Hepatol, Hualein, Taiwan; [Hu, Chi-Tan; Pan, Siou-Mei] Tzu Chi Univ, Dept Internal Med, Hualein, Taiwan; [Lee, Ming-Che] Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Sch Med, Dept Surg, Hualein, Taiwan	Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Tzu Chi University	Wu, WS (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualein, Taiwan.	wuwstcu1234@yahoo.com.tw	Y, RI/AAR-1036-2021; Wu, Wen-Sheng/AAN-9078-2020	Y, RI/0000-0002-6289-1852; Wu, Jia-Ru/0000-0002-8414-6968	Ministry of Science and Technology in Taiwan	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work is supported by the Ministry of Science and Technology in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Buijs JT, 2011, CANCER MICROENVIRON, V4, P261, DOI 10.1007/s12307-011-0075-6; Chan SPL, 2012, J GASTROEN HEPATOL, V27, P862, DOI 10.1111/j.1440-1746.2012.07096.x; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chiang KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093151; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Diaz D, 2013, TOXICOL APPL PHARM, V266, P86, DOI 10.1016/j.taap.2012.10.026; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fu WM, 2012, J PROTEOMICS, V75, P4833, DOI 10.1016/j.jprot.2012.05.032; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Gao JJ, 2012, PHARMACOL RES, V65, P23, DOI 10.1016/j.phrs.2011.11.011; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hagiwara S, 2012, BRIT J CANCER, V106, P1997, DOI 10.1038/bjc.2012.145; Hsu HY, 2008, J CELL PHYSIOL, V215, P15, DOI 10.1002/jcp.21144; Hu CT, 2013, CELL SIGNAL, V25, P1457, DOI 10.1016/j.cellsig.2013.03.011; Jiang Y, 2001, BIOCHEM BIOPH RES CO, V286, P1123, DOI 10.1006/bbrc.2001.5521; Kaposi-Novak Pal, 2009, Magy Onkol, V53, P61, DOI 10.1556/MOnkol.53.2009.1.9; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Kudo M, 2012, WORLD J GASTROENTERO, V18, P6005, DOI 10.3748/wjg.v18.i42.6005; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li T, 2014, ASIAN PAC J CANCER P, V15, P1745, DOI 10.7314/APJCP.2014.15.4.1745; Liao CH, 2006, MOL CARCINOGEN, V45, P220, DOI 10.1002/mc.20161; Liao CH, 2007, BIOCHEM PHARMACOL, V74, P1541, DOI 10.1016/j.bcp.2007.07.025; Lin CC, 2011, CANCER IMMUNOL IMMUN, V60, P1019, DOI 10.1007/s00262-011-1016-4; Lin YL, 2009, J LEUKOCYTE BIOL, V86, P877, DOI 10.1189/jlb.0708441; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Min LH, 2011, SEMIN CANCER BIOL, V21, P10, DOI 10.1016/j.semcancer.2010.10.011; Ogunwobi OO, 2012, J GASTROEN HEPATOL, V27, P566, DOI 10.1111/j.1440-1746.2011.06980.x; Ogunwobi OO, 2011, CLIN EXP METASTAS, V28, P721, DOI 10.1007/s10585-011-9404-x; Osada S, 2008, HEPATO-GASTROENTEROL, V55, P544; PELICCI G, 1995, ONCOGENE, V10, P1631; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Radtke S, 2013, J CELL SCI, V126, P2381, DOI 10.1242/jcs.115832; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Santoro A, 2013, BRIT J CANCER, V108, P21, DOI 10.1038/bjc.2012.556; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Wang PH, 2007, REPROD SCI, V14, P475, DOI 10.1177/1933719107305035; Wang ZL, 2008, J GASTROINTEST SURG, V12, P327, DOI 10.1007/s11605-007-0310-0; Wu CT, 2011, CARCINOGENESIS, V32, P1890, DOI 10.1093/carcin/bgr221; Xue Q, 2008, J GEN APPL MICROBIOL, V54, P393, DOI 10.2323/jgam.54.393; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Zhai B, 2013, WORLD J HEPATOL, V5, P345, DOI 10.4254/wjh.v5.i7.345; Zhang SZ, 2005, MOL CANCER THER, V4, P1577, DOI 10.1158/1535-7163.MCT-05-0106; Zhang YH, 2011, MED ONCOL, V28, P966, DOI 10.1007/s12032-010-9568-2; Zhu AX, 2013, CLIN CANCER RES, V19, P920, DOI 10.1158/1078-0432.CCR-12-2616; Zhu AX, 2012, SEMIN ONCOL, V39, P493, DOI 10.1053/j.seminoncol.2012.05.014; Zhu KK, 2014, EXPERT OPIN THER PAT, V24, P217, DOI 10.1517/13543776.2014.864279	58	44	46	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0114495	10.1371/journal.pone.0114495	http://dx.doi.org/10.1371/journal.pone.0114495			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607934	gold, Green Submitted, Green Published			2022-12-27	WOS:000348205300004
J	Cenedese, V; Mezzavilla, M; Morgan, A; Marino, R; Ettorre, CP; Margaglione, M; Gasparini, P; Menini, A				Cenedese, Valentina; Mezzavilla, Massimo; Morgan, Anna; Marino, Renato; Ettorre, Cosimo Pietro; Margaglione, Maurizio; Gasparini, Paolo; Menini, Anna			Assessment of the Olfactory Function in Italian Patients with Type 3 von Willebrand Disease Caused by a Homozygous 253 Kb Deletion Involving VWF and TMEM16B/ANO2	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; SMELL IDENTIFICATION TEST; VONWILLEBRAND-FACTOR; TMEM16A; PROTEIN; CURRENTS; GERMAN; SITES; GENE	Type 3 Von Willebrand disease is an autosomal recessive disease caused by the virtual absence of the von Willebrand factor (VWF). A rare 253 kb gene deletion on chromosome 12, identified only in Italian and German families, involves both the VWF gene and the N-terminus of the neighbouring TMEM16B/ANO2 gene, a member of the family named transmembrane 16 (TMEM16) or anoctamin (ANO). TMEM16B is a calcium-activated chloride channel expressed in the olfactory epithelium. As a patient homozygous for the 253 kb deletion has been reported to have an olfactory impairment possibly related to the partial deletion of TMEM16B, we assessed the olfactory function in other patients using the University of Pennsylvania Smell Identification Test (UPSIT). The average UPSIT score of 4 homozygous patients was significantly lower than that of 5 healthy subjects with similar sex, age and education. However, 4 other members of the same family, 3 heterozygous for the deletion and 1 wild type, had a slightly reduced olfactory function indicating that socio-cultural or other factors were likely to be responsible for the observed difference. These results show that the ability to identify odorants of the homozygous patients for the deletion was not significantly different from that of the other members of the family, showing that the 253 kb deletion does not affect the olfactory performance. As other genes may compensate for the lack of TMEM16B, we identified some predicted functional partners from in silico studies of the protein-protein network of TMEM16B. Calculation of diversity for the corresponding genes for individuals of the 1000 Genomes Project showed that TMEM16B has the highest level of diversity among all genes of the network, indicating that TMEM16B may not be under purifying selection and suggesting that other genes in the network could compensate for its function for olfactory ability.	[Cenedese, Valentina; Menini, Anna] SISSA, Int Sch Adv Studies, Neurobiol Grp, I-34014 Trieste, Italy; [Mezzavilla, Massimo; Morgan, Anna; Gasparini, Paolo] Univ Trieste, Ist Ricovero & Cura Carattere Sci Burlo Garofo, Inst Maternal & Child Hlth, Trieste, Italy; [Mezzavilla, Massimo; Morgan, Anna; Gasparini, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Marino, Renato; Ettorre, Cosimo Pietro] Azienda Osped Univ Osped Policlin Consorziale Gio, Ctr Emofilia & Trombosi, Bari, Italy; [Margaglione, Maurizio] Univ Foggia, Dipartimento Med Clin & Sperimentale, Genet Med, Foggia, Italy	International School for Advanced Studies (SISSA); University of Trieste; University of Trieste; University of Foggia	Menini, A (corresponding author), SISSA, Int Sch Adv Studies, Neurobiol Grp, I-34014 Trieste, Italy.	menini@sissa.it	Gasparini, Paolo/B-6173-2014; Morgan, Anna/K-2238-2018; Mezzavilla, Massimo/AAL-8225-2020; Mezzavilla, Massimo/J-2948-2018	Morgan, Anna/0000-0001-6290-445X; Mezzavilla, Massimo/0000-0002-9000-4595; Mezzavilla, Massimo/0000-0002-9000-4595; Menini, Anna/0000-0001-9304-0412; MARGAGLIONE, MAURIZIO/0000-0001-5627-9221; Gasparini, Paolo/0000-0002-0859-0856	PRIN grant from the Italian Ministry of Education, University and Research (MIUR) [2010599KBR]	PRIN grant from the Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work is supported by PRIN 2010599KBR grant from the Italian Ministry of Education, University and Research (MIUR)to A. Menini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; BLOOM AL, 1991, MAYO CLIN PROC, V66, P743, DOI 10.1016/S0025-6196(12)62088-6; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castaman G, 2013, CURR OPIN HEMATOL, V20, P424, DOI 10.1097/MOH.0b013e328363c11f; Cenedese V, 2012, J GEN PHYSIOL, V139, P285, DOI 10.1085/jgp.201110764; Cumming AM, 2010, J COAG DIS, V2, P29; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Eikenboom JCJ, 1998, THROMB HAEMOSTASIS, V79, P709; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gonzalez-Silva C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069295; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Klimmeck D, 2009, J COMP NEUROL, V515, P585, DOI 10.1002/cne.22075; MANNUCCI PM, 1984, BRIT J HAEMATOL, V57, P163, DOI 10.1111/j.1365-2141.1984.tb02876.x; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; Nei M., 1987, MOLECULAR EVOLUTIONA; NGO KY, 1988, P NATL ACAD SCI USA, V85, P2753, DOI 10.1073/pnas.85.8.2753; Nickell MD, 2012, J COMP NEUROL, V520, P2608, DOI 10.1002/cne.23052; Parola S, 1999, ITAL J NEUROL SCI, V20, P287, DOI 10.1007/s100720050043; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Picillo M, 2014, NEUROL SCI, V35, P379, DOI 10.1007/s10072-013-1522-6; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pifferi S, 2012, EXP PHYSIOL, V97, P193, DOI 10.1113/expphysiol.2011.058230; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Piirsoo M, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-10; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sagheddu C, 2010, J PHYSIOL-LONDON, V588, P4189, DOI 10.1113/jphysiol.2010.194407; Saidu SP, 2013, J GEN PHYSIOL, V141, P691, DOI 10.1085/jgp.201210937; Schneppenheim R, 2007, J THROMB HAEMOST, V5, P722, DOI 10.1111/j.1538-7836.2007.02460.x; SCHNEPPENHEIM R, 1994, HUM GENET, V94, P640; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SHELTONINLOES BB, 1987, J CLIN INVEST, V79, P1459, DOI 10.1172/JCI112974; Sondo E, 2014, BBA-BIOMEMBRANES, V1838, P89, DOI 10.1016/j.bbamem.2013.08.010; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu TT, 2005, J COMP NEUROL, V483, P251, DOI 10.1002/cne.20429	41	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116483	10.1371/journal.pone.0116483	http://dx.doi.org/10.1371/journal.pone.0116483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635880	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700040
J	Petrantonakis, PC; Poirazi, P				Petrantonakis, Panagiotis C.; Poirazi, Panayiota			Dentate Gyrus Circuitry Features Improve Performance of Sparse Approximation Algorithms	PLOS ONE			English	Article							PATTERN SEPARATION; COMPUTATIONAL THEORY; PLACE CELLS; HIPPOCAMPUS; CA3; INTERNEURONS; OSCILLATIONS; INHIBITION; PLASTICITY; FREQUENCY	Memory-related activity in the Dentate Gyrus (DG) is characterized by sparsity. Memory representations are seen as activated neuronal populations of granule cells, the main encoding cells in DG, which are estimated to engage 2-4% of the total population. This sparsity is assumed to enhance the ability of DG to perform pattern separation, one of the most valuable contributions of DG during memory formation. In this work, we investigate how features of the DG such as its excitatory and inhibitory connectivity diagram can be used to develop theoretical algorithms performing Sparse Approximation, a widely used strategy in the Signal Processing field. Sparse approximation stands for the algorithmic identification of few components from a dictionary that approximate a certain signal. The ability of DG to achieve pattern separation by sparsifing its representations is exploited here to improve the performance of the state of the art sparse approximation algorithm "Iterative Soft Thresholding" (IST) by adding new algorithmic features inspired by the DG circuitry. Lateral inhibition of granule cells, either direct or indirect, via mossy cells, is shown to enhance the performance of the IST. Apart from revealing the potential of DG-inspired theoretical algorithms, this work presents new insights regarding the function of particular cell types in the pattern separation task of the DG.	[Petrantonakis, Panagiotis C.; Poirazi, Panayiota] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece	Foundation for Research & Technology - Hellas (FORTH)	Poirazi, P (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.	poirazi@imbb.forth.gr	Petrantonakis, Panagiotis/L-2286-2018	Poirazi, Panayiota/0000-0001-6152-595X	European Research Council Starting Grant dEMORY [ERC-2012-StG-311435]	European Research Council Starting Grant dEMORY	Support was provided by the European Research Council Starting Grant dEMORY (ERC-2012-StG-311435) [URL: http://erc.europa.eu/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 2007, PROG BRAIN RES, V163, P577, DOI 10.1016/S0079-6123(07)63031-3; Akam T, 2012, NAT NEUROSCI, V15, P763, DOI 10.1038/nn.3081; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Daubechies I, 2004, COMMUN PUR APPL MATH, V57, P1413, DOI 10.1002/cpa.20042; de Almeida L, 2009, J NEUROSCI, V29, P7497, DOI 10.1523/JNEUROSCI.6044-08.2009; Donoho DL, 2009, P NATL ACAD SCI USA, V106, P18914, DOI 10.1073/pnas.0909892106; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Figueiredo MAT, 2007, IEEE T IMAGE PROCESS, V16, P2980, DOI 10.1109/TIP.2007.909318; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Jinde S, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00014; Jinde S, 2012, NEURON, V76, P1189, DOI 10.1016/j.neuron.2012.10.036; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lisman JE, 2005, NEURAL NETWORKS, V18, P1191, DOI 10.1016/j.neunet.2005.08.008; Maleki A, 2010, IEEE J-STSP, V4, P330, DOI 10.1109/JSTSP.2009.2039176; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Myers CE, 2011, HIPPOCAMPUS, V21, P1190, DOI 10.1002/hipo.20828; Myers CE, 2009, HIPPOCAMPUS, V19, P321, DOI 10.1002/hipo.20516; Neunuebel JP, 2014, NEURON, V81, P416, DOI 10.1016/j.neuron.2013.11.017; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Petrantonakis P, 2014, COMPRESSED SENSING P; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Rolls ET, 2010, BEHAV BRAIN RES, V215, P180, DOI 10.1016/j.bbr.2010.03.027; Ross ST, 2001, P NATL ACAD SCI USA, V98, P8874, DOI 10.1073/pnas.141042398; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Sardy S, 2000, J COMPUT GRAPH STAT, V9, P361, DOI 10.2307/1390659; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209	36	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117023	10.1371/journal.pone.0117023	http://dx.doi.org/10.1371/journal.pone.0117023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635776	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700068
J	Rajaram, N; Reesor, AF; Mulvey, CS; Frees, AE; Ramanujam, N				Rajaram, Narasimhan; Reesor, Andrew F.; Mulvey, Christine S.; Frees, Amy E.; Ramanujam, Nirmala			Non-Invasive, Simultaneous Quantification of Vascular Oxygenation and Glucose Uptake in Tissue	PLOS ONE			English	Article							TUMOR OXYGENATION; AEROBIC GLYCOLYSIS; PYRUVATE-KINASE; METABOLIC MICROMILIEU; OPTICAL SPECTROSCOPY; BLOOD-FLOW; CANCER; HYPOXIA; METASTASES; M2	We report the development of non-invasive, fiber-based diffuse optical spectroscopy for simultaneously quantifying vascular oxygenation (SO2) and glucose uptake in solid tumors in vivo. Glucose uptake was measured using a fluorescent glucose analog, 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-deoxyglucose (2-NBDG). Quantification of label-free SO2 and 2-NBDG-fluorescence-based glucose uptake 60 minutes after administration of the tracer (2-NBDG(60)) was performed using computational models of light-tissue interaction. This study was carried out on normal tissue and 4T1 and 4T07 murine mammary tumor xenografts in vivo. Injection of 2-NBDG did not cause a significant change in optical measurements of SO2, demonstrating its suitability as a functional reporter of tumor glucose uptake. Correction of measured 2-NBDG-fluorescence for the effects of absorption and scattering significantly improved contrast between tumor and normal tissue. The 4T1 and 4T07 tumors showed significantly decreased SO2, and 4T1 tumors demonstrated increased 2-NBDG(60) compared with normal tissue (60 minutes after the administration of 2-NBDG when perfusion-mediated effects have cleared). 2-NBDG-fluorescence was found to be highly sensitive to food deprivation-induced reduction in blood glucose levels, demonstrating that this endpoint is indeed sensitive to glycolytic demand. 2-NBDG(60) was also found to be linearly related to dose, underscoring the importance of calibrating for dose when comparing across animals or experiments. 4T1 tumors demonstrated an inverse relationship between 2-NBDG(60) and SO2 that was consistent with the Pasteur effect, particularly when exposed to hypoxic gas breathing. Our results illustrate the potential of optical spectroscopy to provide valuable information about the metabolic status of tumors, with important implications for cancer prognosis.	[Rajaram, Narasimhan; Reesor, Andrew F.; Mulvey, Christine S.; Frees, Amy E.; Ramanujam, Nirmala] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University	Rajaram, N (corresponding author), Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA.	nrajaram@uark.edu	Rajaram, Narasimhan/A-2249-2010; Ramanujam, Nimmi/AAA-7575-2021	Rajaram, Narasimhan/0000-0003-1224-8567; Ramanujam, Nimmi/0000-0001-7319-8415; Martinez, Amy/0000-0002-8088-7398	Department of Defense Era of Hope Scholar Award [W81XWH-091-0410]	Department of Defense Era of Hope Scholar Award(United States Department of Defense)	Funding was provided by a Department of Defense Era of Hope Scholar Award (W81XWH-091-0410; PI: Nirmala Ramanujam). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Bender JE, 2009, IEEE T BIO-MED ENG, V56, P960, DOI 10.1109/TBME.2008.2005994; Brizel DM, 1996, CANCER RES, V56, P941; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Brown JQ, 2009, CANCER RES, V69, P2919, DOI 10.1158/0008-5472.CAN-08-3370; Busk M, 2008, INT J CANCER, V122, P2726, DOI 10.1002/ijc.23449; Bydlon TM, 2010, OPT EXPRESS, V18, P8058, DOI 10.1364/OE.18.008058; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DeBerardinis RJ, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-5; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Frees AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115529; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heppner GH, 2000, BREAST CANCER RES, V2, P331; KALLINOWSKI F, 1988, CANCER RES, V48, P7264; KALLINOWSKI F, 1989, INT J CANCER, V44, P266, DOI 10.1002/ijc.2910440214; Kasischke KA, 2011, J CEREBR BLOOD F MET, V31, P68, DOI 10.1038/jcbfm.2010.158; KHANDELWAL SR, 1993, AM J PHYSIOL, V265, pH1450, DOI 10.1152/ajpheart.1993.265.4.H1450; Khodarev NN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005821; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lim LA, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3525288; Liu CB, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077012; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Manka D, 2005, CANCER RES, V65, P11689, DOI 10.1158/0008-5472.CAN-05-3091; Marcinek DJ, 2003, AM J PHYSIOL-HEART C, V285, pH1900, DOI 10.1152/ajpheart.00192.2003; Matsumoto S, 2008, J CLIN INVEST, V118, P1965, DOI 10.1172/JCI34928; Matsumoto S, 2013, MAGN RESON MED, V69, P1443, DOI 10.1002/mrm.24355; Miller S, 2010, BOOK MIDWIVES CARE P, V2nd, P1; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Palmer GM, 2006, APPL OPTICS, V45, P1062, DOI 10.1364/AO.45.001062; Palmer GM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523363; Palmer GM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907161; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pitroda SP, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-68; Rajaram N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076524; Rajaram N, 2010, LASER SURG MED, V42, P716, DOI 10.1002/lsm.21009; Rajendran JG, 2005, RADIOL CLIN N AM, V43, P169, DOI 10.1016/j.rcl.2004.08.004; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Snyder SA, 2001, INT J RADIAT ONCOL, V51, P494, DOI 10.1016/S0360-3016(01)01654-6; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; Vishwanath K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3251013; Vishwanath K, 2009, NEOPLASIA, V11, P889, DOI 10.1593/neo.09580; Young CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023205; Yu B, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3524303; Zasadny KR, 2003, EUR J NUCL MED MOL I, V30, P274, DOI 10.1007/s00259-002-1022-z; Zhang GQ, 2009, NAT MATER, V8, P747, DOI [10.1038/NMAT2509, 10.1038/nmat2509]	50	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117132	10.1371/journal.pone.0117132	http://dx.doi.org/10.1371/journal.pone.0117132			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635865	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700071
J	Yan, RT; He, L; Zhan, WJ; Wang, SZ				Yan, Run-Tao; He, Li; Zhan, Wenjie; Wang, Shu-Zhen			Induction of Ectopic Retina-Like Tissue by Transgenic Expression of neurogenin	PLOS ONE			English	Article							CILIARY EPITHELIAL-CELLS; PHOTORECEPTOR-LIKE CELLS; ADULT MAMMALIAN EYE; PIGMENT-EPITHELIUM; IN-VIVO; NEURAL RETINA; STEM-CELLS; MACULAR DEGENERATION; RPE CELLS; MOUSE	Degeneration of retinal neurons is an underlying cause of several major types of blinding diseases, and effective therapies remain to be developed. The suppositive strategy of re-populating a degenerative retina with new cells generated onsite faces serious challenges, because the mammalian retina seems to lack the ability to regenerate itself or replace its lost neurons. We investigated the possibility of using a transcriptional factor with proneural activities to reprogram ocular tissue with regenerative capability to give rise to retinal cells. Transgenic mice were generated with DNA constructs that targeted the expression in the retinal pigment epithelium of proneural gene neurogenin1 from the promoter of Bestrophin1, or neurogenin3 from RPE65 promoter. Here we report the presence of ectopic retina-like tissue in some of the transgenic mice, young and aged. The ectopic retina-like tissue contained cells positive for photoreceptor proteins Crx, recoverin, red opsin, and rhodopsin, and cells positive for proteins that label other types of retinal neurons, including AP2 alpha and Pax6 for amacrine cells, Otx2 for bipolar cells, and Brn3A for ganglion cells. The retina-like tissue often co-existed with darkly pigmented tissue positive for RPE proteins: cytokeratin 18, Otx2, and RPE65. The ectopic retina-like tissue was detected in the subretinal space, including two retinae co-existing in the same eye, and/or in the optic nerve or in the vicinity of the optic nerve head. On rare occasions, it was detected in the choroid and in the vicinity of the ciliary body. The presence of ectopic retina-like tissue in the transgenic mouse supports the possibility of inducing retinal regeneration in the mammalian eyes through gene-directed reprograming.	[Yan, Run-Tao; He, Li; Zhan, Wenjie; Wang, Shu-Zhen] Univ Alabama Birmingham, Dept Ophthalmol, Med Sch Birmingham, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Wang, SZ (corresponding author), Univ Alabama Birmingham, Dept Ophthalmol, Med Sch Birmingham, Birmingham, AL 35294 USA.	szwang@uab.edu	He, Li/I-6060-2015		NIH/NEI grant [EY011640]; International Retinal Research Foundation grant [FY2011-12-276]; Research to Prevent Blindness; NIH/NEI core grant [P30 EY003039]; NATIONAL EYE INSTITUTE [R01EY011640, P30EY003039] Funding Source: NIH RePORTER	NIH/NEI grant; International Retinal Research Foundation grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH/NEI core grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by NIH/NEI grant EY011640, the International Retinal Research Foundation grant FY2011-12-276, Research to Prevent Blindness (non-restricted award to the University of Alabama Department of Ophthalmology), and NIH/NEI core grant P30 EY003039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; Al-Hussaini H, 2008, MOL VIS, V14, P1784; ANDERSON DH, 1981, INVEST OPHTH VIS SCI, V21, P10; Bakall B, 2003, INVEST OPHTH VIS SCI, V44, P3622, DOI 10.1167/iovs.03-0030; Bassett EA, 2010, HUM MOL GENET, V19, P1791, DOI 10.1093/hmg/ddq060; Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450; Bernier G, 2000, MECH DEVELOP, V93, P59, DOI 10.1016/S0925-4773(00)00271-9; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Bumsted KM, 2000, INVEST OPHTH VIS SCI, V41, P903; Chow RL, 1999, DEVELOPMENT, V126, P4213; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; COULOMBRE JL, 1965, DEV BIOL, V12, P79, DOI 10.1016/0012-1606(65)90022-9; Crisanti S, 1995, INVEST OPHTH VIS SCI, V36, P391; DELPRIORE LV, 1995, ARCH OPHTHALMOL-CHIC, V113, P939, DOI 10.1001/archopht.1995.01100070113034; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Gualdoni S, 2010, STEM CELLS, V28, P1048, DOI 10.1002/stem.423; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Kiilgaard JF, 2007, INVEST OPHTH VIS SCI, V48, P355, DOI 10.1167/iovs.05-1565; Kubota R, 2002, DEV BRAIN RES, V134, P31, DOI 10.1016/S0165-3806(01)00287-5; la Cour M, 2008, ACTA OPHTHALMOL, V86, P593, DOI 10.1111/j.1755-3768.2008.01373.x; Lagutin O, 2001, DEV DYNAM, V221, P342, DOI 10.1002/dvdy.1148; Lauqa H, 1975, AM J OPHTHALMOL, V80, P913; Loosli F, 1999, GENE DEV, V13, P649, DOI 10.1101/gad.13.6.649; LOPEZ PF, 1995, ARCH OPHTHALMOL-CHIC, V113, P1437, DOI 10.1001/archopht.1995.01100110097032; Ma WX, 2009, MOL CELL NEUROSCI, V40, P187, DOI 10.1016/j.mcn.2008.10.006; MACHEMER R, 1975, AM J OPHTHALMOL, V80, P1; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Ohta K, 2008, DEV GROWTH DIFFER, V50, P253, DOI [10.1111/j.1440-169x.2008.01006.x, 10.1111/j.1440-169X.2008.01006.x]; Ozaki S, 1997, CURR EYE RES, V16, P349, DOI 10.1076/ceyr.16.4.349.10696; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; Rabenlehner D, 2008, GRAEF ARCH CLIN EXP, V246, P345, DOI 10.1007/s00417-007-0658-6; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Sakami S, 2008, MECH DEVELOP, V125, P106, DOI 10.1016/j.mod.2007.10.001; Salero E, 2012, CELL STEM CELL, V10, P88, DOI 10.1016/j.stem.2011.11.018; Sugino IK, 2003, MOL NEUROBIOL, V28, P177, DOI 10.1385/MN:28:2:177; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Vergara MN, 2009, MOL VIS, V15, P1000; Yan RT, 2013, INVEST OPHTH VIS SCI, V54, P4766, DOI 10.1167/iovs.13-11936; Yan RT, 2013, MOL VIS, V19, P1178; Yan RT, 2010, J COMP NEUROL, V518, P526, DOI 10.1002/cne.22236; Yan RT, 2009, INVEST OPHTH VIS SCI, V50, P5567, DOI 10.1167/iovs.09-3647; ZHANG NL, 1993, INVEST OPHTH VIS SCI, V34, P2412; ZHAO SL, 1995, BRAIN RES, V677, P300, DOI 10.1016/0006-8993(95)00163-K; Zhu ML, 2010, ADV EXP MED BIOL, V664, P211, DOI 10.1007/978-1-4419-1399-9_24	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116171	10.1371/journal.pone.0116171	http://dx.doi.org/10.1371/journal.pone.0116171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635399	gold, Green Submitted, Green Published			2022-12-27	WOS:000350680700026
J	Fjellstrom, O; Akkaya, S; Beisel, HG; Eriksson, PO; Erixon, K; Gustafsson, D; Jurva, U; Kang, D; Karis, D; Knecht, W; Nerme, V; Nilsson, I; Olsson, T; Redzic, A; Roth, R; Sandmark, J; Tigerstrom, A; Oster, L				Fjellstrom, Ola; Akkaya, Sibel; Beisel, Hans-Georg; Eriksson, Per-Olof; Erixon, Karl; Gustafsson, David; Jurva, Ulrik; Kang, Daiwu; Karis, David; Knecht, Wolfgang; Nerme, Viveca; Nilsson, Ingemar; Olsson, Thomas; Redzic, Alma; Roth, Robert; Sandmark, Jenny; Tigerstrom, Anna; Oster, Linda			Creating Novel Activated Factor XI Inhibitors through Fragment Based Lead Generation and Structure Aided Drug Design	PLOS ONE			English	Article							COAGULATION-FACTOR XI; PROTEIN-LIGAND COMPLEXES; RAY CRYSTALLOGRAPHY; CRYSTAL-STRUCTURES; BIOLOGICAL EVALUATION; THROMBUS PROPAGATION; PROVIDES PROTECTION; ACCURATE DOCKING; CHEMICAL BIOLOGY; ISCHEMIC-STROKE	Activated factor XI (FXIa) inhibitors are anticipated to combine anticoagulant and profibrinolytic effects with a low bleeding risk. This motivated a structure aided fragment based lead generation campaign to create novel FXIa inhibitor leads. A virtual screen, based on docking experiments, was performed to generate a FXIa targeted fragment library for an NMR screen that resulted in the identification of fragments binding in the FXIa S1 binding pocket. The neutral 6-chloro-3,4-dihydro-1H-quinolin-2-one and the weakly basic quinolin-2-amine structures are novel FXIa P1 fragments. The expansion of these fragments towards the FXIa prime side binding sites was aided by solving the X-ray structures of reported FXIa inhibitors that we found to bind in the S1-S1'-S2' FXIa binding pockets. Combining the X-ray structure information from the identified S1 binding 6-chloro-3,4-dihydro-1H-quinolin-2-one fragment and the S1-S1'-S2' binding reference compounds enabled structure guided linking and expansion work to achieve one of the most potent and selective FXIa inhibitors reported to date, compound 13, with a FXIa IC50 of 1.0 nM. The hydrophilicity and large polar surface area of the potent S1-S1'-S2' binding FXIa inhibitors compromised permeability. Initial work to expand the 6-chloro-3,4-dihydro-1H-quinolin-2-one fragment towards the prime side to yield molecules with less hydrophilicity shows promise to afford potent, selective and orally bioavailable compounds.	[Fjellstrom, Ola; Akkaya, Sibel; Beisel, Hans-Georg; Erixon, Karl; Karis, David; Nilsson, Ingemar; Olsson, Thomas; Redzic, Alma] AstraZeneca R&D, Med Chem, Cardiovasc & Metab Dis Innovat Medicines, Molndal, Sweden; [Eriksson, Per-Olof; Roth, Robert; Sandmark, Jenny; Tigerstrom, Anna; Oster, Linda] AstraZeneca R&D, Discovery Sci, Molndal, Sweden; [Gustafsson, David; Kang, Daiwu; Knecht, Wolfgang; Nerme, Viveca] AstraZeneca R&D, Biosci, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden; [Jurva, Ulrik] AstraZeneca R&D, Drug Metab & Pharmacokinet, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca	Fjellstrom, O (corresponding author), AstraZeneca R&D, Med Chem, Cardiovasc & Metab Dis Innovat Medicines, Molndal, Sweden.	ola.fjellstrom@astrazeneca.com						[Anonymous], 2013, ACD PKADB VERS 6 0, DOI [10.1016/j.amsu.2013.12.001, DOI 10.1016/J.AMSU.2013.12.001]; Antonysamy SS, 2008, BIOORG MED CHEM LETT, V18, P2990, DOI 10.1016/j.bmcl.2008.03.056; ASAKAI R, 1991, NEW ENGL J MED, V325, P153, DOI 10.1056/NEJM199107183250303; Baker M, 2013, NAT REV DRUG DISCOV, V12, P5, DOI 10.1038/nrd3926; Basse N, 2010, CHEM BIOL, V17, P46, DOI 10.1016/j.chembiol.2009.12.011; Blundell TL, 2002, NAT REV DRUG DISCOV, V1, P45, DOI 10.1038/nrd706; Brough PA, 2009, J MED CHEM, V52, P4794, DOI 10.1021/jm900357y; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cushman M, 2009, BLOOD, V114, P2878, DOI 10.1182/blood-2009-05-219915; Dalvit C, 2002, J MED CHEM, V45, P2610, DOI 10.1021/jm011122k; Danielson UH, 2009, CURR TOP MED CHEM, V9, P1725, DOI 10.2174/156802609790102392; Deng HF, 2006, BIOORG MED CHEM LETT, V16, P3049, DOI 10.1016/j.bmcl.2006.02.052; Doggen CJM, 2006, BLOOD, V108, P4045, DOI 10.1182/blood-2005-12-023697; Drinkwater N, 2010, BIOCHEM J, V431, P51, DOI 10.1042/BJ20100651; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fradera X, 2012, ACTA CRYSTALLOGR F, V68, P404, DOI 10.1107/S1744309112009037; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gailani D, 1997, BLOOD COAGUL FIBRIN, V8, P134, DOI 10.1097/00001721-199703000-00008; Geschwindner S, 2007, J MED CHEM, V50, P5903, DOI 10.1021/jm070825k; Gruber A, 2003, BLOOD, V102, P953, DOI 10.1182/blood-2003-01-0324; Hajduk PJ, 1997, J AM CHEM SOC, V119, P12257, DOI 10.1021/ja9715962; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hanessian S, 2010, BIOORG MED CHEM LETT, V20, P6925, DOI 10.1016/j.bmcl.2010.09.141; He R, 2012, THROMB RES, V129, P541, DOI 10.1016/j.thromres.2011.11.051; Howard N, 2006, J MED CHEM, V49, P1346, DOI 10.1021/jm050850v; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Innasimuthu AL, 2013, CARDIOLOGY, V126, P41, DOI 10.1159/000353484; Jacobson L, 2007, ASSAY DRUG DEV TECHN, V5, P403, DOI 10.1089/adt.2007.059; Jin L, 2005, ACTA CRYSTALLOGR D, V61, P1418, DOI [10.1107/S0907444905024340, 10.1107/S090744905024340]; Jin L, 2005, J BIOL CHEM, V280, P4704, DOI 10.1074/jbc.M411309200; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARLSSON R, 1994, ANAL BIOCHEM, V221, P142, DOI 10.1006/abio.1994.1390; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Lazarova TI, 2006, BIOORG MED CHEM LETT, V16, P5022, DOI 10.1016/j.bmcl.2006.07.043; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leung PY, 2012, TRANSL STROKE RES, V3, P381, DOI 10.1007/s12975-012-0186-5; Lin J, 2006, J MED CHEM, V49, P7781, DOI 10.1021/jm060978s; Lowenberg EC, 2010, J THROMB HAEMOST, V8, P2349, DOI 10.1111/j.1538-7836.2010.04031.x; Lu YX, 2012, EXPERT OPIN DRUG DIS, V7, P375, DOI 10.1517/17460441.2012.678829; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Minnema MC, 1998, J CLIN INVEST, V101, P10, DOI 10.1172/JCI781; Murray CW, 2007, J MED CHEM, V50, P1116, DOI 10.1021/jm0611962; Murray CW, 2002, J COMPUT AID MOL DES, V16, P741, DOI 10.1023/A:1022446720849; Murray JS, 2010, AUST J CHEM, V63, P1598, DOI 10.1071/CH10259; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navratilova I, 2010, ACS MED CHEM LETT, V1, P44, DOI 10.1021/ml900002k; Nazare M, 2012, ANGEW CHEM INT EDIT, V51, P905, DOI 10.1002/anie.201107091; Neumann T, 2007, CURR TOP MED CHEM, V7, P1630, DOI 10.2174/156802607782341073; Pinto DJ, 2008, PCT Int Appl, Patent No. [2007-US87396, 2006-870110P, 200787396]; Pinto DJP, 2008, PCT Int Appl, Patent No. [2008-US66506, 2007-943791P, 200866506]; Pinto DJP, 2007, PCT Int Appl, Patent No. [2006-US62005, 2005-750130P, 200662005]; Politzer P, 2013, CHEMPHYSCHEM, V14, P278, DOI 10.1002/cphc.201200799; Quan MML, 2014, J MED CHEM, V57, P955, DOI 10.1021/jm401670x; Rosen ED, 2002, THROMB HAEMOSTASIS, V87, P774; Salomon O, 2006, HAEMOPHILIA, V12, P490, DOI 10.1111/j.1365-2516.2006.01304.x; Salomon O, 2008, BLOOD, V111, P4113, DOI 10.1182/blood-2007-10-120139; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schumacher WA, 2007, EUR J PHARMACOL, V570, P167, DOI 10.1016/j.ejphar.2007.05.043; Schumacher WA, 2010, ARTERIOSCL THROM VAS, V30, P388, DOI 10.1161/ATVBAHA.109.197178; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; Seligsohn U, 2009, J THROMB HAEMOST, V7, P84, DOI 10.1111/j.1538-7836.2009.03395.x; Seligsohn U, 2007, THROMB HAEMOSTASIS, V98, P84, DOI 10.1160/Th07-04-0246; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang XK, 2006, J THROMB HAEMOST, V4, P1982, DOI 10.1111/j.1538-7836.2006.02093.x; Wang X, 2005, J THROMB HAEMOST, V3, P695, DOI 10.1111/j.1538-7836.2005.01236.x; Wilcken R, 2013, J MED CHEM, V56, P1363, DOI 10.1021/jm3012068; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wyatt PG, 2008, J MED CHEM, V51, P4986, DOI 10.1021/jm800382h; Xiang YB, 2011, BIOORG MED CHEM LETT, V21, P3050, DOI 10.1016/j.bmcl.2011.03.030; Yamashita A, 2006, J THROMB HAEMOST, V4, P1496, DOI 10.1111/j.1538-7836.2006.01973.x; Yang DT, 2006, AM J CLIN PATHOL, V126, P411, DOI 10.1309/QC259F09UNMKVP0R; Young MB, 2004, J MED CHEM, V47, P2995, DOI 10.1021/jm030303e; Younis HS, 2012, BLOOD, V119, P2401, DOI 10.1182/blood-2011-10-387134; Zhang H, 2010, BLOOD, V116, P4684, DOI 10.1182/blood-2010-04-277798	82	25	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0113705	10.1371/journal.pone.0113705	http://dx.doi.org/10.1371/journal.pone.0113705			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629509	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100005
J	Lakota, K; Carns, M; Podlusky, S; Mrak-Poljsak, K; Hinchcliff, M; Lee, J; Tomsic, M; Sodin-Semrl, S; Varga, J				Lakota, Katja; Carns, Mary; Podlusky, Sofia; Mrak-Poljsak, Katjusa; Hinchcliff, Monique; Lee, Jungwha; Tomsic, Matija; Sodin-Semrl, Snezna; Varga, John			Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic Sclerosis	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; C-REACTIVE PROTEIN; CORONARY-ARTERY; INTERLEUKIN-6; INFLAMMATION; VALIDITY; SKIN; OVEREXPRESSION; ACTIVATION; RESPONSES	Inflammation in systemic sclerosis (SSc) is a prominent, but incompletely characterized feature in early stages of the disease. The goal of these studies was to determine the circulating levels, clinical correlates and biological effects of the acute phase protein serum amyloid A (SAA), a marker of inflammation, in patients with SSc. Circulating levels of SAA were determined by multiplex assays in serum from 129 SSc patients and 98 healthy controls. Correlations between SAA levels and clinical and laboratory features of disease were analyzed. The effects of SAA on human pulmonary fibroblasts were studied ex vivo. Elevated levels of SAA were found in 25% of SSc patients, with the highest levels in those with early-stage disease and diffuse cutaneous involvement. Significant negative correlations of SAA were found with forced vital capacity and diffusion capacity for carbon monoxide. Patients with elevated SAA had greater dyspnea and more frequent interstitial lung disease, and had worse scores on patient-reported outcome measures. Incubation with recombinant SAA induced dose-dependent stimulation of IL-6 and IL-8 in normal lung fibroblasts in culture. Serum levels of the inflammatory marker SAA are elevated in patients with early diffuse cutaneous SSc, and correlate with pulmonary involvement. In lung fibroblasts, SAA acts as a direct stimulus for increased cytokine production. These findings suggest that systemic inflammation in SSc may be linked to lung involvement and SAA could serve as a potential biomarker for this complication.	[Lakota, Katja; Mrak-Poljsak, Katjusa; Tomsic, Matija; Sodin-Semrl, Snezna] Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia; [Lakota, Katja; Carns, Mary; Podlusky, Sofia; Hinchcliff, Monique; Varga, John] Northwestern Univ, Div Rheumatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Lee, Jungwha] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Sodin-Semrl, Snezna] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia	University Medical Centre Ljubljana; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Primorska	Lakota, K (corresponding author), Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia.	katja.lakota@guest.arnes.si	Sodin-Semrl, Snezna/AAJ-8954-2020; Varga, John/AAK-6472-2021; Lakota, Katja/AAH-8033-2020	Lakota, Katja/0000-0002-8062-7908; Hinchcliff, Monique/0000-0002-8652-9890; Lee, Jungwha/0000-0002-0806-0847	Fullbright Foreign Student Program, grants from the National Institutes of Health [AR-42309]; National Research Program (Ministry of Higher Education, Science and Technology of Slovenia) [P3-0314]; Association for the Development of Rheumatology, Slovenia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042309, K23AR059763, R56AR042309] Funding Source: NIH RePORTER	Fullbright Foreign Student Program, grants from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Program (Ministry of Higher Education, Science and Technology of Slovenia); Association for the Development of Rheumatology, Slovenia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Fullbright Foreign Student Program, grants from the National Institutes of Health (AR-42309), the National Research Program (Ministry of Higher Education, Science and Technology of Slovenia, #P3-0314), and the Association for the Development of Rheumatology, Slovenia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Bargagli E, 2011, RESP MED, V105, P775, DOI 10.1016/j.rmed.2010.12.010; Beretta L, 2007, RHEUMATOLOGY, V46, P296, DOI 10.1093/rheumatology/kel221; Bhattacharyya S, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S18; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; BRANDWEIN SR, 1984, ANN RHEUM DIS, V43, P586, DOI 10.1136/ard.43.4.586; Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; Czirjak L, 2008, ANN RHEUM DIS, V67, P59, DOI 10.1136/ard.2006.066340; De Lauretis A, 2013, J RHEUMATOL, V40, P435, DOI 10.3899/jrheum.120725; Dullaart RPF, 2013, OBESITY, V21, P361, DOI 10.1002/oby.20058; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Fasshauer M, 2004, J ENDOCRINOL, V183, P561, DOI 10.1677/joe.1.05699; Faty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034031; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gourh P, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2821; Hinchcliff M, 2011, J RHEUMATOL, V38, P2172, DOI 10.3899/jrheum.101243; Hinchcliff M, 2011, ARTHRIT CARE RES, V63, P1620, DOI 10.1002/acr.20591; Hudson M, 2007, SEMIN ARTHRITIS RHEU, V37, P93, DOI 10.1016/j.semarthrit.2007.01.005; Joven BE, 2010, SEMIN ARTHRITIS RHEU, V39, P285, DOI 10.1016/j.semarthrit.2009.06.002; Kadono T, 1998, J RHEUMATOL, V25, P296, DOI 10.1016/S0923-1811(98)84143-1; Khan K, 2012, ANN RHEUM DIS, V71, P1235, DOI 10.1136/annrheumdis-2011-200955; Kim TH, 2010, AM J RESP CRIT CARE, V182, P633, DOI 10.1164/rccm.200905-0659OC; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Kitaba S, 2012, AM J PATHOL, V180, P165, DOI 10.1016/j.ajpath.2011.09.013; KRALING BM, 1995, PATHOBIOLOGY, V63, P48, DOI 10.1159/000163933; Lakota K, 2007, EUR J INFLAMM, V5, P73, DOI 10.1177/1721727X0700500203; Lakota K, 2013, MICROVASC RES, V90, P55, DOI 10.1016/j.mvr.2013.07.011; Lakota K, 2010, RECENT PATENTS ENDOC, V4, P89, DOI 10.2174/187221410791196632; Liu XC, 2013, ARTHRIT CARE RES, V65, P1375, DOI 10.1002/acr.21968; Liu XC, 2013, ARTHRITIS RHEUM-US, V65, P226, DOI 10.1002/art.37742; Lopez-Campos JL, 2013, INT J MED SCI, V10, P938, DOI 10.7150/ijms.6152; Migita K, 1998, LAB INVEST, V78, P535; Milette K, 2013, RHEUMATOLOGY, V52, P1715, DOI 10.1093/rheumatology/ket223; Minier T, 2010, RHEUMATOLOGY, V49, P1133, DOI 10.1093/rheumatology/keq022; Muangchan C, 2012, ARTHRIT CARE RES, V64, P1405, DOI 10.1002/acr.21716; O'Reilly S, 2014, IMMUNOLOGY, pn/a; O'Reilly S, 2012, CYTOKINE GROWTH F R, V23, P99, DOI 10.1016/j.cytogfr.2012.04.003; Obici L, 2009, ARTHRIT CARE RES, V61, P1435, DOI 10.1002/art.24735; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; REITAMO S, 1993, ARCH DERMATOL, V129, P189, DOI 10.1001/archderm.129.2.189; Schmidt K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2766; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Shima Y, 2010, RHEUMATOLOGY, V49, P2408, DOI 10.1093/rheumatology/keq275; Sodin-Semrl S, 2004, INT J IMMUNOPATH PH, V17, P145, DOI 10.1177/039463200401700206; Song CJ, 2009, ATHEROSCLEROSIS, V207, P374, DOI 10.1016/j.atherosclerosis.2009.05.007; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Strange C, 2008, AM J RESP CRIT CARE, V177, P91, DOI 10.1164/rccm.200705-655OC; Thorn CF, 2004, SCAND J IMMUNOL, V59, P152, DOI 10.1111/j.0300-9475.2004.01369.x; Tolle M, 2012, CARDIOVASC RES, V94, P154, DOI 10.1093/cvr/cvs089; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; Wilson PG, 2008, AM J PATHOL, V173, P1902, DOI 10.2353/ajpath.2008.080201; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yeager ME, 2012, PROTEOM CLIN APPL, V6, P257, DOI 10.1002/prca.201100078; Yilmaz N, 2012, RHEUMATOL INT, V32, P1921, DOI 10.1007/s00296-011-1872-4	55	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0110820	10.1371/journal.pone.0110820	http://dx.doi.org/10.1371/journal.pone.0110820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629975	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100001
J	Lam, PY; Mangos, S; Green, JM; Reiser, J; Huttenlocher, A				Lam, Pui-ying; Mangos, Steve; Green, Julie M.; Reiser, Jochen; Huttenlocher, Anna			In Vivo Imaging and Characterization of Actin Microridges	PLOS ONE			English	Article							NEUTROPHIL MOTILITY; FOCAL ADHESIONS; SURFACE; MORPHOGENESIS; WOUNDS; MODEL; CARP	Actin microridges form labyrinth like patterns on superficial epithelial cells across animal species. This highly organized assembly has been implicated in mucus retention and in the mechanical structure of mucosal surfaces, however the mechanisms that regulate actin microridges remain largely unknown. Here we characterize the composition and dynamics of actin microridges on the surface of zebrafish larvae using live imaging. Microridges contain phospho-tyrosine, cortactin and VASP, but not focal adhesion kinase. Time-lapse imaging reveals dynamic changes in the length and branching of microridges in intact animals. Transient perturbation of the microridge pattern occurs before cell division with rapid re-assembly during and after cytokinesis. Microridge assembly is maintained with constitutive activation of Rho or inhibition of myosin II activity. However, expression of dominant negative RhoA or Rac alters microridge organization, with an increase in distance between microridges. Latrunculin A treatment and photoconversion experiments suggest that the F-actin filaments are actively treadmilling in microridges. Accordingly, inhibition of Arp2/3 or PI3K signaling impairs microridge structure and length. Taken together, actin microridges in zebrafish represent a tractable in vivo model to probe pattern formation and dissect Arp2/3-mediated actin dynamics in vivo.	[Lam, Pui-ying; Green, Julie M.; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Lam, Pui-ying] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Mangos, Steve; Reiser, Jochen] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Rush University; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	huttenlocher@wisc.edu		Lam, Pui-Ying/0000-0002-6319-5752; Mangos, Steve/0000-0003-1402-1008	NIH/NCI [R01 CA085862]; NIH [R01 GM102924-01]; NATIONAL CANCER INSTITUTE [R01CA085862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102924] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH/NCI R01 CA085862 and NIH R01 GM102924-01 to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Blanco MT, 2012, J CELL SCI, V125, P5984, DOI 10.1242/jcs.109066; Bereither-Hahn J, 1979, J ULTRASTRUCT RES, V69, P15; Brock J, 1996, J CELL BIOL, V135, P1097, DOI 10.1083/jcb.135.4.1097; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Burridge K, 1997, TRENDS CELL BIOL, V7, P342, DOI 10.1016/S0962-8924(97)01127-6; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chen CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020654; Clark AG, 2009, CURR BIOL, V19, P1389, DOI 10.1016/j.cub.2009.06.044; Collin HB, 2000, PHILOS T ROY SOC B, V355, P1171, DOI 10.1098/rstb.2000.0661; Correr S, 2006, HISTOL HISTOPATHOL, V21, P219, DOI 10.14670/HH-21.219; Deng Q, 2011, DEV CELL, V21, P735, DOI 10.1016/j.devcel.2011.07.013; Doyle AD, 2005, J CELL SCI, V118, P369, DOI 10.1242/jcs.01590; Figard Lauren, 2014, Bioarchitecture, V4, P39, DOI 10.4161/bioa.29069; Figard L, 2013, DEV CELL, V27, P648, DOI 10.1016/j.devcel.2013.11.006; Gamal AM, 2012, J BASIC APPL ZOOLOGY, V65, P8; GARDNER IC, 1976, MICRON, V7, P199, DOI 10.1016/0047-7206(76)90003-0; Gilmore AP, 1996, STRUCTURE, V4, P647, DOI 10.1016/S0969-2126(96)00069-X; Hafez EAAE, 2013, J HISTOLOGY, V2013, P10; Holt MR, 1998, INT J BIOCHEM CELL B, V30, P307, DOI 10.1016/S1357-2725(97)00101-5; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Li JJ, 2013, J CELL SCI, V126, P5005, DOI 10.1242/jcs.133421; Li QL, 2011, DIS MODEL MECH, V4, P777, DOI 10.1242/dmm.007146; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Miyazawa S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1071; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Rice WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057051; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sharma A, 2005, FEBS LETT, V579, P2001, DOI 10.1016/j.febslet.2005.02.049; Simmich J, 2012, CLIN EXP OPTOM, V95, P140, DOI 10.1111/j.1444-0938.2011.00701.x; SPERRY DG, 1976, ANAT RECORD, V185, P253, DOI 10.1002/ar.1091850212; Thie M, 1998, HUMAN REPROD, V13, P9; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; UEHARA K, 1991, ANAT REC, V230, P164, DOI 10.1002/ar.1092300203; Uppal RK, 2013, VET OPHTHALMOL; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Villava CE, 2007, BIOTECHNIQUES, V43, P313, DOI 10.2144/000112555; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wong CKC, 2000, AQUAT TOXICOL, V48, P517, DOI 10.1016/S0166-445X(99)00060-0; Yashpal M, 2006, BELG J ZOOL, V136, P155; Yashpal M, 2009, J MORPHOL, V270, P714, DOI 10.1002/jmor.10713; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015; Zhao XPC, 2006, INVEST OPHTH VIS SCI, V47, P4341, DOI 10.1167/iovs.05-1611	47	29	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115639	10.1371/journal.pone.0115639	http://dx.doi.org/10.1371/journal.pone.0115639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629723	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100023
J	Boatin, AA; Wylie, B; Goldfarb, I; Azevedo, R; Pittel, E; Ng, C; Haberer, J				Boatin, Adeline A.; Wylie, Blair; Goldfarb, Ilona; Azevedo, Robin; Pittel, Elena; Ng, Courtney; Haberer, Jessica			Wireless Fetal Heart Rate Monitoring in Inpatient Full-Term Pregnant Women: Testing Functionality and Acceptability	PLOS ONE			English	Article								We tested functionality and acceptability of a wireless fetal monitoring prototype technology in pregnant women in an inpatient labor unit in the United States. Women with full-term singleton pregnancies and no evidence of active labor were asked to wear the prototype technology for 30 minutes. We assessed functionality by evaluating the ability to successfully monitor the fetal heartbeat for 30 minutes, transmit this data to Cloud storage and view the data on a web portal. Three obstetricians also rated fetal cardiotocographs on ease of readability. We assessed acceptability by administering closed and open-ended questions on perceived utility and likeability to pregnant women and clinicians interacting with the prototype technology. Thirty-two women were enrolled, 28 of whom (87.5%) successfully completed 30 minutes of fetal monitoring including transmission of cardiotocographs to the web portal. Four sessions though completed, were not successfully uploaded to the Cloud storage. Six non-study clinicians interacted with the prototype technology. The primary technical problem observed was a delay in data transmission between the prototype and the web portal, which ranged from 2 to 209 minutes. Delays were ascribed to Wi-Fi connectivity problems. Recorded cardiotocographs received a mean score of 4.2/5 (+/- 1.0) on ease of readability with an interclass correlation of 0.81(95% CI 0.45, 0.96). Both pregnant women and clinicians found the prototype technology likable (81.3% and 66.7% respectively), useful (96.9% and 66.7% respectively), and would either use it again or recommend its use to another pregnant woman (77.4% and 66.7% respectively). In this pilot study we found that this wireless fetal monitoring prototype technology has potential for use in a United States inpatient setting but would benefit from some technology changes. We found it to be acceptable to both pregnant women and clinicians. Further research is needed to assess feasibility of using this technology in busy inpatient settings.	[Boatin, Adeline A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA 02163 USA; [Wylie, Blair; Goldfarb, Ilona] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Maternal Fetal Med,Dept Obstet & Gynecol, Boston, MA USA; [Azevedo, Robin; Pittel, Elena] Massachusetts Gen Hosp, Dept Nursing, Boston, MA 02114 USA; [Ng, Courtney; Haberer, Jessica] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Global Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Boatin, AA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA 02163 USA.	aboatin@partners.org	Haberer, Jessica/AAH-7976-2019	Haberer, Jessica/0000-0001-5845-3190	Gary and Mary West Health Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES021471] Funding Source: NIH RePORTER	Gary and Mary West Health Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was conducted at the Massachusetts General Hospital with support provided by the Gary and Mary West Health Institute, an independent, not for profit medical research organization that works with healthcare providers and research institutions to create new, more effective ways of delivering care. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Cahill AG, 2009, OBSTET GYNECOL, V114, P124, DOI 10.1097/AOG.0b013e3181aef106; DeFrances Carol J, 2007, Adv Data, P1; Di Lieto A, 2001, J TELEMED TELECARE, V7, P119, DOI 10.1258/1357633011936255; Harkey KT, 2014, OBSTET GYNECOL, V123, p55S, DOI 10.1097/01.AOG.0000447351.46587.ce; Holden RJ, 2010, J BIOMED INFORM, V43, P159, DOI 10.1016/j.jbi.2009.07.002; HON EH, 1958, AM J OBSTET GYNECOL, V75, P1215, DOI 10.1016/0002-9378(58)90707-5; Rauf Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028129; Roham M., 2011, 2011 5th International Symposium on Medical Information and Communication Technology (ISMICT 2011), P135, DOI 10.1109/ISMICT.2011.5759813; Vijgen SMC, 2011, ACTA OBSTET GYN SCAN, V90, P772, DOI 10.1111/j.1600-0412.2011.01138.x	9	15	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117043	10.1371/journal.pone.0117043	http://dx.doi.org/10.1371/journal.pone.0117043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622043	Green Published, Green Submitted, gold			2022-12-27	WOS:000348470400016
J	Schween, R; Gehring, D; Gollhofer, A				Schween, Raphael; Gehring, Dominic; Gollhofer, Albert			Immediate Effects of an Elastic Knee Sleeve on Frontal Plane Gait Biomechanics in Knee Osteoarthritis	PLOS ONE			English	Article							RESONANCE ELECTRICAL-STIMULATION; HIP; PROPRIOCEPTION; LOAD; PREVALENCE; ANKLE; POWER	Introduction Osteoarthritis of the knee affects millions of people. Elastic knee sleeves aim at relieving symptoms. While symptomatic improvements have been demonstrated as a consequence of elastic knee sleeves, evidence for biomechanical alterations only exists for the sagittal plane. We therefore asked what effect an elastic knee sleeve would have on frontal plane gait biomechanics. Methods 18 subjects (8 women, 10 men) with osteoarthritis of the medial tibiofemoral joint walked over ground with and without an elastic knee sleeve. Kinematics and forces were recorded and joint moments were calculated using an inverse dynamics approach. Conditions with sleeve and without sleeve were compared with paired t- Tests. Results With the sleeve, knee adduction angle at ground contact was reduced by 1.9 +/- 2.1 degrees (P = 0.006). Peak knee adduction was reduced by 1.5 +/- 1.6 degrees (P = 0.004). The first peak knee adduction moment and positive knee adduction impulse were decreased by 10.1% (0.74 +/- 0.9 Nm.kg-1; P = 0.002) and 12.9% (0.28 +/- 0.3 Nm.s.kg-1; P < 0.004), respectively. Conclusion Our study provides evidence that wearing an elastic knee sleeve during walking can reduce knee adduction angles, moments and impulse in subjects with knee osteoarthritis. As a higher knee adduction moment has previously been identified as a risk factor for disease progression in patients with medial knee osteoarthritis, we speculate that wearing a knee sleeve may be beneficial for this specific subgroup.	[Schween, Raphael; Gehring, Dominic; Gollhofer, Albert] Univ Freiburg, Dept Sport Sci, D-79117 Freiburg, Germany	University of Freiburg	Schween, R (corresponding author), Univ Freiburg, Dept Sport Sci, Schwarzwaldstr 175, D-79117 Freiburg, Germany.	raphael.schween@sport.uni-giessen.de	Gehring, Dominic/F-9680-2013; Albert, Gollhofer/V-3291-2019; Gollhofer, Albert/ABF-5766-2020	Gehring, Dominic/0000-0001-5577-8846; Schween, Raphael/0000-0003-1804-9438	BAUERFEIND AG (Zeulenroda, Germany); German Research Foundation (DFG); Albert Ludwigs University Freiburg; Department of Sport Science of the University of Freiburg	BAUERFEIND AG (Zeulenroda, Germany); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg; Department of Sport Science of the University of Freiburg	Part of the funding and material (knee sleeves) for the study were provided by the BAUERFEIND AG (Zeulenroda, Germany, www.bauerfeind.com). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. All other funding was acquired from internal means of the Department of Sport Science (www.sport.unifreiburg.de) of the University of Freiburg (www.unifreiburg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT DS, 1991, J BONE JOINT SURG BR, V73, P53, DOI 10.1302/0301-620X.73B1.1991775; Beaudreuil J, 2009, JOINT BONE SPINE, V76, P629, DOI 10.1016/j.jbspin.2009.02.002; Bennell KL, 2011, ANN RHEUM DIS, V70, P1770, DOI 10.1136/ard.2010.147082; BERRY H, 1992, European Journal of Rheumatology and Inflammation, V12, P30; BORTZ J, 2010, STAT HUMAN SOZIALWIS, DOI DOI 10.1016/J.VASCN.2013.05.004; Bryk FF, 2011, REV BRAS REUMATOL, V51, P434, DOI 10.1590/S0482-50042011000500004; Butler RJ, 2011, PHYS THER, V91, P1235, DOI 10.2522/ptj.20100324; Childs JD, 2004, CLIN BIOMECH, V19, P44, DOI 10.1016/j.clinbiomech.2003.08.007; Chuang SH, 2007, KAOHSIUNG J MED SCI, V23, P405, DOI 10.1016/S0257-5655(07)70004-4; Collins A, 2011, CLIN BIOMECH, V26, P853, DOI 10.1016/j.clinbiomech.2011.04.011; Collins AT, 2011, KNEE, V18, P317, DOI 10.1016/j.knee.2010.07.001; DEGROOT G, 1994, ERGONOMICS, V37, P31, DOI 10.1080/00140139408963620; Draganich L, 2006, J BONE JOINT SURG AM, V88A, P2645, DOI 10.2106/JBJS.D.02787; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Guillemin F, 2011, OSTEOARTHR CARTILAGE, V19, P1314, DOI 10.1016/j.joca.2011.08.004; Henriksen M, 2012, KNEE, V19, P392, DOI 10.1016/j.knee.2011.07.003; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kean CO, 2012, CLIN BIOMECH, V27, P520, DOI 10.1016/j.clinbiomech.2011.12.007; Keyaki K, 2010, OSTEOARTHR CARTILAGE, V18, pS229, DOI 10.1016/S1063-4584(10)60537-7; Kirkley A, 1999, J BONE JOINT SURG AM, V81A, P539, DOI 10.2106/00004623-199904000-00012; Knoop J, 2011, OSTEOARTHR CARTILAGE, V19, P381, DOI 10.1016/j.joca.2011.01.003; Krohn K, 2005, CURR OPIN RHEUMATOL, V17, P653, DOI 10.1097/01.bor.0000175460.75675.d3; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Morgan WA, 1939, BIOMETRIKA, V31, P13, DOI 10.2307/2334972; Mundermann A, 2005, ARTHRITIS RHEUM-US, V52, P2835, DOI 10.1002/art.21262; Muraki S, 2010, OSTEOARTHR CARTILAGE, V18, P1227, DOI 10.1016/j.joca.2010.06.001; Naal FD, 2009, OSTEOARTHR CARTILAGE, V17, P49, DOI 10.1016/j.joca.2008.05.017; Pagani CHF, 2012, J ORTHOP RES, V30, P1125, DOI 10.1002/jor.22032; Pereira D, 2011, OSTEOARTHR CARTILAGE, V19, P1270, DOI 10.1016/j.joca.2011.08.009; Turcot K, 2013, CLIN BIOMECH, V28, P34, DOI 10.1016/j.clinbiomech.2012.09.004; Weidow J, 2006, J ORTHOP RES, V24, P1890, DOI 10.1002/jor.20194; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Zhao D, 2007, J ORTHOP RES, V25, P789, DOI 10.1002/jor.20379	34	17	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0115782	10.1371/journal.pone.0115782	http://dx.doi.org/10.1371/journal.pone.0115782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621488	Green Published, Green Submitted, gold			2022-12-27	WOS:000348470400002
J	Liu, LL; Zhao, H; Ma, TF; Ge, F; Chen, CS; Zhang, YP				Liu, Lin-Lin; Zhao, Hui; Ma, Teng-Fei; Ge, Fei; Chen, Ce-Shi; Zhang, Ya-Ping			Identification of Valid Reference Genes for the Normalization of RT-qPCR Expression Studies in Human Breast Cancer Cell Lines Treated with and without Transient Transfection	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE GENE; ENDOGENOUS CONTROL GENES; TIME QUANTITATIVE PCR; MESSENGER-RNA QUANTIFICATION; POLYMERASE-CHAIN-REACTION; HOUSEKEEPING GENES; TUMOR-TISSUES; CARCINOMAS; INTEGRITY; SELECTION	Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is a powerful technique for examining gene expression changes during tumorigenesis. Target gene expression is generally normalized by a stably expressed endogenous reference gene; however, reference gene expression may differ among tissues under various circumstances. Because no valid reference genes have been documented for human breast cancer cell lines containing different cancer subtypes treated with transient transfection, we identified appropriate and reliable reference genes from thirteen candidates in a panel of 10 normal and cancerous human breast cell lines under experimental conditions with/without transfection treatments with two transfection reagents. Reference gene expression stability was calculated using four algorithms (geNorm, NormFinder, BestKeeper and comparative delta Ct), and the recommended comprehensive ranking was provided using geometric means of the ranking values using the RefFinder tool. GeNorm analysis revealed that two reference genes should be sufficient for all cases in this study. A stability analysis suggests that 18S rRNA-ACTB is the best reference gene combination across all cell lines; ACTB-GAPDH is best for basal breast cancer cell lines; and HSPCB-ACTB is best for ER+ breast cancer cells. After transfection, the stability ranking of the reference gene fluctuated, especially with Lipofectamine 2000 transfection reagent in two subtypes of basal and ER+ breast cell lines. Comparisons of relative target gene (HER2) expression revealed different expressional patterns depending on the reference genes used for normalization. We suggest that identifying the most stable and suitable reference genes is critical for studying specific cell lines under certain circumstances.	[Liu, Lin-Lin; Zhao, Hui; Ma, Teng-Fei; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China; [Ge, Fei] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine Surg, Chongqing 400016, Peoples R China; [Ge, Fei; Chen, Ce-Shi] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China	Yunnan University; Chongqing Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, YP (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn			National Natural Science Foundation of China [31060302, 31260032]; Natural Science Foundation of Yunnan Province [2010CD010]; Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province	This work was supported by grants of the National Natural Science Foundation of China (Grant Nos. 31060302 and 31260032) (http://www.nsfc.gov.cn), the Natural Science Foundation of Yunnan Province (Grant No. 2010CD010) (http://www.ynstc.gov.cn) and Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province (http://www.ynjy.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Ceelen L, 2011, BIOCHEM PHARMACOL, V81, P1255, DOI 10.1016/j.bcp.2011.03.004; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; De Spiegelaere W, 2008, ANAL BIOCHEM, V382, P72, DOI 10.1016/j.ab.2008.07.004; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; FEUER EJ, 1993, J NATL CANCER I, V85, P892, DOI 10.1093/jnci/85.11.892; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gur-Dedeoglu B, 2009, ONCOL RES, V17, P353, DOI 10.3727/096504009788428460; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jacobsen LB, 2009, BIOTECHNIQUES, V47, P617, DOI 10.2144/000113132; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Kilic Y, 2014, CLIN TRANSL ONCOL, V16, P184, DOI 10.1007/s12094-013-1058-5; Kim JW, 1998, GYNECOL ONCOL, V71, P266, DOI 10.1006/gyno.1998.5195; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Majidzadeh-A Keivan, 2011, BMC Res Notes, V4, P215, DOI 10.1186/1756-0500-4-215; McNeill RE, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-107; Mitri Zahi, 2012, Chemother Res Pract, V2012, P743193, DOI 10.1155/2012/743193; Morse DL, 2005, ANAL BIOCHEM, V342, P69, DOI 10.1016/j.ab.2005.03.034; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Rho HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-240; Rondinelli RH, 1997, PROSTATE CANCER P D, V1, P66, DOI 10.1038/sj.pcan.4500208; SCHEK N, 1988, CANCER RES, V48, P6354; Shen YM, 2010, ANAL BIOCHEM, V405, P224, DOI 10.1016/j.ab.2010.06.029; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sirover MA, 1997, J CELL BIOCHEM, V66, P133, DOI 10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.3.CO;2-V; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143	36	36	38	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117058	10.1371/journal.pone.0117058	http://dx.doi.org/10.1371/journal.pone.0117058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617865	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000037
J	Murthy, S; Leligdowicz, A; Adhikari, NKJ				Murthy, Srinivas; Leligdowicz, Aleksandra; Adhikari, Neill K. J.			Intensive Care Unit Capacity in Low-Income Countries: A Systematic Review	PLOS ONE			English	Review							SEVERE SEPSIS; HEALTH-CARE; SERVICES; ADMISSIONS; OUTCOMES; AFRICA; BURDEN; INFECTIONS; PREVALENCE; EXPERIENCE	Purpose Access to critical care is a crucial component of healthcare systems. In low-income countries, the burden of critical illness is substantial, but the capacity to provide care for critically ill patients in intensive care units (ICUs) is unknown. Our aim was to systematically review the published literature to estimate the current ICU capacity in low-income countries. Methods We searched 11 databases and included studies of any design, published 2004-August 2014, with data on ICU capacity for pediatric and adult patients in 36 low-income countries (as defined by World Bank criteria; population 850 million). Neonatal, temporary, and military ICUs were excluded. We extracted data on ICU bed numbers, capacity for mechanical ventilation, and information about the hospital, including referral population size, public accessibility, and the source of funding. Analyses were descriptive. Results Of 1,759 citations, 43 studies from 15 low-income countries met inclusion criteria. They described 36 individual ICUs in 31 cities, of which 16 had population greater than 500,000, and 14 were capital cities. The median annual ICU admission rate was 401 (IQR 234-711; 24 ICUs with data) and median ICU size was 8 beds (IQR 5-10; 32 ICUs with data). The mean ratio of adult and pediatric ICU beds to hospital beds was 1.5% (SD 0.9%; 15 hospitals with data). Nepal and Uganda, the only countries with national ICU bed data, had 16.7 and 1.0 ICU beds per million population, respectively. National data from other countries were not available. Conclusions Low-income countries lack ICU beds, and more than 50% of these countries lack any published data on ICU capacity. Most ICUs in low-income countries are located in large referral hospitals in cities. A central database of ICU resources is required to evaluate health system performance, both within and between countries, and may help to develop related health policy.	[Murthy, Srinivas] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Leligdowicz, Aleksandra; Adhikari, Neill K. J.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Adhikari, Neill K. J.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada	University of British Columbia; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Murthy, S (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada.	Srinivas.murthy@cw.bc.ca	Leligdowicz, Aleksandra/Q-2494-2016; Murthy, Srinivas/AAS-7243-2020; Leligdowicz, Aleksandra/GLS-9028-2022	Leligdowicz, Aleksandra/0000-0001-6055-4644; Leligdowicz, Aleksandra/0000-0001-6055-4644; Murthy, Srinivas/0000-0002-9476-839X				Acharya S P, 2007, Kathmandu Univ Med J (KUMJ), V5, P475; Acharya SP, 2013, INT HEALTH, V5, P92, DOI 10.1093/inthealth/iht010; Adhikari N., 2011, Journal of Nepal Paediatric Society, V31, P49; Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Agalu Asrat, 2012, Int Arch Med, V5, P15, DOI 10.1186/1755-7682-5-15; Anichini V, 2013, OPEN J ANESTHESIOLOG, V3, P315; Annez P.C., 2010, AGENDA RES URBANIZAT; Arul GS, 2012, ANN ROY COLL SURG, V94, P52, DOI 10.1308/003588412X13171221499027; Austin S, 2014, INTENS CARE MED, V40, P342, DOI 10.1007/s00134-013-3174-7; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baelani I, 2011, CRIT CARE, V15, DOI 10.1186/cc9410; Baker T, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-140; Baranwal AK, 2009, INDIAN J PEDIATR, V76, P1180, DOI 10.1007/s12098-009-0275-y; Basnet S, 2012, CRITICAL CARE MED, DOI [10.3390/jpm2020050, DOI 10.3390/JPM2020050]; Basnet S, 2011, PEDIATRICS, V128, pE986, DOI 10.1542/peds.2010-3657; Blackwell N, 2011, TREATMENT SEVERE SEV, P1142; Chalya PL, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-61; Dhillon GS, 2010, AM J RESP CRIT CARE, V181; Diango D M, 2012, Mali Med, V27, P66; Djibril A M, 2010, Med Trop (Mars), V70, P311; Dunser MW, 2006, CRIT CARE MED, V34, P1234, DOI 10.1097/01.CCM.0000208360.70835.87; Durasnel P, 2005, Med Trop (Mars), V65, P537; Firth P, 2012, NEW ENGL J MED, V367, P1974, DOI 10.1056/NEJMp1204957; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Joshi S, 2006, Kathmandu Univ Med J (KUMJ), V4, P275; Kwizera Arthur, 2012, BMC Res Notes, V5, P475, DOI 10.1186/1756-0500-5-475; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacLeod JBA, 2011, WORLD J SURG, V35, P9, DOI 10.1007/s00268-010-0810-z; Melaku Zenebe, 2006, Ethiop Med J, V44, P33; Mitchell KB, 2013, J BURN CARE RES, V34, P78, DOI 10.1097/BCR.0b013e318269be63; Morestin S, 2004, ARCH MAL COEUR VAISS, V97, P285; Muganyizi PS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-41; Mulat Tesfaye, 2006, Ethiop Med J, V44, P369; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murthy Srinivas, 2013, Ann Am Thorac Soc, V10, P509, DOI 10.1513/AnnalsATS.201307-246OT; Murthy S, 2012, CRIT CARE, V16, DOI 10.1186/cc11140; Murunga E M, 2005, East Afr Med J, V82, P414; Muteya MM, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.93.2180; Ndugulile F, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-86; Ngumi ZWW, 2006, DERMATOLOGY, V212, P4, DOI 10.1159/000089192; Olotu A, 2009, RESUSCITATION, V80, P69, DOI 10.1016/j.resuscitation.2008.09.019; Paudel R, 2011, ARCH PHARM PRACT, V2, P163; Pazvakavambwa I E, 2004, Cent Afr J Med, V50, P107; Pnadey R, 2011, Kathmandu Univ Med J (KUMJ), V9, P256; Pollach G, 2013, PEDIATR CRIT CARE ME, V14, P561, DOI 10.1097/PCC.0b013e318291774b; Ranjit S, 2011, Kathmandu Univ Med J (KUMJ), V9, P28; Riviello ED, 2011, CRIT CARE MED; Shankar P R, 2005, Kathmandu Univ Med J (KUMJ), V3, P130; Shrestha G S, 2011, Nepal Med Coll J, V13, P50; Smith ZA, 2013, ANAESTH INTENS CARE, V41, P363, DOI 10.1177/0310057X1304100314; Smitson C, 2013, ANN SCI SESS 2013 VA; Stoesser N, 2013, T ROY SOC TROP MED H, V107, P248, DOI 10.1093/trstmh/trt005; Tomlinson J, 2013, TROP DOCT, V43, P27, DOI 10.1177/0049475513480773; Towey RM, 2007, ANAESTHESIA, V62, P32, DOI 10.1111/j.1365-2044.2007.05295.x; Towey RM, 2008, AFR HEALTH SCI, V8, P61; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; von Saint Andre-von Arnim A, 2011, PEDIATR CRIT CARE ME, V12, P393, DOI 10.1097/PCC.0b013e318219268d; Webster K, 2012, INT J OBSTET ANESTH, pS2; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8	61	162	169	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116949	10.1371/journal.pone.0116949	http://dx.doi.org/10.1371/journal.pone.0116949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617837	gold, Green Submitted, Green Published			2022-12-27	WOS:000350336000033
J	Tian, E; Stevens, SR; Guan, Y; Springer, DA; Anderson, SA; Starost, MF; Patel, V; Ten Hagen, KG; Tabak, LA				Tian, E.; Stevens, Sharon R.; Guan, Yu; Springer, Danielle A.; Anderson, Stasia A.; Starost, Matthew F.; Patel, Vyomesh; Ten Hagen, Kelly G.; Tabak, Lawrence A.			Galnt1 Is Required for Normal Heart Valve Development and Cardiac Function	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; O-GLYCOSYLATION; PROTEOLYTIC CLEAVAGE; VERSICAN CLEAVAGE; TGF-BETA; MICE; DISEASE; ADAMTS5; FAMILY; DIFFERENTIATION	Congenital heart valve defects in humans occur in approximately 2% of live births and are a major source of compromised cardiac function. In this study we demonstrate that normal heart valve development and cardiac function are dependent upon Galnt1, the gene that encodes a member of the family of glycosyltransferases (GalNAc- Ts) responsible for the initiation of mucin-type O-glycosylation. In the adult mouse, compromised cardiac function that mimics human congenital heart disease, including aortic and pulmonary valve stenosis and regurgitation; altered ejection fraction; and cardiac dilation, was observed in Galnt1 null animals. The underlying phenotype is aberrant valve formation caused by increased cell proliferation within the outflow tract cushion of developing hearts, which is first detected at developmental stage E11.5. Developing valves from Galnt1 deficient animals displayed reduced levels of the proteases ADAMTS1 and ADAMTS5, decreased cleavage of the proteoglycan versican and increased levels of other extracellular matrix proteins. We also observed increased BMP and MAPK signaling. Taken together, the ablation of Galnt1 appears to disrupt the formation/ remodeling of the extracellular matrix and alters conserved signaling pathways that regulate cell proliferation. Our study provides insight into the role of this conserved protein modification in cardiac valve development and may represent a new model for idiopathic valve disease.	[Tian, E.; Ten Hagen, Kelly G.] Natl Inst Dent & Craniofacial Res, Dev Glycobiol Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Stevens, Sharon R.; Guan, Yu; Tabak, Lawrence A.] Natl Inst Dent & Craniofacial Res, Sect Biol Chem, NIH, Bethesda, MD 20892 USA; [Springer, Danielle A.; Anderson, Stasia A.] NHLBI, NIH, Bethesda, MD 20892 USA; [Starost, Matthew F.] NIH, Div Vet Resources, Bethesda, MD 20892 USA; [Patel, Vyomesh] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Tabak, LA (corresponding author), Natl Inst Dent & Craniofacial Res, Sect Biol Chem, NIH, Bethesda, MD 20892 USA.	Lawrence.Tabak@nih.gov		Anderson, Stasia/0000-0002-2566-6947; Stevens, Sharon/0000-0003-2238-8029	Intramural Research Programs of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005909, ZIGHL006190, ZIGHL006020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739, ZIADE000713] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Programs of the National Institutes of Health.	Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Barrick CJ, 2009, AM J PHYSIOL-HEART C, V297, pH65, DOI 10.1152/ajpheart.00866.2008; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; DeLaughter DM, 2013, J MOL CELL CARDIOL, V59, P196, DOI 10.1016/j.yjmcc.2013.03.016; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Foulcer SJ, 2014, J BIOL CHEM, V289, P27859, DOI 10.1074/jbc.M114.573287; Freitas VM, 2013, MOL CANCER, V5, P12; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Krenz M, 2008, P NATL ACAD SCI USA, V105, P18930, DOI 10.1073/pnas.0806556105; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Kruithof BPT, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.003; Kumar S, 2012, AM J PATHOL, V181, P1056, DOI 10.1016/j.ajpath.2012.05.022; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Llamazares M, 2003, J BIOL CHEM, V278, P13382, DOI 10.1074/jbc.M211900200; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; Radisic M, 2013, MAYO CLIN PROC, V88, P884, DOI 10.1016/j.mayocp.2013.05.003; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Wirrig EE, 2007, DEV BIOL, V310, P291, DOI 10.1016/j.ydbio.2007.07.041	32	29	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115861	10.1371/journal.pone.0115861	http://dx.doi.org/10.1371/journal.pone.0115861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615642	Green Submitted, Green Published, gold			2022-12-27	WOS:000349122100020
J	Taghavi, S; Wu, X; Ouyang, LM; Zhang, YB; Stadler, A; McCorkle, S; Zhu, W; Maslov, S; Van der Lelie, D				Taghavi, Safiyh; Wu, Xiao; Ouyang, Liming; Zhang, Yian Biao; Stadler, Andrea; McCorkle, Sean; Zhu, Wei; Maslov, Sergei; Van der Lelie, Daniel			Transcriptional Responses to Sucrose Mimic the Plant-Associated Life Style of the Plant Growth Promoting Endophyte Enterobacter sp 638	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; DIFFERENTIAL EXPRESSION ANALYSIS; QUORUM-SENSING SIGNAL; BINDING PROTEIN CSRA; GENE-EXPRESSION; BIOFILM FORMATION; RNA-SEQ; INDOLE-3-ACETIC-ACID BIOSYNTHESIS; PSEUDOMONAS-AERUGINOSA; SYSTEMIC RESISTANCE	Growth in sucrose medium was previously found to trigger the expression of functions involved in the plant associated life style of the endophytic bacterium Enterobacter sp. 638. Therefore, comparative transcriptome analysis between cultures grown in sucrose or lactate medium was used to gain insights in the expression levels of bacterial functions involved in the endophytic life style of strain 638. Growth on sucrose as a carbon source resulted in major changes in cell physiology, including a shift from a planktonic life style to the formation of bacterial aggregates. This shift was accompanied by a decrease in transcription of genes involved in motility (e.g. flagella biosynthesis) and an increase in the transcription of genes involved in colonization, adhesion and biofilm formation. The transcription levels of functions previously suggested as being involved in endophytic behavior and functions responsible for plant growth promoting properties, including the synthesis of indole-acetic acid, acetoin and 2,3-butanediol, also increased significantly for cultures grown in sucrose medium. Interestingly, despite an abundance of essential nutrients transcription levels of functions related to uptake and processing of nitrogen and iron became increased for cultures grown on sucrose as sole carbon source. Transcriptome data were also used to analyze putative regulatory relationships. In addition to the small RNA csrABCD regulon, which seems to play a role in the physiological adaptation and possibly the shift between free-living and plant-associated endophytic life style of Enterobacter sp. 638, our results also pointed to the involvement of rcsAB in controlling responses by Enterobacter sp. 638 to a plant-associated life style. Targeted mutagenesis was used to confirm this role and showed that compared to wild-type Enterobacter sp. 638 a Delta rcsB mutant was affected in its plant growth promoting ability.	[Taghavi, Safiyh; Ouyang, Liming; Van der Lelie, Daniel] Ctr Agr & Environm Biotechnol, RTI Int, Charlotte, NC USA; [Taghavi, Safiyh; Wu, Xiao; Zhang, Yian Biao; Stadler, Andrea; McCorkle, Sean; Maslov, Sergei; Van der Lelie, Daniel] Dept Biosci, Brookhaven Natl Lab, Upton, NY USA; [Wu, Xiao; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Ouyang, Liming] E China Univ Sci & Technol, Sch Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Research Triangle Institute; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; East China University of Science & Technology	Van der Lelie, D (corresponding author), FMC Corp, Ctr Excellence Agr Biotechnol, Res Triangle Pk, Charlotte, NC 28208 USA.	daniel.vanderlelie@FMC.com	Maslov, Sergei/C-2397-2009	Maslov, Sergei/0000-0002-3701-492X; McCorkle, Sean/0000-0003-1126-4071	U.S. Department of Energy, Office of Science, BER [KP1102010, DE-AC02-98CH10886]; Laboratory Directed Research and Development funds at the Brookhaven National Laboratory [LDRD09-005]	U.S. Department of Energy, Office of Science, BER(United States Department of Energy (DOE)); Laboratory Directed Research and Development funds at the Brookhaven National Laboratory	This research was funded by the U.S. Department of Energy, Office of Science, BER, Project KP1102010 under Contract DE-AC02-98CH10886, and by Laboratory Directed Research and Development funds (LDRD09-005) at the Brookhaven National Laboratory under contract with the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Barac T, 2004, NAT BIOTECHNOL, V22, P583, DOI 10.1038/nbt960; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Burse A, 2004, MOL PLANT MICROBE IN, V17, P43, DOI 10.1094/MPMI.2004.17.1.43; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Clarke MB, 2005, MOL MICROBIOL, V57, P1734, DOI 10.1111/j.1365-2958.2005.04792.x; COGAN TM, 1981, APPL ENVIRON MICROB, V41, P1; Dorr J, 1998, MOL MICROBIOL, V30, P7, DOI 10.1046/j.1365-2958.1998.01010.x; Dosanjh NS, 2007, BIOCHEMISTRY-US, V46, P2520, DOI 10.1021/bi062092w; Ferrieres L, 2007, MICROBIOL-SGM, V153, P1070, DOI 10.1099/mic.0.2006/002907-0; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hofte Monica, 2007, V12, P121; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; JUNI E, 1952, J BIOL CHEM, V195, P727; Kasari V, 2010, J BACTERIOL, V192, P2908, DOI 10.1128/JB.01266-09; Kincaid R, 2008, BIOINFORMATICS, V24, P2112, DOI 10.1093/bioinformatics/btn368; KOGA J, 1994, BBA-PROTEIN STRUCT M, V1209, P241, DOI 10.1016/0167-4838(94)90191-0; KOGA J, 1995, BBA-PROTEIN STRUCT M, V1249, P1, DOI 10.1016/0167-4838(95)00011-I; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MISAGHI IJ, 1990, PHYTOPATHOLOGY, V80, P808, DOI 10.1094/Phyto-80-808; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEWMAN L, 2013, Patent No. 2011027842; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Prigent-Combaret C, 1999, J BACTERIOL, V181, P5993, DOI 10.1128/JB.181.19.5993-6002.1999; Reid SJ, 2005, APPL MICROBIOL BIOT, V67, P312, DOI 10.1007/s00253-004-1885-y; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers A, 2012, GCB BIOENERGY, V4, P364, DOI 10.1111/j.1757-1707.2011.01119.x; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Rozhon W, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-56; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; SCHATZ A, 1952, J BACTERIOL, V63, P87, DOI 10.1128/JB.63.1.87-98.1952; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stanley NR, 2003, J BACTERIOL, V185, P1951, DOI 10.1128/JB.185.6.1951-1957.2003; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Walsh UF, 2001, CURR OPIN BIOTECH, V12, P289, DOI 10.1016/S0958-1669(00)00212-3; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Wood TK, 2009, ENVIRON MICROBIOL, V11, P1, DOI 10.1111/j.1462-2920.2008.01768.x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhang XS, 2008, ISME J, V2, P615, DOI 10.1038/ismej.2008.24	63	16	18	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115455	10.1371/journal.pone.0115455	http://dx.doi.org/10.1371/journal.pone.0115455			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607953	Green Submitted, Green Published, gold			2022-12-27	WOS:000348205300014
J	Kang, N; Kim, H; Jae, Y; Lee, N; Ku, CR; Margolis, F; Lee, EJ; Bahk, YY; Kim, MS; Koo, J				Kang, NaNa; Kim, Hyerin; Jae, YoonGyu; Lee, NaHye; Ku, Cheol Ryong; Margolis, Frank; Lee, Eun Jig; Bahk, Young Yil; Kim, Min-Soo; Koo, JaeHyung			Olfactory Marker Protein Expression Is an Indicator of Olfactory Receptor-Associated Events in Non-Olfactory Tissues	PLOS ONE			English	Article							ODORANT RECEPTOR; GENE-EXPRESSION; FUNCTIONAL EXPRESSION; INTERSTITIAL-CELLS; SENSORY NEURONS; URINARY-BLADDER; MOLECULAR-BASIS; MOUSE; OMP; IDENTIFICATION	Olfactory receptor (OR)-associated events are mediated by well-conserved components in the olfactory epithelium, including olfactory G-protein (G(olf)), adenylate cyclase III (ACIII), and olfactory marker protein (OMP). The expression of ORs has recently been observed in non-olfactory tissues where they are involved in monitoring extracellular chemical cues. The large number of OR genes and their sequence similarities illustrate the need to find an effective and simple way to detect non-olfactory OR-associated events. In addition, expression profiles and physiological functions of ORs in non-olfactory tissues are largely unknown. To overcome limitations associated with using OR as a target protein, this study used OMP with G(olf) and ACIII as targets to screen for potential OR-mediated sensing systems in non-olfactory tissues. Here, we show using western blotting, real-time PCR, and single as well as double immunoassays that ORs and OR-associated proteins are co-expressed in diverse tissues. The results of immunohistochemical analyses showed OMP (+) cells in mouse heart and in the following cells using the corresponding marker proteins c-kit, keratin 14, calcitonin, and GFAP in mouse tissues: interstitial cells of Cajal of the bladder, medullary thymic epithelial cells of the thymus, parafollicular cells of the thyroid, and Leydig cells of the testis. The expression of ORs in OMP (+) tissues was analyzed using a refined microarray analysis and validated with RT-PCR and real-time PCR. Three ORs (olfr544, olfr558, and olfr1386) were expressed in the OMP (+) cells of the bladder and thyroid as shown using a co-immunostaining method. Together, these results suggest that OMP is involved in the OR-mediated signal transduction cascade with olfactory canonical signaling components between the nervous and endocrine systems. The results further demonstrate that OMP immunohistochemical analysis is a useful tool for identifying expression of ORs, suggesting OMP expression is an indicator of potential OR-mediated chemoreception in non-olfactory systems.	[Kang, NaNa; Jae, YoonGyu; Lee, NaHye; Koo, JaeHyung] DGIST, Dept Brain Sci, Taegu, South Korea; [Kim, Hyerin; Kim, Min-Soo] DGIST, Dept Informat & Commun Engn, Taegu, South Korea; [Ku, Cheol Ryong; Lee, Eun Jig] Yonsei Univ, Coll Med, Seoul, South Korea; [Margolis, Frank] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Bahk, Young Yil] Konkuk Univ, Dept Biotechnol, Chungju, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Yonsei University; Yonsei University Health System; University System of Maryland; University of Maryland Baltimore; Konkuk University	Kim, MS (corresponding author), DGIST, Dept Informat & Commun Engn, Taegu, South Korea.	mskim@dgist.ac.kr; jkoo001@dgist.ac.kr	Koo, JaeHyung/R-3036-2019	Koo, JaeHyung/0000-0002-5538-8001; Lee, Eun Jig/0000-0002-9876-8370; Ku, Cheol Ryong/0000-0001-8693-9630	National Research Foundation of Korea [2013R1A1A2009145]; Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs [HI13C0423]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs	This work was supported by the National Research Foundation of Korea [No. 2013R1A1A2009145 (JHK)]; Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs (HI13C0423).	BAKER H, 1989, J COMP NEUROL, V285, P246, DOI 10.1002/cne.902850207; Baldisseri DM, 2002, J MOL BIOL, V319, P823, DOI 10.1016/S0022-2836(02)00282-6; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; Chen HY, 2005, J NEUROCYTOL, V34, P37, DOI 10.1007/s11068-005-5046-8; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Davidoff MS, 2002, ACTA HISTOCHEM, V104, P39, DOI 10.1078/0065-1281-00630; Doucet S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007579; Ekberg JAK, 2011, J NEUROSCI METH, V196, P88, DOI 10.1016/j.jneumeth.2011.01.008; Farbman A, 2000, NEUROBIOLOGY TASTE S, P131; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fleischer J, 2006, HISTOCHEM CELL BIOL, V125, P337, DOI 10.1007/s00418-005-0077-x; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Fuss SH, 2005, EUR J NEUROSCI, V22, P2649, DOI 10.1111/j.1460-9568.2005.04468.x; Gray SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053423; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Horth L, 2007, GENOMICS, V90, P159, DOI 10.1016/j.ygeno.2007.03.021; Ivic L, 2000, NAT NEUROSCI, V3, P1113, DOI 10.1038/80632; Jacob S, 2002, HORM BEHAV, V42, P274, DOI 10.1006/hbeh.2002.1826; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Koo JH, 2005, J COMP NEUROL, V487, P1, DOI 10.1002/cne.20486; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kubota Y, 2011, ADV UROL, V2011, DOI 10.1155/2011/816342; Kwon HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004260; Ma MH, 2012, ADV EXP MED BIOL, V739, P93, DOI 10.1007/978-1-4614-1704-0_6; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MARGOLIS FL, 1972, P NATL ACAD SCI USA, V69, P1221, DOI 10.1073/pnas.69.5.1221; McCloskey KD, 2010, NEUROUROL URODYNAM, V29, P82, DOI 10.1002/nau.20739; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Morillo-Bernal J, 2009, J ANAT, V215, P150, DOI 10.1111/j.1469-7580.2009.01095.x; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Murphy C, 2009, ANN NY ACAD SCI, V1170, P680, DOI 10.1111/j.1749-6632.2009.04491.x; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Nguyen MQ, 2010, J NEUROSCI, V30, P9271, DOI 10.1523/JNEUROSCI.1502-10.2010; Pifferi S., 2010, NEUROBIOLOGY OLFACTI; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Reisert J, 2007, J PHYSIOL-LONDON, V585, P731, DOI 10.1113/jphysiol.2007.142471; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Restrepo D, 1996, J NEUROBIOL, V30, P37; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Smith PC, 2002, J MOL BIOL, V319, P807, DOI 10.1016/S0022-2836(02)00242-5; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Sui GP, 2002, BJU INT, V90, P118, DOI 10.1046/j.1464-410X.2002.02834.x; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Ukhanov K, 2011, J NEUROSCI, V31, P273, DOI 10.1523/JNEUROSCI.3698-10.2011; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Welge-Lussen A, 2009, B-ENT, P129; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153; Youngentob SL, 2001, BEHAV NEUROSCI, V115, P626, DOI 10.1037//0735-7044.115.3.626; Youngentob SL, 2003, J NEUROPHYSIOL, V90, P3864, DOI 10.1152/jn.00806.2002; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	67	49	49	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116097	10.1371/journal.pone.0116097	http://dx.doi.org/10.1371/journal.pone.0116097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635859	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700023
J	Numasawa, Y; Kohsaka, S; Miyata, H; Noma, S; Suzuki, M; Ishikawa, S; Nakamura, I; Nishi, Y; Ohki, T; Negishi, K; Takahashi, T; Fukuda, K				Numasawa, Yohei; Kohsaka, Shun; Miyata, Hiroaki; Noma, Shigetaka; Suzuki, Masahiro; Ishikawa, Shiro; Nakamura, Iwao; Nishi, Yutaro; Ohki, Takahiro; Negishi, Koji; Takahashi, Toshiyuki; Fukuda, Keiichi			Gender Differences in In-Hospital Clinical Outcomes after Percutaneous Coronary Interventions: An Insight from a Japanese Multicenter Registry	PLOS ONE			English	Article							CARDIOVASCULAR DATA REGISTRY; ELEVATION MYOCARDIAL-INFARCTION; DRUG-ELUTING STENTS; BLEEDING COMPLICATIONS; ADVERSE OUTCOMES; WOMEN; IMPACT; MEN; SEX; ARTERY	Background Gender differences in clinical outcomes after percutaneous coronary intervention (PCI) among different age groups are controversial in the era of drug-eluting stents, especially among the Asian population who are at higher risk for bleeding complications. Methods and Results We analyzed data from 10,220 patients who underwent PCI procedures performed at 14 Japanese hospitals from September 2008 to April 2013. A total of 2,106 (20.6%) patients were women. Women were older (72.7 +/- 9.7 vs 66.6 +/- 10.8 years, p< 0.001), and had a lower body mass index (23.4 +/- 4.0 vs 24.3 +/- 3.5, p< 0.001), with a higher prevalence of hypertension (p< 0.001), hyperlipidemia (p< 0.001), insulin-dependent diabetes (p< 0.001), renal failure (p< 0.001), and heart failure (p< 0.001) compared with men. Men tended to have more bifurcation lesions (p = 0.003) and chronic totally occluded lesions (p< 0.001) than women. Crude overall complications (14.8% vs 9.5%, p< 0.001) and the rate of bleeding complications (5.3% vs 2.8%, p< 0.001) were significantly higher in women than in men. On multivariate analysis in the total cohort, female sex was an independent predictor of overall complications (OR, 1.47; 95% CI, 1.26-1.71; p< 0.001) and bleeding complications (OR, 1.74; 95% CI, 1.36-2.24; p< 0.001) after adjustment for confounding variables. A similar trend was observed across the middle-aged group (>= 55 and < 75 years) and old age group (>= 75 years). Conclusions Women are at higher risk than men for post-procedural complications after PCI, regardless of age.	[Numasawa, Yohei; Takahashi, Toshiyuki] Ashikaga Red Cross Hosp, Dept Cardiol, Ashikaga, Tochigi, Japan; [Kohsaka, Shun; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Miyata, Hiroaki] Univ Tokyo, Healthcare Qual Assessment, Tokyo, Japan; [Noma, Shigetaka] Saiseikai Utsunomiya Hosp, Dept Cardiol, Utsunomiya, Tochigi, Japan; [Suzuki, Masahiro] Saitama Natl Hosp, Natl Hosp Org, Dept Cardiol, Saitama, Japan; [Ishikawa, Shiro] Saitama City Hosp, Dept Cardiol, Saitama, Japan; [Nakamura, Iwao] Hino Municipal Hosp, Dept Cardiol, Tokyo, Japan; [Nishi, Yutaro] St Lukes Int Hosp Heart Ctr, Dept Cardiol, Tokyo, Japan; [Ohki, Takahiro] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Cardiol, Chiba, Japan; [Negishi, Koji] Yokohama Municipal Hosp, Dept Cardiol, Kanagawa, Japan	Keio University; University of Tokyo; St. Luke's International Hospital; Tokyo Dental College	Numasawa, Y (corresponding author), Ashikaga Red Cross Hosp, Dept Cardiol, Ashikaga, Tochigi, Japan.	numasawa@cpnet.med.keio.ac.jp	Fukuda, Keiichi/L-3777-2013; Numasawa, Yohei/AAC-9604-2020	Numasawa, Yohei/0000-0002-1739-2800; Kohsaka, Shun/0000-0003-3779-2972	Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI) [21790751]	Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI No. 21790751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2003, AM J CARDIOL, V91, P968, DOI 10.1016/S0002-9149(03)00114-0; Ahmed B, 2013, CIRCULATION, V127, P641, DOI 10.1161/CIRCULATIONAHA.112.108290; Ahmed B, 2009, CIRC-CARDIOVASC INTE, V2, P423, DOI 10.1161/CIRCINTERVENTIONS.109.860494; Alexander KP, 2006, CIRCULATION, V114, P1380, DOI 10.1161/CIRCULATIONAHA.106.620815; Alexander KP, 2005, JAMA-J AM MED ASSOC, V294, P3108, DOI 10.1001/jama.294.24.3108; Arai T, 2013, HEART VESSELS, V28, P714, DOI 10.1007/s00380-012-0314-x; Argulian E, 2006, AM J CARDIOL, V98, P48, DOI 10.1016/j.amjcard.2006.01.048; Ashby DT, 2003, AM J CARDIOL, V91, P979, DOI 10.1016/S0002-9149(03)00118-8; Bangalore S, 2012, AM J MED, V125, P1000, DOI 10.1016/j.amjmed.2011.11.016; Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016; Chiu JH, 2004, AM HEART J, V148, P998, DOI 10.1016/j.ahj.2004.05.045; Cho L, 2000, J AM COLL CARDIOL, V36, P381, DOI 10.1016/S0735-1097(00)00746-4; Daugherty SL, 2013, J AM COLL CARDIOL, V61, P2070, DOI 10.1016/j.jacc.2013.02.030; Endo A, 2013, AM J CARDIOVASC DRUG, V13, P103, DOI 10.1007/s40256-013-0021-8; Glaser R, 2006, AM J CARDIOL, V98, P1446, DOI 10.1016/j.amjcard.2006.06.044; Kodaira M, 2013, INT J CARDIOL, V168, P534, DOI 10.1016/j.ijcard.2013.01.276; Kohsaka S, 2010, AM J CARDIOL, V105, P1698, DOI 10.1016/j.amjcard.2010.01.349; Kuno T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072672; Lansky AJ, 2004, AM J CARDIOL, V93, P916, DOI 10.1016/j.amjcard.2003.12.046; Manoukian SV, 2009, AM J CARDIOL, V104, p9C, DOI 10.1016/j.amjcard.2009.06.020; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Mogi S, 2011, INT J CARDIOL, V153, P85, DOI 10.1016/j.ijcard.2011.08.075; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Numasawa Y, 2014, HEART VESSELS, V29, P49, DOI 10.1007/s00380-013-0324-3; Numasawa Y, 2013, CARDIOVASC INTERV TH, V28, P242, DOI 10.1007/s12928-013-0162-3; Numasawa Y, 2013, CARDIOVASC INTERV TH, V28, P148, DOI 10.1007/s12928-012-0138-8; Ohno Y, 2013, J AM COLL CARDIOL, V62, P1260, DOI 10.1016/j.jacc.2013.03.086; Onuma Y, 2009, JACC-CARDIOVASC INTE, V2, P603, DOI 10.1016/j.jcin.2009.03.016; Pendyala LK, 2013, AM J CARDIOL, V111, P1092, DOI 10.1016/j.amjcard.2012.12.040; Pristipino C, 2007, AM J CARDIOL, V99, P1216, DOI 10.1016/j.amjcard.2006.12.038; Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007; Shin JS, 2014, AM J CARDIOL, V113, P2002, DOI 10.1016/j.amjcard.2014.03.042; Stefanini GG, 2012, JACC-CARDIOVASC INTE, V5, P301, DOI 10.1016/j.jcin.2011.11.011; Wang TY, 2007, AM J CARDIOL, V100, P391, DOI 10.1016/j.amjcard.2007.03.035; Woo M, 2011, CHINESE MED J-PEKING, V124, P862, DOI 10.3760/cma.j.issn.0366-6999.2011.06.011; Yatskar L, 2007, CATHETER CARDIO INTE, V69, P961, DOI 10.1002/ccd.21087	36	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116496	10.1371/journal.pone.0116496	http://dx.doi.org/10.1371/journal.pone.0116496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635905	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700041
J	Sathyamoorthy, T; Sandhu, G; Tezera, LB; Thomas, R; Singhania, A; Woelk, CH; Dimitrov, BD; Agranoff, D; Evans, CAW; Friedland, JS; Elkington, PT				Sathyamoorthy, Tarangini; Sandhu, Gurjinder; Tezera, Liku B.; Thomas, Richard; Singhania, Akul; Woelk, Christopher H.; Dimitrov, Borislav D.; Agranoff, Dan; Evans, Carlton A. W.; Friedland, Jon S.; Elkington, Paul T.			Gender-Dependent Differences in Plasma Matrix Metalloproteinase-8 Elevated in Pulmonary Tuberculosis	PLOS ONE			English	Article							TISSUE INHIBITORS; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE-9; DISEASE; PROTEIN; SEVERITY; LEVEL; MMP-8; SERUM	Tuberculosis (TB) remains a global health pandemic and greater understanding of underlying pathogenesis is required to develop novel therapeutic and diagnostic approaches. Matrix metalloproteinases (MMPs) are emerging as key effectors of tissue destruction in TB but have not been comprehensively studied in plasma, nor have gender differences been investigated. We measured the plasma concentrations of MMPs in a carefully characterised, prospectively recruited clinical cohort of 380 individuals. The collagenases, MMP-1 and MMP-8, were elevated in plasma of patients with pulmonary TB relative to healthy controls, and MMP-7 (matrilysin) and MMP-9 (gelatinase B) were also increased. MMP-8 was TB- specific (p<0.001), not being elevated in symptomatic controls (symptoms suspicious of TB but active disease excluded). Plasma MMP-8 concentrations inversely correlated with body mass index. Plasma MMP-8 concentration was 1.51-fold higher in males than females with TB (p<0.05) and this difference was not due to greater disease severity in men. Gender-specific analysis of MMPs demonstrated consistent increase in MMP-1 and -8 in TB, but MMP-8 was a better discriminator for TB in men. Plasma collagenases are elevated in pulmonary TB and differ between men and women. Gender must be considered in investigation of TB immunopathology and development of novel diagnostic markers.	[Sathyamoorthy, Tarangini; Sandhu, Gurjinder; Agranoff, Dan; Evans, Carlton A. W.; Friedland, Jon S.; Elkington, Paul T.] Univ London Imperial Coll Sci Technol & Med, Infect Dis & Immun, London, England; [Tezera, Liku B.; Singhania, Akul; Woelk, Christopher H.; Dimitrov, Borislav D.; Elkington, Paul T.] Univ Southampton, Fac Med, NIHR Southampton Resp Biomed Res Unit, Clin & Expt Sci Acad Unit, Southampton SO9 5NH, Hants, England; [Thomas, Richard] Royal London Hosp, London, England; [Dimitrov, Borislav D.] Univ Southampton, Fac Med, Primary Care & Populat Sci, Southampton SO9 5NH, Hants, England; [Agranoff, Dan] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Evans, Carlton A. W.] Univ Peruana Cayetano Heredia, Microbiol, Lima, Peru; [Elkington, Paul T.] Univ Southampton, Inst Life Sci, Southampton, Hants, England	Imperial College London; University of Southampton; Barts Health NHS Trust; Royal London Hospital; University of Southampton; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; Universidad Peruana Cayetano Heredia; University of Southampton	Elkington, PT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Infect Dis & Immun, London, England.	p.elkington@soton.ac.uk	Singhania, Akul/I-4633-2019; Evans, Carlton/AAI-1653-2020; Dimitrov, Borislav D/A-1246-2010; Tezera, Liku/GYJ-3244-2022	Singhania, Akul/0000-0002-6941-3618; Evans, Carlton/0000-0002-6873-5447; Dimitrov, Borislav D/0000-0002-5896-2072; Woelk, Christopher/0000-0002-1977-0502; Friedland, Jonathan S/0000-0001-7789-9649; Elkington, Paul/0000-0003-0390-0613	MRC; Wellcome Clinical Research training fellowship; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme at Imperial College; Imperial College Healthcare Charity; MRC [MR/K007467/1, G0900429] Funding Source: UKRI; Medical Research Council [MR/K007467/1, G0900429] Funding Source: researchfish; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1118545] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Clinical Research training fellowship; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme at Imperial College; Imperial College Healthcare Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative	TS was funded by an MRC and GS by a Wellcome Clinical Research training fellowship. PE and JSF are grateful for support from the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme at Imperial College. The authors are grateful for support from the Imperial College Healthcare Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktogu S, 1996, EUR RESPIR J, V9, P2031, DOI 10.1183/09031936.96.09102031; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Chen MS, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-32; Chiang TY, 2012, CLIN CHEM LAB MED, V50, P449, DOI [10.1515/cclm.2011.805, 10.1515/CCLM.2011.805]; Choi CM, 2007, INT J TUBERC LUNG D, V11, P233; DAVIDSON JM, 1990, EUR RESPIR J, V3, P1048; De Groote MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061002; Diwan VK, 1999, LANCET, V353, P1000, DOI 10.1016/S0140-6736(99)01318-5; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Elkington PT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001847; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390; Hartog CM, 2003, AM J RESP CRIT CARE, V167, P593, DOI 10.1164/rccm.200203-258OC; HIBBS MS, 1989, J CLIN INVEST, V84, P1395, DOI 10.1172/JCI114312; Hrabec E, 2002, INT J TUBERC LUNG D, V6, P713; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; Mannello F, 2008, ARTERIOSCL THROM VAS, V28, P611, DOI 10.1161/ATVBAHA.107.159608; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Mattey DL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4042; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Parks WC, 2001, RESP RES, V2, P10, DOI 10.1186/rr33; Puljiz I, 2012, MED SCI MONITOR, V18, pCR500, DOI 10.12659/MSM.883270; Rodrigo T, 1997, INT J TUBERC LUNG D, V1, P352; Sandhu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038080; Seddon J, 2013, J INFECT DIS, V208, P1571, DOI 10.1093/infdis/jit343; SEPPER R, 1995, CHEST, V107, P1641, DOI 10.1378/chest.107.6.1641; Smith JM, 2007, AM J REPROD IMMUNOL, V58, P111, DOI 10.1111/j.1600-0897.2007.00494.x; Sundararajan S, 2012, HUM IMMUNOL, V73, P985, DOI 10.1016/j.humimm.2012.07.042; Tadokera R, 2014, EUR J IMMUNOL, V44, P127, DOI 10.1002/eji.201343593; Udwadia ZF, 2012, THORAX, V67, P286, DOI 10.1136/thoraxjnl-2012-201663; Ugarte-Gil CA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061333, 10.1371/journal.pone.0069514]; Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Walker NF, 2012, AM J RESP CRIT CARE, V185, P989, DOI 10.1164/rccm.201110-1769OC; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Weiss MG, 2006, GENDER AND TUBERCULO; WHO, 2014, GLOBAL TUBERCULOSIS; Yang SF, 2005, CLIN CHIM ACTA, V352, P209, DOI 10.1016/j.cccn.2004.09.025; Yoder MA, 2004, CURR SCI INDIA, V86, P74	41	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117605	10.1371/journal.pone.0117605	http://dx.doi.org/10.1371/journal.pone.0117605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635689	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000350680700091
J	Vai, S; Ghirotto, S; Pilli, E; Tassi, F; Lari, M; Rizzi, E; Matas-Lalueza, L; Ramirez, O; Lalueza-Fox, C; Achilli, A; Olivieri, A; Torroni, A; Lancioni, H; Giostra, C; Bedini, E; Baricco, LP; Matullo, G; Di Gaetano, C; Piazza, A; Veeramah, K; Geary, P; Caramelli, D; Barbujani, G				Vai, Stefania; Ghirotto, Silvia; Pilli, Elena; Tassi, Francesca; Lari, Martina; Rizzi, Ermanno; Matas-Lalueza, Laura; Ramirez, Oscar; Lalueza-Fox, Carles; Achilli, Alessandro; Olivieri, Anna; Torroni, Antonio; Lancioni, Hovirag; Giostra, Caterina; Bedini, Elena; Baricco, Luisella Pejrani; Matullo, Giuseppe; Di Gaetano, Cornelia; Piazza, Alberto; Veeramah, Krishna; Geary, Patrick; Caramelli, David; Barbujani, Guido			Genealogical Relationships between Early Medieval and Modern Inhabitants of Piedmont	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; GENETIC POPULATION-STRUCTURE; EVOLUTION; SEQUENCE; ORIGIN	In the period between 400 to 800 AD, also known as the period of the Barbarian invasions, intense migration is documented in the historical record of Europe. However, little is known about the demographic impact of these historical movements, potentially ranging from negligible to substantial. As a pilot study in a broader project on Medieval Europe, we sampled 102 specimens from 5 burial sites in Northwestern Italy, archaeologically classified as belonging to Lombards or Longobards, a Germanic people ruling over a vast section of the Italian peninsula from 568 to 774. We successfully amplified and typed the mitochondrial hypervariable region I (HVR-I) of 28 individuals. Comparisons of genetic diversity with other ancient populations and haplotype networks did not suggest that these samples are heterogeneous, and hence allowed us to jointly compare them with three isolated contemporary populations, and with a modern sample of a large city, representing a control for the effects of recent immigration. We then generated by serial coalescent simulations 16 millions of genealogies, contrasting a model of genealogical continuity with one in which the contemporary samples are genealogically independent from the medieval sample. Analyses by Approximate Bayesian Computation showed that the latter model fits the data in most cases, with one exception, Trino Vercellese, in which the evidence was compatible with persistence up to the present time of genetic features observed among this early medieval population. We conclude that it is possible, in general, to detect evidence of genealogical ties between medieval and specific modern populations. However, only seldom did mitochondrial DNA data allow us to reject with confidence either model tested, which indicates that broader analyses, based on larger assemblages of samples and genetic markers, are needed to understand in detail the effects of medieval migration.	[Vai, Stefania; Pilli, Elena; Lari, Martina; Caramelli, David] Univ Florence, Dipartimento Biol Evoluzionist, I-50122 Florence, Italy; [Ghirotto, Silvia; Tassi, Francesca; Barbujani, Guido] Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44121 Ferrara, Italy; [Rizzi, Ermanno] CNR, Inst Biomed Technol, I-20090 Milan, Italy; [Matas-Lalueza, Laura; Ramirez, Oscar; Lalueza-Fox, Carles] CSIC UPF, Inst Biol Evolut, Barcelona 08003, Spain; [Achilli, Alessandro; Lancioni, Hovirag] Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06123 Perugia, Italy; [Olivieri, Anna; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Giostra, Caterina] Univ Cattolica Sacro Cuore, Dipartimento Storia Archeol & Storia Arte, I-20123 Milan, Italy; [Bedini, Elena] Anthropozool LBA Snc, I-57123 Livorno, Italy; [Baricco, Luisella Pejrani] Soprintendenza Beni Archeol Piemonte, I-10122 Turin, Italy; [Matullo, Giuseppe; Di Gaetano, Cornelia; Piazza, Alberto] Human Genet Fdn, I-10125 Turin, Italy; [Veeramah, Krishna] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Geary, Patrick] Inst Adv Study, Sch Hist Studies, Princeton, NJ 08540 USA	University of Florence; University of Ferrara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Perugia; University of Pavia; Catholic University of the Sacred Heart; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Institute for Advanced Study - USA	Barbujani, G (corresponding author), Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44121 Ferrara, Italy.	g.barbujani@unife.it	Lancioni, Hovirag/F-9067-2014; Torroni, Antonio/E-1557-2011; rizzi, ermanno/Q-3399-2016; Ramirez, Oscar/E-7293-2012; Di Gaetano, Cornelia/AAA-5477-2019; LALUEZA-FOX, CARLES/AAG-5341-2020; Matullo, Giuseppe/K-6383-2016; Achilli, Alessandro/I-9236-2012; Barbujani, Guido/ABE-9998-2020; OLIVIERI, ANNA/I-9235-2012; Lari, Martina/A-4085-2009	Lancioni, Hovirag/0000-0001-5514-1853; Torroni, Antonio/0000-0002-4163-4478; rizzi, ermanno/0000-0002-9898-2326; Ramirez, Oscar/0000-0001-5164-6790; Di Gaetano, Cornelia/0000-0001-8938-7093; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Matullo, Giuseppe/0000-0003-0674-7757; Achilli, Alessandro/0000-0001-6871-3451; Barbujani, Guido/0000-0001-7854-6669; OLIVIERI, ANNA/0000-0002-3941-8098; VAI, STEFANIA/0000-0003-3844-5147; tassi, francesca/0000-0001-8310-323X; Pilli, Elena/0000-0002-3150-5082; Piazza, Alberto/0000-0002-2355-4183	Italian Ministry for Universities and Research (MIUR), PRIN; FIRB funds "Futuro in Ricerca" [RBFR08U07M, RBFR126B8I]; Compagnia di San Paolo, Turin; Anneliese Maier Research Award of the Alexander von Humboldt Foundation; German Federal Ministry for Education and Research; FEDER and Spanish Government [BFU2012-34157]; European Research Council (ERC) [295733]	Italian Ministry for Universities and Research (MIUR), PRIN(Ministry of Education, Universities and Research (MIUR)); FIRB funds "Futuro in Ricerca"; Compagnia di San Paolo, Turin(Compagnia di San Paolo); Anneliese Maier Research Award of the Alexander von Humboldt Foundation; German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); FEDER and Spanish Government; European Research Council (ERC)(European Research Council (ERC))	This work was supported by the Italian Ministry for Universities and Research (MIUR), PRIN 2012 funds to DC, AA, AT and GB, FIRB funds "Futuro in Ricerca" 2008 (RBFR08U07M) and 2012 (RBFR126B8I) to AA, AO and ER; Compagnia di San Paolo, Turin to DC; the Anneliese Maier Research Award of the Alexander von Humboldt Foundation and the German Federal Ministry for Education and Research to PG; FEDER and Spanish Government grant BFU2012-34157 to CLF; European Research Council (ERC Advanced Grant No. 295733 "LanGe-Lin") to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2002, THE MYTH OF NATIONS; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbiera I., 2005, CHANGING LANDS CHANG; BARBUJANI G, 1991, AM J HUM GENET, V48, P398; BARBUJANI G, 1991, HUM BIOL, V63, P253; Bazin E, 2010, GENETICS, V185, P587, DOI 10.1534/genetics.109.112391; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2008, SIMULATIONS GENETICS, P135; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bedini E, 1997, PALEOBIOLOGIA GRUPPO; Bedini E, 2012, CONOSCENZA LONGOBARD, P448; Belle EMS, 2006, P NATL ACAD SCI USA, V103, P8012, DOI 10.1073/pnas.0509718103; BIRABEN JN, 1979, POPULATION, V34, P13, DOI 10.2307/1531855; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brather S, 2010, FORSCHUNGEN GESCH MI, V17, P25; Caramelli D, 2007, HUM GENET, V122, P327, DOI 10.1007/s00439-007-0403-6; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ghirotto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055519; Ghirotto S, 2010, MOL BIOL EVOL, V27, P875, DOI 10.1093/molbev/msp292; Giostra C, 2007, LONGOBARDI MONFERRAT, P43; Giostra C, 2011, POSTCLASSICAL ARCHAE, V1, P7; Guimaraes S, 2009, MOL BIOL EVOL, V26, P2157, DOI 10.1093/molbev/msp126; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; HUDSON RR, 1992, GENETICS, V132, P583; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lalueza-Fox C, 2011, P NATL ACAD SCI USA, V108, P250, DOI 10.1073/pnas.1011553108; Micheletto E., 1997, ARCHEOLOGIA FUNERARI; Micheletto E, 2007, LONGOBARDI MONFERRAT, P99; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Panto G, 2001, CHIESE RURALI 7 8 SE, P17; Pejrani Baricco L, 2007, DOCUMENTI ARCHEOLOGI, P363; Pejrani Baricco L, 2004, PRESENZE LONGOBARDE; PIAZZA A, 1988, ANN HUM GENET, V52, P203, DOI 10.1111/j.1469-1809.1988.tb01098.x; Pilli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052524; Pohl W, 2005, FORSCHUNGEN GESCH MI, V9; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; R Development Core Team, 2006, R LANG ENV STAT COMP; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Sampietro ML, 2005, ANN HUM GENET, V69, P535, DOI 10.1111/j.1529-8817.2005.00194.x; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sousa VC, 2012, HEREDITY, V108, P521, DOI 10.1038/hdy.2011.116; Turchi C, 2008, INT J LEGAL MED, V122, P199, DOI 10.1007/s00414-007-0207-1; Vai S, 2012, J BIOL RES, V1; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921	52	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116801	10.1371/journal.pone.0116801	http://dx.doi.org/10.1371/journal.pone.0116801			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635682	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700059
J	Kucharzewska, P; Christianson, HC; Belting, M				Kucharzewska, Paulina; Christianson, Helena C.; Belting, Mattias			Global Profiling of Metabolic Adaptation to Hypoxic Stress in Human Glioblastoma Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR 1-ALPHA; ALDOSE REDUCTASE; CANCER-CELLS; TUMOR-GROWTH; CELLULAR-METABOLISM; MEDIATED INDUCTION; MALIGNANT GLIOMA; INHIBITION; EXPRESSION	Oncogenetic events and unique phenomena of the tumor microenvironment together induce adaptive metabolic responses that may offer new diagnostic tools and therapeutic targets of cancer. Hypoxia, or low oxygen tension, represents a well- established and universal feature of the tumor microenvironment and has been linked to increased tumor aggressiveness as well as resistance to conventional oncological treatments. Previous studies have provided important insights into hypoxia induced changes of the transcriptome and proteome; however, how this translates into changes at the metabolite level remains to be defined. Here, we have investigated dynamic, time- dependent effects of hypoxia on the cancer cell metabolome across all families of macromolecules, i.e., carbohydrate, protein, lipid and nucleic acid, in human glioblastoma cells. Using GC/MS and LC/MS/ MS, 345 and 126 metabolites were identified and quantified in cells and corresponding media, respectively, at short (6 h), intermediate (24 h), and prolonged (48 h) incubation at normoxic or hypoxic (1% O-2) conditions. In conjunction, we performed gene array studies with hypoxic and normoxic cells following short and prolonged incubation. We found that levels of several key metabolites varied with the duration of hypoxic stress. In some cases, metabolic changes corresponded with hypoxic regulation of key pathways at the transcriptional level. Our results provide new insights into the metabolic response of glioblastoma cells to hypoxia, which should stimulate further work aimed at targeting cancer cell adaptive mechanisms to microenvironmental stress.	[Kucharzewska, Paulina; Christianson, Helena C.; Belting, Mattias] Lund Univ, Dept Clin Sci, Sect Oncol & Pathol, Lund, Sweden; [Belting, Mattias] Skane Univ Hosp, Skane Oncol Clin, Lund, Sweden	Lund University; Lund University; Skane University Hospital	Belting, M (corresponding author), Lund Univ, Dept Clin Sci, Sect Oncol & Pathol, Lund, Sweden.	mattias.belting@med.lu.se	Kucharzewska, Paulina/AAI-6248-2020	Belting, Mattias/0000-0003-1585-5434	Swedish Cancer Fund; Swedish Research Council; Gunnar Nilsson; Anna Lisa and Sven Eric Lundgren; Kamprad Foundations; Skayne University Hospital donation funds	Swedish Cancer Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson; Anna Lisa and Sven Eric Lundgren; Kamprad Foundations; Skayne University Hospital donation funds	This work was supported by grants (to MB) from the Swedish Cancer Fund (www.cancerfonden. se); the Swedish Research Council (www.vr.se); the Gunnar Nilsson (www.cancerstiftelsen.com), Anna Lisa and Sven Eric Lundgren (www.med.lu.se), and Kamprad Foundations (www.med.lu.se); the Skayne University Hospital donation funds (www.med.lu.se); and the Governmental funding of clinical research within the national health services (www.med.lu.se).	Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Chinnaiyan P, 2012, CANCER RES, V72, P5878, DOI 10.1158/0008-5472.CAN-12-1572-T; Crucet M, 2013, ATHEROSCLEROSIS, V229, P110, DOI 10.1016/j.atherosclerosis.2013.04.034; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Eberstal S, 2014, INT J CANCER, V134, P2748, DOI 10.1002/ijc.28607; Elsherbiny ME, 2013, PROG LIPID RES, V52, P562, DOI 10.1016/j.plipres.2013.08.004; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Ferretti A, 2002, BRIT J CANCER, V86, P1180, DOI 10.1038/sj/bjc/6600189; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GARTY H, 1991, AM J PHYSIOL, V260, pF650, DOI 10.1152/ajprenal.1991.260.5.F650; Glunde K, 2008, CANCER RES, V68, P172, DOI 10.1158/0008-5472.CAN-07-2678; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Gorin A, 2012, CURR OPIN PHARMACOL, V12, P710, DOI 10.1016/j.coph.2012.06.011; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koike T, 2004, P NATL ACAD SCI USA, V101, P8132, DOI 10.1073/pnas.0402088101; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Kuruvilla R, 1998, J NEUROCHEM, V71, P775; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liu HB, 2010, CANCER RES, V70, P6368, DOI 10.1158/0008-5472.CAN-09-4615; Lorenzi M, 2007, EXP DIABETES RES, DOI 10.1155/2007/61038; Lynch TP, 2011, CELL CYCLE, V10, P1712, DOI 10.4161/cc.10.11.15561; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Myung J, 2010, NEUROPATHOLOGY, V30, P224, DOI 10.1111/j.1440-1789.2009.01072.x; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pelletier J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00018; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Sato S, 2003, CHEM-BIOL INTERACT, V143, P363, DOI 10.1016/S0009-2797(02)00209-0; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Simic P, 2013, CELL REP, V3, P1175, DOI 10.1016/j.celrep.2013.03.019; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki K, 2013, NEURO-ONCOLOGY, V15, P1186, DOI 10.1093/neuonc/not062; Svensson KJ, 2008, CANCER RES, V68, P9291, DOI 10.1158/0008-5472.CAN-08-2340; Tammali R, 2011, CURR CANCER DRUG TAR, V11, P560, DOI 10.2174/156800911795655958; Tammali R, 2011, J BIOL CHEM, V286, P24089, DOI 10.1074/jbc.M111.219733; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Uzozie A, 2014, MOL CELL PROTEOMICS, V13, P1198, DOI 10.1074/mcp.M113.035105; Wang T, 2014, P NATL ACAD SCI US; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wu LY, 2010, CELL STRESS CHAPERON, V15, P387, DOI 10.1007/s12192-009-0153-6; Yandim MK, 2013, CANCER CHEMOTH PHARM, V71, P13, DOI 10.1007/s00280-012-1984-x; Yin J, 2010, FEBS LETT, V584, P1872, DOI 10.1016/j.febslet.2009.11.019; Yuan HF, 2013, ONCOTARGETS THER, V6, P1399, DOI 10.2147/OTT.S37750; Zhang CZ, 2013, NEURO-ONCOLOGY, V15, P1114, DOI 10.1093/neuonc/not087; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zodro E, 2014, TUMOR BIOL, V35, P2607, DOI 10.1007/s13277-013-1344-4	65	64	65	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116740	10.1371/journal.pone.0116740	http://dx.doi.org/10.1371/journal.pone.0116740			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633823	Green Published, Green Submitted, gold			2022-12-27	WOS:000348609800009
J	Deng, CW; Hu, CJ; Chen, S; Li, J; Wen, XT; Wu, ZY; Li, Y; Zhang, FC; Li, YZ				Deng, Chuiwen; Hu, Chaojun; Chen, Si; Li, Jing; Wen, Xiaoting; Wu, Ziyan; Li, Yuan; Zhang, Fengchun; Li, Yongzhe			Meta-Analysis of Anti-Muscarinic Receptor Type 3 Antibodies for the Diagnosis of Sjogren Syndrome	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; AUTOANTIBODIES; PEPTIDE	Purpose To conduct a meta-analysis to evaluate the diagnostic value of anti-muscarinic receptor type 3 (M3R) antibodies in Sjogren syndrome (SS). Methods Two databases, PUBMED and the Cochrane Library, were systematically searched. Approximately 2,000 participants from several studies were included in this research. STATA 11.2 software and Meta-DiSc 1.4 was used to conduct the meta-analysis. Results Eleven studies were included in the meta-analysis. The pooled DOR was 13.00 (95% CI, 6.00-26.00). The sensitivity was 0.43 (95% CI, 0.28-0.58) and the specificity was 0.95 (95%CI, 0.91-0.97). The LR+ and LR- were 7.90 (95% CI, 4.70-13.40), 0.61 (95% CI, 0.46-0.79), respectively. The AUC was 0.89 (95% CI, 0.86-0.92). Conclusion The anti-M3R antibody had high specificity but relatively low sensitivity for the diagnosis of SS.	[Li, Yongzhe] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; Peking Union Med Coll, Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, YZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China.	yongzhelipumch@126.com			Research Special Fund for Public Welfare Industry of Health [201202004]; National Natural Science Foundation of China [81302591, 81172857, 81373188]; Chinese National High Technology Research and Development Program; Ministry of Science and Technology Grants [2011AA02A113]; National Science Technology Pillar Program [2014BAI07B00]	Research Special Fund for Public Welfare Industry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National High Technology Research and Development Program(National High Technology Research and Development Program of China); Ministry of Science and Technology Grants; National Science Technology Pillar Program	This work was supported by funding from the Research Special Fund for Public Welfare Industry of Health (201202004), and the National Natural Science Foundation of China Grants (81302591, 81172857, 81373188), the Chinese National High Technology Research and Development Program, Ministry of Science and Technology Grants (2011AA02A113), and the National Science Technology Pillar Program in the 12th Five-year Plan (2014BAI07B00). This funding played an important role in the study design, data collection and analysis, and decision to publish.	Bacman S, 1996, CLIN EXP IMMUNOL, V104, P454, DOI 10.1046/j.1365-2249.1996.42748.x; Bacman S, 2001, INVEST OPHTH VIS SCI, V42, P321; Bournia VK, 2012, J AUTOIMMUN, V39, P15, DOI 10.1016/j.jaut.2012.03.001; Deak M, 2013, NEUROIMMUNOMODULAT, V20, P79, DOI 10.1159/000345177; Eglen R. M., 2006, Autonomic & Autacoid Pharmacology, V26, P219, DOI 10.1111/j.1474-8673.2006.00368.x; He J, 2012, CLIN EXP RHEUMATOL, V30, P322; He J, 2011, RHEUMATOLOGY, V50, P879, DOI 10.1093/rheumatology/keq420; Hu Q, 2013, CLIN BIOCHEM, V46, P1372, DOI 10.1016/j.clinbiochem.2013.04.020; Kovacs L, 2005, RHEUMATOLOGY, V44, P1021, DOI 10.1093/rheumatology/keh672; Marczinovits I, 2005, J AUTOIMMUN, V24, P47, DOI 10.1016/j.jaut.2004.11.005; Mavragani CP, 2010, AUTOIMMUN REV, V9, pA305, DOI 10.1016/j.autrev.2009.11.004; Naito Y, 2005, ANN RHEUM DIS, V64, P510, DOI 10.1136/ard.2004.025478; Nakamura Y, 2008, ANN RHEUM DIS, V67, P136, DOI 10.1136/ard.2007.072421; Roescher N, 2011, ANN RHEUM DIS, V70, P235, DOI 10.1136/ard.2010.129049; Tsuboi H, 2010, CLIN EXP IMMUNOL, V162, P53, DOI 10.1111/j.1365-2249.2010.04188.x; Wu Yu-Huan, 2008, P3	16	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116744	10.1371/journal.pone.0116744	http://dx.doi.org/10.1371/journal.pone.0116744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629973	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100048
J	Sundaramoorthy, P; Sim, JJ; Jang, YS; Mishra, SK; Jeong, KY; Mander, P; Chul, OB; Shim, WS; Oh, SH; Nam, KY				Sundaramoorthy, Pasupathi; Sim, Jae Jun; Jang, Yeong-Su; Mishra, Siddhartha Kumar; Jeong, Keun-Yeong; Mander, Poonam; Chul, Oh Byung; Shim, Won-Sik; Oh, Seung Hyun; Nam, Ky-Youb			Modulation of Intracellular Calcium Levels by Calcium Lactate Affects Colon Cancer Cell Motility through Calcium-Dependent Calpain	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; TUMOR-GROWTH; METABOLISM; P53; MICROENVIRONMENT; PROLIFERATION; DIETARY	Cancer cell motility is a key phenomenon regulating invasion and metastasis. Focal adhesion kinase (FAK) plays a major role in cellular adhesion and metastasis of various cancers. The relationship between dietary supplementation of calcium and colon cancer has been extensively investigated. However, the effect of calcium (Ca2+) supplementation on calpain-FAK-motility is not clearly understood. We sought to identify the mechanism of FAK cleavage through Ca2+ bound lactate (CaLa), its downstream signaling and role in the motility of human colon cancer cells. We found that treating HCT116 and HT-29 cells with CaLa immediately increased the intracellular Ca2+ (iCa(2+)) levels for a prolonged period of time. Ca2+ influx induced cleavage of FAK into an N-terminal FAK (FERM domain) in a dose-dependent manner. Phosphorylated FAK (p-FAK) was also cleaved in to its p-N-terminal FAK. CaLa increased colon cancer cells motility. Calpeptin, a calpain inhibitor, reversed the effects of CaLa on FAK and pFAK cleavage in both cancer cell lines. The cleaved FAK translocates into the nucleus and modulates p53 stability through MDM2-associated ubiquitination. CaLa-induced Ca2+ influx increased the motility of colon cancer cells was mediated by calpain activity through FAK and pFAK protein destabilization. In conclusion, these results suggest that careful consideration may be given in deciding dietary Ca2+ supplementation to patient undergoing treatment for metastatic cancer.	[Sundaramoorthy, Pasupathi; Sim, Jae Jun; Jang, Yeong-Su; Mishra, Siddhartha Kumar; Jeong, Keun-Yeong; Mander, Poonam; Chul, Oh Byung; Shim, Won-Sik; Oh, Seung Hyun; Nam, Ky-Youb] Gachon Univ, Gachon Inst Pharmaceut Sci, Inchon 406840, South Korea; [Chul, Oh Byung] Gachon Univ, Dept Mol Med, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea; [Mishra, Siddhartha Kumar] Dr Harisingh Gour Cent Univ, Sch Biol Sci, Dept Zool, Sagar 470003, India	Gachon University; Gachon University; Dr. Hari Singh Gour University	Nam, KY (corresponding author), Gachon Univ, Gachon Inst Pharmaceut Sci, Inchon 406840, South Korea.	hwanmook@gachon.ac.kr	Oh, Seung/AAN-6744-2021; Jeong, Keun-Yeong/B-8845-2015; Sundaramoorthy, Pasupathi/AAC-9823-2021; Mishra, Siddhartha Kumar/A-4344-2016; Sundaramoorthy, Pasupathi/I-4307-2019; Shim, Won-Sik/HGU-0398-2022	Jeong, Keun-Yeong/0000-0002-4933-3493; Sundaramoorthy, Pasupathi/0000-0003-1045-093X; Mishra, Siddhartha Kumar/0000-0003-1627-1377; Sundaramoorthy, Pasupathi/0000-0003-1045-093X; 	Gachon Institute of Pharmaceutical Sciences Research Fund, Gachon University, Republic of Korea	Gachon Institute of Pharmaceutical Sciences Research Fund, Gachon University, Republic of Korea	This work was supported by Gachon Institute of Pharmaceutical Sciences Research Fund 2013, Gachon University, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Choi SYC, 2013, J PATHOL, V230, P350, DOI 10.1002/path.4218; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Golubovskaya VM, 2009, INT J CANCER, V125, P1735, DOI 10.1002/ijc.24486; Hao HF, 2012, BIOCHEM BIOPH RES CO, V423, P744, DOI 10.1016/j.bbrc.2012.06.030; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kato Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-89; Kennedy KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075154; Kim Y, 2009, CURR MOL MED, V9, P425, DOI 10.2174/156652409788167113; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mierke CT, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065005; Miller EA, 2007, CANCER-AM CANCER SOC, V109, P510, DOI 10.1002/cncr.22453; Mishra SK, 2013, EUR J INFLAMM, V11, P615, DOI 10.1177/1721727X1301100306; Mishra SK, 2013, MOL CELLS, V36, P219, DOI 10.1007/s10059-013-0050-9; Mishra SK, 2012, J ETHNOPHARMACOL, V143, P524, DOI 10.1016/j.jep.2012.07.008; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parkash J, 2010, LIFE SCI, V87, P587, DOI 10.1016/j.lfs.2010.09.013; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rinella ES, 2012, CANCER BIOL THER, V13, P130, DOI 10.4161/cbt.13.3.18690; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	31	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116984	10.1371/journal.pone.0116984	http://dx.doi.org/10.1371/journal.pone.0116984			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629974	gold, Green Published, Green Submitted			2022-12-27	WOS:000348732100056
J	Wang, QX; Li, SH; Zhang, X; Xie, L; Cai, PQ; An, X; Pan, ZZ; Ding, PR				Wang, Qiao-Xuan; Li, Shao-Hua; Zhang, Xu; Xie, Lan; Cai, Pei-Qiang; An, Xin; Pan, Zhi-Zhong; Ding, Pei-Rong			Identification of Locally Advanced Rectal Cancer with Low Risk of Local Recurrence	PLOS ONE			English	Article							TOTAL MESORECTAL EXCISION; CIRCUMFERENTIAL RESECTION MARGIN; SPHINCTER PRESERVATION RATE; PREOPERATIVE RADIOTHERAPY; POSTOPERATIVE CHEMORADIOTHERAPY; NEOADJUVANT CHEMORADIOTHERAPY; PROGNOSTIC-SIGNIFICANCE; FOLLOW-UP; SURGERY; MULTICENTER	Background The routine application of neoadjuvant chemoradiotherapy for T3N0 rectal cancer remains controversial. The aim of this study was to use clinical, Magnetic resonance imaging, and pathological parameters to identify a subgroup of patients with low risk of local recurrence who might be precluded from neoadjuvant chemoradiotherapy. Methods We retrospectively reviewed a prospectively maintained database of consecutive rectal cancer patients who underwent curative resection. 166 pathologic confirmed T3N0 rectal cancer patients with tumor located 5-12cm above the anal verge and preoperative circumferential resection margin> 1mm were included in analysis. The primary outcomes measured were 3-and 5-year local recurrence rates. Results Local recurrence was demonstrated during follow-up in 5 patients; the actuarial overall 3-and 5-year local recurrence rates were 2.5% and 3.4%, respectively. Inadequate sampling of lymph nodes (<= 12) was associated with higher local recurrence (P = 0.03) in this group of patients. Conclusion For upper and middle T3N0 rectal cancer with preoperative circumferential resection margin> 1mm, local recurrence rate after total mesorectal excision is low and surgery alone may be enough for this group of patients.	[Wang, Qiao-Xuan; Li, Shao-Hua; Zhang, Xu; Xie, Lan; Cai, Pei-Qiang; An, Xin; Pan, Zhi-Zhong; Ding, Pei-Rong] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Wang, Qiao-Xuan; Li, Shao-Hua; Zhang, Xu; Xie, Lan; Cai, Pei-Qiang; An, Xin; Pan, Zhi-Zhong; Ding, Pei-Rong] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Qiao-Xuan] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Shao-Hua] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xu] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Surg, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Lan] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Pei-Qiang] Sun Yat Sen Univ, Ctr Canc, Dept Med Imaging & Intervent Radiol, Guangzhou 510275, Guangdong, Peoples R China; [An, Xin] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Zhi-Zhong; Ding, Pei-Rong] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Pan, ZZ (corresponding author), Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	panzhzh@sysucc.org.cn; dingpr@mail.sysu.edu.cn						Al-Sukhni E, 2012, ANN SURG ONCOL, V19, P2212, DOI 10.1245/s10434-011-2210-5; Baik SH, 2008, J GASTROINTEST SURG, V12, P176, DOI 10.1007/s11605-007-0254-4; Beets-Tan RGH, 2001, LANCET, V357, P497, DOI 10.1016/S0140-6736(00)04040-X; Birgisson H, 2008, BRIT J SURG, V95, P206, DOI 10.1002/bjs.5918; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Dahlberg M, 1998, DIS COLON RECTUM, V41, P543, DOI 10.1007/BF02235256; De Caluwe L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006041.pub3; Engstrom PF, 2009, J NATL COMPR CANC NE, V7, P838, DOI 10.6004/jnccn.2009.0057; ENKER WE, 1995, J AM COLL SURGEONS, V181, P335; Ferenschild FTJ, 2009, DIGEST SURG, V26, P291, DOI 10.1159/000227771; Frasson M, 2011, CANCER-AM CANCER SOC, V117, P3118, DOI 10.1002/cncr.25866; Glimelius B, 2013, ANN ONCOL, V24, P81, DOI 10.1093/annonc/mdt240; HEALD RJ, 1986, LANCET, V1, P1479; Kim DW, 2006, EJSO-EUR J SURG ONC, V32, P162, DOI 10.1016/j.ejso.2005.10.002; Kim SH, 2009, J MAGN RESON IMAGING, V29, P1093, DOI 10.1002/jmri.21742; MCDERMOTT FT, 1985, BRIT J SURG, V72, P34, DOI 10.1002/bjs.1800720115; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Nissan A, 2006, J CLIN ONCOL, V24, P4078, DOI 10.1200/JCO.2006.06.2968; Picon AI, 2003, INT J COLORECTAL DIS, V18, P487, DOI 10.1007/s00384-003-0504-1; Sarli L, 2005, EUR J CANCER, V41, P272, DOI 10.1016/j.ejca.2004.10.010; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Wibe A, 2002, BRIT J SURG, V89, P327, DOI 10.1046/j.0007-1323.2001.02024.x	24	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117141	10.1371/journal.pone.0117141	http://dx.doi.org/10.1371/journal.pone.0117141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629521	Green Submitted, Green Published, gold			2022-12-27	WOS:000348732100068
J	Webster, B; Hayes, W; Pike, TW				Webster, Ben; Hayes, William; Pike, Thomas W.			Avian Egg Odour Encodes Information on Embryo Sex, Fertility and Development	PLOS ONE			English	Article							OLFACTORY NAVIGATION; CHEMICAL CUES; BIRDS; YOLK; CAROTENOIDS; TEMPERATURE; ATTRACTION; INVESTMENT; EVOLUTION; RESPONSES	Avian chemical communication is a rapidly emerging field, but has been hampered by a critical lack of information on volatile chemicals that communicate ecologically relevant information (semiochemicals). A possible, but as yet unexplored, function of olfaction and chemical communication in birds is in parent-embryo and embryo-embryo communication. Communication between parents and developing embryos may act to mediate parental behaviour, while communication between embryos can control the synchronicity of hatching. Embryonic vocalisations and vibrations have been implicated as a means of communication during the later stages of development but in the early stages, before embryos are capable of independent movement and vocalisation, this is not possible. Here we show that volatiles emitted from developing eggs of Japanese quail (Coturnix japonica) convey information on egg fertility, along with the sex and developmental status of the embryo. Specifically, egg volatiles changed over the course of incubation, differed between fertile and infertile eggs, and were predictive of embryo sex as early as day 1 of incubation. Egg odours therefore have the potential to facilitate parent-embryo and embryo-embryo interactions by allowing the assessment of key measures of embryonic development long before this is possible through other modalities. It also opens up the intriguing possibility that parents may be able to glean further relevant information from egg volatiles, such as the health, viability and heritage of embryos. By determining information conveyed by egg-derived volatiles, we hope to stimulate further investigation into the ecological role of egg odours.	[Webster, Ben; Hayes, William; Pike, Thomas W.] Lincoln Univ, Sch Life Sci, Lincoln, England	University of Lincoln	Pike, TW (corresponding author), Lincoln Univ, Sch Life Sci, Lincoln, England.	tpike@lincoln.ac.uk			Natural Environment Research Council [NE/J01382X/1]; Royal Society; NERC [NE/J01382X/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by grants awarded to TWP from the Natural Environment Research Council (NE/J01382X/1) and Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ar A, 2004, AVIAN POULT BIOL REV, V15, P105, DOI 10.3184/147020604783638218; Badyaev AV, 2006, J EVOLUTION BIOL, V19, P1044, DOI 10.1111/j.1420-9101.2006.01106.x; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Balthazart J, 2009, BEHAV BRAIN RES, V200, P248, DOI 10.1016/j.bbr.2008.08.036; Berlin KE, 1998, ETHOLOGY, V104, P531, DOI 10.1111/j.1439-0310.1998.tb00088.x; Boal JG, 2010, J CHEM ECOL, V36, P834, DOI 10.1007/s10886-010-9816-0; Brua RB, 1996, AUK, V113, P525, DOI 10.2307/4088972; Brua RB, 2002, OX ORN SER, V13, P88; Campagna S, 2012, CHEM SENSES, V37, P3, DOI 10.1093/chemse/bjr067; Cook MI, 2004, BEHAV ECOL, V15, P205, DOI 10.1093/beheco/arg096; Cunningham GB, 2012, ANTARCT SCI, V24, P337, DOI 10.1017/S0954102012000168; EVANS RM, 1990, ANIM BEHAV, V40, P969, DOI 10.1016/S0003-3472(05)80999-6; EVANS RM, 1990, ANIM BEHAV, V40, P963, DOI 10.1016/S0003-3472(05)80998-4; FRANKEL EN, 1989, LIPIDS, V24, P976, DOI 10.1007/BF02544544; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gilbert L, 2005, NATURWISSENSCHAFTEN, V92, P178, DOI 10.1007/s00114-004-0603-z; Golubeya TB, 1985, ACT 18 INT ORN C NAU, P259; GRUBB TC, 1974, ANIM BEHAV, V22, P192, DOI 10.1016/S0003-3472(74)80069-2; Himanen SJ, 2010, PLANT SIGNAL BEHAV, V5, P1234, DOI 10.4161/psb.5.10.12919; Jahantigh Mohammad, 2012, Comparative Clinical Pathology, V21, P1049, DOI 10.1007/s00580-011-1226-3; Kochhar HPS, 2001, THERIOGENOLOGY, V55, P3, DOI 10.1016/S0093-691X(00)00441-6; MAGA JA, 1982, J AGR FOOD CHEM, V30, P9, DOI 10.1021/jf00109a002; MAGRATH RD, 1992, AUK, V109, P474; Mardon J, 2010, CHEM SENSES, V35, P309, DOI 10.1093/chemse/bjq021; Martins TLF, 2004, BEHAV ECOL, V15, P174, DOI 10.1093/beheco/arg094; McNabb FMA, 1998, AVIAN GROWTH DEV, P288; Meiners T, 2000, ENTOMOL EXP APPL, V95, P151, DOI 10.1023/A:1004098802806; Mirza RS, 2002, J FISH BIOL, V61, P532, DOI 10.1006/jfbi.2002.2052; Moreno J, 2003, ECOL LETT, V6, P803, DOI 10.1046/j.1461-0248.2003.00505.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Petrie M, 2001, NATURE, V412, P498, DOI 10.1038/35087652; Pike TW, 2011, AVIAN BIOL RES, V4, P231, DOI 10.3184/175815511X13228268534598; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; Rajchard J, 2008, VET MED-CZECH, V53, P412, DOI 10.17221/1926-VETMED; Reed WL, 2011, INTEGR COMP BIOL, V51, P73, DOI 10.1093/icb/icr032; Rubel EW M, HDB SENSORY PHYSL DE, P13; Saino N, 2003, J EVOLUTION BIOL, V16, P516, DOI 10.1046/j.1420-9101.2003.00534.x; SCHWAGMEYER PL, 1991, ANIM BEHAV, V41, P887, DOI 10.1016/S0003-3472(05)80355-0; Spurr E. B., 1999, Science for Conservation, P1; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; Surai P. F., 2002, NATURAL ANTIOXIDANTS; Trimeche A, 1997, CRYOBIOLOGY, V34, P385, DOI 10.1006/cryo.1997.2009; VINCE MA, 1970, ANIM BEHAV, V18, P210, DOI 10.1016/S0003-3472(70)80030-6; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; Weissmann A, 2013, THERIOGENOLOGY, V80, P199, DOI 10.1016/j.theriogenology.2013.04.014; Whittaker DJ, 2011, J CHEM ECOL, V37, P1349, DOI 10.1007/s10886-011-0050-1; Whittaker DJ, 2010, BEHAV ECOL, V21, P608, DOI 10.1093/beheco/arq033; Yavno S, 2011, J FISH BIOL, V78, P1944, DOI 10.1111/j.1095-8649.2011.02964.x	51	33	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116345	10.1371/journal.pone.0116345	http://dx.doi.org/10.1371/journal.pone.0116345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629413	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000348732100035
J	Badisa, RB; Kumar, SS; Mazzio, E; Haughbrook, RD; Allen, JR; Davidson, MW; Fitch-Pye, CA; Goodman, CB				Badisa, Ramesh B.; Kumar, Sanjay S.; Mazzio, Elizabeth; Haughbrook, Rasheda D.; Allen, John R.; Davidson, Michael W.; Fitch-Pye, Cheryl A.; Goodman, Carl B.			N-Acetyl Cysteine Mitigates the Acute Effects of Cocaine-Induced Toxicity in Astroglia-Like Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; GLIAL-CELLS; RAT; BRAIN; GLUTATHIONE; ACTIVATION; EXPRESSION; NEURONS; PHOSPHORYLATION; ACETYLCYSTEINE	Cocaine has a short half-life of only about an hour but its effects, predominantly on the central nervous system (CNS), are fairly long-lasting. Of all cells within the CNS, astrocytes may be the first to display cocaine toxicity owing to their relative abundance in the brain. Cocaine entry could trigger several early response changes that adversely affect their survival, and inhibiting these changes could conversely increase their rate of survival. In order to identify these changes and the minimal concentrations of cocaine that can elicit them in vitro, rat C6 astroglia-like cells were treated with cocaine (2-4 mM for 1h) and assayed for alterations in gross cell morphology, cytoplasmic vacuolation, viability, reactive oxygen species (ROS) generation, glutathione (GSH) levels, cell membrane integrity, F-actin cytoskeleton, and histone methylation. We report here that all of the above identified features are significantly altered by cocaine, and may collectively represent the key pathology underlying acute toxicity-mediated death of astroglia-like cells. Pretreatment of the cells with the clinically available antioxidant N-acetyl cysteine (NAC, 5 mM for 30 min) inhibited these changes during subsequent application of cocaine and mitigated cocaine-induced toxicity. Despite repeated cocaine exposure, NAC pretreated cells remained highly viable and post NAC treatment also increased viability of cocaine treated cells to a smaller yet significant level. We show further that this alleviation by NAC is mediated through an increase in GSH levels in the cells. These findings, coupled with the fact that astrocytes maintain neuronal integrity, suggest that compounds which target and mitigate these early toxic changes in astrocytes could have a potentially broad therapeutic role in cocaine-induced CNS damage.	[Badisa, Ramesh B.; Mazzio, Elizabeth; Goodman, Carl B.] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Kumar, Sanjay S.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Haughbrook, Rasheda D.] Florida A&M Univ, Dept Biol, Tallahassee, FL 32307 USA; [Allen, John R.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32307 USA; [Fitch-Pye, Cheryl A.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida A&M University; State University System of Florida; Florida State University; State University System of Florida; Florida A&M University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Badisa, RB (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	badisa66@gmail.com		Kumar, Sanjay/0000-0002-1952-3624	National Institute on Minority Health and Health Disparities of the National Institutes of Health of the USA [G12MD007582]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007582, P20MD006738] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities of the National Institutes of Health of the USA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under award number G12MD007582 of the USA.	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Araque A, 2006, CURR OPIN INVEST DR, V7, P619; ATTWELL D, 1994, NATURE, V369, P707, DOI 10.1038/369707a0; Badisa RB, 2014, MOL MED REP, V10, P2287, DOI 10.3892/mmr.2014.2524; Badisa RB, 2013, INT J MOL MED, V32, P497, DOI 10.3892/ijmm.2013.1391; Badisa RB, 2012, INT J MOL MED, V30, P687, DOI 10.3892/ijmm.2012.1038; Badisa RB, 2010, NEUROCHEM RES, V35, P288, DOI 10.1007/s11064-009-0053-2; Badisa RB, 2003, PHYTOTHER RES, V17, P472, DOI 10.1002/ptr.1175; Bahar M, 1984, Eur J Anaesthesiol, V1, P293; BARNETT G, 1981, J ETHNOPHARMACOL, V3, P353, DOI 10.1016/0378-8741(81)90063-5; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; BISSELL MG, 1974, BRAIN RES, V82, P77, DOI 10.1016/0006-8993(74)90894-4; Bragin DE, 2010, J CEREBR BLOOD F MET, V30, P734, DOI 10.1038/jcbfm.2010.9; Buttner Andreas, 2006, Forensic Sci Med Pathol, V2, P115, DOI 10.1385/FSMP:2:2:115; Cechin SR, 2005, NEUROCHEM RES, V30, P603, DOI 10.1007/s11064-005-2747-4; Chen TJ, 2006, TOXICOLOGY, V223, P113, DOI 10.1016/j.tox.2006.03.007; Chen YC, 2006, TOXICOL APPL PHARM, V216, P263, DOI 10.1016/j.taap.2006.05.008; CHIU SY, 1994, GLIA, V11, P191, DOI 10.1002/glia.440110213; CHOW MJ, 1985, CLIN PHARMACOL THER, V38, P318, DOI 10.1038/clpt.1985.179; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; CUBELLS JF, 1994, J NEUROSCI, V14, P2260, DOI 10.1523/jneurosci.14-04-02260.1994; Cunha-Oliveira T, 2006, TOXICOLOGY, V217, P54, DOI 10.1016/j.tox.2005.08.022; Cunha-Oliveira T, 2006, BRAIN RES, V1089, P44, DOI 10.1016/j.brainres.2006.03.061; Deigner HP, 2000, EXPERT OPIN INV DRUG, V9, P747, DOI 10.1517/13543784.9.4.747; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Fattore L, 2002, NEUROSCIENCE, V110, P1, DOI 10.1016/S0306-4522(01)00598-X; Feng Z, 2004, FREE RADICAL BIO MED, V37, P1790, DOI 10.1016/j.freeradbiomed.2004.08.023; Finol H. J., 2000, Journal of Submicroscopic Cytology and Pathology, V32, P111; FRAKER TD, 1990, CIRCULATION, V81, P1012, DOI 10.1161/01.CIR.81.3.1012; Fumagalli F, 2006, MOL PHARMACOL, V70, P1726, DOI 10.1124/mol.106.026302; Funchal C, 2005, METAB BRAIN DIS, V20, P205, DOI 10.1007/s11011-005-7208-x; GARG UC, 1993, NEUROSCIENCE, V57, P467, DOI 10.1016/0306-4522(93)90079-U; GU J, 1993, NEUROTOXICOLOGY, V14, P19; Ipsen J., 1970, BANCROFTS INTRO BIOS; Kramer Jamie M, 2013, Biomol Concepts, V4, P1, DOI 10.1515/bmc-2012-0026; KUGELMASS AD, 1993, CIRCULATION, V88, P876, DOI 10.1161/01.CIR.88.3.876; LaRowe SD, 2006, AM J ADDICTION, V15, P105, DOI 10.1080/10550490500419169; Little KY, 2009, PSYCHIAT RES, V168, P173, DOI 10.1016/j.psychres.2008.10.034; Lopez-Erauskin J, 2013, HUM MOL GENET, V22, P3296, DOI 10.1093/hmg/ddt186; Lotharius J, 1999, J NEUROSCI, V19, P1284; MANGOURA D, 1989, NEUROCHEM RES, V14, P941, DOI 10.1007/BF00965927; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; National Institute on Drug Abuse, 2010, NAT I DRUG AB RES RE; Odewumi CO, 2011, INT J MOL MED, V27, P243, DOI 10.3892/ijmm.2010.564; Oliveira MT, 2002, ANN NY ACAD SCI, V965, P487; Park SJ, 2012, J IMMUNOL, V188, P5132, DOI 10.4049/jimmunol.1101600; Pearson J, 1979, HDB CLIN NEUROLOGY 2, P365; Phillips K, 2009, AM J CARDIOVASC DRUG, V9, P177, DOI 10.2165/00129784-200909030-00005; PIXLEY SK, 1992, NEURON, V8, P1191, DOI 10.1016/0896-6273(92)90139-5; Quincozes-Santos A, 2007, NEUROTOXICOLOGY, V28, P886, DOI 10.1016/j.neuro.2007.03.008; Quincozes-Santos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064372; Repetto G, 1997, TOXICOL IN VITRO, V11, P519, DOI 10.1016/S0887-2333(97)00066-0; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Shao ZJ, 2006, J PSYCHIATR NEUROSCI, V31, P32; Sibenaller Zita A, 2005, Neurosurg Focus, V19, pE1; SMART RG, 1987, J FORENSIC SCI, V32, P303; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; STEWART A, 1990, POSTGRAD MED J, V66, P659, DOI 10.1136/pgmj.66.778.659; Stichenwirth M, 2000, FORENSIC SCI INT, V108, P61, DOI 10.1016/S0379-0738(99)00142-5; Su TP, 2001, TRENDS PHARMACOL SCI, V22, P456, DOI 10.1016/S0165-6147(00)01740-5; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; VITULLO JC, 1989, AM J PATHOL, V135, P85; Yu CTR, 2008, J BIOMED SCI, V15, P215, DOI 10.1007/s11373-007-9213-z; Zheng F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002610; ZIMMER DB, 1989, J CELL BIOL, V108, P141, DOI 10.1083/jcb.108.1.141	68	23	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0114285	10.1371/journal.pone.0114285	http://dx.doi.org/10.1371/journal.pone.0114285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617894	Green Submitted, Green Published, gold			2022-12-27	WOS:000350336000002
J	Chen, YC; Ho, HO; Liu, DZ; Siow, WS; Sheu, MT				Chen, Ying-Chen; Ho, Hsiu-O; Liu, Der-Zen; Siow, Wen-Shian; Sheu, Ming-Thau			Swelling/Floating Capability and Drug Release Characterizations of Gastroretentive Drug Delivery System Based on a Combination of Hydroxyethyl Cellulose and Sodium Carboxymethyl Cellulose	PLOS ONE			English	Article							FLOATING MATRIX TABLETS; SUSTAINED-RELEASE; DOSAGE FORMS; IN-VITRO; HELICOBACTER-PYLORI; GASTRIC RETENTION; BIOADHESIVE; FORMULATION; DESIGN; HYDROCHLORIDE	The aim of this study was to characterize the swelling and floating behaviors of gastroretentive drug delivery system (GRDDS) composed of hydroxyethyl cellulose (HEC) and sodium carboxymethyl cellulose (NaCMC) and to optimize HEC/NaCMC GRDDS to incorporate three model drugs with different solubilities (metformin, ciprofloxacin, and esomeprazole). Various ratios of NaCMC to HEC were formulated, and their swelling and floating behaviors were characterized. Influences of media containing various NaCl concentrations on the swelling and floating behaviors and drug solubility were also characterized. Finally, release profiles of the three model drugs from GRDDS formulation (F1-4) and formulation (F1-1) were examined. Results demonstrated when the GRDDS tablets were tested in simulated gastric solution, the degree of swelling at 6 h was decreased for each formulation that contained NaCMC in comparison to those in de-ionized water (DIW). Of note, floating duration was enhanced when in simulated gastric solution compared to DIW. Further, the hydration of tablets was found to be retarded as the NaCl concentration in the medium increased resulting in smaller gel layers and swelling sizes. Dissolution profiles of the three model drugs in media containing various concentrations of NaCl showed that the addition of NaCl to the media affected the solubility of the drugs, and also their gelling behaviors, resulting in different mechanisms for controlling a drug's release. The release mechanism of the freely water-soluble drug, metformin, was mainly diffusion-controlled, while those of the water-soluble drug, ciprofloxacin, and the slightly water-soluble drug, esomeprazole, were mainly anomalous diffusion. Overall results showed that the developed GRDDS composed of HEC 250HHX and NaCMC of 450 cps possessed proper swelling extents and desired floating periods with sustained-release characteristics.	[Chen, Ying-Chen; Ho, Hsiu-O; Siow, Wen-Shian; Sheu, Ming-Thau] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan; [Liu, Der-Zen] Taipei Med Univ, Grad Inst Biomed Mat & Engn, Taipei, Taiwan; [Liu, Der-Zen] Hsuan Chuang Univ, Ctr Gen Educ, Hsinchu, Taiwan; [Sheu, Ming-Thau] Taipei Med Univ Hosp, Canc & Chinese Herb Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Hsuan Chuang University; Taipei Medical University; Taipei Medical University Hospital	Sheu, MT (corresponding author), Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan.	mingsheu@tmu.edu.tw						ALFREY T, 1966, J POLYM SCI POL SYM, P249, DOI 10.1002/polc.5070120119; Arza RAK, 2009, AAPS PHARMSCITECH, V10, P220, DOI 10.1208/s12249-009-9200-y; Atyabi F, 1996, J CONTROL RELEASE, V42, P25, DOI 10.1016/0168-3659(96)01343-0; Atyabi F., 1994, P INT S CONTR REL BI, V21, P806; Bardonnet PL, 2006, J CONTROL RELEASE, V111, P1, DOI 10.1016/j.jconrel.2005.10.031; Basak SC, 2007, PHARMAZIE, V62, P145, DOI 10.1691/ph.2007.2.6108; Bermudez JM, 2008, AAPS PHARMSCITECH, V9, P924, DOI 10.1208/s12249-008-9098-9; Berner B., 2002, U.S. Patent, Patent No. [6,488,962, 6488962]; BOGENTOFT C, 1982, PHARM INT, V3, P366; Chavanpatil MD, 2006, INT J PHARMACEUT, V316, P86, DOI 10.1016/j.ijpharm.2006.02.038; Chen J, 2000, J CONTROL RELEASE, V64, P39, DOI 10.1016/S0168-3659(99)00139-X; Chen J, 1999, J BIOMED MATER RES, V44, P53, DOI 10.1002/(SICI)1097-4636(199901)44:1<53::AID-JBM6>3.0.CO;2-W; Chen RN, 2010, EUR J PHARM SCI, V39, P82, DOI 10.1016/j.ejps.2009.10.015; Chen YC, 2013, INT J PHARMACEUT, V441, P162, DOI 10.1016/j.ijpharm.2012.12.002; Conway BR, 2005, CURR PHARM DESIGN, V11, P775, DOI 10.2174/1381612053381819; de la Torre PM, 2003, BIOMATERIALS, V24, P1459, DOI 10.1016/S0142-9612(02)00541-0; Edgren DE, 2004, US Patent, Patent No. [6,797,283, 6797283]; Flashner-Barak M, 2005, US Patent, Patent No. [6,881,420, 6881420]; Gusler G., 2004, U.S. Patent, Patent No. 6723340; Iannuccelli V, 1998, INT J PHARM, V174, P47, DOI 10.1016/S0378-5173(98)00229-4; ICHIKAWA M, 1991, J PHARM SCI, V80, P1062, DOI 10.1002/jps.2600801113; Jimenez-Martinez I, 2008, INT J PHARMACEUT, V362, P37, DOI 10.1016/j.ijpharm.2008.05.040; JIMENEZCASTELLANOS MR, 1994, INT J PHARM, V105, P65, DOI 10.1016/0378-5173(94)90236-4; Klausner EA, 2002, PHARMACEUT RES, V19, P1516, DOI 10.1023/A:1020412817716; Nur AO, 2000, DRUG DEV IND PHARM, V26, P965, DOI 10.1081/DDC-100101323; Preda M, 2003, J MICROENCAPSUL, V20, P777, DOI 10.1080/02652040310001599742; SHELL JW, 2003, Patent No. 6635280; Sheth PR, 1979, US patent application US Patent, Patent No. 4167558; Streubel A, 2002, INT J PHARMACEUT, V241, P279, DOI 10.1016/S0378-5173(02)00241-7; Streubel Alexander, 2006, Expert Opin Drug Deliv, V3, P217, DOI 10.1517/17425247.3.2.217; Streubel A, 2006, CURR OPIN PHARMACOL, V6, P501, DOI 10.1016/j.coph.2006.04.007; Strubing S, 2008, EUR J PHARM BIOPHARM, V69, P708, DOI 10.1016/j.ejpb.2007.12.009; Strubing S, 2008, J CONTROL RELEASE, V126, P149, DOI 10.1016/j.jconrel.2007.11.013; Sujja-areevath J, 1998, EUR J PHARM SCI, V6, P207, DOI 10.1016/S0928-0987(97)00072-9; Torrado S, 2004, BIOMATERIALS, V25, P917, DOI 10.1016/S0142-9612(03)00579-9; Varshosaz J, 2006, DRUG DELIV, V13, P277, DOI 10.1080/10717540500395106; Zuleger S, 2001, INT J PHARMACEUT, V217, P139, DOI 10.1016/S0378-5173(01)00596-8; [No title captured], Patent No. 4126672	38	33	35	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116914	10.1371/journal.pone.0116914	http://dx.doi.org/10.1371/journal.pone.0116914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617891	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000030
J	Tinholt, M; Stavik, B; Louch, W; Carlson, CR; Sletten, M; Ruf, W; Skretting, G; Sandset, PM; Iversen, N				Tinholt, Mari; Stavik, Benedicte; Louch, William; Carlson, Cathrine Rein; Sletten, Marit; Ruf, Wolfram; Skretting, Grethe; Sandset, Per Morten; Iversen, Nina			Syndecan-3 and TFPI Colocalize on the Surface of Endothelial-, Smooth Muscle-, and Cancer Cells	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; HEPARAN-SULFATE PROTEOGLYCANS; TISSUE FACTOR; GROWTH-FACTOR; IN-VITRO; BINDING; EXPRESSION; TERMINUS; PROTEIN; ALPHA	Background Tissue factor (TF) pathway inhibitor (TFPI) exists in two isoforms; TFPI alpha and TFPI beta. Both isoforms are cell surface attached mainly through glycosylphosphatidylinositol (GPI) anchors. TFPI alpha has also been proposed to bind other surface molecules, like glycosaminoglycans (GAGs). Cell surface TFPI beta has been shown to exert higher anticoagulant activity than TFPI alpha, suggesting alternative functions for TFPI alpha. Further characterization and search for novel TFPI binding partners is crucial to completely understand the biological functions of cell associated TFPI. Methods and Results Potential association of TFPI to heparan sulphate (HS) proteoglycans in the syndecan family were evaluated by knock down studies and flow cytometry analysis. Cell surface colocallzation was assessed by confocal microscopy, and native PAGE or immunoprecipitation followed by Western blotting was used to test for protein interaction. Heparanase was used to enzymatically degrade cell surface HS GAGs. Anticoagulant potential was evaluated using a factor Xa (FXa) activity assay. Knock down of syndecan-3 in endothelial,- smooth muscle- and breast cancer cells reduced the TFPI surface levels by 20-50%, and an association of TFPI alpha to syndecan-3 on the cell surface was demonstrated. Western blotting indicated that TFPI alpha was found in complex with syndecan-3. The TFPI bound to syndecan-3 did not inhibit the FXa generation. Removal of HS GAGs did not release TFPI antigen from the cells. Conclusions We demonstrated an association between TFPI alpha and syndecan-3 in vascular cells and in cancer cells, which did not appear to depend on HS GAGs. No anticoagulant activity was detected for the TFPI associated with syndecan-3, which may indicate coagulation independent functions for this cell associated TFPI pool. This will, however, require further investigation.	[Tinholt, Mari; Sletten, Marit; Iversen, Nina] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Tinholt, Mari; Sletten, Marit; Iversen, Nina] Univ Oslo, Oslo, Norway; [Tinholt, Mari; Stavik, Benedicte; Skretting, Grethe; Sandset, Per Morten] Oslo Univ Hosp, Dept Haematol, Oslo, Norway; [Tinholt, Mari; Stavik, Benedicte; Skretting, Grethe; Sandset, Per Morten] Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Tinholt, Mari; Sandset, Per Morten] Univ Oslo, Inst Clin Med, Oslo, Norway; [Louch, William; Carlson, Cathrine Rein] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Scripps Research Institute	Iversen, N (corresponding author), Oslo Univ Hosp, Dept Med Genet, Oslo, Norway.	nina.iversen@medisin.uio.no	Stavik, Benedicte/U-3406-2017; Sandset, Per Morten/J-8141-2019	Stavik, Benedicte/0000-0003-3341-9847; Sandset, Per Morten/0000-0001-5556-8099	South-Eastern Norway Regional Health Authority, Hamar, Norway; A. Jahre foundation; H. G. Andrine Berg son foundation	South-Eastern Norway Regional Health Authority, Hamar, Norway; A. Jahre foundation; H. G. Andrine Berg son foundation	This work was funded by research grants from the South-Eastern Norway Regional Health Authority, Hamar, Norway and A. Jahre and H. G. Andrine Berg & son foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Blackhall FH, 2001, BRIT J CANCER, V85, P1094, DOI 10.1054/bjoc.2001.2054; Caplice NM, 1998, CIRC RES, V83, P1264, DOI 10.1161/01.RES.83.12.1264; Chang JY, 1999, THROMB HAEMOSTASIS, V81, P45; CHERNOUSOV MA, 1993, J BIOL CHEM, V268, P16810; Dealy CN, 1997, DEV BIOL, V184, P343, DOI 10.1006/dbio.1997.8525; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Hansen JB, 2000, THROMB HAEMOSTASIS, V83, P937; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; Ho GY, 1997, J BIOL CHEM, V272, P16838, DOI 10.1074/jbc.272.27.16838; Iverson N, 1996, THROMB RES, V84, P267, DOI 10.1016/S0049-3848(96)00186-7; Kojima T, 1996, J BIOL CHEM, V271, P5914, DOI 10.1074/jbc.271.10.5914; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lupu C, 1997, ARTERIOSCL THROM VAS, V17, P2964, DOI 10.1161/01.ATV.17.11.2964; Lupu C, 1999, ARTERIOSCL THROM VAS, V19, P2251, DOI 10.1161/01.ATV.19.9.2251; Maroney SA, 2013, J THROMB HAEMOST, V11, P911, DOI 10.1111/jth.12188; Maroney SA, 2006, J THROMB HAEMOST, V4, P1114, DOI 10.1111/j.1538-7836.2006.01873.x; Mast AE, 2002, ARTERIOSCL THROM VAS, V22, P2099, DOI 10.1161/01.ATV.0000042456.84190.F0; Mast AE, 1997, BIOCHEM J, V327, P577; Nadir Y, 2008, THROMB HAEMOSTASIS, V99, P133, DOI 10.1055/s-0037-1608919; NOVOTNY WF, 1988, BLOOD, V72, P2020; Ott I, 2001, BLOOD, V97, P3721, DOI 10.1182/blood.V97.12.3721; Piro O, 2005, J THROMB HAEMOST, V3, P2677, DOI 10.1111/j.1538-7836.2005.01636.x; Piro O, 2004, CIRCULATION, V110, P3567, DOI 10.1161/01.CIR.0000148778.76917.89; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Sharifpoor S, 2011, BIOMATERIALS, V32, P4816, DOI 10.1016/j.biomaterials.2011.03.034; Stavik B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-357; Stavik B, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-5; Tiemann C, 1997, EUR J CLIN CHEM CLIN, V35, P855; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; VALENTIN S, 1993, BLOOD COAGUL FIBRIN, V4, P713, DOI 10.1097/00001721-199304050-00007; VALENTIN S, 1994, THROMB RES, V75, P173, DOI 10.1016/0049-3848(94)90066-3; WARSHAWSKY I, 1995, J CLIN INVEST, V95, P1773, DOI 10.1172/JCI117855; WUN TC, 1988, J BIOL CHEM, V263, P6001; Zhang J, 2003, CIRCULATION, V108, P623, DOI 10.1161/01.CIR.0000078642.45127.7B	35	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117404	10.1371/journal.pone.0117404	http://dx.doi.org/10.1371/journal.pone.0117404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617766	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000044
J	Beutel, ME; Fischbeck, S; Binder, H; Blettner, M; Brahler, E; Emrich, K; Friedrich-Mai, P; Imruck, BH; Weyer, V; Zeissig, SR				Beutel, Manfred E.; Fischbeck, Sabine; Binder, Harald; Blettner, Maria; Braehler, Elmar; Emrich, Katharina; Friedrich-Mai, Peter; Imruck, Barbara H.; Weyer, Veronika; Zeissig, Sylke R.			Depression, Anxiety and Quality of Life in Long-Term Survivors of Malignant Melanoma: A Register-Based Cohort Study	PLOS ONE			English	Article							PSYCHOLOGICAL ADJUSTMENT; FOLLOW-UP; CANCER; STANDARDIZATION; ASSOCIATION; QLQ-C30	Aim The purpose of the study was to determine anxiety and depression, quality of life, and their determinants in long-term survivors of malignant melanoma. Methods In a state cancer registry a cohort of survivors of malignant melanoma was contacted via the physician registered. Of 1302 contactable patients, 689 (52.2%) completed a questionnaire including the Patient Health Questionnaire with generalized anxiety (GAD-7) and depression (PHQ-9) and the EORTC Quality of Life Questionnaire (EORTC QLQ 30). Based on multiple regression analysis, predictors of quality of life and distress were identified. Comparison data were assessed in two waves of representative face-to-face household surveys of the adult German population. Results An average of 8.4 (5.7 to 12.2) years after diagnosis, distress was higher in women compared to men and in middle adulthood (vs. older patients). Symptoms were higher in women than in men, and there was a decline of functioning and increase of symptoms across the age range of both genders. Compared to the general population, there were slightly increased depression and anxiety (only women), but no impaired global quality of life. Yet, survivors evidenced functional decline and more physical symptoms. Distress and reduced quality of life were consistently predicted by lack of social support, fear of recurrence, pessimism and self-blame. Distress was increased by a family history of melanoma, and additional mental and somatic diseases. Conclusion Overall, long-term survivors have adjusted well achieving a global quality of life comparable to the general population. Yet, compromised functional dimensions, physical symptoms and distress indicate the need for integrating psychooncological screening into oncological follow-up, which might be guided by predictors such as family history or social support. Further prospective study is needed to determine the course of adaptation to the disease and corroborate the risk factors identified.	[Beutel, Manfred E.; Braehler, Elmar; Friedrich-Mai, Peter; Imruck, Barbara H.] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Binder, Harald; Blettner, Maria; Emrich, Katharina; Weyer, Veronika; Zeissig, Sylke R.] Univ Med Ctr Mainz, Inst Med Biostat Epidemiol & Informat, Mainz, Germany; [Fischbeck, Sabine] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Beutel, ME (corresponding author), Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany.	Manfred.Beutel@unimedizin-mainz.de	Binder, Harald/C-7413-2009; Weyer-Elberich, Veronika/AAB-8993-2020; Braehler, Elmar/C-6535-2009	Binder, Harald/0000-0002-5666-8662; Braehler, Elmar/0000-0002-2648-2728	German Cancer Aid [109225]	German Cancer Aid(Deutsche Krebshilfe)	This work was supported by German Cancer Aid (grant number 109225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Albrecht K, 2013, PSYCHO-ONCOLOGY, V22, P1972, DOI 10.1002/pon.3238; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Eakin EG, 2006, CANCER EPIDEM BIOMAR, V15, P1969, DOI 10.1158/1055-9965.EPI-06-0122; Francken AB, 2005, LANCET ONCOL, V6, P608, DOI 10.1016/S1470-2045(05)70283-7; Hamama-Raz Y, 2007, PSYCHO-ONCOLOGY, V16, P287, DOI 10.1002/pon.1055; Hamama-Raz Y, 2012, PSYCHO-ONCOLOGY, V21, P255, DOI 10.1002/pon.1889; Hinz A, 2014, ACTA ONCOL, V53, P958, DOI 10.3109/0284186X.2013.879998; Holterhues C, 2011, ARCH DERMATOL, V147, P177, DOI 10.1001/archdermatol.2010.433; Kasparian NA, 2013, CLIN DERMATOL, V31, P41, DOI 10.1016/j.clindermatol.2011.11.005; Kocalevent RD, 2013, GEN HOSP PSYCHIAT, V35, P551, DOI 10.1016/j.genhosppsych.2013.04.006; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Loquai C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066800; Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393; McLoone J, 2012, QUAL HEALTH RES, V22, P1102, DOI 10.1177/1049732312448542; Mehnert A, 2008, J PSYCHOSOM RES, V64, P383, DOI 10.1016/j.jpsychores.2007.12.005; Pflugfelder A, 2013, J DTSCH DERMATOL GES, V11, P1, DOI 10.1111/ddg.12113_suppl; Ramm GC, 2003, Z MED PSYCHOL, V12, P29; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Stava C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-95; Strittmatter G, 1998, PSYCHOTHER PSYCH MED, V48, P349; Thong MSY, 2013, CANCER-AM CANCER SOC, V119, P2109, DOI 10.1002/cncr.28056; Trotter Shannon C, 2013, J Clin Aesthet Dermatol, V6, P18	24	51	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116440	10.1371/journal.pone.0116440	http://dx.doi.org/10.1371/journal.pone.0116440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25615573	gold, Green Published, Green Submitted			2022-12-27	WOS:000349122100027
J	Madhuprakash, J; El Gueddari, NE; Moerschbacher, BM; Podile, AR				Madhuprakash, Jogi; El Gueddari, Nour Eddine; Moerschbacher, Bruno M.; Podile, Appa Rao			Catalytic Efficiency of Chitinase-D on Insoluble Chitinous Substrates Was Improved by Fusing Auxiliary Domains	PLOS ONE			English	Article							SERRATIA-PROTEAMACULANS 568; BINDING DOMAIN; AROMATIC RESIDUES; DEGRADATION; MARCESCENS; CHITOOLIGOSACCHARIDES; TRANSGLYCOSYLATION; EXPRESSION; CELLULASE; SYNERGISM	Chitin is an abundant renewable polysaccharide, next only to cellulose. Chitinases are important for effective utilization of this biopolymer. Chitinase D from Serratia proteamaculans (SpChiD) is a single domain chitinase with both hydrolytic and transglycosylation (TG) activities. SpChiD had less of hydrolytic activity on insoluble polymeric chitin substrates due to the absence of auxiliary binding domains. We improved catalytic efficiency of SpChiD in degradation of insoluble chitin substrates by fusing with auxiliary domains like polycystic kidney disease (PKD) domain and chitin binding protein 21 (CBP21). Of the six different SpChiD fusion chimeras, two C-terminal fusions viz. ChiD+ PKD and ChiD+CBP resulted in improved hydrolytic activity on alpha-and beta-chitin, respectively. Time-course degradation of colloidal chitin also confirmed that these two C-terminal SpChiD fusion chimeras were more active than other chimeras. More TG products were produced for a longer duration by the fusion chimeras ChiD+ PKD and PKD+ChiD+CBP.	[Madhuprakash, Jogi; Podile, Appa Rao] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India; [El Gueddari, Nour Eddine; Moerschbacher, Bruno M.] Westphalian Wilhelms Univ Munster, Dept Plant Biol & Biotechnol, Munster, Germany	University of Hyderabad; University of Munster	Podile, AR (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	arpsl@uohyd.ernet.in	Moerschbacher, Bruno M/C-2012-2017; Jogi, Madhuprakash/AAU-9958-2021; Podile, Appa Rao/W-5077-2018	Podile, Appa Rao/0000-0003-3208-765X	Department of Biotechnology (DBT), Government of India [BT/PR5800/PID/6/681/2012]; Council of Scientific and Industrial Research (CSIR), Govt. of India; Deutsche Forschungsgemeinschaft (DFG) (Germany); UGC (India)	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Deutsche Forschungsgemeinschaft (DFG) (Germany)(German Research Foundation (DFG)); UGC (India)(University Grants Commission, India)	This work was carried out under Deutsche Forschungsgemeinschaft (DFG) (Germany) and UGC (India)-supported International Research and Training Group on "Molecular and Cellular Glycosciences" between University of Munster and University of Hyderabad. The authors also thank Department of Biotechnology (DBT), Government of India for the research grant No: BT/PR5800/PID/6/681/2012 to ARP. JM thanks Council of Scientific and Industrial Research (CSIR), Govt. of India for Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Das SN, 2015, CRIT REV BIOTECHNOL, V35, P29, DOI 10.3109/07388551.2013.798255; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; GARDNER KH, 1975, BIOPOLYMERS, V14, P1581, DOI 10.1002/bip.1975.360140804; Hashimoto M, 2000, J BACTERIOL, V182, P3045, DOI 10.1128/JB.182.11.3045-3054.2000; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Madhuprakash J, 2012, J BIOL CHEM, V287, P44619, DOI 10.1074/jbc.M112.400879; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; Neeraja C, 2010, BIORESOURCE TECHNOL, V101, P3635, DOI 10.1016/j.biortech.2009.12.118; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; Purushotham P, 2012, J BACTERIOL, V194, P4260, DOI 10.1128/JB.06473-11; Purushotham P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036714; Purushotham P, 2012, BIORESOURCE TECHNOL, V112, P261, DOI 10.1016/j.biortech.2012.02.062; Songsiriritthigul C, 2010, BIORESOURCE TECHNOL, V101, P4096, DOI 10.1016/j.biortech.2010.01.036; Suma K, 2013, BIORESOURCE TECHNOL, V133, P213, DOI 10.1016/j.biortech.2013.01.103; Suzuki K, 2002, BIOSCI BIOTECH BIOCH, V66, P1075, DOI 10.1271/bbb.66.1075; Tang CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064766; Thongekkaew J, 2013, ENZYME MICROB TECH, V52, P241, DOI 10.1016/j.enzmictec.2013.02.002; UCHIDA Y, 1989, CHITIN CHITOSAN SOUR, P373; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Uni F, 2012, BIOSCI BIOTECH BIOCH, V76, P530, DOI 10.1271/bbb.110835; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Villa-Lerma G, 2013, BIORESOURCE TECHNOL, V146, P794, DOI 10.1016/j.biortech.2013.08.003; Zakariassen H, 2011, BIOCHEMISTRY-US, V50, P5693, DOI 10.1021/bi2002532; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200	30	19	22	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116823	10.1371/journal.pone.0116823	http://dx.doi.org/10.1371/journal.pone.0116823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615694	Green Submitted, Green Published, gold			2022-12-27	WOS:000349122100044
J	Salinas, S; Munch, SB				Salinas, Santiago; Munch, Stephan B.			Where Should I Send It? Optimizing the Submission Decision Process	PLOS ONE			English	Article							IMPACT FACTOR; JOURNALS	How do scientists decide where to submit manuscripts? Many factors influence this decision, including prestige, acceptance probability, turnaround time, target audience, fit, and impact factor. Here, we present a framework for evaluating where to submit a manuscript based on the theory of Markov decision processes. We derive two models, one in which an author is trying to optimally maximize citations and another in which that goal is balanced by either minimizing the number of resubmissions or the total time in review. We parameterize the models with data on acceptance probability, submission-to-decision times, and impact factors for 61 ecology journals. We find that submission sequences beginning with Ecology Letters, Ecological Monographs, or PLOS ONE could be optimal depending on the importance given to time to acceptance or number of resubmissions. This analysis provides some guidance on where to submit a manuscript given the individual-specific values assigned to these disparate objectives.	[Salinas, Santiago] Univ Calif Santa Cruz, Ctr Stock Assessment Res, Santa Cruz, CA 95064 USA; [Munch, Stephan B.] NOAA, SW Fisheries Sci Ctr, Santa Cruz, CA USA	University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA	Salinas, S (corresponding author), Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA.	ssalinas@pacific.edu		Salinas, Santiago/0000-0002-8400-4740				Aarssen L.W., 2008, OPEN ECOL J, V1, P14, DOI [10.2174/1874213000801010014, DOI 10.2174/1874213000801010014]; Aarssen LW, 2010, WEB ECOL, V10, P23, DOI DOI 10.5194/WE-10-23-2010; Adam D, 2002, NATURE, V415, P726, DOI 10.1038/415726a; Archambault E, 2009, SCIENTOMETRICS, V79, P635, DOI 10.1007/s11192-007-2036-x; Bertsekas D. P., 2007, DYNAMIC PROGRAMMING; Bjork BC, 2013, J INFORMETR, V7, P914, DOI 10.1016/j.joi.2013.09.001; Calcagno V, 2012, SCIENCE, V338, P1065, DOI 10.1126/science.1227833; Cohon J. L., 1978, MULTIOBJECTIVE PROGR; Colquhoun D, 2003, NATURE, V423, P479, DOI 10.1038/423479a; GARFIELD E, 1994, CURR CONTENTS, V20, P3; Lariviere V, 2009, J AM SOC INF SCI TEC, V60, P858, DOI 10.1002/asi.21011; Liu GP., 2003, MULTIOBJECTIVE OPTIM; Munch SB, 2000, ICES J MAR SCI, V57, P393, DOI 10.1006/jmsc.1999.0636; Petersen CW, 2010, COPEIA, P203, DOI 10.1643/CP-08-229; Phase5 Research, 2014, CAN RES PUBL ATT BEH; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Ross S.M., 1970, APPL PROBABILITY MOD; Seglen PO, 1997, BRIT MED J, V314, P498; Smith R, 2006, INT J EPIDEMIOL, V35, P1129, DOI 10.1093/ije/dyl191; Vanclay JK, 2012, SCIENTOMETRICS, V92, P211, DOI 10.1007/s11192-011-0561-0; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Weale Andy R, 2004, BMC Med Res Methodol, V4, P14, DOI 10.1186/1471-2288-4-14; West JD, 2014, ECON INQ, V52, P1315, DOI 10.1111/ecin.12117	23	30	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115451	10.1371/journal.pone.0115451	http://dx.doi.org/10.1371/journal.pone.0115451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25616103	gold, Green Submitted, Green Published			2022-12-27	WOS:000349122100012
J	Waye, KP; Magnusson, L; Fredriksson, S; Croy, I				Waye, Kerstin Persson; Magnusson, Lennart; Fredriksson, Sofie; Croy, Ilona			A Screening Approach for Classroom Acoustics Using Web-Based Listening Tests and Subjective Ratings	PLOS ONE			English	Article							SPEECH-INTELLIGIBILITY; NOISE; PERFORMANCE; PERCEPTION; RECALL	Background Perception of speech is crucial in school where speech is the main mode of communication. The aim of the study was to evaluate whether a web based approach including listening tests and questionnaires could be used as a screening tool for poor classroom acoustics. The prime focus was the relation between pupils' comprehension of speech, the classroom acoustics and their description of the acoustic qualities of the classroom. Methodology/Principal Findings In total, 1106 pupils aged 13-19, from 59 classes and 38 schools in Sweden participated in a listening study using Hagerman's sentences administered via Internet. Four listening conditions were applied: high and low background noise level and positions close and far away from the loudspeaker. The pupils described the acoustic quality of the classroom and teachers provided information on the physical features of the classroom using questionnaires. Conclusions/Significance In 69% of the classes, at least three pupils described the sound environment as adverse and in 88% of the classes one or more pupil reported often having difficulties concentrating due to noise. The pupils' comprehension of speech was strongly influenced by the background noise level (p<0.001) and distance to the loudspeakers (p<0.001). Of the physical classroom features, presence of suspended acoustic panels (p<0.05) and length of the classroom (p<0.01) predicted speech comprehension. Of the pupils' descriptions of acoustic qualities, clattery significantly (p<0.05) predicted speech comprehension. Clattery was furthermore associated to difficulties understanding each other, while the description noisy was associated to concentration difficulties. The majority of classrooms do not seem to have an optimal sound environment. The pupil's descriptions of acoustic qualities and listening tests can be one way of predicting sound conditions in the classroom.	[Waye, Kerstin Persson; Fredriksson, Sofie; Croy, Ilona] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Magnusson, Lennart] Univ Gothenburg, Sect Audiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Waye, KP (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.	kerstin.persson.waye@amm.gu.se	Persson Waye, Kerstin/J-7136-2012	Persson Waye, Kerstin/0000-0003-3789-4557; Fredriksson, Sofie/0000-0003-0698-527X; Croy, Ilona/0000-0002-0361-5559	Regional Hospital fundings	Regional Hospital fundings	Support was provided by Regional Hospital fundings; KPW received the funding (www.vgregion.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg F. S., 1993, ACOUSTICS SOUND SYST; Berg FS, 1996, LANG SPEECH HEAR SER, V27, P16, DOI 10.1044/0161-1461.2701.16; Bradley JS, 2011, APPL ACOUST, V72, P713, DOI 10.1016/j.apacoust.2011.04.004; Clark C, 2012, NOISE HEALTH, V14, P292, DOI 10.4103/1463-1741.104896; COX RM, 1991, J SPEECH HEAR RES, V34, P904, DOI 10.1044/jshr.3404.904; DAVIS R, 1989, SOUND REINFORCEMENT; EVEREST A, 1989, MASTER HDB ACOUSTICS; Fallon M, 2000, J ACOUST SOC AM, V108, P3023, DOI 10.1121/1.1323233; Finitzo T., 1988, AUDITORY DISORDERS S, V2, P221; FINITZOHIEBER T, 1978, J SPEECH HEAR RES, V21, P440, DOI 10.1044/jshr.2103.440; Hagerman B, 2002, INT J AUDIOL, V41, P321, DOI 10.3109/14992020209090406; HAGERMAN B, 1982, SCAND AUDIOL, V11, P79, DOI 10.3109/01050398209076203; Haines M M, 2003, Noise Health, V5, P19; Kjellberg A, 2008, APPL COGNITIVE PSYCH, V22, P1088, DOI 10.1002/acp.1422; Klatte M, 2010, ENVIRON BEHAV, V42, P659, DOI 10.1177/0013916509336813; KUTTRUFF H, 2002, ROOM ACOUSTICS; LANDSTROM U, 1999, ARBETE HALSA, V27; Ljung R, 2009, BUILD ACOUST, V16, P301, DOI 10.1260/135101009790291273; Ljung R, 2009, BUILD ACOUST, V16, P257, DOI 10.1260/135101009789877031; Lundquist Par, 2000, Noise Health, V2, P39; MARSHALL LG, 1995, J ACOUST SOC AM, V98, P2845, DOI 10.1121/1.413184; PEKKARINEN E, 1991, SCAND AUDIOL, V20, P257, DOI 10.3109/01050399109045973; Picard M, 2001, AUDIOLOGY, V40, P221; POPLAVSKA O. M., 2006, ERGONOMICS TXB; SALA E, 2013, ACTIVITY NOISE COMPR; Shield B. M., 2003, Building Acoustics, V10, P97, DOI 10.1260/135101003768965960; Shield BM, 2008, J ACOUST SOC AM, V123, P133, DOI 10.1121/1.2812596; STEENEKEN HJM, 1980, J ACOUST SOC AM, V67, P318, DOI 10.1121/1.384464; Talarico M, 2007, AUDIOL NEURO-OTOL, V12, P13, DOI 10.1159/000096153; Waye KP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002408; Werner LA, 2012, SPRINGER HANDB AUDIT, V42, P1, DOI 10.1007/978-1-4614-1421-6_1	31	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116572	10.1371/journal.pone.0116572	http://dx.doi.org/10.1371/journal.pone.0116572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25615692	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100033
J	Sun, LL; Nguyen, AT; Spitsbergen, JM; Gong, ZY				Sun, Lili; Anh Tuan Nguyen; Spitsbergen, Jan M.; Gong, Zhiyuan			Myc-Induced Liver Tumors in Transgenic Zebrafish Can Regress in tp53 Null Mutation	PLOS ONE			English	Article							DIFFERENT DEVELOPMENTAL-STAGES; C-MYC; HEPATOCELLULAR-CARCINOMA; GENOME DUPLICATION; EXPOSURE ROUTES; GENE-EXPRESSION; CANCER; TUMORIGENESIS; NEOPLASIA; MODELS	Hepatocellular carcinoma (HCC) is currently one of the top lethal cancers with an increasing trend. Deregulation of MYC in HCC is frequently detected and always correlated with poor prognosis. As the zebrafish genome contains two differentially expressed zebrafish myc orthologs, myca and mycb, it remains unclear about the oncogenicity of the two zebrafish myc genes. In the present study, we developed two transgenic zebrafish lines to over-express myca and mycb respectively in the liver using a mifepristone-inducible system and found that both myc genes were oncogenic. Moreover, the transgenic expression of myca in hepatocytes caused robust liver tumors with several distinct phenotypes of variable severity. similar to 5% of myca transgenic fish developing multinodular HCC with cirrhosis after 8 months of induced myca expression. Apoptosis was also observed with myca expression; introduction of homozygous tp53(-/) -mutation into the myca transgenic fish reduced apoptosis and accelerated tumor progression. The malignant status of hepatocytes was dependent on continued expression of myca; withdrawal of the mifepristone inducer resulted in a rapid regression of liver tumors, and the tumor regression occurred even in the tp53(-/-) mutation background. Thus, our data demonstrated the robust oncogenicity of zebrafish myca and the requirement of sustained Myc overexpression for maintenance of the liver tumor phenotype in this transgenic model. Furthermore, tumor regression is independent of the function of Tp53.	[Sun, Lili; Anh Tuan Nguyen; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Spitsbergen, Jan M.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Spitsbergen, Jan M.] Oregon State Univ, Marine & Freshwater Biomed Sci Ctr, Corvallis, OR 97331 USA	National University of Singapore; Oregon State University; Oregon State University	Gong, ZY (corresponding author), Inst Cell & Mol Biol, Singapore 138673, Singapore.	dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012; Sun, lili/GQH-2057-2022	Gong, Zhiyuan/0000-0002-9660-5260; 	National Medical Research Council of Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by a grant from National Medical Research Council of Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Berghmans S, 2005, BIOTECHNIQUES, V39, P227, DOI 10.2144/05392RV02; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Beverly LJ, 2009, ONCOGENE, V28, P1274, DOI 10.1038/onc.2008.466; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Emelyanov A, 2006, GENETICS, V174, P1095, DOI 10.1534/genetics.106.061184; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Huang XQ, 2012, FUTURE ONCOL, V8, P21, DOI [10.2217/FON.11.137, 10.2217/fon.11.137]; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Li Z, 2013, DIS MODEL MECH, V6, P414, DOI 10.1242/dmm.010462; Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025; Loosveld M, 2014, GENE CHROMOSOME CANC, V53, P52, DOI 10.1002/gcc.22117; Marandel L, 2012, MOL REPROD DEV, V79, P85, DOI 10.1002/mrd.22004; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Menescal LA, 2012, DIS MODEL MECH, V5, P492, DOI 10.1242/dmm.008730; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Ruggeri BA, 2014, BIOCHEM PHARMACOL, V87, P150, DOI 10.1016/j.bcp.2013.06.020; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Spitsbergen JM, 2012, ILAR J, V53, P114, DOI 10.1093/ilar.53.2.114; Spitsbergen JM, 2000, TOXICOL PATHOL, V28, P705, DOI 10.1177/019262330002800511; Spitsbergen JM, 2000, TOXICOL PATHOL, V28, P716, DOI 10.1177/019262330002800512; Takahashi Y, 2007, PATHOL INT, V57, P437, DOI 10.1111/j.1440-1827.2007.02120.x; Thompson EB, 1998, ANNU REV PHYSIOL, V60, P575, DOI 10.1146/annurev.physiol.60.1.575; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Xue XY, 2012, DEV NEUROBIOL, V72, P475, DOI 10.1002/dneu.20887	35	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117249	10.1371/journal.pone.0117249	http://dx.doi.org/10.1371/journal.pone.0117249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612309	gold, Green Published, Green Submitted			2022-12-27	WOS:000348562900035
J	Berg, S; Kaschka, I; Utz, KS; Huhn, K; Lammer, A; Lammer, R; Waschbisch, A; Kloska, S; Lee, DH; Doerfler, A; Linker, RA				Berg, Sebastian; Kaschka, Iris; Utz, Kathrin S.; Huhn, Konstantin; Laemmer, Alexandra; Laemmer, Robert; Waschbisch, Anne; Kloska, Stephan; Lee, De-Hyung; Doerfler, Arnd; Linker, Ralf A.			Baseline Magnetic Resonance Imaging of the Optic Nerve Provides Limited Predictive Information on Short-Term Recovery after Acute Optic Neuritis	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; VISUAL DYSFUNCTION; AXONAL LOSS; MRI; ENHANCEMENT; ASSOCIATION; MANAGEMENT; DIAGNOSIS; RISK	Background In acute optic neuritis, magnetic resonance imaging (MRI) may help to confirm the diagnosis as well as to exclude alternative diagnoses. Yet, little is known on the value of optic nerve imaging for predicting clinical symptoms or therapeutic outcome. Purpose To evaluate the benefit of optic nerve MRI for predicting response to appropriate therapy and recovery of visual acuity. Methods Clinical data as well as visual evoked potentials (VEP) and MRI results of 104 patients, who were treated at the Department of Neurology with clinically definite optic neuritis between December 2010 and September 2012 were retrospectively reviewed including a follow up within 14 days. Results Both length of the Gd enhancing lesion (r = -0.38; p = 0.001) and the T2 lesion (r = -0.25; p = 0.03) of the optic nerve in acute optic neuritis showed a medium correlation with visual acuity after treatment. Although visual acuity pre-treatment was little but nonsignificantly lower if Gd enhancement of the optic nerve was detected via orbital MRI, improvement of visual acuity after adequate therapy was significantly better (0.40 vs. 0.24; p = 0.04). Intraorbitally located Gd enhancing lesions were associated with worse visual improvement compared to canalicular, intracranial and chiasmal lesions (0.35 vs. 0.54; p = 0.02). Conclusion Orbital MRI is a broadly available, valuable tool for predicting the improvement of visual function. While the accurate individual prediction of long-term outcomes after appropriate therapy still remains difficult, lesion length of Gd enhancement and T2 lesion contribute to its prediction and a better short-term visual outcome may be associated with detection and localization of Gd enhancement along the optic nerve.	[Berg, Sebastian; Utz, Kathrin S.; Huhn, Konstantin; Laemmer, Alexandra; Waschbisch, Anne; Lee, De-Hyung; Linker, Ralf A.] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany; [Kaschka, Iris; Kloska, Stephan; Doerfler, Arnd] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Neuroradiol, Erlangen, Germany; [Laemmer, Robert] Univ Erlangen Nurnberg, Dept Ophthalmol, Univ Hosp Erlangen, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Linker, RA (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany.	ralf.linker@uk-erlangen.de	Mühlen, Iris/AAN-4729-2020; Laemmer, Robert/C-1810-2017; Linker, Ralf/AAD-8884-2020	Laemmer, Robert/0000-0002-6294-0730; Muhlen, Iris/0000-0001-8679-2587	Novartis; Biogen Idec; Merck Serono; Genzyme; Bayer Schering	Novartis(Novartis); Biogen Idec(Biogen); Merck Serono(Merck & Company); Genzyme(Sanofi-AventisGenzyme Corporation); Bayer Schering(Bayer AG)	Dr. Sebastian Berg reports personal fees from Biogen Idec, personal fees from Novartis, outside the submitted work. Dr. Iris Kaschka has nothing to disclose. Dr. Kathrin Utz reports grants from Novartis, grants from Biogen Idec, outside the submitted work. Dr. Konstantin Huhn reports personal fees from Biogen Idec, personal fees from Novartis, personal fees from Merck Serono, outside the submitted work. Dr. Alexandra Lammer has nothing to disclose. Dr. Robert Lammer has nothing to disclose. Dr. Anne Waschbisch reports grants, personal fees and non-financial support from Biogen Idec GmbH, grants, personal fees and non-financial support from Merck Serono GmbH, personal fees and non-financial support from Teva/Sanofi Aventis, grants and personal fees from Bayer Schering, outside the submitted work. Dr. Stephan Kloska has nothing to disclose. Dr. De-Hyung Lee has nothing to disclose. Dr. Arnd Dorfler has nothing to disclose. Dr. Ralf Linker received honoraria and travel support from Bayer, BiogenIdec, Genzyme, Merck Serono, Novartis, TEVA Pharma and Research Support from BiogenIdec, Merck Serono and Genzyme, outside the submitted work. The authors confirm that co-author Ralf Linker is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria.	Arnold AC, 2005, AM J OPHTHALMOL, V139, P1101, DOI 10.1016/j.ajo.2005.01.031; Balcer LJ, 2006, NEW ENGL J MED, V354, P1273, DOI 10.1056/NEJMcp053247; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; de Seze J, 2012, REV NEUROL-FRANCE, V168, P697, DOI 10.1016/j.neurol.2012.07.013; Deschamps R, 2002, REV NEUROL-FRANCE, V158, P446; Dooley Mary Caitlin, 2010, J Ophthalmic Vis Res, V5, P182; Dunker S, 1996, OPHTHALMOLOGY, V103, P1768, DOI 10.1016/S0161-6420(96)30429-6; Foroozan Rod, 2002, Curr Opin Ophthalmol, V13, P375, DOI 10.1097/00055735-200212000-00006; Frederiksen JL, 1999, SURV OPHTHALMOL, V44, pS54, DOI 10.1016/S0039-6257(99)00095-8; Frohman EM, 2005, LANCET NEUROL, V4, P111, DOI 10.1016/S1474-4422(05)00992-0; Gal RL, 2008, OPHTHALMOLOGY, V115, P1079, DOI 10.1016/j.ophtha.2007.08.004; Gass A, 1996, NEURORADIOLOGY, V38, P317; GUY J, 1992, OPHTHALMOLOGY, V99, P713; Hickman SJ, 2005, NEURORADIOLOGY, V47, P51, DOI 10.1007/s00234-004-1308-x; Hickman SJ, 2004, J NEUROL, V251, P996, DOI 10.1007/s00415-004-0477-1; Hickman SJ, 2004, BRAIN, V127, P2498, DOI 10.1093/brain/awh284; Hickman SJ, 2004, BRAIN, V127, P692, DOI 10.1093/brain/awh076; Hoorbakht H, 2012, OPEN OPHTHALMOL J, V6, P65, DOI 10.2174/1874364101206010065; Jeon J, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-36; Kale N, 2012, CURR OPIN OPHTHALMOL, V23, P472, DOI 10.1097/ICU.0b013e328358b202; KATZ D, 1993, ANN NEUROL, V34, P661, DOI 10.1002/ana.410340507; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Klistorner A, 2008, DOC OPHTHALMOL, V116, P19, DOI 10.1007/s10633-007-9072-y; Klistorner A, 2007, INVEST OPHTH VIS SCI, V48, P4549, DOI 10.1167/iovs.07-0381; Kolbe S, 2009, NEUROIMAGE, V45, P679, DOI 10.1016/j.neuroimage.2008.12.047; Kupersmith MJ, 2002, BRAIN, V125, P812, DOI 10.1093/brain/awf087; Lim SA, 2009, ANN ACAD MED SINGAP, V38, P821; MILLER DH, 1988, NEUROLOGY, V38, P175, DOI 10.1212/WNL.38.2.175; Naismith RT, 2009, NEUROLOGY, V72, P589, DOI 10.1212/01.wnl.0000335766.22758.cd; Naismith RT, 2012, ARCH NEUROL-CHICAGO, V69, P65, DOI 10.1001/archneurol.2011.243; Nilsson P, 2005, J NEUROL, V252, P396, DOI 10.1007/s00415-005-0655-9; Pirko I, 2004, ARCH NEUROL-CHICAGO, V61, P1401, DOI 10.1001/archneur.61.9.1401; Roesner S, 2012, ACTA NEUROL SCAND, V126, P103, DOI 10.1111/j.1600-0404.2011.01612.x; Ruprecht K, 2004, NEUROLOGY, V63, P1081, DOI 10.1212/01.WNL.0000138437.99046.6B; Schinzel J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-94; Smith SA, 2011, AM J NEURORADIOL, V32, P1662, DOI 10.3174/ajnr.A2574; Swanton JK, 2010, MULT SCLER, V16, P156, DOI 10.1177/1352458509353650; Swanton JK, 2007, LANCET NEUROL, V6, P677, DOI 10.1016/S1474-4422(07)70176-X; TIEN RD, 1991, J COMPUT ASSIST TOMO, V15, P223, DOI 10.1097/00004728-199103000-00006; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Tourbah A, 2012, REV NEUROL-FRANCE, V168, P702, DOI 10.1016/j.neurol.2012.07.012; Trip SA, 2006, NEUROIMAGE, V30, P498, DOI 10.1016/j.neuroimage.2005.09.024; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; van der Walt A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083825; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052291; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437	46	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0113961	10.1371/journal.pone.0113961	http://dx.doi.org/10.1371/journal.pone.0113961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635863	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700001
J	Derache, A; Shin, HS; Balamane, M; White, E; Israelski, D; Klausner, JD; Freeman, AH; Katzenstein, D				Derache, Anne; Shin, Hyoung-Shik; Balamane, Maya; White, Elizabeth; Israelski, Dennis; Klausner, Jeffrey D.; Freeman, Alexandra H.; Katzenstein, David			HIV Drug Resistance Mutations in Proviral DNA from a Community Treatment Program	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; BLOOD MONONUCLEAR-CELLS; CD4(+) T-CELLS; LONG-TERM HAART; REVERSE-TRANSCRIPTASE; INFECTED PATIENTS; IMMUNOLOGICAL CONSEQUENCES; HIV-1-INFECTED PATIENTS; GENOTYPIC RESISTANCE; VIROLOGICAL FAILURE	Background Drug resistance mutations archived in resting memory CD4+ cells may persist despite suppression of HIV RNA to <50 copies/ml. We sequenced pol gene from proviral DNA among viremic and suppressed patients to identify drug resistance mutations. Methods The Peninsula AIDS Research Cohort study enrolled and followed over 2 years 120 HIV infected patients from San Mateo and San Francisco Counties. HIV-1 pol genotyping by bulk sequencing was performed on 38 DNA and RNA from viremic patients and DNA only among 82 suppressed patients at baseline. Antiretroviral susceptibility was predicted by HIVDB.stanford.edu. Results Among 120 subjects, 81% were on antiretroviral therapy and had been treated for a median time of 7 years. Thirty-two viremic patients showed concordant RNA and DNA genotypes (84%); the discordant profiles were mainly observed in patients with low-level viremia. Among suppressed patients, 21 had drug resistance mutations in proviral DNA (26%) with potential resistance to one, two or three ARV classes in 16, 4 and 1 samples respectively. Conclusions The high level of genotype concordance between DNA and RNA in viremic patients suggested that DNA genotyping might be used to assess drug resistance in resource-limited settings, and further investigation of extracted DNA from dried blood spots is needed. Drug resistance mutations in proviral DNA in 26% of subjects with less than 50 copies/ml pose a risk for the transmission of drug resistant virus with virologic failure, treatment interruption or decreased adherence.	[Derache, Anne; Balamane, Maya; White, Elizabeth; Israelski, Dennis; Katzenstein, David] Stanford Univ, Dept Infect Dis, Sch Med, Stanford, CA 94305 USA; [Shin, Hyoung-Shik] Natl Med Ctr, Ctr Infect Dis, Seoul, South Korea; [Klausner, Jeffrey D.] Univ Calif Los Angeles, Los Angeles, CA USA; [Freeman, Alexandra H.] Kaiser Permanente San Francisco, San Francisco, CA USA	Stanford University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; National Medical Center - Korea; University of California System; University of California Los Angeles; Kaiser Permanente	Derache, A (corresponding author), Stanford Univ, Dept Infect Dis, Sch Med, Stanford, CA 94305 USA.	aderache@stanford.edu	Shin, Hyoung-Shik/H-6772-2018	Shin, Hyoung-Shik/0000-0001-6504-3413; katzenstein, david/0000-0002-8593-4560	California HIV Research Program [CH05-SMCH-612]	California HIV Research Program	This work was funded by California HIV Research Program CH05-SMCH-612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa NDoHS, 2010, CLINICAL GUIDELINES; Banks Lauren, 2012, J AIDS Clin Res, V3, P141; Bi XQ, 2003, JAIDS-J ACQ IMM DEF, V34, P1, DOI 10.1097/00126334-200309010-00001; Bon I, 2007, NEW MICROBIOL, V30, P313; Bon I, 2007, J CLIN VIROL, V38, P313, DOI 10.1016/j.jcv.2006.12.018; Bowser BP, 2014, JOURNAL OF EQUITY IN, V3, P45; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Chew CB, 2005, J CLIN VIROL, V33, P206, DOI 10.1016/j.jcv.2004.11.006; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Delaugerre C, 2012, HIV MED, V13, P517, DOI 10.1111/j.1468-1293.2012.01002.x; Delaugerre C, 2010, AIDS, V24, P2391, DOI 10.1097/QAD.0b013e32833d214c; Delaugerre C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-85; Devereux HL, 2000, AIDS RES HUM RETROV, V16, P1025, DOI 10.1089/08892220050075273; Diallo K, 2012, INT J MOL EPIDEMIOL, V3, P56; Falasca F, 2013, CLIN MICROBIOL INFEC, V19, pE318, DOI 10.1111/1469-0691.12175; Felsenstein J, 2008, PHYLIP PHYLOGENY INF; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fourati S, 2012, J ANTIMICROB CHEMOTH, V67, P2323, DOI 10.1093/jac/dks219; Fourati S, 2012, AIDS, V26, P1619, DOI 10.1097/QAD.0b013e3283560703; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Geretti AM, 2014, J ANTIMICROB CHEMOTH, V69, P1090, DOI 10.1093/jac/dkt474; Greub G, 2002, AIDS, V16, P1967, DOI 10.1097/00002030-200209270-00017; Gunthard HF, 1998, J VIROL, V72, P2422; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Imade GE, 2014, AIDS RES HUM RETROV, V30, P127, DOI [10.1089/aid.2013.0074, 10.1089/AID.2013.0074]; Imaz A, 2013, ANTIVIR THER, V18, P125, DOI 10.3851/IMP2249; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Kabamba-Mukadi B, 2010, HIV MED, V11, P483, DOI 10.1111/j.1468-1293.2009.00814.x; Kantor R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093537; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; Kleyn TJ, 2014, ANN PHARMACOTHER; Lai CC, 2012, J ANTIMICROB CHEMOTH, V67, P1254, DOI 10.1093/jac/dkr601; Lambotte O, 2004, AIDS, V18, P1147, DOI 10.1097/00002030-200405210-00008; Macias J, 2005, J INFECTION, V51, P195, DOI 10.1016/j.jinf.2004.11.010; MacLeod IJ, 2010, J CLIN VIROL, V48, P162, DOI 10.1016/j.jcv.2010.03.017; Martinez V, 2005, AIDS, V19, P1065, DOI 10.1097/01.aids.0000174453.55627.de; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; Mohamed S, 2014, J MED VIROL, V86, P394, DOI 10.1002/jmv.23853; Monno L, 2003, J MED VIROL, V70, P1, DOI 10.1002/jmv.10354; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Murillo W, 2010, HIV MED, V11, P95, DOI 10.1111/j.1468-1293.2009.00747.x; Neogi U, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18472; Noe A, 2005, J ANTIMICROB CHEMOTH, V55, P410, DOI 10.1093/jac/dki038; Nottet HSLM, 2009, JAIDS-J ACQ IMM DEF, V50, P345, DOI 10.1097/QAI.0b013e318197eb04; Organization WH, 2014, TO THE 2013 CONSOLID; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; Palmisano L, 2009, HIV MED, V10, P477, DOI 10.1111/j.1468-1293.2009.00715.x; Pillay S, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-3; Prakash R, 2009, DNA STRUCTURE IS MOR; Quan YD, 2014, J ANTIMICROB CHEMOTH, V69, P21, DOI 10.1093/jac/dkt326; Rowley CF, 2010, AIDS RES HUM RETROV, V26, P293, DOI 10.1089/aid.2009.0082; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Soto-Ramirez LE, 2008, AIDS RES HUM RETROV, V24, P797, DOI 10.1089/aid.2007.0246; Stekler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028952; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Trotter AB, 2013, AIDS REV, V15, P162; Turriziani O, 2010, CLIN MICROBIOL INFEC, V16, P1518, DOI 10.1111/j.1469-0691.2010.03329.x; Verhofstede C, 2004, JAIDS-J ACQ IMM DEF, V35, P473, DOI 10.1097/00126334-200404150-00005; Verhofstede C, 1999, AIDS, V13, P2541, DOI 10.1097/00002030-199912240-00007; Vlad IM, 2008, ADVANCES IN NEURAL I; WATTERS JK, 1994, J ACQ IMMUN DEF SYND, V7, P1276; Wirden M, 2011, J ANTIMICROB CHEMOTH, V66, P709, DOI 10.1093/jac/dkq544; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6	68	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117430	10.1371/journal.pone.0117430	http://dx.doi.org/10.1371/journal.pone.0117430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635815	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700085
J	Koepke, J; Dresel, M; Schmid, S; Greulich, T; Beutel, B; Schmeck, B; Vogelmeier, CF; Janciauskiene, S; Koczulla, AR				Koepke, Janine; Dresel, Marc; Schmid, Severin; Greulich, Timm; Beutel, Bjoern; Schmeck, Bernd; Vogelmeier, Claus Franz; Janciauskiene, Sabina; Koczulla, Andreas Rembert			Therapy with Plasma Purified Alpha1-Antitrypsin (Prolastin((R))) Induces Time-Dependent Changes in Plasma Levels of MMP-9 and MPO	PLOS ONE			English	Article							FC-ALPHA-RI; AUGMENTATION THERAPY; GELATINASE-B; MATRIX METALLOPROTEINASES; ANTITRYPSIN DEFICIENCY; Z ALPHA(1)-ANTITRYPSIN; HUMAN NEUTROPHILS; SERUM BIOMARKERS; ALPHA-1-ANTITRYPSIN; MATRIX-METALLOPROTEINASE-9	The common Z mutation (Glu342Lys) of alpha 1-antitrypsin (A1AT) results in the polymerization and intracellular retention of A1AT protein. The concomitant deficiency of functional A1AT predisposes PiZZ subjects to early onset emphysema. Clinical studies have implied that, among the biomarkers associated with emphysema, matrix metalloproteinase 9 (MMP-9) is of particular importance. Increased plasma MMP-9 levels are proposed to predict the decline of lung function as well as greater COPD exacerbations in A1AT deficiency-associated emphysema. The aim of the present study was to investigate the effect of A1AT therapy (Prolastin) on plasma MMP-9 and myeloperoxidase (MPO) levels. In total 34 PiZZ emphysema patients were recruited: 12 patients without and 22 with weekly intravenous (60 mg/kg body weight) A1AT therapy. The quantitative analysis of A1AT, MMP-9 and MPO was performed in serum and in supernatants of blood neutrophils isolated from patients before and after therapy. Patients with Prolastin therapy showed significantly lower serum MMP-9 and MPO levels than those without therapy. However, parallel analysis revealed that a rapid infusion of Prolastin is accompanied by a transient elevation of plasma MMP-9 and MPO levels. Experiments with freshly isolated blood neutrophils confirmed that therapy with Prolastin causes transient MMP-9 and MPO release. Prolastin induced the rapid release of MMP-9 and MPO when added directly to neutrophil cultures and this reaction was associated with the presence of IgA in A1AT preparation. Our data support the conclusion that changes in plasma levels of MMP-9 and MPO mirror the effect of Prolastin on blood neutrophils.	[Koepke, Janine; Dresel, Marc; Schmid, Severin; Greulich, Timm; Beutel, Bjoern; Vogelmeier, Claus Franz; Koczulla, Andreas Rembert] Univ Marburg, Dept Med Pulm & Crit Care Med, Univ Med Ctr Giessen & Marburg, Marburg, Germany; [Schmeck, Bernd] Univ Marburg, Inst Lung Res, Univ Giessen, Lung Ctr, Marburg, Germany; [Schmeck, Bernd] Univ Marburg, Inst Lung Res, Univ Marburg, Lung Ctr, Marburg, Germany; [Janciauskiene, Sabina] Hannover Med Sch, Dept Resp Med, Hannover, Germany	University Hospital of Giessen & Marburg; Justus Liebig University Giessen; Philipps University Marburg; Philipps University Marburg; Hannover Medical School	Koepke, J (corresponding author), Univ Marburg, Dept Med Pulm & Crit Care Med, Univ Med Ctr Giessen & Marburg, Baldingerstr 1, Marburg, Germany.	koepke@staff.uni-marburg.de		Schmid, Severin/0000-0001-8077-082X; Schmeck, Bernd/0000-0002-2767-3606	German Center for Lung Reseach (DZL, COPD II)	German Center for Lung Reseach (DZL, COPD II)	This study was supported by the German Center for Lung Reseach (DZL, COPD II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Omari M, 2011, MOL MED, DOI [10.2119/molmed.2011.00303, DOI 10.2119/MOLMED.2011.00303]; Alam S, 2011, AM J RESP CELL MOL, V45, P261, DOI 10.1165/rcmb.2010-0328OC; Aldonyte Ruta, 2004, COPD, V1, P155, DOI 10.1081/COPD-120030828; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Bergin DA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007116; Blanco I, 2006, EUR RESPIR J, V27, P77, DOI 10.1183/09031936.06.00062305; Boschetto P, 2006, THORAX, V61, P1037, DOI 10.1136/thx.2006.058321; Boskovic G, 1997, BIOCHEM J, V322, P751, DOI 10.1042/bj3220751; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; Brajer B, 2008, J PHYSIOL PHARMACOL, V59, P145; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Cowden DI, 2005, CURR MED RES OPIN, V21, P877, DOI 10.1185/030079905X46395; Dickens JA, 2011, DRUG DES DEV THER, V5, P391, DOI 10.2147/DDDT.S14018; Ferry G, 1997, FEBS LETT, V402, P111, DOI 10.1016/S0014-5793(96)01508-6; Higashimoto Y, 2009, RESP MED, V103, P1231, DOI 10.1016/j.rmed.2009.01.021; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Jonigk D, 2013, P NATL ACAD SCI USA, V110, P15007, DOI 10.1073/pnas.1309648110; Kalsheker NA, 2009, J CLIN PATHOL, V62, P865, DOI 10.1136/jcp.2008.063495; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kolarich D, 2006, TRANSFUSION, V46, P1959, DOI 10.1111/j.1537-2995.2006.01004.x; Kowluru RA, 2012, EXPERT OPIN INV DRUG, V21, P797, DOI 10.1517/13543784.2012.681043; Lieberman J, 2000, CHEST, V118, P1480, DOI 10.1378/chest.118.5.1480; Mahadeva R, 2005, AM J PATHOL, V166, P377, DOI 10.1016/S0002-9440(10)62261-4; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; Mohanka M, 2012, EXPERT OPIN BIOL TH, V12, P685, DOI 10.1517/14712598.2012.676638; Nita I, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-12; Omachi TA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-35; Opdenakker G, 1998, IMMUNOL TODAY, V19, P182, DOI 10.1016/S0167-5699(97)01243-7; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Otten MA, 2004, IMMUNOL LETT, V92, P23, DOI 10.1016/j.imlet.2003.11.018; Ozeri E, 2012, J IMMUNOL, V189, P146, DOI 10.4049/jimmunol.1101340; Parmar JS, 2002, AM J RESP CELL MOL, V26, P723, DOI 10.1165/ajrcmb.26.6.4739; Parr DG, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-75; Pinto-Plata V, 2007, THORAX, V62, P595, DOI 10.1136/thx.2006.064428; Pruijt JFM, 1999, P NATL ACAD SCI USA, V96, P10863, DOI 10.1073/pnas.96.19.10863; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Schmid ST, 2012, INT J CHRONIC OBSTR, V7, P687, DOI 10.2147/COPD.S34560; Seersholm N, 1998, THORAX, V53, P265, DOI 10.1136/thx.53.4.265; Seersholm N, 1997, EUR RESPIR J, V10, P2260, DOI 10.1183/09031936.97.10102260; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Shand JA, 2010, BIOMARK MED, V4, P385, DOI 10.2217/BMM.10.16; Stockley RA, 2002, AM J RESP CRIT CARE, V165, P1494, DOI 10.1164/rccm.2109013; Stockley RA, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-149; Stockley RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-136; Stone H, 2012, EUR RESPIR J, V40, P561, DOI 10.1183/09031936.00162811; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vernooy JHJ, 2004, CHEST, V126, P1802, DOI 10.1378/chest.126.6.1802; VOULGARI F, 1982, BRIT HEART J, V48, P352; Vreim CE, 1998, AM J RESP CRIT CARE, V158, P49; Wang KF, 2013, CORONARY ARTERY DIS, V24, P23, DOI 10.1097/MCA.0b013e32835aab4a; Wehrli M, 2014, J IMMUNOL, V193, P5649, DOI 10.4049/jimmunol.1400028; Wencker M, 2001, CHEST, V119, P737, DOI 10.1378/chest.119.3.737	54	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117497	10.1371/journal.pone.0117497	http://dx.doi.org/10.1371/journal.pone.0117497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635861	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700087
J	Mishra, S; Upadhyay, S; Sen, MR; Maurya, AP; Choudhury, D; Bhattacharjee, A				Mishra, Shweta; Upadhyay, Supriya; Sen, Malay Ranjan; Maurya, Anand Prakash; Choudhury, Debarati; Bhattacharjee, Amitabha			Genetic Acquisition of NDM Gene Offers Sustainability among Clinical Isolates of Pseudomonas aeruginosa in Clinical Settings	PLOS ONE			English	Article							ACINETOBACTER-BAUMANNII; CARBAPENEM RESISTANCE; PCR; ENTEROBACTERIACEAE; IDENTIFICATION; BLA(NDM-1)	New Delhi metallo beta-lactamases are one of the most significant emerging resistance determinants towards carbapenem drugs. Their persistence and adaptability often depends on their genetic environment and linkage. This study reports a unique and novel arrangement of bla(NDM-1) gene within clinical isolates of Pseudomonas aeruginosa from a tertiary referral hospital in north India. Three NDM positive clonally unrelated clinical isolates of P. aeruginosa were recovered from hospital patients. Association of integron with bla(NDM-1) and presence of gene cassettes were assessed by PCR. Genetic linkage of NDM gene with ISAba125 was determined and in negative cases linkage in upstream region was mapped by inverse PCR. In which only one isolate's NDM gene was linked with ISAba125 for mobility, while other two reveals new genetic arrangement and found to be inserted within DNA directed RNA polymerase gene of the host genome detected by inverse PCR followed by sequencing analysis. In continuation significance of this novel linkage was further analyzed wherein promoter site detected by Softberry BPROM software and activity were assessed by cloning succeeding semi-quantitative RT-PCR indicating the higher expression level of NDM gene. This study concluded out that the unique genetic makeup of NDM gene with DNA-dependent-RNA-polymerase favours adaptability to the host in hospital environment against huge antibiotic pressure.	[Mishra, Shweta; Sen, Malay Ranjan] Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi 221005, Uttar Pradesh, India; [Upadhyay, Supriya] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Shillong, Meghalaya, India; [Maurya, Anand Prakash; Bhattacharjee, Amitabha] Assam Univ, Dept Microbiol, Silchar 788011, India; [Choudhury, Debarati] Assam Univ, Dept Life Sci & Bioinformat, Silchar 788011, India	Banaras Hindu University (BHU); North Eastern Hill University; Assam University; Assam University	Sen, MR (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi 221005, Uttar Pradesh, India.	mr_senbhu@yahoo.com		Maurya, Anand Prakash/0000-0001-5231-8174	Department of Biotechnology, Govt. of India, New Delhi, India [P-07-467, BT/PR11812/BRB/10/692]	Department of Biotechnology, Govt. of India, New Delhi, India(Department of Biotechnology (DBT) India)	This work was financially supported by Department of Biotechnology, Govt. of India, New Delhi, India under the research project (P-07-467), Grant BT/PR11812/BRB/10/692. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bercot B, 2011, J ANTIMICROB CHEMOTH, V66, P2295, DOI 10.1093/jac/dkr296; Bhattacharjee A, 2008, J ANTIMICROB CHEMOTH, V61, P309, DOI 10.1093/jac/dkm494; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; CLSI, 2005, PAM100S15 CLSI; Collee JG, 1996, MACKIE MCCARTNEY PRA; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Dortet L, 2012, ANTIMICROB AGENTS CH, V56, P1693, DOI 10.1128/AAC.05583-11; Janvier F, 2013, ANTIMICROB AGENTS CH, V57, P3408, DOI 10.1128/AAC.02334-12; Jeong SH, 2006, J MICROBIOL, V44, P423; Karthikeyan K, 2010, J ANTIMICROB CHEMOTH, V65, P2253, DOI 10.1093/jac/dkq273; Koeleman JGM, 2001, J CLIN MICROBIOL, V39, P8, DOI 10.1128/JCM.39.1.8-13.2001; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Mesaros N, 2007, J ANTIMICROB CHEMOTH, V59, P378, DOI 10.1093/jac/dkl504; Mishra S, 2013, INT J ANTIMICROB AG, V41, P452, DOI 10.1016/j.ijantimicag.2013.01.007; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Patridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6605; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P202, DOI 10.1128/AAC.49.1.202-208.2005; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Quale J, 2003, CLIN INFECT DIS, V37, P214, DOI 10.1086/375821; Sambrook J, 1989, MOL CLONING LAB MANU, P32, DOI Cold Spring Harbour, N.Y; Seema K, 2011, J ANTIMICROB CHEMOTH, V66, P1646, DOI 10.1093/jac/dkr180; Senda K, 1996, J CLIN MICROBIOL, V34, P2909, DOI 10.1128/JCM.34.12.2909-2913.1996; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; Toleman MA, 2012, ANTIMICROB AGENTS CH, V56, P2773, DOI 10.1128/AAC.06297-11; Tsakris A, 2000, J CLIN MICROBIOL, V38, P1290, DOI 10.1128/JCM.38.3.1290-1292.2000; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Yong DE, 2002, J CLIN MICROBIOL, V40, P3798, DOI 10.1128/JCM.40.10.3798-3801.2002; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116611	10.1371/journal.pone.0116611	http://dx.doi.org/10.1371/journal.pone.0116611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635921	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700048
J	Shao, LJ; Hong, FX; Zou, Y; Hao, XF; Hou, HJ; Tian, M				Shao, Liujiazi; Hong, Fangxiao; Zou, Yi; Hao, Xiaofang; Hou, Haijun; Tian, Ming			Hypertonic Saline for Brain Relaxation and Intracranial Pressure in Patients Undergoing Neurosurgical Procedures: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							MANNITOL; ANESTHESIA; CRANIOTOMY; RESUSCITATION; SURGERY; TUMORS; SHOCK	Background A wealth of evidence from randomized controlled trials (RCTs) has indicated that hypertonic saline (HS) is at least as effective as, if not better than, mannitol in the treatment of increased intracranial pressure(ICP). However, there is little known about the effects of HS in patients during neurosurgery. Thus, this meta-analysis was performed to compare the intraoperative effects of HS with mannitol in patients undergoing craniotomy. Methods According to the research strategy, we searched PUBMED, EMBASE and Cochrane Central Register of Controlled Trials. Other sources such as the internet-based clinical trial registries and conference proceedings were also searched. After literature searching, two investigators independently performed literature screening, quality assessment of the included trials and data extraction. The outcomes included intraoperative brain relaxation, intraoperative ICP, total volume of fluid required, diuresis, hemodynamic parameters, electrolyte level, mortality or dependence and adverse events. Results Seven RCTs with 468 participants were included. The quality of the included trials was acceptable. HS could significantly increase the odds of satisfactory intraoperative brain relaxation (OR: 2.25, 95% CI: 1.32-3.81; P = 0.003) and decrease the mean difference (MD) of maximal ICP (MD: -2.51mmHg, 95% CI: -3.39-1.93mmHg; P < 0.00001) in comparison with mannitol with no significant heterogeneity among the study results. Compared with HS, mannitol had a more prominent diuretic effect. And patients treated with HS had significantly higher serum sodium than mannitol-treated patients. Conclusions Considering that robust outcome measures are absent because brain relaxation and ICP can be influenced by several factors except for the hyperosmotic agents, the results of present meta-analysis should be interpreted with cautions. Well-designed RCTs in the future are needed to further test the present results, identify the impact of HS on the clinically relevant outcomes and explore the potential mechanisms of HS.	[Shao, Liujiazi; Hong, Fangxiao; Zou, Yi; Hao, Xiaofang; Hou, Haijun; Tian, Ming] Capital Med Univ, Beijing Friendship Hosp, Dept Anesthesiol, Beijing 100050, Peoples R China	Capital Medical University	Tian, M (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Anesthesiol, Beijing 100050, Peoples R China.	youyihospital@163.com						Attari MA, 2012, J ISFAHAN MED SCH, V30, P1386; Azoubel G, 2008, CLINICS, V63, P833, DOI 10.1590/S1807-59322008000600021; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; [陈佳瑶 Chen Jiayao], 2005, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V25, P485; Ciesla DJ, 2001, SURGERY, V129, P567, DOI 10.1067/msy.2001.113286; De Vivo P, 2001, Minerva Anestesiol, V67, P603; Dinsmore J, 2007, BRIT J ANAESTH, V99, P68, DOI 10.1093/bja/aem132; Dubick MA, 2006, SHOCK, V25, P321, DOI 10.1097/01.shk.0000209525.50990.28; Gemma M, 1997, J NEUROSURG ANESTH, V9, P329, DOI 10.1097/00008506-199710000-00007; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Infanti JL, 2008, J NEUROSCI NURS, V40, P362, DOI 10.1097/01376517-200812000-00009; Iversen BN, 2008, ACTA NEUROCHIR, V150, P337, DOI 10.1007/s00701-008-1461-1; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Keyrouz SG, 2008, NEUROCRIT CARE, V9, P204, DOI 10.1007/s12028-008-9118-3; McAlister V, 2010, COCHRANE DB SYST REV, pD5576; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Peng X, 2007, J YOUJIANG MED COLL, V29, P343; Rasmussen M, 2004, J NEUROSURG, V101, P621, DOI 10.3171/jns.2004.101.4.0621; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rozet I, 2007, ANESTHESIOLOGY, V107, P697, DOI 10.1097/01.anes.0000286980.92759.94; Sabharwal N, 2009, J NEUROSURG ANESTH, V21, P248, DOI 10.1097/ANA.0b013e3181a6aebf; Shao LJZ, 2013, CLINICS, V68, P323, DOI 10.6061/clinics/2013(03)OA07; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Tseng MY, 2003, STROKE, V34, P1389, DOI 10.1161/01.STR.0000071526.45277.44; Turner CR, 1996, J NEUROSURG ANESTH, V8, P126, DOI 10.1097/00008506-199604000-00005; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; Wang JW, 2014, J SURG RES, V191, P448, DOI 10.1016/j.jss.2014.04.027; Wu CT, 2010, ANESTH ANALG, V110, P903, DOI 10.1213/ANE.0b013e3181cb3f8b	29	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117314	10.1371/journal.pone.0117314	http://dx.doi.org/10.1371/journal.pone.0117314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635862	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700079
J	Shen, HS; Liang, D; Luo, MY; Duan, CJ; Cai, WL; Zhu, SS; Qiu, JP; Li, WR				Shen, Hesong; Liang, Dan; Luo, Mingyue; Duan, Chaijie; Cai, Wenli; Zhu, Shanshan; Qiu, Jianping; Li, Wenru			Pilot Study on Image Quality and Radiation Dose of CT Colonography with Adaptive Iterative Dose Reduction Three-Dimensional	PLOS ONE			English	Article							TUBE-CURRENT MODULATION; COLORECTAL LESIONS; MDCT COLONOGRAPHY; RECONSTRUCTION; FEASIBILITY; CANCER; RISK; REIMBURSEMENT; COLONOSCOPY; PERFORMANCE	Objective To investigate image quality and radiation dose of CT colonography (CTC) with adaptive iterative dose reduction three-dimensional (AIDR3D). Methods Ten segments of porcine colon phantom were collected, and 30 pedunculate polyps with diameters ranging from 1 to 15 mm were simulated on each segment. Image data were acquired with tube voltage of 120 kVp, and current doses of 10 mAs, 20 mAs, 30 mAs, 40 mAs, 50 mAs, respectively. CTC images were reconstructed using filtered back projection (FBP) and AIDR3D. Two radiologists blindly evaluated image quality. Quantitative evaluation of image quality included image noise, signal-to-noise ratio (SNR), and contrast-tonoise ratio (CNR). Qualitative image quality was evaluated with a five-score scale. Radiation dose was calculated based on dose-length product. Ten volunteers were examined supine 50 mAs with FBP and prone 20 mAs with AIDR3D, and image qualities were assessed. Paired t test was performed for statistical analysis. Results For 20 mAs with AIDR3D and 50 mAs with FBP, image noise, SNRs and CNRs were (16.4 +/- 1.6) HU vs. (16.8 +/- 2.6) HU, 1.9 +/- 0.2 vs. 1.9 +/- 0.4, and 62.3 +/- 6.8 vs. 62.0 +/- 6.2, respectively; qualitative image quality scores were 4.1 and 4.3, respectively; their differences were all not statistically significant. Compared with 50 mAs with FBP, radiation dose (1.62 mSv) of 20 mAs with AIDR3D was decreased by 60.0%. There was no statistically significant difference in image noise, SNRs, CNRs and qualitative image quality scores between prone 20 mAs with AIDR3D and supine 50 mAs with FBP in 10 volunteers, the former reduced radiation dose by 61.1%. Conclusion Image quality of CTC using 20 mAs with AIDR3D could be comparable to standard 50 mAs with FBP, radiation dose of the former reduced by about 60.0% and was only 1.62 mSv.	[Shen, Hesong; Liang, Dan; Luo, Mingyue; Zhu, Shanshan; Qiu, Jianping; Li, Wenru] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Duan, Chaijie] Tsinghua Univ, Grad Sch Shenzhen, Biomed Engn Res Ctr, Shenzhen 518057, Guangdong, Peoples R China; [Cai, Wenli] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Cai, Wenli] Harvard Univ, Sch Med, Boston, MA USA	Sun Yat Sen University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Luo, MY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China.	myluo720@163.com	Li, Wenjun/F-5634-2015	Li, Wenjun/0000-0001-5335-7386	National Natural Science Foundation of China [81230035]; Guangdong Provincial Science and Technology Program [2011B031800182, 2013B051000016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Program	This study was supported by The National Natural Science Foundation of China (81230035), http://www.nsfc.gov.cn/; and Guangdong Provincial Science and Technology Program (2011B031800182, 2013B051000016), http://pro.gdstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2013, AM J ROENTGENOL, V201, pW81, DOI 10.2214/AJR.12.9226; An S, 2008, AM J ROENTGENOL, V191, pW100, DOI 10.2214/AJR.07.3367; Branschofsky M, 2006, EUR J MED RES, V11, P13; Brenner DJ, 2005, GASTROENTEROLOGY, V129, P328, DOI 10.1053/j.gastro.2005.05.021; Chang KJ, 2013, ABDOM IMAGING, V38, P224, DOI 10.1007/s00261-012-9968-1; Chang KJ, 2013, RADIOLOGY, V266, P791, DOI 10.1148/radiol.12120134; Chen JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092414; Chen ZY, 2013, WORLD J GASTROENTERO, V19, P561, DOI 10.3748/wjg.v19.i4.561; Cohnen M, 2004, AM J ROENTGENOL, V183, P1355, DOI 10.2214/ajr.183.5.1831355; Cohnen M, 2002, ROFO-FORTSCHR RONTG, V174, P835, DOI 10.1055/s-2002-32691; Dachman AH, 2013, J AM COLL RADIOL, V10, P937, DOI 10.1016/j.jacr.2013.09.014; de Gonzalez AB, 2011, AM J ROENTGENOL, V196, P816, DOI 10.2214/AJR.10.4907; Duan XH, 2011, AM J ROENTGENOL, V197, P689, DOI 10.2214/AJR.10.6061; Elojeimy S, 2010, RADIAT PROT DOSIM, V141, P43, DOI 10.1093/rpd/ncq138; Fei WU, 2012, CHIN CANC, V21, P81; Fisichella VA, 2010, EUR RADIOL, V20, P630, DOI 10.1007/s00330-009-1601-5; Flicek KT, 2010, AM J ROENTGENOL, V195, P126, DOI 10.2214/AJR.09.3855; Graser A, 2006, AM J ROENTGENOL, V187, P695, DOI 10.2214/AJR.05.0662; Iannaccone R, 2003, RADIOLOGY, V229, P775, DOI 10.1148/radiol.2293021399; Iannaccone R, 2005, RADIOLOGY, V237, P927, DOI 10.1148/radiol.2373041747; Iannaccone R, 2003, EUR RADIOL, V13, P1297, DOI 10.1007/s00330-002-1704-8; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Kambadakone AR, 2011, AM J ROENTGENOL, V196, pW743, DOI 10.2214/AJR.10.5303; Leipsic J, 2010, AM J ROENTGENOL, V195, P649, DOI 10.2214/AJR.10.4285; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lieberman D, 2014, JAMA INTERN MED, V174, P10, DOI 10.1001/jamainternmed.2013.11499; Liedenbaum MH, 2008, EUR RADIOL, V18, P2222, DOI 10.1007/s00330-008-0994-x; Robbins JB, 2013, SEMIN ROENTGENOL, V48, P264, DOI 10.1053/j.ro.2013.03.010; Silva AC, 2010, AM J ROENTGENOL, V194, P191, DOI 10.2214/AJR.09.2953; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Steward MJ, 2014, COLORECTAL DIS, V16, P347, DOI 10.1111/codi.12451; van Gelder RE, 2004, RADIOLOGY, V232, P611, DOI 10.1148/radiol.2322031069; van Gelder RE, 2002, RADIOLOGY, V224, P25, DOI 10.1148/radiol.2241011126; Yee J, 2013, AM J ROENTGENOL, V201, P73, DOI 10.2214/AJR.13.10656; Yoo RE, 2013, INT J CARDIOVAS IMAG, V29, P669, DOI 10.1007/s10554-012-0113-6; Yoon MA, 2012, J COMPUT ASSIST TOMO, V36, P596, DOI 10.1097/RCT.0b013e31826092be	37	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117116	10.1371/journal.pone.0117116	http://dx.doi.org/10.1371/journal.pone.0117116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635839	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700070
J	Smole, U; Radauer, C; Lengger, N; Svoboda, M; Rigby, N; Bublin, M; Gaier, S; Hoffmann-Sommergruber, K; Jensen-Jarolim, E; Mechtcheriakova, D; Breiteneder, H				Smole, Ursula; Radauer, Christian; Lengger, Nina; Svoboda, Martin; Rigby, Neil; Bublin, Merima; Gaier, Sonja; Hoffmann-Sommergruber, Karin; Jensen-Jarolim, Erika; Mechtcheriakova, Diana; Breiteneder, Heimo			The Major Birch Pollen Allergen Bet v 1 Induces Different Responses in Dendritic Cells of Birch Pollen Allergic and Healthy Individuals	PLOS ONE			English	Article							NF-KAPPA-B; FC-EPSILON-RI; IMMUNE-RESPONSES; FOOD ALLERGENS; RECEPTOR; IGE; PROTEIN; AFFINITY; ACTIVATION; EPITHELIUM	Dendritic cells play a fundamental role in shaping the immune response to allergens. The events that lead to allergic sensitization or tolerance induction during the interaction of the major birch pollen allergen Bet v 1 and dendritic cells are not very well studied. Here, we analyzed the uptake of Bet v 1 and the cross-reactive celery allergen Api g 1 by immature monocyte-derived dendritic cells (iMoDCs) of allergic and normal donors. In addition, we characterized the allergen-triggered intracellular signaling and transcriptional events. Uptake kinetics, competitive binding, and internalization pathways of labeled allergens by iMoDCs were visualized by live-cell imaging. Surface-bound IgE was detected by immunofluorescence microscopy and flow cytometry. Allergen- and IgE-induced gene expression of early growth response genes and Th1 and Th2 related cytokines and chemokines were analyzed by real-time PCR. Phosporylation of signaling kinases was analyzed by Western blot. Internalization of Bet v 1 by iMoDCs of both donor groups, likely by receptor-mediated caveolar endocytosis, followed similar kinetics. Bet v 1 outcompeted Api g 1 in cell surface binding and uptake. MoDCs of allergic and healthy donors displayed surface-bound IgE and showed a pronounced upregulation of Th2 cytokine-and NF kappa B-dependent genes upon non-specific Fc epsilon receptor cross-linking. In contrast to these IgE-mediated responses, Bet v 1-stimulation increased transcript levels of the Th2 cytokines IL-4 and IL-13 but not of NF kappa B-related genes in MoDCs of BP allergic donors. Cells of healthy donors were either unresponsive or showed elevated mRNA levels of Th1-promoting chemokines. Moreover, Bet v 1 was able to induce Erk1/2 and p38 MAPK activation in BP allergics but only a slight p38 activation in normal donors. In conclusion, our data indicate that Bet v 1 favors the activation of a Th2 program only in DCs of BP allergic individuals.	[Smole, Ursula; Radauer, Christian; Lengger, Nina; Svoboda, Martin; Bublin, Merima; Gaier, Sonja; Hoffmann-Sommergruber, Karin; Jensen-Jarolim, Erika; Mechtcheriakova, Diana; Breiteneder, Heimo] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Smole, Ursula] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Rigby, Neil] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Jensen-Jarolim, Erika] Vet Univ Vienna, Med Univ Vienna, Messerli Res Inst, Vienna, Austria; [Jensen-Jarolim, Erika] Univ Vienna, A-1010 Vienna, Austria	Medical University of Vienna; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Mechtcheriakova, D (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	diana.mechtcheriakova@meduniwien.ac.at; heimo.breiteneder@meduniwien.ac.at	Radauer, Christian/AAN-6260-2021; Jensen-Jarolim, Erika/C-5120-2018	Radauer, Christian/0000-0001-9920-4449; Jensen-Jarolim, Erika/0000-0003-4019-5765; Breiteneder, Heimo/0000-0003-2022-8689; Smole, Ursula/0000-0001-5124-2024; Bublin, Merima/0000-0002-7191-9431; Mechtcheriakova, Diana/0000-0002-8737-3592; Hoffmann-Sommergruber, Karin/0000-0002-8830-058X	Austrian Science Fund (FWF) [SFB-F4608, P 22441-B13]; Erwin Schroedinger Fellowship [J3332-B21]; Austrian Science Fund (FWF) [J 3332] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Erwin Schroedinger Fellowship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the following three Austrian Science Fund (FWF; http://www.fwf.ac.at/) grants: SFB-F4608 to HB, P 22441-B13 to DM, and the Erwin Schroedinger Fellowship J3332-B21 to US. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Bellinghausen I, 2008, CLIN EXP ALLERGY, V38, P539, DOI 10.1111/j.1365-2222.2007.02910.x; Bellinghausen I, 2003, IMMUNOLOGY, V108, P167, DOI 10.1046/j.1365-2567.2003.01576.x; Bieber T, 2007, IMMUNOBIOLOGY, V212, P499, DOI 10.1016/j.imbio.2007.03.001; Bohle B, 2007, ALLERGY, V62, P3, DOI 10.1111/j.1398-9995.2006.01258.x; Bohle B, 2003, EUR J IMMUNOL, V33, P3303, DOI 10.1002/eji.200324321; Bratke K, 2011, ALLERGY, V66, P386, DOI 10.1111/j.1398-9995.2010.02497.x; Calderon Moises A, 2012, Clin Transl Allergy, V2, P20, DOI 10.1186/2045-7022-2-20; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Emara M, 2012, J BIOL CHEM, V287, P5756, DOI 10.1074/jbc.M111.312520; Gilles S, 2009, J IMMUNOL, V182, P6653, DOI 10.4049/jimmunol.0802613; Goel C, 2012, CLIN EXP ALLERGY, V42, P412, DOI 10.1111/j.1365-2222.2011.03937.x; Herre J, 2013, J IMMUNOL, V191, P1529, DOI 10.4049/jimmunol.1300284; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jacquet A, 2011, CLIN EXP ALLERGY, V41, P305, DOI 10.1111/j.1365-2222.2010.03661.x; Joenvaara S, 2009, J ALLERGY CLIN IMMUN, V124, P135, DOI 10.1016/j.jaci.2008.11.048; Kazemi-Shirazi L, 2000, J ALLERGY CLIN IMMUN, V105, P116, DOI 10.1016/S0091-6749(00)90186-6; Kean DE, 2006, J IMMUNOL, V177, P1561, DOI 10.4049/jimmunol.177.3.1561; Kitzmuller C, 2012, ALLERGY, V67, P1375, DOI 10.1111/all.12016; Kraft S, 2002, J INVEST DERMATOL, V118, P830, DOI 10.1046/j.1523-1747.2002.01757.x; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Lebre MC, 2005, IMMUNOL CELL BIOL, V83, P525, DOI 10.1111/j.1440-1711.2005.01365.x; Li B, 2006, BLOOD, V107, P2814, DOI 10.1182/blood-2005-09-3610; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lohoff M, 2010, J BIOL CHEM, V285, P1643, DOI 10.1074/jbc.M109.011585; Lundberg K, 2008, CLIN IMMUNOL, V128, P358, DOI 10.1016/j.clim.2008.04.011; Maroof A, 2006, IMMUNOLOGY, V117, P271, DOI 10.1111/j.1365-2567.2005.02305.x; MAURER D, 1995, J IMMUNOL, V154, P6285; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Neves BM, 2009, MOL IMMUNOL, V46, P2481, DOI 10.1016/j.molimm.2009.05.021; Noirey N, 2000, J ALLERGY CLIN IMMUN, V105, P1194, DOI 10.1067/mai.2000.106545; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Renkonen J, 2009, ALLERGY, V64, P868, DOI 10.1111/j.1398-9995.2008.01919.x; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; Salazar F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00356; Saxon A, 2005, NAT IMMUNOL, V6, P223, DOI 10.1038/ni0305-223; Seutter von Loetzen C, 2014, BIOCHEM J, V457, P379, DOI 10.1042/BJ20130413; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Smole U, 2010, ALLERGY, V65, P1388, DOI 10.1111/j.1398-9995.2010.02407.x; Smole U, 2008, INT ARCH ALLERGY IMM, V147, P289, DOI 10.1159/000144036; Smole U, 2010, IMMUNOBIOLOGY, V215, P903, DOI 10.1016/j.imbio.2009.11.003; Thomas WR, 2013, CLIN EXP ALLERGY, V43, P152, DOI 10.1111/j.1365-2222.2012.04059.x; Traidl-Hoffmann C, 2009, J ALLERGY CLIN IMMUN, V123, P558, DOI 10.1016/j.jaci.2008.12.003; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; van Riet E, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-9; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064; Wills-Karp M, 2010, CURR OPIN IMMUNOL, V22, P777, DOI 10.1016/j.coi.2010.10.011; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080	58	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117904	10.1371/journal.pone.0117904	http://dx.doi.org/10.1371/journal.pone.0117904			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635684	Green Submitted, gold, Green Published			2022-12-27	WOS:000350680700107
J	Zhang, XL; Wang, Q; Xu, J; Gilliam, FS; Tremblay, N; Li, CH				Zhang, Xuelin; Wang, Qun; Xu, Jun; Gilliam, Frank S.; Tremblay, Nicolas; Li, Chaohai			In Situ Nitrogen Mineralization, Nitrification, and Ammonia Volatilization in Maize Field Fertilized with Urea in Huanghuaihai Region of Northern China	PLOS ONE			English	Article							USE EFFICIENCY; CEREAL PRODUCTION; PADDY FIELDS; SOIL; MANAGEMENT; YIELD; CROP; EMISSIONS; SYSTEM; FLUXES	Nitrogen (N) fertilization potentially affects soil N mineralization and leaching, and can enhance NH3 volatilization, thus impacting crop production. A fertilizer experiment with five levels of N addition (0, 79, 147, 215 and 375 kg N ha(-1)) was performed in 2009 and 2010 in a maize field in Huanghuaihai region, China, where > 300 kg N ha(-1) has been routinely applied to soil during maize growth period of 120 days. Responses of net N mineralization, inorganic N flux (0-10cm), NH3 volatilization, and maize yield to N fertilization were measured. During the growth period, net N mineralization and nitrification varied seasonally, with higher rates occurring in August and coinciding with the R1 stage of maize growth. Soil NO3--N contributed to more than 60% of inorganic N flux during maize growth. Cumulative NH3 volatilization increased with N additions, with total NH3 volatilization during maize growth accounting for about 4% of added N. Relative to the control, mean maize yield in the fertilizer treatments increased by 17% and 20% in 2009 and 2010, respectively. However, grain yield, aboveground biomass, and plant N accumulation did not increase with added N at levels > 215 kg N ha(-1). These results suggest that the current N rate of 300 kg N ha(-1) is not only excessive, but also reduces fertilizer efficacy and may contribute to environmental problems such as global warming and eutrophication of ground water and streams.	[Zhang, Xuelin; Wang, Qun; Xu, Jun; Li, Chaohai] Henan Agr Univ, Agron Coll, Collaborat Innovat Ctr Henan Grain Crops, Incubat Base Natl Key Lab Physiol Ecol & Genet Im, Zhengzhou 450002, Peoples R China; [Gilliam, Frank S.] Marshall Univ, Dept Biol Sci, Huntington, WV 25755 USA; [Tremblay, Nicolas] Agr & Agri Food Canada, Hort Res & Dev Ctr, St Jean, PQ J3B 3E6, Canada	Henan Agricultural University; Marshall University; Agriculture & Agri Food Canada	Zhang, XL (corresponding author), Henan Agr Univ, Agron Coll, Collaborat Innovat Ctr Henan Grain Crops, Incubat Base Natl Key Lab Physiol Ecol & Genet Im, 95 Wenhua Rd, Zhengzhou 450002, Peoples R China.	xuelinzhang1998@163.com	Tremblay, Nicolas/AAG-7408-2020; Gilliam, Frank S./M-9767-2019	Tremblay, Nicolas/0000-0003-1409-4442; Gilliam, Frank S./0000-0002-5525-0766	Henan Science and Technology Department of China under the Key Research Project [30200051]	Henan Science and Technology Department of China under the Key Research Project	This study was financially supported by grants from the Henan Science and Technology Department of China under the Key Research Project (30200051).	Basso B, 2005, AGR ECOSYST ENVIRON, V108, P329, DOI 10.1016/j.agee.2005.01.011; Cao YS, 2013, FIELD CROP RES, V147, P23, DOI 10.1016/j.fcr.2013.03.015; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Cui ZL, 2010, FIELD CROP RES, V116, P140, DOI 10.1016/j.fcr.2009.12.004; Dawson JC, 2008, FIELD CROP RES, V107, P89, DOI 10.1016/j.fcr.2008.01.001; Delgado JA, 2008, ECOL ENG, V32, P108, DOI 10.1016/j.ecoleng.2007.10.006; Delin S, 2002, ACTA AGR SCAND B-S P, V52, P78, DOI 10.1080/090647102321089819; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Heumann S, 2013, NUTR CYCL AGROECOSYS, V95, P395, DOI 10.1007/s10705-013-9572-y; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kadono A, 2008, SOIL BIOL BIOCHEM, V40, P947, DOI 10.1016/j.soilbio.2007.11.015; Korsaeth A, 2002, SOIL BIOL BIOCHEM, V34, P789, DOI 10.1016/S0038-0717(02)00008-1; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; Loecke TD, 2012, NUTR CYCL AGROECOSYS, V93, P65, DOI 10.1007/s10705-012-9500-6; Ma BL, 2010, AGRON J, V102, P134, DOI 10.2134/agronj2009.0021; Ma WQ, 2008, AGR SYST, V99, P53, DOI 10.1016/j.agsy.2008.10.001; Malhi SS, 2001, SOIL TILL RES, V60, P101, DOI 10.1016/S0167-1987(01)00176-3; Martines AM, 2010, BIORESOURCE TECHNOL, V101, P4690, DOI 10.1016/j.biortech.2010.01.104; NOMMIK H, 1973, PLANT SOIL, V39, P309, DOI 10.1007/BF00014798; RAISON RJ, 1987, SOIL BIOL BIOCHEM, V19, P521, DOI 10.1016/0038-0717(87)90094-0; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Rodhe L, 2006, SOIL USE MANAGE, V22, P229, DOI 10.1111/j.1475-2743.2006.00043.x; Roelle PA, 2002, ATMOS ENVIRON, V36, P1087, DOI 10.1016/S1352-2310(01)00355-7; Saarijarvi K, 2006, ATMOS ENVIRON, V40, P5137, DOI 10.1016/j.atmosenv.2006.03.052; Schjorring JK, 1998, NEW PHYTOL, V139, P59, DOI 10.1046/j.1469-8137.1998.00173.x; Schroder JJ, 2000, FIELD CROP RES, V66, P151, DOI 10.1016/S0378-4290(00)00072-1; Sehy U, 2003, AGR ECOSYST ENVIRON, V99, P97, DOI 10.1016/S0167-8809(03)00139-7; Shisanya CA, 2009, SOIL TILL RES, V103, P239, DOI 10.1016/j.still.2008.05.016; Smil V, 2002, AMBIO, V31, P126, DOI 10.1639/0044-7447(2002)031[0126:NAFPPF]2.0.CO;2; Sommer SG, 2004, ADV AGRON, V82, P557, DOI 10.1016/S0065-2113(03)82008-4; Sommer SG, 2003, EUR J AGRON, V19, P465, DOI 10.1016/S1161-0301(03)00037-6; Stokstad E, 2014, SCIENCE, V343, P238, DOI 10.1126/science.343.6168.238; Subbarao GV, 2009, P NATL ACAD SCI USA, V106, P17302, DOI 10.1073/pnas.0903694106; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Wu TY, 2008, NUTR CYCL AGROECOSYS, V81, P279, DOI 10.1007/s10705-007-9163-x; Xing GX, 2000, NUTR CYCL AGROECOSYS, V57, P67, DOI 10.1023/A:1009717603427; Zhang JS, 2011, AGR ECOSYST ENVIRON, V140, P164, DOI 10.1016/j.agee.2010.11.023; Zhang X, 2012, GRASS FORAGE SCI, V67, P219, DOI 10.1111/j.1365-2494.2011.00836.x; Zhou S, 2009, WATER AIR SOIL POLL, V201, P135, DOI 10.1007/s11270-008-9933-3; Zhu JH, 2005, AGR ECOSYST ENVIRON, V111, P70, DOI 10.1016/j.agee.2005.04.025; Zhu X, 2013, P NATL ACAD SCI USA, V110, P6328, DOI 10.1073/pnas.1219993110	44	20	24	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115649	10.1371/journal.pone.0115649	http://dx.doi.org/10.1371/journal.pone.0115649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635864	gold, Green Submitted, Green Published			2022-12-27	WOS:000350680700016
J	Lankester, F; Lugelo, A; Kazwala, R; Keyyu, J; Cleaveland, S; Yoder, J				Lankester, Felix; Lugelo, Ahmed; Kazwala, Rudovick; Keyyu, Julius; Cleaveland, Sarah; Yoder, Jonathan			The Economic Impact of Malignant Catarrhal Fever on Pastoralist Livelihoods	PLOS ONE			English	Article							CATTLE; WILDEBEEST; PREFERENCE; WILDLIFE; REGION; AGENT	This study is the first to partially quantify the potential economic benefits that a vaccine, effective at protecting cattle against malignant catarrhal fever (MCF), could accrue to pastoralists living in East Africa. The benefits would result from the removal of household resource and management costs that are traditionally incurred avoiding the disease. MCF, a fatal disease of cattle caused by a virus transmitted from wildebeest calves, has plagued Maasai communities in East Africa for generations. The threat of the disease forces the Maasai to move cattle to less productive grazing areas to avoid wildebeest during calving season when forage quality is critical. To assess the management and resource costs associated with moving, we used household survey data. To estimate the costs associated with changes in livestock body condition that result from being herded away from wildebeest calving grounds, we exploited an ongoing MCF vaccine field trial and we used a hedonic price regression, a statistical model that allows estimation of the marginal contribution of a good's attributes to its market price. We found that 90 percent of households move, on average, 82 percent of all cattle away from home to avoid MCF. In doing so, a herd's productive contributions to the household was reduced, with 64 percent of milk being unavailable for sale or consumption by the family members remaining at the boma (the children, women, and the elderly). In contrast cattle that remained on the wildebeest calving grounds during the calving season (and survived MCF) remained fully productive to the family and gained body condition compared to cattle that moved away. This gain was, however, short-lived. We estimated the market value of these condition gains and losses using hedonic regression. The value of a vaccine for MCF is the removal of the costs incurred in avoiding the disease.	[Lankester, Felix] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Lankester, Felix; Cleaveland, Sarah] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Lugelo, Ahmed; Kazwala, Rudovick] Sokoine Univ Agr, Fac Vet Med, Morogoro, Tanzania; [Keyyu, Julius] Tanzanian Wildlife Res Inst, Arusha, Tanzania; [Yoder, Jonathan] Washington State Univ, Sch Econ, Pullman, WA 99164 USA	Washington State University; University of Glasgow; Sokoine University of Agriculture; Washington State University	Lankester, F (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	lankesterf@vetmed.wsu.edu	Yoder, Jonathan K/F-4840-2011	Cleaveland, Sarah/0000-0002-0456-0959; Lankester, Felix/0000-0002-0802-0693	Biotechnology and Biological Science Research Council [BB/H009035/1]; BBSRC [BB/H009116/1, BB/H009035/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H009116/1, BB/H009035/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Science Research Council (grant number BB/H009035/1 to SC RK JK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BAS FACTS FIG HUM SE; Ayele G, 2006, J FOOD PROD MARK, V12, P59, DOI 10.1300/J038v12n04_05; Bedelian C, 2007, PREV VET MED, V78, P296, DOI 10.1016/j.prevetmed.2006.10.012; Ben-shahar AR, 2014, OECOLOGIA, V90, P422; Boone R, 2002, INTEGRATED ASSESSMEN; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRIDGEN A, 1991, RES VET SCI, V50, P38, DOI 10.1016/0034-5288(91)90051-O; Cleaveland S, 2001, TECHNICAL REPORT; Coatney K. T., 1996, Review of Agricultural Economics, V18, P193, DOI 10.2307/1349432; Cook R. D., 1982, RESIDUALS INFLUENCE, V5; Davidson R, 1993, ESTIMATION INFERENCE; ESTES R D, 1976, East African Wildlife Journal, V14, P135; EVANS DG, 1978, ANIM PROD, V26, P119, DOI 10.1017/S0003356100039520; Food and Agricultural Organization / World Health Organization (FAO/ WHO), 1973, WHO TECHN REP SER, V522; Fratkin EM, 1999, CURR ANTHROPOL, V40, P729, DOI 10.1086/300093; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Getachew Terefe, 2012, Ethiopian Veterinary Journal, V16, P15; Greene H., 2003, ECONOMETRIC ANAL; Haig DM, 2008, VACCINE, V26, P4461, DOI 10.1016/j.vaccine.2008.06.056; Holdo RM, 2009, AM NAT, V173, P431, DOI 10.1086/597229; Homewood K. M., 1992, Ecology of Food and Nutrition, V29, P61, DOI 10.1080/03670244.1992.9991291; Homewood K, 2009, STUD HUM ECOL ADAPT, V5, P369, DOI 10.1007/978-0-387-87492-0_10; Jahnke H. E., 1982, Livestock production systems and livestock development in tropical Africa.; Jan vanGarderen K., 2003, ECONOMET J, DOI [10.1111/1368-423x.00078, 10.1111/1368-423x.00078., DOI 10.1111/1368-423X.00078]; Jehle G. A., 2011, ADV MICROECONOMIC TH; Kennedy PE, 1981, AM EC REV, V71; Li H, 2008, J GEN VIROL, V89, P1699, DOI 10.1099/vir.0.2008/000554-0; Lybbert TJ, 2004, ECON J, V114, P750, DOI 10.1111/j.1468-0297.2004.00242.x; Mdoe N, 1997, AGR ECON, V17, P75, DOI 10.1016/S0169-5150(97)00006-6; Morrison TA, 2012, J ANIM ECOL, V81, P543, DOI 10.1111/j.1365-2656.2011.01941.x; Nicholson M, 1984, PASTORALISM MILK PRO; Plowright W, 1986, Rev Sci Tech, V5, P897, DOI 10.20506/rst.5.4.271; PLOWRIGHT W, 1960, NATURE, V188, P1167, DOI 10.1038/1881167a0; ROSEN S, 1974, J POLIT ECON, V82, P34, DOI 10.1086/260169; Russell GC, 2009, VET J, V179, P324, DOI 10.1016/j.tvjl.2007.11.007; Sachedina HT, 2010, ANTIPODE, V42, P603, DOI 10.1111/j.1467-8330.2010.00765.x; Scarpa R, 2003, ECOL ECON, V45, P409, DOI 10.1016/S0921-8009(03)00094-6; Trench P. C., 2010, STAYING MAASAI LIVEL; Voeten M, 1999, THESIS WAGENINGEN U; Voeten MM, 1999, OECOLOGIA, V120, P287, DOI 10.1007/s004420050860; WANDERSTOCK JJ, 1946, J ANIM SCI, V5, P264, DOI 10.2527/jas1946.53264x; WESTERN D, 1986, HUM ECOL, V14, P77, DOI 10.1007/BF00889211	42	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116059	10.1371/journal.pone.0116059	http://dx.doi.org/10.1371/journal.pone.0116059			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629896	Green Accepted, Green Published, gold			2022-12-27	WOS:000348732100031
J	Weber, CF; King, GM; Aho, K				Weber, Carolyn F.; King, Gary M.; Aho, Ken			Relative Abundance of and Composition within Fungal Orders Differ between Cheatgrass (Bromus tectorum) and Sagebrush (Artemisia tridentate)-Associated Soils	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ANNUAL GRASS; CARBON; MOISTURE; GLOMALIN; DIVERSITY; STEPPE; CYCLE; AGGREGATION; COMMUNITIES	Nonnative Bromus tectorum (cheatgrass) is decimating sagebrush steppe, one of the largest ecosystems in the Western United States, and is causing regional-scale shifts in the predominant plant-fungal interactions. Sagebrush, a native perennial, hosts arbuscular mycorrhizal fungi (AMF), whereas cheatgrass, a winter annual, is a relatively poor host of AMF. This shift is likely intertwined with decreased carbon (C)-sequestration in cheatgrass-invaded soils and alterations in overall soil fungal community composition and structure, but the latter remain unresolved. We examined soil fungal communities using high throughput amplicon sequencing (ribosomal large subunit gene) in the 0-4 cm and 4-8 cm depth intervals of six cores from cheatgrass- and six cores from sagebrush-dominated soils. Sagebrush core surfaces (0-4 cm) contained higher nitrogen and total C than cheatgrass core surfaces; these differences mirrored the presence of glomalin related soil proteins (GRSP), which has been associated with AMF activity and increased C-sequestration. Fungal richness was not significantly affected by vegetation type, depth or an interaction of the two factors. However, the relative abundance of seven taxonomic orders was significantly affected by vegetation type or the interaction between vegetation type and depth. Teloschistales, Spizellomycetales, Pezizales and Cantharellales were more abundant in sagebrush libraries and contain mycorrhizal, lichenized and basal lineages of fungi. Only two orders (Coniochaetales and Sordariales), which contain numerous economically important pathogens and opportunistic saprotrophs, were more abundant in cheatgrass libraries. Pleosporales, Agaricales, Helotiales and Hypocreales were most abundant across all libraries, but the number of genera detected within these orders was as much as 29 times lower in cheatgrass relative to sagebrush libraries. These compositional differences between fungal communities associated with cheatgrass-and sagebrush-dominated soils warrant future research to examine soil fungal community composition across more sites and time points as well as in association with native grass species that also occupy cheatgrass-invaded ecosystems.	[Weber, Carolyn F.; Aho, Ken] Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA; [King, Gary M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Idaho; Idaho State University; Louisiana State University System; Louisiana State University	Weber, CF (corresponding author), Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA.	webecaro@isu.edu			National Science Foundation EPSCoR [EPS-0814387]; Idaho State University Office of Research; College of Science and Engineering; Direct For Biological Sciences [1241069] Funding Source: National Science Foundation	National Science Foundation EPSCoR(National Science Foundation (NSF)); Idaho State University Office of Research; College of Science and Engineering; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by new faculty start up funding provided by a National Science Foundation EPSCoR grant (EPS-0814387) and new faculty startup funds from the Idaho State University Office of Research and the College of Science and Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho K.A., 2014, FDN APPL STAT BIOL U; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; [Anonymous], 2006, BLACKWELL PUB PROF; [Anonymous], 2005, GEN TECHNICAL REPORT; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Baughman OW, 2013, INVAS PLANT SCI MANA, V6, P105, DOI 10.1614/IPSM-D-12-00043.1; Bedini S, 2009, SOIL BIOL BIOCHEM, V41, P1491, DOI 10.1016/j.soilbio.2009.04.005; Belnap J, 2001, ECOL APPL, V11, P1261; Belnap J, 1994, ECOLOGY MANAGEMENT A; Blight GE, 2012, MECH RESIDUAL SOILS, p[50, 41], DOI [10.3390/jpm2020050, DOI 10.3390/JPM2020050]; BOYLE SA, 2005, COLORADO SAGEBRUSH C; Bradley BA, 2005, REMOTE SENS ENVIRON, V94, P204, DOI 10.1016/j.rse.2004.08.016; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brunner E, 2002, NONPARAMETRIC ANAL L; Busby RR, 2012, J ECOSYS ECOG, pS8; Busby RR, 2013, MYCORRHIZA, V23, P129, DOI 10.1007/s00572-012-0455-x; Carter KA, 2014, MYCORRHIZA, V24, P301, DOI 10.1007/s00572-013-0537-4; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Chambers JC, 2007, ECOL MONOGR, V77, P117, DOI 10.1890/05-1991; Cregger MA, 2012, APPL ENVIRON MICROB, V78, P8587, DOI 10.1128/AEM.02050-12; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; DUKE SE, 1994, CAN J BOT, V72, P998, DOI 10.1139/b94-125; EVANS RD, 1993, OECOLOGIA, V94, P314, DOI 10.1007/BF00317104; Evans RD, 2001, ECOL APPL, V11, P1259; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Goldberry S, 2006, NCUR 20 U N CAR ASH; Harris D, 2001, SOIL SCI SOC AM J, V65, P1853, DOI 10.2136/sssaj2001.1853; HARRIS GA, 1970, ECOLOGY, V51, P530, DOI 10.2307/1935392; Hawkes CV, 2006, PLANT SOIL, V281, P369, DOI 10.1007/s11104-005-4826-3; Hoover AN, 2012, RANGELAND ECOL MANAG, V65, P160, DOI 10.2111/REM-D-11-00026.1; HULBERT LC, 1955, ECOL MONOGR, V25, P181, DOI 10.2307/1943550; Inouye RS, 2006, J ARID ENVIRON, V65, P604, DOI 10.1016/j.jaridenv.2005.10.005; Inouye RS, 2002, WEST N AM NATURALIST, V62, P360; King GM, 2011, TRENDS MICROBIOL, V19, P75, DOI 10.1016/j.tim.2010.11.006; Klironomos JN, 1998, NEW PHYTOL, V138, P599, DOI 10.1046/j.1469-8137.1998.00141.x; Knapp PA, 1996, GLOBAL ENVIRON CHANG, V6, P37, DOI 10.1016/0959-3780(95)00112-3; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kuske CR, 2002, APPL ENVIRON MICROB, V68, P1854, DOI 10.1128/AEM.68.4.1854-1863.2002; Letcher PM, 2002, MYCOLOGIA, V94, P761, DOI 10.2307/3761691; Lindahl BD, 2010, ISME J, V4, P872, DOI 10.1038/ismej.2010.19; Liu KL, 2012, APPL ENVIRON MICROB, V78, P1523, DOI 10.1128/AEM.06826-11; McDonald MC, 2013, NEW PHYTOL, V199, P241, DOI 10.1111/nph.12257; Menkis A, 2012, FOREST PATHOL, V42, P79, DOI 10.1111/j.1439-0329.2011.00712.x; Meyer SE, 2008, USDA FOREST SERVICE; Nash III TH, 2008, PHYSL SYMBIOSIS, P134, DOI [10.1161/CIRCOUTCOMES.108.825232, DOI 10.1161/CIRCOUTCOMES.108.825232]; Norton JB, 2004, USDA FOREST SERVICE; Norton U, 2008, SOIL BIOL BIOCHEM, V40, P1421, DOI 10.1016/j.soilbio.2007.12.021; Norton U, 2012, SOIL SCI SOC AM J, V76, P1038, DOI 10.2136/sssaj2011.0270; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pellant M, 1996, CHEATGRASSS INVADER; Porras-Alfaro A, 2008, APPL ENVIRON MICROB, V74, P2805, DOI 10.1128/AEM.02769-07; Porras-Alfaro A, 2011, MYCOLOGIA, V103, P10, DOI 10.3852/09-297; Promputtha I, 2007, MICROB ECOL, V53, P579, DOI 10.1007/s00248-006-9117-x; R Core Team, 2021, R LANGUAGE ENV STAT; Rau BM, 2011, RANGELAND ECOL MANAG, V64, P139, DOI 10.2111/REM-D-10-00063.1; Rillig MC, 2010, SOIL BIOL BIOCHEM, V42, P1189, DOI 10.1016/j.soilbio.2010.03.027; Rillig MC, 2002, SOIL BIOL BIOCHEM, V34, P1371, DOI 10.1016/S0038-0717(02)00060-3; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2003, PLANT SOIL, V253, P293, DOI 10.1023/A:1024807820579; Sankey JB, 2012, INT J WILDLAND FIRE, V21, P545, DOI 10.1071/WF11092; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt SK, 2012, FUNGAL ECOL, V5, P443, DOI 10.1016/j.funeco.2011.10.005; Sigma-Aldrich Co. LLC, 2013, BRADF REAG TECHN B; Sperry LJ, 2006, ECOLOGY, V87, P603, DOI 10.1890/05-0836; van der Putten WH, 2007, ISME J, V1, P28, DOI 10.1038/ismej.2007.9; Weber CF, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00078; West NE, 1999, PUBLICATION BOISE ST; WHISENANT SG, 1990, USDA INTERM, V276, P4; Wilcox RR, 2005, INTRO ROBUST ESTIMAT, P369; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wisdom MJ, 2005, HABITAT THREATS SAGE, p[5, 5]	72	18	18	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117026	10.1371/journal.pone.0117026	http://dx.doi.org/10.1371/journal.pone.0117026			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629158	Green Published, gold			2022-12-27	WOS:000348732100057
J	Villagomez, R; Hatti-Kaul, R; Sterner, O; Almanza, G; Linares-Pasten, JA				Villagomez, Rodrigo; Hatti-Kaul, Rajni; Sterner, Olov; Almanza, Giovanna; Linares-Pasten, Javier A.			Effect of Natural and Semisynthetic Pseudoguianolides on the Stability of NF-kappa B: DNA Complex Studied by Agarose Gel Electrophoresis	PLOS ONE			English	Article							SESQUITERPENE LACTONES; TRANSCRIPTION; INHIBITORS; CANCER; ALPHA; IKK; P65/NF-KAPPA-B; ACTIVATION; LUCIFERASE; EXPRESSION	The nuclear factor.B (NF-kappa B) is a promising target for drug discovery. NF-kappa B is a heterodimeric complex of RelA and p50 subunits that interact with the DNA, regulating the expression of several genes; its dysregulation can trigger diverse diseases including inflammation, immunodeficiency, and cancer. There is some experimental evidence, based on whole cells studies, that natural sesquiterpene lactones (Sls) can inhibit the interaction of NF-kappa B with DNA, by alkylating the RelA subunit via a Michael addition. In the present work, 28 natural and semisynthetic pseudoguianolides were screened as potential inhibitors of NF-kappa B in a biochemical assay that was designed using pure NF-kappa B heterodimer, pseudoguianolides and a similar to 1000 bp palindromic DNA fragment harboring two NF-kappa B recognition sequences. By comparing the relative amount of free DNA fragment to the NF-kappa B -DNA complex, in a routine agarose gel electrophoresis, the destabilizing effect of a compound on the complex is estimated. The results of the assay and the following structure-activity relationship study, allowed the identification of several relevant structural features in the pseudoguaianolide skeleton, which are necessary to enhance the dissociating capacity of NF-kappa B-DNA complex. The most active compounds are substituted at C-3 (alpha-carbonyl), in addition to having the alpha-methylene-gamma-lactone moiety which is essential for the alkylation of RelA.	[Villagomez, Rodrigo; Sterner, Olov] Lund Univ, Ctr Anal & Synth, S-22100 Lund, Sweden; [Villagomez, Rodrigo; Almanza, Giovanna] Univ Mayor San Andres, Fac Ciencias Puras & Nat, Inst Invest Quim, La Paz, Bolivia; [Hatti-Kaul, Rajni; Linares-Pasten, Javier A.] Lund Univ, Dept Chem, SE-22100 Lund, Sweden	Lund University; Universidad Mayor de San Andres; Lund University	Linares-Pasten, JA (corresponding author), Lund Univ, Dept Chem, POB 124, SE-22100 Lund, Sweden.	Javier.Linares_Pasten@biotek.lu.se	Linares-Pastén, Javier/N-8450-2018	Linares-Pastén, Javier/0000-0001-6999-6334; Almanza, Giovanna Rocio/0000-0002-5362-252X	Research Department of the Swedish International Development Cooperation Agency (SIDA-SAREC)	Research Department of the Swedish International Development Cooperation Agency (SIDA-SAREC)	This work was financially supported by the Research Department of the Swedish International Development Cooperation Agency (SIDA-SAREC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHOND A, 1968, J AM CHEM SOC, V90, P5622, DOI 10.1021/ja01022a063; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bremner P, 2002, J PHARM PHARMACOL, V54, P453, DOI 10.1211/0022357021778637; Castro AC, 2003, BIOORG MED CHEM LETT, V13, P2419, DOI 10.1016/S0960-894X(03)00408-6; Chen FE, 1999, PROTEIN ENG, V12, P423, DOI 10.1093/protein/12.5.423; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Di L, 2006, DRUG DISCOV TODAY, V11, P446, DOI 10.1016/j.drudis.2006.03.004; Ding CY, 2014, ORG BIOMOL CHEM, V12, P8442, DOI 10.1039/c4ob01040j; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; DJALALIBEHZAD G, 1981, MUTAT RES, V84, P1, DOI 10.1016/0027-5107(81)90044-0; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; Garcia-Pineres AJ, 2004, LIFE SCI, V75, P841, DOI 10.1016/j.lfs.2004.01.024; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gasparian AV, 2009, CELL CYCLE, V8, P1559, DOI 10.4161/cc.8.10.8415; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; ISRAEL N, 1992, J IMMUNOL, V149, P3386; Johansson MH, 2012, MINI-REV MED CHEM, V12, P1330; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Lai CF, 2006, ASSAY DRUG DEV TECHN, V4, P307, DOI 10.1089/adt.2006.4.307; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Lindenmeyer MT, 2004, ANAL BIOCHEM, V328, P147, DOI 10.1016/j.ab.2004.01.021; Ma DL, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr106; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Miller SC, 2010, BIOCHEM PHARMACOL, V79, P1272, DOI 10.1016/j.bcp.2009.12.021; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Olivier S, 2006, BIOCHEM PHARMACOL, V72, P1054, DOI 10.1016/j.bcp.2006.07.023; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Riganti C, 2008, MOL PHARMACOL, V74, P476, DOI 10.1124/mol.108.045286; Rungeler P, 1999, BIOORGAN MED CHEM, V7, P2343, DOI 10.1016/S0968-0896(99)00195-9; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Sue SC, 2008, J MOL BIOL, V380, P917, DOI 10.1016/j.jmb.2008.05.048; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Villagomez R., 2014, J BIOMEDICAL SCI ENG, DOI DOI 10.4236/JBISE.2014.710083; VILLAGOMEZ R, 2014, THESIS LUND U LUND; Villagomez R, 2013, ANTICANCER RES, V33, P3799; Zhao XN, 2003, ASSAY DRUG DEV TECHN, V1, P823, DOI 10.1089/154065803772613453	41	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115819	10.1371/journal.pone.0115819	http://dx.doi.org/10.1371/journal.pone.0115819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615602	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100018
J	Bi, YD; Li, W; Xiao, JL; Lin, H; Liu, M; Liu, M; Luan, XY; Zhang, BX; Xie, XJ; Guo, DL; Lai, YC				Bi, Yingdong; Li, Wei; Xiao, Jialei; Lin, Hong; Liu, Ming; Liu, Miao; Luan, Xiaoyan; Zhang, Bixian; Xie, Xuejun; Guo, Donglin; Lai, Yongcai			Heterosis and Combining Ability Estimates in Isoflavone Content Using Different Parental Soybean Accessions: Wild Soybean, a Valuable Germplasm for Soybean Breeding	PLOS ONE			English	Article							GENETIC-RESOURCES; CROP IMPROVEMENT; RESISTANCE; QTL; SOY; IDENTIFICATION; ENVIRONMENT; TOLERANCE; CULTIVARS; DIVERSITY	Isoflavone, a group of secondary metabolites in soybean, is beneficial to human health. Improving isoflavone content in soybean seeds has become one of the most important breeding objectives. However, the narrow genetic base of soybean cultivars hampered crop improvement. Wild soybean is an extraordinarily important gene pool for soybean breeding. In order to select an optimal germplasm for breeding programs to increase isoflavone concentration, 36 F1 soybean progenies from different parental accessions (cultivars, wild, Semi-wild and Interspecific) with various total isoflavone (TIF) concentration (High, Middle, Low) were analyzed for their isoflavone content. Results showed that male parents, except for Cultivars, showed positive GCA effects. In particular, wild soybean had higher positive GCA effects for TIF concentration. Both MP and BP heterosis value declined in the hybrid in which male parents were wild soybean, semi-wild soybean, interspecific offspring and cultivar in turn. In general, combining ability and heterosis in hybrids which had relative higher TIF concentration level parents showed better performance than those which had lower TIF concentration level parents. These results indicated characteristics of isoflavone content were mainly governed by additive type of gene action, and wild relatives could be utilized for breeding of soybean cultivars with this trait. A promising combination was found as the best potential hybrid for isoflavone content improvement.	[Bi, Yingdong] Northeast Forestry Univ, Heilongjiang Acad Agr Sci, Postdoctoral Programme, Harbin 150086, Peoples R China; [Bi, Yingdong; Li, Wei; Xiao, Jialei; Liu, Ming; Liu, Miao; Zhang, Bixian; Lai, Yongcai] Heilongjiang Acad Agr Sci, Inst Crops Tillage & Cultivat, Harbin 150086, Peoples R China; [Lin, Hong] Heilongjiang Acad Agr Sci, Crops Breeding Inst, Harbin 150086, Peoples R China; [Luan, Xiaoyan] Heilongjiang Acad Agr Sci, Inst Soybean, Harbin 150086, Peoples R China; [Xie, Xuejun] Heilongjiang Acad Agr Sci, Inst Food Proc, Harbin 150086, Peoples R China; [Guo, Donglin] Harbin Normal Univ, Life Sci & Technol Coll, Harbin 150025, Peoples R China	Heilongjiang Academy of Agricultural Sciences; Northeast Forestry University - China; Heilongjiang Academy of Agricultural Sciences; Heilongjiang Academy of Agricultural Sciences; Heilongjiang Academy of Agricultural Sciences; Heilongjiang Academy of Agricultural Sciences; Harbin Normal University	Lai, YC (corresponding author), Heilongjiang Acad Agr Sci, Inst Crops Tillage & Cultivat, 368 Xuefu Rd, Harbin 150086, Peoples R China.	ydbi308@163.com			Special Financial Grant from China Postdoctoral Science Foundation [2014T70373]; China Postdoctoral Science Foundation [2013M541422]; Department of Science and Technology of Heilongjiang Province [LC2011C30]; Haerbin Science and Technology Bureau [2011RFLYN019]; Young Foundation major project of HAAS [2012ZD031]; Department of Human Resource of Heilongjiang Province [2012-134]; Conservation and utilization of wild plant resources in agriculture, China Ministry of Agriculture [201003021]; National Natural Science Foundation of China [31101171]	Special Financial Grant from China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Department of Science and Technology of Heilongjiang Province; Haerbin Science and Technology Bureau; Young Foundation major project of HAAS; Department of Human Resource of Heilongjiang Province; Conservation and utilization of wild plant resources in agriculture, China Ministry of Agriculture; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is a part of a project financed by Special Financial Grant from China Postdoctoral Science Foundation (2014T70373); 54-class General Financial Grant from China Postdoctoral Science Foundation (2013M541422); Department of Science and Technology of Heilongjiang Province (LC2011C30); Haerbin Science and Technology Bureau (2011RFLYN019); Young Foundation major project of HAAS (2012ZD031); Department of Human Resource of Heilongjiang Province (2012-134); Conservation and utilization of wild plant resources in agriculture, China Ministry of Agriculture (201003021); and National Natural Science Foundation of China (Grant No. 31101171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gallegos JA, 2007, CROP SCI, V47, pS44, DOI 10.2135/cropsci2007.04.0008IPBS; Berger JD, 2012, FIELD CROP RES, V126, P119, DOI 10.1016/j.fcr.2011.09.020; Berger M, 2008, CROP SCI, V48, P700, DOI 10.2135/cropsci2007.08.0431; Burton JW, 2006, CROP SCI, V46, P2643, DOI 10.2135/cropsci2006.03.0156; Chiari L, 2004, EUPHYTICA, V138, P55, DOI 10.1023/B:EUPH.0000047060.03101.4a; Cvejic J, 2011, FOOD RES INT, V44, P2698, DOI 10.1016/j.foodres.2011.05.024; Damania AB, 2008, AGRON J, V100, P9, DOI 10.2134/agronj2005.0239c; Dixon RA, 2003, PLANT PHYSIOL, V131, P878, DOI 10.1104/pp.102.017319; Djuric Z, 2001, CANCER LETT, V172, P1, DOI 10.1016/S0304-3835(01)00627-9; DUDLEY JW, 1969, CROP SCI, V9, P257, DOI 10.2135/cropsci1969.0011183X000900030001x; ELDRIDGE AC, 1983, J AGR FOOD CHEM, V31, P394, DOI 10.1021/jf00116a052; Forkmann G, 2001, CURR OPIN BIOTECH, V12, P155, DOI 10.1016/S0958-1669(00)00192-0; Gutierrez-Gonzalez JJ, 2009, THEOR APPL GENET, V119, P1069, DOI 10.1007/s00122-009-1109-z; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Heywood Vernon Hilton, 2008, Turkish Journal of Botany, V32, P421; Hill CB, 2004, J ECON ENTOMOL, V97, P1071, DOI 10.1603/0022-0493(2004)097[1071:ROGSAV]2.0.CO;2; Hill CB, 2006, CROP SCI, V46, P1601, DOI 10.2135/cropsci2005.11-0421; Hoeck JA, 2000, CROP SCI, V40, P48, DOI 10.2135/cropsci2000.40148x; Huizhen L, 2005, AGR SCI CHINA, V4, P555; Jin Y, 2003, NEW PHYTOL, V159, P513, DOI 10.1046/j.1469-8137.2003.00824.x; Jung W, 2000, NAT BIOTECHNOL, V18, P208, DOI 10.1038/72671; Kim KS, 2012, THEOR APPL GENET, V125, P1353, DOI 10.1007/s00122-012-1944-1; Kim M, 2011, CROP SCI, V51, P934, DOI 10.2135/cropsci2010.08.0459; Kim SH, 2005, EUR FOOD RES TECHNOL, V220, P207, DOI 10.1007/s00217-004-1048-5; KORNEGAY JL, 1986, CROP SCI, V26, P1153, DOI 10.2135/cropsci1986.0011183X002600060015x; Kuroda Y, 2013, ECOL EVOL, V3, P2150, DOI 10.1002/ece3.606; [来永才 LAI Yongcai], 2008, [大豆科学, Soybean Science], V27, P212; Lakew B, 2011, FIELD CROP RES, V120, P161, DOI 10.1016/j.fcr.2010.09.011; Lee SJ, 2003, FIELD CROP RES, V81, P181, DOI 10.1016/S0378-4290(02)00220-4; Li DD, 2008, CROP SCI, V48, P571, DOI 10.2135/cropsci2007.06.0361; Liang HuiZhen, 2005, Scientia Agricultura Sinica, V38, P2147; Lin H, 2005, J PLANT GENETIC RESO, V6, P53; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Luo XJ, 2011, PLANT SCI, V181, P14, DOI 10.1016/j.plantsci.2010.12.009; Makanda I, 2010, FIELD CROP RES, V116, P75, DOI 10.1016/j.fcr.2009.11.015; Messina M, 2004, CURR OPIN CLIN NUTR, V7, P649, DOI 10.1097/00075197-200411000-00010; Messina M, 2010, J NUTR, V140, p1350S, DOI 10.3945/jn.109.118315; Morrison MJ, 2010, FIELD CROP RES, V117, P113, DOI 10.1016/j.fcr.2010.02.005; Ohara Masashi, 2002, Plant Species Biology, V17, P51, DOI 10.1046/j.1442-1984.2002.00073.x; Primomo VS, 2005, CROP SCI, V45, P2454, DOI 10.2135/cropsci2004.0672; Primomo VS, 2005, CROP SCI, V45, P2203, DOI 10.2135/cropsci2004.0610; Riday H, 2005, CROP SCI, V45, P8; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; Sebolt AM, 2000, CROP SCI, V40, P1438, DOI 10.2135/cropsci2000.4051438x; Seguin P, 2004, J SCI FOOD AGR, V84, P1327, DOI 10.1002/jsfa.1825; Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S; Singh RJ, 1999, GENOME, V42, P605, DOI 10.1139/gen-42-4-605; Singh SP, 2001, CROP SCI, V41, P1659, DOI 10.2135/cropsci2001.1659; Sneller CH, 2005, J CROP IMPROV, V14, P103, DOI 10.1300/J411v14n01_06; Sun JunMing, 2002, Agricultural Sciences in China, V1, P274; TAYYAB M A, 1990, PKV Research Journal, V14, P1; Tepavcevic V, 2010, J MED FOOD, V13, P657, DOI 10.1089/jmf.2009.0050; Ulukan H, 2007, J TEKIRDAG AGR FACUL, V4, P113; Ulukan H, 2011, ACTA AGR SCAND B-S P, V61, P97, DOI 10.1080/09064710903573390; Verpoorte R, 2002, CURR OPIN BIOTECH, V13, P181, DOI 10.1016/S0958-1669(02)00308-7; Wang CY, 2000, J AM OIL CHEM SOC, V77, P483, DOI 10.1007/s11746-000-0077-6; WANG HJ, 1994, J AGR FOOD CHEM, V42, P1674, DOI 10.1021/jf00044a017; Wang KJ, 2011, PLANT BREEDING, V130, P117, DOI 10.1111/j.1439-0523.2010.01815.x; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	59	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0114827	10.1371/journal.pone.0114827	http://dx.doi.org/10.1371/journal.pone.0114827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607952	gold, Green Published, Green Submitted			2022-12-27	WOS:000348205300005
J	All, AH; Gharibani, P; Gupta, S; Bazley, FA; Pashai, N; Chou, BK; Shah, S; Resar, LM; Cheng, LZ; Gearhart, JD; Kerr, CL				All, Angelo H.; Gharibani, Payam; Gupta, Siddharth; Bazley, Faith A.; Pashai, Nikta; Chou, Bin-Kuan; Shah, Sandeep; Resar, Linda M.; Cheng, Linzhao; Gearhart, John D.; Kerr, Candace L.			Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MARROW STROMAL CELLS; NEURAL DIFFERENTIATION; CONTUSION MODEL; GLIAL SCAR; TRANSPLANTATION; RECOVERY; RATS; TISSUE; HYPOTHERMIA	Induced pluripotent stem (iPS) cells are at the forefront of research in regenerative medicine and are envisaged as a source for personalized tissue repair and cell replacement therapy. Here, we demonstrate for the first time that oligodendrocyte progenitors (OPs) can be derived from iPS cells generated using either an episomal, non-integrating plasmid approach or standard integrating retroviruses that survive and differentiate into mature oligodendrocytes after early transplantation into the injured spinal cord. The efficiency of OP differentiation in all 3 lines tested ranged from 40% to 60% of total cells, comparable to those derived from human embryonic stem cells. iPS cell lines derived using episomal vectors or retroviruses generated a similar number of early neural progenitors and glial progenitors while the episomal plasmid-derived iPS line generated more OPs expressing late markers O1 and RIP. Moreover, we discovered that iPS-derived OPs (iPS-OPs) engrafted 24 hours following a moderate contusive spinal cord injury (SCI) in rats survived for approximately two months and that more than 70% of the transplanted cells differentiated into mature oligodendrocytes that expressed myelin associated proteins. Transplanted OPs resulted in a significant increase in the number of myelinated axons in animals that received a transplantation 24 h after injury. In addition, nearly a 5-fold reduction in cavity size and reduced glial scarring was seen in iPS-treated groups compared to the control group, which was injected with heat-killed iPS-OPs. Although further investigation is needed to understand the mechanisms involved, these results provide evidence that patient-specific, iPS-derived OPs can survive for three months and improve behavioral assessment (BBB) after acute transplantation into SCI. This is significant as determining the time in which stem cells are injected after SCI may influence their survival and differentiation capacity.	[All, Angelo H.; Gharibani, Payam; Gupta, Siddharth; Bazley, Faith A.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Chou, Bin-Kuan; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD USA; [Chou, Bin-Kuan; Resar, Linda M.; Cheng, Linzhao; Kerr, Candace L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Shah, Sandeep; Resar, Linda M.; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [All, Angelo H.; Pashai, Nikta] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kerr, Candace L.] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Gearhart, John D.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Gearhart, John D.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Resar, Linda M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Resar, Linda M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [All, Angelo H.; Bazley, Faith A.] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore 117548, Singapore; [All, Angelo H.] Natl Univ Singapore, Dept Orthoped Surg, Div Neurol, Singapore 117548, Singapore; [All, Angelo H.] Natl Univ Singapore, Dept Biomed Engn, Div Neurol, Singapore 117548, Singapore; [All, Angelo H.] Natl Univ Singapore, Dept Med, Div Neurol, Singapore 117548, Singapore; [Kerr, Candace L.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Johns Hopkins University	Kerr, CL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	ckerr@som.umaryland.edu		Gharibani, Payam/0000-0002-4546-0890	Maryland Stem Cell Research Fund (MSCRF) [2007-MSCRFII-0159-00, 2009-MSCRFII-0091-00, 2013-MSCRFII-0109-00]; National Institute of Child Health and Human Development [R21HD057487-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057487] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund (MSCRF); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided by the Maryland Stem Cell Research Fund (MSCRF): Grant#2007-MSCRFII-0159-00 (awarded to CLK), Grant#2009-MSCRFII-0091-00 (awarded to AHA), and Grant#2013-MSCRFII-0109-00 (awarded to AHA). URL: http://mscrf.org/. Grant# R21HD057487-01A1 from National Institute of Child Health and Human Development (awarded to CLK). URL: https://www.nichd.nih.gov/Pages/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; All AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047645; Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bazley FA, 2014, IEEE T NEUR SYS REH, V22, P953, DOI 10.1109/TNSRE.2014.2319313; Bazley FA, 2014, THER HYPOTHERMIA TEM, V4, P115, DOI 10.1089/ther.2014.0002; Bazley FA, 2012, J NEUROSURG-SPINE, V16, P414, DOI 10.3171/2012.1.SPINE11684; Bilic J, 2012, STEM CELLS, V30, P33, DOI 10.1002/stem.700; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Chaerkady R, 2011, PROTEOMICS, V11, P4007, DOI 10.1002/pmic.201100107; Chaerkady R, 2009, J PROTEOME RES, V8, P1315, DOI 10.1021/pr8006667; Chang YW, 2009, J NEUROTRAUM, V26, P979, DOI 10.1089/neu.2008-0762; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Czepiel M, 2011, GLIA, V59, P882, DOI 10.1002/glia.21159; Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Durongphongtorn S, 2006, AM J VET RES, V67, P32, DOI 10.2460/ajvr.67.1.32; English K, 2011, J CELL BIOCHEM, V112, P1963, DOI 10.1002/jcb.23119; Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gunaseeli I, 2010, CURR MED CHEM, V17, P759, DOI 10.2174/092986710790514480; HAMEED A, 1994, HUM PATHOL, V25, P872, DOI 10.1016/0046-8177(94)90005-1; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Jakovcevski I, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.005.2009; Jang J, 2011, ANN NEUROL, V70, P402, DOI 10.1002/ana.22486; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keirstead HS, 1999, J NEUROSCI, V19, P7529, DOI 10.1523/JNEUROSCI.19-17-07529.1999; Kerr CL, 2010, INT J NEUROSCI, V120, P305, DOI 10.3109/00207450903585290; Kerr DA, 2003, J NEUROSCI, V23, P5131; Krsulovic J, 1999, BIOL RES, V32, P253; Kumagai G, 2013, EXP NEUROL, V248, P369, DOI 10.1016/j.expneurol.2013.06.028; Lau Frank, 2009, F1000 Biol Rep, V1, P84, DOI 10.3410/B1-84; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; Li J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/786475; Lu P, 2014, CURR OPIN NEUROBIOL, V27, P103, DOI 10.1016/j.conb.2014.03.010; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Lu HZ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-127; Maybhate A, 2012, CRIT CARE MED, V40, P573, DOI 10.1097/CCM.0b013e318232d97e; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Mohammad-Gharibani P, 2013, CYTOTHERAPY, V15, P1073, DOI 10.1016/j.jcyt.2013.05.002; Montague P, 2006, DEV NEUROSCI-BASEL, V28, P479, DOI 10.1159/000095110; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Onifer SM, 2007, ILAR J, V48, P385, DOI 10.1093/ilar.48.4.385; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Park DY, 2013, GLOB SPINE J, V3, P1, DOI 10.1055/s-0033-1337118; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Pawelczyk E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006712; Penha EM, 2014, STEM CELLS INT, V2014, P437; Pouya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027925; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Reeves A, 2012, ADV EXP MED BIOL, V760, P16; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Shah SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048533; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tokumoto Y, 2010, J BIOSCI BIOENG, V109, P622, DOI 10.1016/j.jbiosc.2009.11.013; Torres-Espin A, 2014, EUR J NEUROSCI, V39, P1704, DOI 10.1111/ejn.12542; TRAPP BD, 1989, J CELL BIOL, V109, P2417, DOI 10.1083/jcb.109.5.2417; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Urdzikova LM, 2014, INT J MOL SCI, V15, P11275, DOI 10.3390/ijms150711275; Wang LJ, 2014, ACTA NEUROCHIR, V156, P1409, DOI 10.1007/s00701-014-2089-6; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Watanabe M, 2006, J NEUROSCI RES, V84, P525, DOI 10.1002/jnr.20950; WU E, 1992, LAB INVEST, V67, P88; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yoshihara H, 2006, BRAIN RES, V1119, P65, DOI 10.1016/j.brainres.2006.08.080; Young W, 2002, PROG BRAIN RES, V137, P231; Yuan YM, 2013, NEUROSCI BULL, V29, P421, DOI 10.1007/s12264-013-1358-3; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	78	54	57	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116933	10.1371/journal.pone.0116933	http://dx.doi.org/10.1371/journal.pone.0116933			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635918	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700064
J	Montagna, M; Chouaia, B; Mazza, G; Prosdocimi, EM; Crotti, E; Mereghetti, V; Vacchini, V; Giorgi, A; De Biase, A; Longo, S; Cervo, R; Lozzia, GC; Alma, A; Bandi, C; Daffonchio, D				Montagna, Matteo; Chouaia, Bessem; Mazza, Giuseppe; Prosdocimi, Erica Maria; Crotti, Elena; Mereghetti, Valeria; Vacchini, Violetta; Giorgi, Annamaria; De Biase, Alessio; Longo, Santi; Cervo, Rita; Lozzia, Giuseppe Carlo; Alma, Alberto; Bandi, Claudio; Daffonchio, Daniele			Effects of the Diet on the Microbiota of the Red Palm Weevil (Coleoptera: Dryophthoridae)	PLOS ONE			English	Article							RHYNCHOPHORUS-FERRUGINEUS COLEOPTERA; NONPARAMETRIC-ESTIMATION; GENOMIC PERSPECTIVE; BACTERIAL COMMUNITY; R PACKAGE; SYMBIONTS; CURCULIONIDAE; DIVERSITY; EVOLUTION; GUT	Rhynchophorus ferrugineus, also known as the red palm weevil, is regarded as the major pest of palm trees. Although studies of the microbiota associated with this species have been performed in recent years, little attention has been dedicated to the influence of the diet in shaping the host bacterial community. Here, we investigated the influence of food sources (i.e. palm tissues vs apple based substrate) on the microbial diversity associated with RPW, which was compared with the microbiota associated with wild individuals of the sister species Rhynchophorus vulneratus. The bacterial characterization was performed using a culture independent approach, i.e. the 16S rRNA pyrotag, and a culture dependent approach for a subset of the samples, in order to obtain bacterial isolates from RPW tissues. The bacterial community appeared significantly influenced by diet. Proteobacteria resulted to be the most abundant clade and was present in all the specimens of the three examined weevil groups. Within Proteobacteria, Enterobacteriaceae were identified in all the organs analysed, including hemolymph and reproductive organs. The apple-fed RPWs and the wild R. vulneratus showed a second dominant taxon within Firmicutes that was scarcely present in the microbiota associated with palm-fed RPWs. A comparative analysis on the bacteria associated with the palm tissues highlighted that 12 bacterial genera out of the 13 identified in the plant tissues were also present in weevils, thus indicating that palm tissues may present a source for bacterial acquisition.	[Montagna, Matteo; Giorgi, Annamaria; Lozzia, Giuseppe Carlo] Univ Milan, Dipartimento Sci Agr & Ambientali, Milan, Italy; [Chouaia, Bessem; Prosdocimi, Erica Maria; Crotti, Elena; Vacchini, Violetta; Daffonchio, Daniele] Univ Milan, Dipartimento Sci Alimenti, Nutr, Ambiente, Milan, Italy; [Mazza, Giuseppe] Res Ctr Agrobiol & Pedol, Consiglio Ric Sperimentaz Agr, Cascine Del Riccio, Italy; [Mereghetti, Valeria; Bandi, Claudio] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy; [De Biase, Alessio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Longo, Santi] Univ Catania, Dipartimento Gest Sistemi Agroalimentari & Ambien, Catania, Italy; [Cervo, Rita] Univ Florence, Dipartimento Biol, Florence, Italy; [Alma, Alberto] Univ Turin, Dipartimento Sci Agr Forestali & Alimentari, Grugliasco, Italy; [Daffonchio, Daniele] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia	University of Milan; University of Milan; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Milan; Sapienza University Rome; University of Catania; University of Florence; University of Turin; King Abdullah University of Science & Technology	Montagna, M (corresponding author), Univ Milan, Dipartimento Sci Agr & Ambientali, Milan, Italy.	matteo.montagna@unimi.it	Bandi, Claudio/J-7835-2018; Mazza, Giuseppe/Y-9504-2019; Daffonchio, Daniele/AAF-4922-2019; Montagna, Matteo/AAF-8281-2021; CERVO, Rita/B-5441-2018	Bandi, Claudio/0000-0002-0181-4618; Mazza, Giuseppe/0000-0002-6644-1429; Daffonchio, Daniele/0000-0003-0947-925X; Montagna, Matteo/0000-0003-4465-7146; CERVO, Rita/0000-0002-0405-6402; chouaia, bessem/0000-0003-0726-7237; Crotti, Elena/0000-0002-3466-8274; giorgi, annamaria/0000-0001-5386-7378	European Union [GA-245746]; Italian Ministry of Education, University and Research (MIUR) [009L27YC8_003]; Linea B Piano di sviluppo Unimi [15-6-3]; "Accordo di Programma, affermazione in Edolo del Centro di Eccellenza Universita della Montagna" MIUR-Universita degli Studi di Milano [1293-05/08/2011]	European Union(European Commission); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Linea B Piano di sviluppo Unimi; "Accordo di Programma, affermazione in Edolo del Centro di Eccellenza Universita della Montagna" MIUR-Universita degli Studi di Milano	This work was supported by the project BIODESERT GA-245746 "Biotechnology from Desert Microbial Extremophiles for Supporting Agriculture Research Potential in Tunisia and Southern Europe" (European Union), the Prin 2009 (grant 009L27YC8_003) from the Italian Ministry of Education, University and Research (MIUR), Linea B Piano di sviluppo Unimi 2014 (grant 15-6-3) and "Accordo di Programma, affermazione in Edolo del Centro di Eccellenza Universita della Montagna" MIUR-Universita degli Studi di Milano, prot. n. 1293-05/08/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI [10.1093/nar/gkv1290, 10.1093/nar/gku1130]; Al-Ayedh H, 2008, FLA ENTOMOL, V91, P353, DOI 10.1653/0015-4040(2008)91[353:EODPCF]2.0.CO;2; Anonymous, 2008, Bulletin OEPP, V38, P55; Barranco P., 1996, PHYTOMA ESPANA, V76, P36; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baumann L, 1999, J MOL EVOL, V48, P77, DOI 10.1007/PL00006447; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Butera G, 2012, LETT APPL MICROBIOL, V54, P530, DOI 10.1111/j.1472-765X.2012.03238.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chouaia B, 2010, APPL ENVIRON MICROB, V76, P7444, DOI 10.1128/AEM.01747-10; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; Costopoulos K, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-5; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Dembilio O, 2009, J APPL ENTOMOL, V133, P565, DOI 10.1111/j.1439-0418.2009.01385.x; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Epis S, 2013, TICKS TICK-BORNE DIS, V4, P39, DOI 10.1016/j.ttbdis.2012.06.005; Esteban-Duran J., 1998, Boletin de Sanidad Vegetal Plagas, V24, P737; Estes AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079061; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foster SD, 2010, BIOMETRICS, V66, P186, DOI 10.1111/j.1541-0420.2009.01263.x; Giblin-Davis RM, 2013, CABI INVASIVE SER, P1, DOI 10.1079/9781845938291.0001; GiblinDavis RM, 1996, FLA ENTOMOL, V79, P153, DOI 10.2307/3495812; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Hui W, 2008, J STAT SOFTW, V28, P1; Hurwitz I, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-82; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [10.5169/seals.266450, DOI 10.5169/SEALS.266450, DOI 10.5169/SEALS-266450]; Jia SG, 2013, ENVIRON MICROBIOL, V15, P3020, DOI 10.1111/1462-2920.12262; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khiyami M, 2008, AFR J BIOTECHNOL, V7, P1432; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Kounatidis I, 2009, APPL ENVIRON MICROB, V75, P3281, DOI 10.1128/AEM.02933-08; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kuriwada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013101; Lancaster Jeremiah D, 2012, BMC Res Notes, V5, P688, DOI 10.1186/1756-0500-5-688; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lefevre C, 2004, MOL BIOL EVOL, V21, P965, DOI 10.1093/molbev/msh063; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Li YZ, 2009, FLA ENTOMOL, V92, P386, DOI 10.1653/024.092.0229; Llacer E, 2012, PEST MANAG SCI, V68, P878, DOI 10.1002/ps.3245; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Lopez-Sanchez MJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000721; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mazza G, 2014, B INSECTOL, V67, P281; Mazza G, 2014, BIOL CONTROL, V77, P83, DOI 10.1016/j.biocontrol.2014.06.010; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Montagna M, 2015, INSECT SCI, V22, P340, DOI 10.1111/1744-7917.12143; Montagna M, 2013, APPL ENVIRON MICROB, V79, P3241, DOI 10.1128/AEM.03971-12; Montagna M, 2012, ECOL ENG, V47, P242, DOI 10.1016/j.ecoleng.2012.06.025; Montagna M, 2012, FRONT MICROBIOL SER, P29; Moran NA, 2003, P NATL ACAD SCI USA, V100, P14543, DOI 10.1073/pnas.2135345100; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Murphy ST, 1999, BIOCONTROL NEWS INF, V20, P35; Nardon P, 2002, SYMBIOSIS, V33, P227; Peccoud J, 2014, INSECT SCI, V21, P291, DOI 10.1111/1744-7917.12083; Petti S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078999, 10.1371/journal.pone.0073827]; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rector BG, 2010, INVAS PLANT SCI MANA, V3, P429, DOI 10.1614/IPSM-D-10-00019.1; Ricci I, 2012, PATHOG GLOB HEALTH, V106, P380, DOI 10.1179/2047773212Y.0000000051; Rugman-Jones PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078379; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Sacchetti P, 2005, NOTIZIARIO CTR SPERI, V144, P6; Sacchetti P, 2006, INFORM FITOPATOLOGIC, V20, P35; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Tagliavia M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-136; Takiya DM, 2006, MOL ECOL, V15, P4175, DOI 10.1111/j.1365-294X.2006.03071.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thomas MC, 2010, GIANT PALM WEEVILS O; Valzano M., 2012, Journal of Entomological and Acarological Research, V44, P85, DOI 10.4081/jear.2012.e16; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Yuliansyah AT, 2012, RESOUR MANAG SUSTAIN, P3; Zhang RZ, 2003, CHINA FOREST INSECT, V22, P3, DOI DOI 10.1673/031.013.9101; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	87	53	55	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117439	10.1371/journal.pone.0117439	http://dx.doi.org/10.1371/journal.pone.0117439			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635833	Green Published, gold			2022-12-27	WOS:000350680700086
J	Liu, H; Chen, YH; Wang, P; Li, B; Wang, WF; Su, Y; Sheng, MJ				Liu, Hao; Chen, Yihui; Wang, Peng; Li, Bing; Wang, Weifang; Su, Yan; Sheng, Minjie			Efficacy and Safety of Deep Anterior Lamellar Keratoplasty vs. Penetrating Keratoplasty for Keratoconus: A Meta-Analysis	PLOS ONE			English	Article							BIG-BUBBLE TECHNIQUE; LONG-TERM OUTCOMES; CORNEAL GRAFTS; ENDOTHELIUM; THICKNESS; QUALITY	Purpose To evaluate difference in therapeutic outcomes between deep anterior lamellar keratoplasty (DALK) and penetrating keratoplasty (PKP) for the clinical treatment of keratoconus. Methods A comprehensive search was conducted in Pubmed, EMBASE, Cochrane Library, and Web of science. Eligible studies should include at least one of the following factors: best corrected visual acuity (BCVA), postoperative spherical equivalent (SE), postoperative astigmatism and endothelial cell count (ECC), central corneal thickness (CCT), graft rejection and graft failure, of which BCVA, graft rejection and graft failure were used as the primary outcome measures, and postoperative SE, astigmatism, CCT and ECC as the secondary outcome measures. Given the lack of randomized clinical trials (RCTs), cohort studies and prospective studies were considered eligible. Results Sixteen clinical trials involving 6625 eyes were included in this review, including 1185 eyes in DALK group, and 5440 eyes in PKP group. The outcomes were analyzed using Cochrane Review Manager (RevMan) version 5.0 software. The postoperative BCVA in DALK group was significantly better than that in PKP group (OR = 0.48; 95% CI 0.39 to 0.60; p< 0.001). There were fewer cases of graft rejection in DALK group than those in PKP group (OR = 0.28; 95% CI 0.15 to 0.50; p< 0.001). Nevertheless the rate of graft failure was similar between DALK and PKP groups (OR = 1.05; 95% CI 0.81 to 1.36; p = 0.73). There were no significant differences in the secondary outcomes of SE (p = 0.70), astigmatism (p = 0.14) and CCT (p = 0.58) between DALK and PKP groups. And ECC in DALK group was significantly higher than PKP group (p< 0.001). The postoperative complications, high intraocular pressure (high-IOP) and cataract were analyzed, fewer cases of complications occurred in DALK group than those in PKP group (high-IOP, OR 0.22, 95% CI 0.11-0.44, P < 0.001) (cataract, OR 0.22; 95% CI 0.08-0.61, P = 0.004). And no cases of expulsive hemorrhage and endophthalmitis were reported. Conclusion The visual outcomes for DALK were not equivalent to PKP. The rate of graft failure was similar between DALK and PKP. Fewer postoperative complications occurred in DALK group, indicating that compared with PKP, DALK has lower efficacy but higher safety.	[Liu, Hao; Chen, Yihui; Wang, Peng; Li, Bing; Wang, Weifang; Su, Yan; Sheng, Minjie] Tongji Univ, Dept Ophthalmol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China	Tongji University	Sheng, MJ (corresponding author), Tongji Univ, Dept Ophthalmol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China.	drsmj2014@gmail.com			Natural Science Foundation of China [81300771]; Young Talent Training Plan of Shanghai Tenth People's Hospital [11RQ108]; Shanghai Municipal Commission of Health and Family Planning [2013SY041]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Talent Training Plan of Shanghai Tenth People's Hospital; Shanghai Municipal Commission of Health and Family Planning	This work was supported by grants from the Natural Science Foundation of China (81300771) (http://www.nsfc.gov.cn/),the Young Talent Training Plan of Shanghai Tenth People's Hospital (11RQ108) (www.shdsyy.com.cn/), the Project of Shanghai Municipal Commission of Health and Family Planning (2013SY041) (http://www.wsjsw.gov.cn/wsj/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir MO, 2012, INT J OPHTHALMOL-CHI, V5, P737, DOI 10.3980/j.issn.2222-3959.2012.06.16; Al-Torbak AA, 2006, CORNEA, V25, P408, DOI 10.1097/01.ico.0000220777.70981.46; Alio Jorge L, 2002, Curr Opin Ophthalmol, V13, P224, DOI 10.1097/00055735-200208000-00006; Amayem AF, 2013, CORNEA, V32, pE2, DOI 10.1097/ICO.0b013e31825ca70b; Anwar M, 2002, J CATARACT REFR SURG, V28, P398, DOI 10.1016/S0886-3350(01)01181-6; Anwar M, 2002, CORNEA, V21, P374, DOI 10.1097/00003226-200205000-00009; Archila E A, 1984, Cornea, V3, P217; Armitage WJ, 2003, INVEST OPHTH VIS SCI, V44, P3326, DOI 10.1167/iovs.02-1255; Bahar I, 2008, AM J OPHTHALMOL, V146, P905, DOI 10.1016/j.ajo.2008.06.034; BENSON WH, 1993, AM J OPHTHALMOL, V116, P207, DOI 10.1016/S0002-9394(14)71287-5; Borderie VM, 2012, OPHTHALMOLOGY, V119, P249, DOI 10.1016/j.ophtha.2011.07.057; Brierly SC, 2000, CORNEA, V19, P329, DOI 10.1097/00003226-200005000-00014; Cohen Alex W., 2010, International Ophthalmology, V30, P675, DOI 10.1007/s10792-010-9393-9; Coombes AGA, 2001, BRIT J OPHTHALMOL, V85, P788, DOI 10.1136/bjo.85.7.788; Coster DJ, 2014, OPHTHALMOLOGY, V121, P979, DOI 10.1016/j.ophtha.2013.12.017; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Edwards M, 2011, CLIN EXPT OPHTHALMOL, V29, P345; Fogla R, 2006, AM J OPHTHALMOL, V141, P254, DOI 10.1016/j.ajo.2005.08.064; Fontana L, 2007, AM J OPHTHALMOL, V143, P117, DOI 10.1016/j.ajo.2006.09.025; Funnell CL, 2006, EYE, V20, P527, DOI 10.1038/sj.eye.6701903; Gore DM, 2013, EYE, V27, P329, DOI 10.1038/eye.2012.257; Han DCY, 2009, AM J OPHTHALMOL, V148, P744, DOI 10.1016/j.ajo.2009.05.028; Ing JJ, 1998, OPHTHALMOLOGY, V105, P1855, DOI 10.1016/S0161-6420(98)91030-2; Javadi MA, 2005, CORNEA, V24, P941, DOI 10.1097/01.ico.0000159730.45177.cd; Javadi MA, 2010, CORNEA, V29, P365, DOI 10.1097/ICO.0b013e3181b81b71; Jones MNA, 2009, INVEST OPHTH VIS SCI, V50, P5625, DOI 10.1167/iovs.09-3994; Keenan TDL, 2012, ARCH OPHTHALMOL-CHIC, V130, P621, DOI 10.1001/archophthalmol.2011.2585; Kettesy B, 2014, WIEN KLIN WOCHENSCHR, V126, P286, DOI 10.1007/s00508-014-0524-6; Kim KH, 2011, JPN J OPHTHALMOL, V55, P93, DOI 10.1007/s10384-010-0914-x; Klein AP, 2009, ARCH OPHTHALMOL-CHIC, V127, P649, DOI 10.1001/archophthalmol.2009.61; Kubaloglu A, 2012, INDIAN J OPHTHALMOL, V60, P35, DOI 10.4103/0301-4738.90490; Kus MM, 1999, AM J OPHTHALMOL, V127, P600, DOI 10.1016/S0002-9394(98)00406-1; Lee MJ, 2007, J KOREAN OPHTHALMOL, V48, P555; Lim L, 2000, OPHTHALMOLOGY, V107, P1125, DOI 10.1016/S0161-6420(00)00112-3; MacIntyre R, 2014, CORNEA, V33, P6, DOI 10.1097/ICO.0b013e3182a9fbfd; Mashor RS, 2011, CAN J OPHTHALMOL, V46, P403, DOI 10.1016/j.jcjo.2011.07.003; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nielsen K, 2007, ACTA OPHTHALMOL SCAN, V85, P890, DOI 10.1111/j.1600-0420.2007.00981.x; Oh Baek Lok, 2013, Korean J Ophthalmol, V27, P322, DOI 10.3341/kjo.2013.27.5.322; Pramanik S, 2006, OPHTHALMOLOGY, V113, P1633, DOI 10.1016/j.ophtha.2006.02.058; Reinhart WJ, 2011, OPHTHALMOLOGY, V118, P209, DOI 10.1016/j.ophtha.2010.11.002; Saini JS, 2003, CORNEA, V22, P111, DOI 10.1097/00003226-200303000-00005; Sari ES, 2012, BRIT J OPHTHALMOL, V96, P1063, DOI 10.1136/bjophthalmol-2011-301349; Sarnicola V, 2010, CORNEA, V29, P53, DOI 10.1097/ICO.0b013e3181a31aea; Shimazaki J, 2002, AM J OPHTHALMOL, V134, P159, DOI 10.1016/S0002-9394(02)01523-4; Shimazaki J, 2000, Curr Opin Ophthalmol, V11, P217, DOI 10.1097/00055735-200008000-00002; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sugita J, 1997, BRIT J OPHTHALMOL, V81, P184, DOI 10.1136/bjo.81.3.184; Terry MA, 2000, CORNEA, V19, P611, DOI 10.1097/00003226-200009000-00006; Thompson RW, 2003, OPHTHALMOLOGY, V110, P1396, DOI 10.1016/S0161-6420(03)00463-9; TROUTMAN RC, 1987, CORNEA, V6, P298, DOI 10.1097/00003226-198706040-00013; Volk RJ, 2011, JAMA-J AM MED ASSOC, V306, P2715, DOI 10.1001/jama.2011.1893; Wagner H, 2007, Cont Lens Anterior Eye, V30, P223, DOI 10.1016/j.clae.2007.03.001; Watson SL, 2004, OPHTHALMOLOGY, V111, P1676, DOI 10.1016/j.ophtha.2004.02.010; Yeh S, 2008, CORNEA, V27, P1062, DOI 10.1097/ICO.0b013e31817618c2; Zhang YM, 2013, J ZHEJIANG UNIV-SC B, V14, P438, DOI 10.1631/jzus.B1200272	57	49	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0113332	10.1371/journal.pone.0113332	http://dx.doi.org/10.1371/journal.pone.0113332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633311	gold, Green Submitted, Green Published			2022-12-27	WOS:000348609800002
J	Monleon, VJ; Lintz, HE				Monleon, Vicente J.; Lintz, Heather E.			Evidence of Tree Species' Range Shifts in a Complex Landscape	PLOS ONE			English	Article							DRIVE DOWNHILL SHIFTS; CLIMATE; MIGRATION; MORTALITY; BUTTERFLIES; EXPANSION; RESPONSES; RICHNESS; UPSLOPE; FORESTS	Climate change is expected to change the distribution of species. For long-lived, sessile species such as trees, tracking the warming climate depends on seedling colonization of newly favorable areas. We compare the distribution of seedlings and mature trees for all but the rarest tree species in California, Oregon and Washington, United States of America, a large, environmentally diverse region. Across 46 species, the mean annual temperature of the range of seedlings was 0.120 degrees C colder than that of the range of trees (95% confidence interval from 0.096 to 0.144 degrees C). The extremes of the seedling distributions also shifted towards colder temperature than those of mature trees, but the change was less pronounced. Although the mean elevation and mean latitude of the range of seedlings was higher than and north of those of the range of mature trees, elevational and latitudinal shifts run in opposite directions for the majority of the species, reflecting the lack of a direct biological relationship between species' distributions and those variables. The broad scale, environmental diversity and variety of disturbance regimes and land uses of the study area, the large number and exhaustive sampling of tree species, and the direct causal relationship between the temperature response and a warming climate, provide strong evidence to attribute the observed shifts to climate change.	[Monleon, Vicente J.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Lintz, Heather E.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Oregon Climate Change Res Inst, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Forest Service; Oregon State University	Monleon, VJ (corresponding author), US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA.	vjmonleon@fs.fed.us			Oregon Department of Forestry	Oregon Department of Forestry	HEL received partial funding from the Oregon Department of Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; BECHTOLD WA, 2005, ENHANCED FOREST INVE, P27; Bell DM, 2014, GLOBAL ECOL BIOGEOGR, V23, P168, DOI 10.1111/geb.12109; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Blackburn TM, 2004, ECOGRAPHY, V27, P715, DOI 10.1111/j.0906-7590.2004.03999.x; Breshears DD, 2008, P NATL ACAD SCI USA, V105, P11591, DOI 10.1073/pnas.0806579105; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; CORDY CB, 1993, STAT PROBABIL LETT, V18, P353, DOI 10.1016/0167-7152(93)90028-H; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DAVIS MB, 1989, CLIMATIC CHANGE, V15, P75, DOI 10.1007/BF00138846; *FAO, 2000, 33 FAO FOR RES ASS; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Fellows AW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002044; Geils BW, 2010, FOREST PATHOL, V40, P147, DOI 10.1111/j.1439-0329.2010.00654.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Hitchcock C.L., 1973, FLORA PACIFIC NW; Holzinger B, 2008, PLANT ECOL, V195, P179, DOI 10.1007/s11258-007-9314-9; Horn H.S., 1975, ECOLOGY EVOLUTION CO, P196; Jenkins MA, 2002, J TORREY BOT SOC, V129, P194, DOI 10.2307/3088770; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2009, ECOGRAPHY, V32, P765, DOI 10.1111/j.1600-0587.2009.05791.x; Little E.L., 1971, MISC PUBL, V1146; Little E. L. J., 1976, USDA MISCELLANEOUS P, V3; MCROBERTS RE, 2005, SRS80 USDA FOR SERV, P1; Murphy HT, 2010, ECOL LETT, V13, P1233, DOI 10.1111/j.1461-0248.2010.01526.x; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P374; Parmesan C, 2011, NAT CLIM CHANGE, V1, P2, DOI 10.1038/nclimate1056; Sarndal C.-E., 1992, MODEL ASSISTED SURVE; Schwilk DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031173; Smith W. B., 2009, WO78 USDA FOR SERV; Stephenson NL, 2011, SCIENCE, V334, DOI 10.1126/science.1205740; *USDA FOR SERV, 2008, FIELD INSTR ANN INV; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wolf A, 2011, SCIENCE, V334, DOI 10.1126/science.1204607; Woodall CW, 2009, FOREST ECOL MANAG, V257, P1434, DOI 10.1016/j.foreco.2008.12.013; Zhu K, 2014, GLOBAL CHANGE BIOL, V20, P251, DOI 10.1111/gcb.12382; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	44	46	51	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0118069	10.1371/journal.pone.0118069	http://dx.doi.org/10.1371/journal.pone.0118069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25634090	gold, Green Published, Green Submitted			2022-12-27	WOS:000348609800015
J	Boutin, S; Graeber, SY; Weitnauer, M; Panitz, J; Stahl, M; Clausznitzer, D; Kaderali, L; Einarsson, G; Tunney, MM; Elborn, JS; Mall, MA; Dalpke, AH				Boutin, Sebastien; Graeber, Simon Y.; Weitnauer, Michael; Panitz, Jessica; Stahl, Mirjam; Clausznitzer, Diana; Kaderali, Lars; Einarsson, Gisli; Tunney, Michael M.; Elborn, J. Stuart; Mall, Marcus A.; Dalpke, Alexander H.			Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; INFECTION; IDENTIFICATION; EPIDEMIOLOGY; BACTERIA; DISEASE	Changes in the airway microbiome may be important in the pathophysiology of chronic lung disease in patients with cystic fibrosis. However, little is known about the microbiome in early cystic fibrosis lung disease and the relationship between the microbiomes from different niches in the upper and lower airways. Therefore, in this cross-sectional study, we examined the relationship between the microbiome in the upper (nose and throat) and lower (sputum) airways from children with cystic fibrosis using next generation sequencing. Our results demonstrate a significant difference in both a and beta-diversity between the nose and the two other sampling sites. The nasal microbiome was characterized by a polymicrobial community while the throat and sputum communities were less diverse and dominated by a few operational taxonomic units. Moreover, sputum and throat microbiomes were closely related especially in patients with clinically stable lung disease. There was a high inter-individual variability in sputum samples primarily due to a decrease in evenness linked to increased abundance of potential respiratory pathogens such as Pseudomonas aeruginosa. Patients with chronic Pseudomonas aeruginosa infection exhibited a less diverse sputum microbiome. A high concordance was found between pediatric and adult sputum microbiomes except that Burkholderia was only observed in the adult cohort. These results indicate that an adult-like lower airways microbiome is established early in life and that throat swabs may be a good surrogate in clinically stable children with cystic fibrosis without chronic Pseudomonas aeruginosa infection in whom sputum sampling is often not feasible.	[Boutin, Sebastien; Weitnauer, Michael; Panitz, Jessica; Dalpke, Alexander H.] Univ Heidelberg Hosp, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany; [Graeber, Simon Y.; Stahl, Mirjam; Mall, Marcus A.] Univ Heidelberg Hosp, Dept Translat Pulmonol, Heidelberg, Germany; [Graeber, Simon Y.; Stahl, Mirjam; Mall, Marcus A.] Univ Heidelberg Hosp, Div Pediat Pulmonol & Allergol, Heidelberg, Germany; [Graeber, Simon Y.; Stahl, Mirjam; Mall, Marcus A.] Univ Heidelberg Hosp, Cyst Fibrosis Ctr, Dept Pediat, Heidelberg, Germany; [Boutin, Sebastien; Graeber, Simon Y.; Panitz, Jessica; Stahl, Mirjam; Mall, Marcus A.; Dalpke, Alexander H.] Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Clausznitzer, Diana; Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometry, D-01062 Dresden, Germany; [Einarsson, Gisli; Tunney, Michael M.; Elborn, J. Stuart] Queens Univ Belfast, CF & Airways Microbiol Grp, Belfast, Antrim, North Ireland; [Tunney, Michael M.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Elborn, J. Stuart] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Queens University Belfast; Queens University Belfast; Queens University Belfast	Dalpke, AH (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany.	alexander.dalpke@med.uni-heidelberg.de	Boutin, Sébastien/AAX-5334-2021; Mall, Marcus A./AAA-1498-2022; Graeber, Simon/AGX-6006-2022; Stahl, Mirjam/S-9442-2019	Boutin, Sébastien/0000-0002-0499-2460; Mall, Marcus A./0000-0002-4057-2199; Kaderali, Lars/0000-0002-2359-2294; Graeber, Simon Y./0000-0002-1666-8924; Einarsson, Gisli/0000-0003-1353-950X; TUNNEY, MICHAEL/0000-0002-7433-7074	European Commission (Seventh Framework Programme Project) [603038]; Gilead; Public Health Agency [CDV/3650/07, COM/4978/14, STL/3713/07] Funding Source: researchfish	European Commission (Seventh Framework Programme Project); Gilead(Gilead Sciences); Public Health Agency	This study was supported in part by a grant to MAM, JSE, MT and GE from the European Commission (Seventh Framework Programme Project No. 603038, CFMatters). This study was further supported by a grant from Gilead to AD and MAM. This does not alter our adherence to PLOS ONE policies on sharing data and materials. Gilead had no impact on design, realization and interpretation of this study or on manuscript preparation.	Beck JM, 2012, TRANSL RES, V160, P258, DOI 10.1016/j.trsl.2012.02.005; Bonestroo HJC, 2010, J CYST FIBROS, V9, P130, DOI 10.1016/j.jcf.2010.01.001; BRANDT I, 1988, KLIN PADIATR, V200, P451, DOI 10.1055/s-2008-1033752; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Coenye T, 2002, EMERG INFECT DIS, V8, P692, DOI 10.3201/eid0807.010472; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; De Boeck K, 2011, J CYST FIBROS, V10, pS53, DOI 10.1016/S1569-1993(11)60009-X; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; GILLIGAN PH, 1991, CLIN MICROBIOL REV, V4, P35, DOI 10.1128/CMR.4.1.35-51.1991; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; GOVAN JRW, 1992, BRIT MED BULL, V48, P912, DOI 10.1093/oxfordjournals.bmb.a072585; Hansen CR, 2010, J CYST FIBROS, V9, P51, DOI 10.1016/j.jcf.2009.10.005; Hansen CR, 2008, J CYST FIBROS, V7, P523, DOI 10.1016/j.jcf.2008.06.009; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; Hirtz S, 2004, GASTROENTEROLOGY, V127, P1085, DOI 10.1053/j.gastro.2004.07.006; HOIBY N, 1977, Acta Pathologica et Microbiologica Scandinavica Supplementum, V262, P8; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Jorgensen IM, 2003, PEDIATR PULM, V36, P439, DOI 10.1002/ppul.10383; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Marchandin H, 2012, CYSTIC FIBROSIS RENE, P225, DOI 10.1007/s12070-011-0437-x; Maughan H, 2012, PULMONARY MED, V2012; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Nonnenmacher C, 2004, J MICROBIOL METH, V59, P117, DOI 10.1016/j.mimet.2004.06.006; Pressler T, 2011, J CYST FIBROS, V10, pS75, DOI 10.1016/S1569-1993(11)60011-8; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Zhao JC, 2014, EUR RESPIR MONOGR, P32, DOI 10.1183/1025448x.10008713	49	97	98	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116029	10.1371/journal.pone.0116029	http://dx.doi.org/10.1371/journal.pone.0116029			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629612	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100029
J	Chen, YY; Chang, JR; Kuo, SC; Tseng, FC; Huang, WC; Huang, TS; Chen, YS; Chiueh, TS; Sun, JR; Su, IJ; Dou, HY				Chen, Yih-Yuan; Chang, Jia-Ru; Kuo, Shu-Chen; Tseng, Fan-Chen; Huang, Wel-Chen; Huang, Tsl-Shu; Chen, Yao-Shen; Chiueh, Tzong-Shi; Sun, Jun-Ren; Su, Ih-Jen; Dou, Horng-Yunn			Molecular Epidemiology of Tuberculosis in Kaohsiung City Located at Southern Taiwan, 2000-2008	PLOS ONE			English	Article							LEVEL STREPTOMYCIN RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; GENETIC DIVERSITY; MUTATIONS; FITNESS; ASSOCIATION; DATABASE; LINEAGE; STRAINS	Background We present the first comprehensive analysis of Mycobacterium tuberculosis (MTB) isolates circulating in southern Taiwan. In this 9-year population-based study, the TB situation in the Kaohsiung region was characterized by genotypic analysis of 421 MTB isolates. Methods All 421 isolates of MTB were analyzed by spoligotyping and MIRU-VNTR typing. Drug-resistance patterns were also analyzed. Results The percentage of EAI (East African-Indian) strains increased across sampling years (2000-2008) in southern Taiwan, whereas the proportion of Beijing lineages remained unchanged. Clustering was more frequent with EAI genotype infections (odds ratio = 3.6, p<0.0001) when compared to Beijing genotypes. Notably, MTB resistance to streptomycin (STR) had significantly increased over time, but resistance to other antibiotics, including multidrug resistance, had not. Three major genes (gidB, rpsL and rrs) implicated in STR resistance were sequenced and specific mutations identified. Conclusions This study revealed that EAI strains were highly transmissible and that STR resistance has increased between 2000 and 2008 in Kaohsiung, Taiwan.	[Chen, Yih-Yuan; Chang, Jia-Ru; Kuo, Shu-Chen; Tseng, Fan-Chen; Huang, Wel-Chen; Su, Ih-Jen; Dou, Horng-Yunn] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan; [Tseng, Fan-Chen] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Huang, Tsl-Shu; Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Microbiol, Kaohsiung, Taiwan; [Chiueh, Tzong-Shi; Sun, Jun-Ren] Triserv Gen Hosp, Dept Pathol, Div Clin Pathol, Taipei, Taiwan; [Chiueh, Tzong-Shi; Sun, Jun-Ren] Natl Def Med Ctr, Taipei, Taiwan; [Chen, Yih-Yuan] Ditmanson Med Fdn Chiayi Christian Hosp, Dept Internal Med, Chiaya City, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; Kaohsiung Veterans General Hospital; Tri-Service General Hospital; National Defense Medical Center; Chia-Yi Christian Hospital	Dou, HY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan.	hydou@nhri.org.tw	Tseng, Fan-Chen/D-2097-2010; Kuo, Shu-Chen/G-9108-2011; Su, Ih-Jen/B-2655-2010; Dou, Horng-Yunn/B-2652-2010	Sun, jun-ren/0000-0002-8769-9170	National Health Research Institutes; National Science Council, Taiwan (HYD) [NSC 102-2320-B-400-006]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); National Science Council, Taiwan (HYD)	This project was supported by grants from National Health Research Institutes and National Science Council (NSC 102-2320-B-400-006), Taiwan (HYD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1993, INFECT IMMUN, V61, P4173, DOI 10.1128/IAI.61.10.4173-4181.1993; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; CDC, 2012, TUB CONTR REP 2012; Chang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043018; Chen YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039792; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Feuerriegel S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-90; Gagneux S, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02685.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Huang SF, 2012, INFECT GENET EVOL, V12, P28, DOI 10.1016/j.meegid.2011.10.001; KOLK AHJ, 1992, J CLIN MICROBIOL, V30, P2567, DOI 10.1128/JCM.30.10.2567-2575.1992; Krishnan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023870; Lee JH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1724; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Nhu NTQ, 2012, INT J TUBERC LUNG D, V16, P527, DOI 10.5588/ijtld.11.0202; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Pepperell CS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003543; Qin LH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-247; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tudo G, 2010, J ANTIMICROB CHEMOTH, V65, P2341, DOI 10.1093/jac/dkq322; von Groll A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010191; Von Groll A, 2010, FEMS IMMUNOL MED MIC, V58, P119, DOI 10.1111/j.1574-695X.2009.00611.x; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10	28	11	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117061	10.1371/journal.pone.0117061	http://dx.doi.org/10.1371/journal.pone.0117061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629610	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100061
J	Hirschl, TA; Rank, MR				Hirschl, Thomas A.; Rank, Mark R.			The Life Course Dynamics of Affluence	PLOS ONE			English	Article							INTERGENERATIONAL INCOME MOBILITY	Social science research finds that the only group to have experienced real economic gains over the past four decades is the top 20 percent of the income distribution. This finding, along with greater awareness of growing inequality, has renewed interest in mobility research that identifies how individuals and their progeny move into and out of upper versus lower income categories. In this study a new mobility methodology is proposed using life course concepts and life table statistical techniques. Panel data from a prospective national sample of the U.S. population age 25 to 60 are analyzed to estimate the extent of mobility associated with top percentiles in the income distribution. Empirical results suggest high mobility associated with top-level income. For example, 11 percent of the population is found to occupy the top one percentile for one or more years between the ages of 25 and 60. The study findings suggest that many experience short-term and/or intermittent mobility into top-level income, versus a smaller set that persist within top-level income over many consecutive years. Implications of the findings are discussed in terms of inequality buffering, opportunity versus insecurity, and the demographics of income inequality.	[Hirschl, Thomas A.] Cornell Univ, Dept Dev Sociol, Ithaca, NY 14850 USA; [Rank, Mark R.] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA	Cornell University; Washington University (WUSTL)	Hirschl, TA (corresponding author), Cornell Univ, Dept Dev Sociol, Ithaca, NY 14850 USA.	tah4@cornell.edu			Cornell University Agricultural Experiment Station; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069609] Funding Source: NIH RePORTER	Cornell University Agricultural Experiment Station; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a grant from the Cornell University Agricultural Experiment Station, Thomas A. Hirschl, Principal Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberge R., 2013, IZA DISCUSSION PAPER; Allison P. D., 1995, SURVIVAL ANAL USING; [Anonymous], 1987, LIFE TABLES THEIR AP; Auten G, 2013, AM ECON REV, V103, P168, DOI 10.1257/aer.103.3.168; Bjorklund A, 1997, AM ECON REV, V87, P1009; Carroll R, 2010, INCOME MOBILITY PERS; Corak M, 2011, INEQUALITY GENERATIO; Duncan GJ, 2004, TELESCOPE SOC SURVEY, P156; Fitzgerald J, 1998, J HUM RESOUR, V33, P251, DOI 10.2307/146433; Gouskova E., 2010, COMP ESTIMATES FAMIL, V10-01; Gouskova E. S., 2008, PANEL STUDY INCOME D; Hill M.S., 1992, PANEL STUDY INCOME D; Hirschl TA, 2014, SOCIAL DYNAMICS EC P; Internal Revenue Service, 2012, 400 IND INC TAX RET; Issacs JB, 2008, EC MOBILITY FAMILIES; Jantti M., 2006, AM EXCEPTIONALISM NE; Kim Y.-S., 2000, QUALITY PSID INCOME; Mayer K.U., 1990, EVENT HIST ANAL LIFE, P3; Mervis J, 2014, SCIENCE, V344, P836, DOI 10.1126/science.344.6186.836; Panel Study of Income Dynamics (PSID), 2014, US GUID; Pew Charitable Trusts, 2012, PURS AM DREAM EC MOB; Picketty Thomas, 2014, CAPITAL 21 CENTURY; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Rank M, 2014, CHASING AM DREAM UND; Saez Emmanuel, 2013, STRIKING IT RICHER E; Solon G, 2002, J ECON PERSPECT, V16, P59, DOI 10.1257/089533002760278712; SOLON G, 1992, AM ECON REV, V82, P393; Stiglitz G, 2012, THE PRICE INEQUALITY; U.S. Census Bureau, 2013, CURRENT POPULATION R	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116370	10.1371/journal.pone.0116370	http://dx.doi.org/10.1371/journal.pone.0116370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629530	Green Submitted, Green Published, gold			2022-12-27	WOS:000348732100036
J	Hozhabri, NST; Benson, MD; Vu, MD; Patel, RH; Martinez, RM; Nakhaie, FN; Kim, HKW; Varanasi, VG				Hozhabri, Neda S. T.; Benson, M. Douglas; Vu, Michael D.; Patel, Rinkesh H.; Martinez, Rebecca M.; Nakhaie, Fatemeh N.; Kim, Harry K. W.; Varanasi, Venu G.			Decreasing NF-kappa B Expression Enhances Odontoblastic Differentiation and Collagen Expression in Dental Pulp Stem Cells Exposed to Inflammatory Cytokines	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PROTEASOME INHIBITION; GENE-EXPRESSION; IN-VIVO; TNF; ACTIVATION; INDUCTION; SYNOVIOCYTES; CHONDROCYTES; DEGRADATION	Inflammatory response in the dental pulp can alter the collagen matrix formation by dental pulp stem cells and lead to a delay or poor healing of the pulp. This inflammatory response is mediated by cytokines, including interleukin-1 beta and tumor necrosis factor-alpha. In this study, it is hypothesized that suppressing the actions of these inflammatory cytokines by knocking down the activity of transcription factor Nuclear Factor-kappa B will lead to dental pulp stem cell differentiation into odontoblasts and the production of collagen. Here, the role of Nuclear Factor-kappa B signaling and its reduction was examined during odontogenic behavior in the presence of these cytokines. The results showed a significant increase in Nuclear Factor-kappa B gene expression and p65 protein expression by interleukin-1 beta and tumor necrosis factor-alpha. Nuclear Factor-kappa B activation in the presence of these cytokines decreased significantly in a dose-dependent manner by a Nuclear Factor-kappa B inhibitor (MG132) and p65 siRNA. Down-regulation of Nuclear Factor-kappa B activity also enhanced the gene expression of the odontoblastic markers (dentin sialophosphoprotein, Nestin, and alkaline phosphatase) and displayed an odontoblastic cell morphology indicating the promotion of odontogenic differentiation of dental pulp stem cells. Finally, dental pulp stem cells exposed to reduced Nuclear Factor-kappa B activity resulted in a significant increase in collagen (I)-alpha 1 expression in the presence of these cytokines. In conclusion, a decrease in Nuclear Factor-kappa B in dental pulp stem cells in the presence of inflammatory cytokines enhanced odontoblastic differentiation and collagen matrix formation.	[Hozhabri, Neda S. T.; Benson, M. Douglas; Vu, Michael D.; Patel, Rinkesh H.; Martinez, Rebecca M.; Nakhaie, Fatemeh N.; Varanasi, Venu G.] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA; [Hozhabri, Neda S. T.; Benson, M. Douglas; Vu, Michael D.; Patel, Rinkesh H.; Martinez, Rebecca M.; Nakhaie, Fatemeh N.; Varanasi, Venu G.] Texas A&M Univ, Baylor Coll Dent, Ctr Craniofacial Res & Diag, Dallas, TX 75246 USA; [Kim, Harry K. W.] Texas Scottish Rite Hosp Children, Ctr Excellence Hip Disorders, Dallas, TX 75219 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas Scottish Rite Hospital for Children	Varanasi, VG (corresponding author), Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA.	varanasi@bcd.tamhsc.edu	Kim, Harry/AAF-7176-2020; Kim, Harry/AAE-1892-2020; Benson, M. Douglas/L-9125-2019	Kim, Harry/0000-0002-0330-4777; 	TAMHSC [304-244441]; NIH/NIDCR [P30DE20742]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P30DE020742] Funding Source: NIH RePORTER	TAMHSC; NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by TAMHSC 304-244441 and NIH/NIDCR P30DE20742.	Ahmed AS, 2010, ARTHRITIS RHEUM-US, V62, P2160, DOI 10.1002/art.27492; Aupperle KR, 1999, J IMMUNOL, V163, P427; Avino A, 2000, J ENDOVASC THER, V7, P469, DOI 10.1583/1545-1550(2000)007<0469:DPCONS>2.0.CO;2; Awasthi N, 2008, INVEST OPHTH VIS SCI, V49, P1998, DOI 10.1167/iovs.07-0624; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Barron MJ, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/915620; Bletsa A, 2004, NEUROIMMUNOMODULAT, V11, P376, DOI 10.1159/000080148; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Braun T, 2006, BLOOD, V107, P1156; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chang J, 2005, J DENT RES, V84, P994, DOI 10.1177/154405910508401105; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; Clutterbuck AL, 2009, ANN NY ACAD SCI, V1171, P428, DOI 10.1111/j.1749-6632.2009.04687.x; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Etienne S, 2008, BIO-MED MATER ENG, V18, P253, DOI 10.3233/BME-2008-0534; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goldberg M, 2008, PHARMACOL RES, V58, P137, DOI 10.1016/j.phrs.2008.05.013; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Ke J, 2007, J DENT RES, V86, P363, DOI 10.1177/154405910708600412; Lee UJ, 2008, MOL BIOL REP, V35, P291, DOI 10.1007/s11033-007-9084-4; Lianxu C, 2006, OSTEOARTHR CARTILAGE, V14, P367, DOI 10.1016/j.joca.2005.10.009; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Paula-Silva FWG, 2009, J DENT RES, V88, P339, DOI 10.1177/0022034509334070; Pezelj-Ribaric S, 2002, ARCH MED RES, V33, P482, DOI 10.1016/S0188-4409(02)00396-X; Rutherford RB, 2000, EUR J ORAL SCI, V108, P202, DOI 10.1034/j.1600-0722.2000.108003202.x; Safranek R, 2006, INT J EXP PATHOL, V87, P369, DOI 10.1111/j.1365-2613.2006.00490.x; Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x; Smith Anthony J, 2003, J Dent Educ, V67, P678; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tian F, 2006, ACTA BIOCH BIOPH SIN, V38, P318, DOI 10.1111/j.1745-7270.2006.00166.x; Tipton DA, 2006, TOXICOL IN VITRO, V20, P248, DOI 10.1016/j.tiv.2005.07.004; Tousi NS, 2013, MAT SCI ENG C-MATER, V33, P2757, DOI 10.1016/j.msec.2013.02.044; Varanasi VG, 2009, ACTA BIOMATER, V5, P3536, DOI 10.1016/j.actbio.2009.05.035; Varanasi VG, 2012, J ORAL IMPLANTOL, V38, P325, DOI 10.1563/AAID-JOI-D-11-00108; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wisithphrom K, 2006, J ENDODONT, V32, P853, DOI 10.1016/j.joen.2006.03.017; Yamakoshi Y, 2005, J BIOL CHEM, V280, P17472, DOI 10.1074/jbc.M413220200; Yamaza T, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt5; [杨雪超 YANG Xuechao], 2011, [中华口腔医学杂志, Chinese Journal of Stomatology], V46, P406; Zehnder M, 2003, CYTOKINE, V22, P84, DOI 10.1016/S1043-4666(03)00116-9	40	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0113334	10.1371/journal.pone.0113334	http://dx.doi.org/10.1371/journal.pone.0113334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629155	Green Submitted, Green Published, gold			2022-12-27	WOS:000348732100002
J	Piccardi, L; Palermo, L; Bocchi, A; Guariglia, C; D'Amico, S				Piccardi, Laura; Palermo, Liana; Bocchi, Alessia; Guariglia, Cecilia; D'Amico, Simonetta			Does Spatial Locative Comprehension Predict Landmark-Based Navigation?	PLOS ONE			English	Article							BRAIN-DAMAGED PATIENTS; DEVELOPMENTAL TOPOGRAPHICAL DISORIENTATION; WORKING-MEMORY; SEX-DIFFERENCES; CORSI TEST; LANGUAGE; ORIENTATION; CHILDREN; DEFICITS; WALKING	In the present study we investigated the role of spatial locative comprehension in learning and retrieving pathways when landmarks were available and when they were absent in a sample of typically developing 6- to 11-year-old children. Our results show that the more proficient children are in understanding spatial locatives the more they are able to learn pathways, retrieve them after a delay and represent them on a map when landmarks are present in the environment. These findings suggest that spatial language is crucial when individuals rely on sequences of landmarks to drive their navigation towards a given goal but that it is not involved when navigational representations based on the geometrical shape of the environment or the coding of body movements are sufficient for memorizing and recalling short pathways.	[Piccardi, Laura; Bocchi, Alessia; D'Amico, Simonetta] Univ Aquila, Hlth & Environm Sci Dept, I-67100 Laquila, Italy; [Piccardi, Laura; Palermo, Liana; Guariglia, Cecilia] Fdn Santa Lucia, IRCCS, Neuropsychol Unit, Rome, Italy; [Palermo, Liana] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Guariglia, Cecilia] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy	University of L'Aquila; IRCCS Santa Lucia; Aston University; Sapienza University Rome	Piccardi, L (corresponding author), Univ Aquila, Hlth & Environm Sci Dept, I-67100 Laquila, Italy.	laura.piccardi@cc.univaq.it	Palermo, Liana/ABG-2726-2021; guariglia, cecilia/J-9898-2018; Piccardi, laura/AAC-7587-2022	Palermo, Liana/0000-0001-8047-7201; guariglia, cecilia/0000-0001-7474-6030; Piccardi, Laura/0000-0002-1322-5538				ACREDOLO LP, 1980, DEV PSYCHOL, V16, P312, DOI 10.1037/0012-1649.16.4.312; ACREDOLO LP, 1978, DEV PSYCHOL, V14, P224, DOI 10.1037/0012-1649.14.3.224; Balcomb F, 2011, J COGN DEV, V12, P315, DOI 10.1080/15248372.2010.544692; Barkas LJ, 2010, BEHAV BRAIN RES, V208, P535, DOI 10.1016/j.bbr.2009.12.035; Bek J, 2010, J EXP PSYCHOL LEARN, V36, P646, DOI 10.1037/a0018281; Belacchi C, 2008, MANUALE CPM COLOURED; Bianchini F, 2014, AM J ALZHEIMERS DIS, V29, P749, DOI 10.1177/1533317514536597; Bianchini F, 2010, NEUROPSYCHOLOGIA, V48, P1563, DOI 10.1016/j.neuropsychologia.2010.01.025; Bianchini F, 2014, J NEUROPSYCHOL, V8, P107, DOI 10.1111/jnp.12007; Bishop D. V. M, 1982, TEST RECEPTION GRAMM; BREMNER JG, 1978, DEV PSYCHOL, V14, P346, DOI 10.1037/0012-1649.14.4.346; Chilosi A. M., 1995, TEST COMPRENSIONE GR; Coluccia E, 2004, J ENVIRON PSYCHOL, V24, P329, DOI 10.1016/j.jenvp.2004.08.006; Corsi P., 1972, THESIS MCGILL U MONT, V34; Dessalegn B, 2008, PSYCHOL SCI, V19, P189, DOI 10.1111/j.1467-9280.2008.02066.x; Dorffierger S, 2009, BEHAV BRAIN RES, V198, P165, DOI 10.1016/j.bbr.2008.10.033; Frank MC, 2008, COGNITION, V108, P819, DOI 10.1016/j.cognition.2008.04.007; GOPNIK A, 1987, CHILD DEV, V58, P1523, DOI 10.2307/1130692; GOPNIK A, 1986, CHILD DEV, V57, P1040, DOI 10.2307/1130378; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Haun DBM, 2006, P NATL ACAD SCI USA, V103, P17568, DOI 10.1073/pnas.0607999103; Hermer L, 1996, COGNITION, V61, P195, DOI 10.1016/S0010-0277(96)00714-7; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Hermer-Vazquez L, 1999, COGNITIVE PSYCHOL, V39, P3, DOI 10.1006/cogp.1998.0713; Hermer-Vazquez L, 2001, COGNITION, V79, P263, DOI 10.1016/S0010-0277(00)00120-7; Landau B, 2005, J MEM LANG, V53, P163, DOI 10.1016/j.jml.2004.05.007; Landau B, 2009, CURR OPIN NEUROBIOL, V19, P12, DOI 10.1016/j.conb.2009.02.001; Laurance HE, 2003, J COGN DEV, V4, P211, DOI 10.1207/S15327647JCD0402_04; Lehnung M, 2003, BRAIN INJURY, V17, P855, DOI 10.1080/0269905031000089369; Lehnung M, 1998, BRIT J PSYCHOL, V89, P463, DOI 10.1111/j.2044-8295.1998.tb02697.x; Leon I, 2014, NEUROPSYCHOLOGY, DOI [10.1111/jnp.12056, DOI 10.1111/JNP.12056]; Leplow B, 2003, BRIT J PSYCHOL, V94, P299, DOI 10.1348/000712603767876244; Nemmi F, 2013, NEUROPSYCHOLOGIA, V51, P1561, DOI 10.1016/j.neuropsychologia.2013.03.031; Nichelli F, 2001, NEUROL SCI, V22, P377, DOI 10.1007/s100720100068; Nico D, 2008, NEUROPSYCHOLOGIA, V46, P1898, DOI 10.1016/j.neuropsychologia.2008.01.013; Overman WH, 1996, BEHAV NEUROSCI, V110, P1205, DOI 10.1037/0735-7044.110.6.1205; Pagulayan KF, 2006, J CLIN EXP NEUROPSYC, V28, P1043, DOI 10.1080/13803390500350977; Palermo L, 2014, J CLIN EXP NEUROPSYC, V36, P464, DOI 10.1080/13803395.2014.904843; Palermo L, 2012, J CLIN EXP NEUROPSYC, V34, P1065, DOI 10.1080/13803395.2012.727385; Phillips CE, 2004, CORTEX, V40, P85, DOI 10.1016/S0010-9452(08)70922-5; Piaget J., 1948, REPRESENTATION ESPAC; Piccardi L, 2014, NEUROSCI LETT, V566, P226, DOI 10.1016/j.neulet.2014.03.005; Piccardi L, 2014, CLIN NEUROPSYCHOL, V28, P84, DOI 10.1080/13854046.2013.863976; Piccardi L, 2013, NEUROL SCI, V34, P971, DOI 10.1007/s10072-012-1175-x; Piccardi L, 2011, AGING NEUROPSYCHOL C, V18, P362, DOI 10.1080/13825585.2011.560243; Piccardi L, 2011, LEARN INDIVID DIFFER, V21, P114, DOI 10.1016/j.lindif.2010.11.003; Piccardi L, 2010, EXP BRAIN RES, V206, P171, DOI 10.1007/s00221-010-2234-2; Piccardi L, 2008, NEUROSCI LETT, V432, P127, DOI 10.1016/j.neulet.2007.12.044; Piccardi Laura, 2014, BMC Res Notes, V7, P524, DOI 10.1186/1756-0500-7-524; Piccardi L, 2014, BRIT J DEV PSYCHOL, V32, P205, DOI 10.1111/bjdp.12036; Piccardi L, 2009, COGN NEUROPSYCHOL, V26, P247, DOI 10.1080/02643290902978390; Postma A, 1999, PSYCHONEUROENDOCRINO, V24, P175, DOI 10.1016/S0306-4530(98)00073-0; Pyers JE, 2010, P NATL ACAD SCI USA, V107, P12116, DOI 10.1073/pnas.0914044107; RAVEN JC, 1986, COLOURED PROGR MATRI; RIGAL R, 1994, PERCEPT MOTOR SKILL, V79, P1259, DOI 10.2466/pms.1994.79.3.1259; Siegel A W, 1975, Adv Child Dev Behav, V10, P9, DOI 10.1016/S0065-2407(08)60007-5; Spelke ES, 2001, COGNITION, V78, P45, DOI 10.1016/S0010-0277(00)00108-6; Thorndike P.W., 1981, COGNITION SOC BEHAV, P137; Wang RF, 2002, TRENDS COGN SCI, V6, P376, DOI 10.1016/S1364-6613(02)01961-7; Waxman SR, 1995, COGNITIVE PSYCHOL, V29, P257, DOI 10.1006/cogp.1995.1016	60	17	17	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115432	10.1371/journal.pone.0115432	http://dx.doi.org/10.1371/journal.pone.0115432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629814	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000348732100016
J	Rawi, R; El Anbari, M; Bensmail, H				Rawi, Reda; El Anbari, Mohamed; Bensmail, Halima			Model Selection Emphasises the Importance of Non-Chromosomal Information in Genetic Studies	PLOS ONE			English	Article							MISSING HERITABILITY; INHERITANCE	Ever since the case of the missing heritability was highlighted some years ago, scientists have been investigating various possible explanations for the issue. However, none of these explanations include non-chromosomal genetic information. Here we describe explicitly how chromosomal and non-chromosomal modifiers collectively influence the heritability of a trait, in this case, the growth rate of yeast. Our results show that the non-chromosomal contribution can be large, adding another dimension to the estimation of heritability. We also discovered, combining the strength of LASSO with model selection, that the interaction of chromosomal and non-chromosomal information is essential in describing phenotypes.	[Rawi, Reda; El Anbari, Mohamed; Bensmail, Halima] Qatar Comp Res Inst, Computat Sci & Engn Ctr, Doha, Qatar; [El Anbari, Mohamed] Sidra Med & Res Ctr, Div Biomed Informat, Doha, Qatar	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute; Sidra Medical & Research Center	Bensmail, H (corresponding author), Qatar Comp Res Inst, Computat Sci & Engn Ctr, Doha, Qatar.	hbensmail@qf.org.qa	Bensmail, Halima/AAT-7858-2020					[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Ben-Ari G, 2006, PLOS GENET, V2, P1815, DOI 10.1371/journal.pgen.0020195; Bien J, 2013, ANN STAT, V41, P1111, DOI 10.1214/13-AOS1096; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Bogdan M, 2004, GENETICS, V167, P989, DOI 10.1534/genetics.103.021683; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Edwards MD, 2014, P NATL ACAD SCI USA, V111, P7719, DOI 10.1073/pnas.1407126111; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; FINK GR, 1972, P NATL ACAD SCI USA, V69, P2846, DOI 10.1073/pnas.69.10.2846; Kim HS, 2009, GENETICS, V183, P1141, DOI 10.1534/genetics.109.108068; Magliani W, 1997, CLIN MICROBIOL REV, V10, P369, DOI 10.1128/CMR.10.3.369; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nadeau JH, 2009, HUM MOL GENET, V18, pR202, DOI 10.1093/hmg/ddp366; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sinha H, 2008, GENETICS, V180, P1661, DOI 10.1534/genetics.108.092932; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117014	10.1371/journal.pone.0117014	http://dx.doi.org/10.1371/journal.pone.0117014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25626013	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821400027
J	Catarsi, P; Rosti, V; Morreale, G; Poletto, V; Villani, L; Bertorelli, R; Pedrazzini, M; Zorzetto, M; Barosi, G				Catarsi, Paolo; Rosti, Vittorio; Morreale, Giacomo; Poletto, Valentina; Villani, Laura; Bertorelli, Roberto; Pedrazzini, Matteo; Zorzetto, Michele; Barosi, Giovanni		AGIMM Investigators	JAK2 Exon 14 Skipping in Patients with Primary Myelofibrosis: A Minor Splice Variant Modulated by the JAK2-V617F Allele Burden	PLOS ONE			English	Article							NONSENSE-MEDIATED DECAY; QUANTITATIVE FLUORESCENT PCR; TYROSINE KINASE JAK2; MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; MUTATION; DIAGNOSIS; ANEUPLOIDIES; DISORDERS; DEFINITION	Background Primary myelofibrosis (PMF) is an acquired clonal disease of the hematopoietic stem cell compartment, characterized by bone marrow fibrosis, anemia, splenomegaly and extramedullary hematopoiesis. About 60% of patients with PMF harbor a somatic mutation of the JAK2 gene (JAK2-V617F) in their hematopoietic lineage. Recently, a splicing isoform of JAK2, lacking exon 14 (JAK2 Delta 14) was described in patients affected by myeloproliferative diseases. Materials and Methods By using a specific RT-qPCR method, we measured the ratio between the splicing isoform and the JAK2 full-length transcript (JAK2+14) in granulocytes, isolated from peripheral blood, of forty-four patients with PMF and nine healthy donors. Results We found that JAK2.14 was only slightly increased in patients and, at variance with published data, the splicing isoform was also detectable in healthy controls. We also found that, in patients bearing the JAK2-V617F mutation, the percentage of mutated alleles correlated with the observed increase in JAK2 Delta 14. Homozygosity for the mutation was also associated with a higher level of JAK2+14. Bioinformatic analysis indicates the possibility that the G> T transversion may interfere with the correct splicing of exon 14 by modifying a splicing regulatory sequence. Conclusions Increased levels of JAK2 full-length transcript and a small but significant increase in JAK2 exon 14 skipping, are associated with the JAK2-V617F allele burden in PMF granulocytes. Our data do not confirm a previous claim that the production of the JAK2 Delta 14 isoform is related to the pathogenesis of PMF.	[Catarsi, Paolo; Rosti, Vittorio; Poletto, Valentina; Villani, Laura; Barosi, Giovanni] Fdn IRCCS Policlin San Matteo, Biotechnol Res Labs, Ctr Study & Treatment Myelofibrosis, Pavia, PV, Italy; [Morreale, Giacomo] Consiglio Ric & Sperimentaz Agr, Viticulture Res Ctr, Conegliano, TV, Italy; [Bertorelli, Roberto] Fdn Bruno Kessler, Lab Biomol Sequence & Struct Anal Hlth, Trento, TN, Italy; [Pedrazzini, Matteo] Ist Auxol Italiano, Biomed & Technol Res Ctr, Cardiovasc Genet Lab, Cusano Milanino, MI, Italy; [Zorzetto, Michele] Fdn IRCCS Policlin San Matteo, Dept Mol Med, Div Pneumol, Lab Biochem & Genet, Pavia, PV, Italy	IRCCS Fondazione San Matteo; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Fondazione Bruno Kessler; IRCCS Istituto Auxologico Italiano; IRCCS Fondazione San Matteo; University of Pavia	Catarsi, P (corresponding author), Fdn IRCCS Policlin San Matteo, Biotechnol Res Labs, Ctr Study & Treatment Myelofibrosis, Pavia, PV, Italy.	p.catarsi@smatteo.pv.it	Zorzetto, Michele/K-2281-2015; Rosti, Vittorio/K-1743-2018; Barosi, Giovanni/AAI-1714-2019; Catarsi, Paolo/J-4463-2016; Villani, Laura/K-1794-2018	Zorzetto, Michele/0000-0002-7826-3666; Rosti, Vittorio/0000-0003-4195-2289; Catarsi, Paolo/0000-0002-1862-8168; Villani, Laura/0000-0003-4199-5633; Morreale, Giacomo/0000-0003-3833-7103	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano), Special Program Molecular Clinical Oncology [1005]	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano), Special Program Molecular Clinical Oncology(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano), Special Program Molecular Clinical Oncology "5x1000" to the AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative) project number # 1005. A detailed description of the AGIMM project is available at http://www.progettoagimm.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bench AJ, 2013, BRIT J HAEMATOL, V160, P25, DOI 10.1111/bjh.12075; Bonomi S, 2013, NUCLEIC ACIDS RES, V41, P8665, DOI 10.1093/nar/gkt579; Campbell PJ, 2009, NAT GENET, V41, P385, DOI 10.1038/ng0409-385; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chern T-M, 2006, PLOS GENET, V2, pe45, DOI [10.1371/journal.pgen.0020045, DOI 10.1371/JOURNAL.PGEN.0020045]; Cirigliano V, 2002, MOL HUM REPROD, V8, P1042, DOI 10.1093/molehr/8.11.1042; Cross NCP, 2011, HEMATOL-AM SOC HEMAT, P208, DOI 10.1182/asheducation-2011.1.208; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Fiedler W, 2000, CANCER-AM CANCER SOC, V88, P344, DOI 10.1002/(SICI)1097-0142(20000115)88:2<344::AID-CNCR14>3.0.CO;2-6; Filippov V, 2008, GENE, V420, P34, DOI 10.1016/j.gene.2008.05.008; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jensen MA, 2014, NAT STRUCT MOL BIOL, V21, P189, DOI 10.1038/nsmb.2756; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lippert E, 2006, BLOOD, V108, P1865, DOI 10.1182/blood-2006-01-013540; Ma WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012165; MANSFIELD ES, 1993, HUM MOL GENET, V2, P43, DOI 10.1093/hmg/2.1.43; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Rahil H, 2002, EUR J HUM GENET, V10, P462, DOI 10.1038/sj.ejhg.5200833; Spasovski V, 2013, J APPL GENET, V54, P21, DOI 10.1007/s13353-012-0125-x; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tefferi A, 2011, LEUKEMIA, V25, P1059, DOI 10.1038/leu.2011.92; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Zhang CL, 2008, P NATL ACAD SCI USA, V105, P5797, DOI 10.1073/pnas.0801692105; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; ZHUANG HM, 1995, J BIOL CHEM, V270, P14500, DOI 10.1074/jbc.270.24.14500	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116636	10.1371/journal.pone.0116636	http://dx.doi.org/10.1371/journal.pone.0116636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617626	Green Submitted, gold, Green Published			2022-12-27	WOS:000350336000019
J	Rouet, F; Deleplancque, L; Mboumba, BB; Sica, J; Mouinga-Ondeme, A; Liegeois, F; Goudeau, A; Dubois, F; Gaudy-Graffin, C				Rouet, Francois; Deleplancque, Luc; Mboumba, Berthold Bivigou; Sica, Jeanne; Mouinga-Ondeme, Augustin; Liegeois, Florian; Goudeau, Alain; Dubois, Frederic; Gaudy-Graffin, Catherine			Usefulness of a Fourth Generation ELISA Assay for the Reliable Identification of HCV Infection in HIV-Positive Adults from Gabon (Central Africa)	PLOS ONE			English	Article							C VIRUS-INFECTION; CORE ANTIGEN-ASSAY; TO-CUTOFF RATIOS; LIMITED RESOURCES; PREGNANT-WOMEN; SCREENING-TEST; BLOOD-DONORS; HEPATITIS; RNA; VIREMIA	Background/Objectives Guidelines for optimized HCV screening are urgently required in Africa, especially for patients infected with HIV, who sometimes show false positive or false negative reactivity in anti-HCV antibody assays. Here, we assessed the usefulness of a fourth-generation HCV Ag-Ab ELISA for the identification of active HCV infection in HIV-positive patients. Methods This cross-sectional study was conducted between 03/2010 and 01/2013 and included 762 Gabonese HIV-positive adult patients. The results of ELISA (Monolisa HCV Ag-Ab ULTRA, Bio-Rad) were compared with those obtained by RT-PCR (gold standard). The optimal ELISA signal-to-cutoff (S/CO) ratio to identify patients with active hepatitis C (positive HCV RNA) was determined. Specimens were further tested by the INNO-LIA HCV core assay (Innogenetics) and the Architect HCV Ag kit (Abbott) to define the best diagnostic strategy. Results Sixty-seven patients tested positive for HCV (S/CO ratio >= 1) by ELISA. Of these, 47 (70.1%) tested positive for HCV RNA. The optimal S/CO associated with active HCV infection was 1.7. At this threshold, the sensitivity of ELISA was 97.9%(95% confidence interval (CI) 90.0-99.9%), its specificity was 91.3% (95% CI 85.0-95.5%), and HCV seroprevalence rate was 7.3% (56/762) (95% CI 5.6-9.4%). Among 57 HCV-seropositive patients with available INNO-LIA results, false reactivity was identified in 14 (24.6%), resolved HCV infection in two (3.5%), possible acute HCV infections in nine (15.8%) and likely chronic HCV infections in 32 (56.1%) patients. HCV core Ag was undetectable in 14/15 (93.3%) specimens that tested negative for HCV RNA whereas it was quantified in 34 (out of 39, 87.2%) samples that tested positive for HCV RNA. Conclusions Our study provides comprehensive guidance for HCV testing in Gabon, and will help greatly clinicians to improve case definitions for both the notification and surveillance of HCV in patients co-infected with HIV.	[Rouet, Francois; Deleplancque, Luc; Mboumba, Berthold Bivigou; Mouinga-Ondeme, Augustin; Liegeois, Florian] CIRMF, Lab Retrovirol, Franceville, Gabon; [Sica, Jeanne] CTA, Franceville, Gabon; [Liegeois, Florian] IRD, UMI Trans VIH MI Transit Epidemiol Rech Translat, Montpellier, France; [Liegeois, Florian] Univ Montpellier I, Montpellier, France; [Goudeau, Alain; Dubois, Frederic; Gaudy-Graffin, Catherine] CHRU Tours, Hop Bretonneau, Serv Bacteriol Virol, Tours, France; [Goudeau, Alain; Gaudy-Graffin, Catherine] Univ Tours, PRES Ctr Val de Loire Univ, INSERM, U966, Tours, France; [Dubois, Frederic] Inst Inter Reg Sante IRSA, La Riche, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Rouet, F (corresponding author), Pasteur Inst Cambodia, HIV Hepatitis Unit, Phnom Penh, Cambodia.	frouet@pasteur-kh.org	Florian, Liegeois/D-3798-2013	Florian, Liegeois/0000-0003-1048-0661				Acar A, 2010, TRANSFUSION MED, V20, P152, DOI 10.1111/j.1365-3148.2009.00987.x; Agha S, 2004, J MED VIROL, V73, P216, DOI 10.1002/jmv.20078; Alipour A, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.13593; Alter Miriam J, 2003, MMWR Recomm Rep, V52, P1; Berger A, 2008, J CLIN VIROL, V43, P158, DOI 10.1016/j.jcv.2008.05.009; BUKH J, 1992, P NATL ACAD SCI USA, V89, P187, DOI 10.1073/pnas.89.1.187; Castelain S, 2008, J INFECT DIS, V198, P332, DOI 10.1086/589777; Caudai C, 1998, INFECTION, V26, P151, DOI 10.1007/BF02771840; Chasela CS, 2012, J CLIN VIROL, V54, P318, DOI 10.1016/j.jcv.2012.05.003; Dawson GJ, 2012, ANTIVIR THER, V17, P1431, DOI 10.3851/IMP2463; Descamps V, 2012, J CLIN MICROBIOL, V50, P465, DOI 10.1128/JCM.06503-11; Dubois F, 1998, ANN BIOL CLIN-PARIS, V56, P417; Easterbrook P, 2012, SEMIN LIVER DIS, V32, P147, DOI 10.1055/s-0032-1316476; El Sharkawi FZ, 2008, J MED VIROL, V80, P2086, DOI 10.1002/jmv.21325; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Firdaus R, 2013, J VIRAL HEPATITIS, V20, P290, DOI 10.1111/jvh.12002; Gaudy C, 2005, J CLIN MICROBIOL, V43, P1722, DOI 10.1128/JCM.43.4.1722-1726.2005; Gaudy-Graffin C, 2010, J CLIN MICROBIOL, V48, P3281, DOI 10.1128/JCM.00303-10; Getchell JP, 2013, MMWR-MORBID MORTAL W, V62, P362; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hanley JA, 1996, STAT MED, V15, P1575, DOI 10.1002/(SICI)1097-0258(19960730)15:14<1575::AID-SIM283>3.0.CO;2-2; Kamili S., 2012, Clinical Infectious Diseases, V55, P43, DOI 10.1093/cid/cis368; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kiely P, 2010, TRANSFUSION, V50, P1344, DOI 10.1111/j.1537-2995.2009.02572.x; Liegeois F, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17985; Lin S, 2005, J CLIN MICROBIOL, V43, P3917, DOI 10.1128/JCM.43.8.3917-3924.2005; Maniez-Montreuil M, 2000, TRANSFUS CLIN BIOL, V7, p25S, DOI 10.1016/S1246-7820(00)80012-9; Martel-Laferriere V, 2014, J CLIN GASTROENTEROL, V48, P106, DOI 10.1097/MCG.0000000000000010; McGovern BH, 2009, CLIN INFECT DIS, V49, P1051, DOI 10.1086/605561; Medici MC, 2011, J CLIN VIROL, V51, P260, DOI 10.1016/j.jcv.2011.05.003; Messick K, 2001, HAEMOPHILIA, V7, P568, DOI 10.1046/j.1365-2516.2001.00559.x; Moretti M, 2012, CLIN VACCINE IMMUNOL, V19, P1329, DOI 10.1128/CVI.00175-12; Mullis CE, 2013, CLIN INFECT DIS, V57, P1747, DOI 10.1093/cid/cit602; Njouom R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042002; Obach D, 2014, CLIN INFECT DIS, V58, P1064, DOI 10.1093/cid/ciu066; Ottiger C, 2013, J CLIN VIROL, V58, P535, DOI 10.1016/j.jcv.2013.08.028; Perz JF, 2013, HEPATOLOGY, V57, P917, DOI 10.1002/hep.25688; Proust B, 2000, J CLIN MICROBIOL, V38, P3125, DOI 10.1128/JCM.38.8.3125-3127.2000; Rouet F, 2004, J MED VIROL, V74, P34, DOI 10.1002/jmv.20143; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Scheiblauer H, 2006, TRANSFUSION, V46, P708, DOI 10.1111/j.1537-2995.2006.00789.x; Schnuriger A, 2006, J CLIN MICROBIOL, V44, P1561, DOI 10.1128/JCM.44.4.1561-1563.2006; Tagny CT, 2014, J VIROL METHODS, V199, P119, DOI 10.1016/j.jviromet.2014.01.002; VECCHIO TJ, 1966, NEW ENGL J MED, V274, P1171, DOI 10.1056/NEJM196605262742104; Wu SJ, 2011, J MED VIROL, V83, P1930, DOI 10.1002/jmv.22168; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	46	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116975	10.1371/journal.pone.0116975	http://dx.doi.org/10.1371/journal.pone.0116975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617896	gold, Green Submitted, Green Published			2022-12-27	WOS:000350336000034
J	Choi, JR; Pingguan-Murphy, B; Abas, WAW; Yong, KW; Poon, CT; Azmi, MAN; Omar, SZ; Chua, KH; Xu, F; Safwani, WKZW				Choi, Jane Ru; Pingguan-Murphy, Belinda; Abas, Wan Abu Bakar Wan; Yong, Kar Wey; Poon, Chi Tat; Azmi, Mat Adenan Noor; Omar, Siti Zawiah; Chua, Kien Hui; Xu, Feng; Safwani, Wan Kamarul Zaman Wan			In Situ Normoxia Enhances Survival and Proliferation Rate of Human Adipose Tissue-Derived Stromal Cells without Increasing the Risk of Tumourigenesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LOW-OXYGEN TENSION; BONE-MARROW; HYPOXIA INCREASES; VITRO EXPANSION; DNA-REPAIR; TELOMERASE; CANCER; DIFFERENTIATION; P53	Adipose tissue-derived stromal cells (ASCs) natively reside in a relatively low-oxygen tension (i.e., hypoxic) microenvironment in human body. Low oxygen tension (i.e., in situ normoxia), has been known to enhance the growth and survival rate of ASCs, which, however, may lead to the risk of tumourigenesis. Here, we investigated the tumourigenic potential of ASCs under their physiological condition to ensure their safe use in regenerative therapy. Human ASCs isolated from subcutaneous fat were cultured in atmospheric O-2 concentration (21% O-2) or in situ normoxia (2% O-2). We found that ASCs retained their surface markers, tri-lineage differentiation potential, and self-renewal properties under in situ normoxia without altering their morphology. In situ normoxia displayed a higher proliferation and viability of ASCs with less DNA damage as compared to atmospheric O-2 concentration. Moreover, low oxygen tension significantly up-regulated VEGF and bFGF mRNA expression and protein secretion while reducing the expression level of tumour suppressor genes p16, p21, p53, and pRb. However, there were no significant differences in ASCs telomere length and their relative telomerase activity when cultured at different oxygen concentrations. Collectively, even with high proliferation and survival rate, ASCs have a low tendency of developing tumour under in situ normoxia. These results suggest 2% O-2 as an ideal culture condition for expanding ASCs efficiently while maintaining their characteristics.	[Choi, Jane Ru; Pingguan-Murphy, Belinda; Abas, Wan Abu Bakar Wan; Yong, Kar Wey; Poon, Chi Tat; Safwani, Wan Kamarul Zaman Wan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia; [Azmi, Mat Adenan Noor; Omar, Siti Zawiah] Univ Malaya, Fac Med, Dept Obstet & Gynaecol, Kuala Lumpur 50603, Malaysia; [Chua, Kien Hui] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur 50300, Malaysia; [Xu, Feng] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lib Biomed Informat Engn, Xian 710049, Peoples R China; [Xu, Feng] Xi An Jiao Tong Univ, Bioinspired Engn & Biomech Ctr, Xian 710049, Peoples R China	Universiti Malaya; Universiti Malaya; Universiti Kebangsaan Malaysia; Xi'an Jiaotong University; Xi'an Jiaotong University	Safwani, WKZW (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.	wansafwani@um.edu.my	Xu, Feng/H-4468-2011; Zaman, Wan Safwani Wan Kamarul/L-1321-2015; OMAR, SITI ZAWIAH BINTI/B-9817-2010; Xu, Feng/C-7430-2011; chua, kienhui kh/M-7245-2017; Pingguan-Murphy, Belinda/B-8332-2010; Choi, Jane Ru/A-1245-2015; Yong, Kar Wey/Q-4248-2017	Xu, Feng/0000-0003-4351-0222; Zaman, Wan Safwani Wan Kamarul/0000-0002-8113-0370; Pingguan-Murphy, Belinda/0000-0001-5567-1141; Choi, Jane Ru/0000-0002-1537-6989; Yong, Kar Wey/0000-0002-9761-9402; Kien Hui, Chua/0000-0002-2595-5087	University of Malaya, High Impact Research Grant from the Ministry of Higher Education Malaysia [UM.C/HIR/MOHE/ENG/44]; Major International Joint Research Program of China [11120101002]; National Natural Science Foundation of China [11372243]; National 111 Project of China [B06024]	University of Malaya, High Impact Research Grant from the Ministry of Higher Education Malaysia; Major International Joint Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 111 Project of China(Ministry of Education, China - 111 Project)	This work was financially supported by the University of Malaya, High Impact Research Grant (UM.C/HIR/MOHE/ENG/44) from the Ministry of Higher Education Malaysia. FX was partially supported by the Major International Joint Research Program of China (11120101002), the National Natural Science Foundation of China (11372243), and the National 111 Project of China (B06024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2009, FEBS LETT, V583, P2922, DOI 10.1016/j.febslet.2009.07.056; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Barkholt L, 2013, CYTOTHERAPY, V15, P753, DOI 10.1016/j.jcyt.2013.03.005; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Berniakovich I, 2013, INT J MOL SCI, V14, P2119, DOI 10.3390/ijms14012119; Blasco MA, 2003, CURR OPIN GENET DEV, V13, P70, DOI 10.1016/S0959-437X(02)00011-4; Buchheiser A, 2012, CYTOTHERAPY, V14, P967, DOI 10.3109/14653249.2012.671518; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Charbord P, 2011, M S-MED SCI, V27, P261, DOI 10.1051/medsci/2011273261; Chen GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073673; Choi JR, 2014, BIOCHEM BIOPH RES CO, V448, P218, DOI 10.1016/j.bbrc.2014.04.096; Chung HM, 2009, EXPERT OPIN BIOL TH, V9, P1499, DOI 10.1517/14712590903307362; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Doulatov S, 2013, SCIENCE, V342, P700, DOI 10.1126/science.1238363; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Gomez DE, 2012, INT J ONCOL, V41, P1561, DOI 10.3892/ijo.2012.1611; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsiao ST, 2013, STEM CELLS DEV, V22, P1614, DOI 10.1089/scd.2012.0602; Hung SP, 2013, CELL TRANSPLANT, V22, P1869, DOI 10.3727/096368912X657954; Inoue K, 2012, MED MOL MORPHOL, V45, P115, DOI 10.1007/s00795-012-0575-6; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Jin YH, 2010, BIOCHEM BIOPH RES CO, V391, P1471, DOI 10.1016/j.bbrc.2009.12.096; Kikuchi S, 2013, ANTICANCER RES, V33, P3891; Kim JH, 2011, STEM CELLS DEV, V20, P1753, DOI 10.1089/scd.2010.0469; Kim S, 2013, STEM CELLS DEV, V20, P20; Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Lilian C-N, 2010, DUAL ROLE SENESCENCE, P28; Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005; Matsumoto A, 2005, MAGN RESON MED, V54, P1530, DOI 10.1002/mrm.20714; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Murofushi Y, 2006, INT J ONCOL, V29, P681; Offer H, 2002, CARCINOGENESIS, V23, P1025, DOI 10.1093/carcin/23.6.1025; Pan Q, 2013, EXPT BIOL MED; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pelicci PG, 2004, J CLIN INVEST, V113, P4, DOI 10.1172/JCI200420750; Pilgaard L, 2009, EXP CELL RES, V315, P1937, DOI 10.1016/j.yexcr.2009.01.020; Plotkin JB, 2002, J THEOR BIOL, V214, P453, DOI 10.1006/jtbi.2001.2471; Prockop DJ, 2012, STEM CELLS, V30, P1051, DOI 10.1002/stem.1103; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Rubin JP, 2013, LANCET, V382, P1077, DOI 10.1016/S0140-6736(13)61744-4; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105; Shih-Chieh H, 2007, PLOS ONE, V2; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Smith A, 2006, NATURE, V441, P1060, DOI 10.1038/nature04954; Solozobova V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-46; Stampfer MR, 2003, ONCOGENE, V22, P5238, DOI 10.1038/sj.onc.1206667; Stewart SA, 2002, ONCOGENE, V21, P627, DOI 10.1038/sj.onc.1205062; Stoeltzing O, 2004, JNCI-J NATL CANCER I, V96, P946, DOI 10.1093/jnci/djh168; Stubbs SL, 2012, STEM CELLS DEV, V21, P1887, DOI 10.1089/scd.2011.0289; Tamama K, 2011, J CELL BIOCHEM, V112, P804, DOI 10.1002/jcb.22961; Thangarajah H, 2009, STEM CELLS, V27, P266, DOI 10.1634/stemcells.2008-0276; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Valorani MG, 2012, CELL PROLIFERAT, V45, P225, DOI 10.1111/j.1365-2184.2012.00817.x; Valorani MG, 2010, CELL TISSUE RES, V341, P111, DOI 10.1007/s00441-010-0982-8; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Xu Y, 2007, TISSUE ENG, V13, P2981, DOI 10.1089/ten.2007.0050; Yanada S, 2006, CELL PROLIFERAT, V39, P575, DOI 10.1111/j.1365-2184.2006.00397.x; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023965; Zaman WSWK, 2014, J TISSUE ENG REGEN M, V8, P67, DOI 10.1002/term.1501	76	61	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115034	10.1371/journal.pone.0115034	http://dx.doi.org/10.1371/journal.pone.0115034			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615717	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100008
J	Lilja, A; Weeden, CE; McArthur, K; Nguyen, T; Donald, A; Wong, ZX; Dousha, L; Bozinovski, S; Vlahos, R; Burns, CJ; Asselin-Labat, ML; Anderson, GP				Lilja, Andrew; Weeden, Clare E.; McArthur, Kate; Thao Nguyen; Donald, Alastair; Wong, Zi Xin; Dousha, Lovisa; Bozinovski, Steve; Vlahos, Ross; Burns, Christopher J.; Asselin-Labat, Marie-Liesse; Anderson, Gary P.			HSP90 Inhibition Suppresses Lipopolysaccharide-Induced Lung Inflammation In Vivo	PLOS ONE			English	Article							POTENT ANTITUMOR-ACTIVITY; PROTEIN 90 INHIBITORS; NF-KAPPA-B; BACTERIAL LIPOPOLYSACCHARIDE; INNATE IMMUNITY; PHASE-II; GM-CSF; CANCER; GANETESPIB; ACTIVATION	Inflammation is an important component of cancer diathesis and treatment-refractory inflammation is a feature of many chronic degenerative lung diseases. HSP90 is a 90kDa protein which functions as an ATP-dependent molecular chaperone that regulates the signalling conformation and expression of multiple protein client proteins especially oncogenic mediators. HSP90 inhibitors are in clinical development as cancer therapies but the myeleosuppressive and neutropenic effect of first generation geldanamycin-class inhibitors has confounded studies on the effects on HSP90 inhibitors on inflammation. To address this we assessed the ability of Ganetespib, a non-geldanamycin HSP90 blocker, to suppress lipopolysaccharide (LPS)-induced cellular infiltrates, proteases and inflammatory mediator and transcriptional profiles. Ganetespib (10-100mg/kg, i.v.) did not directly cause myelosuppression, as assessed by video micrography and basal blood cell count, but it strongly and dosedependently suppressed LPS-induced neutrophil mobilization into blood and neutrophil-and mononuclear cell-rich steroid-refractory lung inflammation. Ganetespib also suppressed B cell and NK cell accumulation, inflammatory cytokine and chemokine induction and MMP9 levels. These data identify non-myelosuppresssive HSP90 inhibitors as potential therapies for inflammatory diseases refractory to conventional therapy, in particular those of the lung.	[Lilja, Andrew; Wong, Zi Xin; Dousha, Lovisa; Bozinovski, Steve; Vlahos, Ross; Anderson, Gary P.] Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Parkville, Vic 3010, Australia; [Weeden, Clare E.; Asselin-Labat, Marie-Liesse] Walter & Eliza Hall Inst Med Res, Div ACRF Stem Cells & Canc, Parkville, Vic 3052, Australia; [McArthur, Kate; Thao Nguyen; Donald, Alastair; Burns, Christopher J.] Walter & Eliza Hall Inst Med Res, Div Chem Biol, Parkville, Vic 3052, Australia; [McArthur, Kate; Thao Nguyen; Donald, Alastair; Burns, Christopher J.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	University of Melbourne; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne	Asselin-Labat, ML (corresponding author), Walter & Eliza Hall Inst Med Res, Div ACRF Stem Cells & Canc, Parkville, Vic 3052, Australia.	labat@wehi.edu.au; gpa@unimelb.edu.au	Nguyen, Thao/GWN-0419-2022; Vlahos, Ross/AAM-3837-2020	Vlahos, Ross/0000-0001-8443-7071; Burns, Christopher/0000-0002-4463-4916; Weeden, Clare/0000-0002-1561-1416; Anderson, Gary/0000-0001-6580-3398; Bozinovski, Steven/0000-0001-6533-8641; McArthur, Kate/0000-0002-8838-4146	Australian National Health and Medical Research Council [1038895]; Victorian State Government Operational Infrastructure Support (OIS) Grant; Australian Cancer Research Foundation; Australian Research Council Queen Elizabeth II Fellowship; Dyson Bequest funding	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support (OIS) Grant; Australian Cancer Research Foundation; Australian Research Council Queen Elizabeth II Fellowship(Australian Research Council); Dyson Bequest funding	This work is supported by scholarships, fellowships and grants from the Australian National Health and Medical Research Council (Development Grant 1038895); Victorian State Government Operational Infrastructure Support (OIS) Grant; Australian Cancer Research Foundation; Australian Research Council Queen Elizabeth II Fellowship (MLAL); and, Dyson Bequest funding (Dunn Fellowship to CJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva J, 2012, MOL CANCER THER, V11, P2633, DOI 10.1158/1535-7163.MCT-12-0615; Anthony D, 2014, FASEB J, V28, P3867, DOI 10.1096/fj.14-250332; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; BOZIC CR, 1995, J IMMUNOL, V154, P6048; Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; Bucci M, 2000, BRIT J PHARMACOL, V131, P13, DOI 10.1038/sj.bjp.0703549; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Cauwe B, 2009, INTEGR BIOL-UK, V1, P404, DOI 10.1039/b904701h; Croker BA, 2011, P NATL ACAD SCI USA, V108, P13135, DOI 10.1073/pnas.1110358108; Croker BA, 2011, J IMMUNOL, V186, P1131, DOI 10.4049/jimmunol.1002702; Fuchs CS, 2003, J CLIN ONCOL, V21, P807, DOI 10.1200/JCO.2003.08.058; Hacker S, 2009, CLIN LAB, V55, P31; Hance MW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.389015; He WG, 2007, MOL IMMUNOL, V44, P2850, DOI 10.1016/j.molimm.2007.01.022; Hendrickson AEW, 2012, GYNECOL ONCOL, V124, P210, DOI 10.1016/j.ygyno.2011.10.002; Iyer G, 2012, CANCER CHEMOTH PHARM, V69, P1089, DOI 10.1007/s00280-011-1789-3; Jhaveri K, 2014, EXPERT OPIN INV DRUG, V23, P611, DOI 10.1517/13543784.2014.902442; Laederich MB, 2011, J BIOL CHEM, V286, P19597, DOI 10.1074/jbc.M110.206151; Lai CH, 2014, ONCOGENE, V33, P4867, DOI 10.1038/onc.2013.439; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Madrigal-Matute J, 2010, CARDIOVASC RES, V86, P330, DOI 10.1093/cvr/cvq046; Malhotra V, 2001, AM J RESP CELL MOL, V25, P92, DOI 10.1165/ajrcmb.25.1.4384; Maus U, 2002, AM J RESP CRIT CARE, V165, P95, DOI 10.1164/ajrccm.165.1.2106148; Miyajima N, 2013, CANCER RES, V73, P7022, DOI 10.1158/0008-5472.CAN-13-1156; Porter JR, 2010, CURR OPIN CHEM BIOL, V14, P412, DOI 10.1016/j.cbpa.2010.03.019; Poulaki V, 2007, FASEB J, V21, P2113, DOI 10.1096/fj.06-7637com; Proia DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018552; Rice JW, 2008, ARTHRITIS RHEUM-US, V58, P3765, DOI 10.1002/art.24047; Salminen A, 2008, IMMUNOL LETT, V117, P9, DOI 10.1016/j.imlet.2007.12.017; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tartour E, 2013, LANCET RESP MED, V1, P551, DOI 10.1016/S2213-2600(13)70159-0; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Thangjam GS, 2014, AM J RESP CELL MOL, V50, P942, DOI 10.1165/rcmb.2013-0214OC; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Triantafilou K, 2001, J CELL SCI, V114, P2535; Triantafilou M, 2005, J ENDOTOXIN RES, V11, P5, DOI 10.1179/096805105225006641; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Vega VL, 2003, MOL BIOL CELL, V14, P764, DOI 10.1091/mbc.E02-08-0498; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Yun TJ, 2011, J IMMUNOL, V186, P563, DOI 10.4049/jimmunol.1000222	46	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0114975	10.1371/journal.pone.0114975	http://dx.doi.org/10.1371/journal.pone.0114975			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615645	Green Published, gold			2022-12-27	WOS:000349122100007
J	Scharton, D; Van Wettere, AJ; Bailey, KW; Vest, Z; Westover, JB; Siddharthan, V; Gowen, BB				Scharton, Dionna; Van Wettere, Amaud J.; Bailey, Kevin W.; Vest, Zachary; Westover, Jonna B.; Siddharthan, Venkatraman; Gowen, Brian B.			Rift Valley Fever Virus Infection in Golden Syrian Hamsters	PLOS ONE			English	Article							PUNTA-TORO VIRUS; MESOCRICETUS-AURATUS; LETHAL DISEASE; ANIMAL-MODELS; PATHOGENESIS; PHLEBOVIRUS; ENCEPHALITIS; BUNYAVIRIDAE; EPIDEMIC; PROTECTS	Rift Valley fever virus (RVFV) is a formidable pathogen that causes severe disease and abortion in a variety of livestock species and a range of disease in humans that includes hemorrhagic fever, fulminant hepatitis, encephalitis and blindness. The natural transmission cycle involves mosquito vectors, but exposure can also occur through contact with infected fluids and tissues. The lack of approved antiviral therapies and vaccines for human use underlies the importance of small animal models for proof-of-concept efficacy studies. Several mouse and rat models of RVFV infection have been well characterized and provide useful systems for the study of certain aspects of pathogenesis, as well as antiviral drug and vaccine development. However, certain host-directed therapeutics may not act on mouse or rat pathways. Here, we describe the natural history of disease in golden Syrian hamsters challenged subcutaneously with the pathogenic ZH501 strain of RVFV. Peracute disease resulted in rapid lethality within 2 to 3 days of RVFV challenge. High titer viremia and substantial viral loads were observed in most tissues examined; however, histopathology and immunostaining for RVFV antigen were largely restricted to the liver. Acute hepatocellular necrosis associated with a strong presence of viral antigen in the hepatocytes indicates that fulminant hepatitis is the likely cause of mortality. Further studies to assess the susceptibility and disease progression following respiratory route exposure are warranted. The use of the hamsters to model RVFV infection is suitable for early stage antiviral drug and vaccine development studies.	[Scharton, Dionna; Van Wettere, Amaud J.; Bailey, Kevin W.; Vest, Zachary; Westover, Jonna B.; Siddharthan, Venkatraman; Gowen, Brian B.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Scharton, Dionna; Bailey, Kevin W.; Vest, Zachary; Westover, Jonna B.; Siddharthan, Venkatraman; Gowen, Brian B.] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA; [Van Wettere, Amaud J.; Gowen, Brian B.] Utah State Univ, Sch Vet Med, Logan, UT 84322 USA; [Van Wettere, Amaud J.] Utah Vet Diagnost Lab, Logan, UT USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Gowen, BB (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.	brian.gowen@usu.edu		Van Wettere, Arnaud/0000-0002-9611-1316	National Institute of Health [HSN272201000039I]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by the National Institute of Health contract HSN272201000039I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GW, 1990, ARCH VIROL, V114, P203, DOI 10.1007/BF01310749; ANDERSON GW, 1988, ARCH VIROL, V102, P187, DOI 10.1007/BF01310824; Bales JM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00105; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Chevalier V, 2004, REV SCI TECH OIE, V23, P535, DOI 10.20506/rst.23.2.1505; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Easterday B C, 1965, Adv Vet Sci, V10, P65; Findlay GM, 1931, LANCET, V2, P1350; Fisher AF, 2003, AM J TROP MED HYG, V69, P269, DOI 10.4269/ajtmh.2003.69.269; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; GARGAN TP, 1988, AM J TROP MED HYG, V38, P440, DOI 10.4269/ajtmh.1988.38.440; Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Gowen BB, 2008, ANTIVIR RES, V77, P215, DOI 10.1016/j.antiviral.2007.12.002; Gowen BB, 2014, VIRUSES-BASEL, V6, P1410, DOI 10.3390/v6031410; Gowen BB, 2013, ANTIVIR RES, V98, P135, DOI 10.1016/j.antiviral.2013.03.009; Gowen BB, 2012, ANTIMICROB AGENTS CH, V56, P4168, DOI 10.1128/AAC.00376-12; Gowen BB, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-240; Gray KK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001529; Hartley David M, 2011, Emerg Infect Dis, V17, pe1, DOI 10.3201/eid1708.101088; Hartman AL, 2014, J VIROL, V88, P2235, DOI 10.1128/JVI.02341-13; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; LAUGHLIN LW, 1979, T ROY SOC TROP MED H, V73, P630, DOI 10.1016/0035-9203(79)90006-3; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; Morrey JD, 2004, ANTIVIR RES, V63, P41, DOI 10.1016/j.antiviral.2004.02.005; MORRILL JC, 1990, ARCH VIROL, V110, P195, DOI 10.1007/BF01311288; Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288; NIKLASSON BS, 1984, ACTA PATH MICRO IM C, V92, P197; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; PETERS CJ, 1986, ANTIVIR RES, V6, P285, DOI 10.1016/0166-3542(86)90024-0; PETERS CJ, 1988, ARCH VIROL, V99, P31, DOI 10.1007/BF01311021; PIFAT DY, 1987, MICROB PATHOGENESIS, V3, P409, DOI 10.1016/0882-4010(87)90011-8; Reed C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002156; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROSSI CA, 1988, J GEN VIROL, V69, P817, DOI 10.1099/0022-1317-69-4-817; SALUZZO JF, 1989, RES VIROLOGY, V140, P155, DOI 10.1016/S0923-2516(89)80093-7; Scharton D, 2014, ANTIVIR RES, V104, P84, DOI 10.1016/j.antiviral.2014.01.016; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Smith DR, 2014, ANTIVIR RES, V112, P59, DOI 10.1016/j.antiviral.2014.10.001; Smith DR, 2012, J VIROL, V86, P2109, DOI 10.1128/JVI.06190-11; Smith DR, 2010, VIROLOGY, V407, P256, DOI 10.1016/j.virol.2010.08.016; Wahl-Jensen V, 2012, VIRUSES-BASEL, V4, P3754, DOI 10.3390/v4123754; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; *WHO, 2007, OCHR A EV CERT FOOD, P169; Xiao SY, 2001, AM J TROP MED HYG, V64, P111, DOI 10.4269/ajtmh.2001.64.111; Xiao SY, 2001, EMERG INFECT DIS, V7, P714	47	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116722	10.1371/journal.pone.0116722	http://dx.doi.org/10.1371/journal.pone.0116722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607955	gold, Green Published, Green Submitted			2022-12-27	WOS:000348205300032
J	Aisenberg, D; Cohen, N; Pick, H; Tressman, I; Rappaport, M; Shenberg, T; Henik, A				Aisenberg, Daniela; Cohen, Noga; Pick, Hadas; Tressman, Iris; Rappaport, Michal; Shenberg, Tal; Henik, Avishai			Social Priming Improves Cognitive Control in Elderly Adults-Evidence from the Simon Task	PLOS ONE			English	Article							STEREOTYPE ACTIVATION; AGE; BEHAVIOR; INTERFERENCE; PERFORMANCE; CONFLICT; ASSIMILATION; INFORMATION; PERCEPTION; RELEVANCE	We examined whether social priming of cognitive states affects the inhibitory process in elderly adults, as aging is related to deficits in inhibitory control. Forty-eight elderly adults and 45 young adults were assigned to three groups and performed a cognitive control task (Simon task), which was followed by 3 different manipulations of social priming (i.e., thinking about an 82 year-old person): 1) negative-characterized by poor cognitive abilities, 2) neutral-characterized by acts irrelevant to cognitive abilities, and 3) positive-excellent cognitive abilities. After the manipulation, the Simon task was performed again. Results showed improvement in cognitive control effects in seniors after the positive manipulation, indicated by a significant decrease in the magnitude of the Simon and interference effects, but not after the neutral and negative manipulations. Furthermore, a healthy pattern of sequential effect (Gratton) that was absent before the manipulation in all 3 groups appeared after the positive manipulation. Namely, the Simon effect was only present after congruent but not after incongruent trials for the positive manipulation group. No influence of manipulations was found in young adults. These meaningful results were replicated in a second experiment and suggest a decrease in conflict interference resulting from positive cognitive state priming. Our study provides evidence that an implicit social concept of a positive cognitive condition in old age can affect the control process of the elderly and improve cognitive abilities.	[Aisenberg, Daniela] Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Aisenberg, D (corresponding author), Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel.	aisenber@post.bgu.ac.il	HENIK, AVISHAI/F-1176-2012	Henik, Avishai/0000-0002-5665-6004; Cohen, Noga/0000-0002-7682-0289	Ben-Gurion University of the Negev; Myers-JDC-Brookdale Institute of Gerontology; Human Development and Eshel	Ben-Gurion University of the Negev; Myers-JDC-Brookdale Institute of Gerontology; Human Development and Eshel	This study was supported in part by a Kreitman Scholarship from Ben-Gurion University of the Negev (http://in.bgu.ac.il/en/kreitman_school/Pages/default.aspx) and a grant from the Myers-JDC-Brookdale Institute of Gerontology and Human Development and Eshel, the association for the planning and development of services for the aged in Israel (http://brookdale.jdc.org.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2002, BRIT J SOC PSYCHOL, V41, P123, DOI 10.1348/014466602165090; Aisenberg D, 2014, ACTA PSYCHOL, V153, P169, DOI 10.1016/j.actpsy.2014.10.005; Aisenberg D, 2012, Q J EXP PSYCHOL, V65, P295, DOI 10.1080/17470218.2010.507819; Augustinova M, 2014, COGNITION, V130, P442, DOI 10.1016/j.cognition.2013.11.014; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 2014, SOC COGNITION, V32, P209, DOI 10.1521/soco.2014.32.supp.209; Baumeister RF, 2011, ANNU REV PSYCHOL, V62, P331, DOI 10.1146/annurev.psych.093008.131126; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bry C, 2008, J EXP SOC PSYCHOL, V44, P751, DOI 10.1016/j.jesp.2007.06.005; Cesario J, 2006, J PERS SOC PSYCHOL, V90, P893, DOI 10.1037/0022-3514.90.6.893; CRAFT JL, 1970, J EXP PSYCHOL, V83, P415, DOI 10.1037/h0028843; Craik FIM, 2006, MEM COGNITION, V34, P1236, DOI 10.3758/BF03193268; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Dijksterhuis A, 1998, J PERS SOC PSYCHOL, V74, P865, DOI 10.1037/0022-3514.74.4.865; Dijksterhuis A, 2001, J EXP SOC PSYCHOL, V37, P286, DOI 10.1006/jesp.2000.1449; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Finucane AM, 2010, J ATTEN DISORD, V13, P629, DOI 10.1177/1087054709334514; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galinsky AD, 2008, J PERS SOC PSYCHOL, V95, P404, DOI 10.1037/0022-3514.95.2.404; Goldfarb L, 2007, J EXP PSYCHOL HUMAN, V33, P1170, DOI 10.1037/0096-1523.33.5.1170; Goldfarb L, 2011, COGNITION, V118, P193, DOI 10.1016/j.cognition.2010.11.004; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hansen J, 2009, SOC COGNITION, V27, P76, DOI 10.1521/soco.2009.27.1.76; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hassin RR, 2009, SOC COGNITION, V27, P20, DOI 10.1521/soco.2009.27.1.20; Hess TM, 2004, PSYCHOL AGING, V19, P495, DOI 10.1037/0882-7974.19.3.495; HIGGINS ET, 1985, J EXP PSYCHOL LEARN, V11, P59, DOI 10.1037/0278-7393.11.1.59; Hommel B, 2011, ACTA PSYCHOL, V136, P189, DOI 10.1016/j.actpsy.2010.04.011; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Kahneman D, 2012, NATURE, DOI [10.1038/nature11779, DOI 10.1038/NATURE11779]; Kawakami K, 2002, PERS SOC PSYCHOL B, V28, P3, DOI 10.1177/0146167202281001; Ku G, 2010, J EXP SOC PSYCHOL, V46, P792, DOI 10.1016/j.jesp.2010.04.001; Lamers MJM, 2011, Q J EXP PSYCHOL, V64, P1056, DOI 10.1080/17470218.2010.523792; LeBoeuf RA, 2004, SOC COGNITION, V22, P607, DOI 10.1521/soco.22.6.607.54817; Levy B, 1996, J PERS SOC PSYCHOL, V71, P1092, DOI 10.1037/0022-3514.71.6.1092; Levy BR, 2012, JAMA-J AM MED ASSOC, V308, P1972, DOI 10.1001/jama.2012.14541; Levy BR, 2003, J GERONTOL B-PSYCHOL, V58, pP203, DOI 10.1093/geronb/58.4.P203; Lowery BS, 2007, BASIC APPL SOC PSYCH, V29, P151, DOI 10.1080/01973530701331718; Martin EA, 2010, PSYCHIAT RES, V178, P419, DOI 10.1016/j.psychres.2009.08.018; Maylor EA, 2011, FRONT PSYCHOL, V2, DOI [10.3389/fpsyg.2011.00354, DOI 10.3389/FPSYG.2011.00354]; Nussinson R, 2010, SOC COGNITION, V28, P40, DOI 10.1521/soco.2010.28.1.40; PROCTOR RW, 1994, PSYCHOL RES-PSYCH FO, V56, P185, DOI 10.1007/BF00419706; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Shih M, 2002, J PERS SOC PSYCHOL, V83, P638, DOI 10.1037//0022-3514.83.3.638; SIMON JR, 1969, J APPL PSYCHOL, V53, P433, DOI 10.1037/h0028034; Smith ER, 2001, BLACKWELL HDB SOCIAL, VI, P111, DOI 10.1002/9780470998519.ch6; Stroebe W, 2014, PERSPECT PSYCHOL SCI, V9, P59, DOI 10.1177/1745691613514450; TZELGOV J, 1992, MEM COGNITION, V20, P727, DOI 10.3758/BF03202722; Umilta C, 1985, ATTENTION PERFORM, VXI, P456; Van der Lubbe RHJ, 2002, PSYCHOPHYSIOLOGY, V39, P100, DOI 10.1017/S0048577202001221; van Veen V, 2006, CURR DIR PSYCHOL SCI, V15, P237, DOI 10.1111/j.1467-8721.2006.00443.x; West R, 2000, PSYCHOPHYSIOLOGY, V37, P179, DOI 10.1111/1469-8986.3720179; Wuhr P, 2005, Q J EXP PSYCHOL-A, V58, P705, DOI 10.1080/02724980443000269; Zeef EJ, 1996, PSYCHOPHYSIOLOGY, V33, P555, DOI 10.1111/j.1469-8986.1996.tb02432.x	59	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117151	10.1371/journal.pone.0117151	http://dx.doi.org/10.1371/journal.pone.0117151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HX	25635946	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700072
J	Markiewicz-Zukowska, R; Gutowska, A; Borawska, MH				Markiewicz-Zukowska, Renata; Gutowska, Anna; Borawska, Maria H.			Serum Zinc Concentrations Correlate with Mental and Physical Status of Nursing Home Residents	PLOS ONE			English	Article							GERIATRIC DEPRESSION SCALE; PLASMA-CONCENTRATIONS; TRACE-ELEMENTS; MICRONUTRIENT; HEALTH; COPPER; PREVALENCE; WOMEN; PERFORMANCE; DISABILITY	Introduction Zinc (Zn) is one of the most important trace elements in the body. Zn deficiency seems to play a role in the development of age-related diseases and impairment of quality of life. Zn status has been especially studied in free-living or hospitalised people, but data from older residents of nursing homes are scarce. This study aimed to determine the Zn status among the older individuals in correlation to their mental and physical performance. Methods A total of 100 participants aged between 60-102 years were recruited between October 2010 and May 2012 at the nursing home in Bialystok (Poland). Zn status was evaluated by determining the concentration in serum by flame atomic absorption spectrometry. Anthropometric variables and fitness score (FS) were measured. Abbreviated Mental Test Score (AMTS), Geriatric Depression Scale (GDS), Self-Rated Health (SRH), independence in Activities of Daily Living (ADL) were recorded. Results and Discussion The mean serum Zn concentration was 0.83 +/- 0.20 mg/L, 28% of residents had Zn deficiency. Cognitive functions were impaired (AMTS <= 8) in 45% of the studied persons and 48% showed depressive symptoms (GDS >= 1). The ability to independently perform activities of daily living (ADL = 6) was found in 61% of participants, but most of them (90%) had weak body type (FS<70), correlating with GDS, SRH and body mass index (BMI). Serum Zn concentration correlated with mental efficiency and was statistically significantly higher in older people with normal cognitive function and without depression than in patients with memory impairment and showing depressive symptoms. Conclusions Nursing home residents seem at risk of marginal Zn status, which correlates with their mental status as measured by the AMTS and GDS. Their low FS is associated with mental health deterioration and obesity.	[Markiewicz-Zukowska, Renata; Borawska, Maria H.] Med Univ Bialystok, Dept Bromatol, Bialystok, Poland; [Gutowska, Anna] Nursing Home Bialystok, Bialystok, Poland	Medical University of Bialystok	Borawska, MH (corresponding author), Med Univ Bialystok, Dept Bromatol, Bialystok, Poland.	bromatos@umb.edu.pl		Borawska, Maria/0000-0003-0999-9650; Markiewicz Zukowska, Renata/0000-0003-0716-9573	Polish Ministry of Science and Higher Education [133 16523F]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was funded by a grant from Polish Ministry of Science and Higher Education (No 133 16523F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani R, 2010, BIOL TRACE ELEM RES, V137, P150, DOI 10.1007/s12011-009-8572-x; Andriollo-Sanchez M, 2005, EUR J CLIN NUTR, V59, pS37, DOI 10.1038/sj.ejcn.1602296; [Anonymous], 2013, OB OV; Bailey AL, 1997, BRIT J NUTR, V77, P225, DOI 10.1079/BJN19970026; Bartali B, 2006, ARCH INTERN MED, V166, P2335, DOI 10.1001/archinte.166.21.2335; BLAZER DG, 1979, J AM GERIATR SOC, V27, P330, DOI 10.1111/j.1532-5415.1979.tb06051.x; Bureau I, 2002, J TRACE ELEM MED BIO, V16, P9, DOI 10.1016/S0946-672X(02)80003-7; Cheng ST, 2005, INT J GERIATR PSYCH, V20, P1131, DOI 10.1002/gps.1405; DATH P, 1994, FAM PRACT, V11, P260, DOI 10.1093/fampra/11.3.260; Del Corso L, 2000, PANMINERVA MED, V42, P273; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Gensler G, 2002, J NUTR, V132, P697; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gray Shelly L, 2003, Am J Geriatr Pharmacother, V1, P3, DOI 10.1016/S1543-5946(03)80011-9; Gronli O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082793; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Hoshi T., 2013, Health, V5, P1303; Hotz C, 2003, AM J CLIN NUTR, V78, P756, DOI 10.1093/ajcn/78.4.756; Hyun TH, 2004, AM J CLIN NUTR, V80, P715; Jackson TA, 2013, AGE AGEING, V42, P689, DOI 10.1093/ageing/aft145; Jongenelis K, 2004, J AFFECT DISORDERS, V83, P135, DOI 10.1016/j.jad.2004.06.001; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KING JC, 1994, J NUTR, V124, P508, DOI 10.1093/jn/124.4.508; Laudisio A, 2008, CLIN NUTR, V27, P747, DOI 10.1016/j.clnu.2008.07.001; MAES M, 1994, J AFFECT DISORDERS, V31, P135, DOI 10.1016/0165-0327(94)90117-1; Maes M, 1997, BIOL PSYCHIAT, V42, P349, DOI 10.1016/S0006-3223(96)00365-4; MCGIVNEY SA, 1994, J AM GERIATR SOC, V42, P490, DOI 10.1111/j.1532-5415.1994.tb04969.x; MCLOUGHLIN IJ, 1990, ACTA PSYCHIAT SCAND, V82, P451, DOI 10.1111/j.1600-0447.1990.tb03077.x; Meunier N, 2005, EUR J CLIN NUTR, V59, pS1, DOI 10.1038/sj.ejcn.1602286; Meydani M, 2001, ANN NY ACAD SCI, V928, P226; Neumeister B, 2013, KLIN LABORDIAGNOSTIK; Nowak G, 1999, HUM PSYCHOPHARM CLIN, V14, P83, DOI 10.1002/(SICI)1099-1077(199903)14:2<83::AID-HUP74>3.3.CO;2-Y; Paik HY, 1999, BIOL TRACE ELEM RES, V69, P45, DOI 10.1007/BF02783914; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Pepersack T, 2001, ARCH GERONTOL GERIAT, V33, P243, DOI 10.1016/S0167-4943(01)00186-8; Perruccio AV, 2010, SOC SCI MED, V71, P1636, DOI 10.1016/j.socscimed.2010.07.042; PRASAD AS, 1965, J LAB CLIN MED, V66, P508; Ravaglia G, 2000, J CLIN ENDOCR METAB, V85, P2260, DOI 10.1210/jc.85.6.2260; Rockwood K, 1996, J AM GERIATR SOC, V44, P578, DOI 10.1111/j.1532-5415.1996.tb01446.x; Romero CD, 2002, J TRACE ELEM MED BIO, V16, P75, DOI 10.1016/S0946-672X(02)80032-3; ROVNER BW, 1991, JAMA-J AM MED ASSOC, V265, P993, DOI 10.1001/jama.265.8.993; Rukgauer M, 1997, J TRACE ELEM MED BIO, V11, P92; Schmuck A, 1996, J AM COLL NUTR, V15, P462; Semba RD, 2006, J GERONTOL A-BIOL, V61, P594, DOI 10.1093/gerona/61.6.594; Siwek M, 2009, J AFFECT DISORDERS, V118, P187, DOI 10.1016/j.jad.2009.02.014; Smalbrugge M, 2006, INT J GERIATR PSYCH, V21, P325, DOI 10.1002/gps.1466; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Socha K, 2009, FRESEN ENVIRON BULL, V18, P1932; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Swain DG, 1999, CLIN REHABIL, V13, P503, DOI 10.1191/026921599670895633; Takeda A, 2005, NEUROCHEM INT, V46, P221, DOI 10.1016/j.neuint.2004.10.003; Teresi J, 2001, SOC PSYCH PSYCH EPID, V36, P613, DOI 10.1007/s127-001-8202-7; Webber AP, 2005, J AM GERIATR SOC, V53, P1017, DOI 10.1111/j.1532-5415.2005.53322.x	55	31	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117257	10.1371/journal.pone.0117257	http://dx.doi.org/10.1371/journal.pone.0117257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635818	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700077
J	Vander Zanden, MJ; Clayton, MK; Moody, EK; Solomon, CT; Weidel, BC				Vander Zanden, M. Jake; Clayton, Murray K.; Moody, Eric K.; Solomon, Christopher T.; Weidel, Brian C.			Stable Isotope Turnover and Half-Life in Animal Tissues: A Literature Synthesis	PLOS ONE			English	Article							CARBON TURNOVER; NITROGEN; DELTA-N-15; DELTA-C-13; C-13; RATES; ENRICHMENT; MODELS; GOBY	Stable isotopes of carbon, nitrogen, and sulfur are used as ecological tracers for a variety of applications, such as studies of animal migrations, energy sources, and food web pathways. Yet uncertainty relating to the time period integrated by isotopic measurement of animal tissues can confound the interpretation of isotopic data. There have been a large number of experimental isotopic diet shift studies aimed at quantifying animal tissue isotopic turnover rate lambda (%.day(-1), often expressed as isotopic half-life, ln(2)/lambda, days). Yet no studies have evaluated or summarized the many individual half-life estimates in an effort to both seek broad-scale patterns and characterize the degree of variability. Here, we collect previously published half-life estimates, examine how half-life is related to body size, and test for tissue-and taxa-varying allometric relationships. Half-life generally increases with animal body mass, and is longer in muscle and blood compared to plasma and internal organs. Half-life was longest in ecotherms, followed by mammals, and finally birds. For ectotherms, different taxa-tissue combinations had similar allometric slopes that generally matched predictions of metabolic theory. Half-life for ectotherms can be approximated as: ln (half-life) = 0.22*ln (body mass) + group-specific intercept; n = 261, p<0.0001, r(2) = 0.63. For endothermic groups, relationships with body mass were weak and model slopes and intercepts were heterogeneous. While isotopic half-life can be approximated using simple allometric relationships for some taxa and tissue types, there is also a high degree of unexplained variation in our models. Our study highlights several strong and general patterns, though accurate prediction of isotopic half-life from readily available variables such as animal body mass remains elusive.	[Vander Zanden, M. Jake; Moody, Eric K.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Clayton, Murray K.] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Moody, Eric K.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Solomon, Christopher T.] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada; [Weidel, Brian C.] USGS, Lake Ontario Biol Stn, Oswego, NY USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Arizona State University; Arizona State University-Tempe; McGill University; United States Department of the Interior; United States Geological Survey	Vander Zanden, MJ (corresponding author), Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA.	mjvanderzand@wisc.edu	Solomon, Christopher T./E-6284-2014	Solomon, Christopher T./0000-0002-2850-4257; Vander Zanden, Jake/0000-0002-8122-1416				Bauchinger U, 2009, INTEGR COMP BIOL, V49, pE11; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bosley KL, 2002, MAR ECOL PROG SER, V236, P233, DOI 10.3354/meps236233; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Carleton SA, 2008, RAPID COMMUN MASS SP, V22, P3008, DOI 10.1002/rcm.3691; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; Church MR, 2009, CAN J FISH AQUAT SCI, V66, P1, DOI 10.1139/F08-206; del Rio CM, 2012, J MAMMAL, V93, P353, DOI 10.1644/11-MAMM-S-165.1; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Fry B, 1982, RAPID 13C 12C TURNOV; Guelinckx J, 2007, MAR ECOL PROG SER, V341, P205, DOI 10.3354/meps341205; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; KLING GW, 1992, ECOLOGY, V73, P561, DOI 10.2307/1940762; Logan J, 2006, OECOLOGIA, V147, P391, DOI 10.1007/s00442-005-0277-z; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; Maruyama A, 2001, CAN J FISH AQUAT SCI, V58, P2125, DOI 10.1139/cjfas-58-11-2125; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McIntyre PB, 2006, OECOLOGIA, V148, P12, DOI 10.1007/s00442-005-0354-3; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306, DOI 10.4319/lo.2002.47.1.0306; Ogden LJE, 2004, AUK, V121, P170, DOI 10.1642/0004-8038(2004)121[0170:BICANT]2.0.CO;2; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Suzuki KW, 2005, CAN J FISH AQUAT SCI, V62, P671, DOI 10.1139/F04-231; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vander Zanden MJ, 1998, T AM FISH SOC, V127, P729, DOI 10.1577/1548-8659(1998)127<0729:AOSITT>2.0.CO;2; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Weidel BC, 2011, CAN J FISH AQUAT SCI, V68, P387, DOI 10.1139/F10-158; Witting DA, 2004, CAN J FISH AQUAT SCI, V61, P2069, DOI 10.1139/F04-156; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Wright, 1995, NITROGEN METABOLISM	37	343	344	4	173	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116182	10.1371/journal.pone.0116182	http://dx.doi.org/10.1371/journal.pone.0116182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635686	gold, Green Published			2022-12-27	WOS:000350680700027
J	Wiens, MO; Gan, H; Barigye, C; Zhou, GH; Kumbakumba, E; Kabakyenga, J; Kissoon, N; Ansermino, JM; Karlen, W; Larson, CP; MacLeod, SM				Wiens, Matthew O.; Gan, Heng; Barigye, Celestine; Zhou, Guohai; Kumbakumba, Elias; Kabakyenga, Jerome; Kissoon, Niranjan; Ansermino, J. Mark; Karlen, Walter; Larson, Charles P.; MacLeod, Stuart M.			A Cohort Study of Morbidity, Mortality and Health Seeking Behavior following Rural Health Center Visits by Children under 12 in Southwestern Uganda	PLOS ONE			English	Article							WESTERN KENYA; DISTANCE; FACILITIES	Background Children discharged from hospitals in developing countries are at high risk of morbidity and mortality. However, few data describe these outcomes among children seen and discharged from rural outpatient centers. Objective The objective of this exploratory study was to identify predictors of immediate and follow-up morbidity and mortality among children visiting a rural health center in Uganda. Methods Subjects 0-12 years of age seeking care with a caregiver were consecutively enrolled from a single rural health center in Southwestern Uganda. Baseline variables were collected by research nurses and outcomes of referral, admission or death were recorded (immediate events). Death, hospital admission and health seeking occurring during the 30 days following the clinic visit were also determined (follow-up events). Univariate logistic regression was performed to identify baseline variables associated with immediate outcome and follow-up outcomes. Results Over the four-month recruitment period 717 subjects were enrolled. There were 85 (11.9%) immediate events (10.1% were admitted, 2.2% were referred, none died). Forty-seven (7.8%) events occurred within 30 days after the visit (7.3% sought care from a health provider, 1.5% were admitted and 0.5% died). Variables associated with immediate events included living more than 30 minutes from the health center, age older than 5 years, having received an antimalarial prior to the visit, having seen a community health worker prior to the visit, elevated respiratory rate or temperature, and depressed weight-for-age z score or decreased oxygen saturation. These variables were not associated with follow-up events. Conclusions Sick-child visits at a rural health center in South Western Uganda were associated with rates of mortality and subsequent admission of less than 2% in the period following the sick child visits. Other types of health seeking behavior occurred in approximately 7% of subjects during this same period. Several variables were associated with immediate events but there were no reliable predictors of follow-up events, possibly due to low statistical power.up outcomes.	[Wiens, Matthew O.; Larson, Charles P.] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Wiens, Matthew O.; Kumbakumba, Elias] Mbarara Univ Sci & Technol, Dept Pediat, Mbarara, Uganda; [Gan, Heng] NHS Fdn Trust, Guys & St Thomas Hosp, London, England; [Barigye, Celestine] Govt Uganda, Minist Hlth, Kampala, Uganda; [Zhou, Guohai] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Kabakyenga, Jerome] Mbarara Univ Sci & Technol, Maternal Newborn & Child Hlth Inst, Mbarara, Uganda; [Kissoon, Niranjan; Larson, Charles P.; MacLeod, Stuart M.] BC Childrens Hosp, Dept Pediat, Vancouver, BC, Canada; [Kissoon, Niranjan; Ansermino, J. Mark; Larson, Charles P.; MacLeod, Stuart M.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Ansermino, J. Mark] BC Childrens Hosp, Dept Pediat Anesthesia, Vancouver, BC, Canada; [Karlen, Walter] ETH, Dept Hlth Sci & Technol, Zurich, Switzerland; [Larson, Charles P.] BC Childrens Hosp, Ctr Int Child Hlth, Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; Mbarara University of Science & Technology; Guy's & St Thomas' NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of British Columbia; Mbarara University of Science & Technology; BC Childrens Hospital; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; Swiss Federal Institutes of Technology Domain; ETH Zurich; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia	Wiens, MO (corresponding author), Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	mowiens@outlook.com	Karlen, Walter/C-6290-2008; Kissoon, Niranjan/AAC-6140-2021; Wiens, Matthew/J-9249-2019; Karlen, Walter/AAN-9397-2020	Karlen, Walter/0000-0001-8643-3074; Karlen, Walter/0000-0001-8643-3074; Ansermino, J Mark/0000-0001-8427-2035; Wiens, Matthew/0000-0002-3287-5181; Kissoon, Niranjan/0000-0001-8847-9973; Zhou, Guohai/0000-0002-8826-403X; Gan, Heng/0000-0003-2894-9114	Global Health Research Initiative of the Canadian government (Canadian Institutes for Health Research, International Development Research Centre, Canadian International Development Agency and Public Health Agency of Canada); Pediatric Anesthesia Research Team, University of British Columbia; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Canadian Child Health Clinician Scientist Program	Global Health Research Initiative of the Canadian government (Canadian Institutes for Health Research, International Development Research Centre, Canadian International Development Agency and Public Health Agency of Canada); Pediatric Anesthesia Research Team, University of British Columbia; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Child Health Clinician Scientist Program	Some funds were provided through the Global Health Research Initiative of the Canadian government (Canadian Institutes for Health Research, International Development Research Centre, Canadian International Development Agency and Public Health Agency of Canada). Some funds were provided by the Pediatric Anesthesia Research Team, University of British Columbia. M. Wiens is funded through fellowships from the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research and the Canadian Child Health Clinician Scientist Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, UGANDA CLIN GUIDELIN; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hudson J, 2012, ANAESTHESIA, V67, P957, DOI 10.1111/j.1365-2044.2012.07196.x; Karlen W, 2012, PHYSIOL MEAS, V33, P1617, DOI 10.1088/0967-3334/33/10/1617; Karlen W, 2011, HEALTHINF 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON HEALTH INFORMATICS, P433; Lindblade KA, 2007, TROP MED INT HEALTH, V12, P1258, DOI 10.1111/j.1365-3156.2007.01898.x; Modi P, 2013, J EMERG MED, V45, P752, DOI 10.1016/j.jemermed.2013.04.041; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P725, DOI 10.2471/BLT.11.089235; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386; Siedner MJ, 2013, AIDS, V27, P1503, DOI 10.1097/QAD.0b013e32835fd873; West TE, 1999, B WORLD HEALTH ORGAN, V77, P144; WHO/UNICEF joint statement: Integrated Community Case Management, 2012, EQ FOC STRAT IMPR AC, DOI [10.4269/ajtmh.2012.12-0221, DOI 10.4269/AJTMH.2012.12-0221]; Wiens MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066698	16	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0118055	10.1371/journal.pone.0118055	http://dx.doi.org/10.1371/journal.pone.0118055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635947	Green Published, gold			2022-12-27	WOS:000350680700113
J	Lan, B; Hayama, E; Kawaguchi, N; Furutani, Y; Nakanishi, T				Lan, Beidi; Hayama, Emiko; Kawaguchi, Nanako; Furutani, Yoshiyuki; Nakanishi, Toshio			Therapeutic Efficacy of Valproic Acid in a Combined Monocrotaline and Chronic Hypoxia Rat Model of Severe Pulmonary Hypertension	PLOS ONE			English	Article							HISTONE DEACETYLASE; HDAC INHIBITORS; ACETYLATION; EXPRESSION; TARGET; CANCER; GENE	Background Pulmonary hypertension (PH) is a serious disease with poor prognosis. Reports show that cells in remodeled pulmonary arteries of PH patients have similar characteristics to cancer cells, such as exuberant inflammation, increased proliferation, and decreased apoptosis. An ideal strategy for developing PH therapies is to directly target pulmonary vascular remodeling. High levels of histone deacetylase (HDAC) expression and activity are found in certain cancers, and research has shown the potential of HDAC inhibitors in repressing tumor growth via anti-inflammatory and anti-proliferative effects. To date, little is known about the effectiveness of HDAC inhibitors against pulmonary vascular remodeling in severe PH. Objective To investigate whether class I HDAC inhibitors suppress or reverse the development of severe PH in rats. Methods Male Sprague-Dawley rats were injected with a single, subcutaneous dose of monocrotaline (60mg/kg), and were exposed to chronic hypoxia to induce severe PH. Valproic acid, a class I HDAC inhibitor, was administered to rats daily via gastric gavage (300mg/kg) in a PH prevention study (during the first 3 weeks) or a PH reversal study (from 3 to 5 weeks). At the end of experiment, hemodynamic indices were measured, ventricular hypertrophy indices were calculated and vascular remodeling phenotypes were analyzed. Results: After 3 weeks exposure to a combined stimulation of monocrotaline and chronic hypoxia, rats exhibited a reduced body weight, elevated right ventricular systolic pressure, an increased Fulton index, right ventricle weight ratio, medial wall thickness and muscularized peripheral pulmonary arteries. These parameters for PH evaluation were exacerbated from 3 to 5 weeks. Daily administration of valproic acid therapy prevented and partially reversed the development of severe PH in rats, and decreased inflammation and proliferation in remodeled pulmonary arteries. Conclusion These data show that class I HDAC inhibitors may be effective for treating severe PH.	[Lan, Beidi; Hayama, Emiko; Kawaguchi, Nanako; Furutani, Yoshiyuki; Nakanishi, Toshio] Tokyo Womens Med Univ, Dept Pediat Cardiol, Tokyo, Japan	Tokyo Women's Medical University	Nakanishi, T (corresponding author), Tokyo Womens Med Univ, Dept Pediat Cardiol, Tokyo, Japan.	pnakanis@hij.twmu.ac.jp						Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brodie SA, 2014, EXPERT REV ANTICANC, V14, P1, DOI [10.1586/14737140.2014.863713, DOI 10.1586/14737140.2014.863713]; Bush EW, 2010, CIRC RES, V106, P272, DOI 10.1161/CIRCRESAHA.109.209338; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Cho YK, 2010, CIRC J, V74, P760, DOI 10.1253/circj.CJ-09-0580; Dahal BK, 2010, EUR RESPIR J, V36, P808, DOI 10.1183/09031936.00140309; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Duenas-Gonzalez A, 2008, CANCER TREAT REV, V34, P206, DOI 10.1016/j.ctrv.2007.11.003; Glenn DJ, 2009, HYPERTENSION, V53, P549, DOI 10.1161/HYPERTENSIONAHA.108.125088; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Iyer A, 2010, BRIT J PHARMACOL, V159, P1408, DOI 10.1111/j.1476-5381.2010.00637.x; Jurkin J, 2011, CELL CYCLE, V10, P406, DOI 10.4161/cc.10.3.14712; Klampfer L, 2004, J BIOL CHEM, V279, P30358, DOI 10.1074/jbc.M401359200; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Morimatsu Y, 2012, J VASC RES, V49, P33, DOI 10.1159/000329594; Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37; Okada K, 1997, AM J PATHOL, V151, P1019; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rondelet B, 2003, CIRCULATION, V107, P1329, DOI 10.1161/01.CIR.0000053443.27512.33; Sharma NL, 2013, BJU INT, V111, P537, DOI 10.1111/j.1464-410X.2012.11647.x; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Ververis K, 2013, BIOL-TARGETS THER, V7, P47, DOI 10.2147/BTT.S29965; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176	27	33	36	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117211	10.1371/journal.pone.0117211	http://dx.doi.org/10.1371/journal.pone.0117211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629315	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100074
J	Maddaloni, M; Kochetkova, I; Jun, S; Callis, G; Thornburg, T; Pascual, DW				Maddaloni, Massimo; Kochetkova, Irina; Jun, SangMu; Callis, Gayle; Thornburg, Theresa; Pascual, David W.			Milk-Based Nutraceutical for Treating Autoimmune Arthritis via the Stimulation of IL-10-and TGF-beta-producing CD39(+) Regulatory T Cells	PLOS ONE			English	Article							FACTOR ANTIGEN-I; RHEUMATOID-ARTHRITIS; AUTOANTIGEN PROTECTS; ESCHERICHIA-COLI; VACCINATION; EXPRESSION; FIMBRIAE; THERAPY; ABSENCE; CFA/I	Autoimmune diseases arise from the loss of tolerance to self, and because the etiologies of such diseases are largely unknown, symptomatic treatments rely on anti-inflammatory and analgesic agents. Tolerogenic treatments that can reverse disease are preferred, but again, often thwarted by not knowing the responsible auto-antigens (auto-Ags). Hence, a viable alternative to stimulating regulatory T cells (Tregs) is to induce bystander tolerance. Colonization factor antigen I (CFA/I) has been shown to evoke bystander immunity and to hasten Ag-specific Treg development independent of auto-Ag. To translate in treating human autoimmune diseases, the food-based Lactococcus was engineered to express CFA/I fimbriae, and Lactococcus-CFA/I fermented milk fed to arthritic mice proved highly efficacious. Protection occurred via CD39(+) Tregs producing TGF-beta and IL-10 to potently suppress TNF-alpha production and neutrophil influx into the joints. Thus, these data demonstrate the feasibility of oral nutraceuticals for treating arthritis, and potency of protection against arthritis was improved relative to that obtained with Salmonella-CFA/I.	[Maddaloni, Massimo; Jun, SangMu; Pascual, David W.] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA; [Kochetkova, Irina; Callis, Gayle; Thornburg, Theresa] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	State University System of Florida; University of Florida; Montana State University System; Montana State University Bozeman	Pascual, DW (corresponding author), Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.	pascuald@ufl.edu	Pascual, David/AAC-2248-2022		U.S. Public Health [P01 AT-004986]; University of Florida; Emerging Pathogens Institute; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004986] Funding Source: NIH RePORTER	U.S. Public Health(United States Department of Health & Human ServicesUnited States Public Health Service); University of Florida(University of Florida); Emerging Pathogens Institute; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by U.S. Public Health Grant P01 AT-004986, and in part by funds from the University of Florida and by the Emerging Pathogens Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; Behnsen J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010074; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brand DD, 2004, METH MOLEC MED, V102, P295; Carmona L, 2010, BEST PRACT RES CL RH, V24, P733, DOI 10.1016/j.berh.2010.10.001; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1261; Cross M, 2014, ANN RHEUM DIS, V73, P1316, DOI 10.1136/annrheumdis-2013-204627; Daniel C, 2013, APPL ENVIRON MICROB, V79, P1086, DOI 10.1128/AEM.03221-12; Daniel C, 2011, TRENDS BIOTECHNOL, V29, P499, DOI 10.1016/j.tibtech.2011.05.002; De Keyser F, 2011, CURR RHEUMATOL REV, V7, P77, DOI 10.2174/157339711794474620; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hu YP, 2013, CLIN RHEUMATOL, V32, P161, DOI 10.1007/s10067-012-2041-1; Kannan Krishnaswamy, 2005, Pathophysiology, V12, P167, DOI 10.1016/j.pathophys.2005.07.011; Kochetkova I, 2008, J IMMUNOL, V181, P2741, DOI 10.4049/jimmunol.181.4.2741; Kochetkova I, 2014, J IMMUNOL, V192, P804, DOI 10.4049/jimmunol.1302018; Kochetkova I, 2011, J IMMUNOL, V187, P4654, DOI 10.4049/jimmunol.1100530; Kochetkova I, 2010, J IMMUNOL, V184, P7144, DOI 10.4049/jimmunol.0902739; Li YF, 2009, P NATL ACAD SCI USA, V106, P10793, DOI 10.1073/pnas.0812843106; Ochoa-Reparaz J, 2007, J IMMUNOL, V178, P1791, DOI 10.4049/jimmunol.178.3.1791; Oddone GM, 2009, PLASMID, V61, P151, DOI 10.1016/j.plasmid.2008.12.001; Pascual D. W., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P203, DOI 10.2174/187153007781662549; Rosenblum H, 2011, AUTOIMMUN REV, V10, P563, DOI 10.1016/j.autrev.2011.04.010; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; SMITH HR, 1982, J BACTERIOL, V149, P264, DOI 10.1128/JB.149.1.264-275.1982; Steidler L, 2009, ANN NY ACAD SCI, V1182, P135, DOI 10.1111/j.1749-6632.2009.05067.x; Wells J, 2011, ANNU REV FOOD SCI T, V2, P423, DOI 10.1146/annurev-food-022510-133640; WU SG, 1995, INFECT IMMUN, V63, P4933, DOI 10.1128/IAI.63.12.4933-4938.1995	31	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117825	10.1371/journal.pone.0117825	http://dx.doi.org/10.1371/journal.pone.0117825			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629976	gold, Green Published, Green Submitted			2022-12-27	WOS:000348732100096
J	van Giessen, A; Moons, KGM; de Wit, GA; Verschuren, WMM; Boer, JMA; Koffijberg, H				van Giessen, A.; Moons, K. G. M.; de Wit, G. A.; Verschuren, W. M. M.; Boer, J. M. A.; Koffijberg, H.			Tailoring the Implementation of New Biomarkers Based on Their Added Predictive Value in Subgroups of Individuals	PLOS ONE			English	Article							NET RECLASSIFICATION IMPROVEMENT; CARDIOVASCULAR RISK-ASSESSMENT; CLINICAL-PRACTICE; INCREMENTAL VALUE; VALIDATION; DISEASE; MODELS; IMPACT; MARKERS; SCORE	Background The value of new biomarkers or imaging tests, when added to a prediction model, is currently evaluated using reclassification measures, such as the net reclassification improvement (NRI). However, these measures only provide an estimate of improved reclassification at population level. We present a straightforward approach to characterize subgroups of reclassified individuals in order to tailor implementation of a new prediction model to individuals expected to benefit from it. Methods In a large Dutch population cohort (n = 21,992) we classified individuals to low (< 5%) and high (>= 5%) fatal cardiovascular disease risk by the Framingham risk score (FRS) and reclassified them based on the systematic coronary risk evaluation (SCORE). Subsequently, we characterized the reclassified individuals and, in case of heterogeneity, applied cluster analysis to identify and characterize subgroups. These characterizations were used to select individuals expected to benefit from implementation of SCORE. Results Reclassification after applying SCORE in all individuals resulted in an NRI of 5.00% (95% CI [-0.53%; 11.50%]) within the events, 0.06% (95% CI [-0.08%; 0.22%]) within the nonevents, and a total NRI of 0.051 (95% CI [-0.004; 0.116]). Among the correctly downward reclassified individuals cluster analysis identified three subgroups. Using the characterizations of the typically correctly reclassified individuals, implementing SCORE only in individuals expected to benefit (n = 2,707,12.3%) improved the NRI to 5.32% (95% CI [-0.13%; 12.06%]) within the events, 0.24% (95% CI [0.10%; 0.36%]) within the nonevents, and a total NRI of 0.055 (95% CI [0.001; 0.123]). Overall, the risk levels for individuals reclassified by tailored implementation of SCORE were more accurate. Discussion In our empirical example the presented approach successfully characterized subgroups of reclassified individuals that could be used to improve reclassification and reduce implementation burden. In particular when newly added biomarkers or imaging tests are costly or burdensome such a tailored implementation strategy may save resources and improve (cost-) effectiveness.	[van Giessen, A.; Moons, K. G. M.; de Wit, G. A.; Verschuren, W. M. M.; Koffijberg, H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Wit, G. A.; Verschuren, W. M. M.; Boer, J. M. A.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	van Giessen, A (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	a.vangiessen@umcutrecht.nl		Koffijberg, Hendrik/0000-0002-1753-0652; de Wit, G. Ardine/0000-0002-1375-7657	NWO, the Netherlands Organization for Scientific Research [916.11.126, 912.08.004, 918.10.615]	NWO, the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by NWO, the Netherlands Organization for Scientific Research (916.11.126 to HK and 912.08.004 and 918.10.615 to KGMM).	ALDENDERFER MS, 1984, CLUSTER ANALYSIS; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Ankerst DP, 2012, BIOMETRICAL J, V54, P127, DOI 10.1002/bimj.201100062; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; BACHER J, 2004, PROCEEDINGS OF THE R; BLOKSTRA A, 2005, MONITORING VAN RISIC; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2012, AM J EPIDEMIOL, V176, P488, DOI 10.1093/aje/kws208; den Ruijter HM, 2013, J HYPERTENS, V31, P782, DOI 10.1097/HJH.0b013e32835e8ee5; Dolnicar S, 2010, MARKET LETT, V21, P83, DOI 10.1007/s11002-009-9083-4; Efron B., 1993, INTRO BOOTSTRAP; EVERITT B, 2011, CLUSTER ANALYSIS; EVERITT BS, 1979, BIOMETRICS, V35, P169, DOI 10.2307/2529943; Formann A.K, 1984, DIE LATENT CLASS ANA; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; GAMBERGER G, 2002, J ARTIF INT RES, V17, P501; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Herrera F, 2011, KNOWL INF SYST, V29, P495, DOI 10.1007/s10115-010-0356-2; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hung CL, 2013, INT J CARDIOVAS IMAG, V29, P765, DOI 10.1007/s10554-012-0146-x; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; JAIN AK, 1987, PATTERN RECOGN, V20, P547, DOI 10.1016/0031-3203(87)90081-1; KAUFMAN L, 1990, FINDING GROUPS IN DA; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Koller MT, 2012, ANN INTERN MED, V157, P389, DOI 10.7326/0003-4819-157-6-201209180-00002; Leening MJG, 2014, STAT MED, V33, P3415, DOI 10.1002/sim.6133; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; LEVY D, 1990, CIRCULATION, V81, P815, DOI 10.1161/01.CIR.81.3.815; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; NORUSIS MJ, 2012, IBM SPSS STATISTICS, P361; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Perk J, 2012, INT J BEHAV MED, V19, P403, DOI 10.1007/s12529-012-9242-5; R Core Team, 2012, R LANG ENV STAT COMP; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; SPSS, 2011, IBM SPSS STATISTICS; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; Tian L, 2009, BIOMETRICS, V65, P894, DOI 10.1111/j.1541-0420.2008.01125.x; van Dis I, 2010, EUR J CARDIOV PREV R, V17, P244, DOI 10.1097/HJR.0b013e328337cca2; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2; Vickers AJ, 2014, ANN INTERN MED, V160, P136, DOI 10.7326/M13-2841; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; Wierzbicki AS, 2012, INT J CLIN PRACT, V66, P622, DOI 10.1111/j.1742-1241.2012.02956.x; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	50	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0114020	10.1371/journal.pone.0114020	http://dx.doi.org/10.1371/journal.pone.0114020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622035	Green Published, gold, Green Submitted			2022-12-27	WOS:000348470400001
J	King, K; Meader, N; Wright, K; Graham, H; Power, C; Petticrew, M; White, M; Sowden, AJ				King, Kristel; Meader, Nick; Wright, Kath; Graham, Hilary; Power, Christine; Petticrew, Mark; White, Martin; Sowden, Amanda J.			Characteristics of Interventions Targeting Multiple Lifestyle Risk Behaviours in Adult Populations: A Systematic Scoping Review	PLOS ONE			English	Review							HEALTH-RELATED BEHAVIORS; PREVALENCE; OLDER; PREVENTION; PROGRAM	Background Modifiable lifestyle risk behaviours such as smoking, unhealthy diet, physical inactivity and alcohol misuse are the leading causes of major, non-communicable diseases worldwide. It is increasingly being recognised that interventions which target more than one risk behaviour may be an effective and efficient way of improving people's lifestyles. To date, there has been no attempt to summarise the global evidence base for interventions targeting multiple risk behaviours. Objective To identify and map the characteristics of studies evaluating multiple risk behaviour change interventions targeted at adult populations in any country. Methods Seven bibliographic databases were searched between January, 1990, and January/May, 2013. Authors of protocols, conference abstracts, and other relevant articles were contacted. Study characteristics were extracted and inputted into Eppi-Reviewer 4. Results In total, 220 studies were included in the scoping review. Most were randomised controlled trials (62%) conducted in the United States (49%), and targeted diet and physical activity (56%) in people from general populations (14%) or subgroups of general populations (45%). Very few studies had been conducted in the Middle East (2%), Africa (0.5%), or South America (0.5%). There was also a scarcity of studies conducted among young adults (1%), or racial and minority ethnic populations (4%) worldwide. Conclusions Research is required to investigate the interrelationships of lifestyle risk behaviours in varying cultural contexts around the world. Cross-cultural development and evaluation of multiple risk behaviour change interventions is also needed, particularly in populations of young adults and racial and minority ethnic populations.	[King, Kristel; Meader, Nick; Wright, Kath; Sowden, Amanda J.] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Graham, Hilary] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Power, Christine] UCL, Inst Child Hlth, London, England; [Petticrew, Mark] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [White, Martin] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [White, Martin] Univ Cambridge, Ctr Diet & Act Res CEDAR, Cambridge, England	University of York - UK; University of York - UK; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of Cambridge	Sowden, AJ (corresponding author), Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.	amanda.sowden@york.ac.uk	Petticrew, Mark/AAY-6274-2021; Wright, Kath/P-1516-2019	White, Martin/0000-0002-1861-6757; Wright, Kath/0000-0002-9020-1572; Meader, Nicholas/0000-0001-9332-6605; Craven, Kristelle/0000-0003-4728-6213; Graham, Hilary/0000-0001-7949-6819	England's Department of Health; ESRC [ES/G007462/1, ES/G007470/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1, ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1] Funding Source: researchfish	England's Department of Health; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This scoping review was undertaken as part of the Public Health Research Consortium, funded by England's Department of Health (https://www.gov.uk/government/organisations/department-of-health). Views expressed in the paper are those of authors and not necessarily those of the funders. The funders were involved in the decision to publish the scoping review. The funders had no role in the research design, data collection and analysis, or preparation of the manuscript.	Baskin-Sommers A, 2006, J ADOLESCENT HEALTH, V38, P609, DOI 10.1016/j.jadohealth.2005.07.010; Burke V, 1997, PREV MED, V26, P724, DOI 10.1006/pmed.1997.0198; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; Chou KL, 2008, J AGING HEALTH, V20, P788, DOI 10.1177/0898264308321082; Coups EJ, 2004, AM J PREV MED, V27, P34, DOI 10.1016/j.amepre.2004.04.021; Demark-Wahnefried W, 2012, J CLIN ONCOL, V30, P2354, DOI 10.1200/JCO.2011.40.0895; Galambos NL, 1998, HLTH REP, P10; HOLT MC, 1995, AM J HEALTH PROMOT, V9, P421, DOI 10.4278/0890-1171-9.6.421; Iso H, 1994, Nihon Koshu Eisei Zasshi, V41, P1015; Jackson CA, 2012, J PUBLIC HEALTH-UK, V34, pI31, DOI 10.1093/pubmed/fdr113; Keller S, 2008, PREV MED, V46, P189, DOI 10.1016/j.ypmed.2007.09.008; Lawder R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-330; Leatherdale ST, 2010, J PRIM PREV, V31, P99, DOI 10.1007/s10935-010-0211-y; Levac D, 2010, IMPLEMENT SCI, V5, P9, DOI [10.1186/1748-5908-5-9, DOI 10.1186/1748-5908-5-9]; MacArthur G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009927, DOI 10.1002/14651858]; McAloney K, 2013, PREV MED, V56, P365, DOI 10.1016/j.ypmed.2013.03.002; Michie S, 2011, IMPLEMENT SCI, P6, DOI [10.1186/1748-5908-6-133, DOI 10.1186/1748-5908-6-133]; Ministry of Public Health Welfare and Sport (VWS), 2012, HLTH CLOS PEOPL NAT, P86; Montgomery P, 2013, J CLIN EPIDEMIOL, V66, P874, DOI 10.1016/j.jclinepi.2013.03.006; National Library of Medicine, 2014, MEDLINE PUBMED PMC P; National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease, 2011, NICE CLIN GUID, P125; NHS Health and Social Care Information Centre, 2005, HLTH SURV ENGL 2004, P59; Parekh S, 2012, INT J BEHAV NUTR PHY, P9, DOI [10.1186/1479-5868-9-153, DOI 10.1186/1479-5868-9-153]; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; Preventative Health Taskforce, 2009, AUSTR HLTH COUNTRY 2, DOI [10.1071/PY11041, DOI 10.1071/PY11041]; Prochaska JJ, 2008, PREV MED, V46, P260, DOI 10.1016/j.ypmed.2007.07.035; Prochaska JJ, 2008, PREV MED, V46, P181, DOI 10.1016/j.ypmed.2008.02.001; Prochaska JJ, 2011, AM J LIFESTYLE MED, V5, P208, DOI 10.1177/1559827610391883; Pronk NP, 2004, AM J PREV MED, V27, P25, DOI 10.1016/j.amepre.2004.04.022; Quintiliani L, 2010, PATIENT EDUC COUNS, V79, P134, DOI 10.1016/j.pec.2009.08.007; Martin CR, 2009, REV ESP SALUD PUBLIC, V83, P441, DOI 10.1590/s1135-57272009000300009; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Secretary of State for Health, 2010, HLTH LIV HLTH PEOPL, P100; Shankar A, 2010, AM J PREV MED, V38, P39, DOI 10.1016/j.amepre.2009.08.026; Silva DAS, 2013, PREV MED, V56, P20, DOI 10.1016/j.ypmed.2012.10.022; Stevens P, 2011, CHALLENGE NONCOMMUNI, P40; Strecher V, 2002, HEALTH EDUC RES, V17, P619, DOI 10.1093/her/17.5.619; Swedish National Institute of Public Health, NAT PUBL HLTH STRAT, P12; Vio F, 2011, ARCH LATINOAM NUTR, V61, P406; Wadsworth EJK, 2004, J PSYCHOPHARMACOL, V18, P238, DOI 10.1177/0269881104042628; Werch CE, 2010, PREV MED, V50, P30, DOI 10.1016/j.ypmed.2009.12.010; WHO, 2003, OB OV; Wilcox S, 2013, AM J PREV MED, V44, P122, DOI 10.1016/j.amepre.2012.09.062; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 2010, GLOBAL STATUS REPORT, P176; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2004, GLOB STRAT DIET PHYS, P21, DOI [10.1016/j.talanta.2004.11.005, DOI 10.1016/J.TALANTA.2004.11.005]	47	53	53	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117015	10.1371/journal.pone.0117015	http://dx.doi.org/10.1371/journal.pone.0117015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4PT	25617783	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000350336000036
J	Zhong, X; Shi, CZ; Gong, J; Guo, B; Li, MZ; Xu, H				Zhong, Xing; Shi, Changzheng; Gong, Jian; Guo, Bin; Li, Mingzhu; Xu, Hao			Experimental Study of Nasopharyngeal Carcinoma Radionuclide Imaging and Therapy Using Transferred Human Sodium/Iodide Symporter Gene	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; APPARENT DIFFUSION-COEFFICIENT; PROSTATE-CANCER; RADIOIODINE THERAPY; RADIATION-THERAPY; TUMOR XENOGRAFTS; WEIGHTED MRI; CELL-DEATH; APOPTOSIS; RADIOTHERAPY	Purpose The aim of this study was to design a method of radionuclide for imaging and therapy of nasopharyngeal carcinoma (NPC) using the transferred human sodium/iodide symporter (hNIS) gene. Methods A stable NPC cell line expressing hNIS was established (CNE-2-hNIS). After I-131 treatment, we detected proliferation and apoptosis of NPC cells, both in vitro and vivo. In vivo, the radioactivity of different organs of nude mice was counted and Tc-99m imaging using SPECT was performed. The apparent diffusion coefficient (ADC) value changes of tumor xenografts were observed by diffusion-weighted magnetic resonance imaging (DW-MRI) within 6-24 days of I-131 treatment. The correlation of ADC changes with apoptosis and proliferation was investigated. Post-treatment expression levels of P53, Bax, Bcl-2, Caspase-3, and Survivin proteins were detected by western blotting. Results I-131 uptake was higher in CNE-2-hNIS than in CNE-2 cells. The proliferation and apoptosis rate decreased and increased respectively both in vitro and vivo in the experimental group after I-131 treatment. The experimental group tumors accumulated 99mTc in vivo, leading to a good visualization by SPECT. DW-MRI showed that ADC values increased in the experimental group 6 days after treatment, while ADC values were positively and negatively correlated with the apoptotic and Ki-67 proliferation indices, respectively. After treatment, CNE-2-hNIS cells up-regulated the expression of P53 and Survivin proteins and activated Caspase-3, and down-regulated the expression of Bcl-2 proteins. Conclusions The radionuclide imaging and therapy technique for NPC hNIS-transfected cell lines can provide a new therapy strategy for monitoring and treatment of NPC.	[Zhong, Xing; Shi, Changzheng; Li, Mingzhu] Jinan Univ, Affiliated Hosp 1, Dept Med Imaging Ctr, Guangzhou 510630, Guangdong, Peoples R China; [Gong, Jian; Guo, Bin; Xu, Hao] Jinan Univ, Affiliated Hosp 1, Dept Nucl Med, Guangzhou 510630, Guangdong, Peoples R China	Jinan University; Jinan University	Xu, H (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Nucl Med, Guangzhou 510630, Guangdong, Peoples R China.	txh@jnu.edu.cn			Guangdong Provincial Science and Technology Project [2011B061200028]; major science and technology projects of Guangdong Province [2003 A3080501]	Guangdong Provincial Science and Technology Project; major science and technology projects of Guangdong Province	This work was supported by Guangdong Provincial Science and Technology Project - Project Government's commitment to a particular task (2011B061200028), and the major science and technology projects of Guangdong Province (2003 A3080501). Guangdong Province Medical Research Foundation (A2012342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braren R, 2011, J HEPATOL, V55, P1034, DOI 10.1016/j.jhep.2011.01.049; Buchsbaum DJ, 2005, J NUCL MED, V46, p179S; Chang JTC, 2000, RADIOTHER ONCOL, V54, P135, DOI 10.1016/S0167-8140(99)00177-2; Chen L, 2006, J NUCL MED, V47, P854; Chow SM, 2002, INT J RADIAT ONCOL, V52, P784, DOI 10.1016/S0360-3016(01)02686-4; Dadachova E, 2004, SEMIN NUCL MED, V34, P23, DOI 10.1053/j.semnuclmed.2003.09.004; Dingli D, 2004, BLOOD, V103, P1641, DOI 10.1182/blood-2003-07-2233; Dutta P, 2012, PITUITARY, V15, P166, DOI 10.1007/s11102-011-0300-9; Dwyer RM, 2006, GENE THER, V13, P60, DOI 10.1038/sj.gt.3302599; Dwyer RM, 2005, MOL THER, V12, P835, DOI 10.1016/j.ymthe.2005.05.013; Geschwind JFH, 2000, J VASC INTERV RADIOL, V11, P1245, DOI 10.1016/S1051-0443(07)61299-8; Goldman M, 2006, J NEUROSURG, V105, P175, DOI 10.3171/sup.2006.105.7.175; Humphries PD, 2007, RADIOLOGY, V245, P848, DOI 10.1148/radiol.2452061535; Kauppinen RA, 2002, NMR BIOMED, V15, P6, DOI 10.1002/nbm.742; Kim H, 2008, RADIOLOGY, V248, P844, DOI 10.1148/radiol.2483071740; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Larson SM, 2005, J NUCL MED, V46, p1S; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Liu Z, 2010, CLIN CANCER RES, V16, P6009, DOI 10.1158/1078-0432.CCR-10-1627; Mairs RJ, 2003, J BIOMED BIOTECHNOL, P102; Mardor Y, 2004, NEOPLASIA, V6, P136, DOI 10.1593/neo.03349; Mardor Y, 2003, J CLIN ONCOL, V21, P1094, DOI 10.1200/JCO.2003.05.069; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Riesco-Eizaguirre G, 2006, EUR J ENDOCRINOL, V155, P495, DOI 10.1530/eje.1.02257; Spitzweg C, 2000, CANCER RES, V60, P6526; Spitzweg C, 2001, GENE THER, V8, P1524, DOI 10.1038/sj.gt.3301558; Taatjes DJ, 2008, HISTOCHEM CELL BIOL, V129, P33, DOI 10.1007/s00418-007-0356-9; van Meerten ELV, 2010, EUR RADIOL, V20, P1456, DOI 10.1007/s00330-009-1685-y; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090	30	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117053	10.1371/journal.pone.0117053	http://dx.doi.org/10.1371/journal.pone.0117053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615643	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100054
J	Zhang, ZY; Jiang, WW; Jian, Q; Song, WC; Zheng, ZT; Wang, DL; Liu, XJ				Zhang, Zhiyong; Jiang, Wayne W.; Jian, Qiu; Song, Wencheng; Zheng, Zuntao; Wang, Donglan; Liu, Xianjin			Changes of Field Incurred Chlorpyrifos and Its Toxic Metabolite Residues in Rice during Food Processing from-RAC-to-Consumption	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDE-RESIDUES; HOME PREPARATION; RISK-ASSESSMENT; DISSIPATION; PRODUCTS; TOMATOES; STORAGE; MARKET; HEALTH; CHINA	The objectives of this study were to determine the effects of food processing on field incurred residues levels of chlorpyrifos and its metabolite 3,5,6-Trichloro-2-pyridinol (TCP) in rice. The chlorpyrifos and TCP were found to be 1.27 and 0.093 mg kg-1 in straw and 0.41 and 0.073 mg kg-1 in grain, respectively. It is observed that the sunlight for 2 hours does not decrease the chlorpyrifos and TCP residues in grain significantly. Their residues in rice were reduced by up to 50% by hulling. The cooking reduced the chlorpyrifos and TCP in rice to undetectable level (below 0.01 mg kg-1). Processing factors (PFs) of chlorpyrifos and TCP residues in rice during food processing were similar. Various factors have impacts on the fates of chlorpyrifos and TCP residues and the important steps to reduce their residues in rice were hulling and cooking. The results can contribute to assure the consumer of a safe wholesome food supply.	[Zhang, Zhiyong; Wang, Donglan; Liu, Xianjin] Minist Agr PR China, Key Lab Control Technol & Standard Agroprod Safet, State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Jiang, Wayne W.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Jian, Qiu; Song, Wencheng; Zheng, Zuntao] Minist Agr PR China, Inst Control Agrochem, Beijing, Peoples R China	Ministry of Agriculture & Rural Affairs; Michigan State University; Ministry of Agriculture & Rural Affairs	Zhang, ZY (corresponding author), Minist Agr PR China, Key Lab Control Technol & Standard Agroprod Safet, State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.	yzuzzy@163.com			Natural Science Foundation of China [31471797]; Independent Innovation of Agricultural Sciences in Jiangsu Province [CX (14) 2060]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation of Agricultural Sciences in Jiangsu Province	This work was financially supported by the Natural Science Foundation of China (Grant No. 31471797) and Independent Innovation of Agricultural Sciences in Jiangsu Province [Grant No. CX (14) 2060]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Arab AAK, 1999, FOOD CHEM, V65, P509, DOI 10.1016/S0308-8146(98)00231-3; Akoto O, 2013, CHEMOSPHERE, V92, P67, DOI 10.1016/j.chemosphere.2013.02.057; Andreia NOJ, 2012, FOOD CONTROL, V25, P607; [Anonymous], 2013, JAPANESE POSITVE LIS; [Anonymous], 2009, KOREA MRLS PESTICIDE; [Anonymous], 2014, GB 2763 2014; [Anonymous], 2004, 7882004 NYT; Bonnechere A., 2012, J FOOD RES, V3, P68; Bonnechere A, 2012, FOOD CONTROL, V25, P397, DOI 10.1016/j.foodcont.2011.11.010; Burchat CS, 1998, FOOD ADDIT CONTAM, V15, P61, DOI 10.1080/02652039809374599; Cabras P, 2000, J AGR FOOD CHEM, V48, P6128, DOI 10.1021/jf0007176; Chen C, 2011, FOOD CONTROL, V22, P1114, DOI 10.1016/j.foodcont.2011.01.007; Chen C, 2009, FOOD ADDIT CONTAM A, V26, P340, DOI 10.1080/02652030802524516; Codex Pesticide Residues Limits in Food, 2005, COD PEST RES LIM FOO; John PJ, 2001, ENVIRON INT, V26, P231, DOI 10.1016/S0160-4120(00)00111-2; Kaushik G, 2009, FOOD RES INT, V42, P26, DOI 10.1016/j.foodres.2008.09.009; Keikotlhaile BM, 2010, FOOD CHEM TOXICOL, V48, P1, DOI 10.1016/j.fct.2009.10.031; Lee WJ, 2004, JNCI-J NATL CANCER I, V96, P1781, DOI 10.1093/jnci/djh324; Lehotay SJ, 2005, J AOAC INT, V88, P595; Liang Y, 2012, FOOD CHEM, V133, P636, DOI 10.1016/j.foodchem.2012.01.016; Ling Y, 2011, FOOD CONTROL, V22, P54, DOI 10.1016/j.foodcont.2010.06.009; Lu HY, 2013, J SCI FOOD AGR, V93, P2917, DOI 10.1002/jsfa.6080; Lu MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100556; Lucia P, 2011, TRENDS ANAL CHEM, V30, P270; Meeker JD, 2006, EPIDEMIOLOGY, V17, P61, DOI 10.1097/01.ede.0000190602.14691.70; Ministero per le Politiche Agricole e Forestali, 2004, 738F01006 EPA; NAKAMURA Y, 1993, J AGR FOOD CHEM, V41, P1910, DOI 10.1021/jf00035a019; Nguyen D, 2007, RAPID COMMUN MASS SP, V21, P3115, DOI [10.1002/rcm.3199, DOI 10.1002/RCM.3199]; OECD, 2008, TEST NO 407 REP DOS; Osman KA, 2011, FOOD CONTROL, V22, P947, DOI 10.1016/j.foodcont.2010.11.031; Pazzirota T, 2013, FOOD ADDIT CONTAM A, V30, P1752, DOI 10.1080/19440049.2013.815806; Shen Yan, 2011, Jiangsu Journal of Agricultural Sciences, V27, P1376; Soliman KM, 2001, FOOD CHEM TOXICOL, V39, P887, DOI 10.1016/S0278-6915(00)00177-0; The Institute for the Control of Agrochemicals Ministry of Agriculture (ICAMA), 2009, GUID SAF APPL PEST; Ticha J, 2008, FOOD CONTROL, V19, P247, DOI 10.1016/j.foodcont.2007.03.011; Uddin R, 2011, B ENVIRON CONTAM TOX, V86, P83, DOI 10.1007/s00128-010-0178-7; Wang RH, 2013, THESIS ZHEJIANG U; Wang SM, 2013, FOOD CHEM, V138, P2016, DOI 10.1016/j.foodchem.2012.11.116; Zhang CunZheng, 2010, Scientia Agricultura Sinica, V43, P151; Zhang JL, 2007, PETROL SCI, V4, P1, DOI 10.1007/s12182-007-0001-1; Zhang X, 2012, ECOTOX ENVIRON SAFE, V78, P276, DOI 10.1016/j.ecoenv.2011.11.036; Zhang ZY, 2007, FOOD CONTROL, V18, P1484, DOI 10.1016/j.foodcont.2006.11.002	42	5	7	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116467	10.1371/journal.pone.0116467	http://dx.doi.org/10.1371/journal.pone.0116467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608031	Green Submitted, Green Published, gold			2022-12-27	WOS:000348205300026
J	Magnus, MC; Stigum, H; Haberg, SE; Nafstad, P; London, SJ; Nystad, W				Magnus, Maria C.; Stigum, Hein; Haberg, Siri E.; Nafstad, Per; London, Stephanie J.; Nystad, Wenche			Peak Weight and Height Velocity to Age 36 Months and Asthma Development: The Norwegian Mother and Child Cohort Study	PLOS ONE			English	Article							EUROPEAN BIRTH COHORTS; LUNG DEVELOPMENT; INFANT GROWTH; FETAL-GROWTH; GENERATION R; RISK; SYMPTOMS; NEWBORNS; GAIN; 1ST	Background The immediate postnatal period is the period of the fastest growth in the entire life span and a critical period for lung development. Therefore, it is interesting to examine the association between growth during this period and childhood respiratory disorders. Methods We examined the association of peak weight and height velocity to age 36 months with maternal report of current asthma at 36 months (n = 50,311), recurrent lower respiratory tract infections (LRTIs) by 36 months (n = 47,905) and current asthma at 7 years (n = 24,827) in the Norwegian Mother and Child Cohort Study. Peak weight and height velocity was calculated using the Reed1 model through multilevel mixed-effects linear regression. Multivariable log-binomial regression was used to calculate adjusted relative risks (adj.RR) and 95% confidence intervals (CI). We also conducted a sibling pair analysis using conditional logistic regression. Results Peak weight velocity was positively associated with current asthma at 36 months [adj. RR 1.22 (95% CI: 1.18, 1.26) per standard deviation (SD) increase], recurrent LRTIs by 36 months [adj. RR 1.14 (1.10, 1.19) per SD increase] and current asthma at 7 years [adj. RR 1.13 (95% CI: 1.07, 1.19) per SD increase]. Peak height velocity was not associated with any of the respiratory disorders. The positive association of peak weight velocity and asthma at 36 months remained in the sibling pair analysis. Conclusions Higher peak weight velocity, achieved during the immediate postnatal period, increased the risk of respiratory disorders. This might be explained by an influence on neonatal lung development, shared genetic/epigenetic mechanisms and/or environmental factors.	[Magnus, Maria C.; Stigum, Hein; Nafstad, Per; Nystad, Wenche] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Chron Dis, Oslo, Norway; [Stigum, Hein; Nafstad, Per] Univ Oslo, Fac Med, Dept Community Med, Oslo, Norway; [Haberg, Siri E.] Norwegian Inst Publ Hlth, Inst Management & Staff, Oslo, Norway; [London, Stephanie J.] NIEHS, Epidemiol Branch, Div Intramural Res, NIH,US Dept HHS, Res Triangle Pk, NC 27709 USA	Norwegian Institute of Public Health (NIPH); University of Oslo; Norwegian Institute of Public Health (NIPH); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Magnus, MC (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Dept Chron Dis, Oslo, Norway.	Maria.Christine.Magnus@fhi.no	London, Stephanie/C-3734-2019	London, Stephanie/0000-0003-4911-5290	National Institutes of Health (NIH) (NIH/National Institute of Environmental Health Sciences (NIEHS)) [N01-ES-75558]; National Institutes of Health (NIH) (NIH/National Institute of Neurological Disorders and Stroke) [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; Norwegian Research Council/FUGE [151918/S10]; Division of Intramural Research, NIEHS, NIH; Norwegian Extra-Foundation for Health and Rehabilitation [2011.2.0218]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	National Institutes of Health (NIH) (NIH/National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health (NIH) (NIH/National Institute of Neurological Disorders and Stroke); Norwegian Research Council/FUGE(Research Council of Norway); Division of Intramural Research, NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Norwegian Extra-Foundation for Health and Rehabilitation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Norwegian Mother and Child Cohort Study is supported by National Institutes of Health (NIH) (NIH/National Institute of Environmental Health Sciences (NIEHS) contract number N01-ES-75558, NIH/National Institute of Neurological Disorders and Stroke grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS 047537-06A1) and the Norwegian Research Council/FUGE (grant number 151918/S10). Supported in part by the Division of Intramural Research, NIEHS, NIH. Ms. Magnus is also supported by the Norwegian Extra-Foundation for Health and Rehabilitation (grant number 2011.2.0218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2013, PEDIAT ALLERG IMM-UK, V24, P122, DOI 10.1111/pai.12049; BERKEY CS, 1987, HUM BIOL, V59, P973; Bisgaard H, 2012, AM J RESP CRIT CARE, V185, P1183, DOI 10.1164/rccm.201110-1922OC; Bisgaard H, 2009, J ALLERGY CLIN IMMUN, V123, P651, DOI 10.1016/j.jaci.2008.11.036; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brew BK, 2011, PAEDIATR PERINAT EP, V25, P507, DOI 10.1111/j.1365-3016.2011.01233.x; Chirwa ED, 2014, ANN HUM BIOL, V41, P166, DOI 10.3109/03014460.2013.839742; Dijk FN, 2013, CURR OPIN ALLERGY CL, V13, P193, DOI 10.1097/ACI.0b013e32835eb707; Engel SM, 2014, AM J EPIDEMIOL, V179, P834, DOI 10.1093/aje/kwt433; Flexeder C, 2012, ALLERGY, V67, P257, DOI 10.1111/j.1398-9995.2011.02748.x; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Furu K, 2011, J CLIN EPIDEMIOL, V64, P878, DOI 10.1016/j.jclinepi.2010.10.014; Galambos C, 2008, PATHOLOGY, V40, P124, DOI 10.1080/00313020701818981; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Govarts E, 2012, ENVIRON HEALTH PERSP, V120, P162, DOI 10.1289/ehp.1103767; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Haberg SE, 2011, J ALLERGY CLIN IMMUN, V127, P262, DOI 10.1016/j.jaci.2010.10.004; Hansen S, 2014, ENVIRON HEALTH PERSP, V122, P93, DOI 10.1289/ehp.1206397; Haschke F, 2013, WORLD REV NUTR DIET, V106, P33, DOI 10.1159/000342559; Henderson J, 2009, ARCH DIS CHILD, V94, P333, DOI 10.1136/adc.2008.143636; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Mai XM, 2005, PEDIAT ALLERG IMM-UK, V16, P380, DOI 10.1111/j.1399-3038.2005.00290.x; Mannino DM, 2006, INT J OBESITY, V30, P6, DOI 10.1038/sj.ijo.0803145; Maritz GS, 2001, PEDIATR PULM, V32, P201, DOI 10.1002/ppul.1109; Metsala J, 2008, AM J EPIDEMIOL, V168, P170, DOI 10.1093/aje/kwn105; Mook-Kanamori DO, 2011, EUR J ENDOCRINOL, V165, P623, DOI 10.1530/EJE-11-0067; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Nwaru BI, 2011, CLIN RESPIR J, V5, P211, DOI 10.1111/j.1752-699X.2010.00222.x; Paul IM, 2010, PEDIAT ALLERG IMM-UK, V21, P82, DOI 10.1111/j.1399-3038.2009.00926.x; Pike KC, 2010, THORAX, V65, P1099, DOI 10.1136/thx.2010.134742; Rona RJ, 2005, THORAX, V60, P549, DOI 10.1136/thx.2004.032359; Rzehak P, 2013, J ALLERGY CLIN IMMUN, V131, P1528, DOI 10.1016/j.jaci.2013.01.001; Scholtens S, 2009, J ALLERGY CLIN IMMUN, V123, P1312, DOI 10.1016/j.jaci.2009.02.029; Sevelsted A, 2012, ALLERGY, V67, P670, DOI 10.1111/j.1398-9995.2012.02805.x; Sharma S, 2010, AM J RESP CRIT CARE, V181, P328, DOI 10.1164/rccm.200907-1009OC; SIMONDON KB, 1992, AM J HUM BIOL, V4, P327, DOI 10.1002/ajhb.1310040308; Sonnenschein-van der Voort AMM, 2012, AM J RESP CRIT CARE, V185, P731, DOI 10.1164/rccm.201107-1266OC; Suren P, 2013, EPIDEMIOLOGY, V24, P660, DOI 10.1097/EDE.0b013e31829e1d45; Taveras EM, 2008, J ALLERGY CLIN IMMUN, V121, P1161, DOI 10.1016/j.jaci.2008.03.021; Tedner SG, 2012, CLIN EXP ALLERGY, V42, P1430, DOI 10.1111/j.1365-2222.2012.03997.x; The Norwegian Directorate of Health, 2010, NASJ FAGL RETN VEIIN; Turner S, 2011, AM J RESP CRIT CARE, V184, P407, DOI 10.1164/rccm.201012-2075OC; van der Gugten AC, 2012, EUR RESPIR J, V39, P403, DOI 10.1183/09031936.00188310; van der Valk RJP, 2012, ALLERGY, V67, P767, DOI 10.1111/j.1398-9995.2012.02819.x; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; Weber D, 2013, EUR J CLIN NUTR, V67, P1029, DOI 10.1038/ejcn.2013.158	48	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116362	10.1371/journal.pone.0116362	http://dx.doi.org/10.1371/journal.pone.0116362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635872	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700031
J	Schmidt, VJ; Hilgert, JG; Covi, JM; Leibig, N; Wietbrock, JO; Arkudas, A; Polykandriotis, E; de Wit, C; Horch, RE; Kneser, U				Schmidt, Volker J.; Hilgert, Johannes G.; Covi, Jennifer M.; Leibig, Nico; Wietbrock, Johanna O.; Arkudas, Andreas; Polykandriotis, Elias; de Wit, Cor; Horch, Raymund E.; Kneser, Ulrich			Flow Increase Is Decisive to Initiate Angiogenesis in Veins Exposed to Altered Hemodynamics	PLOS ONE			English	Article							CONSTRUCTED ARTERIOVENOUS-FISTULA; CAPILLARY BED FORMATION; GAP-JUNCTIONS; BLOOD-FLOW; IN-VIVO; ENDOTHELIAL-CELLS; VASCULAR-TONE; SHUNT LOOP; TISSUE; CONNEXIN43	Exposing a vein to altered hemodynamics by creating an arteriovenous (AV) shunt evokes considerable vessel formation that may be of therapeutic potential. However, it is unclear whether the introduction of oscillatory flow and/or flow increase is decisive. To distinguish between these mechanical stimuli we grafted a femoral vein into the arterial flow pathway of the contralateral limb in rats creating an arterioarterial (AA) loop (n = 7). Alternatively, we connected the femoral artery and vein using the vein graft, whereby we created an AV-loop (n = 27). Vessel loops were embedded in a fibrin filled chamber and blood flow was measured by means of flow probes immediately after surgery (day 0) and 15 days after loop creation. On day 15, animals were sacrificed and angiogenesis was evaluated using mu CT and histological analysis. Mean flow increased from 0.5 to 2.4 mL/min and was elevated throughout the cardiac cycle at day 0 in AV-loops whereas, as expected, it remained unchanged in AA-loops. Flow in AV-loops decreased with time, and was at day 15 not different from untreated femoral vessels or AA-loop grafts. Pulsatile flow oscillations were similar in AV-and AA-loops at day 0. The flow amplitude amounted to similar to 1.3 mL/min which was comparable to values in untreated arteries. Flow amplitude remained constant in AA-loops, whereas it decreased in AV-loops (day 15: 0.4 mL/min). A large number of newly formed vessels were present in AV-loops at day 15 arising from the grafted vein. In marked contrast, angiogenesis originating from the grafted vein was absent in AA-loops. We conclude that exposure to substantially increased flow is required to initiate angiogenesis in grafted veins, whereas selective enhancement of pulsatile flow is unable to do so. This suggests that indeed flow and most likely wall shear stress is decisive to initiate formation of vessels in this hemodynamically driven angiogenesis model.	[Schmidt, Volker J.; Hilgert, Johannes G.; Covi, Jennifer M.; Arkudas, Andreas; Polykandriotis, Elias; Horch, Raymund E.; Kneser, Ulrich] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, D-91054 Erlangen, Germany; [Schmidt, Volker J.; Leibig, Nico; Wietbrock, Johanna O.; Kneser, Ulrich] Heidelberg Univ, Dept Hand Plast & Reconstruct Surg, BG Unfallklin Ludwigshafen, Heidelberg, Germany; [de Wit, Cor] Med Univ Lubeck, Dept Physiol, D-23538 Lubeck, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; University of Lubeck	Schmidt, VJ (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, D-91054 Erlangen, Germany.	schmidtvolker@gmx.net	Arkudas, Andreas/AAQ-6745-2021; Horch, Raymund E./H-8128-2019; de Wit, Cor/A-5560-2009	Horch, Raymund E./0000-0002-6561-2353; de Wit, Cor/0000-0003-4621-0399; Arkudas, Andreas/0000-0002-2473-5816; Polykandriotis, Elias/0000-0002-8152-6420	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg [TP J-15]; Xue Hong und Hans Georg Geis Foundation	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg; Xue Hong und Hans Georg Geis Foundation	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg (to VJS, TP J-15, www.izkf.med.unierlangen.de) and by the Xue Hong und Hans Georg Geis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkudas A, 2007, MOL MED, V13, P480, DOI 10.2119/2007-00057.Arkudas; Arkudas A, 2013, TISSUE ENG PART C-ME, V19, P479, DOI [10.1089/ten.tec.2012.0572, 10.1089/ten.TEC.2012.0572]; Arkudas A, 2012, PLAST RECONSTR SURG, V129, p55E, DOI 10.1097/PRS.0b013e3182361f97; Arkudas A, 2010, TISSUE ENG PART C-ME, V16, P1503, DOI 10.1089/ten.tec.2010.0016; Asano Y, 2005, MED BIOL ENG COMPUT, V43, P126, DOI 10.1007/BF02345133; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Conway Daniel, 2012, F1000 Biol Rep, V4, P1, DOI 10.3410/B4-1; Cowan DB, 1998, CIRC RES, V82, P786, DOI 10.1161/01.RES.82.7.786; de Wit C, 2006, BIOL CHEM, V387, P3, DOI 10.1515/BC.2006.002; de Wit C, 2007, CURR PHARM BIOTECHNO, V8, P11; Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3; EROL OO, 1979, SURG FORUM, V30, P530; EROL OO, 1980, PLAST RECONSTR SURG, V66, P109, DOI 10.1097/00006534-198007000-00021; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Gabriels JE, 1998, CIRC RES, V83, P636, DOI 10.1161/01.RES.83.6.636; Glen K, 2012, J CELL PHYSIOL, V227, P2710, DOI 10.1002/jcp.23015; Hofer SOP, 2005, BRIT J PLAST SURG, V58, P1104, DOI 10.1016/j.bjps.2005.04.033; Horch RE, 2014, J CELL MOL MED, V18, P1478, DOI 10.1111/jcmm.12296; Horch RE, 2013, J CELL MOL MED, V17, P1197, DOI 10.1111/jcmm.12130; HUANG M, 1992, AM J PHYSIOL, V262, pH846; Klumpp D, 2012, J BIOMED MATER RES A, V100A, P2302, DOI 10.1002/jbm.a.34172; Laws MJ, 2008, DEVELOPMENT, V135, P2659, DOI 10.1242/dev.019810; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Liu D, 2011, INT J DEV BIOL, V55, P419, DOI 10.1387/ijdb.103220dl; Lokmic Z, 2007, FASEB J, V21, P511, DOI 10.1096/fj.06-6614com; Manasseri B, 2007, MICROSURG, V27, P623, DOI 10.1002/micr.20415; Mian RW, 2000, TISSUE ENG, V6, P595, DOI 10.1089/10763270050199541; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Obi S, 2012, AM J PHYSIOL-CELL PH, V303, pC595, DOI 10.1152/ajpcell.00133.2012; Polykandriotis E, 2008, MICROVASC RES, V75, P25, DOI 10.1016/j.mvr.2007.04.003; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Schmidt VJ, 2008, PHARMACOL REP, V60, P68; Schmidt VJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078782; Schmidt VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042287; Tanaka Y, 2003, PLAST RECONSTR SURG, V112, P1636, DOI 10.1097/01.PRS.0000086140.49022.AB; Tanaka Y, 2000, BRIT J PLAST SURG, V53, P51, DOI 10.1054/bjps.1999.3186; Wang HH, 2008, CARDIOVASC RES, V79, P509, DOI 10.1093/cvr/cvn112; Watson O, 2013, CARDIOVASC RES, V100, P252, DOI 10.1093/cvr/cvt170; Westerband A, 2001, J VASC SURG, V33, P561, DOI 10.1067/mva.2001.112230; Wragg JW, 2014, MICROCIRCULATION, DOI [10.1111/micc.12186PMID: 25556713, DOI 10.1111/MICC.12186]; Zdolsek JM, 2011, J VASC SURG, V53, P435, DOI 10.1016/j.jvs.2010.08.019	43	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117407	10.1371/journal.pone.0117407	http://dx.doi.org/10.1371/journal.pone.0117407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635764	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700084
J	Xu, DB; Chen, M; Ma, YN; Xu, ZS; Li, LC; Chen, YF; Ma, YZ				Xu, Dong-bei; Chen, Ming; Ma, Ya-nan; Xu, Zhao-shi; Li, Lian-cheng; Chen, Yao-feng; Ma, You-zhi			A G-Protein beta Subunit, AGB1, Negatively Regulates the ABA Response and Drought Tolerance by Down-Regulating AtMPK6-Related Pathway in Arabidopsis	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; ABIOTIC STRESS TOLERANCE; ABSCISIC-ACID REGULATION; ALPHA-SUBUNIT; GAMMA-SUBUNIT; BZIP PROTEIN; GENE; EXPRESSION; INTERACTS; KINASE	Heterotrimeric G-proteins are versatile regulators involved in diverse cellular processes in eukaryotes. In plants, the function of G-proteins is primarily associated with ABA signaling. However, the downstream effectors and the molecular mechanisms in the ABA pathway remain largely unknown. In this study, an AGB1 mutant (agb1-2) was found to show enhanced drought tolerance, indicating that AGB1 might negatively regulate drought tolerance in Arabidopsis. Data showed that AGB1 interacted with protein kinase AtMPK6 that was previously shown to phosphorylate AtVIP1, a transcription factor responding to ABA signaling. Our study found that transcript levels of three ABA responsive genes, AtMPK6, AtVIP1 and AtMYB44 (downstream gene of AtVIP1), were significantly up-regulated in agb1-2 lines after ABA or drought treatments. Other ABA-responsive and drought-inducible genes, such as RD29A (downstream gene of AtMYB44), were also up-regulated in agb1-2 lines. Furthermore, overexpression of AtVIP1 resulted in hypersensitivity to ABA at seed germination and seedling stages, and significantly enhanced drought tolerance in transgenic plants. These results suggest that AGB1 was involved in the ABA signaling pathway and drought tolerance in Arabidopsis through down-regulating the AtMPK6, AtVIP1 and AtMYB44 cascade.	[Xu, Dong-bei; Ma, Ya-nan; Chen, Yao-feng] Northwest A&F Univ, Coll Agr, Yangling 712100, Shaanxi, Peoples R China; [Xu, Dong-bei; Chen, Ming; Ma, Ya-nan; Xu, Zhao-shi; Li, Lian-cheng; Ma, You-zhi] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,Minist Agr, Beijing 100081, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Chen, YF (corresponding author), Northwest A&F Univ, Coll Agr, Yangling 712100, Shaanxi, Peoples R China.	chenf3828@126.com; mayouzhi@caas.cn	Ma, Yanan/ABG-4104-2021		National Key Project for Research on Transgenic Biology [2013ZX08002-002]; Natural Science Foundation of China [31271715]	National Key Project for Research on Transgenic Biology; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Project for Research on Transgenic Biology (2013ZX08002-002) and Natural Science Foundation of China (31271715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2013, J PROTEOME RES, V12, P1487, DOI 10.1021/pr301159u; Anderson DJ, 2007, PLANT CELL REP, V26, P1469, DOI 10.1007/s00299-007-0356-1; Bhardwaj D, 2011, PLANT SIGNAL BEHAV, V6, P287, DOI 10.4161/psb.6.2.14971; Booker KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012833; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Chen JG, 2004, PLANT PHYSIOL, V135, P907, DOI 10.1104/pp.104.038992; Chen Jin-Gui, 2008, Front Biosci, V13, P3321; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kansup J, 2013, J EXP BOT, V64, P5611, DOI 10.1093/jxb/ert327; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Kobayashi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049207; LANG V, 1992, PLANT MOL BIOL, V20, P951, DOI 10.1007/BF00027165; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Mishra NS, 2006, ARCH BIOCHEM BIOPHYS, V452, P55, DOI 10.1016/j.abb.2006.05.001; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Mudgil Y, 2009, PLANT CELL, V21, P3591, DOI 10.1105/tpc.109.065557; Nilson SE, 2010, NEW PHYTOL, V185, P734, DOI 10.1111/j.1469-8137.2009.03120.x; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitzschke A, 2010, CELL CYCLE, V9, P18, DOI 10.4161/cc.9.1.10329; Pitzschke A, 2009, P NATL ACAD SCI USA, V106, P18414, DOI 10.1073/pnas.0905599106; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Shi HT, 2013, J EXP BOT, V64, P1367, DOI 10.1093/jxb/ers400; Shi HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053422; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Tsugama D, 2013, PLANT PHYSIOL BIOCH, V71, P240, DOI 10.1016/j.plaphy.2013.07.024; Tsugama D, 2013, J EXP BOT, V64, P3213, DOI 10.1093/jxb/ert159; Tsugama D, 2012, BBA-MOL CELL RES, V1823, P2254, DOI 10.1016/j.bbamcr.2012.10.001; Tsugama D, 2012, BIOCHEM BIOPH RES CO, V426, P626, DOI 10.1016/j.bbrc.2012.08.141; Tsugama D, 2012, PLANT PHYSIOL, V159, P144, DOI 10.1104/pp.112.197020; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang HX, 2006, MOL BIOL CELL, V17, P4257, DOI 10.1091/mbc.E06-01-0046; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Xing Y, 2009, PLANT MOL BIOL, V70, P725, DOI 10.1007/s11103-009-9503-0; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Nguyen XC, 2012, BIOCHEM BIOPH RES CO, V423, P703, DOI 10.1016/j.bbrc.2012.06.019; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang JF, 2008, PLANT CELL ENVIRON, V31, P562, DOI 10.1111/j.1365-3040.2008.01786.x; Zhao J, 2004, J BIOL CHEM, V279, P1794, DOI 10.1074/jbc.M309529200	61	44	49	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116385	10.1371/journal.pone.0116385	http://dx.doi.org/10.1371/journal.pone.0116385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635681	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700035
J	Cranford, TW; Krysl, P				Cranford, Ted W.; Krysl, Petr			Fin Whale Sound Reception Mechanisms: Skull Vibration Enables Low-Frequency Hearing	PLOS ONE			English	Article							ATLANTIC RIGHT WHALES; BALAENOPTERA-ACUTOROSTRATA; MINKE WHALE; NORTH; TRANSMISSION; CETACEANS; PLAYBACK; PHYSALUS; MIDDLE; NOISE	Hearing mechanisms in baleen whales (Mysticeti) are essentially unknown but their vocalization frequencies overlap with anthropogenic sound sources. Synthetic audiograms were generated for a fin whale by applying finite element modeling tools to X-ray computed tomography (CT) scans. We CT scanned the head of a small fin whale (Balaenoptera physalus) in a scanner designed for solid-fuel rocket motors. Our computer (finite element) modeling toolkit allowed us to visualize what occurs when sounds interact with the anatomic geometry of the whale's head. Simulations reveal two mechanisms that excite both bony ear complexes, (1) the skull-vibration enabled bone conduction mechanism and (2) a pressure mechanism transmitted through soft tissues. Bone conduction is the predominant mechanism. The mass density of the bony ear complexes and their firmly embedded attachments to the skull are universal across the Mysticeti, suggesting that sound reception mechanisms are similar in all baleen whales. Interactions between incident sound waves and the skull cause deformations that induce motion in each bony ear complex, resulting in best hearing sensitivity for low-frequency sounds. This predominant low-frequency sensitivity has significant implications for assessing mysticete exposure levels to anthropogenic sounds. The din of man-made ocean noise has increased steadily over the past half century. Our results provide valuable data for U.S. regulatory agencies and concerned largescale industrial users of the ocean environment. This study transforms our understanding of baleen whale hearing and provides a means to predict auditory sensitivity across a broad spectrum of sound frequencies.	[Cranford, Ted W.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Cranford, Ted W.] Quantitat Morphol Consulting Inc, San Diego, CA USA; [Krysl, Petr] Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego	Cranford, TW (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	Ted.W.Cranford@gmail.com		Krysl, Petr/0000-0003-1761-5047	Michael Wiese and James Eckman, at the Office of Naval Research [N00014-12-1-0516]; Frank Stone, Ernie Young, and Robert Gisiner at the Chief of Naval Operations Environmental Readiness Division as well as Curtis Collins and John Joseph at the Naval Postgraduate School [N00244-08-1-0025]	Michael Wiese and James Eckman, at the Office of Naval Research; Frank Stone, Ernie Young, and Robert Gisiner at the Chief of Naval Operations Environmental Readiness Division as well as Curtis Collins and John Joseph at the Naval Postgraduate School	TWC received funding from Michael Wiese and James Eckman, at the Office of Naval Research (N00014-12-1-0516); Frank Stone, Ernie Young, and Robert Gisiner at the Chief of Naval Operations Environmental Readiness Division as well as Curtis Collins and John Joseph at the Naval Postgraduate School (N00244-08-1-0025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castellote M, 2012, BIOL CONSERV, V147, P115, DOI 10.1016/j.biocon.2011.12.021; Clark C.W., 2004, ECHOLOCATION BATS DO, P564; Clark CW, 2006, IEEE J OCEANIC ENG, V31, P120, DOI 10.1109/JOE.2006.872213; CLARK CW, 1990, NATO ADV SCI I A-LIF, V196, P571; CLARK CW, 1980, SCIENCE, V207, P663, DOI 10.1126/science.207.4431.663; Cranford TW, 2008, ANAT REC, V291, P353, DOI 10.1002/ar.20652; Cranford TW, 2014, BIOACOUSTICS, V23, P161, DOI 10.1080/09524622.2013.843061; Cranford TW, 2012, ADV EXP MED BIOL, V730, P69, DOI 10.1007/978-1-4419-7311-5_15; Cranford TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011927; Cranford TW, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/016001; Croll DA, 2001, ANIM CONSERV, V4, P13, DOI 10.1017/S1367943001001020; DAHLHEIM ME, 1990, NATO ADV SCI I A-LIF, V196, P335; DeVRIES H., 1950, ACTA OTO LARYNGOL, V38, P262, DOI 10.3109/00016485009118384; DWIGHT T, 1872, DESCRIPTION BALAENOP; Ekdale EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021311; FLEISCHER G, 1976, J PALEONTOL, V50, P133; Fleischer G., 1980, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V28, P891; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Ginsberg J.H., 2001, MECH STRUCTURAL VIBR; HICKLING R, 1966, J ACOUST SOC AM, V39, P276, DOI 10.1121/1.1909887; Hildebrand J, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P101; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Homma K, 2011, AIP CONF PROC, V1403, DOI 10.1063/1.3658146; JOHNSON CS, 1968, J ACOUST SOC AM, V44, P965, DOI 10.1121/1.1911236; KELLOGG R, 1936, REV ARCHAROCETI; Ketten D.R., 1994, IEEE P UNDERWATER AC, V1, P264; Ketten Darlene R., 1997, Bioacoustics, V8, P103; Ketten DR, 2000, SPR HDB AUD, V12, P43; KETTEN DR, 1992, MARINE MAMMAL SENSORY SYSTEMS, P53; Krysl P, 2006, J ACOUST SOC AM, V120, P2328, DOI 10.1121/1.2257988; KRYSL P, 2014, EFFECTS NOISE AQUATI; Krysl P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042591; Lancaster W.C., 1990, Journal of Vertebrate Paleontology, V10, P117; Lancaster WC, 2015, MAR MAMMAL SCI, V31, P369, DOI 10.1111/mms.12145; Li Z, 2014, AM MINERAL, V99, P645, DOI 10.2138/am.2014.4571; Lillie D.G., 1910, P ZOOL SOC LOND, VLXXIV, P769, DOI DOI 10.1111/J.1096-3642.1910.TB01916.X; Matthews J. N., 1999, Bioacoustics, V10, P47; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; MEAD JG, 2009, SMITHSONIAN CONTRIB, V627, P216; *NAT RES COUNC, 2003, OC NOIS MAR MAMM, P208; Norris K. S., 1964, P317; Norris K. S., 1969, P391; Norris K.S., 1968, EVOLUTION ENV, P297; Nummela S, 2007, ANAT REC, V290, P716, DOI 10.1002/ar.20528; OBERRECHT SP, 2014, EFFECTS NOISE AQUATI; Parks SE, 2003, MAR MAMMAL SCI, V19, P563, DOI 10.1111/j.1748-7692.2003.tb01321.x; Parks SE, 2009, J ACOUST SOC AM, V125, P1230, DOI 10.1121/1.3050282; Purves P.E., 1966, WHALES DOLPHINS PORP, P320; Rayleigh J.W.S.B, 1896, THEORY SOUND, V2; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Ruggero MA, 2002, P NATL ACAD SCI USA, V99, P13206, DOI 10.1073/pnas.202492699; Sargent J.R., 1975, BIOCH BIOPHYSICAL PE, V2, P215; Schilt CR, 2012, ADV EXP MED BIOL, V730, P105, DOI 10.1007/978-1-4419-7311-5_23; Sirovic A, 2013, MAR BIOL, V160, P47, DOI 10.1007/s00227-012-2061-z; Southall BL, 2012, MAR TECHNOL SOC J, V46, P48, DOI 10.4031/MTSJ.46.4.1; Southall Brandon L., 2007, Aquatic Mammals, V33, pI; Stokstad Erik, 2014, Science, V343, P128, DOI 10.1126/science.343.6167.128; Szymanski MD, 1999, J ACOUST SOC AM, V106, P1134, DOI 10.1121/1.427121; Thompson T.J., 1979, Behavior of Marine Animals, V3, P403; True F. W., 1904, WHALEBONE WHALES W N; Tubelli AA, 2012, J ACOUST SOC AM, V132, P3263, DOI 10.1121/1.4756950; Tyack PL, 2000, SPR HDB AUD, V12, P156; WATKINS WA, 1985, MAR MAMMAL SCI, V1, P219, DOI 10.1111/j.1748-7692.1985.tb00011.x; Yamato M, 2012, ANAT REC, V295, P991, DOI 10.1002/ar.22459	65	37	37	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116222	10.1371/journal.pone.0116222	http://dx.doi.org/10.1371/journal.pone.0116222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633412	Green Published, Green Submitted, gold			2022-12-27	WOS:000348609800006
J	Beyeler, N; Liu, J; Sieverding, M				Beyeler, Naomi; Liu, Jenny; Sieverding, Maia			A Systematic Review of the Role of Proprietary and Patent Medicine Vendors in Healthcare Provision in Nigeria	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MALARIA TREATMENT SERVICES; SPECIALIZED DRUG SHOPS; SEEKING BEHAVIOR; COMBINATION THERAPY; ANTIMALARIAL-DRUGS; RETAIL SECTOR; INTERVENTIONS; PROVIDERS; KNOWLEDGE	Background Interventions to reduce the burden of disease and mortality in sub-Saharan Africa increasingly recognize the important role that drug retailers play in delivering basic healthcare services. In Nigeria, owner-operated drug retail outlets, known as patent and proprietary medicine vendors (PPMVs), are a main source of medicines for acute conditions, but their practices are not well understood. Greater understanding of the role of PPMVs and the quality of care they provide is needed in order to inform ongoing national health initiatives that aim to incorporate PPMVs as a delivery mechanism. Objective and Methods This paper reviews and synthesizes the existing published and grey literature on the characteristics, knowledge and practices of PPMVs in Nigeria. We searched published and grey literature using a number of electronic databases, supplemented with website searches of relevant international agencies. We included all studies providing outcome data on PPMVs in Nigeria, including non-experimental studies, and assessed the rigor of each study using the WHO-Johns Hopkins Rigor scale. We used narrative synthesis to evaluate the findings. Results We identified 50 articles for inclusion. These studies provided data on a wide range of PPMV outcomes: training; health knowledge; health practices, including drug stocking and dispensing, client interaction, and referral; compliance with regulatory guidelines; and the effects of interventions targeting PPMVs. In general, PPMVs have low health knowledge and poor health treatment practices. However, the literature focuses largely on services for adult malaria, and little is known about other health areas or services for children. Conclusions This review highlights several concerns with the quality of the private drug retail sector in Nigeria, as well as gaps in the existing evidence base. Future research should adopt a more holistic view of the services provided by PPMV shops, and evaluate intervention strategies that may improve the services provided in this sector.	[Beyeler, Naomi; Liu, Jenny; Sieverding, Maia] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Beyeler, N (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	Naomi.Beyeler@ucsf.edu			Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulraheem IS, 2009, EARLY CHILD DEV CARE, V179, P671, DOI 10.1080/03004430701500885; Abuya T, 2009, AM J TROP MED HYG, V80, P905, DOI 10.4269/ajtmh.2009.80.905; Abuya TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008937; ACT watch Group SFH/Nigeria and the Independent Evaluation Team, 2012, ENDLINE OUTLET SURVE, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; ACTwatch Group SFH/Nigeria and the Independent Evaluation Team, 2009, OUTLET SURVEY REPORT; Adedeji AA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-230; Africa Health Workforce Observatory [AHWO], 2008, HUMAN RESOURCES FOR; Aguwa EN, 2010, INT J MED MED SCI, V2, P88; Ajayi IO., 2002, INT Q COMMUNITY HEAL, V21, P271, DOI [10.2190/569A-XLPX-YF5C-H9HU, DOI 10.2190/569A-XLPX-YF5C-H9HU]; Akiode A, 2010, EBONYI MED J, V9, P96, DOI DOI 10.4314/EB0MED.V9I2.71688; Akuse RM, 2010, MALAR RES TREAT; Alba S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-163; Aniebue PN, 2010, NIGERIAN MED J, V51, P30; [Anonymous], 2013, FHI360; [Anonymous], MALARIA J S1, DOI DOI 10.1186/1475-2875-11-S1-P28; Auta A, 2012, N AM J MED SCI, V4, P24, DOI 10.4103/1947-2714.92899; Awodele Olufunsho, 2012, Int J Risk Saf Med, V24, P65, DOI 10.3233/JRS-2012-0562; Awofisayo OS, 2008, TROP J PHARM RES, V7, P1013; Barnes J, 2008, NIGERIA PRIVATE SECT; Berendes S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044775; Brieger WR, 2004, HEALTH POLICY PLANN, V19, P177, DOI 10.1093/heapol/czh021; Brieger WR, 2002, INT Q COMMUNITY HLTH, V21, P19; Chukwuocha UM, 2013, J COMMUN HEALTH, V38, P759, DOI 10.1007/s10900-013-9676-y; Emeka N. C., 2005, Annals of African Medicine, V4, P68; Enato EFO, 2006, SCAND J INFECT DIS, V38, P474, DOI 10.1080/00365540500525153; Enwere OO, 2014, P H MED J, V7, P210; Erhun WO, 2004, J HEALTH POPUL DEV C, V8, P1; Fajola A, 2012, INT Q COMMUNITY HEAL, V32, P195, DOI 10.2190/IQ.32.3.c; Fayemi MM, 2010, J PUBLIC HEALTH POL, V31, P281, DOI 10.1057/jphp.2010.14; Federal Ministry of Health Nigeria, 2013, NATIONAL GUIDELINE F, DOI [10.1016/j.jsps.2013.12.015, DOI 10.1016/J.JSPS.2013.12.015]; Federal Republic of Nigeria, 2005, NATIONAL ANTIMALARIA; Forsberg BC, 2011, HEALTH POLICY PLANN, V26, pi1, DOI 10.1093/heapol/czr050; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Greer G, 2004, IMPROVING MANAGEMENT; Hebert LE, 2013, J FAM PLAN REPROD H, V39, P29, DOI 10.1136/jfprhc-2011-100244; Higgins JP., 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/14651858.ED000142, DOI 10.1002/14651858.ED000142]; Idowu O A, 2006, Tanzan Health Res Bull, V8, P45; Jimmy EO, 2000, PUBLIC HEALTH, V114, P282, DOI 10.1016/S0033-3506(00)00346-2; Livinus C, 2009, SAHEL MED J, V12; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Marek T, 2005, TRENDS AND OPPORTUNI; Marriott A, 2009, OXFAM BRIEFING PAPER; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; National Bureau of Statistics UNICEF UNFPA, 2013, NIGERIA MULTIPLE IND, DOI [10.1016/j.jsps.2013.12.015, DOI 10.1016/J.JSPS.2013.12.015]; National Population Commission ICF Macro, 2009, NIGERIA DEMOGRAPHIC; National Population Commission National Malaria Control Programme ICF International, 2012, NIGERIA MALARIA INDI, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; National Primary Health Care Development Agency, 2011, DRAFT ESSENTIAL CHIL, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Nduka SO, 2013, INT J COLLAB RES INT, V5; Nigerian Federal Ministry of Health, 2010, ESSENTIAL MEDICINE L; Obi I. E., 2010, Journal of College of Medicine, V15, P29; Obitte NC, 2009, SCI RES ESSAYS, V4, P1354; Okeke TA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-260; Okeke TA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-97; Okonkwo AD, 2010, AFR HEALTH SCI, V10, P253; Oladepo O, 2011, Afr J Med Med Sci, V40, P345; Oladepo O, 2008, MALARIA TREATMENT IN; Oladepo O, 2007, WORKING PAPER; Onwujekwe O, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-50; Onwujekwe O, 2011, TROP MED INT HEALTH, V16, P1087, DOI 10.1111/j.1365-3156.2011.02821.x; Onwujekwe O, 2011, J PUBLIC HEALTH-UK, V33, P93, DOI 10.1093/pubmed/fdq065; Onwujekwe O, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-22; Onwujekwe O, 2010, HEALTH POLICY, V96, P72, DOI 10.1016/j.healthpol.2009.12.014; Onwujekwe O, 2010, HEALTH POLICY, V94, P144, DOI 10.1016/j.healthpol.2009.09.010; Onwujekwe O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-22; Onyeneho NG, 2010, J HEALTH POPUL NUTR, V28, P567, DOI 10.3329/jhpn.v28i6.6605; Oyeyemi AS, 2014, TROP J PHARM RES, V13, P163, DOI 10.4314/tjpr.v13i1.23; Palafox B, 2012, ACTWATCH 2009 SUPPLY; Rutta E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-22; Shah NM, 2011, HEALTH POLICY PLANN, V26, P275, DOI 10.1093/heapol/czq074; Spaid B, 2011, IMPROVED REPRODUCTIV, DOI 10.1016/j.asjsur.2012.06.010; Tekobo AM, 2008, NIGER Q J HOSP MED, V14, P84; Tobin-West CI, 2012, INDIAN J PHARM PRACT, V5, P34; Tobin-West CI, 2011, INT J HEALTH RES, V4, P127; Uguru NP, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-21; Ujuju C, 2014, J MULTIDISCIP HEALTH, V7, P163, DOI 10.2147/JMDH.S57117; Um L, 2007, BORNO MEDICAL JOURNA, V4, P7; Uzochukwu BSC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091667; Wafula FN, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-223; Wafula FN, 2010, INT J QUAL HEALTH C, V22, P316, DOI 10.1093/intqhc/mzq022; WHO-Johns Hopkins, 2012, 9 POINT RIGOUR SCALE	80	64	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117165	10.1371/journal.pone.0117165	http://dx.doi.org/10.1371/journal.pone.0117165			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629900	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100071
J	Kim, Y; Powathil, G; Kang, H; Trucu, D; Kim, H; Lawler, S; Chaplain, M				Kim, Yangjin; Powathil, Gibin; Kang, Hyunji; Trucu, Dumitru; Kim, Hyeongi; Lawler, Sean; Chaplain, Mark			Strategies of Eradicating Glioma Cells: A Multi-Scale Mathematical Model with miR-451-AMPK-mTOR Control	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HYBRID MODEL; BREAST-CANCER; TUMOR; INVASION; BRAIN; PROLIFERATION; GLIOBLASTOMA; MIGRATION; MICROENVIRONMENT	The cellular dispersion and therapeutic control of glioblastoma, the most aggressive type of primary brain cancer, depends critically on the migration patterns after surgery and intracellular responses of the individual cancer cells in response to external biochemical and bio-mechanical cues in the microenvironment. Recent studies have shown that a particular microRNA, miR-451, regulates downstream molecules including AMPK and mTOR to determine the balance between rapid proliferation and invasion in response to metabolic stress in the harsh tumor microenvironment. Surgical removal of main tumor is inevitably followed by recurrence of the tumor due to inaccessibility of dispersed tumor cells in normal brain tissue. In order to address this multi-scale nature of glioblastoma proliferation and invasion and its response to conventional treatment, we propose a hybrid model of glioblastoma that analyses spatio-temporal dynamics at the cellular level, linking individual tumor cells with the macroscopic behaviour of cell organization and the microenvironment, and with the intracellular dynamics of miR-451-AMPK-mTOR signaling within a tumour cell. The model identifies a key mechanism underlying the molecular switches between proliferative phase and migratory phase in response to metabolic stress and biophysical interaction between cells in response to fluctuating glucose levels in the presence of blood vessels (BVs). The model predicts that cell migration, therefore efficacy of the treatment, not only depends on oxygen and glucose availability but also on the relative balance between random motility and strength of chemoattractants. Effective control of growing cells near BV sites in addition to relocalization of invisible migratory cells back to the resection site was suggested as a way of eradicating these migratory cells.	[Kim, Yangjin; Kang, Hyunji] Konkuk Univ, Dept Math, Seoul 143701, South Korea; [Kim, Yangjin] Ohio State Univ, Dept Math, Columbus, OH 43210 USA; [Powathil, Gibin; Trucu, Dumitru; Chaplain, Mark] Univ Dundee, Div Math, Dundee, Scotland; [Kim, Hyeongi] Konkuk Univ, Dept Phys, Seoul 143701, South Korea; [Lawler, Sean] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Powathil, Gibin] Swansea Univ, Dept Math, Swansea, W Glam, Wales	Konkuk University; University System of Ohio; Ohio State University; University of Dundee; Konkuk University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Swansea University	Kim, Y (corresponding author), Konkuk Univ, Dept Math, Seoul 143701, South Korea.	ahyouhappy@konkuk.ac.kr	Kim, Yangjin/C-9681-2014; POWATHIL, GIBIN/D-4711-2014; Chaplain, Mark AJ/A-5355-2010	Kim, Yangjin/0000-0002-8905-8481; POWATHIL, GIBIN/0000-0002-8372-7349; Chaplain, Mark AJ/0000-0001-5727-2160	Konkuk University, South Korea	Konkuk University, South Korea	This work was supported by 2014 Faculty research grant at Konkuk University, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Chintala SK, 1999, INT J DEV NEUROSCI, V17, P495, DOI 10.1016/S0736-5748(99)00010-6; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dallon JC, 2004, J THEOR BIOL, V231, P203, DOI 10.1016/j.jtbi.2004.06.015; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Enderling H, 2012, MATH MED BIOL, V29, P21, DOI 10.1093/imammb/dqq015; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gordon K, 2006, THESIS, P154; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hong BJ, 2013, AM J CLIN ONCOL-CANC, V36, P261, DOI 10.1097/COC.0b013e3182467bb1; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; JAIN RK, 1987, CANCER RES, V47, P3039; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kim HD, 2008, MOL BIOL CELL, V19, P4249, DOI 10.1091/mbc.E08-05-0501; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Kim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102499; Kim Y, 2013, B MATH BIOL, V75, P1304, DOI 10.1007/s11538-012-9787-0; Kim Y, 2013, DISCRETE CONT DYN-B, V18, P969, DOI 10.3934/dcdsb.2013.18.969; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kim Y, 2011, PROG BIOPHYS MOL BIO, V106, P353, DOI 10.1016/j.pbiomolbio.2011.06.006; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; KUDLOW JE, 1986, J BIOL CHEM, V261, P4134; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; LI CKN, 1982, CANCER-AM CANCER SOC, V50, P2066, DOI 10.1002/1097-0142(19821115)50:10<2066::AID-CNCR2820501017>3.0.CO;2-X; MCCABE M, 1975, BIOCHIM BIOPHYS ACTA, V399, P131, DOI 10.1016/0304-4165(75)90219-6; Mercapide J, 2003, INT J CANCER, V106, P676, DOI 10.1002/ijc.11286; MUELLERKLIESER WF, 1984, ADV EXP MED BIOL, V180, P311; Owen MR, 2004, J THEOR BIOL, V226, P377, DOI 10.1016/j.jtbi.2003.09.004; Palsson E, 2000, P NATL ACAD SCI USA, V97, P10448, DOI 10.1073/pnas.97.19.10448; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Pogoda K, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/075002; Powathil G, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/410602; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; Rong ZM, 2006, ANALYST, V131, P816, DOI 10.1039/b600334f; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Silbergeld DL, 1997, J NEUROSURG, V86, P525, DOI 10.3171/jns.1997.86.3.0525; Stylli SS, 2005, J CLIN NEUROSCI, V12, P389, DOI 10.1016/j.jocn.2005.01.006; Thorne RG, 2004, J NEUROPHYSIOL, V92, P3471, DOI 10.1152/jn.00352.2004; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	59	57	60	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0114370	10.1371/journal.pone.0114370	http://dx.doi.org/10.1371/journal.pone.0114370			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629604	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100006
J	Shaw, AK; Pickup, MW; Chytil, A; Aakre, M; Owens, P; Moses, HL; Novitskiy, SV				Shaw, Aubie K.; Pickup, Michael W.; Chytil, Anna; Aakre, Mary; Owens, Philip; Moses, Harold L.; Novitskiy, Sergey V.			TGF beta Signaling in Myeloid Cells Regulates Mammary Carcinoma Cell Invasion through Fibroblast Interactions	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BREAST-CANCER CELLS; SUPPRESSOR-CELLS; TUMOR-METASTASIS; II RECEPTOR; T-CELLS; EXPRESSION; THERAPY; CXCR3; MODEL	Metastasis is the most devastating aspect of cancer, however we know very little about the mechanisms of local invasion, the earliest step of metastasis. During tumor growth CD11b(+)Gr1(+) cells, known also as MDSCs, have been shown to promote tumor progression by a wide spectrum of effects that suppress the anti-tumor immune response. In addition to immunosuppression, CD11b(+)Gr1(+) cells promote metastasis by mechanisms that are currently unknown. CD11b(+)Gr1(+) cells localize near fibroblasts, which remodel the ECM and leave tracks for collective cell migration of carcinoma cells. In this study we discovered that CD11b(+)Gr1(+) cells promote invasion of mammary carcinoma cells by increasing fibroblast migration. This effect was directed by secreted factors derived from CD11b(+)Gr1(+) cells. We have identified several CD11b(+)Gr1(+) cell secreted proteins that activate fibroblast migration, including CXCL11, CXCL15, FGF2, IGF-I, IL1Ra, Resistin, and Shh. The combination of CXCL11 and FGF2 had the strongest effect on fibroblast migration that is associated with Akt1 and ERK1/2 phosphorylation. Analysis of subsets of CD11b(+)Gr1(+) cells identified that CD11b(+)Ly6C(high)Ly6G(low) cells increase fibroblast migration more than other myeloid cell populations. Additionally, tumor-derived CD11b(+)Gr1(+) cells promote fibroblast migration more than splenic CD11b(+)Gr1(+) cells of tumor-bearing mice. While TGF beta signaling in fibroblasts does not regulate their migration toward CD11b(+)Gr1(+) cells, however deletion of TGF beta receptor II on CD11b(+)Gr1(+) cells downregulates CXCL11, Shh, IGF1 and FGF2 resulting in reduced fibroblast migration. These studies show that TGF beta signaling in CD11b(+)Gr1(+) cells promotes fibroblast directed carcinoma invasion and suggests that perivascular CD11b(+)Ly6C(high)Ly6G(low) cells may be the stimulus for localized invasion leading to metastasis.	[Shaw, Aubie K.; Pickup, Michael W.; Chytil, Anna; Aakre, Mary; Owens, Philip; Moses, Harold L.; Novitskiy, Sergey V.] Vanderbilt Univ, Dept Canc Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA	Vanderbilt University	Novitskiy, SV (corresponding author), Vanderbilt Univ, Dept Canc Biol, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	sergey.v.novitskiy@vanderbilt.edu		Shaw, Aubie/0000-0002-5298-801X	Vanderbilt-Ingram Cancer Center [P30 CA068485]; T.J. Martell Foundation/Frances Preston Williams Laboratory; Department of Defense Breast Cancer Research Program [W81XWH-09-4-0468, W81XWH-09-1-0421]; National Institutes of Health [CA085492, CA102162]; Robert J. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE [R01CA085492, P30CA068485, R01CA102162] Funding Source: NIH RePORTER	Vanderbilt-Ingram Cancer Center; T.J. Martell Foundation/Frances Preston Williams Laboratory; Department of Defense Breast Cancer Research Program(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert J. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Vanderbilt-Ingram Cancer Center Core Facilities P30 CA068485; T.J. Martell Foundation/Frances Preston Williams Laboratory; Department of Defense Breast Cancer Research Program Postdoctoral Fellowship W81XWH-09-4-0468 (to AS); Department of Defense Breast Cancer Research Program Postdoctoral Fellowship W81XWH-09-1-0421 (to P.O.); National Institutes of Health grants CA085492, CA102162 and the Robert J. and Helen C. Kleberg Foundation to HLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PROPOSAL TO WITHDRAW; Barcellos-Hoff MH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2224; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Fang WB, 2011, CLIN EXP METASTAS, V28, P351, DOI 10.1007/s10585-011-9373-0; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Hartog H, 2012, ANTICANCER RES, V32, P1309; Iiizumi M, 2008, BBA-REV CANCER, V1786, P87, DOI 10.1016/j.bbcan.2008.07.002; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kerbel RS, 2011, BREAST, V20, pS56, DOI 10.1016/S0960-9776(11)70295-8; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Korah R, 2004, BREAST CANCER RES TR, V88, P17, DOI 10.1007/s10459-004-6006-2; Lau MT, 2012, CANCER LETT, V326, P191, DOI 10.1016/j.canlet.2012.08.016; Li RS, 2009, J MED CHEM, V52, P4981, DOI 10.1021/jm9002395; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Matise LA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3217; Mognetti B, 2013, J CELL MOL MED, V17, P287, DOI 10.1111/jcmm.12010; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Novitskiy SV, 2012, J LEUKOCYTE BIOL, V92, P641, DOI 10.1189/jlb.1211639; Pang YL, 2013, CANCER DISCOV, V3, P936, DOI 10.1158/2159-8290.CD-12-0527; Perks Claire M, 2003, Breast Dis, V18, P45; Richardsen E, 2009, ANTICANCER RES, V29, P3861; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Ryzhov S, 2011, J IMMUNOL, V187, P6120, DOI 10.4049/jimmunol.1101225; Ryzhov SV, 2014, J IMMUNOL, V193, P3155, DOI 10.4049/jimmunol.1400578; Vlaicu P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-197; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yan HH, 2010, CANCER RES, V70, P6139, DOI 10.1158/0008-5472.CAN-10-0706; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yiangou C, 1997, BRIT J CANCER, V75, P28, DOI 10.1038/bjc.1997.5; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117908	10.1371/journal.pone.0117908	http://dx.doi.org/10.1371/journal.pone.0117908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629162	Green Submitted, gold, Green Published			2022-12-27	WOS:000348732100097
J	Takahashi, A; Inoue, H; Mishima, K; Ide, F; Nakayama, R; Hasaka, A; Ryo, K; Ito, Y; Sakurai, T; Hasegawa, Y; Saito, I				Takahashi, Ayako; Inoue, Hiroko; Mishima, Kenji; Ide, Fumio; Nakayama, Ryoko; Hasaka, Ayaka; Ryo, Koufuchi; Ito, Yumi; Sakurai, Takashi; Hasegawa, Yoshinori; Saito, Ichiro			Evaluation of the Effects of Quercetin on Damaged Salivary Secretion	PLOS ONE			English	Article							OXIDATIVE STRESS; POSSIBLE INVOLVEMENT; INDUCED XEROSTOMIA; SJOGRENS-SYNDROME; WATER CHANNELS; PAROTID-GLAND; MICE; RADIATION; CELLS; IRRADIATION	With the aim of discovering an effective method to treat dry mouth, we analyzed the effects of quercetin on salivary secretion and its mechanism of action. We created a mouse model with impaired salivary secretion by exposure to radiation and found that impaired secretion is suppressed by quercetin intake. Moreover, secretion levels were enhanced in quercetinfed normal mice. To elucidate the mechanisms of these effects on salivary secretion, we conducted an analysis using mouse submandibular gland tissues, a human salivary gland epithelial cell line (HSY), and mouse aortic endothelial cells (MAECs). The results showed that quercetin augments aquaporin 5 (AQP5) expression and calcium uptake, and suppresses oxidative stress and inflammatory responses induced by radiation exposure, suggesting that quercetin intake may be an effective method to treat impaired salivary secretion.	[Takahashi, Ayako; Inoue, Hiroko; Ide, Fumio; Nakayama, Ryoko; Hasaka, Ayaka; Ryo, Koufuchi; Ito, Yumi; Saito, Ichiro] Tsurumi Univ, Sch Dent Med, Dept Pathol, Yokohama, Kanagawa, Japan; [Inoue, Hiroko] Nihon Pharmaceut Univ, Dept Pharmaceut Sci, Saitama, Japan; [Mishima, Kenji] Showa Univ, Sch Dent, Dept Oral Diagnost Sci, Div Pathol, Tokyo 142, Japan; [Sakurai, Takashi] Kanagawa Dent Univ, Grad Sch Dent, Dept Radiopraxis Sci, Yokosuka, Kanagawa, Japan; [Hasegawa, Yoshinori] Kazusa DNA Res Inst, Dept Human Genome Res, Chiba, Japan	Tsurumi University; Showa University; Kanagawa Dental College; Kazusa DNA Research Institute	Saito, I (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Pathol, Yokohama, Kanagawa, Japan.	saito-i@tsurumi-u.ac.jp		Hasegawa, Yoshinori/0000-0003-2904-6611; Ushikoshi, Ryoko/0000-0002-6688-0413	Ministry of Agriculture, Forestry and Fisheries of Japan; Grants-in-Aid for Scientific Research [24592783] Funding Source: KAKEN	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant for a research project towards the creation of new agricultural products from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Botsoglou Nickos A., 1994, J AGR FOOD CHEM, V42, P1931; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Coppes RP, 2001, BRIT J CANCER, V85, P1055, DOI 10.1054/bjoc.2001.2038; Cotrim AP, 2007, MOL THER, V15, P2101, DOI 10.1038/sj.mt.6300296; De Zwart LL, 1999, FREE RADICAL BIO MED, V26, P202, DOI 10.1016/S0891-5849(98)00196-8; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; DUARTE J, 1993, GEN PHARMACOL-VASC S, V24, P857, DOI 10.1016/0306-3623(93)90159-U; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Evans RL, 2000, J BIOL CHEM, V275, P26720; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Ishikawa Y, 2006, J PHARMACOL SCI, V100, P495, DOI 10.1254/jphs.CRJ06007X; Jung JH, 2012, NUTR RES PRACT, V6, P301, DOI 10.4162/nrp.2012.6.4.301; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Kobori M, 2009, MOL NUTR FOOD RES, V53, P859, DOI 10.1002/mnfr.200800310; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Lamas DJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069106; McClung JM, 2007, J PHYSIOL-LONDON, V585, P203, DOI 10.1113/jphysiol.2007.141119; Mishima K, 2012, STEM CELLS, V30, P1925, DOI 10.1002/stem.1173; Mohammadi Narmin, 2007, J Dent Res Dent Clin Dent Prospects, V1, P65, DOI 10.5681/joddd.2007.011; Morita T, 2011, ARCH ORAL BIOL, V56, P1356, DOI 10.1016/j.archoralbio.2011.06.001; MOUTSOPOULOS HM, 1994, CLIN IMMUNOL IMMUNOP, V72, P162, DOI 10.1006/clin.1994.1123; Murdiastuti K, 2002, PFLUG ARCH EUR J PHY, V445, P405, DOI 10.1007/s00424-002-0940-8; Nakamura T, 2004, J PHYSIOL-LONDON, V558, P561, DOI 10.1113/jphysiol.2004.064626; Nishida S, 2009, KOREAN J PHYSIOL PHA, V13, P361, DOI 10.4196/kjpp.2009.13.5.361; Nishiyama T, 2007, J VASC RES, V44, P138, DOI 10.1159/000098520; Ryo K, 2006, PATHOBIOLOGY, V73, P252, DOI 10.1159/000098211; Singh BB, 2001, FASEB J, V15, P1652, DOI 10.1096/fj.00-0749fje; Surni M, 2013, LIFE SCI, V93, P814, DOI 10.1016/j.lfs.2013.09.005; Tai Y, 2009, RADIAT RES, V172, P331, DOI 10.1667/RR1557.1; Turner MD, 2007, J AM DENT ASSOC, V138, p15S, DOI 10.14219/jada.archive.2007.0358; VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Vitolo JM, 2004, CLIN CANCER RES, V10, P1807, DOI 10.1158/1078-0432.CCR-03-0194; Xu LP, 2013, LARYNGOSCOPE, V123, pE23, DOI 10.1002/lary.24276; Yamamoto T, 2004, ANTICANCER RES, V24, P3065; YANAGAWA T, 1986, VIRCHOWS ARCH B, V51, P187, DOI 10.1007/BF02899028; Yemisci M, 2008, CEREBROVASC DIS, V26, P190, DOI 10.1159/000145327	41	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116008	10.1371/journal.pone.0116008	http://dx.doi.org/10.1371/journal.pone.0116008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629520	Green Submitted, gold, Green Published			2022-12-27	WOS:000348732100028
J	Patrut, A; Woodborne, S; von Reden, KF; Hall, G; Hofmeyr, M; Lowy, DA; Patrut, RT				Patrut, Adrian; Woodborne, Stephan; von Reden, Karl F.; Hall, Grant; Hofmeyr, Michele; Lowy, Daniel A.; Patrut, Roxana T.			African Baobabs with False Inner Cavities: The Radiocarbon Investigation of the Lebombo Eco Trail Baobab	PLOS ONE			English	Article							PERFORMANCE; CARBON; AGE	The article reports the radiocarbon investigation results of the Lebombo Eco Trail tree, a representative African baobab from Mozambique. Several wood samples collected from the large inner cavity and from the outer part of the tree were investigated by AMS radiocarbon dating. According to dating results, the age values of all samples increase from the sampling point with the distance into the wood. For samples collected from the cavity walls, the increase of age values with the distance into the wood (up to a point of maximum age) represents a major anomaly. The only realistic explanation for this anomaly is that such inner cavities are, in fact, natural empty spaces between several fused stems disposed in a ring-shaped structure. We named them false cavities. Several important differences between normal cavities and false cavities are presented. Eventually, we dated other African baobabs with false inner cavities. We found that this new architecture enables baobabs to reach large sizes and old ages. The radiocarbon date of the oldest sample was 1425 +/- 24 BP, which corresponds to a calibrated age of 1355 +/- 15 yr. The dating results also show that the Lebombo baobab consists of five fused stems, with ages between 900 and 1400 years; these five stems build the complete ring. The ring and the false cavity closed 800-900 years ago. The results also indicate that the stems stopped growing toward the false cavity over the past 500 years.	[Patrut, Adrian] Univ Babes Bolyai, Dept Chem, Fac Chem, R-3400 Cluj Napoca, Romania; [Woodborne, Stephan] iThemba Labs, Somerset West, South Africa; [von Reden, Karl F.] Woods Hole Oceanog Inst, Dept Geol & Geophys, NOSAMS Facil, Woods Hole, MA 02543 USA; [Hall, Grant] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Hofmeyr, Michele] SANPk Sci Serv, Skukuza, South Africa; [Lowy, Daniel A.] Nova Univ, Alexandria, VA USA; [Patrut, Roxana T.] Univ Babes Bolyai, Fac Biol & Geol, R-3400 Cluj Napoca, Romania	Babes Bolyai University from Cluj; National Research Foundation - South Africa; iThemba LABS; Woods Hole Oceanographic Institution; University of Pretoria; Babes Bolyai University from Cluj	Patrut, A (corresponding author), Univ Babes Bolyai, Dept Chem, Fac Chem, Arany Janos 11, R-3400 Cluj Napoca, Romania.	apatrut@gmail.com	Hall, Grant/J-9886-2016; Patrut, Adrian/C-3566-2012; Lowy, Daniel A/C-3265-2016	Hall, Grant/0000-0002-2164-4900; Patrut, Adrian/0000-0002-9862-6735; Patrut, Roxana/0000-0002-8691-2160; von Reden, Karl/0000-0001-6413-9018	Romanian Ministry of National Education CNCS-UEFISCDI [PN-II-ID-PCE-2013-76]; Directorate For Geosciences [1239667] Funding Source: National Science Foundation	Romanian Ministry of National Education CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The research was fully funded by the Romanian Ministry of National Education CNCS-UEFISCDI under grant PN-II-ID-PCE-2013-76. URL:http://uefiscdi.gov.ro/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adam JG, 1962, NOTES AFRICAINES, V94, P33; BAUM DA, 1995, ANN MO BOT GARD, V82, P440, DOI 10.2307/2399893; Breitenbach F, 1985, J DENDROLOGY, V5, P1; Coates Palgrave K., 2002, TREES SO AFRICA; Esterhuyse N., 2001, REMARKABLE TREES S A; FISHER JB, 1981, IAWA BULL, V2, P193, DOI 10.1163/22941932-90000732; Guy G. L., 1970, Proceedings & Transactions, Rhodesia Scientific Association, Salisbury, V54, P68; Guy GL, 1967, RHODESIANA, V16, P17; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Olsson I.U., 1986, P273; Pakenham T., 2004, REMARKABLE BAOBAB; Patrut A, 2007, TREE PHYSIOL, V27, P1569, DOI 10.1093/treephys/27.11.1569; Patrut A, 2013, NUCL INSTRUM METH B, V294, P622, DOI 10.1016/j.nimb.2012.04.025; Patrut A, 2011, ANN FOREST SCI, V68, P993, DOI 10.1007/s13595-011-0107-x; Patrut A, 2010, RADIOCARBON, V52, P727; Patrut A, 2010, NUCL INSTRUM METH B, V268, P910, DOI 10.1016/j.nimb.2009.10.062; Pettigrew JD, 2012, TAXON, V61, P1240, DOI 10.1002/tax.616006; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Roberts ML, 2010, RADIOCARBON, V52, P228, DOI 10.1017/S0033822200045252; Robertson I, 2006, APPL GEOCHEM, V21, P1674, DOI 10.1016/j.apgeochem.2006.07.005; SOFER Z, 1980, ANAL CHEM, V52, P1389, DOI 10.1021/ac50058a063; Stutchbury R, 2013, THE BAOBAB, DOI [10.1002/jobm.201300390, DOI 10.1002/JOBM.201300390]; SWART ER, 1963, NATURE, V198, P708, DOI 10.1038/198708b0; VOGEL JS, 1984, NUCL INSTRUM METH B, V5, P289, DOI 10.1016/0168-583X(84)90529-9; VONREDEN KF, 1994, NUCL INSTRUM METH B, V92, P7, DOI 10.1016/0168-583X(94)95964-1; Watson R, 2007, THE AFRICAN BAOBAB; WICKENS G E, 1982, Kew Bulletin, V37, P173, DOI 10.2307/4109961; Wickens G.E., 2008, BAOBABS PACHYCAULS A, DOI DOI 10.1007/978-1-4020-6431-9	28	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117193	10.1371/journal.pone.0117193	http://dx.doi.org/10.1371/journal.pone.0117193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621989	Green Published, gold, Green Submitted			2022-12-27	WOS:000348470400021
J	Savage, SR; Bretz, CA; Penn, JS				Savage, Sara R.; Bretz, Colin A.; Penn, John S.			RNA-Seq Reveals a Role for NFAT-Signaling in Human Retinal Microvascular Endothelial Cells Treated with TNF alpha	PLOS ONE			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; SMALL ORGANIC-MOLECULES; LARGE GENE LISTS; NUCLEAR FACTOR; T-CELLS; EXPRESSION; ADHESION; DISEASE; INFLAMMATION; INHIBITION	TNF alpha has been identified as playing an important role in pathologic complications associated with diabetic retinopathy and retinal inflammation, such as retinal leukostasis. However, the transcriptional effects of TNF alpha on retinal microvascular endothelial cells and the different signaling pathways involved are not yet fully understood. In the present study, RNA-seq was used to profile the transcriptome of human retinal microvascular endothelial cells (HRMEC) treated for 4 hours with TNF alpha in the presence or absence of the NFAT-specific inhibitor INCA-6, in order to gain insight into the specific effects of TNF alpha on RMEC and identify any involvement of NFAT signaling. Differential expression analysis revealed that TNF alpha treatment significantly upregulated the expression of 579 genes when compared to vehicle-treated controls, and subsequent pathway analysis revealed a TNF alpha-induced enrichment of transcripts associated with cytokine-cytokine receptor interactions, cell adhesion molecules, and leukocyte transendothelial migration. Differential expression analysis comparing TNF alpha-treated cells to those co-treated with INCA-6 revealed 10 genes whose expression was significantly reduced by the NFAT inhibitor, including those encoding the proteins VCAM1 and CX3CL1 and cytokines CXCL10 and CXCL11. This study identifies the transcriptional effects of TNF alpha on HRMEC, highlighting its involvement in multiple pathways that contribute to retinal leukostasis, and identifying a previously unknown role for NFAT-signaling downstream of TNF alpha.	[Savage, Sara R.; Penn, John S.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Bretz, Colin A.; Penn, John S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Penn, John S.] Vanderbilt Univ, Sch Med, Dept Ophthalmol & Visual Sci, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Penn, JS (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.	john.penn@vanderbilt.edu		Bretz, Colin/0000-0001-5296-9399	National Eye institute [R01-EY07533, R01-EY023639, P30-EY08126]; National Institute of General Medical Sciences [T32-GM007628]; National Center for Advancing Translational Sciences [UL1-TR000445]; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126, R01EY023639, R01EY007533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628] Funding Source: NIH RePORTER	National Eye institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the National Eye institute: R01-EY07533 (JSP) and R01-EY023639 (JSP), the National Institute of General Medical Sciences: T32-GM007628, the National Center for Advancing Translational Sciences: UL1-TR000445, and an unrestricted grant from Research to Prevent Blindness, Inc. The sequencing was performed by the Vanderbilt VANTAGE core which is funded by a grant from the National Eye Institute: P30-EY08126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Alvarez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016100; Arndt H, 1996, GUT, V38, P911, DOI 10.1136/gut.38.6.911; Bittner S, 2013, NAT MED, V19, P1161, DOI 10.1038/nm.3303; Boss V, 1998, MOL PHARMACOL, V54, P264, DOI 10.1124/mol.54.2.264; Centers for Disease Control and Prevention, 1996, JAMA-J AM MED ASSOC, V276, P1865; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Guo Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/248090; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P1336, DOI 10.1167/iovs.10-5768; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Joussen AM, 2009, MOL VIS, V15, P1418; Kaminuma O, 2008, J IMMUNOL, V180, P319, DOI 10.4049/jimmunol.180.1.319; Kang SH, 2005, J BIOL CHEM, V280, P37698, DOI 10.1074/jbc.M502247200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lawrence MC, 2011, J BIOL CHEM, V286, P1025, DOI 10.1074/jbc.M110.158675; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Murugeswari P, 2008, RETINA-J RET VIT DIS, V28, P817, DOI 10.1097/IAE.0b013e31816576d5; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Patel KD, 1999, J IMMUNOL, V162, P6209; Porter JC, 2008, J IMMUNOL, V180, P1866, DOI 10.4049/jimmunol.180.3.1866; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Roehrl MHA, 2004, P NATL ACAD SCI USA, V101, P7554, DOI 10.1073/pnas.0401835101; Saaddine JB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1740, DOI 10.1001/archopht.126.12.1740; SCHRODER S, 1991, AM J PATHOL, V139, P81; Schweighofer B, 2009, THROMB HAEMOSTASIS, V102, P544, DOI 10.1160/TH08-12-0830; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Xue JP, 2009, PHYSIOL GENOMICS, V38, P42, DOI 10.1152/physiolgenomics.00012.2009; Yarilina A, 2011, P NATL ACAD SCI USA, V108, P1573, DOI 10.1073/pnas.1010030108; Zhang JL, 2010, INT J CLIN EXP MED, V3, P233; Zhang QH, 2013, MOL VIS, V19, P796	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116941	10.1371/journal.pone.0116941	http://dx.doi.org/10.1371/journal.pone.0116941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617622	Green Published, gold, Green Submitted			2022-12-27	WOS:000350336000031
J	Tang, Y; Wu, S; Liu, Q; Xie, JY; Zhang, JX; Han, D; Lu, QX; Lu, QJ				Tang, Yong; Wu, Shen; Liu, Qian; Xie, Jiayi; Zhang, Jingxue; Han, Dong; Lu, Qingxian; Lu, Qingjun			Mertk Deficiency Affects Macrophage Directional Migration via Disruption of Cytoskeletal Organization	PLOS ONE			English	Article							FOCAL ADHESION KINASE; RECEPTOR TYROSINE KINASE; RETINAL-PIGMENT EPITHELIUM; ALPHA-V-BETA-5 INTEGRIN; APOPTOTIC CELLS; TYRO-3 FAMILY; LEADING-EDGE; PHAGOCYTOSIS; MOTILITY; ACTIVATION	Mertk belongs to the Tyro3, Axl and Mertk (TAM) family of receptor tyrosine kinases, and plays a pivotal role in regulation of cytoskeletal rearrangement during phagocytosis. Phagocytosis by either professional or non-professional phagocytes is impaired in the Mertk deficient individual. In the present study, we further investigated the effects of Mertk mutation on peritoneal macrophage morphology, attachment, spreading and movement. Mertk-mutated macrophages exhibited decreased attachment, weak spreading, loss of spindle-like body shape and lack of clear leading and trailing edges within the first few hours of culture, as observed by environmental scanning electron microscopy. Time-lapse video photography recording showed that macrophage without Mertk conducted mainly random movement with oscillating swing around the cell body, and lost the directional migration action seen on the WT cells. Western blotting showed a decreased phosphorylation of focal adhesion kinase (FAK). Immunocytochemistry revealed that actin filaments and dynamic protein myosin II failed to concentrate in the leading edge of migrating cells. Microtubules were localized mainly in one side of mutant cell body, with no clear MTOC and associated radial-ly- distributed microtubule bundles, which were clearly evident in the WT cells. Our results suggest that Mertk deficiency affects not only phagocytosis but also cell shape and migration, likely through a common regulatory mechanism on cytoskeletons.	[Tang, Yong; Lu, Qingxian; Lu, Qingjun] Capital Med Univ, Beijing Tong Ren Hosp, Beijing Inst Ophthalmol, Beijing 100069, Peoples R China; [Wu, Shen; Liu, Qian; Zhang, Jingxue; Lu, Qingjun] Capital Med Univ, Beijing Tong Ren Hosp, Beijing Tong Ren Eye Ctr, Beijing 100069, Peoples R China; [Wu, Shen; Liu, Qian; Zhang, Jingxue; Lu, Qingjun] Beijing Ophthalmol & Visual Sci Key Lab, Beijing 100069, Peoples R China; [Xie, Jiayi; Han, Dong] Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China; [Lu, Qingxian] Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA	Capital Medical University; Capital Medical University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; University of Louisville	Lu, QX (corresponding author), Capital Med Univ, Beijing Tong Ren Hosp, Beijing Inst Ophthalmol, Beijing 100069, Peoples R China.	q.lu@louisville.edu; biocmu@163.com			National Institutes of Health [R01-EY018830]; National Natural Science Foundation of China [30400229]; Beijing Natural Science Foundation [7093116]; NATIONAL EYE INSTITUTE [R01EY018830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health grant R01-EY018830 (to Qingxian Lu), by National Natural Science Foundation of China 30400229, and Beijing Natural Science Foundation 7093116 (to Qingjun Lu). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; BHISEY AN, 1971, EXP CELL RES, V64, P419, DOI 10.1016/0014-4827(71)90096-6; CHEUNG HT, 1978, EXP CELL RES, V111, P95, DOI 10.1016/0014-4827(78)90240-9; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Deramaudt TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092059; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Finnemann SC, 2003, ADV EXP MED BIOL, V533, P337; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Ganguly A, 2012, J BIOL CHEM, V287, P43359, DOI 10.1074/jbc.M112.423905; Georgescu MM, 1999, MOL CELL BIOL, V19, P1171; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Hall MO, 2003, ADV EXP MED BIOL, V533, P331; Hoshino D, 2013, J CELL SCI, V126, P2979, DOI 10.1242/jcs.079475; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; MALECH HL, 1977, J CELL BIOL, V75, P666, DOI 10.1083/jcb.75.3.666; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; OSBORN M, 1976, P NATL ACAD SCI USA, V73, P867, DOI 10.1073/pnas.73.3.867; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers AEJ, 2012, ONCOGENE, V31, P4171, DOI 10.1038/onc.2011.588; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sieg DJ, 1999, J CELL SCI, V112, P2677; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Strick DJ, 2009, INVEST OPHTH VIS SCI, V50, P2427, DOI 10.1167/iovs.08-3058; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Todt JC, 2004, J LEUKOCYTE BIOL, V75, P705, DOI 10.1189/jlb.0903439; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Wu YM, 2004, CANCER RES, V64, P7311, DOI 10.1158/0008-5472.CAN-04-0972	44	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117787	10.1371/journal.pone.0117787	http://dx.doi.org/10.1371/journal.pone.0117787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617898	gold, Green Submitted, Green Published			2022-12-27	WOS:000350336000046
J	Adolfsson, L; Solymosi, K; Andersson, MX; Keresztes, A; Uddling, J; Schoefs, B; Spetea, C				Adolfsson, Lisa; Solymosi, Katalin; Andersson, Mats X.; Keresztes, Aron; Uddling, Johan; Schoefs, Benoit; Spetea, Cornelia			Mycorrhiza Symbiosis Increases the Surface for Sunlight Capture in Medicago truncatula for Better Photosynthetic Production	PLOS ONE			English	Article							CADMIUM STRESS ALLEVIATION; ARBUSCULAR MYCORRHIZAE; TEMPERATURE RESPONSE; FUNGI; PLANT; GROWTH; PHOSPHORUS; ROOTS; NITROGEN; CARBON	Arbuscular mycorrhizal (AM) fungi play a prominent role in plant nutrition by supplying mineral nutrients, particularly inorganic phosphate (P-i), and also constitute an important carbon sink. AM stimulates plant growth and development, but the underlying mechanisms are not well understood. In this study, Medicago truncatula plants were grown with Rhizophagus irregularis BEG141 inoculum (AM), mock inoculum (control) or with P-i fertilization. We hypothesized that AM stimulates plant growth through either modifications of leaf anatomy or photosynthetic activity per leaf area. We investigated whether these effects are shared with Pi fertilization, and also assessed the relationship between levels of AM colonization and these effects. We found that increased P-i supply by either mycorrhization or fertilization led to improved shoot growth associated with increased nitrogen uptake and carbon assimilation. Both mycorrhized and P-i-fertilized plants had more and longer branches with larger and thicker leaves than the control plants, resulting in an increased photosynthetically active area. AM-specific effects were earlier appearance of the first growth axes and increased number of chloroplasts per cell section, since they were not induced by P-i fertilization. Photosynthetic activity per leaf area remained the same regardless of type of treatment. In conclusion, the increase in growth of mycorrhized and P-i-fertilized Medicago truncatula plants is linked to an increase in the surface for sunlight capture, hence increasing their photosynthetic production, rather than to an increase in the photosynthetic activity per leaf area.	[Adolfsson, Lisa; Andersson, Mats X.; Uddling, Johan; Spetea, Cornelia] Univ Gothenburg, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden; [Solymosi, Katalin; Keresztes, Aron] Eotvos Lorand Univ, Dept Plant Anat, H-1117 Budapest, Hungary; [Schoefs, Benoit] Univ Le Mans, IUML CNRS FR 3473, LUNAM Univ, Mer Mol Sante MicroMar EA2160, F-72085 Le Mans, France	University of Gothenburg; Eotvos Lorand University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Le Mans Universite	Schoefs, B (corresponding author), Univ Le Mans, IUML CNRS FR 3473, LUNAM Univ, Mer Mol Sante MicroMar EA2160, F-72085 Le Mans, France.	benoit.schoefs@univ-lemans.fr; cornelia.spetea.wiklund@bioenv.gu.se	Schoefs, Benoit/AAE-4010-2019; Andersson, Mats/E-7958-2010; Wiklund, Cornelia Spetea/S-3635-2019	Schoefs, Benoit/0000-0002-7804-8130; Andersson, Mats/0000-0003-4279-6572; Solymosi, Katalin/0000-0001-5246-2547; Uddling, Johan/0000-0003-4893-1915	Swedish Research Council; Carl Tryggers Foundation; Engkvists Stiftelser; Adlebertska Forskningsstiftelser; University of Gothenburg; Ministry of Research and Education of the Republic of France; University of Le Mans; Helge Ax:Son Johnsons Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Foundation; Engkvists Stiftelser; Adlebertska Forskningsstiftelser; University of Gothenburg; Ministry of Research and Education of the Republic of France; University of Le Mans; Helge Ax:Son Johnsons Foundation	Research in the C.S. laboratory has been supported by grants from the Swedish Research Council, Carl Tryggers Foundation, Engkvists Stiftelser, Adlebertska Forskningsstiftelser and University of Gothenburg. B.S. acknowledges funding from the Ministry of Research and Education of the Republic of France and the University of Le Mans. C.S. and B.S. also thank the University of Le Mans and the Region "Pays de la Loire" for guest professor and 'chercheur haut niveau' positions. L.A. acknowledges a travel grant from Helge Ax:Son Johnsons Foundation.	Aloui A, 2009, PROTEOMICS, V9, P420, DOI 10.1002/pmic.200800336; Aloui A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-75; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Andersson MX, 2006, PLANT J, V47, P947, DOI 10.1111/j.1365-313X.2006.02844.x; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1111/j.1365-3040.2001.00668.x; Bestel-Corre G, 2002, ELECTROPHORESIS, V23, P122, DOI 10.1002/1522-2683(200201)23:1&lt;122::AID-ELPS122&gt;3.0.CO;2-4; Boldt K, 2011, J PLANT PHYSIOL, V168, P1256, DOI 10.1016/j.jplph.2011.01.026; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Bucciarelli B, 2006, PLANT PHYSIOL, V142, P207, DOI 10.1104/pp.106.082594; Bucher M, 2007, NEW PHYTOL, V173, P11, DOI 10.1111/j.1469-8137.2006.01935.x; Doidy J, 2012, MOL PLANT, V5, P1346, DOI 10.1093/mp/sss079; DUMASGAUDOT E, 1994, MYCORRHIZA, V4, P215, DOI 10.1007/BF00206783; Dutt S, 2013, SCI HORTIC-AMSTERDAM, V155, P97, DOI 10.1016/j.scienta.2013.03.012; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fester T., 2008, Plant cell compartments: selected topics, P335; Fusconi A, 2014, ANN BOT-LONDON, V113, P19, DOI 10.1093/aob/mct258; Gong MG, 2013, NEW FOREST, V44, P399, DOI 10.1007/s11056-012-9349-1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrison MJ, 1999, J EXP BOT, V50, P1013, DOI 10.1093/jexbot/50.suppl_1.1013; Hartwig UA, 2002, J EXP BOT, V53, P1207, DOI 10.1093/jexbot/53.371.1207; Hata S, 2010, INT REV CEL MOL BIO, V281, P1, DOI 10.1016/S1937-6448(10)81001-9; Hewitt E. J., 1966, Technical Communications. Commonwealth Bureau of Horticulture and Plantation Crops, P547; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; KRISHNA KR, 1981, NEW PHYTOL, V87, P717, DOI 10.1111/j.1469-8137.1981.tb01706.x; Leigh J, 2009, NEW PHYTOL, V181, P199, DOI 10.1111/j.1469-8137.2008.02630.x; Lendenmann M, 2011, MYCORRHIZA, V21, P689, DOI 10.1007/s00572-011-0371-5; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lohse S, 2005, PLANT PHYSIOL, V139, P329, DOI 10.1104/pp.105.061457; Louche-Tessandier D, 1999, NEW PHYTOL, V142, P539, DOI 10.1046/j.1469-8137.1999.00408.x; Meddad-Hamza A, 2010, AFR J BIOTECHNOL, V9, P1159; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1167, DOI 10.1046/j.1365-3040.2002.00891.x; Moreau D, 2006, PLANT CELL ENVIRON, V29, P1087, DOI 10.1111/j.1365-3040.2005.01483.x; Muller A, 2013, PLANT SOIL, V364, P341, DOI 10.1007/s11104-012-1372-7; Paradi I, 2003, BIOL PLANTARUM, V46, P563, DOI 10.1023/A:1024819729317; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; Rai MK, 2008, PLANT BIOSYST, V142, P191, DOI 10.1080/11263500802150225; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Redecker D, 2013, MYCORRHIZA, V23, P515, DOI 10.1007/s00572-013-0486-y; Rohacek K., 2008, Plant cell compartments: selected topics, P41; Sheng M, 2008, MYCORRHIZA, V18, P287, DOI 10.1007/s00572-008-0180-7; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2011, PLANT PHYSIOL, V156, P1050, DOI 10.1104/pp.111.174581; Solymosi K, 2006, TREE PHYSIOL, V26, P1087, DOI 10.1093/treephys/26.8.1087; STREETER J, 1988, CRIT REV PLANT SCI, V7, P1, DOI 10.1080/07352688809382257; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Tsimilli-Michael M, 2000, APPL SOIL ECOL, V15, P169, DOI 10.1016/S0929-1393(00)00093-7; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; Valentine AJ, 2001, SCI HORTIC-AMSTERDAM, V88, P177, DOI 10.1016/S0304-4238(00)00205-3; Verbruggen E, 2013, NEW PHYTOL, V197, P1104, DOI 10.1111/j.1469-8137.2012.04348.x; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Yin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046206; Zhang QA, 2011, ANN BOT-LONDON, V107, P407, DOI 10.1093/aob/mcq249	55	21	23	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115314	10.1371/journal.pone.0115314	http://dx.doi.org/10.1371/journal.pone.0115314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615871	gold, Green Published, Green Submitted			2022-12-27	WOS:000349122100009
J	Zhang, JL; Upadhya, D; Lu, L; Reneker, LW				Zhang, Jinglin; Upadhya, Dinesh; Lu, Lin; Reneker, Lixing W.			Fibroblast Growth Factor Receptor 2 (FGFR2) Is Required for Corneal Epithelial Cell Proliferation and Differentiation during Embryonic Development	PLOS ONE			English	Article							LENS-SPECIFIC EXPRESSION; ECTOPIC GLAND INDUCTION; EYE DEVELOPMENT; FACTOR-ALPHA; MOUSE; MORPHOGENESIS; PAX6; EGF; KERATOCAN; CYTOKINE	Fibroblast growth factors (FGFs) play important roles in many aspects of embryonic development. During eye development, the lens and corneal epithelium are derived from the same surface ectodermal tissue. FGF receptor (FGFR)-signaling is essential for lens cell differentiation and survival, but its role in corneal development has not been fully investigated. In this study, we examined the corneal defects in Fgfr2 conditional knockout mice in which Cre expression is activated at lens induction stage by Pax6 P0 promoter. The cornea in LeCre, Fgfr2(loxP/loxP) mice (referred as Fgfr2(CKO)) was analyzed to assess changes in cell proliferation, differentiation and survival. We found that Fgfr2(CKO) cornea was much thinner in epithelial and stromal layer when compared to WT cornea. At embryonic day 12.5-13.5 (E12.5-13.5) shortly after the lens vesicle detaches from the overlying surface ectoderm, cell proliferation (judged by labeling indices of Ki-67, BrdU and phospho-histone H3) was significantly reduced in corneal epithelium in Fgfr2(CKO) mice. At later stage, cell differentiation markers for corneal epithelium and underlying stromal mesenchyme, keratin-12 and keratocan respectively, were not expressed in Fgfr2(CKO) cornea. Furthermore, Pax6, a transcription factor essential for eye development, was not present in the Fgfr2(CKO) mutant corneal epithelial at E16.5 but was expressed normally at E12.5, suggesting that FGFR2-signaling is required for maintaining Pax6 expression in this tissue. Interestingly, the role of FGFR2 in corneal epithelial development is independent of ERK1/2-signaling. In contrast to the lens, FGFR2 is not required for cell survival in cornea. This study demonstrates for the first time that FGFR2 plays an essential role in controlling cell proliferation and differentiation, and maintaining Pax6 levels in corneal epithelium via ERK-independent pathways during embryonic development.	[Zhang, Jinglin; Lu, Lin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Upadhya, Dinesh; Reneker, Lixing W.] Univ Missouri, Mason Eye Inst, Dept Ophthalmol, Columbia, MO 65211 USA	Sun Yat Sen University; University of Missouri System; University of Missouri Columbia	Reneker, LW (corresponding author), Univ Missouri, Mason Eye Inst, Dept Ophthalmol, Columbia, MO 65211 USA.	renekerl@health.missouri.edu	Upadhya, Dinesh/I-1224-2019; Upadhya, Dinesh/GOV-6410-2022	Upadhya, Dinesh/0000-0003-0673-9765; Upadhya, Dinesh/0000-0003-0673-9765	International Program of Project 985 (Sun Yat-Sen University, China); NIH [EY13146, EY14795]; Research to Prevent Blindness (RPB); NATIONAL EYE INSTITUTE [R24EY014795, R01EY013146] Funding Source: NIH RePORTER	International Program of Project 985 (Sun Yat-Sen University, China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	JZ was supported by International Program of Project 985 (Sun Yat-Sen University, China). LWR was supported by NIH EY13146. This work was also supported by NIH minicore grant EY14795 and unrestricted funding from Research to Prevent Blindness (RPB) to the Department of Ophthalmology at University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen JL, 1998, CURR EYE RES, V17, P79; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Burgess D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-13; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carrington LM, 2005, J CATARACT REFR SURG, V31, P412, DOI 10.1016/j.jcrs.2004.04.072; Chandrasekher G, 2001, EXP EYE RES, V73, P191, DOI 10.1006/exer.2001.1026; Chikama T, 2008, AM J PATHOL, V172, P638, DOI 10.2353/ajpath.2008.070897; Collinson JM, 2003, DEV BIOL, V255, P303, DOI 10.1016/S0012-1606(02)00095-7; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; deIongh RU, 1997, INVEST OPHTH VIS SCI, V38, P1688; Dora NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109193; Faber SC, 2001, DEVELOPMENT, V128, P4425; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; FROMM L, 1994, MOL CELL BIOL, V14, P6743, DOI 10.1128/MCB.14.10.6743; Garcia CM, 2005, DEV DYNAM, V233, P516, DOI 10.1002/dvdy.20356; Govindarajan V, 2000, DEV BIOL, V225, P188, DOI 10.1006/dbio.2000.9812; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Hay E D, 1979, Curr Top Eye Res, V1, P1; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kao WWY, 2008, OCUL SURF, V6, P9; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Li CL, 2001, DEV DYNAM, V222, P471, DOI 10.1002/dvdy.1205; Li DQ, 1997, J CELL PHYSIOL, V172, P361, DOI 10.1002/(SICI)1097-4652(199709)172:3<361::AID-JCP10>3.0.CO;2-9; LI DQ, 1995, J CELL PHYSIOL, V163, P61, DOI 10.1002/jcp.1041630108; Li DQ, 1996, INVEST OPHTH VIS SCI, V37, P2068; Li SX, 2007, INVEST OPHTH VIS SCI, V48, P3292, DOI 10.1167/iovs.06-1482; Liu CY, 1998, J BIOL CHEM, V273, P22584, DOI 10.1074/jbc.273.35.22584; Liu JJ, 1999, EXP EYE RES, V68, P295, DOI 10.1006/exer.1998.0593; Lovicu FJ, 1999, MECH DEVELOP, V88, P43, DOI 10.1016/S0925-4773(99)00169-0; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Mort RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028895; OGUIN WM, 1987, CURR TOP DEV BIOL, V22, P97; Ornitz DM, 2001, GENOME BIOL, V2; Ou JX, 2010, INVEST OPHTH VIS SCI, V51, P1415, DOI 10.1167/iovs.09-4023; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; Reneker LW, 2000, DEVELOPMENT, V127, P533; Robinson ML, 2006, SEMIN CELL DEV BIOL, V17, P726, DOI 10.1016/j.semcdb.2006.10.002; Robinson ML, 1998, DEV BIOL, V198, P13, DOI 10.1016/S0012-1606(98)80026-2; Saika S, 2001, DEV BIOL, V240, P419, DOI 10.1006/dbio.2001.0480; SOTOZONO C, 1995, INVEST OPHTH VIS SCI, V36, P1524; Tanifuji-Terai N, 2006, INVEST OPHTH VIS SCI, V47, P545, DOI 10.1167/iovs.05-1182; Upadhya D, 2013, DEVELOPMENT, V140, P1573, DOI 10.1242/dev.081042; WATANABE K, 1987, INVEST OPHTH VIS SCI, V28, P205; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2544; Xie LK, 2006, DEV BIOL, V298, P403, DOI 10.1016/j.ydbio.2006.06.045; Yanai R, 2006, EXP EYE RES, V83, P76, DOI 10.1016/j.exer.2005.10.033; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang Y, 2007, MOL VIS, V13, P2289; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz; ZIESKE JD, 1993, J CELL SCI, V106, P145	59	28	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117089	10.1371/journal.pone.0117089	http://dx.doi.org/10.1371/journal.pone.0117089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615698	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100055
J	Kainz, P; Mayrhofer-Reinhartshuber, M; Ahammer, H				Kainz, Philipp; Mayrhofer-Reinhartshuber, Michael; Ahammer, Helmut			IQM: An Extensible and Portable Open Source Application for Image and Signal Analysis in Java	PLOS ONE			English	Article							OPEN-SOURCE SOFTWARE; PHYSIOLOGICAL TIME-SERIES; FRACTAL CHARACTERIZATION; FREQUENCY-ANALYSIS; CLASSIFICATION; PLATFORM; ENTROPY; REGISTRATION; DIMENSIONS; ALGORITHM	Image and signal analysis applications are substantial in scientific research. Both open source and commercial packages provide a wide range of functions for image and signal analysis, which are sometimes supported very well by the communities in the corresponding fields. Commercial software packages have the major drawback of being expensive and having undisclosed source code, which hampers extending the functionality if there is no plugin interface or similar option available. However, both variants cannot cover all possible use cases and sometimes custom developments are unavoidable, requiring open source applications. In this paper we describe IQM, a completely free, portable and open source (GNU GPLv3) image and signal analysis application written in pure Java. IQM does not depend on any natively installed libraries and is therefore runnable out-of-the-box. Currently, a continuously growing repertoire of 50 image and 16 signal analysis algorithms is provided. The modular functional architecture based on the three-tier model is described along the most important functionality. Extensibility is achieved using operator plugins, and the development of more complex workflows is provided by a Groovy script interface to the JVM. We demonstrate IQM's image and signal processing capabilities in a proof-of-principle analysis and provide example implementations to illustrate the plugin framework and the scripting interface. IQM integrates with the popular ImageJ image processing software and is aiming at complementing functionality rather than competing with existing open source software. Machine learning can be integrated into more complex algorithms via the WEKA software package as well, enabling the development of transparent and robust methods for image and signal analysis.	[Kainz, Philipp; Mayrhofer-Reinhartshuber, Michael; Ahammer, Helmut] Med Univ Graz, Ctr Physiol Med, Inst Biophys, Graz, Austria	Medical University of Graz	Ahammer, H (corresponding author), Med Univ Graz, Ctr Physiol Med, Inst Biophys, Graz, Austria.	helmut.ahammer@medunigraz.at		Ahammer, Helmut/0000-0001-5400-294X				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AGUILAR M, 1993, J MICROSC-OXFORD, V172, P233, DOI 10.1111/j.1365-2818.1993.tb03417.x; Ahammer H, 2008, PHYSICA D, V237, P446, DOI 10.1016/j.physd.2007.09.016; Ahammer H, 2005, CHAOS SOLITON FRACT, V26, P707, DOI 10.1016/j.chaos.2005.01.050; Ahammer H, 2004, CHAOS, V14, P183, DOI 10.1063/1.1638947; Ahammer H, 2012, FRACTALS, V20, P281, DOI 10.1142/S0218348X12500260; Ahammer H, 2011, CHAOS SOLITON FRACT, V44, P86, DOI 10.1016/j.chaos.2010.12.004; AHAMMER H, 2010, IMAGEJ US DEV C 2010; AHAMMER H, 2011, HIGUCHI DIMENSION DI; Ahonen T, 2004, LECT NOTES COMPUT SC, V3021, P469; ANGUIANO E, 1993, J MICROSC-OXFORD, V172, P223, DOI 10.1111/j.1365-2818.1993.tb03416.x; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Barboriak DP, 2005, J DIGIT IMAGING, V18, P91, DOI 10.1007/s10278-004-1879-4; Barnsley M, 1993, FRACTALS EVERYWHERE; Bishop Christopher M., 2006, PATTERN RECOGNITION; Bonaccorsi A, 2003, RES POLICY, V32, P1243, DOI 10.1016/S0048-7333(03)00051-9; Bradski G., 2000, DOBBS J SOFTWARE TOO; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carpenter AE, 2012, NAT METHODS, V9, P666, DOI 10.1038/nmeth.2073; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Eckerson W, 1995, OPEN INFORM SYST, V3, P46; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Eliceiri KW, 2005, PHOTOCHEM PHOTOBIOL, V81, P1116, DOI 10.1562/2004-11-22-IR-377; FUCHS TJ, 2010, THESIS SWISS FEDERAL; Gallego MD, 2008, COMPUT HUM BEHAV, V24, P2199, DOI 10.1016/j.chb.2007.10.006; Gamma E., 1994, DESIGN PATTERNS ELEM; Gering E, 2004, J PARASITOL, V90, P879, DOI 10.1645/GE-222R; Gonzalez R.C., 2008, DIGITAL IMAGE PROCES; Hajnal JV, 2001, MED IMAGE REGISTRATI; Hall M., 2009, ACM SIGKDD EXPLOR NE, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HENON M, 1976, COMMUN MATH PHYS, V50, P69, DOI 10.1007/BF01608556; Henriksson J, 2013, NAT METHODS, V10, P454, DOI 10.1038/nmeth.2478; Hibbard B, 2003, COMPUT GRAPHICS-US, V37, P5, DOI 10.1145/941552.941556; Janamanchi B, 2009, INT J MED INFORM, V78, P457, DOI 10.1016/j.ijmedinf.2009.02.006; JIN XC, 1995, PATTERN RECOGN LETT, V16, P457, DOI 10.1016/0167-8655(94)00119-N; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; KARPERIEN A, 1999, FRACLAC FOR IMAGEJ; KOENIG D, 2007, GROOVY IN ACTION; KOVACS G, 2010, P INT C MULT MM 10 A, P1489, DOI DOI 10.1145/1873951.1874255; Kumar N, 2005, SIAM PROC S, P531; Lake DE, 2006, IEEE T BIO-MED ENG, V53, P21, DOI 10.1109/TBME.2005.859782; Lake DE, 2011, AM J PHYSIOL-HEART C, V300, pH319, DOI 10.1152/ajpheart.00561.2010; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; LIEBOVITCH LS, 1989, PHYS LETT A, V141, P386, DOI 10.1016/0375-9601(89)90854-2; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Lu W, 2006, MED PHYS, V33, P3634, DOI 10.1118/1.2348764; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Mandelbrot BB, 1983, FRACTAL GEOMETRY NAT; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rasband W.S., 1997, IMAGEJ; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rueden C, 2004, TRAFFIC, V5, P411, DOI 10.1111/j.1600-0854.2004.00189.x; SARKAR N, 1995, SIGNAL PROCESS, V42, P181, DOI 10.1016/0165-1684(94)00126-K; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuffler Peter J, 2013, J Pathol Inform, V4, pS2, DOI 10.4103/2153-3539.109804; Shelhamer M, 2007, NONLINEAR DYNAMICS IN PHYSIOLOGY: A STATE-SPACE APPROACH, P1; Sprott JC, 2003, CHAOS TIME SERIES AN; Subramaniam C, 2009, DECIS SUPPORT SYST, V46, P576, DOI 10.1016/j.dss.2008.10.005; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; VOKES MS, 2008, CURRENT PROTOCOLS MO, P1; Yoo TS, 2002, STUD HEALTH TECHNOL, V85, P586; Zenil H, 2012, COMPLEXITY, V17, P26, DOI 10.1002/cplx.20388	72	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116329	10.1371/journal.pone.0116329	http://dx.doi.org/10.1371/journal.pone.0116329			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612319	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000348562900012
J	Oliveira, U; Brescovit, AD; Santos, AJ				Oliveira, Ubirajara; Brescovit, Antonio D.; Santos, Adalberto J.			Delimiting Areas of Endemism through Kernel Interpolation	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST; PARSIMONY ANALYSIS; BIOGEOGRAPHY; DIVERSITY; PHYLOGEOGRAPHY; BIODIVERSITY; PATTERNS; AMAZON; DIVERSIFICATION; DISTRIBUTIONS	We propose a new approach for identification of areas of endemism, the Geographical Interpolation of Endemism (GIE), based on kernel spatial interpolation. This method differs from others in being independent of grid cells. This new approach is based on estimating the overlap between the distribution of species through a kernel interpolation of centroids of species distribution and areas of influence defined from the distance between the centroid and the farthest point of occurrence of each species. We used this method to delimit areas of endemism of spiders from Brazil. To assess the effectiveness of GIE, we analyzed the same data using Parsimony Analysis of Endemism and NDM and compared the areas identified through each method. The analyses using GIE identified 101 areas of endemism of spiders in Brazil GIE demonstrated to be effective in identifying areas of endemism in multiple scales, with fuzzy edges and supported by more synendemic species than in the other methods. The areas of endemism identified with GIE were generally congruent with those identified for other taxonomic groups, suggesting that common processes can be responsible for the origin and maintenance of these biogeographic units.	[Oliveira, Ubirajara; Santos, Adalberto J.] Univ Fed Minas Gerais, Dept Zool, Belo Horizonte, MG, Brazil; [Brescovit, Antonio D.] Inst Butantan, Lab Especial Colecoes Zool, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Instituto Butantan	Oliveira, U (corresponding author), Univ Fed Minas Gerais, Dept Zool, Belo Horizonte, MG, Brazil.	ubiologia@yahoo.com.br	Brescovit, Antonio/B-5215-2016; Santos, Adalberto J/H-8349-2012; BRESCOVIT, ANTONIO/Y-1169-2019	Brescovit, Antonio/0000-0002-1511-5324; Santos, Adalberto J/0000-0002-0010-346X; 	FAPEMIG [PPM-00335-13]; CAPES; CNPq [301776/2004-0, 475179/2012-9, 308072/2012-0]; FAPESP [2011/50689-0]; Instituto Nacional de Ciencia e Tecnologia dos Hymenoptera Parasitoides da Regiao Sudeste Brasileira	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia dos Hymenoptera Parasitoides da Regiao Sudeste Brasileira	This study was sponsored by a FAPEMIG and CAPES graduate fellowships to UO and by research grants from CNPq (301776/2004-0) and FAPESP (2011/50689-0) to ADB; and CNPq (475179/2012-9, 308072/2012-0), FAPEMIG (PPM-00335-13) and Instituto Nacional de Ciencia e Tecnologia dos Hymenoptera Parasitoides da Regiao Sudeste Brasileira (http://www.hympar.ufscar.br/) to AJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagesen L, 2013, J BIOGEOGR, V40, P2011, DOI 10.1111/jbi.12172; AXELIUS B, 1991, CLADISTICS, V7, P197, DOI 10.1111/j.1096-0031.1991.tb00032.x; Bailey T, 1995, INTERACTIVE SPATIAL; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Bridgewater S, 2004, BIODIVERS CONSERV, V13, P2295, DOI 10.1023/B:BIOC.0000047903.37608.4c; Brunes TO, 2010, MOL PHYLOGENET EVOL, V57, P1120, DOI 10.1016/j.ympev.2010.08.026; Cabanne GS, 2011, BIOL J LINN SOC, V103, P801, DOI 10.1111/j.1095-8312.2011.01678.x; Cabanne GS, 2008, MOL PHYLOGENET EVOL, V49, P760, DOI 10.1016/j.ympev.2008.09.013; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Costa LP, 2000, BIOTROPICA, V32, P872; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; Crisci J. V., 2003, HIST BIOGEOGRAPHY IN; Crother BI, 2011, J BIOGEOGR, V38, P1009, DOI 10.1111/j.1365-2699.2011.02483.x; da Silva JMC, 2004, GLOBAL ECOL BIOGEOGR, V13, P85, DOI 10.1111/j.1466-882X.2004.00077.x; de Moraes-Barros N, 2006, GENETICA, V126, P189, DOI 10.1007/s10709-005-1448-x; Deo AJ, 2006, J BIOGEOGR, V33, P1511, DOI 10.1111/j.1365-2699.2006.01559.x; Duffey E., 1997, P 17 EUR C AR ED; Ferretti N, 2014, J INSECT CONSERV, V18, P1087, DOI 10.1007/s10841-014-9718-5; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Gamble T, 2012, MOL PHYLOGENET EVOL, V62, P943, DOI 10.1016/j.ympev.2011.11.033; Garcia-Barros E, 2002, J BIOGEOGR, V29, P109, DOI 10.1046/j.1365-2699.2002.00653.x; Gillespie RG, 2013, SPIDER RES 21 CENTUR, P154; Goldani A., 2006, Braz. J. Biol., V66, P61, DOI 10.1590/S1519-69842006000100009; Goloboff P. A., 2005, NDM VNDM VER 2 5 PRO; Goloboff P, 2008, CLADISTICS, V24, P91; Guo DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072352; Haffer J., 2002, Estud. av., V16, P175, DOI 10.1590/S0103-40142002000300014; Haffer J., 1985, Ornithological Monographs, P113; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HAROLD AS, 1994, SYST BIOL, V43, P261, DOI 10.2307/2413466; Harris MB, 2005, CONSERV BIOL, V19, P714, DOI 10.1111/j.1523-1739.2005.00708.x; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; Hopkins MJG, 2007, J BIOGEOGR, V34, P1400, DOI 10.1111/j.1365-2699.2007.01737.x; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Linder HP, 2001, SYST BIOL, V50, P892, DOI 10.1080/106351501753462867; Lowenberg-Neto P, 2009, J BIOGEOGR, V36, P1750, DOI 10.1111/j.1365-2699.2009.02112.x; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Moline PM, 2006, J BIOGEOGR, V33, P47, DOI 10.1111/j.1365-2699.2005.01369.x; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; Nelson G., 1981, SYSTEMATICS BIOGEORA; OLIVEIRA U., 2011, DIVERSIDADE BIOGEOGR; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Platnick N. I., 2013, WORLD SPIDER CATALOG; Platnick NI, 1991, AUSTR SYSTEMATIC BOT; Porto TJ, 2013, DIVERS DISTRIB, V19, P330, DOI 10.1111/j.1472-4642.2012.00944.x; Porzecanski AL, 2005, J BIOGEOGR, V32, P261, DOI 10.1111/j.1365-2699.2004.01138.x; Posadas P, 2001, CONSERV BIOL, V15, P1325, DOI 10.1046/j.1523-1739.2001.99404.x; Rasanen ME, 1990, TERRA NOVA, V2, P320, DOI 10.1111/j.1365-3121.1990.tb00084.x; Rasanen ME, 1996, SCIENCE, V273, P124, DOI 10.1126/science.273.5271.124; Rosen B.R., 1988, P437; SAADI A, 1993, GEONOMOS, V1, P1, DOI DOI 10.18285/GEONOMOS.V1I1E2.233; Santos JC, 2011, TROP CONSERV SCI, V4, P276, DOI 10.1177/194008291100400306; Nihei SS, 2006, J BIOGEOGR, V33, P2099, DOI 10.1111/j.1365-2699.2006.01619.x; Sigrist Mário Sérgio, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000400002; Silva SM, 2012, BIOL J LINN SOC, V107, P39, DOI 10.1111/j.1095-8312.2012.01919.x; Soderstrom T. R, 1988, P WORKSH NEOTR DISTR, P121; Szumik CA, 2002, SYST BIOL, V51, P806, DOI 10.1080/10635150290102483; Szumik CA, 2004, SYST BIOL, V53, P968, DOI 10.1080/10635150490888859; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Townsend Peterson A., 1998, Diversity & Distributions, V4, P189, DOI 10.1046/j.1472-4642.1998.00021.x; TYLER HA, 1994, SWALLOWTAIL BUTTERFL	64	46	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116673	10.1371/journal.pone.0116673	http://dx.doi.org/10.1371/journal.pone.0116673			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611971	Green Submitted, gold, Green Published			2022-12-27	WOS:000348562900019
J	Almagro, G; Viale, AM; Montero, M; Rahimpour, M; Munoz, FJ; Baroja-Fernandez, E; Bahaji, A; Zuniga, M; Gonzalez-Candelas, F; Pozueta-Romero, J				Almagro, Goizeder; Viale, Alejandro M.; Montero, Manuel; Rahimpour, Mehdi; Munoz, Francisco Jose; Baroja-Fernandez, Edurne; Bahaji, Abdellatif; Zuniga, Manuel; Gonzalez-Candelas, Fernando; Pozueta-Romero, Javier			Comparative Genomic and Phylogenetic Analyses of Gammaproteobacterial glg Genes Traced the Origin of the Escherichia coli Glycogen glgBXCAP Operon to the Last Common Ancestor of the Sister Orders Enterobacteriales and Pasteurellales	PLOS ONE			English	Article							HORIZONTALLY TRANSFERRED GENES; BACTERIAL GLYCOGEN; AGROBACTERIUM-TUMEFACIENS; SEQUENCE ALIGNMENT; SELFISH OPERONS; METABOLISM; GLUCOSE; EXPRESSION; EVOLUTION; GROWTH	Production of branched a-glucan, glycogen-like polymers is widely spread in the Bacteria domain. The glycogen pathway of synthesis and degradation has been fairly well characterized in the model enterobacterial species Escherichia coli (order Enterobacteriales, class Gammaproteobacteria), in which the cognate genes (branching enzyme glgB, debranching enzyme glgX, ADP-glucose pyrophosphorylase glgC, glycogen synthase glgA, and glycogen phosphorylase glgP) are clustered in a glgBXCAP operon arrangement. However, the evolutionary origin of this particular arrangement and of its constituent genes is unknown. Here, by using 265 complete gammaproteobacterial genomes we have carried out a comparative analysis of the presence, copy number and arrangement of glg genes in all lineages of the Gammaproteobacteria. These analyses revealed large variations in glg gene presence, copy number and arrangements among different gammaproteobacterial lineages. However, the glgBXCAP arrangement was remarkably conserved in all glg-possessing species of the orders Enterobacteriales and Pasteurellales (the E/P group). Subsequent phylogenetic analyses of glg genes present in the Gammaproteobacteria and in other main bacterial groups indicated that glg genes have undergone a complex evolutionary history in which horizontal gene transfer may have played an important role. These analyses also revealed that the E/P glgBXCAP genes (a) share a common evolutionary origin, (b) were vertically transmitted within the E/P group, and (c) are closely related to glg genes of some phylogenetically distant betaproteobacterial species. The overall data allowed tracing the origin of the E. coli glgBXCAP operon to the last common ancestor of the E/P group, and also to uncover a likely glgBXCAP transfer event from the E/P group to particular lineages of the Betaproteobacteria.	[Almagro, Goizeder; Montero, Manuel; Rahimpour, Mehdi; Munoz, Francisco Jose; Baroja-Fernandez, Edurne; Bahaji, Abdellatif; Pozueta-Romero, Javier] CSIC UPNA Gobierno Navarra, Inst Agrobiotecnol, Mutiloabeti 31192, Nafarroa, Spain; [Viale, Alejandro M.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR CONICET, Dept Microbiol, RA-2000 Rosario, Argentina; [Zuniga, Manuel] CSIC, Inst Agroquim & Tecnol Alimentos, Dpt Biotecnol Alimentos, Valencia 46980, Spain; [Gonzalez-Candelas, Fernando] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, FISABIO Salud Publ, Unidad Mixta Genom & Salud, Valencia 246980, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Valencia	Almagro, G (corresponding author), Univ Alberta, Alberta Glyc Ctr, Dept Biol Sci, CW405 Biol Sci Bldg, Edmonton, AB, Canada.	goizeder.almagro@unavarra.es; javier.pozueta@unavarra.es	Candelas, Fernando Gonzalez/G-5681-2010; Rahimpour, Mehdi/M-4042-2017; Edurne, Baroja-Fernandez/I-4037-2012; Pozueta-Romero, Javier/AAP-9341-2021; Zúñiga, Manuel/A-7519-2012; Zúñiga, Manuel/AAI-4370-2021; Bahaji, Abdellatif/C-4105-2015; Muñoz, Francisco/I-3547-2012; Pozueta-Romero, Javier/G-3766-2011; Almagro, Goizeder/Y-9900-2019	Candelas, Fernando Gonzalez/0000-0002-0879-5798; Edurne, Baroja-Fernandez/0000-0003-0049-6045; Pozueta-Romero, Javier/0000-0002-0335-9663; Zúñiga, Manuel/0000-0003-1750-6975; Bahaji, Abdellatif/0000-0002-5270-497X; Muñoz, Francisco/0000-0002-0426-2118; Pozueta-Romero, Javier/0000-0002-0335-9663; Almagro, Goizeder/0000-0001-7035-9965	Comision Inter-ministerial de Ciencia y Tecnologia [BIO2010-18239]; Fondo Europeo de Desarrollo Regional (Spain); Consejo Superior de Investigaciones Cientificas; Programa Campus Iberus de Excelencia Internacional, Ministerio de Educacion, Spain; Ministerio de Ciencia e Innovacion (Spain) [BFU2011-24112]	Comision Inter-ministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Fondo Europeo de Desarrollo Regional (Spain)(European Commission); Consejo Superior de Investigaciones Cientificas; Programa Campus Iberus de Excelencia Internacional, Ministerio de Educacion, Spain; Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was partially supported by the grant [BIO2010-18239] from the Comision Inter-ministerial de Ciencia y Tecnologia and Fondo Europeo de Desarrollo Regional (Spain). MR acknowledges a pre-doctoral JAE fellowship from the Consejo Superior de Investigaciones Cientificas. AMV is grateful to the funding of the Programa Campus Iberus de Excelencia Internacional, Ministerio de Educacion, Spain. His 2-month visit (January-March 2014) to the Institute of Agrobiotechnology, Public Universtity of Navarra, Pamplona, Spain, was included into the Proyecto financiado por el Ministerio de Educacion en el marco del Programa Campus de Excelencia Internacional. FGC was supported by project [BFU2011-24112] from the Ministerio de Ciencia e Innovacion (Spain).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alonso-Casajus N, 2006, J BACTERIOL, V188, P5266, DOI 10.1128/JB.01566-05; ALTSCHUL F, 1997, J MOL BIOL, V215, P403; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Becq J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009989; Belanger AE, 1999, J BACTERIOL, V181, P6670, DOI 10.1128/JB.181.21.6670-6678.1999; Bonafonte MA, 2000, FEMS MICROBIOL LETT, V191, P31, DOI 10.1016/S0378-1097(00)00366-9; Bourassa L, 2009, MOL MICROBIOL, V72, P124, DOI 10.1111/j.1365-2958.2009.06629.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chandra G, 2011, MICROBIOL-SGM, V157, P1565, DOI 10.1099/mic.0.044263-0; CHEN GS, 1968, ARCH BIOCHEM BIOPHYS, V127, P164, DOI 10.1016/0003-9861(68)90213-0; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dauvillee D, 2005, J BACTERIOL, V187, P1465, DOI 10.1128/JB.187.4.1465-1473.2005; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Doolittle WF, 1999, TRENDS BIOCHEM SCI, V24, pM5, DOI 10.1016/S0968-0004(99)01471-1; Eydallin G, 2007, FEBS LETT, V581, P4417, DOI 10.1016/j.febslet.2007.08.016; Eydallin G, 2010, DNA RES, V17, P61, DOI 10.1093/dnares/dsp028; Gao B, 2009, INT J SYST EVOL MICR, V59, P234, DOI 10.1099/ijs.0.002741-0; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Garrity GM, 2005, BERGEYS MANUAL OF SY; Guerra LT, 2013, J BIOTECHNOL, V166, P65, DOI 10.1016/j.jbiotec.2013.04.005; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Henrissat B, 2002, TRENDS GENET, V18, P437, DOI 10.1016/S0168-9525(02)02734-8; Husnik F, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-87; Itoh T, 1999, MOL BIOL EVOL, V16, P332, DOI 10.1093/oxfordjournals.molbev.a026114; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Lawrence J, 1999, CURR OPIN GENET DEV, V9, P642, DOI 10.1016/S0959-437X(99)00025-8; Lawrence JG, 1996, GENETICS, V143, P1843; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Lawrence JG, 2002, CELL, V110, P407, DOI 10.1016/S0092-8674(02)00900-5; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LEWIN B, 1997, GENES IV; Martin MC, 1997, J BACTERIOL, V179, P7784, DOI 10.1128/jb.179.24.7784-7789.1997; Menigaud S, 2012, BIOINFORMATICS, V28, P1270, DOI 10.1093/bioinformatics/bts118; Merino S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035707; Montero M, 2011, BIOCHEM J, V433, P107, DOI 10.1042/BJ20101186; Montero M, 2009, BIOCHEM J, V424, P129, DOI 10.1042/BJ20090980; Moran-Zorzano MT, 2007, FEBS LETT, V581, P4423, DOI 10.1016/j.febslet.2007.08.017; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; NEIJSSEL OM, 1990, BIOCHIM BIOPHYS ACTA, V1018, P252, DOI 10.1016/0005-2728(90)90260-B; NEWSHOLME EA, 1984, TRENDS BIOCHEM SCI, V9, P277, DOI 10.1016/0968-0004(84)90165-8; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Park JT, 2011, J BACTERIOL, V193, P2517, DOI 10.1128/JB.01238-10; Pieper R, 2013, INFECT IMMUN, V81, P4635, DOI 10.1128/IAI.00975-13; PREISS J, 2009, ECOSAL CELLULAR AND; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Quiles F, 2012, BIOMACROMOLECULES, V13, P2118, DOI 10.1021/bm300497c; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHWARTZ M, 1967, EUR J BIOCHEM, V2, P132, DOI 10.1111/j.1432-1033.1967.tb00117.x; Seibold GM, 2007, MICROBIOL-SGM, V153, P2212, DOI 10.1099/mic.0.2006/005181-0; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sneppen K, 2010, MBIO, V1, DOI 10.1128/mBio.00177-10; STRANGE RE, 1968, NATURE, V220, P606, DOI 10.1038/220606a0; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tabor JJ, 2008, MOL BIOSYST, V4, P754, DOI 10.1039/b801245h; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ugalde JE, 1998, J BACTERIOL, V180, P6557, DOI 10.1128/JB.180.24.6557-6564.1998; UTTARO AD, 1994, GENE, V150, P117, DOI 10.1016/0378-1119(94)90869-9; Van Houte J, 1970, J BACTERIOL, V101, P1083, DOI 10.1128/JB.101.3.1083-1085.1970; Wang L, 2011, NATURWISSENSCHAFTEN, V98, P719, DOI 10.1007/s00114-011-0832-x; Watanabe H, 1997, J MOL EVOL, V44, pS57, DOI 10.1007/PL00000052; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Yamamotoya T, 2012, BBA-PROTEINS PROTEOM, V1824, P1442, DOI 10.1016/j.bbapap.2012.06.010	73	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115516	10.1371/journal.pone.0115516	http://dx.doi.org/10.1371/journal.pone.0115516			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607991	Green Submitted, Green Published, gold			2022-12-27	WOS:000348205300016
J	De-Oliveira, ACAX; Poca, KS; Totino, PRR; Paumgartten, FJR				De-Oliveira, Ana C. A. X.; Poca, Katia S.; Totino, Paulo R. R.; Paumgartten, Francisco J. R.			Modulation of Cytochrome P450 2A5 Activity by Lipopolysaccharide: Low-Dose Effects and Non-Monotonic Dose-Response Relationship	PLOS ONE			English	Article							OXIDATIVE STRESS; COUMARIN 7-HYDROXYLASE; METABOLIZING-ENZYMES; TRANSCRIPTION FACTOR; S-NITROSYLATION; SEPTIC SHOCK; MOUSE MODEL; CYP2A5; EXPRESSION; LIVER	Mouse cytochrome P450 (CYP) 2A5 is induced by inflammatory conditions and infectious diseases that down-regulate the expression and activity of most other CYP isoforms. Enhanced oxidative stress and nuclear factor (erythroid 2-related factor) 2 (Nrf2) transcription factor activation have been hypothesised to mediate up-regulation of CYP2A5 expression in the murine liver. The unique and complex regulation of CYP2A5, however, is far from being thoroughly elucidated. Sepsis and high doses of bacterial lipopolysaccharide (LPS) elicit oxidative stress in the liver, but depression, not induction, of CYP2A5 has been observed in studies of mice treated with LPS. The foregoing facts prompted us to evaluate the response of CYP2A5 liver activity in female DBA-2 mice over a broad range of LPS doses (0, 0.025, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, and 20 mg/kg). Cytokine levels (interleukin [IL]-2, IL-4, IL-6, IL-10, IL-17A, interferon gamma, tumour necrosis factor alpha) and nitric oxide (NO) were measured in the blood serum. Activities of CYP1A (EROD) and CYP2B (BROD) in the liver were also determined for comparative purposes. LPS depressed CYP2A5 at low doses (0.025-2.0 mg/kg) but not at doses (>2 mg/kg) that increased pro-inflammatory cytokines and NO serum levels, and depressed CYP1A and CYP2B activities. Blockade of proinflammatory cytokines and the overproduction of NO induced by co-treatment with pentoxifylline and LPS and iNOS inhibition with aminoguanidine both extended down-regulation of CYP2A5 to the high dose range while not affecting LPS-induced depression of CYP1A and CYP2B. Overall, the results suggested that NO plays a role in the reversal of the low-dose LPS-induced depression of CYP2A5 observed when mice were challenged with higher doses of LPS.	[De-Oliveira, Ana C. A. X.; Poca, Katia S.; Paumgartten, Francisco J. R.] Fundacao Oswaldo Cruz, Lab Environm Toxicol, Dept Biol Sci, Natl Sch Publ Hlth,Oswaldo Cruz Inst, BR-21040361 Rio De Janeiro, RJ, Brazil; [Totino, Paulo R. R.] Fundacao Oswaldo Cruz, Malaria Res Lab, Inst Oswaldo Cruz, BR-21040361 Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	De-Oliveira, ACAX (corresponding author), Fundacao Oswaldo Cruz, Lab Environm Toxicol, Dept Biol Sci, Natl Sch Publ Hlth,Oswaldo Cruz Inst, BR-21040361 Rio De Janeiro, RJ, Brazil.	ana.oliveira@ensp.fiocruz.br	Totino, Paulo/GLV-4516-2022; Paumgartten, Francisco JR/R-3618-2016	Paumgartten, Francisco JR/0000-0002-6207-0149; Totino, Paulo/0000-0002-4790-3317	Fundacao Carlos Chagas Filho de Amparo a Pesquisa (FAPERJ) [E-26/111.706/2012]; Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)/FIOCRUZ [407754/2012-1]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)/FIOCRUZ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This study was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa (FAPERJ), (www.faperj.br) Grant number E-26/111.706/2012; Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)/FIOCRUZ, (www.papes.fiocruz.br/edital_papesVI) Grant number 407754/2012-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Bakar A, 2012, TOXICOL APPL PHARM, V261, P50, DOI 10.1016/j.taap.2012.03.010; Abu-Bakar A, 2011, TOXICOL APPL PHARM, V257, P14, DOI 10.1016/j.taap.2011.08.011; Aitken AE, 2006, ANNU REV PHARMACOL, V46, P123, DOI 10.1146/annurev.pharmtox.46.120604.141059; Arpiainen S, 2008, TOXICOL APPL PHARM, V232, P135, DOI 10.1016/j.taap.2008.06.001; Begara-Morales JC, 2014, J EXP BOT, V65, P527, DOI 10.1093/jxb/ert396; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley DB, 2007, DRUG METAB DISPOS, V35, P121, DOI 10.1124/dmd.106.012070; Chemin I, 1996, HEPATOLOGY, V24, P649, DOI 10.1002/hep.510240330; Chomarat P, 1997, CARCINOGENESIS, V18, P2179, DOI 10.1093/carcin/18.11.2179; Conte FP, 2007, BRAZ J MED BIOL RES, V40, P657, DOI 10.1590/S0100-879X2007000500008; De-Oliveira ACAX, 2006, EXP PARASITOL, V113, P256, DOI 10.1016/j.exppara.2006.01.013; De-Oliveira ACAX, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-81; DeOliveira ACAX, 1997, TOXICOL LETT, V92, P39, DOI 10.1016/S0378-4274(97)00034-9; Gilmore WJ, 2004, J PHARMACOL EXP THER, V308, P600, DOI 10.1124/jpet.103.060111; Gilmore WJ, 2003, TOXICOLOGY, V184, P211, DOI 10.1016/S0300-483X(02)00581-4; HAHNEMANN B, 1992, BIOCHEM J, V286, P289, DOI 10.1042/bj2860289; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hou CC, 2011, EUR J PHARMACOL, V667, P6, DOI 10.1016/j.ejphar.2011.05.075; JUVONEN RO, 1988, EUR J BIOCHEM, V171, P205, DOI 10.1111/j.1432-1033.1988.tb13777.x; KENNEDY SW, 1994, ANAL BIOCHEM, V222, P217, DOI 10.1006/abio.1994.1476; Kim SD, 2013, TOXICOL APPL PHARM, V270, P129, DOI 10.1016/j.taap.2013.04.013; KIRBY GM, 1994, MOL CARCINOGEN, V11, P81, DOI 10.1002/mc.2940110205; KIRBY GM, 1994, MOL CARCINOGEN, V11, P74, DOI 10.1002/mc.2940110204; Kirby GM, 2011, CURR DRUG METAB, V12, P186; KOBLIAKOV V, 1993, MOL CARCINOGEN, V7, P276, DOI 10.1002/mc.2940070411; Lamsa V, 2012, TOXICOL SCI, V130, P132, DOI 10.1093/toxsci/kfs237; Montero R, 1999, MUTAGENESIS, V14, P217, DOI 10.1093/mutage/14.2.217; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Mori M, 2007, J NUTR, V137, p1616S, DOI 10.1093/jn/137.6.1616S; Nichols KD, 2008, BIOCHEM PHARMACOL, V75, P1230, DOI 10.1016/j.bcp.2007.10.032; Nichols KD, 2008, BIOCHEM PHARMACOL, V75, P538, DOI 10.1016/j.bcp.2007.09.009; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Renton KW, 2004, CURR DRUG METAB, V5, P235, DOI 10.2174/1389200043335559; Sakaguchi S, 2006, FEMS IMMUNOL MED MIC, V47, P167, DOI 10.1111/j.1574-695X.2006.00072.x; Salvemini D, 2002, FREE RADICAL BIO MED, V33, P1173, DOI 10.1016/S0891-5849(02)00961-9; SCHMIDT HHHW, 1989, BIOCHEM BIOPH RES CO, V165, P284, DOI 10.1016/0006-291X(89)91067-X; Su T, 2004, TOXICOL APPL PHARM, V199, P285, DOI 10.1016/j.taap.2003.11.029; Um HC, 2011, NITRIC OXIDE-BIOL CH, V25, P161, DOI 10.1016/j.niox.2011.06.001; VANIERSEL M, 1994, FOOD CHEM TOXICOL, V32, P387, DOI 10.1016/0278-6915(94)90078-7	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117842	10.1371/journal.pone.0117842	http://dx.doi.org/10.1371/journal.pone.0117842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635819	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700101
J	Tsou, SH; Chen, TM; Hsiao, HT; Chen, YH				Tsou, Shang-Hsun; Chen, Tzer-Ming; Hsiao, Hui-Ting; Chen, Yen-Hui			A Critical Dose of Doxorubicin Is Required to Alter the Gene Expression Profiles in MCF-7 Cells Acquiring Multidrug Resistance	PLOS ONE			English	Article							BREAST-CANCER CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR PROTEIN; DRUG-RESISTANCE; STEM-CELLS; DOWN-REGULATION; OVARIAN-CANCER; MUTANT P53; MDR1; TRANSPORTERS	Cellular mechanisms of multidrug resistance (MDR) are related to ABC transporters, apoptosis, antioxidation, drug metabolism, DNA repair and cell proliferation. It remains unclear whether the process of resistance development is programmable. We aimed to study gene expression profiling circumstances in MCF-7 during MDR development. Eleven MCF-7 sublines with incremental doxorubicin resistance were established as a valued tool to study resistance progression. MDR marker P-gp was overexpressed only in cells termed MCF-7/ADR-1024 under the selection dose approaching 1024 nM. MCF-7/ADR-1024 and authentic MCF-7/ADR shared common features in cell morphology and DNA ploidy status. MCF-7/ADR-1024 and authentic MCF-7/ADR down regulated repair genes BRCA1/2 and wild type p53, apoptosis-related gene Bcl-2 and epithelial-mesenchymal transition (EMT) epithelial marker gene E-cadherin. While detoxifying enzymes glutathione-S transferase-p and protein kinase C-a were up-regulated. The genes involving in EMT mesenchymal formation were also overexpressed, including N-cadherin, vimentin and the E-cadherin transcription reppressors Slug, Twist and ZEB1/2. PI3K/AKT inhibitor wortmannin suppressed expression of Slug, Twist and mdr1. Mutant p53 with a deletion at codons 127-133 markedly appeared in MCF-7/ADR-1024 and authentic MCF-7/ADR as well. In addition, MCF-7/ADR-1024 cells exerted CSC-like cell surface marker CD44 high/CD24 low and form mammospheres. Overall, results suggest that resistance marker P-gp arises owing to turn on/off or mutation of the genes involved in DNA repair, apoptosis, detoxifying enzymes, EMT and ABC transporters at a turning point (1.024 mu M doxorubicin challenge). Behind this point, no obvious alterations were found in most tested genes. Selection for CSC-like cells under this dose may importantly attribute to propagation of the population presenting invasive properties and drug resistance. We thereby suggest two models in the induction of drug resistance. Model 1: Selection for CSC-like cells. Model 2: Mutations for gain-of resistance. Either model 1 or model 2 requires doxorubicin dose approaching 1 mu M to alter gene regulation.	[Tsou, Shang-Hsun; Hsiao, Hui-Ting; Chen, Yen-Hui] Natl Taiwan Univ, Coll Med, Sch Pharm, Grad Inst Pharmaceut Sci, Taipei 10764, Taiwan; [Chen, Tzer-Ming] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Chen, Yen-Hui] Natl Taiwan Univ, Coll Med, Sch Pharm, Grad Inst Clin Pharm, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chen, YH (corresponding author), Natl Taiwan Univ, Coll Med, Sch Pharm, Grad Inst Pharmaceut Sci, Taipei 10764, Taiwan.	tcyhchen@ntu.edu.tw			Taiwan Cancer Foundation [TCF100-TM01-B2]	Taiwan Cancer Foundation	This work was supported by the Taiwan Cancer Foundation (www.cancercare.org.tw) #TCF100-TM01-B2. YC received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bahr O, 2001, J CLIN INVEST, V107, P643, DOI 10.1172/JCI12415; BALCERKUBICZEK EK, 1995, RADIAT RES, V142, P256, DOI 10.2307/3579133; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; CAAMANO J, 1992, PROG CLIN BIOL RES, V376, P331; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; Colas E, 2012, CLIN TRANSL ONCOL, V14, P715, DOI 10.1007/s12094-012-0866-3; Dhillon KK, 2011, CANCER SCI, V102, P663, DOI 10.1111/j.1349-7006.2010.01840.x; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Furusawa S, 2001, BIOL PHARM BULL, V24, P474, DOI 10.1248/bpb.24.474; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gudjonsson T, 2005, APMIS, V113, P922, DOI 10.1111/j.1600-0463.2005.apm_371.x; Hardt O, 2012, CANCER LETT, V325, P165, DOI 10.1016/j.canlet.2012.06.010; Iseri OD, 2011, BIOMED PHARMACOTHER, V65, P40, DOI 10.1016/j.biopha.2010.10.004; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kuo MT, 2009, ANTIOXID REDOX SIGN, V11, P99, DOI 10.1089/ars.2008.2095; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Li XX, 2012, BIOCHEM BIOPH RES CO, V419, P728, DOI 10.1016/j.bbrc.2012.02.090; Lim B, 2013, ADV EXP MED BIOL, V779, P35, DOI 10.1007/978-1-4614-6176-0_2; Lin X, 2012, NEOPLASMA, V59, P248, DOI 10.4149/neo_2012_032; Liu YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-145; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; MAXWELL SA, 1994, CRIT REV ONCOGENESIS, V5, P23, DOI 10.1615/CritRevOncog.v5.i1.20; Mehta K, 2002, J NATL CANCER I, V94, P1652; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Munoz M, 2007, IUBMB LIFE, V59, P752, DOI 10.1080/15216540701736285; Nugoli M, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-13; O'Connor R, 2007, ANTICANCER RES, V27, P1267; O'Flaherty JD, 2012, J THORAC ONCOL, V7, P1880, DOI 10.1097/JTO.0b013e31826bfbc6; Ogretmen B, 1997, ONCOGENE, V14, P499, DOI 10.1038/sj.onc.1200855; Ogretmen B, 1996, INT J CANCER, V67, P608, DOI 10.1002/(SICI)1097-0215(19960904)67:5<608::AID-IJC3>3.0.CO;2-Y; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; Rusetskaya N. V., 2009, Experimental Oncology, V31, P140; RYAN JJ, 1994, P NATL ACAD SCI USA, V91, P5878, DOI 10.1073/pnas.91.13.5878; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Saleh EM, 2009, CELL BIOCHEM BIOPHYS, V55, P95, DOI 10.1007/s12013-009-9058-3; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Schuliga M, 2002, TOXICOL SCI, V70, P183, DOI 10.1093/toxsci/70.2.183; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; Shim GS, 2009, FREE RADICAL BIO MED, V47, P1619, DOI 10.1016/j.freeradbiomed.2009.09.006; Shinoda C, 2005, INT J CANCER, V117, P21, DOI 10.1002/ijc.21094; Stavrovskaya AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P592, DOI 10.1134/S0006297908050118; Subramaniam D, 2010, MINI-REV MED CHEM, V10, P359, DOI 10.2174/138955710791330954; Walsh AC, 2001, TOXICOL SCI, V61, P218, DOI 10.1093/toxsci/61.2.218; Walter RB, 2003, BLOOD, V102, P1466, DOI 10.1182/blood-2003-02-0396; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Weberpals J, 2009, INT J CANCER, V124, P806, DOI 10.1002/ijc.23987; WOSIKOWSKI K, 1995, CELL GROWTH DIFFER, V6, P1395; Yu ST, 2007, BIOCHEM BIOPH RES CO, V358, P79, DOI 10.1016/j.bbrc.2007.04.107; Yu ST, 2009, ANTI-CANCER DRUG, V20, P382, DOI 10.1097/CAD.0b013e32832a2cd4; Zhao LJ, 2012, ASIAN PAC J CANCER P, V13, P3631, DOI 10.7314/APJCP.2012.13.8.3631	55	56	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116747	10.1371/journal.pone.0116747	http://dx.doi.org/10.1371/journal.pone.0116747			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635866	gold, Green Submitted, Green Published			2022-12-27	WOS:000350680700056
J	Zhao, BH; Zhao, Q; Li, JH; Xing, T; Wang, F; Wang, NS				Zhao, Binghui; Zhao, Qing; Li, Junhui; Xing, Tao; Wang, Feng; Wang, Niansong			Renalase Protects against Contrast-Induced Nephropathy in Sprague-Dawley Rats	PLOS ONE			English	Article							INSULIN-RESISTANCE; KIDNEY; HYPERTENSION; OXIDASE; TISSUE	Background Contrast-induced nephropathy (CIN) is the third leading cause of hospital-acquired acute renal failure. Oxidative stress, apoptosis and inflammation play crucial roles in CIN. Renalase is a newly discovered monoamine oxidase from the kidney. We hypothesize that renalase could protect against CIN through anti-oxidation, anti-inflammation and anti-apoptosis pathways. Methods We tested our hypothesis in vivo with a rat model of Ioversol-induced CIN and in vitro. Sprague-Dawley rats were divided into 4 groups (n = 6 per group): control group, Ioversol group (rats subjected to Ioversol-induced CIN), Ioversol plus vehicle group (CIN rats pretreated with vehicle) and Ioversol plus renalase group (CIN rats pretreated with 2 mg/kg recombinant renalase). HK2 cells were treated with Ioversol or H2O2. Results The results showed that pretreatment with renalase attenuated the deterioration of renal function, tubular necrosis, oxidative stress, apoptosis and inflammation (P< 0.05). Furthermore, renalase protected HK2 cells against the cytotoxicity of Ioversol and suppressed Caspase-3 activity, oxidative stress and apoptosis induced by H2O2. Conclusion Recombinant renalase protected CIN in rats through anti-oxidation, anti-apoptosis and antiinflammation mechanisms.	[Zhao, Binghui] Tongji Univ, Affiliated Shanghai Peoples Hosp 10, Dept Radiol, Shanghai 200092, Peoples R China; [Li, Junhui; Wang, Feng; Wang, Niansong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai 200030, Peoples R China; [Zhao, Qing] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Cardiol, Shanghai 200030, Peoples R China; [Xing, Tao] St Vincents Hosp, Melbourne, Vic, Australia	Tongji University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; St Vincent's Hospital Melbourne	Zhao, BH (corresponding author), Tongji Univ, Affiliated Shanghai Peoples Hosp 10, Dept Radiol, Shanghai 200092, Peoples R China.	drzhaobinghui@163.com; zyzwq1030@gmail.com			National Natural Science Foundation of China [81100528]; New-100 Talent Plan of Shanghai Jiao Tong University School of Medicine; Shanghai talents development fund; Shanghai Science and Technology Commission [124119a4900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New-100 Talent Plan of Shanghai Jiao Tong University School of Medicine; Shanghai talents development fund; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was sponsored by the National Natural Science Foundation of China (81100528) (http://www.nsfc.gov.cn/), the New-100 Talent Plan of Shanghai Jiao Tong University School of Medicine, Shanghai talents development fund and Shanghai Science and Technology Commission (124119a4900)(http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2009, CIRC J, V73, P1518, DOI 10.1253/circj.CJ-08-0784; Ari E, 2012, BRIT J RADIOL, V85, P1038, DOI 10.1259/bjr/16327485; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Buyuklu M, 2014, EUR REV MED PHARMACO, V18, P461; Caiazza A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/578974; Desir GV, 2014, NEPHROL DIAL TRANSPL, V29, P22, DOI 10.1093/ndt/gft083; Finn WF, 2006, NEPHROL DIAL TRANSPL, V21, pi2, DOI DOI 10.1093/NDT/GFL213; Guo XJ, 2014, CURR OPIN NEPHROL HY, V23, P513, DOI 10.1097/MNH.0000000000000044; James MT, 2011, CIRCULATION, V123, P409, DOI 10.1161/CIRCULATIONAHA.110.970160; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kodama A, 2013, KIDNEY INT, V83, P446, DOI 10.1038/ki.2012.429; Kwasa EA, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130738; Lee HT, 2013, J AM SOC NEPHROL, V24, P445, DOI 10.1681/ASN.2012090943; Mahmoodi Khalil, 2014, Heart Views, V15, P33, DOI 10.4103/1995-705X.137489; Melnikov VY, 2002, J CLIN INVEST, V110, P1083, DOI 10.1172/JCI200215623; Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329; Romano G, 2008, EUR HEART J, V29, P2569, DOI 10.1093/eurheartj/ehn197; Sendeski MM, 2011, CLIN EXP PHARMACOL P, V38, P292, DOI 10.1111/j.1440-1681.2011.05503.x; Solomon R, 2010, CIRCULATION, V122, P2451, DOI 10.1161/CIRCULATIONAHA.110.953851; Thomsen HS, 2008, ACTA RADIOL, V49, P646, DOI 10.1080/02841850801995413; Wang F, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/203458; Wang F, 2014, RENAL FAILURE, V36, P552, DOI 10.3109/0886022X.2013.876352; Wang F, 2013, RENAL FAILURE, V35, P1255, DOI 10.3109/0886022X.2013.823874; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046442; Wang Feng, 2009, Journal of Shanghai Jiaotong University (English Edition), V14, P376, DOI 10.1007/s12204-009-0376-9; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066	27	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116583	10.1371/journal.pone.0116583	http://dx.doi.org/10.1371/journal.pone.0116583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635854	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700046
J	Ahmad, P; Sarwat, M; Bhat, NA; Wani, MR; Kazi, AG; Tran, LSP				Ahmad, Parvaiz; Sarwat, Maryam; Bhat, Nazir Ahmad; Wani, Mohd Rafiq; Kazi, Alvina Gul; Lam-Son Phan Tran			Alleviation of Cadmium Toxicity in Brassica juncea L. (Czern. & Coss.) by Calcium Application Involves Various Physiological and Biochemical Strategies	PLOS ONE			English	Article							LIPID-PEROXIDATION; OXIDATIVE DAMAGE; STRESS; ANTIOXIDANTS; EXPRESSION; TOLERANCE; ASCORBATE; RESPONSES; PROLINE; CELLS	Calcium (Ca) plays important role in plant development and response to various environmental stresses. However, its involvement in mitigation of heavy metal stress in plants remains elusive. In this study, we examined the effect of Ca (50 mM) in controlling cadmium (Cd) uptake in mustard (Brassica juncea L.) plants exposed to toxic levels of Cd (200 mg L-1 and 300 mg L-1). The Cd treatment showed substantial decrease in plant height, root length, dry weight, pigments and protein content. Application of Ca improved the growth and biomass yield of the Cd-stressed mustard seedlings. More importantly, the oil content of mustard seeds of Cd-stressed plants was also enhanced with Ca treatment. Proline was significantly increased in mustard plants under Cd stress, and exogenously sprayed Ca was found to have a positive impact on proline content in Cd-stressed plants. Different concentrations of Cd increased lipid peroxidation but the application of Ca minimized it to appreciable level in Cd-treated plants. Excessive Cd treatment enhanced the activities of antioxidant enzymes superoxide dismutase, ascorbate peroxidase and glutathione reductase, which were further enhanced by the addition of Ca. Additionally, Cd stress caused reduced uptake of essential elements and increased Cd accumulation in roots and shoots. However, application of Ca enhanced the concentration of essential elements and decreased Cd accumulation in Cd-stressed plants. Our results indicated that application of Ca enables mustard plant to withstand the deleterious effect of Cd, resulting in improved growth and seed quality of mustard plants.	[Ahmad, Parvaiz] SP Coll, Dept Bot, Srinagar 190001, Jammu & Kashmir, India; [Sarwat, Maryam] Amity Univ, Amity Inst Pharm, NOIDA, Noida 201303, India; [Sarwat, Maryam] Prince Salman Bin Abdul Aziz Univ, Coll Appl Med Sci, Riyadh 11942, Saudi Arabia; [Bhat, Nazir Ahmad; Wani, Mohd Rafiq] Govt Degree Coll Boys, Dept Bot, Anantnag 192102, Jammu & Kashmir, India; [Kazi, Alvina Gul] Natl Univ Sci & Technol, Atta Ur Rehman Sch Appl Biosci, Islamabad 44000, Pakistan; [Lam-Son Phan Tran] RIKEN, Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa 2300045, Japan	Amity University Noida; Prince Sattam Bin Abdulaziz University; National University of Sciences & Technology - Pakistan; RIKEN	Ahmad, P (corresponding author), SP Coll, Dept Bot, Srinagar 190001, Jammu & Kashmir, India.	parvaizbot@yahoo.com; son.tran@riken.jp	ahmad, parvaiz/D-2887-2009; Sarwat, Maryam/E-6836-2010; Ahmad, Parvaiz/Y-3531-2019; Gul, Alvina/Z-4497-2019; Tran, Lam-Son P/A-1346-2009	ahmad, parvaiz/0000-0003-2734-4180; Sarwat, Maryam/0000-0003-3972-3321; Ahmad, Parvaiz/0000-0003-2734-4180; Gul, Alvina/0000-0002-7323-1905; Tran, Lam-Son P/0000-0001-9883-9768; Wani, Mohd Rafiq/0000-0003-0548-9581				Ahmad P, 2008, INT J PLANT PROD, V2, P353; Ahmad P, 2011, S AFR J BOT, V77, P36, DOI 10.1016/j.sajb.2010.05.003; Ahmad P, 2010, RUSS J PLANT PHYSL+, V57, P509, DOI 10.1134/S1021443710040084; Ahmad P., 2012, ENV ADAPTATIONS STRE, P297, DOI DOI 10.1007/978-1-4614-0815-4_14; Ahmad P, 2012, FRESEN ENVIRON BULL, V21, P2953; Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243; AIDID SB, 1993, BIOMETALS, V6, P245, DOI 10.1007/BF00187763; Anjum NA, 2008, PLANT GROWTH REGUL, V54, P271, DOI 10.1007/s10725-007-9251-6; Arnon DI, 1940, SOIL SCI, V50, P463; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Behera RK, 2002, J PLANT PHYSIOL, V159, P967, DOI 10.1078/0176-1617-00823; Beyer WN, 2000, J ENVIRON QUAL, V29, P1380, DOI 10.2134/jeq2000.00472425002900050002x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Choudhary SP, 2012, J EXP BOT, V63, P5659, DOI 10.1093/jxb/ers219; Choudhary SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033210; DalCorso G, 2010, PLANT SIGNAL BEHAV, V5, P663, DOI 10.4161/psb.5.6.11425; Gopavajhula VR, 2013, GENET MOL BIOL, V36, P225, DOI [10.1590/S1415-47572013005000023, 10.1590/s1415-47572013005000023]; Hajiboland R, 2010, SOIL SCI PLANT NUTR, V56, P427, DOI 10.1111/j.1747-0765.2010.00478.x; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hirschi KD, 2004, PLANT PHYSIOL, V136, P2438, DOI 10.1104/pp.104.046490; Indra V, 2006, J ENVIRON BIOL, V27, P723; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jihen E, 2010, TOXICOL LETT, V196, P104, DOI 10.1016/j.toxlet.2010.04.006; Jogaiah S, 2013, CRIT REV BIOTECHNOL, V33, P23, DOI 10.3109/07388551.2012.659174; John R., 2009, International Journal of Plant Production, V3, P65; Kader MA, 2010, PLANT SIGNAL BEHAV, V5, P233, DOI 10.4161/psb.5.3.10740; Kangasjarvi S, 2008, BIOCHEM J, V412, P275, DOI 10.1042/BJ20080030; Khan GA, 2014, J EXP BOT, V65, P871, DOI 10.1093/jxb/ert444; Kupper H, 1996, J EXP BOT, V47, P259, DOI 10.1093/jxb/47.2.259; Lag M, 2010, TOXICOL LETT, V193, P252, DOI 10.1016/j.toxlet.2010.01.015; Liu D, 2003, BIOL PLANTARUM, V47, P79, DOI 10.1023/A:1027384932338; Luck H., 1965, METHOD ENZYMATIC ANA, P885, DOI DOI 10.1016/B978-0-12-395630-9.50158-4; Mishra S, 2006, PLANT PHYSIOL BIOCH, V44, P25, DOI 10.1016/j.plaphy.2006.01.007; Monteiro MS, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P387, DOI 10.1007/978-1-4614-0634-1_21; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; PADMAJA K, 1990, PHOTOSYNTHETICA, V24, P399; Palma JM, 2002, PLANT PHYSIOL BIOCH, V40, P521, DOI 10.1016/S0981-9428(02)01404-3; Park HY, 2008, P NATL ACAD SCI USA, V105, P542, DOI 10.1073/pnas.0710810105; POSCHENRIEDER C, 1989, PLANT PHYSIOL, V90, P1365, DOI 10.1104/pp.90.4.1365; Sarwat M, 2013, CRIT REV BIOTECHNOL, V33, P97, DOI 10.3109/07388551.2012.672398; Schutzendubel A, 2001, PLANT PHYSIOL, V127, P887, DOI 10.1104/pp.010318; SHARMA P, 2006, CADMIUM TOXICITY TOL, P63; Sharma P., 2012, J BOT, V2012, P26, DOI [10.1155/2012/217037, DOI 10.1155/2012/217037]; Siddiqui MH, 2012, INT J MOL SCI, V13, P6604, DOI 10.3390/ijms13066604; Siddiqui MH, 2011, PROTOPLASMA, V248, P503, DOI 10.1007/s00709-010-0197-6; Singh AP, 2001, SUSTAINABLE USE CHEM, V2, P23; Song WY, 2008, INT J BIOL SCI, V4, P116; Srivalli B., 2003, J PLANT BIOL, V30, P121; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; Suzuki N, 2005, PLANT BIOTECHNOL, V22, P19, DOI DOI 10.5511/PLANTBIOTECHNOLOGY.22.19; Tian SK, 2011, CHEMOSPHERE, V84, P63, DOI 10.1016/j.chemosphere.2011.02.054; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P525, DOI 10.4161/psb.3.8.6186; van Rossum MWPC, 1997, PLANT SCI, V130, P207, DOI 10.1016/S0168-9452(97)00215-X; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; Vig K, 2003, ADV ENVIRON RES, V8, P121, DOI 10.1016/S1093-0191(02)00135-1; Watanabe T, 1998, SCI TOTAL ENVIRON, V217, P1, DOI 10.1016/S0048-9697(98)00151-X; Yamauchi Y, 2008, PLANT PHYSIOL BIOCH, V46, P786, DOI 10.1016/j.plaphy.2008.04.018; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Zhifang G, 2003, PLANT CELL ENVIRON, V26, P275, DOI 10.1046/j.1365-3040.2003.00958.x; Zorrig W., 2012, African Journal of Biotechnology, V11, P8441	63	206	213	10	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0114571	10.1371/journal.pone.0114571	http://dx.doi.org/10.1371/journal.pone.0114571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629695	gold, Green Published, Green Submitted			2022-12-27	WOS:000348732100007
J	Belbachir, F; Pettorelli, N; Wacher, T; Belbachir-Bazi, A; Durant, SM				Belbachir, Farid; Pettorelli, Nathalie; Wacher, Tim; Belbachir-Bazi, Amel; Durant, Sarah M.			Monitoring Rarity: The Critically Endangered Saharan Cheetah as a Flagship Species for a Threatened Ecosystem	PLOS ONE			English	Article							CAPTURE PROBABILITIES VARY; ACINONYX-JUBATUS; POPULATION-SIZE; RECAPTURE DATA; CAMERA-TRAPS; HOME-RANGE; CONSERVATION; AFRICA; BIODIVERSITY; DENSITY	Deserts are particularly vulnerable to human impacts and have already suffered a substantial loss of biodiversity. In harsh and variable desert environments, large herbivores typically occur at low densities, and their large carnivore predators occur at even lower densities. The continued survival of large carnivores is key to healthy functioning desert ecosystems, and the ability to gather reliable information on these rare low density species, including presence, abundance and density, is critical to their monitoring and management. Here we test camera trap methodologies as a monitoring tool for an extremely rare wide-ranging large felid, the critically endangered Saharan cheetah (Acinonyx jubatus hecki). Two camera trapping surveys were carried out over 2-3 months across a 2,551km(2) grid in the Ti-nhaggen region in the Ahaggar Cultural Park, south central Algeria. A total of 32 records of Saharan cheetah were obtained. We show the behaviour and ecology of the Saharan cheetah is severely constrained by the harsh desert environment, leading them to be more nocturnal, be more wide-ranging, and occur at lower densities relative to cheetah in savannah environments. Density estimates ranged from 0.21-0.55/1,000km(2), some of the lowest large carnivore densities ever recorded in Africa, and average home range size over 2-3 months was estimated at 1,583km(2). We use our results to predict that, in order to detect presence of cheetah with p>0.95 a survey effort of at least 1,000 camera trap days is required. Our study identifies the Ahaggar Cultural Park as a key area for the conservation of the Saharan cheetah. The Saharan cheetah meets the requirements for a charismatic flagship species that can be used to "market" the Saharan landscape at a sufficiently large scale to help reverse the historical neglect of threatened Saharan ecosystems.	[Belbachir, Farid; Pettorelli, Nathalie; Durant, Sarah M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Belbachir, Farid] UCL, Dept Anthropol, London, England; [Belbachir, Farid; Belbachir-Bazi, Amel] Univ Bejaia, Lab Ecol & Environm, Bejaia, Algeria; [Wacher, Tim] Zool Soc London, Conservat Programmes, London, England; [Durant, Sarah M.] Wildlife Conservat Soc, Bronx, NY USA	Zoological Society of London; University of London; University College London; Universite de Bejaia; Zoological Society of London; Wildlife Conservation Society	Durant, SM (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	s.durant@ucl.ac.uk	Pettorelli, Nathalie/AAW-8438-2021; Durant, Sarah M/AAB-9659-2019	Durant, Sarah M/0000-0003-0724-0878	Office National du Parc Culturel de l'Ahaggar/Ministry of Culture (Algeria); Institute of Zoology and Zoological Society of London; University College London and Wildlife Conservation Society; Howard G. Buffett Foundation; PANTHERA and Dunstable Runners; Dorothy Hodgkins Postgraduate Award	Office National du Parc Culturel de l'Ahaggar/Ministry of Culture (Algeria); Institute of Zoology and Zoological Society of London; University College London and Wildlife Conservation Society; Howard G. Buffett Foundation; PANTHERA and Dunstable Runners; Dorothy Hodgkins Postgraduate Award	The following institutions and persons are warmly thanked for their support: the Office National du Parc Culturel de l'Ahaggar/Ministry of Culture (Algeria), Institute of Zoology and Zoological Society of London, University College London and Wildlife Conservation Society. The study was funded by the Howard G. Buffett Foundation, PANTHERA and Dunstable Runners and FB was supported by a Dorothy Hodgkins Postgraduate Award. This study would not have been possible without the support of the staff and Former Director, F. Ighilahriz, of the Office du Parc National de l'Ahaggar (now the Office National du Parc Culturel de l'Ahaggar). The authors would also like to thank T. Abaigar from the Estacion Experimental de Zonas Aridas (Spain) for her inputs and support.	[Anonymous], 1991, USERS GUIDE INTERACT; [Anonymous], 2012, REG CONS STRAT CHEET; BATES P. J. J., 1991, MAMMALS ARABIA; Belbachir, 2008, ACINONYX JUBATUS SSP, DOI DOI 10.2305/IUCN.UK.2008.RLTS.T221A13035738.EN; Belbachir Farid, 2009, Cat News, V50, P17; Bernezat JL, 2004, SAHARIEN, V170, P33; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Bowland T, 1995, CUSTOS, P8; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Broomhall LS, 2003, J ZOOL, V261, P119, DOI 10.1017/S0952836903004059; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Busby G.B.J., 2006, REPORT SAHELO SAHA 5; Busby GBJ, 2009, ORYX, V43, P412, DOI 10.1017/S0030605309001197; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Caro T., 1994, CHEETAHS SERENGETI P; CARO TM, 1991, J HERED, V82, P8, DOI 10.1093/jhered/82.1.8; CHAO A, 1992, BIOMETRICS, V48, P201, DOI 10.2307/2532750; Charruau P, 2011, MOL ECOL, V20, P706, DOI 10.1111/j.1365-294X.2010.04986.x; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Darkoh MBK, 2003, J ARID ENVIRON, V54, P261, DOI 10.1006/jare.2002.1089; Davies J, 2012, CONSERVING DRYLAND B; Dillon A, 2008, J ZOOL, V275, P391, DOI 10.1111/j.1469-7998.2008.00452.x; Dragesco-Joffe A., 1993, VIE SAUVAGE SAHARA; Durant SM, 2014, DIVERS DISTRIB, V20, P114, DOI 10.1111/ddi.12157; Durant SM, 2012, SCIENCE, V336, P1379, DOI 10.1126/science.336.6087.1379; Durant Sarah M., 2013, P313; Durant SM, 2011, J APPL ECOL, V48, P1490, DOI 10.1111/j.1365-2664.2011.02042.x; Durant Sarah M., 2010, P373; Durant SM, 2004, BEHAV ECOL, V15, P11, DOI 10.1093/beheco/arg098; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Government of Algeria, 2003, CONS SUST US G UNPUB; Hamdine W, 2003, MAMMALIA, V67, P439, DOI 10.1515/mamm.2003.67.3.439; Hirche A, 2011, ENVIRON MONIT ASSESS, V179, P403, DOI 10.1007/s10661-010-1744-5; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Jackson Rodney M., 2010, P417; Jones Julia P.G., 2013, P335; Journal Officiel de la Republique Alg?rienne D?mocratique et Populaire (JORADP), 2012, J OFFICIEL REPUBLIQU; Kohl I, 2010, J ANTHROPOL RES, V66, P449, DOI 10.3998/jar.0521004.0066.401; Kruger O, 2005, BIODIVERS CONSERV, V14, P579, DOI 10.1007/s10531-004-3917-4; Lhote H., 1946, MAMMALIA, V10, P26, DOI 10.1515/mamm.1946.10.1.26; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Marker L, 2002, THESIS U OXFORD; Marker LL, 2008, J ZOOL, V274, P226, DOI 10.1111/j.1469-7998.2007.00375.x; Marnewick KA, 2006, S AFR J WILDL RES, V36, P139; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; McCabe J. Terrence, 2004, CATTLE BRING US OUR; McNeilage Alastair, 1996, P334; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Nichols James D., 2002, P121; O'Farrell PJ, 2011, J ARID ENVIRON, V75, P612, DOI 10.1016/j.jaridenv.2011.01.005; Oliver LJ, 2011, ECOL MODEL, V222, P776, DOI 10.1016/j.ecolmodel.2010.11.021; Olson KA, 2010, J ARID ENVIRON, V74, P1435, DOI 10.1016/j.jaridenv.2010.05.022; Otis DL, 1978, STAT INFERENCE CAPTU, P7; Scantlebury DM, 2014, SCIENCE, V346, P79, DOI 10.1126/science.1256424; Sharma RK, 2010, ANIM CONSERV, V13, P94, DOI 10.1111/j.1469-1795.2009.00305.x; Sharp NCC, 1997, J ZOOL, V241, P493, DOI 10.1111/j.1469-7998.1997.tb04840.x; Smith RJ, 2012, CONSERV LETT, V5, P205, DOI 10.1111/j.1755-263X.2012.00229.x; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Stanley TR, 2005, WILDLIFE SOC B, V33, P782, DOI 10.2193/0091-7648(2005)33[782:SRAPFT]2.0.CO;2; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Sunquist ME, 2002, WILD CATS WORLD; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Turner MD, 2008, HUM ECOL, V36, P59, DOI 10.1007/s10745-007-9149-y; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; Verissimo D, 2011, CONSERV LETT, V4, P1, DOI 10.1111/j.1755-263X.2010.00151.x; Verlinden A, 1998, AFR J ECOL, V36, P117; WACHER T, 2005, SAHELO SAHARAN INTER; Walpole MJ, 2002, BIODIVERS CONSERV, V11, P543, DOI 10.1023/A:1014864708777; White G.C., 1982, LA8787NERP; Xiang ZF, 2011, CHINESE SCI BULL, V56, P2553, DOI 10.1007/s11434-011-4613-x	71	40	40	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115136	10.1371/journal.pone.0115136	http://dx.doi.org/10.1371/journal.pone.0115136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629400	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100012
J	Ebert, M; Kolbl-Ebert, M; Lane, JA				Ebert, Martin; Koelbl-Ebert, Martina; Lane, Jennifer A.			Fauna and Predator-Prey Relationships of Ettling, an Actinopterygian Fish-Dominated Konservat-Lagerstatte from the Late Jurassic of Southern Germany	PLOS ONE			English	Article							CROSSOGNATHIFORM FISHES; TELEOSTEI; LIMESTONES; AREA	The newly recognized Konservat-Lagerstatte of Ettling (Bavaria), field site of the Jura-Museum Eichstatt (JME), is unique among Late Jurassic plattenkalk basins (Solnhofen region) in its abundant, extremely well preserved fossil vertebrates, almost exclusively fishes. We report actinopterygians (ginglymodins, pycnodontiforms, halecomorphs, aspidorynchiforms, "pholidophoriforms,"teleosts); turtles; and non-vertebrates (echinoderms, arthropods, brachiopods, mollusks, jellyfish, sponges, biomats, plants) in a current faunal list. Ettling has yielded several new fish species (Bavarichthys incognitus; Orthogonikleithrus hoelli; Aspidorhynchus sanzenbacheri; Macrosemimimus fegerti). Upper and lower Ettling strata differ in faunal content, with the lower dominated by the small teleost Orthogonikleithrus hoelli (absent from the upper layers, where other prey fishes, Leptolepides sp. and Tharsis sp., occur instead). Pharyngeal and stomach contents of Ettling fishes provide direct evidence that Orthogonikleithrus hoelli was a primary food source during early Ettling times. Scarcity of ammonites and absence of vampyromorph coleoids at Ettling differ markedly from the situation at other nearby localities in the region (e.g., Eichstett,Painten, Schamhaupten, the Mornsheim beds), where they are more common. Although the exact biochronological age of Ettling remains uncertain (lack of suitable index fossils), many Ettling fishes occur in other plattenkalk basins of Germany (e.g., Kelheim) and France (Cerin) dated as Late Kimmeridgian to Early Tithonian (eigeltingense horizon), suggesting a comparable geologic age. The Ettling deposits represent an independent basin within the larger Upper Jurassic "Solnhofen Archipelago", a shallow subtropical sea containing scattered islands, sponge-microbial and coral reefs, sandbars, and deeper basins on a vast carbonate platform along the northern margin of the Tethys Ocean.	[Ebert, Martin; Koelbl-Ebert, Martina] Jura Museum Eichstatt, Eichstatt, Germany; [Lane, Jennifer A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Lane, JA (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	jlane@amnh.org		Ebert, Martin/0000-0002-0732-7706	Volkswagen Foundation [I/84 636]	Volkswagen Foundation(Volkswagen)	Funding for this project was provided by Volkswagen Foundation grant I/84 636 "The Dynamic of the Solnhofen Archipelago (to MKE), in the years 2010-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1833, RECHERCHES POISSONS; Arratia G, 2001, J VERTEBR PALEONTOL, V21, P767, DOI 10.1671/0272-4634(2001)021[0767:TSGOTC]2.0.CO;2; Arratia G, 2009, ACTA ZOOL S1, V90, P259; Arratia G., 2008, MESOZOIC FISHES 4 HO, P40; Arratia G, 2007, J VERTEBR PALEONTOL, V27, P838, DOI 10.1671/0272-4634(2007)27[838:ANHFFT]2.0.CO;2; Arratia Gloria, 1999, P265; Arratia G, 2013, J VERTEBR PALEONTOL, V33, P1, DOI 10.1080/02724634.2013.835642; Arratia Gloria, 1997, Palaeo Ichthyologica, V7, P5; Arratia G, 2010, FOSS REC, V13, P317, DOI 10.1002/mmng.201000005; Arratia Gloria, 2000, Palaeontologische Zeitschrift, V74, P113; Arratia G, 2008, GEOL SOC SPEC PUBL, V295, P71, DOI 10.1144/SP295.6; Barthel K. W., 1978, SOLNHOFEN BLICK ERDG; Barthel K.W., 1990, SOLNHOFEN STUDY MESO; Berg L. S., 1940, T I ZOOLOGY ACAD SCI, V5, P85; BERNIER P, 1991, SEDIMENTOLOGY, V38, P127, DOI 10.1111/j.1365-3091.1991.tb01858.x; BOUCOT AJ, 1990, EVOLUTIONARY PALEOBI, P1; Brito PM, 2009, CR PALEVOL, V8, P395, DOI 10.1016/j.crpv.2008.12.003; Brito PM, 2002, C R PALEVOL, V1, P697, DOI 10.1016/S1631-0683(02)00080-5; Clarkson ENK, 1986, INVERTEBRATE PALEONT; de Pinna Mario C.C., 1996, P147; DIETL G., 2001, REICH MEERENGEL NUSP; Ebert Martin, 2011, Archaeopteryx, V29, P41; Ebert Martin, 2010, Archaeopteryx, V28, P1; Ebert Martin, 2009, Archaeopteryx, V27, P45; Ebert Martin, 2008, Archaeopteryx, V26, P61; Ebert Martin, 2008, Archaeopteryx, V26, P11; Egger LM, 2011, ARCHAEOPTERYX, V29, P24; Enay Raymond, 1994, Geobios Memoire Special (Villeurbanne), V16, P25; Fesefeldt K., 1962, ERLANGER GEOL ABH, V46, P1; Frey E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031945; Fuersich FT, 2007, PALAEOGEOGR PALAEOCL, V243, P92, DOI 10.1016/j.palaeo.2006.07.007; Giebel CG, 1848, FAUNA VORWELT STETER; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; GRANDE L, 1984, GEOLOGICAL SURVEY WY, V63; Grande L, 2010, SPECIAL PUBLICATION, V6; Hanlon RT, 1996, CEPHALOPOD BEHAV; Helfman GS, 2009, DIVERSITY FISHES BIO; Joyce Walter G., 2003, Paleobios, V23, P1; Keupp H., 1993, GEOBIOS-LYON, V16, P71; Keupp H, 2007, NEUES JAHRB GEOL P-A, V245, P3, DOI 10.1127/0077-7749/2007/0245-0003; Konwert Martin, 2011, Archaeopteryx, V29, P31; Kroger B, 2011, BIOESSAYS, V33, P602, DOI 10.1002/bies.201100001; Lane J, 2015, J VERT PALE IN PRESS; Lane JA, 2012, J VERTEBR PALEONTOL, V32, P799, DOI 10.1080/02724634.2012.680325; MAISEY JG, 1994, ENVIRON BIOL FISH, V40, P1, DOI 10.1007/BF00002179; MARTILL DM, 1990, PALAEONTOLOGY, V33, P739; Meyer R, 1983, ERDGESCHICHTE SICHTB; Moers T, 1993, N JB GEOL PALAONTOL, V188, P345; Munnecke A, 2008, SEDIMENTOLOGY, V55, P1931, DOI 10.1111/j.1365-3091.2008.00975.x; Munster G von, 1836, N JB MINER GEOGR GEO, V1836, P580; Nursall J. Ralph, 1999, P189; Nursall J. Ralph, 1996, P125; Nybelin O., 1964, Goteborgs Vetenskaps Samhalles Handlingar (6), V9B, P1; Nybelin O., 1974, ACTA REGIAE SOC SCI, V9, P1; PATTERSON C, 1977, Bulletin of the American Museum of Natural History, V158, P83; Patterson C., 1977, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V14, P579; Patzelt W, 1963, ERLANGEN GEOL ABH, V50, P1; Poyato-Ariza Francisco Jose, 2005, Bulletin of the Kitakyushu Museum of Natural History and Human History Series A Natural History, V3, P169; Poyato-Ariza Francisco Jose, 2002, Geodiversitas, V24, P139; Prothero DR, 1997, SEDIMENTARY GEOLOGY; REIMCHEN TE, 1991, CAN J ZOOL, V69, P2912, DOI 10.1139/z91-410; Reisdorf Achim G., 2012, Palaeobiodiversity Palaeoenvironments, V92, P119, DOI 10.1007/s12549-011-0068-y; Roper M, 2005, ZITTELIANA, V26, P57; Rpper M, 2000, PLATTENKALKE SCHERNF; Saint-Seine P.de., 1949, Nouvelles Archives du Museum d'Histoire Naturelle de Lyon Fasc, V2, P1; Schnitzer WA, 1965, ERLANGER GEOL ABH, V57, P1; Schroder KM, 2012, J VERTEBR PALEONTOL, V32, P512, DOI 10.1080/02724634.2012.649626; Schweigert G, 1998, JBER MITT OBERRHEIN, V80, P271; Schweigert G, 2007, NEUES JAHRB GEOL P-A, V245, P117, DOI 10.1127/0077-7749/2007/0245-0117; Taverne L., 2011, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V81, P129; Thiolliere, 1850, ANN SCI PHYS NATUR 2, V2, P111; Tischlinger H, 1992, PFORRING 1850 JAHRE, P9; Tischlinger Helmut, 1998, Archaeopteryx, V16, P1; Viohl G., 1990, P287; Viohl G., 1987, Archaeopteryx, V5, P33; Viohl G, 1979, F10 ABTEILUNG SOLNHO; Viohl G, 2006, ARCHAEOPTERYX, V24, P27; Viohl Gunter, 1998, Archaeopteryx, V16, P37; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; Wenz S, 1993, GEOBIOS MS, V16, P61; [No title captured]	81	34	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116140	10.1371/journal.pone.0116140	http://dx.doi.org/10.1371/journal.pone.0116140			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629970	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100032
J	Grindler, NM; Allsworth, JE; Macones, GA; Kannan, K; Roehl, KA; Cooper, AR				Grindler, Natalia M.; Allsworth, Jenifer E.; Macones, George A.; Kannan, Kurunthachalam; Roehl, Kimberly A.; Cooper, Amber R.			Persistent Organic Pollutants and Early Menopause in US Women	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; POLYCHLORINATED-BIPHENYLS PCBS; OVARIAN ANTRAL FOLLICLES; PREIMPLANTATION EMBRYOS; REPRODUCTIVE TOXICITY; NATURAL MENOPAUSE; EXPOSURE; HEALTH; NHANES; MOUSE	Objective Endocrine-disrupting chemicals (EDCs) adversely affect human health. Our objective was to determine the association of EDC exposure with earlier age of menopause. Methods Cross-sectional survey using National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2008 (n = 31,575 females). Eligible participants included: menopausal women > 30 years of age; not currently pregnant, breastfeeding, using hormonal contraception; no history of bilateral oophorectomy or hysterectomy. Exposures, defined by serum lipid and urine creatinine-adjusted measures of EDCs, data were analyzed: > 90th percentile of the EDC distribution among all women, log-transformed EDC level, and decile of EDC level. Multi linear regression models considered complex survey design characteristics and adjusted for age, race/ethnicity, smoking, body mass index. EDCs were stratified into long (> 1 year), short, and unknown half-lives; principle analyses were performed on those with long half-lives as well as phthalates, known reproductive toxicants. Secondary analysis determined whether the odds of being menopausal increased with EDC exposure among women aged 45-55 years. Findings This analysis examined 111 EDCs and focused on known reproductive toxicants or chemicals with half-lives >1 year. Women with high levels of beta-hexachlorocyclohexane, mirex, p,p'-DDE, 1,2,3,4,6,7,8-heptachlorodibenzofuran, mono-(2-ethyl-5-hydroxyhexyl) and mono-(2-ethyl-5-oxohexyl) phthalate, polychlorinated biphenyl congeners -70, -99, -105, -118, -138, -153, -156, -170, and -183 had mean ages of menopause 1.9 to 3.8 years earlier than women with lower levels of these chemicals. EDC-exposed women were up to 6 times more likely to be menopausal than non-exposed women. Conclusions This study of a representative sample of US women documents an association between EDCs and earlier age at menopause. We identified 15 EDCs that warrant closer evaluation because of their persistence and potential detrimental effects on ovarian function. Earlier menopause can alter the quantity and quality of a woman's life and has profound implications for fertility, human reproduction, and our global society.	[Grindler, Natalia M.] Univ Colorado Denver, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Aurora, CO USA; [Grindler, Natalia M.; Cooper, Amber R.] Washington Univ, Barnes Jewish Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, St Louis, MO 63130 USA; [Allsworth, Jenifer E.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA; [Macones, George A.; Roehl, Kimberly A.] Washington Univ, Barnes Jewish Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, St Louis, MO USA; [Kannan, Kurunthachalam] SUNY Albany, Wadsworth Ctr, New York State Dept Hlth, Albany, NY 12222 USA; [Kannan, Kurunthachalam] SUNY Albany, Dept Environm Hlth Sci, Albany, NY 12222 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Barnes-Jewish Hospital; Washington University (WUSTL); University of Missouri System; University of Missouri Kansas City; Barnes-Jewish Hospital; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Cooper, AR (corresponding author), Washington Univ, Barnes Jewish Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, St Louis, MO 63130 USA.	coopera@wudosis.wustl.edu	Allsworth, Jenifer/J-2475-2019	Kannan, Kurunthachalam/0000-0002-1926-7456	National Institute of Health [K12HD063086-01, UL1RR024992]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD063086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was support by National Institute of Health grants K12HD063086-01 (ARC) and UL1RR024992 (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Soc Reprod Med, 2013, FERTIL STERIL, V100, P931, DOI 10.1016/j.fertnstert.2013.08.043; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; BEAN JA, 1979, AM J EPIDEMIOL, V109, P181, DOI 10.1093/oxfordjournals.aje.a112673; Bergman A, 2012, STATE OF THE SCIENCE; Bergman EA, 2012, J ACAD NUTR DIET, V112, P1709, DOI 10.1016/j.jand.2012.09.014; Buttke DE, 2012, ENVIRON HEALTH PERSP, V120, P1613, DOI 10.1289/ehp.1104748; Cooper GS, 1999, EPIDEMIOLOGY, V10, P771, DOI 10.1097/00001648-199911000-00021; Craig ZR, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105122; Curtin Lester R, 2012, Vital Health Stat 2, P1; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Denham M, 2005, PEDIATRICS, V115, pE127, DOI 10.1542/peds.2004-1161; Fleming LE, 2008, MENOPAUSE, V15, P1103, DOI 10.1097/gme.0b013e3181706292; Hannon PR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.119032; Harada Kouji H., 2009, Environmental Health and Preventive Medicine, V14, P7, DOI 10.1007/s12199-008-0058-5; Kato I, 1998, J CLIN EPIDEMIOL, V51, P1271, DOI 10.1016/S0895-4356(98)00119-X; KHOLKUTE SD, 1994, REPROD TOXICOL, V8, P69, DOI 10.1016/0890-6238(94)90069-8; Knox SS, 2011, J CLIN ENDOCR METAB, V96, P1747, DOI 10.1210/jc.2010-2401; Krogenaes AK, 1998, REPROD TOXICOL, V12, P575, DOI 10.1016/S0890-6238(98)00040-9; Kuchenhoff A, 1999, MOL REPROD DEV, V54, P126, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;126::AID-MRD4&gt;3.0.CO;2-B; Layton AC, 2002, TOXICOL APPL PHARM, V180, P157, DOI 10.1006/taap.2002.9395; Lindenau A, 1996, REPROD TOXICOL, V10, P227, DOI 10.1016/0890-6238(96)00026-3; Louis GMB, 2013, ENVIRON HEALTH PERSP, V121, P231, DOI 10.1289/ehp.1205301; MELTON LJ, 1986, AM J EPIDEMIOL, V124, P254, DOI 10.1093/oxfordjournals.aje.a114383; Ogliari KS, 2013, FERTIL STERIL, V99, P1681, DOI 10.1016/j.fertnstert.2013.01.103; Pocar P, 2012, TOXICOL SCI, V126, P213, DOI 10.1093/toxsci/kfr327; Quinn CL, 2011, ENVIRON HEALTH PERSP, V119, P641, DOI 10.1289/ehp.1002415; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Shekhar PVM, 1997, JNCI-J NATL CANCER I, V89, P1774, DOI 10.1093/jnci/89.23.1774; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Sinkkonen S, 2000, CHEMOSPHERE, V40, P943, DOI 10.1016/S0045-6535(99)00337-9; Sweeney AM, 2001, ENVIRON RES, V86, P128, DOI 10.1006/enrs.2001.4261; Taylor KW, 2014, ENVIRON HEALTH PERSP, V122, P145, DOI 10.1289/ehp.1306707; Tuttle AM, 2009, HUM REPROD, V24, P1452, DOI 10.1093/humrep/dep023; Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775; Vo TT, 2008, CANCER EPIDEM BIOMAR, V17, P2729, DOI 10.1158/1055-9965.EPI-08-0379; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Walker NJ, 2005, ENVIRON HEALTH PERSP, V113, P43, DOI 10.1289/ehp.7351; Wang W, 2012, TOXICOL APPL PHARM, V258, P288, DOI 10.1016/j.taap.2011.11.008; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422	40	79	81	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116057	10.1371/journal.pone.0116057	http://dx.doi.org/10.1371/journal.pone.0116057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629726	gold, Green Published, Green Submitted			2022-12-27	WOS:000348732100030
J	Lundin, S; Jemt, A; Terje-Hegge, F; Foam, N; Pettersson, E; Kaller, M; Wirta, V; Lexow, P; Lundeberg, J				Lundin, Sverker; Jemt, Anders; Terje-Hegge, Finn; Foam, Napoleon; Pettersson, Erik; Kaller, Max; Wirta, Valtteri; Lexow, Preben; Lundeberg, Joakim			Endonuclease Specificity and Sequence Dependence of Type IIS Restriction Enzymes	PLOS ONE			English	Article							GENE-EXPRESSION; DNA RESTRICTION; CLEAVAGE; GENOME; RECOGNITION; SYSTEMS	Restriction enzymes that recognize specific sequences but cleave unknown sequence outside the recognition site are extensively utilized tools in molecular biology. Despite this, systematic functional categorization of cleavage performance has largely been lacking. We established a simple and automatable model system to assay cleavage distance variation (termed slippage) and the sequence dependence thereof. We coupled this to massively parallel sequencing in order to provide sensitive and accurate measurement. With this system 14 enzymes were assayed (AcuI, BbvI, BpmI, BpuEI, BseRI, BsgI, Eco57I, Eco57MI, EcoP15I, FauI, FokI, GsuI, MmeI and SmuI). We report significant variation of slippage ranging from 1-54%, variations in sequence context dependence, as well as variation between isoschizomers. We believe this largely overlooked property of enzymes with shifted cleavage would benefit from further large scale classification and engineering efforts seeking to improve performance. The gained insights of in-vitro performance may also aid the in-vivo understanding of these enzymes.	[Lundin, Sverker; Jemt, Anders; Lundeberg, Joakim] KTH, Sci Life Lab, S-17165 Solna, Sweden; [Terje-Hegge, Finn; Foam, Napoleon; Pettersson, Erik; Kaller, Max; Wirta, Valtteri; Lexow, Preben] LingVitae AS, N-3132 Husoysund, Norway	Royal Institute of Technology	Lundeberg, J (corresponding author), KTH, Sci Life Lab, S-17165 Solna, Sweden.	joakim.lundeberg@scilifelab.se		Jemt, Anders/0000-0002-2219-0197	European Community's Seventh Framework Programme FP7 [222913]; Norwegian SkatteFUNN system; Swedish Foundation for Strategic Research; Swedish Scientific Council; LingVitae AS	European Community's Seventh Framework Programme FP7; Norwegian SkatteFUNN system; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Scientific Council; LingVitae AS	The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 (under grant agreement 222913) http://ec.europa.eu/research/fp7/index_en.cfm, the Norwegian SkatteFUNN system, Swedish Foundation for Strategic Research, and the Swedish Scientific Council. At the time when the experiments were performed, Finn Terje-Hegge, Napoleon Foam, Erik Pettersson, Max Kaller, Valtteri Wirta and Preben Lexow were employed by LingVitae AS. LingVitae AS provided support in the form of salaries for authors Finn Terje-Hegge, Napoleon Foam, Erik Pettersson, Max Kaller, Valtteri Wirta and Preben Lexow, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; BRINKLEY P, 1991, GENE, V100, P267, DOI 10.1016/0378-1119(91)90379-P; Chan SH, 2011, NUCLEIC ACIDS RES, V39, P1, DOI 10.1093/nar/gkq742; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Drmanac R, 2009, SCIENCE; GEORGE J, 1980, J BIOL CHEM, V255, P6521; Kamps-Hughes N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt257; KESSLER C, 1986, GENE, V47, P1, DOI 10.1016/0378-1119(86)90245-3; KLEID D, 1976, P NATL ACAD SCI USA, V73, P293, DOI 10.1073/pnas.73.2.293; MALYGUINE E, 1980, GENE, V8, P163, DOI 10.1016/0378-1119(80)90035-9; Matsumura H, 2005, CELL MICROBIOL, V7, P11, DOI 10.1111/j.1462-5822.2004.00478.x; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C; Vanamee ES, 2001, J MOL BIOL, V309, P69, DOI 10.1006/jmbi.2001.4635; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; VENETIANER P, 1988, NUCLEIC ACIDS RES, V16, P3053, DOI 10.1093/nar/16.7.3053; VISSEL B, 1988, NUCLEIC ACIDS RES, V16, P4731, DOI 10.1093/nar/16.10.4731; Wei H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn182; Xu SY, 2012, J BACTERIOL, V194, P49, DOI 10.1128/JB.06248-11	26	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117059	10.1371/journal.pone.0117059	http://dx.doi.org/10.1371/journal.pone.0117059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629514	gold, Green Submitted, Green Published			2022-12-27	WOS:000348732100060
J	Papuc, E; Kurys-Denis, E; Krupski, W; Rejdak, K				Papuc, Ewa; Kurys-Denis, Ewa; Krupski, Witold; Rejdak, Konrad			Humoral Response against Small Heat Shock Proteins in Parkinson's Disease	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; IGG ANTIBODY REPERTOIRE; FIBRIL FORMATION; SYNUCLEIN; AUTOANTIBODIES; AUTOIMMUNITY; ANTIGENS	Introduction In the light of evidence for the increased heat shock proteins (HSP) expression in neurodegenerative disorders, the presence of the adaptive humoral response of the immune system can be expected. The aim of the study was to check whether Parkinson's disease (PD) has the ability to elicit immune response against small heat shock proteins. Methods IgG and IgM autoantibodies against alpha beta-crystallin were assessed in 26 PD patients 26 healthy subjects. For the assessment of anti-HSP IgG autoantibodies serum samples from 31 parkinsonian patients and 31 healthy control subjects were collected. Serum samples from PD patients and healthy control subjects were collected twice, at baseline and after mean of 13 months follow up. Results Both IgM and IgG autoantibodies against alpha beta-crystallin in PD patients were significantly higher compared to healthy controls (p<0.05). We also found statistically significant increase in antibodies titers against alpha beta-crystallin over the time of 13 months, both for IgG (p = 0.021) and for IgM (p<0.0001). Additionally, PD patients presented higher levels of anti-HSP IgG autoantibodies than healthy controls (p = 0.02). Conclusions Increase of IgG and IgM autoantibodies against alpha B-crystallin in PD patients over time may suggest their involvement in the disease pathogenesis and progression. Further studies are required to confirm the role of this antibody as a biomarker of the disease progression.	[Papuc, Ewa; Rejdak, Konrad] Med Univ, Chair & Dept Neurol, Lublin, Poland; [Kurys-Denis, Ewa; Krupski, Witold] Med Univ, Dept Radiol 2, Lublin, Poland	Medical University of Lublin; Medical University of Lublin	Papuc, E (corresponding author), Med Univ, Chair & Dept Neurol, Lublin, Poland.	ewapap@yahoo.pl	Kurys-Denis, Ewa/AAT-8967-2020	Kurys-Denis, Ewa/0000-0002-2664-7588; Rejdak, Konrad/0000-0002-7019-6681				Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; COHEN IR, 1991, IMMUNOL TODAY, V12, P105, DOI 10.1016/0167-5699(91)90093-9; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Dehle FC, 2010, CELL STRESS CHAPERON, V15, P1013, DOI 10.1007/s12192-010-0212-z; Dufek M, 2009, PARKINSONISM RELAT D, V15, P318, DOI 10.1016/j.parkreldis.2008.05.014; Ellis RJ, 2007, ADV EXP MED BIOL, V594, P1; Ghayour-Mobarhan M, 2007, INT J EXP PATHOL, V88, P249, DOI 10.1111/j.1365-2613.2007.00542.x; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; LACROIXDESMAZES S, 1995, EUR J IMMUNOL, V25, P2598, DOI 10.1002/eji.1830250929; Mayr M, 1999, ISR MED ASSOC J, V1, P272; Moudgil KD, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/621417; Mouthon L, 1996, SCAND J IMMUNOL, V44, P243, DOI 10.1046/j.1365-3083.1996.d01-306.x; MOUTHON L, 1995, J IMMUNOL, V154, P5769; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Prohaszka Z, 2001, EUR J CLIN INVEST, V31, P285, DOI 10.1046/j.1365-2362.2001.00819.x; Rajaiah R, 2009, AUTOIMMUN REV, V8, P388, DOI 10.1016/j.autrev.2008.12.004; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Rothbard JB, 2011, J IMMUNOL, V186, P4263, DOI 10.4049/jimmunol.1003934; Shoenfeld Y, 2000, J AUTOIMMUN, V15, P199, DOI 10.1006/jaut.2000.0393; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Temajo NO, 2014, AUTOIMMUN REV, V13, P1013, DOI 10.1016/j.autrev.2014.08.030; Varbiro S, 2010, ACTA PHYSIOL HUNG, V97, P1, DOI 10.1556/APhysiol.97.2010.1.1; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P14, DOI 10.1007/PL00007400; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Wick G, 2004, Autoimmun Rev, V3 Suppl 1, pS30; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Yokota S, 2010, MICROBIOL IMMUNOL, V54, P299, DOI 10.1111/j.1348-0421.2010.00214.x	29	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115480	10.1371/journal.pone.0115480	http://dx.doi.org/10.1371/journal.pone.0115480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629316	Green Published, gold			2022-12-27	WOS:000348732100019
J	Yang, XL; Chen, YQ; Pacenka, S; Gao, WS; Zhang, M; Sui, P; Steenhuis, TS				Yang, Xiaolin; Chen, Yuanquan; Pacenka, Steven; Gao, Wangsheng; Zhang, Min; Sui, Peng; Steenhuis, Tammo S.			Recharge and Groundwater Use in the North China Plain for Six Irrigated Crops for an Eleven Year Period	PLOS ONE			English	Article							WATER-USE EFFICIENCY; WINTER-WHEAT; DEFICIT IRRIGATION; PIEDMONT REGION; YIELD; BALANCE; MAIZE; SYSTEM; TABLE; CONSUMPTION	Water tables are dropping by approximately one meter annually throughout the North China Plain mainly due to water withdrawals for irrigating winter wheat year after year. In order to examine whether the drawdown can be reduced we calculate the net water use for an 11 year field experiment from 2003 to 2013 where six irrigated crops (winter wheat, summer maize, cotton, peanuts, sweet potato, ryegrass) were grown in different crop rotations in the North China Plain. As part of this experiment moisture contents were measured each at 20 cm intervals in the top 1.8 m. Recharge and net water use were calculated based on these moisture measurement. Results showed that winter wheat and ryegrass had the least recharge with an average of 27 mm/year and 39 mm/year, respectively; cotton had the most recharge with an average of 211 mm/year) followed by peanuts with 118 mm/year, sweet potato with 76 mm/year, and summer maize with 44 mm/year. Recharge depended on the amount of irrigation water pumped from the aquifer and was therefore a poor indicator of future groundwater decline. Instead net water use (recharge minus irrigation) was found to be a good indicator for the decline of the water table. The smallest amount of net (ground water) used was cotton with an average of 14 mm/year, followed by peanut with 32 mm/year, summer maize with 71 mm/year, sweet potato with 74 mm/year. Winter wheat and ryegrass had the greatest net water use with the average of 198 mm/year and 111 mm/year, respectively. Our calculations showed that any single crop would use less water than the prevalent winter wheat summer maize rotation. This growing one crop instead of two will reduce the decline of groundwater and in some rain rich years increase the ground water level, but will result in less income for the farmers.	[Yang, Xiaolin; Chen, Yuanquan; Gao, Wangsheng; Zhang, Min; Sui, Peng] China Agr Univ, Coll Agron & Biotechnol, Beijing 100193, Peoples R China; [Yang, Xiaolin; Pacenka, Steven; Steenhuis, Tammo S.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA	China Agricultural University; Cornell University	Sui, P (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100193, Peoples R China.	tss1@cornell.edu; suipeng@cau.edu.cn	Chen, Yuanquan/AAU-9492-2020	Yang, XiaoLin/0000-0001-9146-8722	National Key Technology R&D Program of the People's Republic of China [2011BAD16B15, 2012BAD14B03]; China Scholarship Council for Xiaolin Yang [201306350107]; Chinese Universities Scientific Fund [2013YJ001]; College of Agriculture and Life Sciences at Cornell University	National Key Technology R&D Program of the People's Republic of China(National Key Technology R&D Program); China Scholarship Council for Xiaolin Yang(China Scholarship Council); Chinese Universities Scientific Fund; College of Agriculture and Life Sciences at Cornell University	The authors are grateful for grants from the National Key Technology R&D Program of the People's Republic of China (2011BAD16B15 and 2012BAD14B03), the China Scholarship Council for Xiaolin Yang (Grant No. 201306350107) and the Chinese Universities Scientific Fund (2013YJ001) and the support of College of Agriculture and Life Sciences at Cornell University by providing the use of their facilities free of charge.	Allen RG, 2006, AGR WATER MANAGE, V81, P1, DOI 10.1016/j.agwat.2005.03.007; BRADBURY KR, 2000, REFINEMENT 2 METHODS, P42331; Chen C, 2010, AGR WATER MANAGE, V97, P1175, DOI 10.1016/j.agwat.2008.11.012; Chen JY, 2003, ENVIRON GEOL, V44, P564, DOI 10.1007/s00254-003-0792-3; Cui NB, 2008, AGR WATER MANAGE, V95, P489, DOI 10.1016/j.agwat.2007.11.007; Currell MJ, 2012, HYDROL PROCESS, V26, P4050, DOI 10.1002/hyp.9208; Fan ZL, 2013, EUR J AGRON, V45, P52, DOI 10.1016/j.eja.2012.10.010; Fang QX, 2010, AGR WATER MANAGE, V97, P1102, DOI 10.1016/j.agwat.2010.01.008; Fang QX, 2006, PLANT SOIL, V284, P335, DOI 10.1007/s11104-006-0055-7; Hou XQ, 2012, FIELD CROP RES, V129, P7, DOI 10.1016/j.fcr.2011.12.021; Hu TT, 2009, AGR WATER MANAGE, V96, P208, DOI 10.1016/j.agwat.2008.07.011; Hu YK, 2010, J HYDROL, V393, P219, DOI 10.1016/j.jhydrol.2010.08.017; Huo ZL, 2012, IRRIG DRAIN, V61, P348, DOI 10.1002/ird.685; [贾金生 Jia Jinsheng], 2002, [地理学报, Acta Geographica Sinica], V57, P201; Kendy E, 2004, HYDROL PROCESS, V18, P2289, DOI 10.1002/hyp.5529; Kendy E, 2003, HYDROL PROCESS, V17, P2011, DOI 10.1002/hyp.1240; Kong FL, 2012, PROCEDIA ENGINEER, V28, P376, DOI 10.1016/j.proeng.2012.01.736; LIN XY, 1991, WATER SCI TECHNOL, V24, P71, DOI 10.2166/wst.1991.0338; Liu CM, 2002, AGR FOREST METEOROL, V111, P109, DOI 10.1016/S0168-1923(02)00015-1; Liu HJ, 2011, AGR WATER MANAGE, V98, P483, DOI 10.1016/j.agwat.2010.09.006; Liu MX, 2013, PEDOSPHERE, V23, P620, DOI 10.1016/S1002-0160(13)60055-7; Liu XW, 2013, AGR WATER MANAGE, V129, P173, DOI 10.1016/j.agwat.2013.08.002; *LUANCH COUNT WAT, 1993, INVESTIGATION REPORT, P42331; [马丽 MA Li], 2008, [干旱地区农业研究, Agricultural Research in the Arid Areas], V26, P177; Ma Y, 2013, AGR WATER MANAGE, V127, P13, DOI 10.1016/j.agwat.2013.05.011; Mo XG, 2009, AGR ECOSYST ENVIRON, V134, P67, DOI 10.1016/j.agee.2009.05.017; Moiwo JP, 2010, HYDROL PROCESS, V24, P3026, DOI 10.1002/hyp.7716; National Bureau of Statistics of China, 2008, CHIN STAT YB 2008; Passioura J, 2006, AGR WATER MANAGE, V80, P176, DOI 10.1016/j.agwat.2005.07.012; Qin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078828; Sas I.I., 2011, SAS STAT US GUID VER; Shu YQ, 2012, J HYDROL, V464, P79, DOI 10.1016/j.jhydrol.2012.06.048; Sun HY, 2006, AGR WATER MANAGE, V85, P211, DOI 10.1016/j.agwat.2006.04.008; Sun HY, 2010, AGR WATER MANAGE, V97, P1139, DOI 10.1016/j.agwat.2009.06.004; Sun QP, 2011, AGR WATER MANAGE, V98, P808, DOI 10.1016/j.agwat.2010.12.007; Yang JF, 2007, HYDROL PROCESS, V21, P717, DOI 10.1002/hyp.6246; YANG XL, 2014, DATA RECHARGE GROUND, P42331; Yang YM, 2010, AGR WATER MANAGE, V97, P1711, DOI 10.1016/j.agwat.2010.06.002; Yang YH, 2006, AGR WATER MANAGE, V82, P25, DOI 10.1016/j.agwat.2005.07.020; Yang YH, 2002, WATER SA, V28, P171; Ye YL, 2008, CHINESE AGR SCI B, V24, P445; [张敏 Zhang Min], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P251; Zhang MY, 2013, J CLEAN PROD, V54, P101, DOI 10.1016/j.jclepro.2013.04.033; Zhang XY, 2008, IRRIGATION SCI, V27, P1, DOI 10.1007/s00271-008-0131-2; Zhang XY, 2013, IRRIGATION SCI, V31, P1103, DOI 10.1007/s00271-012-0391-8; Zhang YQ, 2004, AGR WATER MANAGE, V64, P107, DOI 10.1016/S0378-3774(03)00201-4; ZHANG Z, 2003, REV CHINA AGR TECHNO, V5, P42; Zhao LY, 2013, ACTA METEOROL SIN, V27, P585, DOI 10.1007/s13351-013-0405-3; Zhao RF, 2006, AGRON J, V98, P938, DOI 10.2134/agronj2005.0157; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	50	47	50	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115269	10.1371/journal.pone.0115269	http://dx.doi.org/10.1371/journal.pone.0115269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625765	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821400006
J	Yao, JS; Xu, Y; Qin, YH; Liu, J; Shen, YD; Wang, W; Chen, W				Yao, Jiashu; Xu, You; Qin, Yanhua; Liu, Jing; Shen, Yuedi; Wang, Wei; Chen, Wei			Relationship between Personality Disorder Functioning Styles and the Emotional States in Bipolar I and II Disorders	PLOS ONE			English	Article							EARLY MALADAPTIVE SCHEMAS; 5-FACTOR MODEL; TRAITS; MOOD; SPECTRUM; QUESTIONNAIRE; COMORBIDITY; DEPRESSION; VALIDITY; DIMENSIONS	Background Bipolar disorder types I (BD I) and II (BD II) behave differently in clinical manifestations, normal personality traits, responses to pharmacotherapies, biochemical backgrounds and neuroimaging activations. How the varied emotional states of BD I and II are related to the comorbid personality disorders remains to be settled. Methods We therefore administered the Plutchick - van Praag Depression Inventory (PVP), the Mood Disorder Questionnaire (MDQ), the Hypomanic Checklist-32 (HCL-32), and the Parker Personality Measure (PERM) in 37 patients with BD I, 34 BD II, and in 76 healthy volunteers. Results Compared to the healthy volunteers, patients with BD I and II scored higher on some PERM styles, PVP, MDQ and HCL-32 scales. In BD I, the PERM Borderline style predicted the PVP scale; and Antisocial predicted HCL-32. In BD II, Borderline, Dependant, Paranoid (-) and Schizoid (-) predicted PVP; Borderline predicted MDQ; Passive-Aggressive and Schizoid (-) predicted HCL-32. In controls, Borderline and Narcissistic (-) predicted PVP; Borderline and Dependant (-) predicted MDQ. Conclusion Besides confirming the different predictability of the 11 functioning styles of personality disorder to BD I and II, we found that the prediction was more common in BD II, which might underlie its higher risk of suicide and poorer treatment outcome.	[Yao, Jiashu; Qin, Yanhua; Liu, Jing; Wang, Wei; Chen, Wei] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Psychiat, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, You; Wang, Wei] Zhejiang Univ, Sch Publ Hlth, Dept Clin Psychol & Psychiat, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Yuedi] Hangzhou Normal Univ, Sch Med, Dept Diagnost, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Hangzhou Normal University	Wang, W (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Psychiat, Hangzhou 310003, Zhejiang, Peoples R China.	wangmufan@msn.com; srrcw@zju.edu.cn	Wang, Wei/B-8303-2008; wang, chu/GYJ-2191-2022	Wang, Wei/0000-0002-6822-8162; 	Natural Science Foundation of China [91132715, 81272502, 81371490]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the grants from the Natural Science Foundation of China to Drs. W. Wang (No. 91132715), Y. Shen (No. 81272502), and W. Chen (No. 81371490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela JRZ, 2003, J PERS DISORD, V17, P319, DOI 10.1521/pedi.17.4.319.23968; American Psychiatric Association, 2000, DIAGNOSTIC CRITERIA; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Angst J, 2005, J AFFECT DISORDERS, V88, P217, DOI 10.1016/j.jad.2005.05.011; Antoniadis D, 2012, PSYCHIAT QUART, V83, P449, DOI 10.1007/s11126-012-9214-6; Baek JH, 2011, J AFFECT DISORDERS, V131, P59, DOI 10.1016/j.jad.2010.11.020; Bagby RM, 2008, CAN J PSYCHIAT, V53, P14, DOI 10.1177/070674370805300104; Barbato N, 1998, AUST NZ J PSYCHIAT, V32, P276, DOI 10.3109/00048679809062739; Bassett D, 2012, AUST NZ J PSYCHIAT, V46, P327, DOI 10.1177/0004867411435289; BELLODI L, 1992, COMPR PSYCHIAT, V33, P128, DOI 10.1016/0010-440X(92)90010-N; Benazzi F, 2008, PROG NEURO-PSYCHOPH, V32, P1022, DOI 10.1016/j.pnpbp.2008.01.015; Benazzi F, 2007, CNS DRUGS, V21, P727, DOI 10.2165/00023210-200721090-00003; BLATT SJ, 1982, J CONSULT CLIN PSYCH, V50, P113, DOI 10.1037/0022-006X.50.1.113; Brieger P, 2003, COMPR PSYCHIAT, V44, P28, DOI 10.1053/comp.2003.50009; CARPENTER D, 1995, J AFFECT DISORDERS, V34, P269, DOI 10.1016/0165-0327(95)00024-H; Chou YH, 2010, BIPOLAR DISORD, V12, P312, DOI 10.1111/j.1399-5618.2010.00800.x; Dunayevich E, 2000, J CLIN PSYCHIAT, V61, P134; Elisei S, 2012, PSYCHIAT DANUB, V24, pS143; George EL, 2003, BIPOLAR DISORD, V5, P115, DOI 10.1034/j.1399-5618.2003.00028.x; Grant BF, 2005, J PSYCHIATR RES, V39, P1, DOI 10.1016/j.jpsychires.2004.05.004; Ha TH, 2009, NEUROSCI LETT, V456, P44, DOI 10.1016/j.neulet.2009.03.077; Hawke LD, 2012, J AFFECT DISORDERS, V136, P803, DOI 10.1016/j.jad.2011.09.036; Hawke LD, 2011, J AFFECT DISORDERS, V133, P428, DOI 10.1016/j.jad.2011.04.040; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Huang CC, 2012, AM J MED GENET B, V159B, P501, DOI 10.1002/ajmg.b.32055; Huang JY, 2011, PSYCHIAT RES, V186, P320, DOI 10.1016/j.psychres.2010.07.010; Judd LL, 2003, J AFFECT DISORDERS, V73, P19, DOI 10.1016/S0165-0327(02)00324-5; Kelly T, 2008, J AFFECT DISORDERS, V107, P237, DOI 10.1016/j.jad.2007.07.027; Kim B, 2012, PSYCHIAT INVEST, V9, P347, DOI 10.4306/pi.2012.9.4.347; Kim B, 2011, PSYCHIAT RES, V185, P135, DOI 10.1016/j.psychres.2010.05.020; KLEVIN DN, 2011, ANNU REV CLIN PSYCHO, V7, P269, DOI DOI 10.1146/ANNUREV-CLINPSY-032210-104540; Kwapil TR, 2000, J ABNORM PSYCHOL, V109, P222, DOI 10.1037/0021-843X.109.2.222; Latalova K, 2012, PSYCHIAT QUART, V83, P293, DOI 10.1007/s11126-011-9200-4; Lee SY, 2012, PROG NEURO-PSYCHOPH, V38, P247, DOI 10.1016/j.pnpbp.2012.04.005; Lee SY, 2011, WORLD J BIOL PSYCHIA, V12, P385, DOI 10.3109/15622975.2010.505298; Lee SY, 2010, PHARMACOGENET GENOM, V20, P500, DOI 10.1097/FPC.0b013e32833caa2b; Lozano BE, 2001, J AFFECT DISORDERS, V63, P103, DOI 10.1016/S0165-0327(00)00191-9; Magill CA, 2004, CAN J PSYCHIAT, V49, P551, DOI 10.1177/070674370404900806; Maina G, 2007, J CLIN PSYCHIAT, V68, P207, DOI 10.4088/JCP.v68n0205; McMahon FJ, 2001, ARCH GEN PSYCHIAT, V58, P1025, DOI 10.1001/archpsyc.58.11.1025; Medda P, 2009, J AFFECT DISORDERS, V118, P55, DOI 10.1016/j.jad.2009.01.014; NEWTONHOWES G, 2013, J PERS DISORD, P42331; Paris J, 2007, COMPR PSYCHIAT, V48, P145, DOI 10.1016/j.comppsych.2006.10.001; Parker G, 2001, J PERS DISORD, V15, P300, DOI 10.1521/pedi.15.4.300.19186; PESELOW ED, 1995, AM J PSYCHIAT, V152, P232; PLUTCHIK R, 1987, PSYCHIAT RES, V22, P243, DOI 10.1016/0165-1781(87)90039-4; Rihmer Z, 1999, PSYCHIAT CLIN N AM, V22, P667, DOI 10.1016/S0193-953X(05)70101-5; Ruggero CJ, 2010, J PSYCHIATR RES, V44, P405, DOI 10.1016/j.jpsychires.2009.09.011; Saulsman LM, 2004, CLIN PSYCHOL REV, V23, P1055, DOI 10.1016/j.cpr.2002.09.001; Schrijvers DL, 2010, J NEURAL TRANSM, V117, P869, DOI 10.1007/s00702-010-0419-2; Tondo L, 2013, ACTA PSYCHIAT SCAND, V127, P355, DOI 10.1111/acps.12023; Tondo L, 1998, AM J PSYCHIAT, V155, P638, DOI 10.1176/ajp.155.5.638; Trull TJ, 2005, J PERS DISORD, V19, P262, DOI 10.1521/pedi.2005.19.3.262; Ucok A, 1998, COMPR PSYCHIAT, V39, P72, DOI 10.1016/S0010-440X(98)90081-5; VANSLYKE S, 2010, PSYCHIATRIC AND MENT, P576; Vieta E, 1997, COMPR PSYCHIAT, V38, P98, DOI 10.1016/S0010-440X(97)90088-2; Vieta E, 1999, J NERV MENT DIS, V187, P245, DOI 10.1097/00005053-199904000-00009; Wang W, 2002, SOC BEHAV PERSONAL, V30, P757, DOI 10.2224/sbp.2002.30.8.757; Wang W, 2003, BMC PSYCHIATRY, V3, DOI 10.1186/1471-244X-3-11; Yang HC, 2011, PSYCHIAT RES, V189, P446, DOI 10.1016/j.psychres.2011.02.007; Yang HC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-84; Zimmerman Mark, 2013, Dialogues Clin Neurosci, V15, P155; Zimmerman M, 2010, J CLIN PSYCHIAT, V71, P26, DOI 10.4088/JCP.08m04633	63	8	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117353	10.1371/journal.pone.0117353	http://dx.doi.org/10.1371/journal.pone.0117353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QM	25625553	gold, Green Submitted, Green Published			2022-12-27	WOS:000348821400032
J	Gueler, F; Shushakova, N; Mengel, M; Hueper, K; Chen, R; Liu, XK; Park, JK; Haller, H; Wensvoort, G; Rong, S				Gueler, Faikah; Shushakova, Nelli; Mengel, Michael; Hueper, Katja; Chen, Rongjun; Liu, Xiaokun; Park, Joon-Keun; Haller, Hermann; Wensvoort, Gert; Rong, Song			A Novel Therapy to Attenuate Acute Kidney Injury and Ischemic Allograft Damage after Allogenic Kidney Transplantation in Mice	PLOS ONE			English	Article							LONG-TERM OUTCOMES; PERITUBULAR CAPILLARIES; DELAYED GRAFT; INHIBITION; REPERFUSION; RECEPTOR; HYPOXIA; MODEL; AKI	Ischemia followed by reperfusion contributes to the initial damage to allografts after kidney transplantation (ktx). In this study we tested the hypothesis that a tetrapeptide EA-230 (AQGV), might improve survival and attenuate loss of kidney function in a mouse model of renal ischemia/reperfusion injury (IRI) and ischemia-induced delayed graft function after allogenic kidney transplantation. IRI was induced in male C57Bl/6N mice by transient bilateral renal pedicle clamping for 35 min. Treatment with EA-230 (20-50mg/kg twice daily i.p. for four consecutive days) was initiated 24 hours after IRI when acute kidney injury (AKI) was already established. The treatment resulted in markedly improved survival in a dose dependent manner. Acute tubular injury two days after IRI was diminished and tubular epithelial cell proliferation was significantly enhanced by EA-230 treatment. Furthermore, CTGF up-regulation, a marker of post-ischemic fibrosis, at four weeks after IRI was significantly less in EA-230 treated renal tissue. To learn more about these effects, we measured renal blood flow (RBF) and glomerular filtration rate (GFR) at 28 hours after IRI. EA-230 improved both GFR and RBF significantly. Next, EA-230 treatment was tested in a model of ischemia-induced delayed graft function after allogenic kidney transplantation. The recipients were treated with EA-230 (50 mg/kg) twice daily i.p. which improved renal function and allograft survival by attenuating ischemic allograft damage. In conclusion, EA-230 is a novel and promising therapeutic agent for treating acute kidney injury and preventing IRI-induced post-transplant ischemic allograft injury. Its beneficial effect is associated with improved renal perfusion after IRI and enhanced regeneration of tubular epithelial cells.	[Gueler, Faikah; Shushakova, Nelli; Chen, Rongjun; Liu, Xiaokun; Park, Joon-Keun; Haller, Hermann; Rong, Song] Hannover Med Sch, Dept Nephrol, Hannover, Germany; [Shushakova, Nelli; Rong, Song] Phenos GmbH, Hannover, Germany; [Mengel, Michael] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Hueper, Katja] Hannover Med Sch, Hannover, Germany; [Chen, Rongjun] Zhejiang Univ, Affiliated Hosp 1, Kidney Dis Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Xiaokun] Zhejiang Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Wensvoort, Gert] Exponential Biotherapies Inc, The Hague, Netherlands; [Rong, Song] Zunyi Med Coll, Affiliated Hosp, Transplantat Ctr, Zunyi, Peoples R China	Hannover Medical School; University of Alberta; Hannover Medical School; Zhejiang University; Zhejiang University; Zunyi Medical University	Wensvoort, G (corresponding author), Exponential Biotherapies Inc, The Hague, Netherlands.	hetwittehuis@planet.nl	Hueper, Katja/J-9566-2016	Hueper, Katja/0000-0002-3195-4400; /0000-0001-9985-1515	Exponential Biotherapies Inc.	Exponential Biotherapies Inc.	Studies were outsourced by, funded by, and designed in guidance with Exponential Biotherapies Inc. The funders, through GW, had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Chapal M, 2013, TRANSPLANTATION, V96, P739, DOI 10.1097/TP.0b013e31829f4772; Chatterjee PK, 2002, KIDNEY INT, V61, P862, DOI 10.1046/j.1523-1755.2002.00234.x; Cooper JE, 2013, CURR OPIN NEPHROL HY, V22, P698, DOI 10.1097/MNH.0b013e328365b388; Feng MG, 2012, AM J PHYSIOL-RENAL, V303, pF775, DOI 10.1152/ajprenal.00233.2012; Gentle ME, 2013, J AM SOC NEPHROL, V24, P787, DOI 10.1681/ASN.2012101024; Grossini E, 2013, J APPL PHYSIOL, V115, P422, DOI 10.1152/japplphysiol.00425.2013; Gueler F, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000026609.45827.3D; Gueler F, 2008, J AM SOC NEPHROL, V19, P2302, DOI 10.1681/ASN.2007111267; Hueper K, 2013, RADIOLOGY; Hueper K, 2013, INVEST RADIOL, V48, P834, DOI 10.1097/RLI.0b013e31829d0414; Hueper K, 2012, INVEST RADIOL, V47, P430, DOI 10.1097/RLI.0b013e31824f272d; Ishii Y, 2005, TRANSPL P, V37, P981, DOI 10.1016/j.transproceed.2004.12.284; Khan NA, 2002, HUM IMMUNOL, V63, P1, DOI 10.1016/S0198-8859(01)00372-X; Khan NA, 2009, NEPHROL DIAL TRANSPL, V24, P2701, DOI 10.1093/ndt/gfp369; Le Dorze M, 2009, CURR OPIN CRIT CARE, V15, P503, DOI 10.1097/MCC.0b013e328332f6cf; Legrand M, 2009, AM J PHYSIOL-RENAL, V296, pF1109, DOI 10.1152/ajprenal.90371.2008; Matsumoto M, 2004, J AM SOC NEPHROL, V15, P1574, DOI 10.1097/01.ASN.0000128047.13396.48; Nakagawa T, 2003, CURR OPIN NEPHROL HY, V12, P233, DOI 10.1097/00041552-200305000-00003; Parikh CR, 2008, BIOL BLOOD MARROW TR, V14, P309, DOI 10.1016/j.bbmt.2007.12.492; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Rong S, 2014, AM J PHYSL RENAL PHY; Rong S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/127215; Snoeijs MGJ, 2011, ANN SURG, V253, P598, DOI 10.1097/SLA.0b013e31820d9ae9; van den Berg JW, 2011, CRIT CARE MED, V39, P126, DOI 10.1097/CCM.0b013e3181fa3a93; Wehbe E, 2013, CLIN J AM SOC NEPHRO, V8, P19, DOI 10.2215/CJN.04800512; Wehbe E, 2012, J HEART LUNG TRANSPL, V31, P244, DOI 10.1016/j.healun.2011.08.016; Wong MG, 2008, J AM SOC NEPHROL, V19, P290, DOI 10.1681/ASN.2007020226	28	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0115709	10.1371/journal.pone.0115709	http://dx.doi.org/10.1371/journal.pone.0115709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617900	Green Published, gold, Green Submitted			2022-12-27	WOS:000350336000006
J	Zhu, XM; Bai, YJ; Yu, WZ; Pan, CT; Jin, EZ; Song, D; Xu, Q; Yao, YO; Huang, LZ; Tao, Y; Li, XX; Zhao, MW				Zhu, Xuemei; Bai, Yujing; Yu, Wenzhen; Pan, Chungting; Jin, Enzhong; Song, Dan; Xu, Qiong; Yao, Yuou; Huang, Lvzhen; Tao, Yong; Li, Xiaoxin; Zhao, Mingwei			The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; GLYCATION END-PRODUCTS; SIGNALING PATHWAYS; PANCREATIC-CANCER; ENDOTHELIAL-CELLS; NEURAL APOPTOSIS; VEGF EXPRESSION; SEMAPHORIN 3A; GROWTH; RAT	Pleiotrophin (PTN), a secreted, multifunctional cytokine, is involved in angiogenic, fibrotic and neurodegenerative diseases. However, little is known about its effects on diabetic retinopathy, a neurovascular disease. To investigate the role of PTN in proliferative diabetic retinopathy (PDR), PTN concentration in the vitreous was evaluated in PDR patients and non-diabetic controls. PTN expression was observed in epiretinal membranes from patients. PTN knockdown was performed using small interfering (si) RNA, and the effects on retinal pigment epithelium (RPE) cells and human umbilical vascular endothelia cells (HUVECs) were observed in vitro under hyperglycemic and hypoxic conditions. Cell attachment, proliferation, migration, tube formation, cell cycle, apoptosis, extracellular signal-regulated kinase 1/2 (ERK 1/2) phosphorylation, and VEGF levels were studied. The vitreous PTN concentration in PDR patients was higher than that in non-diabetic controls, and PTN was highly expressed in the fibrovascular membranes of PDR patients. Under hyperglycemic and hypoxic conditions, PTN knockdown reduced cell attachment, proliferation, migration, and tube formation and induced cell cycle arrest and apoptosis in vitro. Mechanically, PTN depletion decreased ERK 1/2 phosphorylation. Recombinant PTN up regulated the concentration of VEGF in vitro, which can be attenuated by the ERK 1/2 inhibitor. Taken together, our results implied that elevated PTN in PDR patients might participate in the critical processes of the development of PDR, most likely playing roles in angiogenesis and proliferation, possibly by activating the ERK 1/2 pathway and regulating VEGF secretion. These findings provide new insight into the roles of PTN in PDR and suggest that PTN may become a new target for therapeutic intervention in PDR. .	[Zhu, Xuemei; Bai, Yujing; Yu, Wenzhen; Pan, Chungting; Jin, Enzhong; Song, Dan; Xu, Qiong; Yao, Yuou; Huang, Lvzhen; Tao, Yong; Li, Xiaoxin; Zhao, Mingwei] Peking Univ, Peoples Hosp, Dept Ophthalmol,Minist Educ, Key Lab Vis Loss & Restorat,Beijing Key Lab Diago, Beijing 100044, Peoples R China	Peking University	Zhao, MW (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol,Minist Educ, Key Lab Vis Loss & Restorat,Beijing Key Lab Diago, Beijing 100044, Peoples R China.	zhaomingwei@medmail.com.cn		Jin, Enzhong/0000-0003-1450-5846	Specialized Research Fund for the Doctoral Program of Higher Education [20130001110086]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education for ZMW (20130001110086) http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/2013/10/1382602963718681.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YJ, 2013, INVEST OPHTH VIS SCI, V54, P6628, DOI 10.1167/iovs.13-12625; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; BLOCH B, 1992, DEV BRAIN RES, V70, P267, DOI 10.1016/0165-3806(92)90206-C; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; Chen M, 2013, CURR MED CHEM, V20, P3234, DOI 10.2174/09298673113209990025; Cheung N, 2014, DIABETES CARE, V37, P900, DOI 10.2337/dc13-1990; Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025; CZUBAYKO F, 1994, J BIOL CHEM, V269, P21358; D'Amico AG, 2014, J MOL NEUROSCI, V54, P405, DOI 10.1007/s12031-014-0335-2; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Deuel TF, 2013, BBA-PROTEINS PROTEOM, V1834, P2219, DOI 10.1016/j.bbapap.2013.06.004; Early Treatment Diabetic Retinopathy Study Research Group, 1991, OPHTHALMOLOGY, V98, P766; Fan JB, 2014, BIOCHEM BIOPH RES CO, V447, P425, DOI 10.1016/j.bbrc.2014.04.002; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; FERRIS FL, 1991, JAMA-J AM MED ASSOC, V266, P1263, DOI 10.1001/jama.266.9.1263; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Heng LZ, 2013, DIABETIC MED, V30, P640, DOI 10.1111/dme.12089; Herradon G, 2014, BRIT J PHARMACOL, V171, P837, DOI 10.1111/bph.12312; Herradon G, 2009, CURR MED CHEM, V16, P3322, DOI 10.2174/092986709788803240; Hida H, 2003, EUR J NEUROSCI, V17, P2127, DOI 10.1046/j.1460-9568.2003.02661.x; Isenovic ER, 2010, ANGIOLOGY, V61, P357, DOI 10.1177/0003319709358693; Jindal V., 2014, MOL NEUROBIOL; Jung KI, 2013, J PHARMACOL EXP THER, V345, P457, DOI 10.1124/jpet.113.203067; Kohashi T, 2002, GROWTH FACTORS, V20, P53, DOI 10.1080/08977190290023913; Kong Y, 2012, INT J COLORECTAL DIS, V27, P287, DOI 10.1007/s00384-011-1344-z; Koutsioumpa M, 2013, J BIOL CHEM, V288, P343, DOI 10.1074/jbc.M112.387076; Li JL, 2007, J BIOL CHEM, V282, P34984, DOI 10.1074/jbc.M703513200; Li PY, 2011, CURR EYE RES, V36, P673, DOI 10.3109/02713683.2011.572220; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Liu J, 2013, INT J MOL MED, V32, P1150, DOI 10.3892/ijmm.2013.1491; Mentlein R, 2002, J NEUROCHEM, V83, P747, DOI 10.1046/j.1471-4159.2002.01179.x; Miao JY, 2012, NEUROSCI RES, V74, P269, DOI 10.1016/j.neures.2012.09.001; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Osaadon P, 2014, EYE, V28, P510, DOI 10.1038/eye.2014.13; Perez-Pinera P, 2006, P NATL ACAD SCI USA, V103, P17795, DOI 10.1073/pnas.0607299103; Pufe T, 2003, ARTHRITIS RHEUM, V48, P660, DOI 10.1002/art.10839; Rumsby M, 1999, GLIA, V26, P361, DOI 10.1002/(SICI)1098-1136(199906)26:4<361::AID-GLIA10>3.0.CO;2-Q; Saker S, 2014, EXP EYE RES, V121, P161, DOI 10.1016/j.exer.2014.02.016; Simo R, 2009, DIABETES CARE, V32, P1556, DOI 10.2337/dc09-0565; Tsai TT, 2014, J ORTHOP RES, V32, P238, DOI 10.1002/jor.22508; Weber D, 2000, CANCER RES, V60, P5284; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Yao J, 2013, WORLD J GASTROENTERO, V19, P6555, DOI 10.3748/wjg.v19.i39.6555; Ye XF, 2010, INVEST OPHTH VIS SCI, V51, P5226, DOI 10.1167/iovs.09-4899; Yokoi H, 2012, KIDNEY INT, V81, P160, DOI 10.1038/ki.2011.305; Yu WZ, 2013, MOL VIS, V19, P1397; Zhang N, 1997, J BIOL CHEM, V272, P16733, DOI 10.1074/jbc.272.27.16733; Zhang Q, 2013, J MOL HISTOL, V44, P91, DOI 10.1007/s10735-012-9453-8; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	52	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0115523	10.1371/journal.pone.0115523	http://dx.doi.org/10.1371/journal.pone.0115523			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617851	gold, Green Published, Green Submitted			2022-12-27	WOS:000350336000005
J	Alho, L; Soares, SC; Ferreira, J; Rocha, M; Silva, CF; Olsson, MJ				Alho, Laura; Soares, Sandra C.; Ferreira, Jacqueline; Rocha, Marta; Silva, Carlos F.; Olsson, Mats J.			Nosewitness Identification: Effects of Negative Emotion	PLOS ONE			English	Article							EYEWITNESS IDENTIFICATION; MEMORY; ODORS; CUE; PERFORMANCE; ACCURACY; SCENT	Every individual has a unique body odor (BO), similar to a fingerprint. In forensic research, identification of culprit BOs has been performed by trained dogs, but not by humans. We introduce the concept of nosewitness identification and present the first experimental results on BO memory in witness situations involving violent crimes. Two experiments indicated that BO associated with male characters in authentic videos could later be identified in BO lineup tests well above chance. Moreover, culprit BO in emotional crime videos could be identified considerably better than the BO of a male person in neutral videos. This indicates that nosewitness identification benefits from emotional encoding. Altogether, the study testifies to the virtue of body odor as a cue to identify individuals observed under negative emotion.	[Alho, Laura; Soares, Sandra C.; Ferreira, Jacqueline; Rocha, Marta; Silva, Carlos F.] Univ Aveiro, Dept Educ, P-3800 Aveiro, Portugal; [Alho, Laura; Soares, Sandra C.; Ferreira, Jacqueline; Silva, Carlos F.] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci IBILI, Coimbra, Portugal; [Soares, Sandra C.; Silva, Carlos F.] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, P-4100 Oporto, Portugal; [Olsson, Mats J.] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden	Universidade de Aveiro; Universidade de Coimbra; Universidade do Porto; Karolinska Institutet	Soares, SC (corresponding author), Univ Aveiro, Dept Educ, P-3800 Aveiro, Portugal.	sandra.soares@ua.pt	Silva, Carlos F/K-5584-2013; Soares, Sandra C./K-5576-2013	Silva, Carlos F/0000-0002-1399-6674; Soares, Sandra C./0000-0002-0346-7840; Coelho Rocha, Marta/0000-0002-1068-1773; Ferreira, Jacqueline/0000-0003-0534-0322; Olsson, Mats/0000-0001-5592-3759; Alho, Laura/0000-0002-2386-6451	Swedish Research Council [421-2012-1125]; Bank of Sweden Tercentenary Foundation [P12-1017]; Foundation for Science and Technology [SFRH/BD/78911/2011]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Bank of Sweden Tercentenary Foundation; Foundation for Science and Technology	This study was supported by grants from the Swedish Research Council (421-2012-1125) and Bank of Sweden Tercentenary Foundation (P12-1017 to MJO), and by a doctoral grant from the Foundation for Science and Technology (SFRH/BD/78911/2011 to LA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunel M, 2013, PSYCHOL CRIME LAW, V19, P845, DOI 10.1080/1068316X.2012.684058; Christianson SA., 1992, HDB EMOTION MEMORY R; Clark SE, 2008, LAW HUMAN BEHAV, V32, P187, DOI 10.1007/s10979-006-9082-4; Deffenbacher KA, 2004, LAW HUMAN BEHAV, V28, P687, DOI 10.1007/s10979-004-0565-x; Degel J, 1999, CHEM SENSES, V24, P317, DOI 10.1093/chemse/24.3.317; Doege D, 1992, RAPE VICTIM REMEMBER, P9; DOTY RL, 1975, SCIENCE, V190, P1316, DOI 10.1126/science.1239080; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Eggert F, 1998, GENETICA, V104, P265, DOI 10.1023/A:1026431303879; Engen T., 1991, ODOR SENSATION MEMOR; Havlicek J, 2006, CHEM SENSES, V31, P747, DOI 10.1093/chemse/bjl017; Herz RS, 2004, CHEM SENSES, V29, P217, DOI 10.1093/chemse/bjh025; Herz RS, 1997, AM J PSYCHOL, V110, P489, DOI 10.2307/1423407; Hollien H, 2012, INVESTIG SCI J, V4, P1; Houston KA, 2013, EMOTION, V13, P118, DOI 10.1037/a0029220; Jonsson FU, 2011, MEM COGNITION, V39, P1023, DOI 10.3758/s13421-011-0080-5; Kensinger EA, 2007, CURR DIR PSYCHOL SCI, V16, P213, DOI 10.1111/j.1467-8721.2007.00506.x; Krug K, 2007, APPL PSYCHOL CRIM JU, V3, P7; Krusemark EA, 2013, J NEUROSCI, V33, P587, DOI [10.1523/JNEUROSCI.1379-12.2013, 10.1523/JNEUROSCI.1835-13.2013]; Leach AM, 2009, ANNU REV LAW SOC SCI, V5, P157, DOI 10.1146/annurev.lawsocsci.093008.131529; LGIT, 2011, LGITS ROLL CALL REP; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Mitro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038110; Olsson MJ, 2014, PSYCHOL SCI, V25, P817, DOI 10.1177/0956797613515681; Olsson MJ, 2009, CHEMOSENS PERCEPT, V2, P161, DOI 10.1007/s12078-009-9051-7; Pinc L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020704; Prada PA, 2008, REV CIENC FOREN, V1, P81; Rodriguez D. N., 2013, J CRIMINOLOGY, V2013, P1, DOI [10.1155/2013/530523, DOI 10.1155/2013/530523]; Rodriguez-Lujan I, 2013, KNOWL-BASED SYST, V52, P279, DOI 10.1016/j.knosys.2013.08.002; Schoon GAA, 2005, FORENSIC SCI INT, V147, P43, DOI 10.1016/j.forsciint.2004.04.080; Spielberger C. D., 1973, MANUAL STATE TRAIT I; SPORER SL, 1995, PSYCHOL BULL, V118, P315, DOI 10.1037/0033-2909.118.3.315; Stevenson RJ, 2014, COGNITIVE SCI, V38, P1360, DOI 10.1111/cogs.12111; Wells GL, 1998, LAW HUMAN BEHAV, V22, P603, DOI 10.1023/A:1025750605807	34	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116706	10.1371/journal.pone.0116706	http://dx.doi.org/10.1371/journal.pone.0116706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612211	gold, Green Submitted, Green Published			2022-12-27	WOS:000348562900021
J	Regan, JM; Worley, E; Shelburne, C; Pullarkat, R; Watson, JC				Regan, Jacqueline M.; Worley, Emmagene; Shelburne, Christopher; Pullarkat, Ranjit; Watson, Joseph C.			Burr Hole Washout versus Craniotomy for Chronic Subdural Hematoma: Patient Outcome and Cost Analysis	PLOS ONE			English	Article							SURGICAL-TREATMENT; EVACUATION; EXPERIENCE; MANAGEMENT; RECURRENCE	Chronic subdural hematomas (CSDH), which are frequently encountered in neurosurgical practice, are, in the majority of cases, ideally treated with surgical drainage. Despite this common practice, there is still controversy surrounding the best surgical procedure. With lack of clear evidence of a superior technique, surgeons are free to base the decision on other factors that are not related to patient care. A retrospective chart review of 119 patients requiring surgical drainage of CSDH was conducted at a large tertiary care center over a three-year period. Of the cases reviewed, 58 patients underwent craniotomy, while 61 patients underwent burr hole washout. The study focused on re-operation rates, mortality, and morbidity, as measured by Glasgow coma scores (GCS), discharge Rankin disability scores, and discharge disposition. Secondary endpoints included length of stay and cost of procedure. Burr hole washout was superior to craniotomy with respect to patient outcome, length of stay and recurrence rates. In both study groups, patients required additional surgical procedures (6.6% of burr hole patients and 24.1% of craniotomy patients) (P = 0.0156). Of the patients treated with craniotomy, 51.7% were discharged home, whereas 65.6% of the burr hole patients were discharged home. Patients who underwent burr hole washout spent a mean of 78.8 minutes in the operating suite while the patients undergoing craniotomy spent 129.4 minutes (P < 0.001). The difference in mean cost per patient, based solely on operating time, was $2,828 (P < 0.001). This does not include the further cost due to additional procedures and hospital stay. The mean length of stay after surgical intervention was 3 days longer for the craniotomy group (P = 0.0465). Based on this retrospective study, burr hole washout is superior for both patients' clinical and financial outcome; however, prospective long-term multicenter clinical studies are required to verify these findings.	[Regan, Jacqueline M.] Univ Michigan, Ann Arbor, MI 48109 USA; [Worley, Emmagene; Pullarkat, Ranjit] Virginia Commonwealth Univ, Falls Church, VA USA; [Shelburne, Christopher] Inova Fairfax Hosp, Dept Neurosci, Falls Church, VA USA; [Watson, Joseph C.] Cerebrum MD, Vienna, VA 22182 USA	University of Michigan System; University of Michigan; Virginia Commonwealth University; Inova Fairfax Hospital	Watson, JC (corresponding author), Cerebrum MD, Vienna, VA 22182 USA.	jwatson4@vcu.edu	Watson, Joe/AAP-2155-2020					Cenic A, 2005, CAN J NEUROL SCI, V32, P501, DOI 10.1017/S0317167100004510; Chen JCT, 2000, NEUROSURG CLIN N AM, V11, P399, DOI 10.1016/S1042-3680(18)30101-3; Ernestus RI, 1997, SURG NEUROL, V48, P220, DOI 10.1016/S0090-3019(97)80031-6; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; Klimo P, 2011, J NEUROSURG-PEDIATR, V8, P423, DOI 10.3171/2011.8.PEDS1131; Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026; Lega BC, 2010, J NEUROSURG, V113, P615, DOI 10.3171/2009.9.JNS08825; LISK DR, 1994, NEUROLOGY, V44, P133, DOI 10.1212/WNL.44.1.133; Mondorf Y, 2009, BRIT J NEUROSURG, V23, P612, DOI 10.3109/02688690903370297; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Sambasivan M, 1997, SURG NEUROL, V47, P418, DOI 10.1016/S0090-3019(97)00188-2; Santarius T, 2008, BRIT J NEUROSURG, V22, P529, DOI 10.1080/02688690802195381; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; White M, 2010, BRIT J NEUROSURG, V24, P257, DOI 10.3109/02688691003675218	16	31	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115085	10.1371/journal.pone.0115085	http://dx.doi.org/10.1371/journal.pone.0115085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611468	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900003
J	Kaulfers, AM; Deka, R; Dolan, L; Martin, LJ				Kaulfers, Anne-Marie; Deka, Ranjan; Dolan, Lawrence; Martin, Lisa J.			Association of INSIG2 Polymorphism with Overweight and LDL in Children	PLOS ONE			English	Article							COMMON GENETIC VARIANT; BODY-MASS INDEX; RS7566605 POLYMORPHISM; NO ASSOCIATION; OBESITY; UPSTREAM; REPLICATION; CHOLESTEROL; METABOLISM; PHENOTYPES	Background Dyslipidemia and overweight are common issues in children. Identifying genetic markers of risk could lead to targeted interventions. A polymorphism of SNP rs7566605 near insulin-induced gene 2 (INSIG2) has been identified as a strong candidate gene for obesity, through its feedback control of lipid synthesis. Objective To identify polymorphisms in INSIG2 which are associated with overweight (BMI >= 85% for age) and dyslipidemia in children. Hypothesis: The C allele of rs7566605 would be significantly associated with BMI and LDL. Design/Methods We genotyped 15 SNPs in/near INSIG2 in 1,058 healthy children (53% non-Hispanic white (NHW), 37% overweight) participating in a school based study. Genotype was compared with BMI and lipid markers, adjusting for age, gender, and puberty. Results We found a significant association between the SNP rs12464355 and LDL in NHW children, p < 0.001. The G allele is protective (lower LDL). A different SNP was associated with overweight in NHW: rs17047757. SNP rs7566605 was not associated with overweight or lipid levels. Conclusions We identified novel genetic associations between INSIG2 and both overweight and LDL in NHW children. Polymorphisms in INSIG2 may be important in the development of obesity through its effects on lipid regulation.	[Kaulfers, Anne-Marie] Univ S Alabama, Div Pediat Endocrinol, Mobile, AL 36688 USA; [Deka, Ranjan] Univ Cincinnati, Sch Med, Dept Environm Hlth, Cincinnati, OH USA; [Dolan, Lawrence] Cincinnati Childrens Hosp Med Ctr, Div Endocrinol, Cincinnati, OH 45229 USA; [Dolan, Lawrence; Martin, Lisa J.] Univ Cincinnati, Sch Med, Cincinnati, OH USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Biostat, Cincinnati, OH 45229 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Epidemiol, Div Human Genet, Cincinnati, OH 45229 USA	University of South Alabama; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Kaulfers, AM (corresponding author), Univ S Alabama, Div Pediat Endocrinol, Mobile, AL 36688 USA.	akaulfers@health.southalabama.edu	Martin, Lisa/E-2425-2016	Martin, Lisa/0000-0001-8702-9946	National Institute of Health (NIH) [DK59183]; Institutional Clinical and Translational Science Award; NIH/NCRR [1UL1RR026314-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059183, P30DK078392] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Clinical and Translational Science Award; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Institute of Health (NIH) Grant DK59183 and by an Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number 1UL1RR026314-01; www.nih.gov. LD received the funding. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002872; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Boes E, 2008, OBESITY, V16, P827, DOI 10.1038/oby.2007.132; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Ciullo M, 2008, DIABETES, V57, P783, DOI 10.2337/db07-0970; Dahlman I, 2007, INT J OBESITY, V31, P1629, DOI 10.1038/sj.ijo.0803657; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Do R, 2010, CIRC-CARDIOVASC GENE, V3, P454, DOI 10.1161/CIRCGENETICS.109.917039; Dolan LM, 2005, J PEDIATR-US, V146, P751, DOI 10.1016/j.jpeds.2005.01.045; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Feng Y, 2007, HUM GENET, V120, P743, DOI 10.1007/s00439-006-0258-2; Freedman DS, 2009, AM J CLIN NUTR, V90, P210, DOI 10.3945/ajcn.2009.27525; Hall DH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-83; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hotta K, 2008, J HUM GENET, V53, P857, DOI 10.1007/s10038-008-0317-8; Krapivner S, 2008, J CLIN ENDOCR METAB, V93, P1995, DOI 10.1210/jc.2007-1850; Kumar J, 2007, CLIN GENET, V71, P415, DOI 10.1111/j.1399-0004.2007.00795.x; Kuzuya M, 2007, OBESITY, V15, P2531, DOI 10.1038/oby.2007.301; Le Hellard S, 2009, MOL PSYCHIATR, V14, P308, DOI 10.1038/sj.mp.4002133; Lyon HN, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030061; Oki K, 2009, BRIT J NUTR, V101, P322, DOI 10.1017/S0007114508006557; Pal P, 2007, HUM GENET, V122, P251, DOI 10.1007/s00439-007-0394-3; Skelly T, 2007, MOL PSYCHIATR, V12, P321, DOI 10.1038/sj.mp.4001956; Smith AJP, 2007, INT J OBESITY, V31, P1753, DOI 10.1038/sj.ijo.0803645; Tabara Y, 2008, OBESITY, V16, P211, DOI 10.1038/oby.2007.25; Vimaleswaran KS, 2009, OBESITY, V17, P1453, DOI 10.1038/oby.2008.650; Wang HJ, 2008, BIOMED ENVIRON SCI, V21, P528, DOI 10.1016/S0895-3988(09)60013-1; Wiedmann S, 2009, OBESITY, V17, P1390, DOI 10.1038/oby.2008.669; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang L, 2008, EUR J HUM GENET, V16, P759, DOI 10.1038/ejhg.2008.8; Zhang Jun, 2008, Diabetes Res Clin Pract, V81, pe11, DOI 10.1016/j.diabres.2008.03.022	32	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116340	10.1371/journal.pone.0116340	http://dx.doi.org/10.1371/journal.pone.0116340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607990	Green Published, gold, Green Submitted			2022-12-27	WOS:000348205300024
J	Kim, SH; Park, J; Joo, C; Kim, D; Ha, T				Kim, Sung Hyun; Park, Jeehae; Joo, Chirlmin; Kim, Doseok; Ha, Taekjip			Dynamic Growth and Shrinkage Govern the pH Dependence of RecA Filament Stability	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; C-TERMINUS; PROTEIN; MOLECULES; EXCHANGE; REPLICATION; MECHANISM; MONOMER	RecA proteins form a long stable filament on a single-stranded DNA and catalyze strand exchange reaction. The stability of RecA filament changes dramatically with pH, yet its detailed mechanism is not known. Here, using a single molecule assay, we determined the binding and dissociation rates of RecA monomers at the filament ends at various pH. The pH-induced rate changes were moderate but occurred in opposite directions for binding and dissociation, resulting in a substantial increase in filament stability in lower pH. The highly charged residues in C-terminal domain do not contribute to the pH dependent stability. The stability enhancement of RecA filament in low pH may help the cell to cope with acidic stress by fine-tuning of the binding and dissociation rates without losing the highly dynamic nature of the filament required for strand exchange.	[Kim, Sung Hyun; Kim, Doseok] Sogang Univ, Dept Phys, Seoul 100611, South Korea; [Kim, Sung Hyun; Kim, Doseok] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul 100611, South Korea; [Park, Jeehae; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Joo, Chirlmin] Delft Univ Technol, Kavli Inst NanoSci, Dept BioNanoSci, Delft, Netherlands; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Dept Phys, Urbana, IL USA	Sogang University; Sogang University; University of Illinois System; University of Illinois Urbana-Champaign; Delft University of Technology; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Kim, D (corresponding author), Sogang Univ, Dept Phys, Seoul 100611, South Korea.	doseok@sogang.ac.kr; tjha@illinois.edu	Ha, Taekjip/B-9506-2009; Kim, Doseok/N-9521-2019; Joo, Chirlmin/B-9294-2008	Ha, Taekjip/0000-0003-2195-6258; Joo, Chirlmin/0000-0003-2803-0335; Kim, Sung Hyun/0000-0001-9272-7036	US National Science Foundation [PHY-0646550, PHY-1430124]; US National Institutes of Health [GM065367]; Korean Government (MEST) [2011-0017435]; European Research Council under the European Union's Seventh Framework Programme/ERC grant [309509]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); European Research Council under the European Union's Seventh Framework Programme/ERC grant(European Research Council (ERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by a grant from the US National Science Foundation [PHY-0646550, PHY-1430124 to TH]; US National Institutes of Health [GM065367 to TH]. DK acknowledges support from the Korean Government (MEST) grant No. 2011-0017435. CJ has received funding from the European Research Council under the European Union's Seventh Framework Programme [FP7/2007-2013]/ERC grant agreement no [309509]. RecA mutant was a kind gift from M. M. Cox (University of Wisconsin, Madison, USA).	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; EGELMAN EH, 1993, MICRON, V24, P309, DOI 10.1016/0968-4328(93)90056-7; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Fu HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066712; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Jeong KC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-181; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kim SH, 2013, NUCLEIC ACIDS RES, V41, P7738, DOI 10.1093/nar/gkt570; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16381, DOI 10.1074/jbc.M212916200; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MIKAWA T, 1995, J MOL BIOL, V250, P471, DOI 10.1006/jmbi.1995.0391; MUENCH KA, 1990, J BIOL CHEM, V265, P11560; PINSINCE JM, 1993, J MOL BIOL, V233, P59, DOI 10.1006/jmbi.1993.1484; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Vaze MB, 1999, BIOCHEMISTRY-US, V38, P3175, DOI 10.1021/bi9819125; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P8829	25	36	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115611	10.1371/journal.pone.0115611	http://dx.doi.org/10.1371/journal.pone.0115611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608006	Green Published, gold			2022-12-27	WOS:000348205300017
J	Aguado, E; Pascaretti-Grizon, F; Goyenvalle, E; Audran, M; Chappard, D				Aguado, Eric; Pascaretti-Grizon, Florence; Goyenvalle, Eric; Audran, Maurice; Chappard, Daniel			Bone Mass and Bone Quality Are Altered by Hypoactivity in the Chicken	PLOS ONE			English	Article							BOTULINUM TOXIN INJECTION; X-RAY RADIOGRAPHS; CANCELLOUS BONE; TRABECULAR BONE; JAPANESE-QUAIL; SIMULATED WEIGHTLESSNESS; SKELETAL DEFORMITIES; DISUSE OSTEOPOROSIS; MUSCLE PARALYSIS; TEXTURE ANALYSIS	Disuse induces a rapid bone loss in adults; sedentarity is now recognized as a risk factor for osteoporosis. Hypoactivity or confinement also decrease bone mass in adults but their effects are largely unknown and only few animal models have been described. We have used 10 chickens of the rapidly growing strain 857K bred in a large enclosure (FREE group); 10 others were confined in small cages with little space to move around (HYPO group). They were sacrificed at 53 days and femurs and tibias were evaluated by texture analysis, dual energy X-ray densitometry, microcomputed tomography (microCT) and histomorphometry. Hypoactivity had no effect on the length and diameter of the bones. Bone mineral density (BMD), microCT (trabecular bone volume and trabecular microarchitecture) and texture analysis were always found significantly reduced in the animals of the HYPO group. BMD was reduced at both femur and tibia diaphysises; BMD of the metaphysis was significantly reduced in the femur but not in the tibia. An increase in osteoid volume and surfaces was noted in the HYPO group. However, there was no alteration of the mineral phase as the osteoid thickness did not differ from control animals. Bone loss was much more pronounced at the lower femur metaphysis than at the upper metaphysis of the tibia. At the tibia, only microarchitectural changes of trabecular bone could be evidenced. The confined chicken represents a new method for the study of hypodynamia since these animals do not have surgical lesions.	[Aguado, Eric; Goyenvalle, Eric] ONIRIS, Ecole Natl Vet, Unite Biol & Biomat Tissu Osseux Chirurg Expt, F-44307 Nantes 3, France; [Aguado, Eric; Pascaretti-Grizon, Florence; Goyenvalle, Eric; Audran, Maurice; Chappard, Daniel] LUNAM Univ, CHU Angers, LHEA Lab Histol Embryol, GEROM Grp Etud Remodelage Osseux & BioMat,IBS, F-49933 Angers, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Chappard, D (corresponding author), LUNAM Univ, CHU Angers, LHEA Lab Histol Embryol, GEROM Grp Etud Remodelage Osseux & BioMat,IBS, F-49933 Angers, France.	daniel.chappard@univ-angers.fr		Aguado, Eric/0000-0003-1094-1042	Contrat Region Pays de la Loire: Bioregos2 program	Contrat Region Pays de la Loire: Bioregos2 program(Region Pays de la Loire)	This work was made possible by grants from Contrat Region Pays de la Loire: Bioregos2 program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikle Daniel D, 2003, Gravit Space Biol Bull, V16, P45; Bizeray D, 2004, PROD ANIM, V17, P45; Bouvard B, 2012, BONE, V50, P858, DOI 10.1016/j.bone.2011.12.023; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; Caldwell CB, 1998, J BONE MINER RES, V13, P978, DOI 10.1359/jbmr.1998.13.6.978; Chappard D, 2005, J BONE MINER METAB, V23, P24, DOI 10.1007/s00774-004-0536-9; Chappard D, 2005, J BONE MINER RES, V20, P1177, DOI 10.1359/JBMR.050205; Chappard D, 2011, OSTEOPOROSIS INT, V22, P2225, DOI 10.1007/s00198-011-1573-6; Chappard D, 2003, BIOMATERIALS, V24, P1399, DOI 10.1016/S0142-9612(02)00524-0; Chappard D, 2001, BONE, V28, P72, DOI 10.1016/S8756-3282(00)00438-5; Chappard D, 1986, AMPUTATION INDUCED O, P115; Chappard D, 2010, BONE CANCER: PROGRESSION AND THERAPEUTIC APPROACHES, P203; COMPSTON JE, 1987, BONE, V8, P289, DOI 10.1016/8756-3282(87)90004-4; Cook ME, 2000, POULTRY SCI, V79, P982, DOI 10.1093/ps/79.7.982; Croucher PI, 1996, J BONE MINER RES, V11, P955; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Frost H M, 1983, Henry Ford Hosp Med J, V31, P3; Grimston SK, 2011, J BONE MINER RES, V26, P2151, DOI 10.1002/jbmr.425; Hiney KM, 2004, J ANIM SCI, V82, P2313; Jee W.S.S., 1999, Morphologie, V83, P25; Julian RJ, 1998, POULTRY SCI, V77, P1773, DOI 10.1093/ps/77.12.1773; Jurani M, 1996, ACTA VET BRNO, V65, P57, DOI 10.2754/avb199665010057; KROLNER B, 1983, CLIN SCI, V64, P537, DOI 10.1042/cs0640537; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Le Drevo M, 2008, J BONE MINER RES, V23, pS130; LEBLANC B, 1986, POULTRY SCI, V65, P1787, DOI 10.3382/ps.0651787; Leterrier C, 1998, PROD ANIM, V11, P125; LI XJ, 1990, ANAT RECORD, V227, P12, DOI 10.1002/ar.1092270103; Manske SL, 2010, BONE, V46, P24, DOI 10.1016/j.bone.2009.10.016; Miller ME, 1999, CALCIFIED TISSUE INT, V64, P137, DOI 10.1007/s002239900592; Milstead JR, 2004, TECH PAPERS ISA, V449, P105; MINAIRE P, 1974, CALC TISS RES, V17, P57, DOI 10.1007/BF02547214; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; Oganov VS, 1988, ONTOGENESIS MAMMALS, P56; Passi N, 2005, J BIOMECH ENG-T ASME, V127, P198, DOI 10.1115/1.1835366; Pinheiro MM, 2009, OSTEOPOROSIS INT, V20, P399, DOI 10.1007/s00198-008-0680-5; Rittweger J, 2005, BONE, V36, P1019, DOI 10.1016/j.bone.2004.11.014; Sharrard W J, 1967, J Bone Joint Surg Br, V49, P731; Shen V, 1997, BONE, V21, P345, DOI 10.1016/S8756-3282(97)00153-1; Shen V, 1997, BONE, V21, P71, DOI 10.1016/S8756-3282(97)00070-7; Shipov A, 2010, VET J, V183, P153, DOI 10.1016/j.tvjl.2008.11.015; Simsa S, 2007, POULTRY SCI, V86, P565, DOI 10.1093/ps/86.3.565; SKERRY TM, 1990, CALCIFIED TISSUE INT, V46, P318, DOI 10.1007/BF02563823; Skrobanek P, 2004, ACTA VET BRNO, V73, P157, DOI 10.2754/avb200473020157; Tarlton JF, 2013, BONE, V52, P578, DOI 10.1016/j.bone.2012.11.003; Thomsen JS, 2012, CALCIFIED TISSUE INT, V90, P294, DOI 10.1007/s00223-012-9576-7; TURNER RT, 1986, J BONE MINER RES, V1, P399; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Weiler U, 2006, J VET MED A, V53, P450, DOI 10.1111/j.1439-0442.2006.00885.x; Whitehead CC, 2004, POULTRY SCI, V83, P193, DOI 10.1093/ps/83.2.193; WRONSKI TJ, 1987, AVIAT SPACE ENVIR MD, V58, P63; Zerath E, 1999, J Gravit Physiol, V6, pP77; Zibrin M, 2003, ACTA VET BRNO, V72, P143, DOI 10.2754/avb200372020143	54	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116763	10.1371/journal.pone.0116763	http://dx.doi.org/10.1371/journal.pone.0116763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635404	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700058
J	Konstantynowicz-Nowicka, K; Harasim, E; Baranowski, M; Chabowski, A				Konstantynowicz-Nowicka, Karolina; Harasim, Ewa; Baranowski, Marcin; Chabowski, Adrian			New Evidence for the Role of Ceramide in the Development of Hepatic Insulin Resistance	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; MUSCLE-CELLS; LIVER-CELLS; IN-VIVO; HEPATOCYTES; PALMITATE; DIACYLGLYCEROL; TRAFFICKING; MECHANISMS; STEATOSIS	Aim There are few and contradictory data on the role of excessive accumulation of intracellular sphingolipids, particularly ceramides, in the development of hepatic insulin resistance. In our study we assessed accumulated sphingolipid fractions and clarify the mechanisms of hepatic insulin resistance development as well as involvement of fatty acid and ceramide transporters in this process. Methods In culture of primary rat hepatocytes, exposed to high concentration of palmitic acid (0.75mM) during short and prolonged incubation, high performance liquid chromatography was used to assess intra- and extracellular sphingolipid fractions content. Degree of palmitate-induced insulin resistance was estimated by measuring changes in phosphorylation of insulin pathway proteins by western blotting as well as changes in expression of different type of transporters. Results In our study short and prolonged exposure of primary hepatocytes to palmitic acid resulted in increased intracellular accumulation of ceramide which inhibited insulin signaling pathway. We observed a significant increase in the expression of fatty-acid transport protein (FATP2) and ceramide transfer protein (CERT) what is consistent with enhanced intracellular ceramide content. The content of extracellular ceramide was increased nearly threefold after short and twofold after long incubation period. Expression of microsomal triglyceride transfer protein (MTP) and ATP-binding cassette transporter (ABCA1) was increased significantly mainly after short palmitate incubation. Conclusion Our data showed that increase in intarcellular ceramide content contributes to the development of hepatic insulin resistance. We suggest pivotal role of transporters in facilitating fatty acid influx (FATP2), accumulation of ceramides (CERT) and export to themedia (MTP and ABCA1).	[Konstantynowicz-Nowicka, Karolina; Harasim, Ewa; Baranowski, Marcin; Chabowski, Adrian] Med Univ Bialystok, Dept Physiol, Bialystok, Poland	Medical University of Bialystok	Konstantynowicz-Nowicka, K (corresponding author), Med Univ Bialystok, Dept Physiol, Bialystok, Poland.	karolina.konstantynowicz@umb.edu.pl	Baranowski, Marcin/F-6718-2011; Chabowski, Adrian/T-2225-2018; Harasim-Symbor, Ewa/T-6483-2018; Konstantynowicz-Nowicka, Karolina/T-9339-2018	Baranowski, Marcin/0000-0002-3714-5815; Chabowski, Adrian/0000-0002-7407-8156; Harasim-Symbor, Ewa/0000-0003-3507-4686; Konstantynowicz-Nowicka, Karolina/0000-0001-9274-5488	Medical University of Bialystok [134-18711L, 134-18715L, 25/KNOW/2013]	Medical University of Bialystok	These studies were funded by the Medical University of Bialystok (Grant 134-18711L, 134-18715L, 25/KNOW/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard CS, 2012, ENDOCRINOLOGY, V153, P2164, DOI 10.1210/en.2011-1881; Aguilera-Romero A, 2014, BBA-MOL CELL BIOL L, V1841, P647, DOI 10.1016/j.bbalip.2013.10.014; Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Bechmann LP, 2010, LIVER INT, V30, P850, DOI 10.1111/j.1478-3231.2010.02248.x; Bonen A, 1999, CAN J APPL PHYSIOL, V24, P515, DOI 10.1139/h99-033; Bouzakri K, 2005, CURR DIABETES REV, V1, P167, DOI 10.2174/1573399054022785; Cai N, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-28; Chabowski A, 2013, ACTA PHYSIOL, V207, P346, DOI 10.1111/apha.12022; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Galbo T, 2013, P NATL ACAD SCI USA, V110, P12780, DOI 10.1073/pnas.1311176110; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Hamilton JA, 1998, J LIPID RES, V39, P467; Hamilton JA, 2002, MOL CELL BIOCHEM, V239, P17, DOI 10.1023/A:1020542220599; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Knapp M, 2013, PROSTAG OTH LIPID M, V106, P53, DOI 10.1016/j.prostaglandins.2013.10.001; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Longato L, 2012, HEPATOL RES, V42, P412, DOI 10.1111/j.1872-034X.2011.00934.x; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Moya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030014; Oram JF, 2001, J LIPID RES, V42, P1173; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Schinner S, 2005, DIABETIC MED, V22, P674, DOI 10.1111/j.1464-5491.2005.01566.x; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Watt MJ, 2012, DIABETOLOGIA, V55, P2741, DOI 10.1007/s00125-012-2649-3; Wierzbicki M, 2009, ADV MED SCI-POLAND, V54, P59, DOI 10.2478/v10039-009-0010-y; Yew NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011239	34	46	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116858	10.1371/journal.pone.0116858	http://dx.doi.org/10.1371/journal.pone.0116858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635851	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700062
J	Lee, SH; Moon, JY; Jung, SJ; Kang, JG; Choi, SP; Jang, JH				Lee, Sang Hoon; Moon, Jee Youn; Jung, Sung Jun; Kang, Jin Gu; Choi, Seung Pyo; Jang, Jun Ho			Eugenol Inhibits the GABA(A) Current in Trigeminal Ganglion Neurons	PLOS ONE			English	Article							SPINAL-CORD; RECEPTOR; SUBUNIT; SUPERFAMILY	Eugenol has sedative, antioxidant, anti-inflammatory, and analgesic effects, but also serves as an irritant through the regulation of a different set of ion channels. Activation of gamma aminobutyric acid (GABA) receptors on sensory neurons leads to the stabilization of neuronal excitability but contributes to formalin-induced inflammatory pain. In this study, we examined the effect of eugenol on the GABA-induced current in rat trigeminal ganglia (TG) neurons and in human embryonic kidney (HEK) 293 cells expressing the GABA(A) receptor alpha 1 beta 2 gamma 2 subtype using the whole-cell patch clamp technique. RT-PCR and Western blot analysis were used to confirm the expression of GABA(A) receptor gamma 2 subunit mRNA and protein in the TG and hippocampus. Eugenol decreased the amplitude ratio of the GABA-induced current to 27.5 +/- 3.2% (p < 0.05) in TG neurons, which recovered after a 3-min washout. In HEK 293 cells expressing the alpha 1 beta 2.2 subtype, eugenol inhibited GABA-induced currents in a dose-dependent manner. Application of eugenol also decreased the GABA response in the presence of a G-protein blocker. Eugenol pretreatment with different concentrations of GABA resulted in similar inhibition of the GABA-induced current in a noncompetitive manner. In conclusion, eugenol inhibits the GABA-induced current in TG neurons and HEK 293 cells expressing the GABA(A) receptor in a reversible, dose-dependent, and non-competitive manner, but not via the G-protein pathway. We suggest that the GABA(A) receptor could be a molecular target for eugenol in the modulation of nociceptive information.	[Lee, Sang Hoon; Jang, Jun Ho] Hanyang Univ, Grad Sch Biomed Sci, Engn, Dept Biomed Sci, Seoul 133791, South Korea; [Moon, Jee Youn; Choi, Seung Pyo] Seoul Natl Univ Hosp, Coll Med, Dept Anesthesiol & Pain Med, Seoul 110744, South Korea; [Jung, Sung Jun] Hanyang Univ, Sch Med, Dept Physiol, Seoul 133791, South Korea; [Kang, Jin Gu] Hallim Univ, Dongtan Sacred Heart Hosp, Dept Anaesthesiol & Pain Med, Kyonggi Do, South Korea	Hanyang University; Seoul National University (SNU); Seoul National University Hospital; Hanyang University	Moon, JY (corresponding author), Seoul Natl Univ Hosp, Coll Med, Dept Anesthesiol & Pain Med, Seoul 110744, South Korea.	jymoon0901@gmail.com; eurijj@hanyang.ac.kr			Basic Science Research Program and Nano and Material Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2012R1A1A2009458, NRF-2012M3A7B4035199]	Basic Science Research Program and Nano and Material Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program and Nano and Material Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2012R1A1A2009458 and NRF-2012M3A7B4035199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasipour F, 2009, INT ENDOD J, V42, P794, DOI 10.1111/j.1365-2591.2009.01585.x; Alvarez FJ, 1996, J COMP NEUROL, V365, P392, DOI 10.1002/(SICI)1096-9861(19960212)365:3<392::AID-CNE5>3.0.CO;2-#; Aoshima H, 1999, BIOSCI BIOTECH BIOCH, V63, P743, DOI 10.1271/bbb.63.743; AULT B, 1994, NEUROPHARMACOLOGY, V33, P109, DOI 10.1016/0028-3908(94)90104-X; Bravo-Hernandez M, 2014, EUR J PHARMACOL, V734, P91, DOI 10.1016/j.ejphar.2014.03.051; Carlton SM, 1999, NEUROSCIENCE, V93, P713, DOI 10.1016/S0306-4522(99)00101-3; Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124; Chebib M, 1999, CLIN EXP PHARMACOL P, V26, P937, DOI 10.1046/j.1440-1681.1999.03151.x; Chung G, 2008, J DENT RES, V87, P137, DOI 10.1177/154405910808700201; CURTIS DR, 1977, BRAIN RES, V130, P360, DOI 10.1016/0006-8993(77)90283-9; Hayasaki H, 2006, EUR J NEUROSCI, V23, P745, DOI 10.1111/j.1460-9568.2006.04602.x; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Klein AH, 2014, NEUROSCIENCE, V271, P45, DOI 10.1016/j.neuroscience.2014.04.019; Krishek BJ, 1996, NEUROPHARMACOLOGY, V35, P1289, DOI 10.1016/S0028-3908(96)00089-5; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; Lee MH, 2005, J DENT RES, V84, P848, DOI 10.1177/154405910508400913; Li HY, 2007, J DENT RES, V86, P898, DOI 10.1177/154405910708600918; MA W, 1993, J COMP NEUROL, V338, P337, DOI 10.1002/cne.903380303; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; MACHU TK, 1993, J NEUROCHEM, V61, P375, DOI 10.1111/j.1471-4159.1993.tb03582.x; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Park CK, 2006, J DENT RES, V85, P900, DOI 10.1177/154405910608501005; Park SH, 2011, ARCH PHARM RES, V34, P501, DOI 10.1007/s12272-011-0320-z; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SINGER E, 1980, BRAIN RES, V202, P484, DOI 10.1016/0006-8993(80)90160-2; WHITING P, 1990, P NATL ACAD SCI USA, V87, P9966, DOI 10.1073/pnas.87.24.9966; Whiting PJ, 1995, INT REV NEUROBIOL, V38, P95, DOI 10.1016/S0074-7742(08)60525-5; Yang BH, 2003, J DENT RES, V82, P781, DOI 10.1177/154405910308201004; Yano S, 2006, EUR J PHARMACOL, V553, P99, DOI 10.1016/j.ejphar.2006.09.020; Yeon KY, 2011, PAIN, V152, P2108, DOI 10.1016/j.pain.2011.05.018; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	32	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117316	10.1371/journal.pone.0117316	http://dx.doi.org/10.1371/journal.pone.0117316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635877	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700080
J	Osborne, A; Aldarwesh, A; Rhodes, JD; Broadway, DC; Everitt, C; Sanderson, J				Osborne, Andrew; Aldarwesh, Amal; Rhodes, Jeremy D.; Broadway, David C.; Everitt, Claire; Sanderson, Julie			Hydrostatic Pressure Does Not Cause Detectable Changes in Survival of Human Retinal Ganglion Cells	PLOS ONE			English	Article							OPTIC-NERVE HEAD; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; DEATH; BIOMECHANICS; APOPTOSIS; NEURODEGENERATION; ACTIVATION; ISCHEMIA; KINASES	Purpose Elevated intraocular pressure (IOP) is a major risk factor for glaucoma. One consequence of raised IOP is that ocular tissues are subjected to increased hydrostatic pressure (HP). The effect of raised HP on stress pathway signaling and retinal ganglion cell (RGC) survival in the human retina was investigated. Methods A chamber was designed to expose cells to increased HP (constant and fluctuating). Accurate pressure control (10-100mmHg) was achieved using mass flow controllers. Human organotypic retinal cultures (HORCs) from donor eyes (<24h post mortem) were cultured in serum-free DMEM/HamF12. Increased HP was compared to simulated ischemia (oxygen glucose deprivation, OGD). Cell death and apoptosis were measured by LDH and TUNEL assays, RGC marker expression by qRT-PCR (THY-1) and RGC number by immunohistochemistry (NeuN). Activated p38 and JNK were detected by Western blot. Results Exposure of HORCs to constant (60mmHg) or fluctuating (10-100mmHg; 1 cycle/min) pressure for 24 or 48h caused no loss of structural integrity, LDH release, decrease in RGC marker expression (THY-1) or loss of RGCs compared with controls. In addition, there was no increase in TUNEL-positive NeuN-labelled cells at either time-point indicating no increase in apoptosis of RGCs. OGD increased apoptosis, reduced RGC marker expression and RGC number and caused elevated LDH release at 24h. p38 and JNK phosphorylation remained unchanged in HORCs exposed to fluctuating pressure (10-100mmHg; 1 cycle/min) for 15, 30, 60 and 90min durations, whereas OGD (3h) increased activation of p38 and JNK, remaining elevated for 90min post-OGD. Conclusions Directly applied HP had no detectable impact on RGC survival and stress-signalling in HORCs. Simulated ischemia, however, activated stress pathways and caused RGC death. These results show that direct HP does not cause degeneration of RGCs in the ex vivo human retina.	[Osborne, Andrew; Aldarwesh, Amal; Broadway, David C.; Sanderson, Julie] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Rhodes, Jeremy D.; Broadway, David C.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Broadway, David C.] Norfolk & Norwich Univ Hosp, Dept Ophthalmol, Norwich, Norfolk, England; [Everitt, Claire] Pfizer Ltd, Design Ctr Excellence, Cambridge, England	University of East Anglia; University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Pfizer	Sanderson, J (corresponding author), Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England.	j.sanderson@uea.ac.uk	Aldarwesh, Amal/HDM-1182-2022; Aldarwesh, Amal/ABC-8238-2020	Aldarwesh, Amal/0000-0002-0922-8541; Aldarwesh, Amal/0000-0002-0922-8541	Humane Research Trust; Norwich Glaucoma Research Fund; Edith Murphy Foundation	Humane Research Trust; Norwich Glaucoma Research Fund; Edith Murphy Foundation	This work was supported by The Humane Research Trust, The Edith Murphy Foundation, and The Norwich Glaucoma Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Downs JC, 2011, EXP EYE RES, V93, P133, DOI 10.1016/j.exer.2010.08.004; Dreixler JC, 2009, EXP EYE RES, V89, P782, DOI 10.1016/j.exer.2009.07.006; Ethier CR, 2006, INVEST OPHTH VIS SCI, V47, P1991, DOI 10.1167/iovs.05-0327; Inatani M, 2008, J GLAUCOMA, V17, P275, DOI 10.1097/IJG.0b013e31815c3ab7; Kikuchi M, 2000, J NEUROSCI, V20, P5037; Lei Y, 2011, INVEST OPHTH VIS SCI, V52, P6329, DOI 10.1167/iovs.11-7836; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Leske MC, 1997, ARCH OPHTHALMOL-CHIC, V115, P1051, DOI 10.1001/archopht.1997.01100160221012; MAO LK, 1991, AM J OPHTHALMOL, V111, P51, DOI 10.1016/S0002-9394(14)76896-5; Mester L, 2009, NEUROTOX RES, V16, P68, DOI 10.1007/s12640-009-9049-6; Morris G, 1974, BIOL PHYS CHEM; Niyadurupola N, 2013, INVEST OPHTH VIS SCI, V54, P2163, DOI 10.1167/iovs.12-10968; Niyadurupola N, 2011, BRIT J OPHTHALMOL, V95, P720, DOI 10.1136/bjo.2010.181404; Osborne NN, 1999, BRIT J OPHTHALMOL, V83, P980, DOI 10.1136/bjo.83.8.980; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Resta V, 2007, EUR J NEUROSCI, V25, P2741, DOI 10.1111/j.1460-9568.2007.05528.x; Ribas VT, 2011, NEUROSCIENCE, V180, P64, DOI 10.1016/j.neuroscience.2011.01.059; Roth S, 2003, INVEST OPHTH VIS SCI, V44, P5383, DOI 10.1167/iovs.03-0451; Sappington RM, 2006, INVEST OPHTH VIS SCI, V47, P2932, DOI 10.1167/iovs.05-1407; Sappington RM, 2009, INVEST OPHTH VIS SCI, V50, P717, DOI 10.1167/iovs.08-2321; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Tezel G, 2000, J NEUROSCI, V20, P8693; The AGIS Investigators, 2000, AM J OPHTHALMOL, V130, P429, DOI DOI 10.1016/S0002-9394(00)00538-9; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059	29	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115591	10.1371/journal.pone.0115591	http://dx.doi.org/10.1371/journal.pone.0115591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635827	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700014
J	Gautam, A; Arpa, PD; Donohue, DE; Muhie, S; Chakraborty, N; Luke, BT; Grapov, D; Carroll, EE; Meyerhoff, JL; Hammamleh, R; Jett, M				Gautam, Aartl; Arpa, Peter D'; Donohue, Duncan E.; Muhie, Seid; Chakraborty, Nabarun; Luke, Brian T.; Grapov, Dmitry; Carroll, Erica E.; Meyerhoff, James L.; Hammamleh, Rasha; Jett, Marti			Acute and Chronic Plasma Metabolomic and Liver Transcriptomic Stress Effects in a Mouse Model with Features of Post-Traumatic Stress Disorder	PLOS ONE			English	Article							GUT MICROBIOTA; PSYCHOSOCIAL STRESS; ACID-METABOLISM; INJURY; PHASE; PTSD; MATRIX-METALLOPROTEINASE-9; MYELOPEROXIDASE; COMORBIDITY; COMPLEMENT	Acute responses to intense stressors can give rise to post-traumatic stress disorder (PTSD). PTSD diagnostic criteria include trauma exposure history and self-reported symptoms. Individuals who meet PTSD diagnostic criteria often meet criteria for additional psychiatric diagnoses. Biomarkers promise to contribute to reliable phenotypes of PTSD and comorbidities by linking biological system alterations to behavioral symptoms. Here we have analyzed unbiased plasma metabolomics and other stress effects in a mouse model with behavioral features of PTSD. In this model, C57BL/6 mice are repeatedly exposed to a trained aggressor mouse (albino SJL) using a modified, resident-intruder, social defeat paradigm. Our recent studies using this model found that aggressor-exposed mice exhibited acute stress effects including changed behaviors, body weight gain, increased body temperature, as well as inflammatory and fibrotic histopathologies and transcriptomic changes of heart tissue. Some of these acute stress effects persisted, reminiscent of PTSD. Here we report elevated proteins in plasma that function in inflammation and responses to oxidative stress and damaged tissue at 24 hrs post-stressor. Additionally at this acute time point, transcriptomic analysis indicated liver inflammation. The unbiased metabolomics analysis showed altered metabolites in plasma at 24 hrs that only partially normalized toward control levels after stress-withdrawal for 1.5 or 4 wks. In particular, gut-derived metabolites were altered at 24 hrs post-stressor and remained altered up to 4 wks after stress-withdrawal. Also at the 4 wk time point, hyperlipidemia and suppressed metabolites of amino acids and carbohydrates in plasma coincided with transcriptomic indicators of altered liver metabolism (activated xenobiotic and lipid metabolism). Collectively, these system-wide sequelae to repeated intense stress suggest that the simultaneous perturbed functioning of multiple organ systems (e.g., brain, heart, intestine and liver) can interact to produce injuries that lead to chronic metabolic changes and disorders that have been associated with PTSD.	[Gautam, Aartl; Arpa, Peter D'; Donohue, Duncan E.; Chakraborty, Nabarun; Meyerhoff, James L.; Hammamleh, Rasha; Jett, Marti] US Army Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA; [Gautam, Aartl; Arpa, Peter D'; Donohue, Duncan E.; Chakraborty, Nabarun; Meyerhoff, James L.] Geneva Fdn, Tacoma, WA 98402 USA; [Muhie, Seid; Luke, Brian T.] Adv Biomed Comp Ctr, Frederick Natl Lab Canc Res, Frederick, MD USA; [Grapov, Dmitry] Univ Calif Davis, NIH, West Coast Metabol Ctr, Davis, CA USA; [Carroll, Erica E.] Army Inst Publ Hlth, Aberdeen Proving Ground, MD 21010 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; University of California System; University of California Davis	Jett, M (corresponding author), US Army Ctr Environm Hlth Res, Ft Detrick, Ft Detrick, MD 21702 USA.	marti.jett-tilton.civ@mail.mil		Grapov, Dmitry/0000-0002-7204-3128; Hammamieh, Rasha/0000-0001-8643-6232; D'Arpa, Peter/0000-0002-0562-0263; Donohue, Duncan/0000-0002-3137-8773	Office of the Assistant Secretary of Defense for Health Affairs; Military Operational Medicine Research Program (MOMRP); NIH [1 U24 DK097154];  [09284002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097154] Funding Source: NIH RePORTER	Office of the Assistant Secretary of Defense for Health Affairs; Military Operational Medicine Research Program (MOMRP)(United States Department of DefenseUnited States ArmyUnited States Army Medical Research & Development Command (USAMRDC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project is supported by the Office of the Assistant Secretary of Defense for Health Affairs and the Military Operational Medicine Research Program (MOMRP), and the support of grant #USAMRMC NO: 09284002 is highly acknowledged. DG was supported by NIH 1 U24 DK097154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055766; ARAGOZZINI F, 1979, APPL ENVIRON MICROB, V38, P544, DOI 10.1128/AEM.38.3.544-546.1979; Association AP, 2013, DIAGN STAT MAN MENT, DOI [10.1016/j.amsu.2013.12.001, DOI 10.1016/J.AMSU.2013.12.001]; Atkinson C, 2005, EXP BIOL MED, V230, P155, DOI 10.1177/153537020523000302; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 2006, J NEUROIMMUNOL, V171, P29, DOI 10.1016/j.jneuroim.2005.09.008; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Bartoli F, 2013, METAB SYNDR RELAT D, V11, P301, DOI 10.1089/met.2013.0010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Bessede A, 2014, NATURE; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Calabrese JR, 2011, J CLIN PSYCHIAT, V72, P1072, DOI 10.4088/JCP.11m06956; Camprecios G, 2009, GROWTH FACTORS, V27, P300, DOI 10.1080/08977190903137736; Cho JH, 2014, P NATL ACAD SCI USA, V111, P3188, DOI 10.1073/pnas.1400113111; Choudhary SP, 2011, CURR MED CHEM, V18, P4557; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; Coughlin SS, 2011, OPEN CARDIOVASC MED, V5, P164, DOI 10.2174/1874192401105010164; CRISPENS CG, 1973, LAB ANIM SCI, V23, P408; Czech B, 2013, INT J CLIN EXP PATHO, V6, P1585; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Freidman MJ, 2007, PTSD HIST OVERVIEW, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Galley JD, 2014, GUT MICROBES, V5, DOI [10.4161/19490976.2014.973349, DOI 10.4161/19490976.2014.973349]; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Garvin P, 2009, PSYCHOSOM MED, V71, P292, DOI 10.1097/PSY.0b013e3181960e7f; GOODWIN BL, 1994, BIOCHEM PHARMACOL, V47, P2294, DOI 10.1016/0006-2952(94)90268-2; Green BT, 2012, FOOD CHEM TOXICOL, V50, P2049, DOI 10.1016/j.fct.2012.03.049; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Hall JE, 2011, GUYTON HALL TXB MED, DOI [10.3390/jpm1010005, DOI 10.3390/JPM1010005]; Hammamieh R, 2012, BEHAV BRAIN RES, V235, P55, DOI 10.1016/j.bbr.2012.07.022; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; Health NIoM, 2008, NAT I MENT HLTH STRA; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Heslop CL, 2010, J AM COLL CARDIOL, V55, P1102, DOI 10.1016/j.jacc.2009.11.050; HOLLANDER M, 1973, NONPARAMETRIC STAT M, P15; Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146; Jensen KJ, 2013, COMPR PHYSIOL, V3, P655, DOI 10.1002/cphy.c120018; JOYCE PR, 1992, BIOL PSYCHIAT, V32, P1035, DOI 10.1016/0006-3223(92)90065-8; KEANE TM, 1987, J CLIN PSYCHOL, V43, P32, DOI 10.1002/1097-4679(198701)43:1<32::AID-JCLP2270430106>3.0.CO;2-X; Keeney A, 2006, J NEUROENDOCRINOL, V18, P330, DOI 10.1111/j.1365-2826.2006.01422.x; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kramer A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-253; Lee CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076817; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord RS, 2008, ALTERN MED REV, V13, P292; Lu K, 2012, J PROTEOME RES, V11, P4916, DOI 10.1021/pr300429x; Lyte M, 2011, CELL TISSUE RES, V343, P23, DOI 10.1007/s00441-010-1050-0; Ma BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047416; MacFarlane G.T., 1991, LARGE INTESTINE PHYS, P51; Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89; McFarlane AC, 2010, WORLD PSYCHIATRY, V9, P3; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; R Core Team, 2018, R LANG ENV STAT COMP; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Sanchez O, 2002, CELL STRESS CHAPERON, V7, P36, DOI 10.1379/1466-1268(2002)007<0036:ASITII>2.0.CO;2; Sanchez O, 2007, AM J PHYSIOL-REG I, V293, pR1908, DOI 10.1152/ajpregu.00113.2007; Sanghez V, 2013, PSYCHONEUROENDOCRINO, V38, P2933, DOI 10.1016/j.psyneuen.2013.07.022; Saura-Calixto F, 2010, MOL NUTR FOOD RES, V54, P939, DOI 10.1002/mnfr.200900276; Savignac HM, 2011, BEHAV BRAIN RES, V216, P576, DOI 10.1016/j.bbr.2010.08.049; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith EA, 1997, ANAEROBE, V3, P327, DOI 10.1006/anae.1997.0121; SONG C, 1994, J AFFECT DISORDERS, V30, P283, DOI 10.1016/0165-0327(94)90135-X; Stengel A, 2009, ANNU REV PHYSIOL, V71, P219, DOI 10.1146/annurev.physiol.010908.163221; Sundstrom J, 2006, CURR OPIN LIPIDOL, V17, P45, DOI 10.1097/01.mol.0000203891.34890.b5; Uschold-Schmidt N, 2013, J ENDOCRINOL, V218, P193, DOI 10.1530/JOE-13-0027; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wilson EB, J AM STAT ASS, V22, P209; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhao Y, 2013, J PROTEOME RES, V12, P2987, DOI 10.1021/pr400263n	88	33	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117092	10.1371/journal.pone.0117092	http://dx.doi.org/10.1371/journal.pone.0117092			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629821	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100063
J	Kriebel, S; Schmidt, D; Holdenrieder, S; Goltz, D; Kristiansen, G; Moritz, R; Fisang, C; Muller, SC; Ellinger, J				Kriebel, Stephanie; Schmidt, Doris; Holdenrieder, Stefan; Goltz, Diane; Kristiansen, Glen; Moritz, Rudolf; Fisang, Christian; Mueller, Stefan C.; Ellinger, Joerg			Analysis of Tissue and Serum MicroRNA Expression in Patients with Upper Urinary Tract Urothelial Cancer	PLOS ONE			English	Article							BLADDER-CANCER; CIRCULATING MICRORNAS; PROSTATE-CANCER; MIRNA; BIOMARKERS; DIAGNOSIS; GROWTH; GENES	Introduction MicroRNAs play an important role in many human malignancies; so far, their expression remains to be studied in upper urinary tract urothelial cancer (UUTUC). Materials and Methods The expression of eleven microRNAs (miR-10a, miR-21, miR-96, miR-135, miR-141, miR-182, miR-200b, miR-205, miR-429, miR-520b, miR-1244) formerly shown to be upregulated in urothelial bladder cancer were studied in corresponding normal and cancerous tissue samples of patients undergoing nephroureterectomy for UUTUC. Upregulated microRNAs were then measured in serum samples of patients with UUTUC and patients with nonmalignant urological diseases to evaluate their potential as non-invasive biomarkers for UUTUC. Results MicroRNA expression allowed differentiation of normal and cancerous tissue: miR-21, miR-96, miR-135, miR-141, miR-182, miR-205, miR-429 and miR-520b were significantly over-expressed. Furthermore, miR-205 was upregulated in poorly differentiated UUTUC. The analysis of circulating RNA in serum demonstrated an increase of miR-141 in patients with UUTUC; receiver operator characteristic analysis demonstrated an area under the curve of 0.726 for miR-141 as a diagnostic biomarker. Furthermore, we observed lower levels of miR-10a and miR-135 in UUTUC patients. Conclusions MicroRNA expression is altered in UUTUC. The analysis of circulating miR-141 may be useful to identify patients with UUTUC.	[Kriebel, Stephanie; Schmidt, Doris; Fisang, Christian; Mueller, Stefan C.; Ellinger, Joerg] Univ Klinikum Bonn, Klin & Poliklin Urol & Kinderurol, Bonn, Germany; [Holdenrieder, Stefan] Univ Klinikum Bonn, Inst Klin Chem & Klin Pharmakol, Bonn, Germany; [Goltz, Diane; Kristiansen, Glen] Univ Klinikum Bonn, Inst Pathol, Bonn, Germany; [Moritz, Rudolf] Univ Klinikum Munster, Urol Klin, Munster, Germany	University of Bonn; University of Bonn; University of Bonn; University of Munster	Ellinger, J (corresponding author), Univ Klinikum Bonn, Klin & Poliklin Urol & Kinderurol, Bonn, Germany.	joerg.ellinger@ukb.uni-bonn.de	Ellinger, Jörg/D-8389-2011	Ellinger, Jörg/0000-0002-7526-0857	Deutsche Krebshilfe	Deutsche Krebshilfe(Deutsche Krebshilfe)	The collection of serum and tissue samples at the Universitatsklinikum Bonn was performed within the framework of the Biobank initiative at the Centrum fur integrierte Onkologie (CIO) Koln Bonn (http://www.cio-koelnbonn.de/mediziner/biobank/), which is financially supported by the Deutsche Krebshilfe. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Dieckmann KP, 2012, BRIT J CANCER, V107, P1754, DOI 10.1038/bjc.2012.469; Dietrich D, 2014, CRIT REV CLIN LAB SC, V30, P1, DOI DOI 10.3109/10408363.2014.950407; Dip N, 2012, J UROLOGY, V188, P1951, DOI 10.1016/j.juro.2012.07.004; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Izquierdo L, 2013, BJU INT, DOI [10.1111/bju.12334, DOI 10.1111/BJU.12334]; Johannes JR, 2010, J UROLOGY, V184, P879, DOI 10.1016/j.juro.2010.05.023; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Messer J, 2011, BJU INT, V108, P701, DOI 10.1111/j.1464-410X.2010.09899.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pignot G, 2013, INT J CANCER, V132, P2479, DOI 10.1002/ijc.27949; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Ratert N, 2013, J MOL DIAGN, V15, P695, DOI 10.1016/j.jmoldx.2013.05.008; Sanders I, 2012, INT J UROL, V19, P1017, DOI 10.1111/j.1442-2042.2012.03082.x; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Scheffer AR, 2012, WORLD J UROL, DOI [10.1007/s00345-012-1015-x, DOI 10.1007/S00345-012-1015-X]; Selth LA, 2013, BRIT J CANCER, V109, P641, DOI 10.1038/bjc.2013.369; Song T, 2010, ASIAN PAC J CANCER P, V11, P905; van Jaarsveld MTM, 2013, ONCOGENE, V32, P4284, DOI 10.1038/onc.2012.433; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Verhoest G, 2011, WORLD J UROL, V29, P495, DOI 10.1007/s00345-011-0710-3; Walsh IK, 2001, UROLOGY, V58, P532, DOI 10.1016/S0090-4295(01)01307-3; Wang G, 2012, CLIN GENITOURIN CANC, V10, P106, DOI 10.1016/j.clgc.2012.01.001; Wang WT, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-6; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Westermann AM, 2014, ANTICANCER RES, V34, P665; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Zaravinos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091646; Zaravinos A, 2012, J UROLOGY, V188, P615, DOI 10.1016/j.juro.2012.03.122; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335	40	33	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117284	10.1371/journal.pone.0117284	http://dx.doi.org/10.1371/journal.pone.0117284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629698	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100078
J	Loch, C; Kieser, JA; Fordyce, RE				Loch, Carolina; Kieser, Jules A.; Fordyce, R. Ewan			Enamel Ultrastructure in Fossil Cetaceans (Cetacea: Archaeoceti and Odontoceti)	PLOS ONE			English	Article							DIETARY ADAPTATIONS; DENTAL ENAMEL; WHALES; MICROSTRUCTURE; DELPHINOIDEA; EVOLUTION; MAMMALS; ORIGIN	The transition from terrestrial ancestry to a fully pelagic life profoundly altered the body systems of cetaceans, with extreme morphological changes in the skull and feeding apparatus. The Oligocene Epoch was a crucial time in the evolution of cetaceans when the ancestors of modern whales and dolphins (Neoceti) underwent major diversification, but details of dental structure and evolution are poorly known for the archaeocete-neocete transition. We report the morphology of teeth and ultrastructure of enamel in archaeocetes, and fossil platanistoids and delphinoids, ranging from late Oligocene (Waitaki Valley, New Zealand) to Pliocene (Caldera, Chile). Teeth were embedded in epoxy resin, sectioned in cross and longitudinal planes, polished, etched, and coated with gold palladium for scanning electron microscopy (SEM) observation. SEM images showed that in archaeocetes, squalodontids and Prosqualodon (taxa with heterodont and nonpolydont/limited polydont teeth), the inner enamel was organized in Hunter-Schreger bands (HSB) with an outer layer of radial enamel. This is a common pattern in most large-bodied mammals and it is regarded as a biomechanical adaptation related to food processing and crack resistance. Fossil Otekaikea sp. and delphinoids, which were polydont and homodont, showed a simpler structure, with inner radial and outer prismless enamel. Radial enamel is regarded as more wear-resistant and has been retained in several mammalian taxa in which opposing tooth surfaces slide over each other. These observations suggest that the transition from a heterodont and nonpolydont/limited polydont dentition in archaeocetes and early odontocetes, to homodont and polydont teeth in crownward odontocetes, was also linked to a marked simplification in the enamel Schmelzmuster. These patterns probably reflect functional shifts in food processing from shear-and-mastication in archaeocetes and early odontocetes, to pierce-and-grasp occlusion in crownward odontocetes, with the implication of less demanding feeding biomechanics as seen in most extant odontocetes.	[Loch, Carolina; Fordyce, R. Ewan] Univ Otago, Dept Geol, Dunedin, New Zealand; [Loch, Carolina; Kieser, Jules A.] Univ Otago, Fac Dent, Sir John Walsh Res Inst, Dunedin, New Zealand	University of Otago; University of Otago	Loch, C (corresponding author), Univ Otago, Dept Geol, Dunedin, New Zealand.	carolina.loch@otago.ac.nz		Loch, Carolina/0000-0001-8949-4008; Fordyce, Ewan/0000-0002-2656-730X	University of Otago; Sir John Walsh Research Institute	University of Otago; Sir John Walsh Research Institute	CL received an University of Otago PhD scholarship and Sir John Walsh Research Institute Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergqvist L.P., 2003, BRAZ J ORAL SCI, V2, P249, DOI 10.20396/bjos.v2i6.8641693; BOYDE A, 1967, P ROY SOC MED, V60, P923, DOI 10.1177/003591576706000965; Boyde A, 1980, REP INT WHALING COMM, V3, P65; CARLSON S J, 1985, Contributions from the Museum of Paleontology University of Michigan, V27, P1; Carpenter K., 1986, Mississippi Geology, V7, P1; Ciampaglio CN, 2005, SEDIMENTARY REC, V3, P4, DOI [DOI 10.1371/JOURNAL.P0NE.0063586, 10.2110/sedred.2005.4.4]; Fahlke JM, 2013, PALAEOGEOGR PALAEOCL, V386, P690, DOI 10.1016/j.palaeo.2013.06.032; Fordyce RE, 2004, J VERTEBR PALEONTOL, V24, p59A; Fordyce RE, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P201; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; Gingerich PD, 1998, ADV VERT PALEOBIOL, P423; Gingerich PD, 2001, SCIENCE, V293, P2239, DOI 10.1126/science.1063902; Hillson S, 2005, TEETH, V2nd, P373; ISHIYAMA M, 1987, SCANNING MICROSCOPY, V1, P1071; Karlsen K., 1962, HVALRADETS SKRIFTER, V45, P5; Kellogg R, 1928, Q REV BIOL, V3, P29, DOI 10.1086/394293; Lawn BR, 2009, ACTA BIOMATER, V5, P2213, DOI 10.1016/j.actbio.2009.02.001; Loch C, 2013, ZOOMORPHOLOGY, V132, P215, DOI 10.1007/s00435-012-0180-1; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Maas MC, 1999, EVOL ANTHROPOL, V8, P133; Maas MC, 1995, J PALEONTOL, P1154; Murakami M, 2012, J VERTEBR PALEONTOL, V32, P1157, DOI 10.1080/02724634.2012.677299; Nanci A, 2007, 10 CATES ORAL HISTOL, P418; RENSBERGER JM, 1992, SCANNING MICROSCOPY, V6, P495; ROTHAUSEN K, 1968, Palaeontologische Zeitschrift, V42, P83; Sahni A, 1997, TOOTH ENAMEL MICROSTRUCTURE, P177; Sahni A, 1981, J PALAEONTOL SOC IND, V25, P33; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Tomilin AG, 1957, CAN J FISH AQUAT SCI, V95, P1; Uhen MD, 2000, J MAMMAL, V81, P123, DOI 10.1644/1545-1542(2000)081<0123:RODFPA>2.0.CO;2; Ungar PS, 2010, MAMMAL TEETH ORIGIN, P304; von Koenigswald W., 2000, P107, DOI 10.1017/CBO9780511542626.008; von Koenigswald W., 1991, P113; Von Koenigswald W, 1997, TOOTH ENAMEL MICROST, P267; Von Koenigswald W, 2010, J VERTEBR PALEONTOL, V30, P1797, DOI 10.1080/02724634.2010.521931; VONKOENIGSWALD W, 1992, SCANNING MICROSCOPY, V6, P195; vonKoenigswald W, 1997, TOOTH ENAMEL MICROSTRUCTURE, P203; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4; Wood C. B., 1999, Journal of Mammalian Evolution, V6, P177, DOI 10.1023/A:1020624222324	40	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116557	10.1371/journal.pone.0116557	http://dx.doi.org/10.1371/journal.pone.0116557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629995	Green Submitted, gold, Green Published			2022-12-27	WOS:000348732100040
J	Ricketts, CD; Bates, WR; Reid, SD				Ricketts, Chelsea D.; Bates, William R.; Reid, Scott D.			The Effects of Acute Waterborne Exposure to Sublethal Concentrations of Molybdenum on the Stress Response in Rainbow Trout, Oncorhynchus mykiss	PLOS ONE			English	Article							HEPATIC METALLOTHIONEIN; HEAT-SHOCK; SALMO-GAIRDNERI; ACUTE TOXICITY; SWIMMING PERFORMANCE; PLASMA-CORTISOL; EXPRESSION; FISH; INDUCTION; PROTEINS	To determine if molybdenum (Mo) is a chemical stressor fingerling and juvenile rainbow trout (Oncorhynchus mykiss) were exposed to waterborne sodium molybdate (0 2 20 or 1,000 mg l(-1) of Mo) and components of the physiological (plasma cortisol blood glucose and hematocrit) and cellular (heat shock protein [hsp] 72 hsp73 and hsp90 in the liver gills heart and erythrocytes and metallothionein [MT] in the liver and gills) stress responses were measured prior to initiation of exposure and at 8 24 and 96 h. During the acute exposure plasma cortisol blood glucose and hematocrit levels remained unchanged in all treatments. Heat shock protein 72 was not induced as a result of exposure and there were no detectable changes in total hsp70 (72 and 73) hsp90 and MT levels in any of the tissues relative to controls. Both fingerling and juvenile fish responded with similar lack of apparent sensitivity to Mo exposure. These experiments demonstrate that exposure to waterborne Mo of up to 1,000 mg l(-1) did not activate a physiological or cellular stress response in fish. Information from this study suggests that Mo water quality guidelines for the protection of aquatic life are highly protective of freshwater fish namely rainbow trout.	[Ricketts, Chelsea D.; Bates, William R.; Reid, Scott D.] Univ British Columbia, Dept Biol, Irving K Barber Sch Arts & Sci, Kelowna, BC V1V 1V7, Canada	University of British Columbia	Reid, SD (corresponding author), Univ British Columbia, Dept Biol, Irving K Barber Sch Arts & Sci, Okanagan Campus,3333 Univ Way, Kelowna, BC V1V 1V7, Canada.	scott.reid@ubc.ca			NSERC Discovery Grant awarded; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; University of British Columbia; Pacific Leaders Graduate Fellowship	NSERC Discovery Grant awarded; Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; University of British Columbia; Pacific Leaders Graduate Fellowship	This work was funded primarily through an NSERC Discovery Grant awarded to Dr. S.D.Reid and a Graduate Scholarship awarded to Ms. C.D. Ricketts (www.nserc-crsng.gc.ca). Supplemental funding was provided from the Canadian Foundation for Innovation (http://www.innovation.ca), the British Columbia Knowledge Development Fund (http://www. aved.gov.bc.ca/researchandinnovation/Funding/ BCKDF/) and the University of British Columbia (Dr. S.D. Reid) and a Pacific Leaders Graduate Fellowship (http://www2.gov.bc.ca/myhr/article.page?ContentID=542bf8d0-f652-c01e-eaa7-2e8ded21542f; Ms. C.D. Ricketts). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PA, 2001, J AQUAT ANIM HEALTH, V13, P173, DOI 10.1577/1548-8667(2001)013&lt;0173:PACSRO&gt;2.0.CO;2; ALBORES A, 1992, CHEM-BIOL INTERACT, V85, P127, DOI 10.1016/0009-2797(92)90057-R; Anke MB, 1985, TRACE ELEMENTS MAN A, P154; Basu N, 2003, COMP BIOCHEM PHYS A, V134, P655, DOI 10.1016/S1095-6433(02)00372-0; Benfey TJ, 2000, AQUACULTURE, V184, P167, DOI 10.1016/S0044-8486(99)00314-2; Bentley RE, 1973, ACUTE TOXICITY SODIU; Bleau H, 1996, AQUAT TOXICOL, V34, P221, DOI 10.1016/0166-445X(95)00040-B; Boone AN, 2002, COMP BIOCHEM PHYS C, V132, P223, DOI 10.1016/S1532-0456(02)00066-2; BROWN SB, 1986, GEN COMP ENDOCR, V62, P493, DOI 10.1016/0016-6480(86)90060-2; Canadian Council of Ministers of the Environment, 1999, CAN WAT QUAL GUID PR; CARBALLO M, 1995, APPL ENVIRON MICROB, V61, P2108, DOI 10.1128/AEM.61.6.2108-2112.1995; Chappell WR, 1979, EPA600179006 HLTH EF; Cho WJ, 1997, BIOCHEM BIOPH RES CO, V233, P316, DOI 10.1006/bbrc.1997.6387; Chowdhury MJ, 2004, COMP BIOCHEM PHYS C, V139, P163, DOI 10.1016/j.cca.2004.10.006; Currie S, 2000, J FISH BIOL, V56, P398, DOI 10.1111/j.1095-8649.2000.tb02114.x; Currie S, 2008, PHYSIOL BIOCHEM ZOOL, V81, P414, DOI 10.1086/589095; DE SK, 1990, J BIOL CHEM, V265, P15267; Dethloff GM, 1999, ARCH ENVIRON CON TOX, V36, P415, DOI 10.1007/PL00006614; Duffy LK, 1999, COMP BIOCHEM PHYS C, V124, P181, DOI 10.1016/S0742-8413(99)00055-9; DURNAM DM, 1981, J BIOL CHEM, V256, P5712; Eisler R, 1989, 85119 US FISH WILDL; FLEET JC, 1990, AM J PHYSIOL, V258, pG926, DOI 10.1152/ajpgi.1990.258.6.G926; Goyer R.A., 1986, CASARETT DOULLS TOXI, P582; Gregory TR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P286, DOI 10.1086/316673; Grosell M, 2012, FISH PHYSIOL, V31A, P53, DOI 10.1016/S1546-5098(11)31002-3; HAMILTON SJ, 1990, ARCH ENVIRON CON TOX, V19, P366, DOI 10.1007/BF01054980; Hamilton SJ, 1997, ECOTOX ENVIRON SAFE, V38, P296, DOI 10.1006/eesa.1997.1600; Harper ER, 2007, ENVIRON POLLUT, V147, P677, DOI 10.1016/j.envpol.2006.09.013; Hassanein HMA, 1999, ARCH ENVIRON CON TOX, V37, P78, DOI 10.1007/s002449900492; Heath A.G., 1995, WATER POLLUTION FISH; HEIKKILA JJ, 1982, J BIOL CHEM, V257, P2000; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; HODSON PV, 1978, WATER RES, V12, P869, DOI 10.1016/0043-1354(78)90039-8; HODSON PV, 1980, CAN J FISH AQUAT SCI, V37, P233, DOI 10.1139/f80-030; Hogstrand C., 2011, FISH PHYSIOL, V31, P135; Hollis L, 1999, AQUAT TOXICOL, V46, P101, DOI 10.1016/S0166-445X(98)00118-0; Hori TSF, 2008, COMP BIOCHEM PHYS C, V147, P416, DOI 10.1016/j.cbpc.2008.01.003; Jakobsen SS, 2007, BASIC CLIN PHARMACOL, V101, P441, DOI 10.1111/j.1742-7843.2007.00137.x; Janz DM, 1997, TOXICOL APPL PHARM, V147, P391, DOI 10.1006/taap.1997.8283; Jones CE, 1999, P 1999 WORKSH MOL IS, P1; KAGI JHR, 1993, ADV LIF SCI, P29; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Kobayashi K, 2005, BIOL PHARM BULL, V28, P1859, DOI 10.1248/bpb.28.1859; Kobayashi K, 2006, TOXICOLOGY, V228, P162, DOI 10.1016/j.tox.2006.08.022; KOIZUMI T, 1984, CHEM-BIOL INTERACT, V51, P219, DOI 10.1016/0009-2797(84)90031-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martinez C. B. R., 2004, Braz. J. Biol., V64, P797, DOI 10.1590/S1519-69842004000500009; Matsuura H, 2003, ANAL SCI, V19, P117, DOI 10.2116/analsci.19.117; MCBRIDE JR, 1979, B ENVIRON CONTAM TOX, V23, P806, DOI 10.1007/BF01770046; MCCARTHY DH, 1973, J FISH BIOL, V5, P1, DOI 10.1111/j.1095-8649.1973.tb04425.x; MCCONNELL RP, 1977, MOLYBDENUM ENV GEOCH, P725; McGeer JC, 2012, FISH PHYSIOL, V31B, P125, DOI 10.1016/S1546-5098(11)31025-4; McNeely RN, 1979, MOLYBDENUM WATER QUA; Miller LL, 2007, AQUAT TOXICOL, V83, P263, DOI 10.1016/j.aquatox.2007.05.001; MILLIGAN CL, 1987, J EXP BIOL, V133, P263; Ministry of Environment and Energy, 1994, WAT MAN POL GUID PRO; MISRA S, 1989, BIOCHIM BIOPHYS ACTA, V1007, P325, DOI 10.1016/0167-4781(89)90155-3; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Mugnier C, 1998, AQUACULT INT, V6, P33, DOI 10.1023/A:1009217719227; NADDY RB, 1995, ENVIRON TOXICOL CHEM, V14, P329, DOI 10.1002/etc.5620140219; NELL JA, 1980, BRIT POULTRY SCI, V21, P193, DOI 10.1080/00071668008416657; NIEBOER E, 1980, ENVIRON POLLUT B, V1, P3, DOI 10.1016/0143-148X(80)90017-8; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; Pane EF, 2003, AQUAT TOXICOL, V63, P65, DOI 10.1016/S0166-445X(02)00131-5; Phillips G. R., 1978, EPA600378103 ENV RES; Pyle GG, 2001, ECOTOX ENVIRON SAFE, V48, P202, DOI 10.1006/eesa.2000.2016; Reid SD, 2012, FISH PHYSIOL, V31A, P375, DOI 10.1016/S1546-5098(11)31008-4; Reid SD, 2002, COMP BIOCHEM PHYS C, V133, P355, DOI 10.1016/S1532-0456(02)00121-7; Rendell JL, 2006, COMP BIOCHEM PHYS D, V1, P238, DOI 10.1016/j.cbd.2005.12.004; Ricard AC, 1998, ARCH ENVIRON CON TOX, V34, P377, DOI 10.1007/s002449900333; Ron B, 1995, AQUACULTURE, V135, P216, DOI 10.1016/0044-8486(96)81306-8; Ruane NM, 2000, FISH SHELLFISH IMMUN, V10, P451, DOI 10.1006/fsim.1999.0260; Ruane NM, 2002, AQUAC RES, V33, P777, DOI 10.1046/j.1365-2109.2002.00717.x; SANDERS BM, 1993, CRIT REV TOXICOL, V23, P49, DOI 10.3109/10408449309104074; Sanders BM, 1995, COMP BIOCHEM PHYS C, V112, P335, DOI 10.1016/0742-8413(95)02029-2; SMITH C, 1987, J ENVIRON QUAL, V16, P377, DOI 10.2134/jeq1987.00472425001600040015x; Sohlberg S, 1996, J VET PHARMACOL THER, V19, P460, DOI 10.1111/j.1365-2885.1996.tb00083.x; SOIVIO A, 1975, J EXP BIOL, V63, P207; Suzuki Y, 1976, IND HLTH, V14, P25; Swain LG, 1986, WATER QUALITY CRITER; Syvokiene Janina, 2006, Acta Zoologica Lituanica, V16, P235, DOI 10.1080/13921657.2006.10512737; Trucco RG, 1990, P 17 ANN AQ TOX WORK, V1774, P102; Ulmer D. D., 1969, TRACE SUBSTANCES ENV, VII, P7; United States Geological Survey, 2004, MIN COMM SUMM MOL; United States Geological Survey, 2009, MIN COMM SUMM MOL; Vijayan MM, 1998, AQUAT TOXICOL, V40, P101, DOI 10.1016/S0166-445X(97)00057-X; WAALKES MP, 1984, TOXICOL LETT, V20, P33, DOI 10.1016/0378-4274(84)90179-6; Washburn BS, 2002, ENVIRON TOXICOL CHEM, V21, P557, DOI [10.1897/1551-5028(2002)021&lt;0557:EOHOHS&gt;2.0.CO;2, 10.1002/etc.5620210313]; Watanabe T, 1997, AQUACULTURE, V151, P185, DOI 10.1016/S0044-8486(96)01503-7; WELLS RMG, 1991, J FISH BIOL, V38, P53, DOI 10.1111/j.1095-8649.1991.tb03090.x; WHITING ER, 1994, J FRESHWATER ECOL, V9, P299, DOI 10.1080/02705060.1994.9664900; Williams JH, 1996, ENVIRON TOXICOL CHEM, V15, P1324, DOI [10.1002/etc.5620150810, 10.1897/1551-5028(1996)015&lt;1324:AOHIJA&gt;2.3.CO;2]; WOLF KENNETH W., 1963, PROGR FISH CULT, V25, P135, DOI 10.1577/1548-8659(1963)25[135:PSFFT]2.0.CO;2; Wood AW, 1996, CAN J FISH AQUAT SCI, V53, P2424, DOI 10.1139/cjfas-53-11-2424; Wood Chris M., 2001, P1; Wu SM, 2006, ZOOL STUD, V45, P363; Yamaguchi S, 2007, AQUAT TOXICOL, V83, P43, DOI 10.1016/j.aquatox.2007.03.010; Zarate J, 2003, AQUACULTURE, V223, P175, DOI 10.1016/S0044-8486(03)00160-1	99	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115334	10.1371/journal.pone.0115334	http://dx.doi.org/10.1371/journal.pone.0115334			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629693	Green Submitted, gold, Green Published			2022-12-27	WOS:000348732100015
J	Nie, C; Hu, HX; Shen, CL; Ye, B; Wu, H; Xiang, ML				Nie, Chen; Hu, Haixia; Shen, Chenling; Ye, Bin; Wu, Hao; Xiang, Mingliang			Expression of EFR3A in the Mouse Cochlea during Degeneration of Spiral Ganglion following Hair Cell Loss	PLOS ONE			English	Article							WALLERIAN DEGENERATION; ROLLING BLACKOUT; AUDITORY-NERVE; TIME-COURSE; IN-VIVO; KANAMYCIN; FUROSEMIDE; NEURONS; MICE	Retrograde degeneration of spiral ganglion cells in the cochlea following hair cell loss is similar to dying back in pathology. The EFR3A gene has recently been discovered to be involved in the pathogenesis of dying back. The relationship of EFR3A and spiral ganglion degeneration, however, was rarely investigated. In this study, we destroyed the hair cells of the mouse cochlea by co-administration of kanamycin and furosemide and then investigated the EFR3A expression during the induced spiral ganglion cell degeneration. Our results revealed that co-administration of kanamycin and furosemide quickly induced hair cell loss in the C57BL/6J mice and then resulted in progressive degeneration of the spiral ganglion beginning at day 5 following drug administration. The number of the spiral ganglion cells began to decrease at day 15. The expression of EFR3A increased remarkably in the spiral ganglion at day 5 and then decreased to near normal level within the next 10 days. Our study suggested that the change of EFR3A expression in the spiral ganglion was coincident with the time of the spiral ganglion degeneration, which implied that high expression of EFR3A may be important to prompt initiation of spiral ganglion degeneration following hair cell loss.	[Nie, Chen; Hu, Haixia; Shen, Chenling; Ye, Bin; Wu, Hao; Xiang, Mingliang] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Otolaryngol & Head & Neck Surg, Sch Med, Shanghai 200030, Peoples R China; [Nie, Chen; Hu, Haixia; Shen, Chenling; Ye, Bin; Wu, Hao; Xiang, Mingliang] Shanghai Jiao Tong Univ, Ear Inst, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wu, H (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Otolaryngol & Head & Neck Surg, Sch Med, Shanghai 200030, Peoples R China.	wuhao622@sina.cn; mingliangxiang@163.com			National Natural Science Foundation [81271088]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation (No. 81271088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agterberg MJH, 2009, JARO-J ASSOC RES OTO, V10, P355, DOI 10.1007/s10162-009-0170-2; Alam SA, 2007, J COMP NEUROL, V503, P832, DOI 10.1002/cne.21430; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Edge ASB, 2008, CURR OPIN NEUROBIOL, V18, P377, DOI 10.1016/j.conb.2008.10.001; Hirose K, 2011, HEARING RES, V272, P108, DOI 10.1016/j.heares.2010.10.011; Huang FD, 2006, J NEUROSCI, V26, P2369, DOI 10.1523/JNEUROSCI.3770-05.2006; Huang FD, 2004, NAT NEUROSCI, V7, P1070, DOI 10.1038/nn1313; Imamura S, 2003, JARO-J ASSOC RES OTO, V4, P196, DOI 10.1007/s10162-002-2037-7; Iseki E, 2001, J NEUROL SCI, V185, P129, DOI 10.1016/S0022-510X(01)00481-6; Kong WJ, 2010, BRAIN RES, V1331, P28, DOI 10.1016/j.brainres.2010.02.058; McFadden SL, 2004, BRAIN RES, V997, P40, DOI 10.1016/j.brainres.2003.10.031; Munemoto Y, 2004, MOL BRAIN RES, V128, P131, DOI 10.1016/j.molbrainres.2004.06.022; Murray LM, 2008, J ANAT, V213, P633, DOI 10.1111/j.1469-7580.2008.01007.x; Nourski KV, 2004, HEARING RES, V187, P131, DOI 10.1016/S0378-5955(03)00336-8; Parker MA, 2011, J SPEECH LANG HEAR R, V54, P1709, DOI 10.1044/1092-4388(2011/10-0149); Sugawara M, 2005, JARO-J ASSOC RES OTO, V6, P136, DOI 10.1007/s10162-004-5050-1; Tang WX, 2006, J NEUROSCI, V26, P1991, DOI 10.1523/JNEUROSCI.5055-05.2006; Versnel H, 2007, HEARING RES, V231, P1, DOI 10.1016/j.heares.2007.03.003; Vijayakrishnan N, 2009, J CELL SCI, V122, P114, DOI 10.1242/jcs.036673; Xiong H, 2011, LAB ANIM-UK, V45, P95, DOI 10.1258/la.2010.009142	21	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117345	10.1371/journal.pone.0117345	http://dx.doi.org/10.1371/journal.pone.0117345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622037	Green Published, Green Submitted, gold			2022-12-27	WOS:000348470400023
J	Luo, N; Sun, QS; Chen, Q; Ji, ZX; Xia, DS				Luo, Nan; Sun, Quansen; Chen, Qiang; Ji, Zexuan; Xia, Deshen			A Novel Tracking Algorithm via Feature Points Matching	PLOS ONE			English	Article							ROBUST OBJECT TRACKING; SHIFT BLOB-TRACKING; MEAN-SHIFT; SURVEILLANCE; SCALE; SIFT	Visual target tracking is a primary task in many computer vision applications and has been widely studied in recent years. Among all the tracking methods, the mean shift algorithm has attracted extraordinary interest and been well developed in the past decade due to its excellent performance. However, it is still challenging for the color histogram based algorithms to deal with the complex target tracking. Therefore, the algorithms based on other distinguishing features are highly required. In this paper, we propose a novel target tracking algorithm based on mean shift theory, in which a new type of image feature is introduced and utilized to find the corresponding region between the neighbor frames. The target histogram is created by clustering the features obtained in the extraction strategy. Then, the mean shift process is adopted to calculate the target location iteratively. Experimental results demonstrate that the proposed algorithm can deal with the challenging tracking situations such as: partial occlusion, illumination change, scale variations, object rotation and complex background clutter. Meanwhile, it outperforms several state-of-the-art methods.	[Luo, Nan; Sun, Quansen; Chen, Qiang; Ji, Zexuan; Xia, Deshen] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Sun, QS (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China.	sunquansen@mail.njust.edu.cn	chen, qiang/HGU-5418-2022; chen, qiang/GWZ-7308-2022		National Natural Science Foundation of China [61273251, 61473310]; project of civil space technology pre-research of the 12th five-year plan [D040201]; Fundamental Research Funds for the Central Universities [30920140111004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of civil space technology pre-research of the 12th five-year plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from Programs of the National Natural Science Foundation of China (61273251,61473310) (http://www.nsfc.gov.cn), the project of civil space technology pre-research of the 12th five-year plan (D040201) and the Fundamental Research Funds for the Central Universities (30920140111004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahi A, 2012, PROC CVPR IEEE, P510, DOI 10.1109/CVPR.2012.6247715; Avidan S, 2004, IEEE T PATTERN ANAL, V26, P1064, DOI 10.1109/TPAMI.2004.53; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Birchfield S, 1998, PROC CVPR IEEE, P232, DOI 10.1109/CVPR.1998.698614; Birchfield ST, 2005, PROC CVPR IEEE, P1158; Calonder M, 2010, LECT NOTES COMPUT SC, V6314, P778, DOI 10.1007/978-3-642-15561-1_56; Chen J, 2012, INTERNATIONAL SYMPOSIUM ON COMPUTER SCIENCE & TECHNOLOGY: PROCEEDINGS, P1; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790, DOI 10.1109/34.400568; Collins RT, 2003, PROC CVPR IEEE, P234; Comaniciu D, 2003, IEEE T PATTERN ANAL, V25, P564, DOI 10.1109/TPAMI.2003.1195991; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Comaniciu D, 2000, PROC CVPR IEEE, P142, DOI 10.1109/CVPR.2000.854761; Dinh T. B., 2011, P IEEE WORKSH APPL C, P642, DOI DOI 10.1109/WACV.2011.5711565; Ferryman JM, 2000, INT J COMPUT VISION, V37, P187, DOI 10.1023/A:1008155721192; Fischer J., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P2365, DOI 10.1109/IROS.2011.6048421; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Godec M, 2011, P INT C COMP VIS; Guo Y, 2010, INT CONF SIGN PROCES, P1198, DOI 10.1109/ICOSP.2010.5656102; Haner S., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3488, DOI 10.1109/ICPR.2010.1112; Haritaoglu I, 2000, IEEE T PATTERN ANAL, V22, P809, DOI 10.1109/34.868683; Heinly J, 2012, LECT NOTES COMPUT SC, V7573, P759, DOI 10.1007/978-3-642-33709-3_54; Jeyakar J, 2008, COMPUT VIS IMAGE UND, V112, P296, DOI 10.1016/j.cviu.2008.05.005; Jia X, 2012, PROC CVPR IEEE, P1822, DOI 10.1109/CVPR.2012.6247880; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; Kalal Z, 2012, IEEE T PATTERN ANAL, V34, P1409, DOI 10.1109/TPAMI.2011.239; Kwon J, 2010, PROC CVPR IEEE, P1269, DOI 10.1109/CVPR.2010.5539821; Leichter I, 2012, IEEE T PATTERN ANAL, V34, P695, DOI 10.1109/TPAMI.2011.167; Li Y, 1998, INT C PATT RECOG, P175, DOI 10.1109/ICPR.1998.711108; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mair E, 2010, LECT NOTES COMPUT SC, V6312, P183, DOI 10.1007/978-3-642-15552-9_14; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Ning J, 2012, IET COMPUT VIS, V6, P62, DOI 10.1049/iet-cvi.2009.0075; Ning J, 2012, IET COMPUT VIS, V6, P52, DOI 10.1049/iet-cvi.2010.0112; Oikonomidis I, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.101; Peng NS, 2005, PATTERN RECOGN LETT, V26, P605, DOI 10.1016/j.patrec.2004.08.023; Ross DA, 2008, INT J COMPUT VISION, V77, P125, DOI 10.1007/s11263-007-0075-7; Rosten E, 2006, LECT NOTES COMPUT SC, V3951, P430, DOI 10.1007/11744023_34; Rublee E, 2011, IEEE I CONF COMP VIS, P2564, DOI 10.1109/ICCV.2011.6126544; Santner J, 2010, IEEE COMP SOC C COMP; Tola E., 2008, P 2008 IEEE C COMP V, P1, DOI DOI 10.1109/CVPR.2008.4587673; Tola E, 2010, IEEE T PATTERN ANAL, V32, P815, DOI 10.1109/TPAMI.2009.77; Wu Y, 2013, PROC CVPR IEEE, P2411, DOI 10.1109/CVPR.2013.312; Wu Z., 2009, P WORKSH MOT VID COM, P1, DOI [10.1109/WMVC.2009.5399245, DOI 10.1109/WMVC.2009.5399245]; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4; Zhang JY, 2011, ADV MATER RES-SWITZ, V186, P281, DOI 10.4028/www.scientific.net/AMR.186.281; Zhang KH, 2012, LECT NOTES COMPUT SC, V7574, P864, DOI 10.1007/978-3-642-33712-3_62; Zhao Q., 2007, P ICWSM, P1; Zhao Q, 2010, IEEE T PATTERN ANAL, V32, P274, DOI 10.1109/TPAMI.2008.299; Zhong W, 2012, PROC CVPR IEEE, P1838, DOI 10.1109/CVPR.2012.6247882; Zhou HY, 2009, COMPUT VIS IMAGE UND, V113, P345, DOI 10.1016/j.cviu.2008.08.006; Zivkovic Z, 2004, PROC CVPR IEEE, P798	52	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116315	10.1371/journal.pone.0116315	http://dx.doi.org/10.1371/journal.pone.0116315			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617769	gold, Green Published, Green Submitted			2022-12-27	WOS:000350336000012
J	Meirelles, LA; Montoya, QV; Solomon, SE; Rodrigues, A				Meirelles, Lucas A.; Montoya, Quimi V.; Solomon, Scott E.; Rodrigues, Andre			New Light on the Systematics of Fungi Associated with Attine Ant Gardens and the Description of Escovopsis kreiselii sp nov.	PLOS ONE			English	Article							LEAF-CUTTING ANTS; ANAMORPHIC BASIDIOMYCETOUS YEAST; FORMICIDAE MYRMICINAE ATTINI; MICROBE SYMBIOSIS; GROWING ANTS; HYMENOPTERA-FORMICIDAE; ENDOPHYTIC FUNGI; ATTA-SEXDENS; NESTS; COEVOLUTION	Since the formal description of fungi in the genus Escovopsis in 1990, only a few studies have focused on the systematics of this group. For more than two decades, only two Escovopsis species were described; however, in 2013, three additional Escovopsis species were formally described along with the genus Escovopsioides, both found exclusively in attine ant gardens. During a survey for Escovopsis species in gardens of the lower attine ant Mycetophylax morschi in Brazil, we found four strains belonging to the pink-colored Escovopsis clade. Careful examination of these strains revealed significant morphological differences when compared to previously described species of Escovopsis and Escovopsioides. Based on the type of conidiogenesis (sympodial), as well as morphology of conidiogenous cells (percurrent), non-vesiculated conidiophores, and DNA sequences, we describe the four new strains as a new species, Escovopsis kreiselii sp. nov. Phylogenetic analyses using three nuclear markers (Large subunit RNA; translation elongation factor 1-alpha; and internal transcribed spacer) from the new strains as well as available sequences in public databases confirmed that all known fungi infecting attine ant gardens comprise a monophyletic group within the Hypocreaceae family, with very diverse morphological characteristics. Specifically, Escovopsis kreiselii is likely associated with gardens of lower-attine ants and its pathogenicity remains uncertain.	[Meirelles, Lucas A.; Montoya, Quimi V.; Rodrigues, Andre] UNESP, Dept Biochem & Microbiol, Rio Claro, SP, Brazil; [Solomon, Scott E.] Rice Univ, Dept Biosci, Houston, TX USA	Universidade Estadual Paulista; Rice University	Rodrigues, A (corresponding author), UNESP, Dept Biochem & Microbiol, Rio Claro, SP, Brazil.	andrer@rc.unesp.br	Rodrigues, Andre/B-8148-2012; Montoya, Quimi Vidaurre/I-1479-2018; Montoya, Quimi Vidaurre/L-3569-2019	Rodrigues, Andre/0000-0002-4164-9362; Montoya, Quimi Vidaurre/0000-0002-3285-5981; Montoya, Quimi Vidaurre/0000-0002-3285-5981; Meirelles, Lucas/0000-0003-3194-7136; Solomon, Scott/0000-0002-6376-5671	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/16765-0]; NSF IRFP (United States National Science Foundation International Research Fellowship Program) [07012333]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NSF IRFP (United States National Science Foundation International Research Fellowship Program)	The authors thank FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) for providing financial support (grant # 2011/16765-0) and a scholarship to LAM and NSF IRFP (United States National Science Foundation International Research Fellowship Program no. 07012333) for supporting SES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attili-Angelis D, 2014, FUNGAL DIVERS, V65, P65, DOI 10.1007/s13225-013-0275-0; Augustin JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082265; Belt T., 1874, NATURALIST NICARAGUA; Bollazzi M, 2002, INSECT SOC, V49, P153, DOI 10.1007/s00040-002-8295-x; Carreiro SC, 2004, INT J SYST EVOL MICR, V54, P1891, DOI 10.1099/ijs.0.63200-0; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie C, 2001, OECOLOGIA, V128, P99106; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Folgarait PJ, 2011, ENVIRON ENTOMOL, V40, P342, DOI 10.1603/EN10111; Folgarait P, 2011, CURR MICROBIOL, V63, P250, DOI 10.1007/s00284-011-9944-y; Gerardo NM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-88; Gerardo NM, 2004, P ROY SOC B-BIOL SCI, V271, P1791, DOI 10.1098/rspb.2004.2792; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klingenberg C, 2007, STUD NEOTROP FAUNA E, V42, P121, DOI 10.1080/01650520601065509; Klingenberg C, 2009, ZOOTAXA, P1; KREISEL H, 1972, Z ALLG MIKROBIOL, V12, P643, DOI 10.1002/jobm.3630120805; Little AEF, 2008, ECOLOGY, V89, P1216, DOI 10.1890/07-0815.1; Mehdiabadi NJ, 2010, MYRMECOL NEWS, V13, P37; Meirelles LA, 2014, ENV MICROBIOL REP, V6, P339, DOI 10.1111/1758-2229.12132; Melo WGP, 2014, INT J SYST EVOL MICR, V64, P1428, DOI 10.1099/ijs.0.058818-0; Mendes Thais D., 2012, Insects, V3, P228, DOI 10.3390/insects3010228; Middelhoven WJ, 2003, ANTON LEEUW INT J G, V83, P167, DOI 10.1023/A:1023384830802; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mikheyev AS, 2008, MOL ECOL, V17, P4480, DOI 10.1111/j.1365-294X.2008.03940.x; Mikheyev AS, 2006, P NATL ACAD SCI USA, V103, P10702, DOI 10.1073/pnas.0601441103; Mikheyev AS, 2010, AM NAT, V175, pE126, DOI 10.1086/652472; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; MUCHOVEJ JJ, 1990, MYCOTAXON, V37, P191; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012668; Muller A, 1893, BOT MITTHEILUNGEN TR; Nixon KC., 2002, WINCLADA VER 1 0000; Pagnocca FC, 2010, INT J SYST EVOL MICR, V60, P1454, DOI 10.1099/ijs.0.015727-0; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Reynolds HT, 2004, MYCOLOGIA, V96, P955, DOI 10.2307/3762079; Rodrigues A, 2008, MICROB ECOL, V56, P604, DOI 10.1007/s00248-008-9380-0; Rodrigues A, 2014, J BASIC MICROB, V54, P1186, DOI 10.1002/jobm.201200458; Rodrigues A, 2011, FEMS MICROBIOL ECOL, V78, P244, DOI 10.1111/j.1574-6941.2011.01152.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; SEIFERT KA, 1995, MYCOLOGIA, V87, P407, DOI 10.2307/3760838; Silva-Pinhati ACO, 2004, BRAZ J MED BIOL RES, V37, P1463, DOI 10.1590/S0100-879X2004001000004; Sosa-Calvo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080498; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Taerum SJ, 2010, ENVIRON ENTOMOL, V39, P105, DOI 10.1603/EN09137; Taerum SJ, 2007, P ROY SOC B-BIOL SCI, V274, P1971, DOI 10.1098/rspb.2007.0431; Van Bael SA, 2012, ECOL ENTOMOL, V37, P318, DOI 10.1111/j.1365-2311.2012.01364.x; Van Bael SA, 2009, P ROY SOC B-BIOL SCI, V276, P2419, DOI 10.1098/rspb.2009.0196; Weber N. A., 1972, GARDENING ANTS ATTIN; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	54	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0112067	10.1371/journal.pone.0112067	http://dx.doi.org/10.1371/journal.pone.0112067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617836	Green Published, gold, Green Submitted			2022-12-27	WOS:000350336000001
J	Rusu, MC; Poalelungi, CV; Vrapciu, AD; Nicolescu, MI; Hostiuc, S; Mogoanta, L; Taranu, T				Rusu, Mugurel C.; Poalelungi, Cristian V.; Vrapciu, Alexandra D.; Nicolescu, Mihnea I.; Hostiuc, Sorin; Mogoanta, Laurentiu; Taranu, Traian			Endocardial Tip Cells in the Human Embryo - Facts and Hypotheses	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; SPROUTING ANGIOGENESIS; CORONARY-ARTERIES; AVIAN HEART; PROGENITORS; EPICARDIUM; FILOPODIA; LINEAGE; MUCOSA	Experimental studies regarding coronary embryogenesis suggest that the endocardium is a source of endothelial cells for the myocardial networks. As this was not previously documented in human embryos, we aimed to study whether or not endothelial tip cells could be correlated with endocardial-dependent mechanisms of sprouting angiogenesis. Six human embryos (43-56 days) were obtained and processed in accordance with ethical regulations; immunohistochemistry was performed for CD105 (endoglin), CD31, CD34, alpha-smooth muscle actin, desmin and vimentin antibodies. Primitive main vessels were found deriving from both the sinus venosus and aorta, and were sought to be the primordia of the venous and arterial ends of cardiac microcirculation. Subepicardial vessels were found branching into the outer ventricular myocardium, with a pattern of recruiting alpha-SMA+/desmin+ vascular smooth muscle cells and pericytes. Endothelial sprouts were guided by CD31+/CD34+/CD105+/vimentin+ endothelial tip cells. Within the inner myocardium, we found endothelial networks rooted from endocardium, guided by filopodia-projecting CD31+/CD34+/CD105+/vimentin+ endocardial tip cells. The myocardial microcirculatory bed in the atria was mostly originated from endocardium, as well. Nevertheless, endocardial tip cells were also found in cardiac cushions, but they were not related to cushion endothelial networks. A general anatomical pattern of cardiac microvascular embryogenesis was thus hypothesized; the arterial and venous ends being linked, respectively, to the aorta and sinus venosus. Further elongation of the vessels may be related to the epicardium and subepicardial stroma and the intramyocardial network, depending on either endothelial and endocardial filopodia-guided tip cells in ventricles, or mostly on endocardium, in atria.	[Rusu, Mugurel C.; Vrapciu, Alexandra D.] Carol Davila Univ Med & Pharm, Fac Med Dent, Div Anat, Bucharest, Romania; [Rusu, Mugurel C.] MEDCTR Ctr Excellence Lab Med & Pathol, Bucharest, Romania; [Poalelungi, Cristian V.] Carol Davila Univ Med & Pharm, Dr I Cantacuzino Hosp, Dept Obstet & Gynaecol, Bucharest, Romania; [Nicolescu, Mihnea I.] Carol Davila Univ Med & Pharm, Fac Med Dent, Div Histol & Cytol, Bucharest, Romania; [Nicolescu, Mihnea I.] Victor Babes Natl Inst Pathol, Mol Med Lab, Bucharest, Romania; [Hostiuc, Sorin] Carol Davila Univ Med & Pharm, Fac Med, Dept Morphol Sci 2, Div Legal Med & Bioeth, Bucharest, Romania; [Mogoanta, Laurentiu] Univ Med & Pharm Craiova, Dept Morphol, Res Ctr Microscop Morphol & Immunol, Craiova, Romania; [Taranu, Traian] Gr T Popa Univ Med & Pharm, Fac Med, Div Anat, Iasi, Romania	Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; Victor Babes National Institute of Pathology; Carol Davila University of Medicine & Pharmacy; University of Medicine & Pharmacy of Craiova; Grigore T Popa University of Medicine & Pharmacy	Nicolescu, MI (corresponding author), Carol Davila Univ Med & Pharm, Fac Med Dent, Div Histol & Cytol, Bucharest, Romania.	mihnea.nicolescu@gmail.com	Poalelungi, Cristian/A-3965-2017; Mogoanta, Laurentiu/M-5856-2017; Rusu, Mugurel Constantin/C-7565-2009; Hostiuc, Sorin/I-2017-2019; Jalali, Amir/V-2562-2018; Nicolescu, Mihnea Ioan/C-6033-2011; Hostiuc, Sorin I/A-2292-2009	Mogoanta, Laurentiu/0000-0002-0350-834X; Rusu, Mugurel Constantin/0000-0002-8723-0540; Hostiuc, Sorin/0000-0003-4130-9402; Jalali, Amir/0000-0002-0307-879X; Nicolescu, Mihnea Ioan/0000-0001-8051-1166; Hostiuc, Sorin I/0000-0003-4130-9402				Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Carmona R, 2010, J CELL MOL MED, V14, P2066, DOI 10.1111/j.1582-4934.2010.01088.x; Crawford MH, 2010, CARDIOLOGY; del Monte G, 2012, CELL, V151, P932, DOI 10.1016/j.cell.2012.11.004; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Diaz-Flores L, 2011, HISTOL HISTOPATHOL, V26, P623, DOI 10.14670/HH-26.623; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Fantin A, 2013, BLOOD, V121, P2352, DOI 10.1182/blood-2012-05-424713; Gerhardt H, 2005, EXP SUPPL, V94, P3; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Gittenberger-de Groot AC, 2003, CARDIOL YOUNG, V13, P175, DOI 10.1017/S1047951103000337; Gutierrez R, 2014, HISTOL HISTOPATHOL; Hagedorn M, 2004, DEV DYNAM, V230, P23, DOI 10.1002/dvdy.20020; Hoffman J. I. E., 2012, PEDIAT CARDIOVASCULA; Ishii Y, 2009, CELL TISSUE RES, V335, P67, DOI 10.1007/s00441-008-0663-z; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Kattan J, 2004, DEV DYNAM, V230, P34, DOI 10.1002/dvdy.20022; Magara J, 2012, J ANAT, V220, P612, DOI 10.1111/j.1469-7580.2012.01501.x; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Milgrom-Hoffman M, 2011, DEVELOPMENT, V138, P4777, DOI 10.1242/dev.061192; Morabito CJ, 2002, CURR OPIN CARDIOL, V17, P235, DOI 10.1097/00001573-200205000-00005; Ott Harald C, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS27, DOI 10.1038/ncpcardio0771; Perez-Pomares JM, 2003, DEV DYNAM, V227, P56, DOI 10.1002/dvdy.10284; Perez-Pomares JM, 1998, DEV BIOL, V200, P57, DOI 10.1006/dbio.1998.8949; Perez-Pomares JM, 2006, ANAT REC PART A, V288A, P700, DOI 10.1002/ar.a.20338; Phng LK, 2013, DEVELOPMENT, V140, P4031, DOI 10.1242/dev.097352; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Reese DE, 2002, CIRC RES, V91, P761, DOI 10.1161/01.RES.0000038961.53759.3C; RHODIN JAG, 1989, J SUBMICR CYTOL PATH, V21, P1; Rusu MC, 2013, ANAT SCI INT, V88, P25, DOI 10.1007/s12565-012-0154-x; Rusu MC, 2014, ANAT REC, V297, P301, DOI 10.1002/ar.22837; Rusu MC, 2013, ANAT REC, V296, P350, DOI 10.1002/ar.22630; Sadler TW, 2009, LANGMANS MED EMBRYOL; Siemerink MJ, 2013, J HISTOCHEM CYTOCHEM, V61, P101, DOI 10.1369/0022155412467635; Siemerink MJ, 2012, ANGIOGENESIS, V15, P151, DOI 10.1007/s10456-011-9251-z; Stanescu R, 2012, ROM J MORPHOL EMBRYO, V53, P375; Vrapciu AD, 2014, MED HYPOTHESES, V83, P497, DOI 10.1016/j.mehy.2014.08.014; Weinstein BM, 1999, DEV DYNAM, V215, P2, DOI 10.1002/(SICI)1097-0177(199905)215:1<2::AID-DVDY2>3.0.CO;2-U; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070570; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	48	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0115853	10.1371/journal.pone.0115853	http://dx.doi.org/10.1371/journal.pone.0115853			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617624	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000007
J	Dagleish, MP; Martin, S; Steele, P; Finlayson, J; Eaton, SL; Siso, S; Stewart, P; Fernandez-Borges, N; Hamilton, S; Pang, Y; Chianini, F; Reid, HW; Goldmann, W; Gonzalez, L; Castilla, J; Jeffrey, M				Dagleish, Mark P.; Martin, Stuart; Steele, Philip; Finlayson, Jeanie; Eaton, Samantha L.; Siso, Silvia; Stewart, Paula; Fernandez-Borges, Natalia; Hamilton, Scott; Pang, Yvonne; Chianini, Francesca; Reid, Hugh W.; Goldmann, Wilfred; Gonzalez, Lorenzo; Castilla, Joaquin; Jeffrey, Martin			Susceptibility of European Red Deer (Cervus elaphus elaphus) to Alimentary Challenge with Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; PRION PROTEIN; TRANSGENIC MICE; ODOCOILEUS-HEMIONUS; PRP ACCUMULATION; SHEEP; SCRAPIE; BSE; INFECTION; ANIMALS	European red deer (Cervus elaphus elaphus) are susceptible to the agent of bovine spongiform encephalopathy, one of the transmissible spongiform encephalopathies, when challenged intracerebrally but their susceptibility to alimentary challenge, the presumed natural route of transmission, is unknown. To determine this, eighteen deer were challenged via stomach tube with a large dose of the bovine spongiform encephalopathy agent and clinical signs, gross and histological lesions, presence and distribution of abnormal prion protein and the attack rate recorded. Only a single animal developed clinical disease, and this was acute with both neurological and respiratory signs, at 1726 days post challenge although there was significant (27.6%) weight loss in the preceding 141 days. The clinically affected animal had histological lesions of vacuolation in the neuronal perikaryon and neuropil, typical of transmissible spongiform encephalopathies. Abnormal prion protein, the diagnostic marker of transmissible encephalopathies, was primarily restricted to the central and peripheral nervous systems although a very small amount was present in tingible body macrophages in the lymphoid patches of the caecum and colon. Serial protein misfolding cyclical amplification, an in vitro ultra-sensitive diagnostic technique, was positive for neurological tissue from the single clinically diseased deer. All other alimentary challenged deer failed to develop clinical disease and were negative for all other investigations. These findings show that transmission of bovine spongiform encephalopathy to European red deer via the alimentary route is possible but the transmission rate is low. Additionally, when deer carcases are subjected to the same regulations that ruminants in Europe with respect to the removal of specified offal from the human food chain, the zoonotic risk of bovine spongiform encephalopathy, the cause of variant Creutzfeldt-Jakob disease, from consumption of venison is probably very low.	[Dagleish, Mark P.; Steele, Philip; Finlayson, Jeanie; Hamilton, Scott; Pang, Yvonne; Chianini, Francesca; Reid, Hugh W.] Pentlands Sci Pk, Moredun Res Inst, Edinburgh EH26 0PZ, Midlothian, Scotland; [Martin, Stuart; Siso, Silvia; Gonzalez, Lorenzo; Jeffrey, Martin] Pentlands Sci Pk, Anim Hlth & Vet Labs Agcy Lasswade, Edinburgh EH26 0PZ, Midlothian, Scotland; [Eaton, Samantha L.; Stewart, Paula; Goldmann, Wilfred] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Div Neurobiol, Edinburgh EH25 9RG, Midlothian, Scotland; [Fernandez-Borges, Natalia; Castilla, Joaquin] CIC bioGUNE, Derio 48160, Spain; [Castilla, Joaquin] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Bizkaia, Spain	Moredun Research Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; CIC bioGUNE; Basque Foundation for Science	Dagleish, MP (corresponding author), Pentlands Sci Pk, Moredun Res Inst, Edinburgh EH26 0PZ, Midlothian, Scotland.	mark.dagleish@moredun.ac.uk	SISO, SILVIA/D-4240-2009; Castilla, Joaquin/D-5261-2011; Chianini, Francesca/K-1451-2013; Castilla, Joaquín/J-8414-2019; Fernández-Borges, Natalia/H-1875-2012; Siso, Silvia/X-7690-2019; González, Lorenzo/A-5325-2010	Castilla, Joaquin/0000-0002-2216-1361; Chianini, Francesca/0000-0001-9962-446X; Castilla, Joaquín/0000-0002-2216-1361; González, Lorenzo/0000-0003-4199-4526; Siso, Silvia/0000-0002-3642-2956; Fernandez-Borges, Natalia/0000-0001-6274-0096	UK Food Standards Agency [M03024];  [AGL2012-37988-C04-01];  [CTP2013-P05];  [EFA282/11]; BBSRC [BBS/E/D/20251968, BBS/E/D/20251967] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: researchfish	UK Food Standards Agency; ; ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	These studies were funded by the UK Food Standards Agency grant M03024 and three Spanish grants (AGL2012-37988-C04-01, CTP2013-P05 and EFA282/11).	[Anonymous], 1990, SPECIFIED BOVINE OFF; Brayton KA, 2004, GENE, V326, P167, DOI 10.1016/j.gene.2003.10.022; Brun A, 2004, NEUROSCI RES, V48, P75, DOI 10.1016/j.neures.2003.09.004; Brun A, 2007, J GEN VIROL, V88, P1842, DOI 10.1099/vir.0.82568-0; Carlson NR, 2007, PHYSIOL BEHAV, P69; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2004, J NEUROSCI, V24, P2156, DOI 10.1523/JNEUROSCI.3811-03.2004; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collins SJ, 2004, LANCET, V363, P51, DOI 10.1016/S0140-6736(03)15171-9; Dagleish MP, 2010, J GEN VIROL, V91, P3116, DOI 10.1099/vir.0.025049-0; Dagleish MP, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-17; Espinosa JC, 2007, J GEN VIROL, V88, P1379, DOI 10.1099/vir.0.82647-0; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Foster JD, 2004, J GEN VIROL, V85, P3159, DOI 10.1099/vir.0.80099-0; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Gavier-Widen D, 2005, J VET DIAGN INVEST, V17, P509, DOI 10.1177/104063870501700601; Goldmann W, 2008, VET RES, V39, DOI [10.1051/vetres:2008038, DOI 10.1051/VETRES:2008038]; Goldmann W, 2006, J GEN VIROL, V87, P3741, DOI 10.1099/vir.0.82083-0; Gonzalez L, 2008, VET REC, V162, P397, DOI 10.1136/vr.162.13.397; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gonzalez L, 2007, J GEN VIROL, V88, P714, DOI 10.1099/vir.0.82426-0; Gonzalez L, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-55; Haase B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-15; Happ GM, 2007, J WILDLIFE DIS, V43, P224, DOI 10.7589/0090-3558-43.2.224; Houston F, 2003, NATURE, V423, P498, DOI 10.1038/423498a; Hunter N, 2012, J VIROL, V86, P11856, DOI 10.1128/JVI.01573-12; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Jeffrey M, 2007, NEUROPATH APPL NEURO, V33, P373, DOI 10.1111/j.1365-2990.2007.00868.x; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2000, ARCH VIROL, P23; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; Jewell JE, 2005, J GEN VIROL, V86, P2127, DOI 10.1099/vir.0.81077-0; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; KIRKWOOD JK, 1994, VET REC, V135, P296, DOI 10.1136/vr.135.13.296; Konold T, 2004, VET REC, V155, P659, DOI 10.1136/vr.155.21.659; McBride SD, 2015, BEHAV BRAIN RES, V276, P45, DOI 10.1016/j.bbr.2014.05.057; Mitchell GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039055; O'Rourke KI, 1999, J GEN VIROL, V80, P2765, DOI 10.1099/0022-1317-80-10-2765; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Peletto S, 2009, J VET SCI, V10, P115, DOI 10.4142/jvs.2009.10.2.115; Perucchini M, 2008, J GEN VIROL, V89, P1324, DOI 10.1099/vir.0.83424-0; Robinson SJ, 2012, PRION, V6, P153, DOI 10.4161/pri.19640; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Siso S, 2009, NEUROPATH APPL NEURO, V35, P232, DOI 10.1111/j.1365-2990.2008.00978.x; Tan BC, 2012, J GEN VIROL, V93, P2749, DOI 10.1099/vir.0.039008-0; Terry LA, 2003, VET REC, V152, P387, DOI 10.1136/vr.152.13.387; Vickery CM, 2014, J VIROL, V88, P1830, DOI 10.1128/JVI.02762-13; Watson P, 2009, DEER CULLING EXMOOR; WELLS GAH, 1992, RES VET SCI, V53, P1, DOI 10.1016/0034-5288(92)90076-E; WELLS GAH, 1995, BRAIN PATHOL, V5, P91, DOI 10.1111/j.1750-3639.1995.tb00580.x; WILLIAMS ES, 1993, VET PATHOL, V30, P36, DOI 10.1177/030098589303000105; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Williams ES, 2004, P AM ASS VET LAB DIA; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204; WYATT JM, 1991, VET REC, V129, P233, DOI 10.1136/vr.129.11.233	56	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116094	10.1371/journal.pone.0116094	http://dx.doi.org/10.1371/journal.pone.0116094			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615837	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100022
J	Mostafa, A; Kanrai, P; Petersen, H; Ibrahim, S; Rautenschlein, S; Pleschka, S				Mostafa, Ahmed; Kanrai, Pumaree; Petersen, Henning; Ibrahim, Sherif; Rautenschlein, Silke; Pleschka, Stephan			Efficient Generation of Recombinant Influenza A Viruses Employing a New Approach to Overcome the Genetic Instability of HA Segments	PLOS ONE			English	Article							CANDIDATE VACCINE VIRUSES; ESCHERICHIA-COLI; REVERSE GENETICS; VERO CELLS; DNA-REPAIR; TRANSCRIPTION; REPLICATION; SYSTEM; MAINTENANCE; RESTRICTION	Influenza A viruses (IAVs) are the most relevant and continual source of severe infectious respiratory complications in humans and different animal species, especially poultry. Therefore, an efficient vaccination that elicits protective and neutralizing antibodies against the viral hemagglutinin (HA) and neuraminidase (NA) is an important strategy to counter annual epidemics or occasional pandemics. With the help of plasmid-based reverse genetics technology, it is possible that IAV vaccine strains (IVVS) are rapidly generated. However, the genetic instability of some cloned HA-cDNAs after transformation into competent bacteria represents a major obstacle. Herein, we report efficient cloning strategies of different genetically volatile HA segments (H5- and H9-subtypes) employing either a newly constructed vector for reverse genetics (pMKPccdB) or by the use of the Escherichia coli strain HB101. Both approaches represent improved and generalizable strategies to establish functional reverse genetics systems preventing genetic changes to the cloned (HA) segments of IAV facilitating more efficient rescue of recombinant IAV for basic research and vaccine development.	[Mostafa, Ahmed] Natl Res Ctr, Ctr Sci Excellence Influenza Viruses, Cairo, Egypt; [Kanrai, Pumaree; Pleschka, Stephan] Univ Giessen, Inst Med Virol, D-35390 Giessen, Germany; [Petersen, Henning; Rautenschlein, Silke] Univ Vet Med Hannover, Clin Poultry, Hannover, Germany; [Ibrahim, Sherif] Agr Res Ctr, VSVRI, Dept Genet Engn, Cairo, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Justus Liebig University Giessen; University of Veterinary Medicine Hannover, Foundation; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Pleschka, S (corresponding author), Univ Giessen, Inst Med Virol, D-35390 Giessen, Germany.	stephan.pleschka@viro.med.uni-giessen.de	Mostafa, Ahmed/S-7462-2016; Pleschka, Stephan/HGU-9354-2022	Mostafa, Ahmed/0000-0002-2878-5714; Pleschka, Stephan/0000-0002-7372-7089; Ibrahim, Sherif/0000-0002-1503-8701	FluResearchNet, "Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses" - German Federal Ministry of Education and Research (BMBF) [01 KI 1006E, 01 KI 1006D]; German-Egyptian Research Long-Term Scholarship "GERLS" program - Egyptian government; German Academic Exchange Service (DAAD); Egyptian Science and Technology Development Fund (STDF)	FluResearchNet, "Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses" - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German-Egyptian Research Long-Term Scholarship "GERLS" program - Egyptian government; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Egyptian Science and Technology Development Fund (STDF)(Science and Technology Development Fund (STDF))	This work was supported in part by the FluResearchNet, "Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses", funded by the German Federal Ministry of Education and Research (BMBF, grant 01 KI 1006E, to S. P. and grant, 01 KI 1006D to S. R.) and by a fellowship of the German-Egyptian Research Long-Term Scholarship "GERLS" program co-funded by the Egyptian government and the German Academic Exchange Service (DAAD, to A. M.). This work was also supported by a fellowship of the Egyptian Science and Technology Development Fund (STDF, to S. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; Al-Allaf FA, 2013, 3 BIOTECH, V3, P61, DOI 10.1007/s13205-012-0070-8; BERNARD P, 1994, GENE, V148, P71, DOI 10.1016/0378-1119(94)90235-6; Bowater RP, 2001, PROG NUCLEIC ACID RE, V66, P159; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; CESARENI G, 1982, P NATL ACAD SCI-BIOL, V79, P6313, DOI 10.1073/pnas.79.20.6313; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Corchero JL, 1998, BIOTECHNOL BIOENG, V58, P625, DOI 10.1002/(SICI)1097-0290(19980620)58:6<625::AID-BIT8>3.3.CO;2-1; CUNNINGHAM TP, 1993, GENE, V124, P93, DOI 10.1016/0378-1119(93)90766-V; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Feng T, 2002, BIOTECHNIQUES, V32, P992, DOI 10.2144/02325bm03; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Harvey R, 2011, J VIROL, V85, P6086, DOI 10.1128/JVI.00096-11; Harvey R, 2010, VACCINE, V28, P8008, DOI 10.1016/j.vaccine.2010.09.006; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2000, VIROLOGY, V267, P310, DOI 10.1006/viro.1999.0140; Hoffmann E, 2002, P NATL ACAD SCI USA, V99, P11411, DOI 10.1073/pnas.172393399; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; HOWARDFLANDERS P, 1966, GENETICS, V53, P1137; Kang HY, 1996, GENOMICS, V35, P189, DOI 10.1006/geno.1996.0338; KIYAMA R, 1994, GENE, V150, P57; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Lewin A, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-19; Liao H H, 1991, Protein Expr Purif, V2, P43, DOI 10.1016/1046-5928(91)90008-7; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; LUYTJES W, 1989, CELL, V59, P1107, DOI 10.1016/0092-8674(89)90766-6; Ma WJ, 2010, J VIROL, V84, P2122, DOI 10.1128/JVI.01668-09; Malagon F, 1998, MOL GEN GENET, V259, P639, DOI 10.1007/s004380050858; Mostafa A, 2013, J VIROL METHODS, V193, P603, DOI 10.1016/j.jviromet.2013.07.021; Neumann G, 2000, J VIROL, V74, P547, DOI 10.1128/JVI.74.1.547-551.2000; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; Okamatsu M, 2008, ARCH VIROL, V153, P2189, DOI 10.1007/s00705-008-0243-2; Ozaki H, 2004, J VIROL, V78, P1851, DOI 10.1128/JVI.78.4.1851-1857.2004; Parry J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2151; PEREIRA HG, 1967, B WORLD HEALTH ORGAN, V37, P553; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Schambach A, 2006, GENE THER, V13, P1524, DOI 10.1038/sj.gt.3302807; Sorrell EM, 2011, CURR OPIN VIROL, V1, P635, DOI 10.1016/j.coviro.2011.07.003; Stech J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn646; STUEBER D, 1982, EMBO J, V1, P1399, DOI 10.1002/j.1460-2075.1982.tb01329.x; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; SUGAWARA K, 1991, J GEN VIROL, V72, P103, DOI 10.1099/0022-1317-72-1-103; To KKW, 2014, J INFECTION, V68, P205, DOI 10.1016/j.jinf.2013.12.014; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WU Y, 2014, TRENDS MICROBIOL; Yoon SW, 2013, J VIROL, V87, P4786, DOI 10.1128/JVI.03551-12; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou B, 2011, J VIROL METHODS, V173, P378, DOI 10.1016/j.jviromet.2011.01.021	64	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116917	10.1371/journal.pone.0116917	http://dx.doi.org/10.1371/journal.pone.0116917			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615576	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100049
J	Pua, YH; Clark, RA; Ong, PH				Pua, Yong-Hao; Clark, Ross A.; Ong, Peck-Hoon			Evaluation of the Wii Balance Board for Walking Aids Prediction: Proof-of-Concept Study in Total Knee Arthroplasty	PLOS ONE			English	Article							STANDING BALANCE; OSTEOARTHRITIS; REPLACEMENT; RELIABILITY; INJURIES; MODELS; PAIN; HIP	Background and Objectives To provide proof-of-concept for the validity of the Wii Balance Board (WBB) measures to predict the type of walking aids required by inpatients with a recent (<= 4days) total knee arthroplasty (TKA). Methods A cross-sectional sample of 89 inpatients (mean age, 67.0 +/- 8years) with TKA was analyzed. A multivariable proportional odds prediction model was constructed using 8 pre-specified predictors - namely, age, sex, body mass index, knee pain, knee range-of-motion, active knee lag, and WBB-derived standing balance. The type of walking aids prescribed on day 4 post-surgery was the outcome of interest - an ordinal variable with 4 categories (walking stick, narrow-and broad-base quadstick, and walking frame). Results Women, increasing body mass index, and poorer standing balance were independently associated with greater odds for requiring walking aids with a larger base-of-support. The concordance-index of the prediction model was 0.74. The model comprising only WBB-derived standing balance had nearly half (44%) the explanatory power of the full model. Adding WBB-derived standing balance to conventional demographic and knee variables resulted in a continuous net reclassification index of 0.60 (95% CI, 0.19-1.01), predominantly due to better identification of patients who required walking aids with a large base-of-support (sensitivity gain). Conclusions The WBB was able to provide quantitative measures of standing balance which could assist healthcare professionals in prescribing the appropriate type of walking aids for patients. Further investigation is needed to assess whether using the WBB could lead to meaningful changes in clinical outcomes such as falls.	[Pua, Yong-Hao; Ong, Peck-Hoon] Singapore Gen Hosp, Dept Physiotherapy, Singapore, Singapore; [Clark, Ross A.] Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic, Australia	Singapore General Hospital; Australian Catholic University	Clark, RA (corresponding author), Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic, Australia.	ross.clark@acu.edu.au	Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019	Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553; Pua, Yong-Hao/0000-0003-2313-9665	Singhealth Foundation Grant [SHF/FG444S/2009]	Singhealth Foundation Grant(SingHealth)	This study was supported by Singhealth Foundation Grant (SHF/FG444S/2009). The study sponsors had no involvement in study design, collection, analysis and interpretation of the data, writing of the manuscript and in the decision to submit the manuscript for publication.	Bateni H, 2005, ARCH PHYS MED REHAB, V86, P134, DOI 10.1016/j.apmr.2004.04.023; Bradley SM, 2011, AM FAM PHYSICIAN, V84, P405; Brooks L L, 1994, Wis Med J, V93, P16; CHARRON PM, 1995, AM J PHYS MED REHAB, V74, P237, DOI 10.1097/00002060-199505000-00011; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Cibere J, 2004, ARTHRITIS RHEUM, V50, P458, DOI 10.1002/art.20025; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Fitz Gerald JD, 2004, ARTHRIT RHEUM-ARTHR, V51, P100, DOI 10.1002/art.20090; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE, 2013, RMS REGRESSION MODEL; Harrell FE, 2001, REGRESSION MODELING; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Holmes JD, 2013, CLIN REHABIL, V27, P361, DOI 10.1177/0269215512458684; Kaye H. S., 2000, MOBILITY DEVICE USE; Kearns Richard J, 2008, Orthopedics, V31, P225, DOI 10.3928/01477447-20080301-20; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Moons KGM, 2004, J CLIN EPIDEMIOL, V57, P1262, DOI 10.1016/j.jclinepi.2004.01.020; O'Hare MP, 2013, PHYS THER REV, V18, P11, DOI 10.1179/1743288X12Y.0000000036; Oliver D, 2008, AGE AGEING, V37, P248, DOI 10.1093/ageing/afn088; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Prieto-Alhambra D, 2011, ANN RHEUM DIS, V70, P134, DOI 10.1136/ard.2010.131110; Pua YH, 2013, J ARTHROPLASTY, V28, P1521, DOI 10.1016/j.arth.2012.10.020; Ritter PL, 2006, J RHEUMATOL, V33, P574; Simpson C, 1991, PHYSIOTHERAPY, V77, P231; Stevens JA, 2009, J AM GERIATR SOC, V57, P1464, DOI 10.1111/j.1532-5415.2009.02365.x; Takacs J, 2014, GAIT POSTURE, V40, P270, DOI 10.1016/j.gaitpost.2014.03.016; Tung JY, 2011, J BIOMECH, V44, P1466, DOI 10.1016/j.jbiomech.2011.03.015; Van der Esch M, 2003, ARTHRIT RHEUM-ARTHR, V49, P838, DOI 10.1002/art.11463; Watson SC, 2004, AUSTRALAS J AGEING, V23, P77, DOI 10.1111/j.1741-6612.2004.00021.x	30	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117124	10.1371/journal.pone.0117124	http://dx.doi.org/10.1371/journal.pone.0117124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615952	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100057
J	Boldrin, E; Rumiato, E; Fassan, M; Cappellesso, R; Rugge, M; Chiarion-Sileni, V; Ruol, A; Alfieri, R; Cagol, M; Castoro, C; Amadori, A; Saggioro, D				Boldrin, Elisa; Rumiato, Enrica; Fassan, Matteo; Cappellesso, Rocco; Rugge, Massimo; Chiarion-Sileni, Vanna; Ruol, Alberto; Alfieri, Rita; Cagol, Matteo; Castoro, Carlo; Amadori, Alberto; Saggioro, Daniela			Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin's Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FREQUENT LOSS; MICROSATELLITE INSTABILITY; HETEROZYGOSITY; ADENOCARCINOMA; RISK; PATTERNS; ETIOLOGY; THERAPY; REGIONS	Background Development of novel therapeutic drugs and regimens for cancer treatment has led to improvements in patient long-term survival. This success has, however, been accompanied by the increased occurrence of second primary cancers. Indeed, patients who received regional radiotherapy for Hodgkin's Lymphoma (HL) or breast cancer may develop, many years later, a solid metachronous tumor in the irradiated field. Despite extensive epidemiological studies, little information is available on the genetic changes involved in the pathogenesis of these solid therapy-related neoplasms. Methods Using microsatellite markers located in 7 chromosomal regions frequently deleted in sporadic esophageal cancer, we investigated loss of heterozygosity (LOH) and microsatellite instability (MSI) in 46 paired (normal and tumor) samples. Twenty samples were of esophageal carcinoma developed in HL or breast cancer long-term survivors: 14 squamous cell carcinomas (ESCC) and 6 adenocarcinomas (EADC), while 26 samples, used as control, were of sporadic esophageal cancer (15 ESCC and 11 EADC). Results We found that, though the overall LOH frequency at the studied chromosomal regions was similar among metachronous and sporadic tumors, the latter exhibited a statistically different higher LOH frequency at 17q21.31 (p = 0.018). By stratifying for tumor histotype we observed that LOH at 3p24.1, 5q11.2 and 9p21.3 were more frequent in ESCC than in EADC suggesting a different role of the genetic determinants located nearby these regions in the development of the two esophageal cancer histotypes. Conclusions Altogether, our results strengthen the genetic diversity among ESCC and EADC whether they occurred spontaneously or after therapeutic treatments. The presence of histotype-specific alterations in esophageal carcinoma arisen in HL or breast cancer long-term survivors suggests that their transformation process, though the putative different etiological origin, may retrace sporadic ESCC and EADC carcinogenesis.	[Boldrin, Elisa; Rumiato, Enrica; Chiarion-Sileni, Vanna; Alfieri, Rita; Cagol, Matteo; Castoro, Carlo; Amadori, Alberto; Saggioro, Daniela] IOV IRCCS, Veneto Inst Oncol, Padua, Italy; [Fassan, Matteo; Cappellesso, Rocco; Rugge, Massimo] Univ Padua, Dept Med Surg Pathol & Cytopathol, Padua, Italy; [Ruol, Alberto; Amadori, Alberto] Univ Padua, Dept Surg Sci Oncol & Gastroenterol, Padua, Italy	IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua	Saggioro, D (corresponding author), IOV IRCCS, Veneto Inst Oncol, Padua, Italy.	d.saggioro@unipd.it	Rugge, Massimo/K-7525-2016; Castoro, Carlo/AAO-6927-2020; Alfieri, Rita/HCH-3044-2022; Cappellesso, Rocco/L-5463-2016; sileni, vanna chiarion/B-9042-2018; Alfieri, Rita/F-1676-2018; Boldrin, Elisa/V-9766-2018; Fassan, Matteo/F-5152-2012; Saggioro, Daniela/W-1443-2018; Castoro, Carlo/GNM-8249-2022	Cappellesso, Rocco/0000-0002-0480-3412; sileni, vanna chiarion/0000-0001-9191-9124; Alfieri, Rita/0000-0002-4993-2197; Boldrin, Elisa/0000-0002-7898-5845; Rumiato, Enrica/0000-0002-1142-0006; Fassan, Matteo/0000-0001-6515-5482; Saggioro, Daniela/0000-0002-7136-2821; Castoro, Carlo/0000-0001-9601-9336	Associazione Italiana per la Ricerca sul Cancro (AIRC) [10430]; Ministero della Istruzione, della Universita e della Ricerca (MIUR) [2010MCLPLB-003]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Istruzione, della Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the following grants: Associazione Italiana per la Ricerca sul Cancro (AIRC, Ref. 10430), Ministero della Istruzione, della Universita e della Ricerca (MIUR, Prot. 2010MCLPLB-003); AA received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Araki K, 2004, ONCOLOGY-BASEL, V67, P151, DOI 10.1159/000081002; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Behrens C, 2000, CANCER EPIDEM BIOMAR, V9, P1027; Brat DJ, 1999, AM J PATHOL, V154, P1431, DOI 10.1016/S0002-9440(10)65397-7; Cai YYC, 2007, INT J ONCOL, V30, P1059; Chai JY, 2012, WORLD J GASTROENTERO, V18, P6521, DOI 10.3748/wjg.v18.i45.6521; Chattopadhyay I, 2010, MUTAT RES-GEN TOX EN, V696, P130, DOI 10.1016/j.mrgentox.2010.01.001; DeBenedetti VMG, 1996, CANCER EPIDEM BIOMAR, V5, P93; Dolan K, 1998, BRIT J CANCER, V78, P950, DOI 10.1038/bjc.1998.607; Dores GM, 2002, J CLIN ONCOL, V20, P3484, DOI 10.1200/JCO.2002.09.038; Dubrova YE, 1996, NATURE, V380, P683, DOI 10.1038/380683a0; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Evans SC, 2004, CANCER LETT, V212, P241, DOI 10.1016/j.canlet.2004.03.011; Fekete F, 1994, Dysphagia, V9, P289; Foulkes WD, 2013, J PATHOL, V230, P347, DOI 10.1002/path.4205; Gleeson CM, 1996, CANCER RES, V56, P259; Hu N, 2000, GENE CHROMOSOME CANC, V27, P217, DOI 10.1002/(SICI)1098-2264(200003)27:3<217::AID-GCC1>3.0.CO;2-A; Ko JMY, 2001, CANCER LETT, V170, P131, DOI 10.1016/S0304-3835(01)00577-8; Little JB, 2000, CARCINOGENESIS, V21, P397, DOI 10.1093/carcin/21.3.397; Liu M, 2011, INT J MOL SCI, V12, P7401, DOI 10.3390/ijms12117401; Mertens F, 2000, CANCER GENET CYTOGEN, V116, P89, DOI 10.1016/S0165-4608(99)00105-3; Micke O, 1999, JPN J CLIN ONCOL, V29, P164, DOI 10.1093/jjco/29.3.164; Montesano R, 1996, INT J CANCER, V69, P225, DOI 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6; Morgan WF, 1996, RADIAT RES, V146, P247, DOI 10.2307/3579454; MORI T, 1994, CANCER RES, V54, P1638; Morton LM, 2012, ANN ONCOL, V23, P3081, DOI 10.1093/annonc/mds144; Muzeau F, 1997, BRIT J CANCER, V75, P1336, DOI 10.1038/bjc.1997.226; Nancarrow DJ, 2008, CANCER RES, V68, P4163, DOI 10.1158/0008-5472.CAN-07-6710; Ng AK, 2008, HEMATOL ONCOL CLIN N, V22, P271, DOI 10.1016/j.hoc.2008.01.007; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Peralta RC, 1998, INT J CANCER, V78, P600, DOI 10.1002/(SICI)1097-0215(19981123)78:5<600::AID-IJC12>3.0.CO;2-1; Rumiato E, 2011, CANCER LETT, V310, P84, DOI 10.1016/j.canlet.2011.06.017; Ruol A, 2009, ARCH SURG-CHICAGO, V144, P247, DOI 10.1001/archsurg.2008.574; Shoshan Y, 2000, J NEUROPATH EXP NEUR, V59, P614, DOI 10.1093/jnen/59.7.614; Stoner GD, 2001, CARCINOGENESIS, V22, P1737, DOI 10.1093/carcin/22.11.1737; TARMIN L, 1994, CANCER RES, V54, P6094; Yang LC, 2004, CANCER LETT, V203, P71, DOI 10.1016/j.canlet.2003.09.027	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117070	10.1371/journal.pone.0117070	http://dx.doi.org/10.1371/journal.pone.0117070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611972	Green Submitted, Green Published, gold			2022-12-27	WOS:000348562900031
J	Anckar, J; Bonni, A				Anckar, Julius; Bonni, Azad			Regulation of Neuronal Morphogenesis and Positioning by Ubiquitin-Specific Proteases in the Cerebellum	PLOS ONE			English	Article							SIGNALING PATHWAY; CELL-CYCLE; CENTROSOME; UBIQUITYLATION; DOMAINS; USP33	Ubiquitin signaling mechanisms play fundamental roles in the cell-intrinsic control of neuronal morphogenesis and connectivity in the brain. However, whereas specific ubiquitin ligases have been implicated in key steps of neural circuit assembly, the roles of ubiquitin-specific proteases (USPs) in the establishment of neuronal connectivity have remained unexplored. Here, we report a comprehensive analysis of USP family members in granule neuron morphogenesis and positioning in the rodent cerebellum. We identify a set of 32 USPs that are expressed in granule neurons. We also characterize the subcellular localization of the 32 USPs in granule neurons using a library of expression plasmids encoding GFP-USPs. In RNAi screens of the 32 neuronally expressed USPs, we uncover novel functions for USP1, USP4, and USP20 in the morphogenesis of granule neuron dendrites and axons and we identify a requirement for USP30 and USP33 in granule neuron migration in the rodent cerebellar cortex in vivo. These studies reveal that specific USPs with distinct spatial localizations harbor key functions in the control of neuronal morphogenesis and positioning in the mammalian cerebellum, with important implications for our understanding of the cell-intrinsic mechanisms that govern neural circuit assembly in the brain.	[Anckar, Julius; Bonni, Azad] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bonni, Azad] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Washington University (WUSTL)	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	bonni@wustl.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051255] Funding Source: NIH RePORTER; NINDS NIH HHS [NS051255] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1997, DEVELOPMENT OF THE C, P89023; Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Courchet J, 2013, CELL, V153, P1510, DOI 10.1016/j.cell.2013.05.021; de la Torre-Ubieta L, 2011, NEURON, V72, P22, DOI 10.1016/j.neuron.2011.09.018; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Famulski JK, 2010, SCIENCE, V330, P1834, DOI 10.1126/science.1198480; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Huynh MA, 2011, NEURON, V69, P930, DOI 10.1016/j.neuron.2011.02.008; Kawabe H, 2011, NAT REV NEUROSCI, V12, P251, DOI 10.1038/nrn3009; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Komuro H, 1998, J NEUROSCI, V18, P1478; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Palay S. L., 1974, CEREBELLAR CORTEX CY; Puram SV, 2011, NAT NEUROSCI, V14, P973, DOI 10.1038/nn.2857; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Urbe S, 2012, MOL BIOL CELL, V23, P1095, DOI 10.1091/mbc.E11-08-0668; Yamada T, 2014, NEURON, V83, P122, DOI 10.1016/j.neuron.2014.05.039; Yamada T, 2013, TRENDS NEUROSCI, V36, P218, DOI 10.1016/j.tins.2012.12.004; Yang Y, 2009, SCIENCE, V326, P575, DOI 10.1126/science.1177087	38	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0117076	10.1371/journal.pone.0117076	http://dx.doi.org/10.1371/journal.pone.0117076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607801	gold, Green Published, Green Submitted			2022-12-27	WOS:000348205300048
J	Burk, LM; Wang, KH; Wait, JM; Kang, E; Willis, M; Lu, JP; Zhou, O; Lee, YZ				Burk, Laurel M.; Wang, Ko-Han; Wait, John Matthew; Kang, Eunice; Willis, Monte; Lu, Jianping; Zhou, Otto; Lee, Yueh Z.			Delayed Contrast Enhancement Imaging of a Murine Model for Ischemia Reperfusion with Carbon Nanotube Micro-CT	PLOS ONE			English	Article							X-RAY SOURCE; TOMOGRAPHY	We aim to demonstrate the application of free-breathing prospectively gated carbon nanotube (CNT) micro-CT by evaluating a myocardial infarction model with a delayed contrast enhancement technique. Evaluation of murine cardiac models using micro-CT imaging has historically been limited by extreme imaging requirements. Newly-developed CNT-based x-ray sources offer precise temporal resolution, allowing elimination of physiological motion through prospective gating. Using free-breathing, cardiac-gated CNT micro-CT, a myocardial infarction model can be studied non-invasively and with high resolution. Myocardial infarction was induced in eight male C57BL/6 mice aged 8-12 weeks. The ischemia reperfusion model was achieved by surgically occluding the LAD artery for 30 minutes followed by 24 hours of reperfusion. Tail vein catheters were placed for contrast administration. Iohexol 300mgI/mL was administered followed by images obtained in diastole. Iodinated lipid blood pool contrast agent was then administered, followed with images at systole and diastole. Respiratory and cardiac signals were monitored externally and used to gate the scans of free-breathing subjects. Seven control animals were scanned using the same imaging protocol. After imaging, the heart was harvested, cut into 1mm slices and stained with TTC. Post-processing analysis was performed using ITK-Snap and MATLAB. All animals demonstrated obvious delayed contrast enhancement in the left ventricular wall following the Iohexol injection. The blood pool contrast agent revealed significant changes in cardiac function quantified by 3-D volume ejection fractions. All subjects demonstrated areas of myocardial infarct in the LAD distribution on both TTC staining and micro-CT imaging. The CNT micro-CT system aids straightforward, free-breathing, prospectively-gated 3D murine cardiac imaging. Delayed contrast enhancement allows identification of infarcted myocardium after a myocardial ischemic event. We demonstrate the ability to consistently identify areas of myocardial infarct in mice and provide functional cardiac information using a delayed contrast enhancement technique.	[Burk, Laurel M.; Wait, John Matthew; Lu, Jianping; Zhou, Otto; Lee, Yueh Z.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; [Wang, Ko-Han; Lee, Yueh Z.] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA; [Kang, Eunice; Willis, Monte] Univ N Carolina, McAllister Heart Inst, Div Cardiol, Chapel Hill, NC 27599 USA; [Lu, Jianping; Zhou, Otto] Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Burk, LM (corresponding author), Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA.	laurelburk@gmail.com	Lee, Yueh/AAF-1430-2021; Lu, Jianping/E-2457-2018; Willis, Monte S/J-9994-2015	Lee, Yueh/0000-0003-1846-7680; Lu, Jianping/0000-0001-9963-9741; Willis, Monte S/0000-0002-0769-5816; Zhou, Otto/0000-0003-1476-5517	National Institute of Biomedical Imaging and Bioengineering (Bethesda, MD) [4R33EB004204-01]; National Cancer Institute (Bethesda, MD) [U54CA119343]; UNC Clinician-Scientist Training Program in Cardiovascular Medicine [HL083828]; AHA Scientist Development Grant; NHLBI [R01HL104129];  [UCM_443318]; NATIONAL CANCER INSTITUTE [U54CA119343, P50CA058223] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083828, R01HL104129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R33EB004204] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Cancer Institute (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UNC Clinician-Scientist Training Program in Cardiovascular Medicine; AHA Scientist Development Grant(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by grant 4R33EB004204-01 from the National Institute of Biomedical Imaging and Bioengineering (Bethesda, MD), http://www.nibib.nih.gov/; grant U54CA119343 from the National Cancer Institute (Bethesda, MD), http://www.cancer.gov/; UNC Clinician-Scientist Training Program in Cardiovascular Medicine (HL083828 to E. K.), http://medicine.med.unc.edu/cardiology/fellows/cardiovascular-disease-fellowship; AHA Scientist Development Grant (to J.M.W.), http://my.americanheart.org/professional/Research/FundingOpportunities/ SupportingInformation/Winter-2013-Scientist-Development- Grant_UCM_443318_Article.jsp; and NHLBI, http://www.nhlbi.nih.gov/ (R01HL104129 to J.M.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartling SH, 2007, INVEST RADIOL, V42, P704, DOI 10.1097/RLI.0b013e318070dcad; Bordelon DE, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3043417; Calderon-Colon X, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/32/325707; Cao GH, 2010, MED PHYS, V37, P5306, DOI 10.1118/1.3491806; Curley GF, 2009, ANESTHESIOLOGY, V111, P701, DOI 10.1097/01.anes.0000358753.29528.fb; Li HH, 2011, AM J PATHOL, V178, P1043, DOI 10.1016/j.ajpath.2010.11.049; Mahnken AH, 2009, JACC-CARDIOVASC IMAG, V2, P1167, DOI 10.1016/j.jcmg.2009.05.014; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Nahrendorf M, 2007, AM J PHYSIOL-HEART C, V292, pH3172, DOI 10.1152/ajpheart.01307.2006; Ordovas KG, 2011, RADIOLOGY, V261, P358, DOI 10.1148/radiol.11091882; Qian X, 2012, MED PHYS, V39, P2090, DOI 10.1118/1.3694667; RICH S, 1986, AM HEART J, V112, P392, DOI 10.1016/0002-8703(86)90280-2; Sosnovik DE, 2009, CIRC-CARDIOVASC IMAG, V2, P460, DOI 10.1161/CIRCIMAGING.109.859678; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang J, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2041589	15	2	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115607	10.1371/journal.pone.0115607	http://dx.doi.org/10.1371/journal.pone.0115607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635838	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700015
J	Day, JM; Oakley, BB; Seal, BS; Zsak, L				Day, J. Michael; Oakley, Brian B.; Seal, Bruce S.; Zsak, Laszlo			Comparative Analysis of the Intestinal Bacterial and RNA Viral Communities from Sentinel Birds Placed on Selected Broiler Chicken Farms	PLOS ONE			English	Article							INFECTIOUS-BRONCHITIS VIRUS; RUNTING-STUNTING SYNDROME; POULT ENTERITIS SYNDROME; MOLECULAR CHARACTERIZATION; MALABSORPTION-SYNDROME; TURKEY ASTROVIRUSES; GROWTH-PERFORMANCE; UNITED-STATES; PATHOGENESIS; PICOBIRNAVIRUS	There is a great deal of interest in characterizing the complex microbial communities in the poultry gut, and in understanding the effects of these dynamic communities on poultry performance, disease status, animal welfare, and microbes with human health significance. Investigations characterizing the poultry enteric virome have identified novel poultry viruses, but the roles these viruses play in disease and performance problems have yet to be fully characterized. The complex bacterial community present in the poultry gut influences gut development, immune status, and animal health, each of which can be an indicator of overall performance. The present metagenomic investigation was undertaken to provide insight into the colonization of specific pathogen free chickens by enteric microorganisms under field conditions and to compare the pre-contact intestinal microbiome with the altered microbiome following contact with poultry raised in the field. Analysis of the intestinal virome from contact birds ("sentinels") placed on farms revealed colonization by members of the Picornaviridae, Picobirnaviridae, Reoviridae, and Astroviridae that were not present in pre-contact birds or present in proportionally lower numbers. Analysis of the sentinel gut bacterial community revealed an altered community in the post-contact birds, notably by members of the Lachnospiracea/Clostridium and Lactobacillus families and genera. Members of the avian enteric Reoviridae and Astroviridae have been well-characterized and have historically been implicated in poultry enteric disease; members of the Picobirnaviridae and Picornaviridae have only relatively recently been described in the poultry and avian gut, and their roles in the recognized disease syndromes and in poultry performance in general have not been determined. This metagenomic analysis has provided insight into the colonization of the poultry gut by enteric microbes circulating in commercial broiler flocks, and has identified enteric viruses and virus communities that warrant further study in order to understand their role(s) in avian gut health and disease.	[Day, J. Michael; Zsak, Laszlo] ARS, USDA, Southeast Poultry Res Lab, Athens, GA 30605 USA; [Oakley, Brian B.; Seal, Bruce S.] ARS, USDA, Poultry Microbiol Safety Res Unit, Athens, GA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Day, JM (corresponding author), ARS, USDA, Southeast Poultry Res Lab, Athens, GA 30605 USA.	Michael.day@ars.usda.gov	Oakley, Brian Oakley B/AAG-4015-2019	Oakley, Brian/0000-0003-2098-6439	USDA ARS CRIS project [6612-32000-067-00D]; United States Poultry and Egg Association Project [684]	USDA ARS CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United States Poultry and Egg Association Project	Funding was provided by the USDA ARS CRIS project 6612-32000-067-00D Intervention Strategies to Control and Prevent Enteric Viral Diseases of Poultry and the United States Poultry and Egg Association Project #684 Molecular Characterization of Novel Enteric Viruses Circulating in Poultry in the United States (http://www.uspoultry.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2014, ARCH VIROL, DOI [10.1007/s00705-014-2295-9, DOI 10.1007/S00705-014-2295-9]; Barnes H. J., 2003, DIS POULTRY, P1171; Barnes HJ, 2000, REV SCI TECH OIE, V19, P565, DOI 10.20506/rst.19.2.1234; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Boros A, 2012, J GEN VIROL, V93, P2171, DOI 10.1099/vir.0.043224-0; BRACEWELL CD, 1981, VET REC, V109, P64, DOI 10.1136/vr.109.3.64-b; Bullman S, 2014, J GEN VIROL, V95, P1094, DOI 10.1099/vir.0.061085-0; Chacon JL, 2014, BRIT POULTRY SCI, V55, P271, DOI 10.1080/00071668.2014.903558; Danzeisen JL, 2013, PEERJ, V1, DOI 10.7717/peerj.237; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; Day J.M., 2013, DIS POULTRY, P381; Day JM, 2014, AVIAN DIS, V58, P137, DOI 10.1637/10593-061313-ResNote.1; Day JM, 2013, AVIAN DIS, V57, P573, DOI 10.1637/10390-092712-Review.1; Day JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313; DECAESSTECKER M, 1986, AVIAN PATHOL, V15, P769, DOI 10.1080/03079458608436339; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farkas T, 2012, VIRUS GENES, V44, P262, DOI 10.1007/s11262-011-0695-4; Gabriel I, 2006, WORLD POULTRY SCI J, V62, P499, DOI 10.1017/S0043933906001115; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; GOODWIN MA, 1993, AVIAN DIS, V37, P451, DOI 10.2307/1591672; Heggen-Peay CL, 2002, AVIAN DIS, V46, P32, DOI 10.1637/0005-2086(2002)046[0032:IOARFP]2.0.CO;2; Jindal N, 2010, POULTRY SCI, V89, P217, DOI 10.3382/ps.2009-00424; Jindal N, 2010, AVIAN PATHOL, V39, P53, DOI 10.1080/03079450903490289; Jindal N, 2009, AVIAN DIS, V53, P268, DOI 10.1637/8513-110308-Reg.1; Keegan KP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002541; Kim T, 2011, METHODS MOL BIOL, V733, P185, DOI 10.1007/978-1-61779-089-8_13; Lau SKP, 2014, J GEN VIROL, V95, P1929, DOI 10.1099/vir.0.066597-0; Lee KW, 2010, POULTRY SCI, V89, P203, DOI 10.3382/ps.2009-00418; Lefkowitz E.J., 2012, VIRUS TAXONOMY, P39, DOI [10.1016/B978-0-12-384684-6.00001-X, DOI 10.1016/B978-0-12-384684-6.00001-X]; Lister S. A., 2006, Avian gut function in health and disease, P350, DOI 10.1079/9781845931803.0350; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Luginbuhl RE, 2000, AVIAN DIS, V44, P632, DOI 10.2307/1593103; Masachessi G, 2012, ARCH VIROL, V157, P2075, DOI 10.1007/s00705-012-1400-1; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Oakley BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057190; Oakley BB, 2012, ISME J, V6, P905, DOI 10.1038/ismej.2011.165; Oakley BB, 2012, FEMS MICROBIOL ECOL, V79, P327, DOI 10.1111/j.1574-6941.2011.01219.x; Oksanen JF, 2010, VEGAN COMMUNITY ECOL; PAGE RK, 1982, AVIAN DIS, V26, P618, DOI 10.2307/1589910; Pantin-Jackwood MJ, 2011, ARCH VIROL, V156, P235, DOI 10.1007/s00705-010-0849-z; Pantin-Jackwood MJ, 2008, AVIAN DIS, V52, P235, DOI 10.1637/8174-111507-Reg.1; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P674, DOI 10.1637/0005-2086(2007)51[674:PMOCTF]2.0.CO;2; Pantin-Jackwood MJ, 2008, AVIAN PATHOL, V37, P193, DOI 10.1080/03079450801932200; Pantin-Jackwood MJ, 2006, AVIAN DIS, V50, P397, DOI 10.1637/7512-020606R.1; Pantin-Jackwood MJ, 2013, DIS POULTRY, V13th, P1322; Pedroso AA, 2013, INT J ENV RES PUB HE, V10, P4534, DOI 10.3390/ijerph10104534; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R DCT, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Raj GD, 1997, AVIAN PATHOL, V26, P677, DOI 10.1080/03079459708419246; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Silva RR, 2014, J GEN VIROL, V95, P117, DOI 10.1099/vir.0.054783-0; Skraban J, 2013, VET MICROBIOL, V165, P416, DOI 10.1016/j.vetmic.2013.04.014; Songserm T, 2000, AVIAN DIS, V44, P556, DOI 10.2307/1593095; Songserm T, 2002, AVIAN DIS, V46, P87, DOI 10.1637/0005-2086(2002)046[0087:EROMSW]2.0.CO;2; Spackman E, 2005, AVIAN PATHOL, V34, P291, DOI 10.1080/03079450500178501; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Tamehiro CY, 2003, BRAZ J MICROBIOL, V34, P349, DOI 10.1590/S1517-83822003000400013; Villarreal LYB, 2007, AVIAN DIS, V51, P974, DOI 10.1637/7983-041307.1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI [10.1186/1471-2105-13-S13-S6, DOI 10.1186/1471-2105-13-S13-S6]; Wolf S, 2012, ARCH VIROL, V157, P1499, DOI 10.1007/s00705-012-1326-7; Wolf S, 2011, ARCH VIROL, V156, P1143, DOI 10.1007/s00705-011-0964-5; Woo PCY, 2010, J GEN VIROL, V91, P2433, DOI 10.1099/vir.0.021717-0; YASON CV, 1986, AVIAN DIS, V30, P551, DOI 10.2307/1590420; Zhang ZF, 2014, POULTRY SCI, V93, P364, DOI 10.3382/ps.2013-03314; Zsak L, 2013, AVIAN DIS, V57, P123, DOI 10.1637/10371-091212-ResNote.1	69	30	31	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117210	10.1371/journal.pone.0117210	http://dx.doi.org/10.1371/journal.pone.0117210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635690	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700075
J	Kaya, M; Lelesius, E; Nagrockaite, R; Sargin, I; Arslan, G; Mol, A; Baran, T; Can, E; Bitim, B				Kaya, Murat; Lelesius, Evaldas; Nagrockaite, Radvile; Sargin, Idris; Arslan, Gulsin; Mol, Abbas; Baran, Talat; Can, Esra; Bitim, Betul			Differentiations of Chitin Content and Surface Morphologies of Chitins Extracted from Male and Female Grasshopper Species	PLOS ONE			English	Article							PHYSICOCHEMICAL CHARACTERIZATION; BETA-CHITIN; CHITOSAN	In this study, we used Fourier transform infrared spectroscopy (FT-IR), elemental analysis (EA), thermogravimetric analysis (TGA), X-ray diffractometry (XRD), and scanning electron microscopy (SEM) to investigate chitin structure isolated from both sexes of four grasshopper species. FT-IR, EA, XRD, and TGA showed that the chitin was in the alpha form. With respect to gender, two main differences were observed. First, we observed that the quantity of chitin was greater in males than in females and the dry weight of chitin between species ranged from 4.71% to 11.84%. Second, using SEM, we observed that the male chitin surface structure contained 25 - 90nm wide nanofibers and 90 - 250 nm nanopores, while no pores or nanofibers were observed in the chitin surface structure of the majority of females (nanofibers were observed only in M. desertus females). In contrast, the elemental analysis, thermal properties, and crystalline index values for chitin were similar in males and females. Also, we carried out enzymatic digestion of the isolated chitins using commercial chitinase from Streptomyces griseus. We observed that there were no big differences in digestion rate of the chitins from both sexes and commercial chitin. The digestion rates were for grasshoppers' chitins; 88.45-95.48% and for commercial chitin; 94.95%.	[Kaya, Murat; Can, Esra; Bitim, Betul] Aksaray Univ, Fac Sci & Letters, Dept Biotechnol & Mol Biol, TR-68100 Aksaray, Turkey; [Kaya, Murat; Lelesius, Evaldas; Nagrockaite, Radvile; Baran, Talat; Can, Esra; Bitim, Betul] Aksaray Univ, Sci & Technol Applicat, TR-68100 Aksaray, Turkey; [Kaya, Murat; Lelesius, Evaldas; Nagrockaite, Radvile; Baran, Talat; Can, Esra; Bitim, Betul] Aksaray Univ, Res Ctr, TR-68100 Aksaray, Turkey; [Lelesius, Evaldas; Nagrockaite, Radvile] Vytautas Magnus Univ, Dept Biol, LT-44404 Kaunas, Lithuania; [Sargin, Idris] Selcuk Univ, Fac Sci, Dept Chem, TR-42075 Konya, Turkey; [Arslan, Gulsin] Selcuk Univ, Fac Sci, Dept Biochem, TR-42075 Konya, Turkey; [Mol, Abbas] Aksaray Univ, Guzelyurt Vocat Sch, Guzelyurt, Aksaray, Turkey; [Baran, Talat] Aksaray Univ, Fac Sci & Letters, Dept Chem, TR-68100 Aksaray, Turkey	Aksaray University; Aksaray University; Aksaray University; Vytautas Magnus University; Selcuk University; Selcuk University; Aksaray University; Ministry of National Education - Turkey; Aksaray University	Kaya, M (corresponding author), Aksaray Univ, Fac Sci & Letters, Dept Biotechnol & Mol Biol, TR-68100 Aksaray, Turkey.	muratkaya3806@yahoo.com	Arslan, Gülşin/AAG-5549-2019; Sargin, Idris/O-6937-2018; Sargın, İdris/AAB-8748-2020; Kaya, Murat/AAA-7668-2020; BARAN, TALAT/GPF-8414-2022; DOGRU, ALI HIKMET/N-5918-2017	Arslan, Gülşin/0000-0002-4836-8651; Sargin, Idris/0000-0003-3785-9575; Sargın, İdris/0000-0003-3785-9575; DOGRU, ALI HIKMET/0000-0003-0992-7024; Kaya, Murat/0000-0001-6954-2703; BARAN, TALAT/0000-0003-0206-3841				Abdou ES, 2008, BIORESOURCE TECHNOL, V99, P1359, DOI 10.1016/j.biortech.2007.01.051; Al Sagheer FA, 2009, CARBOHYD POLYM, V77, P410, DOI 10.1016/j.carbpol.2009.01.032; CABIB E, 1988, MICROBIOL SCI, V5, P370; Domard A., 2001, POLYM BIOMATER, V9, P187, DOI DOI 10.1201/9780203904671.CH9; Ehrlich H, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0339; Felse PA, 1999, BIOPROCESS ENG, V20, P505, DOI 10.1007/s004490050622; FOCHER B, 1992, CARBOHYD POLYM, V18, P43, DOI 10.1016/0144-8617(92)90186-T; Hajji S, 2014, INT J BIOL MACROMOL, V65, P298, DOI 10.1016/j.ijbiomac.2014.01.045; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Ifuku S, 2011, MATERIALS, V4, P1417, DOI 10.3390/ma4081417; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Jang MK, 2004, J POLYM SCI POL CHEM, V42, P3423, DOI 10.1002/pola.20176; Jiang CJ, 2006, CHEM ENG TECHNOL, V29, P511, DOI 10.1002/ceat.200500293; Juarez-de La Rosa BA, 2012, J MATER SCI, V47, P990, DOI 10.1007/s10853-011-5878-9; Kaya M, 2014, ZOOMORPHOLOGY, V133, P285, DOI 10.1007/s00435-014-0227-6; Kaya M, 2014, INT J BIOL MACROMOL, V65, P553, DOI 10.1016/j.ijbiomac.2014.02.010; Kaya M, 2013, INT J BIOL MACROMOL, V61, P459, DOI 10.1016/j.ijbiomac.2013.08.016; Kaya M, 2013, EXCLI J, V12, P503; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Lavall RL, 2007, BIORESOURCE TECHNOL, V98, P2465, DOI 10.1016/j.biortech.2006.09.002; Liu SF, 2012, MOLECULES, V17, P4604, DOI 10.3390/molecules17044604; Majtan J, 2007, INT J BIOL MACROMOL, V40, P237, DOI 10.1016/j.ijbiomac.2006.07.010; Park BK, 2010, INT J MOL SCI, V11, P5153, DOI 10.3390/ijms11125152; Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032; Proespraiwong P, 2010, COMP BIOCHEM PHYS B, V156, P86, DOI 10.1016/j.cbpb.2010.02.007; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; RUDALL KM, 1973, BIOL REV, V48, P597, DOI 10.1111/j.1469-185X.1973.tb01570.x; Sajomsang W, 2010, MAT SCI ENG C-MATER, V30, P357, DOI 10.1016/j.msec.2009.11.014; Shahidi F, 2005, ADV FOOD NUTR RES, V49, P93, DOI 10.1016/S1043-4526(05)49003-8; Suginta W, 2007, ENZYME MICROB TECH, V41, P212, DOI 10.1016/j.enzmictec.2007.01.006; Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473; Vetter J, 2007, FOOD CHEM, V102, P6, DOI 10.1016/j.foodchem.2006.01.037; Waghmare S, 2013, BIODIVERS ENDANGER S, V1, P110; Wang YC, 2013, CARBOHYD POLYM, V92, P90, DOI 10.1016/j.carbpol.2012.09.084; Xu J, 1996, MACROMOLECULES, V29, P3436, DOI 10.1021/ma951638b; Yen MT, 2009, CARBOHYD POLYM, V75, P15, DOI 10.1016/j.carbpol.2008.06.006; Youn DK, 2009, CARBOHYD POLYM, V78, P41, DOI 10.1016/j.carbpol.2009.03.038; Zhang JZ, 2013, FOOD CHEM, V138, P1225, DOI 10.1016/j.foodchem.2012.11.067; Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3	39	63	64	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115531	10.1371/journal.pone.0115531	http://dx.doi.org/10.1371/journal.pone.0115531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635814	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700013
J	Lebwohl, B; Emilsson, L; Frobert, O; Einstein, AJ; Green, PHR; Ludvigsson, JF				Lebwohl, Benjamin; Emilsson, Louise; Frobert, Ole; Einstein, Andrew J.; Green, Peter H. R.; Ludvigsson, Jonas F.			Mucosal Healing and the Risk of Ischemic Heart Disease or Atrial Fibrillation in Patients with Celiac Disease; A Population-Based Study	PLOS ONE			English	Article							GLUTEN-FREE DIET; FOLLOW-UP; MORTALITY; PREVALENCE; RECOVERY; ADULTS; HISTOPATHOLOGY; INFLAMMATION; VALIDATION; PREDICTION	Background Patients with celiac disease (CD), characterized histologically by villous atrophy (VA) of the small intestine, have an increased risk of ischemic heart disease (IHD) and atrial fibrillation (AF), risks that persist for years after commencing the gluten-free diet. It is unknown whether persistent VA on follow-up biopsy, rather than mucosal healing, affects the risk of IHD or AF. Methods We identified patients with histologic evidence of CD diagnosed at all 28 pathology departments in Sweden. Among patients who underwent a follow-up small intestinal biopsy, we compared patients with persistent VA to those who showed histologic improvement, with regard to the development of IHD (angina pectoris or myocardial infarction) or AF. Results Among patients with CD and a follow-up biopsy (n = 7,440), the median age at follow-up biopsy was 25 years, with 1,063 (14%) patients who were >= 60 years at the time of follow-up biopsy. Some 196 patients developed IHD and 205 patients developed AF. After adjusting for age, gender, duration of CD, calendar period, and educational attainment, there was no significant effect of persistent VA on IHD (adjusted HR 0.97; 95%CI 0.73-1.30). Adjusting for diabetes had a negligible effect (adjusted HR 0.98; 95%CI 0.73-1.31). There was no significant association between persistent VA and the risk of AF (adjusted HR 0.98; 95%CI 0.74-1.30). Conclusions In this population-based study of patients with CD, persistent VA on follow-up biopsy was not associated with an increased risk of IHD or AF. Failed mucosal healing does not influence the risk of these cardiac events.	[Lebwohl, Benjamin; Green, Peter H. R.] Columbia Univ Coll Phys & Surg, Dept Med, Celiac Dis Ctr, New York, NY 10032 USA; [Lebwohl, Benjamin; Ludvigsson, Jonas F.] Karolinska Univ Hosp, Dept Med Epidemiol & Biostatst, Stockholm, Sweden; [Lebwohl, Benjamin; Ludvigsson, Jonas F.] Karolinska Inst, Stockholm, Sweden; [Emilsson, Louise] Vardcentralen Varmlands Nysater, Primary Care Res Unit, Varmlands Nysater, Varmland County, Sweden; [Emilsson, Louise] Univ Orebro, Dept Med, SE-70182 Orebro, Sweden; [Frobert, Ole] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden; [Einstein, Andrew J.] Columbia Univ Coll Phys & Surg, Dept Med, Div Cardiol, New York, NY 10032 USA; [Einstein, Andrew J.] Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA; [Einstein, Andrew J.] New York Presbyterian Hosp, New York, NY USA; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Pediat, Orebro, Sweden	Columbia University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Orebro University; Orebro University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Orebro University	Ludvigsson, JF (corresponding author), Karolinska Univ Hosp, Dept Med Epidemiol & Biostatst, Stockholm, Sweden.	jonasludvigsson@yahoo.com	Emilsson, Louise/K-4589-2013; Ludvigsson, Jonas F/A-8560-2012	Emilsson, Louise/0000-0001-9137-2800; Ludvigsson, Jonas F/0000-0003-1024-5602; Frobert, Ole/0000-0002-5846-345X	National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000040]; Orebro University Hospital; Swedish Society of Medicine; Swedish Research Council-Medicine [522-2A09-195]; Swedish Celiac Society; Karolinska Institutet; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Orebro University Hospital; Swedish Society of Medicine; Swedish Research Council-Medicine(Swedish Research Council); Swedish Celiac Society; Karolinska Institutet(Karolinska Institutet); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants to BL from the National Center for Advancing Translational Sciences, National Institutes of Health (UL1 TR000040); and to JFL from Orebro University Hospital, Karolinska Institutet, the Swedish Society of Medicine, the Swedish Research Council-Medicine (522-2A09-195) and the Swedish Celiac Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Daya H, 2013, CLIN GASTROENTEROL H, V11, P1472, DOI 10.1016/j.cgh.2013.05.030; Andersson T, 2013, EUR HEART J, V34, P1061, DOI 10.1093/eurheartj/ehs469; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Bardella MT, 2007, HISTOPATHOLOGY, V50, P465, DOI 10.1111/j.1365-2559.2007.02621.x; Brar P, 2006, AM J MED, V119, P786, DOI 10.1016/j.amjmed.2005.12.025; Ciacci C, 2002, DIGESTION, V66, P178, DOI 10.1159/000066757; Collin P, 2004, GASTROINTEST ENDOSC, V59, P158, DOI 10.1016/S0016-5107(03)01311-7; De Marchi S, 2013, ALIMENT PHARM THER, V38, P162, DOI 10.1111/apt.12360; Emilsson L, 2013, ALIMENT PHARM THER, V37, P905, DOI 10.1111/apt.12271; Emilsson L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001594; Emilsson L, 2011, EUR HEART J, V32, P2430, DOI 10.1093/eurheartj/ehr167; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Kabbani TA, 2013, GASTROENTEROLOGY, V144, P912, DOI 10.1053/j.gastro.2013.01.033; KANNEL WB, 1998, AM J CARDIOL, V0082; Lanzini A, 2009, ALIMENT PHARM THER, V29, P1299, DOI 10.1111/j.1365-2036.2009.03992.x; Lebwohl B, 2014, Aliment Pharmacol Ther, V39, P488, DOI 10.1111/apt.12621; Lebwohl B, 2013, ALIMENT PHARM THER, V37, P332, DOI 10.1111/apt.12164; Lebwohl B, PERSISTENT MUCOSAL D; Lebwohl B, 2013, ANN INTERN MED, V159, P169, DOI 10.7326/0003-4819-159-3-201308060-00006; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; Ludvigsson JF, 2005, CLIN GASTROENTEROL H, V3, P869, DOI 10.1016/S1542-3565(05)00414-3; Ludvigsson JF, 2012, J STROKE CEREBROVASC, V21, P860, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.008; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2011, CIRCULATION, V123, P483, DOI 10.1161/CIRCULATIONAHA.110.965624; Ludvigsson JF, 2009, JAMA-J AM MED ASSOC, V302, P1171, DOI 10.1001/jama.2009.1320; Ludvigsson JF, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-19; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Nilsson A C, 1994, Lakartidningen, V91, P603; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Sharkey LM, 2013, ALIMENT PHARM THER, V38, P1278, DOI 10.1111/apt.12510; Smith JG, 2010, EUR J EPIDEMIOL, V25, P95, DOI 10.1007/s10654-009-9404-1; Snook JA, 1996, GUT, V39, P60, DOI 10.1136/gut.39.1.60; Turesson C, 2007, ANN RHEUM DIS, V66, P70, DOI 10.1136/ard.2006.052506; Wahab PJ, 2002, AM J CLIN PATHOL, V118, P459; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; WHO, 2014, THE TOP 10 CAUSES OF; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117529	10.1371/journal.pone.0117529	http://dx.doi.org/10.1371/journal.pone.0117529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635403	Green Submitted, gold, Green Published			2022-12-27	WOS:000350680700090
J	Marchiori, M; Possamai, L				Marchiori, Massimo; Possamai, Lino			Micro-Macro Analysis of Complex Networks	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; WEIGHTED NETWORKS; SUBWAY NETWORKS; DYNAMICS	Complex systems have attracted considerable interest because of their wide range of applications, and are often studied via a "classic" approach: study a specific system, find a complex network behind it, and analyze the corresponding properties. This simple methodology has produced a great deal of interesting results, but relies on an often implicit underlying assumption: the level of detail on which the system is observed. However, in many situations, physical or abstract, the level of detail can be one out of many, and might also depend on intrinsic limitations in viewing the data with a different level of abstraction or precision. So, a fundamental question arises: do properties of a network depend on its level of observability, or are they invariant? If there is a dependence, then an apparently correct network modeling could in fact just be a bad approximation of the true behavior of a complex system. In order to answer this question, we propose a novel micro-macro analysis of complex systems that quantitatively describes how the structure of complex networks varies as a function of the detail level. To this extent, we have developed a new telescopic algorithm that abstracts from the local properties of a system and reconstructs the original structure according to a fuzziness level. This way we can study what happens when passing from a fine level of detail ("micro") to a different scale level ("macro"), and analyze the corresponding behavior in this transition, obtaining a deeper spectrum analysis. The obtained results show that many important properties are not universally invariant with respect to the level of detail, but instead strongly depend on the specific level on which a network is observed. Therefore, caution should be taken in every situation where a complex network is considered, if its context allows for different levels of observability.	[Marchiori, Massimo; Possamai, Lino] Univ Padua, Dept Math, Padua, Italy; [Marchiori, Massimo] Atomium Culture, Brussels, Belgium	University of Padua	Marchiori, M (corresponding author), Univ Padua, Dept Math, Padua, Italy.	massimo.marchiori@unipd.it						Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Biasiolo M, 2010, BIOCOMPUT-PAC SYM, P397; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Braha D, 2011, SOC NETWORKS, V33, P219, DOI 10.1016/j.socnet.2011.05.004; Cardy J., 1996, SCALING RENORMALIZAT; Creswick RJ, 1992, INTRO RENORMALIZATIO; Crucitti P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036125; Daqing L., 2011, NAT PHYS, V7, P481, DOI DOI 10.1038/NPHYS1932; Diestel Reinhard, 2005, GRAPH THEORY; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Kadanoff L. P., 1966, PHYSICS, V2, P263, DOI DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.2.263; Kim BJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.168701; Latora V, 2002, PHYSICA A, V314, P109, DOI 10.1016/S0378-4371(02)01089-0; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Luque B, 2012, CHAOS, V22, DOI 10.1063/1.3676686; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Marill JL, 2004, ACM-IEEE J CONF DIG, P403, DOI 10.1145/996350.996469; Miller OM, 1942, GEOGR REV, V32, P424, DOI 10.2307/210384; Mustafa Z, 2006, J NONLINEAR CONVEX A, V7, P289; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Philippe Rigaux AV Michel Scholl, 2001, SPATIAL DATABASES; Radicchi F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.148701; Radicchi F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026104; Roth C, 2012, J R SOC INTERFACE, V9, P2540, DOI 10.1098/rsif.2012.0259; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Srivastava A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036106; Strogatz S.H., 2004, SYNC ORDER EMERGES C; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.015101; Victek T, 1992, FRACTAL GROWTH PHENO; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	41	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116670	10.1371/journal.pone.0116670	http://dx.doi.org/10.1371/journal.pone.0116670			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635812	Green Submitted, gold, Green Published			2022-12-27	WOS:000350680700053
J	Soininen, EM; Gauthier, G; Bilodeau, F; Berteaux, D; Gielly, L; Taberlet, P; Gussarova, G; Bellemain, E; Hassel, K; Stenoien, HK; Epp, L; Schroder-Nielsen, A; Brochmann, C; Yoccoz, NG				Soininen, Eeva M.; Gauthier, Gilles; Bilodeau, Frederic; Berteaux, Dominique; Gielly, Ludovic; Taberlet, Pierre; Gussarova, Galina; Bellemain, Eva; Hassel, Kristian; Stenoien, Hans K.; Epp, Laura; Schroder-Nielsen, Audun; Brochmann, Christian; Yoccoz, Nigel G.			Highly Overlapping Winter Diet in Two Sympatric Lemming Species Revealed by DNA Metabarcoding	PLOS ONE			English	Article							DESERT RODENT COMMUNITY; HABITAT USE; DICROSTONYX-GROENLANDICUS; BYLOT ISLAND; NUTRITIONAL ECOLOGY; NORWEGIAN LEMMINGS; MICROTINE RODENTS; ARCTIC VEGETATION; LEMMUS-SIBIRICUS; SHRUB EXPANSION	Sympatric species are expected to minimize competition by partitioning resources, especially when these are limited. Herbivores inhabiting the High Arctic in winter are a prime example of a situation where food availability is anticipated to be low, and thus reduced diet overlap is expected. We present here the first assessment of diet overlap of high arctic lemmings during winter based on DNA metabarcoding of feces. In contrast to previous analyses based on microhistology, we found that the diets of both collared (Dicrostonyx groenlandicus) and brown lemmings (Lemmus trimucronatus) on Bylot Island were dominated by Salix while mosses, which were significantly consumed only by the brown lemming, were a relatively minor food item. The most abundant plant taxon, Cassiope tetragona, which alone composes more than 50% of the available plant biomass, was not detected in feces and can thus be considered to be non-food. Most plant taxa that were identified as food items were consumed in proportion to their availability and none were clearly selected for. The resulting high diet overlap, together with a lack of habitat segregation, indicates a high potential for resource competition between the two lemming species. However, Salix is abundant in the winter habitats of lemmings on Bylot Island and the non-Salix portion of the diets differed between the two species. Also, lemming grazing impact on vegetation during winter in the study area is negligible. Hence, it seems likely that the high potential for resource competition predicted between these two species did not translate into actual competition. This illustrates that even in environments with low primary productivity food resources do not necessarily generate strong competition among herbivores.	[Soininen, Eeva M.; Yoccoz, Nigel G.] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway; [Gauthier, Gilles; Bilodeau, Frederic] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Gauthier, Gilles; Bilodeau, Frederic] Univ Laval, Ctr Etudes Nord, Quebec City, PQ, Canada; [Berteaux, Dominique] Univ Quebec Rimouski, Chaire Rech Canada Biodiversite Nord, Quebec City, PQ, Canada; [Berteaux, Dominique] Univ Quebec Rimouski, Ctr Etudes Nord, Quebec City, PQ, Canada; [Gielly, Ludovic; Taberlet, Pierre] Univ Grenoble Alpes, CNRS, Lab Ecol Alpine LECA, Grenoble, France; [Gussarova, Galina; Bellemain, Eva; Epp, Laura; Schroder-Nielsen, Audun; Brochmann, Christian] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Gussarova, Galina] St Petersburg State Univ, Dept Bot, St Petersburg 199034, Russia; [Bellemain, Eva] SPYGEN, Savoie Technolac, Le Bourget Du Lac, France; [Hassel, Kristian; Stenoien, Hans K.] Norwegian Univ Sci & Technol, NTNU Univ Museum, N-7034 Trondheim, Norway	UiT The Arctic University of Tromso; Laval University; Laval University; University of Quebec; Universite du Quebec a Rimouski; University of Quebec; Universite du Quebec a Rimouski; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; University of Oslo; Saint Petersburg State University; Norwegian University of Science & Technology (NTNU)	Soininen, EM (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway.	eeva.soininen@uit.no	Gielly, Ludovic/ADQ-6036-2022; Brochmann, Christian/A-4105-2009; Epp, Laura Saskia/J-5301-2016; Gussarova, Galina/ABC-8696-2021; Gussarova, Galina/E-4758-2015; Yoccoz, Nigel/C-8561-2014; Soininen, Eeva/AAJ-5909-2021; Epp, Laura/AFS-1695-2022; Hassel, Kristian/AAD-7241-2022; Berteaux, Dominique/J-3276-2016; Yannick, OUTREMAN/B-9309-2012	Epp, Laura Saskia/0000-0002-2230-9477; Gussarova, Galina/0000-0001-5388-7491; Gussarova, Galina/0000-0001-5388-7491; Yoccoz, Nigel/0000-0003-2192-1039; Soininen, Eeva/0000-0003-4280-8350; Hassel, Kristian/0000-0002-1906-8166; Berteaux, Dominique/0000-0003-2728-5985; Gauthier, Gilles/0000-0002-2624-3508; Yannick, OUTREMAN/0000-0002-7337-3049	Oskar Huttunen foundation (PhD scholarship); Research Council of Norway (Leiv Eiriksson scholarship); Research Council of Norway (BarFrost project FRIBIO) [191627/V40]; University of Tromso; Natural Sciences and Engineering Research government's International Polar Year program [MD-021]; Northern Student Training Program; Canadian Network of Centres of Excellence ArcticNet; Polar Continental Shelf Program; SPYGEN	Oskar Huttunen foundation (PhD scholarship); Research Council of Norway (Leiv Eiriksson scholarship)(Research Council of Norway); Research Council of Norway (BarFrost project FRIBIO)(Research Council of Norway); University of Tromso; Natural Sciences and Engineering Research government's International Polar Year program; Northern Student Training Program; Canadian Network of Centres of Excellence ArcticNet; Polar Continental Shelf Program; SPYGEN	This work was financed by Oskar Huttunen foundation (PhD scholarship to EMS), the Research Council of Norway (Leiv Eiriksson scholarship to EMS and the BarFrost project FRIBIO 191627/V40 to CB), the University of Tromso (travel grant for EMS), the Natural Sciences and Engineering Research government's International Polar Year program (project MD-021) and the Northern Student Training Program, both administered by Indian and Northern Affairs Canada, the Canadian Network of Centres of Excellence ArcticNet and the Polar Continental Shelf Program. SPYGEN provided support in the form of a salary for author EB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Baamrane MAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035643; BATZLI GO, 1995, OIKOS, V72, P88, DOI 10.2307/3546042; BATZLI GO, 1980, ARCTIC ALPINE RES, V12, P483, DOI 10.2307/1550496; BATZLI GO, 1983, J MAMMAL, V64, P648, DOI 10.2307/1380521; BATZLI GO, 1983, HOLARCTIC ECOL, V6, P255; BERGMAN CM, 1993, CAN J ZOOL, V71, P1703, DOI 10.1139/z93-241; Bilodeau F, 2014, POLAR BIOL, V37, P845, DOI 10.1007/s00300-014-1486-x; Bilodeau F, 2013, J MAMMAL, V94, P813, DOI 10.1644/12-MAMM-A-260.1; Bilodeau F, 2013, OIKOS, V122, P1167, DOI 10.1111/j.1600-0706.2012.00220.x; Bilodeau F, 2013, OECOLOGIA, V172, P1007, DOI 10.1007/s00442-012-2549-8; Bilodeau F, 2013, ARCTIC, V66, P32; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; BRASSARD G R, 1971, Bryologist, V74, P282, DOI 10.2307/3241638; BRASSARD GR, 1976, BRYOLOGIST, V79, P480, DOI 10.2307/3241941; BRASSARD GR, 1979, LINDBERGIA, V5, P99; BROWN JS, 1989, ECOL MONOGR, V59, P1, DOI 10.2307/2937289; Darmon G, 2012, ECOGRAPHY, V35, P44, DOI 10.1111/j.1600-0587.2011.06664.x; Duchesne D, 2011, OECOLOGIA, V167, P967, DOI 10.1007/s00442-011-2045-6; Elven R., 2011, ANNOTATED CHECKLIST; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; GALINDO C, 1985, OECOLOGIA, V66, P430, DOI 10.1007/BF00378311; Gauthier G, 1996, GEOSCI CAN, V23, P253; Gauthier G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0482; Gauthier G, 2011, ECOSCIENCE, V18, P223, DOI 10.2980/18-3-3453; Gornall JL, 2007, OECOLOGIA, V153, P931, DOI 10.1007/s00442-007-0785-0; Gruyer N, 2008, CAN J ZOOL, V86, P910, DOI 10.1139/Z08-059; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HESKE EJ, 1994, ECOLOGY, V75, P438, DOI 10.2307/1939547; HUGHES RJ, 1994, J WILDLIFE MANAGE, V58, P536, DOI 10.2307/3809326; Ihl C, 2001, J WILDLIFE MANAGE, V65, P964, DOI 10.2307/3803045; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Ims RA, 2011, P NATL ACAD SCI USA, V108, P1970, DOI 10.1073/pnas.1012714108; KLEIN DR, 1994, OECOLOGIA, V97, P439, DOI 10.1007/BF00325880; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; KREBS C J, 1972, P694; Krebs CJ, 2011, P ROY SOC B-BIOL SCI, V278, P481, DOI 10.1098/rspb.2010.1992; Krebs CJ, 2003, CAN J ZOOL, V81, P827, DOI [10.1139/z03-061, 10.1139/Z03-061]; Legagneux P, 2012, ECOLOGY, V93, P1707, DOI 10.1890/11-1973.1; MACLEAN S F JR, 1974, Arctic and Alpine Research, V6, P1, DOI 10.2307/1550365; Manly B., 2002, RESOURCE SELECTION A, V2, DOI 10.1007/978-94-011-1558-2; MOEN J, 1993, ARCTIC ALPINE RES, V25, P130, DOI 10.2307/1551549; Moncrieff GR, 2014, OIKOS, V123, P315, DOI 10.1111/j.1600-0706.2013.00904.x; Morris DW, 2000, EVOL ECOL RES, V2, P41; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Mysterud A, 2000, OECOLOGIA, V124, P130, DOI 10.1007/s004420050032; Olofsson J, 2012, NAT CLIM CHANGE, V2, P880, DOI 10.1038/NCLIMATE1537; Parker DM, 2006, J WILDLIFE MANAGE, V70, P1477, DOI 10.2193/0022-541X(2006)70[1477:ACOTDA]2.0.CO;2; Plante S, 2014, POLAR BIOL, V37, P611, DOI 10.1007/s00300-014-1461-6; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; PRINS HHT, 1982, OIKOS, V38, P374, DOI 10.2307/3544680; R Core Team, 2021, R LANGUAGE ENV STAT; Ravolainen VT, 2014, J APPL ECOL, V51, P234, DOI 10.1111/1365-2664.12180; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Reid DG, 2012, OECOLOGIA, V168, P935, DOI 10.1007/s00442-011-2167-x; RODGERS AR, 1986, CAN J ZOOL, V64, P2717, DOI 10.1139/z86-396; RODGERS AR, 1986, CAN J ZOOL, V64, P1684, DOI 10.1139/z86-253; RODGERS AR, 1985, CAN J ZOOL, V63, P1161, DOI 10.1139/z85-174; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Saetnan ER, 2009, J MAMMAL, V90, P183, DOI 10.1644/07-MAMM-A-259.1; SALTER KC, 1993, COMMUN STAT SIMULAT, V22, P137, DOI 10.1080/03610919308813085; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Soininen EM, 2014, ISOT ENVIRON HEALT S, V50, P361, DOI 10.1080/10256016.2014.915824; Soininen EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068128; Soininen EM, 2013, POLAR BIOL, V36, P1069, DOI 10.1007/s00300-013-1328-2; Soininen EM, 2010, POLAR RES, V29, P404, DOI 10.1111/j.1751-8369.2010.00172.x; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Soininen EM, 2012, THESIS U TROMSO TROM; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Stech M, 2011, MOL ECOL RESOUR, V11, P404, DOI 10.1111/j.1755-0998.2010.02938.x; Stenseth NC, 1993, BIOL LEMMIMGS; Sundell J, 2012, J ANIM ECOL, V81, P747, DOI 10.1111/j.1365-2656.2012.01956.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Tape KD, 2012, ECOSYSTEMS, V15, P711, DOI 10.1007/s10021-012-9540-4; Tarroux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042427; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; VAVRA M, 1980, J RANGE MANAGE, V33, P371, DOI 10.2307/3897886; Virtanen R, 2000, OIKOS, V90, P295, DOI 10.1034/j.1600-0706.2000.900209.x; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921; Yoccoz Nigel G., 1999, Ecological Bulletins, V47, P137; Zaccarelli N, 2013, METHODS ECOL EVOL, V4, P1018, DOI 10.1111/2041-210X.12079	84	149	152	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115335	10.1371/journal.pone.0115335	http://dx.doi.org/10.1371/journal.pone.0115335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635852	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700007
J	Assenzio, B; Martin, EL; Stankevicius, E; Civiletti, F; Fontanella, M; Boccaletti, R; Berardino, M; Mazzeo, A; Ducati, A; Simonsen, U; Mascia, L				Assenzio, Barbara; Martin, Erica L.; Stankevicius, Edgaras; Civiletti, Federica; Fontanella, Marco; Boccaletti, Riccardo; Berardino, Maurizio; Mazzeo, AnnaTeresa; Ducati, Alessandro; Simonsen, Ulf; Mascia, Luciana			Cerebrospinal Fluid from Patients with Subarachnoid Haemorrhage and Vasospasm Enhances Endothelin Contraction in Rat Cerebral Arteries	PLOS ONE			English	Article							RECEPTOR ANTAGONIST; ETA-RECEPTOR; DOUBLE-BLIND; B-RECEPTOR; CEREBROVASCULAR CHARACTERIZATION; SMOOTH-MUSCLE; UP-REGULATION; CLAZOSENTAN; EXPRESSION; MECHANISMS	Introduction Previous studies have suggested that cerebrospinal fluid from patients with subarachnoid hemorrhage (SAH) leads to pronounced vasoconstriction in isolated arteries. We hypothesized that only cerebrospinal fluid from SAH patients with vasospasm would produce an enhanced contractile response to endothelin-1 in rat cerebral arteries, involving both endothelin ETA and ETB receptors. Methods Intact rat basilar arteries were incubated for 24 hours with cerebrospinal fluid from 1) SAH patients with vasospasm, 2) SAH patients without vasospasm, and 3) control patients. Arterial segments with and without endothelium were mounted in myographs and concentration-response curves for endothelin-1 were constructed in the absence and presence of selective and combined ETA and ETB receptor antagonists. Endothelin concentrations in culture medium and receptor expression were measured. Results Compared to the other groups, the following was observed in arteries exposed to cerebrospinal fluid from patients with vasospasm: 1) larger contractions at lower endothelin concentrations (p < 0.05); 2) the increased endothelin contraction was absent in arteries without endothelium; 3) higher levels of endothelin secretion in the culture medium (p < 0.05); 4) there was expression of ETA receptors and new expression of ETB receptors was apparent; 5) reduction in the enhanced response to endothelin after ETB blockade in the low range and after ETA blockade in the high range of endothelin concentrations; 6) after combined ETA and ETB blockade a complete inhibition of endothelin contraction was observed. Conclusions Our experimental findings showed that in intact rat basilar arteries exposed to cerebrospinal fluid from patients with vasospasm endothelin contraction was enhanced in an endothelium-dependent manner and was blocked by combined ETA and ETB receptor antagonism. Therefore we suggest that combined blockade of both receptors may play a role in counteracting vasospasm in patients with SAH.	[Assenzio, Barbara; Martin, Erica L.; Civiletti, Federica; Berardino, Maurizio; Mazzeo, AnnaTeresa; Mascia, Luciana] Univ Turin, Azienda Osped Citta Salute & Sci Torino, Dept Anesthesia & Intens Care, Turin, Italy; [Stankevicius, Edgaras] Lithuanian Univ Hlth Sci, Med Acad, Inst Physiol & Pharmacol, Kaunas, Lithuania; [Fontanella, Marco; Boccaletti, Riccardo; Ducati, Alessandro] Univ Turin, Azienda Osped Citta Salute & Sci Torino, Dept Neurosci, Div Neurosurg, Turin, Italy; [Simonsen, Ulf] Univ Aarhus, Dept Biomed Pulm & Cardiovasc Pharmacol, Aarhus, Denmark	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Lithuanian University of Health Sciences; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Aarhus University	Mascia, L (corresponding author), Univ Turin, Azienda Osped Citta Salute & Sci Torino, Dept Anesthesia & Intens Care, Turin, Italy.	luciana.mascia@unito.it	FONTANELLA, Marco Maria/AAD-1160-2022; mascia, Luciana/L-3039-2018	FONTANELLA, Marco Maria/0000-0002-4023-1909; Conte, Erica/0000-0002-2699-9591; Mazzeo, Anna Teresa/0000-0002-8454-7243; Fontanella, Marco/0000-0002-2084-0504; BOCCALETTI, Riccardo/0000-0002-9327-6393	Comitato Interministeriale per al Programmazione Economica [CIPE LM2004]; Ministero della Salute, Programma Ricerca Finalizzata [LM2007]	Comitato Interministeriale per al Programmazione Economica; Ministero della Salute, Programma Ricerca Finalizzata	This study was supported by grant CIPE LM2004 from the Comitato Interministeriale per al Programmazione Economica and grant LM2007 from the Ministero della Salute, Programma Ricerca Finalizzata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Beg SS, 2007, J CEREBR BLOOD F MET, V27, P21, DOI 10.1038/sj.jcbfm.9600313; CLOZEL M, 1992, BIOCHEM BIOPH RES CO, V186, P867, DOI 10.1016/0006-291X(92)90826-7; Davie N, 2002, AM J RESP CRIT CARE, V165, P398, DOI 10.1164/ajrccm.165.3.2104059; De Mey JGR, 2011, TRENDS PHARMACOL SCI, V32, P345, DOI 10.1016/j.tips.2011.02.018; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; Dietrich HH, 2000, NEUROSURGERY, V46, P517, DOI 10.1097/00006123-200003000-00001; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Fontanella M, 2008, NEUROL RES, V30, P256, DOI 10.1179/016164107X229939; Hansen-Schwartz J, 2004, ACTA NEUROL SCAND, V109, P33, DOI 10.1034/j.1600-0404.2003.00170.x; Hansen-Schwartz J, 2003, NEUROSURGERY, V52, P1188, DOI 10.1227/01.NEU.0000058467.82442.64; Henriksson M, 2003, STROKE, V34, P1479, DOI 10.1161/01.STR.0000072984.79136.79; Henriksson M, 2007, EXP BRAIN RES, V178, P470, DOI 10.1007/s00221-006-0753-7; Hino A, 1996, J CEREBR BLOOD F MET, V16, P688, DOI 10.1097/00004647-199607000-00020; ITOH S, 1994, J NEUROSURG, V81, P759, DOI 10.3171/jns.1994.81.5.0759; Kikkawa Y, 2012, J CEREBR BLOOD F MET, V32, P341, DOI 10.1038/jcbfm.2011.132; Konczalla J, 2006, EXP BIOL MED, V231, P1064; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Macdonald RL, 2012, RANDOMIZED TRIAL CLA; Maddahi A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-274; MASAOKA H, 1989, LANCET, V2, P1402; Mascia L, 2003, INTENS CARE MED, V29, P1088, DOI 10.1007/s00134-003-1780-5; Mascia L, 2001, STROKE, V32, P1185, DOI 10.1161/01.STR.32.5.1185; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nishizawa S, 2005, TRENDS CARDIOVAS MED, V15, P24, DOI 10.1016/j.tcm.2004.12.002; Ogihara K, 2000, NEUROL RES, V22, P209, DOI 10.1080/01616412.2000.11741063; OKWUASABA FK, 1981, NEUROSURGERY, V9, P402, DOI 10.1227/00006123-198110000-00010; Pluta RM, 1997, J NEUROSURG, V87, P287, DOI 10.3171/jns.1997.87.2.0287; Rapoport RM, 2011, J PHARM PHARMACOL, V63, P1373, DOI 10.1111/j.2042-7158.2011.01334.x; Sauvageau S, 2007, J VASC RES, V44, P375, DOI 10.1159/000102534; Shaw MDM, 2000, J NEUROSURG, V93, P992, DOI 10.3171/jns.2000.93.6.0992; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Vanhoutte PM, 2008, J PHYSIOL-LONDON, V586, P5295, DOI 10.1113/jphysiol.2008.161430; Vatter H, 2005, J NEUROSURG, V102, P1101, DOI 10.3171/jns.2005.102.6.1101; Vatter H, 2005, J NEUROSURG, V102, P1108, DOI 10.3171/jns.2005.102.6.1108; Vatter H, 2007, J NEUROSURG, V107, P121, DOI 10.3171/JNS-07/07/0121; Vergouwen MDI, 2012, STROKE, V43, P2671, DOI 10.1161/STROKEAHA.112.666693; Walchenbach R, 2002, J NEUROL NEUROSUR PS, V72, P503; Xie A, 2007, J CEREBR BLOOD F MET, V27, P1692, DOI 10.1038/sj.jcbfm.9600471; Zuccarello M, 1998, STROKE, V29, P1924, DOI 10.1161/01.STR.29.9.1924	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116456	10.1371/journal.pone.0116456	http://dx.doi.org/10.1371/journal.pone.0116456			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629621	Green Submitted, gold, Green Published			2022-12-27	WOS:000348732100037
J	Qin, LJ; Lei, MZ; Zhao, DD; Wang, AH; Jin, YP; Qi, XF				Qin, Lijuan; Lei, Mingzhu; Zhao, Dandan; Wang, Aihua; Jin, Yaping; Qi, Xuefeng			Goat Uterine DBA(+) Leukocytes Differentiation and Cytokines Expression Respond Differently to Cloned versus Fertilized Embryos	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; STROMAL CELLS; PROGESTERONE; ENDOMETRIUM; PREGNANCY; MODULATE; SUBSETS; GROWTH	High rate of fetal mortality in ruminant somatic cell nuclear transfer (SCNT) pregnancies is due, at least in part, to immune-mediated abortion of fetuses. In the present study, goat uterine leukocytes were isolated by Dolichos biflorus agglutinin (DBA) coated magnetic beads, and with majority being were CD56(+)CD16(-) in phenotype with low levels of perforin and Granzyme B expression. The responses of the isolated cells to SCNT and in vitro fertilization (IVF) embryos conditioned mediums containing hormone steroids were compared by measuring their phenotype and cytokines expression. The results showed there was a 2-fold increase in the numbers of isolated uterine leukocytes after incubation with different conditioned mediums for 120 h. However, significantly lower percentage and absolute numbers of uterine CD56(+)CD16(-) leukocytes incubated with SCNT conditioned mediums were detected as compared with those incubated with IVF conditioned mediums (P < 0.05). The group treated with progesterone (P-4) or the combination of P-4 and 17 beta-estradiol (E-2) were associated with significantly higher percentage and absolute numbers of CD56(+)CD16(-) cells as compared with those treated with E-2 alone (P < 0.05). Furthermore, in the presence of steroids, the isolated leukocytes incubated with SCNT conditioned mediums associated with greater levels of IFN-gamma secretion and expression, as well as lesser levels of VEGF, as compared with those treated with IVF conditioned mediums (P < 0.05). In conclusion, this study demonstrates that SCNT embryos have a profound effect on the phenotype expression of goat uterine DBA(+) leukocytes, as well as the secretion and expression of IFN-gamma and VEGF by these cells in vitro.	[Qin, Lijuan; Lei, Mingzhu; Zhao, Dandan; Wang, Aihua; Jin, Yaping; Qi, Xuefeng] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Peoples R China	Northwest A&F University - China	Qi, XF (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Peoples R China.	yxyan2002@163.com			National Natural Science Foundation of China [30901089]; Fundamental Research Funds for the Central Universities of China [ZD2013008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was financially supported by National Natural Science Foundation of China (Grant No. 30901089) and the Fundamental Research Funds for the Central Universities of China (Grant No. ZD2013008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi S, 2013, ANIM SCI J, V84, P191, DOI 10.1111/asj.12035; Amold DR, 2008, PLACENTA, V29, pS108, DOI 10.1016/j.placenta.2007.11.010; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Bizinotto MC, 2008, J REPROD IMMUNOL, V79, P18, DOI 10.1016/j.jri.2008.07.002; Bridges GA, 2013, J ANIM SCI IN PRESS; Campos DB, 2010, GENET MOL RES, V9, P309, DOI 10.4238/vol9-1gmr729; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Chen ZL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102293; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Croy BA, 2006, IMMUNOL REV, V214, P161; Croy BA, 2010, METHODS MOL BIOL, V612, P465, DOI 10.1007/978-1-60761-362-6_31; Davies CJ, 2007, J ANIM SCI, V85, pE32, DOI 10.2527/jas.2006-492; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Fukui A, 2011, J REPROD IMMUNOL, V90, P105, DOI 10.1016/j.jri.2011.04.006; Hanna J, 2004, J IMMUNOL, V173, P6547, DOI 10.4049/jimmunol.173.11.6547; Hansen PJ, 2007, J ANIM SCI, V85, pE30, DOI 10.2527/jas.2006-487; Hill JR, 2002, BIOL REPROD, V67, P55, DOI 10.1095/biolreprod67.1.55; Jonsson AH, 2010, J IMMUNOL, V184, P3424, DOI 10.4049/jimmunol.0904057; Kieckbusch J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4359; Kim M, 2013, EMBO MOL MED, V5, P1415, DOI 10.1002/emmm.201302618; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kohan-Ghadr HR, 2012, REPROD FERT DEVELOP, V24, P588, DOI 10.1071/RD11162; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065379; Mamo S, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099945; Ni F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2484; Noronha LE, 2012, PLACENTA, V33, P379, DOI 10.1016/j.placenta.2012.01.018; Perez-Martinez M, 2002, RES VET SCI, V72, P115, DOI 10.1053/rvsc.2001.0532; Qi XF, 2012, DOMEST ANIM ENDOCRIN, V42, P210, DOI 10.1016/j.domaniend.2011.12.004; Qi XF, 2012, REPROD BIOL, V12, P309, DOI 10.1016/j.repbio.2012.09.003; Rutella S, 2006, BLOOD, V108, P218, DOI 10.1182/blood-2005-08-3141; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Segerson EC, 2000, THERIOGENOLOGY, V54, P1207, DOI 10.1016/S0093-691X(00)00427-1; St-Louis I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-103; Zhang HD, 2013, THERIOGENOLOGY, V80, P228, DOI 10.1016/j.theriogenology.2013.03.027	35	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116649	10.1371/journal.pone.0116649	http://dx.doi.org/10.1371/journal.pone.0116649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629615	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100045
J	Thomas, O; Lybeck, E; Strandberg, K; Tynngard, N; Schott, U				Thomas, Owain; Lybeck, Emanuel; Strandberg, Karin; Tynngard, Nahreen; Schott, Ulf			Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays	PLOS ONE			English	Article							PARTIAL THROMBOPLASTIN TIME; IN-VITRO; SENSITIVITY; FONDAPARINUX; ENOXAPARIN; REAGENTS; DOSAGE; LMWH	Background Low molecular weight heparins (LMWH's) are used to prevent and treat thrombosis. Tests for monitoring LMWH's include anti-factor Xa (anti-FXa), activated partial thromboplastin time (aPTT) and thrombin generation. Anti-FXa is the current gold standard despite LMWH's varying affinities for FXa and thrombin. Aim To examine the effects of two different LMWH's on the results of 4 different aPTT-tests, anti-FXa activity and thrombin generation and to assess the tests' concordance. Method Enoxaparin and tinzaparin were added ex-vivo in concentrations of 0.0, 0.5, 1.0 and 1.5 anti-FXa international units (IU)/mL, to blood from 10 volunteers. aPTT was measured using two whole blood methods (Free oscillation rheometry (FOR) and Hemochron Jr (HCJ)) and an optical plasma method using two different reagents (ActinFSL and PTT-Automat). Anti-FXa activity was quantified using a chromogenic assay. Thrombin generation (Endogenous Thrombin Potential, ETP) was measured on a Ceveron Alpha instrument using the TGA RB and more tissue-factor rich TGA RC reagents. Results Methods' mean aPTT at 1.0 IU/mL LMWH varied between 54s (SD 11) and 69s (SD 14) for enoxaparin and between 101s (SD 21) and 140s (SD 28) for tinzaparin. ActinFSL gave significantly shorter aPTT results. aPTT and anti-FXa generally correlated well. ETP as measured with the TGA RC reagent but not the TGA RB reagent showed an inverse exponential relationship to the concentration of LMWH. The HCJ-aPTT results had the weakest correlation to anti-FXa and thrombin generation (R(s)0.62-0.87), whereas the other aPTT methods had similar correlation coefficients (R(s)0.80-0.92). Conclusions aPTT displays a linear dose-respone to LMWH. There is variation between aPTT assays. Tinzaparin increases aPTT and decreases thrombin generation more than enoxaparin at any given level of anti-FXa activity, casting doubt on anti-FXa's present gold standard status. Thrombin generation with tissue factor-rich activator is a promising method for monitoring LMWH's.	[Thomas, Owain; Lybeck, Emanuel; Strandberg, Karin; Schott, Ulf] Lund Univ, Fac Med, Lund, Sweden; [Thomas, Owain] SUS Lund Univ Hosp, Dept Paediat Anaesthesia & Intens Care, Lund, Sweden; [Strandberg, Karin] Skane Univ Hosp, Div Lab Med, Coagulat Lab, Dept Clin Chem, Malmo, Sweden; [Tynngard, Nahreen] Linkoping Univ, Dept Clin Immunol & Transfus Med, Dept Clin & Expt Med, Linkoping, Sweden; [Tynngard, Nahreen] Linkoping Univ, Dept Clin Chem, Dept Clin Expt Med, Linkoping, Sweden; [Schott, Ulf] SUS Lund Univ Hosp, Dept Anaesthesia & Intens Care, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Linkoping University; Linkoping University	Thomas, O (corresponding author), Lund Univ, Fac Med, Lund, Sweden.	odt@cantab.net	Thomas, Owain/I-6495-2018; Thomas, Owain D/E-2555-2014; Strandberg, Karin/AAW-2777-2021; Schott, Ulf/AAY-6982-2020	Thomas, Owain/0000-0003-2515-6581; Thomas, Owain D/0000-0003-2515-6581; Strandberg, Karin/0000-0001-5554-6631; Tynngard, Nahreen/0000-0001-8591-6074	Medical Faculty, University of Lund; Regional medical research grant, Region Skane ALF	Medical Faculty, University of Lund; Regional medical research grant, Region Skane ALF	1. Medical Faculty, University of Lund. Funding for EL's research term. www.med.lu.se. 2. Regional medical research grant, Region Skane ALF. http://www.skane.se/sv/Webbplatser/FoU-samlingsnod/Forsknings-_och_utvecklingsenheten/Arbetsomraden/ALF_Avtal_om_Lakarutbildning_och_Forskning/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dieri R, 2006, J THROMB HAEMOST, V4, P83, DOI 10.1111/j.1538-7836.2005.01672.x; Al Dieri R, 2004, J THROMB HAEMOST, V2, P1395, DOI 10.1111/j.1538-7836.2004.00798.x; Alban S, 2002, SEMIN THROMB HEMOST, V28, P369, DOI 10.1055/s-2002-34306; Andrassy K, 1996, THROMB RES, V81, pS29, DOI 10.1016/0049-3848(95)00227-8; BENCHEKROUN S, 1986, EUR J CLIN INVEST, V16, P536, DOI 10.1111/j.1365-2362.1986.tb02174.x; Gerotziafas GT, 2007, J THROMB HAEMOST, V5, P955, DOI 10.1111/j.1538-7836.2007.02477.x; Gionis MN, 2013, THROMB RES, V132, P685, DOI 10.1016/j.thromres.2013.09.037; Gouin-Thibault I, 2005, DRUG SAFETY, V28, P333, DOI 10.2165/00002018-200528040-00005; Greaves M, 2002, THROMB HAEMOSTASIS, V87, P163; Hainer JW, 2002, THROMB HAEMOSTASIS, V87, P817; Harris LF, 2010, TALANTA, V81, P1725, DOI 10.1016/j.talanta.2010.03.030; Ip BKH, 2001, PATHOLOGY, V33, P347; Kamal AH, 2007, MAYO CLIN PROC, V82, P864, DOI 10.4065/82.7.864; Kitchen S, 1996, J CLIN PATHOL, V49, P10, DOI 10.1136/jcp.49.1.10; Linkins LA, 2002, THROMB RES, V107, P241, DOI 10.1016/S0049-3848(02)00340-7; Meysman Marc, 2005, Curr Treat Options Cardiovasc Med, V7, P483, DOI 10.1007/s11936-005-0034-y; Sanfelippo MJ, 2009, AM J CLIN PATHOL, V132, P608, DOI 10.1309/AJCPA8KNNLLCV4JI; Shi XB, 2013, CHINESE MED J-PEKING, V126, P3553, DOI 10.3760/cma.j.issn.0366-6999.20131580; Sibbing D, 2014, HAMOSTASEOLOGIE, V34, P78, DOI 10.5482/HAMO-13-11-0055; Takemoto CM, 2013, AM J CLIN PATHOL, V139, P450, DOI 10.1309/AJCPS6OW6DYNOGNH; VERMYLEN CG, 1987, KIDNEY INT, V31, P1396, DOI 10.1038/ki.1987.155; White RH, 2003, BRIT J HAEMATOL, V121, P12, DOI 10.1046/j.1365-2141.2003.04196.x	22	44	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116835	10.1371/journal.pone.0116835	http://dx.doi.org/10.1371/journal.pone.0116835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625201	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821400018
J	Liu, TY; Gong, W; Tan, ZJ; Lu, W; Wu, XS; Weng, H; Ding, Q; Shu, YJ; Bao, RF; Cao, Y; Wang, XA; Zhang, F; Li, HF; Xiang, SS; Jiang, L; Hu, YP; Mu, JS; Li, ML; Wu, WG; Shen, BY; Jiang, LX; Liu, YB				Liu, Tian-Yu; Gong, Wei; Tan, Zhu-Jun; Lu, Wei; Wu, Xiang-Song; Weng, Hao; Ding, Qian; Shu, Yi-Jun; Bao, Run-Fa; Cao, Yang; Wang, Xu-An; Zhang, Fei; Li, Huai-Feng; Xiang, Shan-Shan; Jiang, Lin; Hu, Yun-ping; Mu, Jia-Sheng; Li, Mao-Lan; Wu, Wen-Guang; Shen, Bai-Yong; Jiang, Li-Xin; Liu, Ying-Bin			Baicalein Inhibits Progression of Gallbladder Cancer Cells by Downregulating ZFX	PLOS ONE			English	Article							SELF-RENEWAL; CARCINOMA METASTASIS; PROTEOMIC ANALYSIS; IN-VIVO; PROLIFERATION; GROWTH; SCUTELLARIA; EXPRESSION; KNOCKDOWN; APOPTOSIS	Baicalein, a widely used Chinese herbal medicine, has multiple pharmacological activities. However, the precise mechanisms of the anti-proliferation and anti-metastatic effects of baicalein on gallbladder cancer (GBC) remain poorly understood. Therefore, the aim of this study was to assess the anti-proliferation and anti-metastatic effects of baicalein and the related mechanism(s) on GBC. In the present study, we found that treatment with baicalein induced a significant inhibitory effect on proliferation and promoted apoptosis in GBC-SD and SGC996 cells, two widely used gallbladder cancer cell lines. Additionally, treatment with baicalein inhibited the metastasis of GBC cells. Moreover, we demonstrated for the first time that baicalein inhibited GBC cell growth and metastasis via down-regulation of the expression level of Zinc finger protein X-linked (ZFX). In conclusion, our studies suggest that baicalein may be a potential phytochemical flavonoid for therapeutics of GBC and ZFX may serve as a molecular marker or predictive target for GBC.	[Liu, Tian-Yu; Gong, Wei; Tan, Zhu-Jun; Lu, Wei; Jiang, Lin; Hu, Yun-ping; Liu, Ying-Bin] Shanghai Jiao Tong Univ, Sch Med, Inst Biliary Tract Dis, Shanghai 200030, Peoples R China; [Liu, Tian-Yu; Gong, Wei; Tan, Zhu-Jun; Lu, Wei; Jiang, Lin; Hu, Yun-ping; Liu, Ying-Bin] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Lab Gen Surg, Shanghai 200030, Peoples R China; [Liu, Tian-Yu; Gong, Wei; Tan, Zhu-Jun; Lu, Wei; Wu, Xiang-Song; Weng, Hao; Ding, Qian; Shu, Yi-Jun; Bao, Run-Fa; Cao, Yang; Wang, Xu-An; Zhang, Fei; Li, Huai-Feng; Xiang, Shan-Shan; Jiang, Lin; Hu, Yun-ping; Mu, Jia-Sheng; Li, Mao-Lan; Wu, Wen-Guang; Liu, Ying-Bin] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai 200092, Peoples R China; [Shen, Bai-Yong] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gen Surg, Shanghai 200025, Peoples R China; [Jiang, Li-Xin] Jiangyin Hosp Tradit Chinese Med, Dept Gen Surg, Jiangyin, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Jiang, LX (corresponding author), Jiangyin Hosp Tradit Chinese Med, Dept Gen Surg, Jiangyin, Peoples R China.	15961665000@163.com; liuybphd@126.com	Liu, Yingbin/AAI-1919-2020; wang, xuan/GXF-3679-2022; LIU, YING/GZL-7252-2022	Liu, Yingbin/0000-0001-6110-0185; 	National Natural Science Foundation of China [81172026, 81272402, 81301816, 81172029]; National High Technology Research and Development Program (863 Program) [2012AA022606]; Foundation for Interdisciplinary research of Shanghai Jiao Tong University [YG2011ZD07]; Shanghai science and technology commission inter-governmental international cooperation project [12410705900]; Shanghai science and technology commission medical-guiding project [12401905800]; Natural Science Research Foundation of Shanghai Jiao Tong University School of Medicine [13XJ10037]; Sailing program of Shanghai science and technology commission [14YF1403000]; Specialized Research Foundation for Ph.D Program of Higher Education-Priority Development Field [20130073130014]; Program for Changjiang Scholars; Leading Talent program of Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Foundation for Interdisciplinary research of Shanghai Jiao Tong University; Shanghai science and technology commission inter-governmental international cooperation project; Shanghai science and technology commission medical-guiding project; Natural Science Research Foundation of Shanghai Jiao Tong University School of Medicine; Sailing program of Shanghai science and technology commission; Specialized Research Foundation for Ph.D Program of Higher Education-Priority Development Field; Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Leading Talent program of Shanghai	This study was supported by National Natural Science Foundation of China (No. 81172026, 81272402, 81301816 and 81172029), National High Technology Research and Development Program (863 Program) (No. 2012AA022606), Foundation for Interdisciplinary research of Shanghai Jiao Tong University (No. YG2011ZD07), Shanghai science and technology commission inter-governmental international cooperation project (No. 12410705900), Shanghai science and technology commission medical-guiding project (No. 12401905800), Program for Changjiang Scholars, Natural Science Research Foundation of Shanghai Jiao Tong University School of Medicine (No. 13XJ10037), Leading Talent program of Shanghai, Sailing program of Shanghai science and technology commission (14YF1403000) and Specialized Research Foundation for Ph.D Program of Higher Education-Priority Development Field (No. 20130073130014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 1999, ONCOGENE, V18, P6477, DOI 10.1038/sj.onc.1203067; Akiyoshi S, 2012, BRIT J CANCER, V107, P1345, DOI 10.1038/bjc.2012.326; Buttar NS, 2006, CURR OPIN GASTROEN, V22, P505, DOI 10.1097/01.mog.0000239864.73962.db; Cellot S, 2007, CELL, V129, P239, DOI 10.1016/j.cell.2007.04.002; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chen JC, 2013, INT J MOL SCI, V14, P6012, DOI 10.3390/ijms14036012; Cheng YH, 2012, TOXICOL APPL PHARM, V263, P360, DOI 10.1016/j.taap.2012.07.010; Dong P, 2011, CHINESE MED J-PEKING, V124, P4236, DOI 10.3760/cma.j.issn.0366-6999.2011.24.021; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Harel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042302; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huang WS, 2012, PROTEOMICS, V12, P810, DOI 10.1002/pmic.201100270; KIMURA Y, 1981, CHEM PHARM BULL, V29, P2308; Li K, 2013, INT J CLIN EXP PATHO, V6, P2460; Li ML, 2013, TUMOR BIOL, V34, P3995, DOI 10.1007/s13277-013-0988-4; Li ML, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0587-7; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Lin CC, 1996, AM J CHINESE MED, V24, P31, DOI 10.1142/S0192415X96000050; Liu TY, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-64; Ma GZ, 2013, INFLAMMATION, V36, P457, DOI 10.1007/s10753-012-9566-y; Miller G, 2008, EJSO-EUR J SURG ONC, V34, P306, DOI 10.1016/j.ejso.2007.07.206; Naveenkumar C, 2013, BASIC CLIN PHARMACOL, V112, P270, DOI 10.1111/bcpt.12025; Ohashi K, 2000, CANCER-AM CANCER SOC, V88, P2201, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2201::AID-CNCR2>3.3.CO;2-E; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Quan ZW, 2010, CANCER LETT, V295, P252, DOI 10.1016/j.canlet.2010.03.008; SHIMA I, 1992, CANCER, V70, P2747, DOI 10.1002/1097-0142(19921215)70:12<2747::AID-CNCR2820701204>3.0.CO;2-5; Shimada K, 2011, BRIT J SURG, V98, P117, DOI 10.1002/bjs.7262; Tan ZJ, 2013, GENE, V528, P261, DOI 10.1016/j.gene.2013.06.064; Tan ZJ, 2012, MOL CELL BIOCHEM, V369, P27, DOI 10.1007/s11010-012-1365-0; Wang JD, 2011, MED ONCOL, V28, pS295, DOI 10.1007/s12032-010-9758-y; Wang JW, 2009, CANCER LETT, V281, P71, DOI 10.1016/j.canlet.2009.02.020; Wu S, 2013, CANCER LETT, V337, P293, DOI 10.1016/j.canlet.2013.04.003; Yu SY, 2011, BLOOD, V117, P2166, DOI 10.1182/blood-2010-09-306563; Zha WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074175; Zhang ZP, 2012, PHYTOTHER RES, V26, P932, DOI 10.1002/ptr.3657	35	140	147	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0114851	10.1371/journal.pone.0114851	http://dx.doi.org/10.1371/journal.pone.0114851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617627	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000003
J	Hames, SC; Sinnya, S; Tan, JM; Morze, C; Sahebian, A; Soyer, HP; Prow, TW				Hames, Samuel C.; Sinnya, Sudipta; Tan, Jean-Marie; Morze, Conrad; Sahebian, Azadeh; Soyer, H. Peter; Prow, Tarl W.			Automated Detection of Actinic Keratoses in Clinical Photographs	PLOS ONE			English	Article							BORDER DETECTION; IMAGE-ANALYSIS; RELIABILITY; MELANOMA; TRIAL	Background Clinical diagnosis of actinic keratosis is known to have intra-and inter-observer variability, and there is currently no non-invasive and objective measure to diagnose these lesions. Objective The aim of this pilot study was to determine if automatically detecting and circumscribing actinic keratoses in clinical photographs is feasible. Methods Photographs of the face and dorsal forearms were acquired in 20 volunteers from two groups: the first with at least on actinic keratosis present on the face and each arm, the second with no actinic keratoses. The photographs were automatically analysed using colour space transforms and morphological features to detect erythema. The automated output was compared with a senior consultant dermatologist's assessment of the photographs, including the intra-observer variability. Performance was assessed by the correlation between total lesions detected by automated method and dermatologist, and whether the individual lesions detected were in the same location as the dermatologist identified lesions. Additionally, the ability to limit false positives was assessed by automatic assessment of the photographs from the no actinic keratosis group in comparison to the high actinic keratosis group. Results Conclusions The proposed method was inferior to assessment by the dermatologist in terms of sensitivity and positive predictive value. However, this pilot study used only a single simple feature and was still able to achieve sensitivity of detection of 53.1% on the arms. This suggests that image analysis is a feasible avenue of investigation for overcoming variability in clinical assessment. Future studies should focus on more sophisticated features to improve sensitivity for actinic keratoses without erythema and limit false positives associated with the anatomical structures on the face.The correlation between the automatic and dermatologist counts was 0.62 on the face and 0.51 on the arms, compared to the dermatologist's intra-observer variation of 0.83 and 0.93 for the same. Sensitivity of automatic detection was 39.5% on the face, 53.1% on the arms. Positive predictive values were 13.9% on the face and 39.8% on the arms. Significantly more lesions (p<0.0001) were detected in the high actinic keratosis group compared to the no actinic keratosis group.	[Hames, Samuel C.; Sinnya, Sudipta; Tan, Jean-Marie; Morze, Conrad; Sahebian, Azadeh; Soyer, H. Peter; Prow, Tarl W.] Univ Queensland, Princess Alexandra Hosp, Translat Res Inst, Dermatol Res Ctr,Sch Med, Brisbane, Qld, Australia	University of Queensland	Prow, TW (corresponding author), Univ Queensland, Princess Alexandra Hosp, Translat Res Inst, Dermatol Res Ctr,Sch Med, Brisbane, Qld, Australia.	t.prow@uq.edu.au	Soyer, H. Peter/E-6000-2010; Soyer, H. Peter/W-3791-2017; Prow, Tarl W/A-4764-2010; Prow, Tarl/AAB-8359-2019	Soyer, H. Peter/0000-0002-4770-561X; Soyer, H. Peter/0000-0002-4770-561X; Prow, Tarl W/0000-0003-2892-6238; Prow, Tarl/0000-0003-2892-6238	Epiderm; Cancer Council Queensland [APP1058641]	Epiderm; Cancer Council Queensland(Cancer Council Queensland)	This work was financially supported by Epiderm (non-profit research organisation) and Cancer Council Queensland, through grant APP1058641. Cancer Council Queensland is a not-for-profit charity supporting our research group; their website is located here: http://www.cancerqld.org.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins D, 2006, J INVEST DERMATOL, V126, P591, DOI 10.1038/sj.jid.5700110; Barata C, 2012, IEEE T BIO-MED ENG, V59, P2744, DOI 10.1109/TBME.2012.2209423; Canny J, 1986, MACH INTELL, V8, P679, DOI DOI 10.1109/TPAMI.1986.4767851; Celebi ME, 2013, SKIN RES TECHNOL, V19, pE252, DOI 10.1111/j.1600-0846.2012.00636.x; Chen SC, 2013, BRIT J DERMATOLOGY; Cheng B, 2012, SKIN RES TECHNOL, V18, P389, DOI 10.1111/j.1600-0846.2011.00584.x; Criscione VD, 2009, CANCER-AM CANCER SOC, V115, P2523, DOI 10.1002/cncr.24284; Gareau D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3552639; Gilmore S, 2010, EXP DERMATOL, V19, P830, DOI 10.1111/j.1600-0625.2010.01112.x; He KM, 2013, IEEE T PATTERN ANAL, V35, P1397, DOI 10.1109/TPAMI.2012.213; Ianhez M, 2013, ARCH DERMATOL RES, V305, P841, DOI 10.1007/s00403-013-1413-y; Koller S, 2011, J EUR ACAD DERMATOL, V25, P554, DOI 10.1111/j.1468-3083.2010.03834.x; Kurugol S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3549740; Lee KC, 2013, BRIT J DERMATOLOGY; Lee TK, 2005, IEEE T BIO-MED ENG, V52, P1966, DOI 10.1109/TBME.2005.856301; Mete M, 2012, COMPUT MED IMAG GRAP, V36, P572, DOI 10.1016/j.compmedimag.2012.06.002; Nashan D, 2013, EUR J DERMATOL, V23, P14, DOI 10.1684/ejd.2013.1923; Norton KA, 2012, SKIN RES TECHNOL, V18, P290, DOI 10.1111/j.1600-0846.2011.00569.x; Sadeghi M, 2011, COMPUT MED IMAG GRAP, V35, P137, DOI 10.1016/j.compmedimag.2010.07.002; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Weinstock MA, 2001, ARCH DERMATOL, V137, P1055	21	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0112447	10.1371/journal.pone.0112447	http://dx.doi.org/10.1371/journal.pone.0112447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615930	Green Submitted, gold, Green Published			2022-12-27	WOS:000349122100002
J	Kobayashi, S; Susa, T; Ishiguchi, H; Myoren, T; Murakami, W; Kato, T; Fukuda, M; Hino, A; Suetomi, T; Ono, M; Uchinoumi, H; Tateishi, H; Mochizuki, M; Oda, T; Okuda, S; Doi, M; Yamamoto, T; Yano, M				Kobayashi, Shigeki; Susa, Takehisa; Ishiguchi, Hironori; Myoren, Takeki; Murakami, Wakako; Kato, Takayoshi; Fukuda, Masakazu; Hino, Akihiro; Suetomi, Takeshi; Ono, Makoto; Uchinoumi, Hitoshi; Tateishi, Hiroki; Mochizuki, Mamoru; Oda, Tetsuro; Okuda, Shinichi; Doi, Masahiro; Yamamoto, Takeshi; Yano, Masafumi			A Low-Dose beta 1-Blocker in Combination with Milrinone Improves Intracellular Ca2+ Handling in Failing Cardiomyocytes by Inhibition of Milrinone-Induced Diastolic Ca2+ Leakage from the Sarcoplasmic Reticulum	PLOS ONE			English	Article							CHANNEL RYANODINE RECEPTOR; CALCIUM CYCLING PROTEINS; ACUTE HEART-FAILURE; FKBP12.6-MEDIATED STABILIZATION; INTERDOMAIN INTERACTIONS; DILATED CARDIOMYOPATHY; MECHANICAL ALTERNANS; THERAPEUTIC STRATEGY; DEFECTIVE REGULATION; PULSUS ALTERNANS	Objectives The purpose of this study was to investigate whether adding a low-dose beta 1-blocker to milrinone improves cardiac function in failing cardiomyocytes and the underlying cardioprotective mechanism. Background The molecular mechanism underlying how the combination of low-dose beta 1-blocker and milrinone affects intracellular Ca2+ handling in heart failure remains unclear. Methods We investigated the effect of milrinone plus landiolol on intracellular Ca2+ transient (CaT), cell shortening (CS), the frequency of diastolic Ca2+ sparks (CaSF), and sarcoplasmic reticulum Ca2+ concentration ({Ca2+}(SR)) in normal and failing canine cardiomyocytes and used immunoblotting to determine the phosphorylation level of ryanodine receptor (RyR2) and phospholamban (PLB). Results In failing cardiomyocytes, CaSF significantly increased, and peak CaT and CS markedly decreased compared with normal myocytes. Administration of milrinone alone slightly increased peak CaT and CS, while CaSF greatly increased with a slight increase in {Ca2+}(SR). Co-administration of beta 1-blocker landiolol to failing cardiomyocytes at a dose that does not inhibit cardiomyocyte function significantly decreased CaSF with a further increase in {Ca2+}(SR), and peak CaT and CS improved compared with milrinone alone. Landiolol suppressed the hyperphosphorylation of RyR2 (Ser2808) in failing cardiomyocytes but had no effect on levels of phosphorylated PLB (Ser16 and Thr17). Low-dose landiolol significantly inhibited the alternans of CaT and CS under a fixed pacing rate (0.5 Hz) in failing cardiomyocytes. Conclusion A low-dose beta 1-blocker in combination with milrinone improved cardiac function in failing cardiomyocytes, apparently by inhibiting the phosphorylation of RyR2, not PLB, and subsequent diastolic Ca2+ leak.	[Kobayashi, Shigeki; Susa, Takehisa; Ishiguchi, Hironori; Myoren, Takeki; Murakami, Wakako; Kato, Takayoshi; Fukuda, Masakazu; Hino, Akihiro; Suetomi, Takeshi; Ono, Makoto; Uchinoumi, Hitoshi; Tateishi, Hiroki; Mochizuki, Mamoru; Oda, Tetsuro; Okuda, Shinichi; Doi, Masahiro; Yamamoto, Takeshi; Yano, Masafumi] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Div Cardiol, Ube, Yamaguchi 755, Japan	Yamaguchi University	Kobayashi, S (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Div Cardiol, Ube, Yamaguchi 755, Japan.	skoba@yamaguchi-u.ac.jp	Okuda, Shinichi/AAG-8968-2020; ishiguchi, hironori/AAK-9793-2020	Okuda, Shinichi/0000-0003-2639-5373; Suetomi, Takeshi/0000-0002-5257-9865; Kato, Takayoshi/0000-0001-9723-242X	Ministry of Education in Japan [23592256, 23390215]; Takeda Science Foundation in Japan; SENSHIN Medical Research Foundation; Grants-in-Aid for Scientific Research [26293189] Funding Source: KAKEN	Ministry of Education in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation in Japan(Takeda Science Foundation (TSF)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by grants-in-aid for scientific research from the Ministry of Education in Japan (Grant No. 23592256 to SK and Grant No. 23390215 to MY), grant from Takeda Science Foundation in Japan to SK, and grant from SENSHIN Medical Research Foundation to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG PW, 1986, CIRCULATION, V74, P1075, DOI 10.1161/01.CIR.74.5.1075; Baartscheer A, 2003, CARDIOVASC RES, V58, P99, DOI 10.1016/S0008-6363(02)00854-4; Dobrev D, 2014, CIRC RES, V114, P1311, DOI 10.1161/CIRCRESAHA.114.300568; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Doi M, 2002, CIRCULATION, V105, P1374, DOI 10.1161/hc1102.105270; ENDOH M, 1986, CIRCULATION, V73, P117; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; GWATHMEY JK, 1985, BRIT J PHARMACOL, V85, P97, DOI 10.1111/j.1476-5381.1985.tb08835.x; Gyorke S, 2008, PHARMACOL THERAPEUT, V119, P340, DOI 10.1016/j.pharmthera.2008.06.002; Hasenfuss G, 1996, BASIC RES CARDIOL, V91, P17, DOI 10.1007/BF00795357; Hirashiki A, 2006, J AM COLL CARDIOL, V47, P1382, DOI 10.1016/j.jacc.2005.10.069; Ikeshita K, 2008, J ANESTH, V22, P361, DOI 10.1007/s00540-008-0640-4; INOUE H, GUIDELINE PHARM ATRI; Kapiloff MS, 2002, MOL PHARMACOL, V62, P193, DOI 10.1124/mol.62.2.193; KIHARA Y, 1991, AM J PHYSIOL, V261, pH1746, DOI 10.1152/ajpheart.1991.261.6.H1746; Kobayashi S, 2014, CARDIOLOGY, V127, P105, DOI 10.1159/000355312; Kobayashi S, 2012, CIRC J, V76, P1646, DOI 10.1253/circj.CJ-12-0033; Kobayashi S, 2009, J AM COLL CARDIOL, V53, P1993, DOI 10.1016/j.jacc.2009.01.065; Lowes BD, 2001, INT J CARDIOL, V81, P141, DOI 10.1016/S0167-5273(01)00520-4; Maack K, 2001, BRIT J PHARMACOL, V132, P1817, DOI 10.1038/sj.bjp.0703992; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; Majure DT, 2011, CURR TREAT OPT CARD, V13, P570, DOI DOI 10.1007/S11936-011-0149-2; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Maytin M, 2005, AM J CARDIOL, V96, p26G, DOI 10.1016/j.amjcard.2005.07.018; McCauley MD, 2011, ACTA PHARMACOL SIN, V32, P749, DOI 10.1038/aps.2011.44; Mochizuki M, 2007, J AM COLL CARDIOL, V49, P1722, DOI 10.1016/j.jacc.2007.01.064; MULIERI LA, 1992, CIRCULATION, V85, P1743, DOI 10.1161/01.CIR.85.5.1743; Nagai R, 2013, CIRC J, V77, P908, DOI 10.1253/circj.CJ-12-1618; Oda T, 2005, CIRCULATION, V111, P3400, DOI 10.1161/CIRCULATIONAHA.104.507921; RYAN JM, 1956, CIRCULATION, V14, P1099, DOI 10.1161/01.CIR.14.6.1099; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Thomas SS, 2012, CIRC J, V76, P278, DOI 10.1253/circj.CJ-11-1441; Uchinoumi H, 2010, CIRC RES, V106, DOI 10.1161/CIRCRESAHA.109.209312; Xiao BL, 2006, BIOCHEM J, V396, P7, DOI 10.1042/BJ20060116; Yamada M, 2006, FASEB J, V20, P1197, DOI 10.1096/fj.05-5299fje; Yamamoto T, 2008, CIRCULATION, V117, P762, DOI 10.1161/CIRCULATIONAHA.107.718957; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159; Yano M, 2005, CIRCULATION, V112, P3633, DOI 10.1161/CIRCULATIONAHA.105.555623; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Yoshida Y, 2005, ANESTH ANALG, V100, P294, DOI 10.1213/01.ANE.0000140814.28118.6F; Yoshida Y, 2008, J ANESTH, V22, P64, DOI 10.1007/s00540-007-0573-3; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	45	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0114314	10.1371/journal.pone.0114314	http://dx.doi.org/10.1371/journal.pone.0114314			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25614983	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100003
J	Noman, N; Monjo, T; Moscato, P; Iba, H				Noman, Nasimul; Monjo, Taku; Moscato, Pablo; Iba, Hitoshi			Evolving Robust Gene Regulatory Networks	PLOS ONE			English	Article							TOGGLE SWITCH; EVOLUTION; OSCILLATIONS; GENERATION; DYNAMICS; BEHAVIOR; DESIGN	Design and implementation of robust network modules is essential for construction of complex biological systems through hierarchical assembly of 'parts' and 'devices'. The robustness of gene regulatory networks (GRNs) is ascribed chiefly to the underlying topology. The automatic designing capability of GRN topology that can exhibit robust behavior can dramatically change the current practice in synthetic biology. A recent study shows that Darwinian evolution can gradually develop higher topological robustness. Subsequently, this work presents an evolutionary algorithm that simulates natural evolution in silico, for identifying network topologies that are robust to perturbations. We present a Monte Carlo based method for quantifying topological robustness and designed a fitness approximation approach for efficient calculation of topological robustness which is computationally very intensive. The proposed framework was verified using two classic GRN behaviors: oscillation and bistability, although the framework is generalized for evolving other types of responses. The algorithm identified robust GRN architectures which were verified using different analysis and comparison. Analysis of the results also shed light on the relationship among robustness, cooperativity and complexity. This study also shows that nature has already evolved very robust architectures for its crucial systems; hence simulation of this natural process can be very valuable for designing robust biological systems.	[Noman, Nasimul; Moscato, Pablo] Univ Newcastle, Prior Res Ctr Bioinformat Biomarker Discovery & I, Newcastle, NSW 2300, Australia; [Noman, Nasimul; Moscato, Pablo] Univ Newcastle, Fac Engn & Built Environm, Sch Elect Engn & Comp Sci, Newcastle, NSW 2300, Australia; [Monjo, Taku] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan; [Iba, Hitoshi] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Informat & Commun Engn, Bunkyo Ku, Tokyo, Japan	University of Newcastle; University of Newcastle; University of Tokyo; University of Tokyo	Noman, N (corresponding author), Univ Newcastle, Prior Res Ctr Bioinformat Biomarker Discovery & I, Newcastle, NSW 2300, Australia.	nasimul.noman@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013	Moscato, Pablo/0000-0003-2570-5966; Noman, Nasimul/0000-0002-8566-0870	 [23119009]		This work was supported by Research Project Number: 23119009 (http://kaken.nii.ac.jp/d/p/23119009.en.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Benitez M, 2010, BIOSYSTEMS, V102, P11, DOI 10.1016/j.biosystems.2010.07.007; Cao Hongqing, 2010, Syst Synth Biol, V4, P55, DOI 10.1007/s11693-009-9050-7; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Conrad E, 2008, J R SOC INTERFACE, V5, pS9, DOI 10.1098/rsif.2008.0046.focus; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Donze A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024246; DRENNAN B, 2006, ARTIF LIFE, P22; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Evans DM, 2013, ECOL LETT, V16, P844, DOI 10.1111/ele.12117; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Graudenzi A, 2011, J COMPUT BIOL, V18, P559, DOI 10.1089/cmb.2010.0224; Gunawan R, 2006, BIOPHYS J, V91, P2131, DOI 10.1529/biophysj.105.078006; Hache H, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/617281; Hilgers V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000396; Holme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016605; Hsiao TL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000014; Jostins L, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-17; Karlsson M, 2012, CURR OPIN BIOTECH, V23, P703, DOI 10.1016/j.copbio.2012.01.003; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kitano H, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100039; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Masuda M, 2013, MOL ONCOL, V7, P14, DOI 10.1016/j.molonc.2012.10.009; Mendes P, 2003, BIOINFORMATICS, V19, pII122, DOI 10.1093/bioinformatics/btg1069; Montagne K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.120; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Noman N, 2013, NEW GENERAT COMPUT, V31, P71, DOI 10.1007/s00354-013-0201-8; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Paladugu SR, 2006, IEE P SYST BIOL, V153, P223, DOI 10.1049/ip-syb:20050096; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Plata G, 2014, NUCLEIC ACIDS RES, V42, P2405, DOI 10.1093/nar/gkt1200; Qiu YF, 2012, J IMMUNOL, V188, P3940, DOI 10.4049/jimmunol.1103053; Rizk A, 2009, BIOINFORMATICS, V25, pI169, DOI 10.1093/bioinformatics/btp200; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Staniczenko PPA, 2010, ECOL LETT, V13, P891, DOI 10.1111/j.1461-0248.2010.01485.x; Tenne Y, 2010, ADAPT LEARN OPTIM, V2, P1, DOI 10.1007/978-3-642-10701-6; Tian TH, 2011, INTEGR BIOL-UK, V3, P17, DOI 10.1039/c0ib00046a; van Dijk ADJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030591; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wagner GP., 2005, ROBUSTNESS EVOLVABIL; Wilkins AK, 2009, SIAM J SCI COMPUT, V31, P2706, DOI 10.1137/070707129; Zheng LL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003901; Zhu XY, 1996, IEEE DECIS CONTR P, P3412, DOI 10.1109/CDC.1996.573688	53	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116258	10.1371/journal.pone.0116258	http://dx.doi.org/10.1371/journal.pone.0116258			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25616055	Green Submitted, Green Published, gold			2022-12-27	WOS:000349122100024
J	Kim, WH; Han, W; Chang, JM; Cho, N; Park, IA; Moon, WK				Kim, Won Hwa; Han, Wonshik; Chang, Jung Min; Cho, Nariya; Park, In Ae; Moon, Woo Kyung			Location of Triple-Negative Breast Cancers: Comparison with Estrogen Receptor-Positive Breast Cancers on MR Imaging	PLOS ONE			English	Article							LYMPH-NODE INVOLVEMENT; TUMOR LOCATION; PROGESTERONE-RECEPTOR; MOLECULAR PORTRAITS; SUBTYPE; EXPERIENCE; PHENOTYPES; INVASION; WOMEN	There has been a major need to better understand the biological characteristics of triple-negative breast cancers. Compared with estrogen receptor (ER)-positive cancers, several magnetic resonance (MR) imaging findings have been reported as characteristic findings. However, information regarding their location has not been described. Our study was to compare the location of triple-negative breast cancers with that of ER-positive breast cancers using magnetic resonance (MR) imaging. The locations of 1102 primary breast cancers (256 triple-negative and 846 ER-positive) in 1090 women (mean, 52.1 years) were reviewed using three-dimensional (3D) coordinates. The x-axis measurement was recorded as the transverse distance from the posterior nipple line; y-axis measurement as the anteroposterior distance from the chest wall; z-axis measurement as the superoinferior distance from the posterior nipple line. The association between breast cancer subtype and tumor location was evaluated using multiple linear regression analysis. Triple-negative breast cancers were significantly closer to the chest wall than ER-positive breast cancers in absolute (1.8 cm vs. 2.3 cm, P < .0001) and normalized (0.21 vs. 0.25, P < .0001) y-axis distances. The x- and z-axes distances were not significantly different between triple-negative and ER-positive breast cancers. Multiple linear regression analysis revealed that age, mammographic density, axillary nodal status, and triple-negative subtype were significantly associated with absolute and normalized distances from the chest wall (all P < .05). Our results show that triple-negative breast cancers have a tendency toward a posterior or prepectoral location compared with ER-positive breast cancers.	[Kim, Won Hwa; Chang, Jung Min; Cho, Nariya; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Han, Wonshik] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Park, In Ae] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Moon, WK (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea.	moonwk@snu.ac.kr	Han, Wonshik/B-3699-2008	Han, Wonshik/0000-0001-7310-0764; Chang, Jung Min/0000-0001-5726-9797	National Research Foundation of Korea (NRF) - Korean government (MEST) [2012R1A2A1A01010846]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2012R1A2A1A01010846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Barcellos-Hoff MH, 2013, CLIN CANCER RES, V19, P541, DOI 10.1158/1078-0432.CCR-12-2241; BIRD RE, 1992, RADIOLOGY, V184, P613, DOI 10.1148/radiology.184.3.1509041; Bluemke DA, 2004, JAMA-J AM MED ASSOC, V292, P2735, DOI 10.1001/jama.292.22.2735; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Colleoni M, 2005, J CLIN ONCOL, V23, P1390, DOI 10.1200/JCO.2005.06.052; Collett K, 2005, CANCER EPIDEM BIOMAR, V14, P1108, DOI 10.1158/1055-9965.EPI-04-0394; Crabb SJ, 2008, CLIN BREAST CANCER, V8, P249, DOI 10.3816/CBC.2008.n.028; Curigliano Giuseppe, 2011, Journal of the National Cancer Institute Monographs, P108, DOI 10.1093/jncimonographs/lgr038; Dang TT, 2011, CANCER RES, V71, P6857, DOI 10.1158/0008-5472.CAN-11-1818; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dogan BE, 2012, ANN ONCOL, V23, P23, DOI 10.1093/annonc/mds191; Ellingson BM, 2013, AM J NEURORADIOL, V34, P533, DOI 10.3174/ajnr.A3253; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gilbertson RJ, 2007, CANCER RES, V67, P5579, DOI 10.1158/0008-5472.CAN-07-0760; Guth U, 2006, EJSO-EUR J SURG ONC, V32, P287, DOI 10.1016/j.ejso.2005.12.009; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Harvey JA, 2008, RADIOLOGY, V248, P61, DOI 10.1148/radiol.2481060339; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krizmanich-Conniff KM, 2012, AM J ROENTGENOL, V199, P458, DOI 10.2214/AJR.10.6096; Lee E, 2011, J CLIN ONCOL, V29, P4373, DOI 10.1200/JCO.2010.33.6446; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lohrisch C, 2000, J CLIN ONCOL, V18, P2828, DOI 10.1200/JCO.2000.18.15.2828; Manjer J, 2004, EJSO-EUR J SURG ONC, V30, P610, DOI 10.1016/j.ejso.2004.04.008; Morris EA, 2000, RADIOLOGY, V214, P67, DOI 10.1148/radiology.214.1.r00ja1667; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Sandhu PS, 2007, RADIOLOGY, V245, P160, DOI 10.1148/radiol.2443061370; Schrading S, 2008, RADIOLOGY, V246, P58, DOI 10.1148/radiol.2461062173; Slattery ML, 2011, GENE CHROMOSOME CANC, V50, P196, DOI 10.1002/gcc.20844; Tanis PJ, 2005, J SURG ONCOL, V91, P195, DOI 10.1002/jso.20299; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; Ugras S, 2014, ANN SURG ONCOL, V21, P3780, DOI 10.1245/s10434-014-3851-y; WOLFE JN, 1974, AM J ROENTGENOL, V21, P846, DOI 10.2214/ajr.121.4.846; Yoshihara E, 2012, BREAST; Zlatescu MC, 2001, CANCER RES, V61, P6713	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116344	10.1371/journal.pone.0116344	http://dx.doi.org/10.1371/journal.pone.0116344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608004	Green Submitted, gold, Green Published			2022-12-27	WOS:000348205300025
J	Hinne, M; Ekman, M; Janssen, RJ; Heskes, T; van Gerven, MAJ				Hinne, Max; Ekman, Matthias; Janssen, Ronald J.; Heskes, Tom; van Gerven, Marcel A. J.			Probabilistic Clustering of the Human Connectome Identifies Communities and Hubs	PLOS ONE			English	Article							CONNECTIVITY-BASED PARCELLATION; STATE FUNCTIONAL CONNECTIVITY; DIFFUSION-WEIGHTED MRI; PARIETAL CORTEX; BRAIN; SEGMENTATION; ORGANIZATION; TRACTOGRAPHY; NETWORKS; MODELS	A fundamental assumption in neuroscience is that brain function is constrained by its structural properties. This motivates the idea that the brain can be parcellated into functionally coherent regions based on anatomical connectivity patterns that capture how different areas are interconnected. Several studies have successfully implemented this idea in humans using diffusion weighted MRI, allowing parcellation to be conducted in vivo. Two distinct approaches to connectivity-based parcellation can be identified. The first uses the connection profiles of brain regions as a feature vector, and groups brain regions with similar connection profiles together. Alternatively, one may adopt a network perspective that aims to identify clusters of brain regions that show dense within-cluster and sparse between-cluster connectivity. In this paper, we introduce a probabilistic model for connectivity-based parcellation that unifies both approaches. Using the model we are able to obtain a parcellation of the human brain whose clusters may adhere to either interpretation. We find that parts of the connectome consistently cluster as densely connected components, while other parts consistently result in clusters with similar connections. Interestingly, the densely connected components consist predominantly of major cortical areas, while the clusters with similar connection profiles consist of regions that have previously been identified as the 'rich club'; regions known for their integrative role in connectivity. Furthermore, the probabilistic model allows quantification of the uncertainty in cluster assignments. We show that, while most clusters are clearly delineated, some regions are more difficult to assign. These results indicate that care should be taken when interpreting connectivity-based parcellations obtained using alternative deterministic procedures.	[Hinne, Max; Ekman, Matthias; Janssen, Ronald J.; van Gerven, Marcel A. J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Hinne, Max; Heskes, Tom] Radboud Univ Nijmegen, Inst Comp & Informat Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Hinne, M (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	mhinne@cs.ru.nl	van Gerven, Marcel A. J./D-7800-2012; Hinne, Max/ABD-1486-2021; Heskes, Tom/A-1443-2010; Ekman, Matthias/S-5607-2018	van Gerven, Marcel A. J./0000-0002-2206-9098; Hinne, Max/0000-0002-9279-6725; Heskes, Tom/0000-0002-3398-5235; Ekman, Matthias/0000-0003-1254-1392; Janssen, Ronald/0000-0001-9622-5420	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	The research was funded by the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science (http://www.senternovem.nl/smartmix). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher C, J COMPLEX N IN PRESS; Airoldi E. M., 2009, ADV NEURAL INFORM PR, P33; Aldous D.J., 1985, LECT NOTES MATH, V1117, P1, DOI DOI 10.1007/BFB0099421; Andersen KW, 2014, NEUROIMAGE, V100, P301, DOI 10.1016/j.neuroimage.2014.05.083; Anwander A, 2007, CEREB CORTEX, V17, P816, DOI 10.1093/cercor/bhk034; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Blundell C., 2013, ADV NEURAL INFORM PR, P1601; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Catani M, 2007, BRAIN, V130, P602, DOI 10.1093/brain/awm008; Cloutman LL, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00034; Cook PA, 2007, J MAGN RESON IMAGING, V25, P1051, DOI 10.1002/jmri.20905; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/nmeth.2482, 10.1038/NMETH.2482]; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Ekman M, 2012, P NATL ACAD SCI USA, V109, P16714, DOI 10.1073/pnas.1207523109; Fornito Alex, 2012, Front Psychiatry, V3, P32, DOI 10.3389/fpsyt.2012.00032; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Hagmann P., 2005, DIFFUSION MRI BRAIN; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Hinne M, 2013, NEUROIMAGE, V66, P543, DOI 10.1016/j.neuroimage.2012.09.068; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kemp Charles, 2006, AAAI, DOI DOI 10.1145/1837026.1837061; Klein JC, 2007, NEUROIMAGE, V34, P204, DOI 10.1016/j.neuroimage.2006.08.022; Knosche TR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00058; Liu HG, 2013, J NEUROSCI, V33, P6782, DOI 10.1523/JNEUROSCI.4882-12.2013; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Morup M., 2010, ADV NEURAL INFORM PR, V23, P1750; Nanetti L, 2009, NEUROIMAGE, V47, P1666, DOI 10.1016/j.neuroimage.2009.06.014; Nowicki K, 2001, J AM STAT ASSOC, V96, P1077, DOI 10.1198/016214501753208735; O'Muircheartaigh J, 2011, NEUROIMAGE, V54, P2020, DOI 10.1016/j.neuroimage.2010.09.054; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pavlovic DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097584; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; ROBBINS H, 1964, ANN MATH STAT, V35, P1, DOI 10.1214/aoms/1177703729; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Schleicher A, 1999, NEUROIMAGE, V9, P165, DOI 10.1006/nimg.1998.0385; Schmidt MN, 2013, IEEE SIGNAL PROC MAG, V30, P110, DOI 10.1109/MSP.2012.2235191; Serra L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064578; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Thiebaut de Schotten M, 2012, CORTEX, V48, P82, DOI 10.1016/j.cortex.2011.10.001; Thirion B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00167; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van Oort ESB, 2013, NEUROIMAGE; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; Wolfe A, 2004, CML 04 WORKSH STAT R; Xu Z, 2007, P 5 INT WORKSH MIN L; Yeo BTT, 2014, NEUROIMAGE, V88, P212, DOI 10.1016/j.neuroimage.2013.10.046; Zhang Y, 2012, CEREB CORTEX; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	66	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117179	10.1371/journal.pone.0117179	http://dx.doi.org/10.1371/journal.pone.0117179			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635390	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700074
J	Holloway, KR; Sinha, VC; Toneff, MJ; Bu, W; Hilsenbeck, SG; Li, Y				Holloway, Kimberly R.; Sinha, Vidya C.; Toneff, Michael J.; Bu, Wen; Hilsenbeck, Susan G.; Li, Yi			Krt6a-Positive Mammary Epithelial Progenitors Are Not at Increased Vulnerability to Tumorigenesis Initiated by ErbB2	PLOS ONE			English	Article							BREAST-CANCER; STEM-CELLS; DIFFERENTIATION; RECEPTOR; EXPRESSION; RENEWAL; LRP5	While most breast cancers are thought to arise from the luminal layer of the breast tissue, it remains unclear which specific cells in the luminal layer are the cells of origin of breast cancer. We have previously reported that WAP-positive luminal epithelial cells are at increased susceptibility to tumor initiation by ErbB2 compared to the bulk population, while the mammary cells with canonical Wnt signaling activity fail to evolve into tumors upon ErbB2 activation. Here, we used retrovirus to introduce ErbB2 into the Krt6a-positive mammary progenitor subset of the luminal epithelium and, for comparison, into the mammary luminal epithelium indiscriminately. Tumors developed from both groups of cells with a similar latency. These data indicate that the Krt6a-positive subset of mammary epithelial cells can be induced to form cancer by ErbB2 but it is not more susceptible to tumorigenesis initiated by ErbB2 than the bulk population of the luminal epithelium.	[Holloway, Kimberly R.; Sinha, Vidya C.; Bu, Wen; Hilsenbeck, Susan G.; Li, Yi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Sinha, Vidya C.; Toneff, Michael J.; Bu, Wen; Li, Yi] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Li, Yi] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Li, Y (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA.	liyi@bcm.edu	Li, Yi/A-7635-2009	Li, Yi/0000-0002-9976-518X	National Institutes of Health [CA124820, RR024574]; National Cancer Institute [T32AG000183]; Duncan Cancer Center [P30CA125123]; National Institute of Allergy and Infectious Diseases;  [U54CA149196];  [CA125123]; NATIONAL CANCER INSTITUTE [R01CA124820, U54CA149196, P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Duncan Cancer Center; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (http://www.nih.gov/): #CA124820 (YL); #RR024574 (Cytometry and Cell Sorting Core at Baylor College of Medicine); #T32AG000183 (KRH); National Cancer Institute (http://www.cancer.gov/): #U54CA149196 to YL (PI Stephen Wong); #CA125123 (Cytometry and Cell Sorting Core at Baylor College of Medicine); #P30CA125123 (Duncan Cancer Center); National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/):	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Bu W, 2011, ONCOGENE, V30, P4399, DOI 10.1038/onc.2011.147; Bu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078720; Du ZJ, 2006, P NATL ACAD SCI USA, V103, P17396, DOI 10.1073/pnas.0608607103; Haricharan S, 2014, MOL CELL ENDOCRINOL, V382, P560, DOI 10.1016/j.mce.2013.03.014; Haricharan S, 2013, ONCOGENE, DOI [10.1038/onc.2013.543, DOI 10.1038/ONC.2013.543]; Haricharan S, 2013, ELIFE, V2, DOI 10.7554/eLife.00996; Henry MD, 2004, ONCOGENE, V23, P6980, DOI 10.1038/sj.onc.1207827; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Reddy JP, 2010, P NATL ACAD SCI USA, V107, P3728, DOI 10.1073/pnas.0910665107; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; Toneff MJ, 2010, NEOPLASIA, V12, P718, DOI 10.1593/neo.10516; Wagner KU, 2002, DEVELOPMENT, V129, P1377	21	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117239	10.1371/journal.pone.0117239	http://dx.doi.org/10.1371/journal.pone.0117239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635772	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700076
J	Qin, HD; Chen, M; Yi, XD; Bie, S; Zhang, C; Zhang, YC; Lan, JY; Meng, YY; Yuan, YL; Jiao, CH				Qin, Hongde; Chen, Min; Yi, Xianda; Bie, Shu; Zhang, Cheng; Zhang, Youchang; Lan, Jiayang; Meng, Yanyan; Yuan, Youlu; Jiao, Chunhai			Identification of Associated SSR Markers for Yield Component and Fiber Quality Traits Based on Frame Map and Upland Cotton Collections	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; GENETIC-LINKAGE MAP; POPULATION-STRUCTURE; GOSSYPIUM-BARBADENSE; P-VALUES; DISEQUILIBRIUM; DIVERSITY; L.; INFERENCE; LOCI	Detecting QTLs (quantitative trait loci) that enhance cotton yield and fiber quality traits and accelerate breeding has been the focus of many cotton breeders. In the present study, 359 SSR (simple sequence repeat) markers were used for the association mapping of 241 Upland cotton collections. A total of 333 markers, representing 733 polymorphic loci, were detected. The average linkage disequilibrium (LD) decay distances were 8.58 cM (r(2) > 0.1) and 5.76 cM (r(2) > 0.2). 241 collections were arranged into two subgroups using STRUCTURE software. Mixed linear modeling (MLM) methods (with population structure (Q) and relative kinship matrix (K)) were applied to analyze four phenotypic datasets obtained from four environments (two different locations and two years). Forty-six markers associated with the number of bolls per plant (NB), boll weight (BW), lint percentage (LP), fiber length (FL), fiber strength (FS) and fiber micornaire value (FM) were repeatedly detected in at least two environments. Of 46 associated markers, 32 were identified as new association markers, and 14 had been previously reported in the literature. Nine association markers were near QTLs (at a distance of less than 1-2 LD decay on the reference map) that had been previously described. These results provide new useful markers for marker-assisted selection in breeding programs and new insights for understanding the genetic basis of Upland cotton yields and fiber quality traits at the whole-genome level.	[Qin, Hongde; Yi, Xianda; Bie, Shu; Zhang, Cheng; Zhang, Youchang; Lan, Jiayang; Meng, Yanyan] Hubei Acad Agr Sci, Inst Cash Crops, Wuhan, Peoples R China; [Qin, Hongde; Chen, Min; Yi, Xianda; Bie, Shu; Zhang, Cheng; Zhang, Youchang; Lan, Jiayang; Meng, Yanyan] Minist Agr, Key Lab Cotton Biol & Breeding Middle Reaches Cha, Wuhan, Peoples R China; [Yuan, Youlu] Chinese Acad Agr Sci, Inst Cotton Res, Anyan, Peoples R China; [Jiao, Chunhai] Hubei Acad Agr Sci, Wuhan, Peoples R China	Hubei Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Hubei Academy of Agricultural Sciences	Yi, XD (corresponding author), Hubei Acad Agr Sci, Inst Cash Crops, Wuhan, Peoples R China.	13971325545@163.com; jiaoch@hotmail.com	Meng, Yan/HGC-0394-2022; meng, yan/GSE-2653-2022		National Natural Science Foundation of China [30971823]; National Hi-Tech Research and Development Program of China [2012AA101108-03-07]; International S&T Cooperation Program of China [2011DFB31620]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); International S&T Cooperation Program of China	This research was supported by the National Natural Science Foundation of China (Grant No. 30971823), the National Hi-Tech Research and Development Program of China (Grant No. 2012AA101108-03-07), and by International S&T Cooperation Program of China (Grant No. 2011DFB31620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2008, GENOMICS, V92, P478, DOI 10.1016/j.ygeno.2008.07.013; Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cai CP, 2014, J INTEGR PLANT BIOL, V56, P51, DOI 10.1111/jipb.12124; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fang DD, 2013, EUPHYTICA, V191, P391, DOI 10.1007/s10681-013-0886-2; Fountain J., 2011, Peanut Science, V38, P122, DOI 10.3146/PS10-16.1; GIMELFARB A, 1995, THEOR APPL GENET, V91, P522, DOI 10.1007/BF00222983; Goodman SN, 2001, EPIDEMIOLOGY, V12, P295, DOI 10.1097/00001648-200105000-00006; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; He Dao-hua, 2010, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V30, P1557; Katki HA, 2008, AM J EPIDEMIOL, V168, P384, DOI 10.1093/aje/kwn148; Li ChengQi, 2008, Cotton Science, V20, P163; Liang QZ, 2013, CHINESE SCI BULL, V58, P3233, DOI 10.1007/s11434-013-5807-1; Liang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-539; Liu RZ, 2012, MOL BREEDING, V29, P297, DOI 10.1007/s11032-011-9547-0; Liu S, 2000, CROP SCI, V40, P1459, DOI 10.2135/cropsci2000.4051459x; McRae AF, 2002, GENETICS, V160, P1113; Mei HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082193; Mezmouk S, 2011, THEOR APPL GENET, V122, P1149, DOI 10.1007/s00122-010-1519-y; Mohlke KL, 2001, GENOME RES, V11, P1221, DOI 10.1101/gr.173201; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; [秦永生 QIN Yong-Sheng], 2009, [作物学报, Acta Agronomica Sinica], V35, P1812; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Shappley Z. W., 1998, Journal of Cotton Science, V2, P153; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Stich B, 2006, MOL BREEDING, V17, P217, DOI 10.1007/s11032-005-5296-2; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun FD, 2012, MOL BREEDING, V30, P569, DOI 10.1007/s11032-011-9645-z; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Wang BH, 2006, EUPHYTICA, V152, P367, DOI 10.1007/s10681-006-9224-2; Wang FR, 2013, MOL BREEDING, V32, P547, DOI 10.1007/s11032-013-9888-y; Wang FR, 2011, EUPHYTICA, V181, P41, DOI 10.1007/s10681-011-0378-1; Wang Lin, 2012, Cotton Science, V24, P97; Wang P, 2012, THEOR APPL GENET, V124, P1415, DOI 10.1007/s00122-012-1797-7; Whitt Sr, 2003, METH MOL B, V236, P123; Wu JX, 2009, EUPHYTICA, V165, P231, DOI 10.1007/s10681-008-9748-8; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zeng LH, 2009, THEOR APPL GENET, V119, P93, DOI 10.1007/s00122-009-1020-7; Zhang JianHong, 2008, Cotton Science, V20, P179; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhang ZS, 2011, THEOR APPL GENET, V123, P1075, DOI 10.1007/s00122-011-1649-x; Zhang ZS, 2005, EUPHYTICA, V144, P91, DOI 10.1007/s10681-005-4629-x; Zhao YL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086308, 10.1371/journal.pone.0099704]	55	42	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0118073	10.1371/journal.pone.0118073	http://dx.doi.org/10.1371/journal.pone.0118073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635680	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700115
J	Khurana, S; Coyle, EM; Manischewitz, J; King, LR; Ishioka, G; Alexander, J; Smith, J; Gurwith, M; Golding, H				Khurana, Surender; Coyle, Elizabeth M.; Manischewitz, Jody; King, Lisa R.; Ishioka, Glenn; Alexander, Jeff; Smith, Jon; Gurwith, Marc; Golding, Hana			Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization	PLOS ONE			English	Article							MEMORY B-CELLS; SECRETING CELLS; WILD-TYPE; INFLUENZA; VIRUS; IMMUNOGENICITY; SAFETY; PERSISTENCE; CHIMPANZEES; CHALLENGE	A Phase I trial conducted in 2009-2010 demonstrated that oral vaccination with a replication competent Ad4-H5 (A/Vietnam) vector with dosages ranging from 10(7)-10(11) viral particles was well tolerated. HA-specific T-cell responses were efficiently induced, but very limited hemagglutination-inhibiting (HI) humoral responses were measured. However, a single boost of Ad4-H5-Vtn vaccinated individuals with a unadjuvanted licensed H5N1 (A/Vietnam) subunit vaccine resulted in superior HI titers compared with unprimed subjects. In the current study, the impact of Ad4-H5 priming on the quality of the polyclonal humoral immune response was evaluated using a real-time kinetics assay by surface plasmon resonance (SPR). Total binding of serum polyclonal antibodies from the Ad4-H5-Vtn primed groups against both homologous H5N1-A/Vietnam/1194/2004 (clade 1) and heterologous A/Indonesia- 5/2005 (clade 2.1) HA1 head domain was significantly higher compared with sera from individuals that received subunit H5N1 vaccination alone. SPR measurements also demonstrated that the antigen-antibody complex dissociation rates (a surrogate for antibody affinity) of serum antibodies against the HA1 of H5N1-A/Vietnam were significantly higher in the Ad4-H5 primed groups compared with those from the unprimed group. Furthermore, strong correlations were observed between the antibody affinities for HA1 (but not HA2) and the virus neutralization titers against the homologous strain and a panel of heterologous clade 2 H5N1 strains. These findings support the concept of oral prime-boost vaccine approaches against pandemic influenza to elicit long-term memory B cells with high affinity capable of rapid response to variant pandemic viruses likely to emerge and adapt to human transmissions.	[Khurana, Surender; Coyle, Elizabeth M.; Manischewitz, Jody; King, Lisa R.; Golding, Hana] FDA, CBER, Div Viral Prod, Silver Spring, MD 20903 USA; [Ishioka, Glenn; Alexander, Jeff; Smith, Jon] PaxVax, San Diego, CA 92121 USA; [Gurwith, Marc] PaxVax, Redwood City, CA 94063 USA	US Food & Drug Administration (FDA)	Khurana, S (corresponding author), FDA, CBER, Div Viral Prod, Silver Spring, MD 20903 USA.	surender.khurana@fda.hhs.gov; hana.golding@fda.hhs.gov			Wellcome Trust [Ad4-H5]; PaxVax	Wellcome Trust(Wellcome TrustEuropean Commission); PaxVax	Wellcome Trust funded the development of the Ad4-H5 vector through Phase I clinical trial for PaxVax. Co-authors Glenn Ishioka, Jeff Alexander, Jon Smith and Marc Gurwith are employed by PaxVax. PaxVax provided support in the form of salaries for authors GI, JA, JS and MG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alam S, 2014, J VIROL, V88, P314, DOI 10.1128/JVI.02077-13; Alexander J, 2010, VACCINE, V28, P664, DOI 10.1016/j.vaccine.2009.10.103; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Garcon N, 2012, EXPERT REV VACCINES, V11, P349, DOI [10.1586/erv.11.192, 10.1586/ERV.11.192]; Gurwith M, 2013, LANCET INFECT DIS, V13, P238, DOI 10.1016/S1473-3099(12)70345-6; HYLAND L, 1994, J VIROL, V68, P6083, DOI 10.1128/JVI.68.9.6083-6086.1994; JONES PD, 1987, CELL IMMUNOL, V109, P53, DOI 10.1016/0008-8749(87)90291-7; JONES PD, 1987, VACCINE, V5, P244, DOI 10.1016/0264-410X(87)90109-5; Khurana S, 2013, J INFECT DIS, V208, P413, DOI 10.1093/infdis/jit178; Khurana S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002920; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; LUBECK MD, 1989, P NATL ACAD SCI USA, V86, P6763, DOI 10.1073/pnas.86.17.6763; Lubeck MD, 1997, NAT MED, V3, P651, DOI 10.1038/nm0697-651; Moris P, 2011, J CLIN IMMUNOL, V31, P443, DOI 10.1007/s10875-010-9490-6; NATUK RJ, 1994, DEV BIOL STAND, V82, P71; NATUK RJ, 1995, DEV BIOL STAND, V84, P153; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Spensieri F, 2013, P NATL ACAD SCI USA, V110, P14330, DOI 10.1073/pnas.1311998110; Talaat KR, 2014, J INFECT DIS; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Verma S, 2012, J VIROL, V86, P12283, DOI 10.1128/JVI.01596-12; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Zolla-Pazner S, 1998, J VIROL, V72, P1052, DOI 10.1128/JVI.72.2.1052-1059.1998	32	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115476	10.1371/journal.pone.0115476	http://dx.doi.org/10.1371/journal.pone.0115476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629161	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100018
J	Wan, ZH; Wu, YC; Yi, J; You, SL; Liu, HL; Sun, ZQ; Zhu, B; Zang, H; Li, C; Liu, FF; Li, DZ; Mao, YL; Xin, SJ				Wan, Zhihong; Wu, Yichen; Yi, Jing; You, Shaoli; Liu, Hongling; Sun, Zhiqiang; Zhu, Bing; Zang, Hong; Li, Chen; Liu, Fangfang; Li, Dongze; Mao, Yuanli; Xin, Shaojie			Combining Serum Cystatin C with Total Bilirubin Improves Short-Term Mortality Prediction in Patients with HBV-Related Acute-On-Chronic Liver Failure	PLOS ONE			English	Article							RENAL-FUNCTION; DISEASE; MARKER; MODEL; CREATININE; PROGNOSIS; CIRRHOSIS; RISK	Background & Aims HBV-related acute-on-chronic liver failure (HBV-ACLF) is a severe liver disease which results in a high mortality in China. To early predict the prognosis of the patients may prevent the complications and improve the survival. This study was aimed to develop a new prognostic index to estimate the survival related to HBV-ACLF. Methods Consecutive patients with HBV-ACLF were included in a prospective observational study. Serum Cystatin C concentrations were measured by using the particle-enhanced immuno-nephelometry assay. All of the patients were followed for at least 3 months. Cox regression analysis was carried out to identify which factors were predictive of mortality. The area under the receiver operating characteristic curve (AUC) was used to evaluate the efficacy of the variates for early predicting mortality. Results Seventy-two patients with HBV-ACLF were recruited between January 2012 and January 2013. Thirty patients died (41.7%) during 3-months followed up. Cox multivariate regression analysis identified serum cystatin C (CysC) and total bilirubin (TBil) were independent factors significantly (P < 0.01) associated with survival. Our results further showed that new prognostic index (PI) combining serum CysC with TBil was a good indicator for predicting the mortality of patients with HBV-ACLF. Specifically, the PI had a higher accuracy than the CTP, MELD, or MELD-Na scoring for early prediction short-term survival of HBV-ACLF patients with normal levels of serum creatinine (Cr). The survival rate in low risk group (PI < 3.91) was 94.3%, which was markedly higher than those in the high-risk group (PI >= 3.91) (17.4%, P < 0.001). Conclusion We developed a new prognostic index combining serum CysC with TBil which early predicted the short-term mortality of HBV-ACLF patients.	[Wan, Zhihong; Wu, Yichen; You, Shaoli; Liu, Hongling; Zhu, Bing; Zang, Hong; Li, Chen; Liu, Fangfang; Li, Dongze; Xin, Shaojie] Beijing 302 Hosp, Liver Failure Treatment & Res Ctr, Beijing, Peoples R China; [Yi, Jing] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Hlth Stat & Informat Management, Chongqing, Peoples R China; [Sun, Zhiqiang; Mao, Yuanli] Beijing 302 Hosp, Clin Lab Ctr, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Chongqing Medical University; Fifth Medical Center of Chinese PLA General Hospital	Wan, ZH (corresponding author), Beijing 302 Hosp, Liver Failure Treatment & Res Ctr, Beijing, Peoples R China.	wanzhihong302@163.com; xinshaojie302@163.com			Beijing Municipal Science & Technology Commission [Z131107002213018]; National Natural Science Foundation of China [81371800]; 12th Five-Year National Science and Technology Major Project for Infectious Diseases [2012ZX10002004-005]	Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-Year National Science and Technology Major Project for Infectious Diseases(Chinese Academy of Sciences)	This work was supported by Beijing Municipal Science & Technology Commission (No Z131107002213018, to ZW), http://www.bjkw.gov.cn/n8785584/index.html, National Natural Science Foundation of China (No. 81371800, to ZW), http://www.nsfc.gov.cn/ and partially supported by grants from the 12th Five-Year National Science and Technology Major Project for Infectious Diseases (No 2012ZX10002004-005, to SX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomo R, 2004, INTENS CARE MED, V30, P33, DOI 10.1007/s00134-003-2078-3; Cardenas A, 2011, CURR OPIN CRIT CARE, V17, P184, DOI 10.1097/MCC.0b013e328344b3da; Chinese Association of Infectious Diseases and Parasitology Hepatology, 2000, CHINESE J HEPATOLOGY, V6, P324; Cholongitas E, 2007, ALIMENT PHARM THER, V26, P969, DOI 10.1111/j.1365-2036.2007.03443.x; De Souza V, 2014, HEPATOLOGY, V59, P1522, DOI 10.1002/hep.26886; Francoz C, 2012, CRIT CARE, V16, DOI 10.1186/cc11207; Francoz C, 2010, J HEPATOL, V52, P605, DOI 10.1016/j.jhep.2009.11.025; Garg H, 2012, DIGEST LIVER DIS, V44, P166, DOI 10.1016/j.dld.2011.08.029; Gerbes AL, 2002, GUT, V50, P106, DOI 10.1136/gut.50.1.106; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Karvellas CJ, 2010, CRIT CARE MED, V38, P121, DOI 10.1097/CCM.0b013e3181b42a1c; Katoonizadeh A, 2010, GUT, V59, P1561, DOI 10.1136/gut.2009.189639; Ke WM, 2003, J GASTROENTEROL, V38, P861, DOI 10.1007/s00535-003-1162-3; *LIV FAIL ART LIV, 2006, ZHONGHUA GAN ZANG BI, V14, P643; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; NEWMAN DJ, 1995, KIDNEY INT, V47, P312, DOI 10.1038/ki.1995.40; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Seo YS, 2009, LIVER INT, V29, P1521, DOI 10.1111/j.1478-3231.2009.02105.x; Seto WK, 2012, J GASTROEN HEPATOL, V27, P662, DOI 10.1111/j.1440-1746.2011.06971.x; Sharawey MA, 2011, HEPATOL INT, V5, P927, DOI 10.1007/s12072-011-9266-y; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Sun QF, 2009, J VIRAL HEPATITIS, V16, P464, DOI 10.1111/j.1365-2893.2008.01046.x; Wan ZH, 2013, WORLD J GASTROENTERO, V19, P9432, DOI 10.3748/wjg.v19.i48.9432; Wasmuth HE, 2005, J HEPATOL, V42, P195, DOI 10.1016/j.jhep.2004.10.019; Xia Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064379; You SL, 2013, HEPATOL INT, V7, P714, DOI 10.1007/s12072-013-9424-5; Yu JW, 2006, J GASTROEN HEPATOL, V21, P1519, DOI 10.1111/j.1440-1746.2006.04510.x; Zheng MH, 2011, CLIN GASTROENTEROL H, V9, P351, DOI 10.1016/j.cgh.2010.12.027	30	14	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116968	10.1371/journal.pone.0116968	http://dx.doi.org/10.1371/journal.pone.0116968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629773	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100054
J	Zetterstrom, K; Voss, M; Alexanderson, K; Ivert, T; Pehrsson, K; Hammar, N; Vaez, M				Zetterstrom, Katharina; Voss, Margaretha; Alexanderson, Kristina; Ivert, Torbjorn; Pehrsson, Kenneth; Hammar, Niklas; Vaez, Marjan			Prevalence of All-Cause and Diagnosis-Specific Disability Pension at the Time of First Coronary Revascularisation: A Population-Based Swedish Cross-Sectional Study	PLOS ONE			English	Article							TERM SICKNESS ABSENCE; BYPASS GRAFT-SURGERY; RISK-FACTORS; FOLLOW-UP; EUROPEAN-SOCIETY; YOUNG PERSONS; WOMEN; MORTALITY; GENDER; COHORT	Background Although coronary revascularisation by coronary artery bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) is well documented, scientific knowledge on disability pension (DP) at the time of revascularisation is lacking. The aim was to investigate the prevalence of all-cause and diagnosis-specific DP at the time of a first coronary revascularisation, accounting for socio-demographic and medical factors. Materials and Methods A population-based cross-sectional study using Swedish registers was conducted including all 65,676 patients (80% men) who when aged 30-63 years, within 1994-2006, had a first CABG (n = 22,959) or PCI (n = 42,717) and did not have old-age pension. Associations between socio-demographic and medical factors and the probability of DP were estimated by odds ratios (OR) with 95% confidence intervals (CI) using logistic regression analyses. Findings The prevalence of DP at time of revascularisation was 24%, mainly due to musculoskeletal diagnoses. Sixty-two percent had had DP for at least four years before the revascularisation. In the multivariable analyses, DP was more common in women (OR: 2.40; 95% CI: 2.29-2.50), older patients (50-63 years); especially men aged 60-63 years with CABG (OR: 4.91; 95% CI: 4.27-5.66), lower educational level; especially men with PCI (OR: 2.96; 95% CI: 2.69-3.26), patients born outside Sweden; especially men with PCI (OR: 2.11; 95% CI: 1.96-2.27), and in women with an indication of other diagnoses than acute coronary syndrome (ACS) or stable angina pectoris for PCI (OR: 1.72; 95% CI: 1.31-2.24). Conclusion About a quarter had DP at the time of revascularisation, often due to musculoskeletal diagnoses. More than half had had DP for at least four years before the intervention. DP was associated with female gender, older age, lower educational level, and being born outside Sweden.	[Zetterstrom, Katharina; Voss, Margaretha; Alexanderson, Kristina; Vaez, Marjan] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden; [Voss, Margaretha] Swedish Social Insurance Agcy, Dept Anal & Forecasts, Stockholm, Sweden; [Ivert, Torbjorn] Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden; [Ivert, Torbjorn] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Pehrsson, Kenneth] Karolinska Inst, Dept Med, Stockholm, Sweden; [Hammar, Niklas] AstraZeneca R&D, Molndal, Sweden; [Hammar, Niklas] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Vaez, Marjan] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; AstraZeneca; Karolinska Institutet; Stockholm County Council	Zetterstrom, K (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden.	katharina.zetterstrom@ki.se			Swedish Research Council for Health, Working Life and Welfare [2007-0728 + 1762]; National School of Research in Caring Science, Karolinska Institutet	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); National School of Research in Caring Science, Karolinska Institutet	This work was supported by the Swedish Research Council for Health, Working Life and Welfare (grant number 2007-0728 + 1762; www.fas.se/) and the National School of Research in Caring Science, Karolinska Institutet (www.ki.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen K, 2007, SCAND J PUBLIC HEALT, V35, P78, DOI 10.1080/14034940600858474; Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; Alexanderson Kristina A E, 2005, Work, V25, P115; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P49, DOI 10.1080/14034950410021853; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P36, DOI 10.1080/14034950410021835; [Anonymous], 2009, ARSR SWEDEHEART 2008; [Anonymous], 2014, SJUK; [Anonymous], 2009, OECD EMPLOYMENT OUTL; [Anonymous], 2004, SJUKD SOM ORS PENS; [Anonymous], 2014, SOC INS FIG 2012; Beckman A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-71; Borg K, 2004, SCAND J PUBLIC HEALT, V32, P272, DOI 10.1080/14034940310019524; Borg K, 2001, SCAND J PUBLIC HEALT, V29, P104, DOI 10.1177/14034948010290020701; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Claussen B, 2012, J IMMIGR MINOR HEALT, V14, P259, DOI 10.1007/s10903-010-9430-9; Claussen B, 2009, SCAND J PUBLIC HEALT, V37, P590, DOI 10.1177/1403494809105795; Giesdal S, 2008, SCAND J WORK ENV HEA, V34, P479, DOI 10.5271/sjweh.1286; Gjesdal S, 2004, EUR J PUBLIC HEALTH, V14, P398, DOI 10.1093/eurpub/14.4.398; Gjesdal S, 2004, SCAND J PUBLIC HEALT, V32, P340, DOI 10.1080/14034940410029487; Gjesdal S, 2002, EUR J PUBLIC HEALTH, V12, P180, DOI 10.1093/eurpub/12.3.180; Gjesdal S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-37; Gjesdal S, 2009, SCAND J PUBLIC HEALT, V37, P387, DOI 10.1177/1403494809103994; Gjesdal S, 2009, SCAND J PUBLIC HEALT, V37, P168, DOI 10.1177/1403494808100937; Hamalainen H, 2004, EUR J PUBLIC HEALTH, V14, P350, DOI 10.1093/eurpub/14.4.350; Hammar N, 1997, J AM COLL CARDIOL, V29, P659, DOI 10.1016/S0735-1097(96)00531-1; Hansson T, 2004, SCAND J PUBLIC HEALT, V32, P109, DOI 10.1080/14034950410021862; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Jensen LD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000991; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Jespersen L, 2013, EUR HEART J, V34, P3294, DOI 10.1093/eurheartj/eht395; Johansson B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-845; Jonsson U, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002286; Karlsson NE, 2008, EUR J PUBLIC HEALTH, V18, P224, DOI 10.1093/eurpub/ckm128; Karlsson NE, 2007, SCAND J PUBLIC HEALT, V35, P341, DOI 10.1080/14034940601159229; Kilbom A, 1998, WOMENS HLTH WORK, P311; Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Norheim A, 2011, SCAND CARDIOVASC J, V45, P247, DOI 10.3109/14017431.2011.582139; OECD Labour Market Statistics, 2014, OECD LAB MARK STAT L, DOI [10.1787/data-00309-en, DOI 10.1787/DATA-00309-EN]; Organisation for economic Co-operation and development, 2010, SICKN DIS WORK BREAK; Ostby KA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-12; Osterberg T, 2006, SOC SCI MED, V63, P805, DOI 10.1016/j.socscimed.2006.02.009; Perk J, 2004, SCAND J PUBLIC HEALT, V32, P181, DOI 10.1080/14034950410021880; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; Ropponen A, 2011, SCAND J PUBLIC HEALT, V39, P839, DOI 10.1177/1403494811418283; Samuelsson A, 2012, J OCCUP ENVIRON MED, V54, P10, DOI 10.1097/JOM.0b013e31823d86d5; Stramba-Badiale M, 2006, EUR HEART J, V27, P994, DOI 10.1093/eurheartj/ehi819; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Voss M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040952; Wallman T, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-103; World Health Organisation, 2010, INT CLASS DIS REL HL; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; Zetterstroem K, 2015, EUR J PREV CARDIOL, V22, P304, DOI 10.1177/2047487313518472	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115540	10.1371/journal.pone.0115540	http://dx.doi.org/10.1371/journal.pone.0115540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629517	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100021
J	Choi, SM; Lee, J; Park, YS; Lee, CH; Lee, SM; Yim, JJ; Kim, YW; Han, SK; Yoo, CG				Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Chang-Hoon; Lee, Sang-Min; Yim, Jae-Joon; Kim, Young Whan; Han, Sung Koo; Yoo, Chul-Gyu			Prevalence and Global Initiative for Chronic Obstructive Lung Disease Group Distribution of Chronic Obstructive Pulmonary Disease Detected by Preoperative Pulmonary Function Test	PLOS ONE			English	Article							AIR-FLOW OBSTRUCTION; NONCARDIOTHORACIC SURGERY; COPD; RISK; POPULATION; UNDERDIAGNOSIS; COMPLICATIONS; NONSMOKERS; MORTALITY; BURDEN	Background Despite being a major public health problem, chronic obstructive pulmonary disease (COPD) remains underdiagnosed, and only 2.4% COPD patients are aware of their disease in Korea. The objective of this study was to estimate the prevalence of COPD detected by spirometry performed as a preoperative screening test and to determine the Global Initiative for Chronic Obstructive Lung Disease (GOLD) group distribution and self-awareness of COPD. Methods We reviewed the medical records of adults (age, >= 40 years) who had undergone spirometry during preoperative screening between April and August 2013 at a tertiary hospital in Korea. COPD was defined as a postbronchodilator forced expiratory volume in 1 s/forced vital capacity ratio of <0.7. We analyzed self-administered COPD questionnaires for the assessment of the frequency of acute exacerbation over the previous year and dyspnea severity using the modified Medical Research Council dyspnea scale and COPD assessment test. Results Among 3029 patients aged >40 years who had undergone spirometry as a preoperative screening test, 474 (15.6%; 404 men; median age, 70 years; range, 44-93 years) were diagnosed with COPD. Only 26 (5.5%) patients reported previous diagnosis of COPD (2.1%), emphysema (0.8%), or chronic bronchitis (2.5%). The GOLD group distribution was as follows: 63.3% in group A, 31.2% in group B, 1.7% in group C, and 3.8% in group D. Conclusions The prevalence of COPD diagnosed by preoperative spirometry was 15.6%, and only 5.5% patients were aware of their disease. Approximately one-third of the COPD patients belonged to GOLD groups B, C, and D, which require regular treatment.	[Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Chang-Hoon; Lee, Sang-Min; Yim, Jae-Joon; Kim, Young Whan; Han, Sung Koo; Yoo, Chul-Gyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp,Div Pulm & Crit Care Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University Hospital	Yoo, CG (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp,Div Pulm & Crit Care Med, Seoul 151, South Korea.	cgyoo@snu.ac.kr	Lee, Chang-Hoon/AAC-7650-2021	Yim, Jae-Joon/0000-0002-9605-0074				Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; Birring SS, 2002, AM J RESP CRIT CARE, V166, P1078, DOI 10.1164/rccm.200203-245OC; Brekke PH, 2008, RESP MED, V102, P1243, DOI 10.1016/j.rmed.2008.04.010; Buist AS, 2008, INT J TUBERC LUNG D, V12, P703; Calikoglu M, 2004, RESPIRATION, V71, P45, DOI 10.1159/000075648; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; GrayDonald K, 1996, AM J RESP CRIT CARE, V153, P961, DOI 10.1164/ajrccm.153.3.8630580; Gupta H, 2013, CHEST, V143, P1599, DOI 10.1378/chest.12-1499; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Han MLK, 2013, LANCET RESP MED, V1, P43, DOI 10.1016/S2213-2600(12)70044-9; Jones PW, 2009, COPD, V6, P59, DOI 10.1080/15412550802587943; Kim DS, 2005, AM J RESP CRIT CARE, V172, P842, DOI 10.1164/rccm.200502-259OC; Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435; Licker Marc, 2007, Int J Chron Obstruct Pulmon Dis, V2, P493; Licker MJ, 2006, ANN THORAC SURG, V81, P1830, DOI 10.1016/j.athoracsur.2005.11.048; Linstrom M, 2002, INT J TUBERC LUNG D, V6, P76; Lokke A, 2012, COPD, V9, P458, DOI 10.3109/15412555.2012.685118; Marsh SE, 2008, THORAX, V63, P761, DOI 10.1136/thx.2007.089193; McAlister FA, 2003, AM J RESP CRIT CARE, V167, P741, DOI 10.1164/rccm.200209-985BC; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; Pena VS, 2000, CHEST, V118, P981, DOI 10.1378/chest.118.4.981; Qaseem A, 2006, ANN INTERN MED, V144, P575, DOI 10.7326/0003-4819-144-8-200604180-00008; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Sandelowsky H, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-122; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; Takabatake N, 2001, AM J RESP CRIT CARE, V163, P1314, DOI 10.1164/ajrccm.163.6.2004175; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vestbo J, 2012, CLIN RESPIR J, V6, P208, DOI 10.1111/crj.12002; Wada H, 2010, RESPIROLOGY, V15, P1252, DOI 10.1111/j.1440-1843.2010.01854.x; Yoo KH, 2011, RESPIROLOGY, V16, P659, DOI 10.1111/j.1440-1843.2011.01951.x	33	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115787	10.1371/journal.pone.0115787	http://dx.doi.org/10.1371/journal.pone.0115787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625286	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821400010
J	Jung, M; Lee, J; Seo, HY; Lim, JS; Kim, EK				Jung, Minjeong; Lee, Jaemeun; Seo, Hye-Young; Lim, Ji Sun; Kim, Eun-Kyoung			Cathepsin Inhibition-Induced Lysosomal Dysfunction Enhances Pancreatic Beta-Cell Apoptosis in High Glucose	PLOS ONE			English	Article							CHRONIC OXIDATIVE STRESS; ORGANELLAR DYSFUNCTION; MONITORING AUTOPHAGY; CYSTEINE PROTEASES; IMPAIRED AUTOPHAGY; DIABETES-MELLITUS; STORAGE DISEASES; SELF-DIGESTION; LC3; PATHWAYS	Autophagy is a lysosomal degradative pathway that plays an important role in maintaining cellular homeostasis. We previously showed that the inhibition of autophagy causes pancreatic beta-cell apoptosis, suggesting that autophagy is a protective mechanism for the survival of pancreatic beta-cells. The current study demonstrates that treatment with inhibitors and knockdown of the lysosomal cysteine proteases such as cathepsins B and L impair autophagy, enhancing the caspase-dependent apoptosis of INS-1 cells and islets upon exposure to high concentration of glucose. Interestingly, treatment with cathepsin B and L inhibitors prevented the proteolytic processing of cathepsins B, D and L, as evidenced by gradual accumulation of the respective pro-forms. Of note, inhibition of aspartic cathepsins had no effect on autophagy and cell viability, suggesting the selective role of cathepsins B and L in the regulation of beta-cell autophagy and apoptosis. Lysosomal localization of accumulated pro-cathepsins in the presence of cathepsin B and L inhibitors was verified via immunocytochemistry and lysosomal fractionation. Lysotracker staining indicated that cathepsin B and L inhibitors led to the formation of severely enlarged lysosomes in a time-dependent manner. The abnormal accumulation of pro-cathepsins following treatment with inhibitors of cathepsins B and L suppressed normal lysosomal degradation and the processing of lysosomal enzymes, leading to lysosomal dysfunction. Collectively, our findings suggest that cathepsin defects following the inhibition of cathepsin B and L result in lysosomal dysfunction and consequent cell death in pancreatic beta-cells.	[Jung, Minjeong; Lee, Jaemeun; Seo, Hye-Young; Lim, Ji Sun; Kim, Eun-Kyoung] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain Sci, Taegu, South Korea; [Kim, Eun-Kyoung] Daegu Gyeongbuk Inst Sci & Technol, Neurometabol Res Ctr, Taegu, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Kim, EK (corresponding author), Daegu Gyeongbuk Inst Sci & Technol, Dept Brain Sci, Taegu, South Korea.	ekkim@dgist.ac.kr		Lee, Jaemeun/0000-0003-1766-3241	National Research Foundation [2013M3C7A1056099]; Daegu Gyeongbuk Institute of Science and Technology (DGIST) MIREBraiN program; DGIST R&D Program of the Ministry of Science, Information and Communication Technology, and Future Planning [14-BD-0402]	National Research Foundation; Daegu Gyeongbuk Institute of Science and Technology (DGIST) MIREBraiN program; DGIST R&D Program of the Ministry of Science, Information and Communication Technology, and Future Planning	This work was supported by the National Research Foundation (2013M3C7A1056099), the Daegu Gyeongbuk Institute of Science and Technology (DGIST) MIREBraiN program, and the DGIST R&D Program of the Ministry of Science, Information and Communication Technology, and Future Planning (14-BD-0402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bennett BL, 2003, CURR OPIN PHARMACOL, V3, P420, DOI 10.1016/S1471-4892(03)00068-7; Boland Barry, 2006, Molecular Aspects of Medicine, V27, P503, DOI 10.1016/j.mam.2006.08.009; CHAN SJ, 1986, P NATL ACAD SCI USA, V83, P7721, DOI 10.1073/pnas.83.20.7721; Codogno P, 2006, NAT CELL BIOL, V8, P1045, DOI 10.1038/ncb1006-1045; Elrick MJ, 2013, AUTOPHAGY, V9, P234, DOI 10.4161/auto.22501; ERICKSON AH, 1989, J CELL BIOCHEM, V40, P31, DOI 10.1002/jcb.240400104; Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044; Gukovskaya AS, 2012, AM J PHYSIOL-GASTR L, V303, pG993, DOI 10.1152/ajpgi.00122.2012; Gukovsky I, 2012, J GASTROEN HEPATOL, V27, P27, DOI 10.1111/j.1440-1746.2011.07004.x; Gukovsky I, 2011, ANTIOXID REDOX SIGN, V15, P2699, DOI 10.1089/ars.2011.4068; Gukovsky I, 2010, AUTOPHAGY, V6, P428, DOI 10.4161/auto.6.3.11530; Han D, 2010, BIOCHEM J, V425, P541, DOI 10.1042/BJ20090429; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; ISHIDOH K, 1987, FEBS LETT, V226, P33, DOI 10.1016/0014-5793(87)80545-8; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Jung HS, 2009, AUTOPHAGY, V5, P241, DOI 10.4161/auto.5.2.7518; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaiser N, 2003, J PEDIATR ENDOCR MET, V16, P5, DOI 10.1515/JPEM.2003.16.1.5; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; KATUNUMA N, 1983, CURR TOP CELL REGUL, V22, P71; Katunuma Nobuhiko, 2010, J Signal Transduct, V2010, P375345, DOI 10.1155/2010/375345; KIDO H, 1986, J IMMUNOL, V136, P1061; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maedler K, 2004, HORM RES, V62, P67, DOI 10.1159/000080503; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Muller S, 2012, BBA-PROTEINS PROTEOM, V1824, P34, DOI 10.1016/j.bbapap.2011.07.003; Otomo T, 2011, J BIOL CHEM, V286, P35283, DOI 10.1074/jbc.M111.267930; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Pitocco Dario, 2010, Rev Diabet Stud, V7, P15, DOI 10.1900/RDS.2010.7.15; PUNNONEN EL, 1992, J HISTOCHEM CYTOCHEM, V40, P1579, DOI 10.1177/40.10.1326577; Quan W, 2013, ARCH PHARM RES, V36, P223, DOI 10.1007/s12272-013-0024-7; Quan W, 2012, EXP MOL MED, V44, P81, DOI 10.3858/emm.2012.44.2.030; Que J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.56; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-007-0026-5; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Saftig P., 2006, PHYSL LYSOSOME; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Uchiyama Y, 2001, ARCH HISTOL CYTOL, V64, P233, DOI 10.1679/aohc.64.233; Victor VM, 2011, CURR PHARM DESIGN, V17, P3947, DOI 10.2174/138161211798764915; Winchester B, 2000, BIOCHEM SOC T, V28, P150, DOI 10.1042/bst0280150; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099	72	61	61	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116972	10.1371/journal.pone.0116972	http://dx.doi.org/10.1371/journal.pone.0116972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625842	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821400025
J	McMullan, BJ; Desmarini, D; Djordjevic, JT; Chen, SCA; Roper, M; Sorrell, TC				McMullan, Brendan J.; Desmarini, Desmarini; Djordjevic, Julianne T.; Chen, Sharon C-A.; Roper, Michael; Sorrell, Tania C.			Rapid Microscopy and Use of Vital Dyes: Potential to Determine Viability of Cryptococcus neoformans in the Clinical Laboratory	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; COMBINED COHORT; FLOW-CYTOMETRY; MENINGITIS; INFECTION; CELLS	Background Cryptococcus neoformans is the commonest cause of fungal meningitis, with a substantial mortality despite appropriate therapy. Quantitative culture of cryptococci in cerebrospinal fluid (CSF) during antifungal therapy is of prognostic value and has therapeutic implications, but is slow and not practicable in many resource-poor countries. Methods We piloted two rapid techniques for quantifying viable cryptococci using mixtures of live and heat-killed cryptococci cultured in vitro: (i) quantitative microscopy with exclusion staining using trypan blue dye, and (ii) flow cytometry, using the fluorescent dye 2'-7'-Bis-(2-carboxyethyl)-5-(6)-carboxyfluorescein, acetoxymethyl ester (BCECF-AM). Results were compared with standard quantitative cryptococcal cultures. Quantitative microscopy was also performed on cerebrospinal fluid (CSF) samples. Results Both microscopy and flow cytometry distinguished between viable and non-viable cryptococci. Cell counting (on log scale) by microscopy and by quantitative culture were significantly linearly associated (p<0.0001) and Bland-Altman analysis showed a high level of agreement. Proportions of viable cells (on logit scale), as detected by flow cytometry were significantly linearly associated with proportions detected by microscopy (p<0.0001) and Bland-Altman analysis showed a high level of agreement. Conclusions Direct microscopic examination of trypan blue-stained cryptococci and flow-cytometric assessment of BCECF-AM-stained cryptococci were in good agreement with quantitative cultures. These are promising strategies for rapid determination of the viability of cryptococci, and should be investigated in clinical practice.	[McMullan, Brendan J.; Desmarini, Desmarini; Djordjevic, Julianne T.; Chen, Sharon C-A.; Sorrell, Tania C.] Univ Sydney Westmead Hosp, Westmead Millennium Inst, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [McMullan, Brendan J.; Chen, Sharon C-A.] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia; [Desmarini, Desmarini; Djordjevic, Julianne T.; Sorrell, Tania C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW, Australia; [Chen, Sharon C-A.] Westmead Hosp, ICPMR Pathol West, Westmead, NSW, Australia; [Roper, Michael] Univ Sydney, Sydney Med Sch, Westmead Clin Sch, Discipline Infect Dis & Immunol, Westmead, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; University of Sydney; University of Sydney	McMullan, BJ (corresponding author), Sydney Childrens Hosp, Dept Immunol & Infect Dis, Randwick, NSW, Australia.	brendanoch@yahoo.co.uk	Sorrell, Tania/AAZ-5286-2020; McMullan, Brendan/AAR-6174-2020	McMullan, Brendan/0000-0001-5144-3416; Sorrell, Tania/0000-0001-9460-0960; Djordjevic, Julianne/0000-0003-4207-4115	National Health and Medical Research Council of Australia [1050106]; Marie Bashir Institute for Infectious Diseases and Microbiology, University of Sydney; Public Health Capacity Building Infrastructure Grant from New South Wales Health; Centre for Infectious Diseases and Microbiology-Public Health, ICPMR, Westmead (CI-A)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Marie Bashir Institute for Infectious Diseases and Microbiology, University of Sydney; Public Health Capacity Building Infrastructure Grant from New South Wales Health; Centre for Infectious Diseases and Microbiology-Public Health, ICPMR, Westmead (CI-A)	This work was supported by grant #1050106 from the National Health and Medical Research Council of Australia and the Marie Bashir Institute for Infectious Diseases and Microbiology, University of Sydney. TS is a Sydney Medical School Foundation Fellow. MR was funded by a Public Health Capacity Building Infrastructure Grant from New South Wales Health, the Centre for Infectious Diseases and Microbiology-Public Health, ICPMR, Westmead (CI-A, V. Sintchenko). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Barrientos A, 2000, CLIN MICROBIOL REV, V13, P167, DOI 10.1128/CMR.13.2.167-195.2000; [Anonymous], 2006, BCECF PACK INS, P1; [Anonymous], 2010, TRUC TUB PACK INS, P1; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Bicanic T, 2009, AIDS, V23, P701, DOI 10.1097/QAD.0b013e32832605fe; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boyd AR, 2003, FEMS YEAST RES, V3, P11, DOI 10.1016/S1567-1356(02)00125-3; Brouwer AE, 2005, J INFECT DIS, V192, P681, DOI 10.1086/432073; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Carstensen B, 2011, COMP CLIN MEASUREMEN, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Carstensen B., 2013, METHCOMP FUNCTIONS A; Celis JE, 2005, CELL BIOL, P21, DOI [10.1016/j.nepr.2004.02.003, DOI 10.1016/J.NEPR.2004.02.003]; CHAKA W, 1995, CLIN DIAGN LAB IMMUN, V2, P753, DOI 10.1128/CDLI.2.6.753-759.1995; Chen SCA, 2012, CLIN INFECT DIS, V55, P789, DOI 10.1093/cid/cis529; CIMPRICH P, 1995, FEMS MICROBIOL LETT, V130, P245; CORREA B, 1986, MYCOPATHOLOGIA, V96, P91, DOI 10.1007/BF00436666; HAWORTH RS, 1991, BIOCHIM BIOPHYS ACTA, V1098, P79; HIDORE MR, 1991, INFECT IMMUN, V59, P1747, DOI 10.1128/IAI.59.5.1747-1754.1991; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; PERFECT JR, 1983, MEDICINE, V62, P98, DOI 10.1097/00005792-198303000-00003; Robinson PA, 1999, CLIN INFECT DIS, V28, P82, DOI 10.1086/515074; Sigma Aldrich, PROT VIABL CELL COUN; Singh N, 2005, TRANSPLANTATION, V80, P1033, DOI 10.1097/01.tp.0000173774.74388.49; SLAYMAN CL, 1994, J EXP BIOL, V196, P419; Stie J, 2012, MICROBIOL-SGM, V158, P240, DOI 10.1099/mic.0.051524-0; Team RC, 2014, R LANG ENV STAT COMP; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1	28	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117186	10.1371/journal.pone.0117186	http://dx.doi.org/10.1371/journal.pone.0117186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625210	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821400028
J	Wasnik, V; Wingreen, NS; Mukhopadhyay, R				Wasnik, Vaibhav; Wingreen, Ned S.; Mukhopadhyay, Ranjan			Modeling Curvature-Dependent Subcellular Localization of the Small Sporulation Protein SpoVM in Bacillus subtilis	PLOS ONE			English	Article							MEMBRANE CURVATURE; BAR DOMAINS; MECHANISM; CLUSTERS	Recent in vivo experiments suggest that in the bacterium, Bacillus subtilis, the cue for the localization of the small sporulation protein, SpoVM, an essential factor in spore coat formation, is curvature of the bacterial plasma membrane. In vitro measurements of SpoVM adsorption to vesicles of varying sizes also find high sensitivity of adsorption to vesicle radius. This curvature-dependent adsorption is puzzling given the orders of magnitude difference in length scale between an individual protein and the radius of curvature of the cell or vesicle, suggesting protein clustering on the membrane. Here we develop a minimal model to study the relationship between curvature-dependent membrane adsorption and clustering of SpoVM. Based on our analysis, we hypothesize that the radius dependence of SpoVM adsorption observed in vitro is governed primarily by membrane tension, while for in-vivo localization of SpoVM, we propose a highly sensitive mechanism for curvature sensing based on the formation of macroscopic protein clusters on the membrane.	[Wasnik, Vaibhav; Mukhopadhyay, Ranjan] Clark Univ, Dept Phys, Worcester, MA 01610 USA; [Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Clark University; Princeton University	Mukhopadhyay, R (corresponding author), Clark Univ, Dept Phys, Worcester, MA 01610 USA.	ranjan@clarku.edu			NIH [R01 GM082938]; NSF [PHY08-48550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082938] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH Grant R01 GM082938, NSF Grant PHY08-48550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bhatia VK, 2010, SEMIN CELL DEV BIOL, V21, P381, DOI 10.1016/j.semcdb.2009.12.004; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Daniel A, 2010, ANTIMICROB AGENTS CH, V54, P1603, DOI 10.1128/AAC.01625-09; Destainville N, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051403; Destainville N, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011905; Evans AR, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.041907; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Gitai Z, 2009, CURR OPIN MICROBIOL, V12, P341, DOI 10.1016/j.mib.2009.03.001; GOULIAN M, 1993, EUROPHYS LETT, V22, P145, DOI 10.1209/0295-5075/22/2/012; Groenewold J, 2001, J PHYS CHEM B, V105, P11702, DOI 10.1021/jp011646w; Gurry T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006148; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Huang KC, 2010, MOL MICROBIOL, V76, P822, DOI 10.1111/j.1365-2958.2010.07168.x; JOACHIM OR, 1995, PHYS REV E, V51, P4526; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Meilhac N, 2011, J PHYS CHEM B, V115, P7190, DOI 10.1021/jp1099865; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PHILLIPS R, 2008, PHYSICAL BIOLOGY OF; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Sciortino F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.055701; Segre PN, 2001, PHYS REV LETT, V86, P6042, DOI 10.1103/PhysRevLett.86.6042; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Singh P, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051906; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Stradner A, 2004, NATURE, V432, P492, DOI 10.1038/nature03109; Ursell T, 2007, PLOS COMPUT BIOL, V3, P803, DOI 10.1371/journal.pcbi.0030081; van Ooiij C, 2004, J BACTERIOL, V186, P4441, DOI 10.1128/JB.186.14.4441-4448.2004; van Ooij C, 2003, J BACTERIOL, V185, P1391, DOI 10.1128/JB.185.4.1391-1398.2003; Weikl TR, 1998, PHYS REV E, V57, P6988, DOI 10.1103/PhysRevE.57.6988; Zhu C, 2012, BIOPHYS J, V102, P1837, DOI 10.1016/j.bpj.2012.03.039	33	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0111971	10.1371/journal.pone.0111971	http://dx.doi.org/10.1371/journal.pone.0111971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625300	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821400001
J	Choi, DH; Park, KT; An, SM; Lee, K; Cho, JC; Lee, JH; Kim, D; Jeon, D; Noh, JH				Choi, Dong Han; Park, Ki-Tae; An, Sung Min; Lee, Kitack; Cho, Jang-Cheon; Lee, Jung-Hyun; Kim, Dongseon; Jeon, Dongchull; Noh, Jae Hoon			Pyrosequencing Revealed SAR116 Clade as Dominant dddP-Containing Bacteria in Oligotrophic NW Pacific Ocean	PLOS ONE			English	Article							DIMETHYL SULFIDE; DIMETHYLSULFONIOPROPIONATE LYASE; MAXIMUM-LIKELIHOOD; ATMOSPHERIC SULFUR; CHEMICAL DEFENSE; DISSOLVED DMSP; MARINE; PHYTOPLANKTON; GENE; DEGRADATION	Dimethyl sulfide (DMS) is a climatically active gas released into the atmosphere from oceans. It is produced mainly by bacterial enzymatic cleavage of dimethylsulfoniopropionate (DMSP), and six DMSP lyases have been identified to date. To determine the biogeographical distribution of bacteria relevant to DMS production, we investigated the diversity of dddP-the most abundant DMS-producing gene-in the northwestern Pacific Ocean using newly developed primers and the pyrosequencing method. Consistent with previous studies, the major dddP-containing bacteria in coastal areas were those belonging to the Roseobacter clade. However, genotypes closely related to the SAR116 group were found to represent a large portion of dddP-containing bacteria in the surface waters of the oligotrophic ocean. The addition of DMSP to a culture of the SAR116 strain Candidatus Puniceispirillum marinum IMCC1322 resulted in the production of DMS and upregulated expression of the dddP gene. Considering the large area of oligotrophic water and the wide distribution of the SAR116 group in oceans worldwide, we propose that these bacteria may play an important role in oceanic DMS production and biogeochemical sulfur cycles, especially via bacteriamediated DMSP degradation.	[Choi, Dong Han; Lee, Jung-Hyun] Korea Inst Ocean Sci & Technol, Marine Biotechnol Res Div, Ansan, South Korea; [Choi, Dong Han; Lee, Jung-Hyun] Korea Univ Sci & Technol, Dept Marine Biotechnol, Taejon, South Korea; [Park, Ki-Tae; Lee, Kitack] Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Pohang, South Korea; [An, Sung Min; Noh, Jae Hoon] Korea Inst Ocean Sci & Technol, Marine Ecosyst Res Div, Ansan, South Korea; [Cho, Jang-Cheon] Inha Univ, Div Biol & Ocean Sci, Inchon, South Korea; [Kim, Dongseon; Jeon, Dongchull] Korea Inst Ocean Sci & Technol, Ocean Circulat & Climate Res Div, Ansan, South Korea; [Noh, Jae Hoon] Korea Univ Sci & Technol, Dept Marine Biol, Taejon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Pohang University of Science & Technology (POSTECH); Korea Institute of Ocean Science & Technology (KIOST); Inha University; Korea Institute of Ocean Science & Technology (KIOST)	Noh, JH (corresponding author), Korea Inst Ocean Sci & Technol, Marine Ecosyst Res Div, Ansan, South Korea.	jhnoh@kiost.ac	Park, Ki-Tae/CAF-2480-2022; Lee, Kitack/G-7184-2015	Park, Ki-Tae/0000-0003-4874-6189; Cho, Jang-Cheon/0000-0002-0666-3791; Lee, Kitack/0000-0002-4226-2303	Korea Institute of Ocean and Science Technology (KIOST) [PE98704, PE99231, PE99212]	Korea Institute of Ocean and Science Technology (KIOST)	This study was supported by in-house research programs (PE98704, PE99231, PE99212) of the Korea Institute of Ocean and Science Technology (KIOST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Boyce R, 2009, NUCLEIC ACIDS RES, V37, pW222, DOI 10.1093/nar/gkp379; BURGERMEISTER S, 1990, J GEOPHYS RES-ATMOS, V95, P20607, DOI 10.1029/JD095iD12p20607; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Choi DH, 2013, AQUAT MICROB ECOL, V71, P75, DOI 10.3354/ame01669; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; Curson ARJ, 2011, ISME J, V5, P1191, DOI 10.1038/ismej.2010.203; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hill RW, 1998, AQUAT MICROB ECOL, V14, P1, DOI 10.3354/ame014001; Ichikawa H, 2002, J OCEANOGR, V58, P77, DOI 10.1023/A:1015876701363; KARSTEN U, 1992, POLAR BIOL, V12, P603; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Kiene RP, 2000, LIMNOL OCEANOGR, V45, P849, DOI 10.4319/lo.2000.45.4.0849; Kirkwood M, 2010, ISME J, V4, P147, DOI 10.1038/ismej.2009.102; KIRST GO, 1990, ANNU REV PLANT PHYS, V41, P21, DOI 10.1146/annurev.pp.41.060190.000321; Levine NM, 2012, ENVIRON MICROBIOL, V14, P1210, DOI 10.1111/j.1462-2920.2012.02700.x; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Oh HM, 2010, J BACTERIOL, V192, P3240, DOI 10.1128/JB.00347-10; Park KT, 2008, LIMNOL OCEANOGR-METH, V6, P548, DOI 10.4319/lom.2008.6.548; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Peng MJ, 2012, CAN J MICROBIOL, V58, P523, DOI [10.1139/w2012-019, 10.1139/W2012-019]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reisch CR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00172; Reisch CR, 2008, J BACTERIOL, V190, P8018, DOI 10.1128/JB.00770-08; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Slezak D, 2007, AQUAT SCI, V69, P377, DOI 10.1007/s00027-007-0896-z; SOMERVILLE CC, 1989, APPL ENVIRON MICROB, V55, P548, DOI 10.1128/AEM.55.3.548-554.1989; Steinke M, 2000, J SEA RES, V43, P233, DOI 10.1016/S1385-1101(00)00024-1; Strom S, 2003, LIMNOL OCEANOGR, V48, P230, DOI 10.4319/lo.2003.48.1.0230; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2012, ISME J, V6, P223, DOI 10.1038/ismej.2011.79; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Varaljay VA, 2012, APPL ENVIRON MICROB, V78, P2775, DOI 10.1128/AEM.07559-11; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168; Zhang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-198	45	23	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116271	10.1371/journal.pone.0116271	http://dx.doi.org/10.1371/journal.pone.0116271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615446	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100026
J	Rogoz, K; Stjarne, L; Kullander, K; Lagerstrom, MC				Rogoz, Katarzyna; Stjarne, Ludvig; Kullander, Klas; Lagerstrom, Malin C.			VGLUT2 controls heat and punctuate hyperalgesia associated with nerve injury via TRPV1-Cre primary afferents	PLOS ONE			English	Article							VESICULAR GLUTAMATE TRANSPORTER-2; NMDA RECEPTOR ANTAGONISTS; GENE-RELATED PEPTIDE; NEUROPATHIC PAIN; SENSORY NEURONS; SUBSTANCE-P; VANILLOID RECEPTOR-1; EXPRESSION; MODEL; RAT	Nerve injury induces a state of prolonged thermal and mechanical hypersensitivity in the innervated area, causing distress in affected individuals. Nerve injury-induced hypersensitivity is partially due to increased activity and thereby sustained release of neurotransmitters from the injured fibers. Glutamate, a prominent neurotransmitter in primary afferents, plays a major role in development of hypersensitivity. Glutamate is packed in vesicles by vesicular glutamate transporters (VGLUTs) to enable controlled release upon depolarization. While a role for peripheral VGLUTs in nerve injury-induced pain is established, their contribution in specific peripheral neuronal populations is unresolved. We investigated the role of VGLUT2, expressed by transient receptor potential vanilloid (TRPV1) fibers, in nerve injury-induced hypersensitivity. Our data shows that removal of Vglut2 from Trpv1-Cre neurons using transgenic mice abolished both heat and punctuate hyperalgesia associated with nerve injury. In contrast, the development of cold hypersensitivity after nerve injury was unaltered. Here, we show that, VGLUT2-mediated glutamatergic transmission from Trpv1-Cre neurons selectively mediates heat and mechanical hypersensitivity associated with nerve injury. Our data clarifies the role of the Trpv1-Cre population and the dependence of VGLUT2-mediated glutamatergic transmission in nerve injury-induced hyperalgesia.	[Rogoz, Katarzyna; Stjarne, Ludvig; Kullander, Klas; Lagerstrom, Malin C.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Lagerstrom, MC (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	malin.lagerstrom@neuro.uu.se		Kullander, Klas/0000-0001-6418-5460				Binns BC, 2005, BRAIN RES, V1041, P38, DOI 10.1016/j.brainres.2005.01.088; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Christoph T, 2008, MOL CELL NEUROSCI, V37, P579, DOI 10.1016/j.mcn.2007.12.006; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dickenson AH, 1997, ACTA ANAESTH SCAND, V41, P112, DOI 10.1111/j.1399-6576.1997.tb04624.x; DICKENSON AH, 1990, TRENDS PHARMACOL SCI, V11, P307, DOI 10.1016/0165-6147(90)90228-Z; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Fundytus ME, 2001, CNS DRUGS, V15, P29, DOI 10.2165/00023210-200115010-00004; Gezelius H, 2006, J PHYSIOL-PARIS, V100, P297, DOI 10.1016/j.jphysparis.2007.05.001; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Jang JH, 2004, NEUROSCIENCE, V128, P169, DOI 10.1016/j.neuroscience.2004.06.040; Knowlton WM, 2013, J NEUROSCI, V33, P2837, DOI 10.1523/JNEUROSCI.1943-12.2013; Lagerstrom MC, 2011, P NATL ACAD SCI USA, V108, P5789, DOI 10.1073/pnas.1013602108; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Malmberg AB, 1998, PAIN, V76, P215, DOI 10.1016/S0304-3959(98)00045-1; MAO JR, 1993, BRAIN RES, V605, P164, DOI 10.1016/0006-8993(93)91368-3; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; Rogoz K, 2014, J NEUROSCI, V34, P14055, DOI 10.1523/JNEUROSCI.1722-14.2014; Rogoz K, 2014, MOL PHARMACOL, V85, P322, DOI 10.1124/mol.113.089532; Rogoz K, 2012, PAIN, V153, P1525, DOI 10.1016/j.pain.2012.04.017; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scherrer G, 2010, P NATL ACAD SCI USA, V107, P22296, DOI 10.1073/pnas.1013413108; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Shen J, 2012, ANESTHESIOLOGY, V117, P365, DOI 10.1097/ALN.0b013e318260de41; Sung BK, 2003, J NEUROSCI, V23, P2899; Urano H, 2012, INT J MED SCI, V9, P690, DOI 10.7150/ijms.4706; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Watabiki T, 2011, BIOL PHARM BULL, V34, P1105, DOI 10.1248/bpb.34.1105; Wu ZZ, 2013, PAIN, V154, P2130, DOI 10.1016/j.pain.2013.06.040; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	41	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116568	10.1371/journal.pone.0116568	http://dx.doi.org/10.1371/journal.pone.0116568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615623	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100031
J	Xiao, P; Yang, HX; Di, DD; Piao, DR; Zhang, QX; Hao, R; Yao, SX; Zhao, R; Zhang, FF; Tian, GZ; Zhao, HY; Fan, WX; Cui, BY; Jiang, H				Xiao, Pei; Yang, Hongxia; Di, Dongdong; Piao, Dongri; Zhang, Qiuxiang; Hao, Ruie; Yao, Suxia; Zhao, Rong; Zhang, Fanfei; Tian, Guozhong; Zhao, Hongyan; Fan, Weixing; Cui, Buyun; Jiang, Hai			Genotyping of Human Brucella melitensis Biovar 3 Isolated from Shanxi Province in China by MLVA16 and HOOF	PLOS ONE			English	Article							GENETIC DIVERSITY; STRAINS; ABORTUS	Background Brucellosis presents a significant economic burden for China because it causes reproductive failure in host species and chronic health problems in humans. These problems can involve multiple organs. Brucellosis is highly endemic in Shanxi Province China. Molecular typing would be very useful to epidemiological surveillance. The purpose of this study was to assess the diversity of Brucella melitensis strains for epidemiological surveillance. Historical monitoring data suggest that Brucella melitensis biovar 3 is the predominant strain associated with the epidemic of brucellosis in Shanxi Province. Methods/Principal Findings Multiple-locus variable-number repeat analysis (MLVA-16) and hypervariable octameric oligonucleotide fingerprinting (HOOF-print) were used to type a human-hosted Brucella melitensis population (81 strains). Sixty-two MLVA genotypes (discriminatory index: 0.99) were detected, and they had a genetic similarity coefficient ranging from 84.9% to 100%. Eighty strains of the population belonged to the eastern Mediterranean group with panel 1 genotypes 42 (79 strains) and 43 (1 strain). A new panel 1 genotype was found in this study. It was named 114 MLVAorsay genotype and it showed similarity to the two isolates from Guangdong in a previous study. Brucella melitensis is distributed throughout Shanxi Province, and like samples from Inner Mongolia, the eastern Mediterranean genotype 42 was the main epidemic strain (97%). The HOOF-printing showed a higher diversity than MLVA-16 with a genetic similarity coefficient ranging from 56.8% to 100%. Conclusions According to the MLVA-16 and HOOF-printing results, both methods could be used for the epidemiological surveillance of brucellosis. A new genotype was found in both Shanxi and Guangdong Provinces. In areas with brucellosis, the MLVA-16 scheme is very important for tracing cases back to their origins during outbreak investigations. It may facilitate the expansion and eradication of the disease.	[Xiao, Pei; Piao, Dongri; Tian, Guozhong; Zhao, Hongyan; Cui, Buyun; Jiang, Hai] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Yang, Hongxia; Zhang, Qiuxiang; Hao, Ruie; Yao, Suxia; Zhao, Rong; Zhang, Fanfei] Shanxi Ctr Dis Control & Prevent, Dis Inspect Lab, Taiyuan, Peoples R China; [Di, Dongdong; Fan, Weixing] China Anim Hlth & Epidemiol Ctr, MOA, Lab Zoonoses, Qingdao, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; China Animal Health & Epidemiology Center	Fan, WX (corresponding author), China Anim Hlth & Epidemiol Ctr, MOA, Lab Zoonoses, Qingdao, Peoples R China.	fwxsjl@126.com; cuibuyun@icdc.cn; jianghai@icdc.cn		Xiao, Pei/0000-0001-9976-7655	National Nature Science Foundation [81271900]; National Key Program for Infectious Diseases of China [2013ZX10004221, 2013ZX10004805, 2014ZX10004003]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Program for Infectious Diseases of China	This study was funded by the National Nature Science Foundation (81271900), National Key Program for Infectious Diseases of China (2013ZX10004221, 2013ZX10004805 and 2014ZX10004003). The funders contributed to the study design and data collection.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Alton G G, 1975, Monogr Ser World Health Organ, P1; BANAI M, 1990, J CLIN MICROBIOL, V28, P1057, DOI 10.1128/JCM.28.5.1057-1059.1990; Bodur H, 2003, SCAND J INFECT DIS, V35, P337, DOI 10.1080/00365540310008348; BRICKER BJ, 1994, J CLIN MICROBIOL, V32, P2660, DOI 10.1128/JCM.32.11.2660-2666.1994; Bricker BJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-37; Bricker BJ, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-15; Buyun C, 2007, ENDEMIC SURVEILLANCE, P649; Chen SY, 2014, EMERG INFECT DIS, V20, P126, DOI 10.3201/eid2001.130324; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Gorvel JP, 2008, MICROBES INFECT, V10, P1010, DOI 10.1016/j.micinf.2008.07.007; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Kasymbekov J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002047; Kattar MM, 2008, J CLIN MICROBIOL, V46, P3935, DOI 10.1128/JCM.00464-08; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Menshawy AMS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/353876; Mick E, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087257, 10.1371/journal.pone.0094168]; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Qiu JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034246; Ragan VE, 2002, VET MICROBIOL, V90, P11, DOI 10.1016/S0378-1135(02)00240-7; Rubach MP, 2013, CURR OPIN INFECT DIS, V26, P404, DOI 10.1097/QCO.0b013e3283638104; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; Valdezate S, 2010, J CLIN MICROBIOL, V48, P2734, DOI 10.1128/JCM.00533-10; Zhang WY, 2010, EMERG INFECT DIS, V16, P2001, DOI 10.3201/eid1612.091081	28	14	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115932	10.1371/journal.pone.0115932	http://dx.doi.org/10.1371/journal.pone.0115932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615697	Green Submitted, gold, Green Published			2022-12-27	WOS:000349122100021
J	Ribero, S; Glass, D; Aviv, A; Spector, TD; Bataille, V				Ribero, Simone; Glass, Daniel; Aviv, Abraham; Spector, Timothy David; Bataille, Veronique			Height and Bone Mineral Density Are Associated with Naevus Count Supporting the Importance of Growth in Melanoma Susceptibility	PLOS ONE			English	Article							BODY-MASS INDEX; TERT PROMOTER MUTATIONS; RISK-FACTORS; CUTANEOUS MELANOMA; TELOMERE LENGTH; CELLULAR SENESCENCE; MALIGNANT-MELANOMA; SKIN-CANCER; METAANALYSIS; WOMEN	Naevus count is the strongest risk factor for melanoma. Body Mass Index (BMI) has been linked to melanoma risk. In this study, we investigate the link between naevus count and height, weight and bone mineral density (BMD) in the TwinsUK cohort (N = 2119). In addition we adjusted for leucocyte telomere length (LTL) as LTL is linked to both BMD and naevus count. Naevus count was positively associated with height (p = 0.001) but not with weight (p = 0.187) despite adjusting for age and twin relatedness. This suggests that the previously reported melanoma association with BMI may be explained by height alone. Further adjustment for LTL did not affect the significance of the association between height and naevus count so LTL does not fully explain these results. BMD was associated with naevus count at the spine (coeff 18.9, p = 0.01), hip (coeff = 18.9, p = 0.03) and forearm (coeff = 32.7, p = 0.06) despite adjusting for age, twin relatedness, weight, height and LTL. This large study in healthy individuals shows that growth via height, probably in early life, and bone mass are risk factors for melanoma via increased naevus count. The link between these two phenotypes may possibly be explained by telomere biology, differentiation genes from the neural crests but also other yet unknown factors which may influence both bones and melanocytes biology.	[Ribero, Simone; Glass, Daniel; Spector, Timothy David; Bataille, Veronique] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Ribero, Simone] Univ Turin, Dept Med Sci, Dermatol Sect, Turin, Italy; [Glass, Daniel] Northwick Pk Hosp & Clin Res Ctr, Dept Dermatol, Harrow, Middx, England; [Aviv, Abraham] Univ Med & Dent New Jersey, Ctr Human Dev & Ageing, Newark, NJ 07103 USA; [Bataille, Veronique] West Herts NHS Trust, Dept Dermatol, Watford, Herts, England	University of London; King's College London; University of Turin; Imperial College London; Rutgers State University New Brunswick; Rutgers State University Medical Center	Bataille, V (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.	bataille@doctors.org.uk		ribero, simone/0000-0002-0098-1406	Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR)	Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	Funding for TwinsUK: The study was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility, and Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ZJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3596; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Azvolinsky A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju100; Bataille V, 1996, BRIT J CANCER, V73, P1605, DOI 10.1038/bjc.1996.302; Bataille V, 2000, JNCI-J NATL CANCER I, V92, P457, DOI 10.1093/jnci/92.6.457; Bataille V, 1998, BRIT J CANCER, V77, P505, DOI 10.1038/bjc.1998.81; Bataille V, 2007, CANCER EPIDEM BIOMAR, V16, P1499, DOI 10.1158/1055-9965.EPI-07-0152; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Chen Y, 2012, EUR J CANCER, V48, P2137, DOI 10.1016/j.ejca.2012.02.063; Clewes O, 2011, STEM CELL REV REP, V7, P799, DOI 10.1007/s12015-011-9255-5; Gallus S, 2006, MELANOMA RES, V16, P83, DOI 10.1097/01.cmr.0000194429.77643.76; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Green J, 2011, LANCET ONCOL, V12, P785, DOI 10.1016/S1470-2045(11)70154-1; Guthrie JR, 1998, OSTEOPOROSIS INT, V8, P282, DOI 10.1007/s001980050066; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; Han XS, 2014, INT J CANCER, V135, P2900, DOI 10.1002/ijc.28930; Harris ML, 2010, PIGM CELL MELANOMA R, V23, P496, DOI 10.1111/j.1755-148X.2010.00711.x; Hemminki K, 2003, INT J CANCER, V105, P692, DOI 10.1002/ijc.11150; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Koh JM, 2007, MOL CELLS, V23, P246; Law MH, 2012, J INVEST DERMATOL, V132, P1763, DOI 10.1038/jid.2012.75; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Na YR, 2009, CANCER SCI, V100, P2218, DOI 10.1111/j.1349-7006.2009.01301.x; Nagel G, 2012, BRIT J DERMATOL, V167, P59, DOI 10.1111/j.1365-2133.2012.10974.x; Nan HM, 2011, CANCER RES, V71, P6758, DOI 10.1158/0008-5472.CAN-11-1988; Nelms BL, 2010, DEV BIOL; NEWTON JA, 1993, J AM ACAD DERMATOL, V29, P989, DOI 10.1016/0190-9622(93)70279-3; Olsen CM, 2008, INT J CANCER, V122, P1100, DOI 10.1002/ijc.23214; Peeper DS, 2011, PIGM CELL MELANOMA R, V24, P1107, DOI 10.1111/j.1755-148X.2011.00933.x; Peterson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029177; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Renehan AG, 2011, LANCET ONCOL, V12, P716, DOI 10.1016/S1470-2045(11)70193-0; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Sergentanis TN, 2013, EUR J CANCER, V49, P642, DOI 10.1016/j.ejca.2012.08.028; Tang JY, 2013, CANCER EPIDEM BIOMAR, V22, P2412, DOI 10.1158/1055-9965.EPI-13-0647; Tran SL, 2012, J INVEST DERMATOL, V132, P2226, DOI 10.1038/jid.2012.126; Tripaldi R, 2013, BBA-REV CANCER, V1836, P27, DOI 10.1016/j.bbcan.2013.02.002; Valdes AM, 2007, OSTEOPOROSIS INT, V18, P1203, DOI 10.1007/s00198-007-0357-5; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wachsmuth RC, 2001, J INVEST DERMATOL, V117, P348, DOI 10.1046/j.0022-202x.2001.01415.x; Wallin A, 2011, EUR J CANCER, V47, P1606, DOI 10.1016/j.ejca.2011.01.020; Walter RB, 2013, JNCI-J NATL CANCER I, V105, P860, DOI 10.1093/jnci/djt102; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Zell JA, 2008, J CLIN ONCOL, V26, P66, DOI 10.1200/JCO.2007.12.3604; Zhai G, 2008, OSTEOPOROSIS INT, V19, P1211, DOI 10.1007/s00198-008-0562-x; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494; Zuo C, 2012, OSTEOPOROSIS INT, V23, P1653, DOI 10.1007/s00198-012-1909-x	51	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116863	10.1371/journal.pone.0116863	http://dx.doi.org/10.1371/journal.pone.0116863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612317	Green Submitted, Green Published, gold			2022-12-27	WOS:000348562900024
J	Chen, L; Chu, C; Kong, XY; Huang, T; Cai, YD				Chen, Lei; Chu, Chen; Kong, Xiangyin; Huang, Tao; Cai, Yu-Dong			Discovery of New Candidate Genes Related to Brain Development Using Protein Interaction Information	PLOS ONE			English	Article							NEURAL DEVELOPMENT; MESSENGER-RNA; HORMONE GHRH; EXPRESSION; PREDICTION; SECRETIN; CASPASE; PATHWAY; COMPLEX; ROLES	Human brain development is a dramatic process composed of a series of complex and fine-tuned spatiotemporal gene expressions. A good comprehension of this process can assist us in developing the potential of our brain. However, we have only limited knowledge about the genes and gene functions that are involved in this biological process. Therefore, a substantial demand remains to discover new brain development-related genes and identify their biological functions. In this study, we aimed to discover new brain-development related genes by building a computational method. We referred to a series of computational methods used to discover new disease-related genes and developed a similar method. In this method, the shortest path algorithm was executed on a weighted graph that was constructed using protein-protein interactions. New candidate genes fell on at least one of the shortest paths connecting two known genes that are related to brain development. A randomization test was then adopted to filter positive discoveries. Of the final identified genes, several have been reported to be associated with brain development, indicating the effectiveness of the method, whereas several of the others may have potential roles in brain development.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai 200444, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China; [Chu, Chen] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Kong, Xiangyin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Chu, Chen/J-6527-2019; Chen, Lei/A-2275-2011	Chu, Chen/0000-0001-8084-0867; Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [31371335, 61202021, 61373028, 61303099]; Innovation Program of the Shanghai Municipal Education Commission [12YZ120, 12ZZ087]; Shanghai Educational Development Foundation [12CG55]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Educational Development Foundation	This work was supported by the National Basic Research Program of China (2011CB510101, 2011CB510102), the National Natural Science Foundation of China (31371335, 61202021, 61373028, 61303099), the Innovation Program of the Shanghai Municipal Education Commission (12YZ120, 12ZZ087), and the Shanghai Educational Development Foundation (12CG55). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1989, MOLECULAR BIOLOGY OF; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Brouwers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022187; Chang LR, 2011, MICROSC RES TECHNIQ, V74, P153, DOI 10.1002/jemt.20886; CHANG TM, 1985, PEPTIDES, V6, P193, DOI 10.1016/0196-9781(85)90039-7; Chen C, 2011, BIOCHEM BIOPH RES CO, V411, P360, DOI 10.1016/j.bbrc.2011.06.148; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107767; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen Ming, 2005, In Silico Biology, V5, P111; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Deng M, 2014, GENE EXPR PATTERNS, V15, P31, DOI 10.1016/j.gep.2014.03.001; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Doerfler P, 2000, J IMMUNOL, V164, P4071, DOI 10.4049/jimmunol.164.8.4071; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Frenzel A, 2009, APOPTOSIS, V14, P584, DOI 10.1007/s10495-008-0300-z; Gao P, 2012, PROTEIN PEPTIDE LETT, V19, P910, DOI 10.2174/092986612802084528; Gao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045944; Gautam V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-4; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gormen T. H., 1990, INTRO ALGORITHMS; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; Hayashi M, 2002, NEPHROL DIAL TRANSPL, V17, P8, DOI 10.1093/ndt/17.suppl_9.8; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inestrosa NC, 2012, J NEUROIMMUNE PHARM, V7, P788, DOI 10.1007/s11481-012-9417-5; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang M, 2013, MOL BIOSYST, V9, P2720, DOI 10.1039/c3mb70089e; Kuranaga E, 2011, DEV GROWTH DIFFER, V53, P137, DOI 10.1111/j.1440-169X.2010.01237.x; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Lako M, 1998, HUM MOL GENET, V7, P813, DOI 10.1093/hmg/7.5.813; Laviolette SR, 2006, CELL MOL LIFE SCI, V63, P1597, DOI 10.1007/s00018-006-6027-5; Li BQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/267375; Li XW, 2014, STEM CELL TRANSL MED, V3, P662, DOI 10.5966/sctm.2013-0015; Liao WT, 2014, J PATHOL, V232, P415, DOI 10.1002/path.4309; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Lossi L, 2004, EUR J NEUROSCI, V20, P3259, DOI 10.1111/j.1460-9568.2004.03816.x; Maki RA, 2009, J BIOL CHEM, V284, P3158, DOI 10.1074/jbc.M807731200; Malaterre J, 2007, FRONT BIOSCI-LANDMRK, V12, P492, DOI 10.2741/2077; Matalova E, 2012, ARCH ORAL BIOL, V57, P1474, DOI 10.1016/j.archoralbio.2012.06.009; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Miranda LA, 2002, INT J DEV NEUROSCI, V20, P503, DOI 10.1016/S0736-5748(02)00057-6; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; ODONOHUE TL, 1981, P NATL ACAD SCI-BIOL, V78, P5221, DOI 10.1073/pnas.78.8.5221; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Piper M, 2014, J NEUROSCI, V34, P2921, DOI 10.1523/JNEUROSCI.2319-13.2014; Plaimas K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-67; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sheikh AM, 2010, J NEUROSCI RES, V88, P2641, DOI 10.1002/jnr.22416; Siu FKY, 2005, GENE EXPR PATTERNS, V5, P445, DOI 10.1016/j.modgep.2004.09.001; TAKAHASHI T, 1995, ENDOCRINOLOGY, V136, P4721, DOI 10.1210/en.136.10.4721; Temme C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00143; Waters EM, 2009, J NEUROSCI, V29, P9714, DOI 10.1523/JNEUROSCI.0135-09.2009; Waters M J, 2011, Pediatr Endocrinol Rev, V9, P549; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Xu K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00137; Yakovlev A, 2010, GENE, V450, P103, DOI 10.1016/j.gene.2009.10.008; Yamagata T, 2008, NEUROSCIENCE, V154, P1417, DOI 10.1016/j.neuroscience.2008.04.037; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Zou M, 2012, DEV BIOL, V364, P114, DOI 10.1016/j.ydbio.2012.01.021	69	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0118003	10.1371/journal.pone.0118003	http://dx.doi.org/10.1371/journal.pone.0118003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635857	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700111
J	Xu, J; Huang, HM; Huang, G; Mo, S				Xu Jing; Huang Haiming; Huang Guo; Mo Song			Numerical Simulation of Supersonic Gap Flow	PLOS ONE			English	Article							CAVITY	Various gaps in the surface of the supersonic aircraft have a significant effect on airflows. In order to predict the effects of attack angle, Mach number and width-to-depth ratio of gap on the local aerodynamic heating environment of supersonic flow, two-dimensional compressible Navier-Stokes equations are solved by the finite volume method, where convective flux of space term adopts the Roe format, and discretization of time term is achieved by 5-step Runge-Kutta algorithm. The numerical results reveal that the heat flux ratio is U-shaped distribution on the gap wall and maximum at the windward corner of the gap. The heat flux ratio decreases as the gap depth and Mach number increase, however, it increases as the attack angle increases. In addition, it is important to find that chamfer in the windward corner can effectively reduce gap effect coefficient. The study will be helpful for the design of the thermal protection system in reentry vehicles.	[Xu Jing; Huang Haiming; Huang Guo; Mo Song] Beijing Jiaotong Univ, Inst Engn Mech, Beijing 100044, Peoples R China	Beijing Jiaotong University	Huang, HM (corresponding author), Beijing Jiaotong Univ, Inst Engn Mech, Beijing 100044, Peoples R China.	hmhuang@bjtu.edu.cn			National Natural Sciences Foundation of China [11272042, 11472037]; Project of Education Ministry of China [62501036026]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Education Ministry of China	This work is supported by the National Natural Sciences Foundation of China (No: 11272042, 11472037) and the Project of Education Ministry of China (No: 62501036026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Huang HM, 2014, THERM SCI, V18, P1591, DOI 10.2298/TSCI1405591H; Huang HM, 2014, INT J NUMER METHOD H, V24, P1290, DOI 10.1108/HFF-03-2013-0095; inderks M, 2006, 44 AIAA AER SCI M EX; Jackson AP, 2001, J FLUID MECH, V427, P329, DOI 10.1017/S0022112000002433; Jiang GQ, 1999, J PROPULSION TECHNOL, V20, P50; Larcheveque L, 2004, J FLUID MECH, V516, P265, DOI 10.1017/S0022112004000709; Mori K, 2012, 43 AIAA THERM C NEW; Paolicchi L, 2010, NAT C MECH ENG CAMP; [沈淳 Shen Chun], 2012, [航空学报, Acta Aeronautica et Astronautica Sinica], V33, P34; Spalar PR, 1992, 30 AIAA AER SCI M EX; Tang GM, 2000, EXPT MEASUREMENTS FL, V14, P1; Yang K, 2012, THEOR APPL MECH LETT, V2, DOI 10.1063/2.1201203	12	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117012	10.1371/journal.pone.0117012	http://dx.doi.org/10.1371/journal.pone.0117012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635395	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700066
J	Gao, Y; Xie, YP; Xiong, Q; Liu, WM; Xue, JL				Gao, Ying; Xie, Ying Ping; Xiong, Qi; Liu, Wei Min; Xue, Jiao Liang			Ultrastructural Exploration on the Histopathological Change in Phenacoccus fraxinus Infected with Lecanicillium lecanii	PLOS ONE			English	Article							VERTICILLIUM-LECANII; INVASION; CUTICLE	The histopathological changes of the second instar nymph of the mealybug Phenacoccus fraxinus infected with Lecanicillium lecanii strain 3.4505 were investigated using light, scanning and transmission electron microscopy. The results demonstrated that L. lecanii 3.4505 could infect P. fraxinus in a short period. At 24 h post-inoculation, the conidia of L. lecanii 3.4505 adhered to the indented gloves or intersegmental folds of the insect body surface. Subsequently, the germinated conidia produced germ-tubes, appressoria and extended hyphae, which tightly adhered to the cuticle. Penetration of cuticle could be achieved either by peg form appressoria or directly by hyphae. Also, the conidia and hyphae could secrete massive mucilages causing visible damage to the host cuticle. After 48 h, the body wall, tissues and organs, including cuticle, trachea, fat body, muscle, Malpighian tubules and nerve ganglion, were destroyed by ramification of hyphae as a result of infection. The endoplasmic reticulum hypertrophied and formed obvious fingerprint agglomerates, and the mitochondria swelled and deformed in the haemocytes. Finally, the mycelium fully occupied the entire haemocoel. The entire bodies were wrapped in a white mycelium, with the mycelium extending radically outward.	[Gao, Ying; Xie, Ying Ping; Xiong, Qi; Xue, Jiao Liang] Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China; [Liu, Wei Min] Shanxi Univ, Inst Appl Biol, Taiyuan 030006, Peoples R China	Shanxi University; Shanxi University	Xie, YP (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China.	xieyingping@eyou.com			National Natural Science Foundation of China [30671693, 31070584]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20101401110008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by the National Natural Science Foundation of China (30671693 and 31070584), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20101401110008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askary H, 1999, J INVERTEBR PATHOL, V74, P1, DOI 10.1006/jipa.1999.4857; Feng Mingguang, 1998, Weishengwu Xuebao, V38, P461; Han Zhenzhen, 2010, Weishengwu Xuebao, V50, P211; Liu WM, 2009, J INVERTEBR PATHOL, V101, P96, DOI 10.1016/j.jip.2009.03.002; Peng Guoliang, 2009, Chinese Journal of Applied and Environmental Biology, V15, P220, DOI 10.3724/SP.J.1145.2009.00220; StLeger RJ, 1996, APPL ENVIRON MICROB, V62, P907, DOI 10.1128/AEM.62.3.907-912.1996; XIE Y. P., 2006, WAX SECRETIONS SOFT; Xie Y. P., 1998, SCALE INSECTS FOREST; Zare R, 2001, NOVA HEDWIGIA, V73, P1; Zhang YF, 2009, J ENTOMOL SCI, V44, P59, DOI 10.18474/0749-8004-44.1.59	10	6	6	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117428	10.1371/journal.pone.0117428	http://dx.doi.org/10.1371/journal.pone.0117428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629309	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100082
J	Henry, M; Bobay, LM; Chevallereau, A; Saussereau, E; Ceyssens, PJ; Debarbieux, L				Henry, Marine; Bobay, Louis-Marie; Chevallereau, Anne; Saussereau, Emilie; Ceyssens, Pieter-Jan; Debarbieux, Laurent			The Search for Therapeutic Bacteriophages Uncovers One New Subfamily and Two New Genera of Pseudomonas-Infecting Myoviridae	PLOS ONE			English	Article							HOST-RANGE; PHAGE THERAPY; AERUGINOSA; PROTEIN; CLASSIFICATION; GENOMICS; SERVER; TREAT	In a previous study, six virulent bacteriophages PAK_P1, PAK_P2, PAK_P3, PAK_P4, PAK_P5 and CHA_P1 were evaluated for their in vivo efficacy in treating Pseudomonas aeruginosa infections using a mouse model of lung infection. Here, we show that their genomes are closely related to five other Pseudomonas phages and allow a subdivision into two clades, PAK_P1-like and KPP10-like viruses, based on differences in genome size, % GC and genomic contents, as well as number of tRNAs. These two clades are well delineated, with a mean of 86% and 92% of proteins considered homologous within individual clades, and 25% proteins considered homologous between the two clades. By ESI-MS/ MS analysis we determined that their virions are composed of at least 25 different proteins and electron microscopy revealed a morphology identical to the hallmark Salmonella phage Felix O1. A search for additional bacteriophage homologs, using profiles of protein families defined from the analysis of the 11 genomes, identified 10 additional candidates infecting hosts from different species. By carrying out a phylogenetic analysis using these 21 genomes we were able to define a new subfamily of viruses, the Felixounavirinae within the Myoviridae family. The new Felixounavirinae subfamily includes three genera: Felixounalikevirus, PAK_P1likevirus and KPP10likevirus. Sequencing genomes of bacteriophages with therapeutic potential increases the quantity of genomic data on closely related bacteriophages, leading to establishment of new taxonomic clades and the development of strategies for analyzing viral genomes as presented in this article.	[Henry, Marine; Chevallereau, Anne; Saussereau, Emilie; Debarbieux, Laurent] Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France; [Bobay, Louis-Marie] Inst Pasteur, Dept Genomes & Genet, Microbial Evolutionary Genom Unit, Paris, France; [Bobay, Louis-Marie] CNRS, UMR3525, Paris, France; [Bobay, Louis-Marie; Saussereau, Emilie] Univ Paris 06, Paris, France; [Chevallereau, Anne] Univ Paris 07, Sorbonne Paris Cite, Paris, France; [Ceyssens, Pieter-Jan] Katholieke Univ Leuven, Div Gene Technol, Lab Gene Technol, B-3001 Heverlee, Belgium; [Ceyssens, Pieter-Jan] Sci Inst Publ Hlth WIV ISP, Unit Bacterial Dis, Brussels, Belgium	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; KU Leuven	Debarbieux, L (corresponding author), Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France.	laurent.debarbieux@pasteur.fr	Chevallereau, Anne/H-9675-2019	Chevallereau, Anne/0000-0003-3369-7468; Ceyssens, Pieter-Jan/0000-0001-7735-8316; Debarbieux, Laurent/0000-0001-6875-5758	Vaincre la Mucoviscidose [IC1011]; Ministere de l'enseignement superieur et de la recherche	Vaincre la Mucoviscidose; Ministere de l'enseignement superieur et de la recherche	Funding: This work was supported by a grant from Vaincre la Mucoviscidose (IC1011) to MH and a grant from the Ministere de l'enseignement superieur et de la recherche to LMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048053; Bailly-Bechet M, 2007, GENOME RES, V17, P1486, DOI 10.1101/gr.6649807; Bobay LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003825; Brussow H, 2012, VIROLOGY, V434, P138, DOI 10.1016/j.virol.2012.09.015; Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]; Ceyssens PJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-134; Ceyssens PJ, 2009, ENVIRON MICROBIOL, V11, P1303, DOI 10.1111/j.1462-2920.2008.01862.x; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Comeau AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040102; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; De Paepe M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004181; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Essoh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060575; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Frampton RA, 2014, APPL ENVIRON MICROB, V80, P2216, DOI 10.1128/AEM.00062-14; Garbe J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-102; Gill JJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-542; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Henry M, 2013, ANTIMICROB AGENTS CH, V57, P5961, DOI 10.1128/AAC.01596-13; Huys I, 2013, EMBO REP, V14, P951, DOI 10.1038/embor.2013.163; Jiang XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-194; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Kropinski AM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-76; Krupovic M, 2011, CURR OPIN VIROL, V1, P118, DOI 10.1016/j.coviro.2011.06.001; Lavigne R, 2006, MICROBIOL-SGM, V152, P529, DOI 10.1099/mic.0.28431-0; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224; Lopes A, 2010, NUCLEIC ACIDS RES, V38, P3952, DOI 10.1093/nar/gkq096; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062933; Mahadevan Padmanabhan, 2009, BMC Res Notes, V2, P168, DOI 10.1186/1756-0500-2-168; Martinsohn JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000065; McCallin S, 2013, VIROLOGY, V443, P187, DOI 10.1016/j.virol.2013.05.022; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Moak M, 2004, MOL MICROBIOL, V51, P1169, DOI 10.1046/j.1365-2958.2003.03894.x; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Pier GB, 2009, MANDELL DOUGLAS BENN, P2835, DOI 10.1056/NEJMoa1304839.Two; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Santos SB, 2011, J VIROL, V85, P11265, DOI 10.1128/JVI.01769-10; Saussereau E, 2014, CLIN MICROBIOL INFEC; Saussereau E, 2012, ADV VIRUS RES, V83, P123, DOI 10.1016/B978-0-12-394438-2.00004-9; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; TOUSSAINT B, 1993, BIOCHEM BIOPH RES CO, V196, P416, DOI 10.1006/bbrc.1993.2265; Truncaite L, 2012, ARCH VIROL, V157, P2431, DOI 10.1007/s00705-012-1449-x; Tummler B, 2006, PSEUDOMONAS; Uchiyama J, 2012, ARCH VIROL, V157, P733, DOI 10.1007/s00705-011-1210-x; Verbeken G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/621316; Verbeken G, 2014, ARCH IMMUNOL THER EX, V62, P117, DOI 10.1007/s00005-014-0269-y; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Zilberberg MD, 2013, J HOSP MED, V8, P559, DOI 10.1002/jhm.2080; Zuber S, 2007, J BACTERIOL, V189, P8206, DOI 10.1128/JB.00838-07	58	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117163	10.1371/journal.pone.0117163	http://dx.doi.org/10.1371/journal.pone.0117163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629728	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100070
J	Kitajima, K; Tanaka, U; Ueno, Y; Maeda, T; Suenaga, Y; Takahashi, S; Deguchi, M; Miyahara, Y; Ebina, Y; Yamada, H; Tsurusaki, M; Tamaki, Y; Sugimura, K				Kitajima, Kazuhiro; Tanaka, Utaru; Ueno, Yoshiko; Maeda, Tetsuo; Suenaga, Yuko; Takahashi, Satoru; Deguchi, Masashi; Miyahara, Yoshiya; Ebina, Yasuhiko; Yamada, Hideto; Tsurusaki, Masakatsu; Tamaki, Yukihisa; Sugimura, Kazuro			Role of Diffusion Weighted Imaging and Contrast-Enhanced MRI in the Evaluation of Intrapelvic Recurrence of Gynecological Malignant Tumor	PLOS ONE			English	Article							OVARIAN-CANCER; PERITONEAL DISSEMINATION; CARCINOMA; DIAGNOSIS; FUSION; PET/CT	Background and Purpose To investigate the diagnostic performance of diffusion-weighted imaging (DWI) and contrast-enhanced imaging in combination with T2-weighted imaging (T2WI) for magnetic resonance imaging (MRI) evaluation of intrapelvic recurrence of gynecological malignancies. Materials and Methods Sixty-two patients with suspected intrapelvic recurrence of gynecological malignancies underwent pelvic MRI including T2WI DWI, and contrast-enhanced imaging. Diagnostic performance for detection of local recurrence, pelvic lymph node and bone metastases, and peritoneal lesions was evaluated by consensus reading of two experienced radiologists using a 5-point scoring system, and compared among T2WI with unenhanced T1-weighted imaging (T1WI) (protocol A), a combination of protocol A and DWI (protocol B), and a combination of protocol B and contrast-enhanced imaging (protocol C). Final diagnoses were obtained by histopathological examinations, radiological imaging and clinical follow-up for at least 6 months. Receiver operating characteristic (ROC) analysis and McNemar test were employed for statistical analysis. Results Locally recurrent disease, lymph node recurrence, peritoneal dissemination and bone metastases were present in 48.4%, 29.0%, 16.1%, and 6.5% of the patients, respectively. The patient-based sensitivity, specificity, accuracy, and area under the ROC curve (AUC) for detection of intrapelvic recurrence were 55.0, 81.8, 64.5% and 0.753 for protocol A, 80.0, 77.3,79.0% and 0.838 for protocol B, and 80.0, 90.9, 83.9% and 0.862 for protocol C, respectively. The sensitivity, accuracy, and AUC were significantly better for protocols B and C than for protocol A (p<0.001). There was no significant difference between protocols B and C. Conclusion MRI using a combination of DWI and T2WI gives comparatively acceptable results for assessment of intrapelvic recurrence of gynecological malignancies.	[Kitajima, Kazuhiro; Tanaka, Utaru; Ueno, Yoshiko; Maeda, Tetsuo; Suenaga, Yuko; Takahashi, Satoru; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan; [Deguchi, Masashi; Miyahara, Yoshiya; Ebina, Yasuhiko; Yamada, Hideto] Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Kobe, Hyogo 657, Japan; [Tsurusaki, Masakatsu] Kinki Univ, Sch Med, Dept Diagnost Radiol, Osaka 589, Japan; [Tamaki, Yukihisa] Shimane Univ, Sch Med, Dept Radiat Oncol, Matsue, Shimane, Japan	Kobe University; Kobe University; Kindai University (Kinki University); Shimane University	Kitajima, K (corresponding author), Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan.	kitajima@med.kobe-u.ac.jp	Ebina, Yasuhiko/AAD-8137-2022					Blecharz P, 2011, EUR J GYNAECOL ONCOL, V32, P403; Donati OF, 2013, EUR RADIOL, V23, P2906, DOI 10.1007/s00330-013-2875-1; Fujii S, 2008, EUR RADIOL, V18, P18, DOI 10.1007/s00330-007-0732-9; Kido A, 2013, J MAGN RESON IMAGING, V37, P249, DOI 10.1002/jmri.23716; Kinkel K, 1997, RADIOLOGY, V204, P55, DOI 10.1148/radiology.204.1.9205223; Kitajima K, 2014, ANN NUCL MED, V28, P25, DOI 10.1007/s12149-013-0777-6; Kyriazi S, 2010, RADIOGRAPHICS, V30, P1269, DOI 10.1148/rg.305105073; Low RN, 2005, RADIOLOGY, V235, P918, DOI 10.1148/radiol.2353040447; Namimoto T, 2009, EUR RADIOL, V19, P745, DOI 10.1007/s00330-008-1185-5; Nishie A, 2008, J MAGN RESON IMAGING, V28, P705, DOI 10.1002/jmri.21486; Nougaret S, 2013, AM J ROENTGENOL, V200, P261, DOI 10.2214/AJR.12.9713; Ricke J, 2003, EUR RADIOL, V13, P943, DOI 10.1007/s00330-002-1712-8; Salaa E, 2010, EUR J RADIOL, V76, P367, DOI 10.1016/j.ejrad.2010.01.026; Satoh Y, 2011, AM J ROENTGENOL, V196, P447, DOI 10.2214/AJR.10.4687; Yamashita Y, 1996, JMRI-J MAGN RESON IM, V6, P167, DOI 10.1002/jmri.1880060130	15	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117411	10.1371/journal.pone.0117411	http://dx.doi.org/10.1371/journal.pone.0117411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629156	gold, Green Published, Green Submitted			2022-12-27	WOS:000348732100081
J	Valenti, D; Denaro, G; Spagnolo, B; Conversano, F; Brunet, C				Valenti, Davide; Denaro, Giovanni; Spagnolo, Bernardo; Conversano, Fabio; Brunet, Christophe			How Diffusivity, Thermocline and Incident Light Intensity Modulate the Dynamics of Deep Chlorophyll Maximum in Tyrrhenian Sea	PLOS ONE			English	Article							MEDITERRANEAN SEA; VERTICAL-DISTRIBUTION; PHYTOPLANKTON COMPETITION; NUTRIENT AVAILABILITY; OPTICAL-PROPERTIES; NORTH PACIFIC; NOISE; PICOPHYTOPLANKTON; PROCHLOROCOCCUS; GROWTH	During the last few years theoretical works have shed new light and proposed new hypotheses on the mechanisms which regulate the spatio-temporal behaviour of phytoplankton communities in marine pelagic ecosystems. Despite this, relevant physical and biological issues, such as effects of the time-dependent mixing in the upper layer, competition between groups, and dynamics of non-stationary deep chlorophyll maxima, are still open questions. In this work, we analyze the spatio-temporal behaviour of five phytoplankton populations in a real marine ecosystem by using a one-dimensional reaction-diffusion-taxis model. The study is performed, taking into account the seasonal variations of environmental variables, such as light intensity, thickness of upper mixed layer and profiles of vertical turbulent diffusivity, obtained starting from experimental findings. Theoretical distributions of phytoplankton cell concentration was converted in chlorophyll concentration, and compared with the experimental profiles measured in a site of the Tyrrhenian Sea at four different times (seasons) of the year, during four different oceanographic cruises. As a result we find a good agreement between theoretical and experimental distributions of chlorophyll concentration. In particular, theoretical results reveal that the seasonal changes of environmental variables play a key role in the phytoplankton distribution and determine the properties of the deep chlorophyll maximum. This study could be extended to other marine ecosystems to predict future changes in the phytoplankton biomass due to global warming, in view of devising strategies to prevent the decline of the primary production and the consequent decrease of fish species.	[Valenti, Davide; Denaro, Giovanni; Spagnolo, Bernardo] Univ Palermo, Dipartimento Chim Fis, Grp Interdisciplinary Theoret Phys & Consorzio Na, Unit Palermo, Palermo, Italy; [Spagnolo, Bernardo] Ist Nazl Fis Nucleare, Sez Catania, Catania, Italy; [Spagnolo, Bernardo] Lobachevsky State Univ, Radiophys Dept, Nizhnii Novgorod, Russia; [Conversano, Fabio; Brunet, Christophe] Staz Zoolog Anton Dohrn, Naples, Italy	University of Palermo; Lobachevsky State University of Nizhni Novgorod; Stazione Zoologica Anton Dohrn di Napoli	Valenti, D (corresponding author), Univ Palermo, Dipartimento Chim Fis, Grp Interdisciplinary Theoret Phys & Consorzio Na, Unit Palermo, Palermo, Italy.	davide.valenti@unipa.it	Conversano, Fabio/AAW-9219-2021; brunet, christophe/AAD-7817-2021; Spagnolo, Bernardo/F-6973-2014; Valenti, Davide/K-9228-2015	Spagnolo, Bernardo/0000-0002-6625-3989; Valenti, Davide/0000-0001-5496-1518	Project "PESCA-TEC - Sviluppo di una Pesca Siciliana Sostenibile e Competitiva attraverso l'Innovazione Tecnologica" [PON02_00451_3362121]; Project "SHELF-LIFE-Utilizzo integrato di approcci tecnologici innovativi per migliorare la shelf-life e preservare le proprieta nutrizionali di prodotti agroalimentari" [PON02_00451_3361909]; Ministry of University, Research and Education of Italian Government	Project "PESCA-TEC - Sviluppo di una Pesca Siciliana Sostenibile e Competitiva attraverso l'Innovazione Tecnologica"; Project "SHELF-LIFE-Utilizzo integrato di approcci tecnologici innovativi per migliorare la shelf-life e preservare le proprieta nutrizionali di prodotti agroalimentari"; Ministry of University, Research and Education of Italian Government	The authors acknowledge the financial support by Project PON02_00451_3362121 "PESCA-TEC - Sviluppo di una Pesca Siciliana Sostenibile e Competitiva attraverso l'Innovazione Tecnologica", Project PON02_00451_3361909 "SHELF-LIFE-Utilizzo integrato di approcci tecnologici innovativi per migliorare la shelf-life e preservare le proprieta nutrizionali di prodotti agroalimentari", and partially by Ministry of University, Research and Education of Italian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barale V, 2008, REMOTE SENS ENVIRON, V112, P3300, DOI 10.1016/j.rse.2007.10.014; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Beversdorf LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056103; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Bonanno G, 2006, EUR PHYS J B, V53, P405, DOI 10.1140/epjb/e2006-00388-l; Bonanno G, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016106; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Bougaran G, 2010, J THEOR BIOL, V265, P443, DOI 10.1016/j.jtbi.2010.04.018; Brunet C, 2003, J PLANKTON RES, V25, P1413, DOI 10.1093/plankt/fbg091; Brunet C, 2006, AQUAT MICROB ECOL, V44, P127, DOI 10.3354/ame044127; Brunet C, 2008, J PLANKTON RES, V30, P645, DOI 10.1093/plankt/fbn028; Brunet C, 2007, MAR ECOL PROG SER, V346, P15, DOI 10.3354/meps07017; Caruso A, 2005, FLUCT NOISE LETT, V5, pL349, DOI 10.1142/S0219477505002768; Casotti R, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001541; Casotti R, 2000, MAR ECOL PROG SER, V195, P15, DOI 10.3354/meps195015; Chichigina O, 2005, FLUCT NOISE LETT, V5, pL243, DOI 10.1142/S0219477505002616; Chichigina OA, 2008, EUR PHYS J B, V65, P347, DOI 10.1140/epjb/e2008-00226-6; Chichigina OA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021134; CULLEN JJ, 1982, CAN J FISH AQUAT SCI, V39, P791, DOI 10.1139/f82-108; Cuttitta A, 2003, HYDROBIOLOGIA, V503, P117, DOI 10.1023/B:HYDR.0000008473.96144.d3; d'Alcala MR, 2009, DEEP-SEA RES PT II, V56, P676, DOI 10.1016/j.dsr2.2008.07.028; d'Alcala MR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001650; D'Ortenzio F, 2003, THESIS OPEN U LONDON; Denaro G, 2013, ACTA PHYS POL B, V44, P977, DOI 10.5506/APhysPolB.44.977; Denaro G, 2013, ECOL COMPLEX, V13, P21, DOI 10.1016/j.ecocom.2012.10.002; Denaro G, 2014, THESIS U PALERMO ITA; Denaro G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066765; Denis M, 2010, BIOGEOSCIENCES, V7, P2227, DOI 10.5194/bg-7-2227-2010; DENMAN KL, 1983, LIMNOL OCEANOGR, V28, P801, DOI 10.4319/lo.1983.28.5.0801; Dimier C, 2009, LIMNOL OCEANOGR, V54, P823, DOI 10.4319/lo.2009.54.3.0823; Dubkov AA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041104; Fiasconaro A, 2006, EUR PHYS J B, V50, P189, DOI 10.1140/epjb/e2006-00058-4; Garczarek L, 2007, FEMS MICROBIOL ECOL, V60, P189, DOI 10.1111/j.1574-6941.2007.00297.x; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Haefner J.W, 2005, MODELING BIOL SYSTEM; Hickman AE, 2010, MAR ECOL PROG SER, V406, P1, DOI 10.3354/meps08588; Holm-Hansen O, 2004, POLAR BIOL, V27, P699, DOI 10.1007/s00300-004-0641-1; HUISMAN J, 1994, ECOLOGY, V75, P507, DOI 10.2307/1939554; Huisman J, 2006, NATURE, V439, P322, DOI 10.1038/nature04245; Hundsdorfer WH., 2003, NUMERICAL SOLUTION T, V33; Jennings S, 2001, MARINE FISHERIES ECO, DOI [10.1002/9781119968535.ch21, DOI 10.1002/9781119968535.CH21]; Justic D, 2002, ECOL MODEL, V152, P33, DOI 10.1016/S0304-3800(01)00472-0; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Ki&DEG;rboe T., 2008, MECHANISTIC APPROACH; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Klausmeier CA, 2007, J THEOR BIOL, V246, P278, DOI 10.1016/j.jtbi.2006.12.032; Klausmeier CA, 2001, LIMNOL OCEANOGR, V46, P1998, DOI 10.4319/lo.2001.46.8.1998; Koroleff F., 1976, METHODS SEAWATER ANA, P117; La Barbera A, 2002, PHYSICA A, V314, P120, DOI 10.1016/S0378-4371(02)01173-1; La Cognata A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011121; La Ferla R, 2012, HELGOLAND MAR RES, V66, P635, DOI 10.1007/s10152-012-0297-0; Lemesle V, 2008, ACTA BIOTHEOR, V56, P87, DOI 10.1007/s10441-008-9031-3; Letelier RM, 2004, LIMNOL OCEANOGR, V49, P508, DOI 10.4319/lo.2004.49.2.0508; LI WKW, 1995, MAR ECOL PROG SER, V122, P1, DOI 10.3354/meps122001; Liu QX, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/05/P05011; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Mann KH, 1996, DYNAMICS MARINE ECOS, P480, DOI 10.2307/2960585; Massel S. R., 1999, FLUID MECH MARINE EC; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; Mei ZP, 2009, J THEOR BIOL, V259, P582, DOI 10.1016/j.jtbi.2009.04.018; Melbourne-Thomas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055093; Mella-Flores D, 2011, BIOGEOSCIENCES, V8, P2785, DOI 10.5194/bg-8-2785-2011; Monin A.S., 1971, STAT FLUID MECH MECH, V2; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; MOREL A, 1993, J MAR RES, V51, P617, DOI 10.1357/0022240933223963; Morel A, 1997, LIMNOL OCEANOGR, V42, P1746, DOI 10.4319/lo.1997.42.8.1746; Nakamura Y., 1991, IAHS PUBL INT ASS HY, P227; NISHIMURA H, 1987, CONT SHELF RES, V7, P1245, DOI 10.1016/0278-4343(87)90087-2; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; OAKEY NS, 1982, J PHYS OCEANOGR, V12, P171, DOI 10.1175/1520-0485(1982)012<0171:DWTSML>2.0.CO;2; Olson R.J., 2018, HDB METHODS AQUATIC, P175, DOI DOI 10.1201/9780203752746; Pankratov EL, 2005, EUR PHYS J B, V46, P15, DOI 10.1140/epjb/e2005-00233-1; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Patti B, 2010, SCI MAR, V74, P577, DOI 10.3989/scimar.2010.74n3577; PETERS H, 1988, J GEOPHYS RES-OCEANS, V93, P1199, DOI 10.1029/JC093iC02p01199; Quevedo M, 2001, MAR ECOL PROG SER, V221, P29, DOI 10.3354/meps221029; Raven JA, 2005, VIE MILIEU, V55, P209; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Roache P. J., 1998, FUNDAMENTALS COMPUTA; Roache P.J., 1976, COMPUTATIONAL FLUID; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; Ryabov AB, 2008, MATH MODEL NAT PHENO, V3, P42, DOI 10.1051/mmnp:2008064; Ryabov AB, 2012, THEOR ECOL-NETH, V5, P373, DOI 10.1007/s12080-012-0158-0; Ryabov AB, 2011, ECOL LETT, V14, P220, DOI 10.1111/j.1461-0248.2010.01574.x; Ryabov AB, 2010, J THEOR BIOL, V263, P120, DOI 10.1016/j.jtbi.2009.10.034; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Schmittner A, 2005, NATURE, V434, P628, DOI 10.1038/nature03476; SHIGESADA N, 1981, J MATH BIOL, V12, P311, DOI 10.1007/BF00276919; Spagnolo B, 2005, PROG THEOR PHYS SUPP, P312, DOI 10.1143/PTPS.157.312; Spagnolo B, 2004, MATH BIOSCI ENG, V1, P185; Spagnolo B, 2003, FLUCT NOISE LETT, V3, pL177, DOI 10.1142/S0219477503001245; Spagnolo B, 2002, J PHYS-CONDENS MAT, V14, P2247, DOI 10.1088/0953-8984/14/9/313; Spagnolo B, 2002, PHYSICA A, V315, P114, DOI 10.1016/S0378-4371(02)01245-1; Thi NNP, 2005, J COMPUT APPL MATH, V174, P57, DOI 10.1016/j.cam.2004.03.023; THINGSTAD TF, 1995, MAR ECOL PROG SER, V117, P299, DOI 10.3354/meps117299; THINGSTAD TF, 1990, MAR ECOL PROG SER, V63, P261, DOI 10.3354/meps063261; Timmermans KR, 2005, J SEA RES, V53, P109, DOI 10.1016/j.seares.2004.05.003; Turner J. S., 1973, BUOYANCY EFFECTS FLU; Turpin D.H., 1988, P316; Tveito A., 1998, INTRO PARTIAL DIFFER; Valenti D, 2008, EUR PHYS J B, V65, P443, DOI 10.1140/epjb/e2008-00315-6; Valenti D, 2008, ECOL MODEL, V213, P449, DOI 10.1016/j.ecolmodel.2008.01.023; Valenti D, 2006, EUR PHYS J B, V50, P199, DOI 10.1140/epjb/e2006-00102-5; Valenti D, 2004, ACTA PHYS POL B, V35, P1481; Valenti D, 2012, ACTA PHYS POL B, V43, P1227, DOI 10.5506/APhysPolB.43.1227; Valenti D, 2004, PHYSICA A, V331, P477, DOI 10.1016/j.physa.2003.09.036; Veldhuis MJW, 2005, J SEA RES, V53, P7, DOI 10.1016/j.seares.2004.01.006; Veldman AEP, 2001, LECT NOTES; VENRICK EL, 1993, LIMNOL OCEANOGR, V38, P1135, DOI 10.4319/lo.1993.38.6.1135; VENRICK EL, 1973, FISH B-NOAA, V71, P41; Vidussi F, 2001, J GEOPHYS RES-OCEANS, V106, P19939, DOI 10.1029/1999JC000308; Weston K, 2005, J PLANKTON RES, V27, P909, DOI 10.1093/plankt/fbi064; Yeo SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056207; Yoshiyama K, 2009, AM NAT, V174, P190, DOI 10.1086/600113; Zimmer C, 1999, SCIENCE, V284, P83, DOI 10.1126/science.284.5411.83	117	23	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115468	10.1371/journal.pone.0115468	http://dx.doi.org/10.1371/journal.pone.0115468			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629963	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100017
J	van Munster, JM; Nitsche, BM; Akeroyd, M; Dijkhuizen, L; van der Maarel, MJEC; Ram, AFJ				van Munster, Jolanda M.; Nitsche, Benjamin M.; Akeroyd, Michiel; Dijkhuizen, Lubbert; van der Maarel, Marc J. E. C.; Ram, Arthur F. J.			Systems Approaches to Predict the Functions of Glycoside Hydrolases during the Life Cycle of Aspergillus niger Using Developmental Mutants Delta brlA and Delta flbA	PLOS ONE			English	Article							CHITIN SYNTHASE GENES; CELL-WALL; ASEXUAL SPORULATION; CARBON STARVATION; SACCHAROMYCES-CEREVISIAE; EXPRESSION; AUTOLYSIS; NIDULANS; PROTEIN; GROWTH	Background The filamentous fungus Aspergillus niger encounters carbon starvation in nature as well as during industrial fermentations. In response, regulatory networks initiate and control autolysis and sporulation. Carbohydrate-active enzymes play an important role in these processes, for example by modifying cell walls during spore cell wall biogenesis or in cell wall degradation connected to autolysis. Results In this study, we used developmental mutants (Delta flbA and Delta brlA) which are characterized by an aconidial phenotype when grown on a plate, but also in bioreactor-controlled submerged cultivations during carbon starvation. By comparing the transcriptomes, proteomes, enzyme activities and the fungal cell wall compositions of a wild type A. niger strain and these developmental mutants during carbon starvation, a global overview of the function of carbohydrate- active enzymes is provided. Seven genes encoding carbohydrate-active enzymes, including cfcA, were expressed during starvation in all strains; they may encode enzymes involved in cell wall recycling. Genes expressed in the wild-type during starvation, but not in the developmental mutants are likely involved in conidiogenesis. Eighteen of such genes were identified, including characterized sporulation-specific chitinases and An15g02350, member of the recently identified carbohydrate-active enzyme family AA11. Eight of the eighteen genes were also expressed, independent of FlbA or BrlA, in vegetative mycelium, indicating that they also have a role during vegetative growth. The Delta flbA strain had a reduced specific growth rate, an increased chitin content of the cell wall and specific expression of genes that are induced in response to cell wall stress, indicating that integrity of the cell wall of strain Delta flbA is reduced. Conclusion The combination of the developmental mutants Delta flbA and Delta brlA resulted in the identification of enzymes involved in cell wall recycling and sporulation-specific cell wall modification, which contributes to understanding cell wall remodeling mechanisms during development.	[van Munster, Jolanda M.; Dijkhuizen, Lubbert; van der Maarel, Marc J. E. C.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Microbial Physiol Res Grp, Groningen, Netherlands; [Nitsche, Benjamin M.; Ram, Arthur F. J.] Leiden Univ, Kluyver Ctr Genom Ind Fermentat, Inst Biol Leiden, Leiden, Netherlands; [Akeroyd, Michiel] DSM Biotechnol Ctr, Beijerinck Lab, Delft, Netherlands; [van der Maarel, Marc J. E. C.] Univ Groningen, Inst Technol & Management, Aquat Biotechnol & Bioprod Engn Dept, Groningen, Netherlands	University of Groningen; Leiden University; Leiden University - Excl LUMC; DSM NV; University of Groningen	van Munster, JM (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England.	Jolanda.van_Munster@nottingham.ac.uk	Dijkhuizen, Lubbert/K-3539-2019; Dijkhuizen, Lubbert/E-9454-2014; Ram, Arthur FJ/S-4648-2017	Dijkhuizen, Lubbert/0000-0003-2312-7162; Ram, Arthur FJ/0000-0002-2487-8016; Akeroyd, Michiel/0000-0002-3526-5821; van Munster, Jolanda/0000-0003-0412-7001	SenterNovem as IOP Genomics project [IGE07008]	SenterNovem as IOP Genomics project	This work was supported by SenterNovem as IOP Genomics project IGE07008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bennett JW, 2009, MED MYCOL, V47, pS5, DOI 10.1080/13693780802712515; Bennett JW, 1991, MORE GENE MANIPULATI; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; BOS CJ, 1988, CURR GENET, V14, P437, DOI 10.1007/BF00521266; BRODERICK AJ, 1981, J GEN MICROBIOL, V126, P193; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Coyle CM, 2007, MYCOLOGIA, V99, P804, DOI 10.3852/mycologia.99.6.804; Cupertino FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044258; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; Delmas S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002875; Emri T, 2005, MYCOL RES, V109, P757, DOI 10.1017/S0953756205003023; Emri T, 2008, APPL BIOCHEM BIOTECH, V151, P211, DOI 10.1007/s12010-008-8174-7; Erdei E, 2008, ACTA MICROBIOL IMM H, V55, P351, DOI 10.1556/AMicr.55.2008.3.6; Fontaine T, 1997, EUR J BIOCHEM, V243, P315, DOI 10.1111/j.1432-1033.1997.0315a.x; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Freitas FZ, 2010, FUNGAL GENET BIOL, V47, P43, DOI 10.1016/j.fgb.2009.10.011; Fujiwara M, 2000, J BIOCHEM-TOKYO, V127, P359, DOI 10.1093/oxfordjournals.jbchem.a022616; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Garcia-Rivera J, 2004, EUKARYOT CELL, V3, P385, DOI 10.1128/EC.3.2.385-392.2004; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaques AK, 2003, MICROBIOL-SGM, V149, P2931, DOI 10.1099/mic.0.26476-0; JOHNSTON IR, 1965, BIOCHEM J, V96, P651, DOI 10.1042/bj0960651; Jorgensen TR, 2011, APPL ENVIRON MICROB, V77, P5270, DOI 10.1128/AEM.00118-11; Jorgensen TR, 2011, FUNGAL GENET BIOL, V48, P544, DOI 10.1016/j.fgb.2011.01.005; Jorgensen TR, 2010, APPL ENVIRON MICROB, V76, P5344, DOI 10.1128/AEM.00450-10; Kitagaki H, 2002, MOL MICROBIOL, V46, P1011, DOI 10.1046/j.1365-2958.2002.03244.x; Krijgsheld P, 2013, STUD MYCOL, P1, DOI 10.3114/sim0006; Krijgsheld P, 2013, J PROTEOME RES, V12, P1808, DOI 10.1021/pr301154w; Latge JP, 2005, MED MYCOL, V43, pS15, DOI 10.1080/13693780400029155; LEE BN, 1994, GENE DEV, V8, P641, DOI 10.1101/gad.8.6.641; LEE BN, 1994, MOL MICROBIOL, V14, P323, DOI 10.1111/j.1365-2958.1994.tb01293.x; Lee JI, 2004, FUNGAL GENET BIOL, V41, P635, DOI 10.1016/j.fgb.2004.01.009; MacDonald J. W., 2022, AFFYCORETOOLS FUNCTI; Maddi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038872; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; Martens-Uzunova ES, 2009, FUNGAL GENET BIOL, V46, pS170, DOI 10.1016/j.fgb.2008.07.021; MARUYAMA Y, 1994, CARBOHYD RES, V251, P89, DOI 10.1016/0008-6215(94)84278-7; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Nitsche BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-380; PARTA M, 1994, INFECT IMMUN, V62, P4389, DOI 10.1128/IAI.62.10.4389-4395.1994; Peterson SW, 2008, MYCOLOGIA, V100, P205, DOI 10.3852/mycologia.100.2.205; Pocsi I, 2009, J APPL MICROBIOL, V107, P514, DOI 10.1111/j.1365-2672.2009.04237.x; Ram AFJ, 2004, MICROBIOL-SGM, V150, P3315, DOI 10.1099/mic.0.27249-0; Rocklin RD, 1998, ANAL CHEM, V70, P1496, DOI 10.1021/ac970906w; Shimizu K, 2001, GENETICS, V157, P591; Shin KS, 2009, EUKARYOT CELL, V8, P738, DOI 10.1128/EC.00368-08; Sigl C, 2011, APPL ENVIRON MICROB, V77, P972, DOI 10.1128/AEM.01557-10; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sommer U, 2003, J BIOL CHEM, V278, P47724, DOI 10.1074/jbc.M307223200; Szilagyi M, 2010, J APPL MICROBIOL, V109, P1498, DOI 10.1111/j.1365-2672.2010.04782.x; Szilagyi M, 2013, MICROBIOL-SGM, V159, P176, DOI 10.1099/mic.0.062935-0; Tiels P, 2012, NAT BIOTECHNOL, V30, P1225, DOI 10.1038/nbt.2427; Twumasi-Boateng K, 2009, EUKARYOT CELL, V8, P104, DOI 10.1128/EC.00265-08; van Munster JM, 2014, APPL MICROBIOL BIOTE; van Munster JM, 2014, FUNGAL GENET BIOL, V72, P34, DOI 10.1016/j.fgb.2014.04.006; van Munster JM, 2013, MICROBIOL-SGM, V159, P1853, DOI 10.1099/mic.0.067967-0; van Munster JM, 2012, MICROBIOL-SGM, V158, P2168, DOI 10.1099/mic.0.054650-0; Wang J, 2009, CANCER INFORM, V7, P199; Ward OP, 2006, ADV APPL MICROBIOL, V58, P1, DOI 10.1016/S0065-2164(06)58001-8; White S, 2002, CRIT REV BIOTECHNOL, V22, P1, DOI 10.1080/07388550490465817; WIESER J, 1994, CURR GENET, V27, P62, DOI 10.1007/BF00326580; Wu X, 2001, MOL GENET GENOMICS, V265, P622, DOI 10.1007/s004380100455; Yamazaki H, 2008, FUNGAL GENET BIOL, V45, P963, DOI 10.1016/j.fgb.2008.02.008; Yamazaki H, 2007, CURR GENET, V51, P89, DOI 10.1007/s00294-006-0109-7; Yu JH, 1996, EMBO J, V15, P5184, DOI 10.1002/j.1460-2075.1996.tb00903.x; Yu JH, 1999, GENETICS, V151, P97; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	75	19	20	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116269	10.1371/journal.pone.0116269	http://dx.doi.org/10.1371/journal.pone.0116269			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629352	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100034
J	Wu, B; Cao, XM; Liang, XZ; Zhang, XH; Zhang, W; Sun, G; Wang, DW				Wu, Bo; Cao, Xiaoming; Liang, Xuezhi; Zhang, Xuhui; Zhang, Wei; Sun, Guang; Wang, Dongwen			Epigenetic Regulation of Elf5 Is Associated with Epithelial-Mesenchymal Transition in Urothelial Cancer	PLOS ONE			English	Article							BREAST-CANCER; METHYLATION; PROMOTER; CELLS; PLASTICITY; STATES; FATE	E74-like factor 5 (Elf5) has been associated with tumor suppression in breast cancer. However, its role in urothelial cancer (UC) is completely unknown. Immunohistochemistry (IHC) and methylation specific PCR (MSP) were done to detect Elf5 expression level and its promoter methylation. Results revealed that low expression of Elf5 on protein and mRNA levels were associated with tumor progression, early relapse and poor survival. In vitro, downregulation of Elf5 can increase epithelial-mesenchymal transition (EMT). Aberrant Elf5 methylation was identified as major mechanism for Elf5 gene silence. Accordingly, restoration of Elf5 by infection or demethylating treatment effectively reversed EMT processes. In conclusion, we identified Elf5 as a novel biomarker of UC on several biological levels and established a causative link between Elf5 and EMT in UC.	[Wu, Bo; Cao, Xiaoming; Liang, Xuezhi; Zhang, Wei; Wang, Dongwen] Shanxi Med Univ, Hosp 1, Dept Urol, Taiyuan, Peoples R China; [Zhang, Xuhui; Wang, Dongwen] Shanxi Med Univ, Clin Med Coll 1, Taiyuan, Peoples R China; [Sun, Guang] Tianjin Med Univ, Hosp 2, Dept Urol, Tianjin, Peoples R China	Shanxi Medical University; Shanxi Medical University; Tianjin Medical University	Wang, DW (corresponding author), Shanxi Med Univ, Hosp 1, Dept Urol, Taiyuan, Peoples R China.	dongwen_shanyi@126.com						Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Chakrabarti R, 2012, STEM CELLS, V30, P1496, DOI 10.1002/stem.1112; Donat SM, 2003, UROL CLIN N AM, V30, P765, DOI 10.1016/S0094-0143(03)00060-0; Escamilla-Hernandez R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-68; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Hilton HN, 2010, MOL ENDOCRINOL, V24, P1380, DOI 10.1210/me.2009-0516; Kalyuga M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001461; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Lee HJ, 2011, STEM CELLS, V29, P1611, DOI 10.1002/stem.706; Li H, 2014, J UROLOGY, V191, P493, DOI 10.1016/j.juro.2013.08.087; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Menzies KK, 2010, FUNCT INTEGR GENOMIC, V10, P87, DOI 10.1007/s10142-009-0140-0; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; RUBBEN H, 1988, J UROLOGY, V139, P283, DOI 10.1016/S0022-5347(17)42387-1; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Taddei ML, 2013, CANCER LETT, V341, P80, DOI 10.1016/j.canlet.2013.01.042; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian J, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.395574; Veeck J, 2008, ONCOGENE, V27, P865, DOI 10.1038/sj.onc.1210669; Villicana P, 2009, BIOMARK MED, V3, P265, DOI 10.2217/BMM.09.23; Wang Y, 2013, EXP CELL RES, V319, P160, DOI 10.1016/j.yexcr.2012.07.019; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhou ZJ, 2014, CANCER RES, DOI [10.1158/0008-5472.CAN-74-24-Reviewers, DOI 10.1158/0008-5472.CAN-74-24-REVIEWERS]	29	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117510	10.1371/journal.pone.0117510	http://dx.doi.org/10.1371/journal.pone.0117510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629735	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000348732100086
J	Carels, N; Tilli, T; Tuszynski, JA				Carels, Nicolas; Tilli, Tatiana; Tuszynski, Jack A.			A Computational Strategy to Select Optimized Protein Targets for Drug Development toward the Control of Cancer Diseases	PLOS ONE			English	Article							INVASIVE BREAST-CANCER; GROWTH-FACTOR; DOWN-REGULATION; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; PANCREATIC-CANCER; INHIBITION; KINASE; NUCLEOPHOSMIN; COMPLEXITY	In this report, we describe a strategy for the optimized selection of protein targets suitable for drug development against neoplastic diseases taking the particular case of breast cancer as an example. We combined human interactome and transcriptome data from malignant and control cell lines because highly connected proteins that are up-regulated in malignant cell lines are expected to be suitable protein targets for chemotherapy with a lower rate of undesirable side effects. We normalized transcriptome data and applied a statistic treatment to objectively extract the sub-networks of down-and up-regulated genes whose proteins effectively interact. We chose the most connected ones that act as protein hubs, most being in the signaling network. We show that the protein targets effectively identified by the combination of protein connectivity and differential expression are known as suitable targets for the successful chemotherapy of breast cancer. Interestingly, we found additional proteins, not generally targeted by drug treatments, which might justify the extension of existing formulation by addition of inhibitors designed against these proteins with the consequence of improving therapeutic outcomes. The molecular alterations observed in breast cancer cell lines represent either driver events and/or driver pathways that are necessary for breast cancer development or progression. However, it is clear that signaling mechanisms of the luminal A, B and triple negative subtypes are different. Furthermore, the up- and down-regulated networks predicted subtype-specific drug targets and possible compensation circuits between up-and down-regulated genes. We believe these results may have significant clinical implications in the personalized treatment of cancer patients allowing an objective approach to the recycling of the arsenal of available drugs to the specific case of each breast cancer given their distinct qualitative and quantitative molecular traits.	[Carels, Nicolas; Tilli, Tatiana] Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, CNPq,Lab Modelagem Sistemas Biol, INCT IDN,Natl Inst Sci & Technol Innovat Neglecte, Rio De Janeiro, Brazil; [Tuszynski, Jack A.] Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Tuszynski, Jack A.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada	Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; University of Alberta; University of Alberta	Tuszynski, JA (corresponding author), Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB T6G 1Z2, Canada.	jack.tuszynski@gmail.com	Tuszynski, Jack/AAA-2073-2020; Carels, Nicolas/L-4687-2016; Tilli, T M/L-3057-2016; Tilli, Tatiana M/F-8166-2012	Tuszynski, Jack/0000-0001-9976-0429; Carels, Nicolas/0000-0003-4547-7155; Tilli, T M/0000-0003-3699-1494; Tilli, Tatiana M/0000-0002-1111-018X				Alegre MM, 2012, J ONCOL, V2012, DOI 10.1155/2012/575647; Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Atkinson DM, 2008, HEAD NECK-J SCI SPEC, V30, P790, DOI 10.1002/hed.20770; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; Bockmayr M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-78; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyer-Guittaut M, 2014, AUTOPHAGY, V10, P986, DOI 10.4161/auto.28390; Braun Michael, 2009, Cancer Genomics & Proteomics, V6, P31; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Breitkreutz D, 2014, BIOMAT INT S MATH CO, P250; Breitkreutz D, 2012, P NATL ACAD SCI USA, V109, P9209, DOI 10.1073/pnas.1201416109; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Cao WD, 2010, APOPTOSIS, V15, P230, DOI 10.1007/s10495-009-0437-4; Carels N, 2013, BIOINFORM BIOL INSIG, V7, P35, DOI 10.4137/BBI.S10053; Chong R, 2009, CELL HOST MICROBE, V6, P268, DOI 10.1016/j.chom.2009.08.006; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corazzari M, 2007, BRIT J CANCER, V96, P1062, DOI 10.1038/sj.bjc.6603672; Costanzo A, 2014, FEBS LETT, V588, P2590, DOI 10.1016/j.febslet.2014.06.047; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Magalhaes JP, 2013, NAT REV CANCER, V13, P357, DOI 10.1038/nrc3497; Deshiere A, 2011, MOL CELL BIOCHEM, V356, P11, DOI 10.1007/s11010-011-0942-y; Didelot C, 2008, CELL DEATH DIFFER, V15, P859, DOI 10.1038/sj.cdd.4402320; Dong S, 2008, LEUKEMIA, V22, P572, DOI 10.1038/sj.leu.2405064; Faust K, 2010, BIOINFORMATICS, V26, P1211, DOI 10.1093/bioinformatics/btq105; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Garlaschelli D, 2010, SYMMETRY-BASEL, V2, P1683, DOI 10.3390/sym2031683; Gay B, 1999, INT J CANCER, V83, P235, DOI 10.1002/(SICI)1097-0215(19991008)83:2<235::AID-IJC15>3.0.CO;2-B; Ghosh A, 2013, ONCOL REP, V29, P1161, DOI 10.3892/or.2012.2186; Giubellino A, 2007, CANCER RES, V67, P6012, DOI 10.1158/0008-5472.CAN-07-0022; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Guo CM, 2013, FUTURE ONCOL, V9, P1773, DOI [10.2217/FON.13.114, 10.2217/fon.13.114]; Haines E, 2014, J BIOL CHEM, V289, P5687, DOI 10.1074/jbc.M113.516047; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Handa Y, 2010, J MOL BIOL, V404, P260, DOI 10.1016/j.jmb.2010.09.033; HE T, 2013, PLOS ONE, V8, P59345, DOI DOI 10.1371/JOURNAL.PONE.0059345; HINOW P, 2014, ALGEBRAIC TOPOLOGICA, P42331; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Huang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.256; Huang TH, 2013, CANCER CELL, V23, P796, DOI 10.1016/j.ccr.2013.04.027; Ishigaki Y, 2013, EXP BIOL MED, V238, P889, DOI 10.1177/1535370213494646; Jiang N, 2012, CHEMOTHER RES PRACT, V2012, DOI DOI 10.1155/2012/817304; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Klebig C, 2005, CANCER RES, V65, P394; Korsching E, 2005, J PATHOL, V206, P451, DOI 10.1002/path.1797; Krynetskaia NF, 2009, MOL CANCER THER, V8, P864, DOI 10.1158/1535-7163.MCT-08-0695; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Li B, 2013, CLIN CANCER RES, V19, P5835, DOI 10.1158/1078-0432.CCR-12-3629; Li ZW, 2012, BBA-REV CANCER, V1826, P13, DOI 10.1016/j.bbcan.2012.02.001; Lim DHK, 2010, OBSTET GYNAECOL, V12, P37, DOI 10.1576/toag.12.1.037.27556; Ling SHM, 2009, BIOSCIENCE REP, V29, P339, DOI 10.1042/BSR20090034; Lo SJ, 2013, HEPATOLOGY, V57, P1893, DOI 10.1002/hep.26209; Luo Y, 2014, MOL MED REP, V9, P387, DOI 10.3892/mmr.2013.1831; MacArthur BD, 2008, DISCRETE APPL MATH, V156, P3525, DOI 10.1016/j.dam.2008.04.008; Marquardt JU, 2012, BBA-MOL BASIS DIS, V1822, P942, DOI 10.1016/j.bbadis.2012.02.012; Mathur S, 1998, CANCER, V82, P816, DOI 10.1002/(SICI)1097-0142(19980301)82:5<816::AID-CNCR3>3.0.CO;2-H; Mendelsohn J, 2002, J CLIN ONCOL, V20, p1S, DOI 10.1200/JCO.2002.07.121; Miwa D, 2013, ANGIOGENESIS, V16, P675, DOI 10.1007/s10456-013-9345-x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nihira K, 2014, J PATHOL, V234, P277, DOI 10.1002/path.4354; Oltean S, 2012, BIOCHEM SOC T, V40, P831, DOI 10.1042/BST20120051; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Pallares J, 2009, AM J PATHOL, V174, P287, DOI 10.2353/ajpath.2009.080552; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perez-Nadales E, 2004, BREAST CANCER RES, V6, P137, DOI 10.1186/bcr792; Qi W, 2008, ONCOGENE, V27, P4210, DOI 10.1038/onc.2008.54; Rachidi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057911; Ren HN, 2009, MOL CANCER THER, V8, P1106, DOI 10.1158/1535-7163.MCT-08-0779; Rickelt S, 2012, CELL TISSUE RES, V348, P281, DOI 10.1007/s00441-011-1314-3; Roma-Rodrigues C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179486; Sagot Y, 2000, BRIT J PHARMACOL, V131, P721, DOI 10.1038/sj.bjp.0703633; Schneble EJ, 2014, IMMUNOTHERAPY-UK, V6, P519, DOI [10.2217/IMT.14.22, 10.2217/imt.14.22]; Shepelev V, 2006, BRIEF BIOINFORM, V7, P178, DOI 10.1093/bib/bbl003; Shi YK, 2010, CANCER GENE THER, V17, P694, DOI 10.1038/cgt.2010.25; Sillibourne JE, 2007, MOL BIOL CELL, V18, P3667, DOI 10.1091/mbc.E06-07-0604; Taniuchi K, 2005, CANCER RES, V65, P3092, DOI 10.1158/0008.5472.CAN-04-3646; Usuki F, 2013, P NATL ACAD SCI USA, V110, P15037, DOI 10.1073/pnas.1300654110; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wang J, 2009, J CELL MOL MED, V13, P3888, DOI 10.1111/j.1582-4934.2009.00873.x; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; Warren K, 2012, P NATL ACAD SCI USA, V109, P9587, DOI 10.1073/pnas.1204673109; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Wu YH, 2012, DERMATOL SIN, V30, P1, DOI 10.1016/j.dsi.2012.02.004; Ye Diana Zi, 2012, Cell Logist, V2, P105; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zaman N, 2013, CELL REP, V5, P216, DOI 10.1016/j.celrep.2013.08.028; Zeng Q, 2000, J CELL SCI, V113, P471; Zhang Y, 2008, CANCER LETT, V265, P298, DOI 10.1016/j.canlet.2008.02.024; Zheng L, 2004, CELL RES, V14, P497, DOI 10.1038/sj.cr.7290253	92	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115054	10.1371/journal.pone.0115054	http://dx.doi.org/10.1371/journal.pone.0115054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625699	Green Published, gold			2022-12-27	WOS:000348821400005
J	Chen, N; Tanaka, K; Watanabe, K				Chen, Na; Tanaka, Kanji; Watanabe, Katsumi			Color-Shape Associations Revealed with Implicit Association Tests	PLOS ONE			English	Article								Kandinsky proposed a correspondence theory that suggests associations between specific colors and shapes (i.e., circle-blue, square-red, triangle-yellow). Makin and Wuerger tested the theory using the Implicit Association Test (IAT) and did not find clear evidence for Kandinsky's color-shape associations among British participants. In the present study, we first replicated the previous study among Japanese participants and found similar results to those of Makin and Wuerger, showing little support for Kandinsky's theory. In the subsequent experiment, we tested another set of color-shape associations that had been revealed by using an explicit matching method (circle-red, square-blue, triangle-yellow) in Japanese participants. The IAT tests showed that response times were significantly faster when circle-red, square-blue, and triangle-yellow combinations were mapped onto the same response key, rather than different key combinations, indicating that these colorshape combinations were encoded. These results provide the first empirical evidence that color-shape associations can be measured by indirect behavioral methods, and in particular, Japanese people's color-shape associations (circle-red, square-blue, triangle-yellow) can be observed by both direct and indirect experimental methods.	[Chen, Na; Tanaka, Kanji; Watanabe, Katsumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan	University of Tokyo	Chen, N (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan.	nanachen@fennel.rcast.u-tokyo.ac.jp	Tanaka, Kanji/O-5207-2018	Tanaka, Kanji/0000-0001-5584-3521; Watanabe, Katsumi/0000-0003-1282-9994; Chen, Na/0000-0003-4558-2393	Ministry of Education, Culture, Sports, Science and Technology [24300279]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research (24300279) from the Ministry of Education, Culture, Sports, Science and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertazzi L, 2013, J EXP PSYCHOL HUMAN, V39, P37, DOI 10.1037/a0028816; Chen N, PSYCHOL AES IN PRESS; Dumitrescu A, 2011, P 22 INT DAAAM S, V22, P1041; Gattol V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015849; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Ho HN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091854; Holmes Tim, 2013, Front Psychol, V4, P926, DOI 10.3389/fpsyg.2013.00926; Jacobsen T, 2002, PERCEPT MOTOR SKILL, V95, P903, DOI 10.2466/PMS.95.7.903-913; Jacobsen T., 2007, DES J, V10, P16, DOI [DOI 10.2752/146069207789271902, 10.2752/146069207789271902]; Kandinsky W., 1912, SPIRITUAL ART; Kandinsky W., 1947, POINT LINE PLANE; Kharkhurin AV, 2012, EMPIR STUD ARTS, V30, P167, DOI 10.2190/EM.30.2.d; Lupton E, 1991, ABCS DESIGN BAUHAUS; Makin ADJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00616; Nosek B. A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1080/10463280701489053; Parise CV, 2012, EXP BRAIN RES, V220, P319, DOI 10.1007/s00221-012-3140-6	17	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116954	10.1371/journal.pone.0116954	http://dx.doi.org/10.1371/journal.pone.0116954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QM	25625717	Green Submitted, gold, Green Published			2022-12-27	WOS:000348821400024
J	Rider, CF; Shah, S; Miller-Larsson, A; Giembycz, MA; Newton, R				Rider, Christopher F.; Shah, Suharsh; Miller-Larsson, Anna; Giembycz, Mark A.; Newton, Robert			Cytokine-Induced Loss of Glucocorticoid Function: Effect of Kinase Inhibitors, Long-Acting beta 2-Adrenoceptor Agonist and Glucocorticoid Receptor Ligands	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; N-TERMINAL KINASE; INFLAMMATORY GENE-EXPRESSION; PULMONARY EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; BETA(2)-ADRENOCEPTOR AGONISTS; AIRWAY INFLAMMATION; SELECTIVE INHIBITOR; STEROID RESISTANCE	Acting on the glucocorticoid receptor (NR3C1), glucocorticoids are widely used to treat inflammatory diseases. However, glucocorticoid resistance often leads to suboptimal asthma control. Since glucocorticoid-induced gene expression contributes to glucocorticoid activity, the aim of this study was to use a 2xglucocorticoid response element (GRE) reporter and glucocorticoid-induced gene expression to investigate approaches to combat cytokine-induced glucocorticoid resistance. Pre-treatment with tumor necrosis factor-alpha (TNF) or interleukin- 1 beta inhibited dexamethasone-induced mRNA expression of the putative anti-inflammatory genes RGS2 and TSC22D3, or just TSC22D3, in primary human airway epithelial and smooth muscle cells, respectively. Dexamethasone-induced DUSP1 mRNA was unaffected. In human bronchial epithelial BEAS-2B cells, dexamethasone-induced TSC22D3 and CDKN1C expression (at 6 h) was reduced by TNF pre-treatment, whereas DUSP1 and RGS2 mRNAs were unaffected. TNF pre-treatment also reduced dexamethasone-dependent 2xGRE reporter activation. This was partially reversed by PS-1145 and c-jun N-terminal kinase (JNK) inhibitor VIII, inhibitors of IKK2 and JNK, respectively. However, neither inhibitor affected TNF-dependent loss of dexamethasone-induced CDKN1C or TSC22D3 mRNA. Similarly, inhibitors of the extracellular signalregulated kinase, p38, phosphoinositide 3-kinase or protein kinase C pathways failed to attenuate TNF-dependent repression of the 2xGRE reporter. Fluticasone furoate, fluticasone propionate and budesonide were full agonists relative to dexamethasone, while GSK9027, RU24858, des-ciclesonide and GW870086X were partial agonists on the 2xGRE reporter. TNF reduced reporter activity in proportion with agonist efficacy. Full and partial agonists showed various degrees of agonism on RGS2 and TSC22D3 expression, but were equally effective at inducing CDKN1C and DUSP1, and did not affect the repression of CDKN1C or TSC22D3 expression by TNF. Finally, formoterol-enhanced 2xGRE reporter activity was also proportional to agonist efficacy and functionally reversed repression by TNF. As similar effects were apparent on glucocorticoid-induced gene expression, the most effective strategy to overcome glucocorticoid resistance in this model was addition of formoterol to high efficacy NR3C1 agonists.	[Rider, Christopher F.; Shah, Suharsh; Giembycz, Mark A.; Newton, Robert] Univ Calgary, Fac Med, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada; [Miller-Larsson, Anna] AstraZeneca R&D, Molndal, Sweden	University of Calgary; AstraZeneca	Newton, R (corresponding author), Univ Calgary, Fac Med, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada.	rnewton@ucalgary.ca	Rider, Christopher F/H-7073-2019; Newton, Robert/C-6814-2012	Rider, Christopher F/0000-0003-0399-5931; Newton, Robert/0000-0002-4919-8498	AstraZeneca; GlaxoSmithKline; Canadian Institutes of Health Research [68828]; Lung Association of Alberta; NWT; Alberta Innovates-Health Solutions; Gilead Sciences; Alberta Science and Research Authority; Canadian Fund for Innovation (CFI)	AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lung Association of Alberta; NWT; Alberta Innovates-Health Solutions; Gilead Sciences(Gilead Sciences); Alberta Science and Research Authority; Canadian Fund for Innovation (CFI)(Canada Foundation for Innovation)	This research was supported by grants from AstraZeneca and GlaxoSmithKline (RN, MAG); an operating grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) [68828] (RN) and studentships from the Lung Association of Alberta and NWT (http://www.ab.lung.ca/)(SS) and Alberta Innovates-Health Solutions (http://www.aihealthsolutions.ca) (CFR). RN is an AI-HS Senior Scholar. MAG holds a Tier 1 Canada Research Chair in Pulmonary Pharmacology. RN and MAG were also supported by grants from Gilead Sciences. Funding from the Alberta Science and Research Authority and the Canadian Fund for Innovation (CFI) provided real time-PCR infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Antonicelli L, 2004, EUR RESPIR J, V23, P723, DOI 10.1183/09031936.04.00004904; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bareille P, 2013, J ASTHMA, V50, P1077, DOI 10.3109/02770903.2013.837480; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Belvisi MG, 2001, J IMMUNOL, V166, P1975, DOI 10.4049/jimmunol.166.3.1975; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Biggadike Keith, 2004, Proc Am Thorac Soc, V1, P352, DOI 10.1513/pats.200409-048TA; Bouazza B, 2012, AM J RESP CELL MOL, V47, P464, DOI 10.1165/rcmb.2011-0364OC; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Cerasoli F, 2006, CHEST, V130, p54S, DOI 10.1378/chest.130.1_suppl.54S; Chang TS, 2003, J BIOL CHEM, V278, P48092, DOI 10.1074/jbc.M309421200; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; DAVIS PD, 1992, J MED CHEM, V35, P177, DOI 10.1021/jm00079a024; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Giembycz MA, 2008, BRIT J PHARMACOL, V153, P1090, DOI 10.1038/sj.bjp.0707627; Goekjian PG, 1999, CURR MED CHEM, V6, P877; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Heffler E, 2007, BIODRUGS, V21, P345, DOI 10.2165/00063030-200721060-00002; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Holden NS, 2014, J PHARMACOL EXP THER, V348, P12, DOI 10.1124/jpet.113.204586; Holden NS, 2011, P NATL ACAD SCI USA, V108, P19713, DOI 10.1073/pnas.1110226108; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; KAM JC, 1993, J IMMUNOL, V151, P3460; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Keenan CR, 2012, DRUG DISCOV TODAY, V17, P1031, DOI 10.1016/j.drudis.2012.05.011; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; KLEINSCHROTH J, 1993, BIOORG MED CHEM LETT, V3, P1959, DOI 10.1016/S0960-894X(01)80995-1; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Marwick JA, 2010, J ALLERGY CLIN IMMUN, V125, P1146, DOI 10.1016/j.jaci.2010.02.003; Marwick JA, 2009, AM J RESP CRIT CARE, V179, P542, DOI 10.1164/rccm.200810-1570OC; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2007, J PHARMACOL EXP THER, V321, P734, DOI 10.1124/jpet.106.118125; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; Oakley RH, 2011, J BIOL CHEM, V286, P3177, DOI 10.1074/jbc.R110.179325; Onda K, 2006, BIOCHEM BIOPH RES CO, V351, P266, DOI 10.1016/j.bbrc.2006.10.032; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; POWIS G, 1994, CANCER RES, V54, P2419; REDDEL RR, 1988, CANCER RES, V48, P1904; Rider CF, 2013, AM THOR SOC INT C AM, pA4820; Rider CF, 2013, EUR J PHARMACOL, V708, P60, DOI 10.1016/j.ejphar.2013.02.056; Rider CF, 2011, J PHARMACOL EXP THER, V338, P860, DOI 10.1124/jpet.111.181016; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Salem S, 2012, BRIT J PHARMACOL, V166, P2036, DOI 10.1111/j.1476-5381.2012.01885.x; Schacke H, 2008, EXPERT OPIN THER PAT, V18, P339, DOI 10.1517/13543776.18.3.339; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Thomas MJ, 2005, EUR J IMMUNOL, V35, P1283, DOI 10.1002/eji.200425634; Thomas PS, 2002, THORAX, V57, P774, DOI 10.1136/thorax.57.9.774; THOMAS PS, 1995, AM J RESP CRIT CARE, V152, P76, DOI 10.1164/ajrccm.152.1.7599866; Tliba O, 2006, MOL PHARMACOL, V69, P588, DOI 10.1124/mol.105.019679; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Uings IJ, 2013, BRIT J PHARMACOL, V169, P1389, DOI 10.1111/bph.12232; Vayssiere BM, 1997, MOL ENDOCRINOL, V11, P1245, DOI 10.1210/me.11.9.1245; Vazquez-Tello A, 2013, J CLIN IMMUNOL, V33, P466, DOI 10.1007/s10875-012-9828-3; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Xie Y, 2012, J ALLERGY CLIN IMMUN, V130, P968, DOI 10.1016/j.jaci.2012.05.004; Yates CM, 2010, J MED CHEM, V53, P4531, DOI 10.1021/jm100447c; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	71	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116773	10.1371/journal.pone.0116773	http://dx.doi.org/10.1371/journal.pone.0116773			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625944	Green Submitted, gold, Green Published			2022-12-27	WOS:000348821400017
J	Allin, BSR; Tse, WHW; Marven, S; Johnson, PRV; Knight, M				Allin, Benjamin S. R.; Tse, Win Hou W.; Marven, Sean; Johnson, Paul R. V.; Knight, Marian			Challenges of Improving the Evidence Base in Smaller Surgical Specialties, as Highlighted by a Systematic Review of Gastroschisis Management	PLOS ONE			English	Review							SPRING-LOADED SILO; CLOSURE; REDUCTION; NEWBORNS; OUTCOMES	Objective To identify methods of improving the evidence base in smaller surgical specialties, using a systematic review of gastroschisis management as an example. Background Operative primary fascial closure (OPFC), and silo placement with staged reduction and delayed closure (SR) are the most commonly used methods of gastroschisis closure. Relative merits of each are unclear. Methods A systematic review and meta-analysis was performed comparing outcomes following OPFC and SR in infants with simple gastroschisis. Primary outcomes of interest were mortality, length of hospitalization and time to full enteral feeding. Results 751 unique articles were identified. Eight met the inclusion criteria. None were randomized controlled trials. 488 infants underwent OPFC and 316 underwent SR. Multiple studies were excluded because they included heterogeneous populations and mixed intervention groups. Length of stay was significantly longer in the SR group (mean difference 8.97 days, 95% CI 2.14-15.80 days), as was number of post-operative days to complete enteral feeding (mean difference 7.19 days, 95% CI 2.01-12.36 days). Mortality was not statistically significantly different, although the odds of death were raised in the SR group (OR 1.96, 95% CI 0.71-5.35). Conclusions Despite showing some benefit of OPFC over SR, our results are tempered by the low quality of the available studies, which were small and variably reported. Coordinating research through a National Paediatric Surgical Trials Unit could alleviate many of these problems. A similar national approach could be used in other smaller surgical specialties.	[Allin, Benjamin S. R.; Tse, Win Hou W.; Knight, Marian] Radcliffe Infirm, Natl Perinatal Epidemiol Unit, Oxford OX2 6HE, England; [Allin, Benjamin S. R.; Johnson, Paul R. V.] Oxford Radcliffe Univ Hosp, Dept Paediat Surg, Oxford, England; [Marven, Sean] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England	Radcliffe Infirmary; University of Oxford; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital	Allin, BSR (corresponding author), Radcliffe Infirm, Natl Perinatal Epidemiol Unit, Oxford OX2 6HE, England.	benjaminallin@doctors.org.uk	Knight, Marian/B-6225-2009	Knight, Marian/0000-0002-1984-4575	National Institute for Health Research; National Institute for Health Research [NIHR-RP-011-032, ACF-2012-13-012] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Marian Knight is funded by a National Institute for Health Research Professorhip. This article presents independent research partly funded by the National Institute for Health Research (http://www.nihr.ac.uk/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi A, 1998, J PEDIATR SURG, V33, P1338, DOI 10.1016/S0022-3468(98)90002-1; Bonnard A, 2008, PEDIATR SURG INT, V24, P767, DOI 10.1007/s00383-008-2153-5; Bradnock TJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6749; Hardin WD, 1999, J PEDIATR SURG, V34, P908, DOI 10.1016/S0022-3468(99)90396-2; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Kandasamy Y, 2010, J PAEDIATR CHILD H, V46, P40, DOI 10.1111/j.1440-1754.2009.01615.x; Keys C, 2008, J PEDIATR SURG, V43, P654, DOI 10.1016/j.jpedsurg.2007.12.005; Kunz SN, 2013, J PEDIATR SURG, V48, P845, DOI 10.1016/j.jpedsurg.2013.01.020; Lobo JD, 2010, J PEDIATR SURG, V45, P1426, DOI 10.1016/j.jpedsurg.2010.02.047; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Mills JA, 2010, J PERINATOL, V30, P809, DOI 10.1038/jp.2010.43; Orion KC, 2011, SURGERY, V150, P177, DOI 10.1016/j.surg.2011.05.001; Owen A, 2006, J PEDIATR SURG, V41, P1830, DOI 10.1016/j.jpedsurg.2006.06.048; Owen A, 2010, J PEDIATR SURG, V45, P1808, DOI 10.1016/j.jpedsurg.2010.01.036; Pastor AC, 2008, J PEDIATR SURG, V43, P1807, DOI 10.1016/j.jpedsurg.2008.04.003; Payne NR, 2009, J PEDIATR SURG, V44, P918, DOI 10.1016/j.jpedsurg.2009.01.036; Skarsgard ED, 2008, J PEDIATR SURG, V43, P30, DOI 10.1016/j.jpedsurg.2007.09.011; Tsai MH, 2010, PEDIATR NEONATOL, V51, P320, DOI 10.1016/S1875-9572(10)60062-9; Villela Rodriguez J, 2009, Cir Pediatr, V22, P217; Weinsheimer RL, 2008, J PEDIATR SURG, V43, P874, DOI 10.1016/j.jpedsurg.2007.12.030	20	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116908	10.1371/journal.pone.0116908	http://dx.doi.org/10.1371/journal.pone.0116908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621838	Green Submitted, Green Published, gold			2022-12-27	WOS:000348470400011
J	Flachsbarth, I; Willaarts, B; Xie, H; Pitois, G; Mueller, ND; Ringler, C; Garrido, A				Flachsbarth, Insa; Willaarts, Barbara; Xie, Hua; Pitois, Gauthier; Mueller, Nathaniel D.; Ringler, Claudia; Garrido, Alberto			The Role of Latin America's Land and Water Resources for Global Food Security: Environmental Trade-Offs of Future Food Production Pathways	PLOS ONE			English	Article							SUSTAINABLE INTENSIFICATION; LIVESTOCK PRODUCTION; DEFORESTATION; NITROGEN; FOOTPRINT; POLLUTION; DYNAMICS; CLIMATE; IMPACT; MODEL	One of humanity's major challenges of the 21st century will be meeting future food demands on an increasingly resource constrained-planet. Global food production will have to rise by 70 percent between 2000 and 2050 to meet effective demand which poses major challenges to food production systems. Doing so without compromising environmental integrity is an even greater challenge. This study looks at the interdependencies between land and water resources, agricultural production and environmental outcomes in Latin America and the Caribbean (LAC), an area of growing importance in international agricultural markets. Special emphasis is given to the role of LAC's agriculture for (a) global food security and (b) environmental sustainability. We use the International Model for Policy Analysis of Agricultural Commodities and Trade (IMPACT)-a global dynamic partial equilibrium model of the agricultural sector-to run different future production scenarios, and agricultural trade regimes out to 2050, and assess changes in related environmental indicators. Results indicate that further trade liberalization is crucial for improving food security globally, but that it would also lead to more environmental pressures in some regions across Latin America. Contrasting land expansion versus more intensified agriculture shows that productivity improvements are generally superior to agricultural land expansion, from an economic and environmental point of view. Finally, our analysis shows that there are trade-offs between environmental and food security goals for all agricultural development paths.	[Flachsbarth, Insa; Willaarts, Barbara; Garrido, Alberto] Univ Politecn Madrid, Res Ctr Management Agr & Environm Risks CEIGRAM, Dept Agr Econ & Social Sci, Madrid, Spain; [Flachsbarth, Insa; Willaarts, Barbara; Garrido, Alberto] Botin Fdn, Water Observ, Madrid, Spain; [Xie, Hua; Pitois, Gauthier; Ringler, Claudia] Int Food Policy Res Inst, Environm & Prod Technol Div, Washington, DC 20036 USA; [Mueller, Nathaniel D.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA	Universidad Politecnica de Madrid; CGIAR; International Food Policy Research Institute (IFPRI); Harvard University	Flachsbarth, I (corresponding author), Univ Politecn Madrid, Res Ctr Management Agr & Environm Risks CEIGRAM, Dept Agr Econ & Social Sci, Madrid, Spain.	flachsbarth.insa@gmail.com	Garrido, Alberto/B-9524-2008; Mueller, Nathan D/E-5864-2010	Mueller, Nathan D/0000-0003-1857-5104; Flachsbarth, Insa/0000-0003-2642-9211; Willaarts, Barbara Anna/0000-0001-6589-1543	Fundacion Botin-CEIGRAM, Universidad Politecnica de Madrid [P12 0220c-003, P13 0220c-008]	Fundacion Botin-CEIGRAM, Universidad Politecnica de Madrid	Funding provided by Fundacion Botin-CEIGRAM, Universidad Politecnica de Madrid (grant numbers: P12 0220c-003 and P13 0220c-008; URLs: www.ceigram.upm.es and www.fundacionbotin.org): IF BW AG, CGIAR Research Program on Water, Land and Ecosystems: HX GP CR and NDM received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; ANDERSON K, 1992, WORLD ECON, V15, P153, DOI 10.1111/j.1467-9701.1992.tb00801.x; [Anonymous], TECHNICAL REPORT; Antweiler W, 2001, AM ECON REV, V91, P877, DOI 10.1257/aer.91.4.877; Arima EY, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024010; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; CHICHILNISKY G, 1994, AM ECON REV, V84, P851; Cole MA, 2004, ECOL ECON, V48, P71, DOI 10.1016/j.ecolecon.2003.09.007; Conforti P, 2004, TECHNICAL REPORT; de Fraiture C, 2010, AGR WATER MANAGE, V97, P502, DOI 10.1016/j.agwat.2009.08.008; Dingemans A, 2012, 108 CEPAL; Driscoll CT, 2003, BIOSCIENCE, V53, P357, DOI 10.1641/0006-3568(2003)053[0357:NPITNU]2.0.CO;2; Elobeld A, 2006, J AGR ECON, V57, P23, DOI 10.1111/j.1477-9552.2006.00030.x; Ercin AE, 2014, ENVIRON INT, V64, P71, DOI 10.1016/j.envint.2013.11.019; FAO, 2009, STAT FOOD AGR LIF BA, V2; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fargione JE, 2010, ANNU REV ECOL EVOL S, V41, P351, DOI 10.1146/annurev-ecolsys-102209-144720; Finger R, 2011, NATURE, V480, P39, DOI 10.1038/480039e; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Frankel JA, 2005, REV ECON STAT, V87, P85, DOI 10.1162/0034653053327577; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Garrido A, 2010, WATER FOOTPRINT VIRT; Gasparri NI, 2013, GLOBAL ENVIRON CHANG, V23, P1605, DOI 10.1016/j.gloenvcha.2013.09.007; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Healy S, 1998, IMPLICATIONS URUGUAY; Hoekstra A.Y., 2011, WATER FOOTPRINT ASSE, DOI DOI 10.1080/0969160X.2011.593864; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; IPCC Intergovernmental Panel on Climate Change (IPCC), 2013, 5 ASSESSMENT REPORT; Koneswaran G, 2008, ENVIRON HEALTH PERSP, V116, P578, DOI 10.1289/ehp.11034; Lapola DM, 2010, P NATL ACAD SCI USA, V107, P3388, DOI 10.1073/pnas.0907318107; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Liu JG, 2010, P NATL ACAD SCI USA, V107, P8035, DOI 10.1073/pnas.0913658107; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Managi S, 2009, J ENVIRON ECON MANAG, V58, P346, DOI 10.1016/j.jeem.2009.04.008; McIntyre B. D, 2009, AGR CROSSROADS SYNTH; Mejia A, 2014, WATER AM CHALLENGES; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Nations United, 2005, TECHNICAL REPORT; Nelson GC, 2010, INT FOOD POL RES I, DOI DOI 10.2499/9780896291867; OECD (Organisation for Economic Co-operation and Development), 2013, GLOB FOOD SEC CHALL; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pradhan P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044044; Pradhan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062228; Ramankutty N, 2010, GLOBAL AGR LANDS PAS, DOI DOI 10.1111/J.1758-8111.2010.00001.X; Grau HR, 2008, ECOL SOC, V13; Ringler C, 2010, WATER RESOUR DEV MAN, P1, DOI 10.1007/978-3-642-04615-5; Rosegrant MW, 2012, TECHNICAL REPORT; Santhi C, 2001, J AM WATER RESOUR AS, V37, P1169, DOI 10.1111/j.1752-1688.2001.tb03630.x; Schmitz C, 2012, GLOBAL ENVIRON CHANG, V22, P189, DOI 10.1016/j.gloenvcha.2011.09.013; Smith LC, 2000, EXPLAINING CHILD MAL, V39; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Ullrich A, 2009, AGR WATER MANAGE, V96, P1207, DOI 10.1016/j.agwat.2009.03.010; UNEP, 2010, GEO LAC, P380; Valin H, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035019; van Ittersum MK, 2013, FIELD CROP RES, V143, P4, DOI 10.1016/j.fcr.2012.09.009; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007; Willaarts B.A., 2014, WATER FOOD SECURITY; Willaarts BA., 2014, WATER FOOD SECUR HUM, P55; Witcover J., 2001, GLOBAL FOOD PROJECTI	66	37	37	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116733	10.1371/journal.pone.0116733	http://dx.doi.org/10.1371/journal.pone.0116733			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4PT	25617621	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000350336000023
J	Horridge, A				Horridge, Adrian			How Bees Discriminate a Pattern of Two Colours from Its Mirror Image	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; VISION	A century ago, in his study of colour vision in the honeybee (Apis mellifera), Karl von Frisch showed that bees distinguish between a disc that is half yellow, half blue, and a mirror image of the same. Although his inference of colour vision in this example has been accepted, some discrepancies have prompted a new investigation of the detection of polarity in coloured patterns. In new experiments, bees restricted to their blue and green receptors by exclusion of ultraviolet could learn patterns of this type if they displayed a difference in green contrast between the two colours. Patterns with no green contrast required an additional vertical black line as a landmark. Tests of the trained bees revealed that they had learned two inputs; a measure and the retinotopic position of blue with large field tonic detectors, and the measure and position of a vertical edge or line with small-field phasic green detectors. The angle between these two was measured. This simple combination was detected wherever it occurred in many patterns, fitting the definition of an algorithm, which is defined as a method of processing data. As long as they excited blue receptors, colours could be any colour to human eyes, even white. The blue area cue could be separated from the green receptor modulation by as much as 50 degrees. When some blue content was not available, the bees learned two measures of the modulation of the green receptors at widely separated vertical edges, and the angle between them. There was no evidence that the bees reconstructed the lay-out of the pattern or detected a tonic input to the green receptors.	Australian Natl Univ, Canberra, ACT, Australia	Australian National University	Horridge, A (corresponding author), Australian Natl Univ, Canberra, ACT, Australia.	horridge@netspeed.com.au						AUTRUM H, 1964, Z VERGL PHYSIOL, V48, P357, DOI 10.1007/BF00299270; Forel A, 1886, SENSES INSECTS; FRIEDLAENDER M, 1931, Z VERGL PHYSIOL, V15, P193, DOI DOI 10.1007/BF00339109; Frisch K.v, 1914, ZOOLOGISCHE JB, V37, P1, DOI DOI 10.5962/BHL.TITLE.11736; Giger AD, 1996, J COMP PHYSIOL A, V178, P763; Hertz M, 1939, J EXP BIOL, V16, P1; HERTZ MATHILDE, 1933, BIOL ZENTRALBL, V53, P10; Horridge A, 2003, J INSECT PHYSIOL, V49, P1145, DOI 10.1016/j.jinsphys.2003.08.008; Horridge A., 2012, ACTA BIOL HUNGARI S2, V63, P146; Horridge A, 2014, EYE BRAIN, V6, P9, DOI 10.2147/EB.S70522; Horridge A, 2009, J INSECT PHYSIOL, V55, P499, DOI 10.1016/j.jinsphys.2009.03.006; Horridge G. A., 2009, WHAT DOES HONEYBEE S; Horridge GA, 1996, J INSECT PHYSIOL, V42, P373, DOI 10.1016/0022-1910(95)00118-2; Horridge GA, 1999, J COMP PHYSIOL A, V185, P105, DOI 10.1007/s003590050370; Horridge GA, 2003, J EXP BIOL, V206, P2105, DOI 10.1242/jeb.00379; Horridge GA, 1997, J COMP PHYSIOL A, V181, P267, DOI 10.1007/s003590050113; Horridge GA, 1998, J INSECT PHYSIOL, V44, P343, DOI 10.1016/S0022-1910(97)00116-9; Lubbock J, 1881, ANTS BEES WASPS; Plateau F, 1885, B ACAD ROY SOC BELG, P30; Sanchez D., 1915, TRAB LAB INVEST BIOL, V13, P1, DOI DOI 10.5962/BHL.TITLE.37839; SRINIVASAN MV, 1988, J COMP PHYSIOL A, V162, P159, DOI 10.1007/BF00606081; von Hess C., 1918, ARCH GESAMPTE PHYSL, V170, P337, DOI DOI 10.1007/BF01700270; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; Yang EC, 2004, J INSECT PHYSIOL, V50, P913, DOI 10.1016/j.jinsphys.2004.06.010	24	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116224	10.1371/journal.pone.0116224	http://dx.doi.org/10.1371/journal.pone.0116224			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617892	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000010
J	Ling, C; Wang, L; Wang, Z; Xu, LM; Sun, LF; Yang, H; Li, WD; Wang, K				Ling, Chao; Wang, Lin; Wang, Zheng; Xu, Luming; Sun, Lifang; Yang, Hui; Li, Wei-Dong; Wang, Kai			A Pathway-Centric Survey of Somatic Mutations in Chinese Patients with Colorectal Carcinomas	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COLON-CANCER; APC MUTATIONS; MICROSATELLITE INSTABILITY; MOLECULAR CHARACTERIZATION; SUSCEPTIBILITY LOCI; HUMAN BREAST; COPY NUMBER; GENE; IDENTIFICATION	Previous genetic studies on colorectal carcinomas (CRC) have identified multiple somatic mutations in four candidate pathways (TGF-beta, Wnt, P53 and RTK-RAS pathways) on populations of European ancestry. However, it is under-studied whether other populations harbor different sets of hot-spot somatic mutations in these pathways and other oncogenes. In this study, to evaluate the mutational spectrum of novel somatic mutations, we assessed 41 pairs of tumor-stroma tissues from Chinese patients with CRC, including 29 colon carcinomas and 12 rectal carcinomas. We designed Illumina Custom Amplicon panel to target 43 genes, including genes in the four candidate pathways, as well as several known oncogenes for other cancers. Candidate mutations were validated by Sanger sequencing, and we further used SIFT and PolyPhen-2 to assess potentially functional mutations. We discovered 3 new somatic mutations in gene APC, TCF7L2, and PIK3CA that had never been reported in the COSMIC or NCI-60 databases. Additionally, we confirmed 6 known somatic mutations in gene SMAD4, APC, FBXW7, BRAF and PTEN in Chinese CRC patients. While most were previously reported in CRC, one mutation in PTEN was reported only in malignant endometrium cancer. Our study confirmed the existence of known somatic mutations in the four candidate pathways for CRC in Chinese patients. We also discovered a number of novel somatic mutations in these pathways, which may have implications for the pathogenesis of CRC.	[Ling, Chao; Yang, Hui; Wang, Kai] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Ling, Chao] Peking Union Med Coll Hosp, Lab Clin Genet, Beijing 100730, Peoples R China; [Ling, Chao; Li, Wei-Dong] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin 300070, Peoples R China; [Wang, Lin; Wang, Zheng; Xu, Luming; Sun, Lifang] Huazhong Univ Sci & Technol, Ctr Tissue Engn & Regenerat Med, Union Hosp, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China; [Wang, Kai] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90089 USA	University of Southern California; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Tianjin Medical University; Huazhong University of Science & Technology; University of Southern California; University of Southern California	Wang, K (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	kaiwang@usc.edu	LING, CHAO/W-3528-2019	Li, Wei-Dong/0000-0003-0521-7412; LING, CHAO/0000-0001-5328-4906	Zilkha Neurogenetic Institute at the University of Southern California	Zilkha Neurogenetic Institute at the University of Southern California	This project was supported by start-up funds from the Zilkha Neurogenetic Institute at the University of Southern California. KW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169; BABA S, 1994, ANTICANCER RES, V14, P2189; Berg M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013978; Boman BM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00244; Casey G, 2013, GUT, V62, P920, DOI 10.1136/gutjnl-2011-301935; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Ewing I, 2014, FRONTLINE GASTROENTE, V5, P26, DOI 10.1136/flgastro-2013-100329; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gay LJ, 2012, J PATHOL, V228, P405, DOI 10.1002/path.4085; HAN SM, 2013, PLOS GENET, V9, DOI DOI 10.1371/JOURNAL.PONE.0064271; Hanna MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074950; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Hu FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060233; Hutter CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-670; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Kapitanovic S, 2004, EXP MOL PATHOL, V77, P193, DOI 10.1016/j.yexmp.2004.06.001; Kimura ET, 2003, CANCER RES, V63, P1454; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Matsumura G, 1990, NIHON HIFUKA GAKKAI, V100, P57; MIYAKI M, 1994, CANCER RES, V54, P3011; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Naguib A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-99; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Ogino S, 2013, ONCOGENE; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Peterson LM, 2012, INT J GYNECOL PATHOL, V31, P195, DOI 10.1097/PGP.0b013e318231fc51; Planck M, 2002, CANCER GENET CYTOGEN, V134, P46, DOI 10.1016/S0165-4608(01)00587-8; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIDRANSKY D, 1992, SCIENCE, V256, P102, DOI 10.1126/science.1566048; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Vasovcak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024114; Wahlberg SS, 2002, CANCER RES, V62, P3485; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; Yu C, 2014, CELL RES, V24, P701, DOI 10.1038/cr.2014.43; Zhang R, 2012, COLORECTAL DIS, V14, pe80, DOI 10.1111/j.1463-1318.2011.02858.x; Zhou XP, 2002, HUM MOL GENET, V11, P445, DOI 10.1093/hmg/11.4.445	57	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116753	10.1371/journal.pone.0116753	http://dx.doi.org/10.1371/journal.pone.0116753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617745	Green Published, gold, Green Submitted			2022-12-27	WOS:000350336000024
J	Sun, YF; Yang, ZY; Zhang, YP; Xue, J; Wang, MW; Shi, W; Zhu, BL; Hu, SL; Yao, ZF; Pan, HR; Zhang, YJ				Sun, Yifei; Yang, Zhongyi; Zhang, Yongping; Xue, Jing; Wang, Mingwei; Shi, Wei; Zhu, Beiling; Hu, Silong; Yao, Zhifeng; Pan, Herong; Zhang, Yingjian			The Preliminary Study of 16 alpha-[18F] fluoroestradiol PET/CT in Assisting the Individualized Treatment Decisions of Breast Cancer Patients	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ESTROGEN-RECEPTORS; IN-VIVO; F-18-FLUOROESTRADIOL; HETEROGENEITY; EXPRESSION; CARCINOMA	Objective To evaluate the clinical value of 16 alpha-[18F] fluoroestradiol (18F-FES) PET/CT in assisting the individualized treatment decisions of breast cancer patients. Methods Thirty-three breast cancer patients, who underwent both 18F-FES and 18F-FDG PET/CT from July 2010 to March 2013 in our center, were enrolled in this preliminary study. All the patients used 18F-FES PET/CT as a diagnostic tool with a clinical dilemma. We used the maximum Standardized Uptake Value (SUVmax) to quantify ER expression and a cutoff value of 1.5 to dichotomize results into ER positive and negative lesions. All patients were clinically followed up at least 6 months. Results In evaluating equivocal lesions on conventional work-up group (n = 4), three lung lesions and another iliac lesion were enrolled. As for three lung lesions, 18F-FES PET/CT showed one lesion with high uptake, which suggested it was an ER positive metastasis. The other two lesions were 18F-FES negative, which meant an ER negative metastasis or secondary primary tumor. Additionally, one iliac lesion was detected by MRI. 18F-FDG uptake was high at the suspected lesion, whereas 18F-FES uptake was absent; In predicting origin of metastasis group (n = 2), two breast cancer patients had secondary primary tumors were collected. They were 18F-FES negative, which showed low possibility of metastasis from breast cancer and they were all confirmed by biopsy. In detecting ER status in metastasis group (n = 27), 18F-FES PET/CT showed increased 18F-FES uptake in all metastatic lesions in 11 patients; absent in all lesions in 13 patients; and the remaining 3 patients had both 18F-FES positive and negative lesions. Totally, on the basis of the 18F-FES PET/CT results, we found changes in the treatment plans in 16 patients (48.5%,16/33). Conclusions 18F-FES PET/CT could assess the entire tumor volume receptor status; therefore, it may be used to assist the individualized treatment decisions of breast cancer patients.	[Sun, Yifei; Yang, Zhongyi; Zhang, Yongping; Xue, Jing; Wang, Mingwei; Shi, Wei; Zhu, Beiling; Hu, Silong; Yao, Zhifeng; Pan, Herong; Zhang, Yingjian] Fudan Univ, Shanghai Canc Ctr, Dept Nucl Med, Shanghai 200433, Peoples R China; [Sun, Yifei; Yang, Zhongyi; Zhang, Yongping; Xue, Jing; Wang, Mingwei; Shi, Wei; Zhu, Beiling; Hu, Silong; Yao, Zhifeng; Pan, Herong; Zhang, Yingjian] Fudan Univ, Ctr Biomed Imaging, Shanghai 200433, Peoples R China; [Sun, Yifei; Yang, Zhongyi; Zhang, Yongping; Xue, Jing; Wang, Mingwei; Shi, Wei; Zhu, Beiling; Hu, Silong; Yao, Zhifeng; Pan, Herong; Zhang, Yingjian] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Sun, Yifei; Yang, Zhongyi; Zhang, Yongping; Xue, Jing; Wang, Mingwei; Shi, Wei; Zhu, Beiling; Hu, Silong; Yao, Zhifeng; Pan, Herong; Zhang, Yingjian] Shanghai Engn Res Ctr Mol Imaging Probes, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Zhang, YJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Nucl Med, Shanghai 200433, Peoples R China.	profzhangyj@163.com		Wang, Ming-Wei/0000-0003-0020-4700	Science and Technology Commission of Shanghai Municipality [12431900208, 15ZR1407600]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by Science and Technology Commission of Shanghai Municipality (No. 12431900208 and 15ZR1407600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir E, 2012, CANCER TREAT REV, V38, P708, DOI 10.1016/j.ctrv.2011.11.006; Buzdar A, 1996, J CLIN ONCOL, V14, P2000, DOI 10.1200/JCO.1996.14.7.2000; Fisher B, 2008, J CLIN ONCOL, V26, P2068, DOI 10.1200/JCO.2007.14.1804; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Kurland BF, 2011, J NUCL MED, V52, P1541, DOI 10.2967/jnumed.111.091439; Linden HM, 2006, J CLIN ONCOL, V24, P2793, DOI 10.1200/JCO.2005.04.3810; Liu WS, 2014, EUR J CANCER CARE, V23, P36, DOI 10.1111/ecc.12084; MCGUIRE AH, 1991, J NUCL MED, V32, P1526; MINTUN MA, 1988, RADIOLOGY, V169, P45, DOI 10.1148/radiology.169.1.3262228; Mori T, 2006, NUCL MED BIOL, V33, P281, DOI 10.1016/j.nucmedbio.2005.11.002; Mortimer JE, 1996, CLIN CANCER RES, V2, P933; Peterson LM, 2008, J NUCL MED, V49, P367, DOI 10.2967/jnumed.107.047506; Peterson LM, 2014, MOL IMAGING BIOL, V16, P431, DOI 10.1007/s11307-013-0699-7; Pusztai L, 2006, ONCOLOGIST, V11, P868, DOI 10.1634/theoncologist.11-8-868; Sharangpani GM, 2007, J MICROSC-OXFORD, V226, P244, DOI 10.1111/j.1365-2818.2007.01772.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simmons C, 2009, ANN ONCOL, V20, P1499, DOI 10.1093/annonc/mdp028; Sundararajan L, 2007, SEMIN NUCL MED, V37, P470, DOI 10.1053/j.semnuclmed.2007.08.003; van Kruchten M, 2013, LANCET ONCOL, V14, pE465, DOI 10.1016/S1470-2045(13)70292-4; van Kruchten M, 2012, J NUCL MED, V53, P182, DOI 10.2967/jnumed.111.092734; Yang ZY, 2013, CLIN BREAST CANCER, V13, P359, DOI 10.1016/j.clbc.2013.02.012; Yoshida T, 2000, CARCINOGENESIS, V21, P2193, DOI 10.1093/carcin/21.12.2193; Zhang Yu, 2011, Chinese Journal of Applied and Environmental Biology, V17, P196, DOI 10.3724/SP.J.1145.2011.00196	23	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116341	10.1371/journal.pone.0116341	http://dx.doi.org/10.1371/journal.pone.0116341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617853	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000013
J	Sparding, T; Silander, K; Palsson, E; Ostlind, J; Sellgren, C; Ekman, CJ; Joas, E; Hansen, S; Landen, M				Sparding, Timea; Silander, Katja; Palsson, Erik; Ostlind, Josefin; Sellgren, Carl; Ekman, Carl Johan; Joas, Erik; Hansen, Stefan; Landen, Mikael			Cognitive Functioning in Clinically Stable Patients with Bipolar Disorder I and II	PLOS ONE			English	Article							NEUROCOGNITIVE IMPAIRMENT; ATTENTION-DEFICIT; RATING-SCALE; METAANALYSIS; BATTERY	Objectives Bipolar disorder is accompanied by cognitive impairments, which persists during euthymic phases. The purpose of the present study was to identify those neuropsychological tests that most reliably tell euthymic bipolar patients and controls apart, and to clarify the extent to which these cognitive impairments are clinically significant as judged from neuropsychological norms. Methods Patients with bipolar disorder (type I: n = 64; type II: n = 44) and controls (n = 86) were examined with a comprehensive neuropsychological test battery yielding 47 measures of executive functioning, speed, memory, and verbal skills. Multivariate analysis was used to build a model of cognitive performance with the ability to expose underlying trends in data and to reveal cognitive differences between patients and controls. Results Patients with bipolar disorder and controls were partially separated by one predictive component of cognitive performance. Additionally, the relative relevance of each cognitive measure for such separation was decided. Cognitive tests measuring set shifting, inhibition, fluency, and searching (e.g., Trail Making Test, Color-Word) had strongest discriminating ability and most reliably detected cognitive impairments in the patient group. Conclusions Both bipolar disorder type I and type II were associated with cognitive impairment that for a sizeable minority is significant in a clinical neuropsychological sense. We demonstrate a combination of neuropsychological tests that reliably detect cognitive impairment in bipolar disorder.	[Sparding, Timea; Palsson, Erik; Ostlind, Josefin; Joas, Erik; Landen, Mikael] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosc & Physiol, Gothenburg, Sweden; [Sellgren, Carl; Landen, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ekman, Carl Johan] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Silander, Katja; Hansen, Stefan] Univ Gothenburg, Dept Psychol, S-40020 Gothenburg, Sweden	University of Gothenburg; Karolinska Institutet; Karolinska Institutet; University of Gothenburg	Sparding, T (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosc & Physiol, Gothenburg, Sweden.	Timea.Sparding@neuro.gu.se	Joas, Erik/AFO-0523-2022; Landen, Mikael/AAD-7917-2020	Joas, Erik/0000-0001-9546-2192; 	Swedish Medical Research Council [K2011-61X-14647-09-3, K2010-61X-21569-01-1, K2010-61P-21568-01-4]; Swedish Foundation for Strategic Research; Swedish Brain Foundation; Swedish Federal Government under the LUA/ALF [ALF 20100305, ALFGBG-142041]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Brain Foundation; Swedish Federal Government under the LUA/ALF	This research was supported by grants from the Swedish Medical Research Council (K2011-61X-14647-09-3, K2010-61X-21569-01-1, and K2010-61P-21568-01-4), the Swedish Foundation for Strategic Research, the Swedish Brain Foundation, and the Swedish Federal Government under the LUA/ALF agreement (ALF 20100305, ALFGBG-142041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1976, ECDEU ASSESSMENT MAN; ASBERG M, 1979, PROG NEURO-PSYCHOPHA, V3, P405, DOI 10.1016/0364-7722(79)90055-9; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; Bizzarri JV, 2007, BIPOLAR DISORD, V9, P213, DOI 10.1111/j.1399-5618.2007.00383.x; Bora E, 2010, J AFFECT DISORDERS, V127, P1, DOI 10.1016/j.jad.2010.02.117; Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133; Burdick KE, 2010, ACTA PSYCHIAT SCAND, V122, P499, DOI 10.1111/j.1600-0447.2010.01590.x; Clark L, 2002, BRIT J PSYCHIAT, V180, P313, DOI 10.1192/bjp.180.4.313; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Depp CA, 2012, BIPOLAR DISORD, V14, P217, DOI 10.1111/j.1399-5618.2012.01011.x; Dittmann S, 2008, BIPOLAR DISORD, V10, P877, DOI 10.1111/j.1399-5618.2008.00640.x; Ekman CJ, 2010, ACTA PSYCHIAT SCAND, V122, P507, DOI 10.1111/j.1600-0447.2010.01586.x; Eriksson L., 2013, MULTI MEGAVARIATE DA; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Jakobsson J, 2013, NEUROPSYCHOPHARMACOL, V38, P664, DOI 10.1038/npp.2012.231; Koso M, 2006, EUR PSYCHIAT, V21, P167, DOI 10.1016/j.eurpsy.2005.06.004; Levy B, 2008, PSYCHIAT RES, V161, P28, DOI 10.1016/j.psychres.2007.09.009; LUBORSKY L, 1975, B MENNINGER CLIN, V39, P448; Mann-Wrobel MC, 2011, BIPOLAR DISORD, V13, P334, DOI 10.1111/j.1399-5618.2011.00935.x; Martinez-Aran A, 2004, BIPOLAR DISORD, V6, P224, DOI 10.1111/j.1399-5618.2004.00111.x; Moorhead TWJ, 2007, BIOL PSYCHIAT, V62, P894, DOI 10.1016/j.biopsych.2007.03.005; O'Shea R, 2010, J AFFECT DISORDERS, V125, P336, DOI 10.1016/j.jad.2009.12.012; Palsson E, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-165; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Ryden E, 2009, ACTA PSYCHIAT SCAND, V120, P239, DOI 10.1111/j.1600-0447.2009.01399.x; Ryden E, 2009, J NEURAL TRANSM, V116, P1667, DOI 10.1007/s00702-009-0300-3; Sachs GS, 2003, BIOL PSYCHIAT, V53, P1028, DOI 10.1016/S0006-3223(03)00165-3; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Simonsen C, 2008, BIPOLAR DISORD, V10, P245, DOI 10.1111/j.1399-5618.2007.00492.x; Sole B, 2012, CNS NEUROSCI THER, V18, P194, DOI 10.1111/j.1755-5949.2011.00262.x; Torrent C, 2006, BRIT J PSYCHIAT, V189, P254, DOI 10.1192/bjp.bp.105.017269; Torres IJ, 2007, ACTA PSYCHIAT SCAND, V116, P17, DOI 10.1111/j.1600-0447.2007.01055.x; Torres IJ, 2014, BIPOLAR DISORD, V16, P159, DOI 10.1111/bdi.12154; Van Rheenen TE, 2014, BIPOLAR DISORD, V16, P318, DOI 10.1111/bdi.12134; Vargas C, 2013, J AFFECT DISORDERS, V150, P727, DOI 10.1016/j.jad.2013.05.083; Winblad Stefan, 2006, Behav Brain Funct, V2, P16, DOI 10.1186/1744-9081-2-16; Yatham LN, 2010, BIPOLAR DISORD, V12, P351, DOI 10.1111/j.1399-5618.2010.00830.x; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	39	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115562	10.1371/journal.pone.0115562	http://dx.doi.org/10.1371/journal.pone.0115562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25614986	Green Submitted, Green Published, gold			2022-12-27	WOS:000349122100014
J	Vargas-Alarcon, G; Angeles-Martiinez, J; Villarreal-Molina, T; Alvarez-Leon, E; Posadas-Sanchez, R; Cardoso-Saldana, G; Ramirez-Bello, J; Perez-Hernandez, N; Juarez-Rojas, JG; Rodriguez-Perez, JM; Fragoso, JM; Posadas-Romero, C				Vargas-Alarcon, Gilberto; Angeles-Martinez, Javier; Villarreal-Molina, Teresa; Alvarez-Leon, Edith; Posadas-Sanchez, Rosalinda; Cardoso-Saldana, Guillermo; Ramirez-Bello, Julian; Perez-Hernandez, Nonanzit; Gabriel Juarez-Rojas, Juan; Manuel Rodriguez-Perez, Jose; Manuel Fragoso, Jose; Posadas-Romero, Carlos			Interleukin-17A Gene Haplotypes Are Associated with Risk of Premature Coronary Artery Disease in Mexican Patients from the Genetics of Atherosclerotic Disease (GEA) Study	PLOS ONE			English	Article							FAMILY CYTOKINES; ADMIXTURE; FREQUENCIES; POLYMORPHISMS; MECHANISMS; IL-17A; CELLS	Aim The role of interleukin 17A (IL-17A) in the inflammatory process has caused interest in the potential significance of IL-17A as a biomarker for coronary artery disease (CAD). The aim of the present study was to evaluate the role of IL-17A gene polymorphisms as susceptibility markers for CAD in the Mexican population. Methods Four IL-17A gene polymorphisms (rs8193036, rs3819024, rs2275913 and rs8193037) were genotyped by 5' exonuclease TaqMan assays in a group of 900 patients with premature CAD and 667 healthy controls (with negative calcium score by computed tomography), seeking associations with CAD and other metabolic and cardiovascular risk factors using logistic regression analyses. Results No single IL-17A polymorphism was associated with premature CAD, however two haplotypes (CAGG and TAGA) were significantly associated with increased risk of premature CAD (OR = 1.35, 95% CI: 1.00-1.84, P = 0.018 and OR = 2.09, 95% CI: 1.16-3.76, P = 0.003, respectively). Moreover, rs3819024 was associated with increased levels of visceral abdominal fat (P = 0.002) and rs8193036 was significantly associated with risk of central obesity (P = 0.020), hypertriglyceridemia (P = 0.027), and metabolic syndrome (P = 0.027) in the premature CAD group, under dominant models adjusted by age, gender, BMI, smoking history, alcohol consumption, and treatment. Conclusion The results suggest that IL-17A haplotypes are involved in the risk of developing premature CAD and some IL-17A polymorphisms are associated with cardiovascular risk factors in Mexican individuals with premature CAD.	[Vargas-Alarcon, Gilberto; Angeles-Martinez, Javier; Alvarez-Leon, Edith; Perez-Hernandez, Nonanzit; Manuel Rodriguez-Perez, Jose; Manuel Fragoso, Jose] Inst Nacl Cardiol Ignacio Chavez, Dept Mol Biol, Mexico City, DF, Mexico; [Villarreal-Molina, Teresa] Inst Nacl Med Genom INMEGEN, Cardiovasc Genom Lab, Mexico City, DF, Mexico; [Posadas-Sanchez, Rosalinda; Cardoso-Saldana, Guillermo; Gabriel Juarez-Rojas, Juan; Posadas-Romero, Carlos] Inst Nacl Cardiol Ignacio Chavez, Dept Endocrinol, Mexico City, DF, Mexico; [Ramirez-Bello, Julian] Hosp Juarez Mexico, Unit Res, Lab Genom Med, Mexico City, DF, Mexico	National Institute of Cardiology - Mexico; Instituto Nacional de Medicina Genomica; National Institute of Cardiology - Mexico	Vargas-Alarcon, G (corresponding author), Inst Nacl Cardiol Ignacio Chavez, Dept Mol Biol, Mexico City, DF, Mexico.	gvargas63@yahoo.com	Ramírez-Bello, Julian/AAR-1308-2020; Juárez-Rojas, Juan Gabriel/AAM-9486-2020	Ramírez-Bello, Julian/0000-0002-4153-9315; Juárez-Rojas, Juan Gabriel/0000-0001-8864-2304; Angeles Martinez, Javier/0000-0001-5405-0482; Vargas-Alarcon, Gilberto/0000-0001-7916-5163; Cardoso, Guillermo/0000-0001-9525-1731; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690	Consejo Nacional de Ciencia y Tecnologia [156911]; Fundacion Gonzalo Rio Arronte, Mexico City, Mexico	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Gonzalo Rio Arronte, Mexico City, Mexico	This work was supported by grants from the Consejo Nacional de Ciencia y Tecnologia (projects 156911) and Fundacion Gonzalo Rio Arronte, Mexico City, Mexico. All of the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Chang SH, 2011, CELL SIGNAL, V23, P1069, DOI 10.1016/j.cellsig.2010.11.022; Chen SA, 2010, J IMMUNOL, V185, P5619, DOI 10.4049/jimmunol.1001879; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; D'Acquisto F, 2010, BIOCHEM PHARMACOL, V79, P525, DOI 10.1016/j.bcp.2009.09.015; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Garcia-Moll X, 2005, REV ESP CARDIOL, V58, P615, DOI 10.1157/13076412; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hayashi R, 2012, J GASTROINTEST LIVER, V21, P243; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Juarez-Cedillo T, 2008, FORENSIC SCI INT-GEN, V2, pE37, DOI 10.1016/j.fsigen.2007.08.017; Kadkhodazadeh M, 2013, IMMUNOL INVEST, V42, P156, DOI 10.3109/08820139.2012.746697; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; LISKER R, 1988, AM J PHYS ANTHROPOL, V76, P331, DOI 10.1002/ajpa.1330760307; LISKER R, 1986, AM J PHYS ANTHROPOL, V71, P203, DOI 10.1002/ajpa.1330710207; LISKER R, 1990, HUM BIOL, V62, P791; LONGO R, 1993, INVEST RADIOL, V28, P297, DOI 10.1097/00004424-199304000-00006; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maione F, 2009, BIOCHEM PHARMACOL, V77, P878, DOI 10.1016/j.bcp.2008.11.011; MAUTNER GC, 1994, RADIOLOGY, V192, P619, DOI 10.1148/radiology.192.3.8058924; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Villarreal-Molina T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049285; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang XF, 2013, INFLAMM RES, V62, P743, DOI 10.1007/s00011-013-0629-9; Zhang XL, 2011, CLIN CHIM ACTA, V412, P327, DOI 10.1016/j.cca.2010.10.027; Zhao XF, 2010, MOL BIOL REP, V37, P81, DOI 10.1007/s11033-009-9533-3; Zhu QH, 2014, GENE, V537, P328, DOI 10.1016/j.gene.2013.11.007	34	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0114943	10.1371/journal.pone.0114943	http://dx.doi.org/10.1371/journal.pone.0114943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615631	Green Submitted, Green Published, gold			2022-12-27	WOS:000349122100006
J	Watanabe, Y; Nakayama, K; Taniuchi, N; Horai, Y; Kuriyama, C; Ueta, K; Arakawa, K; Senbonmatsu, T; Shiotani, M				Watanabe, Yoshinori; Nakayama, Keiko; Taniuchi, Nobuhiko; Horai, Yasushi; Kuriyama, Chiaki; Ueta, Kiichiro; Arakawa, Kenji; Senbonmatsu, Takaaki; Shiotani, Masaharu			Beneficial Effects of Canagliflozin in Combination with Pioglitazone on Insulin Sensitivity in Rodent Models of Obese Type 2 Diabetes	PLOS ONE			English	Article							GLUCOSE COTRANSPORTER INHIBITOR; SGLT2 INHIBITORS; FATTY RATS; RESISTANCE; HYPERGLYCEMIA; PREVALENCE; STRATEGIES; MANAGEMENT; TOLERANCE; MELLITUS	Background Despite its insulin sensitizing effects, pioglitazone may induce weight gain leading to an increased risk of development of insulin resistance. A novel sodium glucose co-transporter 2 (SGLT2) inhibitor, canagliflozin, provides not only glycemic control but also body weight reduction through an insulin-independent mechanism. The aim of this study was to investigate the combined effects of these agents on body weight control and insulin sensitivity. Methods Effects of combination therapy with canagliflozin and pioglitazone were evaluated in established diabetic KK-Ay mice and prediabetic Zucker diabetic fatty (ZDF) rats. Results In the KK-Ay mice, the combination therapy further improved glycemic control compared with canagliflozin or pioglitazone monotherapy. Furthermore, the combination significantly attenuated body weight and fat gain induced by pioglitazone and improved hyperinsulinemia. In the ZDF rats, early intervention with pioglitazone monotherapy almost completely prevented the progressive development of hyperglycemia, and no further improvement was observed by add-on treatment with canagliflozin. However, the combination significantly reduced pioglitazone-induced weight gain and adiposity and improved the Matsuda index, suggesting improved whole-body insulin sensitivity. Conclusions Our study indicates that combination therapy with canagliflozin and pioglitazone improves insulin sensitivity partly by preventing glucotoxicity and, at least partly, by attenuating pioglitazone-induced body weight gain in two different obese diabetic animal models. This combination therapy may prove to be a valuable option for the treatment and prevention of obese type 2 diabetes.	[Watanabe, Yoshinori; Nakayama, Keiko; Taniuchi, Nobuhiko; Kuriyama, Chiaki; Ueta, Kiichiro; Arakawa, Kenji; Shiotani, Masaharu] Mitsubishi Tanabe Pharma Corp, Div Res, Pharmacol Res Labs 2, Saitama, Japan; [Horai, Yasushi] Mitsubishi Tanabe Pharma Corp, Div Res, Safety Res Lab, Saitama, Japan; [Watanabe, Yoshinori; Senbonmatsu, Takaaki] Saitama Med Univ, Dept Pharmacol, Saitama, Japan	Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation; Saitama Medical University	Watanabe, Y (corresponding author), Mitsubishi Tanabe Pharma Corp, Div Res, Pharmacol Res Labs 2, Saitama, Japan.	watanabe.yoshinori@mr.mt-pharma.co.jp			Mitsubishi Tanabe Pharma Corporation	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation)	Mitsubishi Tanabe Pharma Corporation sponsored this study. Editorial assistance was provided by Tanabe R&D service CO., Ltd. The authors who are employees of Mitsubishi Tanabe Pharma Corporation designed the studies, participated in data collection and analysis, made the decision to publish, and prepared the manuscript.	Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Arakawa K, 2001, BRIT J PHARMACOL, V132, P578, DOI 10.1038/sj.bjp.0703829; Bergenstal RM, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.07.017; BLONDEL O, 1990, METABOLISM, V39, P787, DOI 10.1016/0026-0495(90)90120-2; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; DeFronzo RA, 2011, DIABETES CARE, V34, pS202, DOI 10.2337/dc11-s221; Del Prato S, 2009, DIABETIC MED, V26, P1185, DOI 10.1111/j.1464-5491.2009.02847.x; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; Devineni D, 2012, DIABETES OBES METAB, V14, P539, DOI 10.1111/j.1463-1326.2012.01558.x; Etgen GJ, 2000, METABOLISM, V49, P684, DOI 10.1016/S0026-0495(00)80049-9; Everson SA, 1998, DIABETES CARE, V21, P1637, DOI 10.2337/diacare.21.10.1637; Forst T, 2014, DIABETES OBES METAB, V16, P467, DOI 10.1111/dom.12273; Fujimori Y, 2008, J PHARMACOL EXP THER, V327, P268, DOI 10.1124/jpet.108.140210; Fujimoto Y, 2006, DIABETES, V55, P2479, DOI 10.2337/db05-1511; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Jia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078284; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kuriyama C, 2014, J PHARM EXP THER; Kurosaki E, 2013, PHARMACOL THERAPEUT, V139, P51, DOI 10.1016/j.pharmthera.2013.04.003; Liang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030555; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; Nawano M, 2000, AM J PHYSIOL-ENDOC M, V278, pE535, DOI 10.1152/ajpendo.2000.278.3.E535; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nyenwe EA, 2011, METABOLISM, V60, P1, DOI 10.1016/j.metabol.2010.09.010; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; Sha S, 2011, DIABETES OBES METAB, V13, P669, DOI 10.1111/j.1463-1326.2011.01406.x; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x	35	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116851	10.1371/journal.pone.0116851	http://dx.doi.org/10.1371/journal.pone.0116851			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615826	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100045
J	Hayakawa, T; Iwai, M; Aoki, S; Takimoto, K; Maruyama, M; Maruyama, W; Motoyama, N				Hayakawa, Tomohisa; Iwai, Mika; Aoki, Satoshi; Takimoto, Koichi; Maruyama, Mitsuo; Maruyama, Wakako; Motoyama, Noboru			SIRT1 Suppresses the Senescence-Associated Secretory Phenotype through Epigenetic Gene Regulation	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; HEMATOPOIETIC STEM-CELLS; NF-KAPPA-B; INDUCED PREMATURE SENESCENCE; EXTENDS LIFE-SPAN; CELLULAR SENESCENCE; TRANSCRIPTION FACTORS; HUMAN FIBROBLASTS; DAMAGE; STRESS	Senescent cells develop a pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). As many SASP components affect surrounding cells and alter their microenvironment, SASP may be a key phenomenon in linking cellular senesence with individual aging and age-related diseases. We herein demonstrated that the expression of Sirtuin1 (SIRT1) was decreased and the expression of SASP components was reciprocally increased during cellular senescence. The mRNAs and proteins of SASP components, such as IL-6 and IL-8, quickly accumulated in SIRT1-depleted cells, and the levels of these factors were also higher than those in control cells, indicating that SIRT1 negatively regulated the expression of SASP factors at the transcriptional level. SIRT1 bound to the promoter regions of IL-8 and IL-6, but dissociated from them during cellular senescence. The acetylation of Histone H3 (K9) and H4 (K16) of the IL-8 and IL-6 promoter regions gradually increased during cellular senescence. In SIRT1-depleted cells, the acetylation levels of these regions were already higher than those in control cells in the pre-senescent stage. Moreover, these acetylation levels in SIRT1-depleted cells were significantly higher than those in control cells during cellular senescence. These results suggest that SIRT1 repressed the expression of SASP factors through the deacetylation of histones in their promoter regions.	[Hayakawa, Tomohisa; Iwai, Mika; Aoki, Satoshi; Maruyama, Wakako; Motoyama, Noboru] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Cognit Brain Sci, Obu, Aichi, Japan; [Hayakawa, Tomohisa; Maruyama, Mitsuo; Motoyama, Noboru] Nagoya Univ, Grad Sch Med, Dept Aging Res, Nagoya, Aichi 4648601, Japan; [Aoki, Satoshi; Takimoto, Koichi] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 94021, Japan; [Maruyama, Mitsuo] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Mech Aging, Obu, Aichi, Japan	National Center for Geriatrics & Gerontology; Nagoya University; Nagaoka University of Technology; National Center for Geriatrics & Gerontology	Motoyama, N (corresponding author), Natl Ctr Geriatr & Gerontol, Res Inst, Dept Cognit Brain Sci, Obu, Aichi, Japan.	motoyama@ncgg.go.jp			Japan Society for the Promotion of Science [KAKENHI 24590369]; Research Founding for Longevity Sciences from National Center for Geriatrics and Gerontology [23-1, 26-25]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Founding for Longevity Sciences from National Center for Geriatrics and Gerontology	This work was supported by the Japan Society for the Promotion of Science, KAKENHI 24590369 (to NM) and the Research Founding for Longevity Sciences 23-1 and 26-25 (to NM) from National Center for Geriatrics and Gerontology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Cao L, 2006, EMBO J, V25, P2167, DOI 10.1038/sj.emboj.7601115; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; de Magalhaes JP, 2002, FEBS LETT, V523, P157, DOI 10.1016/S0014-5793(02)02973-3; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Naka K, 2004, J BIOL CHEM, V279, P2030, DOI 10.1074/jbc.M309457200; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Sona Hubackova KK, 2014, AGING, V4, P932; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	55	88	92	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116480	10.1371/journal.pone.0116480	http://dx.doi.org/10.1371/journal.pone.0116480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635860	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700039
J	Lau, KHW; Baylink, DJ; Sheng, MHC				Lau, Kin-Hing William; Baylink, David J.; Sheng, Matilda H. -C.			Osteocyte-Derived Insulin-Like Growth Factor I Is Not Essential for the Bone Repletion Response in Mice	PLOS ONE			English	Article							CALCIUM-DEFICIENT RATS; PARATHYROID-HORMONE PTH; DOWN-REGULATION; IGF-I; RECEPTOR; MINERALIZATION; OSTEOBLASTS; EXPRESSION; RESORPTION; DEPLETION	The present study sought to evaluate the functional role of osteocyte-derived IGF-I in the bone repletion process by determining whether deficient expression of Igf1 in osteocytes would impair the bone repletion response to one week of dietary calcium repletion after two weeks of dietary calcium deprivation. As expected, the two-week dietary calcium depletion led to hypocalcemia, secondary hyperparathyroidism, and increases in bone resorption and bone loss in both Igf1 osteocyte conditional knockout (cKO) mutants and WT control mice. Thus, conditional disruption of Igf1 in osteocytes did not impair the calcium depletion-induced bone resorption. After one week of calcium repletion, both cKO mutants and WT littermates showed an increase in endosteal bone formation attended by the reduction in osteoclast number, indicating that deficient Igf1 expression in osteocytes also did not have deleterious effects on the bone repletion response. The lack of an effect of deficient osteocyte- derived IGF-I expression on bone repletion is unexpected since previous studies show that these Igf1 osteocyte cKO mice exhibited impaired developmental growth and displayed complete resistance to bone anabolic effects of loading. These studies suggest that there is a dichotomy between the mechanisms necessary for anabolic responses to mechanical loading and the regulatory hormonal and anabolic skeletal repletion following low dietary calcium challenge. In conclusion, to our knowledge this study has demonstrated for the first time that osteocyte-derived IGF-I, which is essential for anabolic bone response to mechanical loading, is not a key regulatory factor for bone repletion after a low calcium challenge.	[Lau, Kin-Hing William; Baylink, David J.; Sheng, Matilda H. -C.] Loma Linda Univ, Sch Med, Dept Med, Div Regenerat Med, Loma Linda, CA 92354 USA; [Lau, Kin-Hing William] Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92354 USA	Loma Linda University	Sheng, MHC (corresponding author), Loma Linda Univ, Sch Med, Dept Med, Div Regenerat Med, Loma Linda, CA 92354 USA.	MSheng@llu.edu		Lau, Kin-Hing/0000-0003-1109-5052	Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC) [W81XWH-08-1-0697]	Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	The work is supported by the Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC) under Grant No. W81XWH-08-1-0697. The views, opinions and/or findings contained in this report are those of the authors and should not be construed as an official Department of the Army position, policy or decision, unless so designated by other documentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson K, 1998, J CLIN ENDOCR METAB, V83, P1921, DOI 10.1210/jc.83.6.1921; Atkins GJ, 2012, OSTEOPOROSIS INT, V23, P2067, DOI 10.1007/s00198-012-1915-z; BEHRINGER RR, 1990, ENDOCRINOLOGY, V127, P1033, DOI 10.1210/endo-127-3-1033; Bellido T., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P358; Ben-Awadh AN, 2014, ENDOCRINOLOGY, V155, P2797, DOI 10.1210/en.2014-1046; Bikle Daniel D, 2012, Curr Mol Pharmacol, V5, P135; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; DRIVDAHL RH, 1984, AM J PHYSIOL, V246, pR190, DOI 10.1152/ajpregu.1984.246.2.R190; Feng JQ, 2013, BONE, V54, P213, DOI 10.1016/j.bone.2013.01.046; GRINSPOON SK, 1995, J CLIN INVEST, V96, P900, DOI 10.1172/JCI118137; HAMALAINEN MM, 1994, J NUTR, V124, P874; Jongen JWJM, 1996, J BONE MINER RES, V11, P1218; Kasukawa Y, 2003, ENDOCRINOLOGY, V144, P4682, DOI 10.1210/en.2003-0745; Lau KHW, 2013, AM J PHYSIOL-ENDOC M, V305, pE271, DOI 10.1152/ajpendo.00092.2013; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937, DOI 10.1152/ajpendo.1996.270.6.E937; Liu C C, 1982, Prog Clin Biol Res, V101, P93; LIU CC, 1982, METAB BONE DIS RELAT, V4, P201, DOI 10.1016/0221-8747(82)90019-4; Lloyd SA, 2013, BONE, V57, P76, DOI 10.1016/j.bone.2013.07.022; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; MOHAN S, 1991, CLIN ORTHOP RELAT R, P30; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; POLIG E, 1990, CALCIFIED TISSUE INT, V47, P261, DOI 10.1007/BF02555907; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Ravn P, 1997, CALCIFIED TISSUE INT, V60, P255, DOI 10.1007/s002239900225; Rhee Y, 2013, J BIOL CHEM, V288, P29809, DOI 10.1074/jbc.M113.485938; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Ryan JW, 2013, CURR DRUG TARGETS, V14, P1683, DOI 10.2174/138945011131400212; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Sheng MHC, 2013, BONE, V52, P133, DOI 10.1016/j.bone.2012.09.027; Sheng MHC, 2002, BONE, V30, P486, DOI 10.1016/S8756-3282(01)00693-7; STAUFFER M, 1972, CALC TISS RES, V9, P163, DOI 10.1007/BF02061954; STAUFFER M, 1973, AM J PHYSIOL, V225, P269, DOI 10.1152/ajplegacy.1973.225.2.269; TANIMOTO H, 1991, CALCIFIED TISSUE INT, V48, P101, DOI 10.1007/BF02555874; THOMPSON ER, 1975, ENDOCRINOLOGY, V97, P283, DOI 10.1210/endo-97-2-283; Wang YM, 2006, J BONE MINER RES, V21, P1350, DOI 10.1359/JBMR.060610; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yoo A, 1998, BONE, V22, P225, DOI 10.1016/S8756-3282(97)00277-9; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115897	10.1371/journal.pone.0115897	http://dx.doi.org/10.1371/journal.pone.0115897			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635763	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700020
J	Boehm, JT; Waldman, J; Robinson, JD; Hickerson, MJ				Boehm, J. T.; Waldman, John; Robinson, John D.; Hickerson, Michael J.			Population Genomics Reveals Seahorses (Hippocampus erectus) of the Western Mid-Atlantic Coast to Be Residents Rather than Vagrants	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENETIC DIVERSITY; FISHES; PHYLOGEOGRAPHY; SYNGNATHIDAE; INFERENCE; HISTORY; SCALE; DIFFERENTIATION; COLONIZATION	Understanding population structure and areas of demographic persistence and transients is critical for effective species management. However, direct observational evidence to address the geographic scale and delineation of ephemeral or persistent populations for many marine fishes is limited. The Lined seahorse (Hippocampus erectus) can be commonly found in three western Atlantic zoogeographic provinces, though inhabitants of the temperate northern Virginia Province are often considered tropical vagrants that only arrive during warm seasons from the southern provinces and perish as temperatures decline. Although genetics can locate regions of historical population persistence and isolation, previous evidence of Virginia Province persistence is only provisional due to limited genetic sampling (i.e., mitochondrial DNA and five nuclear loci). To test alternative hypotheses of historical persistence versus the ephemerality of a northern Virginia Province population we used a RADseq generated dataset consisting of 11,708 single nucleotide polymorphisms (SNP) sampled from individuals collected from the eastern Gulf of Mexico to Long Island, NY. Concordant results from genomic analyses all infer three genetically divergent subpopulations, and strongly support Virginia Province inhabitants as a genetically diverged and a historically persistent ancestral gene pool. These results suggest that individuals that emerge in coastal areas during the warm season can be considered "local" and supports offshore migration during the colder months. This research demonstrates how a large number of genes sampled across a geographical range can capture the diversity of coalescent histories (across loci) while inferring population history. Moreover, these results clearly demonstrate the utility of population genomic data to infer peripheral subpopulation persistence in difficult-to-observe species.	[Boehm, J. T.; Hickerson, Michael J.] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Waldman, John] CUNY Queens Coll, Dept Biol, Queens, NY 11367 USA; [Boehm, J. T.; Waldman, John; Hickerson, Michael J.] CUNY, Grad Ctr, Subprogram Ecol Evolut & Behav, New York, NY 10016 USA; [Robinson, John D.] Marine Resources Res Inst, South Carolina Dept Nat Resources, Charleston, SC 29412 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Boehm, JT (corresponding author), CUNY City Coll, Dept Biol, 160 Convent Ave, New York, NY 10031 USA.	jtboehmjr@gmail.com		Robinson, John/0000-0002-9782-1598	National Science Foundation [40C3300-01]	National Science Foundation(National Science Foundation (NSF))	The National Science Foundation (40C3300-01) supported the dissertational research of J. T. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able K, 1998, ECOLOGY ESTUARINE FI; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Boehm JT, 2013, J BIOGEOGR, V40, P1839, DOI 10.1111/jbi.12127; Bratton JF, 2003, GEO-MAR LETT, V22, P188, DOI 10.1007/s00367-002-0112-z; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Briggs PT, 2002, NORTHEAST NAT, V9, P47; Casazza TL, 2008, FISH B-NOAA, V106, P348; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Corander J, 2013, MOL ECOL, V22, P2931, DOI 10.1111/mec.12174; CRONIN TM, 1981, SCIENCE, V211, P233, DOI 10.1126/science.211.4479.233; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Curran M, 1989, OCCURRENCE TROPICAL, P71; Deagle BE, 2013, MOL ECOL, V22, P1917, DOI 10.1111/mec.12215; Dias TL, 2002, ENVIRON BIOL FISH, V65, P326, DOI 10.1023/A:1020539222587; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; FELSENSTEIN J, 1981, EVOLUTION, V35, P1229, DOI 10.1111/j.1558-5646.1981.tb04991.x; Fish M. P., 1970, SOUNDS W N ATLANTIC; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Frichot E, 2014, GENETICS, V196, P973, DOI 10.1534/genetics.113.160572; Gazave E, 2013, GENETICS, V195, P969, DOI 10.1534/genetics.113.153973; Gompert Z, 2014, MOL ECOL, V23, P4555, DOI 10.1111/mec.12811; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Harris SE, 2015, MOL ECOL RESOUR, V15, P382, DOI 10.1111/1755-0998.12301; Hearn J, 2014, MOL ECOL, V23, P198, DOI 10.1111/mec.12578; Hice LA, 2012, ECOL LETT, V15, P568, DOI 10.1111/j.1461-0248.2012.01769.x; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Howell P, 2012, MAR COAST FISH, V4, P481, DOI 10.1080/19425120.2012.685144; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAZZARI MA, 1990, ENVIRON BIOL FISH, V27, P177, DOI 10.1007/BF00001671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-22; Lohse K, 2011, GENETICS, V189, P977, DOI 10.1534/genetics.111.129569; Lourie S.A., 2004, GUIDE IDENTIFICATION; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Lourie SA, 2004, J BIOGEOGR, V31, P1975, DOI 10.1111/j.1365-2699.2004.01153.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lozier JD, 2014, MOL ECOL, V23, P788, DOI 10.1111/mec.12636; Martinez-Solano I, 2008, BIOL J LINN SOC, V95, P824, DOI 10.1111/j.1095-8312.2008.01098.x; McBride RS, 2014, N AM J FISH MANAGE, V34, P710, DOI 10.1080/02755947.2014.902408; McCartney MA, 2013, J BIOGEOGR, V40, P1386, DOI 10.1111/jbi.12103; MILSTEIN C B, 1976, Chesapeake Science, V17, P198, DOI 10.2307/1351198; Mobley KB, 2011, J FISH BIOL, V78, P1624, DOI 10.1111/j.1095-8649.2011.02967.x; Mobley KB, 2010, J BIOGEOGR, V37, P1363, DOI 10.1111/j.1365-2699.2010.02288.x; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pringle JM, 2007, MAR ECOL PROG SER, V335, P69, DOI 10.3354/meps335069; Pritchard JK, 2000, GENETICS, V155, P945; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Robinson JD, 2014, MOL ECOL, V23, P4458, DOI 10.1111/mec.12881; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Sousa V, 2013, NAT REV GENET, V14, P404, DOI 10.1038/nrg3446; Teixeira R. L., 2001, Brazilian Journal of Biology, V61, P79, DOI 10.1590/S0034-71082001000100011; Teske PR, 2005, MAR ECOL PROG SER, V286, P249, DOI 10.3354/meps286249; Teske PR, 2003, MOL ECOL, V12, P1703, DOI 10.1046/j.1365-294X.2003.01852.x; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; ULTSCH GR, 1989, BIOL REV, V64, P435, DOI 10.1111/j.1469-185X.1989.tb00683.x; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wenner CA, 1989, NOAA TECHNICAL REPOR, V79, P1; WICKLUND R I, 1968, Underwater Naturalist, V5, P26; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649	67	38	39	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116219	10.1371/journal.pone.0116219	http://dx.doi.org/10.1371/journal.pone.0116219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629166	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100033
J	Carpenter, KLH; Angold, A; Chen, NK; Copeland, WE; Gaur, P; Pelphrey, K; Song, AW; Egger, HL				Carpenter, Kimberly L. H.; Angold, Adrian; Chen, Nan-Kuei; Copeland, William E.; Gaur, Pooja; Pelphrey, Kevin; Song, Allen W.; Egger, Helen L.			Preschool Anxiety Disorders Predict Different Patterns of Amygdala-Prefrontal Connectivity at School-Age	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; PSYCHIATRIC-DISORDERS; CHILDHOOD ANXIETY; SOCIAL PHOBIA; FACIAL EXPRESSIONS; EMOTION REGULATION; CORTEX ACTIVATION; BRAIN ACTIVATION; FEARFUL FACES; ANGRY FACES	Objective In this prospective, longitudinal study of young children, we examined whether a history of preschool generalized anxiety, separation anxiety, and/or social phobia is associated with amygdala-prefrontal dysregulation at school-age. As an exploratory analysis, we investigated whether distinct anxiety disorders differ in the patterns of this amygdala-prefrontal dysregulation. Methods Participants were children taking part in a 5-year study of early childhood brain development and anxiety disorders. Preschool symptoms of generalized anxiety, separation anxiety, and social phobia were assessed with the Preschool Age Psychiatric Assessment (PAPA) in the first wave of the study when the children were between 2 and 5 years old. The PAPA was repeated at age 6. We conducted functional MRIs when the children were 5.5 to 9.5 year old to assess neural responses to viewing of angry and fearful faces. Results A history of preschool social phobia predicted less school-age functional connectivity between the amygdala and the ventral prefrontal cortices to angry faces. Preschool generalized anxiety predicted less functional connectivity between the amygdala and dorsal prefrontal cortices in response to fearful faces. Finally, a history of preschool separation anxiety predicted less school-age functional connectivity between the amygdala and the ventral prefrontal cortices to angry faces and greater school-age functional connectivity between the amygdala and dorsal prefrontal cortices to angry faces. Conclusions Our results suggest that there are enduring neurobiological effects associated with a history of preschool anxiety, which occur over-and-above the effect of subsequent emotional symptoms. Our results also provide preliminary evidence for the neurobiological differentiation of specific preschool anxiety disorders.	[Carpenter, Kimberly L. H.; Angold, Adrian; Copeland, William E.; Egger, Helen L.] Duke Univ, Med Ctr, Ctr Dev Epidemiol, Dept Psychiat & Behav Sci, Durham, NC 27708 USA; [Chen, Nan-Kuei; Song, Allen W.] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC USA; [Gaur, Pooja] Vanderbilt Univ, Sch Med Chem & Phys Biol, Nashville, TN 37235 USA; [Pelphrey, Kevin] Yale Univ, Yale Child Study Ctr, New Haven, CT USA	Duke University; Duke University; Vanderbilt University; Yale University	Carpenter, KLH (corresponding author), Duke Univ, Med Ctr, Ctr Dev Epidemiol, Dept Psychiat & Behav Sci, Durham, NC 27708 USA.	Kimberly.carpenter@dm.duke.edu	Copeland, William E/N-5413-2014; Chen, Nan-Kuei/E-7791-2016	Copeland, William E/0000-0002-1348-7781; Chen, Nan-Kuei/0000-0001-6564-4219; Egger, Helen/0000-0001-8447-5350; Gaur, Pooja/0000-0003-0433-975X; Carpenter, Kimberly/0000-0002-3838-798X	National Institutes of Mental Health [R01-MH-081025]; National Institute of Mental Health [R01-MH-075766]; National Institute for Neurological Disorders and Stroke [R01-NS074045]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075766, R01MH081025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074045] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Mental Health (http://www.nimh.nih.gov/) grant R01-MH-081025 and a National Alliance for Research in Schizophrenia and Affective Disorders Young Investigator Award (http://bbrfoundation.org/) awarded to HLE, National Institute of Mental Health (http://www.nimh.nih.gov/) grant R01-MH-075766 awarded to AA, and National Institute for Neurological Disorders and Stroke (http://www.ninds.nih.gov/) grant R01-NS074045 awarded to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jawadi AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-274; Angold A, 1996, J CHILD PSYCHOL PSYC, V37, P657, DOI 10.1111/j.1469-7610.1996.tb01457.x; ANGOLD A, 1995, PSYCHOL MED, V25, P739, DOI 10.1017/S003329170003498X; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Barbas H, 2007, J ANAT, V211, P237, DOI 10.1111/j.1469-7580.2007.00777.x; Barch DM, 2012, BIOL PSYCHIAT, V72, P1035, DOI 10.1016/j.biopsych.2012.06.009; Bittner A, 2007, J CHILD PSYCHOL PSYC, V48, P1174, DOI 10.1111/j.1469-7610.2007.01812.x; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Blair KS, 2012, EMOT REV, V4, P133, DOI 10.1177/1754073911430251; Brand S, 2011, J PSYCHIATR RES, V45, P452, DOI 10.1016/j.jpsychires.2010.08.014; Bufferd SJ, 2012, AM J PSYCHIAT, V169, P1157, DOI 10.1176/appi.ajp.2012.12020268; Bufferd SJ, 2011, COMPR PSYCHIAT, V52, P359, DOI 10.1016/j.comppsych.2010.08.006; Campbell-Sills L, 2011, NEUROIMAGE, V54, P689, DOI 10.1016/j.neuroimage.2010.07.041; Canino G, 2004, ARCH GEN PSYCHIAT, V61, P85, DOI 10.1001/archpsyc.61.1.85; Carballo JJ, 2010, EUR CHILD ADOLES PSY, V19, P395, DOI 10.1007/s00787-009-0064-1; Cooney RE, 2006, PSYCHIAT RES-NEUROIM, V148, P55, DOI 10.1016/j.pscychresns.2006.05.003; Copeland WE, 2009, ARCH GEN PSYCHIAT, V66, P764, DOI 10.1001/archgenpsychiatry.2009.85; Costello EJ, 2005, CHILD ADOL PSYCH CL, V14, P631, DOI 10.1016/j.chc.2005.06.003; Danti S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00152; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Dougherty LR, 2013, J CLIN CHILD ADOLESC, V42, P577, DOI 10.1080/15374416.2012.759225; Edwards SL, 2010, J CHILD PSYCHOL PSYC, V51, P313, DOI 10.1111/j.1469-7610.2009.02160.x; Egger H.L., 2006, HDB PRESCHOOL MENTAL, P137; Egger HL, 2006, J AM ACAD CHILD PSY, V45, P538, DOI 10.1097/01.chi.0000205705.71194.b8; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Ehrenrelch JT, 2008, BEHAV PSYCHOL, V16, P389; Esbjorn BH, 2010, J ANXIETY DISORD, V24, P866, DOI 10.1016/j.janxdis.2010.06.009; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2012, DEPRESS ANXIETY, V29, P355, DOI 10.1002/da.21957; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Franz L, 2013, J AM ACAD CHILD PSY, V52, P1294, DOI 10.1016/j.jaac.2013.09.008; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Gillath O, 2005, NEUROIMAGE, V28, P835, DOI 10.1016/j.neuroimage.2005.06.048; Gleason MM, 2011, EUR CHILD ADOLES PSY, V20, P527, DOI 10.1007/s00787-011-0214-0; Goldin PR, 2009, BIOL PSYCHIAT, V66, P1091, DOI 10.1016/j.biopsych.2009.07.014; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Grolnick WS, 1996, CHILD DEV, V67, P928, DOI 10.1111/j.1467-8624.1996.tb01774.x; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Hitchcock CA, 2009, ISR J PSYCHIATR REL, V46, P34; Hoehn-Saric R, 2005, PSYCHIAT RES-NEUROIM, V140, P259, DOI 10.1016/j.pscychresns.2005.05.013; Hoehn-Saric R, 2004, PSYCHIAT RES-NEUROIM, V131, P11, DOI 10.1016/j.pscychresns.2004.02.003; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kern S, 2008, PSYCHONEUROENDOCRINO, V33, P517, DOI 10.1016/j.psyneuen.2008.01.010; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Kossowsky J, 2012, J CHILD PSYCHOL PSYC, V53, P178, DOI 10.1111/j.1469-7610.2011.02465.x; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lavigne J, 2009, J CLIN CHILD ADOLESC, V38, P315, DOI 10.1080/15374410902851382; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; McClure EB, 2007, ARCH GEN PSYCHIAT, V64, P97, DOI 10.1001/archpsyc.64.1.97; Mian ND, 2012, J ANXIETY DISORD, V26, P102, DOI 10.1016/j.janxdis.2011.09.006; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Monk CS, 2006, AM J PSYCHIAT, V163, P1091, DOI 10.1176/appi.ajp.163.6.1091; Nitschke JB, 2009, AM J PSYCHIAT, V166, P302, DOI 10.1176/appi.ajp.2008.07101682; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Paulesu E, 2010, PSYCHOL MED, V40, P117, DOI 10.1017/S0033291709005649; Perlman SB, 2011, J EXP CHILD PSYCHOL, V108, P607, DOI 10.1016/j.jecp.2010.08.006; Perlman SB, 2010, SOC NEUROSCI-UK, V5, P533, DOI 10.1080/17470911003683219; Pine DS, 1999, J CHILD ADOL PSYCHOP, V9, P1, DOI 10.1089/cap.1999.9.1; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prater KE, 2013, DEPRESS ANXIETY, V30, P234, DOI 10.1002/da.22014; Rilling JK, 2001, BIOL PSYCHIAT, V49, P146, DOI 10.1016/S0006-3223(00)00977-X; ROTHBART MK, 1994, J ABNORM PSYCHOL, V103, P55, DOI 10.1037/0021-843X.103.1.55; Roy AK, 2013, J AM ACAD CHILD PSY, V52, P290, DOI 10.1016/j.jaac.2012.12.010; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stein MB, 2006, J CLIN PSYCHIAT, V67, P3; Sterba S, 2007, J CHILD PSYCHOL PSYC, V48, P1005, DOI 10.1111/j.1469-7610.2007.01770.x; Strickland J, 2011, J ABNORM CHILD PSYCH, V39, P601, DOI 10.1007/s10802-011-9487-5; Talairach J., 1988, COPLANAR STEREOTAXIC; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thomas KM, 2001, ARCH GEN PSYCHIAT, V58, P1057, DOI 10.1001/archpsyc.58.11.1057; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Voyvodic JT, 1999, NEUROIMAGE, V10, P91, DOI 10.1006/nimg.1999.0457; Vrticka P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002868; Whalen PJ, 2008, BIOL PSYCHIAT, V63, P858, DOI 10.1016/j.biopsych.2007.08.019; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; WICHSTROM L, 2013, EUR CHILD ADOLESC PS, P42331; Wichstrom L, 2013, J CHILD PSYCHOL PSYC, V54, P1327, DOI 10.1111/jcpp.12116; Wichstrom L, 2012, J CHILD PSYCHOL PSYC, V53, P695, DOI 10.1111/j.1469-7610.2011.02514.x; World Health Organisation (WHO), 2001, INT CLASS FUNCT DIS; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; 2005, DIAGN CLASS 0 3R DIA, P42331	93	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116854	10.1371/journal.pone.0116854	http://dx.doi.org/10.1371/journal.pone.0116854			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625285	Green Submitted, gold, Green Published			2022-12-27	WOS:000348821400019
J	Panagopoulos, I; Gorunova, L; Bjerkehagen, B; Heim, S				Panagopoulos, Ioannis; Gorunova, Ludmila; Bjerkehagen, Bodil; Heim, Sverre			Novel KAT6B-KANSL1 Fusion Gene Identified by RNA Sequencing in Retroperitoneal Leiomyoma with t(10;17)(q22;q21)	PLOS ONE			English	Article							MED12 EXON-2 MUTATIONS; ACUTE MYELOID-LEUKEMIA; HISTONE ACETYLTRANSFERASE; UTERINE LEIOMYOMATA; GLOBULAR DOMAIN; HMGA2; REARRANGEMENTS; GENERATION; DISTINCT; EXPRESSION	Retroperitoneal leiomyoma is a rare type of benign smooth muscle tumor almost exclusively found in women and with histopathological features similar to uterine leiomyomas. The pathogenesis of retroperitoneal leiomyoma is unclear and next to nothing is known about the cytogenetics and molecular genetics of the tumor. Here we present the first cytogenetically analyzed retroperitoneal leiomyoma. It had a t(10; 17)(q22; q21) as the sole chromosomal abnormality. Using RNA-Sequencing and the 'grep' command to search the fastq files of the sequence data we found that the translocation resulted in fusion of the genes KAT6B (10q22) with KANSL1 (17q21). RT-PCR together with direct (Sanger) sequencing verified the presence of a KAT6B-KANSL1 fusion transcript. No reciprocal KANSL1-KAT6B transcript was amplified suggesting that it was either absent or unexpressed. The KAT6B-KANSL1 fusion transcript consists of exons 1 to 3 of KAT6B and exons 11 to 15 of KANSL1, is 3667 bp long, has a 1398 bp long open reading frame, and codes for a 466 amino acid residue protein. The corresponding KAT6B-KANSL1 protein contains the NEMM domain (including the linker histone H1/H5, domain H15) of KAT6B and the PEHE domain of KANSL1. The function of the fusion protein might be regulation of transcription with an affinity for chromatin (linker histone H1/H5) and interaction with the HAT domain of KAT8 (PEHE domain). The tumor expressed HMGA2 and HMGA1 even though 12q14-15 and 6p looked normal by G-banding analysis. The tumor also expressed MED12 in the absence of exon 2 mutations. Overall, the data show that the examined retroperitoneal leiomyoma resembles a subset of uterine leiomyomas in terms of histology and genetics.	[Panagopoulos, Ioannis; Gorunova, Ludmila; Heim, Sverre] Oslo Univ Hosp, Inst Canc Genet & Informat, Norwegian Radium Hosp, Sect Canc Cytogenet, Oslo, Norway; [Panagopoulos, Ioannis; Gorunova, Ludmila; Heim, Sverre] Univ Oslo, Ctr Canc Biomed, Fac Med, Oslo, Norway; [Bjerkehagen, Bodil] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Heim, Sverre] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Panagopoulos, I (corresponding author), Oslo Univ Hosp, Inst Canc Genet & Informat, Norwegian Radium Hosp, Sect Canc Cytogenet, Oslo, Norway.	ioannis.panagopoulos@rr-research.no		Panagopoulos, Ioannis/0000-0003-2159-5341	Norwegian Cancer Society; Norwegian Radium Hospital Foundation	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Radium Hospital Foundation	This work was supported by grants from the Norwegian Cancer Society and the Norwegian Radium Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertsch E, 2014, MODERN PATHOL, V27, P1144, DOI 10.1038/modpathol.2013.243; Billings SD, 2001, AM J SURG PATHOL, V25, P1134, DOI 10.1097/00000478-200109000-00003; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Campeau PM, 2012, HUM MUTAT, V33, P1520, DOI 10.1002/humu.22141; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Carter GJ, 1998, BIOCHEMISTRY-US, V37, P12477, DOI 10.1021/bi980716v; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Dias J, 2014, GENE DEV, V28, P929, DOI 10.1101/gad.240200.114; Dursun P, 2005, INT J GYNECOL CANCER, V15, P1222, DOI 10.1111/j.1525-1438.2005.00329.x; Fasih N, 2008, RADIOGRAPHICS, V28, P1931, DOI 10.1148/rg.287085095; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Fletcher C, 2013, WHO CLASSIFICATION O; Francis RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039987; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Gorunova L, 2011, CANCER GENET-NY, V204, P465, DOI 10.1016/j.cancergen.2011.06.005; Gross KL, 2003, GENE CHROMOSOME CANC, V38, P68, DOI 10.1002/gcc.10240; HEIM S, 2009, CANCER CYTOGENETICS; Kang WD, 2009, ARCH GYNECOL OBSTET, V280, P499, DOI 10.1007/s00404-009-0945-z; Klemke M, 2009, GENE CHROMOSOME CANC, V48, P171, DOI 10.1002/gcc.20627; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Makinen N, 2011, ONCOTARGET, V2, P966; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Marin I, 2003, J MOL EVOL, V56, P527, DOI 10.1007/s00239-002-2422-1; Markowski DN, 2012, INT J CANCER, V131, P1528, DOI 10.1002/ijc.27424; McGuire MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033251; Micci F, 2006, CANCER RES, V66, P107, DOI 10.1158/0008-5472.CAN-05-2485; Moore SDP, 2004, CANCER RES, V64, P5570, DOI 10.1158/0008-5472.CAN-04-0050; Nezhad MH, 2010, CANCER GENET CYTOGEN, V203, P247, DOI 10.1016/j.cancergencyto.2010.08.005; Paal E, 2001, AM J SURG PATHOL, V25, P1355, DOI 10.1097/00000478-200111000-00002; Panagopoulos I, 2001, HUM MOL GENET, V10, P395, DOI 10.1093/hmg/10.4.395; Panagopoulos I, 1996, ONCOGENE, V12, P489; Panagopoulos I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099439; Panagopoulos I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096570; Panagopoulos I, 2014, INT J ONCOL, V44, P1425, DOI 10.3892/ijo.2014.2326; Panagopoulos I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039354; Perot G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040015; Poliquin V, 2008, J MINIM INVAS GYN, V15, P152, DOI 10.1016/j.jmig.2007.12.009; Quade BJ, 2003, CANCER RES, V63, P1351; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; SCHAFFER LG, 2009, ISCN 2009 AN INTERNA; Schwetye KE, 2014, HUM PATHOL, V45, P65, DOI 10.1016/j.humpath.2013.08.005; Sornberger KS, 1999, CANCER GENET CYTOGEN, V114, P9, DOI 10.1016/S0165-4608(99)00054-0; Stutterecker D, 2001, AM J OBSTET GYNECOL, V185, P248, DOI 10.1067/mob.2001.114503; ZUCMAN J, 1993, EMBO J, V12, P4481, DOI 10.1002/j.1460-2075.1993.tb06137.x	46	28	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117010	10.1371/journal.pone.0117010	http://dx.doi.org/10.1371/journal.pone.0117010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621995	gold, Green Published, Green Submitted			2022-12-27	WOS:000348470400013
J	Fu, TF; Cao, ML; Liu, F; Zhu, JA; Ye, DM; Feng, XX; Xu, YM; Wang, G; Bai, YH				Fu, Tengfei; Cao, Manlin; Liu, Fang; Zhu, Jiaan; Ye, Dongmei; Feng, Xianxuan; Xu, Yiming; Wang, Gang; Bai, Yuehong			Carpal Tunnel Syndrome Assessment with Ultrasonography: Value of Inlet-to-Outlet Median Nerve Area Ratio in Patients versus Healthy Volunteers	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; HIGH-RESOLUTION SONOGRAPHY; ULTRASOUND; DIAGNOSIS; ADULTS	Objective To evaluate the diagnostic value of the Inlet-to-outlet median nerve area ratio (IOR) in patients with clinically and electrophysiologically confirmed carpal tunnel syndrome (CTS). Methods Forty-six wrists in 46 consecutive patients with clinical and electrodiagnostic evidence of CTS and forty-four wrists in 44 healthy volunteers were examined with ultrasonography. The cross-sectional area (CSA) of the median nerve was measured at the carpal tunnel inlet (the level of scaphoid-pisiform) and outlet (the level of the hook of the hamate), and the IOR was calculated for each wrist. Ultrasonography and electrodiagnostic tests were performed under blinded conditions. Electrodiagnostic testing combined with clinical symptoms were considered to be the gold standard test. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic value between the inlet CSA and IOR. Results study population included 16 men and 30 women (mean age, 45.3 years; range, 18-83 years). The control population included 18 men and 26 women (mean age, 50.4 years; range, 18-79 years). The mean inlet CSA was 8.7 mm(2) in healthy controls and 14.6mm(2) in CTS group (P < 0.001). The mean IOR in healthy volunteers (1.0) was smaller than that in patients (1.6, P < 0.001). Receiver operating characteristic analysis revealed a diagnostic advantage to using the IOR rather than the inlet CSA (P < 0.01). An IOR cutoff value of >= 1.3 would yield 93% specificity and 91% sensitivity in the diagnosis of CTS. Conclusion The IOR of median nerve area promises to be an effective means in the diagnosis of CTS. A large-scale, randomized controlled trial is required to determine how and when this parameter will be used.	[Fu, Tengfei; Cao, Manlin; Ye, Dongmei; Feng, Xianxuan; Xu, Yiming; Wang, Gang; Bai, Yuehong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Rehabil Med, Shanghai 200030, Peoples R China; [Liu, Fang; Zhu, Jiaan] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ultrasound, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bai, YH (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Rehabil Med, Shanghai 200030, Peoples R China.	aibyhw@126.com	Xu, yiming/E-5687-2012	Xu, yiming/0000-0002-7123-5793				[Anonymous], 1993, NEUROLOGY, V43, P2406, DOI DOI 10.1212/WNL.43.11.2406; Bathala L, 2013, MUSCLE NERVE, V47, P673, DOI 10.1002/mus.23639; Beekman R, 2003, MUSCLE NERVE, V27, P26, DOI 10.1002/mus.10227; BUCHBERGER W, 1991, J ULTRAS MED, V10, P531, DOI 10.7863/jum.1991.10.10.531; BUCHBERGER W, 1992, AM J ROENTGENOL, V159, P793, DOI 10.2214/ajr.159.4.1529845; Cartwright MS, 2008, MUSCLE NERVE, V37, P566, DOI 10.1002/mus.21009; Cartwright MS, 2012, MUSCLE NERVE, V46, P287, DOI 10.1002/mus.23389; Cartwright MS, 2009, J NEUROIMAGING, V19, P47, DOI 10.1111/j.1552-6569.2008.00256.x; Cullen Karen A, 2009, Natl Health Stat Report, P1; Fleiss J. L., 1986, THE DESIGN AND ANALY; Hobson-Webb LD, 2008, CLIN NEUROPHYSIOL, V119, P1353, DOI 10.1016/j.clinph.2008.01.101; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jayaraman S, 2004, NEUROIMAG CLIN N AM, V14, P103, DOI 10.1016/j.nic.2003.12.001; Kaymak B, 2008, ARCH PHYS MED REHAB, V89, P743, DOI 10.1016/j.apmr.2007.09.041; Keberle M, 2000, EUR RADIOL, V10, P1043, DOI 10.1007/s003300000386; Kele H, 2003, NEUROLOGY, V61, P389, DOI 10.1212/01.WNL.0000073101.04845.22; Keles I, 2005, AM J PHYS MED REHAB, V84, P443, DOI 10.1097/01.phm.0000163715.11645.96; Kim HS, 2013, ARCH PHYS MED REHAB, V94, P2151, DOI 10.1016/j.apmr.2013.05.008; Klauser AS, 2011, RADIOLOGY, V259, P808, DOI 10.1148/radiol.11101644; Martinoli C, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781553; MESGARZADEH M, 1989, RADIOLOGY, V171, P749, DOI 10.1148/radiology.171.3.2541464; Nakamichi KI, 2000, MUSCLE NERVE, V23, P1713, DOI 10.1002/1097-4598(200011)23:11<1713::AID-MUS7>3.3.CO;2-7; Nakamichi KI, 2002, MUSCLE NERVE, V26, P798, DOI 10.1002/mus.10276; Schappert Susan M, 2008, Natl Health Stat Report, P1; Sernik RA, 2008, SKELETAL RADIOL, V37, P49, DOI 10.1007/s00256-007-0372-9; Sugimoto T, 2013, ULTRASOUND MED BIOL, V39, P1560, DOI 10.1016/j.ultrasmedbio.2013.03.031; Therimadasamy A, 2012, MUSCLE NERVE, V46, P455, DOI 10.1002/mus.23401; Ulasli AM, 2013, MUSCLE NERVE, V47, P396, DOI 10.1002/mus.23528; Visser LH, 2008, J NEUROL NEUROSUR PS, V79, P63, DOI 10.1136/jnnp.2007.115337; Wang Lin-Yi, 2008, Chang Gung Med J, V31, P469; Werner RA, 2011, MUSCLE NERVE, V44, P597, DOI 10.1002/mus.22208; Won SJ, 2013, MUSCLE NERVE, V47, P864, DOI 10.1002/mus.23691; Wong SM, 2004, RADIOLOGY, V232, P93, DOI 10.1148/radiol.2321030071; Zaidman CM, 2009, MUSCLE NERVE, V40, P960, DOI 10.1002/mus.21431; Ziswiler HR, 2005, ARTHRITIS RHEUM-US, V52, P304, DOI 10.1002/art.20723	35	33	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116777	10.1371/journal.pone.0116777	http://dx.doi.org/10.1371/journal.pone.0116777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617835	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000025
J	Hu, YL; Dun, YH; Li, SN; Zhang, DX; Peng, N; Zhao, SM; Liang, YX				Hu, Yuanliang; Dun, Yaohao; Li, Shenao; Zhang, Dongxiao; Peng, Nan; Zhao, Shumiao; Liang, Yunxiang			Dietary Enterococcus faecalis LAB31 Improves Growth Performance, Reduces Diarrhea, and Increases Fecal Lactobacillus Number of Weaned Piglets	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; NOXIOUS GAS CONTENT; FAECALIBACTERIUM-PRAUSNITZII; INTESTINAL MICROBIOTA; FAECIUM STRAIN; GASTROINTESTINAL MICROBIOTA; ANTIBIOTIC-RESISTANCE; BLOOD CHARACTERISTICS; GUT MICROBIOTA; SWINE FECES	Lactic acid bacteria (LAB) have been shown to enhance performance of weaned piglets. However, few studies have reported the addition of LAB Enterococcus faecalis as alternatives to growth promoting antibiotics for weaned piglets. This study evaluated the effects of dietary E. faecalis LAB31 on the growth performance, diarrhea incidence, blood parameters, fecal bacterial and Lactobacillus communities in weaned piglets. A total of 360 piglets weaned at 26 +/- 2 days of age were randomly allotted to 5 groups (20 pens, with 4 pens for each group) for a trial of 28 days: group N (negative control, without antibiotics or probiotics); group P (Neomycin sulfate, 100 mg/kg feed); groups L, M and H (supplemented with E. faecalis LAB31 0.5x10(9), 1.0x10(9), and 2.5x10(9) CFU/kg feed, respectively). Average daily gain and feed conversion efficiency were found to be higher in group H than in group N, and showed significant differences between group H and group P (P-0 < 0.05). Furthermore, groups H and P had a lower diarrhea index than the other three groups (P-0 < 0.05). Denaturing gradient gel electrophoresis (DGGE) showed that the application of probiotics to the diet changed the bacterial community, with a higher bacterial diversity in group M than in the other four groups. Real-time PCR revealed that the relative number of Lactobacillus increased by addition of probiotics, and was higher in group H than in group N (P-0 < 0.05). However, group-specific PCR-DGGE showed no obvious difference among the five groups in Lactobacillus composition and diversity. Therefore, the dietary addition of E. faecalis LAB31 can improve growth performance, reduce diarrhea, and increase the relative number of Lactobacillus in feces of weaned piglets.	[Hu, Yuanliang; Dun, Yaohao; Li, Shenao; Zhang, Dongxiao; Peng, Nan; Zhao, Shumiao; Liang, Yunxiang] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Hu, Yuanliang] Hubei Normal Univ, Coll Life Sci, Huangshi 435002, Hubei, Peoples R China	Huazhong Agricultural University; Hubei Normal University	Liang, YX (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	fa-lyx@163.com	Peng, Nan/K-3819-2016	Peng, Nan/0000-0002-1637-6729	State Key Laboratory of Agricultural Microbiology [AMLKF201406]; Project of National Science & Technology Support Program in China [2013BAD10B02]; NSFC [31100050, 31100096]	State Key Laboratory of Agricultural Microbiology; Project of National Science & Technology Support Program in China; NSFC(National Natural Science Foundation of China (NSFC))	This work was funded by grant AMLKF201406 from the State Key Laboratory of Agricultural Microbiology (http://hzaml.hzau.edu.cn), grant 2013BAD10B02 from the Project of National Science & Technology Support Program in China (http://program.most.gov.cn), and by grants 31100050 and 31100096 from the NSFC (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonos EM, 2010, S AFR J ANIM SCI, V40, P173; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Castro M., 2007, INT J PROBIOTICS PRE, V2, P215; Chen YJ, 2006, ASIAN AUSTRAL J ANIM, V19, P587, DOI 10.5713/ajas.2006.587; DECUPERE F, 1992, J VET MED B, V39, P277, DOI 10.1111/j.1439-0450.1992.tb01169.x; Domann E, 2007, INT J MED MICROBIOL, V297, P533, DOI 10.1016/j.ijmm.2007.02.008; Fu CJ, 2006, LETT APPL MICROBIOL, V42, P490, DOI 10.1111/j.1472-765X.2006.01893.x; Fuller M, 2012, BRIT J NUTR, V108, pS238, DOI 10.1017/S0007114512002279; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; Gfeller KY., 2003, THESIS; Han KS, 2011, LETT APPL MICROBIOL, V52, P379, DOI 10.1111/j.1472-765X.2011.03012.x; Han W, 2013, J ANIM SCI, V91, P4374, DOI 10.2527/jas.2012-5956; Giang HH, 2012, LIVEST SCI, V143, P132, DOI 10.1016/j.livsci.2011.09.003; Hoffmann M, 2011, MOL NUTR FOOD RES, V55, P703, DOI 10.1002/mnfr.201000361; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Huang CH, 2004, ASIAN AUSTRAL J ANIM, V17, P401, DOI 10.5713/ajas.2004.401; Janczyk P, 2007, FEMS MICROBIOL ECOL, V61, P132, DOI 10.1111/j.1574-6941.2007.00317.x; Jurado H, 2011, REV MVZ CORDOBA, V16, P2538, DOI 10.21897/rmvz.1018; Kayser FH, 2003, INT J FOOD MICROBIOL, V88, P255, DOI 10.1016/S0168-1605(03)00188-0; Keylock CJ, 2005, OIKOS, V109, P203, DOI 10.1111/j.0030-1299.2005.13735.x; Kong XF, 2014, LIVEST SCI, V160, P97, DOI 10.1016/j.livsci.2013.11.023; Konstantinov SR, 2003, FEMS MICROBIOL ECOL, V43, P225, DOI 10.1111/j.1574-6941.2003.tb01062.x; Lee DH, 1996, APPL ENVIRON MICROB, V62, P3112, DOI 10.1128/AEM.62.9.3112-3120.1996; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Li M, 2003, J MICROBIOL METH, V54, P13, DOI 10.1016/S0167-7012(02)00260-9; Loh G, 2006, J NUTR, V136, P1198, DOI 10.1093/jn/136.5.1198; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Mafamane H, 2011, ARCH ANIM NUTR, V65, P415, DOI 10.1080/1745039X.2011.623351; Mallo JJ, 2010, LIVEST SCI, V133, P176, DOI 10.1016/j.livsci.2010.06.057; Marcin A, 2006, BIOLOGIA, V61, P789, DOI 10.2478/s11756-006-0159-9; Martin R, 2014, INFLAMM BOWEL DIS, V20, P417, DOI 10.1097/01.MIB.0000440815.76627.64; Mathur S, 2005, INT J FOOD MICROBIOL, V105, P281, DOI 10.1016/j.ijfoodmicro.2005.03.008; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Metzler-Zebeli BU, 2011, FEMS MICROBIOL ECOL, V75, P402, DOI 10.1111/j.1574-6941.2010.01017.x; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Miquel S, 2012, GASTROENTEROLOGY, V142, pS392; Molist F, 2012, BRIT J NUTR, V108, P9, DOI 10.1017/S0007114511005216; NRC, 1998, NUTRIENT REQUIREMENT; Nueno-Palop C, 2011, INT J FOOD MICROBIOL, V145, P390, DOI 10.1016/j.ijfoodmicro.2010.12.029; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Pieper R, 2009, INT J FOOD MICROBIOL, V130, P227, DOI 10.1016/j.ijfoodmicro.2009.01.026; Ricca DM, 2010, ANAEROBE, V16, P516, DOI 10.1016/j.anaerobe.2010.03.010; Richards JD, 2005, CAN J ANIM SCI, V85, P421, DOI 10.4141/A05-049; Rist VTS, 2014, ANAEROBE, V25, P72, DOI 10.1016/j.anaerobe.2013.10.003; Scharek L, 2005, VET IMMUNOL IMMUNOP, V105, P151, DOI 10.1016/j.vetimm.2004.12.022; Shen YB, 2009, J ANIM SCI, V87, P2614, DOI 10.2527/jas.2008-1512; [沈中艳 SHEN Zhongyan], 2007, [华中农业大学学报, Journal of Huazhong Agricultural University], V26, P348; Shidara Osamu, 2009, Japanese Journal of Swine Science, V46, P144; Smokvina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068731; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sorensen MT, 2009, LIVEST SCI, V123, P314, DOI 10.1016/j.livsci.2008.12.001; Strompfova V, 2006, ANAEROBE, V12, P242, DOI 10.1016/j.anaerobe.2006.09.003; Su Y, 2008, ANAEROBE, V14, P78, DOI 10.1016/j.anaerobe.2007.12.004; Taras D, 2007, LIVEST SCI, V108, P229, DOI 10.1016/j.livsci.2007.01.075; Taras D, 2006, J ANIM SCI, V84, P608, DOI 10.2527/2006.843608x; Tsukahara Takamitsu, 2005, Microbial Ecology in Health and Disease, V17, P107, DOI 10.1080/08910600510044507; Tsukahara T, 2011, ANIM SCI J, V82, P302, DOI 10.1111/j.1740-0929.2010.00829.x; Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158; Vanhoutte T, 2006, APPL ENVIRON MICROB, V72, P5990, DOI 10.1128/AEM.00233-06; vanOrsouw NJ, 1997, MOL CELL PROBE, V11, P95, DOI 10.1006/mcpr.1996.0089; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Whitehead TR, 2013, LETT APPL MICROBIOL, V56, P264, DOI 10.1111/lam.12043; Yan L, 2013, J APPL ANIM RES, V41, P23, DOI 10.1080/09712119.2012.739092; Zeyner A, 2006, J ANIM PHYSIOL AN N, V90, P25, DOI 10.1111/j.1439-0396.2005.00615.x; Zhou XL, 2012, J ANIM SCI, V90, P37, DOI 10.2527/jas.50269	65	39	46	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116635	10.1371/journal.pone.0116635	http://dx.doi.org/10.1371/journal.pone.0116635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617897	Green Submitted, gold, Green Published			2022-12-27	WOS:000350336000018
J	Merkes, C; Turkalo, TK; Wilder, N; Park, H; Wenger, LW; Lewin, SJ; Azuma, M				Merkes, Chris; Turkalo, Timothy K.; Wilder, Nicole; Park, Hyewon; Wenger, Luke W.; Lewin, Seth J.; Azuma, Mizuki			Ewing Sarcoma Ewsa Protein Regulates Chondrogenesis of Meckel's Cartilage through Modulation of Sox9 in Zebrafish	PLOS ONE			English	Article							DIRECT TRANSCRIPTIONAL TARGET; CREB-BINDING PROTEIN; NEURAL CREST; RNA HELICASE; GENE; EXPRESSION; EWS-FLI1; FUSION; SKELETAL; ACTIVATOR	Ewing sarcoma is the second most common skeletal (bone and cartilage) cancer in adolescents, and it is characterized by the expression of the aberrant chimeric fusion gene EWS/FLI1. Wild-type EWS has been proposed to play a role in mitosis, splicing and transcription. We have previously shown that EWS/FLI1 interacts with EWS, and it inhibits EWS activity in a dominant manner. Ewing sarcoma is a cancer that specifically develops in skeletal tissues, and although the above data suggests the significance of EWS, its role in chondrogenesis/ skeletogenesis is not understood. To elucidate the function of EWS in skeletal development, we generated and analyzed a maternal zygotic (MZ) ewsa/ewsa line because the ewsa/wt and ewsa/ewsa zebrafish appeared to be normal and fertile. Compared with wt/wt, the Meckel's cartilage of MZ ewsa/ewsa mutants had a higher number of craniofacial prehypertrophic chondrocytes that failed to mature into hypertrophic chondrocytes at 4 days post-fertilization (dpf). Ewsa interacted with Sox9, which is the master transcription factor for chondrogenesis. Sox9 target genes were either upregulated (ctgfa, ctgfb, col2a1a, and col2a1b) or downregulated (sox5, nog1, nog2, and bmp4) inMZ ewsa/ewsa embryos compared with the wt/wt zebrafish embryos. Among these Sox9 target genes, the chromatin immunoprecipitation (ChIP) experiment demonstrated that Ewsa directly binds to ctgfa and ctgfb loci. Consistently, immunohistochemistry showed that the Ctgf protein is upregulated in the Meckel's cartilage of MZ ewsa/ewsa mutants. Together, we propose that Ewsa promotes the differentiation from prehypertrophic chondrocytes to hypertrophic chondrocytes of Meckel's cartilage through inhibiting Sox9 binding site of the ctgf gene promoter. Because Ewing sarcoma specifically develops in skeletal tissue that is originating from chondrocytes, this new role of EWS may provide a potential molecular basis of its pathogenesis.	[Merkes, Chris; Turkalo, Timothy K.; Wilder, Nicole; Park, Hyewon; Wenger, Luke W.; Lewin, Seth J.; Azuma, Mizuki] Univ Kansas, Lawrence, KS 66045 USA	University of Kansas	Azuma, M (corresponding author), Univ Kansas, 7031 Haworth,1200 Sunnyside Ave, Lawrence, KS 66045 USA.	azumam@ku.edu		Merkes, Christopher/0000-0001-8191-627X	Massman Family Ewing Sarcoma Research Fund; Sarcoma Foundation of America [P20RR016475 / P20GM103418, P20 RR032682-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103638, P20GM103418] Funding Source: NIH RePORTER	Massman Family Ewing Sarcoma Research Fund; Sarcoma Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This manuscript was supported by the Massman Family Ewing Sarcoma Research Fund, the Sarcoma Foundation of America, P20RR016475 / P20GM103418 and P20 RR032682-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2005, ONCOGENE, V24, P2715, DOI 10.1038/sj.onc.1208247; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Anumanthan G, 2006, CANCER RES, V66, P10824, DOI 10.1158/0008-5472.CAN-06-1599; Araya N, 2003, J BIOL CHEM, V278, P5427, DOI 10.1074/jbc.M210234200; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Azuma M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000979; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Bhatt S, 2013, COLD SPRING HARB PER, P5, DOI [10.1101/cshperspect.a019836, DOI 10.1101/CSHPERSPECT.A019836]; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Dale RM, 2011, DEV BIOL, V357, P518, DOI 10.1016/j.ydbio.2011.06.020; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Embree LJ, 2009, CANCER RES, V69, P4363, DOI 10.1158/0008-5472.CAN-08-3229; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Furumatsu T, 2005, J BIOL CHEM, V280, P35203, DOI 10.1074/jbc.M502409200; Hattori T, 2013, J BIOL CHEM, V288, P35138, DOI 10.1074/jbc.M113.486795; Hayashi MT, 2013, ONCOGENE, V32, P4593, DOI 10.1038/onc.2012.615; Henry SP, 2012, J BONE MINER RES, V27, P2511, DOI 10.1002/jbmr.1696; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540; Lakiza O, 2011, DEV BIOL, V359, P149, DOI 10.1016/j.ydbio.2011.08.012; Lee YH, 2004, DEV BIOL, V275, P93, DOI 10.1016/j.ydbio.2004.07.036; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Paronetto MP, 2011, MOL CELL, V43, P353, DOI 10.1016/j.molcel.2011.05.035; Park H, 2014, CELL CYCLE, P13, DOI [10.4161/15384101.2014.949550, DOI 10.4161/15384101.2014.949550]; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossow KL, 2001, CANCER RES, V61, P2690; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Sohn EJ, 2010, CANCER RES, V70, P1154, DOI 10.1158/0008-5472.CAN-09-1993; Spahn L, 2003, ONCOGENE, V22, P6819, DOI 10.1038/sj.onc.1206810; Strahle U, 1996, INT J DEV BIOL, V40, P929; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Tomita N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059226; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yang L, 2000, J BIOL CHEM, V275, P37612, DOI 10.1074/jbc.M005739200; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	55	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116627	10.1371/journal.pone.0116627	http://dx.doi.org/10.1371/journal.pone.0116627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617839	gold, Green Published, Green Submitted			2022-12-27	WOS:000350336000017
J	Cao, ZH; Zhang, JC; Niu, YD; Cui, NZ; Ma, YS; Cao, F; Jin, LJ; Li, Z; Xu, YP				Cao, Zhenhui; Zhang, Jiancheng; Niu, Yan D.; Cui, Naizhong; Ma, Yongsheng; Cao, Fang; Jin, Liji; Li, Zhen; Xu, Yongping			RETRACTED: Isolation and Characterization of a "phiKMV-Like" Bacteriophage and Its Therapeutic Effect on Mink Hemorrhagic Pneumonia (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							TRANSFER-RNA GENES; PSEUDOMONAS-AERUGINOSA; DELIVERY; PROGRAM; OTITIS; TREAT; KMV	The objective of this study was to investigate the potential of using phages as a therapy against hemorrhagic pneumonia in mink both in vitro and in vivo. Five Pseudomonas aeruginosa (P. aeruginosa) strains were isolated from lungs of mink with suspected hemorrhagic pneumonia and their identity was confirmed by morphological observation and 16S rDNA sequence analysis. Compared to P. aeruginosa strains isolated from mink with hemorrhagic pneumonia in 2002, these isolates were more resistant to antibiotics selected. A lytic phage vB_PaeP_PPA-ABTNL (PPA-ABTNL) of the Podoviridae family was isolated from hospital sewage using a P. aeruginosa isolate as host, showing broad host range against P. aeruginosa. A one-step growth curve analysis of PPA-ABTNL revealed eclipse and latent periods of 20 and 35 min, respectively, with a burst size of about 110 PFU per infected cell. Phage PPA-ABTNL significantly reduced the growth of P. aeruginosa isolates in vitro. The genome of PPA-ABTNL was 43,227 bp (62.4% G+C) containing 54 open reading frames and lacked regions encoding known virulence factors, integration-related proteins and antibiotic resistance determinants. Genome architecture analysis showed that PPA-ABTNL belonged to the "phiKMV-like Viruses" group. A repeated dose inhalational toxicity study using PPA-ABTNL crude preparation was conducted in mice and no significantly abnormal histological changes, morbidity or mortality were observed. There was no indication of any potential risk associated with using PPA-ABTNL as a therapeutic agent. The results of a curative treatment experiment demonstrated that atomization by ultrasonic treatment could efficiently deliver phage to the lungs of mink and a dose of 10 multiplicity of infection was optimal for treating mink hemorrhagic pneumonia. Our work demonstrated the potential for phage to fight P. aeruginosa involved in mink lung infections when administered by means of ultrasonic nebulization.	[Cao, Zhenhui; Zhang, Jiancheng; Cao, Fang; Jin, Liji; Li, Zhen; Xu, Yongping] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning, Peoples R China; [Niu, Yan D.] Alberta Agr & Rural Dev, Ctr Agr, Lethbridge, AB, Canada; [Cui, Naizhong] Datong Univ, Sch Life Sci, Datong, Shanxi, Peoples R China; [Ma, Yongsheng] Dalian Ocean Univ, Coll Food Sci & Engn, Dalian, Liaoning, Peoples R China; [Jin, Liji; Xu, Yongping] Minist Educ, Ctr Food Safety Anim Origin, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Shanxi Datong University; Dalian Ocean University	Xu, YP (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning, Peoples R China.	czhlqy@126.com	Xu, Yongping/AAH-3987-2020	Xu, Yongping/0000-0002-3946-9223	National High Technology Research and Development Program [2013AA102805]	National High Technology Research and Development Program(National High Technology Research and Development Program of China)	YPX received a grant supported by the National High Technology Research and Development Program (Grant No. 2013AA102805), URL: http://www.863.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens EM, 2011, APPL ENVIRON MICROB, V77, P3443, DOI 10.1128/AEM.00128-11; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BAI X, 2011, ANIM HUSB VET MED, V43, P31; BENHAJKHALIFA A, 2001, ANN BIOL CLIN-PARIS, V69, P393; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Boratynski J, 2004, CELL MOL BIOL LETT, V9, P253; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; BURSIAN SJ, 2013, DIETARY EXPOSURE MIN; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Chang HC, 2005, APPL ENVIRON MICROB, V71, P1387, DOI 10.1128/AEM.71.3.1387-1393.2005; *CLIN LAB STAND I, 2011, M100S21 CLSI; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Farid AH, 2012, PREV VET MED, V106, P332, DOI 10.1016/j.prevetmed.2012.03.010; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Golshahi L, 2008, J AEROSOL MED PULM D, V21, P351, DOI 10.1089/jamp.2008.0701; Hammer AS, 2003, VET MICROBIOL, V94, P237, DOI 10.1016/S0378-1135(03)00103-2; Harper DR, 2011, J APPL MICROBIOL, V111, P1, DOI 10.1111/j.1365-2672.2011.05003.x; Hawkins C, 2010, VET MICROBIOL, V146, P309, DOI 10.1016/j.vetmic.2010.05.014; Hoe S, 2013, J AEROSOL MED PULM D, V26, P317, DOI 10.1089/jamp.2012.1001; Huff WE, 2005, POULTRY SCI, V84, P655, DOI 10.1093/ps/84.4.655; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KEARY R, 2013, MICROBIAL PATHOGENS, P1028; Korhonen HT, 2012, ANN ANIM SCI, V12, P597; Labiris NR, 2003, BRIT J CLIN PHARMACO, V56, P600, DOI 10.1046/j.1365-2125.2003.01893.x; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lavigne R, 2003, VIROLOGY, V312, P49, DOI 10.1016/S0042-6822(03)00123-5; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAHADEVAN MS, 2009, ASIAN J BIOTECHNOL, V1, P163; MERRIL CR, 2006, BACTERIOPHAGES, P725; Mitra A, 2011, NUCLEIC ACIDS RES, V39, pD129, DOI 10.1093/nar/gkq971; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Niu YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034585; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; Pajunen M, 2000, J BACTERIOL, V182, P5114, DOI 10.1128/JB.182.18.5114-5120.2000; PANTOZZI FL, 2000, ANALECTA VET, V1, P32; Pedersen K, 2009, VET MICROBIOL, V133, P115, DOI 10.1016/j.vetmic.2008.06.005; QI AS, 2008, P SPIE C BIOM APPL M, P1; Ryan EM, 2011, J PHARM PHARMACOL, V63, P1253, DOI 10.1111/j.2042-7158.2011.01324.x; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Salomonsen CM, 2013, VET MICROBIOL, V163, P103, DOI 10.1016/j.vetmic.2012.12.003; Salomonsen CM, 2013, CAN J VET RES, V77, P199; SALOMONSEN CM, 2012, P 10 INT SCI C FUR A, P157; SALOMONSEN CM, 2012, HEMORRHAGIC PNEUMONI, P13; Sambrook J., 2001, MOL CLONING LAB MANU; Skurnik M, 2007, BIOTECHNOL LETT, V29, P995, DOI 10.1007/s10529-007-9346-1; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theuretzbacher U, 2009, INT J ANTIMICROB AG, V34, P15, DOI 10.1016/j.ijantimicag.2009.02.005; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; WANG CA, 2007, BREEDING DIS CONTROL; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x	60	37	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116571	10.1371/journal.pone.0116571	http://dx.doi.org/10.1371/journal.pone.0116571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615639	gold, Green Published, Green Submitted			2022-12-27	WOS:000349122100032
J	Ceacero, F; Landete-Castillejos, T; Olguin, A; Miranda, M; Garcia, A; Martinez, A; Cassinello, J; Miguel, V; Gallego, L				Ceacero, Francisco; Landete-Castillejos, Tomas; Olguin, Augusto; Miranda, Maria; Garcia, Andres; Martinez, Alberto; Cassinello, Jorge; Miguel, Valentin; Gallego, Laureano			Avoiding Toxic Levels of Essential Minerals: A Forgotten Factor in Deer Diet Preferences	PLOS ONE			English	Article							CERVUS-ELAPHUS-HISPANICUS; RED DEER; MEDITERRANEAN ENVIRONMENT; GROWTH-PERFORMANCE; CRUDE PROTEIN; ANTLER GROWTH; HIGH-SULFUR; SELECTION; NUTRITION; FORAGE	Ungulates select diets with high energy, protein, and sodium contents. However, it is scarcely known the influence of essential minerals other than Na in diet preferences. Moreover, almost no information is available about the possible influence of toxic levels of essential minerals on avoidance of certain plant species. The aim of this research was to test the relative importance of mineral content of plants in diet selection by red deer (Cervus elaphus) in an annual basis. We determined mineral, protein and ash content in 35 common Mediterranean plant species (the most common ones in the study area). These plant species were previously classified as preferred and non-preferred. We found that deer preferred plants with low contents of Ca, Mg, K, P, S, Cu, Sr and Zn. The model obtained was greatly accurate identifying the preferred plant species (91.3% of correct assignments). After a detailed analysis of these minerals (considering deficiencies and toxicity levels both in preferred and non-preferred plants) we suggest that the avoidance of excessive sulphur in diet (i.e., selection for plants with low sulphur content) seems to override the maximization for other nutrients. Low sulphur content seems to be a forgotten factor with certain relevance for explaining diet selection in deer. Recent studies in livestock support this conclusion, which is highlighted here for the first time in diet selection by a wild large herbivore. Our results suggest that future studies should also take into account the toxicity levels of minerals as potential drivers of preferences.	[Ceacero, Francisco] Czech Univ Life Sci, Dept Anim Sci & Food Proc, Prague, Czech Republic; [Ceacero, Francisco] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Landete-Castillejos, Tomas; Garcia, Andres] Inst Desarrollo Reg, Secc Recursos Cineget & Ganaderos, Albacete, Spain; [Landete-Castillejos, Tomas; Garcia, Andres; Cassinello, Jorge] CSIC UCLM JCCM, Inst Invest Recursos Cineget, Ciudad Real, Spain; [Landete-Castillejos, Tomas; Garcia, Andres; Gallego, Laureano] Univ Castilla La Mancha, Dept Ciencia Tecnol Agroforestal & Genet, Albacete, Spain; [Miranda, Maria] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, Johannesburg, South Africa; [Martinez, Alberto; Miguel, Valentin] Inst Desarrollo Reg, Lab Ciencia Ingn Mat, Albacete, Spain	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; University of Witwatersrand	Ceacero, F (corresponding author), Czech Univ Life Sci, Dept Anim Sci & Food Proc, Prague, Czech Republic.	ceacero@ftz.czu.cz	Ceacero, Francisco/C-1088-2009; Cassinello, Jorge/A-4324-2009; Garcia Diaz, Andres Jose/A-9162-2012; Gallego, Laureano/G-9715-2015	Ceacero, Francisco/0000-0001-9014-147X; Cassinello, Jorge/0000-0001-8781-2009; Landete Castillejos, Tomas/0000-0001-9753-5295; Garcia Diaz, Andres Jose/0000-0002-4662-2185; miguel, valentin/0000-0003-4770-8180; Miranda, Maria/0000-0002-4236-7455; Gallego, Laureano/0000-0001-8219-087X	Ministry of Economy and Competitiveness, Spain [AGL2012-38898]; Ministry of Agriculture, Czech Republic [MZERO0714]; Czech University of Life Sciences, Czech Republic [CIGA-20145001]; Faculty of Tropical AgriSciences, Czech Republic [IGA-20145026]; Claude Leon postdoctoral fellowship	Ministry of Economy and Competitiveness, Spain; Ministry of Agriculture, Czech Republic(Ministry of Agriculture, Czech Republic); Czech University of Life Sciences, Czech Republic; Faculty of Tropical AgriSciences, Czech Republic; Claude Leon postdoctoral fellowship	This paper has been funded by the projects AGL2012-38898 (Ministry of Economy and Competitiveness, Spain), MZERO0714 (Ministry of Agriculture, Czech Republic), CIGA-20145001 (Czech University of Life Sciences, Czech Republic) and IGA-20145026 (Faculty of Tropical AgriSciences, Czech Republic). MM was supported by a Claude Leon postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricultural Research Council (ARC), 1980, NUTR REQ RUM LIV; Alonso-Diaz MA, 2008, ANIM FEED SCI TECH, V141, P36, DOI 10.1016/j.anifeedsci.2007.04.009; ALVAREZ G, 1991, FOLIA ZOOL, V40, P117; [Anonymous], 2003, MINERALS ANIMAL HUMA, DOI DOI 10.1016/B978-0-444-51367-0.50006-4; Asher GW, 2011, LIVEST SCI, V140, P8, DOI 10.1016/j.livsci.2011.02.002; Asleson MA, 1996, J WILDLIFE MANAGE, V60, P744, DOI 10.2307/3802373; AUSTIN PJ, 1989, J CHEM ECOL, V15, P1335, DOI 10.1007/BF01014834; Barroso FG, 2001, J ARID ENVIRON, V49, P301, DOI 10.1006/jare.2000.0770; BELOVSKY GE, 1978, THEOR POPUL BIOL, V14, P105, DOI 10.1016/0040-5809(78)90007-2; Berteaux D, 1998, OECOLOGIA, V115, P84, DOI 10.1007/s004420050494; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Bugalho MN, 2003, FOREST ECOL MANAG, V181, P23, DOI 10.1016/S0378-1127(03)00125-7; Cammack KM, 2010, J ANIM SCI, V88, P1777, DOI 10.2527/jas.2009-2343; Ceacero F, 2014, BEHAV PROCESS, V103, P28, DOI 10.1016/j.beproc.2013.10.008; Ceacero F, 2010, BRIT J NUTR, V103, P617, DOI 10.1017/S0007114509992091; Ceacero F, 2009, LIVEST SCI, V122, P345, DOI 10.1016/j.livsci.2008.08.002; COOPER SM, 1988, OECOLOGIA, V75, P336, DOI 10.1007/BF00376934; Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7; Dias RS, 2013, J ANIM SCI, V91, P5714, DOI 10.2527/jas.2013-6195; Drewnoski ME, 2014, J ANIM SCI, V92, P3763, DOI 10.2527/jas.2013-7242; Dryden GM, 2011, ANIM PROD SCI, V51, P292, DOI 10.1071/AN10176; Dumont B, 2005, ANIM RES, V54, P369, DOI 10.1051/animres:2005030; Dytham C, 2003, CHOOSING USING STAT; Estell RE, 2010, SMALL RUMINANT RES, V94, P1, DOI 10.1016/j.smallrumres.2010.09.012; Estevez JA, 2009, ACTA THERIOL, V54, P235, DOI 10.4098/j.at.0001-7051.070.2008; Fernandez-Olalla M., 2006, Investigacion Agraria, Sistemas y Recursos Forestales, V15, P329; FREELAND WJ, 1985, BIOCHEM SYST ECOL, V13, P195, DOI 10.1016/0305-1978(85)90079-1; Gonzalez-Hernandez MP, 2000, J CHEM ECOL, V26, P293, DOI 10.1023/A:1005462100010; Hanley TA, 1997, OIKOS, V79, P209, DOI 10.2307/3546006; HARBORNE, 1982, INTRO ECOLOGICAL BIO; Iason GR, 2006, J CHEM ECOL, V32, P1115, DOI 10.1007/s10886-006-9075-2; Ivancic J, 2001, J DAIRY SCI, V84, P225, DOI 10.3168/jds.S0022-0302(01)74472-4; Jeon BT, 2006, ASIAN AUSTRAL J ANIM, V19, P1298, DOI 10.5713/ajas.2006.1298; KYRIAZAKIS I, 1993, BRIT J NUTR, V69, P617, DOI 10.1079/BJN19930064; Landete-Castillejos T, 2013, EUR J WILDLIFE RES, V59, P519, DOI 10.1007/s10344-013-0699-6; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; McArthur C, 2000, FOREST ECOL MANAG, V139, P157, DOI 10.1016/S0378-1127(99)00342-4; McBride MB, 2007, ENVIRON CHEM, V4, P134, DOI 10.1071/EN06066; MCNAUGHTON SJ, 1988, NATURE, V334, P343, DOI 10.1038/334343a0; MCNAUGHTON SJ, 1990, NATURE, V345, P613, DOI 10.1038/345613a0; Miranda M, 2012, J ARID ENVIRON, V85, P97, DOI 10.1016/j.jaridenv.2012.05.011; Miranda M, 2011, PLANT BIOLOGY, V13, P160, DOI 10.1111/j.1438-8677.2009.00316.x; Miranda M, 2012, WILDLIFE RES, V39, P171, DOI 10.1071/WR11146; MUIR PD, 1987, NEW ZEAL J AGR RES, V30, P305; MURRAY MG, 1991, J ANIM ECOL, V60, P1029, DOI 10.2307/5429; Nelson AC, 1999, CHEMOECOLOGY, V9, P81, DOI 10.1007/s000490050037; NRC-National Research Council Committee on the Nutrient Requirements of Small Ruminants Board on Agriculture Division on Earth & Life Studies, 2007, NUTR REQ SMALL RUM; Plumlee K., 2003, CLIN VET TOXICOLOGY; PROVENZA FD, 1995, J RANGE MANAGE, V48, P2, DOI 10.2307/4002498; Quinn JC, 2014, INT J MOL SCI, V15, P1441, DOI 10.3390/ijms15011441; Robbins C. T., 1993, WILDLIFE FEEDING NUT; RODRIGUEZBERROCAL J, 1978, ARCH ZOOTEC, V27, P73; Rogosic J, 2006, SMALL RUMINANT RES, V64, P169, DOI 10.1016/j.smallrumres.2005.04.017; SCHROENER TW, 1971, ANNU REV ECOL SYST, V2, P369; Spears JW, 2011, J ANIM SCI, V89, P2502, DOI 10.2527/jas.2010-3265; Stephens D.W., 1986, pi; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P306, DOI 10.1079/9781845934729.0306; Verheyden-Tixier H, 2008, OECOLOGIA, V156, P715, DOI 10.1007/s00442-008-1020-3; Yang FH, 2012, ANIM PROD SCI, V52, P728, DOI 10.1071/AN12010; Zhou LY, 2009, CAN VET J, V50, P1269; Zinn RA, 1997, J ANIM SCI, V75, P1723; Zuur AF, 2007, STAT BIOL HEALTH, P163	62	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115814	10.1371/journal.pone.0115814	http://dx.doi.org/10.1371/journal.pone.0115814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615596	Green Published, gold			2022-12-27	WOS:000349122100017
J	Chiew, YS; Pretty, C; Docherty, PD; Lambermont, B; Shaw, GM; Desaive, T; Chase, JG				Chiew, Yeong Shiong; Pretty, Christopher; Docherty, Paul D.; Lambermont, Bernard; Shaw, Geoffrey M.; Desaive, Thomas; Chase, J. Geoffrey			Time-Varying Respiratory System Elastance: A Physiological Model for Patients Who Are Spontaneously Breathing	PLOS ONE			English	Article							MECHANICAL VENTILATION; ESOPHAGEAL PRESSURE; LUNG-MECHANICS; PARAMETERS; SUPPORT; STRESS	Background Respiratory mechanics models can aid in optimising patient-specific mechanical ventilation (MV), but the applications are limited to fully sedated MV patients who have little or no spontaneously breathing efforts. This research presents a time-varying elastance (E-drs) model that can be used in spontaneously breathing patients to determine their respiratory mechanics. Methods A time-varying respiratory elastance model is developed with a negative elastic component (E-demand), to describe the driving pressure generated during a patient initiated breathing cycle. Data from 22 patients who are partially mechanically ventilated using Pressure Support (PS) and Neurally Adjusted Ventilatory Assist (NAVA) are used to investigate the physiology relevance of the time-varying elastance model and its clinical potential. E-drs of every breathing cycle for each patient at different ventilation modes are presented for comparison. Results At the start of every breathing cycle initiated by patient, E-drs is < 0. This negativity is attributed from the E-demand due to a positive lung volume intake at through negative pressure in the lung compartment. The mapping of E-drs trajectories was able to give unique information to patients' breathing variability under different ventilation modes. The area under the curve of E-drs (AUCE(drs)) for most patients is > 25 cmH(2)Os/ and thus can be used as an acute respiratory distress syndrome (ARDS) severity indicator. Conclusion The Edrs model captures unique dynamic respiratory mechanics for spontaneously breathing patients with respiratory failure. The model is fully general and is applicable to both fully controlled and partially assisted MV modes.	[Chiew, Yeong Shiong; Pretty, Christopher; Docherty, Paul D.; Chase, J. Geoffrey] Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand; [Shaw, Geoffrey M.] Christchurch Hosp, Dept Intens Care, Christchurch, New Zealand; [Lambermont, Bernard; Desaive, Thomas] Univ Liege, GIGA Cardiovasc Sci, Liege, Belgium	University of Canterbury; Christchurch Hospital New Zealand; University of Liege	Chiew, YS (corresponding author), Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand.	yeongshiong.chiew@canterbury.ac.nz	Chiew, Yeong Shiong/M-7028-2016; Pretty, Christopher G/B-6300-2014; Chiew, Yeong Shiong/AAL-8505-2021	Chiew, Yeong Shiong/0000-0003-3222-2006; Pretty, Christopher G/0000-0002-2265-6065; Chiew, Yeong Shiong/0000-0003-3222-2006; Docherty, Paul/0000-0003-1661-2573	FNRS (Belgium); FRST (New Zealand); University of Liege; Belgian French Community (ARC-Academie Wallonie Europe)	FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); FRST (New Zealand)(New Zealand Foundation for Research, Science and Technology); University of Liege(University of Liege); Belgian French Community (ARC-Academie Wallonie Europe)	This work was supported in part by the FNRS 474 (Belgium), the FRST (New Zealand), the University of Liege, the 475, Belgian French Community (ARC-Academie Wallonie Europe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoumianaki E, 2013, CHEST, V143, P927, DOI 10.1378/chest.12-1817; Alencar AM, 2002, NATURE, V417, P809, DOI 10.1038/417809b; Avanzolini G, 1997, ANN BIOMED ENG, V25, P154, DOI 10.1007/BF02738546; Bates JHT, 2009, LUNG MECHANICS: AN INVERSE MODELING APPROACH, P1, DOI 10.1017/CBO9780511627156; Bauer K, 2009, J BIOMECH, V42, P1108, DOI 10.1016/j.jbiomech.2009.02.018; Benditt Joshua O, 2005, Respir Care, V50, P68; Brander L, 2006, CRIT CARE, V10, DOI 10.1186/cc3953; Brochard L, 2012, CRIT CARE, V16, DOI 10.1186/cc11146; Burchardi H, 2004, Minerva Anestesiol, V70, P137; Carvalho ARS, 2007, CRIT CARE, V11, DOI 10.1186/cc6093; Chiew YS, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-111; Chiumello D, 2008, AM J RESP CRIT CARE, V178, P346, DOI 10.1164/rccm.200710-1589OC; Docherty PD, 2014, BIOMED SIGNAL PROCES, V12, P47, DOI 10.1016/j.bspc.2013.12.001; Gilstrap D, 2013, AM J RESP CRIT CARE, V188, P1058, DOI 10.1164/rccm.201212-2214CI; Guerin C, 2012, RESP CARE, V57, P2045, DOI 10.4187/respcare.01883; IOTTI GA, 1995, INTENS CARE MED, V21, P406, DOI 10.1007/BF01707409; Khirani S, 2010, RESP MED, V104, P463, DOI 10.1016/j.rmed.2009.09.014; Kogler VM, 2009, SIGNA VITAE, V4, P10, DOI 10.22514/SV41.042009.2; Kuhlen R, 1999, INTENS CARE MED, V25, P1203, DOI 10.1007/s001340050087; LAUZON AM, 1991, J APPL PHYSIOL, V71, P1159, DOI 10.1152/jappl.1991.71.3.1159; Lucangelo U, 2007, CURR OPIN CRIT CARE, V13, P64, DOI 10.1097/MCC.0b013e32801162df; MOORHEAD K, 2012, JOURNAL OF CLINICAL, P1; Muramatsu K, 2001, EUR RESPIR J, V17, P1158, DOI 10.1183/09031936.01.00017801; Piquilloud L, 2011, INTENS CARE MED, V37, P263, DOI 10.1007/s00134-010-2052-9; Putensen C, 2001, AM J RESP CRIT CARE, V164, P43, DOI 10.1164/ajrccm.164.1.2001078; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Schranz C, 2012, IEEE T BIO-MED ENG, V59, P3396, DOI 10.1109/TBME.2012.2216526; SLUTSKY AS, 2005, MECH VENTILATION, P353; Steimle KL, 2011, COMPUT METH PROG BIO, V101, P144, DOI 10.1016/j.cmpb.2010.06.017; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Tawhai MH, 2011, J APPL PHYSIOL, V110, P1466, DOI 10.1152/japplphysiol.01289.2010; van Drunen EJ, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-33; Wrigge H, 2005, CRIT CARE, V9, pR780, DOI 10.1186/cc3908; Zhao ZQ, 2012, PHYSIOL MEAS, V33, P51, DOI 10.1088/0967-3334/33/1/51	34	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0114847	10.1371/journal.pone.0114847	http://dx.doi.org/10.1371/journal.pone.0114847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611069	Green Published, gold, Green Submitted			2022-12-27	WOS:000348562900001
J	Kaihola, H; Olivier, J; Poromaa, IS; Akerud, H				Kaihola, Helena; Olivier, Jocelien; Poromaa, Inger Sundstrom; Akerud, Helena			The Effect of Antenatal Depression and Selective Serotonin Reuptake Inhibitor Treatment on Nerve Growth Factor Signaling in Human Placenta	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SMOOTH-MUSCLE-CELLS; MATERNAL DEPRESSION; PROTEIN-KINASE; PULMONARY-HYPERTENSION; ANTIDEPRESSANT USE; FETAL-GROWTH; FACTOR NGF; IN-VITRO; PREGNANCY	Depressive symptoms during pregnancy are common and may have impact on the developing child. Selective serotonin reuptake inhibitors (SSRIs) are the most prescribed antidepressant treatment, but unfortunately, these treatments can also negatively affect the behavioral development and health of a child during pregnancy. In addition, serotonin (5-HT) exerts neurotrophic actions with thus far not fully known effects in the offspring. The neurotrophic growth factor (NGF) is involved in neuronal cell survival and differentiation, and altered placenta levels have been found to increase the risk for pregnancy complications, similar to those found in women treated with SSRIs. We therefore investigated whether the NGF signaling pathway was altered in the placenta from women treated with SSRIs (n = 12) and compared them with placenta from depressed (n = 12) and healthy mothers (n = 12). Results from immunohistochemical stainings revealed that placental NGF protein levels of SSRI-treated women were increased in both trophoblasts and endothelial cells compared with depressed and control women. In addition, downstream of the NGF receptor TrkA, increased levels of the signaling proteins ROCK2 and phosphorylated Raf-1 were found in stromal cells and a tendency towards increased levels of ROCK2 in trophoblasts and endothelial cells in SSRI-treated women when compared to healthy controls. SSRI-treated women also displayed increased levels of phosphorylated ROCK2 in all placental cell types studied in comparison with depressed and control women. Interestingly, in placental endothelial cells from depressed women, NGF levels were significantly lower compared to control women, but ROCK2 levels were increased compared with control and SSRI-treated women. Taken together, these results show that the NGF signaling and downstream pathways in the placenta are affected by SSRI treatment and/or antenatal depression. This might lead to an altered placental function, although the clinical relevance of our findings still needs to be investigated.	[Kaihola, Helena; Olivier, Jocelien; Poromaa, Inger Sundstrom; Akerud, Helena] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Olivier, Jocelien] Univ Groningen, Dept Behav Physiol, Groningen, Netherlands	Uppsala University; University of Groningen	Kaihola, H (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	helena.kaihola@kbh.uu.se		Sundstrom Poromaa, Inger/0000-0002-2491-2042; Olivier, Jocelien/0000-0003-4654-9763	Swedish Research Council [K2014-54X-20642-07-4]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding provided by Swedish Research Council K2014-54X-20642-07-4, http://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2003, AM J OBSTET GYNECOL, V189, P148, DOI 10.1067/mob.2003.336; Ansorge MS, 2007, CURR OPIN PHARMACOL, V7, P8, DOI 10.1016/j.coph.2006.11.006; Ark M, 2005, PLACENTA, V26, P81, DOI 10.1016/j.placenta.2004.03.012; Barbey JT, 1998, J CLIN PSYCHIAT, V59, P42; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Bellissima V, 2011, J MATERN-FETAL NEO M, V24, P32, DOI 10.3109/14767058.2011.604931; Bhuiyan M, 2012, REPROD SCI, V19, P407, DOI 10.1177/1933719111424438; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Bottalico B, 2004, PLACENTA, V25, P518, DOI 10.1016/j.placenta.2003.10.017; Brummelte S, 2013, DEV PSYCHOBIOL, V55, P518, DOI 10.1002/dev.21056; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Charnock-Jones DS, 2000, BEST PRACT RES CL OB, V14, P953, DOI 10.1053/beog.2000.0137; Chaves RN, 2013, ZYGOTE, V21, P187, DOI 10.1017/S0967199412000111; Cikos S, 2011, HUM REPROD, V26, P2296, DOI 10.1093/humrep/der233; Dhobale MV, 2013, INT J DEV NEUROSCI, V31, P719, DOI 10.1016/j.ijdevneu.2013.09.006; Dissen GA, 2009, ENDOCRINOLOGY, V150, P2906, DOI 10.1210/en.2008-1575; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; El Marroun H, 2014, EUR CHILD ADOLES PSY, V23, P973, DOI 10.1007/s00787-014-0558-3; Fatemi S, 2002, MOL PSYCHIATR, V7, P919, DOI 10.1038/sj.mp.4001248; Fatemi SH, 2001, NEUROREPORT, V12, P3209, DOI 10.1097/00001756-200110290-00014; Florio P, 2007, ADV CLIN CHEM, V43, P117, DOI 10.1016/S0065-2423(06)43004-3; Forsen T, 2004, HEART, V90, P20, DOI 10.1136/heart.90.1.20; Forsen TJ, 2004, ANN MED, V36, P389, DOI 10.1080/07853890410028438; Frank P, 2014, REPRODUCTION, V148, P179, DOI 10.1530/REP-14-0112; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gentile S, 2005, CNS DRUGS, V19, P623, DOI 10.2165/00023210-200519070-00004; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; GOLDSTEIN LD, 1978, NEUROCHEM RES, V3, P175, DOI 10.1007/BF00964058; Gorman LL, 2004, BRIT J PSYCHIAT, V184, pS17, DOI 10.1192/bjp.184.46.s17; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; Heikkinen T, 2003, CLIN PHARMACOL THER, V73, P330, DOI 10.1016/S0009-9236(02)17634-X; HEINRICH G, 1988, BIOCHEM BIOPH RES CO, V155, P482, DOI 10.1016/S0006-291X(88)81112-4; Hendrick V, 2003, AM J PSYCHIAT, V160, P993, DOI 10.1176/appi.ajp.160.5.993; KanaiAzuma M, 1997, BIOCHEM BIOPH RES CO, V231, P309, DOI 10.1006/bbrc.1996.6032; Kieler H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8012; Knaepen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057608; Larios JA, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-108; Leon DA, 1998, EUR J CLIN NUTR, V52, pS72; Loughhead AM, 2006, AM J PSYCHIAT, V163, P145, DOI 10.1176/appi.ajp.163.1.145; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; MATSUI K, 1990, FEBS LETT, V276, P78, DOI 10.1016/0014-5793(90)80511-G; Melville JL, 2010, OBSTET GYNECOL, V116, P1064, DOI 10.1097/AOG.0b013e3181f60b0a; Moriki N, 2004, HYPERTENS RES, V27, P263, DOI 10.1291/hypres.27.263; Mukai Yasushi, 2001, FASEB Journal, V15, P1062; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Noorlander CW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002782; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Olivier JDA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00073; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; Olivier JDA, 2015, EUR J PHARMACOL, V753, P257, DOI 10.1016/j.ejphar.2014.07.049; Oufkir T, 2010, PLACENTA, V31, P439, DOI 10.1016/j.placenta.2010.02.019; Patkar Ashwin A, 2004, Ann Clin Psychiatry, V16, P87; Pawluski JL, 2012, NEUROENDOCRINOLOGY, V95, P39, DOI 10.1159/000329293; Ponder KL, 2011, DEV PSYCHOBIOL, V53, P711, DOI 10.1002/dev.20549; Qiu CF, 2009, AM J HYPERTENS, V22, P397, DOI 10.1038/ajh.2008.366; Rayen I, 2013, PSYCHONEUROENDOCRINO, V38, P1618, DOI 10.1016/j.psyneuen.2013.01.007; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 1999, CURR BIOL, V9, P136, DOI 10.1016/S0960-9822(99)80067-0; Shimizu T, 2013, ARTERIOSCL THROM VAS, V33, P2780, DOI 10.1161/ATVBAHA.113.301357; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Toh S, 2009, AM J PSYCHIAT, V166, P320, DOI 10.1176/appi.ajp.2008.08060817; Tometten M, 2005, CHEM IMMUNOL ALLERGY, V89, P135, DOI 10.1159/000087962; Tometten M, 2004, AM J REPROD IMMUNOL, V51, P86, DOI 10.1046/j.8755-8920.2003.00123.x; Toti P, 2006, J ENDOCRINOL INVEST, V29, P337, DOI 10.1007/BF03344105; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Viau M, 2009, REPROD BIOMED ONLINE, V19, P207, DOI 10.1016/S1472-6483(10)60074-0; Waters CS, 2014, EUR CHILD ADOLES PSY, V23, P957, DOI 10.1007/s00787-014-0582-3	72	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116459	10.1371/journal.pone.0116459	http://dx.doi.org/10.1371/journal.pone.0116459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611484	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900015
J	Linhares, RD; Gigante, DP; Lopes, FC; de Barros, F; Horta, BL				Linhares, Rogerio da Silva; Gigante, Denise Petrucci; Lopes, Fernando Celso; de Barros, Fernandes; Horta, Bernardo Lessa			Carotid Intima-Media Thickness at Age 30, Birth Weight, Accelerated Growth during Infancy and Breastfeeding: A Birth Cohort Study in Southern Brazil	PLOS ONE			English	Article							BLOOD-PRESSURE; GAIN; ATHEROSCLEROSIS; RISK; ULTRASOUND; CHILDHOOD; ORIGINS; STROKE; HEALTH; FETAL	Objective To examine the relationship between carotid intima-media thickness (IMT) at age 30 and birth characteristics, growth during infancy, and breastfeeding duration, among subjects who have been prospectively followed since birth. Methods and Results In 1982, all births in the city of Pelotas, southern Brazil, were identified and those children (n = 5,914) whose families lived in the urban area of the city have been followed and evaluated at several time points. The cohort participants were evaluated in 2012-13, and IMT was measured at the posterior wall of the right and left common carotid arteries in longitudinal planes using ultrasound imaging. We obtained valid IMT measurements for 3,188 individuals. Weight-for-age z-score (WAZ) at age 2 years, weight-for-height z-score (WHZ) at age 4, height-for-age z-score (HAZ) at 4 years, WAZ at age 4 and relative conditional weight at 4 years were positively associated with IMT, even after controlling for confounding variables. The beta-coefficient associated with >= 1 s.d. WAZ at age 2 (compared to those with a <-1 s.d.) was 3.62 mu m (95% CI 0.86 to 6.38). The beta-coefficient associated with >= 1 s.d. WHZ at 4 (in relation to <-1 s.d) was 3.83 mu m (95% CI 0.24 to 7.42). For HAZ at 4, the beta-coefficient for >= 1 s.d. in relation to <-1 s.d. was 4.19 mu m (95% CI 1.14 to 7.25). For WAZ at 4, the beta-coefficient associated with >= 1 s.d. in relation to <-1 s.d. was 4.28 mu m (95% CI 1.59 to 6.97). The beta-coefficient associated with conditional weight gain at age 2-4 was 1.26 mu m (95% CI 0.49 to 2.02). Conclusion IMT at age 30 was positively associated with WAZ at age 2 years, WHZ at age 4, HAZ at age 4, WAZ at age 4 and conditional weight gain at age 4 years.	[Linhares, Rogerio da Silva; Gigante, Denise Petrucci; Lopes, Fernando Celso; de Barros, Fernandes; Horta, Bernardo Lessa] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil	Universidade Federal de Pelotas	Linhares, RD (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil.	rogerio.linhares@gmail.com	Horta, Bernardo/A-7604-2008; da Silva Linhares, Rogério/E-9172-2014; Gigante, Denise/G-9285-2015	Horta, Bernardo/0000-0001-9843-412X; da Silva Linhares, Rogério/0000-0002-9740-3548; Gigante, Denise/0000-0001-7309-5838; Barros, Fernando/0000-0001-5973-1746	Wellcome Trust; Brazilian Research Council (CNPq); International Development Research Center; World Health Organization; Overseas Development Administration; European Union; National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq); Brazilian Ministry of Health	Wellcome Trust(Wellcome TrustEuropean Commission); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); International Development Research Center; World Health Organization(World Health Organization); Overseas Development Administration; European Union(European Commission); National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health	This article is based on data from the study "Pelotas Birth Cohort, 1982" conducted by the Postgraduate Program in Epidemiology at Universidade Federal de Pelotas with the collaboration of the Brazilian Public Health Association (ABRASCO). This study was supported by the Wellcome Trust and the Brazilian Research Council (CNPq). Previous phases of the study were supported by the International Development Research Center, the World Health Organization, Overseas Development Administration, European Union, National Support Program for Centers of Excellence (PRONEX), the Brazilian National Research Council (CNPq) and Brazilian Ministry of Health.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Amato M, 2007, EUR HEART J, V28, P2094, DOI 10.1093/eurheartj/ehm244; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227; Dratva J, 2012, J PEDIATR-US, V162, P906, DOI [10.1016/j.jpeds.2012.10.060, DOI 10.1016/j.jpeds.2012.10.060]; Evelein AMV, 2013, J CLIN ENDOCR METAB, V98, P794, DOI 10.1210/jc.2012-3208; Evelein AMV, 2011, AM J CLIN NUTR, V93, P712, DOI 10.3945/ajcn.110.002980; Gale CR, 2002, ATHEROSCLEROSIS, V163, P141, DOI 10.1016/S0021-9150(01)00760-2; Horta BL, 2009, INT J EPIDEMIOL, V38, P724, DOI 10.1093/ije/dyp168; Horta BL, 2009, ACTA PAEDIATR, V98, P1024, DOI 10.1111/j.1651-2227.2009.01247.x; Hovi P, 2011, PEDIATRICS, V127, pE304, DOI 10.1542/peds.2010-2199; Jarvisalo MJ, 2009, EUR J CLIN NUTR, V63, P640, DOI 10.1038/ejcn.2008.17; Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004; Leunissen RWJ, 2012, HORM RES PAEDIAT, V77, P394, DOI 10.1159/000338791; Martin RM, 2005, ARTERIOSCL THROM VAS, V25, P1482, DOI 10.1161/01.ATV.0000170129.20609.49; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Mendis S., 2011, GLOBAL ATLAS CARDIOV; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Oren A, 2004, ANN EPIDEMIOL, V14, P8, DOI 10.1016/S1047-2797(03)00068-1; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Regnault N, 2014, INT J EPIDEMIOL, V43, P149, DOI 10.1093/ije/dyt248; Skilton MR, 2014, ATHEROSCLEROSIS, V233, P370, DOI 10.1016/j.atherosclerosis.2014.01.020; Skilton MR, 2013, PEDIATRICS, V131, pE1821, DOI 10.1542/peds.2012-2789; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Victora Cesar G., 2003, Cad. Saúde Pública, V19, P1241, DOI 10.1590/S0102-311X2003000500003; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115166	10.1371/journal.pone.0115166	http://dx.doi.org/10.1371/journal.pone.0115166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611747	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900005
J	Vollmers, C; Penland, L; Kanbar, JN; Quake, SR				Vollmers, Christopher; Penland, Lolita; Kanbar, Jad N.; Quake, Stephen R.			Novel Exons and Splice Variants in the Human Antibody Heavy Chain Identified by Single Cell and Single Molecule Sequencing	PLOS ONE			English	Article							CONSTANT-REGION GENES; ANALYSIS TOOL; GAMMA-GENES; IMMUNOGLOBULIN; MEMBRANE; HUMAN-CHROMOSOME-14; REPERTOIRE; ALIGNMENT; SEGMENTS; DIFFER	Antibody heavy chains contain a variable and a constant region. The constant region of the antibody heavy chain is encoded by multiple groups of exons which define the isotype and therefore many functional characteristics of the antibody. We performed both single B cell RNAseq and long read single molecule sequencing of antibody heavy chain transcripts and were able to identify novel exons for IGHA1 and IGHA2 as well as novel isoforms for IGHM antibody heavy chain.	[Vollmers, Christopher; Penland, Lolita; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Kanbar, Jad N.; Quake, Stephen R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Stanford University; Stanford University; Howard Hughes Medical Institute	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	quake@stanford.edu			Howard Hughes Medical Institute; National Institutes of Health Grant [U19 AI057229]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Howard Hughes Medical Institute (http://www.hhmi.org/) and by National Institutes of Health (http://www.nih.gov/) Grant U19 AI057229 (to SRQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BENSMANA M, 1990, IMMUNOGENETICS, V32, P321; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; COOK GP, 1994, NAT GENET, V7, P162, DOI 10.1038/ng0694-162; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; CUSHLEY W, 1982, NATURE, V298, P77, DOI 10.1038/298077a0; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; ELLISON J, 1982, P NATL ACAD SCI-BIOL, V79, P1984, DOI 10.1073/pnas.79.6.1984; ELLISON JW, 1982, NUCLEIC ACIDS RES, V10, P4071, DOI 10.1093/nar/10.13.4071; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; KEHRY M, 1980, CELL, V21, P393, DOI 10.1016/0092-8674(80)90476-6; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lefranc M-P., 2001, IMMUNOGLOBULIN FACTS; RABBITTS TH, 1981, NUCLEIC ACIDS RES, V9, P4509, DOI 10.1093/nar/9.18.4509; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; Watson CT, 2013, AM J HUM GENET, V92, P530, DOI 10.1016/j.ajhg.2013.03.004; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	25	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117050	10.1371/journal.pone.0117050	http://dx.doi.org/10.1371/journal.pone.0117050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611855	gold, Green Submitted, Green Published			2022-12-27	WOS:000348562900030
J	Barcus, CE; Holt, EC; Keely, PJ; Eliceiri, KW; Schuler, LA				Barcus, Craig E.; Holt, Elizabeth C.; Keely, Patricia J.; Eliceiri, Kevin W.; Schuler, Linda A.			Dense Collagen-I Matrices Enhance Pro-Tumorigenic Estrogen-Prolactin Crosstalk in MCF-7 and T47D Breast Cancer Cells	PLOS ONE			English	Article							ENDOCRINE RESISTANCE; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; MAMMOGRAPHIC DENSITY; RECEPTOR EXPRESSION; ER-ALPHA; ACTIVATION; SURVIVAL; THERAPY; SRC	Breast cancers that express estrogen receptor alpha (ER alpha+) constitute the majority of breast tumors. Estrogen is a major driver of their growth, and targeting ER-mediated signals is a largely successful primary therapeutic strategy. Nonetheless, ER alpha+ tumors also result in the most breast cancer mortalities. Other factors, including altered characteristics of the extracellular matrix such as density and orientation and consequences for estrogen crosstalk with other hormones such as prolactin (PRL), may contribute to these poor outcomes. Here we employed defined three dimensional low density/compliant and high density/stiff collagen-I matrices to investigate the effects on 17 beta-estradiol (E2) activity and PRL/E2 interactions in two well-characterized ER alpha+/PRLR+ luminal breast cancer cell lines in vitro. We demonstrate that matrix density modulated E2-induced transcripts, but did not alter the growth response. However, matrix density was a potent determinant of the behavioral outcomes of PRL/E2 crosstalk. High density/stiff matrices enhanced PRL/E2-induced growth mediated by increased activation of Src family kinases and insensitivity to the estrogen antagonist, 4-hydroxytamoxifen. It also permitted these hormones in combination to drive invasion and modify the alignment of collagen fibers. In contrast, low density/compliant matrices allowed modest if any cooperation between E2 and PRL to growth and did not permit hormone-induced invasion or collagen reorientation. Our studies demonstrate the power of matrix density to determine the outcomes of hormone actions and suggest that stiff matrices are potent collaborators of estrogen and PRL in progression of ER alpha+ breast cancer. Our evidence for bidirectional interactions between these hormones and the extracellular matrix provides novel insights into the regulation of the microenvironment of ER alpha+ breast cancer and suggests new therapeutic approaches.	[Barcus, Craig E.; Holt, Elizabeth C.; Schuler, Linda A.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Barcus, Craig E.; Keely, Patricia J.; Eliceiri, Kevin W.; Schuler, Linda A.] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53706 USA; [Keely, Patricia J.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Keely, Patricia J.; Eliceiri, Kevin W.] Univ Wisconsin, Lab Cellular & Mol Biol, Madison, WI 53706 USA; [Keely, Patricia J.; Eliceiri, Kevin W.] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI 53706 USA; [Keely, Patricia J.; Eliceiri, Kevin W.; Schuler, Linda A.] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Schuler, LA (corresponding author), Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.	schulerl@svm.vetmed.wisc.edu	Eliceiri, Kevin/ABD-4516-2020	Eliceiri, Kevin/0000-0001-8678-670X; Barcus, Craig/0000-0001-9887-0503	 [F31 CA177047];  [T35 OD011078];  [R01 CA157675];  [R01 CA179556];  [R01 CA142833];  [R01 CA114462];  [R01 CA136590]; NATIONAL CANCER INSTITUTE [R01CA157675, R01CA179556, R01CA114462, R01CA136590, F31CA177047, R01CA142833] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD011078] Funding Source: NIH RePORTER	; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by F31 CA177047 (C.E.B.), T35 OD011078 (E.C.H.), R01 CA157675 (L.A.S.), R01 CA179556 (L.A.S. and P.J.K.), R01 CA142833 and R01 CA114462 (P.J.K.), R01 CA136590 (P.J.K. and K.W.E.), www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Anderson WF, 2011, J NATL CANCER I, V103, P1397, DOI 10.1093/jnci/djr257; Arendt LM, 2010, SEMIN CELL DEV BIOL, V21, P11, DOI 10.1016/j.semcdb.2009.10.003; Arendt LM, 2009, AM J PATHOL, V174, P1065, DOI 10.2353/ajpath.2009.080719; Balaguer P, 1999, SCI TOTAL ENVIRON, V233, P47, DOI 10.1016/S0048-9697(99)00178-3; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Barni S, 1998, TUMORI, V84, P45, DOI 10.1177/030089169808400109; Bhatavdekar J M, 1994, Eur J Surg Oncol, V20, P118; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chan SR, 2014, CELL DEATH DIFFER, V21, P234, DOI 10.1038/cdd.2013.116; Charn TH, 2010, MOL ENDOCRINOL, V24, P47, DOI 10.1210/me.2009-0252; Chen YH, 2010, BREAST CANCER RES TR, V120, P369, DOI 10.1007/s10549-009-0400-7; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Conklin MW, 2012, CELL ADHES MIGR, V6, P249, DOI 10.4161/cam.20567; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; DOWSETT M, 1983, BRIT J CANCER, V47, P763, DOI 10.1038/bjc.1983.129; Elsberger B, 2009, AM J PATHOL, V175, P1389, DOI 10.2353/ajpath.2009.090273; Fiorillo AA, 2013, AM J PATHOL, V182, P217, DOI 10.1016/j.ajpath.2012.09.021; Galbaugh T, 2010, MOL CANCER RES, V8, P1413, DOI 10.1158/1541-7786.MCR-10-0130; Gehler S, 2009, MOL BIOL CELL, V20, P3224, DOI 10.1091/mbc.E08-12-1186; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Gonzalez L, 2009, ONCOGENE, V28, P1298, DOI 10.1038/onc.2008.473; Greendale GA, 2007, BREAST CANCER RES TR, V105, P337, DOI 10.1007/s10549-006-9454-y; Gutzman JH, 2007, ONCOGENE, V26, P6341, DOI 10.1038/sj.onc.1210454; Gutzman JH, 2005, MOL ENDOCRINOL, V19, P1765, DOI 10.1210/me.2004-0339; Gutzman JH, 2004, J STEROID BIOCHEM, V88, P69, DOI 10.1016/j.jsbmb.2003.10.008; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Howell SJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2129; Ignatov A, 2010, BREAST CANCER RES TR, V123, P87, DOI 10.1007/s10549-009-0624-6; Kalyuga M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001461; Kanomata N, 2011, J CLIN PATHOL, V64, P578, DOI 10.1136/jclinpath-2011-200042; KAREY KP, 1988, CANCER RES, V48, P4083; Keely PJ, 2011, J MAMMARY GLAND BIOL, V16, P205, DOI 10.1007/s10911-011-9226-0; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; LaPensee EW, 2010, ENDOCR-RELAT CANCER, V17, pR91, DOI 10.1677/ERC-09-0253; LaPensee EW, 2009, CARCINOGENESIS, V30, P1298, DOI 10.1093/carcin/bgp120; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lu JC, 2005, J BIOL CHEM, V280, P33909, DOI 10.1074/jbc.M508118200; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lundstrom E, 1999, AM J OBSTET GYNECOL, V181, P348, DOI 10.1016/S0002-9378(99)70560-0; Miller SL, 2007, ONCOGENE, V26, P4668, DOI 10.1038/sj.onc.1210264; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nitze LM, 2013, BREAST CANCER RES TR, V142, P31, DOI 10.1007/s10549-013-2731-7; Ormandy CJ, 1997, J CLIN ENDOCR METAB, V82, P3692, DOI 10.1210/jc.82.11.3692; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Peck AR, 2011, J CLIN ONCOL, V29, P2448, DOI 10.1200/JCO.2010.30.3552; Perks CC, 2004, BRIT J CANCER, V91, P305, DOI 10.1038/sj.bjc.6601947; Piazza TM, 2009, MOL ENDOCRINOL, V23, P202, DOI 10.1210/me.2008-0341; Planas-Silva MD, 2006, BIOCHEM BIOPH RES CO, V341, P73, DOI 10.1016/j.bbrc.2005.12.164; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2008, MICROSC MICROANAL, V14, P532, DOI 10.1017/S1431927608080884; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rasmussen LM, 2010, ENDOCR-RELAT CANCER, V17, P809, DOI 10.1677/ERC-09-0326; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Roop RP, 2012, FUTURE ONCOL, V8, P273, DOI [10.2217/fon.12.8, 10.2217/FON.12.8]; Sato T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-59; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder MD, 2002, MOL ENDOCRINOL, V16, P45, DOI 10.1210/me.16.1.45; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Speroni L, 2014, TISSUE ENG PART C-ME, V20, P42, DOI [10.1089/ten.tec.2013.0054, 10.1089/ten.TEC.2013.0054]; Swaminathan G, 2008, J MAMMARY GLAND BIOL, V13, P81, DOI 10.1007/s10911-008-9068-6; Touraine P, 1998, J CLIN ENDOCR METAB, V83, P667, DOI 10.1210/jc.83.2.667; Tworoger SS, 2008, J MAMMARY GLAND BIOL, V13, P41, DOI 10.1007/s10911-008-9063-y; Tworoger SS, 2013, CANCER RES, V73, P4810, DOI 10.1158/0008-5472.CAN-13-0665; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wagner KU, 2004, MOL CELL BIOL, V24, P5510, DOI 10.1128/MCB.24.12.5510-5520.2004; Walker RA, 2001, BREAST CANCER RES, V3, P143, DOI 10.1186/bcr287; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095	82	44	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116891	10.1371/journal.pone.0116891	http://dx.doi.org/10.1371/journal.pone.0116891			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607819	gold, Green Published, Green Submitted			2022-12-27	WOS:000348205300039
J	Gnedeva, K; Vorotelyak, E; Cimadamore, F; Cattarossi, G; Giusto, E; Terskikh, VV; Terskikh, AV				Gnedeva, Ksenia; Vorotelyak, Ekaterina; Cimadamore, Flavio; Cattarossi, Giulio; Giusto, Elena; Terskikh, Vasiliy V.; Terskikh, Alexey V.			Derivation of Hair-Inducing Cell from Human Pluripotent Stem Cells	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; EPIGENETIC MEMORY; FOLLICLE DEVELOPMENT; BONE-MARROW; IN-VIVO; GROWTH; INDUCTION; MOUSE; SKIN; DIFFERENTIATION	Dermal Papillae (DP) is a unique population of mesenchymal cells that was shown to regulate hair follicle formation and growth cycle. During development most DP cells are derived from mesoderm, however, functionally equivalent DP cells of cephalic hairs originate from Neural Crest (NC). Here we directed human embryonic stem cells (hESCs) to generate first NC cells and then hair-inducing DP-like cells in culture. We showed that hESC-derived DP-like cells (hESC-DPs) express markers typically found in adult human DP cells (e.g. p-75, nestin, versican, SMA, alkaline phosphatase) and are able to induce hair follicle formation when transplanted under the skin of immunodeficient NUDE mice. Engineered to express GFP, hESC-derived DP-like cells incorporate into DP of newly formed hair follicles and express appropriate markers. We demonstrated that BMP signaling is critical for hESC-DP derivation since BMP inhibitor dorsomorphin completely eliminated hair-inducing activity from hESC-DP cultures. DP cells were proposed as the cell-based treatment for hair loss diseases. Unfortunately human DP cells are not suitable for this purpose because they cannot be obtained in necessary amounts and rapidly loose their ability to induce hair follicle formation when cultured. In this context derivation of functional hESC-DP cells capable of inducing a robust hair growth for the first time shown here can become an important finding for the biomedical science.	[Gnedeva, Ksenia; Cimadamore, Flavio; Cattarossi, Giulio; Giusto, Elena; Terskikh, Alexey V.] Sanford Burnham Med Res Inst, Dept Dev & Stem Cell Biol, La Jolla, CA 92037 USA; [Gnedeva, Ksenia; Vorotelyak, Ekaterina; Terskikh, Vasiliy V.] Koltsov Inst Dev Biol, Lab Cell Proliferat, Moscow, Russia	Sanford Burnham Prebys Medical Discovery Institute; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Terskikh, AV (corresponding author), Sanford Burnham Med Res Inst, Dept Dev & Stem Cell Biol, La Jolla, CA 92037 USA.	terskikh@sanfordburnham.org	Vorotelyak, Ekaterina A/I-2029-2014; Terskikh, Alexey/U-8407-2019; Terskikh, Vasiliy/ABE-6153-2020; Giusto, Elena/AAY-9554-2021	Giusto, Elena/0000-0003-0562-1466; Cimadamore, Flavio/0000-0002-3649-0545	Sanford Burnham Medical Research Institute	Sanford Burnham Medical Research Institute	This work was supported by funds from Sanford Burnham Medical Research Institute to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; BRONNERFRASER M, 1994, FASEB J, V8, P699, DOI 10.1096/fasebj.8.10.8050668; Chermnykh ES, 2010, HISTOCHEM CELL BIOL, V133, P567, DOI 10.1007/s00418-010-0691-0; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hoogduijn MJ, 2006, STEM CELLS DEV, V15, P49, DOI 10.1089/scd.2006.15.49; Inamatsu M, 2006, DEV GROWTH DIFFER, V48, P73, DOI 10.1111/j.1440-169x.2006.00848.x; Jahoda CAB, 1996, DERMATOL CLIN, V14, P573, DOI 10.1016/S0733-8635(05)70385-5; Jahoda CAB, 2001, EXP DERMATOL, V10, P229, DOI 10.1034/j.1600-0625.2001.100402.x; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Jandial R, 2011, WORLD NEUROSURG, V75, P5, DOI 10.1016/j.wneu.2011.01.013; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kishimoto J, 2000, GENE DEV, V14, P1181; Kodaira K, 2006, BIOCHEM BIOPH RES CO, V345, P1224, DOI 10.1016/j.bbrc.2006.05.045; LICHTI U, 1993, J INVEST DERMATOL, V101, pS124, DOI 10.1111/1523-1747.ep12363165; LIU GH, 2011, NATURE; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; MOULD AP, 1994, J BIOL CHEM, V269, P27224; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Sieber-Blum Maya, 2004, Birth Defects Res C Embryo Today, V72, P162, DOI 10.1002/bdrc.20008; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu JJ, 2006, ARCH DERMATOL RES, V298, P183, DOI 10.1007/s00403-006-0686-9; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zouboulis CC, 2008, EXP GERONTOL, V43, P986, DOI 10.1016/j.exger.2008.09.001	43	35	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116892	10.1371/journal.pone.0116892	http://dx.doi.org/10.1371/journal.pone.0116892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607935	gold, Green Submitted, Green Published			2022-12-27	WOS:000348205300040
J	Henriksen, RE; Torsheim, T; Thuen, F				Henriksen, Roger Ekeberg; Torsheim, Torbjorn; Thuen, Frode			Relationship Satisfaction Reduces the Risk of Maternal Infectious Diseases in Pregnancy: The Norwegian Mother and Child Cohort Study	PLOS ONE			English	Article							SOCIAL SUPPORT; MARITAL-STATUS; ANTIBODY-RESPONSE; CHRONIC STRESS; INFLUENZA VACCINATION; PSYCHOLOGICAL STRESS; PRENATAL INFECTION; PHYSICAL HEALTH; QUALITY; MORTALITY	Objectives The aims of this study were to explore the degree to which relationship satisfaction predicts the risk of infectious diseases during pregnancy and to examine whether relationship satisfaction moderates the association between stressful life events and the risk of infections. Methods This was a prospective study based on data from the Norwegian Mother and Child Cohort Study (MoBa) conducted by the Norwegian Institute of Public Health. Pregnant women (n = 67,244) completed questionnaires concerning relationship satisfaction and nine different categories of infectious diseases as well as socioeconomic characteristics and stressful life events. Associations between the predictor variables and the infectious diseases were assessed by logistic regression analyses. A multiple regression analysis was performed to assess a possible interaction of relationship satisfaction with stressful life events on the risk for infectious diseases. Results After controlling for marital status, age, education, income, and stressful life events, high levels of relationship satisfaction at week 15 of gestation were found to predict a significantly lower risk for eight categories of infectious diseases at gestational weeks 17-30. No significant interaction effect was found between relationship satisfaction and stressful life events on the risk for infections.	[Henriksen, Roger Ekeberg; Thuen, Frode] Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway; [Torsheim, Torbjorn] Univ Bergen, Fac Psychol, Dept Psychosocial Sci, Bergen, Norway	Western Norway University of Applied Sciences; University of Bergen	Henriksen, RE (corresponding author), Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway.	roger.ekeberg.henriksen@hib.no		Torsheim, Torbjorn/0000-0001-7825-4463	Norwegian Ministry of Health; Ministry of Education and Research (NIH/NIEHS) [NO1-ES-75558]; Ministry of Education and Research (NIH/NINDS) [1 UO1 NS 047537-01, 2 UO1 NS047537-06A1]; Norwegian Research Council/FUGE [151918/S10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	Norwegian Ministry of Health; Ministry of Education and Research (NIH/NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ministry of Education and Research (NIH/NINDS); Norwegian Research Council/FUGE(Research Council of Norway); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research (NIH/NIEHS contract no. NO1-ES-75558, NIH/NINDS grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS047537-06A1) and the Norwegian Research Council/FUGE (grant no. 151918/S10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and the authors received no specific funding for this work.	BENSHLOMO Y, 1993, J EPIDEMIOL COMMUN H, V47, P200, DOI 10.1136/jech.47.3.200; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Biondi M, 1997, PSYCHOTHER PSYCHOSOM, V66, P3, DOI 10.1159/000289101; Blum JS, 1999, J PERS, V67, P93, DOI 10.1111/1467-6494.00049; Bookwala J, 2005, J AGING HEALTH, V17, P85, DOI 10.1177/0898264304272794; Bradbury TN, 2000, J MARRIAGE FAM, V62, P964, DOI 10.1111/j.1741-3737.2000.00964.x; Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; BURMAN B, 1992, PSYCHOL BULL, V112, P39, DOI 10.1037/0033-2909.112.1.39; Burns VE, 2003, J PSYCHOSOM RES, V55, P569, DOI 10.1016/S0022-3999(03)00073-4; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Cohen J., 2003, APPL MULTIPLE REGRES; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; Creasey G, 2004, J RES ADOLESCENCE, V14, P235, DOI 10.1111/j.1532-7795.2004.01402005.x; Feldman PJ, 2000, PSYCHOSOM MED, V62, P715, DOI 10.1097/00006842-200009000-00016; Fiorillo D, 2011, SOC SCI MED, V73, P1644, DOI 10.1016/j.socscimed.2011.09.007; Gallo LC, 2003, HEALTH PSYCHOL, V22, P453, DOI 10.1037/0278-6133.22.5.453; Giesbrecht GF, 2013, PSYCHOSOM MED, V75, P856, DOI 10.1097/PSY.0000000000000004; Gouin JP, 2008, NEUROIMMUNOMODULAT, V15, P251, DOI 10.1159/000156468; Graham JE, 2006, J BEHAV MED, V29, P389, DOI 10.1007/s10865-006-9057-4; Graham JE, 2009, HEALTH PSYCHOL, V28, P621, DOI 10.1037/a0015208; Gupta K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3140; HENDRICK SS, 1988, J MARRIAGE FAM, V50, P93, DOI 10.2307/352430; Hennessy MB, 2009, FRONT NEUROENDOCRIN, V30, P470, DOI 10.1016/j.yfrne.2009.06.001; Hohmann-Marriott B, 2009, MATERN CHILD HLTH J, V13, P745, DOI 10.1007/s10995-009-0467-0; Holt-Lunstad J, 2008, ANN BEHAV MED, V35, P239, DOI 10.1007/s12160-008-9018-y; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003; Kiecolt-Glaser JK, 2005, ARCH GEN PSYCHIAT, V62, P1377, DOI 10.1001/archpsyc.62.12.1377; Kiecolt-Glaser JK, 1998, ANN NY ACAD SCI, V840, P656, DOI 10.1111/j.1749-6632.1998.tb09604.x; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Lindstrom M, 2012, PUBLIC HEALTH, V126, P790, DOI 10.1016/j.puhe.2012.06.001; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Matthews SG, 2012, EXP NEUROL, V233, P95, DOI 10.1016/j.expneurol.2011.01.009; Mortensen O, 2012, FAM PROCESS, V51, P122, DOI 10.1111/j.1545-5300.2012.01384.x; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Phillips AC, 2006, BRAIN BEHAV IMMUN, V20, P279, DOI 10.1016/j.bbi.2005.08.003; Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068; Robles TF, 2014, PSYCHOL BULL, V140, P140, DOI 10.1037/a0031859; Rosand GMB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-161; Saxbe DE, 2008, HEALTH PSYCHOL, V27, P15, DOI 10.1037/0278-6133.27.1.15; Snyder D. K, 1997, MARITAL SATISFACTION; Stadler G, 2012, PSYCHOSOM MED, V74, P398, DOI 10.1097/PSY.0b013e31825473b8; Stapleton LRT, 2012, J FAM PSYCHOL, V26, P453, DOI 10.1037/a0028332; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Vedhara K, 1999, LANCET, V353, P627, DOI 10.1016/S0140-6736(98)06098-X; Wickrama KAS, 2001, J MARRIAGE FAM, V63, P527, DOI 10.1111/j.1741-3737.2001.00527.x	52	4	4	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116796	10.1371/journal.pone.0116796	http://dx.doi.org/10.1371/journal.pone.0116796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4PR	25608018	Green Published, gold, Green Submitted			2022-12-27	WOS:000348205300035
J	Johnston, SB; Raines, RT				Johnston, Sean B.; Raines, Ronald T.			Catalysis by the Tumor-Suppressor Enzymes PTEN and PTEN-L	PLOS ONE			English	Article							PHOSPHOINOSITIDE PHOSPHATASES; ALLOSTERIC ACTIVATION; ANIONIC PHOSPHOLIPIDS; ASSAY; MYOTUBULARIN; MOLECULES; SURVIVAL; BINDING; ENTERS	Phosphatase and tensin homologue deleted from chromosome ten (PTEN) is a lipid phosphatase tumor suppressor that is lost or inactivated in most human tumors. The enzyme catalyzes the hydrolysis of phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) to form phosphatidylinositol-(4,5)-bisphosphate (PIP2) and inorganic phosphate. Here, we report on the first continuous assay for the catalytic activity of PTEN. Using this assay, we demonstrate that human PTEN is activated by the reaction product PIP2, as well as in solutions of low salt concentration. This activation is abrogated in the K13A variant, which has a disruption in a putative binding site for PIP2. We also demonstrate that PTEN-L, which derives from alternative translation of the PTEN mRNA, is activated constitutively. These findings have implications for catalysis by PTEN in physiological environments and could expedite the development of PTEN-based chemotherapeutic agents.	[Johnston, Sean B.; Raines, Ronald T.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Raines, Ronald T.] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Raines, RT (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	rtraines@wisc.edu	Raines, Ronald T./A-5009-2013	Raines, Ronald T./0000-0001-7164-1719	Dennis Weatherstone Predoctoral Fellowship from Autism Speaks and Molecular Biosciences Training Grant [T32 GM007215, R01 GM044783]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM044783] Funding Source: NIH RePORTER	Dennis Weatherstone Predoctoral Fellowship from Autism Speaks and Molecular Biosciences Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Dennis Weatherstone Predoctoral Fellowship from Autism Speaks and Molecular Biosciences Training Grant T32 GM007215 (National Institutes of Health) to SBJ, and Grant R01 GM044783 (NIH) to RTR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Andersen JF, 2006, BIOCHEMISTRY-US, V45, P5450, DOI 10.1021/bi052444j; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Cornish-Bowden A, 2014, FEBS J, V281, P621, DOI 10.1111/febs.12469; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Lukesh JC, 2012, J AM CHEM SOC, V134, P4057, DOI 10.1021/ja211931f; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; MELANDER W, 1977, ARCH BIOCHEM BIOPHYS, V183, P200, DOI 10.1016/0003-9861(77)90434-9; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Park C, 2001, J AM CHEM SOC, V123, P11472, DOI 10.1021/ja0164834; Porter CM, 2012, BIOORG CHEM, V43, P44, DOI 10.1016/j.bioorg.2011.11.001; Pulido R, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005560; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Taylor GS, 2003, METHOD ENZYMOL, V366, P43; Tipton Keith F., 2002, P1; Turner T, 1997, CLIN CANCER RES, V3, P2275; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Zhong SR, 2012, BIOCHEMISTRY-US, V51, P3170, DOI 10.1021/bi300086c	37	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116898	10.1371/journal.pone.0116898	http://dx.doi.org/10.1371/journal.pone.0116898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607987	Green Published, gold, Green Submitted			2022-12-27	WOS:000348205300041
J	Louvet, L; Bazin, D; Buchel, J; Steppan, S; Passlick-Deetjen, J; Massy, ZA				Louvet, Loic; Bazin, Dominique; Buechel, Janine; Steppan, Sonja; Passlick-Deetjen, Jutta; Massy, Ziad A.			Characterisation of Calcium Phosphate Crystals on Calcified Human Aortic Vascular Smooth Muscle Cells and Potential Role of Magnesium	PLOS ONE			English	Article							STAGE RENAL-DISEASE; IN-VITRO; YOUNG-ADULTS; INFRARED-SPECTROSCOPY; INDUCED CALCIFICATION; GROWTH; CORONARY; UREMIA; FTIR; CRYSTALLIZATION	Background Cardiovascular disease including vascular calcification (VC) remains the leading cause of death in patients suffering from chronic kidney disease (CKD). The process of VC seems likely to be a tightly regulated process where vascular smooth muscle cells are playing a key role rather than just a mere passive precipitation of calcium phosphate. Characterisation of the chemical and crystalline structure of VC was mainly led in patients or animal models with CKD. Likewise, Mg2+ was found to be protective in living cells although a potential role for Mg2+ could not be excluded on crystal formation and precipitation. In this study, the crystal formation and the role of Mg2+ were investigated in an in vitro model of primary human aortic vascular smooth muscle cells (HAVSMC) with physical techniques. Methodology/Principal Findings In HAVSMC incubated with increased Ca x Pi medium, only calcium phosphate apatite crystals (CPA) were detected by Micro-Fourier Transform InfraRed spectroscopy (mu FTIR) and Field Effect Scanning Electron Microscope (FE-SEM) and Energy Dispersive X-ray spectrometry (EDX) at the cell layer level. Supplementation with Mg2+ did not alter the crystal composition or structure. The crystal deposition was preferentially positioned near or directly on cells as pictured by FE-SEM observations and EDX measurements. Large mu FTIR maps revealed spots of CPA crystals that were associated to the cellular layout. This qualitative analysis suggests a potential beneficial effect of Mg2+ at 5 mM in noticeably reducing the number and intensities of CPA mu FTIR spots. Conclusions/Significance For the first time in a model of HAVSMC, induced calcification led to the formation of the sole CPA crystals. Our data seems to exclude a physicochemical role of Mg2+ in altering the CPA crystal growth, composition or structure. Furthermore, Mg2+ beneficial role in attenuating VC should be linked to an active cellular role.	[Louvet, Loic; Massy, Ziad A.] INSERM U 1088, Amiens, France; [Louvet, Loic; Massy, Ziad A.] Univ Picardie Jules Verne, Amiens, France; [Bazin, Dominique] Univ Paris 06, Coll France, Paris, France; [Buechel, Janine; Steppan, Sonja; Passlick-Deetjen, Jutta] Fresenius Med Care, Bad Homburg, Germany; [Passlick-Deetjen, Jutta] Univ Dusseldorf, Dept Nephrol, Dusseldorf, Germany; [Massy, Ziad A.] Paris Ile France Ouest UVSQ Univ, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite; Heinrich Heine University Dusseldorf; UDICE-French Research Universities; Universite Paris Saclay	Massy, ZA (corresponding author), INSERM U 1088, Amiens, France.	massy@u-picardie.fr	, Bazin/C-6306-2014	, Bazin/0000-0002-5112-9061	Fresenius Medical Care Deutschland GmbH	Fresenius Medical Care Deutschland GmbH	The funders (Fresenius Medical Care Deutschland GmbH) participated in part of the study design and revision of the final version of manuscript. They had no role in data collection, analysis, preparation of manuscript and decision to publish.	Bassan P, 2013, ANALYST, V138, P144, DOI 10.1039/c2an36090j; Bazin D, 2012, CHEM REV, V112, P5092, DOI 10.1021/cr200068d; Bazin D, 2009, OSTEOPOROSIS INT, V20, P1065, DOI 10.1007/s00198-009-0868-3; Becker A, 2004, J INORG BIOCHEM, V98, P2032, DOI 10.1016/j.jinorgbio.2004.09.006; BENNETT RM, 1975, J CLIN INVEST, V56, P1571, DOI 10.1172/JCI108239; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; BOSKEY AL, 1980, CALCIFIED TISSUE INT, V32, P139, DOI 10.1007/BF02408533; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; CONTIGUGLIA SR, 1973, KIDNEY INT, V4, P229, DOI 10.1038/ki.1973.104; De Schutter TM, 2013, KIDNEY INT, V83, P1109, DOI 10.1038/ki.2013.34; Eifinger F, 2000, NEPHROL DIAL TRANSPL, V15, P1892, DOI 10.1093/ndt/15.11.1892; Estepa L, 1997, BIOSPECTROSCOPY, V3, P347, DOI 10.1002/(SICI)1520-6343(1997)3:5<347::AID-BSPY3>3.0.CO;2-#; Filik J, 2012, ANALYST, V137, P853, DOI 10.1039/c2an15995c; Fischer DC, 2012, CALCIFIED TISSUE INT, V90, P465, DOI 10.1007/s00223-012-9594-5; Gazi E, 2005, BIOPOLYMERS, V77, P18, DOI 10.1002/bip.20167; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; HAMAD M, 1986, J CRYST GROWTH, V79, P192, DOI 10.1016/0022-0248(86)90435-5; Ibrahim DM, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-74; Ishiyama M, 2009, DIABETES RES CLIN PR, V85, P189, DOI 10.1016/j.diabres.2009.04.023; Kircelli F, 2012, NEPHROL DIAL TRANSPL, V27, P514, DOI 10.1093/ndt/gfr321; LeGeros R Z, 2001, Z Kardiol, V90 Suppl 3, P116; LEGEROS RZ, 1973, CALC TISS RES, V13, P173, DOI 10.1007/BF02015408; Lomashvili KA, 2004, J AM SOC NEPHROL, V15, P1392, DOI 10.1097/01.ASN.0000128955.83129.9C; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Louvet L, 2013, NEPHROL DIAL TRANSPL, V28, P869, DOI 10.1093/ndt/gfs520; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Massy ZA, 2012, CLIN KIDNEY J, V5, P52, DOI 10.1093/ndtplus/sfr167; Meade AD, 2007, ANAL BIOANAL CHEM, V387, P1717, DOI 10.1007/s00216-006-0876-5; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; MONTEL G, 1981, J CRYST GROWTH, V53, P74, DOI 10.1016/0022-0248(81)90057-9; de Oca AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089525; Montezano AC, 2010, HYPERTENSION, V56, P453, DOI 10.1161/HYPERTENSIONAHA.110.152058; Noordzij M, 2011, NEPHROL DIAL TRANSPL, V26, P1662, DOI 10.1093/ndt/gfq582; Oh J, 2002, CIRCULATION, V106, P100, DOI 10.1161/01.CIR.0000020222.63035.C0; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Sage AP, 2011, KIDNEY INT, V79, P414, DOI 10.1038/ki.2010.390; Salem S, 2012, AM J NEPHROL, V35, P31, DOI 10.1159/000334742; SALIMI MH, 1985, LANGMUIR, V1, P119, DOI 10.1021/la00061a019; Sattlecker M, 2011, CHEMOMETR INTELL LAB, V107, P363, DOI 10.1016/j.chemolab.2011.05.007; Schlieper G, 2010, J AM SOC NEPHROL, V21, P689, DOI 10.1681/ASN.2009080829; Shen M, 1998, ANN THORAC SURG, V66, pS236, DOI 10.1016/S0003-4975(98)01102-3; Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; Takasu J, 2010, ATHEROSCLEROSIS, V209, P142, DOI 10.1016/j.atherosclerosis.2009.09.013; TERMINE JD, 1970, ARCH BIOCHEM BIOPHYS, V140, P318, DOI 10.1016/0003-9861(70)90072-X; Verberckmoes SC, 2007, KIDNEY INT, V71, P298, DOI 10.1038/sj.ki.5002028; Villa-Bellosta R, 2011, AM J PHYSIOL-CELL PH, V300, pC210, DOI 10.1152/ajpcell.00229.2010; Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574; Wehbe K, 2013, ANAL BIOANAL CHEM, V405, P1311, DOI 10.1007/s00216-012-6521-6	51	57	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115342	10.1371/journal.pone.0115342	http://dx.doi.org/10.1371/journal.pone.0115342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607936	gold, Green Published, Green Submitted			2022-12-27	WOS:000348205300013
J	Zemtsova, GE; Montgomery, M; Levin, ML				Zemtsova, Galina E.; Montgomery, Merrill; Levin, Michael L.			Relative Sensitivity of Conventional and Real-Time PCR Assays for Detection of SFG Rickettsia in Blood and Tissue Samples from Laboratory Animals	PLOS ONE			English	Article							FEVER GROUP RICKETTSIA; SPOTTED-FEVER; IDENTIFICATION; DNA; DIFFERENTIATION; INFECTION; TICKS	Studies on the natural transmission cycles of zoonotic pathogens and the reservoir competence of vertebrate hosts require methods for reliable diagnosis of infection in wild and laboratory animals. Several PCR-based applications have been developed for detection of infections caused by Spotted Fever group Rickettsiaspp. in a variety of animal tissues. These assays are being widely used by researchers, but they differ in their sensitivity and reliability. We compared the sensitivity of five previously published conventional PCR assays and one SYBR green-based real-time PCR assay for the detection of rickettsial DNA in blood and tissue samples from Rickettsia-infected laboratory animals (n = 87). The realtime PCR, which detected rickettsial DNA in 37.9% of samples, was the most sensitive. The next best were the semi-nested ompA assay and rpoB conventional PCR, which detected as positive 18.4% and 14.9% samples respectively. Conventional assays targeting ompB, gltA and hrtA genes have been the least sensitive. Therefore, we recommend the SYBR green-based real-time PCR as a tool for the detection of rickettsial DNA in animal samples due to its higher sensitivity when compared to more traditional assays.	[Zemtsova, Galina E.; Montgomery, Merrill; Levin, Michael L.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Zemtsova, GE (corresponding author), Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA 30333 USA.	GZemtsova@cdc.gov			United States Federal agency Centers for Disease Control	United States Federal agency Centers for Disease Control	The study was funded by United States Federal agency Centers for Disease Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; AKANE A, 1994, J FORENSIC SCI, V39, P362; ANDERSON BE, 1989, J BACTERIOL, V171, P5199, DOI 10.1128/jb.171.9.5199-5201.1989; Barrett A, 2014, VECTOR-BORNE ZOONOT, V14, P20, DOI 10.1089/vbz.2013.1325; Bastien P, 2008, J CLIN MICROBIOL, V46, P1897, DOI 10.1128/JCM.02258-07; Eremeeva ME, 2003, J CLIN MICROBIOL, V41, P5466, DOI 10.1128/JCM.41.12.5466-5472.2003; Kato CY, 2013, J CLIN MICROBIOL, V51, P314, DOI 10.1128/JCM.01723-12; Kidd L, 2008, VET MICROBIOL, V129, P294, DOI 10.1016/j.vetmic.2007.11.035; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Lledo L, 2014, VECTOR-BORNE ZOONOT, V14, P383, DOI 10.1089/vbz.2013.1513; Lopes LD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-191; Paddock CD, 2010, APPL ENVIRON MICROB, V76, P2689, DOI 10.1128/AEM.02737-09; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; Santibanez S, 2013, ENFERM INFEC MICR CL, V31, P283, DOI 10.1016/j.eimc.2012.08.001; TZIANABOS T, 1989, J CLIN MICROBIOL, V27, P2866, DOI 10.1128/JCM.27.12.2866-2868.1989	17	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116658	10.1371/journal.pone.0116658	http://dx.doi.org/10.1371/journal.pone.0116658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607846	Green Published, gold, Green Submitted			2022-12-27	WOS:000348205300030
J	Arshad, A; Deutsch, E; Vozenin, MC				Arshad, Adnan; Deutsch, Eric; Vozenin, Marie-Catherine			Simultaneous Irradiation of Fibroblasts and Carcinoma Cells Repress the Secretion of Soluble Factors Able to Stimulate Carcinoma Cell Migration	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MAMMARY-GLAND; FARNESYLTRANSFERASE INHIBITORS; LUNG-CANCER; RHOB; RADIATION; STROMA; INVASION; RAS; EXPRESSION	Stroma mediated wound healing signals may share similarities with the ones produced by tumor's microenvironment and their modulation may impact tumor response to the various anti-cancer treatments including radiation therapy. Therefore we conducted this study, to assess the crosstalk between stromal and carcinoma cells in response to radiotherapy by genetic modulation of the stroma and irradiation. We found that fibroblasts irrespective of their RhoB status do not modulate intrinsic radiosensitivity of TC-1 but produce diffusible factors able to modify tumor cell fate. Then we found that Wt and RhoB deficient fibroblasts stimulated TC-1 migration through distinct mechanisms which are TGF-beta 1 and MMP-mediated respectively. Lastly, we found that simultaneous irradiation of fibroblasts and TC-1 abrogated the pro-migratory phenotype by repression of TGF-beta and MMP secretion. This last result is highly relevant to the clinical situation and suggests that conversely to, the current view; irradiated stroma would not enhance carcinoma migration and could be manipulated to promote anti-tumor immune response.	[Arshad, Adnan; Deutsch, Eric; Vozenin, Marie-Catherine] INSERM, LabEx LERMIT, U1030, Villejuif, France; [Arshad, Adnan; Deutsch, Eric; Vozenin, Marie-Catherine] Univ Paris 11, Le Kremlin Bicetre, France; [Arshad, Adnan; Deutsch, Eric; Vozenin, Marie-Catherine] Inst Gustave Roussy, Villejuif, France; [Vozenin, Marie-Catherine] CHU Vaudois, Dept Oncol, Serv Radio Oncol, Lab Rech Radio Oncol, Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Vozenin, MC (corresponding author), INSERM, LabEx LERMIT, U1030, Villejuif, France.	marie-catherine.vozenin@chuv.ch	Vozenin, Marie-Catherine/AAR-2268-2021	Vozenin, Marie-Catherine/0000-0002-2109-8073; deutsch, eric/0000-0002-8223-3697	Higher Education Commission of Pakistan; Fondation Gustave Roussy; Fondation Gustave Roussy Grant; ANR [ANR-10-LABX-33]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Fondation Gustave Roussy; Fondation Gustave Roussy Grant; ANR(French National Research Agency (ANR))	AA was supported by a Scholarship Grant from Higher Education Commission of Pakistan and Fondation Gustave Roussy. The work was supported by Fondation Gustave Roussy Grant. Inserm U1030 is a member of the Laboratory of Excellence LERMIT supported by a grant from ANR (ANR-10-LABX-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Barcellos-Hoff MH, 2000, BREAST CANCER RES, V2, P92, DOI 10.1186/bcr40; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; BARCELLOSHOFF MH, 1993, CANCER RES, V53, P3880; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Dowlati A, 2008, CLIN CANCER RES, V14, P1407, DOI 10.1158/1078-0432.CCR-07-1154; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Farhat FS, 2012, CRIT REV ONCOL HEMAT, V84, P149, DOI 10.1016/j.critrevonc.2012.02.012; Fritz G, 1997, J BIOL CHEM, V272, P30637, DOI 10.1074/jbc.272.49.30637; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hu X, 2010, JOVE-J VIS EXP, V24, P2445, DOI DOI 10.3791/2445; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Lewis MP, 2004, BRIT J CANCER, V90, P822, DOI 10.1038/sj.bjc.6601611; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; Moustakas A, 1999, J CELL SCI, V112, P1169; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; PRENDERGAST GC, 1995, ONCOGENE, V10, P2289; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Rodriguez PL, 2007, CELL SIGNAL, V19, P2361, DOI 10.1016/j.cellsig.2007.07.021; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Yarnold J, 2010, RADIOTHER ONCOL, V97, P149, DOI 10.1016/j.radonc.2010.09.002	27	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115447	10.1371/journal.pone.0115447	http://dx.doi.org/10.1371/journal.pone.0115447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635683	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700011
J	Ma, M; Chen, S; Zhu, BY; Zhao, BW; Wang, HS; Xiang, J; Wu, XB; Lin, YJ; Zhou, ZW; Peng, JS; Chen, YB				Ma, Min; Chen, Shi; Zhu, Bao-yan; Zhao, Bai-Wei; Wang, Hua-She; Xiang, Jun; Wu, Xiao-Bin; Lin, Yi-Jia; Zhou, Zhi-Wei; Peng, Jun-Sheng; Chen, Ying-Bo			The Clinical Significance and Risk Factors of Solitary Lymph Node Metastasis in Gastric Cancer	PLOS ONE			English	Article							FEASIBILITY; NAVIGATION; RESECTION; SURGERY	Aims To assess the clinical significance and risk factors of solitary lymph node metastasis (SLM) in gastric carcinoma and establish a more accurate method to evaluate the possibility of lymph node metastasis (LM). Methods A total of 385 patients with gastric carcinoma who underwent D2 lymphadenectomy at the Cancer Center of Sun Yat-Sen University were included in this research. Then we used a group of data from Sun Yat-sen University Gastrointestinal Hospital (SYSUGIH) to validate the accuracy of our developed method. The x(2) test, Kaplan-Meier analysis, log-rank test, COX model, and discriminate analysis were used to analyze the data with SPSS 13.0. Results We found that the LM number and pathological T staging were independent prognostic risk factors. CEA grading, LN status by CT, and T staging by CT were independent risk factors for LM in gastric carcinoma. In addition, we developed the equation Y = -5.0 + X-1 + 1.8X(3) + 0.7X4 (X-1 = CEA grading, X-3 = LN status by CT, X-4 = T staging by CT) to evaluate the situation of LM. The data from SYSUGIH shows this equation has a better accuracy compared with CT. Conclusions SLM is an independent risk factor in gastric cancer. And there was no survival difference between the skip metastasis group and the other SLM group (P = 0.659). It is inappropriate for the patient with SLM doing a standard D2 lymphadenectomy, due to the fact that LM rarely occurs in the splenic artery, splenic hilum. The risk factors for LM include CEA grading, LN status by CT, and T staging by CT. And we can use Y = -5.0 + X-1 + 1.8X(3) + 0.7X(4) (X-1, CEA grading, X-3 = LN status by CT, X-4 = T staging by CT, the critical value is 0.3) to estimate the possibility of LM, which has a better accuracy compared with CT.	[Ma, Min; Chen, Shi; Zhu, Bao-yan; Zhao, Bai-Wei; Zhou, Zhi-Wei; Chen, Ying-Bo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Min; Zhu, Bao-yan; Zhao, Bai-Wei; Zhou, Zhi-Wei; Chen, Ying-Bo] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Shi; Wang, Hua-She; Xiang, Jun; Wu, Xiao-Bin; Lin, Yi-Jia; Peng, Jun-Sheng] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Surg Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Peng, JS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Surg Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	pengjunsheng@tom.com; chenyb@sysucc.org.cn			Guang-dong Province Fund Committee [2012B0617000879]	Guang-dong Province Fund Committee	This study was supported by the Guang-dong Province Fund Committee (No2012B0617000879).	Ahn HS, 2009, J SURG ONCOL, V99, P20, DOI 10.1002/jso.21170; Aikou T, 2006, CANCER METAST REV, V25, P269, DOI 10.1007/s10555-006-8507-3; Chen WQ, 2013, CHIN J CANCER, V32, P106, DOI 10.5732/cjc.013.10018; Cozzaglio L, 2011, EJSO-EUR J SURG ONC, V37, P55, DOI 10.1016/j.ejso.2010.10.012; Feng XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078846; Gretschel S, 2005, EJSO-EUR J SURG ONC, V31, P393, DOI 10.1016/j.ejso.2004.11.014; Griniatsos J, 2011, SCAND J SURG, V100, P174, DOI 10.1177/145749691110000307; Hirasawa T, 2009, GASTRIC CANCER, V12, P148, DOI 10.1007/s10120-009-0515-x; Huang BJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-18; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kitagawa Y, 2005, J SURG ONCOL, V90, P147, DOI 10.1002/jso.20220; Kitagawa Y, 2002, J SURG ONCOL, V79, P188, DOI 10.1002/jso.10065; Kitagawa Y, 2013, J CLIN ONCOL, V31, P3704, DOI 10.1200/JCO.2013.50.3789; Lee SE, 2009, ANN SURG ONCOL, V16, P603, DOI 10.1245/s10434-008-0283-6; Li XP, 2013, CHIN J CANCER, V32, P512, DOI 10.5732/cjc.012.10200; Liu CG, 2007, WORLD J GASTROENTERO, V13, P4776, DOI 10.3748/wjg.v13.i35.4776; Matsumoto M, 2003, BRIT J SURG, V90, P563, DOI 10.1002/bjs.4083; Moenig SP, 2005, ANTICANCER RES, V25, P1349; Ohgami M, 1999, WORLD J SURG, V23, P187, DOI 10.1007/PL00013167; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Park SS, 2005, ANZ J SURG, V75, P645, DOI 10.1111/j.1445-2197.2005.03485.x; Roukos DH, 2000, CANCER TREAT REV, V26, P243, DOI 10.1053/ctrv.2000.0164; Tokunaga M, 2009, WORLD J SURG, V33, P1235, DOI 10.1007/s00268-009-9985-6; Tsujitani S, 1999, SURGERY, V125, P148, DOI 10.1016/S0039-6060(99)70258-8	24	12	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0114939	10.1371/journal.pone.0114939	http://dx.doi.org/10.1371/journal.pone.0114939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633364	Green Submitted, gold, Green Published			2022-12-27	WOS:000348609800003
J	Hagedorn, M; Carter, V; Zuchowicz, N; Phillips, M; Penfield, C; Shamenek, B; Vallen, EA; Kleinhans, FW; Peterson, K; White, M; Yancey, PH				Hagedorn, Mary; Carter, Virginia; Zuchowicz, Nikolas; Phillips, Micaiah; Penfield, Chelsea; Shamenek, Brittany; Vallen, Elizabeth A.; Kleinhans, Frederick W.; Peterson, Kelly; White, Meghan; Yancey, Paul H.			Trehalose Is a Chemical Attractant in the Establishment of Coral Symbiosis	PLOS ONE			English	Article							LARVAL SETTLEMENT; ALGAL SYMBIONTS; SYMBIODINIUM; RECOGNITION; BEHAVIOR; LIGHT; ACQUISITION; DIVERSITY; INFECTION; SEDIMENT	Coral reefs have evolved with a crucial symbiosis between photosynthetic dinoflagellates (genus Symbiodinium) and their cnidarian hosts (Scleractinians). Most coral larvae take up Symbiodinium from their environment; however, the earliest steps in this process have been elusive. Here we demonstrate that the disaccharide trehalose may be an important signal from the symbiont to potential larval hosts. Symbiodinium freshly isolated from Fungia scutaria corals constantly released trehalose (but not sucrose, maltose or glucose) into seawater, and released glycerol only in the presence of coral tissue. Spawning Fungia adults increased symbiont number in their immediate area by excreting pellets of Symbiodinium, and when these naturally discharged Symbiodinium were cultured, they also released trehalose. In Y-maze experiments, coral larvae demonstrated chemoattractant and feeding behaviors only towards a chamber with trehalose or glycerol. Concomitantly, coral larvae and adult tissue, but not symbionts, had significant trehalase enzymatic activities, suggesting the capacity to utilize trehalose. Trehalase activity was developmentally regulated in F. scutaria larvae, rising as the time for symbiont uptake occurs. Consistent with the enzymatic assays, gene finding demonstrated the presence of a trehalase enzyme in the genome of a related coral, Acropora digitifera, and a likely trehalase in the transcriptome of F. scutaria. Taken together, these data suggest that adult F. scutaria seed the reef with Symbiodinium during spawning and the exuded Symbiodinium release trehalose into the environment, which acts as a chemoattractant for F. scutaria larvae and as an initiator of feeding behavior-the first stages toward establishing the coral-Symbiodinium relationship. Because trehalose is a fixed carbon compound, this cue would accurately demonstrate to the cnidarian larvae the photosynthetic ability of the potential symbiont in the ambient environment. To our knowledge, this is the first report of a chemical cue attracting the motile coral larvae to the symbiont.	[Hagedorn, Mary; Carter, Virginia; Zuchowicz, Nikolas; Phillips, Micaiah; Penfield, Chelsea; Shamenek, Brittany] Smithsonian Conservat Biol Inst, Dept Reprod Sci, Front Royal, VA 22630 USA; [Hagedorn, Mary; Carter, Virginia; Zuchowicz, Nikolas; Phillips, Micaiah; Penfield, Chelsea; Shamenek, Brittany] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Vallen, Elizabeth A.] Swarthmore Coll, Dept Biol, Swarthmore, PA USA; [Kleinhans, Frederick W.] Indiana Univ Purdue Univ Indianapolis, Dept Phys, Indianapolis, IN USA; [Peterson, Kelly; White, Meghan; Yancey, Paul H.] Dept Biol, Whitman Coll, Walla Walla, WA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Hawaii System; Swarthmore College; Indiana University System; Indiana University-Purdue University Indianapolis; Whitman College	Hagedorn, M (corresponding author), Smithsonian Conservat Biol Inst, Dept Reprod Sci, Front Royal, VA 22630 USA.	hagedomm@si.edu		Zuchowicz, Nikolas/0000-0002-3577-0190	Roddenberry Foundation; Anela Kolohe Foundation; Taronga Conservation Society Australia; Whitman College Perry Grant; NIH [1F33GM096488-01]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F33GM096488] Funding Source: NIH RePORTER	Roddenberry Foundation; Anela Kolohe Foundation; Taronga Conservation Society Australia; Whitman College Perry Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These experiments were funded through funds from the Roddenberry Foundation (MH), the Anela Kolohe Foundation (MH), the Taronga Conservation Society Australia (MH), Whitman College Perry Grant (PY) and NIH 1F33GM096488-01 (EAV) and NSF (EAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LM, 2009, MAR ECOL PROG SER, V377, P149, DOI 10.3354/meps07834; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; BENSON AA, 1950, J AM CHEM SOC, V72, P1710, DOI 10.1021/ja01160a080; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Chadwick-Furman NE, 2000, J EXP MAR BIOL ECOL, V249, P199, DOI 10.1016/S0022-0981(00)00204-5; DAVIES PS, 1984, CORAL REEFS, V2, P181; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; Douglas AE, 1994, SYMBIOTIC INTERACTIO; Elbein A D, 1974, Adv Carbohydr Chem Biochem, V30, P227, DOI 10.1016/S0065-2318(08)60266-8; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; FITT WK, 1984, MAR BIOL, V81, P9, DOI 10.1007/BF00397620; FUZESSERY ZM, 1978, BIOL BULL, V154, P226, DOI 10.2307/1541124; Hagedorn M, 2006, CRYOBIOLOGY, V52, P33, DOI 10.1016/j.cryobiol.2005.09.008; Hagedorn M, 2010, CRYOBIOLOGY, V60, P147, DOI 10.1016/j.cryobiol.2009.10.005; Hagedorn M, 2010, PHYSIOL BIOCHEM ZOOL, V83, P157, DOI 10.1086/648484; Harii S, 2009, MAR BIOL, V156, P1203, DOI 10.1007/s00227-009-1162-9; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hirose M, 2008, CORAL REEFS, V27, P247, DOI 10.1007/s00338-007-0330-y; Hoegh-Guldberg O, 2007, CORAL REEFS, V26, P731, DOI 10.1007/s00338-007-0320-0; Hoeksema B, 2014, MONTIPORA BLAINVILLE, V1830; Hoeksema BW, 1988, P 6 INT COR REEF S T, V2, P715; Hollingsworth LL, 2005, CORAL REEFS, V24, P523, DOI 10.1007/s00338-005-0063-8; Horiguchi Takeo, 1999, Phycological Research, V47, P101, DOI 10.1111/j.1440-1835.1999.tb00290.x; Koehl MAR, 2007, EXP FLUIDS, V43, P755, DOI 10.1007/S00348-007-0371-6; Koehl MAR, 2010, INTEGR COMP BIOL, V50, P539, DOI 10.1093/icb/icq101; KOPP M, 1993, J BIOL CHEM, V268, P4766; Krupp D.A., 1983, Coral Reefs, V2, P159, DOI 10.1007/BF00336722; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; Lecchini D, 2014, MAR BIOL, V161, P1677, DOI 10.1007/s00227-014-2451-5; LEE KH, 1994, J BACTERIOL, V176, P1985, DOI 10.1128/jb.176.7.1985-1991.1994; Lehnert EM, 2014, G3-GENES GENOM GENET, V4, P277, DOI 10.1534/g3.113.009084; Lin KL, 2000, ZOOL STUD, V39, P172; Lowe RJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005081; MCAULEY PJ, 1982, PROC R SOC SER B-BIO, V216, P7, DOI 10.1098/rspb.1982.0058; MUSCATIN.L, 1967, SCIENCE, V156, P516, DOI 10.1126/science.156.3774.516; MUSCATINE L, 1965, COMP BIOCHEM PHYSIOL, V16, P77, DOI 10.1016/0010-406X(65)90165-9; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; OLIVER MJ, 1978, BIOCHEM GENET, V16, P927, DOI 10.1007/BF00483744; Pasternak Z, 2006, CORAL REEFS, V25, P201, DOI 10.1007/s00338-005-0085-2; PORTER JW, 1984, PROC R SOC SER B-BIO, V222, P161, DOI 10.1098/rspb.1984.0057; Relman DA, 2008, NAT REV MICROBIOL, V6, P721, DOI 10.1038/nrmicro1990; REUSER AJJ, 1995, MUSCLE NERVE, pS61; Richmond Robert H., 1997, P175; Rodriguez-Lanetty M, 2006, MAR BIOL, V149, P713, DOI 10.1007/s00227-006-0272-x; Schnitzler CE, 2010, MAR GENOM, V3, P107, DOI 10.1016/j.margen.2010.08.002; Schwarz JA, 1999, BIOL BULL-US, V196, P70, DOI 10.2307/1543169; Schwarz JA, 2003, BIOL BULL-US, V205, P339, DOI 10.2307/1543297; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Takabayashi M, 2012, CORAL REEFS, V31, P157, DOI 10.1007/s00338-011-0832-5; Teramoto N, 2008, MOLECULES, V13, P1773, DOI 10.3390/molecules13081773; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; WOOMER PL, 1988, APPL ENVIRON MICROB, V54, P1494, DOI 10.1128/AEM.54.6.1494-1497.1988; Yancey PH, 2010, PHYSIOL BIOCHEM ZOOL, V83, P167, DOI 10.1086/644625; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	57	18	18	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117087	10.1371/journal.pone.0117087	http://dx.doi.org/10.1371/journal.pone.0117087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629699	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100062
J	Zhou, T; Zeng, SX; Ye, DW; Wei, Q; Zhang, X; Huang, YR; Ye, ZQ; Yang, Y; Zhang, W; Tian, Y; Zhou, FJ; Jie, J; Chen, SP; Sun, Y; Xie, LP; Yao, X; Na, YQ; Sun, YH				Zhou, Tie; Zeng, Shu-xiong; Ye, Ding-wei; Wei, Qiang; Zhang, Xu; Huang, Yi-ran; Ye, Zhang-qun; Yang, Yong; Zhang, Wei; Tian, Ye; Zhou, Fang-jian; Jie, Jin; Chen, Shi-ping; Sun, Yan; Xie, Li-ping; Yao, Xing; Na, Yan-qun; Sun, Ying-hao			A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer	PLOS ONE			English	Article							CHANGING THERAPEUTIC LANDSCAPE; PHASE-II; DOUBLE-BLIND; EFFICACY; ANTIGEN; RECOMMENDATIONS; GUIDELINES; SURVIVAL; PLACEBO; MEN	Purpose To explore the feasibility and efficacy of docetaxel plus prednisone for Chinese population with metastatic castration refractory prostate cancer (mCRPC). Patients and methods A total of 228 patients recruited from 15 centers were randomized to receive 10 cycles of D3P arm (docetaxel: 75 mg/m(2), intravenous infusion, every three weeks; Prednisone 10mg orally given daily) or M3P arm (mitoxantrone: 12 mg/m(2), intravenous infusion, every three weeks; Prednisone 10mg orally given daily). Primary end point was overall survival, and secondary end points were events progression-free survival (PFS), response rate, response duration. Quality of life (QoL) was also assessed in both treatment groups. Results The median overall survival was 21.88 months in D3P arm and 13.67 months in M3P arm (P = 0.0011, hazard ratio = 0.63, 95% confidence interval, 0.46-0.86). Subgroup analysis was consistent with the results of overall analysis. Events progression-free survival (pain, PSA, tumor and disease) were significantly improved in D3P arm compared with M3P arm. PSA response rate was 35.11% for patients treated by D3P arm and 19.39% for M3P arm (P = 0.0155). Pain response rate was higher in D3P arm (61.11%, P = 0.0011) than in M3P (23.08%) arm. No statistical differences were found between D3P arm and M3P arm for QoL, tumor response rate and response duration of PSA and pain. The tolerability and overall safety of D3P arm were generally comparable to that of M3P arm. Conclusions Compared with M3P arm, D3P arm significantly prolonged overall survival for the Chinese patients with mCRPC and improved the response rate for PSA and pain.	[Zhou, Tie; Zeng, Shu-xiong; Sun, Ying-hao] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Ye, Ding-wei] Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Wei, Qiang] Sichuan Univ, Dept Urol, West China Hosp, West China Sch Med, Chengdu 610064, Peoples R China; [Zhang, Xu] Chinese PLA, Sch Med, Chinese PLA Gen Hosp, Dept Urol, Beijing, Peoples R China; [Huang, Yi-ran] Shanghai Jiao Tong Univ, Sch Med, Dept Urol, Renji Hosp, Shanghai 200030, Peoples R China; [Ye, Zhang-qun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China; [Yang, Yong] Peking Univ, Beijing Canc Hosp, Dept Urol, Beijing 100871, Peoples R China; [Zhang, Wei] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Tian, Ye] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing, Peoples R China; [Zhou, Fang-jian] Sun Yat Sen Univ, Canc Hosp, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Jie, Jin] Peking Univ, Hosp 1, Dept Urol, Beijing 100871, Peoples R China; [Chen, Shi-ping] Fujian Union Hosp, Dept Urol, Fuzhou, Peoples R China; [Sun, Yan] Chinese Acad Med Sci, Canc Hosp, Dept Urol, Beijing 100730, Peoples R China; [Xie, Li-ping] Zhejiang Univ, Affiliated Hosp 1, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China; [Yao, Xing] Tianjin Med Univ, Tianjin Canc Hosp, Dept Urol, Tianjin, Peoples R China; [Na, Yan-qun] Peking Univ, Dept Urol, Shougang Hosp, Beijing 100871, Peoples R China	Naval Medical University; Fudan University; Sichuan University; Chinese People's Liberation Army General Hospital; Shanghai Jiao Tong University; Huazhong University of Science & Technology; Peking University; Nanjing Medical University; Capital Medical University; Sun Yat Sen University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Zhejiang University; Tianjin Medical University; Peking University	Sun, YH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Urol, 168 Changhai Rd, Shanghai 200433, Peoples R China.	nayanqun@cuan.com; yinghao.sun@yahoo.com	Xie, li/HGE-6052-2022	Zeng, Shuxiong/0000-0001-7656-9437	Sanofi-Aventis company; Changhai hospital GCP platform [2012ZX09303011-002]	Sanofi-Aventis company(Sanofi-Aventis); Changhai hospital GCP platform	This study was sponsored by Sanofi-Aventis company. The study protocol was designed by Sanofi-Aventis personnel, and reviewed and approved by all the study co-authors. All the centers involved in this study received grants from Sanofi-Aventis for recruiting patients and conducting this clinical trial. The data were collected and maintained by Sanofi-Aventis. The statistical analysis was undertaken by an independent statistical department receiving fees from Sanofi-Aventis, but these results were not seen by Aventis, or the study co-authors, or any other investigators until the study closed. Tie Zhou and Shu-xiong Zeng drafted the manuscript and it was reviewed and approved by the all the coauthors. Sanofi-Aventis also reviewed the manuscript, but its final content was entirely determined by the co-authors. We also appreciate the supports from Changhai hospital GCP platform (2012ZX09303011-002).	Berthold DR, 2008, CLIN CANCER RES, V14, P2763, DOI 10.1158/1078-0432.CCR-07-0944; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Bubley GJ, 1999, J CLIN ONCOL, V17, P3461, DOI 10.1200/JCO.1999.17.11.3461; Chi KN, 2010, J CLIN ONCOL, V28, P4247, DOI 10.1200/JCO.2009.26.8771; El Halim Mohamed Abu Hamar Abd, 2010, Hematol Oncol Stem Cell Ther, V3, P121; Ernst DS, 2003, J CLIN ONCOL, V21, P3335, DOI 10.1200/JCO.2003.03.042; Fujiwara K, 1999, ANTICANCER RES, V19, P639; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Howard Diana N, 2008, J Oncol Pharm Pract, V14, P45, DOI 10.1177/1078155207085387; Kantoff PW, 1999, J CLIN ONCOL, V17, P2506, DOI 10.1200/JCO.1999.17.8.2506; Kelly WK, 2012, J CLIN ONCOL, V30, P1534, DOI 10.1200/JCO.2011.39.4767; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; Lee KH, 2013, CANCER CHEMOTH PHARM, V71, P843, DOI 10.1007/s00280-013-2075-3; Naito S, 2008, JPN J CLIN ONCOL, V38, P365, DOI 10.1093/jjco/hyn029; Olbert PJ, 2006, ANTI-CANCER DRUG, V17, P993, DOI 10.1097/01.cad.0000231468.69535.97; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Polite BN, 2012, CANCER-AM CANCER SOC, V118, P1083, DOI 10.1002/cncr.26394; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Seal BS, 2013, VALUE HEALTH, V16, P872, DOI 10.1016/j.jval.2013.03.1628; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Thatai LC, 2004, UROLOGY, V64, P738, DOI 10.1016/j.urology.2004.05.024; Yap TA, 2011, NAT REV CLIN ONCOL, V8, P597, DOI 10.1038/nrclinonc.2011.117; [叶定伟 YE Dingwei], 2007, [中国癌症杂志, China Oncology], V17, P177; Zhang HL, 2007, UROL INT, V79, P307, DOI 10.1159/000109714	25	19	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117002	10.1371/journal.pone.0117002	http://dx.doi.org/10.1371/journal.pone.0117002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625938	gold, Green Published, Green Submitted			2022-12-27	WOS:000348821400026
J	Klix, S; Els, A; Paul, K; Graessl, A; Oezerdem, C; Weinberger, O; Winter, L; Thalhammer, C; Huelnhagen, T; Rieger, J; Mehling, H; Schulz-Menger, J; Niendorf, T				Klix, Sabrina; Els, Antje; Paul, Katharina; Graessl, Andreas; Oezerdem, Celal; Weinberger, Oliver; Winter, Lukas; Thalhammer, Christof; Huelnhagen, Till; Rieger, Jan; Mehling, Heidrun; Schulz-Menger, Jeanette; Niendorf, Thoralf			On the Subjective Acceptance during Cardiovascular Magnetic Resonance Imaging at 7.0 Tesla	PLOS ONE			English	Article							CORONARY MR-ANGIOGRAPHY; 7 T; STRAY FIELDS; CARDIAC MRI; CMR PROTOCOLS; VITAL SIGNS; COIL ARRAY; EXPOSURE; SYNCHRONIZATION; STIMULATION	Purpose This study examines the subjective acceptance during UHF-CMR in a cohort of healthy volunteers who underwent a cardiac MR examination at 7.0T. Methods Within a period of two-and-a-half years (January 2012 to June 2014) a total of 165 healthy volunteers (41 female, 124 male) without any known history of cardiac disease underwent UHF-CMR. For the assessment of the subjective acceptance a questionnaire was used to examine the participants experience prior, during and after the UHF-CMR examination. For this purpose, subjects were asked to respond to the questionnaire in an exit interview held immediately after the completion of the UHF-CMR examination under supervision of a study nurse to ensure accurate understanding of the questions. All questions were answered with "yes" or "no" including space for additional comments. Results Transient muscular contraction was documented in 12.7% of the questionnaires. Muscular contraction was reported to occur only during periods of scanning with the magnetic field gradients being rapidly switched. Dizziness during the study was reported by 12.7% of the subjects. Taste of metal was reported by 10.1% of the study population. Light flashes were reported by 3.6% of the entire cohort. 13% of the subjects reported side effects/observations which were not explicitly listed in the questionnaire but covered by the question about other side effects. No severe side effects as vomiting or syncope after scanning occurred. No increase in heart rate was observed during the UHF-CMR exam versus the baseline clinical examination. Conclusions This study adds to the literature by detailing the subjective acceptance of cardiovascular magnetic resonance imaging examinations at a magnetic field strength of 7.0T. Cardiac MR examinations at 7.0T are well tolerated by healthy subjects. Broader observational and multi-center studies including patient cohorts with cardiac diseases are required to gain further insights into the subjective acceptance of UHF-CMR examinations.	[Klix, Sabrina; Els, Antje; Paul, Katharina; Graessl, Andreas; Oezerdem, Celal; Weinberger, Oliver; Winter, Lukas; Thalhammer, Christof; Huelnhagen, Till; Rieger, Jan; Niendorf, Thoralf] Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany; [Mehling, Heidrun; Schulz-Menger, Jeanette; Niendorf, Thoralf] ECRC, Berlin, Germany; [Schulz-Menger, Jeanette] HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helios Kliniken	Niendorf, T (corresponding author), Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany.	Thoralf.Niendorf@mdc-berlin.de	Niendorf, Thoralf/H-7738-2013	Niendorf, Thoralf/0000-0001-7584-6527; Winter, Lukas/0000-0002-4381-275X; Huelnhagen, Till/0000-0002-6755-2171; Schulz-Menger, Jeanette/0000-0003-3100-1092	DZHK (German Centre for Cardiovascular Research); BMBF (Federal Ministry of Education and Research); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (ICEMED-Project) [1210251]; BMBF (Federal Ministry of Education and Research, "KMU-innovativ": Medizintechnik) [MED-373-046]	DZHK (German Centre for Cardiovascular Research); BMBF (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (ICEMED-Project); BMBF (Federal Ministry of Education and Research, "KMU-innovativ": Medizintechnik)(Federal Ministry of Education & Research (BMBF))	This work was supported (in part, C.O.) by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (Federal Ministry of Education and Research). This work was funded (in part, A.G.) by the Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (ICEMED-Project 1210251). L.W. received support by the BMBF (Federal Ministry of Education and Research, "KMU-innovativ": Medizintechnik MED-373-046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HEALTH PHYSICS, V14, P8; Atkinson IC, 2007, J MAGN RESON IMAGING, V26, P1222, DOI 10.1002/jmri.21150; Atkinson IC, 2010, J MAGN RESON IMAGING, V32, P82, DOI 10.1002/jmri.22221; Becker M, 2010, EUR RADIOL, V20, P1344, DOI 10.1007/s00330-009-1676-z; Bizino MB, 2014, INVEST RADIOL, V49, P326, DOI 10.1097/RLI.0000000000000047; Brandts A, 2010, MAGN RESON MED, V64, P1472, DOI 10.1002/mrm.22529; Chakeres DW, 2005, PROG BIOPHYS MOL BIO, V87, P255, DOI 10.1016/j.pbiomolbio.2004.08.012; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; COREA J, 2012, BESPOKE COILS SCREEN, P434; Cosottini M, 2014, EUR RADIOL, V24, P1923, DOI 10.1007/s00330-014-3177-y; Crozier S, 2007, J MAGN RESON IMAGING, V26, P1236, DOI 10.1002/jmri.21162; Dieringer MA, 2011, J MAGN RESON IMAGING, V33, P736, DOI 10.1002/jmri.22451; Faber SC, 2003, MAGN RESON IMAGING, V21, P715, DOI 10.1016/S0730-725X(03)00106-1; Frauenrath T, 2008, ACTA ACUST UNITED AC, V94, P148, DOI 10.3813/AAA.918017; Frauenrath T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-67; Frauenrath T, 2009, INVEST RADIOL, V44, P539, DOI 10.1097/RLI.0b013e3181b4c15e; Gilles M, 2013, STRESS, V16, P172, DOI 10.3109/10253890.2012.708949; Glover PM, 2007, BIOELECTROMAGNETICS, V28, P349, DOI 10.1002/bem.20316; GRAESSL A, 2013, 2 DIMENSIONAL 16 CHA, P136; Graessl A, 2014, MAGN RESON MED, V72, P276, DOI 10.1002/mrm.24903; Grassl A, 2013, EUR J RADIOL, V82, P752, DOI 10.1016/j.ejrad.2011.08.002; HEILMAIER C, 2011, BIOELECTROMAGNETICS, DOI DOI 10.1002/BEM.20695; Heinrich A, 2014, NEUROREPORT, V25, P1081, DOI 10.1097/WNR.0000000000000225; Heinrich A, 2013, RADIOLOGY, V266, P236, DOI 10.1148/radiol.12112172; Hezel F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052324; *IEC, 2010, 60601 2 33 MEDICAL E; Kraff O, 2015, J MAGN RESON IMAGING, V41, P13, DOI 10.1002/jmri.24573; Kramer CM, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-91; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Lattanzi R, 2012, MAGN RESON MED, V68, P286, DOI 10.1002/mrm.23198; Meloni A, 2014, MAGN RESON MED, V71, P2224, DOI 10.1002/mrm.24856; Mian OS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078748; Niendorf T, 2013, RADIOLOGE, V53, P422, DOI 10.1007/s00117-012-2348-6; Niendorf T, 2013, J MAGN RESON, V229, P208, DOI 10.1016/j.jmr.2012.11.015; Niendorf T, 2010, EUR RADIOL, V20, P2806, DOI 10.1007/s00330-010-1902-8; Rauschenberg J, 2014, INVEST RADIOL, V49, P249, DOI 10.1097/RLI.0000000000000035; RESETAR A, 2014, RETROSPECTIVELY GATE, P436; Roberts DC, 2011, CURR BIOL, V21, P1635, DOI 10.1016/j.cub.2011.08.029; Rodgers CT, 2014, MAGN RESON MED, V72, P304, DOI 10.1002/mrm.24922; Rodgers CT, 2013, MAGN RESON MED, V70, P1038, DOI 10.1002/mrm.24548; RUEHLE A, 2012, SODIUM IMAGING OF TH, P82; Schaap K, 2014, OCCUP ENVIRON MED, V71, P423, DOI 10.1136/oemed-2013-101890; Schlamann M, 2010, J MAGN RESON IMAGING, V31, P1061, DOI 10.1002/jmri.22065; Schlamann M, 2010, ACAD RADIOL, V17, P277, DOI 10.1016/j.acra.2009.10.004; Suttie JJ, 2012, NMR BIOMED, V25, P27, DOI 10.1002/nbm.1708; TAO Y, 2014, MAGN RESON MED, DOI DOI 10.1002/MRM.25522; Thalhammer C, 2012, J MAGN RESON IMAGING, V36, P847, DOI 10.1002/jmri.23724; Theysohn JM, 2008, MAGN RESON MATER PHY, V21, P63, DOI 10.1007/s10334-007-0095-x; Theysohn JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092104; Thormann M, 2013, EUR J RADIOL, V82, P768, DOI 10.1016/j.ejrad.2011.08.001; UWANO I, 2014, MAGN RESON MED SCI; van Elderen SGC, 2009, MAGN RESON MED, V62, P1379, DOI 10.1002/mrm.22168; van Elderen SGC, 2010, RADIOLOGY, V257, P254, DOI 10.1148/radiol.100615; van Nierop LE, 2013, MAGN RESON MED, V70, P232, DOI 10.1002/mrm.24454; van Nierop LE, 2012, OCCUP ENVIRON MED, V69, P759, DOI 10.1136/oemed-2011-100468; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Versluis MJ, 2013, J MAGN RESON IMAGING, V38, P722, DOI 10.1002/jmri.23904; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-23; von Knobelsdorff-Brenkenhoff F, 2010, EUR RADIOL, V20, P2844, DOI 10.1007/s00330-010-1888-2; Ward BK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00028; WINTER L, 2014, MAGN RESON MED; Winter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061661; Winter L, 2012, EUR RADIOL, V22, P2211, DOI 10.1007/s00330-012-2487-1; Ziegelberger G, 2009, HEALTH PHYS, V97, P259, DOI 10.1097/HP.0b013e3181aff9eb	65	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117095	10.1371/journal.pone.0117095	http://dx.doi.org/10.1371/journal.pone.0117095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621491	Green Published, gold, Green Accepted			2022-12-27	WOS:000348470400018
J	Toyono, T; Usui, T; Yokoo, S; Taketani, Y; Nakagawa, S; Kuroda, M; Yamagami, S; Amano, S				Toyono, Tetsuya; Usui, Tomohiko; Yokoo, Seiichi; Taketani, Yukako; Nakagawa, Suguru; Kuroda, Masahiko; Yamagami, Satoru; Amano, Shiro			Angiopoietin-Like 7 Is an Anti-Angiogenic Protein Required to Prevent Vascularization of the Cornea	PLOS ONE			English	Article							TRABECULAR MESHWORK CELLS; KERATOCYTE PHENOTYPE; INFLAMMATION; SUPPRESSION; GLAUCOMA; GENE; BETA	Purpose We sought to identify the anti-angiogenic molecule expressed in corneal keratocytes that is responsible for maintaining the avascularity of the cornea. Methods Human umbilical vein endothelial cells (HUVECs) were cultured with either human dermal fibroblasts or with human corneal keratocytes under serum-free conditions. The areas that exhibited blood vessel formation were estimated by immunostaining the cultures with an antitibody against CD31, a blood vessel marker. We also performed microarray geneexpression analysis and selected one molecule, angiopoietin-like 7 (ANGPTL7) for further functional studies conducted with the keratocytes and in vivo in mice. Results Areas showing blood vessel formation in normal serum-free medium were conditions were markedly smaller when HUVECs were co-cultured with corneal keratocytes than when they were co-cultured with the dermal fibroblasts under the same conditions. Microarray analysis revealed that ANGPTL7 expression was higher in keratocytes than in dermal fibroblasts. In vitro, inhibiting ANGPTL7 expression by using a specific siRNA led to greater tube formation than did the transfection of cells with a control siRNA, and this increase in tube formation was abolished when recombinant ANGPTL7 protein was added to the cultures. In vivo, intrastromal injections of an ANGPTL7 PshRNA into the avascular corneal stroma of mice resulted in the growth of blood vessels. Conclusions ANGPTL7, which is abundantly expressed in keratocytes, plays a major role in maintaining corneal avascularity and transparency.	[Toyono, Tetsuya; Usui, Tomohiko; Yokoo, Seiichi; Taketani, Yukako; Nakagawa, Suguru; Yamagami, Satoru; Amano, Shiro] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan; [Kuroda, Masahiko] Tokyo Med Univ, Dept Pathol, Tokyo 1608402, Japan	University of Tokyo; Tokyo Medical University	Usui, T (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	tomohiko-tky@umin.ac.jp		taketani, yukako/0000-0001-6424-3579	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Azar D, 2008, CURR EYE RES, V33, P954, DOI 10.1080/02713680802461106; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Bouis D, 2006, PHARMACOL RES, V53, P89, DOI 10.1016/j.phrs.2005.10.006; Bouis DRMH, 2007, ANTICANCER RES, V27, P2325; Choudhary A, 2005, MOL VIS, V11, P163; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200; Guo L, 2014, INFLAMM RES, V63, P13, DOI 10.1007/s00011-013-0678-0; Hamasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042655; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hos D, 2011, ARCH OPHTHALMOL-CHIC, V129, P445, DOI 10.1001/archophthalmol.2011.42; Kawakita T, 2006, INVEST OPHTH VIS SCI, V47, P1918, DOI 10.1167/iovs.05-1040; Kroon Marielle E., 2002, Angiogenesis, V5, P257, DOI 10.1023/A:1024540701634; Kuchtey J, 2008, INVEST OPHTH VIS SCI, V49, P3438, DOI 10.1167/iovs.07-1347; Lo WR, 2003, INVEST OPHTH VIS SCI, V44, P473, DOI 10.1167/iovs.02-0444; Nakao S, 2012, INVEST OPHTH VIS SCI, V53, P4323, DOI 10.1167/iovs.11-9119; Peek R, 2002, J BIOL CHEM, V277, P686, DOI 10.1074/jbc.M105746200; Peek R, 1998, INVEST OPHTH VIS SCI, V39, P1782; Rozsa FW, 2006, MOL VIS, V12, P125; Sakai R, 2002, INVEST OPHTH VIS SCI, V43, P1749; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Toyono T, 2013, INVEST OPHTH VIS SCI, V54, P4278, DOI 10.1167/iovs.12-11497; Yamagami S, 2007, OPHTHALMOLOGY, V114, P433, DOI 10.1016/j.ophtha.2006.07.042; Zhao XJ, 2004, INVEST OPHTH VIS SCI, V45, P4023, DOI 10.1167/iovs.04-0535	25	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116838	10.1371/journal.pone.0116838	http://dx.doi.org/10.1371/journal.pone.0116838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622036	Green Published, gold, Green Submitted			2022-12-27	WOS:000348470400008
J	Manzo, G; Scorciapino, MA; Wadhwani, P; Buck, J; Montaldo, NP; Pintus, M; Sanna, R; Casu, M; Giuliani, A; Pirri, G; Luca, V; Ulrich, AS; Rinaldi, AC				Manzo, Giorgia; Scorciapino, Mariano A.; Wadhwani, Parvesh; Buerck, Jochen; Montaldo, Nicola Pietro; Pintus, Manuela; Sanna, Roberta; Casu, Mariano; Giuliani, Andrea; Pirri, Giovanna; Luca, Vincenzo; Ulrich, Anne S.; Rinaldi, Andrea C.			Enhanced Amphiphilic Profile of a Short beta-Stranded Peptide Improves Its Antimicrobial Activity	PLOS ONE			English	Article							F-19 NMR LABEL; CIRCULAR-DICHROISM; DENDRIMERIC PEPTIDE; MEMBRANES; PGLA; SPECTROSCOPY; AGGREGATION	SB056 is a novel semi-synthetic antimicrobial peptide with a dimeric dendrimer scaffold. Active against both Gram-negative and -positive bacteria, its mechanism has been attributed to a disruption of bacterial membranes. The branched peptide was shown to assume a beta-stranded conformation in a lipidic environment. Here, we report on a rational modification of the original, empirically derived linear peptide sequence [WKKIRVRLSA-NH2, SB056-lin]. We interchanged the first two residues [KWKIRVRLSA-NH2, beta-SB056-lin] to enhance the amphipathic profile, in the hope that a more regular beta-strand would lead to a better antimicrobial performance. MIC values confirmed that an enhanced amphiphilic profile indeed significantly increases activity against both Gram-positive and -negative strains. The membrane binding affinity of both peptides, measured by tryptophan fluorescence, increased with an increasing ratio of negatively charged/zwitterionic lipids. Remarkably, beta-SB056- lin showed considerable binding even to purely zwitterionic membranes, unlike the original sequence, indicating that besides electrostatic attraction also the amphipathicity of the peptide structure plays a fundamental role in binding, by stabilizing the bound state. Synchrotron radiation circular dichroism and solid-state F-19-NMR were used to characterize and compare the conformation and mobility of the membrane bound peptides. Both SB056-lin and beta-SB056- lin adopt a beta-stranded conformation upon binding POPC vesicles, but the former maintains an intrinsic structural disorder that also affects its aggregation tendency. Upon introducing some anionic POPG into the POPC matrix, the sequence-optimized beta-SB056- lin forms well-ordered beta-strands once electro-neutrality is approached, and it aggregates into more extended beta-sheets as the concentration of anionic lipids in the bilayer is raised. The enhanced antimicrobial activity of the analogue correlates with the formation of these extended beta-sheets, which also leads to a dramatic alteration of membrane integrity as shown by P-31-NMR. These findings are generally relevant for the design and optimization of other membrane-active antimicrobial peptides that can fold into amphipathic beta-strands.	[Manzo, Giorgia; Scorciapino, Mariano A.; Sanna, Roberta; Casu, Mariano] Univ Cagliari, Dept Chem & Geol Sci, I-09042 Monserrato, CA, Italy; [Wadhwani, Parvesh; Buerck, Jochen; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, D-76021 Karlsruhe, Germany; [Montaldo, Nicola Pietro; Pintus, Manuela; Rinaldi, Andrea C.] Univ Cagliari, Dept Biomed Sci, I-09042 Monserrato, CA, Italy; [Giuliani, Andrea; Pirri, Giovanna] Spider Biotech Srl, Res & Dev Unit, I-10010 Colleretto Giacosa, TO, Italy; [Luca, Vincenzo] Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Organ Chem, D-76131 Karlsruhe, Germany	University of Cagliari; Helmholtz Association; Karlsruhe Institute of Technology; University of Cagliari; Fondazione Cenci Bolognetti; Sapienza University Rome; Helmholtz Association; Karlsruhe Institute of Technology	Rinaldi, AC (corresponding author), Univ Cagliari, Dept Biomed Sci, I-09042 Monserrato, CA, Italy.	rinaldi@unica.it	LUCA, Vincenzo/AAV-7385-2020; Scorciapino, Mariano Andrea/AAD-1256-2020; Montaldo, Nicola Pietro/GXV-6132-2022; Rinaldi, Andrea/N-1007-2019; Ulrich, Anne S./H-5519-2013	LUCA, Vincenzo/0000-0002-7834-0334; Montaldo, Nicola Pietro/0000-0003-3434-615X; Rinaldi, Andrea/0000-0002-9352-1037; Wadhwani, Parvesh/0000-0002-7290-5154; SCORCIAPINO, MARIANO ANDREA/0000-0001-7502-7265; Ulrich, Anne S./0000-0001-5571-9483	Sardinia Regional Government [CRP-17385]; Italian Ministry of Education, University and Research (MIUR); Sardinia Regional Government; Operational Programme of the Autonomous Region of Sardinia, European Social Fund	Sardinia Regional Government(Regione Sardegna); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Sardinia Regional Government(Regione Sardegna); Operational Programme of the Autonomous Region of Sardinia, European Social Fund	ACR is the recipient of a grant from the Sardinia Regional Government (www.regione.sardegna. it/), L.R. 7/2007, bando 2009, grant number: CRP-17385. The Italian Ministry of Education, University and Research (MIUR) is acknowledged for a fellowship to MAS. The Sardinia Regional Government is acknowledged for the Ph.D. scholarship provided to GM (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013). The Ordine Nazionale dei Biologi is acknowledged for the fellowship provided to VL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonin S, 2003, CHEMBIOCHEM, V4, P1151, DOI 10.1002/cbic.200300568; Afonin S, 2008, J AM CHEM SOC, V130, P16512, DOI 10.1021/ja803156d; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Blazyk J, 2001, J BIOL CHEM, V276, P27899, DOI 10.1074/jbc.M102865200; Borges A. Rosa, 2005, Current Drug Targets - Infectious Disorders, V5, P247, DOI 10.2174/1568005054880127; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; Bruschi M, 2010, PEPTIDES, V31, P1459, DOI 10.1016/j.peptides.2010.04.022; Burck J, 2014, JOURNAL OF SYNCHROTR; BUSTAMANTE C, 1983, P NATL ACAD SCI-BIOL, V80, P3568, DOI 10.1073/pnas.80.12.3568; Christiaens B, 2002, EUR J BIOCHEM, V269, P2918, DOI 10.1046/j.1432-1033.2002.02963.x; Clarke DT, 2004, J SYNCHROTRON RADIAT, V11, P142, DOI 10.1107/S0909049503024142; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; Epand RF, 2006, PROTEIN PEPTIDE LETT, V13, P1, DOI 10.2174/092986606774502063; Epand RM, 2009, MOL BIOSYST, V5, P580, DOI 10.1039/b900278m; Giuliani A, 2008, CELL MOL LIFE SCI, V65, P2450, DOI 10.1007/s00018-008-8188-x; Giuliani A, 2011, CELL MOL LIFE SCI, V68, P2255, DOI 10.1007/s00018-011-0717-3; Glaser RW, 2004, J MAGN RESON, V168, P153, DOI 10.1016/j.jmr.2004.02.008; Grage S, 2005, NMR SPECTROSCOPY BIO, P215; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Maisch D, 2009, J AM CHEM SOC, V131, P15596, DOI 10.1021/ja9067595; Meier M, 2008, J AM CHEM SOC, V130, P1017, DOI 10.1021/ja077231r; Melo MN, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00236; Mikhailiuk PK, 2006, ANGEW CHEM INT EDIT, V45, P5659, DOI 10.1002/anie.200600346; Miles AJ, 2006, CHEM SOC REV, V35, P39, DOI 10.1039/b316168b; Mintzer MA, 2012, MOL PHARMACEUT, V9, P342, DOI 10.1021/mp2005033; Mykhailiuk PK, 2010, J FLUORINE CHEM, V131, P217, DOI 10.1016/j.jfluchem.2009.10.004; Opar A, 2007, NAT REV DRUG DISCOV, V6, P943, DOI 10.1038/nrd2477; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pini A, 2005, ANTIMICROB AGENTS CH, V49, P2665, DOI 10.1128/AAC.49.7.2665-2672.2005; Rotem S, 2009, BBA-BIOMEMBRANES, V1788, P1582, DOI 10.1016/j.bbamem.2008.10.020; Sadler Kristen, 2002, J Biotechnol, V90, P195; Salwiczek M, 2010, AMINO ACIDS, V39, P1589, DOI 10.1007/s00726-010-0581-8; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Scorciapino MA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00171; Scorciapino MA, 2012, BIOPHYS J, V102, P1039, DOI 10.1016/j.bpj.2012.01.048; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shaw N, 1974, Adv Appl Microbiol, V17, P63, DOI 10.1016/S0065-2164(08)70555-0; Strandberg E, 2004, CONCEPT MAGN RESON A, V23A, P89, DOI 10.1002/cmr.a.20024; Strandberg E, 2008, BIOCHEMISTRY-US, V47, P2601, DOI 10.1021/bi701944r; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Tew GN, 2010, ACCOUNTS CHEM RES, V43, P30, DOI 10.1021/ar900036b; Tkachenko AN, 2013, ANGEW CHEM INT EDIT, V52, P1486, DOI 10.1002/anie.201208069; Ulrich AS, 2005, PROG NUCL MAG RES SP, V46, P1, DOI 10.1016/j.pnmrs.2004.11.001; Wadhwani P, 2012, BIOPHYS J, V103, P265, DOI 10.1016/j.bpj.2012.06.004; Wadhwani P, 2013, PHYS CHEM CHEM PHYS, V15, P8962, DOI 10.1039/c3cp50896j; Wadhwani P, 2012, J AM CHEM SOC, V134, P6512, DOI 10.1021/ja301328f; Wadhwani P, 2012, EUR BIOPHYS J BIOPHY, V41, P177, DOI 10.1007/s00249-011-0771-7; Wadhwani P, 2008, J AM CHEM SOC, V130, P16515, DOI 10.1021/ja804928q; Wallace BA, 2010, BIOCHEM SOC T, V38, P861, DOI 10.1042/BST0380861; Wallace BA, 2009, Q REV BIOPHYS, V42, P317, DOI 10.1017/S003358351000003X; WALLACE BA, 1987, BIOCHEMISTRY-US, V26, P65, DOI 10.1021/bi00375a010; Wallace BA, 2009, MODERN TECHNIQUES FO; Wien F, 2005, APPL SPECTROSC, V59, P1109, DOI 10.1366/0003702055012546; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao HX, 2002, J BIOL CHEM, V277, P25170, DOI 10.1074/jbc.M203186200; [No title captured]	57	44	44	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116379	10.1371/journal.pone.0116379	http://dx.doi.org/10.1371/journal.pone.0116379			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617899	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000014
J	Sullivan, CB; Diggle, MA; Davies, RL; Clarke, SC				Sullivan, Christopher B.; Diggle, Mathew A.; Davies, Robert L.; Clarke, Stuart C.			Clonal Analysis of Meningococci during a 26 Year Period Prior to the Introduction of Meningococcal Serogroup C Vaccines	PLOS ONE			English	Article							SIAD PCR ELISA; NEISSERIA-MENINGITIDIS; CONJUGATE VACCINES; DISEASE; ENGLAND; IDENTIFICATION; CONFIRMATION; AUTOMATION; EUROPE; IMPACT	Meningococcal disease remains a public health burden in the UK and elsewhere. Invasive Neisseria meningitidis, isolated in Scotland between 1972 and 1998, were characterised retrospectively to examine the serogroup and clonal structure of the circulating population. 2607 isolates causing invasive disease were available for serogroup and MLST analysis whilst 2517 were available for multilocus sequence typing (MLST) analysis only. Serogroup distribution changed from year to year but serogroups B and C were dominant throughout. Serogroup B was dominant throughout the 1970s and early 1980s until serogroup C became dominant during the mid-1980s. The increase in serogroup C was not associated with one particular sequence type (ST) but was associated with a number of STs, including ST-8, ST11, ST-206 and ST-334. This is in contrast to the increase in serogroup C disease seen in the 1990s that was due to expansion of the ST-11 clonal complex. While there was considerable diversity among the isolates (309 different STs among the 2607 isolates), a large proportion of isolates (59.9%) were associated with only 10 STs. These data highlight meningococcal diversity over time and the need for ongoing surveillance during the introduction of new meningococcal vaccines.	[Sullivan, Christopher B.; Diggle, Mathew A.; Clarke, Stuart C.] Scottish Haemophilus Legionella Meningococcus & P, Glasgow, Lanark, Scotland; [Davies, Robert L.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Clarke, Stuart C.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Clarke, Stuart C.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Diggle, Mathew A.] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Dept Clin Microbiol, Nottingham, England	University of Glasgow; University of Southampton; University of Southampton; Nottingham University Hospital NHS Trust; University of Nottingham	Clarke, SC (corresponding author), Scottish Haemophilus Legionella Meningococcus & P, Glasgow, Lanark, Scotland.	s.c.clarke@southampton.ac.uk	Diggle, Mathew/V-7678-2019	Diggle, Mathew/0000-0001-5773-0686	Chief Scientist's Office of the Scottish Executive [CZB/4/28]	Chief Scientist's Office of the Scottish Executive	This work was funded by the Chief Scientist's Office of the Scottish Executive (grant number CZB/4/28) awarded to SCC, MAD and RLD. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1995, TRENDS MICROBIOL, V3, P186, DOI 10.1016/S0966-842X(00)88918-0; Borrow R, 1998, FEMS MICROBIOL LETT, V159, P209, DOI 10.1111/j.1574-6968.1998.tb12862.x; Borrow R, 1997, EPIDEMIOL INFECT, V118, P111, DOI 10.1017/S0950268896007261; Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; CAUGANT DA, 1986, P NATL ACAD SCI USA, V83, P4927, DOI 10.1073/pnas.83.13.4927; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; Diggle MA, 2005, J CLIN MICROBIOL, V43, P4649, DOI 10.1128/JCM.43.9.4649-4653.2005; Diggle MA, 2003, J CLIN MICROBIOL, V41, P1766, DOI 10.1128/JCM.41.4.1766-1768.2003; Diggle MA, 2002, BRIT J BIOMED SCI, V59, P137, DOI 10.1080/09674845.2002.11783649; Diggle MA, 2002, J MOL MICROB BIOTECH, V4, P515; ELDRIDGE J, 1978, MED LAB SCI, V35, P63; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Ibarz-Pavon AB, 2011, J INFECT DIS, V204, P1046, DOI 10.1093/infdis/jir466; JONES DM, 1990, J INFECTION, V21, P21, DOI 10.1016/0163-4453(90)90577-U; Ladhani SN, 2012, VACCINE, V30, P3710, DOI 10.1016/j.vaccine.2012.03.011; Ladhani SN, 2012, EMERG INFECT DIS, V18, P63, DOI 10.3201/eid1801.110901; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 1999, LANCET, V354, P615, DOI 10.1016/S0140-6736(99)00252-4; Martin NG, 2013, EXPERT REV VACCINES, V12, P837, DOI 10.1586/14760584.2013.814862; Mooney JD, 2004, CLIN INFECT DIS, V39, P349, DOI 10.1086/421947; Sullivan CB, 2006, MOL BIOTECHNOL, V32, P219, DOI 10.1385/MB:32:3:219; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P101, DOI 10.1111/j.1574-6976.2006.00053.x; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P27, DOI 10.1111/j.1574-6976.2006.00060.x	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e115741	10.1371/journal.pone.0115741	http://dx.doi.org/10.1371/journal.pone.0115741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615448	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000349122100015
J	Wang, F; Ouyang, G; Zhou, CS; Wang, SP				Wang, Fang; Ouyang, Guang; Zhou, Changsong; Wang, Suiping			Re-Examination of Chinese Semantic Processing and Syntactic Processing: Evidence from Conventional ERPs and Reconstructed ERPs by Residue Iteration Decomposition (RIDE)	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SENTENCE COMPREHENSION; EYE-MOVEMENTS; TIME-COURSE; THEMATIC RELATIONSHIPS; BRAIN RESPONSES; INTEGRATION; VIOLATIONS; FORM; INDEPENDENCE	A number of studies have explored the time course of Chinese semantic and syntactic processing. However, whether syntactic processing occurs earlier than semantics during Chinese sentence reading is still under debate. To further explore this issue, an event-related potentials (ERPs) experiment was conducted on 21 native Chinese speakers who read individually-presented Chinese simple sentences (NP1+VP+NP2) word-by-word for comprehension and made semantic plausibility judgments. The transitivity of the verbs was manipulated to form three types of stimuli: congruent sentences (CON), sentences with a semantically violated NP2 following a transitive verb (semantic violation, SEM), and sentences with a semantically violated NP2 following an intransitive verb (combined semantic and syntactic violation, SEM+SYN). The ERPs evoked from the target NP2 were analyzed by using the Residue Iteration Decomposition (RIDE) method to reconstruct the ERP waveform blurred by trial-to-trial variability, as well as by using the conventional ERP method based on stimulus-locked averaging. The conventional ERP analysis showed that, compared with the critical words in CON, those in SEM and SEM+SYN elicited an N400-P600 biphasic pattern. The N400 effects in both violation conditions were of similar size and distribution, but the P600 in SEM+SYN was bigger than that in SEM. Compared with the conventional ERP analysis, RIDE analysis revealed a larger N400 effect and an earlier P600 effect (in the time window of 500-800 ms instead of 570-810ms). Overall, the combination of conventional ERP analysis and the RIDE method for compensating for trial-to-trial variability confirmed the non-significant difference between SEM and SEM+SYN in the earlier N400 time window. Converging with previous findings on other Chinese structures, the current study provides further precise evidence that syntactic processing in Chinese does not occur earlier than semantic processing.	[Wang, Fang; Wang, Suiping] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Wang, Fang; Wang, Suiping] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Wang, Fang; Wang, Suiping] S China Normal Univ, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Ouyang, Guang; Zhou, Changsong] Hong Kong Baptist Univ, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China; [Ouyang, Guang; Zhou, Changsong] Hong Kong Baptist Univ, Ctr Nonlinear Studies, Kowloon Tong, Hong Kong, Peoples R China; [Ouyang, Guang; Zhou, Changsong] Hong Kong Baptist Univ, Beijing Hong Kong Singapore Joint Ctr Nonlinear &, Inst Computat & Theoret Studies, Kowloon Tong, Hong Kong, Peoples R China	South China Normal University; South China Normal University; South China Normal University; Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University	Wang, SP (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	suiping@scnu.edu.cn	wang, fang/GYD-4295-2022	Zhou, Changsong/0000-0002-4130-0216; Wang, Suiping/0000-0001-8726-169X; Ouyang, Guang/0000-0001-8939-7443	Natural Science Foundation of China [NSF 31271086]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	This work was funded by grants from the Natural Science Foundation of China (NSF 31271086) and Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS 2011) to Suiping Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornkessel-Schlesewsky I, 2011, BRAIN LANG, V117, P133, DOI 10.1016/j.bandl.2010.09.010; Braze D, 2002, J PSYCHOLINGUIST RES, V31, P25, DOI 10.1023/A:1014324220455; Chen HC, 1999, LANG COGNITIVE PROC, V14, P425, DOI 10.1080/016909699386130; Chen S, 1998, APHASIOLOGY, V12, P5, DOI 10.1080/02687039808249441; Chow WY, 2013, BRAIN RES, V1506, P76, DOI 10.1016/j.brainres.2013.02.016; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Fiebach CJ, 2002, J MEM LANG, V47, P250, DOI 10.1016/S0749-596X(02)00004-9; Friederici AD, 2004, NEUROREPORT, V15, P165, DOI 10.1097/00001756-200401190-00032; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friederici AD, 2000, J MEM LANG, V43, P476, DOI 10.1006/jmla.2000.2709; Friederici AD, 2007, BRAIN RES, V1146, P50, DOI 10.1016/j.brainres.2006.08.038; Frisch S, 2004, COGNITION, V91, P191, DOI 10.1016/j.cognition.2003.09.009; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; Hagoort P, 2003, J COGNITIVE NEUROSCI, V15, P883, DOI 10.1162/089892903322370807; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kuperberg GR, 2007, BRAIN LANG, V100, P223, DOI 10.1016/j.bandl.2005.12.006; Kuperberg GR, 2006, LANG COGNITIVE PROC, V21, P489, DOI 10.1080/01690960500094279; Kuperberg GR, 2003, COGNITIVE BRAIN RES, V17, P117, DOI 10.1016/S0926-6410(03)00086-7; Liu Y, 2007, BRAIN LANG, V103, P75, DOI 10.1016/j.bandl.2007.07.052; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1999, LANG COGNITIVE PROC, V14, P283, DOI 10.1080/016909699386310; Ouyang G., 2011, PSYCHOPHYSIOLOGY, V48, P1631, DOI [10.1111/j.1469-8986.2011.01269.x, DOI 10.1111/J.1469-8986.2011.01269.X]; Ouyang G, 2013, PSYCHOPHYSIOLOGY, V50, P253, DOI 10.1111/psyp.12004; Proverbio AM, 2009, NEUROSCI LETT, V459, P142, DOI 10.1016/j.neulet.2009.05.012; RAYNER K, 1983, J VERB LEARN VERB BE, V22, P358, DOI 10.1016/S0022-5371(83)90236-0; Rosler F, 1993, COGNITIVE NEUROSCIEN, V5, P345, DOI [10.1162/jocn.1993.5.3.345, DOI 10.1162/JOCN.1993.5.3.345]; Sitnikova T, 2008, J COGNITIVE NEUROSCI, V20, P2037, DOI 10.1162/jocn.2008.20143; Steinhauer K, 2012, BRAIN LANG, V120, P135, DOI 10.1016/j.bandl.2011.07.001; Sturmer B, 2013, PSYCHOPHYSIOLOGY, V50, P70, DOI 10.1111/j.1469-8986.2012.01479.x; TANENHAUS MK, 1989, J PSYCHOLINGUIST RES, V18, P37, DOI 10.1007/BF01069045; Verleger R, 2014, NEUROIMAGE, V100, P271, DOI 10.1016/j.neuroimage.2014.06.036; Wang S, 2013, LANG COGNITIVE PROC, P1; Wang SP, 2008, NEUROPSYCHOLOGIA, V46, P1371, DOI 10.1016/j.neuropsychologia.2007.12.020; Yang JM, 2009, MEM COGNITION, V37, P1164, DOI 10.3758/MC.37.8.1164; Ye Z, 2006, BRAIN RES, V1071, P186, DOI 10.1016/j.brainres.2005.11.085; Ye Z, 2007, BRAIN RES, V1142, P135, DOI 10.1016/j.brainres.2007.01.030; Yu J, 2008, NEUROREPORT, V19, P745, DOI 10.1097/WNR.0b013e3282fda21d; Zhang YX, 2008, NEUROREPORT, V19, P1039, DOI 10.1097/WNR.0b013e328302f14f; Zhang YX, 2013, BRAIN LANG, V126, P8, DOI 10.1016/j.bandl.2013.04.001; Zhang YX, 2010, J EXP PSYCHOL LEARN, V36, P765, DOI 10.1037/a0019254; Zhou DX, 2009, LANG COGNITIVE PROC, V24, P929; Zhou XL, 2010, NEUROPSYCHOLOGIA, V48, P1551, DOI 10.1016/j.neuropsychologia.2010.02.001	48	19	20	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117324	10.1371/journal.pone.0117324	http://dx.doi.org/10.1371/journal.pone.0117324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25615600	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100061
J	Fernandez, EM; Diaz-Ceso, MD; Vilar, M				Fernandez, Eva M.; Diaz-Ceso, Maria D.; Vilar, Marcal			Brain Expressed and X-Linked (Bex) Proteins Are Intrinsically Disordered Proteins (IDPs) and Form New Signaling Hubs	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; P75 NEUROTROPHIN RECEPTOR; GENOME-WIDE ANALYSIS; CELL-DEATH EXECUTOR; COILED-COIL DOMAINS; IDENTIFIES BEX1; PREDICTION; REGIONS; FAMILY; NADE	Intrinsically disordered proteins (IDPs) are abundant in complex organisms. Due to their promiscuous nature and their ability to adopt several conformations IDPs constitute important points of network regulation. The family of Brain Expressed and X-linked (Bex) proteins consists of 5 members in humans (Bex1-5). Recent reports have implicated Bex proteins in transcriptional regulation and signaling pathways involved in neurodegeneration, cancer, cell cycle and tumor growth. However, structural and biophysical data for this protein family is almost non-existent. We used bioinformatics analyses to show that Bex proteins contain long regions of intrinsic disorder which are conserved across all members. Moreover, we confirmed the intrinsic disorder by circular dichroism spectroscopy of Bex1 after expression and purification in E. coli. These observations strongly suggest that Bex proteins constitute a new group of IDPs. Based on these findings, together with the demonstrated promiscuity of Bex proteins and their involvement in different signaling pathways, we propose that Bex family members play important roles in the formation of protein network hubs.	[Fernandez, Eva M.; Diaz-Ceso, Maria D.; Vilar, Marcal] Spanish Inst Hlth Carlos III ISCIII, Lab Neurodegenerat, Chron Dis Program UFIEC, Madrid, Spain	Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC)	Vilar, M (corresponding author), Spanish Inst Hlth Carlos III ISCIII, Lab Neurodegenerat, Chron Dis Program UFIEC, Madrid, Spain.	mvilar@isciii.es	Vilar, Marçal/B-4581-2016	Vilar, Marçal/0000-0002-9376-6544	Ministry of Economy and Competitiveness (MINECO) from the Government of Spain [BFU2010-15276, BFU2013-42746-P]	Ministry of Economy and Competitiveness (MINECO) from the Government of Spain	Ministry of Economy and Competitiveness (MINECO) from the Government of Spain. Projects: BFU2010-15276 and BFU2013-42746-P to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2005, GENE, V357, P18, DOI 10.1016/j.gene.2005.05.012; Baldisseri DM, 2002, J MOL BIOL, V319, P823, DOI 10.1016/S0022-2836(02)00282-6; Behrens M, 2003, J NEUROCHEM, V86, P1289, DOI 10.1046/j.1471-4159.2003.01940.x; Brown AL, 1999, HUM MOL GENET, V8, P611, DOI 10.1093/hmg/8.4.611; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Chen JH, 2012, ARCH BIOCHEM BIOPHYS, V524, P123, DOI 10.1016/j.abb.2012.04.024; Chien J, 2008, ONCOGENE, V27, P7223, DOI 10.1038/onc.2008.360; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Ding KF, 2009, CARCINOGENESIS, V30, P35, DOI 10.1093/carcin/bgn251; Dosztanyi Z, 2010, BRIEF BIOINFORM, V11, P225, DOI 10.1093/bib/bbp061; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Han CY, 2005, NUCLEIC ACIDS RES, V33, P6555, DOI 10.1093/nar/gki964; Han Qiu-Yue, 2012, Yichuan, V34, P711, DOI 10.3724/SP.J.1005.2012.00711; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hite KC, 2012, PROTEIN SCI, V21, P531, DOI 10.1002/pro.2037; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones DT, 2014, BIOINFORMATICS; Kaczka P, 2014, EUR BIOPHYS J BIOPHY, V43, P581, DOI 10.1007/s00249-014-0987-4; Karakoula K, 2014, CANCER LETT, V346, P34, DOI 10.1016/j.canlet.2013.12.005; Khazaei MR, 2010, J NEUROCHEM, V115, P910, DOI 10.1111/j.1471-4159.2010.06960.x; Kim AJ, 2004, GENE, V343, P79, DOI 10.1016/j.gene.2004.08.031; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kimura MT, 2001, J BIOL CHEM, V276, P17291, DOI 10.1074/jbc.M005453200; Koo JH, 2007, BIOCHEM BIOPH RES CO, V363, P405, DOI 10.1016/j.bbrc.2007.08.186; Latham KE, 2002, BIOL REPROD, V67, P386, DOI 10.1095/biolreprod67.2.386; Lee CH, 2013, J PATHOL, V230, P298, DOI 10.1002/path.4173; Livernois AM, 2009, ANAL BIOCHEM, V392, P70, DOI 10.1016/j.ab.2009.05.023; Longhi S, 2010, METHODS MOL BIOL, V609, P307, DOI 10.1007/978-1-60327-241-4_18; Louis-Jeune C, 2011, PROTEINS; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Meng QM, 2014, J MOL NEUROSCI, V53, P262, DOI 10.1007/s12031-013-0215-1; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mukai J, 2002, J BIOL CHEM, V277, P13973, DOI 10.1074/jbc.M106342200; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Naderi A, 2012, INT J CANCER, V130, P71, DOI 10.1002/ijc.25977; Naderi A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-111; Naderi A, 2010, INT J CANCER, V126, P1596, DOI 10.1002/ijc.24866; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Pancsa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034687; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Peedicayil A, 2009, GYNECOL ONCOL, V114, P260, DOI 10.1016/j.ygyno.2009.03.038; Quentmeier H, 2005, LEUKEMIA, V19, P1488, DOI 10.1038/sj.leu.2403820; Rattan R, 2010, ONCOGENE, V29, P1362, DOI 10.1038/onc.2009.431; Rohrs S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-86; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sano H, 2001, LARYNGOSCOPE, V111, P535, DOI 10.1097/00005537-200103000-00027; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Su CT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-319; Tantos A, 2013, BBA-PROTEINS PROTEOM, V1834, P342, DOI 10.1016/j.bbapap.2012.08.005; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Winter EE, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-54; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Xiao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091782; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yasui S, 2007, MOL CELL NEUROSCI, V35, P100, DOI 10.1016/j.mcn.2007.02.007; Yoon K, 2004, BIOCHEM BIOPH RES CO, V319, P649, DOI 10.1016/j.bbrc.2004.05.043; Yu Y, 2006, BRAIN RES, V1100, P13, DOI 10.1016/j.brainres.2006.05.010; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhang LQ, 2008, BIOCHEM GENET, V46, P293, DOI 10.1007/s10528-008-9148-8; Zhou X, 2012, J MOL NEUROSCI; Zhou XP, 2013, J MOL NEUROSCI, V50, P78, DOI 10.1007/s12031-012-9864-8	81	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117206	10.1371/journal.pone.0117206	http://dx.doi.org/10.1371/journal.pone.0117206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612294	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900034
J	Le Reste, JY; Nabbe, P; Rivet, C; Lygidakis, C; Doerr, C; Czachowski, S; Lingner, H; Argyriadou, S; Lazic, D; Assenova, R; Hasaganic, M; Munoz, MA; Thulesius, H; Le Floch, B; Derriennic, J; Sowinska, A; Van Marwijk, H; Lietard, C; Van Royen, P				Le Reste, Jean Yves; Nabbe, Patrice; Rivet, Charles; Lygidakis, Charilaos; Doerr, Christa; Czachowski, Slawomir; Lingner, Heidrun; Argyriadou, Stella; Lazic, Djurdjica; Assenova, Radost; Hasaganic, Melida; Munoz, Miquel Angel; Thulesius, Hans; Le Floch, Bernard; Derriennic, Jeremy; Sowinska, Agnieska; Van Marwijk, Harm; Lietard, Claire; Van Royen, Paul			The European General Practice Research Network Presents the Translations of Its Comprehensive Definition of Multimorbidity in Family Medicine in Ten European Languages	PLOS ONE			English	Article							DELPHI TECHNIQUE; GLOBAL HEALTH; CARE; QUALITY; FRAILTY; ADAPTATION; GUIDELINES; CONSENSUS	Background Multimorbidity, according to the World Health Organization, exists when there are two or more chronic conditions in one patient. This definition seems inaccurate for the holistic approach to Family Medicine (FM) and long-term care. To avoid this pitfall the European General Practitioners Research Network (EGPRN) designed a comprehensive definition of multimorbidity using a systematic literature review. Objective To translate that English definition into European languages and to validate the semantic, conceptual and cultural homogeneity of the translations for further research. Method Forward translation of the EGPRN's definition of multimorbidity followed by a Delphi consensus procedure assessment, a backward translation and a cultural check with all teamsto ensure the homogeneity of the translations in their national context. Consensus was defined as 70% of the scores being higher than 6. Delphi rounds were repeated in each country until a consensus was reached Results 229 European medical expert FPs participated in the study. Ten consensual translations of the EGPRN comprehensive definition of multimorbidity were achieved. Conclusion A comprehensive definition of multimorbidity is now available in English and ten European languages for further collaborative research in FM and long-term care.	[Le Reste, Jean Yves; Nabbe, Patrice; Rivet, Charles; Le Floch, Bernard; Derriennic, Jeremy] Univ Bretagne Occidentale, Dept Gen Practice, Brest, France; [Lygidakis, Charilaos] AIMEF, Bologna, Italy; [Doerr, Christa] Allgemein Med Hsch Gottingen, Gottingen, Germany; [Czachowski, Slawomir] Nicholas Copernicus Univ, Dept Family Doctor, Torun, Poland; [Lingner, Heidrun] Allgemein Med Hsch Hannover, Hannover, Germany; [Argyriadou, Stella] Greek Assoc Gen Practitioners ELEGEIA, Thessaloniki, Greece; [Lazic, Djurdjica] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Dept Family Med, Zagreb 41000, Croatia; [Assenova, Radost] Paisij Hilendarski Univ Plovdiv, Dept Gen Practice, Plovdiv, Bulgaria; [Hasaganic, Melida] Univ Sarajevo, Dept Gen Practice, Sarajevo 71000, Bosnia & Herceg; [Munoz, Miquel Angel] IDIAP Jordi Gol, Unitat Support Recerca, Barcelona, Spain; [Thulesius, Hans] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Sowinska, Agnieska] Nicholas Copernicus Univ, Dept English, Torun, Poland; [Van Marwijk, Harm] Vrije Univ Amsterdam Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Lietard, Claire] Univ Bretagne Occidentale, Dept Publ Hlth, Brest, France; [Van Royen, Paul] Univ Antwerp, Fac Med & Hlth Sci, Dept Primary & Interdisciplinary Care, Antwerp, Belgium	Universite de Bretagne Occidentale; Nicolaus Copernicus University; University of Zagreb; Plovdiv University; University of Sarajevo; Lund University; Nicolaus Copernicus University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Universite de Bretagne Occidentale; University of Antwerp	Le Reste, JY (corresponding author), Univ Bretagne Occidentale, Dept Gen Practice, Brest, France.	lereste@univ-brest.fr; nabbep@univ-brest.fr	Czachowski, Slawomir/H-7702-2014; , Van Royen Paul/H-7315-2015; Thulesius, Hans/O-4979-2019; Asenova, Radost/AAL-6465-2021; perez, miguel/GXF-5077-2022; Muñoz, Miguel Angel/X-3511-2019; Sowinska, Agnieszka/AGY-4894-2022; Van Marwijk, Harm/K-6306-2013	Czachowski, Slawomir/0000-0002-8055-4833; , Van Royen Paul/0000-0002-9554-1680; Thulesius, Hans/0000-0002-3785-5630; Asenova, Radost/0000-0003-2158-5792; Muñoz, Miguel Angel/0000-0002-4083-3248; Van Marwijk, Harm/0000-0001-6206-485X; Sowinska, Agnieszka/0000-0002-3684-7129; Lygidakis, Charilaos/0000-0003-2571-6286	EGPRN (European General Practitioner Research Network)	EGPRN (European General Practitioner Research Network)	This research has received a grant from the EGPRN (European General Practitioner Research Network). We thank all European FPs who participated in the Delphi procedure. We thank Claire Collins and her team from the Irish College of General Practitioners and Jan Karl Soler from the Malta College of Family Doctors Malta for their checking of the English phrasing of the definition.	Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x; Battles JB, 2014, AM J INFECT CONTROL, V42, pS189, DOI 10.1016/j.ajic.2014.07.006; Beasley JW, 2007, J AM BOARD FAM MED, V20, P518, DOI 10.3122/jabfm.2007.06.070172; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bell BG, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-110; Bourree F, 2008, REV EPIDEMIOL SANTE, V56, P415, DOI 10.1016/j.respe.2008.09.006; Boyd CM, 2008, J GEN INTERN MED, V23, P536, DOI 10.1007/s11606-008-0529-9; Brandlmeier P, 1976, ZFA (Stuttgart), V52, P1269; Brar SS, 2014, JAMA SURG, V149, P18, DOI 10.1001/jamasurg.2013.3959; BULLINGER M, 1993, QUAL LIFE RES, V2, P451, DOI 10.1007/BF00422219; De Villiers MR, 2005, MED TEACH, V27, P639, DOI 10.1080/13611260500069947; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; *EUR AC TEACH GEN, EUR DEF GEN PRACT FA; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P356, DOI 10.1016/j.jamda.2009.11.008; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Herdman M, 1997, QUAL LIFE RES, V6, P237; HEUFT G, 1990, Z GERONTOL, V23, P262; Huber M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4163; Hummers-Pradier E, 2010, EUR J GEN PRACT, V16, P174, DOI 10.3109/13814788.2010.504982; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P319, DOI 10.1016/j.jamda.2013.01.001; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P132, DOI 10.1016/j.jamda.2012.07.017; LERESTE JY, 2013, EUR J GEN PR, V17, P180; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Novakowski N, 2008, ENVIRON PLANN A, V40, P1485, DOI 10.1068/a39267; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Ramirez M, 2006, MED CARE, V44, pS95, DOI 10.1097/01.mlr.0000245181.96133.db; ROURA XJ, 2014, REUMATOL CLIN; Salisbury C, 2012, LANCET, V6736, P12; Skulmoski GJ, 2007, J INF TECHNOL EDUC-R, V6, P1; Soler JK, 2008, FAM PRACT, V25, P312, DOI 10.1093/fampra/cmn028; Starfield B, 2007, J AM BOARD FAM MED, V20, P511, DOI 10.3122/jabfm.2007.06.070176; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; van Kan GA, 2008, J AM MED DIR ASSOC, V9, P71, DOI 10.1016/j.jamda.2007.11.005; Weissbrod R, 2009, TARGET-NETH, V21, P58, DOI 10.1075/target.21.1.03wei; WHO, 2008, WAIST CIRCUMFERENCE	41	28	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115796	10.1371/journal.pone.0115796	http://dx.doi.org/10.1371/journal.pone.0115796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4PR	25607642	gold, Green Published, Green Submitted			2022-12-27	WOS:000348205300020
J	Patalay, P; Deighton, J; Fonagy, P; Wolpert, M				Patalay, Praveetha; Deighton, Jessica; Fonagy, Peter; Wolpert, Miranda			The Relationship between Internalising Symptom Development and Academic Attainment in Early Adolescence	PLOS ONE			English	Article							MENTAL-HEALTH; DEPRESSIVE SYMPTOMS; GENDER-DIFFERENCES; EMOTIONAL-PROBLEMS; SCHOOL READINESS; TRAJECTORIES; ANXIETY; CHILDHOOD; CHILDREN; PSYCHOPATHOLOGY	Evidence for the longitudinal associations between internalising symptom development and academic attainment is sparse and results from existing studies are largely inconclusive. The approaches that have been used in existing studies examining this relationship have in common the limitation of grouping together all individuals in the sample which makes the assumption that the relationship between time, symptoms and attainment across all individuals is the same. The current study aimed to use heterogeneous trajectories of symptom development to examine the longitudinal associations between internalising symptom development and change in academic attainment over a three years period in early adolescence, a key period for internalising symptom development. Internalising symptoms were assessed for 3 consecutive years in a cohort from age 11-14 years (n = 2647, mean age at T1 = 11.7 years). National standardised test scores prior to the first wave and subsequent to the last wave were used as measures of academic attainment. Heterogeneous symptom development trajectories were identified using latent class growth analysis and socio-demographic correlates, such as gender, SES and ethnicity, of the different trajectory groupings were investigated. Derived trajectory groupings were examined as predictors of subsequent academic attainment, controlling for prior attainment. Results demonstrate that symptom trajectories differentially predicted change in academic attainment with increasing trajectories associated with significantly worse academic outcomes when compared to pupils with low levels of symptoms in all waves. Hence, a trajectory based approach provides a more nuanced breakdown of complexities in symptom development and their differential relationships with academic outcomes and in doing so helps clarify the longitudinal relationship between these two key domains of functioning in early adolescence.	[Patalay, Praveetha; Deighton, Jessica; Wolpert, Miranda] UCL, EBPU, London, England; [Patalay, Praveetha; Deighton, Jessica; Wolpert, Miranda] Anna Freud Ctr, London, England; [Fonagy, Peter] UCL, London, England	University of London; University College London; The Anna Freud Centre; University of London; University College London	Patalay, P (corresponding author), UCL, EBPU, 21 Maresfield Gardens, London, England.	praveetha.patalay.11@ucl.ac.uk		Fonagy, Peter/0000-0003-0229-0091; Deighton, Jessica/0000-0002-9516-7545	Department for Education in England; National Institute for Health Research [NF-SI-0514-10157, NF-SI-0510-10228] Funding Source: researchfish	Department for Education in England; National Institute for Health Research(National Institute for Health Research (NIHR))	The data used in this study was collected as part of a wider project supported by a grant from the Department for Children, Schools and Families in England (now the Department for Education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Angold A, 1998, PSYCHOL MED, V28, P51, DOI 10.1017/S003329179700593X; [Anonymous], DEV PSYCHO, DOI DOI 10.1002/9780470939406.CH19; Bardone AM, 1996, DEV PSYCHOPATHOL, V8, P811, DOI 10.1017/S0954579400007446; Bronfenbrenner U., 2007, HDB CHILD DEV, V6th ed., P793, DOI DOI 10.1002/9780470147658.CHPSY0114; Cole DA, 1996, J ABNORM PSYCHOL, V105, P258, DOI 10.1037/0021-843X.105.2.258; Costello EJ, 2011, J CHILD PSYCHOL PSYC, V52, P1015, DOI 10.1111/j.1469-7610.2011.02446.x; Cote SM, 2009, J CHILD PSYCHOL PSYC, V50, P1201, DOI 10.1111/j.1469-7610.2009.02099.x; Crocetti E, 2009, J YOUTH ADOLESCENCE, V38, P839, DOI 10.1007/s10964-008-9302-y; CRYSTAL S, 1992, J GERONTOL, V47, pS213, DOI 10.1093/geronj/47.5.S213; Curran PJ, 1999, AM J COMMUN PSYCHOL, V27, P567, DOI 10.1023/A:1022137429115; De Los Reyes A, 2013, DEV PSYCHOPATHOL, V25, P669, DOI 10.1017/S0954579413000096; Deighton J, 2013, J PSYCHOEDUC ASSESS, V31, P247, DOI 10.1177/0734282912465570; Dekker MC, 2007, J CHILD PSYCHOL PSYC, V48, P657, DOI 10.1111/j.1469-7610.2007.01742.x; DfE, 2021, SCH PUP THEIR CHAR J; DfE, 2011, STAT 1 REL SFR 18 20; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; FAUBER R, 1987, J PSYCHOPATHOL BEHAV, V9, P161, DOI 10.1007/BF00960572; Fergusson DM, 2006, BRIT J PSYCHIAT, V189, P540, DOI 10.1192/bjp.bp.106.022384; Fergusson DM, 2002, ARCH GEN PSYCHIAT, V59, P225, DOI 10.1001/archpsyc.59.3.225; Fonagy P, 2009, J CHILD PSYCHOL PSYC, V50, P607, DOI 10.1111/j.1469-7610.2008.02025.x; Frojd SA, 2008, J ADOLESCENCE, V31, P485, DOI 10.1016/j.adolescence.2007.08.006; Galambos NL, 2006, DEV PSYCHOL, V42, P350, DOI 10.1037/0012-1649.42.2.350; Green H., 2005, J RES SPEC EDUC NEED; Greenberg M., 2010, EFFECTIVE ED, V2, P27, DOI [DOI 10.1080/19415531003616862, https://doi.org/10.1080/19415531003616862]; Hobbs G, 2010, BRIT EDUC RES J, V36, P673, DOI 10.1080/01411920903083111; Humphrey N, 2013, RES DEV DISABIL, V34, P1210, DOI 10.1016/j.ridd.2012.12.008; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Legerstee JS, 2013, J CAN ACAD CHILD ADO, V22, P26; Masten AS, 2005, DEV PSYCHOL, V41, P733, DOI 10.1037/0012-1649.41.5.733; McLeod JD, 2007, AM J SOCIOL, V113, P653, DOI 10.1086/521849; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Moilanen KL, 2010, DEV PSYCHOPATHOL, V22, P635, DOI 10.1017/S0954579410000337; Morin AJS, 2011, STRUCT EQU MODELING, V18, P613, DOI 10.1080/10705511.2011.607714; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Muthen BO, 1995, SOCIOL METHODOL, V25, P267, DOI 10.2307/271070; Nagin DS, 2005, CRIMINOLOGY, V43, P873, DOI 10.1111/j.1745-9125.2005.00026.x; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Patalay P, 2014, CHILD ADOL PSYCH MEN, V8, DOI 10.1186/1753-2000-8-17; Patterson J, 1996, ARCH PEDIAT ADOL MED, V150, P692, DOI 10.1001/archpedi.1996.02170320038006; Poulin C, 2005, ADDICTION, V100, P525, DOI 10.1111/j.1360-0443.2005.01033.x; Riglin L, 2013, J ADOLESCENCE, V36, P507, DOI 10.1016/j.adolescence.2013.03.002; Romano E, 2010, DEV PSYCHOL, V46, P995, DOI 10.1037/a0018880; Roza SJ, 2003, AM J PSYCHIAT, V160, P2116, DOI 10.1176/appi.ajp.160.12.2116; Shoshani A, 2013, J HAPPINESS STUD, P1; Snyder J, 2009, J CLIN CHILD ADOLESC, V38, P837, DOI 10.1080/15374410903258959; StataCorp, 2011, STAT STAT SOFTW REL, P173; Sterba SK, 2007, DEV PSYCHOPATHOL, V19, P345, DOI 10.1017/S0954579407070174; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thelen E, 2006, HDB CHILD PSYCHOL TH; United Nations, 2018, UN NEWS; Von Eye A, 2003, DEV PSYCHOPATHOL, V15, P553, DOI 10.1017/S0954579403000294; Wolpert M., 2011, ME MY SCH FINDINGS N	55	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116821	10.1371/journal.pone.0116821	http://dx.doi.org/10.1371/journal.pone.0116821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4PR	25607541	Green Published, gold, Green Submitted			2022-12-27	WOS:000348205300037
J	Hetterich, H; Jaber, A; Gehring, M; Curta, A; Bamberg, F; Filipovic, N; Rieber, J				Hetterich, Holger; Jaber, Ahmad; Gehring, Moritz; Curta, Adrian; Bamberg, Fabian; Filipovic, Nenad; Rieber, Johannes			Coronary Computed Tomography Angiography Based Assessment of Endothelial Shear Stress and Its Association with Atherosclerotic Plaque Distribution In-Vivo	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; APPROPRIATE USE CRITERIA; HISTOLOGICAL CLASSIFICATION; CARDIOVASCULAR ANGIOGRAPHY; INTRAVASCULAR ULTRASOUND; NUCLEAR CARDIOLOGY; VASCULAR-LESIONS; NATURAL-HISTORY; BLOOD-FLOW; TASK-FORCE	Purpose The relationship between low endothelial shear stress (ESS) and coronary atherosclerosis is well established. ESS assessment so far depended on invasive procedures. The aim of this study was to demonstrate the relationship between ESS and coronary atherosclerosis by using non-invasive coronary computed tomography angiography (CTA) for computational fluid dynamics (CFD) simulations. Methods A total number of 7 consecutive patients with suspected coronary artery disease who received CTA and invasive angiography with IVUS analysis were included in this study. CTA examinations were performed using a dual-source scanner. These datasets were used to build a 3D mesh model. CFD calculations were performed using a validated CFD solver. The presence of plaque was assumed if the thickness of the intima-media complex exceeded 0.3 mm in IVUS. Plaque composition was derived by IVUS radiofrequency data analysis. Results Plaque was present in 32.1% of all analyzed cross-sections. Plaque prevalence was highest in areas of low ESS (49.6%) and high ESS (34.8%). In parts exposed to intermediate-low and intermediate-high ESS few plaques were found (20.0% and 24.0%) (p<0.001). Wall thickness was closely associated with local ESS. Intima-media thickness was 0.43 +/- 0.34mm in low and 0.38 +/- 0.32mm in high ESS segments. It was significantly lower when the arterial wall was exposed to intermediate ESS (0.25 +/- 0.18mm and 0.28 +/- 0.20mm) (p<0.001). Fibrofatty tissue was predominately found in areas exposed to low ESS (p <= 0.023). Conclusions In this study a close association of atherosclerotic plaque distribution and ESS pattern could be demonstrated in-vivo. Adding CFD analysis to coronary CTA offers the possibility to gather morphologic and physiologic data within one non-invasive examination.	[Hetterich, Holger; Bamberg, Fabian] Univ Munich, Inst Clin Radiol, Munich, Germany; [Jaber, Ahmad; Gehring, Moritz; Curta, Adrian] Univ Munich, Dept Cardiol, Munich, Germany; [Filipovic, Nenad] Univ Kragujevac, Fac Mech Engn, Kragujevac, Serbia; [Rieber, Johannes] Heart Ctr Munich Bogenhausen, Dept Cardiol & Intens Care Med, Munich, Germany	University of Munich; University of Munich; University of Kragujevac; German Heart Centre Munich	Hetterich, H (corresponding author), Univ Munich, Inst Clin Radiol, Munich, Germany.	Holger.Hetterich@med.uni-muenchen.de	Filipovic, Nenad/GSN-0499-2022		Siemens AG, Healthcare Sector; Friedrich Baur Foundation	Siemens AG, Healthcare Sector; Friedrich Baur Foundation	The study was supported by the Siemens AG, Healthcare Sector and the Friedrich Baur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caro CG, 2009, ARTERIOSCL THROM VAS, V29, P158, DOI 10.1161/ATVBAHA.108.166736; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Chatzizisis YS, 2007, CURR OPIN CARDIOL, V22, P552, DOI 10.1097/HCO.0b013e3282f07548; Cheng C, 2005, BLOOD, V106, P3691, DOI 10.1182/blood-2005-06-2326; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Frangos SG, 1999, ARCH SURG-CHICAGO, V134, P1142, DOI 10.1001/archsurg.134.10.1142; Frauenfelder T, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-35; Frauenfelder T, 2007, EUR RADIOL, V17, P1291, DOI 10.1007/s00330-006-0465-1; Gambillara V, 2006, AM J PHYSIOL-HEART C, V290, pH2320, DOI 10.1152/ajpheart.00486.2005; Garcia-Garcia HM, 2009, EUROINTERVENTION, V5, P177, DOI 10.4244/EIJV5I2A29; Gimbrone MA, 1999, THROMB HAEMOSTASIS, V82, P722; Goubergrits L, 2008, INT J CARDIOVAS IMAG, V24, P411, DOI 10.1007/s10554-007-9275-z; Goubergrits L, 2009, ANN BIOMED ENG, V37, P682, DOI 10.1007/s10439-009-9656-7; Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0; Katranas SA, 2014, ANGIOLOGY, V65, P413, DOI 10.1177/0003319713483543; Krams R, 1997, ARTERIOSCL THROM VAS, V17, P2061, DOI 10.1161/01.ATV.17.10.2061; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Liu Y, 2002, ARTERIOSCL THROM VAS, V22, P76, DOI 10.1161/hq0102.101822; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; NISSEN SE, 1991, CIRCULATION, V84, P1087, DOI 10.1161/01.CIR.84.3.1087; Politis AK, 2007, J BIOMECH, V40, P1125, DOI 10.1016/j.jbiomech.2006.05.008; Santamarina A, 1998, ANN BIOMED ENG, V26, P944, DOI 10.1114/1.113; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Stone PH, 2007, EUR HEART J, V28, P705, DOI 10.1093/eurheartj/ehl575; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD; Taylor AJ, 2010, CIRCULATION, V122, pE525, DOI 10.1161/CIR.0b013e3181fcae66; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450; Wellnhofer E, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-39; Wentzel JJ, 2003, CIRCULATION, V108, P17, DOI 10.1161/01.CIR.0000078637.21322.D3; Ziegler T, 1998, ARTERIOSCL THROM VAS, V18, P686, DOI 10.1161/01.ATV.18.5.686	35	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115408	10.1371/journal.pone.0115408	http://dx.doi.org/10.1371/journal.pone.0115408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635397	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700010
J	Xiao, LQ; Moller, M				Xiao, Long-Qian; Moeller, Michael			Nuclear Ribosomal ITS Functional Paralogs Resolve the Phylogenetic Relationships of a Late-Miocene Radiation Cycad Cycas (Cycadaceae)	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; SPECIES TREE; EVOLUTION; GENE; INFERENCE; DNA; PSEUDOGENES; SYSTEMATICS; LIKELIHOOD; MORPHOLOGY	Cycas is the most widespread and diverse genus among the ancient cycads, but the extant species could be the product of late Miocene rapid radiations. Taxonomic treatments to date for this genus are quite controversial, which makes it difficult to elucidate its evolutionary history. We cloned 161 genomic ITS sequences from 31 species representing all sections of Cycas. The divergent ITS paralogs were examined within each species and identified as putative pseudogenes, recombinants and functional paralogs. Functional paralogs were used to reconstruct phylogenetic relationships with pseudogene sequences as molecular outgroups, since an unambiguous ITS sequence alignment with their closest relatives, the Zamiaceae, is unachievable. A fully resolved and highly supported tree topology was obtained at the section level, with two major clades including six minor clades. The results fully supported the classification scheme proposed by Hill (2004) at the section level, with the minor clades representing his six sections. The two major clades could be recognised as two subgenera. The obtained pattern of phylogenetic relationships, combined with the different seed dispersal capabilities and paleogeography, allowed us to propose a late Miocene rapid radiation of Cycas that might have been promoted by vicariant events associated with the complex topography and orogeny of South China and adjacent regions. In contrast, transoceanic dispersals might have played an important role in the rapid diversification of sect. Cycas, whose members have evolved a spongy layer in their seeds aiding water dispersals.	[Xiao, Long-Qian] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Moeller, Michael] Royal Bot Garden Edinburgh, Div Sci, Edinburgh, Scotland	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Xiao, LQ (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	xlq@xtbg.ac.cn	Moeller, Michael/O-9748-2015	Moeller, Michael/0000-0002-2819-0323	National Natural Science Foundation of China [31070209]; Yunnan Province Natural Science Foundation [0755051K01]; Rural and Environment Science and Analytical Services division in the Scottish Government	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province Natural Science Foundation(Natural Science Foundation of Yunnan Province); Rural and Environment Science and Analytical Services division in the Scottish Government	This work was supported by National Natural Science Foundation of China [grant number 31070209], the Yunnan Province Natural Science Foundation [grant number 0755051K01], and the Rural and Environment Science and Analytical Services division in the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Amaral AR, 2012, MOL PHYLOGENET EVOL, V64, P243, DOI 10.1016/j.ympev.2012.04.004; [Anonymous], 1943, INTRO HIST PLANT GEO; [Anonymous], [No title captured]; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bogler DJ, 2004, BOT REV, V70, P260, DOI 10.1663/0006-8101(2004)070[0260:MSSICE]2.0.CO;2; Brenner ED, 2003, TRENDS PLANT SCI, V8, P446, DOI 10.1016/S1360-1385(03)00190-0; Buckler ES, 1997, GENETICS, V145, P821; Buckler ES, 1996, MOL BIOL EVOL, V13, P612, DOI 10.1093/oxfordjournals.molbev.a025621; Chamberlain C.J, 1919, THE LIVING CYCADS; Chaw SM, 2005, MOL PHYLOGENET EVOL, V37, P214, DOI 10.1016/j.ympev.2005.01.006; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; COLLINSON ME, 1981, NATURE, V291, P315, DOI 10.1038/291315a0; Crisp MD, 2011, NEW PHYTOL, V192, P997, DOI 10.1111/j.1469-8137.2011.03862.x; De Laubenfels DJ, 1998, BLUMEA, V43, P351; DEHGAN B, 1983, BOT GAZ, V144, P412, DOI 10.1086/337391; Doyle J., 1991, MOL TECHNIQUES TAXON; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Golonka J, 2006, GEOLINES, V20, P40; Graham SW, 2002, MOL BIOL EVOL, V19, P1769, DOI 10.1093/oxfordjournals.molbev.a003999; Griffith MP, 2014, INT J PLANT SCI, V175, P241, DOI 10.1086/673884; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Harris DJ, 2003, NORD J BOT, V23, P725, DOI 10.1111/j.1756-1051.2003.tb00451.x; He X.-J., 2014, RASP RECONSTRUCT ANC; Hermsen EJ, 2009, REV PALAEOBOT PALYNO, V153, P108, DOI 10.1016/j.revpalbo.2008.07.005; Hill K. D., 1996, Telopea, V7, P1; Hill K. D., 1996, P267; Hill KD, 2004, CYCAD CLASSIFICATION: CONCEPTS AND RECOMMENDATIONS, P23, DOI 10.1079/9780851997414.0023; Hill KD, 1995, P 3 INT C CYC BIOL, P139; HOLLOWAY NH, 1982, AAPG BULL, V66, P1355; Jobes DV, 1997, PLANT MOL BIOL REP, V15, P326, DOI 10.1023/A:1007462330699; Jones D.L., 1993, CYCADS OF THE WORLD; Keppel G, 2008, J BIOGEOGR, V35, P1004, DOI 10.1111/j.1365-2699.2007.01869.x; Leloup PH, 1995, TECTONOPHYSICS, V251, P3, DOI 10.1016/0040-1951(95)00070-4; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Li XW, 1997, ANN MO BOT GARD, V84, P888, DOI 10.2307/2992033; Liu YS, 1991, CHINESE SCI BULL, V22, P1758; LOCONTE H, 1990, BRITTONIA, V42, P197, DOI 10.2307/2807216; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; MCDADE LA, 1992, EVOLUTION, V46, P1329, DOI 10.1111/j.1558-5646.1992.tb01127.x; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Nagalingum NS, 2011, SCIENCE, V334, P796, DOI 10.1126/science.1209926; NORSTOG K, 1997, BIOL CYCADS; Nylander JAA., 2004, MRMODELTEST 2 2; Ochieng JW, 2007, MOL PHYLOGENET EVOL, V44, P752, DOI 10.1016/j.ympev.2007.04.017; OSBORNE R, 1995, BIOL CONSERV, V71, P1, DOI 10.1016/0006-3207(95)91086-D; Osborne R., 2012, Proceedings of Cycad 2008. The 8th International Conference on Cycad Biology, Panama City, Panama, 13-15 January 2008, P480; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Petrov DA, 2000, J HERED, V91, P221, DOI 10.1093/jhered/91.3.221; Rai HS, 2003, MOL PHYLOGENET EVOL, V29, P350, DOI 10.1016/S1055-7903(03)00131-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salas-Leiva DE, 2013, ANN BOT-LONDON, V112, P1263, DOI 10.1093/aob/mct192; Sangin P., 2010, Kasetsart Journal, Natural Sciences, V44, P544; Schiele J. H., 2003, RECONCILIATION VIOLE, piii; Schneider D, 2002, NATURWISSENSCHAFTEN, V89, P281, DOI 10.1007/s00114-002-0330-2; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Smitinand T, 1971, NATURAL HIST B SIAM, V24, P163; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEVENSON DW, 1990, MEMOIRS NEW YORK BOT, V57, P8, DOI DOI 10.21135/893273507.003; Tanaka, 1954, SPECIES PROBLEM CITR; Treutlein J, 2002, NATURWISSENSCHAFTEN, V89, P221, DOI 10.1007/s00114-002-0308-0; Wang DY, 2000, THESIS NANJING FORES; Wang WK, 2007, MOL PHYLOGENET EVOL, V44, P503, DOI 10.1016/j.ympev.2007.05.006; Wei XX, 2004, MOL ECOL, V13, P3115, DOI 10.1111/j.1365-294X.2004.02299.x; Wolfe J. A., 1997, EVOLUTION DIVERSIFIC, P269, DOI [10.1007/978-4-431-65918-1_13, DOI 10.1007/978-4-431-65918-1_13]; Xiao LQ, 2010, MOL PHYLOGENET EVOL, V55, P168, DOI 10.1016/j.ympev.2009.11.020; Yang SL, 1996, INT J PLANT SCI, V157, P468, DOI 10.1086/297364; Zheng XY, 2008, MOL PHYLOGENET EVOL, V48, P892, DOI 10.1016/j.ympev.2008.05.039	70	24	26	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117971	10.1371/journal.pone.0117971	http://dx.doi.org/10.1371/journal.pone.0117971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635842	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700110
J	Celin, AR; Rapacioli, M; Gonzalez, MA; Ballarin, VL; de Plazas, SF; Lopez-Costa, JJ; Flores, V				Rodriguez Celin, Alejandra; Rapacioli, Melina; Azul Gonzalez, Mariela; Laura Ballarin, Virginia; Fiszer de Plazas, Sara; Jose Lopez-Costa, Juan; Flores, Vladimir			Temporal-Spatial Correlation between Angiogenesis and Corticogenesis in the Developing Chick Optic Tectum	PLOS ONE			English	Article							SPATIOTEMPORAL GRADIENT; DIFFERENTIATION; BRAIN; MICROVESSELS; EXPRESSION; INTEGRITY; ORIGINS; PATTERN	The developing chick optic tectum is a widely used model of corticogenesis and angiogenesis. Cell behaviors involved in corticogenesis and angiogenesis share several regulatory mechanisms. In this way the 3D organizations of both systems adapt to each other. The consensus about the temporally and spatially organized progression of the optic tectum corticogenesis contrasts with the discrepancies about the spatial organization of its vascular bed as a function of the time. In order to find out spatial and temporal correlations between corticogenesis and angiogenesis, several methodological approaches were applied to analyze the dynamic of angiogenesis in the developing chick optic tectum. The present paper shows that a typical sequence of developmental events characterizes the optic tectum angiogenesis. The first phase, formation of the primitive vascular bed, takes place during the early stages of the tectal corticogenesis along which the large efferent neurons appear and begin their early differentiation. The second phase, remodeling and elaboration of the definitive vascular bed, occurs during the increase in complexity associated to the elaboration of the local circuit networks. The present results show that, apart from the well-known influence of the dorsal-ventral and radial axes as reference systems for the spatial organization of optic tectum angiogenesis, the cephalic-caudal axis also exerts a significant asymmetric influence. The term cortico-angiogenesis to describe the entire process is justified by the fact that tight correlations are found between specific corticogenic and angiogenic events and they take place simultaneously at the same position along the cephalic-caudal and radial axes.	[Rodriguez Celin, Alejandra; Rapacioli, Melina; Flores, Vladimir] Favaloro Univ, Interdisciplinary Grp Theoret Biol, Dept Biostruct Sci, Buenos Aires, DF, Argentina; [Fiszer de Plazas, Sara; Jose Lopez-Costa, Juan; Flores, Vladimir] Buenos Aires Univ CONICET, Inst Cell Biol & Neurosci Prof E De Robertis, Buenos Aires, DF, Argentina; [Azul Gonzalez, Mariela; Laura Ballarin, Virginia] Natl Univ Mar del Plata, Sch Engn, Digital Image Proc Grp, Mar Del Plata, Buenos Aires, Argentina	National University of Mar del Plata	Flores, V (corresponding author), Favaloro Univ, Interdisciplinary Grp Theoret Biol, Dept Biostruct Sci, Buenos Aires, DF, Argentina.	vflores@favaloro.edu.ar	Laura, Virginia/AAC-7511-2019	Laura, Virginia/0000-0002-5648-6463	National Council of Research CONICET [PIP0412]	National Council of Research CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funding for the study was provided by National Council of Research CONICET PIP0412. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautch VL, 2009, CELL ADHES MIGR, V3, P199, DOI 10.4161/cam.3.2.8397; Bertossi M, 2002, ANAT EMBRYOL, V205, P229, DOI 10.1007/s00429-002-0245-x; Bertossi M., 1992, Biological Structures and Morphogenesis, V4, P144; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; Eichmann A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006551; FEENEY JF, 1946, J MORPHOL, V78, P231, DOI 10.1002/jmor.1050780205; Firka D., 2004, WSEAS Transactions on Biology and Biomedicine, V1, P24; Galileo DS, 2003, GLIA, V41, P25, DOI 10.1002/glia.10163; Gonzalez MA, 2011, J PHYS CONF SER, V332, DOI 10.1088/1742-6596/332/1/012031; Gonzalez MA, 2007, J COMPUT SCI TECHNOL, V7, P243; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Han HS, 2005, CURR NEUROVASC RES, V2, P409, DOI 10.2174/156720205774962647; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; ITASAKI N, 1991, DEVELOPMENT, V113, P1133; Kim DW, 2006, BRAIN RES, V1076, P16, DOI 10.1016/j.brainres.2006.01.010; LAVAIL JH, 1971, BRAIN RES, V28, P421; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; Lever M, 2014, BRAIN STRUCT FUNCT, V219, P1009, DOI 10.1007/s00429-013-0550-6; Lindhorst T, 2012, HISTOCHEM CELL BIOL, V137, P629, DOI 10.1007/s00418-012-0912-9; Luksch H, 2003, REV NEUROSCIENCE, V14, P85; Mancuso Michael R., 2008, Lymphatic Research and Biology, V6, P173, DOI 10.1089/lrb.2008.1014; MATSUNO T, 1991, DEV BRAIN RES, V58, P265, DOI 10.1016/0165-3806(91)90014-A; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; Mey J, 2000, BRAIN RES REV, V32, P343, DOI 10.1016/S0165-0173(99)00022-3; Rapacioli M, 2011, J MORPHOL, V272, P675, DOI 10.1002/jmor.10943; RONCALI L, 1985, ACTA ANAT, V122, P229; RONCALI L, 1983, Bollettino Societa Italiana Biologia Sperimentale, V59, P765; RONCALI L, 1985, J SUBMICR CYTOL PATH, V17, P83; Ruhrberg C, 2013, CELL MOL LIFE SCI, V70, P1675, DOI 10.1007/s00018-013-1277-5; Scicolone G, 2006, J COMP NEUROL, V494, P1007, DOI 10.1002/cne.20878; Scicolone G, 1995, INT J DEV NEUROSCI, V13, P845, DOI 10.1016/0736-5748(95)00069-0; Seo JH, 2008, NEUROCHEM RES, V33, P1346, DOI 10.1007/s11064-008-9590-3; Stubbs D, 2009, CEREB CORTEX, V19, pI32, DOI 10.1093/cercor/bhp040; Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074; Vates GE, 2005, J NEUROSURG, V103, P136, DOI 10.3171/jns.2005.103.1.0136; Yasuda Y, 2003, CELL TISSUE RES, V314, P315, DOI 10.1007/s00441-003-0796-z	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116343	10.1371/journal.pone.0116343	http://dx.doi.org/10.1371/journal.pone.0116343			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633659	gold, Green Submitted, Green Published			2022-12-27	WOS:000348609800008
J	Gibaja, JF; Subira, ME; Terradas, X; Santos, FJ; Agullo, L; Gomez-Martinez, I; Alllese, F; de Pablo, JFL				Gibaja, Juan F.; Eulalla Subira, M.; Terradas, Xavier; Javier Santos, F.; Agullo, Lidia; Gomez-Martinez, Isabel; Alllese, Florence; Fernandez-Lopez de Pablo, Javier			The Emergence of Mesolithic Cemeteries in SW Europe: Insights from the El Collado (Oliva, Valencia, Spain) Radiocarbon Record	PLOS ONE			English	Article							BONE; EXTRACTION; CALIBRATION; AGES	Located on the Iberian Mediterranean coast, El Collado is an open-air site where a rescue excavation was conducted over two seasons in 1987 and 1988. The archaeological work excavated a surface area of 143m2 where 14 burials were discovered, providing skeletal remains from 15 individuals. We have obtained AMS dates for 10 of the 15 individuals by means of the direct dating of human bones. The ranges of the probability distribution of the calibrated dates suggest that the cemetery was used during a long period of time (7811020 years at a probability of 95.4%). The new dates consequently set back the chrono-cultural attribution of the cemetery from the initial proposal of Late Mesolithic to an older date in the Early Mesolithic. Therefore, El Collado becomes the oldest known cemetery in the Iberian Peninsula, earlier than the numerous Mesolithic funerary contexts documented on the Atlantic facade such as the Portuguese shell-middens in the Muge and Sado Estuaries or the funerary sites on the northern Iberian coast.	[Gibaja, Juan F.; Terradas, Xavier] IMF CSIC, Barcelona, Spain; [Eulalla Subira, M.] Univ Autonoma Barcelona, Grp Recerca Aplicada Patrimoni Cultural GRAPAC, Unitat Antropol Biol, Dept Biol Anim Biol Vegetal & Ecol, Bellaterra, Spain; [Javier Santos, F.; Agullo, Lidia; Gomez-Martinez, Isabel] Univ Seville, CSIC, Ctr Nacl Aceleradores, Seville, Spain; [Alllese, Florence] Univ Paris 01, UMR Archeol & Sci AntiquiteArScAN 7041, Nanterre, France; [Fernandez-Lopez de Pablo, Javier] Inst Catala Paleoecol Humana & Evolucio Social IP, Tarragona, Spain; [Fernandez-Lopez de Pablo, Javier] URV, Area Prehist, Tarragona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Centro Nacional de Aceleradores (CNA); Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili	Gibaja, JF (corresponding author), IMF CSIC, Barcelona, Spain.	jfgibaja@imf.csic.es	Arévalo, Francisco Javier Santos/G-4266-2015; de Pablo, Javier Fernández-López/G-6590-2016; Fernández-López de Pablo, Javier/GXG-1170-2022; Terradas, Xavier/H-7968-2015	Arévalo, Francisco Javier Santos/0000-0003-1485-8625; Fernández-López de Pablo, Javier/0000-0002-6953-7004; Terradas, Xavier/0000-0002-8000-5607; Gibaja Bao, Juan/0000-0002-0830-3570	AGAUR-Generalitat de Catalunya [2009SGR-0566, 2009SGR-0734, 2014SGR-1169, 2014SGR-1420]; Ramon y Cajal Program [RYC-2010-06628, RYC-2011-09363]; Ministerio de Economia y Competitividad of Spain [HAR2009-13494-C02-01/02, HAR2011-23149, HAR2012-38838-C02-01/02, HAR2013-41197]	AGAUR-Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Ramon y Cajal Program(Spanish Government); Ministerio de Economia y Competitividad of Spain(Spanish Government)	The radiocarbon determinations reported in this study were performed within an agreement between the Consejo Superior de Investigaciones Cientificas (CSIC), the Universitat Autonoma de Barcelona and the Centro Nacional de Aceleradores-Universidad de Sevilla. The research was supported by the research groups 2009SGR-0566, 2009SGR-0734, 2014SGR-1169 and 2014SGR-1420, funded by the AGAUR-Generalitat de Catalunya. J.F.G and J.F.L. are supported by Ramon y Cajal Program (RYC-2010-06628 and RYC-2011-09363). The results have been obtained in the framework of projects HAR2009-13494-C02-01/02, HAR2011-23149, HAR2012-38838-C02-01/02 and HAR2013-41197, financed by the Ministerio de Economia y Competitividad of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ARCHAEOLOGY DEATH LE; Aparicio J, 2008, NECROPOLIS MESOLITIC; Arias Cabal P., 2012, AD ORIENTEM FINAL PA, P253; Arias P, 1996, HUM EVOL, V11, P129, DOI [DOI 10.1007/BF02437396, 10.1007/BF02437396]; Arias P, 2013, BRIT ARCHAEOLOGICAL, VS2417, P7; Armendariz A, P 8 INT C MES EUR SA; Arnaud J.M., 1987, ARQUEOLOGIA-ARGENTIN, V15, P53; Aura JE, 2010, RESTOS VIDA RESTOS M, P169; Aura JE., 2006, MESOLITICO MUESCAS D, P65; Barandiaran I., 2001, CAZADORES RECOLECTOR; Bernabeu J, 2006, ABRIC FALGUERA ALCOI, P189; Bicho N., 2009, ESTUDOS ARQUEOLOGICO, V17, P133; Bicho N, 2013, QUATERN INT, V308, P130, DOI 10.1016/j.quaint.2012.10.049; Bicho N, 2010, J ISL COAST ARCHAEOL, V5, P86, DOI 10.1080/15564891003638184; Boroneant A, 2012, HOMINES FUNERA ASTRA, P45; Bosca E., 1916, B REAL SOC HIST NATU, VXVI, P81; Brock F, 2013, RADIOCARBON, V55, P445, DOI 10.1017/S0033822200057581; Brock F, 2007, RADIOCARBON, V49, P187, DOI 10.1017/S0033822200042107; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; CAILLARD P, 1976, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V13, P363; Campillo D., 2008, NECROPOLIS MESOLITIC, P177; Carvalho AF, 2009, MONOGRAFIAS ARQUEOLO, P33; Chamizo E, 2008, NUCL INSTRUM METH B, V266, P2217, DOI 10.1016/j.nimb.2008.02.061; CHIMENOS E., 1992, MUNIBE, V8, P177; Cintas M, 2012, THESIS U AUTONOMA BA; Duday H, 1990, B MEM SOC ANTHRO PAR, V2, P39; Elder E, 2010, BRIT ARCHAEOLOGICA S, V2143; Aura JE, 2011, QUATERN INT, V242, P348, DOI 10.1016/j.quaint.2011.01.023; de Pablo JFL, 2013, J ARCHAEOL SCI, V40, P671, DOI 10.1016/j.jas.2012.09.005; Fulop RH, 2013, RADIOCARBON, V55, P491; Guixe EG, 2006, CURR ANTHROPOL, V47, P549, DOI 10.1086/504170; Gibaja JF, 2013, BRIT ARCHAEOLOGICA S, V2417; Grunberg JM, HALL C STAT IN PRESS; Hajdas I, 2009, RADIOCARBON, V51, P675, DOI 10.1017/S0033822200056010; Huls CM, 2009, RADIOCARBON, V51, P613, DOI 10.1017/S003382220005596X; Huls MC, 2007, RADIOCARBON, V49, P193, DOI 10.1017/S0033822200042119; Iriarte-Chiapusso M.J., 2010, ZEPHYRUS, V45, P117; Jackes M, 2004, DOCUMENTA PRAEHISTOR, V31, P89, DOI [10.4312/dp.31.7, DOI 10.4312/DP.31.7]; LARSSON L, 1990, J WORLD PREHIST, V4, P257, DOI 10.1007/BF00974882; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Marti Oliver B., 2009, MESOLITICO GEOMETRIC, P205; McClure SB, 2010, RADIOCARBON, V52, P25, DOI 10.1017/S0033822200045008; Meiklejohn C, 1998, HARVESTING SEA FARMI, P203; Meiklejohn C., 2009, MESOLITHIC MISCELLAN, V20, P4; Meiklejohn C, 2009, MESOLITH MISC, V20, P2; Olaria C, 2010, RESTOS VIDA RESTOS M, P175; Pequart M, 1934, ANTHROPOLOGIE, V44, P1; PEREZPEREZ A, 1995, HOMO, V45, P243; Pettitt P, 2011, PALAEOLITHIC ORIGINS OF HUMAN BURIAL, P1; Porras J, 2011, THESIS U AUTONOMA BA; Porras J, 2013, SERIE MONOGRAFICA MU, P495; Ramsey CB, 2010, RADIOCARBON, V52, P953, DOI 10.1017/S0033822200046063; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Reimer PJ, 2001, RADIOCARBON, V43, P461; Reimer PJ, 2002, RADIOCARBON, V44, P159, DOI 10.1017/S0033822200064766; Salazar-Garcia DC, 2014, J ARCHAEOL SCI, V42, P231, DOI 10.1016/j.jas.2013.11.006; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Schulting RJ, 1996, ANTIQUITY, V70, P335, DOI 10.1017/S0003598X00083319; Siani G, 2000, RADIOCARBON, V42, P271, DOI 10.1017/S0033822200059075; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; STUIVER M, 1993, RADIOCARBON, V35, P1, DOI 10.1017/S0033822200013874; Van Strydonck M, 2010, RADIOCARBON, V52, P578; Vidal JM, 2010, ESTUDIOS CATALOGOS J, V18; VINALS MJ, 1995, QUATERN INT, V30, P119; Wacker L, 2010, NUCL INSTRUM METH B, V268, P931, DOI 10.1016/j.nimb.2009.10.067; Wacker L, 2010, NUCL INSTRUM METH B, V268, P976, DOI 10.1016/j.nimb.2009.10.078; Zilhao J, 2001, P NATL ACAD SCI USA, V98, P14180, DOI 10.1073/pnas.241522898	67	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115505	10.1371/journal.pone.0115505	http://dx.doi.org/10.1371/journal.pone.0115505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629403	Green Submitted, Green Published, gold			2022-12-27	WOS:000348732100020
J	Mang, GM; Pradervand, S; Du, NH; Arpat, AB; Preitner, F; Wigger, L; Gatfield, D; Franken, P				Mang, Geraldine M.; Pradervand, Sylvain; Ngoc-Hien Du; Arpat, Alaaddin Bulak; Preitner, Frederic; Wigger, Leonore; Gatfield, David; Franken, Paul			A Neuron-Specific Deletion of the MicroRNA-Processing Enzyme DICER Induces Severe but Transient Obesity in Mice	PLOS ONE			English	Article							OVER-EXPRESSION; LEPTIN; MORPHOGENESIS; DEFICIENCY; METABOLISM; ACTIVATION; DISRUPTS; CORTEX	MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression post-transcriptionally. MiRNAs are implicated in various biological processes associated with obesity, including adipocyte differentiation and lipid metabolism. We used a neuronal-specific inhibition of miRNA maturation in adult mice to study the consequences of miRNA loss on obesity development. Camk2a-CreERT2 (Cre(+)) and floxed Dicer (Dicer(lox/lox)) mice were crossed to generate tamoxifen-inducible conditional Dicer knockouts (cKO). Vehicle- and/or tamoxifen-injected Cre(+); Dicer(lox/lox) and Cre(+); Dicer(+/+) served as controls. Four cohorts were used to a) measure body composition, b) follow food intake and body weight dynamics, c) evaluate basal metabolism and effects of food deprivation, and d) assess the brain transcriptome consequences of miRNA loss. cKO mice developed severe obesity and gained 18 g extra weight over the 5 weeks following tamoxifen injection, mainly due to increased fat mass. This phenotype was highly reproducible and observed in all 38 cKO mice recorded and in none of the controls, excluding possible effects of tamoxifen or the non-induced transgene. Development of obesity was concomitant with hyperphagia, increased food efficiency, and decreased activity. Surprisingly, after reaching maximum body weight, obese cKO mice spontaneously started losing weight as rapidly as it was gained. Weight loss was accompanied by lowered O-2-consumption and respiratory-exchange ratio. Brain transcriptome analyses in obese mice identified several obesity-related pathways (e.g. leptin, somatostatin, and nemo-like kinase signaling), as well as genes involved in feeding and appetite (e.g. Pmch, Neurotensin) and in metabolism (e.g. Bmp4, Bmp7, Ptger1, Cox7a1). A gene cluster with anti-correlated expression in the cerebral cortex of post-obese compared to obese mice was enriched for synaptic plasticity pathways. While other studies have identified a role for miRNAs in obesity, we here present a unique model that allows for the study of processes involved in reversing obesity. Moreover, our study identified the cortex as a brain area important for body weight homeostasis.	[Mang, Geraldine M.; Ngoc-Hien Du; Arpat, Alaaddin Bulak; Gatfield, David; Franken, Paul] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Preitner, Frederic] Univ Lausanne, Ctr Integrat Genom, Mouse Metab Evaluat Facil, Lausanne, Switzerland; [Pradervand, Sylvain; Wigger, Leonore] Univ Lausanne, Ctr Integrat Genom, Genom Technol Facil, Lausanne, Switzerland; [Pradervand, Sylvain; Arpat, Alaaddin Bulak; Wigger, Leonore] SIB Swiss Inst Bioinformat, Vital IT, Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Lausanne; Swiss Institute of Bioinformatics	Franken, P (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	paul.franken@unil.ch	Gatfield, David/C-2354-2011; Du, Ngoc-Hien/AAX-5215-2020; Franken, Paul/A-9633-2018; Arpat, Alaaddin Bulak/C-1336-2008	Gatfield, David/0000-0001-5114-2824; Franken, Paul/0000-0002-2500-2921; Arpat, Alaaddin Bulak/0000-0002-7749-3793	Swiss National Science Foundation (SNF) [130825, 136201, PP00P3 128399]; state of Vaud; Fondation Leenaards; Fondation Pierre Mercier; UNIL International PhD Program	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); state of Vaud; Fondation Leenaards; Fondation Pierre Mercier; UNIL International PhD Program	This study was supported by the Swiss National Science Foundation (SNF no 130825 and 136201 to PF; SNF professorship grant PP00P3 128399 to DG), the state of Vaud supporting GMM and PF, the Fondation Leenaards (DG) and the Fondation Pierre Mercier (DG). NHD received a fellowship from the UNIL International PhD Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2013, TRENDS CELL BIOL, V23, P30, DOI 10.1016/j.tcb.2012.08.013; BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breslow MJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE443, DOI 10.1152/ajpendo.1999.276.3.E443; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Crepin D, 2014, MOL CELL ENDOCRINOL, V384, P1, DOI 10.1016/j.mce.2013.12.016; Davidson TL, 2009, HIPPOCAMPUS, V19, P235, DOI 10.1002/hipo.20499; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dhar M, 2014, MOL ENDOCRINOL, V28, P1073, DOI 10.1210/me.2013-1332; Dorval V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044060; Elsen M, 2014, AM J PHYSIOL-CELL PH, V306, pC431, DOI 10.1152/ajpcell.00290.2013; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Greenman Y, 2013, MOL ENDOCRINOL, V27, P1091, DOI 10.1210/me.2012-1344; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Krill KT, 2013, MOL ENDOCRINOL, V27, P754, DOI 10.1210/me.2012-1331; Land BB, 2014, NAT NEUROSCI, V17, P248, DOI 10.1038/nn.3625; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu J, 2013, J MOL ENDOCRINOL, V50, P103, DOI 10.1530/JME-12-0099; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Ma XQ, 2014, MOL CELL BIOL, V34, P3607, DOI 10.1128/MCB.00583-14; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Metzger Daniel, 2011, Curr Protoc Mouse Biol, V1, P55, DOI 10.1002/9780470942390.mo100128; Mul JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019600; Du NH, 2014, ELIFE, V3, DOI 10.7554/eLife.02510; O'Carroll D, 2013, NEUROPSYCHOPHARMACOL, V38, P39, DOI 10.1038/npp.2012.87; Ohira K, 2013, NEUROPSYCHOPHARMACOL, V38, P909, DOI 10.1038/npp.2013.2; Opland D, 2013, MOL METAB, V2, P423, DOI 10.1016/j.molmet.2013.07.008; Parker JA, 2012, NEUROPHARMACOLOGY, V63, P18, DOI 10.1016/j.neuropharm.2012.02.004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pei YF, 2014, HUM MOL GENET, V23, P820, DOI 10.1093/hmg/ddt464; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Quennell JH, 2011, ENDOCRINOLOGY, V152, P1541, DOI 10.1210/en.2010-1100; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schneeberger M, 2013, MOL METAB, V2, P74, DOI 10.1016/j.molmet.2012.10.001; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sousa-Ferreira L, 2014, TRENDS ENDOCRIN MET, V25, P80, DOI 10.1016/j.tem.2013.10.005; Stengel Andreas, 2012, Front Endocrinol (Lausanne), V3, P178, DOI 10.3389/fendo.2012.00178; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Vinnikov IA, 2014, J NEUROSCI, V34, P10659, DOI 10.1523/JNEUROSCI.4251-13.2014; Williams MD, 2012, EXP DIABETES RES, DOI 10.1155/2012/484696; Yang ZG, 2007, ANN NEUROL, V61, P199, DOI 10.1002/ana.21068	49	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116760	10.1371/journal.pone.0116760	http://dx.doi.org/10.1371/journal.pone.0116760			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629159	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100049
J	Popescu, DM; Lipan, O				Popescu, Dan M.; Lipan, Ovidiu			A Kramers-Moyal Approach to the Analysis of Third-Order Noise with Applications in Option Valuation	PLOS ONE			English	Article								We propose the use of the Kramers-Moyal expansion in the analysis of third-order noise. In particular, we show how the approach can be applied in the theoretical study of option valuation. Despite Pawula's theorem, which states that a truncated model may exhibit poor statistical properties, we show that for a third-order Kramers-Moyal truncation model of an option's and its underlier's price, important properties emerge: (i) the option price can be written in a closed analytical form that involves the Airy function, (ii) the price is a positive function for positive skewness in the distribution, (iii) for negative skewness, the price becomes negative only for price values that are close to zero. Moreover, using third-order noise in option valuation reveals additional properties: (iv) the inconsistencies between two popular option pricing approaches (using a "delta-hedged" portfolio and using an option replicating portfolio) that are otherwise equivalent up to the second moment, (v) the ability to develop a measure R of how accurately an option can be replicated by a mixture of the underlying stocks and cash, (vi) further limitations of second-order models revealed by introducing third-order noise.	[Popescu, Dan M.; Lipan, Ovidiu] Univ Richmond, Dept Phys, Richmond, VA 23173 USA	University of Richmond	Lipan, O (corresponding author), Univ Richmond, Dept Phys, Richmond, VA 23173 USA.	olipan@richmond.edu						[Anonymous], GOOGL FIN STOCK MARK; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Brigo D., 2000, RISK, V13, P123; Frank T, 1996, FOKKER PLANCK EQUATI; Friedrich R, 2000, PHYS REV LETT, V84, P5224, DOI 10.1103/PhysRevLett.84.5224; Gardiner C., 2004, QUANTUM NOISE HDB MA; Hagan PS, 2004, WILMOTT, P84; HESTON SL, 1993, REV FINANC STUD, V6, P327, DOI 10.1093/rfs/6.2.327; Hull J, 1988, ADV FUTURES OPTIONS, V3, P29; JARROW R, 1982, J FINANC ECON, V10, P347, DOI 10.1016/0304-405X(82)90007-1; Kani I., 1994, RISK, V7, P32; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; MERTON RC, 1973, BELL J ECON, V4, P141, DOI 10.2307/3003143; MERTON RC, 1976, J FINANC ECON, V3, P125, DOI 10.1016/0304-405X(76)90022-2; MOYAL JE, 1949, J ROY STAT SOC B, V11, P150; PAWULA RF, 1967, PHYS REV, V162, P186, DOI 10.1103/PhysRev.162.186; Rubenstein Mark, 1994, J FINANC, V49, P771; Vallee O., 2004, AIRY FUNCTIONS APPL; Van Kampen NG, 1992, STOCHASTIC PROCESSES	20	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116752	10.1371/journal.pone.0116752	http://dx.doi.org/10.1371/journal.pone.0116752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625856	Green Submitted, gold, Green Published			2022-12-27	WOS:000348821400016
J	Huang, RX; Duan, YY; Hu, JA				Huang, Rui-Xue; Duan, Yan-Ying; Hu, Jian-An			Fish Intake and Risk of Liver Cancer: A Meta-Analysis	PLOS ONE			English	Article							N-3 FATTY-ACIDS; DOSE-RESPONSE DATA; HEPATOCELLULAR-CARCINOMA; CIGARETTE-SMOKING; TREND ESTIMATION; HEPATITIS-B; CONSUMPTION; INFECTION; COHORT; BIAS	Background Increasing laboratory findings indicate that n-3 fatty acids, mainly derived from fish, inhibit cancer development and progression, but results from epidemiologic studies have been inconsistent and inconclusive. Objective To evaluate the association of fish intake with risk of liver cancer by conducting a meta-analysis. Methods Published case-control/cohort studies that evaluated the relationship between total fish intake and risk of liver cancer were found on PubMed and EMBASE. The pooled relative risks (RRs) with 95% confidence intervals (CIs) were obtained with the random-effects model. Results Five retrospective case-control studies and 5 prospective cohort studies were included in the final analysis, involving a total of 3 624 liver cancer cases. Comparing the highest with the lowest category of total fish intake, the pooled RRs of liver cancer were 0.79 (95% CI, 0.59-1.06) for case-control studies, 0.82 (95% CI, 0.70-0.96) for cohort studies and 0.82 (95% CI, 0.71-0.94) for all studies combined. The protective effects of total fish intake against liver cancer were confirmed by stratified and sensitivity analyses. In addition, an increase in fish intake of 1 serving/week was estimated to be significantly associated with 6% lower risk of liver cancer (RR = 0.94, 95% CI, 0.91-0.98). Conclusions Findings from this meta-analysis suggest that a higher fish intake is associated with reduced risk of liver cancer.	[Huang, Rui-Xue; Duan, Yan-Ying; Hu, Jian-An] Cent S Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Changsha, Hunan, Peoples R China	Central South University	Hu, JA (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Changsha, Hunan, Peoples R China.	huja_xy@126.com						Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Daniel CR, 2011, CANCER PREV RES, V4, P1903, DOI 10.1158/1940-6207.CAPR-11-0241; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donaldson MS, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-19; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227; Fedirko V, 2013, ANN ONCOL, V24, P2166, DOI 10.1093/annonc/mdt168; Fernandez E, 1999, AM J CLIN NUTR, V70, P85; Freedman ND, 2012, GASTROENTEROLOGY, V142, P1411, DOI 10.1053/j.gastro.2012.04.038; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HIRAYAMA T, 1989, CANCER CHEMOTH PHARM, V23, pS114, DOI 10.1007/BF00647254; IKEDA M, 1983, GANN, V74, P640; Kanazir M, 2010, TUMORI J, V96, P911, DOI 10.1177/548.6508; Kurozawa Youichi, 2004, Kurume Medical Journal, V51, P141, DOI 10.2739/kurumemedj.51.141; LAM KC, 1982, CANCER RES, V42, P5246; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; LAVECCHIA C, 1988, INT J CANCER, V42, P872, DOI 10.1002/ijc.2910420614; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; LU SN, 1988, CANCER-AM CANCER SOC, V62, P2051, DOI 10.1002/1097-0142(19881101)62:9<2051::AID-CNCR2820620930>3.0.CO;2-1; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Ohishi W, 2011, HEPATOLOGY, V53, P1237, DOI 10.1002/hep.24207; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Qiu Xiao-qiang, 2008, Zhonghua Zhongliu Zazhi, V30, P113; Sawada N, 2012, GASTROENTEROLOGY, V142, P1468, DOI 10.1053/j.gastro.2012.02.018; SRIVATANAKUL P, 1991, INT J CANCER, V48, P329, DOI 10.1002/ijc.2910480303; Talamini R, 2006, INT J CANCER, V119, P2916, DOI 10.1002/ijc.22267; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Vedin I, 2008, AM J CLIN NUTR, V87, P1616, DOI 10.1093/ajcn/87.6.1616; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Wang MP, 2011, ANN EPIDEMIOL, V21, P164, DOI 10.1016/j.annepidem.2010.10.010; Wang Z J, 1996, Zhonghua Liu Xing Bing Xue Za Zhi, V17, P141; Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018; Yu SZ, 2002, JPN J CANCER RES, V93, P1287, DOI 10.1111/j.1349-7006.2002.tb01236.x	34	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0096102	10.1371/journal.pone.0096102	http://dx.doi.org/10.1371/journal.pone.0096102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615823	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100001
J	Winter, D; Herbert, C; Koplin, K; Schmahl, C; Bohus, M; Lis, S				Winter, Dorina; Herbert, Cornelia; Koplin, Katrin; Schmahl, Christian; Bohus, Martin; Lis, Stefanie			Negative Evaluation Bias for Positive Self-Referential Information in Borderline Personality Disorder	PLOS ONE			English	Article							EMOTIONAL ADJECTIVES; CAUSAL ATTRIBUTIONS; DEPRESSION; MEMORY; REPRESENTATIONS; METAANALYSIS; TRAITS; STYLE; FMRI	Previous research has suggested that patients meeting criteria for borderline personality disorder (BPD) display altered self-related information processing. However, experimental studies on dysfunctional self-referential information processing in BPD are rare. In this study, BPD patients (N = 30) and healthy control participants (N = 30) judged positive, neutral, and negative words in terms of emotional valence. Referential processing was manipulated by a preceding self-referential pronoun, an other-referential pronoun, or no referential context. Subsequently, patients and participants completed a free recall and recognition task. BPD patients judged positive and neutral words as more negative than healthy control participants when the words had self-reference or no reference. In BPD patients, these biases were significantly correlated with self-reported attributional style, particularly for negative events, but unrelated to measures of depressive mood. However, BPD patients did not differ from healthy control participants in a subsequent free recall task and a recognition task. Our findings point to a negative evaluation bias for positive, self-referential information in BPD. This bias did not affect the storage of information in memory, but may be related to self-attributions of negative events in everyday life in BPD.	[Winter, Dorina; Koplin, Katrin; Schmahl, Christian; Bohus, Martin; Lis, Stefanie] Heidelberg Univ, Dept Psychosomat Med & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany; [Herbert, Cornelia] Univ Tubingen, Dept Psychiat, Tubingen, Germany; [Herbert, Cornelia] Univ Tubingen, Dept Biomed Resonance Imaging, Tubingen, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Winter, D (corresponding author), Heidelberg Univ, Dept Psychosomat Med & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany.	Dorina.Winter@zi-mannheim.de	Schmahl, Christian/E-8760-2012	Lis, Stefanie/0000-0002-8051-2756; Schmahl, Christian/0000-0003-0141-0821	German Research Foundation [KFO 256]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the German Research Foundation (KFO 256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer RA, 2012, CLIN PSYCHOL REV, V32, P359, DOI 10.1016/j.cpr.2012.03.002; Barnow S, 2009, BEHAV RES THER, V47, P359, DOI 10.1016/j.brat.2009.02.003; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bender DS, 2007, J PERS DISORD, V21, P500, DOI 10.1521/pedi.2007.21.5.500; Bohus M, 2009, PSYCHOPATHOLOGY, V42, P32, DOI 10.1159/000173701; BREWIN CR, 1985, PSYCHOL BULL, V98, P297, DOI 10.1037/0033-2909.98.2.297; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Di Simplicio M, 2014, PSYCHOL MED, V44, P241, DOI 10.1017/S0033291713000731; Dibble JL, 2012, PSYCHOL ASSESSMENT, V24, P565, DOI 10.1037/a0026265; Domes G, 2008, J PERS DISORD, V22, P135, DOI 10.1521/pedi.2008.22.2.135; Domsalla M, 2014, SOC COGN AFFECT NEUR, V9, P1789, DOI 10.1093/scan/nst176; EISENSTADT D, 1994, J PERS SOC PSYCHOL, V67, P611, DOI 10.1037/0022-3514.67.4.611; Fossati P, 2004, NEUROIMAGE, V22, P1596, DOI 10.1016/j.neuroimage.2004.03.034; Fukami G, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-37; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Herbert C, 2013, SOC COGN AFFECT NEUR, V8, P654, DOI 10.1093/scan/nss043; Herbert C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00378; Herbert C, 2011, SOC COGN AFFECT NEUR, V6, P653, DOI 10.1093/scan/nsq082; Herbert C, 2011, SOC NEUROSCI-UK, V6, P277, DOI 10.1080/17470919.2010.523543; JONES RA, 1974, J PERS SOC PSYCHOL, V30, P36, DOI 10.1037/h0036674; Kinderman P, 1997, J ABNORM PSYCHOL, V106, P341, DOI 10.1037/0021-843X.106.2.341; Kopala-Sibley DC, 2012, J ABNORM PSYCHOL, V121, P680, DOI 10.1037/a0028513; Lazarus SA, 2014, CLIN PSYCHOL REV, V34, P193, DOI 10.1016/j.cpr.2014.01.007; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Lis S, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0338-z; Loranger A. W, 1999, INT PERSONALITY DISO; Lynum LI, 2008, SCAND J PSYCHOL, V49, P469, DOI 10.1111/j.1467-9450.2008.00655.x; Morey LC, 2014, BORDER PERS DIS EMOT, V1, DOI 10.1186/2051-6673-1-4; Moritz S, 2013, NEUROPHARMACOLOGY, V72, P179, DOI 10.1016/j.neuropharm.2013.04.039; Moritz S, 2011, J BEHAV THER EXP PSY, V42, P349, DOI 10.1016/j.jbtep.2011.02.003; Nakao T, 2005, PSYCHOL REP, V96, P1055, DOI 10.2466/pr0.96.3c.1055-1065; Nicol K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073440; NIGG JT, 1992, J ABNORM PSYCHOL, V101, P61, DOI 10.1037/0021-843X.101.1.61; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Poppe P, 2005, ATTRIBUTIONSSTILFRAG, DOI [10.1111/cei.12527, DOI 10.1111/CEI.12527]; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Rusch N, 2007, AM J PSYCHIAT, V164, P500, DOI 10.1176/appi.ajp.164.3.500; Russell JJ, 2007, J ABNORM PSYCHOL, V116, P578, DOI 10.1037/0021-843X.116.3.578; SELIGMAN MEP, 1986, J PERS SOC PSYCHOL, V50, P832, DOI 10.1037/0022-3514.50.4.832; SWEENEY PD, 1986, J PERS SOC PSYCHOL, V50, P974, DOI 10.1037/0022-3514.50.5.974; Symons CS, 1997, PSYCHOL BULL, V121, P371, DOI 10.1037/0033-2909.121.3.371; Unoka ZS, 2014, J PERS DISORD, P1; van den Heuvel TJ, 2012, BRIT J CLIN PSYCHOL, V51, P376, DOI 10.1111/j.2044-8260.2012.02034.x; Walla P, 2007, NEUROPSYCHOLOGIA, V45, P796, DOI 10.1016/j.neuropsychologia.2006.08.017; Weiner B., 1986, ATTRIBUTION THEORY M, DOI [10.1007/978-1-4612-4948-1, DOI 10.1007/978-1-4612-4948-1]; Winter D, 2014, PSYCHOPATHOLOGY, V47, P71, DOI 10.1159/000356360; Wisco BE, 2009, CLIN PSYCHOL REV, V29, P382, DOI 10.1016/j.cpr.2009.03.003; Wittchen H. U., 1997, SKID STRUKTURIERTES, VI; Wood JV, 2009, PSYCHOL SCI, V20, P860, DOI 10.1111/j.1467-9280.2009.02370.x	52	41	41	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117083	10.1371/journal.pone.0117083	http://dx.doi.org/10.1371/journal.pone.0117083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UU	25612212	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900033
J	Niu, YX; Jiang, ML; Guo, M; Wan, CY; Hu, SX; Jin, H; Huang, FH				Niu, Yanxing; Jiang, Mulan; Guo, Mian; Wan, Chuyun; Hu, Shuangxi; Jin, Hu; Huang, Fenghong			Characterization of the Factors that Influence Sinapine Concentration in Rapeseed Meal during Fermentation	PLOS ONE			English	Article							ACID-DERIVATIVES; LACCASE; PERFORMANCE; BIODIESEL; PHENOLS; GROWTH	We analyzed and compared the difference in sinapine concentration in rapeseed meal between the filamentous fungus, Trametes sp 48424, and the yeast, Saccharomyces cerevisiae, in both liquid and solid-state fermentation. During liquid and solid-state fermentation by Trametes sp 48424, the sinapine concentration decreased significantly. In contrast, the liquid and solid-state fermentation process by Saccharomyces cerevisiae just slightly decreased the sinapine concentration (P <= 0.05). After the solid-state fermented samples were dried, the concentration of sinapine in rapeseed meal decreased significantly in Saccharomyces cerevisiae. Based on the measurement of laccase activity, we observed that laccase induced the decrease in the concentration of sinapine during fermentation with Trametes sp 48424. In order to eliminate the influence of microorganisms and the metabolites produced during fermentation, high moisture rapeseed meal and the original rapeseed meal were dried at 90 degrees C and 105 degrees C, respectively. During drying, the concentration of sinapine in high moisture rapeseed meal decreased rapidly and we obtained a high correlation coefficient between the concentration of sinapine and loss of moisture. Our results suggest that drying and enzymes, especially laccase that is produced during the solid-state fermentation process, may be the main factors that affect the concentration of sinapine in rapeseed meal.	[Niu, Yanxing; Jiang, Mulan; Guo, Mian; Wan, Chuyun; Hu, Shuangxi; Jin, Hu; Huang, Fenghong] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China; [Niu, Yanxing; Jiang, Mulan; Guo, Mian; Wan, Chuyun; Hu, Shuangxi; Jin, Hu; Huang, Fenghong] Hubei Key Lab Lipid Chem & Nutr, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS	Huang, FH (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China.	huangfh@oilcrops.cn	Niu, Yanxing/GLV-2117-2022		National Natural Science Foundation of China [31071637]; earmarked fund for Modern Agro-industry Technology Research System	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Modern Agro-industry Technology Research System	This work was supported by National Natural Science Foundation of China (31071637). FH received the funding http://www.nsfc.gov.cn/ and the earmarked fund for Modern Agro-industry Technology Research System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai R, 1999, J AM OIL CHEM SOC, V76, P757, DOI 10.1007/s11746-999-0172-6; Chabanon G, 2007, PROCESS BIOCHEM, V42, P1419, DOI 10.1016/j.procbio.2007.07.009; Fan FF, 2011, BIORESOURCE TECHNOL, V102, P3126, DOI 10.1016/j.biortech.2010.10.079; Fang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048006; Fang JJ, 2012, J AGR FOOD CHEM, V60, P10523, DOI 10.1021/jf303907b; Fleddermann M, 2012, CLIN NUTR, P1; Fu JJ, 2012, BIOCATAL BIOTRANSFOR, V30, P125, DOI [10.3109/10242422.2012.649563, 10.3109/10242422.2012.650450]; Gasiorek E, 2011, POL J CHEM TECHNOL, V13, P58, DOI 10.2478/v10026-011-0012-y; Hu J, 2004, ENG LIFE SCI, V4, P50, DOI 10.1002/elsc.200400005; Jeon JR, 2012, MICROB BIOTECHNOL, V5, P318, DOI 10.1111/j.1751-7915.2011.00273.x; Jeon JR, 2010, MICROB BIOTECHNOL, V3, P324, DOI 10.1111/j.1751-7915.2009.00153.x; Jin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111171; Khattab R, 2010, J AM OIL CHEM SOC, V87, P147, DOI 10.1007/s11746-009-1486-0; Lacki K, 1997, CHEM ENG J, V65, P27; Liu Q, 2012, FOOD CHEM, V135, P616, DOI 10.1016/j.foodchem.2012.04.142; Lomascolo A, 2012, APPL MICROBIOL BIOT, V95, P1105, DOI 10.1007/s00253-012-4250-6; Luo YW, 2012, AQUACULTURE, V368, P109, DOI 10.1016/j.aquaculture.2012.09.013; Niu YX, 2013, J AM OIL CHEM SOC, V90, P307, DOI 10.1007/s11746-012-2167-y; Qian JF, 2013, BIORESOURCE TECHNOL, V128, P8, DOI 10.1016/j.biortech.2012.10.017; Qiao H, 2002, NUTR PHYSL METABOLIC; Rozan P, 1996, INT J FOOD SCI TECH, V31, P85, DOI 10.1111/j.1365-2621.1996.17-315.x; Vig AP, 2001, BIORESOURCE TECHNOL, V78, P309, DOI 10.1016/S0960-8524(01)00030-X; Ward AK, 2009, POULTRY SCI, V88, P714, DOI 10.3382/ps.2008-00430; [肖翼 Xiao Yi], 2011, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V26, P79	24	9	10	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116470	10.1371/journal.pone.0116470	http://dx.doi.org/10.1371/journal.pone.0116470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25606856	Green Published, Green Submitted, gold			2022-12-27	WOS:000348205300027
J	Furukawa, M; Wheeler, S; Clark, AM; Wells, A				Furukawa, Masashi; Wheeler, Sarah; Clark, Amanda M.; Wells, Alan			Lung Epithelial Cells Induce Both Phenotype Alteration and Senescence in Breast Cancer Cells	PLOS ONE			English	Article							E-CADHERIN; MESENCHYMAL TRANSITION; CARCINOMA-CELLS; TUMOR-CELLS; METASTASIS; MICROMETASTASES; PROGRESSION; EXPRESSION; SURVIVAL; CULTURE	Purpose The lung is one of the most common sites of breast cancer metastasis. While metastatic seeding is often accompanied by a dormancy-promoting mesenchymal to epithelial reverting transitions (MErT), we aimed to determine whether lung epithelial cells can impart this phenotype on aggressive breast cancer cells. Methods Co-culture experiments of normal lung epithelial cell lines (SAEC, NHBE or BEAS-2B) and breast cancer cell lines (MCF-7 or MDA-MB-231) were conducted. Flow cytometry analysis, immunofluorescence staining for E-cadherin or Ki-67 and senescence associated betagalactosidase assays assessed breast cancer cell outgrowth and phenotype. Results Co-culture of the breast cancer cells with the normal lung cells had different effects on the epithelial and mesenchymal carcinoma cells. The epithelialMCF-7 cells were increased in number but still clustered even if in a slightlymore mesenchymal-spindle morphology. On the other hand, the mesenchymal MDA-MB-231 cells survived but did not progressively grow out in co-culture. These aggressive carcinoma cells underwent an epithelial shift as indicated by cuboidal morphology and increased E-cadherin. Disruption of E-cadherin expressed in MDAMB- 231 using shRNA prevented this phenotypic reversion in co-culture. Lung cells limited cancer cell growth kinetics as noted by both (1) some of the cells becoming larger and positive for senescencemarkers/negative for proliferation marker Ki-67, and (2) Ki-67 positive cells significantly decreasing in MDA-MB-231 and MCF-7 cells after co-culture. Conclusions Our data indicate that normal lung epithelial cells can drive an epithelial phenotype and suppress the growth kinetics of breast cancer cells coincident with changing their phenotypes.	[Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; Pittsburgh VA Hlth Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	wellsa@upmc.edu	Clark, Amanda/X-2325-2019; Furukawa, Masashi/ABG-5947-2021	Clark, Amanda/0000-0003-1590-2560; Furukawa, Masashi/0000-0001-8102-9072; Wells, Alan/0000-0002-1637-8150; Wheeler, Sarah/0000-0002-7851-9836	National Institutes of Health [NCATS UH2TR000496]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000496, UH3TR000496] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	VA Merit award and a grant from National Institutes of Health (NCATS UH2TR000496). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukholm IK, 2000, J PATHOL, V190, P15; Bussard KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049221; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Chao Y, 2012, CANCER MICROENVIRON, V5, P19, DOI 10.1007/s12307-011-0085-4; Chao Y, 2012, CLIN EXP METASTAS, V29, P39, DOI 10.1007/s10585-011-9427-3; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Clark AM, 2014, EXP BIOL MED, V239, P1170, DOI 10.1177/1535370214532596; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Li M, 2010, J BIOL CHEM, V285, P6285, DOI 10.1074/jbc.M109.057943; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001; Rosenfield Sonia M, 2013, Cells, V2, P43, DOI 10.3390/cells2010043; Ruan JW, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3226; Taylor DP, 2014, BREAST CANCER RES TR, V144, P551, DOI 10.1007/s10549-014-2875-0; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Venturelli S, 2013, MOL CANCER THER, V12, P2226, DOI 10.1158/1535-7163.MCT-13-0137; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Wheeler SE, 2014, BRIT J CANC IN PRESS; Yates CC, 2007, BRIT J CANCER, V96, P1246, DOI 10.1038/sj.bjc.6603700; Yates C, 2007, ADV CANCER RES, V97, P225, DOI 10.1016/S0065-230X(06)97010-9	27	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0118060	10.1371/journal.pone.0118060	http://dx.doi.org/10.1371/journal.pone.0118060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635394	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000350680700114
J	Hussain, MI; Reigosa, MJ				Hussain, M. Iftikhar; Reigosa, Manuel J.			Characterization of Xanthophyll Pigments, Photosynthetic Performance, Photon Energy Dissipation, Reactive Oxygen Species Generation and Carbon Isotope Discrimination during Artemisinin-Induced Stress in Arabidopsis thaliana	PLOS ONE			English	Article							LEAF WATER RELATIONS; SESQUITERPENE LACTONES; NATURAL-PRODUCTS; ANNUA L.; GROWTH; LEAVES; ACID; BIOSYNTHESIS; LOCALIZATION; ALLELOPATHY	Artemisinin, a potent antimalarial drug, is phytotoxic to many crops and weeds. The effects of artemisinin on stress markers, including fluorescence parameters, photosystem II photochemistry, photon energy dissipation, lipid peroxidation, reactive oxygen species generation and carbon isotope discrimination in Arabidopsis thaliana were studied. Arabidopsis ecotype Columbia (Col-0) seedlings were grown in perlite and watered with 50% Hoagland nutrient solution. Adult plants of Arabidopsis were treated with artemisinin at 0, 40, 80, 160 mu M for one week. Artemisinin, in the range 40-160 mu M, decreased the fresh biomass, chl a, b and leaf mineral contents. Photosynthetic efficiency, yield and electron transport rate in Arabidopsis were also reduced following exposure to 80 and 160 mu M artemisinin. The phi(NPQ) and NPQ were less than control. Artemisinin treatment caused an increase in root oxidizability and lipid peroxidation (MDA contents) of Arabidopsis. Calcium and nitrogen contents decreased after 80 and 160 mu M artemisinin treatment compared to control. delta C-13 values were less negative following treatment with artemisinin as compared to the control. Artemisinin also decreased leaf protein contents in Arabidopsis. Taken together, these data suggest that artemisinin inhibits many physiological and biochemical processes in Arabidopsis.	[Hussain, M. Iftikhar; Reigosa, Manuel J.] Univ Vigo, Dept Plant Biol & Soil Sci, Vigo 36310, Spain; [Hussain, M. Iftikhar] Int Ctr Biosaline Agr, Dubai, U Arab Emirates	Universidade de Vigo	Hussain, MI (corresponding author), Univ Vigo, Dept Plant Biol & Soil Sci, Campus Lagoas Marcosende, Vigo 36310, Spain.	mih76@uvigo.es	Hussain, M. Iftikhar/Y-3575-2018; Roger, Manuel Joaquín Reigosa/O-4438-2019; Reigosa, Manuel J/K-3551-2013; Hussain, M. Iftikhar/AGQ-4987-2022	Hussain, M. Iftikhar/0000-0002-9710-3801; Roger, Manuel Joaquín Reigosa/0000-0003-0527-1849; Reigosa, Manuel J/0000-0003-0527-1849; Hussain, M. Iftikhar/0000-0002-9710-3801	Galician Government [10PXIB310261PR]; project (subprograma AGR) "Estudio del modo de accion del citral en la respuesta temprana de plantas superiors" - Ministerio de Ciencia e Innovacion [AGL2010-17885]	Galician Government; project (subprograma AGR) "Estudio del modo de accion del citral en la respuesta temprana de plantas superiors" - Ministerio de Ciencia e Innovacion	The research was supported by project 10PXIB310261PR from the Galician Government and project AGL2010-17885 (subprograma AGR) "Estudio del modo de accion del citral en la respuesta temprana de plantas superiors" funded by Ministerio de Ciencia e Innovacion. Subdireccion General de Proyectos de Investigacion Proyectos de Investigacion Fundamental no orientada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenavoli MR, 2001, NEW PHYTOL, V150, P619, DOI 10.1046/j.1469-8137.2001.00119.x; Bagchi G. D., 1998, Journal of Medicinal and Aromatic Plant Sciences, V20, P5; Bagchi GD, 1997, PHYTOCHEMISTRY, V45, P1131, DOI 10.1016/S0031-9422(97)00126-X; Barbagallo RP, 2003, PLANT PHYSIOL, V132, P485, DOI 10.1104/pp.102.018093; Barkosky RR, 2000, J CHEM ECOL, V26, P2095, DOI 10.1023/A:1005564315131; Bathellier C, 2008, NEW PHYTOL, V177, P406, DOI 10.1111/j.1469-8137.2007.02246.x; Bharati A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038942; Bohnert HJ, 1998, CURR OPIN PLANT BIOL, V1, P267, DOI 10.1016/S1369-5266(98)80115-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cernusak LA, 2013, NEW PHYTOL, V200, P950, DOI 10.1111/nph.12423; CHEN PK, 1991, J AGR FOOD CHEM, V39, P991, DOI 10.1021/jf00005a038; CHEN PK, 1990, J CHEM ECOL, V16, P1867, DOI 10.1007/BF01020500; Davies MJ, 2009, ANN BOT-LONDON, V104, P315, DOI 10.1093/aob/mcp126; Dayan FE, 2000, J CHEM ECOL, V26, P2079, DOI 10.1023/A:1005512331061; Dayan FE, 1999, PHYTOCHEMISTRY, V50, P607, DOI 10.1016/S0031-9422(98)00568-8; Dayan FE, 2012, PEST MANAG SCI, V68, P519, DOI 10.1002/ps.2332; Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046; Delabays N, 2001, CURR MED CHEM, V8, P1795, DOI 10.2174/0929867013371635; DITOMASO JM, 1991, PESTIC BIOCHEM PHYS, V39, P158, DOI 10.1016/0048-3575(91)90136-A; DUKE MV, 1994, INT J PLANT SCI, V155, P365, DOI 10.1086/297173; DUKE SO, 1987, WEED SCI, V35, P499, DOI 10.1017/S0043174500060458; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hussain MI, 2014, PAK J BOT, V46, P995; Hussain MI, 2012, AUST J BOT, V60, P676, DOI 10.1071/BT12072; Hussain MI, 2011, J EXP BOT, V62, P4533, DOI 10.1093/jxb/err161; Hussain MI, 2011, PLANT PHYSIOL BIOCH, V49, P825, DOI 10.1016/j.plaphy.2011.05.003; Imai K, 2008, ANN BOT-LONDON, V101, P135, DOI 10.1093/aob/mcm270; Inderjit, 2003, PLANTA, V217, P529, DOI 10.1007/s00425-003-1054-z; Inderjit, 2007, J PLANT INTERACT, V1, P69; Jessing KK, 2014, J CHEM ECOL, V40, P100, DOI 10.1007/s10886-014-0384-6; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Liu J, 2008, J PLANT BIOL, V51, P11, DOI 10.1007/BF03030735; Lommen WJM, 2007, PLANTA MED, V73, P1133, DOI 10.1055/s-2007-981567; Lydon J, 1997, WEED SCI, V45, P807, DOI 10.1017/S0043174500089001; Macias FA, 2000, J AGR FOOD CHEM, V48, P5288, DOI 10.1021/jf0005364; Macias FA, 2007, PEST MANAG SCI, V63, P327, DOI 10.1002/ps.1342; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; Narwal SS, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P537, DOI 10.1007/1-4020-4280-9_24; Olsson ME, 2009, PHYTOCHEMISTRY, V70, P1123, DOI 10.1016/j.phytochem.2009.07.009; Robertson A, 2001, J GEOPHYS RES-ATMOS, V106, P14783, DOI 10.1029/2000JD900469; SALSAC L, 1987, PLANT PHYSIOL BIOCH, V25, P805; Sanchez-Moreiras AM, 2008, PHYTOCHEMISTRY, V69, P2172, DOI 10.1016/j.phytochem.2008.05.014; Sanchez-Moreiras AM, 2011, J PLANT PHYSIOL, V168, P863, DOI 10.1016/j.jplph.2010.11.011; Shen HC, 1991, J ZHEJIANG AGR U, V17, P423; Spundova M, 2003, J PLANT PHYSIOL, V160, P1051, DOI 10.1078/0176-1617-00902; STILES LH, 1994, J CHEM ECOL, V20, P969, DOI 10.1007/BF02059591; Weathers PJ, 2006, IN VITRO CELL DEV-PL, V42, P309, DOI 10.1079/IVP2006782; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Weston LA, 1996, AGRON J, V88, P860, DOI 10.2134/agronj1996.00021962003600060004x; Xu Q, 1995, ENVIRON EXP BOT, V35, P441, DOI 10.1016/0098-8472(95)00040-2; Yang RY, 2010, PLANTA MED, V76, P734, DOI 10.1055/s-0029-1240620	57	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0114826	10.1371/journal.pone.0114826	http://dx.doi.org/10.1371/journal.pone.0114826			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635811	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700005
J	Jashashvili, T; Dowdeswell, MR; Lebrun, R; Carlson, KJ				Jashashvili, Tea; Dowdeswell, Mark R.; Lebrun, Renaud; Carlson, Kristian J.			Cortical Structure of Hallucal Metatarsals and Locomotor Adaptations in Hominoids	PLOS ONE			English	Article							CROSS-SECTIONAL GEOMETRY; BONE FUNCTIONAL ADAPTATION; IN-VIVO; FOOT BONES; AUSTRALOPITHECUS-AFARENSIS; DIAPHYSEAL STRUCTURE; ANATOMICAL EVIDENCE; MORPHOMETRIC MAPS; MIDTARSAL BREAK; HUMAN SKELETONS	Diaphyseal morphology of long bones, in part, reflects in vivo loads experienced during the lifetime of an individual. The first metatarsal, as a cornerstone structure of the foot, presumably expresses diaphyseal morphology that reflects loading history of the foot during stance phase of gait. Human feet differ substantially from those of other apes in terms of loading histories when comparing the path of the center of pressure during stance phase, which reflects different weight transfer mechanisms. Here we use a novel approach for quantifying continuous thickness and cross-sectional geometric properties of long bones in order to test explicit hypotheses about loading histories and diaphyseal structure of adult chimpanzee, gorilla, and human first metatarsals. For each hallucal metatarsal, 17 cross sections were extracted at regularly-spaced intervals (2.5% length) between 25% and 65% length. Cortical thickness in cross sections was measured in one degree radially-arranged increments, while second moments of area were measured about neutral axes also in one degree radially-arranged increments. Standardized thicknesses and second moments of area were visualized using false color maps, while penalized discriminant analyses were used to evaluate quantitative species differences. Humans systematically exhibit the thinnest diaphyseal cortices, yet the greatest diaphyseal rigidities, particularly in dorsoplantar regions. Shifts in orientation of maximum second moments of area along the diaphysis also distinguish human hallucal metatarsals from those of chimpanzees and gorillas. Diaphyseal structure reflects different loading regimes, often in predictable ways, with human versus non-human differences probably resulting both from the use of arboreal substrates by non-human apes and by differing spatial relationships between hallux position and orientation of the substrate reaction resultant during stance. The novel morphological approach employed in this study offers the potential for transformative insights into form-function relationships in additional long bones, including those of extinct organisms (e.g., fossils).	[Jashashvili, Tea; Carlson, Kristian J.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Jashashvili, Tea] Georgian Natl Museum, Dept Geol & Palaeontol, Tbilisi, Georgia; [Dowdeswell, Mark R.] Univ Witwatersrand, Sch Stat & Actuarial Sci, ZA-2050 Johannesburg, South Africa; [Lebrun, Renaud] Inst Sci Evolut Montpellier, UMR 5554, Montpellier, France; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA	University of Witwatersrand; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Indiana University System; Indiana University Bloomington	Jashashvili, T (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa.	tjashashvili@yahoo.fr		Lebrun, Renaud/0000-0002-5819-2653; Dowdeswell, Mark/0000-0003-0200-653X	post-doctoral fellowship from the Claude Leon Foundation; Strategic Planning and Allocation of Resources Committee at the University of the Witwatersrand; South African Department of Science and Technology; National Research Foundation; Centre of Excellence in Palaeosciences; Evolutionary Studies Institute at the University of the Witwatersrand	post-doctoral fellowship from the Claude Leon Foundation; Strategic Planning and Allocation of Resources Committee at the University of the Witwatersrand; South African Department of Science and Technology; National Research Foundation; Centre of Excellence in Palaeosciences; Evolutionary Studies Institute at the University of the Witwatersrand	TJ was funded by a post-doctoral fellowship from the Claude Leon Foundation and the Strategic Planning and Allocation of Resources Committee at the University of the Witwatersrand. The South African Department of Science and Technology and the National Research Foundation, as well as the Centre of Excellence in Palaeosciences and the Evolutionary Studies Institute at the University of the Witwatersrand provided funding in support of the Virtual Imaging in Palaeosciences laboratory. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; ARCHIBALD JD, 1972, AM J PHYS ANTHROPOL, V37, P93, DOI 10.1002/ajpa.1330370112; Arndt A, 2002, J BIOMECH, V35, P621, DOI 10.1016/S0021-9290(01)00241-X; BOJSENMOLLER F, 1979, J ANAT, V129, P165; Bondioli L, 2010, AM J PHYS ANTHROPOL, V142, P328, DOI 10.1002/ajpa.21271; Caravaggi P, 2009, J EXP BIOL, V212, P2491, DOI 10.1242/jeb.025767; Carlson K, 2008, INT J PRIMATOL, V29, P1401, DOI 10.1007/s10764-008-9297-y; Carlson KJ, 2006, J HUM EVOL, V50, P394, DOI 10.1016/j.jhevol.2005.10.004; Carlson KJ, 2005, AM J PHYS ANTHROPOL, V127, P312, DOI 10.1002/ajpa.20124; Carlson KJ, 2014, RECONSTRUCTING MOBIL, DOI [10.1002/ajpa.22673, DOI 10.1002/AJPA.22673]; Carlson KJ, 2007, J EXP BIOL, V210, P3117, DOI 10.1242/jeb.006544; Cartmill M., 1974, P45; D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; DAout K., 2008, ADV PLANTAR PRESSURE, P44; Davies T.G., 2014, RECONSTRUCTING MOBIL, P67, DOI [DOI 10.1007/978-1-4899-7460-0, 10.1007/978-1-4899-7460-0_5]; DAY MH, 1964, NATURE, V201, P969, DOI 10.1038/201969a0; Dayal MR, 2009, AM J PHYS ANTHROPOL, V140, P324, DOI 10.1002/ajpa.21072; DEMES B, 1991, AM J PHYS ANTHROPOL, V86, P537, DOI 10.1002/ajpa.1330860409; Demes B, 2007, AM J PHYS ANTHROPOL, V133, P717, DOI 10.1002/ajpa.20584; DeSilva JM, 2010, AM J PHYS ANTHROPOL, V141, P245, DOI 10.1002/ajpa.21140; Donahue SW, 1999, J BONE JOINT SURG AM, V81A, P1236, DOI 10.2106/00004623-199909000-00005; Doran Diane M., 1996, P213, DOI 10.1017/CBO9780511752414.018; Elftman H, 1935, J ANAT, V70, P56; Frost HM, 1997, J BONE MINER RES, V12, P1539, DOI 10.1359/jbmr.1997.12.10.1539; Gebo Daniel L., 1993, P175; Gebol DL, 2006, AM J PHYS ANTHROPOL, V129, P499, DOI 10.1002/ajpa.20320; GOMBERG DN, 1985, J HUM EVOL, V14, P553, DOI 10.1016/S0047-2484(85)80080-4; Griffin NL, 2008, HOMO, V59, P27, DOI 10.1016/j.jchb.2006.08.008; Griffin NL, 2010, J HUM EVOL, V59, P608, DOI 10.1016/j.jhevol.2010.07.017; Griffin NL, 2005, BONE, V37, P253, DOI 10.1016/j.bone.2005.04.019; HASTIE T, 1995, ANN STAT, V23, P73, DOI 10.1214/aos/1176324456; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; HICKS JH, 1954, J ANAT, V88, P25; Johnstone IM, 2009, PHILOS T R SOC A, V367, P4237, DOI 10.1098/rsta.2009.0159; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Kidd RS, 1998, FOOT, V8, P75; Kraft TS, 2014, J HUM EVOL, V71, P105, DOI 10.1016/j.jhevol.2014.02.002; LATIMER B, 1990, AM J PHYS ANTHROPOL, V82, P125, DOI 10.1002/ajpa.1330820202; Lazenby RA, 1998, AM J PHYS ANTHROPOL, V106, P157; Lewis O.J., 1989, FUNCTIONAL MORPHOLOG; LEWIS OJ, 1980, J ANAT, V131, P275; Lieberman DE, 2004, AM J PHYS ANTHROPOL, V123, P156, DOI 10.1002/ajpa.10316; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; LOVEJOY CO, 1976, AM J PHYS ANTHROPOL, V44, P489, DOI 10.1002/ajpa.1330440312; Lundgren P, 2008, GAIT POSTURE, V28, P93, DOI 10.1016/j.gaitpost.2007.10.009; Marchi D, 2005, J HUM EVOL, V49, P743, DOI 10.1016/j.jhevol.2005.08.002; Martin RB, 1998, SKELETAL TISSUE MECH; Mays SA, 2002, J ARCHAEOL SCI, V29, P435, DOI 10.1006/jasc.2002.0729; Morimoto N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102074; Morimoto N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041980; Morimoto N, 2011, ANAT REC, V294, P1433, DOI 10.1002/ar.21424; Morimoto N, 2011, ANAT REC, V294, P589, DOI 10.1002/ar.21346; Morton D.J., 1935, HUMAN FOOT ITS EVOLU; MOTT RL, 1996, APPL STRENGTH MAT; Nowak MG, 2010, AM J PHYS ANTHROPOL, V142, P180, DOI 10.1002/ajpa.21210; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Polk JD, 2000, J HUM EVOL, V39, P297, DOI 10.1006/jhev.2000.0420; Preuschoft H., 1970, THE CHIMPANZEE, V3, P221; Puymerail L, 2012, J HUM EVOL, V63, P741, DOI 10.1016/j.jhevol.2012.08.003; Richmond BG, 2007, J HUM EVOL, V53, P678, DOI 10.1016/j.jhevol.2007.05.011; RIESENFELD A, 1974, Primates, V15, P1, DOI 10.1007/BF01749589; RODGERS MM, 1995, J ORTHOP SPORT PHYS, V21, P306, DOI 10.2519/jospt.1995.21.6.306; Rolian C, 2009, J EXP BIOL, V212, P713, DOI 10.1242/jeb.019885; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ruff C.B., 1999, PREHISTORIC LIFEWAYS, P290; RUFF CB, 1992, ANNU REV ANTHROPOL, V21, P407; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; RUFF CB, 1991, AM J PHYS ANTHROPOL, V86, P397, DOI 10.1002/ajpa.1330860306; SCHAFFLER MB, 1985, FOLIA PRIMATOL, V45, P61, DOI 10.1159/000156218; Sharkey N. A., 1995, Journal of Bone and Joint Surgery American Volume, V77, P1050; Shaw CN, 2009, AM J PHYS ANTHROPOL, V140, P160, DOI 10.1002/ajpa.21063; Shaw CN, 2009, AM J PHYS ANTHROPOL, V140, P149, DOI 10.1002/ajpa.21064; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUMNER DR, 1989, AM J PHYS ANTHROPOL, V79, P225, DOI 10.1002/ajpa.1330790210; SUSMAN RL, 1983, FOOT ANKLE, V3, P365, DOI 10.1177/107110078300300605; Trinkaus E, 2005, J ARCHAEOL SCI, V32, P1515, DOI 10.1016/j.jas.2005.04.006; Trinkaus E, 2008, J ARCHAEOL SCI, V35, P1928, DOI 10.1016/j.jas.2007.12.002; Tuttle R. H., 1970, THE CHIMPANZEE, V2, P167; Venkataraman VV, 2013, HUM BIOL, V85, P309; Venkataraman VV, 2013, P NATL ACAD SCI USA, V110, P1237, DOI 10.1073/pnas.1208717110; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; Vereecke EE, 2005, J ANAT, V206, P453, DOI 10.1111/j.1469-7580.2005.00412.x; Wunderlich R.E., 1999, PEDAL FORM PLANTAR P; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703; Zollikofer CPE, 2001, HOM EVOLUT CLIMAT CH, V2, P50	88	32	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117905	10.1371/journal.pone.0117905	http://dx.doi.org/10.1371/journal.pone.0117905			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635768	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700108
J	O'Mullan, G; Dueker, ME; Clauson, K; Yang, Q; Umemoto, K; Zakharova, N; Matter, J; Stute, M; Takahashi, T; Goldberg, D				O'Mullan, Gregory; Dueker, M. Elias; Clauson, Kale; Yang, Qiang; Umemoto, Kelsey; Zakharova, Natalia; Matter, Juerg; Stute, Martin; Takahashi, Taro; Goldberg, David			Microbial Stimulation and Succession following a Test Well Injection Simulating CO2 Leakage into a Shallow Newark Basin Aquifer	PLOS ONE			English	Article							BACTERIAL DIVERSITY; SALINE AQUIFERS; COMMUNITY COMPOSITION; GEOLOGICAL STORAGE; CARBON-DIOXIDE; RIFT BASIN; WATER; GROUNDWATER; REDUCTION; HYDROGENOPHAGA	In addition to efforts aimed at reducing anthropogenic production of greenhouse gases, geological storage of CO2 is being explored as a strategy to reduce atmospheric greenhouse gas emission and mitigate climate change. Previous studies of the deep subsurface in North America have not fully considered the potential negative effects of CO2 leakage into shallow drinking water aquifers, especially from a microbiological perspective. A test well in the Newark Rift Basin was utilized in two field experiments to investigate patterns of microbial succession following injection of CO2-saturated water into an isolated aquifer interval, simulating a CO2 leakage scenario. A decrease in pH following injection of CO2 saturated aquifer water was accompanied by mobilization of trace elements (e.g. Fe and Mn), and increased bacterial cell concentrations in the recovered water. 16S ribosomal RNA gene sequence libraries from samples collected before and after the test well injection were compared to link variability in geochemistry to changes in aquifer microbiology. Significant changes in microbial composition, compared to background conditions, were found following the test well injections, including a decrease in Proteobacteria, and an increased presence of Firmicutes, Verrucomicrobia and microbial taxa often noted to be associated with iron and sulfate reduction. The concurrence of increased microbial cell concentrations and rapid microbial community succession indicate significant changes in aquifer microbial communities immediately following the experimental CO2 leakage event. Samples collected one year post-injection were similar in cell number to the original background condition and community composition, although not identical, began to revert toward the pre-injection condition, indicating microbial resilience following a leakage disturbance. This study provides a first glimpse into the in situ successional response of microbial communities to CO2 leakage after subsurface injection in the Newark Basin and the potential microbiological impact of CO2 leakage on drinking water resources.	[O'Mullan, Gregory; Dueker, M. Elias; Clauson, Kale] CUNY Queens Coll, Sch Earth & Environm Sci, Flushing, NY 11367 USA; [O'Mullan, Gregory; Dueker, M. Elias; Yang, Qiang; Zakharova, Natalia; Matter, Juerg; Stute, Martin; Takahashi, Taro; Goldberg, David] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Umemoto, Kelsey; Stute, Martin] Barnard Coll, Dept Environm Sci, New York, NY USA; [Matter, Juerg] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	City University of New York (CUNY) System; Queens College NY (CUNY); Columbia University; NERC National Oceanography Centre; University of Southampton	O'Mullan, G (corresponding author), CUNY Queens Coll, Sch Earth & Environm Sci, Flushing, NY 11367 USA.	gomullan@qc.cuny.edu	Yang, Qiang/N-8198-2013	Yang, Qiang/0000-0002-6788-8775; Zakharova, Natalia V/0000-0002-7677-258X; O'Mullan, Gregory/0000-0003-0590-7704	United States Environmental Protection Agency Grant [R834503]	United States Environmental Protection Agency Grant(United States Environmental Protection Agency)	This research was funded by a United States Environmental Protection Agency Grant (#R834503) to Columbia University (GO, TT, MS, JM, DG), entitled: "Diagnostic monitoring of biogeochemical interactions of a shallow aquifer in response to a CO<INF>2</INF> leak". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelouas A, 2000, SCI TOTAL ENVIRON, V250, P21, DOI 10.1016/S0048-9697(99)00549-5; Assayag N, 2009, CHEM GEOL, V265, P227, DOI 10.1016/j.chemgeo.2009.02.007; BACHU S, 1994, ENERG CONVERS MANAGE, V35, P269, DOI 10.1016/0196-8904(94)90060-4; Bearson S, 1997, FEMS MICROBIOL LETT, V147, P173, DOI 10.1016/S0378-1097(96)00503-4; BERGMAN PD, 1995, ENERG CONVERS MANAGE, V36, P523, DOI 10.1016/0196-8904(95)00058-L; Booth IR, 2002, ANTON LEEUW INT J G, V81, P33, DOI 10.1023/A:1020565206835; Burgdorff K., 2001, VIS GEOSCI, V6, P1; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Chaban B, 2006, CAN J MICROBIOL, V52, P73, DOI [10.1139/WDS-147, 10.1139/w05-147]; CHRISTENSEN H, 1995, MICROBIAL ECOL, V29, P49, DOI 10.1007/BF00217422; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Flynn TM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-146; Giese R, 2009, ENRGY PROCED, V1, P2251, DOI 10.1016/j.egypro.2009.01.293; Gonzalez-Toril E, 2003, APPL ENVIRON MICROB, V69, P4853, DOI 10.1128/AEM.69.8.4853-4865.2003; Gunter W.D., 2004, GEOLOGICAL SOC SPECI, V233, P129, DOI [DOI 10.1144/GSL.SP.2004.233.01.09, 10.1144/GSL.SP.2004.233.01.09]; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Hitchon B, 1996, AQUIFER DISPOSAL OF; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Holloway S, 2001, ANNU REV ENERG ENV, V26, P145, DOI 10.1146/annurev.energy.26.1.145; Intergovernmental Panel on Climate Change, 2005, IPCC SPECIAL REPORT; Kharaka YK, 2009, APPL GEOCHEM, V24, P1106, DOI 10.1016/j.apgeochem.2009.02.010; Kim J, 2004, SCIENCE, V303, P830, DOI 10.1126/science.1093245; Kwon MJ, 2008, GROUND WATER, V46, P286, DOI 10.1111/j.1745-6584.2007.00401.x; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; Lall U, 2011, J CONTEMP WATER RESE, V123, P4; Lavalleur HJ, 2013, FEMS MICROBIOL ECOL, V85, P62, DOI 10.1111/1574-6941.12098; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; Little MG, 2010, ENVIRON SCI TECHNOL, V44, P9225, DOI 10.1021/es102235w; Lovely DR, 1995, MICROBIOL REV, V55, P259; Lu JM, 2010, ENVIRON EARTH SCI, V60, P335, DOI 10.1007/s12665-009-0382-0; Macalady JL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0383; Matter JM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001427; Matter JM, 2006, HYDROGEOL J, V14, P689, DOI 10.1007/s10040-005-0456-3; McCune B, 2002, ANALYSIS OF ECOLOGIC; McCune B., 2011, PC ORD MULTIVARIATE; McMahon S, 2014, FEMS MICROBIOL ECOL, V87, P113, DOI 10.1111/1574-6941.12196; Morozova D, 2011, ENRGY PROCED, V4, P4362, DOI 10.1016/j.egypro.2011.02.388; Morozova D, 2010, INT J GREENH GAS CON, V4, P981, DOI 10.1016/j.ijggc.2009.11.014; Navarro-Noya YE, 2013, MICROB ECOL, V66, P19, DOI 10.1007/s00248-013-0222-3; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; O'Flaherty V, 1998, PROCESS BIOCHEM, V33, P555, DOI 10.1016/S0032-9592(98)00018-1; Olsen PE, 1996, GEOL SOC AM BULL, V108, P40, DOI 10.1130/0016-7606(1996)108<0040:HRSOTN>2.3.CO;2; Onstott TC, 2005, CARBON DIOXIDE CAPTURE FOR STORAGE IN DEEP GEOLOGIC FORMATIONS - RESULTS FROM THE CO2 CAPTURE PROJECT, VOLS 1 AND 2, P1217; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pedersen K, 1997, GEOLOGY, V25, P827, DOI 10.1130/0091-7613(1997)025<0827:EOALAM>2.3.CO;2; Petsch ST, 2005, PALAEOGEOGR PALAEOCL, V219, P157, DOI 10.1016/j.palaeo.2004.10.019; Pokrovsky OS, 2005, CHEM GEOL, V217, P239, DOI 10.1016/j.chemgeo.2004.12.012; Purkamo L, 2013, FEMS MICROBIOL ECOL, V85, P324, DOI 10.1111/1574-6941.12126; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rhine ED, 2008, ENVIRON SCI TECHNOL, V42, P1423, DOI 10.1021/es071859k; Rochelle C.A., 2004, GEOL SOC LOND SPEC P, V233, P87, DOI [10.1144/GSL.SP.2004.233.01.07, DOI 10.1144/GSL.SP.2004.233.01.07]; Roden EE, 1996, ENVIRON SCI TECHNOL, V30, P1618, DOI 10.1021/es9506216; Routh J, 2005, ACS SYM SER, V915, P132, DOI 10.1021/bk-2005-0915.ch010; Sahl JW, 2008, APPL ENVIRON MICROB, V74, P143, DOI 10.1128/AEM.01133-07; Santillan EU, 2013, GEOMICROBIOL J, V30, P578, DOI 10.1080/01490451.2013.767396; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Senko JM, 2009, GEOMICROBIOL J, V26, P71, DOI 10.1080/01490450802660193; Shani N, 2013, GROUND WATER MONIT R, V33, P31, DOI 10.1111/j.1745-6592.2012.01420.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sorensen JPR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070264; Srinivasan V, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011087; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Szulczewski ML, 2012, P NATL ACAD SCI USA, V109, P5185, DOI 10.1073/pnas.1115347109; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Tischer K, 2013, ENVIRON MICROBIOL, V15, P2603, DOI 10.1111/1462-2920.12168; Trautz RC, 2013, ENVIRON SCI TECHNOL, V47, P298, DOI 10.1021/es301280t; Vaz-Moreira I, 2011, APPL ENVIRON MICROB, V77, P5697, DOI 10.1128/AEM.00579-11; Visser A, 1996, WATER SCI TECHNOL, V33, P99, DOI 10.1016/0273-1223(96)00324-1; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wall JD, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P141, DOI 10.1017/CBO9780511541490.005; Wandrey M, 2011, ENRGY PROCED, V4, P3651, DOI 10.1016/j.egypro.2011.02.296; Weber KA, 2011, APPL ENVIRON MICROB, V77, P4693, DOI 10.1128/AEM.02539-10; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; WILLEMS A, 1989, INT J SYST BACTERIOL, V39, P319, DOI 10.1099/00207713-39-3-319; Williams KH, 2010, ENVIRON SCI TECHNOL, V44, P47, DOI 10.1021/es9017464; Williams WL, 2010, J DAIRY SCI, V93, P4735, DOI 10.3168/jds.2009-2920; Yang CB, 2013, INT J GREENH GAS CON, V18, P375, DOI 10.1016/j.ijggc.2012.12.030; Yang Q, 2014, INT J GREENH GAS CON, V26, P193, DOI 10.1016/j.ijggc.2014.04.025; Yoon JH, 2008, INT J SYST EVOL MICR, V58, P393, DOI 10.1099/ijs.0.65271-0; Zheng LG, 2012, INT J GREENH GAS CON, V7, P202, DOI 10.1016/j.ijggc.2011.10.003; Zhu WY, 2008, GEOCHIM COSMOCHIM AC, V72, P5243, DOI 10.1016/j.gca.2008.08.006; Zhu WY, 2012, GEOMICROBIOL J, V29, P186, DOI 10.1080/01490451.2010.539663	86	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117812	10.1371/journal.pone.0117812	http://dx.doi.org/10.1371/journal.pone.0117812			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635675	Green Accepted, Green Published, gold			2022-12-27	WOS:000350680700099
J	Peng, XJ; Li, WP; Johnson, WD; Torres, KEO; McCormick, DL				Peng, Xinjian; Li, Wenping; Johnson, William D.; Torres, Karen E. O.; McCormick, David L.			Overexpression of Lipocalins and Pro-Inflammatory Chemokines and Altered Methylation of PTGS2 and APC2 in Oral Squamous Cell Carcinomas Induced in Rats by 4-Nitroquinoline-1-Oxide	PLOS ONE			English	Article							BOWMAN-BIRK INHIBITOR; GELATINASE-ASSOCIATED LIPOCALIN; UP-REGULATION; HUMAN-PAPILLOMAVIRUS; OVARIAN-CANCER; KALLIKREIN 6; LIGAND 2; EXPRESSION; CYCLOOXYGENASE-2; CARCINOGENESIS	Oral squamous cell carcinomas (OSCC) induced in F344 rats by 4-nitroquinoline-1-oxide (4-NQO) demonstrate considerable phenotypic similarity to human oral cancers. Gene expression studies (microarray and PCR) were coupled with methylation analysis of selected genes to identify molecular markers of carcinogenesis in this model and potential biochemical and molecular targets for oral cancer chemoprevention. Microarray analysis of 11 pairs of OSCC and site-matched phenotypically normal oral tissues from 4-NQO-treated rats identified more than 3500 differentially expressed genes; 1735 genes were up-regulated in rat OSCC versus non-malignant tissues, while 1803 genes were down-regulated. In addition to several genes involved in normal digestion, genes demonstrating the largest fold increases in expression in 4-NQO-induced OSCC include three lipocalins (VEGP1, VEGP2, LCN2) and three chemokines (CCL, CXCL2, CXCL3); both classes are potentially druggable targets for oral cancer chemoprevention and/or therapy. Down-regulated genes in 4-NQO-induced OSCC include numerous keratins and keratin-associated proteins, suggesting that alterations in keratin expression profiles may provide a useful biomarker of oral cancer in F344 rats treated with 4-NQO. Confirming and extending our previous results, PTGS2 (cyclooxygenase-2) and several cyclooxygenase-related genes were significantly up-regulated in 4-NQO-induced oral cancers; up-regulation of PTGS2 was associated with promoter hypomethylation. Rat OSCC also demonstrated increased methylation of the first exon of APC2; the increased methylation was correlated with down-regulation of this tumor suppressor gene. Overexpression of pro-inflammatory chemokines, hypomethylation of PTGS2, and hypermethylation of APC2 may be causally linked to the etiology of oral cancer in this model.	[Peng, Xinjian; Li, Wenping; Johnson, William D.; McCormick, David L.] IIT Res Inst, Life Sci Grp, Chicago, IL 60616 USA; [Torres, Karen E. O.] GenUs Biosyst, Northbrook, IL 60062 USA	Illinois Institute of Technology	Peng, XJ (corresponding author), IIT Res Inst, Life Sci Grp, Chicago, IL 60616 USA.	xpeng@iitri.org		Torres, Keila E/0000-0002-1855-0989; Li, Wenping/0000-0001-5917-5380	IIT Research Institute	IIT Research Institute	This work was supported by internal research and development funds from IIT Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul B, 2011, J GEN VIROL, V92, P395, DOI 10.1099/vir.0.025064-0; Ambatipudi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070688; Armstrong WB, 2003, LARYNGOSCOPE, V113, P1687, DOI 10.1097/00005537-200310000-00007; Armstrong WB, 2000, CLIN CANCER RES, V6, P4684; Armstrong WB, 2013, CANCER PREV RES, V6, P410, DOI 10.1158/1940-6207.CAPR-13-0004; Baba T, 2013, J EXP MED, V210, P2661, DOI 10.1084/jem.20130112; BLOT WJ, 1988, CANCER RES, V48, P3282; Bremmer JF, 2009, CANCER PREV RES, V2, P128, DOI 10.1158/1940-6207.CAPR-08-0128; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Christodoulou S, 2014, TUMOR BIOL, V35, P4673, DOI 10.1007/s13277-014-1612-y; Ding L, 2014, TUMOR BIOL, V35, P10539, DOI 10.1007/s13277-014-2306-1; Domingo-Gonzalez R, 2012, J IMMUNOL, V189, P4528, DOI 10.4049/jimmunol.1201116; Fernandez-Alvarez A, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.23; Ferreira JG, 2013, J BIOL CHEM, V288, P13641, DOI 10.1074/jbc.M112.404053; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Graveland AP, 2013, ORAL ONCOL, V49, P1129, DOI 10.1016/j.oraloncology.2013.09.005; Hiromoto T, 2011, ONCOL REP, V26, P1415, DOI 10.3892/or.2011.1429; Hu CJ, 2013, WSPOLCZESNA ONKOL, V17, P64, DOI 10.5114/wo.2013.33776; Ida-Yonemochi H, 2012, MODERN PATHOL, V25, P784, DOI 10.1038/modpathol.2011.218; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kademani D, 2007, MAYO CLIN PROC, V82, P878, DOI 10.4065/82.7.878; Kanojia Deepak, 2012, J Carcinog, V11, P14, DOI 10.4103/1477-3163.100861; Kaur S, 2014, CLIN CANCER RES, V20, P688, DOI 10.1158/1078-0432.CCR-13-2174; Kennedy AR, 1998, AM J CLIN NUTR, V68, p1406S, DOI 10.1093/ajcn/68.6.1406S; KENNEDY AR, 1993, NUTR CANCER, V19, P191, DOI 10.1080/01635589309514249; Kim JT, 2011, CANCER-AM CANCER SOC, V117, P2608, DOI 10.1002/cncr.25841; KITANO M, 1992, JPN J CANCER RES, V83, P843, DOI 10.1111/j.1349-7006.1992.tb01989.x; Leng XH, 2011, J CELL PHYSIOL, V226, P309, DOI 10.1002/jcp.22403; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li X, 2014, CARCINOGENESIS, V35, P1362, DOI 10.1093/carcin/bgu046; McCormick DL, 2010, CANCER PREV RES, V3, P73, DOI 10.1158/1940-6207.CAPR-09-0151; Meng XY, 2012, J DIGEST DIS, V13, P208, DOI 10.1111/j.1751-2980.2012.00578.x; Mighty KK, 2014, RECENT RESULTS CANC, V193, P135, DOI 10.1007/978-3-642-38965-8_8; Nakahata AM, 2013, PLANTA MED, V79, P227, DOI 10.1055/s-0032-1328156; National Institute of Dental and Craniofacial Research, ORAL CANCER 5 YEAR S; Oue E, 2012, BIOCHEM BIOPH RES CO, V424, P456, DOI 10.1016/j.bbrc.2012.06.132; Peng XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070442; Pytynia KB, 2014, ORAL ONCOL, V50, P380, DOI 10.1016/j.oraloncology.2013.12.019; Rezze GG, 2011, HUM PATHOL, V42, P409, DOI 10.1016/j.humpath.2010.09.004; ROTHMAN K, 1972, J CHRON DIS, V25, P711, DOI 10.1016/0021-9681(72)90006-9; Sandhu SK, 2013, CANCER CHEMOTH PHARM, V71, P1041, DOI 10.1007/s00280-013-2099-8; Seiz L, 2012, BIOL CHEM, V393, P391, DOI 10.1515/hsz-2011-0264; Shan SJC, 2007, BRIT J CANCER, V96, P362, DOI 10.1038/sj.bjc.6603556; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silva TA, 2007, ONCOL REP, V18, P1107; Tanaka Takuji, 2011, Patholog Res Int, V2011, P431246, DOI 10.4061/2011/431246; Tsimplaki E, 2014, ANTICANCER RES, V34, P1021; Tung MC, 2013, PROSTATE, V73, P1281, DOI 10.1002/pros.22670; Vallet S, 2011, EXPERT OPIN THER TAR, V15, P1037, DOI 10.1517/14728222.2011.586634; Wyss A, 2013, AM J EPIDEMIOL, V178, P679, DOI 10.1093/aje/kwt029; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yoshida K, 2003, CANCER SCI, V94, P365, DOI 10.1111/j.1349-7006.2003.tb01448.x; Zhang J, 2010, PROG MOL BIOL TRANSL, V95, P31, DOI 10.1016/B978-0-12-385071-3.00003-4	53	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116285	10.1371/journal.pone.0116285	http://dx.doi.org/10.1371/journal.pone.0116285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635769	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700028
J	Pratoomsoot, C; Sruamsiri, R; Dilokthornsakul, P; Chaiyakunapruk, N				Pratoomsoot, Chayanin; Sruamsiri, Rosarin; Dilokthornsakul, Piyameth; Chaiyakunapruk, Nathorn			Quality of Reporting of Randomised Controlled Trials of Herbal Interventions in ASEAN Plus Six Countries: A Systematic Review	PLOS ONE			English	Review							KYUKI-CHOUKETSU-IN; TANG UNKEI-TO; DOUBLE-BLIND; CAPSICUM PLASTER; ULCERATIVE-COLITIS; POSTOPERATIVE NAUSEA; GINGER; PLACEBO; EFFICACY; MEDICINE	Background: Many randomised controlled trials (RCTs) of herbal interventions have been conducted in the ASEAN Communities. Good quality reporting of RCTs is essential for assessing clinical significance. Given the importance ASEAN placed on herbal medicines, the reporting quality of RCTs of herbal interventions among the ASEAN Communities deserved a special attention. Objectives: To systematically review the quality of reporting of RCTs of herbal interventions conducted in the ASEAN Plus Six Countries. Methods: Searches were performed using PubMed, EMBASE, The Cochrane Library, and Allied and Complementary Medicine (AMED), from inception through October 2013. These were limited to studies specific to humans and RCTs. Herbal species search terms were based on those listed in the National List of Essential Medicines [NLEM (Thailand, 2011)]. Studies conducted in the ASEAN Plus Six Countries, published in English were included. Results: Seventy-one articles were identified. Thirty (42.25%) RCTs were from ASEAN Countries, whereas 41 RCTs (57.75%) were from Plus Six Group. Adherence to the recommended CONSORT checklist items for reporting of RCTs of herbal interventions among ASEAN Plus Six Countries ranged from 0% to 97.18%. Less than a quarter of the RCTs (18.31%) reported information on standardisation of the herbal products. However, the scope of our interventions of interest was limited to those developed from 20 herbal species listed in the NLEM of Thailand. Conclusions: The present study highlights the need to improve reporting quality of RCTs of herbal interventions across ASEAN Plus Six Communities.	[Pratoomsoot, Chayanin] Naresuan Univ, Fac Publ Hlth, Phitsanulok, Thailand; [Sruamsiri, Rosarin; Dilokthornsakul, Piyameth; Chaiyakunapruk, Nathorn] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Ctr Pharmaceut Outcomes Res, Phitsanulok, Thailand; [Chaiyakunapruk, Nathorn] Monash Univ Malaysia, Sch Pharm, Bandar Sunway, Selangor, Malaysia; [Chaiyakunapruk, Nathorn] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Chaiyakunapruk, Nathorn] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Sruamsiri, Rosarin] Harvard Univ, Sch Med, Drug Policy Res Grp, Dept Populat Med, Boston, MA USA; [Sruamsiri, Rosarin] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Dilokthornsakul, Piyameth] Univ Illinois, Coll Pharm, Ctr Pharmacoepidemiol & Pharmacoecon Res, Chicago, IL USA; [Dilokthornsakul, Piyameth] Univ Illinois, Coll Pharm, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA	Naresuan University; Naresuan University; Monash University; Monash University Sunway; University of Queensland; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chaiyakunapruk, N (corresponding author), Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Ctr Pharmaceut Outcomes Res, Phitsanulok, Thailand.	nathorn.chaiyakunapruk@monash.edu		Dilokthornsakul, Piyameth/0000-0002-6981-1771; Pratoomsoot, Chayanin/0000-0002-1073-5145	Department for Development of Thai Traditional Medicine and Alternative Medicine, Ministry of Public Health, Thailand	Department for Development of Thai Traditional Medicine and Alternative Medicine, Ministry of Public Health, Thailand	This research received funding support from The Department for Development of Thai Traditional Medicine and Alternative Medicine, Ministry of Public Health, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal KA, 2011, SURG ENDOSC, V25, P3805, DOI 10.1007/s00464-011-1793-z; Apariman Sirirat, 2006, Journal of the Medical Association of Thailand, V89, P2003; ASEAN Secretariat, 2009, ASEAN SOC CULT COMM; Banerjee P, 2011, J ETHNOPHARMACOL, V134, P429, DOI 10.1016/j.jep.2010.12.044; Biswas SC, 2011, INT MED SCI ACAD, V24, P167; Bo P, 2010, J TRADIT CHIN MED, V30, P103, DOI 10.1016/S0254-6272(10)60023-4; Cao B, 2012, CHINESE GERMAN J CLI, V11, P605; Chan K, 2003, CHEMOSPHERE, V52, P1361, DOI 10.1016/S0045-6535(03)00471-5; Charuwichitaratana S, 1996, INT J DERMATOL, V35, P665, DOI 10.1111/j.1365-4362.1996.tb03699.x; Chittumma Porndee, 2007, Journal of the Medical Association of Thailand, V90, P15; Chopra A, 2013, RHEUMATOLOGY, V52, P1408, DOI 10.1093/rheumatology/kes414; Chopra Arvind, 2012, J Ayurveda Integr Med, V3, P38, DOI 10.4103/0975-9476.93948; Chopra A, 2012, CLIN RHEUMATOL, V31, P259, DOI 10.1007/s10067-011-1809-z; Chopra A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/724291; Chun CB, 2009, HLTH SYST TRANSIT, V11, P1; Dans AML, 2007, J CLIN EPIDEMIOL, V60, P554, DOI 10.1016/j.jclinepi.2006.07.009; Department of Health Australian Government, 2013, SCHED PHARM BEN; Fuangchan A, 2011, J ETHNOPHARMACOL, V134, P422, DOI 10.1016/j.jep.2010.12.045; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Gagnier JJ, 2006, J CLIN EPIDEMIOL, V59, P1134, DOI 10.1016/j.jclinepi.2005.12.020; Gagnier JJ, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2006.02.006; Guo HF, 2006, J UROLOGY, V175, P665, DOI 10.1016/S0022-5347(05)00158-8; Hanai H, 2006, CLIN GASTROENTEROL H, V4, P1502, DOI 10.1016/j.cgh.2006.08.008; He CQ, 2006, CLIN REHABIL, V20, P1058, DOI 10.1177/0269215506071255; Hu Lingjing, 2008, J Tradit Chin Med, V28, P189; Kim KS, 2002, ANESTH ANALG, V95, P1103, DOI 10.1097/00000539-200210000-00059; Kim KS, 2006, PEDIATR ANESTH, V16, P1036, DOI 10.1111/j.1460-9592.2006.01927.x; Kim KS, 2006, ANESTH ANALG, V103, P709, DOI 10.1213/01.ane.0000228864.74691.9f; Kim KS, 2009, ANESTH ANALG, V108, P992, DOI 10.1213/ane.0b013e318195b78f; Kim SW, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-58; Koosirirat C, 2010, INT IMMUNOPHARMACOL, V10, P815, DOI 10.1016/j.intimp.2010.04.021; Kositchaiwat S, 2006, WORLD J GASTROENTERO, V12, P5536, DOI 10.3748/wjg.v12.i34.5536; Kumar Abhimanyu, 2012, J Ayurveda Integr Med, V3, P215, DOI 10.4103/0975-9476.104446; Kuptniratsaikul V, 2011, J ALTERN COMPLEM MED, V17, P147, DOI 10.1089/acm.2010.0213; Kuptniratsaikul V, 2009, J ALTERN COMPLEM MED, V15, P891, DOI 10.1089/acm.2008.0186; LEELARASAMEE A, 1990, Journal of the Medical Association of Thailand, V73, P299; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Linde K, 2001, INT J EPIDEMIOL, V30, P526, DOI 10.1093/ije/30.3.526; Maenthaisong R, 2014, COMPLEMENT THER MED, V22, P34, DOI 10.1016/j.ctim.2013.08.014; Manusirivithaya S, 2004, INT J GYNECOL CANCER, V14, P1063, DOI 10.1111/j.1048-891X.2004.14603.x; Mato L, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep177; Ministry of Health, 1998, SCHEM CHARG MIN HLTH; Ministry of Health, 2013, NAT LIST DRUGS; Ministry of Health, 2008, NAT LIST ESS MED 200; Ministry of Health, 2012, NAT ESS DRUGS LIST 2; Ministry of Health, 2010, ESS COMPL MED VACC M; Ministry of Health and Family Welfare, 2011, NAT LIST ESS MED IND; Ministry of Health Labour and Welfare, 2012, NAT HLTH INS DRUG LI; Ministry of Health of the Republic of Indonesia, 2008, NAT LIST ESS MED 200; Misra MN, 2005, CAN J ANAESTH, V52, P485, DOI 10.1007/BF03016527; Moher David, 2002, BMC Pediatr, V2, P3, DOI 10.1186/1471-2431-2-3; Nale R., 2007, J ANAESTHESIOL CLIN, V23, P405; Nanthakomon Tongta, 2006, J Med Assoc Thai, V89 Suppl 4, pS130; National Drug Committee, 2011, NAT LIST ESS MED 201; Niempoog Sunyarn, 2012, J Med Assoc Thai, V95 Suppl 1, pS59; Nik Hazlina N. H., 2005, INT MED J, V12, P295; Paocharoen Veeraya, 2010, J Med Assoc Thai, V93 Suppl 7, pS166; Paramdeep Gill, 2013, Indian J Physiol Pharmacol, V57, P177; Park HS, 2004, ANAESTHESIA, V59, P647, DOI 10.1111/j.1365-2044.2004.03739.x; Patankar S, 2008, J ALTERN COMPLEM MED, V14, P1287, DOI 10.1089/acm.2008.0189; Pharmaceutical Management Agency, 2012, NZ PHARM SCHED AUG 2; Pharmaceutical Services Divisions, 2012, NAT ESS DRUG LIST NE; Pillai AK, 2011, PEDIATR BLOOD CANCER, V56, P234, DOI 10.1002/pbc.22778; Pongrojpaw Densak, 2003, J Med Assoc Thai, V86, P244; Pongrojpaw Densak, 2007, Journal of the Medical Association of Thailand, V90, P1703; Premgamone Amorn, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P654; Rassameemasmaung Supanee, 2007, J Int Acad Periodontol, V9, P19; Rassameemasmaung S, 2008, COMPLEMENT THER MED, V16, P262, DOI 10.1016/j.ctim.2007.12.004; Saenghong N, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/383062; Saxena RC, 2010, PHYTOMEDICINE, V17, P178, DOI 10.1016/j.phymed.2009.12.001; Singla V, 2014, J CROHNS COLITIS, V8, P208, DOI 10.1016/j.crohns.2013.08.006; Smith C, 2004, OBSTET GYNECOL, V103, P639, DOI 10.1097/01.AOG.0000118307.19798.EC; Sontakke S., 2003, Indian Journal of Pharmacology, V35, P32; Sripramote Manit, 2003, J Med Assoc Thai, V86, P846; Sukandar E. Y., 2013, Journal of Medical Sciences (Pakistan), V13, P10, DOI 10.3923/jms.2013.10.18; Sukandar EY, 2010, INT J PHARMACOL, V6, P456, DOI 10.3923/ijp.2010.456.463; Tang T, 2011, ALIMENT PHARM THER, V33, P194, DOI 10.1111/j.1365-2036.2010.04515.x; Tang YP, 2009, J MED FOOD, V12, P755, DOI 10.1089/jmf.2008.0204; THAMLIKITKUL V, 1991, Journal of the Medical Association of Thailand, V74, P437; The Committee for Establishing the National Essential Medicines List, 2010, CAMB ESS MED LIST 20; The National Formulary Committee, 2008, PHIL NAT DRUG FORM E, VI; Urata S, 2008, ASEAN 6 EC PARTN SIG; Ushiroyama T, 2006, AM J CHINESE MED, V34, P177, DOI 10.1142/S0192415X06003746; Ushiroyama T, 2005, AM J CHINESE MED, V33, P117, DOI 10.1142/S0192415X05002710; Ushiroyama T, 2007, AM J CHINESE MED, V35, P195, DOI 10.1142/S0192415X07004734; Ushiroyama T, 2006, AM J CHINESE MED, V34, P969, DOI 10.1142/S0192415X06004442; Visalyaputra S, 1998, ANAESTHESIA, V53, P506, DOI 10.1046/j.1365-2044.1998.00369.x; Vutyavanich T, 2001, OBSTET GYNECOL, V97, P577, DOI 10.1016/S0029-7844(00)01228-X; Vyjayanthi G, 2003, RES COMMUN PHARMACOL, V8, P15; Wang G, 2007, CLIN THER, V29, P1456, DOI 10.1016/j.clinthera.2007.07.023; Wattanathorn J, 2008, J ETHNOPHARMACOL, V116, P325, DOI 10.1016/j.jep.2007.11.038; Willetts KE, 2003, AUST NZ J OBSTET GYN, V43, P139, DOI 10.1046/j.0004-8666.2003.00039.x; Wolsko PM, 2005, AM J MED, V118, P1087, DOI 10.1016/j.amjmed.2005.01.076; World Health Organization and Ministry of Health Lao PDR, 2012, HLTH SERV DEL PROF L; Xiaoxiang Zeng, 2006, J Tradit Chin Med, V26, P17; Xuemei Cao, 2006, J Tradit Chin Med, V26, P167; Yang Yiling, 2005, J Tradit Chin Med, V25, P45; Yip YB, 2008, COMPLEMENT THER MED, V16, P131, DOI 10.1016/j.ctim.2007.12.003	98	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e108681	10.1371/journal.pone.0108681	http://dx.doi.org/10.1371/journal.pone.0108681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633206	Green Published, Green Submitted, gold			2022-12-27	WOS:000348609800001
J	Miyake, T; Shimizu, K; Kamiya, K				Miyake, Toshiyuki; Shimizu, Kimiya; Kamiya, Kazutaka			Distribution of Posterior Corneal Astigmatism According to Axis Orientation of Anterior Corneal Astigmatism	PLOS ONE			English	Article							SCHEIMPFLUG PHOTOGRAPHY; SURFACE TORICITY; REPEATABILITY; PENTACAM; AGREEMENT; THICKNESS; SYSTEM; POWER	Purpose To investigate the distribution of posterior corneal astigmatism in eyes with with-the-rule (WTR) and against-the-rule (ATR) anterior corneal astigmatism. Methods We retrospectively examined six hundred eight eyes of 608 healthy subjects (275 men and 333 women; mean age +/- standard deviation, 55.3 +/- 20.2 years). The magnitude and axis orientation of anterior and posterior corneal astigmatism were determined with a rotating Scheimpflug system (Pentacam HR, Oculus) when we divided the subjects into WTR and ATR anterior corneal astigmatism groups. Results The mean magnitudes of anterior and posterior corneal astigmatism were 1.14 +/- 0.76 diopters (D), and 0.37 +/- 0.19 D, respectively. We found a significant correlation between the magnitudes of anterior and posterior corneal astigmatism (Pearson correlation coefficient r = 0.4739, P<0.001). In the WTR anterior astigmatism group, we found ATR astigmatism of the posterior corneal surface in 402 eyes (96.6%). In the ATR anterior astigmatism group, we found ATR posterior corneal astigmatism in 82 eyes (73.9%). Especially in eyes with ATR anterior corneal astigmatism of 1 D or more and 1.5 D or more, ATR posterior corneal astigmatism was found in 28 eyes (59.6%) and 9 eyes (42.9%), respectively. Conclusions WTR anterior astigmatism and ATR posterior astigmatism were found in approximately 68% and 91% of eyes, respectively. The magnitude and the axis orientation of posterior corneal astigmatism were not constant, especially in eyes having high ATR anterior corneal astigmatism, as is often the case in patients who have undergone toric IOL implantation.	[Miyake, Toshiyuki; Shimizu, Kimiya; Kamiya, Kazutaka] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa, Japan	Kitasato University	Miyake, T (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa, Japan.	ys01.w.mmipfirdf@gmail.com						Barkana Y, 2005, J CATARACT REFR SURG, V31, P1729, DOI 10.1016/j.jcrs.2005.03.058; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buehl W, 2006, AM J OPHTHALMOL, V141, P7, DOI 10.1016/j.ajo.2005.08.048; Cheng LS, 2011, ACTA OPHTHALMOL, V89, P417, DOI 10.1111/j.1755-3768.2009.01732.x; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; Dubbelman M, 2002, ACTA OPHTHALMOL SCAN, V80, P379, DOI 10.1034/j.1600-0420.2002.800406.x; DUNNE MCM, 1991, OPTOMETRY VISION SCI, V68, P708, DOI 10.1097/00006324-199109000-00006; Ho JD, 2008, J CATARACT REFR SURG, V34, P137, DOI 10.1016/j.jcrs.2007.09.033; Ho JD, 2010, CORNEA, V29, P632, DOI 10.1097/ICO.0b013e3181c2965f; Ho JD, 2009, AM J OPHTHALMOL, V147, P788, DOI 10.1016/j.ajo.2008.12.020; Kawamorita T, 2009, J CATARACT REFR SURG, V35, P127, DOI 10.1016/j.jcrs.2008.10.019; Koch DD, 2013, J CATARACT REFR SURG, V39, P1803, DOI 10.1016/j.jcrs.2013.06.027; Koch DD, 2012, J CATARACT REFR SURG, V38, P2080, DOI 10.1016/j.jcrs.2012.08.036; Lackner B, 2005, OPTOMETRY VISION SCI, V82, P858, DOI 10.1097/01.opx.0000177804.53192.15; Modis L, 2004, CORNEA, V23, P689; Pinero DP, 2009, J CATARACT REFR SURG, V35, P113, DOI 10.1016/j.jcrs.2008.10.010; Prisant O, 2002, J CATARACT REFR SURG, V28, P1636, DOI 10.1016/S0886-3350(01)01258-5; ROYSTON JM, 1990, OPTOMETRY VISION SCI, V67, P757, DOI 10.1097/00006324-199010000-00002; Shankar H, 2008, J CATARACT REFR SURG, V34, P103, DOI 10.1016/j.jcrs.2007.09.013; Wang L, 2011, INVEST OPHTH VIS SCI, V52, P1716, DOI 10.1167/iovs.09-4982; Wang L, 2010, J CATARACT REFR SURG, V36, P425, DOI 10.1016/j.jcrs.2009.09.034	21	44	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117194	10.1371/journal.pone.0117194	http://dx.doi.org/10.1371/journal.pone.0117194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625283	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821400029
J	Asher, E; Reuveni, H; Shlomo, N; Gerber, Y; Beigel, R; Narodetski, M; Eldar, M; Or, J; Hod, H; Shamiss, A; Matetzky, S				Asher, Elad; Reuveni, Haim; Shlomo, Nir; Gerber, Yariv; Beigel, Roy; Narodetski, Michael; Eldar, Michael; Or, Jacob; Hod, Hanoch; Shamiss, Arie; Matetzky, Shlomi			Clinical Outcomes and Cost Effectiveness of Accelerated Diagnostic Protocol in a Chest Pain Center Compared with Routine Care of Patients with Chest Pain	PLOS ONE			English	Article							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; EMERGENCY-DEPARTMENT PATIENTS; UNIT; EXPERIENCE; TRIAGE	Aims The aim of this study was to compare in patients presenting with acute chest pain the clinical outcomes and cost-effectiveness of an accelerated diagnostic protocol utilizing contemporary technology in a chest pain unit versus routine care in an internal medicine department. Methods and Results Hospital and 90-day course were prospectively studied in 585 consecutive low-moderate risk acute chest pain patients, of whom 304 were investigated in a designated chest pain center using a pre-specified accelerated diagnostic protocol, while 281 underwent routine care in an internal medicine ward. Hospitalization was longer in the routine care compared with the accelerated diagnostic protocol group (p<0.001). During hospitalization, 298 accelerated diagnostic protocol patients (98%) vs. 57 (20%) routine care patients underwent non-invasive testing, (p<0.001). Throughout the 90-day follow-up, diagnostic imaging testing was performed in 125 (44%) and 26 (9%) patients in the routine care and accelerated diagnostic protocol patients, respectively (p<0.001). Ultimately, most patients in both groups had non-invasive imaging testing. Accelerated diagnostic protocol patients compared with those receiving routine care was associated with a lower incidence of readmissions for chest pain [8 (3%) vs. 24 (9%), p<0.01], and acute coronary syndromes [1 (0.3%) vs. 9 (3.2%), p<0.01], during the follow-up period. The accelerated diagnostic protocol remained a predictor of lower acute coronary syndromes and readmissions after propensity score analysis [OR = 0.28 (CI 95% 0.14-0.59)]. Cost per patient was similar in both groups [($2510 vs. $2703 for the accelerated diagnostic protocol and routine care group, respectively, (p = 0.9)]. Conclusion An accelerated diagnostic protocol is clinically superior and as cost effective as routine in acute chest pain patients, and may save time and resources.	[Asher, Elad; Shlomo, Nir; Beigel, Roy; Narodetski, Michael; Eldar, Michael; Hod, Hanoch; Matetzky, Shlomi] Chaim Sheba Med Ctr, Leviev Heart Ctr, IL-52621 Tel Hashomer, Israel; [Reuveni, Haim] Ben Gurion Univ Negev, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; [Gerber, Yariv] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, IL-69978 Tel Aviv, Israel; [Or, Jacob] Chaim Sheba Med Ctr, Dept Emergency Med, IL-52621 Tel Hashomer, Israel; [Shamiss, Arie] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel	Chaim Sheba Medical Center; Ben Gurion University; Soroka Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Asher, E (corresponding author), Chaim Sheba Med Ctr, Leviev Heart Ctr, IL-52621 Tel Hashomer, Israel.	El.asher@gmail.com	Gerber, Yariv/AAU-8222-2021; Asher, Elad/I-3544-2019	Asher, Elad/0000-0003-3381-605X	Israel National Institute for Health Policy Research	Israel National Institute for Health Policy Research	This work was supported by the Israel National Institute for Health Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam EA, 2005, CARDIOL CLIN, V23, pXIII, DOI 10.1016/j.ccl.2005.08.017; Asher E, 2007, EUR J INTERN MED, V18, P35, DOI 10.1016/j.ejim.2006.07.021; Asher E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057108; Asher E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042613; Beigel R, 2010, ISR MED ASSOC J, V12, P329; Clancy M, 2002, BRIT MED J, V325, P116, DOI 10.1136/bmj.325.7356.116; Coit MH, 2011, J GEN INTERN MED, V26, P28, DOI 10.1007/s11606-010-1465-z; Farkouh ME, 1998, NEW ENGL J MED, V339, P1882, DOI 10.1056/NEJM199812243392603; Fuat A, 2003, BRIT MED J, V326, P196, DOI 10.1136/bmj.326.7382.196; GIBLER WB, 1994, AM J EMERG MED, V12, P121, DOI 10.1016/0735-6757(94)90219-4; Goldstein JA, 2011, J AM COLL CARDIOL, V58, P1414, DOI 10.1016/j.jacc.2011.03.068; Gomez MA, 1996, J AM COLL CARDIOL, V28, P25, DOI 10.1016/0735-1097(96)00093-9; Goodacre SW, 2000, J ACCID EMERG MED, V17, P1; Graff LG, 1997, AM J CARDIOL, V80, P563, DOI 10.1016/S0002-9149(97)00422-0; Gudmundsson G, 2005, EUR RESPIR J, V26, P414, DOI 10.1183/09031936.05.00078504; Hoekstra J W, 1994, Acad Emerg Med, V1, P103; Hoffmann U, 2012, NEW ENGL J MED, V367, P299, DOI 10.1056/NEJMoa1201161; Hoffmann U, 2009, J AM COLL CARDIOL, V53, P1642, DOI 10.1016/j.jacc.2009.01.052; Hollander JE, 2009, ACAD EMERG MED, V16, P693, DOI 10.1111/j.1553-2712.2009.00459.x; *ISR MIN HLTH, 2010, COST LIST FOR AMBULA; Januzzi JL, 2010, CIRCULATION, V121, P1227, DOI 10.1161/CIRCULATIONAHA.109.893826; Lewis WR, 2001, J AM COLL CARDIOL, V37, P2050, DOI 10.1016/S0735-1097(01)01297-9; Mikhail MG, 1997, ANN EMERG MED, V29, P88, DOI 10.1016/S0196-0644(97)70314-7; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Nasrallah N, 2011, EUR HEART J, V32, P656; Oluboyede Yemi, 2008, BMC Health Serv Res, V8, P174, DOI 10.1186/1472-6963-8-174; Rubinshtein R, 2007, CIRCULATION, V115, P1762, DOI 10.1161/CIRCULATIONAHA.106.618389; Rubinshtein R, 2006, ISR MED ASSOC J, V8, P329; Sieck S, 2005, CARDIOL CLIN, V23, P589, DOI 10.1016/j.ccl.2005.08.001; Zalenski RJ, 1997, ANN EMERG MED, V29, P99, DOI 10.1016/S0196-0644(97)70315-9; 2007, CIRCULATION, V116, P803	31	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117287	10.1371/journal.pone.0117287	http://dx.doi.org/10.1371/journal.pone.0117287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622029	gold, Green Submitted, Green Published			2022-12-27	WOS:000348470400022
J	Hou, CW; Lee, SD; Kao, CL; Cheng, IS; Lin, YN; Chuang, SJ; Chen, CY; Ivy, JL; Huang, CY; Kuo, CH				Hou, Chien-Wen; Lee, Shin-Da; Kao, Chung-Lan; Cheng, I-Shiung; Lin, Yu-Nan; Chuang, Sheng-Ju; Chen, Chung-Yu; Ivy, John L.; Huang, Chih-Yang; Kuo, Chia-Hua			Improved Inflammatory Balance of Human Skeletal Muscle during Exercise after Supplementations of the Ginseng-Based Steroid Rg1	PLOS ONE			English	Article							LIPID-PEROXIDATION; OXIDATIVE STRESS; PANAX-GINSENG; PERFORMANCE; BILAYERS; HORSES; INJURY; IL-10	The purpose of the study was to determine the effect of ginseng-based steroid Rg1 on TNFalpha and IL-10 gene expression in human skeletal muscle against exercise challenge, as well as on its ergogenic outcomes. Randomized double-blind placebo-controlled crossover trials were performed, separated by a 4-week washout. Healthy young men were randomized into two groups and received capsule containing either 5 mg of Rg1 or Placebo one night and one hour before exercise. Muscle biopsies were conducted at baseline, immediately and 3 h after a standardized 60-min cycle ergometer exercise. While treatment differences in glycogen depletion rate of biopsied quadriceps muscle during exercise did not reach statistical significance, Rg1 supplementations enhanced post-exercise glycogen replenishment and increased citrate synthase activity in the skeletal muscle 3 h after exercise, concurrent with improved meal tolerance during recovery (P<0.05). Rg1 suppressed the exercise-induced increases in thiobarbituric acids reactive substance (TBARS) and reversed the increased TNF-alpha and decreased IL-10 mRNA of quadriceps muscle against the exercise challenge. PGC-1 alpha and GLUT4 mRNAs of exercised muscle were not affected by Rg1. Maximal aerobic capacity (VO2max) was not changed by Rg1. However, cycling time to exhaustion at 80% VO2max increased significantly by similar to 20% (P<0.05). Conclusion: Our result suggests that Rg1 is an ergogenic component of ginseng, which can minimize unwanted lipid peroxidation of exercised human skeletal muscle, and attenuate pro-inflammatory shift under exercise challenge.	[Hou, Chien-Wen; Lin, Yu-Nan; Chuang, Sheng-Ju; Chen, Chung-Yu; Kuo, Chia-Hua] Univ Taipei, Dept Sports Sci, Lab Exercise Biochem, Taipei, Taiwan; [Lee, Shin-Da; Kuo, Chia-Hua] China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan; [Lee, Shin-Da] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Kao, Chung-Lan] Taipei Vet Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kao, Chung-Lan] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Cheng, I-Shiung] Natl Taichung Univ Educ, Dept Phys Educ, Taichung, Taiwan; [Ivy, John L.] Univ Texas Austin, Dept Kinesiol & Hlth, Austin, TX 78712 USA; [Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Kuo, Chia-Hua] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	University of Taipei; China Medical University Taiwan; Asia University Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taichung University of Education; University of Texas System; University of Texas Austin; China Medical University Taiwan; Asia University Taiwan	Kuo, CH (corresponding author), Univ Taipei, Dept Sports Sci, Lab Exercise Biochem, Taipei, Taiwan.	kch@utaipei.edu.tw	Yuang, Chih-Yang/O-5111-2015; Lee, Shin-Da/Q-2798-2015	Lee, Shin-Da/0000-0002-8393-8349; Chuang, Sheng-Ju/0000-0002-4206-8017; Kuo, Chia-Hua/0000-0002-1731-4984	National Science Council, University of Taipei, and NuLiv Wellness, Taiwan [101-2622-H-154-001-CC2]	National Science Council, University of Taipei, and NuLiv Wellness, Taiwan	This study was supported by National Science Council (101-2622-H-154-001-CC2), University of Taipei, and NuLiv Wellness, Taiwan. (URL:http://www.most.gov.tw), (URL:http://www.nulivwellness.com/) (URL:www.utaipei.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrke MS, 2000, SPORTS MED, V29, P113, DOI 10.2165/00007256-200029020-00004; Bosurgi L, 2012, J IMMUNOL, V188, P6267, DOI 10.4049/jimmunol.1102680; Bucci LR, 2000, AM J CLIN NUTR, V72, p624S, DOI 10.1093/ajcn/72.2.624S; Cheng IS, 2012, BRIT J NUTR, V107, P1048, DOI 10.1017/S0007114511003862; Engels HJ, 2001, J STRENGTH COND RES, V15, P290; Faist V, 1998, PFLUG ARCH EUR J PHY, V437, P168, DOI 10.1007/s004240050764; Gondim FJ, 2009, J EQUINE VET SCI, V29, P206, DOI 10.1016/j.jevs.2009.02.006; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; Jander S, 1998, AM J PATHOL, V152, P975; Kim YK, 2002, TOXICOLOGY, V172, P149, DOI 10.1016/S0300-483X(01)00585-6; LIU JD, 1995, MECH AGEING DEV, V83, P43, DOI 10.1016/0047-6374(95)01618-A; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Paolisso G, 1996, J CLIN ENDOCR METAB, V81, P4244, DOI 10.1210/jc.81.12.4244; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Redondo-Morata L, 2012, LANGMUIR, V28, P12851, DOI 10.1021/la302620t; SEWELL DA, 1994, COMP BIOCHEM PHYS A, V108, P87, DOI 10.1016/0300-9629(94)90059-0; SHANLEY TP, 1995, J IMMUNOL, V154, P3454; Sievenpiper JL, 2003, EUR J CLIN NUTR, V57, P243, DOI 10.1038/sj.ejcn.1601550; Um JY, 2001, BIOL PHARM BULL, V24, P872, DOI 10.1248/bpb.24.872; Wang LCH, 1998, PLANTA MED, V64, P130, DOI 10.1055/s-2006-957389; Wasuntarawat C, 2010, J SPORT SCI, V28, P1243, DOI 10.1080/02640414.2010.506221; Zhang DX, 1996, FREE RADICAL BIO MED, V20, P145, DOI 10.1016/0891-5849(95)02020-9; Ziobro A, 2013, MOL CELL BIOCHEM, V378, P267, DOI 10.1007/s11010-013-1617-7	24	15	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116387	10.1371/journal.pone.0116387	http://dx.doi.org/10.1371/journal.pone.0116387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617625	Green Published, gold, Green Submitted			2022-12-27	WOS:000350336000015
J	Liu, HJ; Yan, PJ; Fanning, E				Liu, Hanjian; Yan, Peijun; Fanning, Ellen			Human DNA Helicase B Functions in Cellular Homologous Recombination and Stimulates Rad51-Mediated 5 '-3 ' Heteroduplex Extension In Vitro	PLOS ONE			English	Article							REPLICATION PROTEIN-A; DOUBLE-STRAND BREAKS; YEAST RAD51 PROTEIN; SACCHAROMYCES-CEREVISIAE; COMPLEX-FORMATION; BINDING PROTEIN; EXCHANGE; REPAIR; CELLS; DAMAGE	Homologous recombination is involved in the repair of DNA damage and collapsed replication fork, and is critical for the maintenance of genomic stability. Its process involves a network of proteins with different enzymatic activities. Human DNA helicase B (HDHB) is a robust 5'-3' DNA helicase which accumulates on chromatin in cells exposed to DNA damage. HDHB facilitates cellular recovery from replication stress, but its role in DNA damage response remains unclear. Here we report that HDHB silencing results in reduced sister chromatid exchange, impaired homologous recombination repair, and delayed RPA late-stage foci formation induced by ionizing radiation. Ectopically expressed HDHB colocalizes with Rad51, Rad52, RPA, and ssDNA. In vitro, HDHB stimulates Rad51-mediated hetero-duplex extension in 5'-3' direction. A helicase-defective mutant HDHB failed to promote this reaction. Our studies implicate HDHB promotes homologous recombination in vivo and stimulates 5'-3' heteroduplex extension during Rad51-mediated strand exchange in vitro.	[Liu, Hanjian; Yan, Peijun; Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Liu, HJ (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	hanjianliu@gmail.com			NIH [GM52948, P30CA68485]; HHMI Professors Program [52003905]; Vanderbilt University; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Professors Program; Vanderbilt University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (www.nih.gov) (GM52948 to E.F. and P30CA68485 to the Vanderbilt-Ingram Cancer Center), HHMI Professors Program (52003905), and by Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2004, J BIOL CHEM, V279, P37343, DOI 10.1074/jbc.M313910200; Balajee AS, 2004, EXP CELL RES, V300, P320, DOI 10.1016/j.yexcr.2004.07.022; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006; Chi P, 2006, J BIOL CHEM, V281, P26268, DOI 10.1074/jbc.M602983200; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; Dudas A, 2004, MUTAT RES, V566, P131; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Guler GD, 2012, J BIOL CHEM, V287, P6469, DOI 10.1074/jbc.M111.324582; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; KODADEK T, 1987, NATURE, V326, P312, DOI 10.1038/326312a0; Li X, 2009, NUCLEIC ACIDS RES, V37, P638, DOI 10.1093/nar/gkn980; Liu YL, 2004, J MOL BIOL, V337, P817, DOI 10.1016/j.jmb.2004.02.022; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Mazina OM, 2004, CELL, V117, P47, DOI 10.1016/S0092-8674(04)00294-6; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; Namsaraev E, 1997, MOL CELL BIOL, V17, P5359, DOI 10.1128/MCB.17.9.5359; Namsaraev EA, 1998, P NATL ACAD SCI USA, V95, P10477, DOI 10.1073/pnas.95.18.10477; Namsaraev EA, 2000, J BIOL CHEM, V275, P3970, DOI 10.1074/jbc.275.6.3970; New JH, 2002, J BIOL CHEM, V277, P26171, DOI 10.1074/jbc.M203670200; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; SAITOH A, 1995, NUCLEIC ACIDS RES, V23, P2014, DOI 10.1093/nar/23.11.2014; Shim KS, 2006, DNA REPAIR, V5, P718, DOI 10.1016/j.dnarep.2006.03.006; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Solinger JA, 2001, P NATL ACAD SCI USA, V98, P8447, DOI 10.1073/pnas.121009898; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Tada S, 2001, NUCLEIC ACIDS RES, V29, P3835, DOI 10.1093/nar/29.18.3835; Taneja P, 2002, J BIOL CHEM, V277, P40853, DOI 10.1074/jbc.M208067200; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Wright WD, 2014, MOL CELL, V53, P420, DOI 10.1016/j.molcel.2013.12.027	42	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116852	10.1371/journal.pone.0116852	http://dx.doi.org/10.1371/journal.pone.0116852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617833	gold, Green Submitted, Green Published			2022-12-27	WOS:000350336000029
J	Ahmad, WNHW; Sakri, F; Mokhsin, A; Rahman, T; Nasir, NM; Abdul-Razak, S; Yasin, MM; Ismail, AM; Ismail, Z; Nawawi, H				Ahmad, Wan Nor Hanis Wan; Sakri, Farah; Mokhsin, Atiqah; Rahman, Thuhairah; Nasir, Nadzimah Mohd; Abdul-Razak, Suraya; Yasin, Mazapuspavina Md; Ismail, Aletza Mohd; Ismail, Zaliha; Nawawi, Hapizah			Low Serum High Density Lipoprotein Cholesterol Concentration is an Independent Predictor for Enhanced Inflammation and Endothelial Activation	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; OXIDATIVE STRESS; OXIDIZED LDL; HDL; ATHEROSCLEROSIS; EXPRESSION; BIOMARKERS; INTERLEUKIN-6	Background Inflammation, endothelial activation and oxidative stress have been established as key events in the initiation and progression of atherosclerosis. High-density lipoprotein cholesterol (HDL-c) is protective against atherosclerosis and coronary heart disease, but its association with inflammation, endothelial activation and oxidative stress is not well established. Objectives (1) To compare the concentrations of biomarkers of inflammation, endothelial activation and oxidative stress in subjects with low HDL-c compared to normal HDL-c; (2) To examine the association and correlation between HDL-c and these biomarkers and (3) To determine whether HDL-c is an independent predictor of these biomarkers. Methods 422 subjects (mean age +/- SD = 43.2 +/- 11.9years) of whom 207 had low HDL-c concentrations (HDL-c < 1.0mmol/L and < 1.3mmol/L for males and females respectively) and 215 normal controls (HDL-c >= 1.0 and >= 1.3mmol/L for males and females respectively) were recruited in this study. The groups were matched for age, gender, ethnicity, smoking status, diabetes mellitus and hypertension. Fasting blood samples were collected for analysis of biomarkers of inflammation [high-sensitivity C-reactive protein (hsCRP) and Interleukin-6 (IL-6)], endothelial activation [soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1), soluble Intercellular Adhesion Molecule-1 (sICAM-1) and E-selectin)] and oxidative stress [F2-Isoprostanes, oxidized Low Density Lipoprotein (ox-LDL) and Malondialdehyde (MDA)]. Results Subjects with low HDL-c had greater concentrations of inflammation, endothelial activation and oxidative stress biomarkers compared to controls. There were negative correlations between HDL-c concentration and biomarkers of inflammation (IL-6, p = 0.02), endothelial activation (sVCAM-1 and E-selectin, p = 0.029 and 0.002, respectively), and oxidative stress (MDA and F-2-isoprostane, p = 0.036 and <0.0001, respectively). Multiple linear regression analysis showed HDL-c as an independent predictor of IL-6 (p = 0.02) and sVCAM-1 (p<0.03) after correcting for various confounding factors. Conclusion Low serum HDL-c concentration is strongly correlated with enhanced status of inflammation, endothelial activation and oxidative stress. It is also an independent predictor for enhanced inflammation and endothelial activation, which are pivotal in the pathogenesis of atherosclerosis and atherosclerosis-related complications.	[Ahmad, Wan Nor Hanis Wan; Sakri, Farah; Mokhsin, Atiqah; Rahman, Thuhairah; Nasir, Nadzimah Mohd; Ismail, Aletza Mohd; Nawawi, Hapizah] Univ MARA UiTM, CPDRL, Sungai Buloh, Selangor, Malaysia; [Rahman, Thuhairah; Nasir, Nadzimah Mohd; Ismail, Aletza Mohd; Nawawi, Hapizah] Univ MARA UiTM, Cluster Pathol & Lab Med, Sungai Buloh, Selangor, Malaysia; [Abdul-Razak, Suraya; Yasin, Mazapuspavina Md] Univ MARA UiTM, Primary Care Med Discipline, Sungai Buloh, Selangor, Malaysia; [Ismail, Zaliha] Univ MARA UiTM, Fac Med, Discipline Populat Hlth & Prevent Med, Sungai Buloh, Selangor, Malaysia		Nawawi, H (corresponding author), Univ MARA UiTM, CPDRL, Sungai Buloh Campus, Sungai Buloh, Selangor, Malaysia.	hapizah.nawawi@gmail.com	Mohd Ismail, Aletza/GNH-2399-2022; Suraya, Abdul-Razak/AAG-1206-2020; ISMAIL, ZALIHA/GYU-9969-2022; Ismail, Zaliha/AGR-0412-2022; YASIN, MAZAPUSPAVINA MD/AAU-7866-2021; Abdul Rahman, Thuhairah Hasrah/ABA-5874-2021; Nawawi, Hapizah/N-7446-2019; Nawawi, Hapizah Mohd/J-8873-2019; Mohd Mokhsin, Nurul Atiqah/Q-2575-2018	Mohd Ismail, Aletza/0000-0001-9427-6371; Suraya, Abdul-Razak/0000-0001-5376-2509; ISMAIL, ZALIHA/0000-0003-1144-4451; Ismail, Zaliha/0000-0003-1144-4451; YASIN, MAZAPUSPAVINA MD/0000-0002-2402-1151; Nawawi, Hapizah/0000-0003-4462-8484; Nawawi, Hapizah Mohd/0000-0003-4462-8484; Mohd Mokhsin, Nurul Atiqah/0000-0001-5663-8108; ABDUL RAHMAN, THUHAIRAH/0000-0003-2779-1765; Nawawi, M Ikhsan/0000-0002-1372-453X	Malaysian Higher Education Ministry Long Term Research Grant Scheme (LRGS) [600-RMI/LRGS 5/3 (2/2011)]	Malaysian Higher Education Ministry Long Term Research Grant Scheme (LRGS)	This study was supported by the Malaysian Higher Education Ministry Long Term Research Grant Scheme (LRGS), grant code: 600-RMI/LRGS 5/3 (2/2011), awarded to HN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Barter PJ, 2011, DIABETES METAB J, V35, P101, DOI 10.4093/dmj.2011.35.2.101; Blake Gavin J, 2000, Curr Control Trials Cardiovasc Med, V1, P161, DOI 10.1186/CVM-1-3-161; BODEN WE, 2011, NEW ENGL J MED, V365, P572, DOI DOI 10.1056/NEJMC1106641#SA2; Calabresi L, 2002, ARTERIOSCL THROM VAS, V22, P656, DOI 10.1161/hq0402.105901; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; DIEPLINGER H, 1985, J LIPID RES, V26, P273; ECKARDSTEIN A, 2005, CURR OPIN CLIN NUTR, V8, P147; Feig JE, 2014, CIRC RES, V114, P205, DOI 10.1161/CIRCRESAHA.114.300760; Gomaraschi M, 2005, BBA-MOL CELL BIOL L, V1736, P136, DOI 10.1016/j.bbalip.2005.08.003; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HAYEK T, 1993, J CLIN INVEST, V92, P1143, DOI 10.1172/JCI116683; Holven KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078241; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Kontush A, 2006, NAT CLIN PRACT CARD, V3, P144, DOI 10.1038/ncpcardio0500; Kontush A, 2003, ARTERIOSCL THROM VAS, V23, P1881, DOI 10.1161/01.ATV.0000091338.93223.E8; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Kotur-Stevuljevic J, 2007, CLIN BIOCHEM, V40, P181, DOI 10.1016/j.clinbiochem.2006.09.007; KUNITAKE ST, 1992, P NATL ACAD SCI USA, V89, P6993, DOI 10.1073/pnas.89.15.6993; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Li DY, 2005, CARDIOVASC RES, V68, P353, DOI 10.1016/j.cardiores.2005.09.009; Lupattelli G, 2003, METABOLISM, V52, P1191, DOI 10.1016/S0026-0495(03)00157-4; Mahalle Namita, 2014, Indian J Endocrinol Metab, V18, P48, DOI 10.4103/2230-8210.126532; MASCARENHASMELO F, 2013, MEDIAT INFLAMM, V2013, P1; Maziere C, 2000, BIOCHEM BIOPH RES CO, V276, P718, DOI 10.1006/bbrc.2000.3528; MIYAZAKI A, 1995, ARTERIOSCL THROM VAS, V15, P1882, DOI 10.1161/01.ATV.15.11.1882; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nofer JR, 2003, BIOCHEM BIOPH RES CO, V310, P98, DOI 10.1016/j.bbrc.2003.08.126; Nofer JR, 2002, ATHEROSCLEROSIS, V161, P1, DOI 10.1016/S0021-9150(01)00651-7; Palmas W, 2007, AM J HYPERTENS, V20, P233, DOI 10.1016/j.amjhyper.2006.08.006; Patel S, 2010, ATHEROSCLEROSIS, V212, P392, DOI 10.1016/j.atherosclerosis.2010.05.035; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rizzo M, 2006, CARDIOVASC DRUG THER, V20, P205, DOI 10.1007/s10557-006-8283-x; Ruef J, 2001, CARDIOVASC PATHOL, V10, P311, DOI 10.1016/S1054-8807(01)00095-3; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Sharma RK, 2009, VASC HEALTH RISK MAN, V5, P793; Shimabukuro M, 2006, J DIABETES COMPLICAT, V20, P179, DOI 10.1016/j.jdiacomp.2005.06.012; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Stoner L, 2013, CLIN BIOCHEM, V46, P1353, DOI 10.1016/j.clinbiochem.2013.05.070; Tai ES, 1999, DIABETES, V48, P1088, DOI 10.2337/diabetes.48.5.1088; Tang LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089023; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tehrani DM, 2013, ATHEROSCLEROSIS, V231, P246, DOI 10.1016/j.atherosclerosis.2013.08.036; Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610; Wadham C, 2004, CIRCULATION, V109, P2116, DOI 10.1161/01.CIR.0000127419.45975.26; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wu TY, 2004, CANCER EPIDEM BIOMAR, V13, P1399; Zelzer S, 2011, CLIN CHIM ACTA, V412, P1345, DOI 10.1016/j.cca.2011.03.031; Zhai Y, 2012, BIOMED ENVIRON SCI, V25, P257, DOI 10.3967/0895-3988.2012.03.002; Zhang ZJ, 2013, ANN CLIN BIOCHEM, V50, P108, DOI 10.1258/acb.2012.011263	54	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116867	10.1371/journal.pone.0116867	http://dx.doi.org/10.1371/journal.pone.0116867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25614985	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100047
J	Yu, TY; Pang, WJ; Yang, GS				Yu, Tai-yong; Pang, Wei-jun; Yang, Gong-she			Aryl Hydrocarbon Receptors in Osteoclast Lineage Cells Are a Negative Regulator of Bone Mass	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; DIFFERENTIATION FACTOR; ESTROGEN-RECEPTOR; AH-RECEPTOR; IN-UTERO; KAPPA-B; LIGAND; OSTEOPROTEGERIN; ACTIVATION; INDUCTION	Aryl hydrocarbon receptors (AhRs) play a critical role in various pathological and physiological processes. Although recent research has identified AhRs as a key contributor to bone metabolism following studies in systemic AhR knockout (KO) or transgenic mice, the cellular and molecular mechanism(s) in this process remain unclear. In this study, we explored the function of AhR in bone metabolism using AhR(RANK Delta Oc/Delta Oc) (RANK(Cre/+); AhR(flox/flox)) mice. We observed enhanced bone mass together with decreased resorption in both male and female 12 and 24-week-old AhR(RANK Delta Oc/Delta Oc) mice. Control mice treated with 3-methylcholanthrene (3MC), an AhR agonist, exhibited decreased bone mass and increased bone resorption, whereas AhR(Ctsk Delta Oc/Delta Oc) (Ctsk(Cre/+); AhR(flox/flox)) mice injected with 3MC appeared to have a normal bone phenotype. In vitro, bone marrow-derived macrophages (BMDMs) from AhR(RANK Delta Oc/Delta Oc) mice exhibited impaired osteoclastogenesis and repressed differentiation with downregulated expression of B lymphocyte-induced maturation protein 1 (Blimp1), and cytochrome P450 genes Cyp1b1 and Cyp1a2. Collectively, our results not only demonstrated that AhR in osteoclast lineage cells is a physiologically relevant regulator of bone resorption, but also highlighted the need for further studies on the skeletal actions of AhR inhibitors in osteoclast lineage cells commonly associated with bone diseases, especially diseases linked to environmental pollutants known to induce bone loss.	[Yu, Tai-yong] Ehime Univ, Grad Sch Med, Proteosci Ctr, Div Integrat Pathophysiol, Matsuyama, Ehime 7910295, Japan; [Yu, Tai-yong] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Epigenet Skeletal Dis, Tokyo 1130032, Japan; [Pang, Wei-jun; Yang, Gong-she] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi Provinc, Peoples R China	Ehime University; University of Tokyo; Northwest A&F University - China	Yu, TY (corresponding author), Ehime Univ, Grad Sch Med, Proteosci Ctr, Div Integrat Pathophysiol, Matsuyama, Ehime 7910295, Japan.	utaiei310@yahoo.co.jp			Japan Society for the Promotion of Science (JSPS) [12F02106]; Japanese Government doctoral scholarship	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Government doctoral scholarship	This work was supported by a postdoctoral fellowship for foreign researchers (Grant number 12F02106 to TY) from the Japan Society for the Promotion of Science (JSPS), and a Japanese Government doctoral scholarship in 2008 (to TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; Hayashi M, 2010, BIOCHEM BIOPH RES CO, V393, P432, DOI 10.1016/j.bbrc.2010.02.013; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Hermsen SAB, 2008, TOXICOLOGY, V253, P147, DOI 10.1016/j.tox.2008.09.005; Hirose J, 2014, J EXP MED, V211, P153, DOI 10.1084/jem.20130538; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Ikuta T, 2010, J DERMATOL SCI, V58, P211, DOI 10.1016/j.jdermsci.2010.04.003; Iqbal J, 2013, P NATL ACAD SCI USA, V110, P11115, DOI 10.1073/pnas.1220919110; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Khosla S, 2009, NEW ENGL J MED, V361, P818, DOI 10.1056/NEJMe0905480; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kondoh S, 2014, BONE, V60, P68, DOI 10.1016/j.bone.2013.12.005; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lind PM, 2009, CHEMOSPHERE, V75, P680, DOI 10.1016/j.chemosphere.2008.12.024; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Miettinen HM, 2005, TOXICOL SCI, V85, P1003, DOI 10.1093/toxsci/kfi136; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Nakahama T, 2011, P NATL ACAD SCI USA, V108, P14222, DOI 10.1073/pnas.1111786108; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Nishimura N, 2009, TOXICOL APPL PHARM, V236, P301, DOI 10.1016/j.taap.2009.01.025; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Santiago F, 2012, BIOCHEM BIOPH RES CO, V417, P223, DOI 10.1016/j.bbrc.2011.11.089; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Sato K, 2006, CURR OPIN RHEUMATOL, V18, P419, DOI 10.1097/01.bor.0000231912.24740.a5; Seeman E, 2003, OSTEOPOROSIS INT, V14, pS2, DOI 10.1007/s00198-002-1340-9; Shukla D, 2009, HIGH ALT MED BIOL, V10, P57, DOI 10.1089/ham.2008.1028; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sogawa K, 1997, J BIOCHEM, V122, P1075; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2005, J PERIODONTAL RES, V40, P287, DOI 10.1111/j.1600-0765.2005.00814.x; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Villa A, 2009, CALCIFIED TISSUE INT, V84, P1, DOI 10.1007/s00223-008-9196-4; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wejheden C, 2010, TOXICOL SCI, V114, P48, DOI 10.1093/toxsci/kfp284; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yu TY, 2014, BIOCHEM BIOPH RES CO, V450, P416, DOI 10.1016/j.bbrc.2014.05.114; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	55	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117112	10.1371/journal.pone.0117112	http://dx.doi.org/10.1371/journal.pone.0117112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615839	Green Submitted, Green Published, gold			2022-12-27	WOS:000349122100056
J	Zhou, NN; Ding, B; Agler, M; Cockett, M; McPhee, F				Zhou, Nannan; Ding, Bo; Agler, Michele; Cockett, Mark; McPhee, Fiona			Lethality of PAK3 and SGK2 shRNAs to Human Papillomavirus Positive Cervical Cancer Cells Is Independent of PAK3 and SGK2 Knockdown	PLOS ONE			English	Article							SHORT-INTERFERING RNAS; KINASE REQUIREMENTS; MENTAL-RETARDATION; MAMMALIAN-CELLS; PROTEIN-KINASE; GENE-EXPRESSION; INDUCTION; ACTIVATION; REPRESSION; ISOFORMS	The p21-activated kinase 3 (PAK3) and the serum and glucocorticoid-induced kinase 2 (SGK2) have been previously proposed as essential kinases for human papillomavirus positive (HPV+) cervical cancer cell survival. This was established using a shRNA knockdown approach. To validate PAK3 and SGK2 as potential targets for HPV+ cervical cancer therapy, the relationship between shRNA-induced phenotypes in HPV+ cervical cancer cells and PAK3 or SGK2 knockdown was carefully examined. We observed that the phenotypes of HPV+ cervical cancer cells induced by various PAK3 and SGK2 shRNAs could not be rescued by complement expression of respective cDNA constructs. A knockdown-deficient PAK3 shRNA with a single mismatch was sufficient to inhibit HeLa cell growth to a similar extent as wild-type PAK3 shRNA. The HPV+ cervical cancer cells were also susceptible to several non-human target shRNAs. The discrepancy between PAK3 and SGK2 shRNA-induced apoptosis and gene expression knockdown, as well as cell death stimulation, suggested that these shRNAs killed HeLa cells through different pathways that may not be target-specific. These data demonstrated that HPV+ cervical cancer cell death was not associated with RNAi-induced PAK3 and SGK2 knockdown but likely through off-target effects.	[Zhou, Nannan; Ding, Bo; Cockett, Mark; McPhee, Fiona] R&D Bristol Myers Squibb Co, Dept Virol, Wallingford, CT USA; [Agler, Michele] R&D Bristol Myers Squibb Co, Dept Leads Discovery, Wallingford, CT USA	Bristol-Myers Squibb; Bristol-Myers Squibb	McPhee, F (corresponding author), R&D Bristol Myers Squibb Co, Dept Virol, Wallingford, CT USA.	Fiona.McPhee@bms.com			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Funding of this study was from Bristol-Myers Squibb. BMS provided support in the form of salaries for authors [NZ, BD, MA, MC and FM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Since Michele Agler became an employee of Boehringer Ingleheim, they have provided support in the form of a salary for her, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Baldwin A, 2010, P NATL ACAD SCI USA, V107, P12463, DOI 10.1073/pnas.1007462107; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; Boda B, 2004, J NEUROSCI, V24, P10816, DOI 10.1523/JNEUROSCI.2931-04.2004; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Editorial, 2003, NAT CELL BIOL, V5, P489, DOI [10.1038/ncb0603-490, DOI 10.1038/NCB0603-490]; Friedrich B, 2003, PFLUG ARCH EUR J PHY, V445, P693, DOI 10.1007/s00424-002-0993-8; Gamper N, 2002, PFLUG ARCH EUR J PHY, V445, P60, DOI 10.1007/s00424-002-0873-2; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16490, DOI 10.1073/pnas.0806578105; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kreis P, 2008, J NEUROCHEM, V106, P1184, DOI 10.1111/j.1471-4159.2008.05474.x; Lowy DR, 2001, FIELDS VIROLOGY, P2231; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; McPhie DL, 2003, J NEUROSCI, V23, P6914; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Souopgui J, 2002, EMBO J, V21, P6429, DOI 10.1093/emboj/cdf644; Svoboda P, 2007, CURR OPIN MOL THER, V9, P248; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701	34	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117357	10.1371/journal.pone.0117357	http://dx.doi.org/10.1371/journal.pone.0117357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615606	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100062
J	Koumare, ATCRK; Sakande, LPL; Kabre, E; Sonde, I; Simpore, J; Sakande, J				Koumare, Alice T. C. R. Kiba; Sakande, Linda P. L.; Kabre, Elie; Sonde, Issaka; Simpore, Jacques; Sakande, Jean			Reference Ranges of Cholesterol Sub-Fractions in Random Healthy Adults in Ouagadougou, Burkina Faso	PLOS ONE			English	Article							SMALL DENSE LDL; RANDOM-POPULATION; LIPOPROTEIN; HDL2; ATHEROSCLEROSIS; MALES; RISK	In Burkina Faso, the values that serve as clinical chemistry reference ranges are those provided by European manufacturers' insert sheets based on reference of the Western population. However, studies conducted so far in some African countries reported significant differences in normal laboratory ranges compared with those of the industrialized world. The aim of this study was to determine reference values of cholesterol fractions in apparently normal adults in Burkina Faso that could be used to better assess the risks related to cardiovascular diseases. Study population was 279 healthy subjects aged from 15 to 50 years including 139 men and 140 women recruited at the Regional Center of Blood Transfusion of Ouagadougou, capital city of Burkina Faso (West Africa). Exclusion criteria based on history and clinical examination were used for defining reference individuals. The dual-step precipitation of HDL cholesterol sub-fractions using dextran sulfate was performed according to the procedure described by Hirano. The medians were calculated and reference values were determined at 2.5th and 97.5th percentiles. The median and upper ranges for total cholesterol, LDL cholesterol, total HDL cholesterol and HDL2 cholesterol were observed to be higher in women in comparison to men (p < 0.05). These reference ranges were similar to those derived from other African countries but lower than those recorded in France and in USA. This underscores the need for such comprehensible establishment of reference values for limited resources countries. Our study provides the first cholesterol sub-fractions (HDL2 and HDL3) reference ranges for interpretation of laboratory results for cardiovascular risk management in Burkina Faso.	[Koumare, Alice T. C. R. Kiba; Kabre, Elie; Sonde, Issaka; Sakande, Jean] Univ Ouagadougou, Biochem Lab, Dept Hlth, Ouagadougou, Burkina Faso; [Sakande, Linda P. L.] Clin Lab, Clin Philadelphie Ouagadougou, Ouagadougou, Burkina Faso; [Koumare, Alice T. C. R. Kiba] Reg Blood Transfus Ctr Ouagadougou, Ouagadougou, Burkina Faso; [Simpore, Jacques] Univ Ouagadougou, Ctr Med St Camille, Lab Biol & Genet LABIOGENE, Ctr Rech Biomol Pietro Annigoni CERBA, Ouagadougou, Burkina Faso		Sakande, J (corresponding author), Univ Ouagadougou, Biochem Lab, Dept Hlth, Ouagadougou, Burkina Faso.	jsakande@gmail.com	SIMPORE, Jacques/ABA-4873-2020	SIMPORE, Jacques/0000-0002-0415-9161				Akpona AS, 2009, REV CAMES A, V08, P72, DOI [10.1016/j.repc.2014.08.005, DOI 10.1016/J.REPC.2014.08.005]; ATGER V, 1990, CLIN CHIM ACTA, V189, P111, DOI 10.1016/0009-8981(90)90081-3; Brahim BO, 2004, MED AFRIQUE NOIRE, V54, P366; Clinical and Laboratory Standards Institute, 2008, DEF EST VER REF INT, V28, DOI [10.1097/IAE.0b013e3181846640, DOI 10.1097/IAE.0B013E3181846640]; Das M, 2009, INDIAN J CLIN BIOCHE, V24, P190, DOI 10.1007/s12291-009-0034-x; FERNS GAA, 1986, ANN CLIN BIOCHEM, V23, P504, DOI 10.1177/000456328602300503; Goswami K, 2003, Indian J Clin Biochem, V18, P127, DOI 10.1007/BF02867378; Gupta R, 1997, J Assoc Physicians India, V45, P275; Henny J, 1990, REFERENNCES BIOL CLI, P43, DOI [10.1016/j.biortech.2014.12.058, DOI 10.1016/J.BIORTECH.2014.12.058]; Hirano T, 2008, J LIPID RES, V49, P1130, DOI 10.1194/jlr.D700027-JLR200; KANNEL WB, 1987, AM HEART J, V114, P413, DOI 10.1016/0002-8703(87)90511-4; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; KIRKLAND RT, 1987, JAMA-J AM MED ASSOC, V257, P502, DOI 10.1001/jama.257.4.502; Maeda S, 2012, J ATHEROSCLER THROMB, V19, P444; Miri-Dashe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093919; Ndomou M., 1999, Cahiers d'Etudes et de Recherches Francophones/Sante, V9, P169; NYARKO NK, 1994, J INTERN MED, V236, P251, DOI 10.1111/j.1365-2796.1994.tb00792.x; ROCHE D, 1991, CLIN CHEM, V37, P2111; Sairam S, 2014, INDIAN J CLIN BIOCHE, V29, P290, DOI 10.1007/s12291-013-0365-5; Sakande J, 2004, ANN BIOL CLIN-PARIS, V62, P229; Sodre FL, 2006, J CLIN LAB ANAL, V20, P113, DOI 10.1002/jcla.20111; Srisawasdi P, 2011, AM J CLIN PATHOL, V136, P20, DOI 10.1309/AJCPLHJBGG9L3ILS; Tembe N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097391; Vassault A, 1999, ANN BIOL CLIN-PARIS, V57, P685; Verdier F, 2007, Med Trop (Mars), V67, P552; Wijtske A, 2011, CURR ATHEROSCLER REP, V13, P257, DOI [10.1007/s11883-011-0175-2, DOI 10.1007/S11883-011-0175-2]; Yapo AE, 1989, PHARM AFR, V44, P13	27	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116420	10.1371/journal.pone.0116420	http://dx.doi.org/10.1371/journal.pone.0116420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611320	Green Submitted, gold, Green Published			2022-12-27	WOS:000348562900014
J	Brambert, PR; Kelpsch, DJ; Hameed, R; Desai, CV; Calafiore, G; Godley, LA; Raimondi, SL				Brambert, Patrick R.; Kelpsch, Daniel J.; Hameed, Rabia; Desai, Charmi V.; Calafiore, Gianfranco; Godley, Lucy A.; Raimondi, Stacey L.			DNMT3B7 Expression Promotes Tumor Progression to a More Aggressive Phenotype in Breast Cancer Cells	PLOS ONE			English	Article							BETA-CATENIN; DNA METHYLTRANSFERASES; METHYLATION; METASTASIS; PATHWAYS; SUPPRESSES; INVASION	Epigenetic changes, such as DNA methylation, have been shown to promote breast cancer progression. However, the mechanism by which cancer cells acquire and maintain abnormal DNA methylation is not well understood. We have previously identified an aberrant splice form of a DNA methyltransferase, DNMT3B7, expressed in virtually all cancer cell lines but at very low levels in normal cells. Furthermore, aggressive MDA-MB-231 breast cancer cells have been shown to express increased levels of DNMT3B7 compared to poorly invasive MCF-7 cells, indicating that DNMT3B7 may have a role in promoting a more invasive phenotype. Using data gathered from The Cancer Genome Atlas, we show that DNMT3B7 expression is increased in breast cancer patient tissues compared to normal tissue. To determine the mechanism by which DNMT3B7 was functioning in breast cancer cells, two poorly invasive breast cancer cell lines, MCF-7 and T-47D, were stably transfected with a DNMT3B7 expression construct. Expression of DNMT3B7 led to hypermethylation and down-regulation of E-cadherin, altered localization of beta-catenin, as well as increased adhesion turnover, cell proliferation, and anchorage-independent growth. The novel results presented in this study suggest a role for DNMT3B7 in the progression of breast cancer to a more aggressive state and the potential for future development of novel therapeutics.	[Brambert, Patrick R.; Kelpsch, Daniel J.; Hameed, Rabia; Desai, Charmi V.; Calafiore, Gianfranco; Raimondi, Stacey L.] Elmhurst Coll, Dept Biol, Elmhurst, IL 60126 USA; [Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Raimondi, SL (corresponding author), Elmhurst Coll, Dept Biol, Elmhurst, IL 60126 USA.	raimondis@elmhurst.edu		Raimondi, Stacey/0000-0001-7667-6814	Diana Nicholas Loving Trust; Alfred Koplin; Beta Beta Beta Research Foundation; Elmhurst College Biology Department; Elmhurst College Center for Scholarship and Teaching/Faculty Development Committee; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Diana Nicholas Loving Trust; Alfred Koplin; Beta Beta Beta Research Foundation; Elmhurst College Biology Department; Elmhurst College Center for Scholarship and Teaching/Faculty Development Committee; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Diana Nicholas Loving Trust (SLR), Alfred Koplin (SLR), Beta Beta Beta Research Foundation (RH), the Elmhurst College Biology Department (SLR), and the Elmhurst College Center for Scholarship and Teaching/Faculty Development Committee (SLR, PRB, GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarschab P, 2003, ONCOL REP, V10, P501; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Graff JR, 2000, J BIOL CHEM, V275, P2727, DOI 10.1074/jbc.275.4.2727; Kelpsch Daniel J., 2012, BIOS, V83, P17; Kudo Y, 2004, CLIN CANCER RES, V10, P5455, DOI 10.1158/1078-0432.CCR-04-0372; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lim SC, 2002, ONCOL REP, V9, P915; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orsulic S, 1999, J CELL SCI, V112, P1237; Ostler K, 2007, ONCOGENE, V26, P5553, DOI 10.1038/sj.onc.1210351; Ostler KR, 2012, CANCER RES, V72, P4714, DOI 10.1158/0008-5472.CAN-12-0886; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; Reed KR, 2008, P NATL ACAD SCI USA, V105, P18919, DOI 10.1073/pnas.0805778105; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Semba S, 2000, ENDOCR PATHOL, V11, P243, DOI 10.1385/EP:11:3:243; Shah MY, 2010, CANCER RES, V70, P5840, DOI 10.1158/0008-5472.CAN-10-0847; Siapati EK, 2011, BRIT J HAEMATOL, V152, P164, DOI 10.1111/j.1365-2141.2010.08471.x; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	26	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0117310	10.1371/journal.pone.0117310	http://dx.doi.org/10.1371/journal.pone.0117310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607950	Green Submitted, gold, Green Published			2022-12-27	WOS:000348205300050
J	Tsuruya, K; Fukuma, S; Wakita, T; Ninomiya, T; Nagata, M; Yoshida, H; Fujimi, S; Kiyohara, Y; Kitazono, T; Uchida, K; Shirota, T; Akizawa, T; Akiba, T; Saito, A; Fukuhara, S				Tsuruya, Kazuhiko; Fukuma, Shingo; Wakita, Takafumi; Ninomiya, Toshiharu; Nagata, Masaharu; Yoshida, Hisako; Fujimi, Satoru; Kiyohara, Yutaka; Kitazono, Takanari; Uchida, Kazuhiro; Shirota, Tomoko; Akizawa, Tadao; Akiba, Takashi; Saito, Akira; Fukuhara, Shunichi			Dietary Patterns and Clinical Outcomes in Hemodialysis Patients in Japan: A Cohort Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; COLORECTAL-CANCER; DIALYSIS PATIENTS; HISTORY QUESTIONNAIRES; CLUSTER-ANALYSIS; MORTALITY; HISAYAMA; METAANALYSIS; GUIDELINES	Background & Objectives Little is known about actual dietary patterns and their associations with clinical outcomes in hemodialysis patients. We identified dietary patterns in hemodialysis patients in Japan and examined associations between dietary patterns and clinical outcomes. Design, setting, participants, measurements We used data from 3,080 general-population participants in the Hisayama study (year 2007), and data from 1,355 hemodialysis patients in the Japan Dialysis Outcomes and Practice Patterns Study (JDOPPS: years 2005-2007). Food intake was measured using a brief self-administered diet-history questionnaire (BDHQ). To identify food groups with the Hisayama population data, we used principal components analysis with Promax rotation. We adjusted the resulting food groups for total daily energy intake, and then we used those adjusted food-group scores to identify dietary patterns in the JDOPPS patients by cluster analysis (Ward's method). We then used Cox regression to examine the association between dietary patterns and a composite of adverse clinical outcomes: hospitalization due to cardiovascular disease or death due to any cause. Results We identified three food groups: meat, fish, and vegetables. Using those groups we then identified three dietary patterns: well-balanced, unbalanced, and other. After adjusting for potential confounders, we found an association between an unbalanced diet and important clinical events (hazard ratio 1.90, 95% C.I. 1.19-3.04). Conclusions Hemodialysis patients whose diet was unbalanced were more likely to have adverse clinical outcomes. Thus hemodialysis patients might benefit not only from portion control, but also from a diet that is well-balanced diet with regard to the food groups identified here as meat, fish, and vegetables.	[Tsuruya, Kazuhiko; Yoshida, Hisako] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka 812, Japan; [Fukuma, Shingo; Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Fukuma, Shingo] Inst Hlth Outcomes & Proc Evaluat Res iHope Int, Tokyo, Japan; [Wakita, Takafumi] Kansai Univ, Fac Sociol, Osaka, Japan; [Ninomiya, Toshiharu; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Nagata, Masaharu] Kyushu Univ, Grad Sch Med Sci, Commun Med Educ Unit, Fukuoka 812, Japan; [Fujimi, Satoru] Fukuoka Renal Clin, Fukuoka, Japan; [Kiyohara, Yutaka] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan; [Uchida, Kazuhiro; Shirota, Tomoko] Nakamura Gakuen Univ, Sch Hlth & Nutr Sci, Dept Hlth Promot, Fukuoka, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Akiba, Takashi] Tokyo Womens Med Univ, Kidney Ctr, Dept Blood Purificat & Internal Med, Tokyo, Japan; [Saito, Akira] Shonantobu Gen Hosp, Div Nephrol, Kanagawa, Japan; [Saito, Akira] Shonantobu Gen Hosp, Dialysis Ctr, Kanagawa, Japan; [Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Commun & Clin Excellence, Fukushima, Japan	Kyushu University; Kyoto University; Kansai University; Kyushu University; Kyushu University; Kyushu University; Showa University; Tokyo Women's Medical University; Fukushima Medical University	Fukuhara, S (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan.	fukuhara.shunichi.6m@kyoto-u.ac.jp		Wakita, Takafumi/0000-0003-2293-5918; Fukuma, Shingo/0000-0002-8379-8761	scientific research grants from Kyowa Hakko Kirin (Japan)	scientific research grants from Kyowa Hakko Kirin (Japan)	This study is supported by scientific research grants from Kyowa Hakko Kirin (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CATTELL RB, 1965, BIOMETRICS, V21, P405, DOI 10.2307/2528100; Combe C, 2004, AM J KIDNEY DIS, V44, pS39, DOI 10.1053/j.ajkd.2004.08.010; Everitt B. S., 2001, CLUSTER ANAL; Flood A, 2008, AM J CLIN NUTR, V88, P176, DOI 10.1093/ajcn/88.1.176; Fukuhara M, 2012, J HYPERTENS, V30, P893, DOI 10.1097/HJH.0b013e328351d380; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Heerspink HL, 2009, LANCET, V373, P1009, DOI 10.1016/S0140-6736(09)60212-9; Kalantar-Zadeh K, 2009, CIRCULATION, V119, P671, DOI 10.1161/CIRCULATIONAHA.108.807362; Katsuki S, 1966, Prog Brain Res, V21, P64; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Kopple JD, 2001, AM J KIDNEY DIS, V37, pS66, DOI 10.1053/ajkd.2001.20748; Krishnamurthy VMR, 2012, KIDNEY INT, V81, P300, DOI 10.1038/ki.2011.355; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Kuriyama S, 2008, CLIN EXP NEPHROL, V12, P165, DOI 10.1007/s10157-007-0020-7; Kutner NG, 2002, AM J KIDNEY DIS, V39, P1018, DOI 10.1053/ajkd.2002.32775; Mahabir S, 2006, EUR J CLIN NUTR, V60, P561, DOI 10.1038/sj.ejcn.1602359; Mailloux LU, 2000, SEMIN DIALYSIS, V13, P150, DOI 10.1046/j.1525-139x.2000.00040.x; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P683, DOI 10.2215/CJN.08601209; Okubo H, 2006, AM J CLIN NUTR, V83, P1185, DOI 10.1093/ajcn/83.5.1185; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Pisoni RL, 2004, AM J KIDNEY DIS, V44, pS7, DOI 10.1053/j.ajkd.2004.08.005; Port FK, 2004, AM J KIDNEY DIS, V44, pS1, DOI 10.1053/j.ajkd.2004.08.004; Reedy J, 2010, AM J EPIDEMIOL, V171, P479, DOI 10.1093/aje/kwp393; Sanghavi S, 2013, SEMIN DIALYSIS, V26, P597, DOI 10.1111/sdi.12123; Sasaki S, 2000, J NUTR SCI VITAMINOL, V46, P285, DOI 10.3177/jnsv.46.285; Sasaki S, 1998, J Epidemiol, V8, P203; Sherman RA, 2009, AM J KIDNEY DIS, V54, P18, DOI 10.1053/j.ajkd.2009.01.269; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wirfalt E, 2009, EUR J CLIN NUTR, V63, P707, DOI 10.1038/ejcn.2008.40	30	14	14	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116677	10.1371/journal.pone.0116677	http://dx.doi.org/10.1371/journal.pone.0116677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607947	Green Submitted, Green Published, gold			2022-12-27	WOS:000348205300031
J	Han, XJ; Li, X; Rigon, R; Jin, R; Endrizzi, S				Han, Xujun; Li, Xin; Rigon, Riccardo; Jin, Rui; Endrizzi, Stefano			Soil Moisture Estimation by Assimilating L-Band Microwave Brightness Temperature with Geostatistics and Observation Localization	PLOS ONE			English	Article							LAND DATA ASSIMILATION; MODEL; WATER; RESOLUTION; SYSTEM; VALIDATION; EMISSION; IMPACT	The observation could be used to reduce the model uncertainties with data assimilation. If the observation cannot cover the whole model area due to spatial availability or instrument ability, how to do data assimilation at locations not covered by observation? Two commonly used strategies were firstly described: One is covariance localization (CL); the other is observation localization (OL). Compared with CL, OL is easy to parallelize and more efficient for large-scale analysis. This paper evaluated OL in soil moisture profile characterizations, in which the geostatistical semivariogram was used to fit the spatial correlated characteristics of synthetic L-Band microwave brightness temperature measurement. The fitted semivariogram model and the local ensemble transform Kalman filter algorithm are combined together to weight and assimilate the observations within a local region surrounding the grid cell of land surface model to be analyzed. Six scenarios were compared: 1_Obs with one nearest observation assimilated, 5_Obs with no more than five nearest local observations assimilated, and 9_Obs with no more than nine nearest local observations assimilated. The scenarios with no more than 16, 25, and 36 local observations were also compared. From the results we can conclude that more local observations involved in assimilation will improve estimations with an upper bound of 9 observations in this case. This study demonstrates the potentials of geostatistical correlation representation in OL to improve data assimilation of catchment scale soil moisture using synthetic L-band microwave brightness temperature, which cannot cover the study area fully in space due to vegetation effects.	[Han, Xujun; Li, Xin; Jin, Rui] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Li, Xin; Jin, Rui] Chinese Acad Sci, CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Rigon, Riccardo] Univ Trento, Dept Civil & Environm Engn, Trento, Italy; [Endrizzi, Stefano] Univ Zurich, Dept Geog, Zurich, Switzerland	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; University of Trento; University of Zurich	Han, XJ (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China.	hanxj@lzb.ac.cn	Li, Xin/F-7473-2011; li, xin/HHS-9461-2022; Rigon, Riccardo/B-5395-2008	Li, Xin/0000-0003-2999-9818; Rigon, Riccardo/0000-0002-7668-5806	Chinese Academy of Sciences Action Plan for West Development Program Project [KZCX2-XB3-15]; National Science Foundation of China (NSFC) project [41271357, 91125001]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-312]; Italian Space Agency Project MORFEO	Chinese Academy of Sciences Action Plan for West Development Program Project; National Science Foundation of China (NSFC) project(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Italian Space Agency Project MORFEO	This work was supported by the Chinese Academy of Sciences Action Plan for West Development Program Project (KZCX2-XB3-15), the National Science Foundation of China (NSFC) project (grant number: 41271357, 91125001), the Knowledge Innovation Program of the Chinese Academy of Sciences (grant number: KZCX2-EW-312), and the Italian Space Agency Project MORFEO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogena HR, 2010, VADOSE ZONE J, V9, P1002, DOI 10.2136/vzj2009.0173; Brocca L, 2007, J HYDROL, V333, P356, DOI 10.1016/j.jhydrol.2006.09.004; Buttafuoco G, 2005, J HYDROL, V311, P202, DOI 10.1016/j.jhydrol.2005.01.018; Calvet JC, 2011, IEEE T GEOSCI REMOTE, V49, P1190, DOI 10.1109/TGRS.2010.2050488; Crow WT, 2014, WATER RESOUR RES, V50, P371, DOI 10.1002/2013WR014550; Crow WT, 2003, ADV WATER RESOUR, V26, P137, DOI 10.1016/S0309-1708(02)00088-X; De Lannoy GJM, 2010, J HYDROMETEOROL, V11, P352, DOI 10.1175/2009JHM1192.1; De Lannoy GJM, 2006, J HYDROL, V331, P719, DOI 10.1016/j.jhydrol.2006.06.016; De Lannoy GJM, 2009, J HYDROMETEOROL, V10, P766, DOI 10.1175/2008JHM1037.1; de Rosnay P, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010724; Drusch M, 2009, J HYDROMETEOROL, V10, P213, DOI 10.1175/2008JHM964.1; Entekhabi D, 2010, P IEEE, V98, P704, DOI 10.1109/JPROC.2010.2043918; Evensen G., 2003, OCEAN DYNAM, V53, P343, DOI [DOI 10.1007/S10236-003-0036-9, 10.1007/s10236-003-0036-9]; FAO/IIASA/ISRIC/ISS-CAS/JRC, 2010, HARM WORLD SOIL DAT; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; Greybush SJ, 2011, MON WEATHER REV, V139, P511, DOI 10.1175/2010MWR3328.1; Han X, 2012, HYDROL EARTH SYST SC, V16, P1349, DOI 10.5194/hess-16-1349-2012; Han XJ, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0072; Houtekamer PL, 2014, MON WEATHER REV, V142, P1163, DOI 10.1175/MWR-D-13-00011.1; Houtekamer PL, 1998, MON WEATHER REV, V126, P796, DOI 10.1175/1520-0493(1998)126<0796:DAUAEK>2.0.CO;2; Hunt BR, 2007, PHYSICA D, V230, P112, DOI 10.1016/j.physd.2006.11.008; Janjic T, 2011, MON WEATHER REV, V139, P2046, DOI 10.1175/2011MWR3552.1; Kerr YH, 2010, P IEEE, V98, P666, DOI 10.1109/JPROC.2010.2043032; Kumar SV, 2012, GEOSCI MODEL DEV, V5, P869, DOI 10.5194/gmd-5-869-2012; Kumar SV, 2008, ENVIRON MODELL SOFTW, V23, P169, DOI 10.1016/j.envsoft.2007.05.012; Kumar SV, 2012, WATER RESOUR RES, V48, DOI 10.1029/2010WR010261; Kumar SV, 2009, J HYDROMETEOROL, V10, P1534, DOI 10.1175/2009JHM1134.1; Lewis P, 2012, REMOTE SENS ENVIRON, V120, P219, DOI 10.1016/j.rse.2011.12.027; Li X, 2007, PROG NAT SCI-MATER, V17, P881; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; Lien GY, 2013, TELLUS A, V65, DOI 10.3402/tellusa.v65i0.19915; Liston GE, 2006, J HYDROMETEOROL, V7, P217, DOI 10.1175/JHM486.1; Mascaro G, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008855; McLaughlin D, 2006, J HYDROMETEOROL, V7, P494, DOI 10.1175/JHM493.1; Merlin O, 2013, REMOTE SENS ENVIRON, V130, P25, DOI 10.1016/j.rse.2012.11.008; Merlin O, 2010, REMOTE SENS ENVIRON, V114, P2305, DOI 10.1016/j.rse.2010.05.007; Minasny B, 2005, GEODERMA, V128, P192, DOI 10.1016/j.geoderma.2005.04.003; Miyoshi T, 2007, MON WEATHER REV, V135, P3841, DOI 10.1175/2007MWR1873.1; Miyoshi T, 2014, GEOPHYS RES LETT, V41, P5264, DOI 10.1002/2014GL060863; Montzka C, 2008, J HYDROL, V353, P322, DOI 10.1016/j.jhydrol.2008.02.018; Montzka C, 2013, IEEE T GEOSCI REMOTE, V51, P1728, DOI 10.1109/TGRS.2012.2206031; Nerger L, 2011, Q J ROY METEOR SOC; Niu GY, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015139; Njoku EG, 2006, REMOTE SENS ENVIRON, V100, P190, DOI 10.1016/j.rse.2005.10.017; Oleson KW, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042194; Oleson K. W., 2013, TECHNICAL DESCRIPTIO, DOI [10.5065/D6RR1W7M, DOI 10.5065/D6RR1W7M]; Oliphant T. E., 2006, BAYESIAN PERSPECTIVE; Park S.K., 2009, DATA ASSIMILATION AT; Piles M, 2011, IEEE T GEOSCI REMOTE, V49, P3156, DOI 10.1109/TGRS.2011.2120615; Reichle RH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031986; Reichle RH, 2003, J HYDROMETEOROL, V4, P1229, DOI 10.1175/1525-7541(2003)004<1229:ATIOHE>2.0.CO;2; Reichle RH, 2010, J HYDROMETEOROL, V11, P1103, DOI 10.1175/2010JHM1262.1; Reichle RH, 2008, ADV WATER RESOUR, V31, P1411, DOI 10.1016/j.advwatres.2008.01.001; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Rigon R, 2006, J HYDROMETEOROL, V7, P371, DOI 10.1175/JHM497.1; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Ryu D, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025831; Sahoo AK, 2013, ADV WATER RESOUR, V52, P19, DOI 10.1016/j.advwatres.2012.08.007; Sakov P, 2011, COMPUTAT GEOSCI, V15, P225, DOI 10.1007/s10596-010-9202-6; Song CY, 2014, IEEE J-STARS, V7, P935, DOI 10.1109/JSTARS.2013.2272053; Sun WX, 2008, REMOTE SENS ENVIRON, V112, P1010, DOI 10.1016/j.rse.2007.07.022; TOWNSHEND JRG, 1992, IEEE T GEOSCI REMOTE, V30, P1054, DOI 10.1109/36.175340; Wan Z, 2008, INT J REMOTE SENS, V29, P5373, DOI 10.1080/01431160802036565; Wigneron JP, 2007, REMOTE SENS ENVIRON, V107, P639, DOI 10.1016/j.rse.2006.10.014; WILHEIT TT, 1978, IEEE T GEOSCI REMOTE, V16, P138, DOI 10.1109/TGE.1978.294577; Wood EF, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010090; Zacharias S, 2011, VADOSE ZONE J, V10, P955, DOI 10.2136/vzj2010.0139; Zreda M, 2012, HYDROL EARTH SYST SC, V16, P4079, DOI 10.5194/hess-16-4079-2012	69	6	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116435	10.1371/journal.pone.0116435	http://dx.doi.org/10.1371/journal.pone.0116435			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635771	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700036
J	Hollister, JR; Lee, KS; Dorward, DW; Baron, GS				Hollister, Jason R.; Lee, Kil Sun; Dorward, David W.; Baron, Gerald S.			Efficient Uptake and Dissemination of Scrapie Prion Protein by Astrocytes and Fibroblasts from Adult Hamster Brain	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; DENSITY-LIPOPROTEIN RECEPTOR; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; RAT HIPPOCAMPAL-NEURONS; SMOOTH-MUSCLE-CELLS; IN-VITRO; PRP; INFECTION; TISSUE; SHEEP	Prion infections target neurons and lead to neuronal loss. However, the role of non-neuronal cells in the initiation and spread of infection throughout the brain remains unclear despite the fact these cells can also propagate prion infectivity. To evaluate how different brain cells process scrapie prion protein (PrPres) during acute infection, we exposed neuron-enriched and non-neuronal cell cultures from adult hamster brain to fluorescently-labeled purified PrPres and followed the cultures by live cell confocal imaging over time. Non-neuronal cells present in both types of cultures, specifically astrocytes and fibroblasts, internalized PrPres more efficiently than neurons. PrPres was trafficked to late endosomal/lysosomal compartments and rapidly transported throughout the cell bodies and processes of all cell types, including contacts between astrocytes and neurons. These observations suggest that astrocytes and meningeal fibroblasts play an as yet unappreciated role in prion infections via efficient uptake and dissemination of PrPres.	[Hollister, Jason R.; Lee, Kil Sun; Baron, Gerald S.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Dorward, David W.] NIAID, Microscopy Unit, Res Technol Branch, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Baron, GS (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	gbaron@niaid.nih.gov	Lee, Kil S/D-3678-2012; Lee, Kil Sun/AAL-8564-2020	Lee, Kil S/0000-0002-2390-2774; 	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000982, ZICAI001052] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; Blanpied TA, 2003, NEUROBIOL AGING, V24, P1095, DOI 10.1016/j.neurobiolaging.2003.04.004; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Brewer GJ, 2005, EXP GERONTOL, V40, P426, DOI 10.1016/j.exger.2005.03.007; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cady C, 2001, BRAIN RES, V921, P1, DOI 10.1016/S0006-8993(01)03063-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CLARKE MC, 1976, NATURE, V261, P144, DOI 10.1038/261144a0; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cronier S, 2012, FASEB J, V26, P3854, DOI 10.1096/fj.11-201772; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; DIEDRICH JF, 1991, P NATL ACAD SCI USA, V88, P375, DOI 10.1073/pnas.88.2.375; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Ersdal C, 2009, NEUROPATH APPL NEURO, V35, P259, DOI 10.1111/j.1365-2990.2008.00988.x; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gonzalez L, 2003, J GEN VIROL, V84, P1339, DOI 10.1099/vir.0.18800-0; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Hirsch S, 1999, GLIA, V26, P36, DOI 10.1002/(SICI)1098-1136(199903)26:1<36::AID-GLIA4>3.0.CO;2-C; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; JEFFREY M, 1994, BRAIN RES, V656, P329, DOI 10.1016/0006-8993(94)91477-X; Jen A, 2010, J CELL SCI, V123, P246, DOI 10.1242/jcs.058099; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kobayashi A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-32; Luhr KM, 2002, J VIROL, V76, P12259, DOI 10.1128/JVI.76.23.12259-12264.2002; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Patel JR, 2003, J NEUROSCI RES, V72, P527, DOI 10.1002/jnr.10602; Pihlaja R, 2008, GLIA, V56, P154, DOI 10.1002/glia.20599; PITAS RE, 1992, ARTERIOSCLER THROMB, V12, P1235, DOI 10.1161/01.ATV.12.11.1235; PITAS RE, 1990, J BIOL CHEM, V265, P12722; Pritzkow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020384; RACE RE, 1995, NEURON, V15, P1183, DOI 10.1016/0896-6273(95)90105-1; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Raymond GJ, 2012, J VIROL, V86, P11763, DOI 10.1128/JVI.01353-12; Ritchie DL, 2004, NEUROPATH APPL NEURO, V30, P360, DOI 10.1111/j.1365-2990.2003.00544.x; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sarasa R, 2012, CELL TISSUE RES, V350, P127, DOI 10.1007/s00441-012-1461-1; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Speare JO, 2010, EMBO J, V29, P782, DOI 10.1038/emboj.2009.392; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; THADANI V, 1988, J NEUROSURG, V69, P766, DOI 10.3171/jns.1988.69.5.0766; VANKEULEN LJM, 1995, VET PATHOL, V32, P299, DOI 10.1177/030098589503200312; Vidal E, 2006, J VIROL METHODS, V134, P15, DOI 10.1016/j.jviromet.2005.11.010; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamasaki T, 2014, VIROLOGY, V450, P324, DOI 10.1016/j.virol.2013.11.007; Yamasaki T, 2012, J GEN VIROL, V93, P668, DOI 10.1099/vir.0.037101-0; Yang P, 2003, BRAIN RES PROTOC, V12, P67, DOI 10.1016/S1385-299X(03)00073-4; Ye XM, 1998, BRAIN RES, V809, P277, DOI 10.1016/S0006-8993(98)00833-6	75	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115351	10.1371/journal.pone.0115351	http://dx.doi.org/10.1371/journal.pone.0115351			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635871	Green Submitted, gold, Green Published			2022-12-27	WOS:000350680700008
J	Mistry, V; Bockett, NA; Levine, AP; Mirza, MM; Hunt, KA; Ciclitira, PJ; Hummerich, H; Neuhausen, SL; Simpson, MA; Plagnol, V; van Heel, DA				Mistry, Vanisha; Bockett, Nicholas A.; Levine, Adam P.; Mirza, Muddassar M.; Hunt, Karen A.; Ciclitira, Paul J.; Hummerich, Holger; Neuhausen, Susan L.; Simpson, Michael A.; Plagnol, Vincent; van Heel, David A.			Exome Sequencing of 75 Individuals from Multiply Affected Coeliac Families and Large Scale Resequencing Follow Up	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SMALL-INTESTINAL MUCOSA; T-CELLS; COMMON VARIANTS; CROHNS-DISEASE; RARE VARIANTS; MUTATIONS; GLIADIN; ASSOCIATION; RECEPTOR	Coeliac disease (CeD) is a highly heritable common autoimmune disease involving chronic small intestinal inflammation in response to dietary wheat. The human leukocyte antigen (HLA) region, and 40 newer regions identified by genome wide association studies (GWAS) and dense fine mapping, account for similar to 40% of the disease heritability. We hypothesized that in pedigrees with multiple individuals with CeD rare [minor allele frequency (MAF) <0.5%] mutations of larger effect size (odds ratios of similar to 2-5) might exist. We sequenced the exomes of 75 coeliac individuals of European ancestry from 55 multiply affected families. We selected interesting variants and genes for further follow up using a combination of: an assessment of shared variants between related subjects, a model-free linkage test, and gene burden tests for multiple, potentially causal, variants. We next performed highly multiplexed amplicon resequencing of all RefSeq exons from 24 candidate genes selected on the basis of the exome sequencing data in 2,248 unrelated coeliac cases and 2,230 controls. 1,335 variants with a 99.9% genotyping call rate were observed in 4,478 samples, of which 939 were present in coding regions of 24 genes (Ti/Tv 2.99). 91.7% of coding variants were rare (MAF < 0.5%) and 60% were novel. Gene burden tests performed on rare functional variants identified no significant associations (p<1x10(-3)) in the resequenced candidate genes. Our strategy of sequencing multiply affected families with deep follow up of candidate genes has not identified any new CeD risk mutations.	[Mistry, Vanisha; Bockett, Nicholas A.; Hunt, Karen A.; van Heel, David A.] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, London E1 2AT, England; [Levine, Adam P.] UCL, Div Med, London WC1E 6JF, England; [Mirza, Muddassar M.] UCL Adv Diagnost, Mol Profiling Lab, Sarah Cannon UCL Labs, London WC1E 6JA, England; [Ciclitira, Paul J.] Kings Coll London, Div Diabet & Nutr Sci, St Thomas Hosp, Gastroenterol,Rayne Inst, London SE1 7EH, England; [Hummerich, Holger] UCL, Inst Neurol, MRC, Prion Unit,Dept Neurodegenerat Dis, London WC1N 3BG, England; [Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Simpson, Michael A.] Kings Coll London, Sch Med, Guys Hosp, Div Genet & Mol Med, London SE1 9RY, England; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England	University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; City of Hope; Beckman Research Institute of City of Hope; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London	Mistry, V (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst, 4 Newark St, London E1 2AT, England.	vmm28@medschl.cam.ac.uk	; Simpson, Michael/F-4737-2011	Plagnol, Vincent/0000-0002-5597-9215; Bockett, Nicholas/0000-0002-7630-7637; Simpson, Michael/0000-0002-8539-8753; Levine, Adam/0000-0003-1333-9938; van Heel, David/0000-0002-0637-2265	Medical Research Council [MRC G1001158]; Coeliac UK; National Institutes of Health (NIH) [R01 DK081645]; UK MRC [G0000934]; Wellcome Trust [068545/Z/02]; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; MRC [G1001158, G0000934] Funding Source: UKRI; Medical Research Council [G1001158, G0000934] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081645] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Coeliac UK; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was primarily funded by the Medical Research Council (MRC G1001158 to DAVH), with further funding from Coeliac UK (to DAVH). Families provided by SLN were collected under funding by the National Institutes of Health (NIH R01 DK081645). DNA from the British 1958 Birth Control collection was funded by the UK MRC grant G0000934 and the Wellcome Trust grant 068545/Z/02. The BRC Genomics sequencing facility is funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bensellam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029807; Blaydon DC, 2013, AM SOC HUMAN GENETIC, V93, P1; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; CEPEK KL, 1993, J IMMUNOL, V150, P3459; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Eller E, 2006, HUM IMMUNOL, V67, P940, DOI 10.1016/j.humimm.2006.08.293; FAIS S, 1992, GUT, V33, P472, DOI 10.1136/gut.33.4.472; Fearnhead NS, 2004, P NATL ACAD SCI USA, V101, P15992, DOI 10.1073/pnas.0407187101; Fodinger M, 2001, KIDNEY INT, V59, pS238; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Jostins L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076328; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; King AL, 2000, ANN HUM GENET, V64, P479, DOI 10.1046/j.1469-1809.2000.6460479.x; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Liu JQ, 2001, IMMUNITY, V15, P23, DOI 10.1016/S1074-7613(01)00162-5; LUNDIN KEA, 1994, HUM IMMUNOL, V41, P285, DOI 10.1016/0198-8859(94)90047-7; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Tang H, 2013, NAT GENET, DOI [10.1038/ng/2827, DOI 10.1038/NG/2827]; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhao HR, 2001, J EXP MED, V194, P1441, DOI 10.1084/jem.194.10.1441	47	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116845	10.1371/journal.pone.0116845	http://dx.doi.org/10.1371/journal.pone.0116845			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635822	Green Submitted, gold, Green Published			2022-12-27	WOS:000350680700061
J	Sit, RWS; Yip, BHK; Chan, DCC; Wong, SYS				Sit, Regina W. S.; Yip, Benjamin H. K.; Chan, Dicken C. C.; Wong, Samuel Y. S.			Primary Care Physicians' Attitudes and Beliefs towards Chronic Low Back Pain: An Asian Study	PLOS ONE			English	Article							PRACTITIONERS ATTITUDES; GENERAL-PRACTITIONERS; CLINICAL MANAGEMENT; PROVIDERS; RECOMMENDATIONS; GUIDELINES; THERAPISTS; ILLNESS; COST	Background Chronic low back pain is a serious global health problem. There is substantial evidence that physicians' attitudes towards and beliefs about chronic low back pain can influence their subsequent management of the condition. Objectives (1) to evaluate the attitudes and beliefs towards chronic low back pain among primary care physicians in Asia; (2) to study the cultural differences and other factors that are associated with these attitudes and beliefs. Method A cross sectional online survey was sent to primary care physicians who are members of the Hong Kong College of Family Physician (HKCFP). The Pain Attitudes and Beliefs Scale for Physiotherapist (PABS-PT) was used as the questionnaire to determine the biomedical and biopsychosocial orientation of the participants. Results The mean Biomedical (BM) score was 34.8+/-6.1; the mean biopsychosocial (BPS) score was 35.6 (+/-4.8). Both scores were higher than those of European doctors. Family medicine specialists had a lower biomedical score than General practitioners. Physicians working in the public sector tended to have low BM and low BPS scores; whereas physicians working in private practice tended to have high BM and high BPS scores. Conclusion The lack of concordance in the pain explanatory models used by private and public sector may have a detrimental effect on patients who are under the care of both parties. The uncertain treatment orientation may have a negative influence on patients' attitudes and beliefs, thus contributing to the tension and, perhaps, even ailing mental state of a person with chronic LBP.	[Sit, Regina W. S.; Yip, Benjamin H. K.; Chan, Dicken C. C.; Wong, Samuel Y. S.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Sit, RWS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	reginasit@cuhk.edu.hk	Sit, Regina Wing Shan/V-9982-2017; Yip, Benjamin/AAC-7845-2019; WONG, Samuel Yeung Shan/D-7311-2013	Sit, Regina Wing Shan/0000-0002-4717-7773; Yip, Benjamin/0000-0002-4749-7611; WONG, Samuel Yeung Shan/0000-0003-0934-6385				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Bishop A, 2008, PAIN, V135, P187, DOI 10.1016/j.pain.2007.11.010; Bishop A, 2007, PAIN, V132, P91, DOI 10.1016/j.pain.2007.01.028; Crawford Cameron, 2007, N Z Med J, V120, pU2536; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Darlow B, 2012, EUR J PAIN, V16, P3, DOI 10.1016/j.ejpain.2011.06.006; Domenech J, 2011, PAIN, V152, P2557, DOI 10.1016/j.pain.2011.07.023; Fabb W. E., 1995, Hong Kong Medical Journal, V1, P230; Foster NE, 2003, ORTHOP CLIN N AM, V34, P239, DOI 10.1016/S0030-5898(03)00011-7; Fullen BM, 2011, CLIN J PAIN, V27, P542, DOI 10.1097/AJP.0b013e31821771e2; Gorey TM, 2004, ANN FAM MED, V2, pS3, DOI 10.1370/afm.130; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; Holden MA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1511, DOI 10.1002/art.24829; Houben RMA, 2005, EUR J PAIN, V9, P173, DOI 10.1016/j.ejpain.2004.05.002; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Magalhaes MO, 2012, REV BRAS FISIOTER, V16, P248, DOI 10.1590/S1413-35552012005000014; Medalie JH, 1993, FAMILY SYSTEMS MED, V11, P15; Nicholas MK, 2008, BEST PRACT RES CL RH, V22, P451, DOI 10.1016/j.berh.2007.11.008; Ostelo RWJG, 2003, MANUAL THER, V8, P214, DOI 10.1016/S1356-689X(03)00013-4; Parsons S, 2007, CLIN J PAIN, V23, P91, DOI 10.1097/01.ajp.0000210947.34676.34; Pool JJM, 2010, SPINE, V35, P1017, DOI 10.1097/BRS.0b013e3181c212ee; RASKER JJ, 1995, BRIT J RHEUMATOL, V34, P494; Savigny P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1805; Skelton AM, 1996, BRIT J GEN PRACT, V46, P153; Toye Francine, 2012, Prim Health Care Res Dev, V13, P72, DOI 10.1017/S1463423611000387; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Wieser S, 2005, EUR J HEALTH ECON, V12, P455, DOI DOI 10.1007/S10198-010-0258-Y	28	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117521	10.1371/journal.pone.0117521	http://dx.doi.org/10.1371/journal.pone.0117521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635919	Green Published, gold, Green Submitted			2022-12-27	WOS:000350680700088
J	Pal, R; Yang, JP; Ortiz, D; Qiu, SM; Resto, V; McCammon, S; Vargas, G				Pal, Rahul; Yang, Jinping; Ortiz, Daniel; Qiu, Suimin; Resto, Vicente; McCammon, Susan; Vargas, Gracie			In-Vivo Nonlinear Optical Microscopy (NLOM) of Epithelial-Connective Tissue Interface (ECTI) Reveals Quantitative Measures of Neoplasia in Hamster Oral Mucosa	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; COHERENCE TOMOGRAPHY; MULTIPHOTON MICROSCOPY; STEM-CELLS; CANCER; MATRIX; DIAGNOSIS; METASTASIS; EXPRESSION; INVASION	The epithelial-connective tissue interface (ECTI) plays an integral role in epithelial neoplasia, including oral squamous cell carcinoma (OSCC). This interface undergoes significant alterations due to hyperproliferating epithelium that supports the transformation of normal epithelium to precancers and cancer. We present a method based on nonlinear optical microscopy to directly assess the ECTI and quantify dysplastic alterations using a hamster model for oral carcinogenesis. Neoplastic and non-neoplastic normal mucosa were imaged in-vivo by both multiphoton autofluorescence microscopy (MPAM) and second harmonic generation microscopy (SHGM) to obtain cross-sectional reconstructions of the oral epithelium and lamina propria. Imaged sites were biopsied and processed for histopathological grading and measurement of ECTI parameters. An ECTI shape parameter was calculated based on deviation from the linear geometry (Delta Linearity) seen in normal mucosa was measured using MPAM-SHGM and histology. The ECTI was readily visible in MPAM-SHGM and quantitative shape analysis showed ECTI deformation in dysplasia but not in normal mucosa..Linearity was significantly (p < 0.01) higher in dysplasia (0.41 +/- 0.24) than normal (0.11 +/- 0.04) as measured in MPAM-SHGM and results were confirmed in histology which showed similar trends in Delta Linearity-Increase in Delta Linearity was also statistically significant for different grades of dysplasia. In-vivo Delta Linearity measurement alone from microscopy discriminated dysplasia from normal tissue with 87.9% sensitivity and 97.6% specificity, while calculations from histology provided 96.4% sensitivity and 85.7% specificity. Among other quantifiable architectural changes, a progressive statistically significant increase in epithelial thickness was seen with increasing grade of dysplasia. MPAM-SHGM provides new noninvasive ways for direct characterization of ECTI which may be used in preclinical studies to investigate the role of this interface in early transformation. Further development of the method may also lead to new diagnostic approaches to differentiate non-neoplastic tissue from precancers and neoplasia, possibly with other cellular and layer based indicators of abnormality.	[Pal, Rahul; Yang, Jinping; Vargas, Gracie] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA; [Ortiz, Daniel] Eastern Virginia Med Sch, Dept Radiol, Norfolk, VA 23507 USA; [Resto, Vicente; McCammon, Susan] Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA; [Qiu, Suimin] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Vargas, Gracie] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Pal, Rahul; Resto, Vicente] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Qiu, Suimin; Resto, Vicente; McCammon, Susan; Vargas, Gracie] Univ Texas Med Branch, Ctr Canc Head & Neck, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Eastern Virginia Medical School; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Pal, R (corresponding author), Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA.	rapal@utmb.edu	Vargas, Gracie/ABH-3648-2020; Pal, Rahul/AAT-6342-2020		National Institutes of Health [RO1CA127429, RO1CA127429S1]; NATIONAL CANCER INSTITUTE [R01CA127429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health (www.nih.gov; National Cancer Institute). The grant numbers are: RO1CA127429 and RO1CA127429S1. The funding was received by GV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter M, 2011, J Oral Maxillofac Pathol, V15, P168, DOI 10.4103/0973-029X.84485; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Bouquot JE, 2006, CURR DIAGN PATHOL, V12, P11, DOI DOI 10.1016/J.CDIP.2005.10.008; BOYSEN M, 1983, VIRCHOWS ARCH B, V42, P173, DOI 10.1007/BF02890380; Calenic B, 2010, ROM J MORPHOL EMBRYO, V51, P641; DALE B A, 1990, Critical Reviews in Oral Biology and Medicine, V1, P167; Derka S, 2006, ORAL ONCOL, V42, P540, DOI 10.1016/j.oraloncology.2005.10.008; DESOUZA FL, 2014, ISRN OTOLARYNGOL, V2014; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Durr NJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548646; Edward K, 2012, BIOMED OPT EXPRESS, V3, P1579, DOI 10.1364/BOE.3.001579; Fedele S, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-5; Gimenez-Conti I, 1993, Acta Odontol Latinoam, V7, P3; Hamdoon Z, 2013, PHOTODIAGN PHOTODYN, V10, P17, DOI 10.1016/j.pdpdt.2012.07.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; JOHNSON NW, 1976, P ROY SOC MED, V69, P740, DOI 10.1177/003591577606901006; Jones KB, 2013, INT J ORAL SCI, V5, P121, DOI 10.1038/ijos.2013.46; Jung WG, 2005, IEEE J SEL TOP QUANT, V11, P811, DOI 10.1109/JSTQE.2005.857678; Keith RL, 2013, NAT REV CLIN ONCOL, V10, P334, DOI 10.1038/nrclinonc.2013.64; Kirkpatrick ND, 2007, AM J PHYSIOL-HEART C, V292, pH3198, DOI 10.1152/ajpheart.01234.2006; KOBAT D, 2011, 2011 C LAS EL CLEO; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; LANDINI G, 1993, ANAL QUANT CYTOL, V15, P144; Landini G, 2000, PATHOL RES PRACT, V196, P251, DOI 10.1016/S0344-0338(00)80074-6; Lee CK, 2012, BIOMED OPT EXPRESS, V3, P1632, DOI 10.1364/BOE.3.001632; LIOTTA LA, 1991, CANCER RES, V51, pS5054; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Matheny ES, 2004, J BIOMED OPT, V9, P978, DOI 10.1117/1.1783897; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Oliver RJ, 2000, J ORAL PATHOL MED, V29, P49, DOI 10.1034/j.1600-0714.2000.290201.x; Pande P, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086022; Papakosta V, 2006, ANTICANCER RES, V26, P2957; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paulsen F, 1998, J ANAT, V193, P457, DOI 10.1046/j.1469-7580.1998.19330457.x; Pena AM, 2005, OPT EXPRESS, V13, P6667, DOI 10.1364/OPEX.13.006667; Poh CF, 2008, J CAN DENT ASSOC, V74, P283; POTTEN CS, 1988, J CELL SCI, P45; Psilodimitrakopoulos S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3059627; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; RICH AM, 1991, BRIT J CANCER, V64, P96, DOI 10.1038/bjc.1991.248; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SAMI MM, 2010, ORAL MED PATHOL, V14, P89, DOI DOI 10.1016/J; Sen S, 2011, INVEST OPHTH VIS SCI, V52, P9548, DOI 10.1167/iovs.11-7946; Skala MC, 2005, CANCER RES, V65, P1180, DOI 10.1158/0008-5472.CAN-04-3031; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Squier C A, 2001, J Natl Cancer Inst Monogr, P7; Sun J, 2004, OPT EXPRESS, V12, P2478, DOI 10.1364/OPEX.12.002478; Sutinen M, 1998, BRIT J CANCER, V77, P2239, DOI 10.1038/bjc.1998.372; Teh SK, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.036001; Tsai MT, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2960632; Valraktaris E, 2008, ORAL ONCOL, V44, P315, DOI 10.1016/j.oraloncology.2007.08.015; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Vargas G, 2009, IEEE ENG MED BIO, P6311, DOI 10.1109/IEMBS.2009.5332783; Volgger V, 2013, HEAD NECK-J SCI SPEC, V35, P1558, DOI 10.1002/hed.23189; WANG K, 2013, OPTICS PHOTONICS NEW; Wenig BM, 2002, MODERN PATHOL, V15, P229, DOI 10.1038/modpathol.3880520; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; WHITE FH, 1981, DIAGN HISTOPATHOL, V4, P307; Wilder-Smith P, 2004, LASER SURG MED, V35, P269, DOI 10.1002/lsm.20098; Wilder-Smith P, 2004, LASER SURG MED, V35, P96, DOI 10.1002/lsm.20079; Wilson DF, 1999, AUST DENT J, V44, P93, DOI 10.1111/j.1834-7819.1999.tb00207.x; Winning TA, 2000, CLIN DERMATOL, V18, P499, DOI 10.1016/S0738-081X(00)00140-1; Zhang Y, 2006, J EXP CLIN CANC RES, V25, P417; Zheng W, 2011, OPT LETT, V36, P3620, DOI 10.1364/OL.36.003620; Zhuo SM, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3505762; Zhuo SM, 2007, PHYS MED BIOL, V52, P4967, DOI 10.1088/0031-9155/52/16/017	67	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116754	10.1371/journal.pone.0116754	http://dx.doi.org/10.1371/journal.pone.0116754			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633927	Green Published, Green Submitted, gold			2022-12-27	WOS:000348609800010
J	Snyder, JJ; Wiles, JR				Snyder, Julia J.; Wiles, Jason R.			Peer Led Team Learning in Introductory Biology: Effects on Peer Leader Critical Thinking Skills	PLOS ONE			English	Article							STUDENTS CRITICAL THINKING; ORGANIC-CHEMISTRY; IMPLEMENTATION; INVOLVEMENT; LECTURE	This study evaluated hypothesized effects of the Peer-Led Team Learning (PLTL) instructional model on undergraduate peer leaders' critical thinking skills. This investigation also explored peer leaders' perceptions of their critical thinking skills. A quasi-experimental pretest/post- test with control group design was used to determine critical thinking gains in PLTL/non-PLTL groups. Critical thinking was assessed using the California Critical Thinking Skills Test (CCTST) among participants who had previously completed and been successful in a mixed-majors introductory biology course at a large, private research university in the American Northeast. Qualitative data from open-ended questionnaires confirmed that factors thought to improve critical thinking skills such as interaction with peers, problem solving, and discussion were perceived by participants to have an impact on critical thinking gains. However, no significant quantitative differences in peer leaders' critical thinking skills were found between pre-and post-experience CCTST measurements or between experimental and control groups.	[Snyder, Julia J.; Wiles, Jason R.] Syracuse Univ, Dept Biol, Syracuse, NY 13210 USA; [Snyder, Julia J.; Wiles, Jason R.] Syracuse Univ, Dept Sci Teaching, Syracuse, NY USA	Syracuse University; Syracuse University	Snyder, JJ (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13210 USA.	jjseymou@syr.edu		Wiles, Jason/0000-0003-1011-3546	National Science Foundation; EAGER: Enhancing Recruitment and Retention of Underrepresented Populations through PLTL; Direct For Education and Human Resources [1352740] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); EAGER: Enhancing Recruitment and Retention of Underrepresented Populations through PLTL; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	The development of this manuscript was funded in part by a grant from the National Science Foundation; EAGER: Enhancing Recruitment and Retention of Underrepresented Populations through PLTL (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1352740). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami PC, 2008, REV EDUC RES, V78, P1102, DOI 10.3102/0034654308326084; American Association for the Advancement of Science, 1989, SCI ALL AM; [Anonymous], 2003, J CHEM EDUC, DOI DOI 10.1021/ED080P132; Blake R, 2001, PROGR PLTL NEWSLETTE, V2, P5; College Board, 2021, BENCHMARKS; Commission on the Humanities, 1980, HUM AM LIF REP COMM; Cracolice M. S., 2001, THE SCI TEACHER, V68, P20; Eberlein T, 2008, BIOCHEM MOL BIOL EDU, V36, P262, DOI 10.1002/bmb.20204; Ennis RH., 1993, THEOR PRACT, V32, P179, DOI [10.1080/00405849309543594, DOI 10.1080/00405849309543594]; Facione P., 2000, INFORM LOGIC, V20, P61, DOI [DOI 10.22329/IL.V20I1.2254, 10.22329/il.v20i1.2254]; Facione P.A., 1990, CRITICAL THINKING ST; Facione PA, 2011, CCTST TEST MANUAL; Facione PA, 1990, ED327549 ERIC; Gafney L, 2001, PROGR PLTL PROJECT N, V2, P3; Gafney L, 2002, PROGR PEER LED TEAM, V3, p[1, 8]; Gafney L, 2007, J CHEM EDUC, V84, P535, DOI 10.1021/ed084p535; Gellin A, 2003, J COLL STUDENT DEV, V44, P746, DOI 10.1353/csd.2003.0066; Gosser D., 1996, CHEM ED, V1, P1, DOI DOI 10.1333/S00897960002A; Gosser DK, 1998, J CHEM EDUC, V75, P185, DOI 10.1021/ed075p185; Hewlett, 2004, J COLL SCI TEACH, V33, P28; Hockings SC, 2008, J CHEM EDUC, V85, P990, DOI 10.1021/ed085p990; Johnson E, 2009, P 39 ASEE IEEE FRONT, pM4H1, DOI [10.1109/FIE.2009.5350637, DOI 10.1109/FIE.2009.5350637]; MCMILLAN JH, 1987, RES HIGH EDUC, V26, P3, DOI 10.1007/BF00991931; Micari M, 2005, INNOV HIGH EDUC, V30, P269, DOI 10.1007/s10755-005-8348-y; Monte AE, 2007, P 37 ASEE IEEE FRONT; National Research Council, 1999, TRANSF UND ED SCI MA; National Research Council, 2010, FRAM SCI ED PREL PUB; National Science Foundation, 1996, SHAP FUT EXP UND ED; ORY JC, 1988, RES HIGH EDUC, V28, P116, DOI 10.1007/BF00992886; Pascarella E.T, 1991, COLL AFFECTS STUDENT; Peteroy-Kelly MA, 2007, J MICROBIOL BIOL EDU, V8, P13, DOI 10.1128/193578807X14285805074512; Pithers RT, 2000, EDUC RES-UK, V42, P237, DOI 10.1080/001318800440579; Preszler RW, 2009, CBE-LIFE SCI EDUC, V8, P182, DOI 10.1187/cbe.09-01-0002; Quitadamo I.J., 2009, SCI EDIT, V18, P29, DOI DOI 10.1097/00001888-199610000-00019; Roth V., 2001, PEER LED TEAM LEARNI; SMITH DG, 1977, J EDUC PSYCHOL, V69, P180, DOI 10.1037/0022-0663.69.2.180; Smith DG, 1981, M AM ED RES ASS LOS; Stewart B.N., 2007, AUST J ED CHEM, V67, P31; Tenney A, 2004, J COLL SCI TEACH, V33, P25; Tenney A, 2003, J MATH SCI COLLABORA, V6, P11; TERENZINI PT, 1995, RES HIGH EDUC, V36, P23, DOI 10.1007/BF02207765; TERENZINI PT, 1984, J HIGH EDUC, V55, P621, DOI 10.2307/1981826; Tien LT, 2004, J CHEM EDUC, V81, P1313, DOI 10.1021/ed081p1313; Tien LT, 2002, J RES SCI TEACH, V39, P606, DOI 10.1002/tea.10038; Tiwari A, 2006, MED EDUC, V40, P547, DOI 10.1111/j.1365-2929.2006.02481.x; Tsui L, 1999, RES HIGH EDUC, V40, P185, DOI 10.1023/A:1018734630124; Tsui L, 2002, J HIGH EDUC, V73, P740, DOI 10.1353/jhe.2002.0056; Vygotsky L.., 1978, MIND SOC; Wamser CC, 2006, J CHEM EDUC, V83, P1562, DOI 10.1021/ed083p1562; Woodward A, 1993, J CHEM EDUC, V70, P651, DOI [10.1021/ed070p651.1, DOI 10.1021/ED070P651.1]	50	20	20	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115084	10.1371/journal.pone.0115084	http://dx.doi.org/10.1371/journal.pone.0115084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629311	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100011
J	Lim, MSC; Zhang, XD; Kennedy, E; Li, Y; Yang, Y; Li, L; Li, YX; Temmerman, M; Luchters, S				Lim, Megan S. C.; Zhang, Xu-Dong; Kennedy, Elissa; Li, Yan; Yang, Yin; Li, Lin; Li, Yun-Xia; Temmerman, Marleen; Luchters, Stanley			Sexual and Reproductive Health Knowledge, Contraception Uptake, and Factors Associated with Unmet Need for Modern Contraception among Adolescent Female Sex Workers in China	PLOS ONE			English	Article							TRANSMITTED INFECTIONS; BEHAVIOR; VIOLENCE; WOMEN; HIV; DRINKING; ALCOHOL; RISK	Objective In China, policy and social taboo prevent unmarried adolescents from accessing sexual and reproductive health (SRH) services. Research is needed to determine the SRH needs of highly disadvantaged groups, such as adolescent female sex workers (FSWs). This study describes SRH knowledge, contraception use, pregnancy, and factors associated with unmet need for modern contraception among adolescent FSWs in Kunming, China. Methods A cross-sectional study using a one-stage cluster sampling method was employed to recruit adolescents aged 15 to 20 years, and who self-reported having received money or gifts in exchange for sex in the past 6 months. A semi-structured questionnaire was administered by trained peer educators or health workers. Multivariable logistic regression was conducted to determine correlates of low knowledge and unmet need for modern contraception. Results SRH knowledge was poor among the 310 adolescents surveyed; only 39% had heard of any long-acting reversible contraception (implant, injection or IUD). Despite 98% reporting not wanting to get pregnant, just 43% reported consistent condom use and 28% currently used another form of modern contraception. Unmet need for modern contraception was found in 35% of adolescents, and was associated with having a current non-paying partner, regular alcohol use, and having poorer SRH knowledge. Past abortion was common (136, 44%). In the past year, 76% had reported a contraception consultation but only 27% reported ever receiving SRH information from a health service. Conclusions This study demonstrated a low level of SRH knowledge, a high unmet need for modern contraception and a high prevalence of unintended pregnancy among adolescent FSWs in Kunming. Most girls relied on condoms, emergency contraception, or traditional methods, putting them at risk of unwanted pregnancy. This study identifies an urgent need for Chinese adolescent FSWs to be able to access quality SRH information and effective modern contraception.	[Lim, Megan S. C.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Zhang, Xu-Dong; Temmerman, Marleen; Luchters, Stanley] Univ Ghent, Int Ctr Reprod Hlth, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium; [Kennedy, Elissa; Luchters, Stanley] Burnet Inst, Ctr Int Hlth, Melbourne, Vic, Australia; [Lim, Megan S. C.; Kennedy, Elissa; Luchters, Stanley] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Li, Yan] Kunming Med Univ, Sch Publ Hlth, Kunming, Peoples R China; [Yang, Yin] Kunming Third Peoples Hosp, Dept AIDS Management, Kunming, Peoples R China; [Li, Lin] Kunming Maternal & Child Hlth Care Ctr, Dept Primary Hlth Care, Kunming, Peoples R China; [Li, Yun-Xia] Kunming Maternal & Child Hlth Care Ctr, Dept AIDS Prevent, Kunming, Peoples R China	Burnet Institute; Ghent University; Burnet Institute; Monash University; Kunming Medical University	Zhang, XD (corresponding author), Univ Ghent, Int Ctr Reprod Hlth, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium.	Xudong.Zhang@UGent.be		Luchters, Stanley/0000-0001-5235-5629	FSW research from the AIDS department of Kunming Public Health Bureau [KM2012AIDS]; Kunming Xishan District Center for Disease Prevention and Control [XSCDC-FSW-2012-06]	FSW research from the AIDS department of Kunming Public Health Bureau; Kunming Xishan District Center for Disease Prevention and Control	This study was supported by grants on FSW research from the AIDS department of Kunming Public Health Bureau (KM2012AIDS), the Kunming Xishan District Center for Disease Prevention and Control (XSCDC-FSW-2012-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AS PAC NETW SEX W, 2012, HIV SEX WORK COLL IN, P42331; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Bruce J, 2007, GIRLS LEFT REDIRECTI; Bruce J., 2006, NOTE SOCIAL EC DEV R; Chandra-Mouli V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-1; Cheng Y, 2004, INT J GYNECOL OBSTET, V87, P199, DOI 10.1016/j.ijgo.2004.06.010; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, 2012, OBSTET GYNECOL, V120, P983, DOI DOI 10.1097/AOG.0B013E3182723B7D; *DEP MAT NEWB CHIL, 2011, GUID PREV EARL PREGN, P42331; Ditmore MH., 2013, SEX WORK DRUG USE OV; Fang Xiaoyi, 2007, World Health Popul, V9, P46; Hong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062290; Hu Y., 2010, J INT REPROD HLTH FA, V29.6, P392; *INT WOM HLTH COAL, 2008, TRIPL JEOP FEM AD SE, P42331; Kavanaugh ML, 2011, OBSTET GYNECOL, V117, P1349, DOI 10.1097/AOG.0b013e31821c47c9; KENDAL M, 2010, SEX WORK HIV, P42331; Li JK, 2013, EUR J CONTRACEP REPR, V18, P148, DOI 10.3109/13625187.2013.776673; Li L, 2009, DERMATOL VENEREOL, V31, P1; Luchters S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068855; Luchters S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-384; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Mao Z-Y, 2011, NW POPUL, V32, P95, DOI DOI 10.15884/J.CNKI.ISSN.1007-0672.2011.05.016; MIDDLETONLEE S, 2011, HIV SRHR INTEGRATION, P42331; Moraros J, 2012, J HIV-AIDS SOC SERV, V11, P125, DOI 10.1080/15381501.2012.678117; *NAT BUR STAT CHIN, 2011, NAT POP CENS 2010, P42331; Neal S, 2012, ACTA OBSTET GYN SCAN, V91, P1114, DOI 10.1111/j.1600-0412.2012.01467.x; Okal J, 2011, AIDS CARE, V23, P612, DOI 10.1080/09540121.2010.525605; *PATH, 2013, PHIL INT FAM PLANN H, P42331; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; *POP COUNC, 2001, REPR TRACT INF INTR, P42331; QIAN X, 2004, BMC HEALTH SERV RES, V4, pE1; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Silverman JG, 2011, ARCH DIS CHILD, V96, P478, DOI 10.1136/adc.2009.178715; Tang J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-917; TAYLOR C, 2007, SERVICES YOUNG PEOPL, P42331; TEAL SB, 2013, J ADOLESCENT HEALTH, V52, P35, DOI DOI 10.1016/J.JADOHEALTH.2012.07.016; Tu XW, 2004, B WORLD HEALTH ORGAN, V82, P274; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; *UNFPA, 2013, STAT WORLD POP MOTH, P42331; United Nations Population Fund (UNFPA), 2013, AD PREGN REV EV; Wechsberg WM, 2006, AIDS BEHAV, V10, P131, DOI 10.1007/s10461-005-9036-8; WHO, 2014, HLTH WORLDS AD 2 CHA; WHO, 2011, SEX REPR HLTH YOUNG; *WHO DEP REPR HLTH, 2004, SEL PRACT REC CONTR, P42331; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; World Health Organization, 2013, IMPL COMPR HIV STI P; ZHANG C, 2014, JOURNAL, P42331; Zhang C, 2013, PSYCHOL HEALTH MED, V18, P330, DOI 10.1080/13548506.2012.712705; Zhang XD, 2014, EUR J CONTRACEP REPR, V19, P368, DOI 10.3109/13625187.2014.927421; Zhang XD, 2013, SEX TRANSM INFECT, V89, P237, DOI 10.1136/sextrans-2012-050690; Zheng X., 2010, POPUL DEV, V16, P2; Zhou YY, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-13	52	21	21	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115435	10.1371/journal.pone.0115435	http://dx.doi.org/10.1371/journal.pone.0115435			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QM	25625194	Green Published, gold			2022-12-27	WOS:000348821400008
J	Kim, SR; Han, K; Choi, JY; Ersek, J; Liu, JX; Jo, SJ; Lee, KS; Yim, HW; Lee, WC; Park, YG; Lee, SH; Park, YM				Kim, So-Ra; Han, Kyungdo; Choi, Jin-Young; Ersek, Jennifer; Liu, Junxiu; Jo, Sun-Jin; Lee, Kang-Sook; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong Gyu; Lee, Seung-Hwan; Park, Yong-Moon			Age- and Sex-Specific Relationships between Household Income, Education, and Diabetes Mellitus in Korean Adults: The Korea National Health and Nutrition Examination Survey, 2008-2010	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; METABOLIC SYNDROME; RISK-FACTORS; ASSOCIATION; POSITION; PREVALENCE; OBESITY; LIFE; GENDER; DISPARITIES	Background To investigate the effects of age and sex on the relationship between socioeconomic status (SES) and the prevalence and control status of diabetes mellitus (DM) in Korean adults. Methods Data came from 16,175 adults (6,951 men and 9,227 women) over the age of 30 who participated in the 2008-2010 Korea National Health and Nutrition Examination Survey. SES was measured by household income or education level. The adjusted odds ratios (ORs) and corresponding 95% confidence intervals (95% CI) for the prevalence or control status of diabetes were calculated using multiple logistic regression analyses across household income quartiles and education levels. Results The household income-DM and education level-DM relationships were significant in younger age groups for both men and women. The adjusted ORs and 95% CI for diabetes were 1.51 (0.97, 2.34) and 2.28 (1.29, 4.02) for the lowest vs. highest quartiles of household income and education level, respectively, in women younger than 65 years of age (both P for linear trend < 0.05 with Bonferroni adjustment). The adjusted OR and 95% CI for diabetes was 2.28 (1.53, 3.39) for the lowest vs. highest quartile of household income in men younger than 65 (P for linear trend < 0.05 with Bonferroni adjustment). However, in men and women older than 65, no associations were found between SES and the prevalence of DM. No significant association between SES and the status of glycemic control was detected. Conclusions We found age-and sex-specific differences in the relationship of household income and education with the prevalence of DM in Korea. DM preventive care is needed for groups with a low SES, particularly in young or middle-aged populations.	[Kim, So-Ra; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Grad Sch Publ Hlth, Seoul, South Korea; [Han, Kyungdo; Jo, Sun-Jin; Lee, Kang-Sook; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Dept Prevent Med, Coll Med, Seoul, South Korea; [Han, Kyungdo; Park, Yong Gyu] Catholic Univ Korea, Dept Biostat, Coll Med, Seoul, South Korea; [Choi, Jin-Young] Catholic Univ Korea, Catholic Med Ctr, Seoul, South Korea; [Ersek, Jennifer; Liu, Junxiu; Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Lee, Seung-Hwan] Catholic Univ Korea, Seoul St Marys Hosp, Div Endocrinol & Metab, Dept Internal Med,Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Catholic University of Korea; Seoul St. Mary's Hospital	Lee, SH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Div Endocrinol & Metab, Dept Internal Med,Coll Med, Seoul, South Korea.	hwanx2@catholic.ac.kr; markYMpark@gmail.com	PARK, YONG-MOON ("MARK")/ABA-2765-2021; Lee, Seung-Hwan/C-7568-2018; Lee, Seung-Hwan/AAG-1361-2019	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Lee, Seung-Hwan/0000-0002-3964-3877; Lee, Seung-Hwan/0000-0002-3964-3877; Park, Yong Gyu/0000-0002-8721-3230; Choi, Jin Young/0000-0002-3641-2504	Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation	This study was supported by the grant from the Catholic Medical Center Research Foundation made in the program year of 2014 (to SHL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Agardh EE, 2007, INT J EPIDEMIOL, V36, P84, DOI 10.1093/ije/dyl269; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Assari S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-36; Assari S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-3; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Brezinka V, 1996, SOC SCI MED, V42, P1351, DOI 10.1016/0277-9536(95)00284-7; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Choi BCK, 2001, DIABETOLOGIA, V44, P1221, DOI 10.1007/s001250100648; 박봉숙, 2005, Diabetes and Metabolism Journal, V29, P254; Dallongeville J, 2005, DIABETES CARE, V28, P409, DOI 10.2337/diacare.28.2.409; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Duncan GJ, 1996, INT J HEALTH SERV, V26, P419, DOI 10.2190/1KU0-4Y3K-ACFL-BYU7; Evans JMM, 2000, DIABETIC MED, V17, P478, DOI 10.1046/j.1464-5491.2000.00309.x; Gallegos-Macias Angela R, 2003, Pediatr Diabetes, V4, P19, DOI 10.1034/j.1399-5448.2003.00020.x; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Guariguata L, 2011, DIABETES RES CLIN PR, V94, P322, DOI 10.1016/j.diabres.2011.10.040; Hassan K, 2006, J PEDIATR-US, V149, P526, DOI 10.1016/j.jpeds.2006.05.039; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-912; Hur Inyoung, 2011, Osong Public Health Res Perspect, V2, P192, DOI 10.1016/j.phrp.2011.11.044; Jeffery RW, 1996, ANN EPIDEMIOL, V6, P263, DOI 10.1016/S1047-2797(96)00070-1; Kautzky-Willer A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-392; Kim DJ, 2011, DIABETES METAB J, V35, P303, DOI 10.4093/dmj.2011.35.4.303; KO MJ, 2012, INT J EPIDEMIOL, P1; Kowall B, 2011, J EPIDEMIOL COMMUN H, V65, P606, DOI 10.1136/jech.2009.094086; Larrimore J, 2011, MILBANK Q, V89, P694, DOI 10.1111/j.1468-0009.2011.00647.x; Lee DS, 2013, PUBLIC HEALTH, V127, P554, DOI 10.1016/j.puhe.2013.02.001; Lee J, 2013, ENDOCRINOL METAB, V28, P180, DOI 10.3803/EnM.2013.28.3.180; Lee TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027670; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Myong JP, 2012, IND HEALTH, V50, P115, DOI 10.2486/indhealth.MS1328; Park IB, 2013, DIABETES METAB J, V37, P233, DOI 10.4093/dmj.2013.37.4.233; Park YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085068; Ploubidis GB, 2013, INT J PUBLIC HEALTH, V58, P133, DOI 10.1007/s00038-012-0389-2; Rabi DM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-124; Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76, DOI 10.2105/AJPH.91.1.76; Schooling CM, 2008, AM J EPIDEMIOL, V167, P419, DOI 10.1093/aje/kwm329; SORLIE PD, 1995, AM J PUBLIC HEALTH, V85, P949, DOI 10.2105/AJPH.85.7.949; Tang M, 2003, INT J EPIDEMIOL, V32, P381, DOI 10.1093/ije/dyg075; Turrell G, 2006, PUBLIC HEALTH NUTR, V9, P375, DOI 10.1079/PHN2006850; Wardle J, 2001, J EPIDEMIOL COMMUN H, V55, P185, DOI 10.1136/jech.55.3.185; Wikstrom K, 2011, EUR J PUBLIC HEALTH, V21, P768, DOI 10.1093/eurpub/ckq164; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yoon YS, 2006, OBESITY, V14, P909, DOI 10.1038/oby.2006.105	44	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117034	10.1371/journal.pone.0117034	http://dx.doi.org/10.1371/journal.pone.0117034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ8MR	25622031	Green Published, Green Submitted, gold			2022-12-27	WOS:000348470400014
J	Hu, P; Luo, BH				Hu, Ping; Luo, Bing-Hao			Integrin alpha(IIb)beta(3) Transmembrane Domain Separation Mediates Bi-Directional Signaling across the Plasma Membrane	PLOS ONE			English	Article							CYTOPLASMIC DOMAIN; OUTSIDE-IN; STRUCTURAL BASIS; ALPHA-SUBUNIT; TYROSINE KINASE; CELL-MIGRATION; ACTIVATION; PAXILLIN; ALPHA-IIB-BETA-3; BINDING	Integrins play an essential role in hemostasis, thrombosis, and cell migration, and they transmit bidirectional signals. Transmembrane/cytoplasmic domains are hypothesized to associate in the resting integrins; whereas, ligand binding and intracellular activating signals induce transmembrane domain separation. However, how this conformational change affects integrin outside-in signaling and whether the a subunit cytoplasmic domain is important for this signaling remain elusive. Using Chinese Hamster Ovary (CHO) cells that stably expressed different integrin alpha(IIb)beta(3) constructs, we discovered that an alpha(IIb) cytoplasmic domain truncation led to integrin activation but not defective outside-in signaling. In contrast, preventing transmembrane domain separation abolished both inside-out and outside-in signaling regardless of removing the alpha(IIb) cytoplasmic tail. Truncation of the alpha(IIb) cytoplasmic tail did not obviously affect adhesion-induced outside-in signaling. Our research revealed that transmembrane domain separation is a downstream conformational change after the cytoplasmic domain dissociation in inside-out activation and indispensable for ligand-induced outside-in signaling. The result implicates that the beta TM helix rearrangement after dissociation is essential for integrin transmembrane signaling. Furthermore, we discovered that the PI3K/Akt pathway is not essential for cell spreading but spreading-induced Erk1/2 activation is PI3K dependent implicating requirement of the kinase for cell survival in outside-in signaling.	[Hu, Ping; Luo, Bing-Hao] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Luo, BH (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	luo@tigers.lsu.edu			American Heart Association [10GRNT3960011]	American Heart Association(American Heart Association)	This work was supported by the American Heart Association (#10GRNT3960011) to BHL (http://www.heart.org/HEARTORG/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Chua GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055184; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Gao CJ, 2011, BLOOD, V117, P4946, DOI 10.1182/blood-2010-09-307751; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gottschalk KE, 2002, PROTEIN SCI, V11, P1800, DOI 10.1110/ps.4120102; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Liu JL, 2005, BLOOD, V105, P4345, DOI 10.1182/blood-2004-07-2718; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu SC, 2001, J BIOL CHEM, V276, P37086, DOI 10.1074/jbc.M105114200; Liu SC, 2000, J BIOL CHEM, V275, P22736, DOI 10.1074/jbc.M000388200; Lu CF, 1997, J IMMUNOL, V159, P268; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mehrbod M, 2013, BIOPHYS J, V105, P1304, DOI 10.1016/j.bpj.2013.07.055; Mehrbod M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002948; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Niu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047356; O'Brien KA, 2012, ARTERIOSCL THROM VAS, V32, P2232, DOI 10.1161/ATVBAHA.112.254680; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Pfaff M, 2001, J CELL SCI, V114, P2775; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Romanova LY, 2011, CELL ADHES MIGR, V5, P457, DOI 10.4161/cam.5.6.18219; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Surya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074281; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Wang W, 2010, BIOCHEMISTRY-US, V49, P10158, DOI 10.1021/bi101462h; Wang W, 2010, J CELL BIOCHEM, V109, P447, DOI 10.1002/jcb.22427; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WILLIAMS SE, 1994, ANN NY ACAD SCI, V737, P1, DOI 10.1111/j.1749-6632.1994.tb44297.x; Woodside DG, 2001, CURR BIOL, V11, P1799, DOI 10.1016/S0960-9822(01)00565-6; Zeller KS, 2010, CELL SIGNAL, V22, P1838, DOI 10.1016/j.cellsig.2010.07.011; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	57	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116208	10.1371/journal.pone.0116208	http://dx.doi.org/10.1371/journal.pone.0116208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617834	Green Published, gold, Green Submitted			2022-12-27	WOS:000350336000009
J	Li, TF; Fan, H; Wang, YX				Li, Teng-Fei; Fan, Hui; Wang, Yong-Xiang			Epidural Sustained Release Ropivacaine Prolongs Anti-Allodynia and Anti-Hyperalgesia in Developing and Established Neuropathic Pain	PLOS ONE			English	Article							C-FOS; LOCAL-ANESTHETICS; OIL SUSPENSIONS; SODIUM-CHANNELS; NERVE INJURY; BUPIVACAINE; LIDOCAINE; RAT; SURGERY; MODEL	Ropivacaine is a local anesthetic widely used for regional anesthesia and epidural analgesia, but its relatively short duration limits its clinical use. A novel sustained release lipid formulation of ropivacaine has been recently developed to prolong its duration. We examined the epidural anti-hypersensitivity and preemptive effects of ropivacaine in mesylate injection and sustained release suspension forms in a rat model of neuropathy produced by peripheral nerve injury. Epidural administration of ropivacaine mesylate injection specifically blocked mechanical allodynia and thermal hyperalgesia by approximately 50% with a biological half-effective duration of approximately 3 hrs. The equivalent dose of ropivacaine free-base in sustained release suspension significantly prolonged the duration of anti-allodynia and anti-hyperalgesia by approximately 2 times. Multiple daily epidural injections of ropivacaine in both the mesylate injection and sustained-release suspension forms did not induce tolerance or potentiation to anti-allodynia or anti-hyperalgesia. Moreover, the single or multiple daily administration of ropivacaine mesylate injection before surgery in particular, markedly blocked the initiation and development of neuropathic pain, increasing the biological half-effective duration from less than 4 hrs up to 1 or 2 days. The single and multiple daily epidural injection of ropivacaine sustained release suspension further delayed the biological half-lives to 2 and 3 days, respectively. Our results indicate that the epidural administration of ropivacaine effectively blocks neuropathic pain without the induction of analgesic tolerance, and significantly delays the development of neuropathy produced by peripheral nerve injury. Epidural ropivacaine sustained release suspension produces much longer blockade effects of mechanical allodynia and heat hyperalgesia, and more significantly delays the development of neuropathic pain.	[Li, Teng-Fei; Fan, Hui; Wang, Yong-Xiang] Shanghai Jiao Tong Univ, Sch Pharm, Kings Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, YX (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Kings Lab, Shanghai 200030, Peoples R China.	yxwang@sjtu.edu.cn			Xi'an Libang Pharmaceutical Co. (Xi'an, China)	Xi'an Libang Pharmaceutical Co. (Xi'an, China)	This research was financially supported by Xi'an Libang Pharmaceutical Co. (Xi'an, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram SE, 1996, REGION ANESTH, V21, P117; AKERMAN B, 1988, ACTA ANAESTH SCAND, V32, P571, DOI 10.1111/j.1399-6576.1988.tb02788.x; Albi-Feldzer A, 2013, ANESTHESIOLOGY, V118, P318, DOI 10.1097/ALN.0b013e31827d88d8; Amir R, 2006, J PAIN, V7, pS1, DOI 10.1016/j.jpain.2006.01.444; ARNER S, 1990, PAIN, V43, P287, DOI 10.1016/0304-3959(90)90026-A; Avelino A, 1998, J UROLOGY, V159, P567, DOI 10.1016/S0022-5347(01)63985-5; Batoz H, 2009, ANESTH ANALG, V109, P240, DOI 10.1213/ane.0b013e3181a4928d; CHAPLAN SR, 1995, ANESTHESIOLOGY, V83, P775, DOI 10.1097/00000542-199510000-00017; Charlet A, 2011, J PAIN, V12, P246, DOI 10.1016/j.jpain.2010.07.005; Crosby E, 1998, CAN J ANAESTH, V45, P1066, DOI 10.1007/BF03012393; DEVOR M, 1992, PAIN, V48, P261, DOI 10.1016/0304-3959(92)90067-L; DURANT PAC, 1986, ANESTHESIOLOGY, V64, P43, DOI 10.1097/00000542-198601000-00008; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; England JD, 1996, NEUROLOGY, V47, P272, DOI 10.1212/WNL.47.1.272; Gong N, 2014, J NEUROSCI, V34, P5322, DOI 10.1523/JNEUROSCI.4703-13.2014; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Herbland A, 2006, REGION ANESTH PAIN M, V31, P34, DOI 10.1016/j.rapm.2005.10.008; Hogan QH, 1997, ANESTHESIOLOGY, V86, P216, DOI 10.1097/00000542-199701000-00026; Huang JL, 2012, AMINO ACIDS, V43, P1905, DOI 10.1007/s00726-012-1390-z; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Kanai Y, 1999, REGION ANESTH PAIN M, V24, P444, DOI 10.1016/S1098-7339(99)90012-3; Kemp MI, 2010, PROGR MED CHEM, V49, P81, DOI 10.1016/S0079-6468(10)49003-7; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; KOLTZENBURG M, 1994, BRAIN, V117, P579, DOI 10.1093/brain/117.3.579; LANGERMAN L, 1991, ANESTH ANALG, V72, P635; Larsen SW, 2008, EUR J PHARM SCI, V34, P37, DOI 10.1016/j.ejps.2008.02.005; LEUNG JM, 1995, ANESTHESIOLOGY, V83, P1132, DOI 10.1097/00000542-199511000-00034; Lierz P, 2004, EUR J ANAESTH, V21, P32, DOI 10.1017/S0265021504001061; Lin CT, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/921405; LIU S, 1995, ANESTHESIOLOGY, V82, P1474, DOI 10.1097/00000542-199506000-00019; Lu WD, 2013, Patent, Patent No. [103142458A, 103142458]; McClure JH, 1996, BRIT J ANAESTH, V76, P300, DOI 10.1093/bja/76.2.300; Mitchell VA, 1999, ANESTH ANALG, V89, P989, DOI 10.1097/00000539-199910000-00031; Oda A, 2000, ANESTH ANALG, V91, P1213, DOI 10.1097/00000539-200011000-00031; Pedersen BT, 2008, DRUG DELIV, V15, P23, DOI [10.1080/10717540701828657, 10.1080/10717540701828657 ]; Ratajczak-Enselme M, 2009, EUR J PHARM BIOPHARM, V72, P54, DOI 10.1016/j.ejpb.2008.11.003; Rose FX, 2007, ANESTH ANALG, V105, P859, DOI 10.1213/01.ane.0000278129.37099.fa; ROY ML, 1992, J NEUROSCI, V12, P2104; Shin JW, 2008, ANESTH ANALG, V107, P1587, DOI 10.1213/ane.0b013e31818200aa; Shum P, 2001, ADV DRUG DELIVER REV, V53, P273, DOI 10.1016/S0169-409X(01)00232-0; Smith LJ, 2002, PAIN, V97, P267, DOI 10.1016/S0304-3959(02)00028-3; Stenberg C, 2005, BASIC CLIN PHARMACOL, V96, P381, DOI 10.1111/j.1742-7843.2005.pto_07.x; Sun XH, 2004, ANESTH ANALG, V98, P1093, DOI 10.1213/01.ANE.0000104580.89717.A2; Terpstra AHM, 2001, J NUTR, V131, P2067, DOI 10.1093/jn/131.7.2067; Toda S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-2; Wei H, 2007, BRAIN RES, V1148, P105, DOI 10.1016/j.brainres.2007.02.040; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; Zink W, 2008, CURR OPIN ANESTHESIO, V21, P645, DOI 10.1097/ACO.0b013e32830c214c	48	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117321	10.1371/journal.pone.0117321	http://dx.doi.org/10.1371/journal.pone.0117321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617901	Green Published, Green Submitted, gold			2022-12-27	WOS:000350336000042
J	Dores-Silva, PR; Barbosa, LRS; Ramos, CHI; Borges, JC				Dores-Silva, Paulo R.; Barbosa, Leandro R. S.; Ramos, Carlos H. I.; Borges, Julio C.			Human Mitochondrial Hsp70 (Mortalin): Shedding Light on ATPase Activity, Interaction with Adenosine Nucleotides, Solution Structure and Domain Organization	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONE; SUBSTRATE-BINDING; ANALYTICAL ULTRACENTRIFUGATION; UNFOLDED PROTEINS; CANCER-CELLS; DNAK; FAMILY; IDENTIFICATION; IMPORT	The human mitochondrial Hsp70, also called mortalin, is of considerable importance for mitochondria biogenesis and the correct functioning of the cell machinery. In the mitochondrial matrix, mortalin acts in the importing and folding process of nucleus-encoded proteins. The in vivo deregulation of mortalin expression and/or function has been correlated with age-related diseases and certain cancers due to its interaction with the p53 protein. In spite of its critical biological roles, structural and functional studies on mortalin are limited by its insoluble recombinant production. This study provides the first report of the production of folded and soluble recombinant mortalin when co-expressed with the human Hsp70-escort protein 1, but it is still likely prone to self-association. The monomeric fraction of mortalin presented a slightly elongated shape and basal ATPase activity that is higher than that of its cytoplasmic counterpart Hsp70-1A, suggesting that it was obtained in the functional state. Through small angle X-ray scattering, we assessed the low-resolution structural model of monomeric mortalin that is characterized by an elongated shape. This model adequately accommodated high resolution structures of Hsp70 domains indicating its quality. We also observed that mortalin interacts with adenosine nucleotides with high affinity. Thermally induced unfolding experiments indicated that mortalin is formed by at least two domains and that the transition is sensitive to the presence of adenosine nucleotides and that this process is dependent on the presence of Mg2+ ions. Interestingly, the thermal-induced unfolding assays of mortalin suggested the presence of an aggregation/association event, which was not observed for human Hsp70-1A, and this finding may explain its natural tendency for in vivo aggregation. Our study may contribute to the structural understanding of mortalin as well as to contribute for its recombinant production for antitumor compound screenings.	[Dores-Silva, Paulo R.; Borges, Julio C.] Univ Sao Paulo, Inst Chem Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil; [Barbosa, Leandro R. S.] Univ Sao Paulo, Inst Phys, BR-05508090 Sao Paulo, Brazil; [Ramos, Carlos H. I.] Univ Estadual Campinas, UNICAMP, Inst Chem, BR-13083970 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Borges, JC (corresponding author), Univ Sao Paulo, Inst Chem Sao Carlos, POB 780, BR-13560970 Sao Carlos, SP, Brazil.	borgesjc@iqsc.usp.br	Barbosa, Leandro Ramos Souza/E-6577-2012; Barbosa, L. R. S./AAN-7787-2020; Ramos, CH/C-1571-2012; Barbosa, Leandro Ramos Souza/GRJ-9680-2022; Borges, Julio C/C-6160-2008	Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Ramos, CH/0000-0002-7246-9081; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Borges, Julio C/0000-0003-4856-748X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CHIR) [2011/23110-0, 2012/50161-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [471415/2013-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CHIR); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by 2011/23110-0 (JCB); 2012/50161-8, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/) (CHIR); and 471415/2013-8-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) (JCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amick J, 2014, PROTEIN SCI, V23, P833, DOI 10.1002/pro.2466; [Anonymous], [No title captured]; Araujo TLS, 2014, BIOCHEMISTRY-US, V53, P2884, DOI 10.1021/bi500004q; BARBOSA LRS, 2013, PROTEINS SOLUTION IN, P49; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bohnert M, 2007, FEBS LETT, V581, P2802, DOI 10.1016/j.febslet.2007.03.004; Borges JC, 2011, CURR MED CHEM, V18, P1276; Borges JC, 2006, ARCH BIOCHEM BIOPHYS, V452, P46, DOI 10.1016/j.abb.2006.05.006; Borges JC, 2009, BMB REP, V42, P166, DOI 10.5483/BMBRep.2009.42.3.166; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; da Silva KP, 2011, PROTEIN PEPTIDE LETT, V18, P132; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Deocaris CC, 2007, CANCER LETT, V252, P259, DOI 10.1016/j.canlet.2006.12.038; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; DOMANICO SZ, 1993, MOL CELL BIOL, V13, P3598, DOI 10.1128/MCB.13.6.3598; Dores-Silva PR, 2013, INT J BIOL MACROMOL, V56, P140, DOI 10.1016/j.ijbiomac.2013.02.009; Fan ACY, 2011, PROTEIN PEPTIDE LETT, V18, P122; HUANG SP, 1993, J BIOL CHEM, V268, P2063; Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200; Kaul SC, 2000, FEBS LETT, V474, P159, DOI 10.1016/S0014-5793(00)01594-5; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; Londono C, 2012, BIOMOLECULES, V2, P143, DOI 10.3390/biom2010143; Lopez-Buesa P, 1998, P NATL ACAD SCI USA, V95, P15253, DOI 10.1073/pnas.95.26.15253; Luo WI, 2010, PROTEIN EXPRES PURIF, V72, P75, DOI 10.1016/j.pep.2010.02.003; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Mokranjac D, 2009, BBA-MOL CELL RES, V1793, P33, DOI 10.1016/j.bbamcr.2008.06.021; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Ortore MG, 2009, J R SOC INTERFACE, V6, pS619, DOI 10.1098/rsif.2009.0163.focus; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PALLEROS DR, 1993, FEBS LETT, V336, P124, DOI 10.1016/0014-5793(93)81624-9; PALLEROS DR, 1992, J BIOL CHEM, V267, P5279; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Popp SL, 2009, FEBS LETT, V583, P573, DOI 10.1016/j.febslet.2008.12.062; Qu MY, 2011, BRAIN RES, V1368, P336, DOI 10.1016/j.brainres.2010.10.068; Ran QT, 2000, BIOCHEM BIOPH RES CO, V275, P174, DOI 10.1006/bbrc.2000.3237; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Rodina A, 2013, CHEM BIOL, V20, P1469, DOI 10.1016/j.chembiol.2013.10.008; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Silberg JJ, 2000, J BIOL CHEM, V275, P7779, DOI 10.1074/jbc.275.11.7779; Silva KP, 2013, BBA-PROTEINS PROTEOM, V1834, P351, DOI 10.1016/j.bbapap.2012.08.004; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Spinozzi F, 2014, J APPL CRYSTALLOGR, V47, P1132, DOI 10.1107/S1600576714005147; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Veyel D, 2014, BIOCHEM J, V460, P13, DOI 10.1042/BJ20140001; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vu MT, 2012, PROTEIN SCI, V21, P258, DOI 10.1002/pro.2012; WADHWA R, 1993, J BIOL CHEM, V268, P22239; WADHWA R, 1993, J BIOL CHEM, V268, P6615; WADHWA R, 1993, EXP CELL RES, V207, P442, DOI 10.1006/excr.1993.1213; Wadhwa R, 2005, BIOCHEM J, V391, P185, DOI 10.1042/BJ20050861; Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468; Wadhwa R, 2000, CANCER RES, V60, P6818; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; XU LJ, 2009, J CEREBR BLOOD F MET, V29, P365, DOI DOI 10.1038/JCBFM.2008.125; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200; Zhai P, 2011, BIOCHEM BIOPH RES CO, V408, P589, DOI 10.1016/j.bbrc.2011.04.066; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	70	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117170	10.1371/journal.pone.0117170	http://dx.doi.org/10.1371/journal.pone.0117170			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615450	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100059
J	Jourdan, M; Gagne, S; Dubois-Laurent, C; Maghraoui, M; Huet, S; Suel, A; Hamama, L; Briard, M; Peltier, D; Geoffriau, E				Jourdan, Matthieu; Gagne, Severine; Dubois-Laurent, Cecile; Maghraoui, Mohamed; Huet, Sebastien; Suel, Anita; Hamama, Latifa; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel			Carotenoid Content and Root Color of Cultivated Carrot: A Candidate-Gene Association Study Using an Original Broad Unstructured Population	PLOS ONE			English	Article							PLASTID TERMINAL OXIDASE; DAUCUS-CAROTA; PHYTOENE SYNTHASE; BIOSYNTHESIS; LYCOPENE; FRUIT; ACCUMULATION; ARABIDOPSIS; SOFTWARE; NUMBER	Accumulated in large amounts in carrot, carotenoids are an important product quality attribute and therefore a major breeding trait. However, the knowledge of carotenoid accumulation genetic control in this root vegetable is still limited. In order to identify the genetic variants linked to this character, we performed an association mapping study with a candidate gene approach. We developed an original unstructured population with a broad genetic basis to avoid the pitfall of false positive detection due to population stratification. We genotyped 109 SNPs located in 17 candidate genes - mostly carotenoid biosynthesis genes - on 380 individuals, and tested the association with carotenoid contents and color components. Total carotenoids and beta- carotene contents were significantly associated with genes zeaxanthin epoxydase (ZEP), phytoene desaturase (PDS) and carotenoid isomerase (CRTISO) while alpha-carotene was associated with CRTISO and plastid terminal oxidase (PTOX) genes. Color components were associated most significantly with ZEP. Our results suggest the involvement of the couple PDS/PTOX and ZEP in carotenoid accumulation, as the result of the metabolic and catabolic activities respectively. This study brings new insights in the understanding of the carotenoid pathway in non-photosynthetic organs.	[Jourdan, Matthieu; Gagne, Severine; Dubois-Laurent, Cecile; Maghraoui, Mohamed; Huet, Sebastien; Suel, Anita; Hamama, Latifa; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel] Agrocampus Ouest, UMR1345, Inst Rech Hort & Semences, Angers, France; [Jourdan, Matthieu; Gagne, Severine; Dubois-Laurent, Cecile; Maghraoui, Mohamed; Huet, Sebastien; Suel, Anita; Hamama, Latifa; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel] Univ Angers, UMR1345, Inst Rech Hort & Semences, Angers, France; [Jourdan, Matthieu; Gagne, Severine; Dubois-Laurent, Cecile; Maghraoui, Mohamed; Huet, Sebastien; Suel, Anita; Hamama, Latifa; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel] INRA, UMR1345, Inst Rech Hort & Semences, Beaucouze, France	Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers; INRAE	Geoffriau, E (corresponding author), Agrocampus Ouest, UMR1345, Inst Rech Hort & Semences, Angers, France.	emmanuel.geoffriau@agrocampus-ouest.fr	martel, celine/O-6651-2016	martel, celine/0000-0002-1800-4558	French ministry of Research	French ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was funded by the French ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIO C, 2005, GENETICS MOL BIO, V28, P287; ARANGO J, 2014, PLANT CELL; Auzanneau J, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-183; Baranski R, 2012, FOOD RES INT, V47, P182, DOI 10.1016/j.foodres.2011.05.006; Baranski R, 2012, GENET RESOUR CROP EV, V59, P163, DOI 10.1007/s10722-011-9777-3; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bradeen JM, 1998, THEOR APPL GENET, V97, P960, DOI 10.1007/s001220050977; Brand A, 2012, PLANTA, V235, P579, DOI 10.1007/s00425-011-1530-9; Briard M, 2000, PLANT MOL BIOL REP, V18, P235, DOI 10.1007/BF02823994; BUISHAND JG, 1979, EUPHYTICA, V28, P611, DOI 10.1007/BF00038928; Cardoso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046021; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Cavagnaro PF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-386; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Chandler K, 2013, CROP SCI, V53, P189, DOI 10.2135/cropsci2012.02.0129; Clotault J, 2008, J EXP BOT, V59, P3563, DOI 10.1093/jxb/ern210; Clotault J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038724; Clotault J, 2010, THEOR APPL GENET, V121, P659, DOI 10.1007/s00122-010-1338-1; de Rosso VV, 2007, J AGR FOOD CHEM, V55, P5062, DOI 10.1021/jf0705421; Diretto G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-13; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Santos CAF, 2006, EUPHYTICA, V151, P79, DOI 10.1007/s10681-006-9130-7; Galpaz N, 2008, PLANT J, V53, P717, DOI 10.1111/j.1365-313X.2007.03362.x; Gomez R, 1998, J SCI FOOD AGR, V77, P268, DOI 10.1002/(SICI)1097-0010(199806)77:2&lt;268::AID-JSFA35&gt;3.0.CO;2-V; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Huh JH, 2001, THEOR APPL GENET, V102, P524, DOI 10.1007/s001220051677; Inbaraj BS, 2006, J CHROMATOGR A, V1102, P193, DOI 10.1016/j.chroma.2005.10.055; Josse EM, 2000, PLANT PHYSIOL, V123, P1427, DOI 10.1104/pp.123.4.1427; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Just BJ, 2009, THEOR APPL GENET, V119, P1155, DOI 10.1007/s00122-009-1117-z; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Le Clerc V, 2003, BIODIVERS CONSERV, V12, P2227, DOI 10.1023/A:1024562701150; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu S, 2008, J INTEGR PLANT BIOL, V50, P778, DOI 10.1111/j.1744-7909.2008.00708.x; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; McDonald AE, 2011, BBA-BIOENERGETICS, V1807, P954, DOI 10.1016/j.bbabio.2010.10.024; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Ravel C, 2013, MOL BREEDING, V31, P87, DOI 10.1007/s11032-012-9772-1; Rodriguez-Villalon A, 2009, PLANT J, V60, P424, DOI 10.1111/j.1365-313X.2009.03966.x; Roncallo PF, 2012, EUPHYTICA, V185, P77, DOI 10.1007/s10681-012-0628-x; Sandmann G, 2006, METAB ENG, V8, P291, DOI 10.1016/j.ymben.2006.01.005; Santos CAF, 2002, MOL GENET GENOMICS, V268, P122, DOI 10.1007/s00438-002-0735-9; Shahbazi M, 2007, PLANT PHYSIOL, V145, P691, DOI 10.1104/pp.107.106336; Simon PW, 1996, J HERED, V87, P63, DOI 10.1093/oxfordjournals.jhered.a022955; SINGHA S, 1991, J AM SOC HORTIC SCI, V116, P497, DOI 10.21273/JASHS.116.3.497; Soufflet-Freslon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070801; Surles RL, 2004, J AGR FOOD CHEM, V52, P3417, DOI 10.1021/jf035472m; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Vallabhaneni R, 2009, PLANT PHYSIOL, V150, P562, DOI 10.1104/pp.109.137042; Weber A, 2007, GENETICS, V177, P2349, DOI 10.1534/genetics.107.080424; Wolters AMA, 2010, PLANT MOL BIOL, V73, P659, DOI 10.1007/s11103-010-9647-y; Wu DY, 1999, PLANT CELL, V11, P43, DOI 10.1105/tpc.11.1.43; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yu BY, 2008, TRANSGENIC RES, V17, P573, DOI 10.1007/s11248-007-9131-x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	66	45	46	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116674	10.1371/journal.pone.0116674	http://dx.doi.org/10.1371/journal.pone.0116674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25614987	Green Published, gold			2022-12-27	WOS:000349122100036
J	Lin, JC; Ettinger, RA; Schuman, JT; Zhang, AH; Wamiq-Adhami, M; Nguyen, PCT; Nakaya-Fletcher, SM; Puranik, K; Thompson, AR; Pratt, KP				Lin, Jasper C.; Ettinger, Ruth A.; Schuman, Jason T.; Zhang, Ai-Hong; Wamiq-Adhami, Muhammad; Nguyen, Phuong-Cac T.; Nakaya-Fletcher, Shelley M.; Puranik, Komal; Thompson, Arthur R.; Pratt, Kathleen P.			Six Amino Acid Residues in a 1200 angstrom 2 Interface Mediate Binding of Factor VIII to an IgG4 kappa Inhibitory Antibody	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; COAGULATION-FACTOR-VIII; HEMOPHILIA-A MICE; RECOMBINANT FACTOR-VIII; C2 DOMAIN; PHOSPHOLIPID-BINDING; MASS-SPECTROMETRY; THERMODYNAMIC ANALYSIS; BIOSENSOR TECHNOLOGY; VONWILLEBRAND-FACTOR	The development of neutralizing anti-factor VIII (FVIII) antibodies complicates the treatment of many hemophilia A patients. The C-terminal C2 domain is a particularly antigenic FVIII region. A crystal structure of recombinant FVIII-C2 bound to an Fab fragment of the patient-derived monoclonal antibody BO2C11, which recognizes an immunodominant inhibitor epitope on FVIII and blocks its ability to bind von Willebrand factor (VWF) and phospholipids, revealed that 15 amino acids in FVIII contact this antibody. Forty-three recombinant FVIII-C2 proteins, each with a surface-exposed side chain mutated to alanine or another residue, were generated, and surface plasmon resonance studies were carried out to evaluate effects of these substitutions on BO2C11/FVIII-C2 binding affinity. Thermodynamic analysis of experiments carried out at three temperatures indicated that one beta hairpin turn at the antigen-antibody interface (FVIII-F2196, N2198, M2199 and F2200) plus two non-contiguous arginines (FVIII-R2215 and R2220), contributed appreciably to the affinity. B-domain-deleted (BDD) FVIII-F2196A, FVIII-F2196K and FVIII-M2199A were generated and characterized. Their pro-coagulant activities and binding to VWF were similar to those of WT-BDD-FVIII, and FVIII-F2196K avoided neutralization by BO2C11 and murine inhibitory mAb 1B5. This study suggests specific sites for amino acid substitutions to rationally design FVIII variants capable of evading immunodominant neutralizing anti-FVIII antibodies.	[Lin, Jasper C.; Ettinger, Ruth A.; Nguyen, Phuong-Cac T.; Nakaya-Fletcher, Shelley M.; Puranik, Komal; Thompson, Arthur R.; Pratt, Kathleen P.] Puget Sound Blood Ctr Res Inst, Seattle, WA 98102 USA; [Lin, Jasper C.; Thompson, Arthur R.; Pratt, Kathleen P.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Schuman, Jason T.] Gen Elect GE Healthcare Life Sci, Portland, OR USA; [Zhang, Ai-Hong; Pratt, Kathleen P.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Wamiq-Adhami, Muhammad] Walter Reed Natl Mil Med Ctr, Dept Pathol, Bethesda, MD USA	Puget Sound Blood Center; University of Washington; University of Washington Seattle; General Electric; Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center	Pratt, KP (corresponding author), Puget Sound Blood Ctr Res Inst, Seattle, WA 98102 USA.	Kathleen.pratt@usuhs.edu	Pratt, Kathleen P/E-9489-2019	Pratt, Kathleen/0000-0001-6837-6133	Pfizer ASPIRE Hemophilia award [NIH-HLT3207093, NIH-1RC2-HL101851, NIH-HLR01-071093]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101851] Funding Source: NIH RePORTER	Pfizer ASPIRE Hemophilia award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Pfizer ASPIRE Hemophilia award, https://www.aspireresearch.org/ASPIRE-Hemophilia/index.html (KPP); NIH-HLT3207093 (JCL); NIH-1RC2-HL101851 (KPP) and NIH-HLR01-071093 (ART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansong C, 2006, J THROMB HAEMOST, V4, P842, DOI 10.1111/j.1538-7836.2006.01831.x; Barrow RT, 2001, BLOOD, V97, P169, DOI 10.1182/blood.V97.1.169; Berntorp E, 2006, HAEMOPHILIA, V12, P1, DOI 10.1111/j.1365-2516.2006.01359.x; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Collins PW, 2007, BLOOD, V109, P1870, DOI 10.1182/blood-2006-06-029850; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Deinum J, 2002, ANAL BIOCHEM, V300, P152, DOI 10.1006/abio.2001.5454; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Dimitrov JD, 2010, J THROMB HAEMOST, V8, P1524, DOI 10.1111/j.1538-7836.2010.03878.x; Dimitrov JD, 2012, BIOCHEMISTRY-US, V51, P4108, DOI 10.1021/bi300232d; Dimitrov JD, 2009, MOL IMMUNOL, V47, P290, DOI 10.1016/j.molimm.2009.09.021; EHRENFORTH S, 1992, LANCET, V339, P594, DOI 10.1016/0140-6736(92)90874-3; FOSTER PA, 1990, THROMB HAEMOSTASIS, V63, P403; Fuentes-Prior P, 2002, CURR PROTEIN PEPT SC, V3, P313, DOI 10.2174/1389203023380639; FULCHER CA, 1987, BLOOD, V69, P1475; GILLES JGG, 1993, BLOOD, V82, P2452; Griffiths AE, 2011, J THROMB HAEMOST, V9, P1534, DOI 10.1111/j.1538-7836.2011.04397.x; Hay CRM, 1998, THROMB HAEMOSTASIS, V79, P762; Healey JF, 2007, J THROMB HAEMOST, V5, P512, DOI 10.1111/j.1538-7836.2007.02373.x; Jacquemin MG, 1998, BLOOD, V92, P496, DOI 10.1182/blood.V92.2.496.414k16_496_506; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Kessel C, 2009, CHEMMEDCHEM, V4, P1364, DOI 10.1002/cmdc.200900023; Kuwabara I, 1999, J IMMUNOL METHODS, V224, P89, DOI 10.1016/S0022-1759(99)00012-5; Lewis DA, 2003, THROMB HAEMOSTASIS, V89, P795, DOI 10.1055/s-0037-1613464; Liu ML, 1998, BRIT J HAEMATOL, V103, P1051, DOI 10.1046/j.1365-2141.1998.01122.x; LUBIN IM, 1994, J BIOL CHEM, V269, P8639; Lusher JM, 2003, HAEMOPHILIA, V9, P38, DOI 10.1046/j.1365-2516.2003.00708.x; LUSHER JM, 1993, NEW ENGL J MED, V328, P453, DOI 10.1056/NEJM199302183280701; Meeks SL, 2008, BLOOD, V112, P1151, DOI 10.1182/blood-2008-01-132639; Meeks SL, 2007, BLOOD, V110, P4234, DOI 10.1182/blood-2007-06-096842; Nguyen PCT, 2014, BLOOD, V123, P2732, DOI 10.1182/blood-2013-09-527275; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Parker ET, 2004, BLOOD, V104, P704, DOI 10.1182/blood-2003-11-3891; Pearce KH, 1997, J BIOL CHEM, V272, P20595, DOI 10.1074/jbc.272.33.20595; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Pratt KP, 2004, THROMB HAEMOSTASIS, V92, P522, DOI 10.1160/TH03-12-0755; Qian JJ, 1999, THROMB HAEMOSTASIS, V81, P240, DOI 10.1055/s-0037-1614450; Roos H, 1998, J MOL RECOGNIT, V11, P204, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<204::AID-JMR424>3.0.CO;2-T; SAENKO EL, 1995, J BIOL CHEM, V270, P13826, DOI 10.1074/jbc.270.23.13826; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Sandberg H, 2012, THROMB RES, V130, P808, DOI 10.1016/j.thromres.2012.08.311; SCANDELLA D, 1995, BLOOD, V86, P1811, DOI 10.1182/blood.V86.5.1811.bloodjournal8651811; Sevy AM, 2013, J THROMB HAEMOST, V11, P2128, DOI 10.1111/jth.12433; SHIMA M, 1991, INT J HEMATOL, V54, P515; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Takeshima K, 2003, THROMB HAEMOSTASIS, V89, P788, DOI 10.1055/s-0037-1613463; Thompson AR, 2003, SEMIN THROMB HEMOST, V29, P11, DOI 10.1055/s-2003-37935; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; VANCOTT TC, 1994, J IMMUNOL, V153, P449; Voorberg J, 2000, SEMIN THROMB HEMOST, V26, P143, DOI 10.1055/s-2000-9816; Walter JD, 2013, BLOOD, V122, P4270, DOI 10.1182/blood-2013-08-519124; Walter JD, 2013, J BIOL CHEM, V288, P9905, DOI 10.1074/jbc.M112.424564; Wu HY, 2001, THROMB HAEMOSTASIS, V85, P125, DOI 10.1055/s-0037-1612915	54	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116577	10.1371/journal.pone.0116577	http://dx.doi.org/10.1371/journal.pone.0116577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615825	Green Submitted, Green Published, gold			2022-12-27	WOS:000349122100034
J	Yao, YW; Chen, PR; Li, S; Wang, LJ; Zhang, JT; Yip, SW; Chen, G; Deng, LY; Liu, QX; Fang, XY				Yao, Yuan-Wei; Chen, Pin-Ru; Li, Song; Wang, Ling-Jiao; Zhang, Jin-Tao; Yip, Sarah W.; Chen, Gang; Deng, Lin-Yuan; Liu, Qin-Xue; Fang, Xiao-Yi			Decision-Making for Risky Gains and Losses among College Students with Internet Gaming Disorder	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; ADDICTION; SENSITIVITY; ACTIVATION; DEFICITS; ALCOHOL; REWARD; INDIVIDUALS; PUNISHMENT; DEPENDENCE	Individuals with Internet gaming disorder (IGD) tend to exhibit disadvantageous risky decision-making not only in their real life but also in laboratory tasks. Decision-making is a complex multifaceted function and different cognitive processes are involved in decision-making for gains and losses. However, the relationship between impaired decision-making and gain versus loss processing in the context of IGD is poorly understood. The main aim of the present study was to separately evaluate decision-making for risky gains and losses among college students with IGD using the Cups task. Additionally, we further examined the effects of outcome magnitude and probability level on decision-making related to risky gains and losses respectively. Sixty college students with IGD and 42 matched healthy controls (HCs) participated. Results indicated that IGD subjects exhibited generally greater risk taking tendencies than HCs. In comparison to HCs, IGD subjects made more disadvantageous risky choices in the loss domain (but not in the gain domain). Follow-up analyses indicated that the impairment was associated to insensitivity to changes in outcome magnitude and probability level for risky losses among IGD subjects. In addition, higher Internet addiction severity scores were associated with percentage of disadvantageous risky options in the loss domain. These findings emphasize the effect of insensitivity to losses on disadvantageous decisions under risk in the context of IGD, which has implications for future intervention studies.	[Yao, Yuan-Wei; Chen, Pin-Ru] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Li, Song] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Wang, Ling-Jiao; Zhang, Jin-Tao; Fang, Xiao-Yi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Wang, Ling-Jiao; Zhang, Jin-Tao; Fang, Xiao-Yi] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Zhang, Jin-Tao] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China; [Yip, Sarah W.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Chen, Gang] NIMH, Sci & Stat Comp Core, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Deng, Lin-Yuan] Beijing Normal Univ, Fac Educ, Beijing 100875, Peoples R China; [Liu, Qin-Xue] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Liu, Qin-Xue] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China; [Fang, Xiao-Yi] Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China; [Fang, Xiao-Yi] Tianjin Normal Univ, Acad Psychol & Behav, Tianjin, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Beijing Normal University; Central China Normal University; Beijing Normal University; Tianjin Normal University	Zhang, JT (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zhangjintao@bnu.edu.cn; fangxy@bnu.edu.cn	Yao, Yuan-Wei/J-7368-2019; Yip, Sarah/W-4329-2019	Yao, Yuan-Wei/0000-0002-9635-7826; 	National Natural Science Foundation of China [31170990, 81100992]; fundamental research funds for the central universities [2012WYB01]; National Innovative Foundation Programs for College Students of China [201310027028]; NIDA [T32 DA007238-23]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007238] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); fundamental research funds for the central universities(Fundamental Research Funds for the Central Universities); National Innovative Foundation Programs for College Students of China; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Natural Science Foundation of China (No. 31170990 and No. 81100992), the fundamental research funds for the central universities (No. 2012WYB01), and the National Innovative Foundation Programs for College Students of China (No. 201310027028). SWY received salary support from the grant from NIDA (T32 DA007238-23). The funders had no role in the study design, collection and analysis of the data, or preparation of the manuscript.	[Anonymous], 2013, DIAGN STAT MAN MENT; Balodis IM, 2012, BIOL PSYCHIAT, V71, P749, DOI 10.1016/j.biopsych.2012.01.006; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Brand M, 2008, DRUG ALCOHOL DEPEN, V97, P64, DOI 10.1016/j.drugalcdep.2008.03.017; Brevers D, 2014, ALCOHOL CLIN EXP RES, V38, P1924, DOI 10.1111/acer.12447; Brevers D, 2012, PSYCHIAT RES, V200, P568, DOI 10.1016/j.psychres.2012.03.053; Chen SH, 2003, CHINESE J PSYCHOL, V45, P279, DOI [DOI 10.1037/T44491-000, 10.1037/t44491-000]; Chou C, 2005, EDUC PSYCHOL REV, V17, P363, DOI 10.1007/s10648-005-8138-1; Dalbudak E, 2013, PSYCHIAT RES, V210, P1086, DOI 10.1016/j.psychres.2013.08.014; Dong GH, 2013, BIOL PSYCHOL, V94, P282, DOI 10.1016/j.biopsycho.2013.07.009; Dong GH, 2013, PROG NEURO-PSYCHOPH, V46, P139, DOI 10.1016/j.pnpbp.2013.07.007; Dong GH, 2011, J PSYCHIATR RES, V45, P1525, DOI 10.1016/j.jpsychires.2011.06.017; Ersche KD, 2005, NEUROPSYCHOPHARMACOL, V30, P2115, DOI 10.1038/sj.npp.1300812; Fujiwara J, 2009, J NEUROPHYSIOL, V101, P3284, DOI 10.1152/jn.90909.2008; Gilpin NW, 2012, NEUROSCI BIOBEHAV R, V36, P873, DOI 10.1016/j.neubiorev.2011.11.002; Gowin JL, 2014, ADDICTION, V109, P237, DOI 10.1111/add.12354; Gradin VB, 2014, NEUROPSYCHOPHARMACOL, V39, P885, DOI 10.1038/npp.2013.289; Jasper JD, 2013, J BEHAV DECIS MAKING, V26, P164, DOI 10.1002/bdm.1748; Kim SM, 2014, DRUG ALCOHOL DEPEN, V141, P124, DOI 10.1016/j.drugalcdep.2014.05.017; King DL, 2014, CLIN PSYCHOL REV, V34, P298, DOI 10.1016/j.cpr.2014.03.006; Ko CH, 2014, J PSYCHIATR RES, V53, P103, DOI 10.1016/j.jpsychires.2014.02.008; Ko CH, 2010, PSYCHIAT RES, V175, P121, DOI 10.1016/j.psychres.2008.10.004; Ko CH, 2009, COMPR PSYCHIAT, V50, P378, DOI 10.1016/j.comppsych.2007.05.019; Levin I. P., 2011, FRONTIERS NEUROSCIEN, V6, P15, DOI DOI 10.3389/FNINS; Lin X, 2015, PROG NEURO-PSYCHOPH, V56, P142, DOI 10.1016/j.pnpbp.2014.08.016; Lucantonio F, 2012, NAT NEUROSCI, V15, P358, DOI 10.1038/nn.3014; Mak KK, 2014, J ABNORM CHILD PSYCH, V42, P1237, DOI 10.1007/s10802-014-9851-3; Monterosso J, 2001, ADDICTION, V96, P1825, DOI 10.1046/j.1360-0443.2001.9612182512.x; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Noel X, 2013, CURR OPIN NEUROBIOL, V23, P632, DOI 10.1016/j.conb.2013.01.018; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Pawlikowski M, 2011, PSYCHIAT RES, V188, P428, DOI 10.1016/j.psychres.2011.05.017; Petry NM, 2014, ADDICTION, V109, P1399, DOI 10.1111/add.12457; Robbins TW, 2015, CURR OPIN NEUROBIOL, V30, P66, DOI 10.1016/j.conb.2014.09.005; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Samanez-Larkin GR, 2008, PSYCHOL SCI, V19, P320, DOI 10.1111/j.1467-9280.2008.02087.x; Sescousse G, 2013, BRAIN, V136, P2527, DOI 10.1093/brain/awt126; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Sun DL, 2009, CNS SPECTRUMS, V14, P75, DOI 10.1017/S1092852900000225; Svaldi J, 2010, APPETITE, V54, P84, DOI 10.1016/j.appet.2009.09.010; Tang J, 2014, ADDICT BEHAV, V39, P744, DOI 10.1016/j.addbeh.2013.12.010; Tao R, 2010, ADDICTION, V105, P556, DOI 10.1111/j.1360-0443.2009.02828.x; Weller JA, 2007, PSYCHOL SCI, V18, P958, DOI 10.1111/j.1467-9280.2007.02009.x; Weller JA, 2013, CHILD MALTREATMENT, V18, P184, DOI 10.1177/1077559512467846; Wesley MJ, 2011, PSYCHIAT RES-NEUROIM, V191, P51, DOI 10.1016/j.pscychresns.2010.10.002; [徐四华 Xu Sihua], 2012, [心理学报, Acta Psychologica Sinica], V44, P1523; Yao YW, 2014, PSYCHIAT RES, V219, P583, DOI 10.1016/j.psychres.2014.06.033; Yip SW, 2014, DRUG ALCOHOL DEPEN, V140, P33, DOI 10.1016/j.drugalcdep.2014.03.031	50	58	63	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116471	10.1371/journal.pone.0116471	http://dx.doi.org/10.1371/journal.pone.0116471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25615595	Green Submitted, Green Published, gold			2022-12-27	WOS:000349122100028
J	Essinger, SD; Reichenberger, E; Morrison, C; Blackwood, CB; Rosen, GL				Essinger, Steven D.; Reichenberger, Erin; Morrison, Calvin; Blackwood, Christopher B.; Rosen, Gail L.			A Toolkit for ARB to Integrate Custom Databases and Externally Built Phylogenies	PLOS ONE			English	Article							SEQUENCE ALIGNMENT	Researchers are perpetually amassing biological sequence data. The computational approaches employed by ecologists for organizing this data (e.g . alignment, phylogeny, etc.) typically scale nonlinearly in execution time with the size of the dataset. This often serves as a bottleneck for processing experimental data since many molecular studies are characterized by massive datasets. To keep up with experimental data demands, ecologists are forced to choose between continually upgrading expensive in-house computer hardware or outsourcing the most demanding computations to the cloud. Outsourcing is attractive since it is the least expensive option, but does not necessarily allow direct user interaction with the data for exploratory analysis. Desktop analytical tools such as ARB are indispensable for this purpose, but they do not necessarily offer a convenient solution for the coordination and integration of datasets between local and outsourced destinations. Therefore, researchers are currently left with an undesirable tradeoff between computational throughput and analytical capability. To mitigate this tradeoff we introduce a software package to leverage the utility of the interactive exploratory tools offered by ARB with the computational throughput of cloud-based resources. Our pipeline serves as middleware between the desktop and the cloud allowing researchers to form local custom databases containing sequences and metadata from multiple resources and a method for linking data outsourced for computation back to the local database. A tutorial implementation of the toolkit is provided in the supporting information,	[Essinger, Steven D.; Morrison, Calvin; Rosen, Gail L.] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA; [Reichenberger, Erin] Drexel Univ, Dept Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Blackwood, Christopher B.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	Drexel University; Drexel University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Rosen, GL (corresponding author), Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA.	gailr@ece.drexel.edu	Blackwood, Christopher/B-3839-2010	Blackwood, Christopher/0000-0001-5764-6978; Rosen, Gail/0000-0003-1763-5750	Department of Energy [DE-SC0004335]	Department of Energy(United States Department of Energy (DOE))	This work was supported by Department of Energy Grant DE-SC0004335. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biomatters Limited, 2014, GEN VERS 6 1; Derbyshire MK, 2012, ANNOTATION FUNCTIONA; Fusaro VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002147; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller M, 2009, CIPRES; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	19	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0109277	10.1371/journal.pone.0109277	http://dx.doi.org/10.1371/journal.pone.0109277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607539	gold, Green Published, Green Submitted			2022-12-27	WOS:000348205300001
J	Yassine, HN; Trenchevska, O; He, HJ; Borges, CR; Nedelkov, D; Mack, W; Kono, N; Koska, J; Reaven, PD; Nelson, RW				Yassine, Hussein N.; Trenchevska, Olgica; He, Huijuan; Borges, Chad R.; Nedelkov, Dobrin; Mack, Wendy; Kono, Naoko; Koska, Juraj; Reaven, Peter D.; Nelson, Randall W.			Serum Amyloid A Truncations in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							ACUTE-PHASE PROTEIN; A-PROTEIN; MASS-SPECTROMETRY; ISOFORMS; APOLIPOPROTEIN; PLASMA; SAA; CHOLESTEROL; BIOMARKERS; VARIANTS	Serum Amyloid A (SAA) is an acute phase protein complex consisting of several abundant isoforms. The N-terminus of SAA is critical to its function in amyloid formation. SAA is frequently truncated, either missing an arginine or an arginine-serine dipeptide, resulting in isoforms that may influence the capacity to form amyloid. However, the relative abundance of truncated SAA in diabetes and chronic kidney disease is not known. Methods Using mass spectrometric immunoassay, the abundance of SAA truncations relative to the native variants was examined in plasma of 91 participants with type 2 diabetes and chronic kidney disease and 69 participants without diabetes. Results The ratio of SAA 1.1 (missing N-terminal arginine) to native SAA 1.1 was lower in diabetics compared to non-diabetics (p = 0.004), and in males compared to females (p<0.001). This ratio was negatively correlated with glycated hemoglobin (r = -0.32, p<0.001) and triglyceride concentrations (r = -0.37, p<0.001), and positively correlated with HDL cholesterol concentrations (r = 0.32, p<0.001). Conclusion The relative abundance of the N-terminal arginine truncation of SAA1.1 is significantly decreased in diabetes and negatively correlates with measures of glycemic and lipid control.	[Yassine, Hussein N.; He, Huijuan; Mack, Wendy; Kono, Naoko] Univ So Calif, Los Angeles, CA 90045 USA; [Trenchevska, Olgica; Borges, Chad R.; Nedelkov, Dobrin; Nelson, Randall W.] Arizona State Univ, Tempe, AZ USA; [Koska, Juraj; Reaven, Peter D.] Phoenix VA Hlth Care Syst, Phoenix, AZ USA	University of Southern California; Arizona State University; Arizona State University-Tempe	Yassine, HN (corresponding author), Univ So Calif, Los Angeles, CA 90045 USA.	hyassine@usc.edu	Nedelkov, Dobrin/I-3603-2013		National Institute of Diabetes And Digestive and Kidney Diseases [R01DK082542, R24DK090958]; National Center for Research Resources [UL1RR031986];  [K23HL107389];  [AHA12CRP11750017];  [USC CTSI pilot UL1TR000130]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL107389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090958, R01DK082542] Funding Source: NIH RePORTER	National Institute of Diabetes And Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Yassine was supported by K23HL107389, AHA12CRP11750017 and USC CTSI pilot UL1TR000130. This work was supported by Awards R01DK082542 and R24DK090958 from the National Institute of Diabetes And Digestive and Kidney Diseases. Research reported in this publication was also partially supported by the National Center for Advancing Translational Sciences (http://www.ncats.nih.gov/) of the National Institutes of Health under Award Number UL1TR000130 (formerly by the National Center for Research Resources, Award Number UL1RR031986).	Avgerinos ED, 2011, INT J STROKE, V6, P337, DOI 10.1111/j.1747-4949.2011.00623.x; BEACH CM, 1992, BIOCHEM J, V282, P615, DOI 10.1042/bj2820615; CABANA VG, 1989, J LIPID RES, V30, P39; Cunnane G, 2001, CURR OPIN RHEUMATOL, V13, P67, DOI 10.1097/00002281-200101000-00011; Ducret A, 1996, ELECTROPHORESIS, V17, P866, DOI 10.1002/elps.1150170508; DWULET FE, 1988, BIOCHEMISTRY-US, V27, P1677, DOI 10.1021/bi00405a044; Egashira M, 2011, ARCH BIOCHEM BIOPHYS, V511, P101, DOI 10.1016/j.abb.2011.04.019; ELLIOTT B, 1998, SCANDINAVIAN J IMMUN, V48, P241, DOI DOI 10.1046/J.1365-3083.1998.00384.X; Farwig ZN, 2005, BIOCHEM BIOPH RES CO, V332, P352, DOI 10.1016/j.bbrc.2005.04.129; Gershoni-Baruch R, 2003, J RHEUMATOL, V30, P308; GORDON JI, 1986, CRC CR REV BIOCH MOL, V20, P37, DOI 10.3109/10409238609115900; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Kiernan UA, 2003, FEBS LETT, V537, P166, DOI 10.1016/S0014-5793(03)00097-8; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LIANG JS, 1995, J LIPID RES, V36, P37; Malik P, 2011, J LIPID RES, V52, P951, DOI 10.1194/jlr.M011122; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; MALLE E, 1993, ATHEROSCLEROSIS, V102, P131, DOI 10.1016/0021-9150(93)90155-N; Nelson RW, 2011, J AM SOC MASS SPECTR, V22, P960, DOI 10.1007/s13361-011-0094-z; NELSON RW, 1995, ANAL CHEM, V67, P1153, DOI 10.1021/ac00103a003; ORCHARD TJ, 1990, DIABETES, V39, P1116, DOI 10.2337/diabetes.39.9.1116; RAYNES JG, 1991, SCAND J IMMUNOL, V33, P657, DOI 10.1111/j.1365-3083.1991.tb02538.x; Ristori G, 1998, J NEUROIMMUNOL, V88, P9, DOI 10.1016/S0165-5728(98)00037-X; SKOGEN B, 1981, SCAND J IMMUNOL, V14, P389, DOI 10.1111/j.1365-3083.1981.tb00579.x; STEINKASSERER A, 1990, BIOCHEM J, V268, P187, DOI 10.1042/bj2680187; STRACHAN AF, 1989, J BIOL CHEM, V264, P18368; Sung HJ, 2012, J PROTEOMICS, V75, P2170, DOI 10.1016/j.jprot.2012.01.018; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; Tolle M, 2012, CARDIOVASC RES, V94, P154, DOI 10.1093/cvr/cvs089; Tolson J, 2004, LAB INVEST, V84, P845, DOI 10.1038/labinvest.3700097; Tsun JGS, 2013, ATHEROSCLEROSIS, V231, P405, DOI 10.1016/j.atherosclerosis.2013.10.008; Tumblin A, 2010, HAEMATOL-HEMATOL J, V95, P1467, DOI 10.3324/haematol.2009.018044; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; WESTERMARK GT, 1992, BIOCHEM BIOPH RES CO, V182, P27, DOI 10.1016/S0006-291X(05)80107-X; Zhao YL, 2010, INFLAMM RES, V59, P323, DOI 10.1007/s00011-010-0163-y	37	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115320	10.1371/journal.pone.0115320	http://dx.doi.org/10.1371/journal.pone.0115320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607823	Green Published, Green Submitted, gold			2022-12-27	WOS:000348205300012
J	Correia, M; Snabe, T; Thiagarajan, V; Petersen, SB; Campos, SRR; Baptista, AM; Neves-Petersen, MT				Correia, Manuel; Snabe, Torben; Thiagarajan, Viruthachalam; Petersen, Steffen Bjorn; Campos, Sara R. R.; Baptista, Antonio M.; Neves-Petersen, Maria Teresa			Photonic Activation of Plasminogen Induced by Low Dose UVB	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; EXCITED-STATE CHEMISTRY; AROMATIC-AMINO-ACIDS; CRYSTAL-STRUCTURE; DECAY KINETICS; FLUORESCENCE CHARACTERISTICS; N-FORMYLKYNURENINE; SULFHYDRYL-GROUPS; DISULFIDE BONDS	Activation of plasminogen to its active form plasmin is essential for several key mechanisms, including the dissolution of blood clots. Activation occurs naturally via enzymatic proteolysis. We report that activation can be achieved with 280 nm light. A 2.6 fold increase in proteolytic activity was observed after 10 min illumination of human plasminogen. Irradiance levels used are in the same order of magnitude of the UVB solar irradiance. Activation is correlated with light induced disruption of disulphide bridges upon UVB excitation of the aromatic residues and with the formation of photochemical products, e.g. dityrosine and N-formylkynurenine. Most of the protein fold is maintained after 10 min illumination since no major changes are observed in the near-UV CD spectrum. Far-UV CD shows loss of secondary structure after illumination (33.4% signal loss at 206 nm). Thermal unfolding CD studies show that plasminogen retains a native like cooperative transition at similar to 70 degrees C after UV-illumination. We propose that UVB activation of plasminogen occurs upon photocleavage of a functional allosteric disulphide bond, Cys737-Cys765, located in the catalytic domain and in van der Waals contact with Trp761 (4.3 angstrom). Such proximity makes its disruption very likely, which may occur upon electron transfer from excited Trp761. Reduction of Cys737-Cys765 will result in likely conformational changes in the catalytic site. Molecular dynamics simulations reveal that reduction of Cys737-Cys765 in plasminogen leads to an increase of the fluctuations of loop 760-765, the S1-entrance frame located close to the active site. These fluctuations affect the range of solvent exposure of the catalytic triad, particularly of Asp646 and Ser74, which acquire an exposure profile similar to the values in plasmin. The presented photonic mechanism of plasminogen activation has the potential to be used in clinical applications, possibly together with other enzymatic treatments for the elimination of blood clots.	[Correia, Manuel; Snabe, Torben] Aalborg Univ, Dept Phys & Nanotechnol, Aalborg, Denmark; [Thiagarajan, Viruthachalam; Petersen, Steffen Bjorn; Neves-Petersen, Maria Teresa] Int Iberian Nanotechnol Lab INL, Dept Nanomed, BioPhoton Grp, Braga, Portugal; [Thiagarajan, Viruthachalam] Bharathidasan Univ, Sch Chem, Tiruchirappalli, Tamil Nadu, India; [Petersen, Steffen Bjorn] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Petersen, Steffen Bjorn] SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA; [Campos, Sara R. R.; Baptista, Antonio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal	Aalborg University; International Iberian Nanotechnology Laboratory; Bharathidasan University; Aalborg University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Universidade Nova de Lisboa	Neves-Petersen, MT (corresponding author), Int Iberian Nanotechnol Lab INL, Dept Nanomed, BioPhoton Grp, Braga, Portugal.	nevespetersen@gmail.com	Viruthachalam, Thiagarajan/I-2503-2013; Campos, Sara R. R./C-7550-2012; Petersen, Steffen b/E-8727-2015; INL, Citations/K-3436-2015; Baptista, Antonio M./C-7246-2012	Campos, Sara R. R./0000-0003-1020-6830; Petersen, Steffen b/0000-0002-0739-2751; INL, Citations/0000-0002-3745-5100; Baptista, Antonio M./0000-0002-7044-1210; Thiagarajan, Viruthachalam/0000-0003-4197-2255; Neves-Petersen, Maria Teresa/0000-0003-3178-3709; Correia, Manuel/0000-0001-7619-2780	"Fundacao para a Ciencia e Tecnologia" (FCT) [SFRH/BD/61012/2009]; "Programa Operacional Potencial Humano" (POPH); European Social Fund ("Fundo Social Europeu", FSE)	"Fundacao para a Ciencia e Tecnologia" (FCT)(Portuguese Foundation for Science and Technology); "Programa Operacional Potencial Humano" (POPH); European Social Fund ("Fundo Social Europeu", FSE)(European Social Fund (ESF))	MC acknowledges the support from "Fundacao para a Ciencia e Tecnologia" (FCT) for the PhD grant (SFRH/BD/61012/2009) supported by "Programa Operacional Potencial Humano" (POPH) in the framework of "Quadro de Referencia Estrategico Nacional" (QREN) and co-financed by the European Social Fund ("Fundo Social Europeu", FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACH R, 1976, BIOCHIM BIOPHYS ACTA, V439, P292, DOI 10.1016/0005-2795(76)90064-7; BENT DV, 1975, J AM CHEM SOC, V97, P2599, DOI 10.1021/ja00843a002; BENT DV, 1975, J AM CHEM SOC, V97, P2612, DOI 10.1021/ja00843a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bhushan B., 2007, SPRINGER HDB NANOTEC; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Chen VM, 2006, J THROMB HAEMOST, V4, P2533, DOI 10.1111/j.1538-7836.2006.02236.x; Chen VM, 2006, BIOCHEMISTRY-US, V45, P12020, DOI 10.1021/bi061271a; Christ G, 1999, J THROMB THROMBOLYS, V7, P277, DOI 10.1023/A:1008983110941; Collen D, 2001, Hematology Am Soc Hematol Educ Program, P1; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Correia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050733; Correia M, 2012, J FLUORESC, V22, P323, DOI 10.1007/s10895-011-0963-7; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P563; D'Costa SS, 1998, MICROB PATHOGENESIS, V24, P341, DOI 10.1006/mpat.1998.0207; Duroux M, 2007, PROTEOMICS, V7, P3491, DOI 10.1002/pmic.200700472; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fasman G.D., 1976, HDB BIOCH MOL BIOL P, V1; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; FUKUNAGA Y, 1982, J BIOCHEM-TOKYO, V92, P129, DOI 10.1093/oxfordjournals.jbchem.a133909; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HAN MK, 1990, J BIOL CHEM, V265, P1985; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOFFMAN MZ, 1972, J AM CHEM SOC, V94, P7950, DOI 10.1021/ja00778a002; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Homchaudhuri L, 2001, CHEM LETT, P844; Jacob JS, 1996, J BIOL CHEM, V271, P19950, DOI 10.1074/jbc.271.33.19950; Janes RW, 2009, MODERN TECHNIQUES CI; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Klitgaard S, 2006, J FLUORESC, V16, P595, DOI 10.1007/s10895-006-0081-0; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LEHRER SS, 1967, BIOCHEMISTRY-US, V6, P757, DOI 10.1021/bi00855a017; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Linde V, 1998, EUR J BIOCHEM, V251, P472, DOI 10.1046/j.1432-1327.1998.2510472.x; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lousa D, 2013, PHYS CHEM CHEM PHYS, V15, P13723, DOI 10.1039/c3cp51761f; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; MALENCIK DA, 1991, BIOCHEM BIOPH RES CO, V178, P60, DOI 10.1016/0006-291X(91)91779-C; MALENCIK DA, 1987, BIOCHEMISTRY-US, V26, P695, DOI 10.1021/bi00377a006; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; McCormick ML, 1998, J BIOL CHEM, V273, P32030, DOI 10.1074/jbc.273.48.32030; MILES LA, 1988, J BIOL CHEM, V263, P11928; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Moan J., 2001, RAD HOME OUTDOORS WO, P69; Neves-Petersen MT, 2009, BIOPHYS J, V97, P211, DOI 10.1016/j.bpj.2009.01.065; Neves-Petersen MT, 2006, PROTEIN SCI, V15, P343, DOI 10.1110/ps.051885306; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Novokhatny V, 2008, THROMB RES, V122, pS3, DOI 10.1016/j.thromres.2008.06.018; Parracino A, 2011, BIOTECHNOL BIOENG, V108, P999, DOI 10.1002/bit.23015; Parracino A, 2010, PROTEIN SCI, V19, P1751, DOI 10.1002/pro.461; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; Peisach E, 1999, BIOCHEMISTRY-US, V38, P11180, DOI 10.1021/bi991130r; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; PIRIE A, 1971, BIOCHEM J, V125, P203, DOI 10.1042/bj1250203; PIRIE A, 1972, BIOCHEM J, V128, P1365, DOI 10.1042/bj1281365; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Schaller J, 2011, CELL MOL LIFE SCI, V68, P785, DOI 10.1007/s00018-010-0566-5; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sionkowska A, 2006, J PHOTOCH PHOTOBIO B, V85, P79, DOI 10.1016/j.jphotobiol.2006.05.005; Skovsen E, 2009, PROTEOMICS, V9, P3945, DOI 10.1002/pmic.200800960; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SUENSON E, 1981, BIOCHEM J, V197, P619, DOI 10.1042/bj1970619; TEW D, 1988, J BIOL CHEM, V263, P17880; URANO T, 1987, J BIOL CHEM, V262, P15959; URANO T, 1987, P NATL ACAD SCI USA, V84, P4031, DOI 10.1073/pnas.84.12.4031; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Webb AR, 2006, PHOTOCHEM PHOTOBIOL, V82, P1697, DOI 10.1562/2006-09-01-RA-670; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WILLIS KJ, 1991, J PHYS CHEM-US, V95, P1585, DOI 10.1021/j100157a015; WILSON JM, 1980, J AM CHEM SOC, V102, P359, DOI 10.1021/ja00521a058; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; World Health Organization, KNOWL HLTH EFF UV; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x	83	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116737	10.1371/journal.pone.0116737	http://dx.doi.org/10.1371/journal.pone.0116737			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635856	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700055
J	Gossner, MM; Brandle, M; Brandl, R; Bail, J; Muller, J; Opgenoorth, L				Gossner, Martin M.; Braendle, Martin; Brandl, Roland; Bail, Johannes; Mueller, Joerg; Opgenoorth, Lars			Where Is the Extended Phenotype in the Wild? The Community Composition of Arthropods on Mature Oak Trees Does Not Depend on the Oak Genotype	PLOS ONE			English	Article							GENETIC-VARIATION; PLANT HYBRIDIZATION; ECOSYSTEM GENETICS; BETA-DIVERSITY; CONSEQUENCES; DETERMINANTS; CONSERVATISM; LINEAGES; INSECTS	Through a series of common garden experiments, it has been shown that heritable phenotypic differences between individual trees can affect arthropod communities. However, field studies under heterogeneous environmental conditions remain rare. In the present study, we investigated the genetic constitution of 121 mature oak host trees at different trophic levels from 10 sites across Bavaria, southern Germany and their associated insect communities. A total of 23,576 individuals representing 395 species of beetles and true bugs were evaluated. In particular, we determined whether the composition of arthropod communities is related to the oak genotype and whether the strength of the relationships decreases from lower to higher trophic levels, such as for phytophagous, xylophagous, zoophagous, and mycetophagous species. The genetic differentiation of oaks was assessed using eight microsatellite markers. We found no significant influence of the oak genotype on neither the full beetle and true bug community nor on any of the analyzed trophic guilds. In contrast, the community composition of the insects was highly related to the space and climate, such that the community similarity decreased with increases in spatial distance and climatic differences. The relationship with space and climate was much stronger in beetles than in true bugs, particularly in mycetophagous species. Our results suggest that spatial processes override the genetic effects of the host plant in structuring arthropod communities on oak trees. Because we used neutral markers, we cannot exclude the possibility that trait-specific markers may reveal a genetic imprint of the foundation tree species on the composition of the arthropod community. However, based on the strength of the spatial patterns in our data set, we assume that genetic differences among oaks are less important in the structuring of arthropod communities. Future whole-genome studies are required to draw a final conclusion.	[Gossner, Martin M.; Mueller, Joerg] Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, D-85354 Freising Weihenstephan, Germany; [Braendle, Martin; Brandl, Roland; Opgenoorth, Lars] Univ Marburg, Dept Ecol, D-35043 Marburg, Germany; [Bail, Johannes] Univ Erlangen Nurnberg, D-91058 Erlangen, Germany; [Mueller, Joerg] Bavarian Forest Natl Pk, D-94481 Grafenau, Germany	Technical University of Munich; Philipps University Marburg; University of Erlangen Nuremberg	Gossner, MM (corresponding author), Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Hans Carl Von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany.	martin.gossner@tum.de; opgenoorth@uni-marburg.de	Opgenoorth, Lars/C-9624-2018; Gossner, Martin M./J-2730-2015	Gossner, Martin M./0000-0003-1516-6364; Opgenoorth, Lars/0000-0003-0737-047X; Muller, Jorg/0000-0002-1409-1586	Federal Ministry of Education, Science, Research and Technology, Germany [0339735/8]; Bavarian Forest Service [L49, L51]; German Research Foundation DFG (Biodiversity Exploratories) [WE 3081/21-1]	Federal Ministry of Education, Science, Research and Technology, Germany; Bavarian Forest Service; German Research Foundation DFG (Biodiversity Exploratories)(German Research Foundation (DFG))	The field experimental work was financed by grants of the Federal Ministry of Education, Science, Research and Technology, Germany ('Zukunftsorientierte Waldwirtschaft', project-no. 0339735/8) and the 'Bavarian Forest Service' (project no. L49 and L51). The genetic analysis was paid for by internal university funds of RB and LO. MG is supported by the German Research Foundation DFG (Biodiversity Exploratories, WE 3081/21-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacilieri R, 1996, EVOLUTION, V50, P900, DOI 10.1111/j.1558-5646.1996.tb03898.x; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bailey R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000179; Bangert RK, 2008, HEREDITY, V100, P121, DOI 10.1038/sj.hdy.6800914; Bangert RK, 2006, MOL ECOL, V15, P4215, DOI 10.1111/j.1365-294X.2006.03092.x; Bernhardsson C, 2013, ECOL LETT, V16, P791, DOI 10.1111/ele.12114; Bohme J, 2005, DIE KAFER MITTELEURO; Brandle M, 2006, OIKOS, V113, P296, DOI 10.1111/j.2006.0030-1299.14418.x; Brandle M, 2001, J ANIM ECOL, V70, P491, DOI 10.1046/j.1365-2656.2001.00506.x; Castagneyrol B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044247; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Crutsinger GM, 2008, OECOLOGIA, V158, P65, DOI 10.1007/s00442-008-1130-y; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Crutsinger GM, 2010, ECOLOGY, V91, P1237, DOI 10.1890/09-0613.1; Crutsinger GM, 2009, BASIC APPL ECOL, V10, P535, DOI 10.1016/j.baae.2008.10.011; Crutsinger GM, 2009, ECOL LETT, V12, P285, DOI 10.1111/j.1461-0248.2009.01288.x; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Double MC, 2001, EVOLUTION INT J ORG, V59; Eisenbach J, 1996, OECOLOGIA, V105, P258, DOI 10.1007/BF00328555; FRITZ RS, 1995, ECOL ENTOMOL, V20, P18, DOI 10.1111/j.1365-2311.1995.tb00424.x; FRITZ RS, 1988, ECOLOGY, V69, P845, DOI 10.2307/1941034; Gossner M., 2004, NEOBIOTA, V5, P1; Gossner MM, 2013, BIOL CONSERV, V166, P212, DOI 10.1016/j.biocon.2013.06.033; Gossner MM, 2009, AM NAT, V173, P599, DOI 10.1086/597603; GREENSTONE MH, 1984, OECOLOGIA, V62, P299, DOI 10.1007/BF00384260; Guichoux E, 2011, MOL ECOL RESOUR, V11, P578, DOI 10.1111/j.1755-0998.2011.02983.x; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Haloin JR, 2008, ANN NY ACAD SCI, V1133, P87, DOI 10.1196/annals.1438.003; Hochwender CG, 2004, OECOLOGIA, V138, P547, DOI 10.1007/s00442-003-1472-4; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Koch K, 1989, DIE KAFER MITTELEURO; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Mattila Anu, 1994, Silva Fennica, V28, P251; Nekola JC, 2001, J BIOGEOGRAPHY, V26; Peakall R, 2001, EVOLUTION INT J ORG, V57; PIMENTEL D, 1961, AM NAT, V95, P65, DOI 10.1086/282160; PRESZLER RW, 1994, OECOLOGIA, V100, P66, DOI 10.1007/BF00317131; Pritchard JK, 2001, GENETICS, V155; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037679; Simpson GG, 1943, AM J SCI, V241, P1, DOI 10.2475/ajs.241.1.1; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Southwood TRE, THE COMPOSITION OF T; Southwood TRE, 1961, JOURNAL OF ANIMAL EC, V30; Stone GN, 2009, EVOLUTION, V63, P854, DOI 10.1111/j.1558-5646.2008.00604.x; Tack AJM, 2012, ECOLOGY LETTERS; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tack AJM, 2011, ECOLOGY, V92, P1594, DOI 10.1890/10-2006.1; Tack AJM, 2010, ECOLOGY, V91, P2660, DOI 10.1890/09-1027.1; Vakkari P, 2006, GENETICA, V127, P231, DOI 10.1007/s10709-005-4014-7; Wachmann E., 2004, WANZEN; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitham TG, 2012, TRENDS PLANT SCI, V17, P271, DOI 10.1016/j.tplants.2012.01.005; Wimp GM, 2005, EVOLUTION, V59, P61, DOI 10.1111/j.0014-3820.2005.tb00894.x; Wimp GM, 2001, ECOLOGY, V82, P440, DOI 10.1890/0012-9658(2001)082[0440:BCOPAH]2.0.CO;2; Zytynska SE, 2011, PHILOS T R SOC B, V366, P1329, DOI 10.1098/rstb.2010.0183	62	8	8	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115733	10.1371/journal.pone.0115733	http://dx.doi.org/10.1371/journal.pone.0115733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635387	gold, Green Published, Green Submitted			2022-12-27	WOS:000350680700018
J	Holtappels, M; Noss, C; Hancke, K; Cathalot, C; McGinnis, DF; Lorke, A; Glud, RN				Holtappels, Moritz; Noss, Christian; Hancke, Kasper; Cathalot, Cecile; McGinnis, Daniel F.; Lorke, Andreas; Glud, Ronnie N.			Aquatic Eddy Correlation: Quantifying the Artificial Flux Caused by Stirring-Sensitive O-2 Sensors	PLOS ONE			English	Article							OXYGEN FLUXES; BENTHIC EXCHANGE; BOUNDARY-LAYER; SEDIMENTS; HETEROGENEITY; RATES; FLOW		[Holtappels, Moritz] Max Planck Inst Marine Microbiol, Biogeochem Grp, Bremen, Germany; [Holtappels, Moritz] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Noss, Christian; Lorke, Andreas] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Hancke, Kasper; Glud, Ronnie N.] Univ Southern Denmark, Inst Biol, Odense, Denmark; [Hancke, Kasper; Glud, Ronnie N.] Univ Southern Denmark, Nord Ctr Earth Evolut NordCEE, Odense, Denmark; [Cathalot, Cecile] Royal Netherland Inst Sea Res NIOZ, Yerseke, Netherlands; [McGinnis, Daniel F.] IGB Leibniz Inst Freshwater Ecol & Inland Fisheri, Expt Limnol, Berlin, Germany; [McGinnis, Daniel F.] Univ Geneva, Fac Sci, Inst FA Forel, Geneva, Switzerland; [Glud, Ronnie N.] Aarhus Univ, Arctic Res Ctr, Aarhus, Denmark; [Glud, Ronnie N.] Scottish Assoc Marine, Scottish Marine Inst, Oban, Argyll, Scotland; [Glud, Ronnie N.] Greenland Climate Res Ctr, Greenland Inst Nat Resources, Nuuk, Greenland	Max Planck Society; University of Bremen; University of Koblenz & Landau; University of Southern Denmark; University of Southern Denmark; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Geneva; Aarhus University; Greenland Institute of Natural Resources	Holtappels, M (corresponding author), Max Planck Inst Marine Microbiol, Biogeochem Grp, Bremen, Germany.	mholtapp@mpi-bremen.de	McGinnis, Daniel/G-1389-2011; Holtappels, Moritz/ABC-7901-2020; Lorke, Andreas/B-9195-2008	McGinnis, Daniel/0000-0002-6163-4299; Lorke, Andreas/0000-0001-5533-1817; Cathalot, Cecile/0000-0002-0868-7201; Holtappels, Moritz/0000-0003-3682-1903; Glud, Ronnie N./0000-0002-7069-893X	Max-Planck-Gesellschaft; DFG-Research Center/Cluster of Excellence "The Ocean in the Earth System" at the University of Bremen; European Union project; EC grant [226213]; Faculty of Science at the University of Southern Denmark; Danish Council for Independent Research [FNU-12-125843, DNRF53]; ERC Advanced Grants [ERC-2010-AdG-20100224]; Commission for Scientific Research in Greenland [GCRC6507]; Natural Environment Research Council [NE/F012691/1] Funding Source: researchfish; NERC [NE/F012691/1] Funding Source: UKRI	Max-Planck-Gesellschaft(Max Planck Society); DFG-Research Center/Cluster of Excellence "The Ocean in the Earth System" at the University of Bremen(German Research Foundation (DFG)); European Union project(European Commission); EC grant; Faculty of Science at the University of Southern Denmark; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); ERC Advanced Grants; Commission for Scientific Research in Greenland; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was funded by the Max-Planck-Gesellschaft (www.mpg.de), the DFG-Research Center/Cluster of Excellence "The Ocean in the Earth System" at the University of Bremen (http://www.marum.de), the European Union project "HYPOX - In situ monitoring of oxygen depletion in hypoxic ecosystems of coastal and open seas and land-locked water bodies," EC grant 226213 (http://ec.europa.eu/research/fp7). RNG, DFM and KH received financial support from the Faculty of Science at the University of Southern Denmark, the Danish Council for Independent Research (FNU-12-125843), The Danish Council for Independent Research (DNRF53), ERC Advanced Grants (ERC-2010-AdG-20100224), and The Commission for Scientific Research in Greenland (GCRC6507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Attard KM, 2014, LIMNOL OCEANOGR, V59, P1555, DOI 10.4319/lo.2014.59.5.1555; Berg P, 2003, MAR ECOL PROG SER, V261, P75, DOI 10.3354/meps261075; Berg P, 2013, LIMNOL OCEANOGR, V58, P1329, DOI 10.4319/lo.2013.58.4.1329; Berg P, 2009, LIMNOL OCEANOGR-METH, V7, P576, DOI 10.4319/lom.2009.7.576; Buffin-Belanger T, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004070; Chipman L, 2012, LIMNOL OCEANOGR-METH, V10, P304, DOI 10.4319/lom.2012.10.304; Donis D, 2014, J ATMOSPHERIC OCEANI, DOI [10.1175/JTECH-D-14-00089.1, DOI 10.1175/JTECH-D-14-000891]; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307, DOI 10.4319/lo.1992.37.6.1307; Glud R.N., 2000, SITU MONITORING AQUA SITU MONITORING AQUA, P19; GLUD RN, 1995, DEEP-SEA RES PT I, V42, P1029; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Glud RN, 2007, LIMNOL OCEANOGR, V52, P547, DOI 10.4319/lo.2007.52.2.0547; Glud RN, 2010, MAR ECOL PROG SER, V417, P1, DOI 10.3354/meps08795; Gundersen JK, 1998, LIMNOL OCEANOGR, V43, P1932; GUST G, 1987, NETH J SEA RES, V21, P255, DOI 10.1016/0077-7579(87)90001-9; Holtappels M, 2013, J GEOPHYS RES-OCEANS, V118, P1157, DOI 10.1002/jgrc.20112; Holtappels M, 2011, LIMNOL OCEANOGR-METH, V9, P1, DOI 10.4319/lom.2011.9.1; Holtappels M, 2011, LIMNOL OCEANOGR-METH, V9, P29, DOI 10.4319/lom.2011.9.29; Huettel M, 2014, ANNU REV MAR SCI, V6, P23, DOI 10.1146/annurev-marine-051413-012706; Hume AC, 2011, LIMNOL OCEANOGR, V56, P86, DOI 10.4319/lo.2011.56.1.0086; Kiorboe T, 2001, MAR ECOL PROG SER, V211, P1, DOI 10.3354/meps211001; Kreling J, 2014, LIMNOL OCEANOGR, V59, P1637, DOI 10.4319/lo.2014.59.5.1637; Li MZ, 1996, MAR GEOL, V130, P139, DOI 10.1016/0025-3227(95)00132-8; Long MH, 2012, BIOGEOSCIENCES, V9, P1957, DOI 10.5194/bg-9-1957-2012; Long MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058581; Lorke A, 2013, LIMNOL OCEANOGR-METH, V11, P425, DOI 10.4319/lom.2013.11.425; Lorke A, 2003, LIMNOL OCEANOGR, V48, P2077, DOI 10.4319/lo.2003.48.6.2077; Lorrai C, 2010, J ATMOS OCEAN TECH, V27, P1533, DOI 10.1175/2010JTECHO723.1; McGinnis DF, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032747; Murniati E, 2015, AQUAT SCI, V77, P183, DOI 10.1007/s00027-014-0362-7; RASMUSSEN H, 1992, MAR ECOL PROG SER, V81, P289, DOI 10.3354/meps081289; Reidenbach M.A., 2013, LIMNOL OCEANOGR FLUI, V3, P225, DOI 10.1215/21573689-2395266; REIMERS CE, 1986, NATURE, V320, P741, DOI 10.1038/320741a0; Reimers CE, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007564; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Rheuban JE, 2013, LIMNOL OCEANOGR-METH, V11, P351, DOI 10.4319/lom.2013.11.351; Rosman JH, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006892; Tennekes H., 1972, 1 COURSE TURBULENCE; Voulgaris G, 1998, J ATMOS OCEAN TECH, V15, P272, DOI 10.1175/1520-0426(1998)015<0272:EOTADV>2.0.CO;2	40	31	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116564	10.1371/journal.pone.0116564	http://dx.doi.org/10.1371/journal.pone.0116564			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635679	Green Published, gold			2022-12-27	WOS:000350680700043
J	Prasad, R; Hochmuth, GJ; Boote, KJ				Prasad, Rishi; Hochmuth, George J.; Boote, Kenneth J.			Estimation of Nitrogen Pools in Irrigated Potato Production on Sandy Soil Using the Model SUBSTOR	PLOS ONE			English	Article							NUTRIENT MANAGEMENT; CROPPING SYSTEM; NITRATE; FERTILIZER; YIELD; GROUNDWATER; BALANCE; CROPS; PREDICTION; IMPACTS	Recent increases in nitrate concentrations in the Suwannee River and associated springs in northern Florida have raised concerns over the contributions of non-point sources. The Middle Suwannee River Basin (MSRB) is of special concern because of prevalent karst topography, unconfined aquifers and sandy soils which increase vulnerability of the ground water contamination from agricultural operations-a billion dollar industry in this region. Potato (Solanum tuberosum L.) production poses a challenge in the area due to the shallow root system of potato plants, and low water and nutrient holding capacity of the sandy soils. A four-year monitoring study for potato production on sandy soil was conducted on a commercial farm located in the MSRB to identify major nitrogen (N) loss pathways and determine their contribution to the total environmental N load, using a partial N budget approach and the potato model SUBSTOR. Model simulated environmental N loading rates were found to lie within one standard deviation of the observed values and identified leaching loss of N as the major sink representing 25 to 38% (or 85 to 138 kg ha(-1) N) of the total input N (310 to 349 kg ha(-1) N). The crop residues left in the field after tuber harvest represented a significant amount of N (64 to 110 kg ha(-1) N) and posed potential for indirect leaching loss of N upon their mineralization and the absence of subsequent cover crops. Typically, two months of fallow period exits between harvest of tubers and planting of the fall row crop (silage corn). The fallow period is characterized by summer rains which pose a threat to N released from rapidly mineralizing potato vines. Strategies to reduce N loading into the groundwater from potato production must focus on development and adoption of best management practices aimed on reducing direct as well as indirect N leaching losses.	[Prasad, Rishi; Hochmuth, George J.] Univ Florida, Inst Food & Agr Sci, Dept Soil & Water Sci, Gainesville, FL 32611 USA; [Boote, Kenneth J.] Univ Florida, Inst Food & Agr Sci, Dept Agron, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Prasad, R (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Soil & Water Sci, Gainesville, FL 32611 USA.	rprasad3@ufl.edu		Boote, Kenneth/0000-0002-1358-5496	Florida Department of Agriculture and Consumer Services; Florida Department of Environmental Protection; Suwannee River Water Management District;  [015765]	Florida Department of Agriculture and Consumer Services; Florida Department of Environmental Protection; Suwannee River Water Management District; 	Funding was provided by Grant no: 015765. Funding agencies: Florida Department of Agriculture and Consumer Services, Florida Department of Environmental Protection, Suwannee River Water Management District. GH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdrabbo M.A.A., 2010, J APPL SCI RES, V6, P751; Albert MA, 2002, THESIS U FLORIDA GAI; [Anonymous], 2000, EOS, DOI [DOI 10.1029/00E000244, DOI 10.1029/00EO00244]; Basso B, 2011, SOIL SCI SOC AM J, V75, P69, DOI 10.2136/sssaj2010.0115; Bowen W., 1999, Impact on a changing world. International Potato Center Program Report 1997-1998., P381; Bundy LG, 2005, SOIL SCI SOC AM J, V69, P640, DOI 10.2136/sssaj2004.0216; Cheryl H., 2010, OPER RES INT J, V10, P247, DOI [DOI 10.1007/S12351-009-0059-1, 10.1007/s12351-009-0059-1]; Chintala R, 2014, ENV SCI POLLUT R; Chintala R, 2013, MICROPOR MESOPOR MAT, V179, P250, DOI 10.1016/j.micromeso.2013.05.023; Daccache A, 2011, AGR FOREST METEOROL, V151, P1641, DOI 10.1016/j.agrformet.2011.06.018; Errebhi M, 1998, AGRON J, V90, P10, DOI 10.2134/agronj1998.00021962009000010003x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Giletto CM, 2013, NUTR CYCL AGROECOSYS, V95, P73, DOI 10.1007/s10705-012-9549-2; HALL DW, 1993, WATER RESOUR BULL, V29, P55; Ham LK, 1996, 964037 US GEOL SURV; Hicks R., 2010, FLORIDA SPRINGS INIT; Hochmuth G J, 2000, IFAS STANDARDIZED FE; Hoogenboom G., 2012, DECISION SUPPORT SYS; Hornsby D, 2007, THESIS U FLORIDA GAI; Hutson JL, 1998, J PROD AGRIC, V11, P233, DOI 10.2134/jpa1998.0233; Hyatt CR, 2010, SOIL SCI SOC AM J, V74, P419, DOI 10.2136/sssaj2009.0126; Jamaati-E-Somarin S., 2010, American-Eurasian Journal of Agricultural and Environmental Science, V9, P16; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Katz B.G., 2000, MONTHLY VARIABILITY; Kidder G, 1992, HORTICULTURALLY ENV; Kraft GJ, 2003, AGR ECOSYST ENVIRON, V100, P63, DOI 10.1016/S0167-8809(03)00172-5; Lara MAS, 2012, AGRON J, V104, P600, DOI 10.2134/agronj2011.0272; LESCZYNSKI DB, 1976, AM POTATO J, V53, P69, DOI 10.1007/BF02852656; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; MAHDIAN MH, 1995, T ASAE, V38, P513, DOI 10.13031/2013.27860; Meisinger J.J., 1991, MANAGING NITROGEN GR, P85, DOI DOI 10.2136/1991.MANAGINGNITROGEN.C5; Monteith JL, 1996, AGRON J, V88, P695, DOI 10.2134/agronj1996.00021962008800050003x; Mylavarapu RS, 2009, IFAS EXTENSION SOIL; Naab JB, 2004, AGRON J, V96, P1231, DOI 10.2134/agronj2004.1231; Natural Resources Conservation Service (NRCS), 2006, SOIL SURV SUW COUNT; NEETESON JJ, 1990, FERT RES, V26, P291, DOI 10.1007/BF01048767; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; *NRC, 1993, SOIL WAT QUAL AG AGR; Obreza Tom, 2006, CHARACTERIZING AGR F; Oenema O, 2003, EUR J AGRON, V20, P3, DOI 10.1016/S1161-0301(03)00067-4; Pack JE, 2004, THESIS U FLORIDA GAI; Pittman JR, 1997, 974152 US GEOL SURV; Postma R., 2000, MANAGEMENT NITROGEN, P136; Powell JM, 2007, AGRON J, V99, P211, DOI 10.2134/agronj2006.0116; Prasad R, 2014, CALCULATE PARTIAL NI; Randall G. W., 2008, AGRON MONOGR, P911; Randazzo AF, 1997, GEOLOGY FLORIDA; Ritchie J. T., 1995, P401; Ritchie JT, 1998, SYST APPR S, V7, P41; Ritchie JT, 1985, NATO ASI SERIES A, P293, DOI DOI 10.1007/978-1-4899-3665-3/PAGE/2; Rotz CA, 2005, CROP SCI, V45, P2139, DOI 10.2135/cropsci2004.0523; SAFFIGNA PG, 1976, AGRON J, V68, P337, DOI 10.2134/agronj1976.00021962006800020033x; Sebilo M, 2013, P NATL ACAD SCI USA, V110, P18185, DOI 10.1073/pnas.1305372110; Shrestha RK, 2010, AM J POTATO RES, V87, P229, DOI 10.1007/s12230-010-9131-x; SPALDING RF, 1993, J ENVIRON QUAL, V22, P392, DOI 10.2134/jeq1993.00472425002200030002x; St'astna M, 2010, AGR WATER MANAGE, V97, P286, DOI 10.1016/j.agwat.2009.09.015; Suwannee River Water Management District (SRWMD), 2005, MFL EST LOW SUW RIV; TANNER CB, 1982, AM POTATO J, V59, P107, DOI 10.1007/BF02866365; Travasso MI, 1996, POTATO RES, V39, P305, DOI 10.1007/BF02360922; U.S. Environmental Protection Agency, 2005, PROT WAT QUAL AGR RU; United States Department of Agriculture/Natural Resources Conservation Service (USDA/NRCS), 2013, FLOR SOILS INF ONL S; Unlu K, 1999, EUR J SOIL SCI, V50, P609, DOI 10.1046/j.1365-2389.1999.00260.x; Upchurch SB, 2007, TRENDS NITRATE CONCE; USDA, 2011, US STAND GRAD POT; Verhagen J, 1997, AGR ECOSYST ENVIRON, V66, P165, DOI 10.1016/S0167-8809(97)00086-8; Vos J, 1997, POTATO RES, V40, P237, DOI 10.1007/BF02358249; WALLACH D, 1987, BIOMETRICS, V43, P561, DOI 10.2307/2531995; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2	68	23	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117891	10.1371/journal.pone.0117891	http://dx.doi.org/10.1371/journal.pone.0117891			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635904	Green Published, Green Submitted, gold			2022-12-27	WOS:000350680700105
J	Watson, DM; Anderson, SE; Olson, V				Watson, David M.; Anderson, Susan E.; Olson, Valerie		Inst Land Water & Soc	Reassessing Breeding Investment in Birds: Class-Wide Analysis of Clutch Volume Reveals a Single Outlying Family	PLOS ONE			English	Article							OPTIMAL EGG SIZE; LIFE-HISTORY; GEOGRAPHIC-VARIATION; BODY SIZE; DIVERSIFICATION; EVOLUTION; WEIGHT; MASS; ENVIRONMENT; PHYLOGENY	Reproductive investment is typically considered in terms of size and number of propagules produced. Compared with a thorough understanding of the overall patterns and ecological correlates of avian clutch size, egg size has received less attention and the total effort invested in laying a clutch of eggs is rarely considered. We used clutch volume as an alternative estimate of reproductive investment and present the first class-level analysis of clutch volume in birds using 1,364 randomly-selected species in 204 families. The relationship between body mass and egg volume was very strong (r(2) = 0.946), validating previous studies identifying four families (Apterygidae, Pelecanoidiididae, Sternidae and Dromadidiae) with disproportionately large eggs. Clutch volume was also closely related to body mass (r(2) = 0.909) and all but one of the taxa with disproportionately large eggs conformed to the overall relationship, their greater egg dimensions compensated by diminished clutch size. The only family which departed significantly from the relationship between body mass and clutch volume was the mound builders (Megapodiidae)-the only group of birds that do not rely on body heat for incubation. Although previously known for laying large clutches of large eggs containing disproportionately large yolks, the remarkable investment of megapodes in reproduction (more than seven times greater than other birds of comparable mass) has been hitherto overlooked. We consider the evolutionary basis and ecological implications of this finding, suggesting that energetic costs associated with incubation act as an upper limit on reproductive output of other birds. We recommend clutch volume as a sensitive, fine-grained measure of reproductive effort for research at a wide range of scales and advocate further analysis of ecological correlates of clutch volume in birds and amniotes generally.	[Watson, David M.; Anderson, Susan E.] Charles Sturt Univ, Albury, NSW, Australia; [Olson, Valerie] Zool Soc London, London, England	Charles Sturt University; Zoological Society of London	Watson, DM (corresponding author), Charles Sturt Univ, Albury, NSW, Australia.	dwatson@csu.edu.au		David, Watson/0000-0003-1821-4632	Australian Research Council; NERC	Australian Research Council(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DMW acknowledges the support of the Australian Research Council, and VO was supported by a NERC research grant awarded to Dr Tamas Szekely. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 2002, THESIS C STURT U; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; BENNETT PM, 2002, EVOLUTIONARY ECOLOGY; Bernardo J, 1996, AM ZOOL, V36, P216; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Booth DT, 1988, MEGAPODE NEWSLETTER, V2, P13; Brooke MD, 1999, P ROY SOC B-BIOL SCI, V266, P405, DOI 10.1098/rspb.1999.0652; CALDER WA, 1979, BIOSCIENCE, V29, P461, DOI 10.2307/1307538; Christensen VL, 1996, POULTRY SCI, V75, P1404, DOI 10.3382/ps.0751404; CRACRAFT J, 1974, IBIS, V116, P494, DOI 10.1111/j.1474-919X.1974.tb07648.x; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; D'Alba L, 2014, J EXP BIOL, V217, P1116, DOI 10.1242/jeb.098343; Dickinson EC., 2003, HOWARD MOORE COMPLET; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; FORD NB, 1989, HERPETOLOGICA, V45, P75; Heinroth O., 1922, Journal fuer Ornithologie Leipzig, V70, P172, DOI 10.1007/BF02537515; HOYT DF, 1976, CONDOR, V78, P343, DOI 10.2307/1367694; HOYT DF, 1979, AUK, V96, P73; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; JOHNSGARD P. A., 1997, AVIAN BROOD PARASITE; Jones D. N., 1995, THE MEGAPODES; KLOMP H, 1970, ARDEA, V58, P1; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; LACK D, 1948, IBIS, V90, P25, DOI 10.1111/j.1474-919X.1948.tb01399.x; Ligon JD, 1999, EVOLUTION AVIAN BREE; Lovich JE, 2012, AMPHIBIA-REPTILIA, V33, P161, DOI 10.1163/156853812X634035; Martin TE, 2006, EVOLUTION, V60, P390; Martin TE, 2004, AUK, V121, P289, DOI 10.1642/0004-8038(2004)121[0289:ALEHAE]2.0.CO;2; MOREAU R. E., 1944, IBIS, V86, P286, DOI 10.1111/j.1474-919X.1944.tb04093.x; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Nealen PM, 2001, J ZOOL, V253, P391, DOI 10.1017/S095283690100036X; OLSEN PD, 1994, AUST J ZOOL, V42, P307, DOI 10.1071/ZO9940307; OLSEN PD, 1994, AUST J ZOOL, V42, P323, DOI 10.1071/ZO9940323; OWENS IPF, 1995, P ROY SOC B-BIOL SCI, V261, P227, DOI 10.1098/rspb.1995.0141; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Potti J, 1999, EVOLUTION, V53, P279, DOI 10.1111/j.1558-5646.1999.tb05353.x; PRESTON FW, 1974, AUK, V91, P132, DOI 10.2307/4084667; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; RAHN H, 1975, AUK, V92, P750, DOI 10.2307/4084786; Ramos JA, 2001, IBIS, V143, P83, DOI 10.1111/j.1474-919X.2001.tb04172.x; RAYNER JMV, 1985, J ZOOL, V206, P415; SAETHER BE, 1987, OIKOS, V48, P79, DOI 10.2307/3565691; Schonwetter M, 1960, HDB OOLOGIE HERAU SG; SEIM E, 1983, J THEOR BIOL, V104, P161, DOI 10.1016/0022-5193(83)90408-3; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Spencer RJ, 2001, OIKOS, V93, P401, DOI 10.1034/j.1600-0706.2001.930305.x; Wang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064312; Wojczulanis-Jakubas K, 2014, AUK, V131, P743, DOI 10.1642/AUK-14-62.1; [No title captured]; [No title captured]	52	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0117678	10.1371/journal.pone.0117678	http://dx.doi.org/10.1371/journal.pone.0117678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633998	Green Submitted, Green Published, gold			2022-12-27	WOS:000348609800013
J	Becker, S; Brandl, C; Meister, S; Nagel, E; Miron-Shatz, T; Mitchell, A; Kribben, A; Albrecht, UV; Mertens, A				Becker, Stefan; Brandl, Christopher; Meister, Sven; Nagel, Eckhard; Miron-Shatz, Talya; Mitchell, Anna; Kribben, Andreas; Albrecht, Urs-Vito; Mertens, Alexander			Demographic and Health Related Data of Users of a Mobile Application to Support Drug Adherence is Associated with Usage Duration and Intensity	PLOS ONE			English	Article							DIGITAL DIVIDE; TECHNOLOGY; ACCEPTANCE; MEDICATION; DISPARITIES; USABILITY; THERAPY; ACCESS; CARE	Purpose A wealth of mobile applications are designed to support users in their drug intake. When developing software for patients, it is important to understand the differences between individuals who have, who will or who might never adopt mobile interventions. This study analyzes demographic and health-related factors associated with real-life "longer usage" and the "usage-intensity per day" of the mobile application "Medication Plan". Methods Between 2010-2012, the mobile application "Medication Plan" could be downloaded free of charge from the Apple-App-Store. It was aimed at supporting the regular and correct intake of medication. Demographic and health-related data were collected via an online questionnaire. This study analyzed captured data. Results App-related activities of 1799 users (1708 complete data sets) were recorded. 69% (1183/1708) applied "Medication Plan" for more than a day. 74% were male (872/1183), the median age 45 years. Variance analysis showed a significant effect of the users 'age with respect to duration of usage (p = 0.025). While the mean duration of use was only 23.3 days for users younger than 21 years, for older users, there was a substantial increase over all age cohorts up to users of 60 years and above (103.9 days). Sex and educational status had no effect. "Daily usage intensity" was directly associated with an increasing number of prescribed medications and increased from an average of 1.87 uses per day and 1 drug per day to on average 3.71 uses per day for users stating to be taking more than 7 different drugs a day (p < 0.001). Demographic predictors (sex, age and educational attainment) did not affect usage intensity. Conclusion Users aged 60+ as well as those with complicated therapeutic drug regimens relied on the service we provided for more than three months on average. Mobile applications may be a promising approach to support the treatment of patients with chronic conditions.	[Becker, Stefan; Mitchell, Anna; Kribben, Andreas] Univ Duisburg Essen, Dept Nephrol, Essen, Germany; [Becker, Stefan; Nagel, Eckhard] Univ Hosp Essen, Inst Drug Safety, Essen, Germany; [Brandl, Christopher; Mertens, Alexander] Rhein Westfal TH Aachen, Inst Ind Engn & Ergon, Aachen, Germany; [Meister, Sven] Fraunhofer Inst Software & Syst Engn, Dortmund, Germany; [Miron-Shatz, Talya] Ctr Med Publ Interest, New York, NY USA; [Miron-Shatz, Talya] Ono Acad Coll, Sch Business, Dept Mkt, Kiryat Ono, Israel; [Albrecht, Urs-Vito] Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Peter L Reichertz Inst Med Informat OE8420, Hannover, Germany; [Albrecht, Urs-Vito] Hannover Med Sch, Hannover, Germany	University of Duisburg Essen; University of Duisburg Essen; RWTH Aachen University; Fraunhofer Gesellschaft; Braunschweig University of Technology; Hannover Medical School	Becker, S (corresponding author), Univ Duisburg Essen, Dept Nephrol, Essen, Germany.	stefan.becker@uk-essen.de	Albrecht, Urs-Vito/HGE-6769-2022	Albrecht, Urs-Vito/0000-0002-8989-6696; Brandl, Christopher/0000-0001-6736-7366; Meister, Sven/0000-0003-0522-986X	Roche Pharma, Grenzach-Wyhlen, Germany	Roche Pharma, Grenzach-Wyhlen, Germany	The iNephro project was financed by an unrestricted grant from Roche Pharma, Grenzach-Wyhlen, Germany (http://www.roche.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, YB MED INFORM, DOI DOI 10.15265/IY-2014-0004; APA-American Psychological Association, 2009, PUBL MAN AM PSYCH AS; Becker S, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3328; Becker S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078547; Bjerrum L, 1998, EUR J CLIN PHARMACOL, V54, P197, DOI 10.1007/s002280050445; Boulos MNK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-24; Charland A, 2011, COMMUN ACM, V54, P49, DOI 10.1145/1941487.1941504; Consumer Health Information Corporation, 2011, MOT PAT US SMARTPH H; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; Diamantidis CJ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-7; Diamantidis CJ, 2013, AM J KIDNEY DIS, V61, P644, DOI 10.1053/j.ajkd.2012.09.016; Diamantidis CJ, 2012, CLIN J AM SOC NEPHRO, V7, P1553, DOI 10.2215/CJN.03690412; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Free C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001362; Graef M, 2007, VOLKSWIRTSCHAFTLICHE, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Grindrod KA, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3048; Heinz M, 2013, J GERONTOL NURS, V39, P42, DOI 10.3928/00989134-20121204-04; Hixon T, 2014, FORBES MAGAZINE; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lorence Daniel P, 2006, J Med Syst, V30, P241, DOI 10.1007/s10916-005-9003-y; McHorney CA, 2009, CURR MED RES OPIN, V25, P215, DOI 10.1185/03007990802619425 ; Miron-Scahtz T, 2011, IJPCM, V1, P405, DOI [DOI 10.5750/IJPCM.VLI2.84, 10.5750/ijpcm.vli2.84, DOI 10.5750/IJPCM.V1I2.84]]; Miron-Shatz T, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3390; Morris AB, 2006, PHARMACOTHERAPY, V26, P483, DOI 10.1592/phco.26.4.483; Olphert W, 2013, GERONTOLOGY, V59, P564, DOI 10.1159/000353630; Or CKL, 2011, J AM MED INFORM ASSN, V18, P51, DOI 10.1136/jamia.2010.007336; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pechere JC, 2007, INT J ANTIMICROB AG, V29, P245, DOI 10.1016/j.ijantimicag.2006.09.026; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Sarkar U, 2011, J AM MED INFORM ASSN, V18, P318, DOI [10.1136/jamia.2010.006015, 10.1136/amiajnl.2010.006015]; Siegel D, 2007, AM J MED, V120, P26, DOI 10.1016/j.amjmed.2006.06.028; Smith A., 2012, 46 AM ADULTS ARE SMA; Tacken M., 2005, GERONTECHNOLOGY, V3, P126, DOI DOI 10.4017/GT.2005.03.03.002.00; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; Volmer T, 1999, KOSTEN NONCOMPLIANCE, P55; Vrijens B, 2008, BMJ-BRIT MED J, V336, P1114, DOI 10.1136/bmj.39553.670231.25	37	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116980	10.1371/journal.pone.0116980	http://dx.doi.org/10.1371/journal.pone.0116980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629939	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100055
J	Farnik, H; Driller, M; Kratt, T; Schmidt, C; Fahndrich, M; Filmann, N; Konigsrainer, A; Stallmach, A; Heike, M; Bechstein, WO; Zeuzem, S; Albert, JG				Farnik, Harald; Driller, Marlene; Kratt, Thomas; Schmidt, Carsten; Faehndrich, Martin; Filmann, Natalie; Koenigsrainer, Alfred; Stallmach, Andreas; Heike, Michael; Bechstein, Wolf O.; Zeuzem, Stefan; Albert, Joerg G.			Indication for 'Over the Scope' (OTS)-Clip vs. Covered Self-Expanding Metal Stent (cSEMS) Is Unequal in Upper Gastrointestinal Leakage: Results from a Retrospective Head-to-Head Comparison	PLOS ONE			English	Article							ENDOSCOPIC SUBMUCOSAL DISSECTION; CLIP SYSTEM; CLINICAL-EXPERIENCE; GI TRACT; CLOSURE; PERFORATIONS; FISTULAS; OTSC; SURGERY; DEVICE	Background Intestinal perforation or leakage increases morbidity and mortality of surgical and endoscopic interventions. We identified criteria for use of full-covered, extractable self-expanding metal stents (cSEMS) vs. 'Over the scope'-clips (OTSC) for leak closure. Methods Patients who underwent endoscopic treatment for postoperative leakage, endoscopic perforation, or spontaneous rupture of the upper gastrointestinal tract between 2006 and 2013 were identified at four tertiary endoscopic centers. Technical success, outcome (e.g. duration of hospitalization, in-hospital mortality), and complications were assessed and analyzed with respect to etiology, size and location of leakage. Results Of 106 patients (male: 75 (71%), female: 31 (29%); age (mean +/- SD): 62.5 +/- 1.3 years, 72 (69%) were treated by cSEMS and 34 (31%) by OTSC. For cSEMS vs. OTSC, mean treatment duration was 41.1 vs. 25 days, p<0.001, leakage size 10 (1-50) vs. 5 (1-30) mm (median (range)), and complications were observed in 68% vs. 8.8%, p<0.001, respectively. Clinical success for primary interventional treatment was observed in 29/72 (40%) vs. 24/34 (70%, p = 0.006), and clinical success at the end of follow-up was 46/72 (64%) vs. 29/34 (85%) for patients treated by cSEMS vs. OTSC; p = 0.04. Conclusion OTSC is preferred in small-sized lesions and in perforation caused by endoscopic interventions, cSEMS in patients with concomitant local infection or abscess. cSEMS is associated with a higher frequency of complications. Therefore, OTSC might be preferred if technically feasible. Indication criteria for cSEMS vs. OTSC vary and might impede design of randomized studies.	[Farnik, Harald; Driller, Marlene; Zeuzem, Stefan; Albert, Joerg G.] Goethe Univ Frankfurt, Med Klin 1, D-60054 Frankfurt, Germany; [Kratt, Thomas; Koenigsrainer, Alfred] Univ Klinikum Tuubingen, Klin Allgemeine Viszeral & Transplantationschirur, Tubingen, Germany; [Schmidt, Carsten; Stallmach, Andreas] Klinikum Univ Jena, Innere Med Klin 4, Jena, Germany; [Faehndrich, Martin; Heike, Michael] Stadt Klinikum Dortmund, Med Klin Mitte Gastroenterol, Dortmund, Germany; [Filmann, Natalie] Univ Frankfurt Klinikum, Inst Biostat & Math Modellierung, Frankfurt, Germany; [Bechstein, Wolf O.] Goethe Univ Frankfurt, Klin Allgemein & Viszeralchirurgie, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Friedrich Schiller University of Jena; Klinikum Dortmund; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Albert, JG (corresponding author), Goethe Univ Frankfurt, Med Klin 1, D-60054 Frankfurt, Germany.	J.Albert@med.uni-frankfurt.de	Schmidt, Carsten/AAB-1809-2020; Zeuzem, Stefan/AAE-7435-2019; Bechstein, Wolf/H-5457-2019	Bechstein, Wolf/0000-0002-3267-8145; Albert, Jorg/0000-0002-3420-7371; Filmann, Natalie/0000-0003-0424-2317				Ahrens M, 2010, ENDOSCOPY, V42, P693, DOI 10.1055/s-0030-1255688; Albert JG, 2011, GASTROINTEST ENDOSC, V74, P389, DOI 10.1016/j.gie.2011.03.1128; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; BINMOELLER KF, 1993, GASTROINTEST ENDOSC, V39, P172, DOI 10.1016/S0016-5107(93)70060-7; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Disibeyaz S, 2005, ENDOSCOPY, V37, P1032, DOI 10.1055/s-2005-870439; Feith M, 2011, CLIN GASTROENTEROL H, V9, P202, DOI 10.1016/j.cgh.2010.12.010; Freeman RK, 2009, ANN THORAC SURG, V88, P194, DOI 10.1016/j.athoracsur.2009.04.004; Hagel AF, 2012, J GASTROINTEST SURG, V16, P2132, DOI 10.1007/s11605-012-1983-6; Kantsevoy SV, 2014, GASTROINTEST ENDOSC, V79, P503, DOI 10.1016/j.gie.2013.10.051; Kirschniak A, 2007, GASTROINTEST ENDOSC, V66, P162, DOI 10.1016/j.gie.2007.01.034; Kirschniak A, 2011, SURG ENDOSC, V25, P2901, DOI 10.1007/s00464-011-1640-2; Lim SM, 2013, SURG ENDOSC, V27, P1397, DOI 10.1007/s00464-012-2643-3; Manta R, 2011, ENDOSCOPY, V43, P545, DOI 10.1055/s-0030-1256196; Mennigen R, 2013, J GASTROINTEST SURG, V17, P1058, DOI 10.1007/s11605-013-2156-y; Monkemuller K, 2014, DIGEST ENDOSC, V26, P350, DOI 10.1111/den.12145; Nishiyama N, 2013, WORLD J GASTROENTERO, V19, P2752, DOI 10.3748/wjg.v19.i18.2752; Parodi A, 2010, GASTROINTEST ENDOSC, V72, P881, DOI 10.1016/j.gie.2010.04.006; Rabago LR, 2002, ENDOSCOPY, V34, P632, DOI 10.1055/s-2002-33237; Repici A, 2009, DIGEST LIVER DIS, V41, P406, DOI 10.1016/j.dld.2008.09.002; Sandmann M, 2011, Z GASTROENTEROL, V49, P981, DOI 10.1055/s-0029-1245972; Schecter WP, 2009, J AM COLL SURGEONS, V209, P484, DOI 10.1016/j.jamcollsurg.2009.05.025; Schlag C, 2013, ENDOSCOPY, V45, P4, DOI 10.1055/s-0032-1325760; Seebach L, 2010, ENDOSCOPY, V42, P1108, DOI 10.1055/s-0030-1255924; Swinnen J, 2011, GASTROINTEST ENDOSC, V73, P890, DOI 10.1016/j.gie.2010.12.019; von Renteln D, 2009, ENDOSCOPY, V41, P1056, DOI 10.1055/s-0029-1215241; von Renteln D, 2010, GASTROINTEST ENDOSC, V72, P1289, DOI 10.1016/j.gie.2010.07.033; Wedemeyer J, 2010, GASTROINTEST ENDOSC, V71, P382, DOI 10.1016/j.gie.2009.07.011; Will U, 2004, GASTROINTEST ENDOSC, V59, P581, DOI 10.1016/S0016-5107(04)00005-7	29	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117483	10.1371/journal.pone.0117483	http://dx.doi.org/10.1371/journal.pone.0117483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629619	Green Published, gold, Green Submitted			2022-12-27	WOS:000348732100085
J	Lim, SW; Tran, TM; Abate, AR				Lim, Shaun W.; Tran, Tuan M.; Abate, Adam R.			PCR-Activated Cell Sorting for Cultivation-Free Enrichment and Sequencing of Rare Microbes	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; INDIVIDUAL ENVIRONMENTAL BACTERIA; MICROFLUIDIC DIGITAL PCR; IN-SITU HYBRIDIZATION; FLOW-CYTOMETRY; DROPS; METAGENOMES; COMMUNITIES; POPULATIONS; STRATEGIES	Microbial systems often exhibit staggering diversity, making the study of rare, interesting species challenging. For example, metagenomic analyses of mixed-cell populations are often dominated by the sequences of the most abundant organisms, while those of rare microbes are detected only at low levels, if at all. To overcome this, selective cultivation or fluorescence-activated cell sorting (FACS) can be used to enrich for the target species prior to sequence analysis; however, since most microbes cannot be grown in the lab, cultivation strategies often fail, while cell sorting requires techniques to uniquely label the cell type of interest, which is often not possible with uncultivable microbes. Here, we introduce a culture-independent strategy for sorting microbial cells based on genomic content, which we term PCR-activated cell sorting (PACS). This technology, which utilizes the power of droplet-based microfluidics, is similar to FACS in that it uses a fluorescent signal to uniquely identify and sort target species. However, PACS differs importantly from FACS in that the signal is generated by performing PCR assays on the cells in microfluidic droplets, allowing target cells to be identified with high specificity with suitable design of PCR primers and TaqMan probes. The PACS assay is general, requires minimal optimization and, unlike antibody methods, can be developed without access to microbial antigens. Compared to nonspecific methods in which cells are sorted based on size, granularity, or the ability to take up dye, PACS enables genetic sequence-specific sorting and recovery of the cell genomes. In addition to sorting microbes, PACS can be applied to eukaryotic cells, viruses, and naked nucleic acids.	[Lim, Shaun W.; Tran, Tuan M.] Univ Calif San Francisco, UC Berkeley, UCSF Grad Program Bioengn, San Francisco, CA 94143 USA; [Abate, Adam R.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California San Francisco; University of California System; University of California San Francisco	Abate, AR (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA.	adam.abate@ucsf.edu			NSF Career award [DBI-1253293]; California Institute for Quantitative Biosciences (QB3); Bridging the Gap Award from the Rogers Family Foundation; New Frontiers Research Award from the UCSF/Sandler Foundation Program for Breakthrough Biomedical Research; University of California Proof of Concept Program; Agency of Science, Technology and Research (A*STAR)	NSF Career award(National Science Foundation (NSF)NSF - Office of the Director (OD)); California Institute for Quantitative Biosciences (QB3); Bridging the Gap Award from the Rogers Family Foundation; New Frontiers Research Award from the UCSF/Sandler Foundation Program for Breakthrough Biomedical Research; University of California Proof of Concept Program; Agency of Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by an NSF Career award (DBI-1253293), a Research Award from the California Institute for Quantitative Biosciences (QB3), the Bridging the Gap Award from the Rogers Family Foundation, a New Frontiers Research Award from the UCSF/Sandler Foundation Program for Breakthrough Biomedical Research, and a grant from the University of California Proof of Concept Program. SWL also wishes to acknowledge funding support from the Agency of Science, Technology and Research (A*STAR) for his graduate studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate AR, 2010, P NATL ACAD SCI USA, V107, P19163, DOI 10.1073/pnas.1006888107; Abate AR, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3431281; Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Ahn K, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164911; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Beer NR, 2007, ANAL CHEM, V79, P8471, DOI 10.1021/ac701809w; Blainey PC, 2013, FEMS MICROBIOL REV, V37, P407, DOI 10.1111/1574-6976.12015; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eastburn DJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku606; Eastburn DJ, 2013, ANAL CHEM, V85, P8016, DOI 10.1021/ac402057q; El Debs B, 2012, P NATL ACAD SCI USA, V109, P11570, DOI 10.1073/pnas.1204514109; Franke T, 2010, LAB CHIP, V10, P789, DOI 10.1039/b915522h; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kalyuzhnaya MG, 2006, APPL ENVIRON MICROB, V72, P4293, DOI 10.1128/AEM.00161-06; Lim SW, 2013, LAB CHIP, V13, P4563, DOI 10.1039/c3lc50736j; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013; Sciambi A, 2014, LAB CHIP, V14, P2605, DOI 10.1039/c4lc00078a; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Tadmor AD, 2011, SCIENCE, V333, P58, DOI 10.1126/science.1200758; Taghavi Z, 2013, BIOINFORMATICS, V29, P2395, DOI 10.1093/bioinformatics/btt420; Teh SY, 2008, LAB CHIP, V8, P198, DOI 10.1039/b715524g; Tran TM, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/11/114004; Turner EH, 2009, ANNU REV GENOM HUM G, V10, P263, DOI 10.1146/annurev-genom-082908-150112; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Wendeberg Annelie, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5366; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yilmaz S, 2010, ISME J, V4, P1352, DOI 10.1038/ismej.2010.73	36	40	40	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0113549	10.1371/journal.pone.0113549	http://dx.doi.org/10.1371/journal.pone.0113549			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629401	gold, Green Published, Green Submitted			2022-12-27	WOS:000348732100004
J	Mokhtari, M; Abd Ghaffar, M; Usup, G; Cob, ZC				Mokhtari, Mohammad; Abd Ghaffar, Mazlan; Usup, Gires; Cob, Zaidi Che			Determination of Key Environmental Factors Responsible for Distribution Patterns of Fiddler Crabs in a Tropical Mangrove Ecosystem	PLOS ONE			English	Article							UCA-PUGNAX SMITH; TRACE-METALS; GENUS UCA; SPATIAL-DISTRIBUTION; HUMIC SUBSTANCES; SEDIMENTS; SULFIDES	In tropical regions, different species of fiddler crabs coexist on the mangrove floor, which sometimes makes it difficult to define species-specific habitat by visual inspection. The aim of this study is to find key environmental parameters which affect the distribution of fiddler crabs and to determine the habitats in which each species was most abundant. Crabs were collected from 19 sites within the mudflats of Sepang-Lukut mangrove forest. Temperature, porewater salinity, organic matter, water content, carbon and nitrogen content, porosity, chlorophyll content, pH, redox potential, sediment texture and heavy metals were determined in each 1 m(2) quadrate. Pearson correlation indicated that all sediment properties except pH and redox potential were correlated with sediment grain size. Canonical correspondence analysis (CCA) indicated that Uca paradussumieri was negatively correlated with salinity and redox potential. Sand dwelling species, Uca perplexa and Uca annulipes, were highly dependent on the abundance of 250 mu m and 150 mu m grain size particles in the sediment. Canonical Discriminative Analysis (CDA) indicated that variation in sediment grain size best explained where each crab species was most abundant. Moreover, U. paradussumieri commonly occupies muddy substrates of low shore, while U. forcipata lives under the shade of mangrove trees. U. annulipes and U. perplexa with the high number of spoon tipped setae on their second maxiliped are specialized to feed on the sandy sediments. U. rosea and U. triangularis are more common on muddy sediment with high sediment density. In conclusion, sediment grain size that influences most sediment properties acts as a main factor responsible for sediment heterogeneity. In this paper, the correlation between fiddler crab species and environmental parameters, as well as the interaction between sediment characteristics, was explained in order to define the important environmental factors in fiddler crab distributions.	[Mokhtari, Mohammad] Natl Univ Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Ukm Bangi 43600, Selangor, Malaysia; [Abd Ghaffar, Mazlan; Usup, Gires; Cob, Zaidi Che] Natl Univ Malaysia, Fac Sci & Technol, Marine Ecosyst Res Ctr, Ukm Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Cob, ZC (corresponding author), Natl Univ Malaysia, Fac Sci & Technol, Marine Ecosyst Res Ctr, Ukm Bangi 43600, Selangor, Malaysia.	zaidicob@gmail.com	GHAFFAR, MAZLAN ABD/O-3604-2016; Cob, Zaidi Che/E-9498-2016	GHAFFAR, MAZLAN ABD/0000-0001-9248-5284; 	National University of Malaysia [UKM-GUP-2011-200]	National University of Malaysia	This research was financially supported by National University of Malaysia (grant no: UKM-GUP-2011-200 to ZCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Bezerra LEA, 2006, SCI MAR, V70, P759, DOI 10.3989/scimar.2006.70n4759; Backwell PRY, 1998, ANIM BEHAV, V55, P1659, DOI 10.1006/anbe.1997.0713; Bale A.J., 2005, METHODS STUDY MARINE, V3, P43, DOI DOI 10.1002/9780470995129.CH2; BERTNESS MD, 1984, J EXP MAR BIOL ECOL, V83, P211, DOI 10.1016/S0022-0981(84)80002-7; CALMANO W, 1993, WATER SCI TECHNOL, V28, P223, DOI 10.2166/wst.1993.0622; Clark MW, 1998, CHEM GEOL, V149, P147, DOI 10.1016/S0009-2541(98)00034-5; Clark MW, 1997, J COASTAL RES, V13, P1050; Clarke K., 2001, PRIMER V5 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cooper DC, 1999, AQUAT GEOCHEM, V5, P87, DOI 10.1023/A:1009672022351; Costa TM., 2001, NAUPLIUS, V9, P123; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; DYE AH, 1986, MAR ECOL PROG SER, V32, P259, DOI 10.3354/meps032259; EDNEY EB, 1962, BIOMETEOROLOGY, P79; Edney EB., 1961, T ROY SOC S AFR, V36, P71, DOI [10.1080/00359196109519035, DOI 10.1080/00359196109519035]; HARBISON P, 1986, MAR POLLUT BULL, V17, P246, DOI 10.1016/0025-326X(86)90057-3; Hogarth, 2008, BIOL MANGROVES SEAGR; Horowitz A.J., 1987, APPL GEOCHEM, V2, P437, DOI 10.1016/0883-2927(87)90027-8; HUERTADIAZ MA, 1992, GEOCHIM COSMOCHIM AC, V56, P2681, DOI 10.1016/0016-7037(92)90353-K; ICELY JD, 1978, ESTUAR COAST MAR SCI, V6, P315, DOI 10.1016/0302-3524(78)90019-1; JORGENSEN BB, 1979, APPL ENVIRON MICROB, V38, P46; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; LU JCS, 1977, ENVIRON SCI TECHNOL, V11, P174, DOI 10.1021/es60125a004; Machado W, 2008, J COASTAL RES, V24, P25, DOI 10.2112/06-0736.1; Macintosh D.J., 1982, P243; Macintosh D. J., 1977, PHYSL BEHAV MARINE O, P49; MACINTOSH DJ, 1988, S ZOOL SOC LOND, V59, P315; Macintosh DJ, 1979, THESIS U MALAYA; Marchand C, 2011, GEODERMA, V160, P444, DOI 10.1016/j.geoderma.2010.10.015; MOORE JN, 1989, ENVIRON GEOL WATER S, V14, P107, DOI 10.1007/BF01728502; NISSENBAUM A, 1976, GEOCHIM COSMOCHIM AC, V40, P809, DOI 10.1016/0016-7037(76)90033-8; NISSENBAUM A, 1972, LIMNOL OCEANOGR, V17, P570, DOI 10.4319/lo.1972.17.4.0570; OCONNOR NJ, 1990, J CRUSTACEAN BIOL, V10, P608, DOI 10.2307/1548404; Passino, 1987, METALS SPECIATION SE, P27; Ray AK, 2006, ENVIRON INT, V32, P219, DOI 10.1016/j.envint.2005.08.014; Ribeiro PD, 2005, J EXP MAR BIOL ECOL, V314, P99, DOI 10.1016/j.jembe.2004.09.014; Rosenberg MS, 2001, J CRUSTACEAN BIOL, V21, P839, DOI 10.1651/0278-0372(2001)021[0839:TSATOF]2.0.CO;2; StatSoft, 2011, EL STAT TXB, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Stevenson F J., 1985, MICRONUTRIENTS AGR, P145; TAN CGS, 1994, HYDROBIOLOGIA, V285, P75, DOI 10.1007/BF00005655; TEAL JM, 1958, ECOLOGY, V39, P185, DOI 10.2307/1931862; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; WEISSBURG M, 1992, J EXP MAR BIOL ECOL, V156, P105, DOI 10.1016/0022-0981(92)90019-7	46	24	26	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117467	10.1371/journal.pone.0117467	http://dx.doi.org/10.1371/journal.pone.0117467			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629519	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100084
J	Sroga, GE; Wu, PC; Vashishth, D				Sroga, Grazyna E.; Wu, Ping-Cheng; Vashishth, Deepak			Insulin-Like Growth Factor 1, Glycation and Bone Fragility: Implications for Fracture Resistance of Bone	PLOS ONE			English	Article							FACTOR-I; CROSS-LINKING; LYSYL OXIDASE; BIOMECHANICAL PROPERTIES; NONENZYMATIC GLYCATION; EXTRACELLULAR-MATRIX; MAILLARD PROCESSES; LEUCINE KINETICS; GLUCOSE LEVELS; CORTICAL BONE	Despite our extensive knowledge of insulin-like growth factor 1 (IGF1) action on the growing skeleton, its role in skeletal homeostasis during aging and age-related development of certain diseases is still unclear. Advanced glycation end products (AGEs) derived from glucose are implicated in osteoporosis and a number of diabetic complications. We hypothesized that because in humans and rodents IGF1 stimulates uptake of glucose (a glycation substrate) from the bloodstream in a dose-dependent manner, the decline of IGF1 could be associated with the accumulation of glycation products and the decreasing resistance of bone to fracture. To test the aforementioned hypotheses, we used human tibial posterior cortex bone samples to perform biochemical (measurement of IGF1, fluorescent AGEs and pentosidine (PEN) contents) and mechanical tests (crack initiation and propagation using compact tension specimens). Our results for the first time show a significant, age-independent association between the levels of IGF1 and AGEs. Furthermore, AGEs (fAGEs, PEN) predict propensity of bone to fracture (initiation and propagation) independently of age in human cortical bone. Based on these results we propose a model of IGF1-based regulation of bone fracture. Because IGF1 level increases postnatally up to the juvenile developmental phase and decreases thereafter with aging, we propose that IGF1 may play a protective role in young skeleton and its age-related decline leads to bone fragility and an increased fracture risk. Our results may also have important implications for current understanding of osteoporosis-and diabetes-related bone fragility as well as in the development of new diagnostic tools to screen for fragile bones.	[Vashishth, Deepak] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Vashishth, D (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.	vashid@rpi.edu		Vashishth, Deepak/0000-0001-5712-0167	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH) [AG20618]; NIH [5 U42 RR006042]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG020618, R01AG020618] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health (NIH), under award number AG20618. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors acknowledge use of human bone tissues provided by the National Disease Research Interchange (NDRI) with support from NIH grant 5 U42 RR006042 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery NC, 2005, SCAND J MED SCI SPOR, V15, P231, DOI 10.1111/j.1600-0838.2005.00464.x; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; BAUTISTA CM, 1990, METABOLISM, V39, P96, DOI 10.1016/0026-0495(90)90154-5; Biemel KM, 2001, J BIOL CHEM, V276, P23405, DOI 10.1074/jbc.M102035200; Booth SL, 2013, NAT REV ENDOCRINOL, V9, P43, DOI 10.1038/nrendo.2012.201; BOULWARE SD, 1994, J CLIN INVEST, V93, P1131, DOI 10.1172/JCI117065; Chronopoulos A, 2010, DIABETES, V59, P3159, DOI 10.2337/db10-0365; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; ELAHI D, 1993, AM J PHYSIOL, V265, pE831, DOI 10.1152/ajpendo.1993.265.6.E831; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Frystyk J, 2010, GROWTH HORM IGF RES, V20, P8, DOI 10.1016/j.ghir.2009.09.004; Fulzele K, 2012, BONE, V50, P452, DOI 10.1016/j.bone.2011.06.018; Garnero P, 2000, LANCET, V355, P898, DOI 10.1016/S0140-6736(99)05463-X; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; GULER HP, 1987, NEW ENGL J MED, V317, P137, DOI 10.1056/NEJM198707163170303; Hernandez CJ, 2005, BONE, V37, P825, DOI 10.1016/j.bone.2005.07.019; HOCK JM, 1988, ENDOCRINOLOGY, V122, P254, DOI 10.1210/endo-122-1-254; JACOB R, 1989, J CLIN INVEST, V83, P1717, DOI 10.1172/JCI114072; Karim L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035047; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Ko GTC, 2006, CROAT MED J, V47, P709; LAAGER R, 1993, J CLIN INVEST, V92, P1903, DOI 10.1172/JCI116783; Langlois JA, 1998, J CLIN ENDOCR METAB, V83, P4257, DOI 10.1210/jc.83.12.4257; Lederer MO, 1999, BIOORGAN MED CHEM, V7, P1081, DOI 10.1016/S0968-0896(99)00040-1; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leslie WD, 2012, J BONE MINER RES, V27, P2231, DOI 10.1002/jbmr.1759; Moxley RT, AM J PHYSL, V259, pE561; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Nakamura K, 1997, BIOCHEM BIOPH RES CO, V232, P227, DOI 10.1006/bbrc.1997.6262; NICOLAS V, 1994, J CLIN ENDOCR METAB, V78, P1011, DOI 10.1210/jc.78.5.1011; Ohlsson C, 2011, J BONE MINER RES, V26, P865, DOI 10.1002/jbmr.281; OSULLIVAN JB, 1974, DIABETES, V23, P713, DOI 10.2337/diab.23.8.713; Poundarik AA, 2012, P NATL ACAD SCI USA, V109, P19178, DOI 10.1073/pnas.1201513109; Reiser K, 1996, AM J PHYSIOL-REG I, V271, pR696, DOI 10.1152/ajpregu.1996.271.3.R696; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; Schwartz AV, 2009, J CLIN ENDOCR METAB, V94, P2380, DOI 10.1210/jc.2008-2498; Seck T, 1998, J CLIN ENDOCR METAB, V83, P2331, DOI 10.1210/jc.83.7.2331; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; SRAWLEY JE, 1976, INT J FRACTURE, V12, P475; Sroga GE, 2012, CURR OSTEOPOROS REP, V10, P141, DOI 10.1007/s11914-012-0103-6; Sroga GE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006718; Sroga GE, 2011, J CHROMATOGR B, V879, P379, DOI 10.1016/j.jchromb.2010.12.024; Trackman PC, 1998, HISTOCHEM CELL BIOL, V110, P9, DOI 10.1007/s004180050259; TURKALJ I, 1992, J CLIN ENDOCR METAB, V75, P1186, DOI 10.1210/jc.75.5.1186; Vandenput L, 2012, FRONTIERS ENDOCRINOL, V3, P1, DOI [10.3389/fendo.2012.00001, DOI 10.3389/FENDO.2012.00001]; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Vashishth D, 2004, J BIOMECH, V37, P943, DOI 10.1016/j.jbiomech.2003.11.003; Viguet-Carrin S, 2009, J CHROMATOGR B, V877, P1, DOI 10.1016/j.jchromb.2008.10.043; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Viguet-Carrin S, 2006, BONE, V39, P1073, DOI 10.1016/j.bone.2006.05.013; Yashin AI, 2009, MECH AGEING DEV, V130, P611, DOI 10.1016/j.mad.2009.07.004; ZAPF J, 1986, J CLIN INVEST, V77, P1768, DOI 10.1172/JCI112500; Zimmermann EA, 2010, BIOMATERIALS, V31, P5297, DOI 10.1016/j.biomaterials.2010.03.056	56	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117046	10.1371/journal.pone.0117046	http://dx.doi.org/10.1371/journal.pone.0117046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629402	Green Published, Green Submitted, gold			2022-12-27	WOS:000348732100059
J	Bonanomi, G; Incerti, G; Cesarano, G; Gaglione, SA; Lanzotti, V				Bonanomi, Giuliano; Incerti, Guido; Cesarano, Gaspare; Gaglione, Salvatore A.; Lanzotti, Virginia			Cigarette Butt Decomposition and Associated Chemical Changes Assessed by C-13 CPMAS NMR	PLOS ONE			English	Article							PLANT LITTER DECOMPOSITION; TEMPERATURE SENSITIVITY; DIVERSITY; NITROGEN; SOIL; DEGRADATION; ECOSYSTEMS; TOXICITY; CLIMATE; LIGNIN	Cigarette butts (CBs) are the most common type of litter on earth, with an estimated 4.5 trillion discarded annually. Apart from being unsightly, CBs pose a serious threat to living organisms and ecosystem health when discarded in the environment because they are toxic to microbes, insects, fish and mammals. In spite of the CB toxic hazard, no studies have addressed the effects of environmental conditions on CB decomposition rate. In this study we investigate the interactive effects of substrate fertility and N transfer dynamics on CB decomposition rate and carbon quality changes. We carried out an experiment using smoked CBs and wood sticks, used as a slow decomposing standard organic substrate, incubated in both laboratory and field conditions for two years. CB carbon quality changes during decomposition was assessed by C-13 CPMAS NMR. Our experiment confirmed the low degradation rate of CBs which, on average, lost only 37.8% of their initial mass after two years of decomposition. Although a net N transfer occurred from soil to CBs, contrary to our hypothesis, mass loss in the medium-term (two years) was unaffected by N availability in the surrounding substrate. The opposite held for wood sticks, in agreement with the model that N-rich substrates promote the decomposition of other N-poor natural organic materials with a high C/N ratio. As regards CB chemical quality, after two years of decomposition C-13 NMR spectroscopy highlighted very small changes in C quality that are likely to reflect a limited microbial attack.	[Bonanomi, Giuliano; Incerti, Guido; Cesarano, Gaspare; Gaglione, Salvatore A.; Lanzotti, Virginia] Univ Naples Federico II, Dipartimento Agr, Portici, NA, Italy	University of Naples Federico II	Bonanomi, G (corresponding author), Univ Naples Federico II, Dipartimento Agr, Via Univ 100, Portici, NA, Italy.	giuliano.bonanomi@unina.it	Incerti, Guido/O-5870-2019; Incerti, Guido/B-5106-2017	Incerti, Guido/0000-0003-1288-8708; Incerti, Guido/0000-0003-1288-8708; BONANOMI, Giuliano/0000-0002-1831-4361				Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Almendros G, 2000, SOIL BIOL BIOCHEM, V32, P793, DOI 10.1016/S0038-0717(99)00202-3; Altaner C, 2003, CELLULOSE, V10, P85, DOI 10.1023/A:1023010330865; Ariza E, 2008, WASTE MANAGE, V28, P2604, DOI 10.1016/j.wasman.2007.11.012; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Berglund SL, 2012, OIKOS, V121, P1112, DOI 10.1111/j.1600-0706.2011.19787.x; Bonanomi G, 2014, PLANT SOIL, V381, P307, DOI 10.1007/s11104-014-2119-4; Bonanomi G, 2013, SOIL BIOL BIOCHEM, V56, P40, DOI 10.1016/j.soilbio.2012.03.003; Bonanomi G, 2011, NEW PHYTOL, V191, P1018, DOI 10.1111/j.1469-8137.2011.03765.x; Breitmaier E., 1987, CARBON 13 NMR SPECTR; *CIG LITT ORG, 2001, THE AWFUL TRUTH ABOU; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dieng H, 2013, ACTA TROP, V128, P584, DOI 10.1016/j.actatropica.2013.08.013; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gillon D, 1999, ECOLOGY, V80, P175, DOI 10.1890/0012-9658(1999)080[0175:CLDBPB]2.0.CO;2; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; HAYNES SK, 1991, EASTMAN CHEMICAL CUS; Hodge A, 2000, TRENDS PLANT SCI, V5, P304, DOI 10.1016/S1360-1385(00)01656-3; Hoffmann D, 1997, J TOXICOL ENV HEALTH, V50, P307, DOI 10.1080/009841097160393; Huang Y, 1998, SOIL BIOL BIOCHEM, V30, P1517, DOI 10.1016/S0038-0717(97)00234-4; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Incerti G, 2011, APPL SOIL ECOL, V49, P148, DOI 10.1016/j.apsoil.2011.06.004; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; LUKE JA, 1991, DEGRADABILITY OF FIL; Micevska T, 2006, ARCH ENVIRON CON TOX, V50, P205, DOI 10.1007/s00244-004-0132-y; Novotny TE, 2011, TOB CONTROL, V20, pI17, DOI 10.1136/tc.2011.043489; Novotny TE, 2009, INT J ENV RES PUB HE, V6, P1691, DOI 10.3390/ijerph6051691; *OC CONS, 2007, INTERNATIONAL COASTA; Pane C, 2011, BIOL CONTROL, V56, P115, DOI 10.1016/j.biocontrol.2010.10.002; Preston CM, 2009, ECOSYSTEMS, V12, P1078, DOI 10.1007/s10021-009-9267-z; Puls J, 2011, J POLYM ENVIRON, V19, P152, DOI 10.1007/s10924-010-0258-0; Robertson RM, 2012, GREEN CHEM, V14, P2266, DOI 10.1039/c2gc16635f; Rustemeyer P, 2004, MACROMOL SYMP, V208, P267, DOI 10.1002/masy.200450411; Slaughter E, 2011, TOB CONTROL, V20, pI25, DOI 10.1136/tc.2010.040170; Suarez-Rodriguez M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0931; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wardle DA, 2006, SOIL BIOL BIOCHEM, V38, P1052, DOI 10.1016/j.soilbio.2005.09.003; Wilson M., 2005, MICROBIAL INHABITANT	43	43	44	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117393	10.1371/journal.pone.0117393	http://dx.doi.org/10.1371/journal.pone.0117393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625643	Green Submitted, Green Published, gold			2022-12-27	WOS:000348821400033
J	Kesters, D; Brams, M; Nys, M; Wijckmans, E; Spurny, R; Voets, T; Tytgat, J; Kusch, J; Ulens, C				Kesters, Divya; Brams, Marijke; Nys, Mieke; Wijckmans, Eveline; Spurny, Radovan; Voets, Thomas; Tytgat, Jan; Kusch, Jana; Ulens, Chris			Structure of the SthK Carboxy-Terminal Region Reveals a Gating Mechanism for Cyclic Nucleotide-Modulated Ion Channels	PLOS ONE			English	Article							MOLECULAR-MECHANISM; BINDING DOMAIN; REARRANGEMENTS; TRANSITION; DYNAMICS; FAMILY	Cyclic nucleotide-sensitive ion channels are molecular pores that open in response to cAMP or cGMP, which are universal second messengers. Binding of a cyclic nucleotide to the carboxyterminal cyclic nucleotide binding domain (CNBD) of these channels is thought to cause a conformational change that promotes channel opening. The C-linker domain, which connects the channel pore to this CNBD, plays an important role in coupling ligand binding to channel opening. Current structural insight into this mechanism mainly derives from X-ray crystal structures of the C-linker/CNBD from hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels. However, these structures reveal little to no conformational changes upon comparison of the ligand-bound and unbound form. In this study, we take advantage of a recently identified prokaryote ion channel, SthK, which has functional properties that strongly resemble cyclic nucleotide-gated (CNG) channels and is activated by cAMP, but not by cGMP. We determined X-ray crystal structures of the C-linker/CNBD of SthK in the presence of cAMP or cGMP. We observe that the structure in complex with cGMP, which is an antagonist, is similar to previously determined HCN channel structures. In contrast, the structure in complex with cAMP, which is an agonist, is in a more open conformation. We observe that the CNBD makes an outward swinging movement, which is accompanied by an opening of the C-linker. This conformation mirrors the open gate structures of the K(v)1.2 channel or MthK channel, which suggests that the cAMP-bound C-linker/CNBD from SthK represents an activated conformation. These results provide a structural framework for better understanding cyclic nucleotide modulation of ion channels, including HCN and CNG channels.	[Kesters, Divya; Brams, Marijke; Nys, Mieke; Wijckmans, Eveline; Spurny, Radovan; Ulens, Chris] Katholieke Univ Leuven, Lab Struct Neurobiol, B-3000 Leuven, Belgium; [Voets, Thomas] Katholieke Univ Leuven, Lab Ion Channel Res, B-3000 Leuven, Belgium; [Tytgat, Jan] Katholieke Univ Leuven, Lab Toxicol & Pharmacol, B-3000 Leuven, Belgium; [Kusch, Jana] Univ Hosp Jena, Inst Physiol 2, D-07743 Jena, Germany	KU Leuven; KU Leuven; KU Leuven; Friedrich Schiller University of Jena	Ulens, C (corresponding author), Katholieke Univ Leuven, Lab Struct Neurobiol, Herestraat 49,PB601, B-3000 Leuven, Belgium.	chris.ulens@med.kuleuven.be	Nys, Mieke/AAC-2859-2019; Voets, Thomas/E-2466-2012; Voets, Thomas/AAD-4389-2019; Kusch, Jana/ABC-9738-2020	Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Kusch, Jana/0000-0001-7206-8133; Tytgat, Jan/0000-0003-1778-6022; Nys, Mieke/0000-0003-3976-8538	FWO-Vlaanderen [G.0743.10, G.0939.11, G.0762.13, OT/13/095]	FWO-Vlaanderen(FWO)	Financial support was from FWO-Vlaanderen G.0743.10, G.0939.11, G.0762.13 and Onderzoekstoelage OT/13/095 to CU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altieri SL, 2008, J MOL BIOL, V381, P655, DOI 10.1016/j.jmb.2008.06.011; Baruscotti M, 2004, ANN NY ACAD SCI, V1015, P111, DOI 10.1196/annals.1302.009; Brams M, 2014, P NATL ACAD SCI USA, V111, P7855, DOI 10.1073/pnas.1401917111; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; PULJUNG MC, 2014, P NATL ACAD SCI, P42331; Puljung MC, 2013, J BIOL CHEM, V288, P12944, DOI 10.1074/jbc.M113.464123; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Schunke S, 2009, EMBO REP, V10, P729, DOI 10.1038/embor.2009.68; SCHUNKE S, 2011, P NATL ACAD SCI US, P42331; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Taraska JW, 2007, NAT STRUCT MOL BIOL, V14, P854, DOI 10.1038/nsmb1281; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	33	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116369	10.1371/journal.pone.0116369	http://dx.doi.org/10.1371/journal.pone.0116369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625648	Green Published, Green Submitted, gold			2022-12-27	WOS:000348821400014
J	Rodriguez, XA; Elasraag, YH				Rodriguez, Xose A.; Elasraag, Yahia H.			Assessing the Total Factor Productivity of Cotton Production in Egypt	PLOS ONE			English	Article							TECHNICAL EFFICIENCY; INEFFICIENCY; GROWTH; CHINA	The main objective of this paper is to decompose the productivity growth of Egyptian cotton production. We employ the stochastic frontier approach and decompose the changes in total factor productivity (CTFP) growth into four components: technical progress (TP), changes in scale component (CSC), changes in allocative efficiency (CAE), and changes in technical efficiency (CTE). Considering a situation of scarce statistical information, we propose four alternative empirical models, with the purpose of looking for convergence in the results. The results provide evidence that in this production system total productivity does not increase, which is mainly due to the negative average contributions of CAE and TP. Policy implications are offered in light of the results.	[Rodriguez, Xose A.] Univ Santiago Compostela, Dept Quantitat Econ, Santiago De Compostela, Spain; [Elasraag, Yahia H.] Cairo Univ, Dept Agr Econ, Giza 12613, Egypt	Universidade de Santiago de Compostela; Egyptian Knowledge Bank (EKB); Cairo University	Rodriguez, XA (corresponding author), Univ Santiago Compostela, Dept Quantitat Econ, Santiago De Compostela, Spain.	xoseanton.rodriguez@usc.es		Rodriguez Gonzalez, Xose Anton/0000-0002-4741-7538				Abdel Salam M. E., 2009, EGYPTIAN COTTON CURR; ABOUMANDOUR M, 1995, CIHEAM OPTIONS MED B, V9, P42331; ALI A, 2008, PAK J AGR SCI, V45, P508; Battese G. E., 1995, EMPIR ECON, V20, P325, DOI DOI 10.1007/BF01205442; Battese GE, 1997, J PROD ANAL, V8, P395, DOI 10.1023/A:1007736025686; Battese GE., 1992, J PROD ANAL, V3, P153, DOI DOI 10.1007/BF00158774; Bozoglu M, 2007, AGR SYST, V94, P649, DOI 10.1016/j.agsy.2007.01.007; Coelli T, 1996, AUST J AGR ECON, V40, P103, DOI 10.1111/j.1467-8489.1996.tb00558.x; COELLI TJ, 1996, CEPA WORKING PAPER N, P42331; FAO (Food Agriculture Organization), 2006, FERT PLANT NUTR B, V17; Hasnah, 2004, AGR SYST, V79, P17, DOI 10.1016/S0308-521X(03)00043-X; Headey D, 2010, AGR ECON-BLACKWELL, V41, P1, DOI 10.1111/j.1574-0862.2009.00420.x; Hossain MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046081; Iraizoz B, 2003, AGR SYST, V78, P387, DOI 10.1016/S0308-521X(03)00039-8; Jayasuriya RT, 2003, AGR SYST, V78, P405, DOI 10.1016/S0308-521X(03)00068-4; Jin SQ, 2010, J PROD ANAL, V33, P191, DOI 10.1007/s11123-009-0145-7; KANNAN E, 2011, 265 I SOC EC CHANG, P42331; *KARV, 2009, COTT SEAS REP, P42331; KIANI A, 2008, SARHAD J AGR, V24, P521; Lambarraa F., 2007, Spanish Journal of Agricultural Research, V5, P259; Rae AN, 2006, AM J AGR ECON, V88, P680, DOI 10.1111/j.1467-8276.2006.00888.x; Rao N.C., 2005, AGR EC RES REV, V18, P1; Si W, 2011, AFR J AGR RES, V6, P5606, DOI 10.5897/AJAR11.1080; SOLOW RM, 1957, REV ECON STAT, V39, P312, DOI 10.2307/1926047; Yoo CK, 2012, APPL ECON PERSPECT P, V34, P472, DOI 10.1093/aepp/pps019	25	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116085	10.1371/journal.pone.0116085	http://dx.doi.org/10.1371/journal.pone.0116085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625318	Green Published, gold, Green Submitted			2022-12-27	WOS:000348821400011
J	Ermakov, OA; Simonov, E; Surin, VL; Titov, SV; Brandler, OV; Ivanova, NV; Borisenko, AV				Ermakov, Oleg A.; Simonov, Evgeniy; Surin, Vadim L.; Titov, Sergey V.; Brandler, Oleg V.; Ivanova, Natalia V.; Borisenko, Alex V.			Implications of Hybridization, NUMTs, and Overlooked Diversity for DNA Barcoding of Eurasian Ground Squirrels	PLOS ONE			English	Article							SPECIES IDENTIFICATION; MITOCHONDRIAL PSEUDOGENES; MOLECULAR-IDENTIFICATION; MAXIMUM-LIKELIHOOD; SPERMOPHILUS-MAJOR; RIBOSOMAL-RNA; RODENTIA; PHYLOGENY; EVOLUTION; TAXONOMY	The utility of DNA Barcoding for species identification and discovery has catalyzed a concerted effort to build the global reference library; however, many animal groups of economical or conservational importance remain poorly represented. This study aims to contribute DNA barcode records for all ground squirrel species (Xerinae, Sciuridae, Rodentia) inhabiting Eurasia and to test efficiency of this approach for species discrimination. Cytochrome c oxidase subunit 1 (COI) gene sequences were obtained for 97 individuals representing 16 ground squirrel species of which 12 were correctly identified. Taxonomic allocation of some specimens within four species was complicated by geographically restricted mtDNA introgression. Exclusion of individuals with introgressed mtDNA allowed reaching a 91.6% identification success rate. Significant COI divergence (3.5-4.4%) was observed within the most widespread ground squirrel species (Spermophilus erythrogenys, S. pygmaeus, S. suslicus, Urocitellus undulatus), suggesting the presence of cryptic species. A single putative NUMT (nuclear mitochondrial pseudogene) sequence was recovered during molecular analysis; mitochondrial COI from this sample was amplified following re-extraction of DNA. Our data show high discrimination ability of 100 bp COI fragments for Eurasian ground squirrels (84.3%) with no incorrect assessments, underscoring the potential utility of the existing reference librariy for the development of diagnostic 'mini-barcodes'.	[Ermakov, Oleg A.; Titov, Sergey V.] Penza State Univ, Dept Zool & Ecol, Penza, Russia; [Simonov, Evgeniy] Russian Acad Sci, Inst Systemat & Ecol Anim, Siberian Branch, Novosibirsk, Russia; [Simonov, Evgeniy] Tomsk State Univ, Tomsk 634050, Russia; [Surin, Vadim L.] Russian Acad Med Sci, Hematol Res Ctr, Moscow, Russia; [Brandler, Oleg V.] Russian Acad Sci, NK Koltsov Dev Biol Inst, Moscow, Russia; [Ivanova, Natalia V.; Borisenko, Alex V.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Penza State University; Russian Academy of Sciences; Tomsk State University; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Russian Academy of Sciences; University of Guelph	Ermakov, OA (corresponding author), Penza State Univ, Dept Zool & Ecol, Penza, Russia.	oaermakov@list.ru	Brandler, Oleg V/R-9535-2017; Surin, Vadim/ABB-5867-2020; Titov, Sergey/P-1744-2015; Borisenko, Alex/GQZ-9054-2022; Borisenko, Alex/G-9107-2014; Simonov, Evgeniy/F-7698-2012; Ermakov, Oleg/S-4634-2019; Titov, Sergey/AAT-8491-2020; Ermakov, Oleg/L-9499-2013	Brandler, Oleg V/0000-0003-0658-9680; Borisenko, Alex/0000-0002-3061-3057; Ermakov, Oleg/0000-0003-1486-6799; Titov, Sergey/0000-0001-9634-1157; Ermakov, Oleg/0000-0003-1486-6799; Simonov, Evgeniy/0000-0003-0194-4487; Surin, V. L./0000-0002-1890-4492				Afonin AN, 2008, INTERACTIVE AGR ECOL; Agadzhanyan A. K., 2006, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V111, P4; Artyushin IV, 2009, ZOOTAXA, P40; Barbosa S, 2013, MOL ECOL RESOUR, V13, P43, DOI 10.1111/1755-0998.12024; Bazanova L. P., 2012, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P115; Bazhanov VS, 1944, DOKL AKAD NAUK SSSR, V12, P321; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bitanyi S, 2011, MOL ECOL RESOUR, V11, P442, DOI 10.1111/j.1755-0998.2011.02980.x; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Brandler OV, 2010, RUSS J GENET+, V46, P283, DOI 10.1134/S102279541003004X; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Chaval Yannick, 2010, Kasetsart Journal Natural Sciences, V44, P590; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Coroiu C, 2008, SPERMOPHILUS CITELLU; Denisov V., 1969, Folia Biologica Krakow, V17, P169; DENISOV V. P., 1963, ZOOL ZHUR, V42, P1887; Eaton MJ, 2010, CONSERV GENET, V11, P1389, DOI 10.1007/s10592-009-9967-0; Enzinger K, 2012, 4 EUR GROUND SQUIRR, P19; Epp LS, 2012, MOL ECOL, V21, P1821, DOI 10.1111/j.1365-294X.2012.05537.x; Ermakov OA, 2006, ZOOL ZH, V85, P1474; Ermakov OA, 2006, RUSS J GENET+, V42, P429, DOI 10.1134/S1022795406040107; Ermakov O. A., 2006, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V111, P30; Ermakov OA, 2002, RUSS J GENET+, V38, P796, DOI 10.1023/A:1016395722664; Ermakov OA, 2011, IZV PENZ GOS PEDAGOG, V25, P176; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Furman A, 2014, ZOOL SCR, V43, P549, DOI 10.1111/zsc.12076; Gromov I.M., 1995, GUIDES RUSSIAN FAUNA, V167, P529; Gromov IG, 1965, GROUND SQUIRRELS MAR, V3; Gunduz I, 2007, MOL PHYLOGENET EVOL, V43, P916, DOI 10.1016/j.ympev.2007.02.021; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harrison Richard G., 2003, Journal of Mammalian Evolution, V10, P249, DOI 10.1023/B:JOMM.0000015105.96065.f0; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Helgen KM, 2009, J MAMMAL, V90, P270, DOI 10.1644/07-MAMM-A-309.1; Herron MD, 2004, MOL PHYLOGENET EVOL, V31, P1015, DOI 10.1016/j.ympev.2003.09.015; Howell A. H., 1938, North American Fauna, Vno. 56, P1, DOI 10.3996/nafa.56.0001; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kapustina SY, 2011, TERIOFAUNA ROSSII I, P197; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Korablev VP, 1997, RARE MAMMAL SPECIES, P50; Koshev Yordan Spasov, 2008, Lynx (Prague), P251; Kruskop SV, 2012, ACTA CHIROPTEROL, V14, P1, DOI 10.3161/150811012X654222; Kucheruk VV, 1977, ADV MODERN THERIOLOG, P75; Lakra WS, 2009, MOL BIOL REP, V36, P831, DOI 10.1007/s11033-008-9252-1; LIAPUNOVA EA, 1970, EXPERIENTIA, V26, P1033, DOI 10.1007/BF02114181; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linetskaya ON, 1989, MODERN APPROACHES ST, P99; Meier R, 2008, NEURAL NETWORKS, V21, P1085, DOI 10.1016/j.neunet.2008.06.019; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nesi N, 2011, CR BIOL, V334, P544, DOI 10.1016/j.crvi.2011.05.003; Nikolsky AA, 1997, ZOOL ZH, V76, P845; Ozkurt SO, 2007, ZOOTAXA, P1; Ognev SI, 1947, MAMMALS USSR ADJACEN, VV; Oliveira R, 2010, CONSERV GENET, V11, P1023, DOI 10.1007/s10592-009-9947-4; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Paquin P, 2004, MOL ECOL, V13, P3239, DOI 10.1111/j.1365-294X.2004.02296.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2008, FIGTREE V1 4 TREE FI; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rolo EA, 2013, FORENSIC SCI INT, V228, P160, DOI 10.1016/j.forsciint.2013.02.038; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Shekarova Olga N., 2008, Lynx (Prague), P317; Shilova S. A., 2009, Current Zoology, V55, P81; Sludskiy AA, 1969, MAMMALS KAZACHSTAN R; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Spiridonova LN, 2005, RUSS J GENET+, V41, P991, DOI 10.1007/s11177-005-0190-x; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorington R.W., 2005, MAMMAL SPECIES WORLD; Tokaji K, 2012, 4 EUR GROUND SQUIRR, P17; Tsvirka Marina V., 2012, Vestnik Tomskogo Gosudarstvennogo Universiteta Biologiya, V4, P145; VANDERKUYL AC, 1995, J MOL EVOL, V40, P652, DOI 10.1007/BF00160513; Verzhutsky D.B., 1999, Parazitologiya (St. Petersburg), V33, P242; Vorontsov NN, 1980, GENETICA HAGUE, V52, P229; Zagorodnuk IV, 1995, VESTN ZOOL, V29, P49; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	89	29	33	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117201	10.1371/journal.pone.0117201	http://dx.doi.org/10.1371/journal.pone.0117201			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617768	Green Submitted, Green Published, gold			2022-12-27	WOS:000350336000040
J	Hiyama, Y; Asai, T; Wada, O; Maruno, H; Nitta, S; Mizuno, K; Iwasaki, Y; Okada, S				Hiyama, Yoshinori; Asai, Tsuyoshi; Wada, Osamu; Maruno, Hideto; Nitta, Shingo; Mizuno, Kiyonori; Iwasaki, Yasunobu; Okada, Shuichi			Gait Variability before Surgery and at Discharge in Patients Who Undergo Total Knee Arthroplasty: A Cohort Study	PLOS ONE			English	Article							OLDER-ADULTS; FALLS RISK; REHABILITATION; PAIN; REPLACEMENT; RECOVERY; WOMEN; OSTEOARTHRITIS; RELIABILITY; STRENGTH	This study aimed to determine gait ability at hospital discharge in patients undergoing total knee arthroplasty (TKA) as an indicator of the risk of falling. Fifty-seven patients undergoing primary TKA for knee osteoarthritis participated in this study. Gait variability measured with accelerometers and physical function including knee range of motion (ROM), quadriceps strength, walking speed, and the Timed Up and Go (TUG) test were evaluated preoperatively and at discharge from the hospital (1 month before and 5 days after surgery). All patients were discharged directly home at 5 days after surgery. Knee flexion of ROM, quadriceps strength, walking speed, and the TUG test results were significantly worse at hospital discharge than preoperatively (p < 0.001). However, gait variability was not significantly different before and after TKA. This result indicated that patients following TKA surgery could walk at hospital discharge as stably as preoperatively regardless of the decrease in physical function, including knee ROM, quadriceps strength, and gait speed after surgery.	[Hiyama, Yoshinori; Wada, Osamu; Maruno, Hideto; Nitta, Shingo; Mizuno, Kiyonori; Iwasaki, Yasunobu] Anshin Hosp, Kobe, Hyogo, Japan; [Hiyama, Yoshinori; Okada, Shuichi] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo 657, Japan; [Asai, Tsuyoshi] Kobegakuin Univ, Fac Rehabil, Dept Phys Therapy, Kobe, Hyogo, Japan	Kobe University; Kobe Gakuin University	Hiyama, Y (corresponding author), Anshin Hosp, Kobe, Hyogo, Japan.	yoshinori.hiyama@gmail.com		Wada, Osamu/0000-0001-6918-3499				BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Brach JS, 2007, J GERONTOL A-BIOL, V62, P983, DOI 10.1093/gerona/62.9.983; Brand C, 2005, APLAR J RHEUMATOLOGY, V8, P99, DOI [10.1111/j.1479-8077.2005.00136.x, DOI 10.1111/J.1479-8077.2005.00136.X]; CALLAHAN CM, 1994, JAMA-J AM MED ASSOC, V271, P1349, DOI 10.1001/jama.271.17.1349; Enloe LJ, 1996, J ORTHOP SPORT PHYS, V23, P3, DOI 10.2519/jospt.1996.23.1.3; Foley SJ, 2006, OSTEOARTHR CARTILAGE, V14, P533, DOI 10.1016/j.joca.2005.12.007; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; HAUSDORFF JM, 1995, J BIOMECH, V28, P347, DOI 10.1016/0021-9290(94)00074-E; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Hausdorff JM, 1997, ARCH PHYS MED REHAB, V78, P278, DOI 10.1016/S0003-9993(97)90034-4; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Katoh M, 2009, J PHYS THER SCI, V21, P37, DOI 10.1589/jpts.21.37; Kauppila AM, 2010, CLIN REHABIL, V24, P398, DOI 10.1177/0269215509346089; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Lamb SE, 2000, ANN RHEUM DIS, V59, P331, DOI 10.1136/ard.59.5.331; Leveille SG, 2002, J AM GERIATR SOC, V50, P671, DOI 10.1046/j.1532-5415.2002.50161.x; Levinger P, 2011, KNEE SURG SPORT TR A, V19, P1082, DOI 10.1007/s00167-010-1325-8; Lombardi AV, 2006, CLIN ORTHOP RELAT R, P117, DOI 10.1097/01.blo.0000238824.56024.7a; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; MANSKE PR, 1977, PHYS THER, V57, P915, DOI 10.1093/ptj/57.8.915; Matsumoto H, 2012, ARCH ORTHOP TRAUM SU, V132, P555, DOI 10.1007/s00402-011-1418-y; Mizner RL, 2005, J ORTHOP SPORT PHYS, V35, P424, DOI 10.2519/jospt.2005.35.7.424; Munin MC, 1998, JAMA-J AM MED ASSOC, V279, P847, DOI 10.1001/jama.279.11.847; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Reelick MF, 2009, AGE AGEING, V38, P435, DOI 10.1093/ageing/afp066; Reilly KA, 2005, KNEE, V12, P351, DOI 10.1016/j.knee.2005.01.002; Renkawitz T, 2010, CLIN REHABIL, V24, P230, DOI 10.1177/0269215509353267; Labraca NS, 2011, CLIN REHABIL, V25, P557, DOI 10.1177/0269215510393759; Sturnieks DL, 2004, J RHEUMATOL, V31, P2272; Williams SB, 2010, ARCH PHYS MED REHAB, V91, P106, DOI 10.1016/j.apmr.2009.08.150; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Yeung TSM, 2008, J ORTHOP SPORT PHYS, V38, P410, DOI [10.2519/jospt.2008.2657, 10.519/jospt.2008.2657]	37	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117683	10.1371/journal.pone.0117683	http://dx.doi.org/10.1371/journal.pone.0117683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4PT	25617842	gold, Green Published, Green Submitted			2022-12-27	WOS:000350336000045
J	Shahmanesh, M; Phillips, K; Boothby, M; Tomlinson, JW				Shahmanesh, Mohsen; Phillips, Kenneth; Boothby, Meg; Tomlinson, Jeremy W.			Differential Adipose Tissue Gene Expression Profiles in Abacavir Treated Patients That May Contribute to the Understanding of Cardiovascular Risk: A Microarray Study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; INTIMA-MEDIA THICKNESS; INDIVIDUAL ANTIRETROVIRAL DRUGS; ENDOTHELIAL ACTIVATION MARKERS; ACUTE MYOCARDIAL-INFARCTION; PLATELET REACTIVITY; ADHERENS JUNCTIONS; INSULIN-RESISTANCE; DISEASE EVENTS; SUPPRESSED HIV	Objective To compare changes in gene expression by microarray from subcutaneous adipose tissue from HIV treatment naive patients treated with efavirenz based regimens containing abacavir (ABC), tenofovir (TDF) or zidovidine (AZT). Design Subcutaneous fat biopsies were obtained before, at 6- and 18-24-months after treatment, and from HIV negative controls. Groups were age, ethnicity, weight, biochemical profile, and pre-treatment CD4 count matched. Microarray data was generated using the Agilent Whole Human Genome Microarray. Identification of differentially expressed genes and genomic response pathways was performed using limma and gene set enrichment analysis. Results There were significant divergences between ABC and the other two groups 6 months after treatment in genes controlling cell adhesion and environmental information processing, with some convergence at 18-24 months. Compared to controls the ABC group, but not AZT or TDF showed enrichment of genes controlling adherence junction, at 6 months and 18-24 months (adjusted p<0.05) and focal adhesions and tight junction at 6 months (p<0.5). Genes controlling leukocyte transendothelial migration (p<0.05) and ECM-receptor interactions (p = 0.04) were over-expressed in ABC compared to TDF and AZT at 6 months but not at 18-24 months. Enrichment of pathways and individual genes controlling cell adhesion and environmental information processing were specifically dysregulated in the ABC group in comparison with other treatments. There was little difference between AZT and TDF. Conclusion After initiating treatment, there is divergence in the expression of genes controlling cell adhesion and environmental information processing between ABC and both TDF and AZT in subcutaneous adipose tissue. If similar changes are also taking place in other tissues including the coronary vasculature they may contribute to the increased risk of cardiovascular events reported in patients recently started on abacavir-containing regimens.	[Shahmanesh, Mohsen] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Phillips, Kenneth] ILS Genom, Morrisville, NC USA; [Boothby, Meg] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Tomlinson, Jeremy W.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	University of Birmingham; University of Birmingham; University of Oxford	Tomlinson, JW (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	jeremy.tomlinson@ocdem.ox.ac.uk	Shahmanesh, Mohsen/B-1183-2013	Shahmanesh, Maryam/0000-0001-7129-8535; Tomlinson, Jeremy/0000-0002-3170-8533	Gilead Sciences; Pharmacia Upjohn; Dupont Pharmaceuticals; Sexually Transmitted Infection Research Foundation; Jo Lee Foundation; Medical Research Council [G0802765] Funding Source: researchfish	Gilead Sciences(Gilead Sciences); Pharmacia Upjohn; Dupont Pharmaceuticals; Sexually Transmitted Infection Research Foundation; Jo Lee Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by an unrestricted educational grant from Gilead Sciences, Pharmacia Upjohn, Dupont Pharmaceuticals, Sexually Transmitted Infection Research Foundation (a UK-based charity, http:/stirf.org) and the Jo Lee Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Baum PD, 2011, AIDS, V25, P2243, DOI 10.1097/QAD.0b013e32834d3cc3; Bavinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059551; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Bobryshev YV, 1998, CARDIOVASC RES, V40, P191, DOI 10.1016/S0008-6363(98)00141-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boothby M, 2009, ANTIVIR THER, V14, P1089, DOI 10.3851/IMP1457; Bozzette SA, 2011, CLIN INFECT DIS, V53, P92, DOI 10.1093/cid/cir275; Brothers CH, 2009, JAIDS-J ACQ IMM DEF, V51, P20, DOI 10.1097/QAI.0b013e31819ff0e6; Caron M, 2009, PPAR RES, V2009, DOI 10.1155/2009/507141; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2003, JAIDS-J ACQ IMM DEF, V34, pS73, DOI 10.1097/00126334-200309011-00011; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; Cruciani M, 2011, AIDS, V25, P1993, DOI 10.1097/QAD.0b013e328349c6ee; de Gaetano Donati Katleen, 2010, Mediterr J Hematol Infect Dis, V2, pe2010034, DOI 10.4084/MJHID.2010.034; De Pablo C, 2013, J INFECT DIS, V208, P1448, DOI 10.1093/infdis/jit340; De Pablo C, 2010, AIDS, V24, P1259, DOI 10.1097/QAD.0b013e32833a2b02; Donati KD, 2004, LANCET INFECT DIS, V4, P213, DOI 10.1016/S1473-3099(04)00971-5; Durand M, 2011, JAIDS-J ACQ IMM DEF, V57, P245, DOI 10.1097/QAI.0b013e31821d33a5; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Falcinelli E, 2013, THROMB HAEMOSTASIS, V110, P349, DOI 10.1160/TH12-07-0504; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Gentleman R, 2005, BIOINFORMATICS AND C; Giralt M, 2009, PPAR RES, V2009, DOI 10.1155/2009/607902; Hileman CO, 2012, AIDS RES HUM RETROV, V28, P1561, DOI [10.1089/aid.2012.0034, 10.1089/AID.2012.0034]; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Mallon PWG, 2003, AIDS, V17, P971, DOI 10.1097/00002030-200305020-00005; Martin A, 2010, AIDS, V24, P2657, DOI 10.1097/QAD.0b013e32833f147f; Martinez E, 2013, AIDS RES HUM RETROV, V29, P235, DOI [10.1089/aid.2012.0150, 10.1089/AID.2012.0150]; Martinez E, 2010, AIDS, V24, pF1, DOI 10.1097/QAD.0b013e32833562c5; McComsey GA, 2012, AIDS, V26, P1371, DOI 10.1097/QAD.0b013e328354f4fb; McGee KC, 2012, ANTIVIR THER, V17, P495, DOI 10.3851/IMP2017; Obel N, 2010, HIV MED, V11, P130, DOI 10.1111/j.1468-1293.2009.00751.x; Palella FJ, 2010, AIDS, V24, P1657, DOI 10.1097/QAD.0b013e3283389dfa; Resink TJ, 2009, SWISS MED WKLY, V139, P122, DOI smw-12429; Ribaudo HJ, 2011, CLIN INFECT DIS, V52, P929, DOI 10.1093/cid/ciq244; Ross AC, 2010, ATHEROSCLEROSIS, V211, P492, DOI 10.1016/j.atherosclerosis.2010.04.008; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Satchell CS, 2011, J INFECT DIS, V204, P1202, DOI 10.1093/infdis/jir509; Satchell CS, 2010, AIDS, V24, P649, DOI 10.1097/QAD.0b013e328336098c; Servant Nicolas, 2010, BMC Res Notes, V3, P277, DOI 10.1186/1756-0500-3-277; Shlay JC, 2008, JAIDS-J ACQ IMM DEF, V48, P53, DOI 10.1097/QAI.0b013e31816856ed; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tebas P, 2008, JAIDS-J ACQ IMM DEF, V49, pS86, DOI 10.1097/QAI.0b013e31818651e6; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Trevillyan JM, 2013, SEX HEALTH, V10, P97, DOI 10.1071/SH12081; van Vonderen MGA, 2009, J INFECT DIS, V199, P1186, DOI 10.1086/597475; Wohl DA, 2013, COMPARISON OF CARDIO; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897	61	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117164	10.1371/journal.pone.0117164	http://dx.doi.org/10.1371/journal.pone.0117164			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617630	Green Submitted, Green Published, gold			2022-12-27	WOS:000350336000039
J	Chen, CY; Huang, KYA; Shen, JH; Tsao, KC; Huang, YC				Chen, Chao-Yu; Huang, Kuan-Ying A.; Shen, Jen-Hsiang; Tsao, Kuo-Chien; Huang, Yhu-Chering			A Large-Scale Seroprevalence of Epstein-Barr Virus in Taiwan	PLOS ONE			English	Article							INFECTIOUS-MONONUCLEOSIS; UNIVERSITY-STUDENTS; RISK-FACTORS; CHILDREN; ANTIBODIES; PREVALENCE; SEX; HERPESVIRUSES; ACQUISITION; POPULATION	Background Epstein-Barr virus (EBV) causes a variety of clinical manifestations from asymptomatic infection to acute infectious mononucleosis in human. Moreover, the EBV infection is associated with malignancies. The large-scale EBV seroepidemiology across all age groups has been lacking in Taiwan. Methods A total of 1411 serum samples were tested to examine the seroprevalence of EBV in 2007. The samples were collected during an island-wide seroepidemiological survey of vaccine preventable diseases in Taiwan. The enzyme-linked immunosorbent assay was performed to detect anti-EBV viral capsid IgG in sera. Demographic and personal health data were obtained by questionnaires. Results The overall weighted seropositive rate of EBV was 88.5% (95% CI, 86.7%-90.1%). The seropositive rate of EBV reached 52.8% (95% CI, 44.0%-61.6%) in children aged 2 years, rapidly rose to 88.7%(95% CI, 79.0%-95.1%) in those aged 5-7 years and 93.0%(95% CI, 83.0%-98.1%) for those aged 14-16 years. Age and higher educational level were associated with the increased EBV seropositive rate. Conclusion In Taiwan, people had the EBV infection early in life. Children under 7 years should be the primary target popution of public health measures in the future.	[Chen, Chao-Yu; Shen, Jen-Hsiang; Tsao, Kuo-Chien; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chen, Chao-Yu; Huang, Kuan-Ying A.; Shen, Jen-Hsiang; Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Taoyuan, Taiwan; [Tsao, Kuo-Chien] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	ychuang@cgmh.org.tw	Chen, Chao-Yu/HGE-7352-2022; Shen, Jen-Hsiang/GVS-5543-2022	Chen, Chao-Yu/0000-0003-0302-2347; 	Chang Gung Memorial Hospital [CMRPG470132]; Medical Foundation	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Medical Foundation	This study was support by a grant from Chang Gung Memorial Hospital (CMRPG470132) and partly supported by Medical Foundation in Memory of Dr. Deh-Lin Cheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-111; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; BIGGAR RJ, 1981, LANCET, V2, P115; Chen Chih-Jung, 2004, Journal of Microbiology Immunology and Infection, V37, P157; Chen CJ, 2012, VACCINE, V30, P6721, DOI 10.1016/j.vaccine.2012.05.019; Chen CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024440; Cheng Chia-Chi, 2007, Journal of Microbiology Immunology and Infection, V40, P216; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Crawford DH, 2006, CLIN INFECT DIS, V43, P276, DOI 10.1086/505400; Crowcroft NS, 1998, J EPIDEMIOL COMMUN H, V52, P101, DOI 10.1136/jech.52.2.101; Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921; EPSTEIN MA, 1985, NATURE, V318, P287, DOI 10.1038/318287a0; Gartner BC, 2003, CLIN DIAGN LAB IMMUN, V10, P78, DOI 10.1128/CDLI.10.1.78-82.2003; GERBER P, 1972, LANCET, V2, P988; Haque T, 1996, J MED VIROL, V48, P17, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;17::AID-JMV3&gt;3.0.CO;2-O; HEATH CW, 1972, AM J EPIDEMIOL, V95, P46, DOI 10.1093/oxfordjournals.aje.a121369; HENLE G, 1969, J NATL CANCER I, V43, P1147; Hess RD, 2004, J CLIN MICROBIOL, V42, P3381, DOI 10.1128/JCM.42.8.3381-3387.2004; Higgins CD, 2007, J INFECT DIS, V195, P474, DOI 10.1086/510854; HO SPS, 1982, WORLD DEV, V10, P973, DOI 10.1016/0305-750X(82)90036-5; Jenson H, 1999, J INFECT DIS, V179, P1395, DOI 10.1086/314764; Jenson HB, 2011, PEDIATR REV, V32, P375, DOI 10.1542/pir.32-9-375; KANGRO HO, 1994, J MED VIROL, V43, P91, DOI 10.1002/jmv.1890430117; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; LEMON SM, 1977, NATURE, V268, P268, DOI 10.1038/268268a0; Levine N, 2012, ANN EPIDEMIOL, V22, P783, DOI 10.1016/j.annepidem.2012.06.099; Macsween KF, 2010, CLIN INFECT DIS, V50, P699, DOI 10.1086/650456; MILLER G, 1973, NEW ENGL J MED, V288, P229, DOI 10.1056/NEJM197302012880503; Odumade OA, 2011, CLIN MICROBIOL REV, V24, P193, DOI 10.1128/CMR.00044-10; Pancharoen C, 2001, ASIAN PAC J ALLERGY, V19, P135; Rezza G, 2001, EMERG INFECT DIS, V7, P893; Sidorchuk A, 2003, PEDIATR INFECT DIS J, V22, P642, DOI 10.1097/00006454-200307000-00014; Sokal EM, 2007, J INFECT DIS, V196, P1749, DOI 10.1086/523813; SUMAYA CV, 1975, J INFECT DIS, V131, P403, DOI 10.1093/infdis/131.4.403; Svahn A, 2006, J CLIN VIROL, V37, P118, DOI 10.1016/j.jcv.2006.07.012; Takeuchi K, 2006, PATHOL INT, V56, P112, DOI 10.1111/j.1440-1827.2006.01936.x; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Tsai Ming-Han, 2005, Journal of Microbiology Immunology and Infection, V38, P255; Tsai W S, 1989, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V30, P81; UN, 2007, WORLD URB PROSP 2007; VENKITARAMAN AR, 1985, J MED VIROL, V15, P11, DOI 10.1002/jmv.1890150103; WAGNER HJ, 1994, IMMUNOBIOLOGY, V190, P424, DOI 10.1016/S0171-2985(11)80613-3; WANG PS, 1986, J INFECT DIS, V153, P150, DOI 10.1093/infdis/153.1.150; Xiong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099857	47	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115836	10.1371/journal.pone.0115836	http://dx.doi.org/10.1371/journal.pone.0115836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615611	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100019
J	Kowalczyk, A; Lukaszewicz, E				Kowalczyk, Artur; Lukaszewicz, Ewa			Simple and Effective Methods of Freezing Capercaillie (Tetrao urogallus L.) Semen	PLOS ONE			English	Article							AVIAN SPERMATOZOA; CRYOPRESERVATION; SPERM; POULTRY; CRYOPROTECTANT; CONSERVATION; FROZEN; FERTILITY; TOLERANCE; CRYOBANK	A continuous decline in the number and range of capercaillie (Tetrao urogallus L.) in many European countries can be observed, mostly due to habitat destruction by human activity, unecological forestry management, and increased density of natural predators. Ex situ in vitro gene banks provide a unique opportunity to preserve the genetic material for future generations. Simple and effective cryopreservation methods for capercaillie semen are discussed. Semen was collected from seven males kept in the Capercaillie Breeding Centre at Forestry Wisla in Poland. Within five minutes after collection, ejaculates were diluted with EK diluent, then divided into two parts, and subjected to two freezing procedures: in pellets and in straws. In fresh semen, ejaculate clearness, viscosity, color and volume, as well as sperm concentration, motility and morphology, were evaluated, while in frozen-thawed semen only motility and morphology of sperm were determined. Fertilizing ability of thawed semen was examined for samples frozen in straws. Significant (P < 0.05) differences between individual males were found in relation to the majority of fresh semen traits: ejaculate volume averaged 102.1 mu L (varying from 49.0 to 205.0); average sperm concentration was 632.5 x 10(6) mL(-1) (178.8-1257.1); percentage of live normal cells varied from 39.2 to 70.3% (58.7% on an average); percentage of motile cells ranged from 76.0 to 85.7%) and motility parameters were male dependent, as well. Both cryopreservation methods had a negative effect on morphology and motility of frozen-thawed semen; however, the straw method yielded 60.7% and the pellet method 42.5% of live cells in total in thawed semen (P < 0.05), while the number of live normal (intact) cells was similar (22.4 and 22.2%, respectively). Egg fertility varied between 77.8 and 91.7% (average 84.4%). Both freezing procedures seem to be effective in obtaining acceptable viability and high fertilizing potency of thawed sperm and can be used to create a gene bank of capercaillie semen.	[Kowalczyk, Artur; Lukaszewicz, Ewa] Wroclaw Univ Environm & Life Sci, Div Poultry Breeding, Inst Anim Breeding, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences	Lukaszewicz, E (corresponding author), Wroclaw Univ Environm & Life Sci, Div Poultry Breeding, Inst Anim Breeding, Wroclaw, Poland.	ewa.lukaszewicz@up.wroc.pl	Kowalczyk, Artur/B-5721-2017; ŁUKASZEWICZ, EWA T./B-4114-2017	Kowalczyk, Artur/0000-0001-7446-0147; ŁUKASZEWICZ, EWA T./0000-0002-9505-0056	National Research Centre [NN 311 081040]; Wroclaw Centre of Biotechnology, program The Leading National Research Centre (KNOW)	National Research Centre(National Research Centre (NRC)); Wroclaw Centre of Biotechnology, program The Leading National Research Centre (KNOW)	This experiment was financially supported by the National Research Centre, Grant NN 311 081040. Publication was supported by Wroclaw Centre of Biotechnology, program The Leading National Research Centre (KNOW) for the years 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanch E, 2014, THERIOGENOLOGY, V81, P1174, DOI 10.1016/j.theriogenology.2014.01.019; Blanco JM, 2009, THERIOGENOLOGY, V71, P200, DOI 10.1016/j.theriogenology.2008.09.019; Blanco JM, 2000, BIOL REPROD, V63, P1164, DOI 10.1095/biolreprod63.4.1164; Blanco JM, 2008, CRYOBIOLOGY, V56, P8, DOI 10.1016/j.cryobiol.2007.09.004; Blanco JM, 2012, ANIM REPROD SCI, V131, P1, DOI 10.1016/j.anireprosci.2012.02.001; Blesbois E, 2007, WORLD POULTRY SCI J, V63, P213, DOI 10.1017/S0043933907001419; Blesbois E, 2008, THERIOGENOLOGY, V69, P252, DOI 10.1016/j.theriogenology.2007.09.019; Blesbois E, 2007, POULTRY SCI, V86, P555, DOI 10.1093/ps/86.3.555; Blesbois E, 2005, REPRODUCTION, V129, P371, DOI 10.1530/rep.1.00454; Blesbois E, 2011, AVIAN BIOL RES, V4, P52, DOI 10.3184/175815511X13069413108523; Chalah T, 1999, CRYOBIOLOGY, V39, P185, DOI 10.1006/cryo.1999.2201; Ciereszko A, 2011, EUR J WILDLIFE RES, V57, P383, DOI 10.1007/s10344-010-0436-3; Gee G.F., 1995, P 1 INT S ART INS PO, P262; KOWALCZYK A, 2012, P 12 INT GROUS S 20; Kowalczyk A, 2008, CRYOLETTERS, V29, P199; Kowalczyk A, 2012, THERIOGENOLOGY, V77, P899, DOI 10.1016/j.theriogenology.2011.09.015; Lukaszewicz E, 2004, ANIM REPROD SCI, V80, P163, DOI 10.1016/S0378-4320(03)00119-2; Lukaszewicz E, 2003, THERIOGENOLOGY, V59, P1627, DOI 10.1016/S0093-691X(02)01209-8; Lukaszewicz E, 2002, THERIOGENOLOGY, V58, P19, DOI 10.1016/S0093-691X(01)00690-2; Lukaszewicz E, 2011, ZOO BIOL, V30, P672, DOI 10.1002/zoo.20367; Lukaszewicz E, 2011, ORNIS FENNICA, V88, P110; Saint Jalme M, 2003, THERIOGENOLOGY, V59, P875, DOI 10.1016/S0093-691X(02)01153-6; Santiago-Moreno J, 2011, POULTRY SCI, V90, P2047, DOI 10.3382/ps.2011-01355; Siudzinska A, 2008, ANIM SCI PAP REP, V26, P331; Storch I, 2007, WILDLIFE BIOL, V13, P5, DOI 10.2981/0909-6396(2007)13[5:CSOGWA]2.0.CO;2; TSELUTIN K, 1995, BRIT POULTRY SCI, V36, P805, DOI 10.1080/00071669508417825; Varadi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062759; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; Woelders H, 2006, POULTRY SCI, V85, P216, DOI 10.1093/ps/85.2.216; Zaniboni L, 2014, THERIOGENOLOGY, V82, P251, DOI 10.1016/j.theriogenology.2014.04.007	30	21	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116797	10.1371/journal.pone.0116797	http://dx.doi.org/10.1371/journal.pone.0116797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615640	Green Published, gold, Green Submitted			2022-12-27	WOS:000349122100043
J	Vazquez, L; Renton, K				Vazquez, Leopoldo; Renton, Katherine			High Density of Tree-Cavities and Snags in Tropical Dry Forest of Western Mexico Raises Questions for a Latitudinal Gradient	PLOS ONE			English	Article							LILAC-CROWNED PARROT; NESTING BIRDS; ATLANTIC FOREST; PROBOSCIGER-ATERRIMUS; CONSERVATION STATUS; DECIDUOUS FOREST; PALM COCKATOOS; AVAILABILITY; COMMUNITIES; SELECTION	It has been suggested that a latitudinal gradient exists of a low density of snags and high density of naturally-formed tree-cavities in tropical vs. temperate forests, though few cavities may have characteristics suitable for nesting by birds. We determined snag and cavity density, characteristics, and suitability for birds in a tropical dry forest biome of western Mexico, and evaluated whether our data fits the trend of snag and cavity density typically found in tropical moist and wet forests. We established five 0.25-ha transects to survey and measure tree-cavities and snags in each of three vegetation types of deciduous, semi-deciduous, and mono-dominant Piranhea mexicana forest, comprising a total of 3.75 ha. We found a high density of 77 cavities/ha, with 37 cavities suitable for birds/ha, where density, and characteristics of cavities varied significantly among vegetation types. Lowest abundance of cavities occurred in deciduous forest, and these were in smaller trees, at a lower height, and with a narrower entrance diameter. Only 8.6% of cavities were excavated by woodpeckers, and only 11% of cavities were occupied, mainly by arthropods, though 52% of all cavities were unsuitable for birds. We also found a high density of 56 snags/ha, with greatest density in deciduous forest (70 snags/ha), though these were of significantly smaller diameter, and snags of larger diameter were more likely to contain cavities. The Chamela-Cuixmala tropical dry forest had the highest density of snags recorded for any tropical or temperate forest, and while snag density was significantly correlated with mean snag dbh, neither latitude nor mean dbh predicted snag density in ten forest sites. The high spatial aggregation of snag and cavity resources in tropical dry forest may limit their availability, particularly for large-bodied cavity adopters, and highlights the importance of habitat heterogeneity in providing resources for primary and secondary cavity-nesters.	[Vazquez, Leopoldo] Univ Nacl Autonoma Mexico, Inst Biol, Posgrado Ciencia Biol, Mexico City 04510, DF, Mexico; [Renton, Katherine] Univ Nacl Autonoma Mexico, Inst Biol, Estn Biol Chamela, San Patricio Melaque, Jalisco, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Renton, K (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Estn Biol Chamela, San Patricio Melaque, Jalisco, Mexico.	krenton@ib.unam.mx			Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) of the Direccion General Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (UNAM) [IN203012]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [83441]; CONACYT at the Posgrado en Ciencias Biologicas, UNAM [220265]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) of the Direccion General Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT at the Posgrado en Ciencias Biologicas, UNAM	The study was funded by research grants from the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT; grant number IN203012 to KR) of the Direccion General Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (UNAM), and Consejo Nacional de Ciencia y Tecnologia (CONACyT; grant number 83441 in collaboration with E. Martinez Meyer). LV was supported by a postgraduate grant from CONACYT (grant number 220265) at the Posgrado en Ciencias Biologicas, UNAM. The Fundacion Ecologica de Cuixmala A.C. provided logistical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KEH, 2007, J ORNITHOL, V148, pS425, DOI 10.1007/s10336-007-0166-9; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2005, ARBOLES TROPICALES M; Boyle WA, 2008, BIOTROPICA, V40, P241, DOI 10.1111/j.1744-7429.2007.00357.x; BULLOCK SH, 1986, ARCH METEOR GEOPHY B, V36, P297, DOI 10.1007/BF02263135; Cockle K, 2008, ORNITOL NEOTROP, V19, P269; Cockle K, 2011, BIOTROPICA, V43, P228, DOI 10.1111/j.1744-7429.2010.00661.x; Cockle KL, 2012, FOREST ECOL MANAG, V264, P210, DOI 10.1016/j.foreco.2011.10.015; Cockle KL, 2011, FRONT ECOL ENVIRON, V9, P377, DOI 10.1890/110013; Cockle KL, 2010, BIOL CONSERV, V143, P2851, DOI 10.1016/j.biocon.2010.08.002; Escalante P., 1998, DIVERSIDAD BIOL MEXI, P279; Galicia L, 1999, CATENA, V36, P153, DOI 10.1016/S0341-8162(98)00121-0; GENTRY AH, 1982, EVOL BIOL, V15, P1; Gentry Alwyn H., 1995, P146, DOI 10.1017/CBO9780511753398.007; GIBBS JP, 1993, BIOTROPICA, V25, P236, DOI 10.2307/2389188; Heinsohn R, 2003, AUST J ZOOL, V51, P81, DOI 10.1071/ZO02003; Jauregui E, 2003, ATMOSFERA, V16, P193; Koch AJ, 2008, FOREST ECOL MANAG, V255, P3938, DOI 10.1016/j.foreco.2008.03.025; Lesnoff, 2012, AOD ANAL OVERDISPERS; LOTT EJ, 1987, BIOTROPICA, V19, P228, DOI 10.2307/2388340; Lott EJ, 1993, OCCASIONAL PAPERS CA, V148, P1; Maass J. M., 2002, HIST NATURAL CHAMELA, P525; MARTIJENA NE, 1994, J BIOGEOGR, V21, P63, DOI 10.2307/2845604; Martin K, 2004, CONDOR, V106, P5, DOI 10.1650/7482; Martin K, 1999, FOREST ECOL MANAG, V115, P243, DOI 10.1016/S0378-1127(98)00403-4; Masera OR, 1997, CLIMATIC CHANGE, V35, P265, DOI 10.1023/A:1005309908420; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Miranda A, 1997, DEFORESTACION FRAGME; Monterrubio-Rico TC, 2006, BIOL CONSERV, V128, P67, DOI 10.1016/j.biocon.2005.09.017; MOONEY HA, 1995, SEASONALLY DRY TROPI, P1, DOI DOI 10.1017/CBO9780511753398.001; Murphy S, 2003, J ZOOL, V261, P327, DOI 10.1017/S0952836903004175; Murphy SA, 2007, EMU, V107, P1, DOI 10.1071/MU06012; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pattanavibool A, 1996, J WILDLIFE MANAGE, V60, P67, DOI 10.2307/3802041; Politi N, 2010, FOREST ECOL MANAG, V260, P893, DOI 10.1016/j.foreco.2010.06.009; Politi N, 2009, BIOTROPICA, V41, P354, DOI 10.1111/j.1744-7429.2008.00481.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rayner L, 2011, AUSTRAL ECOL, V36, P252, DOI 10.1111/j.1442-9993.2010.02145.x; Renton K, 2004, CONDOR, V106, P354, DOI 10.1650/7388; Renton K, 2001, CONDOR, V103, P62, DOI 10.1650/0010-5422(2001)103[0062:LCPDAF]2.0.CO;2; Renton K, 1999, WILSON BULL, V111, P488; Rzedowski J., 1978, VEGETACION MEXICO; Salinas-Melgoza A, 2009, CONDOR, V111, P305, DOI 10.1525/cond.2009.090017; Sanchez-Azofeifa GA, 2009, FOREST ECOL MANAG, V258, P907, DOI 10.1016/j.foreco.2008.10.030; Sandoval L, 2006, ORNITOL NEOTROP, V17, P295; Sandoval L, 2009, WILSON J ORNITHOL, V121, P75, DOI 10.1676/07-165.1; SAUNDERS DA, 1984, AUST J ZOOL, V32, P57, DOI 10.1071/ZO9840057; Stojanovic D, 2012, EMU, V112, P350, DOI 10.1071/MU11076; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Watson A, 1970, P167; Wiebe KL, 2011, J FIELD ORNITHOL, V82, P239, DOI 10.1111/j.1557-9263.2011.00327.x; Zar JH, 1999, BIOSTATISTICAL ANAL	53	14	16	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116745	10.1371/journal.pone.0116745	http://dx.doi.org/10.1371/journal.pone.0116745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615612	Green Published, Green Submitted, gold			2022-12-27	WOS:000349122100041
J	Ekizoglu, S; Bulut, P; Karaman, E; Kilic, E; Buyru, N				Ekizoglu, Seda; Bulut, Pelin; Karaman, Emin; Kilic, Erkan; Buyru, Nur			Epigenetic and Genetic Alterations Affect the WWOX Gene in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							GROWTH IN-VITRO; BREAST-CANCER; EXPRESSION; SUPPRESSOR; LUNG; FRA16D; INACTIVATION; RESTORATION; PROGRESSION; REVEALS	Different types of genetic and epigenetic changes are associated with HNSCC. The molecular mechanisms of HNSCC carcinogenesis are still undergoing intensive investigation. WWOX gene expression is altered in many cancers and in a recent work reduced WWOX expression has been associated with miR-134 expression in HNSCC. In this study we investigated the WWOX messenger RNA expression levels in association with the promoter methylation of the WWOX gene and miR-134 expression levels in 80 HNSCC tumor and non-cancerous tissue samples. Our results show that WWOX expression is down-regulated especially in advanced-stage tumor samples or in tumors with SCC. This down-regulation was associated with methylation of the WWOX promoter region but not with miR-134 expression. There was an inverse correlation between the expression level and promoter methylation. We also analyzed whole exons and exon/intron boundries of the WWOX gene by direct sequencing. In our study group we observed 10 different alterations in the coding sequences and 18 different alterations in the non-coding sequences of the WWOX gene in HNSCC tumor samples. These results indicate that the WWOX gene can be functionally inactivated by promoter methylation, epigenetically or by mutations affecting the sequences coding for the enzymatic domain of the gene, functionally. We conclude that inactivation of WWOX gene contributes to the progression of HNSCC.	[Ekizoglu, Seda; Bulut, Pelin; Buyru, Nur] Istanbul Univ, Cerrahpasa Med Fac, Dept Med Biol, Istanbul, Turkey; [Karaman, Emin; Kilic, Erkan] Istanbul Univ, Cerrahpasa Med Fac, Dept Otorhinolaryngol, Istanbul, Turkey	Istanbul University; Istanbul University - Cerrahpasa; Istanbul University; Istanbul University - Cerrahpasa	Buyru, N (corresponding author), Istanbul Univ, Cerrahpasa Med Fac, Dept Med Biol, Istanbul, Turkey.	nbuyru@yahoo.com	Buyru, Nur/D-1810-2019	Buyru, Nur/0000-0002-6920-1455				Abdeen SK, 2011, ONCOGENE, V30, P3900, DOI 10.1038/onc.2011.115; Aldaz CM, 2014, BBA-REV CANCER, V1846, P188, DOI 10.1016/j.bbcan.2014.06.001; Aqeilan RI, 2007, CANCER RES, V67, P5606, DOI 10.1158/0008-5472.CAN-07-1081; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2004, CLIN CANCER RES, V10, P3053, DOI 10.1158/1078-0432.CCR-03-0594; Baykara O, 2010, TUMOR BIOL, V31, P315, DOI 10.1007/s13277-010-0039-3; Bednarek AK, 2000, CANCER RES, V60, P2140; Bednarek AK, 2001, CANCER RES, V61, P8068; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cancemi L, 2011, INT J CANCER, V129, P2816, DOI 10.1002/ijc.25937; Donati V, 2007, CLIN CANCER RES, V13, P884, DOI 10.1158/1078-0432.CCR-06-2016; Ekizoglu S, 2012, MED ONCOL, V29, P1529, DOI 10.1007/s12032-011-0080-0; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Gale NP, 2005, WHO CLASSIFICATION T, P140; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Guo W, 2013, MOL CARCINOGEN, V52, P265, DOI 10.1002/mc.21853; Guo W, 2013, ENVIRON MOL MUTAGEN, V54, P112, DOI 10.1002/em.21748; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Iliopoulos D, 2005, ONCOGENE, V24, P1625, DOI 10.1038/sj.onc.1208398; Iliopoulos D, 2007, CLIN CANCER RES, V13, P268, DOI 10.1158/1078-0432.CCR-06-2038; Jenner MW, 2007, BLOOD, V110, P3291, DOI 10.1182/blood-2007-02-075069; Kuroki T, 2004, CLIN CANCER RES, V10, P2459, DOI 10.1158/1078-0432.CCR-03-0096; Kuroki T, 2002, CANCER RES, V62, P2258; Liu CJ, 2014, INT J CANCER, V134, P811, DOI 10.1002/ijc.28358; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nunez M, 2005, BREAST CANCER RES TR, V89, P99, DOI 10.1007/s10549-004-1474-x; Nunez MI, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-64; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Pimenta FJ, 2006, INT J CANCER, V118, P1154, DOI 10.1002/ijc.21446; Ramos D, 2008, HISTOPATHOLOGY, V52, P831, DOI 10.1111/j.1365-2559.2008.03033.x; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Yan HC, 2013, BIOMED REP, V1, P375, DOI 10.3892/br.2013.86; Yan HC, 2013, ONCOL LETT, V6, P845, DOI 10.3892/ol.2013.1438	35	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115353	10.1371/journal.pone.0115353	http://dx.doi.org/10.1371/journal.pone.0115353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612104	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900008
J	Feistritzer, HJ; Reinstadler, SJ; Klug, G; Kremser, C; Seidner, B; Esterhammer, R; Schocke, MF; Franz, WM; Metzler, B				Feistritzer, Hans-Josef; Reinstadler, Sebastian J.; Klug, Gert; Kremser, Christian; Seidner, Benjamin; Esterhammer, Regina; Schocke, Michael F.; Franz, Wolfgang-Michael; Metzler, Bernhard			Comparison of an Oscillometric Method with Cardiac Magnetic Resonance for the Analysis of Aortic Pulse Wave Velocity	PLOS ONE			English	Article							ARTERIAL STIFFNESS; MYOCARDIAL-INFARCTION; INDEPENDENT PREDICTOR; HYPERTENSIVE PATIENTS; TRAVEL DISTANCE; BRACHIAL CUFF; ALL-CAUSE; AGE; DISTENSIBILITY; VALIDATION	Objectives Pulse wave velocity (PWV) is the proposed gold-standard for the assessment of aortic elastic properties. The aim of this study was to compare aortic PWV determined by a recently developed oscillometric device with cardiac magnetic resonance imaging (CMR). Methods PWV was assessed in 40 volunteers with two different methods. The oscillometric method (PWVOSC) is based on a transfer function from the brachial pressure waves determined by oscillometric blood pressure measurements with a common cuff (Mobil-O-Graph, I.E.M. Stolberg, Germany). CMR was used to determine aortic PWVCMR with the use of the transit time method based on phase-contrast imaging at the level of the ascending and abdominal aorta on a clinical 1.5 Tesla scanner (Siemens, Erlangen, Germany). Results The median age of the study population was 34 years (IQR: 24-55 years, 11 females). A very strong correlation was found between PWVOSC and PWVCMR (r = 0.859, p < 0.001). Mean PWVOSC was 6.7 +/- 1.8 m/s and mean PWVCMR was 6.1 +/- 1.8 m/s (p < 0.001). Analysis of agreement between the two measurements using Bland-Altman method showed a bias of 0.57 m/s (upper and lower limit of agreement: 2.49 m/s and -1.34 m/s). The corresponding coefficient of variation between both measurements was 15%. Conclusion Aortic pulse wave velocity assessed by transformation of the brachial pressure waveform showed an acceptable agreement with the CMR-derived transit time method.	[Feistritzer, Hans-Josef; Reinstadler, Sebastian J.; Klug, Gert; Seidner, Benjamin; Franz, Wolfgang-Michael; Metzler, Bernhard] Med Univ Innsbruck, Univ Clin Internal Med Cardiol & Angiol 3, A-6020 Innsbruck, Austria; [Kremser, Christian; Esterhammer, Regina; Schocke, Michael F.] Med Univ Innsbruck, Dept Radiol 1, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Metzler, B (corresponding author), Med Univ Innsbruck, Univ Clin Internal Med Cardiol & Angiol 3, A-6020 Innsbruck, Austria.	Bernhard.Metzler@uki.at	Schocke, Michael/AAC-3666-2020; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Metzler, Bernhard/0000-0002-5240-2453; Klug, Gert/0000-0002-4737-0979; Reinstadler, Sebastian/0000-0002-7700-1357	Austrian Society of Cardiology; Innsbruck Medical University (MUI-START) [2013042016]	Austrian Society of Cardiology; Innsbruck Medical University (MUI-START)	This study was supported by grants from the Austrian Society of Cardiology and by a grant from the Innsbruck Medical University (MUI-START) (#2013042016) to Gert Klug, Sebastian J Reinstadler, and Bernhard Metzler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVOLIO AP, 1985, CIRCULATION, V71, P202, DOI 10.1161/01.CIR.71.2.202; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Dogui A, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-11; Franssen PML, 2010, BLOOD PRESS MONIT, V15, P229, DOI 10.1097/MBP.0b013e328339be38; Groenink M, 1998, AM J CARDIOL, V82, P203, DOI 10.1016/S0002-9149(98)00315-4; Grotenhuis HB, 2009, J MAGN RESON IMAGING, V30, P521, DOI 10.1002/jmri.21886; Hametner B, 2013, BLOOD PRESS MONIT, V18, P173, DOI 10.1097/MBP.0b013e3283614168; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hickson SS, 2010, JACC-CARDIOVASC IMAG, V3, P1247, DOI 10.1016/j.jcmg.2010.09.016; Huybrechts SAM, 2011, J HYPERTENS, V29, P1577, DOI 10.1097/HJH.0b013e3283487841; Klug G, 2014, INT J CARDIOL, V173, P253, DOI 10.1016/j.ijcard.2014.02.038; Klug G, 2014, MAGN RESON IMAGING; Klug G, 2013, EXPERT REV CARDIOVAS, V11, P203, DOI [10.1586/ERC.12.173, 10.1586/erc.12.173]; Klug G, 2011, CLIN RES CARDIOL, V100, P501, DOI 10.1007/s00392-010-0273-0; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Metafratzi ZM, 2002, J CARDIOV MAGN RESON, V4, P481, DOI 10.1081/JCMR-120016386; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Nunan D, 2014, BLOOD PRESS MONIT, V19, P315, DOI 10.1097/MBP.0000000000000066; Reinstadler SJ, 2014, EUR HEART J-ACUTE CA, V3, P10, DOI 10.1177/2048872613516015; Reinstadler SJ, 2013, HEART, V99, P1525, DOI 10.1136/heartjnl-2013-303975; Rogers WJ, 2001, J AM COLL CARDIOL, V38, P1123, DOI 10.1016/S0735-1097(01)01504-2; Sugawara J, 2008, JACC-CARDIOVASC IMAG, V1, P739, DOI 10.1016/j.jcmg.2008.06.010; van Elderen SGC, 2011, AM J ROENTGENOL, V196, P697, DOI 10.2214/AJR.10.4898; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wassertheurer S, 2010, J HUM HYPERTENS, V24, P498, DOI 10.1038/jhh.2010.27; Wassertheurer S, 2008, SIMUL MODEL PRACT TH, V16, P988, DOI 10.1016/j.simpat.2008.04.016; Weber T, 2011, J HYPERTENS, V29, P2491, DOI 10.1097/HJH.0b013e32834c5951; Weber T, 2011, HYPERTENSION, V58, P825, DOI 10.1161/HYPERTENSIONAHA.111.176313; Weber T, 2009, HYPERTENSION, V54, pE137, DOI 10.1161/HYPERTENSIONAHA.109.139220; Weber T, 2009, J HYPERTENS, V27, P1624, DOI 10.1097/HJH.0b013e32832cb04e; Wentland AL, 2014, CARDIOVASC DIAGN THE, V4, P193, DOI 10.3978/j.issn.2223-3652.2014.03.04; Westenberg JJM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-2; Wilkinson IB, 2010, ARTERY RES, V4, P34, DOI 10.1016/j.artres.2010.03.001	38	45	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116862	10.1371/journal.pone.0116862	http://dx.doi.org/10.1371/journal.pone.0116862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612307	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900023
J	Fukushima, H; Yokoyama, M; Nakanishi, Y; Tobisu, K; Koga, F				Fukushima, Hiroshi; Yokoyama, Minato; Nakanishi, Yasukazu; Tobisu, Ken-ichi; Koga, Fumitaka			Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma	PLOS ONE			English	Article							BODY-MASS INDEX; TRANSITIONAL-CELL CARCINOMA; C-REACTIVE PROTEIN; SKELETAL-MUSCLE; CANCER CACHEXIA; OBESITY; INFLAMMATION; PREVALENCE; SURVIVAL; THERAPY	Objectives Sarcopenia, a novel concept reflecting the degenerative loss of skeletal muscle mass, is an objective indicator of cancer cachexia. We investigated its role as a prognostic biomarker in advanced urothelial carcinoma (UC) patients. Methods This retrospective study consisted of 88 UC patients with cT4 and/or metastases to lymph nodes/distant organs. Skeletal muscle index (SMI), an indicator of whole-body muscle mass, was measured from computed tomography (CT) images at the diagnosis. Sarcopenia was defined as SMIs of <43 cm(2)/m(2) for males with body mass index (BMI) <25 cm(2)/m(2), <53 cm(2)/m(2) for males with BMI >= 25 cm(2)/m(2), and <41 cm(2)/m(2) for females. Predictors of overall survival (OS) were examined using Cox proportional hazard models. Results Sixty-seven patients (76%) died during the median follow-up of 13 months. The median OS rate was 13 months. Multivariate analysis revealed that SMI was a significant and independent predictor of shorter OS (hazard ratio (HR) 0.90, P < 0.001). In the present cohort, 53 (60%) were diagnosed with sarcopenia. The median OS rates were 11 and 31 months for sarcopenic and non-sarcopenic patients, respectively (P < 0.001). On multivariate analysis, sarcopenia was a significant and independent predictor of shorter OS (HR 3.36, P < 0.001), along with higher C-reactive protein (CRP) (P = 0.001), upper urinary tract cancer (P = 0.007), higher lactate dehydrogenase (LDH) (P = 0.047), and higher alkaline phosphatase (ALP) (P = 0.048). Conclusion Sarcopenia, which is readily evaluated on routine CT scans, is a useful prognostic biomarker of advanced UC. Non-sarcopenic patients can expect long-term survival. Evaluating	[Fukushima, Hiroshi; Yokoyama, Minato; Nakanishi, Yasukazu; Tobisu, Ken-ichi; Koga, Fumitaka] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Urol, Tokyo, Japan	Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital	Koga, F (corresponding author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Urol, Tokyo, Japan.	f-koga@cick.jp	KOGA, Fumitaka/AAM-8739-2021; Koga, Fumitaka/AAO-4655-2021; Koga, Fumitaka/AAO-2779-2021; , Fumitaka/AAO-2957-2021	KOGA, Fumitaka/0000-0001-7888-0085; , Fumitaka/0000-0001-7888-0085; Fukushima, Hiroshi/0000-0001-7548-1580	Clinical Research Fund of the Tokyo Metropolitan Government [H260301002]	Clinical Research Fund of the Tokyo Metropolitan Government	This research was supported by the Clinical Research Fund (grant number H260301002, URL: http://www.metro.tokyo.jp/) of the Tokyo Metropolitan Government (HF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, EUR UROL, V52, P1106, DOI 10.1016/j.eururo.2007.02.052; Antoun S, 2010, ANN ONCOL, V21, P1594, DOI 10.1093/annonc/mdp605; Antoun S, 2013, CANCER-AM CANCER SOC, V119, P3377, DOI 10.1002/cncr.28218; Argiles Josep M., 2012, Critical Reviews in Oncogenesis, V17, P253; Bajorin DF, 1999, J CLIN ONCOL, V17, P3173, DOI 10.1200/JCO.1999.17.10.3173; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bellmunt J, 2012, J CLIN ONCOL, V30, P1107, DOI 10.1200/JCO.2011.38.6979; Bellmunt J, 2010, J CLIN ONCOL, V28, P1850, DOI 10.1200/JCO.2009.25.4599; Chung JY, 2013, ARCH GERONTOL GERIAT, V56, P270, DOI 10.1016/j.archger.2012.09.007; Cosqueric G, 2006, BRIT J NUTR, V96, P895, DOI 10.1017/BJN20061943; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Ishioka J, 2012, BRIT J CANCER, V107, P1031, DOI 10.1038/bjc.2012.254; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Mamlouk S, 2013, INT J CANCER, V132, P2721, DOI 10.1002/ijc.27901; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Muliawati Yanti, 2012, Acta Med Indones, V44, P154; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2007, CLIN CANCER RES, V13, P3264, DOI 10.1158/1078-0432.CCR-06-3067; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Safer U, 2013, CLIN NUTR, V32, P662, DOI 10.1016/j.clnu.2013.03.006; Saito K, 2013, INT J UROL, V20, P161, DOI 10.1111/j.1442-2042.2012.03121.x; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Wulan SN, 2010, MATURITAS, V65, P315, DOI 10.1016/j.maturitas.2009.12.012	30	104	104	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115895	10.1371/journal.pone.0115895	http://dx.doi.org/10.1371/journal.pone.0115895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612215	Green Published, Green Submitted, gold			2022-12-27	WOS:000348562900009
J	Chen, XQ; Wales, P; Quinti, L; Zuo, FX; Moniot, S; Herisson, F; Rauf, NA; Wang, H; Silverman, RB; Ayata, C; Maxwell, MM; Steegborn, C; Schwarzschild, MA; Outeiro, TF; Kazantsev, AG				Chen, Xiqun; Wales, Pauline; Quinti, Luisa; Zuo, Fuxing; Moniot, Sebastien; Herisson, Fanny; Rauf, Nazifa Abdul; Wang, Hua; Silverman, Richard B.; Ayata, Cenk; Maxwell, Michelle M.; Steegborn, Clemens; Schwarzschild, Michael A.; Outeiro, Tiago F.; Kazantsev, Aleksey G.			The Sirtuin-2 Inhibitor AK7 Is Neuroprotective in Models of Parkinson's Disease but Not Amyotrophic Lateral Sclerosis and Cerebral Ischemia	PLOS ONE			English	Article							MOUSE MODEL; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; SIRT2; DEACETYLASE; PROTEIN; POLYMORPHISM; GENERATION; RS10410544; DESIGN	Sirtuin deacetylases regulate diverse cellular pathways and influence disease processes. Our previous studies identified the brain-enriched sirtuin-2 (SIRT2) deacetylase as a potential drug target to counteract neurodegeneration. In the present study, we characterize SIRT2 inhibition activity of the brain-permeable compound AK7 and examine the efficacy of this small molecule in models of Parkinson's disease, amyotrophic lateral sclerosis and cerebral ischemia. Our results demonstrate that AK7 is neuroprotective in models of Parkinson's disease; it ameliorates alpha-synuclein toxicity in vitro and prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopamine depletion and dopaminergic neuron loss in vivo. The compound does not show beneficial effects in mouse models of amyotrophic lateral sclerosis and cerebral ischemia. These findings underscore the specificity of protective effects observed here in models of Parkinson's disease, and previously in Huntington's disease, and support the development of SIRT2 inhibitors as potential therapeutics for the two neurodegenerative diseases.	[Chen, Xiqun; Quinti, Luisa; Zuo, Fuxing; Herisson, Fanny; Rauf, Nazifa Abdul; Ayata, Cenk; Maxwell, Michelle M.; Schwarzschild, Michael A.; Kazantsev, Aleksey G.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02129 USA; [Wales, Pauline; Outeiro, Tiago F.] Univ Med Ctr Goettingen, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept NeuroDegenerat & Restorat Res, D-37073 Gottingen, Germany; [Moniot, Sebastien; Steegborn, Clemens] Univ Bayreuth, Dept Biochem, D-95447 Bayreuth, Germany; [Wang, Hua; Silverman, Richard B.] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chem Life Proc Inst, Dept Chem,Dept Mol Biosci, Evanston, IL 60208 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Gottingen; University of Bayreuth; Northwestern University	Chen, XQ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02129 USA.	xchen17@mgh.harvard.edu; AKAZANTSEV@mgh.harvard.edu	Outeiro, Tiago/L-7351-2019; Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/M-8106-2019	Outeiro, Tiago/0000-0003-1679-1727; Outeiro, Tiago F/0000-0003-1679-1727; 	NIH [U01-NS066912]; RJG foundation [2011D004473]; DFG Center of Excellence on Nanoscale Microscopy and Molecular Physiology of the Brain; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS051343, U01NS066912, P01NS055104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RJG foundation; DFG Center of Excellence on Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH U01-NS066912 (http://grants.nih.gov/grants/funding/ac_search_results.htm?text_curr = u01), RJG foundation 2011D004473 (no website), and DFG Center of Excellence on Nanoscale Microscopy and Molecular Physiology of the Brain (http://grc.unigoettingen.de/89.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Chen XQ, 2013, P NATL ACAD SCI USA, V110, P300, DOI 10.1073/pnas.1217296110; Chopra V, 2012, CELL REP, V2, P1492, DOI 10.1016/j.celrep.2012.11.001; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Nguyen GTT, 2013, CHEM BIOL, V20, P1375, DOI 10.1016/j.chembiol.2013.09.019; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Ji SP, 2011, J MOL CELL BIOL, V3, P351, DOI 10.1093/jmcb/mjr009; Kachroo A, 2012, ANN NEUROL, V71, P278, DOI 10.1002/ana.22630; Korner S, 2013, NEURODEGENER DIS, V11, P141, DOI 10.1159/000338048; Lizee G, 2003, HUM GENE THER, V14, P497, DOI 10.1089/104303403764539387; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Maxwell MM, 2011, HUM MOL GENET, V20, P3986, DOI 10.1093/hmg/ddr326; Moniot S, 2013, J STRUCT BIOL, V182, P136, DOI 10.1016/j.jsb.2013.02.012; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Newton K, 2014, NATURE, V506, pE4, DOI 10.1038/nature13024; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Outeiro TF, 2009, CURR PHARM DESIGN, V15, P3968, DOI 10.2174/138161209789649321; Porcelli S, 2013, J NEURAL TRANSM, V120, P1709, DOI 10.1007/s00702-013-1045-6; Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327; Schildknecht S, 2013, ALTEX-ALTERN ANIM EX, V30, P427, DOI 10.14573/altex.2013.4.427; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; Schutkowski M, 2014, EXPERT OPIN DRUG DIS, V9, P183, DOI 10.1517/17460441.2014.875526; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Spires-Jones TL, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00042; Taes I, 2013, HUM MOL GENET, V22, P1783, DOI 10.1093/hmg/ddt028; Taylor DM, 2008, CELL MOL LIFE SCI, V65, P4000, DOI 10.1007/s00018-008-8357-y; Taylor DM, 2011, ACS CHEM BIOL, V6, P540, DOI 10.1021/cb100376q; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Wei WJ, 2014, NEUROMOL MED, V16, P448, DOI 10.1007/s12017-014-8291-0; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Yamagata K, 2014, STRUCTURE, V22, P345, DOI 10.1016/j.str.2013.12.001	39	83	85	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116919	10.1371/journal.pone.0116919	http://dx.doi.org/10.1371/journal.pone.0116919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608039	Green Published, gold, Green Submitted			2022-12-27	WOS:000348205300044
J	Lowry, DW; Tomiyama, AJ				Lowry, David W.; Tomiyama, A. Janet			Air Displacement Plethysmography versus Dual-Energy X-Ray Absorptiometry in Underweight, Normal-Weight, and Overweight/Obese Individuals	PLOS ONE			English	Article							HUMAN-BODY COMPOSITION; IN-VIVO; POD; ADULTS	Background Accurately estimating fat percentage is important for assessing health and determining treatment course. Methods of estimating body composition such as hydrostatic weighing or dual-energy x-ray absorptiometry (DXA), however, can be expensive, require extensive operator training, and, in the case of hydrostatic weighing, be highly burdensome for patients. Our objective was to evaluate air displacement plethysmography via the Bod Pod, a less burdensome method of estimating body fat percentage. In particular, we filled a gap in the literature by testing the Bod Pod at the lower extreme of the Body Mass Index (BMI) distribution. Findings Three BMI groups were recruited and underwent both air displacement plethysmography and dual-energy x-ray absorptiometry. We recruited 30 healthy adults at the lower BMI distribution from the Calorie Restriction (CR) Society and followers of the CR Way. We also recruited 15 normal weight and 19 overweight/obese healthy adults from the general population. Both Siri and Brozek equations derived body fat percentage from the Bod Pod, and Bland-Altman analyses assessed agreement between the Bod Pod and DXA. Compared to DXA, the Bod Pod overestimated body fat percentage in thinner participants and underestimated body fat percentage in heavier participants, and the magnitude of difference was larger for underweight BMI participants, reaching 13% in some. The Bod Pod and DXA had smaller discrepancies in normal weight and overweight/obese participants. Conclusions While less burdensome, clinicians should be aware that Bod Pod estimates may deviate from DXA estimates particularly at the lower end of the BMI distribution.	[Tomiyama, A. Janet] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Lowry, David W.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA	University of California System; University of California Los Angeles; Case Western Reserve University	Tomiyama, AJ (corresponding author), Univ Calif Los Angeles, Dept Psychol, 1285 Franz Hall,502 Portola Plaza, Los Angeles, CA 90095 USA.	tomiyama@psych.ucla.edu			AJT: Robert Wood Johnson Foundation Health and Society Scholars Program; University of California Berkeley Population Center; Appleby Foundation; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant [UL1 RR024131]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	AJT: Robert Wood Johnson Foundation Health and Society Scholars Program; University of California Berkeley Population Center; Appleby Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work was supported by the following: AJT: Robert Wood Johnson Foundation Health and Society Scholars Program, the University of California Berkeley Population Center, and the Appleby Foundation. This project was also supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedogni G, 2013, EUR J CLIN NUTR, V67, P1129, DOI 10.1038/ejcn.2013.159; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; Buskirk ER, 1961, TECHNIQUES MEASURING, P90; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Fields DA, 2005, CURR OPIN CLIN NUTR, V8, P624, DOI 10.1097/01.mco.0000171127.44525.07; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Ginde SR, 2005, OBES RES, V13, P1232, DOI 10.1038/oby.2005.146; Hames KC, 2014, OBESITY, V22, P1078, DOI 10.1002/oby.20655; HEYMSFIELD SB, 1989, AM J CLIN NUTR, V49, P1283, DOI 10.1093/ajcn/49.6.1283; Heymsfield SB, 2003, OBES REV, V1, pe348; MCCRORY MA, 1995, MED SCI SPORT EXER, V27, P1686; Petroni ML, 2003, ACTA DIABETOL, V40, pS59, DOI 10.1007/s00592-003-0028-8; Pietrobelli A, 1996, AM J PHYSIOL-ENDOC M, V271, pE941, DOI 10.1152/ajpendo.1996.271.6.E941; ROUBENOFF R, 1993, AM J CLIN NUTR, V58, P589, DOI 10.1093/ajcn/58.5.589; Siri WE., 1961, TECHNIQUES MEASURING, V61, P223; Tucker LA, 2014, PERCEPT MOTOR SKILL, V118, P563, DOI 10.2466/03.PMS.118k15w5; Vescovi JD, 2001, EUR J APPL PHYSIOL, V85, P326, DOI 10.1007/s004210100459	19	35	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115086	10.1371/journal.pone.0115086	http://dx.doi.org/10.1371/journal.pone.0115086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607661	Green Published, gold			2022-12-27	WOS:000348205300011
J	Orban, M; Goedel, A; Haas, J; Sandrock-Lang, K; Gartner, F; Jung, CB; Zieger, B; Parrotta, E; Kurnik, K; Sinnecker, D; Wanner, G; Laugwitz, KL; Massberg, S; Moretti, A				Orban, Mathias; Goedel, Alexander; Haas, Jessica; Sandrock-Lang, Kirstin; Gaertner, Florian; Jung, Christian Billy; Zieger, Barbara; Parrotta, Elvira; Kurnik, Karin; Sinnecker, Daniel; Wanner, Gerhard; Laugwitz, Karl-Ludwig; Massberg, Steffen; Moretti, Alessandra			Functional Comparison of Induced Pluripotent Stem Cell- and Blood-Derived GPIIbIIIa Deficient Platelets	PLOS ONE			English	Article							EX-VIVO EXPANSION; GLANZMANN THROMBASTHENIA; HUMAN FIBROBLASTS; PROGENITOR CELLS; BONE-MARROW; GLYCOPROTEIN-IIB; IPS CELLS; GENERATION; MOUSE; MEGAKARYOCYTES	Human induced pluripotent stem cells (hiPSCs) represent a versatile tool to model genetic diseases and are a potential source for cell transfusion therapies. However, it remains elusive to which extent patient-specific hiPSC-derived cells functionally resemble their native counterparts. Here, we generated a hiPSC model of the primary platelet disease Glanzmann thrombasthenia (GT), characterized by dysfunction of the integrin receptor GPIIbIIIa, and compared side-by-side healthy and diseased hiPSC-derived platelets with peripheral blood platelets. Both GT-hiPSC-derived platelets and their peripheral blood equivalents showed absence of membrane expression of GPIIbIIIa, a reduction of PAC-1 binding, surface spreading and adherence to fibrinogen. We demonstrated that GT-hiPSC-derived platelets recapitulate molecular and functional aspects of the disease and show comparable behavior to their native counterparts encouraging the further use of hiPSC-based disease models as well as the transition towards a clinical application.	[Orban, Mathias; Gaertner, Florian; Massberg, Steffen] Univ Munich, Klinikum Univ Mnchen, Med Klin & Poliklin 1, Munich, Germany; [Goedel, Alexander; Haas, Jessica; Jung, Christian Billy; Parrotta, Elvira; Sinnecker, Daniel; Laugwitz, Karl-Ludwig; Moretti, Alessandra] Tech Univ Munich, Klinikum Rechts, Med Klin & Poliklin 1, D-80290 Munich, Germany; [Sandrock-Lang, Kirstin] Univ Med Ctr Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany; [Parrotta, Elvira] Magna Graecia Univ Catanzaro, Sch Med, Dept Expt & Clin Med, Catanzaro, Italy; [Kurnik, Karin] Univ Munich, Dr von Hauner Childrens Hosp, Paediat Haemophilia Ctr, Munich, Germany; [Wanner, Gerhard] Univ Munich, Biozentrum, Dept Biol 1, Planegg Martinsried, Germany; [Laugwitz, Karl-Ludwig; Massberg, Steffen; Moretti, Alessandra] DZHK German Ctr Cardiovasc Res Partner Site Munic, Munich, Germany	University of Munich; Technical University of Munich; University of Freiburg; Magna Graecia University of Catanzaro; University of Munich; University of Munich; German Centre for Cardiovascular Research	Massberg, S (corresponding author), Univ Munich, Klinikum Univ Mnchen, Med Klin & Poliklin 1, Munich, Germany.	Steffen.Massberg@med.uni-muenchen.de; amoretti@med1.med.tum.de	Parrotta, Elvira Immacolata/AAB-9018-2019; Gaertner, Florian/GXG-7213-2022; Massberg, Steffen/AAN-6054-2021; Gaertner, Florian/AAY-1420-2021; Goedel, Alexander/AAX-3900-2020; Moretti, Alessandra/O-9271-2015; Orban, Mathias/AAS-8461-2020	Parrotta, Elvira Immacolata/0000-0001-8145-3623; Gaertner, Florian/0000-0001-6120-3723; Goedel, Alexander/0000-0002-5980-2257; Moretti, Alessandra/0000-0001-5782-7832; Orban, Mathias/0000-0001-7846-8808; Sinnecker, Daniel/0000-0002-8116-9750	European Research Council [ERC261053]; Deutsche Forschungsgemeinschaft [923, Mo2217/1-1, La1238 3-1/4-1, Si1747/1-1, SFB914, TP-A3B2Z1]; European Union (PRESTIGE); Deutsches Zentrum fur Herz-Kreislauf-Forschung (German Centre for Cardiovascular Research)	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (PRESTIGE); Deutsches Zentrum fur Herz-Kreislauf-Forschung (German Centre for Cardiovascular Research)	This work was supported by grants from the European Research Council (ERC261053 to KLL (http://erc.europa.eu)); the Deutsche Forschungsgemeinschaft (Research Unit 923, Mo2217/1-1 to AM, La1238 3-1/4-1 to KLL, and Si1747/1-1 to DS; SFB914 and TP-A3&B2&Z1 to SM (http://www.dfg.de)); the Framework Programme 7 of the European Union (PRESTIGE to SM (http://www.prestige-fp7.eu)); and the Deutsches Zentrum fur Herz-Kreislauf-Forschung (German Centre for Cardiovascular Research), partner site Munich Heart Alliance (to AM, KLL, and SM (dzhk.de)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Armstrong PC, 2012, THROMB HAEMOSTASIS, V107, P808, DOI 10.1160/TH11-10-0727; Blondel S, 2014, STEM CELL TRANSL MED, V3, P510, DOI 10.5966/sctm.2013-0168; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Gehling UM, 1997, EXP HEMATOL, V25, P1125; HARRIS DM, 2011, TRANSFORMATION HUMAN; Hartley PS, 2006, THROMB HAEMOSTASIS, V95, P100, DOI 10.1160/TH05-06-0403; HARTLEY PS, 2005, THESIS U EDINBURGH; Hirata S, 2013, J CLIN INVEST, V123, P3802, DOI 10.1172/JCI64721; Jogler C, 2011, P NATL ACAD SCI USA, V108, P1134, DOI 10.1073/pnas.1012694108; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Lin B, 2012, CARDIOVASC RES, V95, P327, DOI 10.1093/cvr/cvs185; Ma DR, 2013, EUR HEART J, V34, P1122, DOI 10.1093/eurheartj/ehs226; Massberg S, 2005, CIRCULATION, V112, P1180, DOI 10.1161/CIRCULATIONAHA.105.539221; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; NACHMAN RL, 1982, J CLIN INVEST, V69, P263, DOI 10.1172/JCI110448; Nakagawa Y, 2013, EXP HEMATOL, V41, P742, DOI 10.1016/j.exphem.2013.04.007; Nakamura S, 2014, CELL STEM CELL, V14, P535, DOI 10.1016/j.stem.2014.01.011; Nurden AT, 2013, SEMIN THROMB HEMOST, V39, P642, DOI 10.1055/s-0033-1353393; Nurden AT, 2011, BLOOD, V118, P5996, DOI 10.1182/blood-2011-07-365635; Nurden P, 2008, THROMB HAEMOSTASIS, V99, P253, DOI 10.1160/TH07-09-0568; Ono Y, 2012, BLOOD, V120, P3812, DOI 10.1182/blood-2012-02-413617; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Schattner M, 1996, STEM CELLS, V14, P207, DOI 10.1002/stem.140207; Schipper LF, 1998, BRIT J HAEMATOL, V101, P425; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Sinnecker D, 2013, CIRC RES, V112, P961, DOI 10.1161/CIRCRESAHA.112.268623; Streckfuss-Bomeke K, 2013, EUR HEART J, V34, P2618, DOI 10.1093/eurheartj/ehs203; Sullivan SK, 2014, BLOOD, V123, P753, DOI 10.1182/blood-2013-10-530725; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAKAYAMA N, 2008, BLOOD, V119, P6234; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Tulpule A, 2013, CELL STEM CELL, V12, P727, DOI 10.1016/j.stem.2013.04.002; Vannier C, 2010, KLIN PADIATR, V222, P150, DOI 10.1055/s-0030-1249064; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wilcox DA, 2000, BLOOD, V95, P3645; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Yuan YP, 1999, J BIOL CHEM, V274, P36241, DOI 10.1074/jbc.274.51.36241; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	45	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115978	10.1371/journal.pone.0115978	http://dx.doi.org/10.1371/journal.pone.0115978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607928	Green Submitted, Green Published, gold			2022-12-27	WOS:000348205300022
J	Teles, F; da Silva, TM; da Cruz, FP; Honorato, VH; Costa, HD; Barbosa, APF; de Oliveira, SG; Porfirio, Z; Liborio, AB; Borges, RL; Fanelli, C				Teles, Flavio; da Silva, Tarcilo Machado; da Cruz Junior, Francisco Pessoa; Honorato, Vitor Hugo; Costa, Henrique de Oliveira; Fernandes Barbosa, Ana Paula; de Oliveira, Sabrina Gomes; Porfirio, Zenaldo; Liborio, Alexandre Braga; Borges, Raquel Lerner; Fanelli, Camilla			Brazilian Red Propolis Attenuates Hypertension and Renal Damage in 5/6 Renal Ablation Model	PLOS ONE			English	Article							EXPERIMENTAL DIABETIC-NEPHROPATHY; RAT THORACIC AORTA; OXIDATIVE STRESS; REMNANT KIDNEY; GLOMERULAR INJURY; MESANGIAL CELLS; LOSARTAN; INFLAMMATION; FAILURE; RENOPROTECTION	The pathogenic role of inflammation and oxidative stress in chronic kidney disease (CKD) is well known. Anti-inflammatories and antioxidant drugs has demonstrated significant renoprotection in experimental nephropathies. Moreover, the inclusion of natural antioxidants derived from food and herbal extracts (such as polyphenols, curcumin and lycopene) as an adjuvant therapy for slowing CKD progression has been largely tested. Brazilian propolis is a honeybee product, whose anti-inflammatory, antimicrobial and antioxidant effects have been widely shown in models of sepsis, cancer, skin irritation and liver fibrosis. Furthermore, previous studies demonstrated that this compound promotes vasodilation and reduces hypertension. However, potential renoprotective effects of propolis in CKD have never been investigated. The aim of this study was to evaluate the effects of a subtype of Brazilian propolis, the Red Propolis (RP), in the 5/6 renal ablation model (Nx). Adult male Wistar rats underwent Nx and were divided into untreated (Nx) and RP-treated (Nx+RP) groups, after 30 days of surgery; when rats already exhibited marked hypertension and proteinuria. Animals were observed for 90 days from the surgery day, when Nx+RP group showed significant reduction of hypertension, proteinuria, serum creatinine retention, glomerulosclerosis, renal macrophage infiltration and oxidative stress, compared to age-matched untreated Nx rats, which worsened progressively over time. In conclusion, RP treatment attenuated hypertension and structural renal damage in Nx model. Reduction of renal inflammation and oxidative stress could be a plausible mechanism to explain this renoprotection.	[Teles, Flavio; da Silva, Tarcilo Machado; da Cruz Junior, Francisco Pessoa; Honorato, Vitor Hugo; Costa, Henrique de Oliveira; Fernandes Barbosa, Ana Paula; de Oliveira, Sabrina Gomes; Porfirio, Zenaldo] State Univ Hlth Sci, Fac Med, Dept Clin Med, Div Renal, Alagoas, Brazil; [Liborio, Alexandre Braga] Fed Univ, Fac Med, Fortaleza, Ceara, Brazil; [Borges, Raquel Lerner] Univ No Colorado, Sch Sport & Exercise Sci, Greeley, CO 80639 USA; [Fanelli, Camilla] Univ Sao Paulo, Fac Med, Dept Clin Med, Div Renal, Sao Paulo, Brazil	University of Northern Colorado; Universidade de Sao Paulo	Fanelli, C (corresponding author), Univ Sao Paulo, Fac Med, Dept Clin Med, Div Renal, Sao Paulo, Brazil.	camilla.fanelli@usp.br	Fanelli, Camilla/D-6287-2012; de Farias Filho, Flávio Teles/G-9033-2016	Fanelli, Camilla/0000-0003-4425-7708; de Farias Filho, Flávio Teles/0000-0002-6937-5615	Universidade Estadual de Ciencias da Saude de Alagoas	Universidade Estadual de Ciencias da Saude de Alagoas	This study was supported by Universidade Estadual de Ciencias da Saude de Alagoas (http:// www.uncisal.edu.br/) (FT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Salem OM, 2009, PAK J PHARM SCI, V22, P205; Ahn MR, 2004, J AGR FOOD CHEM, V52, P7286, DOI 10.1021/jf048726s; Arias SCA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056215; Banday AA, 2011, HYPERTENSION, V57, P452, DOI 10.1161/HYPERTENSIONAHA.110.162339; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2; Cicala C, 2003, LIFE SCI, V73, P73, DOI 10.1016/S0024-3205(03)00235-2; Fanelli C, 2011, HYPERTENSION, V57, P373, DOI 10.1161/HYPERTENSIONAHA.110.167775; Fujihara CK, 1998, AM J PHYSIOL-RENAL, V274, pF573, DOI 10.1152/ajprenal.1998.274.3.F573; Fujihara CK, 2005, KIDNEY INT, V67, P1913, DOI 10.1111/j.1523-1755.2005.00290.x; Fujihara CK, 1998, KIDNEY INT, V54, P1510, DOI 10.1046/j.1523-1755.1998.00138.x; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF92, DOI 10.1152/ajprenal.00184.2006; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF1810, DOI 10.1152/ajprenal.00521.2006; Ghosh SS, 2012, AM J PHYSIOL-RENAL, V302, pF439, DOI 10.1152/ajprenal.00356.2010; Goncalves ARR, 2004, AM J PHYSIOL-RENAL, V286, pF945, DOI 10.1152/ajprenal.00238.2003; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; GREENAWAY W, 1990, BEE WORLD, V71, P107, DOI 10.1080/0005772X.1990.11099047; Jaimes EA, 1998, KIDNEY INT, V54, P775, DOI 10.1046/j.1523-1755.1998.00068.x; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; KHAYYAL MT, 1993, DRUG EXP CLIN RES, V19, P197; Kitamura H, 2013, ADIPOCYTE, V2, P227, DOI 10.4161/adip.25608; Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95; Kubota Yoko, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS29, DOI 10.1111/j.1440-1681.2004.04113.x; Li YJ, 2005, AM J KIDNEY DIS, V46, DOI 10.1053/j.ajkd.2005.08.028; Lopes AA, 2013, BIOORGAN MED CHEM, V21, P7570, DOI 10.1016/j.bmc.2013.10.044; de Faria JBL, 2011, HYPERTENS RES, V34, P413, DOI 10.1038/hr.2010.263; Maruyama H, 2009, BIOL PHARM BULL, V32, P1244, DOI 10.1248/bpb.32.1244; Mishima S, 2005, BIOL PHARM BULL, V28, P1909, DOI 10.1248/bpb.28.1909; Morello S, 2006, LIFE SCI, V78, P825, DOI 10.1016/j.lfs.2005.05.072; Nagai T, 2003, FOOD CHEM, V80, P29, DOI 10.1016/S0308-8146(02)00231-5; Orsolic N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-117; Rodriguez-Iturbe B, 2001, KIDNEY INT, V59, P1626, DOI 10.1046/j.1523-1755.2001.0590051626.x; RuizMunoz LM, 1997, NEPHROL DIAL TRANSPL, V12, P456, DOI 10.1093/ndt/12.3.456; Shimizu MHM, 2005, KIDNEY INT, V68, P2208, DOI 10.1111/j.1523-1755.2005.00677.x; Silva BB, 2008, EVID-BASED COMPL ALT, V5, P313, DOI 10.1093/ecam/nem059; SMITH WR, 1989, AM J NEPHROL, V9, P230, DOI 10.1159/000167970; Tain YL, 2007, AM J PHYSIOL-RENAL, V292, pF1404, DOI 10.1152/ajprenal.00260.2006; Teles F, 2009, KIDNEY INT, V75, P72, DOI 10.1038/ki.2008.528; Tohamy AA, 2014, CYTOTECHNOLOGY, V66, P283, DOI 10.1007/s10616-013-9568-0; Toreti VC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/697390; Utimura R, 2003, KIDNEY INT, V63, P209, DOI 10.1046/j.1523-1755.2003.00736.x; Vaziri ND, 2007, J PHARMACOL EXP THER, V323, P85, DOI 10.1124/jpet.107.123638; Vaziri ND, 2003, KIDNEY INT, V63, P179, DOI 10.1046/j.1523-1755.2003.00702.x; VIENET R, 1994, J CARDIOVASC PHARM, V23, pS19, DOI 10.1097/00005344-199400234-00006; Wu LL, 1997, KIDNEY INT, pS221; Yang NS, 1998, NEPHROL DIAL TRANSPL, V13, P1967, DOI 10.1093/ndt/13.8.1967; Zhu W, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq025	47	40	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116535	10.1371/journal.pone.0116535	http://dx.doi.org/10.1371/journal.pone.0116535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607548	Green Published, gold, Green Submitted			2022-12-27	WOS:000348205300028
J	Looker, KJ; Magaret, AS; Turner, KME; Vickerman, P; Gottlieb, SL; Newman, LM				Looker, Katharine J.; Magaret, Amalia S.; Turner, Katherine M. E.; Vickerman, Peter; Gottlieb, Sami L.; Newman, Lori M.			Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012	PLOS ONE			English	Article							GENITAL HERPES; UNITED-STATES; SEROPOSITIVE WOMEN; HIV ACQUISITION; HSV-2; RISK; TRANSMISSION; MEN; SEROPREVALENCE; SEROCONVERSION	Background: Herpes simplex virus type 2 (HSV-2) infection causes significant disease globally. Adolescent and adult infection may present as painful genital ulcers. Neonatal infection has high morbidity and mortality. Additionally, HSV-2 likely contributes substantially to the spread of HIV infection. The global burden of HSV-2 infection was last estimated for 2003. Here we present new global estimates for 2012 of the burden of prevalent (existing) and incident (new) HSV-2 infection among females and males aged 15-49 years, using updated methodology to adjust for test performance and estimate by World Health Organization (WHO) region. Methods and Findings: We conducted a literature review of HSV-2 prevalence studies world-wide since 2000. We then fitted a model with constant HSV-2 incidence by age to pooled HSV-2 prevalence values by age and sex. Prevalence values were adjusted for test sensitivity and specificity. The model estimated prevalence and incidence by sex for each WHO region to obtain global burden estimates. Uncertainty bounds were computed by refitting the model to reflect the variation in the underlying prevalence data. In 2012, we estimate that there were 417 million people aged 15-49 years (range: 274-678 million) living with HSV-2 infection world-wide (11.3% global prevalence), of whom 267 million were women. We also estimate that in 2012, 19.2 million (range: 13.0-28.6 million) individuals aged 15-49 years were newly-infected (0.5% of all individuals globally). The highest burden was in Africa. However, despite lower prevalence, South-East Asia and Western Pacific regions also contributed large numbers to the global totals because of large population sizes. Conclusions: The global burden of HSV-2 infection is large, leaving over 400 million people at increased risk of genital ulcer disease, HIV acquisition, and transmission of HSV-2 to partners or neonates. These estimates highlight the critical need for development of vaccines, microbicides, and other new HSV prevention strategies.	[Looker, Katharine J.; Turner, Katherine M. E.; Vickerman, Peter] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Magaret, Amalia S.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Gottlieb, Sami L.; Newman, Lori M.] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of Bristol; University of Washington; University of Washington Seattle; World Health Organization	Looker, KJ (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	katharine.looker@bristol.ac.uk	Turner, Katy/R-3853-2019	Turner, Katy/0000-0002-8152-6017; Chen, Yu/0000-0002-1519-4894; Vickerman, Peter/0000-0002-8291-5890	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research; Development and Research Training in Human Reproduction; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research; Development and Research Training in Human Reproduction; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, http://www.who.int/reproductivehealth/hrp/en/. WHO commissioned the study, advised as required during the study, co-ordinated data requests, helped with redrafts, and approved the manuscript submission. KJL had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Abu-Raddad LJ, 2010, EPIDEMICS-NETH, V2, P173, DOI 10.1016/j.epidem.2010.08.003; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P456; Ashley RL, 1999, J CLIN MICROBIOL, V37, P1632, DOI 10.1128/JCM.37.5.1632-1633.1999; Ashley RL, 2001, SEX TRANSM INFECT, V77, P232, DOI 10.1136/sti.77.4.232; Ashley-Morrow R, 2004, CLIN MICROBIOL INFEC, V10, P530, DOI 10.1111/j.1469-0691.2004.00836.x; Ashley-Morrow R, 2003, SEX TRANSM DIS, V30, P310, DOI 10.1097/00007435-200304000-00007; AUGENBRAUN M, 1995, ANN INTERN MED, V123, P845, DOI 10.7326/0003-4819-123-11-199512010-00006; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Broutet N, 2014, VACCINE, V32, P1630, DOI 10.1016/j.vaccine.2014.01.053; Brown JM, 2007, AIDS, V21, P1515, DOI 10.1097/QAD.0b013e3282004929; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Genocea website, GEN ANN POS TOP LIN; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gray E, 2008, NEW ZEAL MED J, V121, P43; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; Johnston C, 2014, VACCINE, V32, P1553, DOI 10.1016/j.vaccine.2013.08.066; Kaushic C, 2011, J REPROD IMMUNOL, V88, P204, DOI 10.1016/j.jri.2010.12.004; Kelsey JL, 1986, METHODS OBSERVATIONS; Kenyon C, 2013, INT J STD AIDS, V24, P375, DOI 10.1177/0956462412472816; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Morrow R, 2006, CLIN MICROBIOL INFEC, V12, P463, DOI 10.1111/j.1469-0691.2006.01370.x; Muench H., CATALYTIC MODELS EPI, P8928; Pena KC, 2010, J CLIN MICROBIOL, V48, P150, DOI 10.1128/JCM.01336-09; Pinninti SG, 2013, AM J PERINAT, V30, P113, DOI 10.1055/s-0032-1332802; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Ryder N, 2009, SEX TRANSM INFECT, V85, P416, DOI 10.1136/sti.2008.033902; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Tassiopoulos KK, 2007, J INFECT DIS, V195, P493, DOI 10.1086/510537; Todd J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059037; Tuokko H, 2014, SEX TRANSM INFECT; United Nations, 2013, WORLD POP AG 2013; Wald A, 2002, CLIN INFECT DIS, V35, pS173, DOI 10.1086/342104; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; WHO, 2012, GLOB INC PREV SEL CU; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	49	483	513	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e114989	10.1371/journal.pone.0114989	http://dx.doi.org/10.1371/journal.pone.0114989			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	26510007	gold, Green Submitted, Green Published			2022-12-27	WOS:000348205300007
J	Shi, SW; Han, PF; Zhang, P; Ding, F; Ma, CL				Shi, Sheng-wei; Han, Peng-fei; Zhang, Ping; Ding, Fan; Ma, Cheng-lin			The Impact of Afforestation on Soil Organic Carbon Sequestration on the Qinghai Plateau, China	PLOS ONE			English	Article							LAND-USE CHANGE; VERTICAL-DISTRIBUTION; AGRICULTURAL SOILS; NITROGEN ADDITIONS; STOCKS; FOREST; ACCUMULATION; GRASSLAND; DYNAMICS; MATTER	Afforestation, the conversion of non-forested land into forest, is widespread in China. However, the dynamics of soil organic carbon (SOC) after afforestation are not well understood, especially in plateau climate zones. For a total of 48 shrub- and/or tree-dominated afforestation sites on the Qinghai Plateau, Northwestern China, post-afforestation changes in SOC, total nitrogen (TN), the carbon-to-nitrogen ratio (C/N) and soil bulk density (BD) were investigated to a soil depth of 60 cm using the paired-plots method. SOC and TN accumulated at rates of 138.2 g C m(-2) yr(-1) and 4.6 g N m(-2) yr(-1), respectively, in shrub-dominated afforestation sites and at rates of 113.3 g C m(-2) yr(-1) and 6.7 g N m(-2)yr(-1), respectively, in tree-dominated afforestation sites. Soil BD was slightly reduced in all layers in the shrub-dominated afforestation plots, and significantly reduced in soil layers from 0-40cm in the tree-dominated afforestation plots. The C/N ratio was higher in afforested sites relative to the reference sites. SOC accumulation was closely related to TN accumulation following afforestation, and the inclusion of N-fixing species in tree-dominated afforestation sites additionally increased the soil accumulation capacity for SOC (p < 0.05). Multiple regression models including the age of an afforestation plot and total number of plant species explained 75% of the variation in relative SOC content change at depth of 0-20 cm, in tree-dominated afforestation sites. We conclude that afforestation on the Qinghai Plateau is associated with great capability of SOC and TN sequestration. This study improves our understanding of the mechanisms underlying SOC and TN accumulation in a plateau climate, and provides evidence on the C sequestration potentials associated with forestry projects in China.	[Shi, Sheng-wei; Han, Peng-fei; Zhang, Ping] Chinese Acad Sci, State Key Lab Atmospher Boundary Layer Phys & Atm, Inst Atmospher Phys, Beijing 100083, Peoples R China; [Shi, Sheng-wei; Han, Peng-fei; Ding, Fan; Ma, Cheng-lin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Shi, Sheng-wei] Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China; [Ding, Fan; Ma, Cheng-lin] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Botany, CAS	Shi, SW (corresponding author), Chinese Acad Sci, State Key Lab Atmospher Boundary Layer Phys & Atm, Inst Atmospher Phys, Beijing 100083, Peoples R China.	weiweishi848@gmail.com	LAPC, IAP/AAI-6991-2020; Ding, Fan/A-3049-2015; Han, Pengfei/F-9082-2018	LAPC, IAP/0000-0002-0025-3484; Ding, Fan/0000-0002-7938-1015; Zhang, Min/0000-0001-5812-9518	national key fundamental research program for the Chinese Science and Technology Department [2010CB950604]	national key fundamental research program for the Chinese Science and Technology Department	This research was sponsored by the national key fundamental research program for the Chinese Science and Technology Department (2010CB950604).	Barcena TG, 2014, GLOBAL CHANGE BIOL, V20, P2393, DOI 10.1111/gcb.12576; Berry SL, 2002, GLOBAL ECOL BIOGEOGR, V11, P23, DOI 10.1046/j.1466-822X.2002.00183.x; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Binkley D, 2005, NATO SCI S SS IV EAR, V55, P155; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Bowman RA, 2002, COMMUN SOIL SCI PLAN, V33, P1629, DOI 10.1081/CSS-120004304; Chang RY, 2011, ENVIRON MANAGE, V48, P1158, DOI 10.1007/s00267-011-9682-8; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Del Galdo I, 2003, GLOBAL CHANGE BIOL, V9, P1204, DOI 10.1046/j.1365-2486.2003.00657.x; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; [董旭 Dong Xu], 2011, [水土保持通报, Bulletin of Soil and Water Conservation], V31, P45; Eclesia RP, 2012, GLOBAL CHANGE BIOL, V18, P3237, DOI 10.1111/j.1365-2486.2012.02761.x; Ellert BH, 1995, CAN J SOIL SCI, V75, P529, DOI 10.4141/cjss95-075; Fan GH, 2008, QINGHAI SCI TECHNOLO, V1, P17; Fornara DA, 2008, J ECOL, V96, P314, DOI 10.1111/j.1365-2745.2007.01345.x; [高国雄 GAO Guoxiong], 2007, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V21, P104; Giardina CP, 2004, OECOLOGIA, V139, P545, DOI 10.1007/s00442-004-1552-0; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; HANSEN EA, 1993, BIOMASS BIOENERG, V5, P431, DOI 10.1016/0961-9534(93)90038-6; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hoogmoed M, 2012, AGR ECOSYST ENVIRON, V159, P176, DOI 10.1016/j.agee.2012.07.011; Hoover CM, 2003, POTENTIAL OF U.S. FOREST SOILS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P211; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; [黄玉霞 Huang Yuxia], 2006, [气象, Meteorological Monthly], V32, P18; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Janssens IA, 2003, SCIENCE, V300, P1538, DOI 10.1126/science.1083592; Jarecki MK, 2003, CRIT REV PLANT SCI, V22, P471, DOI 10.1080/713608318; [敬文茂 Jing Wenmao], 2011, [甘肃农业大学学报, Journal of Gansu Agricultural University], V46, P81; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kaye JP, 2000, ECOLOGY, V81, P3267, DOI 10.1890/0012-9658(2000)081[3267:NACDIA]2.0.CO;2; Knops JMH, 2009, SOIL SCI SOC AM J, V73, P2096, DOI 10.2136/sssaj2009.0058; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Lin ZY, 1981, ACTA GEOGRAPHICA SIN, V1, P22; Liu F, 2011, GLOBAL CHANGE BIOL, V17, P1119, DOI 10.1111/j.1365-2486.2010.02251.x; Liu F, 2010, GLOBAL CHANGE BIOL, V16, P2213, DOI 10.1111/j.1365-2486.2009.02099.x; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Lu F, 2007, THESIS BEIJING FORES; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; LUGO AE, 1993, PLANT SOIL, V149, P27, DOI 10.1007/BF00010760; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Luo YQ, 2006, ECOLOGY, V87, P3, DOI 10.1890/05-0923; Mao R, 2010, ENVIRON MANAGE, V46, P110, DOI 10.1007/s00267-010-9504-4; McKinley DC, 2011, ECOL APPL, V21, P1902, DOI 10.1890/10-0697.1; Morris SJ, 2007, GLOBAL CHANGE BIOL, V13, P1145, DOI 10.1111/j.1365-2486.2007.01359.x; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Pineiro G, 2006, GLOBAL CHANGE BIOL, V12, P804, DOI 10.1111/j.1365-2486.2006.01139.x; Poeplau C, 2011, GLOBAL CHANGE BIOL, V17, P2415, DOI 10.1111/j.1365-2486.2011.02408.x; Powers JS, 2011, P NATL ACAD SCI USA, V108, P6318, DOI 10.1073/pnas.1016774108; Resh SC, 2002, ECOSYSTEMS, V5, P217, DOI 10.1007/s10021-001-0067-3; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Saiz G, 2012, GLOBAL CHANGE BIOL, V18, P1670, DOI 10.1111/j.1365-2486.2012.02657.x; Shi SW, 2013, FOREST ECOL MANAG, V296, P53, DOI 10.1016/j.foreco.2013.01.026; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Smith P, 2012, GLOBAL CHANGE BIOL, V18, P2089, DOI 10.1111/j.1365-2486.2012.02689.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song XZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04460; State Forestry Administration PCC, 2010, CHIN FOR STAT YB, P498; Tang JW, 2009, GLOBAL CHANGE BIOL, V15, P145, DOI 10.1111/j.1365-2486.2008.01741.x; Throop HL, 2008, GLOBAL CHANGE BIOL, V14, P2420, DOI 10.1111/j.1365-2486.2008.01650.x; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Wang SL, 2010, PLANT SOIL, V334, P501, DOI 10.1007/s11104-010-0400-8; Wang WJ, 2011, GLOBAL CHANGE BIOL, V17, P2657, DOI 10.1111/j.1365-2486.2011.02447.x; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; Zhang K, 2010, LAND DEGRAD DEV, V21, P13, DOI 10.1002/ldr.954; Zhou XH, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.17223; Zillich AJ, 2006, HYPERTENSION, V48, P219, DOI 10.1161/01.HYP.0000231552.10054.aa	73	27	29	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116591	10.1371/journal.pone.0116591	http://dx.doi.org/10.1371/journal.pone.0116591			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25621996	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100041
J	Hasebe, Y; Yamamoto, H; Fukuda, K; Nishimiya, K; Hanawa, K; Shindo, T; Kondo, M; Nakano, M; Wakayama, Y; Takayama, K; Shimokawa, H				Hasebe, Yuhi; Yamamoto, Hiroaki; Fukuda, Koji; Nishimiya, Kensuke; Hanawa, Kenichiro; Shindo, Tomohiko; Kondo, Masateru; Nakano, Makoto; Wakayama, Yuji; Takayama, Kazuyoshi; Shimokawa, Hiroaki			Development of a Novel Shock Wave Catheter Ablation System - The First Feasibility Study in Pigs	PLOS ONE			English	Article							RECURRENT VENTRICULAR-TACHYCARDIA; RADIOFREQUENCY ABLATION; ATRIAL-FIBRILLATION; NONISCHEMIC CARDIOMYOPATHY; LESION FORMATION; THERAPY; RISK; DEFIBRILLATOR; COMPLICATIONS; TEMPERATURE	Introduction Radio-frequency catheter ablation (RFCA) using Joule heat has two fundamental weaknesses: the limited depth of treatment and the risk of thrombus formation. In contrast, focused shock wave (SW) therapy could damage tissues at arbitrary depths without heat generation. Thus, we aimed to develop a SWcatheter ablation (SWCA) system that could compensate for the weaknesses of RFCA therapy. Methods and Results We developed a SWCA system where the SW generated by a Q-switched Holmium: yttrium aluminum garnet (YAG) laser beam was reflected by a reflector attached to 14-Fr catheter tip and then was converged onto the focus. We examined the feasibility of our system on pigs in vivo. When applied using the epicardial approach, the SWCA caused persistent spheroidal lesions with mild superficial injury than the RFCA. The lesions were created to a depth based on the focal length (2.0 mm) [2.36 +/- 0.45 (SD) mm immediately after procedure, n = 16]. When applied to the atrioventricular (AV) node using the endocardial approach, the SWCA caused junctional escape rhythms in 2 pigs and AV block in 12 pigs (complete AV block in 9) in acute phase (n = 14). Nine of the 14 pigs survived with pacemakers for the long-term study, and the AV block persisted for 12.6 +/- 3.9 (SD) days in all surviving pigs. Histological examination showed AV nodal cell body atrophy in the acute phase and fibrotic lesions in the chronic phase. Importantly, no acute or chronic fatal complications were noted. Conclusions Our novel SWCA system could be a promising modality as a non-thermal ablation method to compensate for the weaknesses of RFCA therapy. However, further research and development will be necessary as the current prototype still exhibited the presence of micro-thrombus formation in the animal studies.	[Hasebe, Yuhi; Fukuda, Koji; Nishimiya, Kensuke; Hanawa, Kenichiro; Shindo, Tomohiko; Kondo, Masateru; Nakano, Makoto; Wakayama, Yuji; Takayama, Kazuyoshi; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Yamamoto, Hiroaki; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Adv Cardiovasc Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Shimokawa, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan.	shimo@cardio.med.tohoku.ac.jp	Santos-Gomes, G/J-2367-2019; Lago, Joao/W-5238-2019; Fukuda, Koji/AAP-5927-2021; Passero, Luiz Felipe D/B-9549-2012; Laurenti, Marcia Dalastra/C-4734-2012; Santos-Gomes, Gabriela/I-2391-2012; Levy, Debora/G-8208-2014	Lago, Joao/0000-0002-1193-8374; Passero, Luiz Felipe D/0000-0002-5986-6381; FUKUDA, KOJI/0000-0001-7209-8420; Levy, Debora/0000-0001-7492-997X; Santos-Gomes, Gabriela/0000-0001-9264-3887; Yamamoto, Eduardo/0000-0003-2375-6081; Kallas, Esper/0000-0003-2026-6925; Shimokawa, Hiroaki/0000-0001-7534-4826; Rafael-Fernandes, Mariana/0000-0002-5214-7667; Silva, Marcelo/0000-0002-1000-0149; Laurenti, Marcia Dalastra/0000-0002-1080-2440	Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan; Japan Science and Technology Agency, Tokyo, Japan [AS2313010F]	Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency, Tokyo, Japan(Japan Science & Technology Agency (JST))	The authors had no disclosure for this work. This work was supported in part by the grants-in- aid for Medical Equipment Development and Promotion Research Project (H20-Activity-General-002) from the Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan and the grants- in- aid for Adaptable and Seamless Technology transfer Program (A- STEP) through target-driven R& D (AS2313010F) from Japan Science and Technology Agency, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; DELIUS M, 1987, ULTRASOUND MED BIOL, V13, P61, DOI 10.1016/0301-5629(87)90075-5; Dukkipati SR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P185, DOI 10.1161/CIRCEP.110.957290; EVAN AP, 1991, AM J KIDNEY DIS, V17, P445, DOI 10.1016/S0272-6386(12)80639-1; Evan AP, 1998, NEPHRON, V78, P1, DOI 10.1159/000044874; Fenelon G, 2006, J INTERV CARD ELECTR, V15, P57, DOI 10.1007/s10840-006-7620-0; Gaita F, 2010, CIRCULATION, V122, P1667, DOI 10.1161/CIRCULATIONAHA.110.937953; Haqqani HM, 2011, HEART RHYTHM, V8, P1169, DOI 10.1016/j.hrthm.2011.03.008; Hohnloser SH, 2006, EUR HEART J, V27, P3027, DOI 10.1093/eurheartj/ehl276; Hsia HH, 2003, CIRCULATION, V108, P704, DOI 10.1161/01.CIR.0000083725.72693.EA; JACKMAN WM, 1992, NEW ENGL J MED, V327, P313, DOI 10.1056/NEJM199207303270504; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Keane D, 2005, J CARDIOVASC ELECTR, V16, P1025, DOI 10.1111/j.1540-8167.2005.00270.x; Khairy P, 2003, CIRCULATION, V107, P2045, DOI 10.1161/01.CIR.0000058706.82623.A1; Kikuchi Y, 2010, CIRC J, V74, P589, DOI 10.1253/circj.CJ-09-1028; Koruth JS, 2012, HEART RHYTHM, V9, P1932, DOI 10.1016/j.hrthm.2012.08.001; KUWAHARA MA, 1987, J UROLOGY, V137, P837, DOI 10.1016/S0022-5347(17)44268-6; Matlaga BR, 2008, J ENDOUROL, V22, P121, DOI 10.1089/end.2007.9852; MAYER R, 1990, J UROLOGY, V144, P1505, DOI 10.1016/S0022-5347(17)39787-2; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; NAKAGAWA H, 1995, CIRCULATION, V91, P2264, DOI 10.1161/01.CIR.91.8.2264; Nakahara S, 2010, J AM COLL CARDIOL, V55, P2355, DOI 10.1016/j.jacc.2010.01.041; NATH S, 1995, PROG CARDIOVASC DIS, V37, P185, DOI 10.1016/S0033-0620(05)80006-4; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Rassweiler JJ, 2011, EUR UROL, V59, P784, DOI 10.1016/j.eururo.2011.02.033; Raum K, 1997, IEEE T ULTRASON FERR, V44, P810, DOI 10.1109/58.655196; Sacher F, 2010, J AM COLL CARDIOL, V55, P2366, DOI 10.1016/j.jacc.2009.10.084; Sinelnikov YD, 2009, ACOUST PHYS+, V55, P647, DOI 10.1134/S1063771009040216; Soejima K, 2001, CIRCULATION, V103, P1858; Sosa E, 2000, J AM COLL CARDIOL, V35, P1442, DOI 10.1016/S0735-1097(00)00606-9; STRICKBERGER SA, 1995, AM HEART J, V130, P1026, DOI 10.1016/0002-8703(95)90204-X; TAKAYAMA K, 1989, P INT WORKSH SHOCK W, P217; TANNO K, 1994, JPN CIRC J, V58, P123, DOI 10.1253/jcj.58.123; Tokuda M, 2011, CIRC-ARRHYTHMIA ELEC, V4, P889, DOI 10.1161/CIRCEP.111.966283; Zhou L, 1999, J CARDIOVASC ELECTR, V10, P611, DOI 10.1111/j.1540-8167.1999.tb00719.x	35	50	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116017	10.1371/journal.pone.0116017	http://dx.doi.org/10.1371/journal.pone.0116017			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	26674781	Green Published, Green Submitted, gold			2022-12-27	WOS:000348609800005
J	Shi, S; Zhang, M; Guo, R; Miao, Y; Hu, JJ; Xi, Y; Li, B				Shi, Shuo; Zhang, Min; Guo, Rui; Miao, Ying; Hu, Jiajia; Xi, Yun; Li, Biao			In vivo Molecular Imaging and Radionuclide (I-131) Therapy of Human Nasopharyngeal Carcinoma Cells Transfected with a Lentivirus Expressing Sodium Iodide Symporter	PLOS ONE			English	Article							GENE DELIVERY; SODIUM/IODIDE SYMPORTER; VIRAL VECTORS; PROMOTER; EFFICACY; VITRO; LINE	Introduction Despite recent improvements in the survival rates for nasopharyngeal carcinoma (NPC), novel treatment strategies are required to improve distant metastasis-free survival. The sodium iodine symporter (NIS) gene has been applied for in vivo imaging and cancer therapy. In this study, we examined the potential of NIS gene therapy as a therapeutic approach in NPC by performing non-invasive imaging using I-125 and I-131 therapy in vivo. Methods We constructed a lentiviral vector expressing NIS and enhanced green fluorescent protein (EGFP) under the control of the human elongation factor-1 alpha (EF1 alpha) promoter, and stably transfected the vector into CNE-2Z NPC cells to create CNE-2Z-NIS cells. CNE-2Z and CNE-2Z-NIS tumor xenografts were established in nude mice; I-125 uptake, accumulation and efflux were measured using micro-SPECT/CT imaging; the therapeutic effects of treatment with I-131 were assessed over 25 days by measuring tumor volume and immunohistochemical staining of the excised tumors. Results qPCR, immunofluorescence and Western blotting confirmed that CNE-2Z-NIS cells expressed high levels of NIS mRNA and protein. CNE-2Z-NIS cells and xenografts took up and accumulated significantly more I-125 than CNE-2Z cells and xenografts. In vitro, I-131 significantly reduced the clonogenic survival of CNE-2Z-NIS cells. In vivo, I-131 effectively inhibited the growth of CNE-2Z-NIS xenografts. At the end of I-131 therapy, CNE-2Z-NIS xenograft tumor cells expressed higher levels of NIS and caspase-3 and lower levels of Ki-67. Conclusion Lentiviruses effectively delivered and mediated long-lasting expression of NIS in CNE-2Z cells which enabled uptake and accumulation of radioisotopes and provided a significant therapeutic effect in an in vivo model of NPC. NIS-mediated radioiodine treatment merits further investigation as a potentially effective, low toxicity therapeutic strategy for NPC.	[Shi, Shuo; Zhang, Min; Guo, Rui; Miao, Ying; Hu, Jiajia; Xi, Yun; Li, Biao] Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Li, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China.	lb10363@rjh.com.cn	LAPC, IAP/AAI-6991-2020; Ding, Fan/A-3049-2015; Han, Pengfei/F-9082-2018	LAPC, IAP/0000-0002-0025-3484; Ding, Fan/0000-0002-7938-1015; Zhang, Min/0000-0001-5812-9518	National Natural Science Foundation of China [81071181]; Shanghai Outstanding Academic Leaders Project [11XD1403700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Outstanding Academic Leaders Project	This work was supported by grants from the National Natural Science Foundation of China (No. 81071181) (http://isisn.nsfc.gov.cn/egrantweb/), Shanghai Outstanding Academic Leaders Project (11XD1403700) (http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeciga-Diaz CJ, 2009, MOL BIOL REP, V36, P1863, DOI 10.1007/s11033-008-9392-3; Bosch EH, 2000, J APPL MICROBIOL, V89, P215, DOI 10.1046/j.1365-2672.2000.01098.x; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; De Meyer SF, 2006, BLOOD, V107, P4728, DOI 10.1182/blood-2005-09-3605; Guo R, 2011, NUCL MED COMMUN, V32, P402, DOI 10.1097/MNM.0b013e328344a1ad; Hingorani M, 2010, CURR CANCER DRUG TAR, V10, P242, DOI 10.2174/156800910791054194; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509; KAMINSKY SM, 1993, SOC GEN PHY, V48, P251; Li JH, 2000, INT J CANCER, V87, P606; Li JH, 1997, CLIN CANCER RES, V3, P507; Li JH, 2003, MOL THER, V8, P964, DOI 10.1016/j.ymthe.2003.08.018; Li Jia-Xin, 2010, Chin J Cancer, V29, P82; Li XP, 2006, INT J ONCOL, V29, P595; Liu BH, 2004, GENE THER, V11, P52, DOI 10.1038/sj.gt.3302126; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Moiani A, 2012, J CLIN INVEST, V122, P1653, DOI 10.1172/JCI61852; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061305; Petrich T, 2006, CLIN CANCER RES, V12, P1342, DOI 10.1158/1078-0432.CCR-05-1576; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Riesco-Eizaguirre G, 2006, EUR J ENDOCRINOL, V155, P495, DOI 10.1530/eje.1.02257; Sides MD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-152; Skugor M., 2009, CLEVELAND CLIN GUIDE; Vannucci L, 2013, NEW MICROBIOL, V36, P1; Vigna E, 2000, J GENE MED, V2, P308; Wang GL, 1999, BRIT J CANCER, V81, P1122, DOI 10.1038/sj.bjc.6690818; Weeks AJ, 2011, NUCL MED COMMUN, V32, P98, DOI 10.1097/MNM.0b013e3283419540; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Weinrib L, 2001, CANCER GENE THER, V8, P352, DOI 10.1038/sj.cgt.7700319; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Xu T, 2013, CURR ONCOL, V20, pE406, DOI 10.3747/co.20.1456; Zhang XJ, 2006, ADV DRUG DELIVER REV, V58, P515, DOI 10.1016/j.addr.2006.03.006	34	27	29	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116531	10.1371/journal.pone.0116531	http://dx.doi.org/10.1371/journal.pone.0116531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621996	Green Published, Green Submitted, gold			2022-12-27	WOS:000348470400005
J	Wang, Y; Chen, ZH; Yin, C; Ma, JH; Li, DJ; Zhao, F; Sun, YL; Hu, LF; Shang, P; Qian, AR				Wang, Yang; Chen, Zhi-Hao; Yin, Chun; Ma, Jian-Hua; Li, Di-Jie; Zhao, Fan; Sun, Yu-Long; Hu, Li-Fang; Shang, Peng; Qian, Ai-Rong			GeneChip Expression Profiling Reveals the Alterations of Energy Metabolism Related Genes in Osteocytes under Large Gradient High Magnetic Fields	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; GRAVITY; LEVITATION; OSTEOBLAST; MICROGRAVITY; INDUCTION; MUSCLE; CELLS; MICE	The diamagnetic levitation as a novel ground-based model for simulating a reduced gravity environment has recently been applied in life science research. In this study a specially designed superconducting magnet with a large gradient high magnetic field (LG-HMF), which can provide three apparent gravity levels (mu-g, 1-g, and 2-g), was used to simulate a space-like gravity environment. Osteocyte, as the most important mechanosensor in bone, takes a pivotal position in mediating the mechano-induced bone remodeling. In this study, the effects of LG-HMF on gene expression profiling of osteocyte-like cell line MLO-Y4 were investigated by Affymetrix DNA microarray. LG-HMF affected osteocyte gene expression profiling. Differentially expressed genes (DEGs) and data mining were further analyzed by using bioinfomatic tools, such as DAVID, iReport. 12 energy metabolism related genes (PFKL, AK4, ALDOC, COX7A1, STC1, ADM, CA9, CA12, P4HA1, APLN, GPR35 and GPR84) were further confirmed by real-time PCR. An integrated gene interaction network of 12 DEGs was constructed. Bio-data mining showed that genes involved in glucose metabolic process and apoptosis changed notablly. Our results demostrated that LG-HMF affected the expression of energy metabolism related genes in osteocyte. The identification of sensitive genes to special environments may provide some potential targets for preventing and treating bone loss or osteoporosis.	[Wang, Yang; Chen, Zhi-Hao; Yin, Chun; Ma, Jian-Hua; Li, Di-Jie; Zhao, Fan; Sun, Yu-Long; Hu, Li-Fang; Shang, Peng; Qian, Ai-Rong] Northwestern Polytech Univ, Sch Life Sci, Inst Special Environm Biophys, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China	Northwestern Polytechnical University	Shang, P (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Inst Special Environm Biophys, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China.	shangpeng@nwpu.edu.cn; qianair@nwpu.edu.cn	chen, zhihao/GXM-3816-2022; Hu, Lifang/W-8020-2019	Chen, Zhihao/0000-0003-0128-1409	Natural Science Foundation of China [31370845]; National Basic Research Program of China [2011CB710903]; New Century Excellent Talents in University [NCET-12-0469]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the Natural Science Foundation of China (No. 31370845), the National Basic Research Program of China (2011CB710903), and the New Century Excellent Talents in University (NCET-12-0469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Andreis PG, 2004, INT J MOL MED, V13, P551; Babbick M, 2007, ADV SPACE RES, V39, P1182, DOI 10.1016/j.asr.2007.01.001; BEAUGNON E, 1991, NATURE, V349, P470, DOI 10.1038/349470a0; Bonewald LF, 1999, J BONE MINER METAB, V17, P61, DOI 10.1007/s007740050066; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Brooks JS, 2000, J APPL PHYS, V87, P6194, DOI 10.1063/1.372653; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Burger EH, 2003, J BIOMECH, V36, P1453, DOI 10.1016/S0021-9290(03)00126-X; Cao HL, 2013, ACTA CRYSTALLOGR D, V69, P1901, DOI 10.1107/S0907444913016296; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Davet J, 1998, J APPL PHYSIOL, V84, P19, DOI 10.1152/jappl.1998.84.1.19; Di SM, 2012, INT J RADIAT BIOL, V88, P806, DOI 10.3109/09553002.2012.698365; Filvaroff EH, 2002, ENDOCRINOLOGY, V143, P3681, DOI 10.1210/en.2001-211424; Graham JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063884; Guevorkian K, 2006, P NATL ACAD SCI USA, V103, P13051, DOI 10.1073/pnas.0601839103; Hammer BE, 2009, MICROGRAVITY SCI TEC, V21, P311, DOI 10.1007/s12217-008-9092-6; Iolascon G, 2013, AGING CLIN EXP RES, V25, pS3, DOI 10.1007/s40520-013-0101-2; Kawakami S, 2006, JPN J APPL PHYS 1, V45, P6055, DOI 10.1143/JJAP.45.6055; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kondrachuk AV, 2001, ADV SPACE RES, V27, P1001, DOI 10.1016/S0273-1177(01)00167-3; Kuznetsov OA, 1997, J EXP BOT, V48, P1951, DOI 10.1093/jexbot/48.316.1951; Kuznetsov OA, 1996, PLANTA, V198, P87; Lee EG, 2011, INFLAMMATION, V34, P335, DOI 10.1007/s10753-010-9239-7; Liu YM, 2010, ADV SPACE RES, V45, P208, DOI 10.1016/j.asr.2009.08.033; MANCHESTER JK, 1990, FASEB J, V4, P55, DOI 10.1096/fasebj.4.1.1967237; Masakazu TE, 2013, B TOKYO DENT COLL, V53, P203, DOI [10.2209/tdcpublication.53.203, DOI 10.2209/TDCPUBLICATION.53.203]; Meng R, 2011, ACTA BIOCH BIOPH SIN, V43, P133, DOI 10.1093/abbs/gmq121; National Research Council Committee on Opportunities in High Magnetic Field Science Solid State Sciences Committee, 2005, OPP HIGH MAGN FIELD; Qian AR, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2232919; Qian AR, 2012, IEEE T BIO-MED ENG, V59, P68, DOI 10.1109/TBME.2010.2103377; Qian AR, 2010, ADV SPACE RES, V46, P687, DOI 10.1016/j.asr.2010.04.012; Qian AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051036; Qian AR, 2009, BIOELECTROMAGNETICS, V30, P545, DOI 10.1002/bem.20511; Qian AR, 2008, ACTA ASTRONAUT, V63, P929, DOI 10.1016/j.actaastro.2008.03.005; Qian AR, 2009, ACTA BIOCH BIOPH SIN, V41, P561, DOI 10.1093/abbs/gmp041; Qian AR, 2009, IEEE T APPL SUPERCON, V19, P42, DOI 10.1109/TASC.2009.2012422; Ramirez J, 2014, MICROGRAVITY SCI TEC, V25, P303, DOI 10.1007/s12217-013-9356-7; Riihonen R, 2007, BONE, V40, P1021, DOI 10.1016/j.bone.2006.11.028; Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5; Saier MH, 1988, ENZYMES METABOLIC PA, V16, P110; Santos A, 2009, OSTEOPOROSIS INT, V20, P1027, DOI 10.1007/s00198-009-0858-5; Shi DY, 2010, STEM CELL REV REP, V6, P567, DOI 10.1007/s12015-010-9182-x; Simon MD, 2000, J APPL PHYS, V87, P6200, DOI 10.1063/1.372654; Tan SD, 2007, BONE, V41, P745, DOI 10.1016/j.bone.2007.07.019; Tian ZC, 2010, MICROGRAVITY SCI TEC, V22, P163, DOI 10.1007/s12217-009-9170-4; Valiron O, 2005, J MAGN RESON IMAGING, V22, P334, DOI 10.1002/jmri.20398; Valles JM, 2005, ADV SPACE RES, V36, P114, DOI 10.1016/j.asr.2005.01.081; Valles JM, 2002, BIOPHYS J, V82, P1260, DOI 10.1016/S0006-3495(02)75482-9; Valles JM, 1997, BIOPHYS J, V73, P1130, DOI 10.1016/S0006-3495(97)78145-1; Venkataraman C, 2005, IMMUNOL LETT, V101, P144, DOI 10.1016/j.imlet.2005.05.010; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wattanachanya L, 2013, ENDOCRINOLOGY, V154, P2069, DOI 10.1210/en.2012-2034; Wykoff CC, 2000, CANCER RES, V60, P7075; Xie H, 2006, REGUL PEPTIDES, V134, P118, DOI 10.1016/j.regpep.2006.02.004; Yamaguchi M, 2006, SPRINGER SER MATER S, V89, P41	57	60	74	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116359	10.1371/journal.pone.0116359	http://dx.doi.org/10.1371/journal.pone.0116359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25962184	Green Submitted, Green Published, gold			2022-12-27	WOS:000350680700030
J	Yamamoto, ES; Campos, BLS; Jesus, JA; Laurenti, MD; Ribeiro, SP; Kallas, EG; Rafael-Fernandes, M; Santos-Gomes, G; Silva, MS; Sessa, DP; Lago, JHG; Levy, D; Passero, LFD				Yamamoto, Eduardo S.; Campos, Bruno L. S.; Jesus, Jessica A.; Laurenti, Marcia D.; Ribeiro, Susan P.; Kallas, Esper G.; Rafael-Fernandes, Mariana; Santos-Gomes, Gabriela; Silva, Marcelo S.; Sessa, Deborah P.; Lago, Joao H. G.; Levy, Debora; Passero, Luiz F. D.			The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis	PLOS ONE			English	Article							OLEANOLIC ACID; AMPHOTERICIN-B; IN-VITRO; ANTILEISHMANIAL ACTIVITY; VISCERAL LEISHMANIASIS; SECONDARY METABOLITES; TRADITIONAL MEDICINE; APOPTOSIS; DONOVANI; MECHANISM	Among neglected tropical diseases, leishmaniasis is one of the most important ones, affecting more than 12 million people worldwide. The available treatments are not well tolerated, and present diverse side effects, justifying the search for new therapeutic compounds. In the present study, the activity of ursolic acid (UA) and oleanolic acid (OA) were assayed in experimental cutaneous leishmaniasis (in vitro and in vivo). Promastigote forms of L. amazonensis were incubated with OA and UA for 24h, and effective concentration 50% (EC50) was estimated. Ultraestructural alterations in Leishmania amazonensis promastigotes after UA treatment were evaluated by transmission electron microscopy, and the possible mode of action was assayed through Annexin V and propidium iodide staining, caspase 3/7 activity, DNA fragmentation and transmembrane mitochondrial potential. The UA potential was evaluated in intracellular amastigotes, and its therapeutic potential was evaluated in L. amazonensis infected BALB/c mice. UA eliminated L. amazonensis promastigotes with an EC50 of 6.4 mu g/mL, comparable with miltefosine, while OA presented only a marginal effect on promastigote forms at 100 mu g/mL. The possible mechanism by which promastigotes were eliminated by UA was programmed cell death, independent of caspase 3/7, but it was highly dependent on mitochondria activity. UA was not toxic for peritoneal macrophages from BALB/c mice, and it was able to eliminate intracellular amastigotes, associated with nitric oxide (NO) production. OA did not eliminate amastigotes nor trigger NO. L. amazonensis infected BALB/c mice submitted to UA treatment presented lesser lesion size and parasitism compared to control. This study showed, for the first time, that UA eliminate promastigote forms through a mechanism associated with programed cell death, and importantly, was effective in vivo. Therefore, UA can be considered an interesting candidate for future tests as a prototype drug for the treatment of cutaneous leishmaniasis.	[Yamamoto, Eduardo S.; Campos, Bruno L. S.; Jesus, Jessica A.; Laurenti, Marcia D.; Passero, Luiz F. D.] Univ Sao Paulo, Lab Pathol Infect Dis LIM50, Dept Pathol, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Ribeiro, Susan P.; Kallas, Esper G.] Univ Sao Paulo, Lab Clin Immunol & Allergy LIM60, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Rafael-Fernandes, Mariana; Santos-Gomes, Gabriela; Silva, Marcelo S.] Univ Nova Lisboa, Global Hlth & Trop Med, IHMT, P-1349008 Lisbon, Portugal; [Sessa, Deborah P.; Lago, Joao H. G.] Univ Fed Sao Paulo, Inst Environm Chem & Pharmaceut Sci, BR-09920000 Diadema, SP, Brazil; [Levy, Debora] Univ Sao Paulo, Lab Genet & Mol Hematol LIM31, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Ribeiro, Susan P.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Case Western Reserve University	Passero, LFD (corresponding author), Univ Sao Paulo, Lab Pathol Infect Dis LIM50, Dept Pathol, Sch Med, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.	felipepassero@yahoo.com.br	Santos-Gomes, G/J-2367-2019; Lago, Joao/W-5238-2019; Fukuda, Koji/AAP-5927-2021; Passero, Luiz Felipe D/B-9549-2012; Laurenti, Marcia Dalastra/C-4734-2012; Santos-Gomes, Gabriela/I-2391-2012; Levy, Debora/G-8208-2014	Lago, Joao/0000-0002-1193-8374; Passero, Luiz Felipe D/0000-0002-5986-6381; FUKUDA, KOJI/0000-0001-7209-8420; Levy, Debora/0000-0001-7492-997X; Santos-Gomes, Gabriela/0000-0001-9264-3887; Yamamoto, Eduardo/0000-0003-2375-6081; Kallas, Esper/0000-0003-2026-6925; Shimokawa, Hiroaki/0000-0001-7534-4826; Rafael-Fernandes, Mariana/0000-0002-5214-7667; Silva, Marcelo/0000-0002-1000-0149; Laurenti, Marcia Dalastra/0000-0002-1080-2440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/03903-9, 2013/16297-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants: 2012/03903-9 and 2013/16297-2. URL: http://fapesp.br/en/.	Alvarado HL, 2015, COLLOID SURFACE B, V130, P40, DOI 10.1016/j.colsurfb.2015.03.062; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; Begum S, 2014, CHEM BIODIVERS, V11, P709, DOI 10.1002/cbdv.201300151; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bero J, 2011, J ETHNOPHARMACOL, V137, P998, DOI 10.1016/j.jep.2011.07.022; Both DM, 2002, ARCH DERMATOL RES, V293, P569, DOI 10.1007/s00403-001-0272-0; Camargos HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104429; Campos BLS, 2015, PARASITE IMMUNOL, V37, P407, DOI 10.1111/pim.12206; Carneiro MB, 2015, IFN GAMMA DEPENDENT; Chattopadhyay A, 2011, BIOCHEM BIOPH RES CO, V416, P7, DOI 10.1016/j.bbrc.2011.11.023; da Luz RAI, 2011, J ANTIMICROB CHEMOTH, V66, P350, DOI 10.1093/jac/dkq444; da Silva AA, 2009, FITOTERAPIA, V80, P478, DOI 10.1016/j.fitote.2009.06.007; Das M, 2001, J CELL SCI, V114, P2461; Das R, 2008, APOPTOSIS, V13, P867, DOI 10.1007/s10495-008-0224-7; Decuypere S, 2005, ANTIMICROB AGENTS CH, V49, P4616, DOI 10.1128/AAC.49.11.4616-4621.2005; Demicheli C, 2008, CHEM COMMUN, P4828, DOI 10.1039/b809186b; Passero LFD, 2014, CURR CLIN PHARMACOL, V9, P187, DOI 10.2174/1574884709999140606161413; Passero LFD, 2010, APMIS, V118, P973, DOI 10.1111/j.1600-0463.2010.02679.x; Dutta A, 2007, J MED MICROBIOL, V56, P1196, DOI 10.1099/jmm.0.47114-0; Serna ME, 2015, PARASITOL INT, V64, P295, DOI 10.1016/j.parint.2015.03.005; Franca F, 1996, Rev Soc Bras Med Trop, V29, P229, DOI 10.1590/S0037-86821996000300002; Freitas-Junior LH, 2012, INT J PARASITOL-DRUG, V2, P11, DOI 10.1016/j.ijpddr.2012.01.003; Gachet MS, 2010, J ETHNOPHARMACOL, V128, P184, DOI 10.1016/j.jep.2010.01.007; Germonprez N, 2005, J MED CHEM, V48, P32, DOI 10.1021/jm031150y; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; Gnoatto SCB, 2008, J ENZYM INHIB MED CH, V23, P604, DOI [10.1080/14756360802204870, 10.1080/14756360802204870 ]; Hill RA, 2012, NAT PROD REP, V29, P780, DOI 10.1039/c2np20027a; Jesus JA, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/620472; Johann S, 2012, MED MYCOL, V50, P843, DOI 10.3109/13693786.2012.678903; Kontogianni VG, 2009, ANAL CHIM ACTA, V635, P188, DOI 10.1016/j.aca.2009.01.021; Laniado-Laborin R, 2009, REV IBEROAM MICOL, V26, P223, DOI 10.1016/j.riam.2009.06.003; Laurenti MD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/134236; Lin XR, 2014, FOOD FUNCT, V5, P1175, DOI 10.1039/c3fo60720h; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Machado M, 2012, EXP PARASITOL, V130, P223, DOI 10.1016/j.exppara.2011.12.012; Maes L, 2004, ANTIMICROB AGENTS CH, V48, P2056, DOI 10.1128/AAC.48.6.2056-2060.2004; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; Neto RLM, 2011, EXP PARASITOL, V127, P215, DOI 10.1016/j.exppara.2010.07.020; Nam H, 2013, FOOD CHEM TOXICOL, V62, P579, DOI 10.1016/j.fct.2013.09.024; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; Ovesna Z, 2006, MUTAT RES-FUND MOL M, V600, P131, DOI 10.1016/j.mrfmmm.2006.03.008; Passero LFD, 2015, PARASITOL INT, V64, P32, DOI 10.1016/j.parint.2015.01.006; Passero LFD, 2011, PARASITOL RES, V108, P529, DOI 10.1007/s00436-010-2091-8; Rath S, 2003, QUIM NOVA, V26, P550, DOI 10.1590/S0100-40422003000400018; Rego FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122038; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Santos DO, 2008, PARASITOL RES, V103, P1, DOI 10.1007/s00436-008-0943-2; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Seebacher W, 2003, MAGN RESON CHEM, V41, P636, DOI 10.1002/mrc.1214; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Tan N, 2002, PHYTOCHEMISTRY, V61, P881, DOI 10.1016/S0031-9422(02)00361-8; Thakur CP, 1999, T ROY SOC TROP MED H, V93, P319, DOI 10.1016/S0035-9203(99)90037-8; Torrado JJ, 2008, J PHARM SCI-US, V97, P2405, DOI 10.1002/jps.21179; Torres-Santos EC, 2004, PHYTOMEDICINE, V11, P114, DOI 10.1078/0944-7113-00381; Wang X, 2013, CARCINOGENESIS, V34, P1323, DOI 10.1093/carcin/bgt058; Yamamoto ES, 2014, PARASITOL RES, V113, P333, DOI 10.1007/s00436-013-3659-x; Yang L, 2010, CANCER LETT, V298, P128, DOI 10.1016/j.canlet.2010.06.010; You HJ, 2001, FEBS LETT, V509, P156, DOI 10.1016/S0014-5793(01)03161-1; Zeng JW, 2015, MOL MED REP, V12, P1997, DOI 10.3892/mmr.2015.3666	62	50	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144946	10.1371/journal.pone.0144946	http://dx.doi.org/10.1371/journal.pone.0144946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674781	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700076
